PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mudeppa, DG; Kumar, S; Kokkonda, S; White, J; Rathod, PK				Mudeppa, Devaraja G.; Kumar, Shiva; Kokkonda, Sreekanth; White, John; Rathod, Pradipsinh K.			Topoisomerase II from Human Malaria Parasites EXPRESSION, PURIFICATION, AND SELECTIVE INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIHYDROOROTATE DEHYDROGENASE INHIBITORS; C-TERMINAL DOMAIN; PLASMODIUM-FALCIPARUM; DIHYDROFOLATE-REDUCTASE; DNA; FLUOROQUINOLONES; PROTEOMICS; PROTEINS; REVEALS; ASSAY	Historically, type II topoisomerases have yielded clinically useful drugs for the treatment of bacterial infections and cancer, but the corresponding enzymes from malaria parasites remain understudied. This is due to the general challenges of producing malaria proteins in functional forms in heterologous expression systems. Here, we express full-length Plasmodium falciparum topoisomerase II (PfTopoII) in a wheat germ cell-free transcription-translation system. Functional activity of soluble PfTopoII from the translation lysates was confirmed through both a plasmid relaxation and a DNA decatenation activity that was dependent on magnesium and ATP. To facilitate future drug discovery, a convenient and sensitive fluorescence assay was established to follow DNA decatenation, and a stable, truncated PfTopoII was engineered for high level enzyme production. PfTopoII was purified using a DNA affinity column. Existing TopoII inhibitors previously developed for other non-malaria indications inhibited PfTopoII, as well as malaria parasites in culture at submicromolar concentrations. Even before optimization, inhibitors of bacterial gyrase, GSK299423, ciprofloxacin, and etoposide exhibited 15-, 57-, and 3-fold selectivity for the malarial enzyme over human TopoII. Finally, it was possible to use the purified PfTopoII to dissect the different modes by which these varying classes of TopoII inhibitors could trap partially processed DNA. The present biochemical advancements will allow high throughput chemical screening of compound libraries and lead optimization to develop new lines of antimalarials.	[Mudeppa, Devaraja G.; Kumar, Shiva; Kokkonda, Sreekanth; White, John; Rathod, Pradipsinh K.] Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle		rathod@chem.washington.edu	kokkonda, sreekanth/N-4457-2017; Regan, Clinton/E-6250-2012		National Institutes of Health [AI093380, AI099280, AI089688]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099280, U19AI089688, R01AI093380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI093380, AI099280, and AI089688. The authors declare that they have no conflicts of interest with the contents of this article.	Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Auparakkitanon S, 2000, BIOCHEM BIOPH RES CO, V269, P406, DOI 10.1006/bbrc.2000.2305; Barnabe N, 2001, J CHROMATOGR B, V760, P263, DOI 10.1016/S0378-4347(01)00274-2; Bax BD, 2010, NATURE, V466, P935, DOI 10.1038/nature09197; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARON PR, 1994, MOL CELL BIOL, V14, P3197, DOI 10.1128/MCB.14.5.3197; Chavalitshewinkoon Porntip, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P32; CHEESMAN S, 1994, NUCLEIC ACIDS RES, V22, P2547, DOI 10.1093/nar/22.13.2547; Cheesman S, 1998, MOL BIOCHEM PARASIT, V92, P39, DOI 10.1016/S0166-6851(97)00223-5; Cheesman SJ, 2000, PARASITOL TODAY, V16, P277, DOI 10.1016/S0169-4758(00)01697-5; Cortazar TM, 2007, EXP PARASITOL, V116, P475, DOI 10.1016/j.exppara.2007.02.018; Coteron JM, 2011, J MED CHEM, V54, P5540, DOI 10.1021/jm200592f; Dahl EL, 2007, ANTIMICROB AGENTS CH, V51, P3485, DOI 10.1128/AAC.00527-07; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Florens L, 2004, MOL BIOCHEM PARASIT, V135, P1, DOI 10.1016/j.molbiopara.2003.12.007; Ganesan K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000214; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375; HekmatNejad M, 1996, ANTIMICROB AGENTS CH, V40, P1628, DOI 10.1128/AAC.40.7.1628; Jahnz M, 2005, CHEMBIOCHEM, V6, P920, DOI 10.1002/cbic.200400379; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; Kelly JM, 2006, P NATL ACAD SCI USA, V103, P6706, DOI 10.1073/pnas.0510363103; Lasonder E, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000195; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lindner SE, 2013, MOL CELL PROTEOMICS, V12, P1127, DOI 10.1074/mcp.M112.024505; Mahmoudi N, 2003, ANTIMICROB AGENTS CH, V47, P2636, DOI 10.1128/AAC.47.8.2636-2639.2003; Meczes EL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001754; Mehlin C, 2006, MOL BIOCHEM PARASIT, V148, P144, DOI 10.1016/j.molbiopara.2006.03.011; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; Mitscher LA, 2005, CHEM REV, V105, P559, DOI 10.1021/cr030101q; Mudeppa DG, 2007, MOL BIOCHEM PARASIT, V151, P216, DOI 10.1016/j.molbiopara.2006.10.016; Mudeppa DG, 2013, EUKARYOT CELL, V12, P1653, DOI 10.1128/EC.00222-13; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nenortas E, 2003, ANTIMICROB AGENTS CH, V47, P3015, DOI 10.1128/AAC.47.9.3015-3017.2003; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Oehring SC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r108; Pang CKT, 2009, MOL BIOCHEM PARASIT, V168, P74, DOI 10.1016/j.molbiopara.2009.06.011; Phillips MA, 2008, J MED CHEM, V51, P3649, DOI 10.1021/jm8001026; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Ram EVSR, 2007, MOL BIOCHEM PARASIT, V154, P30, DOI 10.1016/j.molbiopara.2007.04.001; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Romero IC, 2005, J PARASITOL, V91, P1474, DOI 10.1645/GE-3489.1; Roy A, 2011, MOL BIOL INT, V2011; SAHAI BM, 1986, ANAL BIOCHEM, V156, P364, DOI 10.1016/0003-2697(86)90267-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Singh PK, 2011, PROTEIN EXPRES PURIF, V76, P165, DOI 10.1016/j.pep.2010.08.001; Taylor JA, 2012, METHODS MOL BIOL, V815, P229, DOI 10.1007/978-1-61779-424-7_17; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Weissig V, 1997, DNA CELL BIOL, V16, P1483, DOI 10.1089/dna.1997.16.1483; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Widdowson K, 2010, FUTURE MED CHEM, V2, P1619, DOI 10.4155/FMC.10.250; Wu CC, 2011, SCIENCE, V333, P459, DOI 10.1126/science.1204117; Zhang K, 2002, SCIENCE, V296, P545, DOI 10.1126/science.1068274	58	15	15	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20313	20324		10.1074/jbc.M115.639039	http://dx.doi.org/10.1074/jbc.M115.639039			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26055707	Green Published, hybrid			2022-12-26	WOS:000359608900030
J	Hudson, GM; Watson, PJ; Fairall, L; Jamieson, AG; Schwabe, JWR				Hudson, Gregg M.; Watson, Peter J.; Fairall, Louise; Jamieson, Andrew G.; Schwabe, John W. R.			Insights into the Recruitment of Class IIa Histone Deacetylases (HDACs) to the SMRT/NCoR Transcriptional Repression Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I; PROTEIN COMPLEXES; STRUCTURAL BASIS; CLASS IIHDACS; REVEALS; DOMAIN; SMRT; PATHWAY; COR; COREPRESSORS	Class IIa histone deacetylases repress transcription of target genes. However, their mechanism of action is poorly understood because they exhibit very low levels of deacetylase activity. The class IIa HDACs are associated with the SMRT/NCoR repression complexes and this may, at least in part, account for their repressive activity. However, the molecular mechanism of recruitment to co-repressor proteins has yet to be established. Here we show that a repeated peptide motif present in both SMRT and NCoR is sufficient to mediate specific interaction, with micromolar affinity, with all the class IIa HDACs (HDACs 4, 5, 7, and 9). Mutations in the consensus motif abrogate binding. Mutational analysis of HDAC4 suggests that the peptide interacts in the vicinity of the active site of the enzyme and requires the "closed" conformation of the zinc-binding loop on the surface of the enzyme. Together these findings represent the first insights into the molecular mechanism of recruitment of class IIa HDACs to the SMRT/NCoR repression complexes.	[Hudson, Gregg M.; Watson, Peter J.; Fairall, Louise; Schwabe, John W. R.] Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England; [Jamieson, Andrew G.] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England	University of Leicester; University of Leicester	Schwabe, JWR (corresponding author), Univ Leicester, Dept Biochem, Henry Wellcome Labs Struct Biol, Leicester LE1 9HN, Leics, England.	john.schwabe@le.ac.uk	Schwabe, John WR/A-9132-2008	Schwabe, John WR/0000-0003-2865-4383; Jamieson, Andrew/0000-0003-1726-7353; Fairall, Louise/0000-0001-9456-3047	Wellcome Trust [WT085408, WT100237]; Royal Society; EPSRC [EP/L018152/1] Funding Source: UKRI; MRC [MC_PC_14117] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L018152/1] Funding Source: researchfish; Medical Research Council [MC_PC_14117] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Wellcome Trust Programme and Senior Investigator Awards WT085408 and WT100237. The authors declare that they have no conflicts of interest with the contents of this article.; Royal Society Merit Award Holder.	Agis-Balboa RC, 2013, J ALZHEIMERS DIS, V33, P35, DOI 10.3233/JAD-2012-121009; Ago T, 2008, CELL, V133, P978, DOI 10.1016/j.cell.2008.04.041; Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Barneda-Zahonero B, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.594; Bellenguez C, 2012, NAT GENET, V44, P328, DOI 10.1038/ng.1081; Bottomley MJ, 2008, J BIOL CHEM, V283, P26694, DOI 10.1074/jbc.M803514200; Burli RW, 2013, J MED CHEM, V56, P9934, DOI 10.1021/jm4011884; Chan JKL, 2003, J BIOL CHEM, V278, P23515, DOI 10.1074/jbc.M301922200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Ding ZH, 2003, MOL CELL BIOL, V23, P250, DOI 10.1128/MCB.23.1.250-258.2003; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guo L, 2007, P NATL ACAD SCI USA, V104, P4297, DOI 10.1073/pnas.0608041104; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Hildmann C, 2007, APPL MICROBIOL BIOT, V75, P487, DOI 10.1007/s00253-007-0911-2; Hu E, 2000, J BIOL CHEM, V275, P15254, DOI 10.1074/jbc.M908988199; Kao HY, 2000, GENE DEV, V14, P55; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Matsuoka H, 2007, BIOCHEM PHARMACOL, V74, P465, DOI 10.1016/j.bcp.2007.05.002; Mielcarek M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001717; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Oberoi J, 2011, NAT STRUCT MOL BIOL, V18, P177, DOI 10.1038/nsmb.1983; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Scott FL, 2008, J BIOL CHEM, V283, P19499, DOI 10.1074/jbc.M800331200; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	35	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18237	18244		10.1074/jbc.M115.661058	http://dx.doi.org/10.1074/jbc.M115.661058			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26055705	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000358511700052
J	Wiria, AE; Hamid, F; Wammes, LJ; Prasetyani, MA; Dekkers, OM; May, L; Kaisar, MMM; Verweij, JJ; Guigas, B; Partono, F; Sartono, E; Supali, T; Yazdanbakhsh, M; Smit, JWA				Wiria, Aprilianto E.; Hamid, Firdaus; Wammes, Linda J.; Prasetyani, Margaretta A.; Dekkers, Olaf M.; May, Linda; Kaisar, Maria M. M.; Verweij, Jaco J.; Guigas, Bruno; Partono, Felix; Sartono, Erliyani; Supali, Taniawati; Yazdanbakhsh, Maria; Smit, Johannes W. A.			Infection with Soil-Transmitted Helminths Is Associated with Increased Insulin Sensitivity	PLOS ONE			English	Article							REGULATORY T-CELLS; METABOLIC SYNDROME; INTESTINAL PARASITOSIS; RISK-FACTORS; MALNUTRITION; INFLAMMATION; RESISTANCE; MICROBIOTA; PATHOLOGY; CHILDREN	Objective Given that helminth infections have been shown to improve insulin sensitivity in animal studies, which may be explained by beneficial effects on energy balance or by a shift in the immune system to an anti-inflammatory profile, we investigated whether soil-transmitted helminth (STH)-infected subjects are more insulin sensitive than STH-uninfected subjects. Design We performed a cross-sectional study on Flores island, Indonesia, an area with high prevalence of STH infections. Methods From 646 adults, stool samples were screened for Trichuris trichiura by microscopy and for Ascaris lumbricoides, Necator americanus, Ancylostoma duodenale, and Strongyloides stercoralis by qPCR. No other helminth was found. We collected data on body mass index (BMI, kg/m(2)), waist-to-hip ratio (WHR), fasting blood glucose (FBG, mmol/L), insulin (pmol/L), high sensitive C-reactive protein (ng/ml) and Immunoglobulin E (IU/ml). The homeostatic model assessment for insulin resistance (HOMAIR) was calculated and regression models were used to assess the association between STH infection status and insulin resistance. Results 424 (66%) participants had at least one STH infection. STH infected participants had lower BMI (23.2 vs 22.5 kg/m(2), p value = 0.03) and lower HOMAIR (0.97 vs 0.81, p value = 0.05). In an age-, sex-and BMI-adjusted model a significant association was seen between the number of infections and HOMAIR: for every additional infection with STH species, the HOMAIR decreased by 0.10 (p for linear trend 0.01). This effect was mainly accounted for by a decrease in insulin of 4.9 pmol/L for every infection (p for trend = 0.07). Conclusion STH infections are associated with a modest improvement of insulin sensitivity, which is not accounted for by STH effects on BMI alone.	[Wiria, Aprilianto E.; Hamid, Firdaus; Wammes, Linda J.; Prasetyani, Margaretta A.; Kaisar, Maria M. M.; Partono, Felix; Supali, Taniawati] Univ Indonesia, Fac Med, Dept Parasitol, Jakarta 10430, Indonesia; [Wiria, Aprilianto E.; Wammes, Linda J.; Prasetyani, Margaretta A.; May, Linda; Kaisar, Maria M. M.; Verweij, Jaco J.; Guigas, Bruno; Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, NL-2333 ZA Leiden, Netherlands; [Hamid, Firdaus] Hasanuddin Univ, Fac Med, Dept Microbiol, Makassar 90245, Indonesia; [Dekkers, Olaf M.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, NL-2333 ZA Leiden, Netherlands; [Dekkers, Olaf M.; Smit, Johannes W. A.] Leiden Univ, Med Ctr, Dept Endocrinol & Gen Internal Med, NL-2333 ZA Leiden, Netherlands; [Verweij, Jaco J.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, NL-5022 GC Tilburg, Netherlands; [Guigas, Bruno] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2333 ZA Leiden, Netherlands; [Smit, Johannes W. A.] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, NL-6525 GA Nijmegen, Netherlands	University of Indonesia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Universitas Hasanuddin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Elisabeth-TweeSteden Ziekenhuis (ETZ); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Smit, JWA (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Gen Internal Med, NL-2333 ZA Leiden, Netherlands.	Jan.Smit@radboudumc.nl	Yazdanbakhsh, Maria/AAI-3996-2020; Wiria, Aprilianto Eddy/AAZ-2419-2021; Hamid, Firdaus/M-6862-2017; Guigas, Bruno/M-2515-2015; Smit, J.W.A./H-8091-2014	Yazdanbakhsh, Maria/0000-0002-7666-1441; Wiria, Aprilianto Eddy/0000-0002-6482-424X; Hamid, Firdaus/0000-0003-1788-0836; Guigas, Bruno/0000-0002-8856-5799; Smit, J.W.A./0000-0003-1052-9314; Kaisar, Maria M. M./0000-0002-7515-7673; Verweij, Jaco J./0000-0001-8553-931X; Dekkers, Olaf/0000-0002-1333-7580	Royal Netherlands Academy of Arts and Science (KNAW) [KNAW-05-PP-35]; European Commission [INCO-CT-2006-031714, INCO-CT-2006-032436]; Prof. Dr. P.C. Flu Foundation	Royal Netherlands Academy of Arts and Science (KNAW); European Commission(European CommissionEuropean Commission Joint Research Centre); Prof. Dr. P.C. Flu Foundation	This work was supported by The Royal Netherlands Academy of Arts and Science (KNAW) (Grant number KNAW-05-PP-35) https://www.knaw.nl/en, to AEW FH LJW MAP ES TS MY; European Commission (Grant number INCO-CT-2006-031714 and INCO-CT-2006-032436) http://ec.europa.eu/contracts_grants/grants_en.htm, to MY; The Prof. Dr. P.C. Flu Foundation, to MMMK and JJV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Aravindhan V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000707; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Celis-Morales CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024690; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chen F, 2012, NAT MED, V18, P260, DOI 10.1038/nm.2628; Chen YH, 2013, J CLIN ENDOCR METAB, V98, pE283, DOI 10.1210/jc.2012-2517; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; D'Elia R, 2009, J IMMUNOL, V182, P2340, DOI 10.4049/jimmunol.0802767; Endara P, 2010, CLIN EXP ALLERGY, V40, P1669, DOI 10.1111/j.1365-2222.2010.03559.x; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; Hamid F, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-83; Han JM, 2014, J IMMUNOL, V192, P623, DOI 10.4049/jimmunol.1302181; Jackson JA, 2004, J INFECT DIS, V190, P1804, DOI 10.1086/425014; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Khoo CM, 2011, DIABETES CARE, V34, P1120, DOI 10.2337/dc10-2097; Martinez-Hervas S, 2011, METABOLISM, V60, P740, DOI 10.1016/j.metabol.2010.07.024; Mishra PK, 2014, MUCOSAL IMMUNOL, V7, P753, DOI 10.1038/mi.2014.23; Nazligul Y, 2001, DIABETES CARE, V24, P1503, DOI 10.2337/diacare.24.8.1503-a; Oberhelman RA, 1998, AM J TROP MED HYG, V58, P470, DOI 10.4269/ajtmh.1998.58.470; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Pasha SM, 2011, J HYPERTENS, V29, P2194, DOI 10.1097/HJH.0b013e32834bbba8; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Reynolds LA, 2014, GUT MICROBES, V5, P522, DOI 10.4161/gmic.32155; Saldiva SR, 1999, PAEDIATR PERINAT EP, V13, P89; Sawant DV, 2014, J IMMUNOL, V192, P2904, DOI 10.4049/jimmunol.1202502; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stephenson LS, 2000, PARASITOLOGY, V121, pS23, DOI 10.1017/S0031182000006491; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Terhell AJ, 2002, PARASITOLOGY, V124, P509, DOI 10.1017/S0031182002001543; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; Verweij JJ, 2007, AM J TROP MED HYG, V77, P685, DOI 10.4269/ajtmh.2007.77.685; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wiria AE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004140; Wiria AE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-77; Wiria AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054855; Wiria AE, 2012, SEMIN IMMUNOPATHOL, V34, P889, DOI 10.1007/s00281-012-0358-0; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zuckerman MK, 2014, GLOBAL HEALTH ACTION, V7, P72, DOI 10.3402/gha.v7.23303	42	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127746	10.1371/journal.pone.0127746	http://dx.doi.org/10.1371/journal.pone.0127746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061042	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500055
J	Janatova, M; Soukupova, J; Stribrna, J; Kleiblova, P; Vocka, M; Boudova, P; Kleibl, Z; Pohlreich, P				Janatova, Marketa; Soukupova, Jana; Stribrna, Jana; Kleiblova, Petra; Vocka, Michal; Boudova, Petra; Kleibl, Zdenek; Pohlreich, Petr			Mutation Analysis of the RAD51C and RAD51D Genes in High-Risk Ovarian Cancer Patients and Families from the Czech Republic	PLOS ONE			English	Article							BREAST-CANCER; GERMLINE MUTATIONS; SUSCEPTIBILITY GENE; CONFER SUSCEPTIBILITY; COLORECTAL-CANCER; FANCONI-ANEMIA; BRCA1; POPULATION	Recent studies have conferred that the RAD51C and RAD51D genes, which code for the essential proteins involved in homologous recombination, are ovarian cancer (OC) susceptibility genes that may explain genetic risks in high-risk patients. We performed a mutation analysis in 171 high-risk BRCA1 and BRCA2 negative OC patients, to evaluate the frequency of hereditary RAD51C and RAD51D variants in Czech population. The analysis involved direct sequencing, high resolution melting and multiple ligation-dependent probe analysis. We identified two (1.2%) and three (1.8%) inactivating germline mutations in both respective genes, two of which (c.379_380insG, p.P127Rfs*28 in RAD51C and c.879delG, p.C294Vfs*16 in RAD51D) were novel. Interestingly, an indicative family cancer history was not present in four carriers. Moreover, the ages at the OC diagnoses in identified mutation carriers were substantially lower than those reported in previous studies (four carriers were younger than 45 years). Further, we also described rare missense variants, two in RAD51C and one in RAD51D whose clinical significance needs to be verified. Truncating mutations and rare missense variants ascertained in OC patients were not detected in 1226 control samples. Although the cumulative frequency of RAD51C and RAD51D truncating mutations in our patients was lower than that of the BRCA1 and BRCA2 genes, it may explain OC susceptibility in approximately 3% of high-risk OC patients. Therefore, an RAD51C and RAD51D analysis should be implemented into the comprehensive multi-gene testing for high-risk OC patients, including early-onset OC patients without a family cancer history.	[Janatova, Marketa; Soukupova, Jana; Stribrna, Jana; Kleiblova, Petra; Boudova, Petra; Kleibl, Zdenek; Pohlreich, Petr] Charles Univ Prague, Inst Biochem & Expt Oncol, Fac Med 1, Prague, Czech Republic; [Kleiblova, Petra] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague, Czech Republic; [Kleiblova, Petra] Gen Univ Hosp Prague, Prague, Czech Republic; [Vocka, Michal] Charles Univ Prague, Dept Oncol, Fac Med 1, Gen Univ Hosp Prague, Prague, Czech Republic; [Vocka, Michal] Mil Univ Hosp Prague, Prague, Czech Republic	Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague; General University Hospital Prague; Military University Hospital Prague	Janatova, M (corresponding author), Charles Univ Prague, Inst Biochem & Expt Oncol, Fac Med 1, Prague, Czech Republic.	mjana@lf1.cuni.cz	Kleibl, Zdenek/A-2009-2008; Soukupová, Jana/ABI-2077-2020; Kleiblova, Petra/K-9899-2017	Kleibl, Zdenek/0000-0003-2050-9667; Kleiblova, Petra/0000-0002-4806-9854; Janatova, Marketa/0000-0003-2816-6769; Zemankova, Petra/0000-0001-7315-1975	Internal Grant Agency, Ministry of Health, Czech Republic [NT13343]; Charles University in Prague [PRVOUK-P27/LF1/1, SVV-UK 3362-2014]	Internal Grant Agency, Ministry of Health, Czech Republic; Charles University in Prague	This study was supported by Internal Grant Agency, Ministry of Health, Czech Republic, NT13343, (http://www.mzcr.cz/Cizinci/); PP, Charles University in Prague, PRVOUK-P27/LF1/1, (http://www.cuni.cz/UKEN-1.html); MJ, Charles University in Prague, SVV-UK 3362-2014, (http://www.cuni.cz/UKEN-1.html); PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker Jennifer L, 2015, Clin Breast Cancer, V15, pe71, DOI 10.1016/j.clbc.2014.08.005; Blanco A, 2014, BREAST CANCER RES TR, V147, P133, DOI 10.1007/s10549-014-3078-4; Coulet F, 2013, CLIN GENET, V83, P332, DOI 10.1111/j.1399-0004.2012.01917.x; Golmard L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-484; Gutierrez-Enriquez S, 2014, INT J CANCER, V134, P2088, DOI 10.1002/ijc.28540; Janatova M, 2013, CANCER EPIDEM BIOMAR, V22, P2323, DOI 10.1158/1055-9965.EPI-13-0745-T; Kleibl Z, 2005, BREAST CANCER RES TR, V90, P165, DOI 10.1007/s10549-004-4023-8; Kleibl Z, 2009, EUR J CANCER, V45, P618, DOI 10.1016/j.ejca.2008.09.022; Loveday C, 2012, NAT GENET, V44, P475, DOI 10.1038/ng.2224; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Oosterwijk JC, 2014, MATURITAS, V78, P252, DOI 10.1016/j.maturitas.2014.05.002; Pelttari LM, 2012, J MED GENET, V49, P429, DOI 10.1136/jmedgenet-2012-100852; Pelttari LM, 2011, HUM MOL GENET, V20, P3278, DOI 10.1093/hmg/ddr229; Pennington KP, 2012, GYNECOL ONCOL, V124, P347, DOI 10.1016/j.ygyno.2011.12.415; Pohlreich P, 2005, BREAST CANCER RES, V7, pR728, DOI 10.1186/bcr1282; Ramus SJ, 2007, HUM MUTAT, V28, P1207, DOI 10.1002/humu.20599; Rashid MU, 2014, BREAST CANCER RES TR, V145, P775, DOI 10.1007/s10549-014-2972-0; Schnurbein G, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3589; Somyajit K, 2010, CARCINOGENESIS, V31, P2031, DOI 10.1093/carcin/bgq210; Sopik V, 2014, CLIN GENET IN PRESS; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thompson ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054772; Tung N, 2015, CANCER-AM CANCER SOC, V121, P25, DOI 10.1002/cncr.29010; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Weissman SM, 2012, CANCER J, V18, P320, DOI 10.1097/PPO.0b013e31826246c2; Wickramanyake A, 2012, GYNECOL ONCOL, V127, P552, DOI 10.1016/j.ygyno.2012.09.009	29	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0127711	10.1371/journal.pone.0127711	http://dx.doi.org/10.1371/journal.pone.0127711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057125	gold, Green Submitted, Green Published			2022-12-26	WOS:000356349000011
J	Stutz, K; Kaech, A; Aebi, M; Kunzler, M; Hengartner, MO				Stutz, Katrin; Kaech, Andres; Aebi, Markus; Kuenzler, Markus; Hengartner, Michael O.			Disruption of the C-elegans Intestinal Brush Border by the Fungal Lectin CCL2 Phenocopies Dietary Lectin Toxicity in Mammals	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; AGGLUTININ; MORPHOGENESIS; BIOSYNTHESIS; MECHANISMS; RESISTANCE; PROTEINS; REQUIRES	Lectins are non-immunoglobulin carbohydrate-binding proteins without enzymatic activity towards the bound carbohydrates. Many lectins of e.g. plants or fungi have been suggested to act as toxins to defend the host against predators and parasites. We have previously shown that the Coprinopsis cinerea lectin 2 (CCL2), which binds to a1,3-fucosylated N-glycan cores, is toxic to Caenorhabditis elegans and results in developmental delay and premature death. In this study, we investigated the underlying toxicity phenotype at the cellular level by electron and confocal microscopy. We found that CCL2 directly binds to the intestinal apical surface and leads to a highly damaged brush border with loss of microvilli, actin filament depolymerization, and invaginations of the intestinal apical plasma membrane through gaps in the terminal web. We excluded several possible toxicity mechanisms such as internalization and pore-formation, suggesting that CCL2 acts directly on intestinal apical plasma membrane or glycocalyx proteins. A genetic screen for C. elegans mutants resistant to CCL2 generated over a dozen new alleles in bre 1, ger 1, and fut 1, three genes required for the synthesis of the sugar moiety recognized by CCL2. CCL2-induced intestinal brush border defects in C. elegans are similar to the damage observed previously in rats after feeding the dietary lectins wheat germ agglutinin or concanavalin A. The evolutionary conserved reaction of the brush border between mammals and nematodes might allow C. elegans to be exploited as model organism for the study of dietary lectin-induced intestinal pathology in mammals.	[Stutz, Katrin; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Kaech, Andres] Univ Zurich, Ctr Microscopy & Image Anal, Zurich, Switzerland; [Aebi, Markus; Kuenzler, Markus] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Hengartner, MO (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	michael.hengartner@uzh.ch		Kunzler, Markus/0000-0003-1275-0629; Hengartner, Michael/0000-0002-7584-596X	Swiss National Science Foundation [31003A-130671]; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the Swiss National Science Foundation (grant no. 31003A-130671 to MK, MOH and MA; http://www.snf.ch). Some C. elegans strains were provided by the Caenorhabditis Genetics Center (CGC; https://www.cbs.umn.edu/research/resources/cgc), which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrows BD, 2007, J BIOL CHEM, V282, P3302, DOI 10.1074/jbc.M606621200; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; Bleuler-Martinez S, 2011, MOL ECOL, V20, P3056, DOI 10.1111/j.1365-294X.2011.05093.x; BRENNER S, 1974, GENETICS, V77, P71; Broderick NA, 2006, P NATL ACAD SCI USA, V103, P15196, DOI 10.1073/pnas.0604865103; Butschi A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000717; Carberry K, 2012, DEVELOPMENT, V139, P1851, DOI 10.1242/dev.075788; Castelein Natascha, 2008, Biotechnology Journal, V3, P803, DOI 10.1002/biot.200800003; Croce A, 2004, NAT CELL BIOL, V6, P1173, DOI 10.1038/ncb1198; Darby Creg, 2005, WormBook, P1; Doitsidou M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015435; ENDO Y, 1987, J BIOL CHEM, V262, P8128; Engelmann I, 2010, ADV EXP MED BIOL, V708, P105; Estes KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002227; Fei YJ, 1998, BIOCHEM J, V332, P565, DOI 10.1042/bj3320565; Felix MA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000586; Feroz Khan, 2011, International Journal of Biological Chemistry, V5, P1, DOI 10.3923/ijbc.2011.1.20; Francis F, 2003, EUR J CELL BIOL, V82, P515, DOI 10.1078/0171-9335-00338; Gabius H, 2001, EJPATHOL, P7; Geiger O, 2013, BBA-MOL CELL BIOL L, V1831, P503, DOI 10.1016/j.bbalip.2012.08.009; Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018; Hamshou M, 2010, INSECT BIOCHEM MOLEC, V40, P883, DOI 10.1016/j.ibmb.2010.08.008; Husken K, 2008, DIFFERENTIATION, V76, P881, DOI 10.1111/j.1432-0436.2008.00264.x; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Khan LA, 2013, NAT CELL BIOL, V15, P143, DOI 10.1038/ncb2656; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; LORENZSONN V, 1982, GASTROENTEROLOGY, V82, P838; Los FCO, 2011, CELL HOST MICROBE, V9, P147, DOI 10.1016/j.chom.2011.01.005; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; MacQueen AJ, 2005, MOL BIOL CELL, V16, P3247, DOI 10.1091/mbc.E04-12-1061; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; McGhee James D, 2007, WormBook, P1; Miyake K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000687; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Praitis V, 2001, GENETICS, V157, P1217; PUSZTAI A, 1995, GLYCOCONJUGATE J, V12, P22, DOI 10.1007/BF00731865; Rabia Hamid, 2009, Pakistan Journal of Nutrition, V8, P293, DOI 10.3923/pjn.2009.293.303; Rasband WS, 2014, IMAGEJ; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Schubert M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002706; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Sharon N, 2007, J BIOL CHEM, V282, P2753, DOI 10.1074/JBC.X600004200; Sifri CD, 2005, TRENDS MICROBIOL, V13, P119, DOI 10.1016/j.tim.2005.01.003; Somers WS, 1998, STRUCTURE, V6, P1601, DOI 10.1016/S0969-2126(98)00157-9; Stiernagle Theresa, 2006, WormBook, P1; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sulzenbacher G, 2010, J MOL BIOL, V400, P715, DOI 10.1016/j.jmb.2010.05.038; Tateno H, 2003, J BIOL CHEM, V278, P40455, DOI 10.1074/jbc.M306836200; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Ubelmann F, 2013, P NATL ACAD SCI USA, V110, pE1380, DOI 10.1073/pnas.1218446110; van Buul VJ, 2014, J CEREAL SCI, V59, P112, DOI 10.1016/j.jcs.2014.01.010; Van Damme EJM, 2004, TRENDS PLANT SCI, V9, P484, DOI 10.1016/j.tplants.2004.08.003; Van Dijk JE, 2002, NUTR HLTH GASTROINTE, P81; Vanfleteren JR, 1999, NEUROBIOL AGING, V20, P487, DOI 10.1016/S0197-4580(99)00087-1; Varrot A, 2013, CURR OPIN STRUC BIOL, V23, P678, DOI 10.1016/j.sbi.2013.07.007; Walker AK, 2011, CELL, V147, P840, DOI 10.1016/j.cell.2011.09.045; Walser PJ, 2005, FUNGAL GENET BIOL, V42, P293, DOI 10.1016/j.fgb.2004.12.004; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Wohlschlager T, 2011, J BIOL CHEM, V286, P30337, DOI 10.1074/jbc.M111.258202; Yan S, 2013, J BIOL CHEM, V288, P21015, DOI 10.1074/jbc.M113.479147; Yook K, 2005, COMPLEMENTATION, DOI [10.1895/wormbook.1.24.1, DOI 10.1895/WORMBOOK.1.24.1]; Zhang HJ, 2011, NAT CELL BIOL, V13, P1189, DOI 10.1038/ncb2328; Zhou H, 2013, ACTA BIOCH BIOPH SIN, V45, P720, DOI 10.1093/abbs/gmt066; Zipperlen P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r19	67	22	22	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129381	10.1371/journal.pone.0129381	http://dx.doi.org/10.1371/journal.pone.0129381			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057124	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000051
J	Apte, MS; Meller, VH				Apte, Manasi S.; Meller, Victoria H.			Sex Differences in Drosophila melanogaster Heterochromatin Are Regulated by Non-Sex Specific Factors	PLOS ONE			English	Article							CHROMOSOME DOSAGE COMPENSATION; TOPOISOMERASE-II-ALPHA; HYBRID-RESCUE ZHR; X-CHROMOSOME; MSL COMPLEX; CENTRIC HETEROCHROMATIN; DETERMINATION SIGNAL; GENE-EXPRESSION; CONDENSIN-II; SISTERLESS-A	The eukaryotic genome is assembled into distinct types of chromatin. Gene-rich euchromatin has active chromatin marks, while heterochromatin is gene-poor and enriched for silencing marks. In spite of this, genes native to heterochromatic regions are dependent on their normal environment for full expression. Expression of genes in autosomal heterochromatin is reduced in male flies mutated for the noncoding roX RNAs, but not in females. roX mutations also disrupt silencing of reporter genes in male, but not female, heterochromatin, revealing a sex difference in heterochromatin. We adopted a genetic approach to determine how this difference is regulated, and found no evidence that known X chromosome counting elements, or the sex determination pathway that these control, are involved. This suggested that the sex chromosome karyotype regulates autosomal heterochromatin by a different mechanism. To address this, candidate genes that regulate chromosome organization were examined. In XX flies mutation of Topoisomerase II (Top2), a gene involved in chromatin organization and homolog pairing, made heterochromatic silencing dependent on roX, and thus male-like. Interestingly, Top2 also binds to a large block of pericentromeric satellite repeats (359 bp repeats) that are unique to the X chromosome. Deletion of X heterochromatin also makes autosomal heterochromatin in XX flies dependent on roX and enhances the effect of Top2 mutations, suggesting a combinatorial action. We postulate that Top2 and X heterochromatin in Drosophila comprise a novel karyotype-sensing pathway that determines the sensitivity of autosomal heterochromatin to loss of roX RNA.	[Apte, Manasi S.; Meller, Victoria H.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Meller, VH (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	vmeller@biology.biosci.wayne.edu			National Science Foundation [0641121]; National Institutes of Health NIH [093110]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Science Foundation 0641121 VHM and National Institutes of Health NIH 093110 VHM.	Apte MS, 2012, GENET RES INT, V2012, DOI 10.1155/2012/430587; Arnold AP, 2012, TRENDS GENET, V28, P55, DOI 10.1016/j.tig.2011.10.004; Bai XY, 2004, EMBO J, V23, P2853, DOI 10.1038/sj.emboj.7600299; Bashaw GJ, 1997, CELL, V89, P789, DOI 10.1016/S0092-8674(00)80262-7; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; Chang KA, 1998, GENETICS, V150, P699; CLINE TW, 1988, GENETICS, V119, P829; CLINE TW, 1983, DEV BIOL, V95, P260, DOI 10.1016/0012-1606(83)90027-1; Cobbe N, 2006, GENETICS, V172, P991, DOI 10.1534/genetics.105.050567; Cugusi S, 2013, TRANSCR-AUSTIN, V4, P238, DOI 10.4161/trns.26185; Dej KJ, 2004, GENETICS, V168, P895, DOI 10.1534/genetics.104.030908; Deng XX, 2009, GENETICS, V182, P481, DOI 10.1534/genetics.109.102087; Deng XX, 2005, MECH DEVELOP, V122, P1094, DOI 10.1016/j.mod.2005.06.004; Elgin SCR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a017780; Enukashvily N, 2005, J CELL SCI, V118, P611, DOI 10.1242/jcs.01605; Erickson JW, 1998, DEVELOPMENT, V125, P3259; ERICKSON JW, 1993, GENE DEV, V7, P1688, DOI 10.1101/gad.7.9.1688; Fagegaltier D, 2014, GENETICS, V198, P647, DOI 10.1534/genetics.114.169268; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; GATTI M, 1992, ANNU REV GENET, V26, P239, DOI 10.1146/annurev.ge.26.120192.001323; Gebauer F, 1998, RNA, V4, P142; Gepner J, 1996, GENETICS, V142, P865; GEYER PK, 1990, EMBO J, V9, P2247, DOI 10.1002/j.1460-2075.1990.tb07395.x; Gonzalez AN, 2008, P NATL ACAD SCI USA, V105, P18436, DOI 10.1073/pnas.0805993105; Hartl TA, 2008, SCIENCE, V322, P1384, DOI 10.1126/science.1164216; Hohl AM., 2012, THESIS I IOWA; Hohl AM, 2012, GENETICS, V192, P843, DOI 10.1534/genetics.112.144006; Hoxha V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003217; Hughes SE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004650; Huisinga KL, 2006, CHROMOSOMA, V115, P110, DOI 10.1007/s00412-006-0052-x; Ilik IA, 2013, MOL CELL, V51, P156, DOI 10.1016/j.molcel.2013.07.001; Ito H, 2012, CELL, V149, P1327, DOI 10.1016/j.cell.2012.04.025; Joyce EF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002667; KAS E, 1992, EMBO J, V11, P705, DOI 10.1002/j.1460-2075.1992.tb05103.x; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; Kelley RL, 1997, NATURE, V387, P195, DOI 10.1038/387195a0; Konev AY, 2003, GENETICS, V165, P2039; Lemos B, 2008, SCIENCE, V319, P91, DOI 10.1126/science.1148861; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; LOHE AR, 1993, GENETICS, V134, P1149; Longworth MS, 2008, GENE DEV, V22, P1011, DOI 10.1101/gad.1631508; Lu BY, 2000, GENETICS, V155, P699; Lupo R, 2001, MOL CELL, V7, P127, DOI 10.1016/S1097-2765(01)00161-7; Maenner S, 2013, MOL CELL, V51, P174, DOI 10.1016/j.molcel.2013.06.011; Meller VH, 2003, MECH DEVELOP, V120, P759, DOI 10.1016/S0925-4773(03)00157-6; Meller VH, 1997, CELL, V88, P445, DOI 10.1016/S0092-8674(00)81885-1; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; MELLER VH, 1994, J CELL BIOL, V126, P1331, DOI 10.1083/jcb.126.6.1331; Menon DU, 2012, GENETICS, V191, P1023, DOI 10.1534/genetics.112.140236; Morra R, 2008, MOL CELL BIOL, V28, P958, DOI 10.1128/MCB.00995-07; Morris JR, 1998, P NATL ACAD SCI USA, V95, P10740, DOI 10.1073/pnas.95.18.10740; Morris JR, 1999, GENETICS, V151, P633; Ramos E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016562; Rattner BP, 2004, GENETICS, V166, P1825, DOI 10.1534/genetics.166.4.1825; Rickmyre JL, 2007, J CELL SCI, V120, P3565, DOI 10.1242/jcs.016626; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Russell B, 2011, CANCER RES, V71, P561, DOI 10.1158/0008-5472.CAN-10-1727; Salz HK, 2010, FLY, V4, P60, DOI 10.4161/fly.4.1.11277; SALZ HK, 1987, GENETICS, V117, P221; Sanders LE, 2008, DEV BIOL, V320, P378, DOI 10.1016/j.ydbio.2008.05.543; SAWAMURA K, 1993, GENETICS, V133, P307; SAWAMURA K, 1993, MOL GEN GENET, V239, P441, DOI 10.1007/BF00276943; Schulze SR, 2006, GENETICS, V173, P1433, DOI 10.1534/genetics.106.056069; Sefton L, 2000, NATURE, V405, P970, DOI 10.1038/35016119; Smith CD, 2007, SCIENCE, V316, P1586, DOI 10.1126/science.1139815; Stevens N. M., 1908, Journal of Experimental Zoology Philadelphia, V5, DOI 10.1002/jez.1400050304; Sun FL, 2000, P NATL ACAD SCI USA, V97, P5340, DOI 10.1073/pnas.090530797; Tsai SC, 2000, NAT GENET, V26, P349, DOI 10.1038/81671; VANDOREN M, 1991, DEVELOPMENT, V113, P245; Wang CI, 2013, NAT STRUCT MOL BIOL, V20, P202, DOI 10.1038/nsmb.2477; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Wijchers PJ, 2010, DEV CELL, V19, P477, DOI 10.1016/j.devcel.2010.08.005; Williams BR, 2007, GENETICS, V177, P31, DOI 10.1534/genetics.107.076356; Yan CM, 2002, GENETICS, V161, P217; Yasuhara JC, 2006, TRENDS GENET, V22, P330, DOI 10.1016/j.tig.2006.04.008; YOUNGERSHEPHERD S, 1992, CELL, V70, P911, DOI 10.1016/0092-8674(92)90242-5; Zhou K, 2003, NUCLEIC ACIDS RES, V31, P2253, DOI 10.1093/nar/gkg328	80	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128114	10.1371/journal.pone.0128114	http://dx.doi.org/10.1371/journal.pone.0128114			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053165	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300022
J	Camarata, TD; Weaver, GC; Vasilyev, A; Arnaout, MA				Camarata, Troy D.; Weaver, Grant C.; Vasilyev, Alexandr; Arnaout, M. Amin			Negative Regulation of TGF beta Signaling by Stem Cell Antigen-1 Protects against Ischemic Acute Kidney Injury	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; GENE-EXPRESSION; RENAL FIBROSIS; SCA-1; PROLIFERATION; RECEPTOR; DIFFERENTIATION; PROGRESSION; DEFICIENCY; EPITHELIUM	Acute kidney injury, often caused by an ischemic insult, is associated with significant short-term morbidity and mortality, and increased risk of chronic kidney disease. The factors affecting the renal response to injury following ischemia and reperfusion remain to be clarified. We found that the Stem cell antigen-1 (Sca-1), commonly used as a stem cell marker, is heavily expressed in renal tubules of the adult mouse kidney. We evaluated its potential role in the kidney using Sca-1 knockout mice submitted to acute ischemia reperfusion injury (IRI), as well as cultured renal proximal tubular cells in which Sca-1 was stably silenced with shRNA. IRI induced more severe injury in Sca-1 null kidneys, as assessed by increased expression of Kim-1 and Ngal, rise in serum creatinine, abnormal pathology, and increased apoptosis of tubular epithelium, and persistent significant renal injury at day 7 post IRI, when recovery of renal function in control animals was nearly complete. Serum creatinine, Kim-1 and Ngal were slightly but significantly elevated even in uninjured Sca-1-/- kidneys. Sca-1 constitutively bound both TGF beta receptors I and II in cultured normal proximal tubular epithelial cells. Its genetic loss or silencing lead to constitutive TGF beta receptor-mediated activation of canonical Smad signaling even in the absence of ligand and to KIM-1 expression in the silenced cells. These studies demonstrate that by normally repressing TGF beta-mediated canonical Smad signaling, Sca-1 plays an important in renal epithelial cell homeostasis and in recovery of renal function following ischemic acute kidney injury.	[Camarata, Troy D.; Weaver, Grant C.; Vasilyev, Alexandr; Arnaout, M. Amin] Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Div Renal, Charlestown, MA 02114 USA; [Camarata, Troy D.; Weaver, Grant C.; Vasilyev, Alexandr; Arnaout, M. Amin] Massachusetts Gen Hosp, Dept Med, Charlestown, MA USA; [Arnaout, M. Amin] Massachusetts Gen Hosp, Dept Med, Ctr Regenerat Med, Charlestown, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Arnaout, MA (corresponding author), Massachusetts Gen Hosp, Leukocyte Biol & Inflammat Program, Div Renal, Charlestown, MA 02114 USA.	aarnaout1@mgh.harvard.edu		Weaver, Grant/0000-0003-1151-2944; Camarata, Troy/0000-0002-7628-2716	NIH [DK088327, DK48549, DK007540]; National Institutes of Diabetes, Digestive and Kidney diseases (NIDDK) of the National Institutes of Health [F32DK088437]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048549, F32DK088437, R01DK088327, T32DK007540] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Diabetes, Digestive and Kidney diseases (NIDDK) of the National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH grants DK088327, DK48549 and DK007540 (to MAA) and F32DK088437 (to TC) from the National Institutes of Diabetes, Digestive and Kidney diseases (NIDDK) of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Bailey B, 2012, CIRC RES, V111, P750, DOI 10.1161/CIRCRESAHA.112.274662; BLAKE PG, 1993, J AM SOC NEPHROL, V4, P1140; Bonyadi M, 2003, P NATL ACAD SCI USA, V100, P5840, DOI 10.1073/pnas.1036475100; Camarata T, 2006, J CELL BIOL, V174, P339, DOI 10.1083/jcb.200511109; Chawla LS, 2011, KIDNEY INT, V79, P1361, DOI 10.1038/ki.2011.42; Chen YG, 2009, CELL RES, V19, P58, DOI 10.1038/cr.2008.315; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Epting CL, 2008, EXP CELL RES, V314, P1125, DOI 10.1016/j.yexcr.2007.11.010; Fragiadaki M, 2011, INT J EXP PATHOL, V92, P143, DOI 10.1111/j.1365-2613.2011.00775.x; Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x; Galliher AJ, 2007, CANCER RES, V67, P3752, DOI 10.1158/0008-5472.CAN-06-3851; Geng H, 2009, AM J PATHOL, V174, P1291, DOI 10.2353/ajpath.2009.080295; Gentle ME, 2013, J AM SOC NEPHROL, V24, P787, DOI 10.1681/ASN.2012101024; Gewin L, 2012, J AM SOC NEPHROL, V23, P2001, DOI 10.1681/ASN.2012020139; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Holmes C, 2007, STEM CELLS, V25, P1339, DOI 10.1634/stemcells.2006-0644; HOUCHENS RL, 2006, HCUP METHODS SERIES; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Kafadar KA, 2009, DEV BIOL, V326, P47, DOI 10.1016/j.ydbio.2008.10.036; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Kutz SM, 2001, J CELL SCI, V114, P3905; Lan HY, 2012, SEMIN NEPHROL, V32, P236, DOI 10.1016/j.semnephrol.2012.04.002; Lee PY, 2013, J LEUKOCYTE BIOL, V94, P585, DOI 10.1189/jlb.0113014; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Nath KA, 2000, KIDNEY INT, V57, P2423, DOI 10.1046/j.1523-1755.2000.00101.x; Nath KA, 2011, AM J PHYSIOL-RENAL, V301, pF436, DOI 10.1152/ajprenal.00162.2011; Renal Data System: USRDS, 2009, ANN DAT REP ATL END; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skrypnyk NI, 2013, JOVE-J VIS EXP, DOI 10.3791/50495; Stanford WL, 1997, J EXP MED, V186, P705, DOI 10.1084/jem.186.5.705; Susantitaphong P, 2013, CLIN J AM SOC NEPHRO, V8, P1482, DOI 10.2215/CJN.00710113; Upadhyay G, 2011, P NATL ACAD SCI USA, V108, P7820, DOI 10.1073/pnas.1103441108; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Winslow V, 2014, BBA-MOL CELL BIOL L, V1841, P868, DOI 10.1016/j.bbalip.2014.03.002; Wu CF, 2013, AM J PATHOL, V182, P118, DOI 10.1016/j.ajpath.2012.09.009; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhou H, 2012, HYPERTENSION, V60, P802, DOI 10.1161/HYPERTENSIONAHA.112.198895	46	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129561	10.1371/journal.pone.0129561	http://dx.doi.org/10.1371/journal.pone.0129561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053644	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300143
J	Freeman, LA				Freeman, Lauren A.			Robust Performance of Marginal Pacific Coral Reef Habitats in Future Climate Scenarios	PLOS ONE			English	Article							TROPICAL CYCLONES; BIODIVERSITY; ENVIRONMENTS; ECOSYSTEM; MODELS	Coral reef ecosystems are under dual threat from climate change. Increasing sea surface temperatures and thermal stress create environmental limits at low latitudes, and decreasing aragonite saturation state creates environmental limits at high latitudes. This study examines the response of unique coral reef habitats to climate change in the remote Pacific, using the National Center for Atmospheric Research Community Earth System Model version 1 alongside the species distribution algorithm Maxent. Narrow ranges of physicochemical variables are used to define unique coral habitats and their performance is tested in future climate scenarios. General loss of coral reef habitat is expected in future climate scenarios and has been shown in previous studies. This study found exactly that for most of the predominant physico-chemical environments. However, certain coral reef habitats considered marginal today at high latitude, along the equator and in the eastern tropical Pacific were found to be quite robust in climate change scenarios. Furthermore, an environmental coral reef refuge previously identified in the central south Pacific near French Polynesia was further reinforced. Studying the response of specific habitats showed that the prevailing conditions of this refuge during the 20th century shift to a new set of conditions, more characteristic of higher latitude coral reefs in the 20th century, in future climate scenarios projected to 2100.	Naval Res Lab, Remote Sensing Div, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Freeman, LA (corresponding author), Naval Res Lab, Remote Sensing Div, Washington, DC 20375 USA.	laurenava@gmail.com			NSF IGERT fellowship under the "Global Change, Marine Ecosystems and Society" program at Scripps Institution of Oceanography [0903551]; National Research Council Postdoctoral Fellowship at the U.S. Naval Research Laboratory	NSF IGERT fellowship under the "Global Change, Marine Ecosystems and Society" program at Scripps Institution of Oceanography; National Research Council Postdoctoral Fellowship at the U.S. Naval Research Laboratory	LAF was supported by an NSF IGERT fellowship under the "Global Change, Marine Ecosystems and Society" program at Scripps Institution of Oceanography (0903551) and a National Research Council Postdoctoral Fellowship at the U.S. Naval Research Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonov J.I., 2006, NOAA ATLAS NESDIS, V62, P182; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bridge T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048203; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Couce E, 2012, J BIOGEOGRAPHY, P1; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Emanuel KA, 2013, P NATL ACAD SCI USA, V110, P12219, DOI 10.1073/pnas.1301293110; Freeman LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082404; Freeman LA, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007099; Garcia HE, 2006, NOAA ATLAS NESDIS, V63, P342; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P391, DOI 10.1007/978-94-007-0114-4_22; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Keppel G, 2015, GLOBAL CHANGE BIOL, V21, P2829, DOI 10.1111/gcb.12936; Key R. M., 2004, GLOBAL BIOGEOCHEMICA, V18; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kleypas JA, 1999, AM ZOOL, V39, P146; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Knutson TR, 2010, NAT GEOSCI, V3, P157, DOI 10.1038/NGEO779; Kreyling J, 2011, RESTOR ECOL, V19, P433, DOI 10.1111/j.1526-100X.2011.00777.x; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Locarnini RA, 2006, WORLD OCEAN ATLAS, V61; Long MC, 2013, J CLIMATE, V26, P6775, DOI 10.1175/JCLI-D-12-00184.1; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Milanovich JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012189; Moberg F, 1992, ECOLOGICAL EC, V29, P215; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Palumbi SR, 2014, SCIENCE, V344, P895, DOI 10.1126/science.1251336; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; PASTOROK RA, 1985, MAR ECOL PROG SER, V21, P175, DOI 10.3354/meps021175; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; SALVAT B, 1992, GLOBAL ENVIRON CHANG, V2, P12, DOI 10.1016/0959-3780(92)90032-3; Schwartz MW, 2012, BIOSCIENCE, V62, P732, DOI 10.1525/bio.2012.62.8.6; SEBENS KP, 1994, AM ZOOL, V34, P115; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Wang MS, 2015, INT J ENV RES PUB HE, V12, P1069, DOI 10.3390/ijerph120201069; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	53	21	21	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128875	10.1371/journal.pone.0128875	http://dx.doi.org/10.1371/journal.pone.0128875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053439	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300064
J	Han, YF; Huang, HW; Li, L; Cai, T; Chen, S; He, XJ				Han, Yong-Feng; Huang, Huan-Wei; Li, Lin; Cai, Tao; Chen, She; He, Xin-Jian			The Cytosolic Iron-Sulfur Cluster Assembly Protein MMS19 Regulates Transcriptional Gene Silencing, DNA Repair, and Flowering Time in Arabidopsis	PLOS ONE			English	Article							POLYMERASE-EPSILON; CATALYTIC SUBUNIT; BIOGENESIS; MATURATION; ENCODES; ACTS; CHROMATIN; INTERACTS; COMPONENT; REPRESSOR	MMS19 is an essential component of the cytoplasmic iron-sulfur (Fe-S) cluster assembly complex in fungi and mammals; the mms19 null mutant alleles are lethal. Our study demonstrates that MMS19/MET18 in Arabidopsis thaliana interacts with the cytoplasmic Fe-S cluster assembly complex but is not an essential component of the complex. We find that MMS19 also interacts with the catalytic subunits of DNA polymerases, which have been demonstrated to be involved in transcriptional gene silencing (TGS), DNA repair, and flowering time regulation. Our results indicate that MMS19 has a similar biological function, suggesting a functional link between MMS19 and DNA polymerases. In the mms19null mutant, the assembly of Fe-S clusters on the catalytic subunit of DNA polymerase a is reduced but not blocked, which is consistent with the viability of the mutant. Our study suggests that MMS19 assists the assembly of Fe-S clusters on DNA polymerases in the cytosol, thereby facilitating transcriptional gene silencing, DNA repair, and flowering time control.	[Han, Yong-Feng; Huang, Huan-Wei; Li, Lin; Cai, Tao; Chen, She; He, Xin-Jian] Natl Inst Biol Sci, Beijing, Peoples R China	National Institute of Biological Sciences, Beijing	He, XJ (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.	hexinjian@nibs.ac.cn			National Basic Research Program of China (973 Program) [2012CB910900]; 973 Program from Chinese Ministry of Science and Technology [2011CB812600]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); 973 Program from Chinese Ministry of Science and Technology	This work was supported by the National Basic Research Program of China (973 Program) (2012CB910900) and the 973 Program (2011CB812600) from the Chinese Ministry of Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AC, 2006, EMBO J, V25, P174, DOI 10.1038/sj.emboj.7600905; Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Balk J, 2011, TRENDS PLANT SCI, V16, P218, DOI 10.1016/j.tplants.2010.12.006; Barrero JM, 2007, PLANT CELL, V19, P2822, DOI 10.1105/tpc.107.054130; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Buzas DM, 2014, P NATL ACAD SCI USA, V111, P13565, DOI 10.1073/pnas.1404058111; Bych K, 2008, J BIOL CHEM, V283, P35797, DOI 10.1074/jbc.M807303200; del Olmo I, 2010, PLANT J, V61, P623, DOI 10.1111/j.1365-313X.2009.04093.x; Feng WY, 2001, MOL CELL BIOL, V21, P4495, DOI 10.1128/MCB.21.14.4495-4504.2001; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; He YH, 2005, TRENDS PLANT SCI, V10, P30, DOI 10.1016/j.tplants.2004.11.003; Helliwell CA, 2006, PLANT J, V46, P183, DOI 10.1111/j.1365-313X.2006.02686.x; Inagaki S, 2006, PLANT CELL, V18, P879, DOI 10.1105/tpc.105.036798; Ito S, 2010, MOL CELL, V39, P632, DOI 10.1016/j.molcel.2010.07.029; Jenik PD, 2005, PLANT CELL, V17, P3362, DOI 10.1105/tpc.105.036889; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kou HP, 2008, P NATL ACAD SCI USA, V105, P15714, DOI 10.1073/pnas.0710736105; Lauder S, 1996, MOL CELL BIOL, V16, P6783; Li F, 2011, NATURE, V475, P244, DOI 10.1038/nature10161; Liu J, 2010, PLANT J, V61, P36, DOI 10.1111/j.1365-313X.2009.04026.x; Liu Q, 2011, CURR OPIN PLANT BIOL, V14, P187, DOI 10.1016/j.pbi.2010.12.001; Luo DX, 2012, PLANT CELL, V24, P4135, DOI 10.1105/tpc.112.102608; Marquardt S, 2006, J EXP BOT, V57, P3379, DOI 10.1093/jxb/erl073; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mok YG, 2010, P NATL ACAD SCI USA, V107, P19225, DOI 10.1073/pnas.1014348107; Nakamura M, 2013, NEW PHYTOL, V199, P925, DOI 10.1111/nph.12350; Nakayama J, 2001, EMBO J, V20, P2857, DOI 10.1093/emboj/20.11.2857; Netz DJA, 2007, NAT CHEM BIOL, V3, P278, DOI 10.1038/nchembio872; Netz DJA, 2014, TRENDS CELL BIOL, V24, P303, DOI 10.1016/j.tcb.2013.11.005; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Pierik AJ, 2009, NAT PROTOC, V4, P753, DOI 10.1038/nprot.2009.39; Ronceret A, 2005, PLANT J, V44, P223, DOI 10.1111/j.1365-313X.2005.02521.x; Searle I, 2006, GENE DEV, V20, P898, DOI 10.1101/gad.373506; Stehling O, 2013, CELL METAB, V18, P187, DOI 10.1016/j.cmet.2013.06.015; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Steimer A, 2000, PLANT CELL, V12, P1165, DOI 10.1105/tpc.12.7.1165; Takeda S, 2004, GENE DEV, V18, P782, DOI 10.1101/gad.295404; Weerapana E, 2010, NATURE, V468, P790, DOI 10.1038/nature09472; Yin HB, 2009, PLANT CELL, V21, P386, DOI 10.1105/tpc.108.061549; Zhang CJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002693; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	47	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129137	10.1371/journal.pone.0129137	http://dx.doi.org/10.1371/journal.pone.0129137			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053632	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300091
J	Karlsson, AC; Svemer, F; Eriksson, J; Darras, VM; Andersson, L; Jensen, P				Karlsson, Anna-Carin; Svemer, Frida; Eriksson, Jonas; Darras, Veerle M.; Andersson, Leif; Jensen, Per			The Effect of a Mutation in the Thyroid Stimulating Hormone Receptor (TSHR) on Development, Behaviour and TH Levels in Domesticated Chickens	PLOS ONE			English	Article							JUNGLEFOWL GALLUS-GALLUS; RED JUNGLEFOWL; RESOURCE-ALLOCATION; HYPOTHYROIDISM; STRESS; RESPONSES; SELECTION; MODEL; DOGS; FEAR	The thyroid stimulating hormone receptor (TSHR) has been suggested to be a "domestication locus" in the chicken, due to a strong selective sweep over the gene found in domesticated chickens, differentiating them from their wild ancestor the Red Junglefowl (RJF). We investigated the effect of the mutation on development (incubation time), behaviour and thyroid hormone levels in intercross chickens homozygous for the mutation (d/d), wild type homozygotes (w/w) or heterozygotes (d/w). This allowed an assessment of the effect of genotype at this locus against a random mix of RJF and WL genotypes throughout the rest of the genome, controlling for family effects. The d/d genotype showed a longer incubation time, less fearful behaviours, lower number of aggressive behaviours and decreased levels of the thyroid hormone T4, in comparison to the w/w genotype. The difference between TSHR genotypes (d/d vs. w/w) in these respects mirrors the differences in development and behaviour between pure domesticated White Leghorns and pure RJF chickens. Higher individual T3 and T4 levels were associated with more aggression. Our study indicates that the TSHR mutation affects typical domestication traits, possibly through modifying plasma levels of thyroid hormones, and may therefore have been important during the evolution of the domestic chicken.	[Karlsson, Anna-Carin; Svemer, Frida; Jensen, Per] Linkoping Univ, Div Zool, IFM Biol, SE-58183 Linkoping, Sweden; [Eriksson, Jonas; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Darras, Veerle M.] Katholieke Univ Leuven, Div Anim Physiol & Neurobiol, Dept Biol, Lab Comparat Endocrinol, B-3000 Leuven, Belgium	Linkoping University; Uppsala University; KU Leuven	Jensen, P (corresponding author), Linkoping Univ, Div Zool, IFM Biol, SE-58183 Linkoping, Sweden.	perje@ifm.liu.se			Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, FORMAS (Formel Excel) [221-2010-35]; Swedish Research Council, VR [621-2011-4731]; European Research Council (ERC grant GENEWELL) [322206]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, FORMAS (Formel Excel); Swedish Research Council, VR(Swedish Research Council); European Research Council (ERC grant GENEWELL)(European Research Council (ERC))	This research was funded by The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, FORMAS (Formel Excel; 221-2010-35), The Swedish Research Council, VR (621-2011-4731) and the European Research Council (ERC grant 322206 GENEWELL). Thanks to Lejla Bektic, Linkoping University, Sweden, and Lut Noterdaeme, KU Leuven, Belgium for technical assistance. The study was performed within the framework of the Swedish Center of Excellence in Animal Welfare Science, and the Linkoping University Neurobiology initiative.	Agnvall B, 2014, ANIMAL, V8, P1498, DOI 10.1017/S1751731114001426; Arhur JR, 2003, INDUSTRIAL PERSPECTI; Buras A, 2014, HORM BEHAV, V65, P88, DOI 10.1016/j.yhbeh.2013.11.008; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; Carneiro M, 2014, PLOS GENET, V10, P1; Carter GR, 2009, J VET BEHAV, V4, P230, DOI 10.1016/j.jveb.2009.06.006; Crockford SJ, 2006, RYTHMS LIFE THYROID, DOI [10.3389/fendo.2014.00019, DOI 10.3389/FENDO.2014.00019]; DARBRA S, 1995, BEHAV BRAIN RES, V68, P159, DOI 10.1016/0166-4328(94)00166-D; Darras VM, 2015, BBA-GENE REGUL MECH, V1849, P130, DOI 10.1016/j.bbagrm.2014.05.004; De Groef B, 2003, MOL CELL ENDOCRINOL, V203, P33, DOI 10.1016/S0303-7207(03)00120-5; De Groef B, 2013, FRONTIERS ENDOCRINOL, V4, P1, DOI [10.3389/fendo.2013.00001, DOI 10.3389/FEND0.2013.00063]; DECUYPERE E, 1988, AM ZOOL, V28, P401; Dodman NH, 2013, J VET BEHAV, V8, P225, DOI 10.1016/j.jveb.2012.12.059; Flink LG, 2014, P NATL ACAD SCI USA, V111, P6184, DOI 10.1073/pnas.1308939110; Grommen SVH, 2011, DOMEST ANIM ENDOCRIN, V40, P10, DOI 10.1016/j.domaniend.2010.08.002; Haba G, 2011, J OBSTET GYNAECOL RE, V37, P1549, DOI 10.1111/j.1447-0756.2011.01573.x; Ikegami K, 2012, MOL CELL ENDOCRINOL, V349, P76, DOI 10.1016/j.mce.2011.06.040; Jensen P, 2006, APPL ANIM BEHAV SCI, V97, P3, DOI 10.1016/j.applanim.2005.11.015; Karlsson AC, 2010, BRIT POULTRY SCI, V51, P170, DOI 10.1080/00071661003745802; Karlsson AC, 2011, BEHAV GENET, V41, P312, DOI 10.1007/s10519-010-9379-4; Kilburn-Watt E, 2010, J NEUROENDOCRINOL, V22, P960, DOI 10.1111/j.1365-2826.2010.02038.x; Kincaid AE, 2001, NEUROSCIENCE, V105, P891, DOI 10.1016/S0306-4522(01)00229-9; LILJEDAHL LE, 1979, ACTA AGR SCAND, V29, P273, DOI 10.1080/00015127909435238; McNabb FMA, 2007, CRIT REV TOXICOL, V37, P163, DOI 10.1080/10408440601123552; McNabb FMA, 2006, GEN COMP ENDOCR, V147, P93, DOI 10.1016/j.ygcen.2005.12.011; MCNABB FMA, 1993, POULTRY SCI, V72, P1764, DOI 10.3382/ps.0721764; MCNICHOLS MJ, 1988, GEN COMP ENDOCR, V70, P109, DOI 10.1016/0016-6480(88)90099-8; Montero-Pedrazuela A, 2006, MOL PSYCHIATR, V11, P361, DOI 10.1038/sj.mp.4001802; Dias GRM, 2014, PHYSIOL BEHAV, V124, P116, DOI 10.1016/j.physbeh.2013.10.036; Natt D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006405; Narimani-Rad M, 2014, KAFKAS UNIV VET FAK, V20, P267, DOI 10.9775/kvfd.2013.9976; Natt D, 2007, BEHAV GENET, V37, P399, DOI 10.1007/s10519-006-9125-0; Natt D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096376; Negishi T, 2005, BEHAV BRAIN RES, V159, P323, DOI 10.1016/j.bbr.2004.11.012; Olivares EL, 2012, NEUROPHARMACOLOGY, V62, P446, DOI 10.1016/j.neuropharm.2011.08.035; Price EO, 1998, GENETICS AND THE BEHAVIOR OF DOMESTIC ANIMALS, P31; Price EO, 1999, APPL ANIM BEHAV SCI, V65, P245, DOI 10.1016/S0168-1591(99)00087-8; Roelens SA, 2005, GEN COMP ENDOCR, V143, P1, DOI 10.1016/j.ygcen.2005.02.015; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Schutz K, 2002, BEHAV GENET, V32, P423, DOI 10.1023/A:1020880211144; Schutz KE, 2001, APPL ANIM BEHAV SCI, V74, P1, DOI 10.1016/S0168-1591(01)00156-3; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; Shimokawa N, 2014, J NEUROENDOCRINOL, V26, P164, DOI 10.1111/jne.12135; TAMASY V, 1986, DEV PSYCHOBIOL, V19, P537, DOI 10.1002/dev.420190606; Tong Q, 2013, POULTRY SCI, V92, P620, DOI 10.3382/ps.2012-02509; Vaisanen J, 2005, BRIT POULTRY SCI, V46, P156, DOI 10.1080/00071660500062638; van Wijk N, 2008, EXP PHYSIOL, V93, P1199, DOI 10.1113/expphysiol.2008.042416; WEST B, 1988, J ARCHAEOL SCI, V15, P515, DOI 10.1016/0305-4403(88)90080-5; Wiren A, 2011, BEHAV GENET, V41, P303, DOI 10.1007/s10519-010-9377-6	49	16	18	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129040	10.1371/journal.pone.0129040	http://dx.doi.org/10.1371/journal.pone.0129040			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053744	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300078
J	Liu, YH; Kui, LW; Deng, C; Warran, B; Wang, L; Yu, B; Yang, HY; Wang, J; Espley, RV; Zhang, JL; Wang, D; Allan, AC				Liu, Yuhui; Kui Lin-Wang; Deng, Cecilia; Warran, Ben; Wang, Li; Yu, Bin; Yang, Hongyu; Wang, Jing; Espley, Richard V.; Zhang, Junlian; Wang, Di; Allan, Andrew C.			Comparative Transcriptome Analysis of White and Purple Potato to Identify Genes Involved in Anthocyanin Biosynthesis	PLOS ONE			English	Article							DNA-BINDING DOMAIN; FLAVONOID BIOSYNTHESIS; MOLECULAR ANALYSIS; ANALYSIS REVEALS; RNA-SEQ; MYB; ARABIDOPSIS; EXPRESSION; PROTEIN; PIGMENTATION	Introduction The potato (Solanum tuberosum) cultivar 'Xin Daping' is tetraploid with white skin and white flesh, while the cultivar 'Hei Meiren' is also tetraploid with purple skin and purple flesh. Comparative transcriptome analysis of white and purple cultivars was carried out using high-throughput RNA sequencing in order to further understand the mechanism of anthocyanin biosynthesis in potato. Methods and Results By aligning transcript reads to the recently published diploid potato genome and de novo assembly, 209 million paired-end Illumina RNA-seq reads from these tetraploid cultivars were assembled on to 60,930 transcripts, of which 27,754 (45.55%) are novel transcripts and 9393 alternative transcripts. Using a comparison of the RNA-sequence datasets, multiple versions of the genes encoding anthocyanin biosynthetic steps and regulatory transcription factors were identified. Other novel genes potentially involved in anthocyanin biosynthesis in potato tubers were also discovered. Real-time qPCR validation of candidate genes revealed good correlation with the transcriptome data. SNPs (Single Nucleotide Polymorphism) and indels were predicted and validated for the transcription factors MYB AN1 and bHLH1 and the biosynthetic gene anthocyanidin 3-O-glucosyltransferase (UFGT). Conclusions These results contribute to our understanding of the molecular mechanism of white and purple potato development, by identifying differential responses of biosynthetic gene family members together with the variation in structural genes and transcription factors in this highly heterozygous crop. This provides an excellent platform and resource for future genetic and functional genomic research.	[Liu, Yuhui; Wang, Li; Yu, Bin; Yang, Hongyu; Zhang, Junlian; Wang, Di] Gansu Agr Univ, Gansu Key Lab Crop Improvement & Germplasm Enhanc, Lanzhou, Peoples R China; [Kui Lin-Wang; Deng, Cecilia; Warran, Ben; Espley, Richard V.; Allan, Andrew C.] New Zealand Inst Plant & Food Res Ltd, Plant & Food Res Mt Albert, Auckland, New Zealand; [Wang, Li] Gansu Agr Univ, Coll Life Sci & Technol, Lanzhou, Peoples R China; [Yang, Hongyu; Zhang, Junlian] Gansu Agr Univ, Coll Hort, Lanzhou, Peoples R China; [Wang, Jing] Gansu Agr Univ, Coll Food Sci & Engn, Lanzhou, Peoples R China; [Allan, Andrew C.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand	Gansu Agricultural University; New Zealand Institute for Plant & Food Research Ltd; Gansu Agricultural University; Gansu Agricultural University; Gansu Agricultural University; University of Auckland	Zhang, JL (corresponding author), Gansu Agr Univ, Gansu Key Lab Crop Improvement & Germplasm Enhanc, Lanzhou, Peoples R China.	zhangjunlian77@163.com; andrew.allan@plantandfood.co.nz	Espley, Richard V/D-1942-2011; Allan, Andrew C/L-3253-2016; Deng, Cecilia Hong/O-2891-2017	Espley, Richard V/0000-0002-1732-3688; Allan, Andrew C/0000-0003-1944-7067; Deng, Cecilia Hong/0000-0002-2954-762X	Fostering Foundation for the Excellent Ph.D. Dissertation of Gansu Agricultural University; International Science & Technology Cooperation Program of China [2014DFG31570]; New Zealand Institute of Plant and Food Research; Basic Research of Innovative Group of Gansu Province [1308RJIA005]	Fostering Foundation for the Excellent Ph.D. Dissertation of Gansu Agricultural University; International Science & Technology Cooperation Program of China; New Zealand Institute of Plant and Food Research; Basic Research of Innovative Group of Gansu Province	This research program is financially supported by the Fostering Foundation for the Excellent Ph.D. Dissertation of Gansu Agricultural University (2013), International Science & Technology Cooperation Program of China (No. 2014DFG31570) (http://www.istcp.org.cn/), and is the part of a collaborative programme with the New Zealand Institute of Plant and Food Research (DW); and Basic Research of Innovative Group of Gansu Province (No. 1308RJIA005) (http://www.gsstc.gov.cn/) (JZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre CM, 2007, J AGR FOOD CHEM, V55, P366, DOI 10.1021/jf062740i; Bazzano Lydia A, 2003, Curr Atheroscler Rep, V5, P492, DOI 10.1007/s11883-003-0040-z; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Boss P. K., 1996, Australian Journal of Grape and Wine Research, V2, P163, DOI 10.1111/j.1755-0238.1996.tb00104.x; Boss PK, 1996, PLANT MOL BIOL, V32, P565, DOI 10.1007/BF00019111; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Chagne D, 2013, PLANT PHYSIOL, V161, P225, DOI 10.1104/pp.112.206771; Clark ST, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-343; De Jong WS, 2004, THEOR APPL GENET, V108, P423, DOI 10.1007/s00122-003-1455-1; Devaiah BN, 2007, PLANT PHYSIOL, V143, P1789, DOI 10.1104/pp.106.093971; Du H, 2009, BIOCHEMISTRY-MOSCOW+, V74, P1, DOI 10.1134/S0006297909010015; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Fraser CM, 2011, THE ARABIDOPSIS BOOK, P9, DOI [10.1199/tab.0156, DOI 10.1199/TAB.0156]; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; GOODRICH J, 1992, CELL, V68, P955, DOI 10.1016/0092-8674(92)90038-E; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; Hichri I, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-117; Hichri I, 2010, MOL PLANT, V3, P509, DOI 10.1093/mp/ssp118; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; Hu CY, 2011, MOL BIOL REP, V38, P561, DOI 10.1007/s11033-010-0141-z; Huang JL, 2010, PLANT PHYSIOL, V153, P1526, DOI 10.1104/pp.110.157370; Irani NG, 2006, CELLULAR AND MOLECUL; Ishida T, 2007, PLANT CELL, V19, P2531, DOI 10.1105/tpc.107.052274; Jaakola L, 2013, TRENDS PLANT SCI, V18, P477, DOI 10.1016/j.tplants.2013.06.003; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jones P, 2003, J BIOL CHEM, V278, P43910, DOI 10.1074/jbc.M303523200; Jung CS, 2009, THEOR APPL GENET, V120, P45, DOI 10.1007/s00122-009-1158-3; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kayesh E, 2013, ACTA PHYSIOL PLANT, V35, P2879, DOI 10.1007/s11738-013-1332-8; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Koopman F, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-155; KUBASEK WL, 1992, PLANT CELL, V4, P1229, DOI 10.1105/tpc.4.10.1229; Lepiniec L, 2006, ANNU REV PLANT BIOL, V57, P405, DOI 10.1146/annurev.arplant.57.032905.105252; Li W, 2014, J INTEGR PLANT BIOL, V56, P364, DOI 10.1111/jipb.12136; Li XA, 2011, PLANT CELL ENVIRON, V34, P374, DOI 10.1111/j.1365-3040.2010.02249.x; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Lu QiNeng, 2009, Acta Agriculturae Zhejiangensis, V21, P544; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Morishita T, 2009, PLANT CELL PHYSIOL, V50, P2210, DOI 10.1093/pcp/pcp159; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pan YH, 2009, PLANT PHYSIOL, V150, P858, DOI 10.1104/pp.108.130757; Pasche JS, 2013, PLANT DIS, V97, P608, DOI 10.1094/PDIS-06-12-0554-RE; Pattanaik S, 2010, PLANTA, V231, P1061, DOI 10.1007/s00425-010-1108-y; Payyavula RS, 2013, J EXP BOT, V64, P5115, DOI 10.1093/jxb/ert303; Pelletier MK, 1996, PLANT PHYSIOL, V111, P339, DOI 10.1104/pp.111.1.339; Pelletier MK, 1997, PLANT PHYSIOL, V113, P1437, DOI 10.1104/pp.113.4.1437; Quattrocchio F, 1999, PLANT CELL, V11, P1433, DOI 10.1105/tpc.11.8.1433; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Reyes LF, 2003, J AGR FOOD CHEM, V51, P5296, DOI 10.1021/jf034213u; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rommens CM, 2008, PLANT BIOTECHNOL J, V6, P870, DOI 10.1111/j.1467-7652.2008.00362.x; Sainz MB, 1997, PLANT CELL, V9, P611, DOI 10.1105/tpc.9.4.611; Schieber A., 2009, FOOD, V3, P23, DOI DOI 10.7939/R33T9DM0H; Schoenbohm C, 2000, BIOL CHEM, V381, P749, DOI 10.1515/BC.2000.095; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shockey JM, 2003, PLANT PHYSIOL, V132, P1065, DOI 10.1104/pp.103.020552; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; Stushnoff C, 2008, AM J POTATO RES, V85, P267, DOI 10.1007/s12230-008-9032-4; Stushnoff C, 2010, J EXP BOT, V61, P1225, DOI 10.1093/jxb/erp394; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Thompson MD, 2009, J FOOD COMPOS ANAL, V22, P571, DOI 10.1016/j.jfca.2008.09.002; Uitdewilligen JGAML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062355; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Wang BL, 2005, PLANT SCI, V169, P1155, DOI 10.1016/j.plantsci.2005.07.020; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei Q, 2012, PLANT BIOTECHNOL REP, V6, P69, DOI 10.1007/s11816-011-0201-4; Wu RM, 2014, J EXP BOT, V65, P4985, DOI 10.1093/jxb/eru264; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yonekura-Sakakibara K, 2012, PLANT J, V69, P154, DOI 10.1111/j.1365-313X.2011.04779.x; Zhang YF, 2009, THEOR APPL GENET, V119, P143, DOI 10.1007/s00122-009-1024-3; Zhou H, 2015, PLANT J, V82, P105, DOI 10.1111/tpj.12792	79	45	52	5	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129148	10.1371/journal.pone.0129148	http://dx.doi.org/10.1371/journal.pone.0129148			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053878	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300094
J	Sengupta, A; Grover, M; Chakraborty, A; Saxena, S				Sengupta, Abhishek; Grover, Monendra; Chakraborty, Amlan; Saxena, Sarika			HEPNet: A Knowledge Base Model of Human Energy Pool Network for Predicting the Energy Availability Status of an Individual	PLOS ONE			English	Article							GLOBAL RECONSTRUCTION; SYSTEMS BIOLOGY	HEPNet is an electronic representation of metabolic reactions occurring within human cellular organization focusing on inflow and outflow of the energy currency ATP, GTP and other energy associated moieties. The backbone of HEPNet consists of primary bio-molecules such as carbohydrates, proteins and fats which ultimately constitute the chief source for the synthesis and obliteration of energy currencies in a cell. A series of biochemical pathways and reactions constituting the catabolism and anabolism of various metabolites are portrayed through cellular compartmentalization. The depicted pathways function synchronously toward an overarching goal of producing ATP and other energy associated moieties to bring into play a variety of cellular functions. HEPNet is manually curated with raw data from experiments and is also connected to KEGG and Reactome databases. This model has been validated by simulating it with physiological states like fasting, starvation, exercise and disease conditions like glycaemia, uremia and dihydrolipoamide dehydrogenase deficiency (DLDD). The results clearly indicate that ATP is the master regulator under different metabolic conditions and physiological states. The results also highlight that energy currencies play a minor role. However, the moiety creatine phosphate has a unique character, since it is a ready-made source of phosphoryl groups for the rapid synthesis of ATP from ADP. HEPNet provides a framework for further expanding the network diverse age groups of both the sexes, followed by the understanding of energetics in more complex metabolic pathways that are related to human disorders.	[Sengupta, Abhishek; Chakraborty, Amlan; Saxena, Sarika] Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Lucknow, Uttar Pradesh, India; [Grover, Monendra] ICAR Res Complex, IASRI, Ctr Agr Bioinformat CABin, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Statistics Research Institute	Saxena, S (corresponding author), Amity Univ Uttar Pradesh, Amity Inst Biotechnol, Lucknow, Uttar Pradesh, India.	ssaxena1@amity.edu	Saxena, Sarika/AAH-6792-2021; Chakraborty, Amlan/N-4065-2015; Sengupta, Abhishek/AAH-8996-2021	Saxena, Sarika/0000-0002-4162-7403; Chakraborty, Amlan/0000-0002-2917-6486; Sengupta, Abhishek/0000-0002-3958-3675				Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004; Bordbar A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-180; Dada JO, 2010, BIOINFORMATICS, V26, P932, DOI 10.1093/bioinformatics/btq069; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Funahashi Akira, 2007, In Silico Biology, V7, pS81; Gille C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.62; Hong YS, 1996, HUM MOL GENET, V5, P1925, DOI 10.1093/hmg/5.12.1925; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Le Novere N, 2005, NAT BIOTECHNOL, V23, P1509, DOI 10.1038/nbt1156; Marcovina SM, 2013, TRANSL RES, V161, P73, DOI 10.1016/j.trsl.2012.10.006; Moles CG, 2003, GENOME RES, V13, P2467, DOI 10.1101/gr.1262503; NEELY JR, 1974, ANNU REV PHYSIOL, V36, P413, DOI 10.1146/annurev.ph.36.030174.002213; Reed JL, 2006, NAT REV GENET, V7, P130, DOI 10.1038/nrg1769; Rojas Isabel, 2007, In Silico Biology, V7, pS37; Rolfsson O, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-155; Sahoo S, 2013, HUM MOL GENET, V22, P2705, DOI 10.1093/hmg/ddt119; Sangar V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00404; Schneider M, 2009, J PROTEOMICS, V72, P567, DOI 10.1016/j.jprot.2008.11.010; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Thiele I, 2005, J BIOL CHEM, V280, P11683, DOI 10.1074/jbc.M409072200; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Zolkipli Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017534	29	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0127918	10.1371/journal.pone.0127918	http://dx.doi.org/10.1371/journal.pone.0127918			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053019	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300019
J	Sethuramanujam, S; Slaughter, MM				Sethuramanujam, Santhosh; Slaughter, Malcolm M.			Properties of a Glutamatergic Synapse Controlling Information Output from Retinal Bipolar Cells	PLOS ONE			English	Article							METHYL-D-ASPARTATE; INTRINSIC PHYSIOLOGICAL-PROPERTIES; MAMMALIAN RIBBON SYNAPSE; GANGLION-CELLS; RABBIT RETINA; MOUSE RETINA; INNER RETINA; MUDPUPPY RETINA; AMPA RECEPTORS; RAT RETINA	One general categorization of retinal ganglion cells is to segregate them into tonically or phasically responding neurons, each conveying discrete aspects of the visual scene. Although best identified in the output signals of the retina, this distinction is initiated at the first synapse: between photoreceptors and the dendrites of bipolar cells. In this study we found that the output synapses of bipolar cells also contribute to separate these pathways. Both transient and sustained ganglion cells can produce maintained spike activity, but bipolar cell glutamate release exhibits a divergence that corresponds to the response characteristics of the ganglion cells. Comparing light intensity coding in the sustained and transient ON pathways revealed that they shared the intensity spectrum. The transient pathway had greater sensitivity but smaller dynamic range, and switched from intensity coding to event detection at light levels where sustained pathway sensitivity began to rise. The distinctive properties of the sustained pathway depended upon inhibition and shifted toward those of the transient pathway in the absence of inhibition. The transient system was comparatively unaffected by the loss of inhibition and this was due to the concomitant activation of perisynaptic NMDA receptors. Overall, the properties of bipolar cell dendritic and axon terminals both contribute to the formation of key aspects of the sustained/transient dichotomy normally associated with ganglion cells.	SUNY Buffalo, Ctr Neurosci, Buffalo, NY 14260 USA; SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Sethuramanujam, S (corresponding author), Univ Victoria, Dept Biol, POB 1700, Victoria, BC V8W 2Y2, Canada.	santhosh@buffalo.edu		sethuramanujam, santhosh/0000-0001-6199-1221	National Eye Institute (US) grant [NEI 05725]	National Eye Institute (US) grant	This work was supported by National Eye Institute (US) grant NEI 05725.	Asari H, 2012, NAT NEUROSCI, V15, P1581, DOI 10.1038/nn.3241; Baden T, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001972; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; Bieda MC, 2000, VISUAL NEUROSCI, V17, P243, DOI 10.1017/S0952523800172062; Borghuis BG, 2013, J NEUROSCI, V33, P10972, DOI 10.1523/JNEUROSCI.1241-13.2013; Buldyrev I, 2012, J NEUROPHYSIOL, V107, P1795, DOI 10.1152/jn.00924.2011; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P299, DOI 10.1113/jphysiol.1978.sp012234; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; Chen X, 2010, J NEUROPHYSIOL, V103, P2618, DOI 10.1152/jn.01109.2009; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COHEN ED, 1994, VISUAL NEUROSCI, V11, P317, DOI 10.1017/S0952523800001668; COLEMAN PA, 1989, J NEUROPHYSIOL, V62, P495, DOI 10.1152/jn.1989.62.2.495; COLEMAN PA, 1988, J NEUROSCI, V8, P4728; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DIAMOND JS, 1995, J PHYSIOL-LONDON, V487, P711, DOI 10.1113/jphysiol.1995.sp020912; Eggers ED, 2007, J PHYSIOL-LONDON, V582, P569, DOI 10.1113/jphysiol.2007.131763; Eggers ED, 2011, VISUAL NEUROSCI, V28, P95, DOI 10.1017/S0952523810000209; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1948, DOI 10.1152/jn.1997.78.4.1948; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1935, DOI 10.1152/jn.1997.78.4.1935; Hsueh HA, 2008, J NEUROPHYSIOL, V100, P2077, DOI 10.1152/jn.90417.2008; Ichinose T, 2014, J NEUROSCI, V34, P8761, DOI 10.1523/JNEUROSCI.3965-13.2014; Manookin MB, 2010, NEURON, V67, P280, DOI 10.1016/j.neuron.2010.06.020; Margolis DJ, 2007, J NEUROSCI, V27, P5994, DOI 10.1523/JNEUROSCI.0130-07.2007; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; MASSEY SC, 1990, J NEUROPHYSIOL, V63, P16, DOI 10.1152/jn.1990.63.1.16; MASSEY SC, 1988, J PHYSIOL-LONDON, V405, P635, DOI 10.1113/jphysiol.1988.sp017353; Matsui K, 1998, J NEUROSCI, V18, P4500; MOBBS P, 1992, BRAIN RES, V574, P217, DOI 10.1016/0006-8993(92)90819-U; Molnar A, 2007, J NEUROPHYSIOL, V98, P3423, DOI 10.1152/jn.00838.2007; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P536, DOI 10.1113/jphysiol.1966.sp008001; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Puthussery T, 2013, J NEUROSCI, V33, P16045, DOI 10.1523/JNEUROSCI.1249-13.2013; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sagdullaev BT, 2006, NEURON, V50, P923, DOI 10.1016/j.neuron.2006.05.015; Saszik S, 2012, J NEUROSCI, V32, P297, DOI 10.1523/JNEUROSCI.2739-08.2012; Schwartz GW, 2012, NAT NEUROSCI, V15, P1572, DOI 10.1038/nn.3225; Sethuramanujam S, 2014, J NEUROPHYSIOL, V112, P193, DOI 10.1152/jn.00817.2013; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Singer JH, 2007, J PHYSIOL-LONDON, V580, P23, DOI 10.1113/jphysiol.2006.125302; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SLAUGHTER MM, 1983, J NEUROSCI, V3, P1701; Stafford BK, 2014, J PHYSIOL-LONDON, V592, P4877, DOI 10.1113/jphysiol.2014.276543; Tabata T, 2002, J NEUROPHYSIOL, V87, P30, DOI 10.1152/jn.00179.2001; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P79, DOI 10.1113/jphysiol.1978.sp012294; Vaney DI, 2012, NAT REV NEUROSCI, V13, P194, DOI 10.1038/nrn3165; Vigh J, 2011, J NEUROSCI, V31, P15884, DOI 10.1523/JNEUROSCI.2959-11.2011; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Wong RCS, 2012, J NEUROPHYSIOL, V108, P2008, DOI 10.1152/jn.01091.2011; Wu SM, 2000, J NEUROSCI, V20, P4462, DOI 10.1523/JNEUROSCI.20-12-04462.2000; Zhang J, 2006, J COMP NEUROL, V498, P810, DOI 10.1002/cne.21089; Zhang J, 2009, J NEUROSCI, V29, P4274, DOI 10.1523/JNEUROSCI.5602-08.2009	55	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129133	10.1371/journal.pone.0129133	http://dx.doi.org/10.1371/journal.pone.0129133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053500	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300090
J	von Einem, B; Wahler, A; Schips, T; Serrano-Pozo, A; Proepper, C; Boeckers, TM; Rueck, A; Wirth, T; Hyman, BT; Danzer, KM; Thal, DR; von Arnim, CAF				von Einem, Bjoern; Wahler, Anke; Schips, Tobias; Serrano-Pozo, Alberto; Proepper, Christian; Boeckers, Tobias M.; Rueck, Angelika; Wirth, Thomas; Hyman, Bradley T.; Danzer, Karin M.; Thal, Dietmar R.; von Arnim, Christine A. F.			The Golgi-Localized gamma-Ear-Containing ARF-Binding (GGA) Proteins Alter Amyloid-beta Precursor Protein (APP) Processing through Interaction of Their GAE Domain with the Beta-Site APP Cleaving Enzyme 1 (BACE1)	PLOS ONE			English	Article							SECRETASE CYTOSOLIC DOMAIN; FACTOR-II RECEPTOR; ALZHEIMERS-DISEASE; TRANS-GOLGI; VHS DOMAINS; CARBOXYL-TERMINUS; ACIDIC-CLUSTER; MUTATIONAL ANALYSIS; CYTOPLASMIC DOMAIN; SORTING-SIGNAL	Proteolytic processing of amyloid-beta precursor protein (APP) by beta-site APP cleaving enzyme 1 (BACE1) is the initial step in the production of amyloid beta (A beta), which accumulates in senile plaques in Alzheimer's disease (AD). Essential for this cleavage is the transport and sorting of both proteins through endosomal/Golgi compartments. Golgi-localized.-ear-containing ARF-binding (GGA) proteins have striking cargo-sorting functions in these pathways. Recently, GGA1 and GGA3 were shown to interact with BACE1, to be expressed in neurons, and to be decreased in AD brain, whereas little is known about GGA2. Since GGA1 impacts A beta generation by confining APP to the Golgi and perinuclear compartments, we tested whether all GGAs modulate BACE1 and APP transport and processing. We observed decreased levels of secreted APP alpha (sAPP alpha), sAPP beta, and A beta upon GGA overexpression, which could be reverted by knockdown. GGA-BACE1 co-immunoprecipitation was impaired upon GGA-GAE but not VHS domain deletion. Autoinhibition of the GGA1-VHS domain was irrelevant for BACE1 interaction. Our data suggest that all three GGAs affect APP processing via the GGA-GAE domain.	[von Einem, Bjoern; Wahler, Anke; Danzer, Karin M.; von Arnim, Christine A. F.] Univ Ulm, Inst Neurol, D-89081 Ulm, Germany; [Schips, Tobias; Wirth, Thomas] Univ Ulm, Inst Physiol Chem, D-89081 Ulm, Germany; [Serrano-Pozo, Alberto; Hyman, Bradley T.] Massachusetts Gen Hosp, Inst Neurodegenerat Dis, Charlestown, MA USA; [Proepper, Christian; Boeckers, Tobias M.] Univ Ulm, Inst Anat & Cell Biol, D-89081 Ulm, Germany; [Rueck, Angelika] Univ Ulm, Core Facil Laser Microscopy, D-89081 Ulm, Germany; [Thal, Dietmar R.] Univ Ulm, Inst Pathol, Lab Neuropathol, D-89081 Ulm, Germany	Ulm University; Ulm University; Harvard University; Massachusetts General Hospital; Ulm University; Ulm University; Ulm University	von Arnim, CAF (corresponding author), Univ Ulm, Inst Neurol, Helmholtzstr 8-1, D-89081 Ulm, Germany.	christine.arnim@uni-ulm.de	Wirth, Thomas/X-7172-2019; Thal, Dietmar R/O-7483-2018; Serrano-Pozo, Alberto/L-1519-2019	Thal, Dietmar R/0000-0002-1036-1075; Serrano-Pozo, Alberto/0000-0003-0899-7530	Alzheimer Forschung Initiative e.V. (AFI) [05825]; AiF/IGF grant of Bundesministerium fur Wirtschaft [15727 N/1]; Ernst Schering Foundation; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	Alzheimer Forschung Initiative e.V. (AFI); AiF/IGF grant of Bundesministerium fur Wirtschaft; Ernst Schering Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants to C.A.F. v.A from the Alzheimer Forschung Initiative e.V. (AFI) (grant number 05825) and from an AiF/IGF grant (grant number 15727 N/1) of the Bundesministerium fur Wirtschaft, as well as a Doctoral Fellowship to A.W. from the Ernst Schering Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeckers TM, 1999, J NEUROSCI, V19, P6506; Boman AL, 2000, MOL BIOL CELL, V11, P1241, DOI 10.1091/mbc.11.4.1241; Boman AL, 2001, J CELL SCI, V114, P3413; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Brannstrom K, 2014, J AM CHEM SOC, V136, P10956, DOI 10.1021/ja503535m; CHEN HJ, 1993, J BIOL CHEM, V268, P22338; Chen HJ, 1997, J BIOL CHEM, V272, P7003, DOI 10.1074/jbc.272.11.7003; Cramer JF, 2010, TRAFFIC, V11, P259, DOI 10.1111/j.1600-0854.2009.01017.x; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Doray B, 2002, P NATL ACAD SCI USA, V99, P8072, DOI 10.1073/pnas.082235699; Doray B, 2012, TRAFFIC, V13, P1315, DOI 10.1111/j.1600-0854.2012.01396.x; Fath T, 2009, NAT PROTOC, V4, P78, DOI 10.1038/nprot.2008.199; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; HAASS C, 1991, J NEUROSCI, V11, P3783; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; He XY, 2002, FEBS LETT, V524, P183, DOI 10.1016/S0014-5793(02)03052-1; Herskowitz JH, 2012, MOL BIOL CELL, V23, P2645, DOI 10.1091/mbc.E12-01-0014; Hirst J, 2000, J CELL BIOL, V149, P67, DOI 10.1083/jcb.149.1.67; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hong HS, 2003, BIOCHEM BIOPH RES CO, V307, P922, DOI 10.1016/S0006-291X(03)01270-1; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; John BA, 2014, FEBS J, V281, P2074, DOI 10.1111/febs.12763; JOHNSON KF, 1992, J BIOL CHEM, V267, P17110; Kalthoff C, 2002, MOL BIOL CELL, V13, P4060, DOI 10.1091/mbc.E02-03-0171; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kinoshita A, 2001, J NEUROSCI, V21, P8354, DOI 10.1523/JNEUROSCI.21-21-08354.2001; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lui WWY, 2003, MOL BIOL CELL, V14, P2385, DOI 10.1091/mbc.e02-11-0735; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; McAllister C, 2005, J MOL BIOL, V354, P1028, DOI 10.1016/j.jmb.2005.10.012; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Misra S, 2002, NATURE, V415, P933, DOI 10.1038/415933a; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Poussu A, 2000, J BIOL CHEM, V275, P7176, DOI 10.1074/jbc.275.10.7176; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Santosa C, 2011, NEUROBIOL DIS, V43, P176, DOI 10.1016/j.nbd.2011.03.009; Sarajarvi T, 2009, J BIOL CHEM, V284, P34433, DOI 10.1074/jbc.M109.036202; Schmidt V, 2007, J BIOL CHEM, V282, P32956, DOI 10.1074/jbc.M705073200; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Shiba Y, 2004, J BIOL CHEM, V279, P7105, DOI 10.1074/jbc.M311702200; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Su Y, 2001, BRAIN RES, V893, P287, DOI 10.1016/S0006-8993(00)03322-9; Takatsu H, 2000, BIOCHEM BIOPH RES CO, V271, P719, DOI 10.1006/bbrc.2000.2700; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; von Arnim CAF, 2008, BIOCHEM BIOPH RES CO, V370, P207, DOI 10.1016/j.bbrc.2008.03.047; von Arnim CAF, 2006, J NEUROSCI, V26, P9913, DOI 10.1523/JNEUROSCI.2290-06.2006; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Walker KR, 2012, J NEUROSCI, V32, P10423, DOI 10.1523/JNEUROSCI.5491-11.2012; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Walter L, 2002, J BIOL CHEM, V277, P20869, DOI 10.1074/jbc.M110813200; Wasiak S, 2002, J CELL BIOL, V158, P855, DOI 10.1083/jcb.200205078; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150; Zhu GY, 2003, FEBS LETT, V537, P171, DOI 10.1016/S0014-5793(03)00095-4	66	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129047	10.1371/journal.pone.0129047	http://dx.doi.org/10.1371/journal.pone.0129047			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053850	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300079
J	Zalenskaya, IA; Joseph, T; Bavarva, J; Yousefieh, N; Jackson, SS; Fashemi, T; Yamamoto, HS; Settlage, R; Fichorova, RN; Doncel, GF				Zalenskaya, Irina A.; Joseph, Theresa; Bavarva, Jasmin; Yousefieh, Nazita; Jackson, Suzanne S.; Fashemi, Titilayo; Yamamoto, Hidemi S.; Settlage, Robert; Fichorova, Raina N.; Doncel, Gustavo F.			Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CCR6-EXPRESSING TH17 CELLS; T-CELLS; SEXUAL TRANSMISSION; EPITHELIAL-CELLS; CERVICOVAGINAL INFLAMMATION; NEISSERIA-GONORRHOEAE; TOPICAL MICROBICIDES; BACTERIAL VAGINOSIS; IMMUNE-RESPONSES	Background Inflammation and immune activation of the cervicovaginal mucosa are considered factors that increase susceptibility to HIV infection. Therefore, it is essential to screen candidate anti-HIV microbicides for potential mucosal immunomodulatory/inflammatory effects prior to further clinical development. The goal of this study was to develop an in vitro method for preclinical evaluation of the inflammatory potential of new candidate microbicides using a microarray gene expression profiling strategy. Methods To this end, we compared transcriptomes of human vaginal cells (Vk2/E6E7) treated with well-characterized pro-inflammatory (PIC) and non-inflammatory (NIC) compounds. PICs included compounds with different mechanisms of action. Gene expression was analyzed using Affymetrix U133 Plus 2 arrays. Data processing was performed using GeneSpring 11.5 (Agilent Technologies, Santa Clara, CA). Results Microarraray comparative analysis allowed us to generate a panel of 20 genes that were consistently deregulated by PICs compared to NICs, thus distinguishing between these two groups. Functional analysis mapped 14 of these genes to immune and inflammatory responses. This was confirmed by the fact that PICs induced NF kappa B pathway activation in Vk2 cells. By testing microbicide candidates previously characterized in clinical trials we demonstrated that the selected PIC-associated genes properly identified compounds with mucosa-altering effects. The discriminatory power of these genes was further demonstrated after culturing vaginal cells with vaginal bacteria. Prevotella bivia, prevalent bacteria in the disturbed microbiota of bacterial vaginosis, induced strong upregulation of seven selected PIC-associated genes, while a commensal Lactobacillus gasseri associated to vaginal health did not cause any changes. Conclusions In vitro evaluation of the immunoinflammatory potential of microbicides using the PIC-associated genes defined in this study could help in the initial screening of candidates prior to entering clinical trials. Additional characterization of these genes can provide further insight into the cervicovaginal immunoinflammatory and mucosal-altering processes that facilitate or limit HIV transmission with implications for the design of prevention strategies.	[Zalenskaya, Irina A.; Joseph, Theresa; Yousefieh, Nazita; Jackson, Suzanne S.; Doncel, Gustavo F.] Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA; [Bavarva, Jasmin; Settlage, Robert] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Fashemi, Titilayo; Yamamoto, Hidemi S.; Fichorova, Raina N.] Harvard Univ, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Lab Genital Tract Biol,Med Sch, Boston, MA 02115 USA	Eastern Virginia Medical School; Virginia Polytechnic Institute & State University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Zalenskaya, IA (corresponding author), Eastern Virginia Med Sch, Dept Obstet & Gynecol, CONRAD, Norfolk, VA 23501 USA.	ZalensIA@EVMS.edu; DoncelGF@EVMS.edu			CONRAD funds; USAID [GPO-A-00-08-00005-00]; NIH/NIAID [YI-AI-1756-01]; Bill and Melinda Gates Foundation [41266]	CONRAD funds(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by CONRAD funds from a cooperative agreement with USAID GPO-A-00-08-00005-00 with additional funds from an interagency agreement with NIH/NIAID YI-AI-1756-01 (GFD), and grant 41266 from the Bill and Melinda Gates Foundation(GFD). The views of the authors expressed in this manuscript do not necessarily reflect those of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Leidos Biomedical Research, Inc. provided support in the form of salaries for author JB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JL, 2012, BEST PRACT RES CLIN; Aleman-Muench GR, 2012, IMMUNOL CELL BIOL, V90, P137, DOI 10.1038/icb.2011.32; Anderson AC, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0312-5; Antonio MAD, 1999, J INFECT DIS, V180, P1950, DOI 10.1086/315109; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Baggiolini M, 1997, J EXP MED, V186, P1189, DOI 10.1084/jem.186.8.1189; Ballagh SA, 2002, CONTRACEPTION, V66, P369, DOI 10.1016/S0010-7824(02)00433-X; Ballweber L, 2011, J VIROL, V85, P13443, DOI 10.1128/JVI.05615-11; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; Blauvelt A, 2000, AIDS, V14, P647, DOI 10.1097/00002030-200004140-00003; Borrow P, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-84; Buve A, 2014, AIDS, V28, P2333, DOI 10.1097/QAD.0000000000000432; Catalone BJ, 2004, ANTIMICROB AGENTS CH, V48, P1837, DOI 10.1128/AAC.48.5.1837-1847.2004; Cone RA, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-90; Coombs RW, 2003, AIDS, V17, P455, DOI 10.1097/00002030-200303070-00001; Cremel M, 2005, J LEUKOCYTE BIOL, V78, P158, DOI 10.1189/jlb.0305147; Cummins JE, 2009, SEX TRANSM DIS, V36, pS84, DOI 10.1097/OLQ.0b013e3181994191; Darnell GA, 2006, J BIOL CHEM, V281, P31348, DOI 10.1074/jbc.M604220200; de Jong MAWP, 2008, J GEN VIROL, V89, P2398, DOI 10.1099/vir.0.2008/003129-0; Doncel GF, 2004, JAIDS-J ACQ IMM DEF, V37, pS174, DOI 10.1097/00126334-200410013-00008; Doncel GF, 2010, ANTIVIR RES, V88, pS10, DOI 10.1016/j.antiviral.2010.09.018; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Dumais N, 1998, J BIOL CHEM, V273, P27306, DOI 10.1074/jbc.273.42.27306; El Hed A, 2010, J INFECT DIS, V201, P843, DOI 10.1086/651021; Fahrbach KM, 2007, J VIROL, V81, P6858, DOI 10.1128/JVI.02472-06; Fazeli A, 2005, HUM REPROD, V20, P1372, DOI 10.1093/humrep/deh775; Feldblum PJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001474; Fichorova RN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048418; Fichorova RN, 2011, MBIO, V2, DOI 10.1128/mBio.00168-11; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Fichorova RN, 2002, J IMMUNOL, V168, P2424, DOI 10.4049/jimmunol.168.5.2424; Fields S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110980; Friend DR, 2013, ANTIVIR RES, V99, P391, DOI 10.1016/j.antiviral.2013.06.021; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Gengiah TN, 2012, EXPERT OPIN INV DRUG, V21, P695, DOI 10.1517/13543784.2012.667072; Gray RH, 2012, J INFECT DIS, V205, P351, DOI 10.1093/infdis/jir751; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; HILL GB, 1993, AM J OBSTET GYNECOL, V169, P450, DOI 10.1016/0002-9378(93)90339-K; Hirata T, 2010, ENDOCRINOLOGY, V151, P5468, DOI 10.1210/en.2010-0398; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Hladik F, 2010, ANTIVIR RES, V88, pS3, DOI 10.1016/j.antiviral.2010.09.011; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jespers V, 2013, SEX TRANSM DIS, V40, P729, DOI 10.1097/01.olq.0000431070.38601.03; Johnson TJ, 2012, ANTIMICROB AGENTS CH, V56, P6272, DOI 10.1128/AAC.01431-12; JONES KA, 1994, ANNU REV BIOCHEM, V63, P717, DOI 10.1146/annurev.bi.63.070194.003441; Joseph T, 2012, AM J REPROD IMMUNOL, V67, P482, DOI 10.1111/j.1600-0897.2011.01099.x; Kabashima K, 2003, NAT MED, V9, P744, DOI 10.1038/nm872; Kader M, 2009, MUCOSAL IMMUNOL, V2, P439, DOI 10.1038/mi.2009.90; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2012, BEST PRACT RES CL OB, V26, P427, DOI 10.1016/j.bpobgyn.2012.01.010; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; Khaidakov M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020277; Kim H, 2010, NAT IMMUNOL, V11, P743, DOI 10.1038/ni.1897; Lane BR, 2001, J VIROL, V75, P8195, DOI 10.1128/JVI.75.17.8195-8202.2001; Li DY, 2000, CIRCULATION, V101, P2889, DOI 10.1161/01.CIR.101.25.2889; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McKinnon LR, 2011, J IMMUNOL, V187, P6032, DOI 10.4049/jimmunol.1101836; Medzhitov R, 2000, TRENDS MICROBIOL, V8, P452, DOI 10.1016/S0966-842X(00)01845-X; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Miossec P, 2009, MICROBES INFECT, V11, P625, DOI 10.1016/j.micinf.2009.04.003; Monteiro P, 2011, J IMMUNOL, V186, P4618, DOI 10.4049/jimmunol.1004151; Narimatsu R, 2005, AIDS RES HUM RETROV, V21, P228, DOI 10.1089/aid.2005.21.228; Nasu K, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/976024; NIRUTHISARD S, 1991, SEX TRANSM DIS, V18, P176, DOI 10.1097/00007435-199107000-00010; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; Obiero J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-289; Onderdonk AB, 2003, J CLIN MICROBIOL, V41, P1073, DOI 10.1128/JCM.41.3.1073-1079.2003; Patton DL, 2007, ANTIMICROB AGENTS CH, V51, P1608, DOI 10.1128/AAC.00984-06; Pavlova SI, 2002, J APPL MICROBIOL, V92, P451, DOI 10.1046/j.1365-2672.2002.01547.x; Pendharkar S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-43; Peterson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001312; Prendergast A, 2010, AIDS, V24, P491, DOI 10.1097/QAD.0b013e3283344895; Pudney J, 2005, BIOL REPROD, V73, P1253, DOI 10.1095/biolreprod.105.043133; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; REDONDOLOPEZ V, 1990, REV INFECT DIS, V12, P856; Romano JW, 2012, CURR HIV RES, V10, P9, DOI 10.2174/157016212799304625; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Sabroe I, 2008, J PATHOL, V214, P126, DOI 10.1002/path.2264; Schroder WA, 2011, CRIT REV IMMUNOL, V31, P15, DOI 10.1615/CritRevImmunol.v31.i1.20; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Shacklett BL, 2010, CURR OPIN HIV AIDS, V5, P128, DOI 10.1097/COH.0b013e328335c178; Shattock RJ, 2003, NAT REV MICROBIOL, V1, P25, DOI 10.1038/nrmicro729; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; Sokal DC, 2013, ANTIVIR THER, V18, P301, DOI 10.3851/IMP2311; Spandorfer SD, 2001, J REPROD MED, V46, P806; Stone AB, 2013, AIDS, V27, P2261, DOI 10.1097/QAD.0b013e32836239b4; Sugaya M, 2004, J IMMUNOL, V172, P2219, DOI 10.4049/jimmunol.172.4.2219; Szameit S, 2008, CLIN CHEM, V54, P525, DOI 10.1373/clinchem.2007.097386; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; Tureci O, 2003, FASEB J, V17, P836, DOI 10.1096/fj.02-0724com; Turini ME, 2002, ANNU REV MED, V53, P35, DOI 10.1146/annurev.med.53.082901.103952; Van Damme L, 2004, TROP MED INT HEALTH, V9, P1290, DOI 10.1111/j.1365-3156.2004.01338.x; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Verstrepen L, 2010, BIOCHEM PHARMACOL, V80, P2009, DOI 10.1016/j.bcp.2010.06.044; Ward H, 2010, CURR OPIN HIV AIDS, V5, P305, DOI 10.1097/COH.0b013e32833a8844; WARREN JS, 1990, CRIT REV CL LAB SCI, V28, P37, DOI 10.3109/10408369009105897; Weiler AM, 2008, J VIROL, V82, P4154, DOI 10.1128/JVI.01947-07; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Yu L, 2009, AM J REPROD IMMUNOL, V62, P1, DOI 10.1111/j.1600-0897.2009.00712.x; Zalenskaya IA, 2000, BIOCHEM BIOPH RES CO, V279, P213, DOI 10.1006/bbrc.2000.3917; Zalenskaya IA, 2011, AM J REPROD IMMUNOL, V65, P569, DOI 10.1111/j.1600-0897.2010.00964.x; Zhong MH, 2012, ANTIMICROB AGENTS CH, V56, P3121, DOI 10.1128/AAC.05950-11	122	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128557	10.1371/journal.pone.0128557	http://dx.doi.org/10.1371/journal.pone.0128557			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052926	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300044
J	Ghaleb, AM; Bialkowska, AB; Snider, AJ; Gnatenko, DV; Hannun, YA; Yang, VW; Schmidt, VA				Ghaleb, Amr M.; Bialkowska, Agnieszka B.; Snider, Ashley J.; Gnatenko, Dmitri V.; Hannun, Yusuf A.; Yang, Vincent W.; Schmidt, Valentina A.			IQ Motif-Containing GTPase-Activating Protein 2 (IQGAP2) Is a Novel Regulator of Colonic Inflammation in Mice	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION PATHWAY; SODIUM-INDUCED COLITIS; TIME QUANTITATIVE PCR; BOWEL-DISEASE; GENE-EXPRESSION; CANCER; TUMORIGENESIS; MACROPHAGES; INVASION	IQ motif-containing GTPase-activating protein 2 (IQGAP2) is a multidomain scaffolding protein that plays a role in cytoskeleton regulation by juxtaposing Rho GTPase and Ca2+/calmodulin signals. While IQGAP2 suppresses tumorigenesis in liver, its role in pathophysiology of the gastrointestinal tract remains unexplored. Here we report that IQGAP2 is required for the inflammatory response in colon. Mice lacking Iqgap2 gene (Iqgap2(-/-) mice) were resistant to chemically-induced colitis. Unlike wild-type controls, Iqgap2(-/-) mice treated with 3% dextran sulfate sodium (DSS) in water for 13 days displayed no injury to colonic epithelium. Mechanistically, resistance to colitis was associated with suppression of colonic NF-kappa B signaling and IL-6 synthesis, along with diminished neutrophil and macrophage production and recruitment in Iqgap2(-/-) mice. Finally, alterations in IQGAP2 expression were found in colons of patients with inflammatory bowel disease (IBD). Our findings indicate that IQGAP2 promotes inflammatory response at two distinct levels; locally, in colonic epithelium through TLR4/NF-kappa B signaling pathway, and systemically, via control of maturation and recruitment of myeloid immune cells. This work identifies a novel mechanism of colonic inflammation mediated by signal transducing scaffolding protein IQGAP2. IQGAP2 domain-specific blocking agents may represent a conceptually novel strategy for therapy of IBD and other inflammation-associated disorders, including cancer.	[Ghaleb, Amr M.; Bialkowska, Agnieszka B.; Snider, Ashley J.; Gnatenko, Dmitri V.; Hannun, Yusuf A.; Yang, Vincent W.; Schmidt, Valentina A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Snider, Ashley J.] Northport Vet Affairs Med Ctr, Northport, NY USA; [Snider, Ashley J.; Hannun, Yusuf A.; Yang, Vincent W.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Gnatenko, Dmitri V.] SUNY Stony Brook, Genom Core Facil, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Schmidt, VA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	Valentina.Schmidt@stonybrookmedicine.edu			Research Scholar Grant from the American Cancer Society [RSG-09-033-01-CSM]; National Institutes of Health [DK052230, DK093680]; Sphingolipid Animal Cancer Pathobiology Core grant [P01CA097132]; Department of Medicine and Cancer Center, Stony Brook University; NATIONAL CANCER INSTITUTE [R01CA172517, P01CA097132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093680] Funding Source: NIH RePORTER	Research Scholar Grant from the American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sphingolipid Animal Cancer Pathobiology Core grant; Department of Medicine and Cancer Center, Stony Brook University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Research Scholar Grant RSG-09-033-01-CSM from the American Cancer Society (to VAS), National Institutes of Health grants DK052230 and DK093680 (to VWY); Sphingolipid Animal Cancer Pathobiology Core grant (P01CA097132), and the Institutional Funding from the Department of Medicine and Cancer Center, Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Anakk S, 2013, CELL REP, V5, P1060, DOI 10.1016/j.celrep.2013.10.030; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Briggs MW, 2002, J BIOL CHEM, V277, P7453, DOI 10.1074/jbc.M104315200; Buettner R, 2002, CLIN CANCER RES, V8, P945; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Cario E, 2010, INFLAMM BOWEL DIS, V16, P1583, DOI 10.1002/ibd.21282; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Fan BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029824; Gnatenko DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071826; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Jameson KL, 2013, NAT MED, V19, P626, DOI 10.1038/nm.3165; Jin SH, 2008, INT J CANCER, V122, P1040, DOI 10.1002/ijc.23181; Joseph F., 2012, P 103 ANN M AM ASS C; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Mahler M, 1998, AM J PHYSIOL-GASTR L, V274, pG544, DOI 10.1152/ajpgi.1998.274.3.G544; Marrero JA, 2000, AM J PHYSIOL-GASTR L, V278, pG797, DOI 10.1152/ajpgi.2000.278.5.G797; McLean DTF, 2013, BIOCHIMIE, V95, P875, DOI 10.1016/j.biochi.2012.12.004; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Muise AM, 2011, GASTROENTEROLOGY, V141, P633, DOI 10.1053/j.gastro.2011.04.057; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977; Osman MA, 2013, BBA-REV CANCER, V1836, P166, DOI 10.1016/j.bbcan.2013.04.005; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Qualls JE, 2006, J LEUKOCYTE BIOL, V80, P802, DOI 10.1189/jlb.1205734; Raddatz D, 2005, EUR J GASTROEN HEPAT, V17, P547, DOI 10.1097/00042737-200505000-00012; Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Sbroggio M, 2011, CARDIOVASC RES, V91, P456, DOI 10.1093/cvr/cvr103; Schmidt VA, 2003, BLOOD, V101, P3021, DOI 10.1182/blood-2002-09-2807; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schmidt VA, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/958673; Schreiber S, 1998, GUT, V42, P477, DOI 10.1136/gut.42.4.477; Tang MC, 2011, CANCER LETT, V308, P162, DOI 10.1016/j.canlet.2011.05.001; Turgeon N, 2014, AM J PHYSIOL-GASTR L, V306, pG594, DOI 10.1152/ajpgi.00393.2013; Uno JK, 2010, GASTROENTEROLOGY, V139, P1642, DOI 10.1053/j.gastro.2010.07.008; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Wu F DF, 2014, GSE59648, Patent No. GSE59648; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xie YZ, 2012, ORG LETT, V14, P3, DOI 10.1021/ol202923u; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073	51	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129314	10.1371/journal.pone.0129314	http://dx.doi.org/10.1371/journal.pone.0129314			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047140	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200149
J	Jian, YT; Yang, Y; Tian, T; Stanford, C; Zhang, XP; Zhao, K				Jian, Yu-Tao; Yang, Yue; Tian, Tian; Stanford, Clark; Zhang, Xin-Ping; Zhao, Ke			Effect of Pore Size and Porosity on the Biomechanical Properties and Cytocompatibility of Porous NiTi Alloys	PLOS ONE			English	Article							TISSUE; FABRICATION; SCAFFOLDS; IMPLANTS; CELLS	Five types of porous Nickel-Titanium (NiTi) alloy samples of different porosities and pore sizes were fabricated. According to compressive and fracture strengths, three groups of porous NiTi alloy samples underwent further cytocompatibility experiments. Porous NiTi alloys exhibited a lower Young's modulus (2.0 GPa similar to 0.8 GPa). Both compressive strength (108.8 MPa similar to 56.2 MPa) and fracture strength (64.6 MPa similar to 41.6 MPa) decreased gradually with increasing mean pore size (MPS). Cells grew and spread well on all porous NiTi alloy samples. Cells attached more strongly on control group and blank group than on all porous NiTi alloy samples (p < 0.05). Cell adhesion on porous NiTi alloys was correlated negatively to MPS (277.2 mu m similar to 566.5 mu m; p < 0.05). More cells proliferated on control group and blank group than on all porous NiTi alloy samples (p < 0.05). Cellular ALP activity on all porous NiTi alloy samples was higher than on control group and blank group (p < 0.05). The porous NiTi alloys with optimized pore size could be a potential orthopedic material.	[Jian, Yu-Tao] Sun Yat Sen Univ, Inst Stomatol Res, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Yang, Yue; Tian, Tian; Zhao, Ke] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Prosthodont, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Stanford, Clark] Univ Iowa, Coll Dent, Dows Inst Dent Res, Iowa City, IA 52242 USA; [Zhang, Xin-Ping] S China Univ Technol, Sch Mat Sci & Engn, Dept Metall Mat Sci & Engn, Guangzhou 510641, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; University of Iowa; South China University of Technology	Zhao, K (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Prosthodont, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China.	zhaoke@mail.sysu.edu.cn			Natural Science Foundation of China [50871039]; Guangdong Provincial Natural Science Foundation [S2013020012805]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	Funding for this work came from the Natural Science Foundation of China (No. 50871039, http://www.nsfc.gov.cn/) to KZ and the Guangdong Provincial Natural Science Foundation (Key Grant No. S2013020012805, http://www.gdstc.gov.cn/) also to KZ.	Aly MS, 2010, MATER LETT, V64, P935, DOI 10.1016/j.matlet.2010.01.064; Ayers RA, 2007, J BIOMED MATER RES A, V81A, P634, DOI 10.1002/jbm.a.31017; Bayraktar HH, 2004, J BIOMECH, V37, P27, DOI 10.1016/S0021-9290(03)00257-4; CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Frosch K.-H., 2006, EUR J TRAUMA, V32, P149, DOI [10.1007/s00068-006-6041-1, DOI 10.1007/s00068-006-6041-1]; Goldberg M, 2007, J BIOMAT SCI-POLYM E, V18, P241, DOI 10.1163/156856207779996931; Gonzalez-Barcenas LA, 2003, AIP CONF PROC, V682, P173, DOI 10.1063/1.1615117; HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309; Jiang B, 2007, SCRIPTA MATER, V56, P169, DOI 10.1016/j.scriptamat.2006.08.070; Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4; Le Guehennec L, 2007, DENT MATER, V23, P844, DOI 10.1016/j.dental.2006.06.025; Li DS, 2009, J ALLOY COMPD, V470, pL1, DOI 10.1016/j.jallcom.2008.02.059; Li YH, 2002, J ALLOY COMPD, V345, P271, DOI 10.1016/S0925-8388(02)00412-7; Li YC, 2010, J ALLOY COMPD, V494, P323, DOI 10.1016/j.jallcom.2010.01.026; Lim JY, 2007, TISSUE ENG, V13, P1879, DOI 10.1089/ten.2006.0154; Liu XM, 2011, BIOMATERIALS, V32, P330, DOI 10.1016/j.biomaterials.2010.08.102; Parthasarathy J, 2010, J MECH BEHAV BIOMED, V3, P249, DOI 10.1016/j.jmbbm.2009.10.006; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Ryan G, 2006, BIOMATERIALS, V27, P2651, DOI 10.1016/j.biomaterials.2005.12.002; Sargeant TD, 2008, BIOMATERIALS, V29, P161, DOI 10.1016/j.biomaterials.2007.09.012; St-Pierre JP, 2005, BIOMATERIALS, V26, P7319, DOI 10.1016/j.biomaterials.2005.05.046; Stangl R., 2001, European Cells & Materials, V2, P1; Subramaniam M, 2002, J CELL BIOCHEM, V87, P9, DOI 10.1002/jcb.10259; Wang JF, 2008, J MATER PROCESS TECH, V197, P428, DOI 10.1016/j.jmatprotec.2007.06.065; Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0; Yen ML, 2007, STEM CELLS, V25, P125, DOI 10.1634/stemcells.2006-0295; Zhang YP, 2007, SCRIPTA MATER, V57, P1020, DOI 10.1016/j.scriptamat.2007.07.043	28	19	22	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128138	10.1371/journal.pone.0128138	http://dx.doi.org/10.1371/journal.pone.0128138			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047515	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200042
J	Khokhlova, OE; Hung, WC; Wan, TW; Iwao, Y; Takano, T; Higuchi, W; Yachenko, SV; Teplyakova, OV; Kamshilova, VV; Kotlovsky, YV; Nishiyama, A; Reva, IV; Sidorenko, SV; Peryanova, OV; Reva, GV; Teng, LJ; Salmina, AB; Yamamoto, T				Khokhlova, Olga E.; Hung, Wei-Chun; Wan, Tsai-Wen; Iwao, Yasuhisa; Takano, Tomomi; Higuchi, Wataru; Yachenko, Svetlana V.; Teplyakova, Olga V.; Kamshilova, Vera V.; Kotlovsky, Yuri V.; Nishiyama, Akihito; Reva, Ivan V.; Sidorenko, Sergey V.; Peryanova, Olga V.; Reva, Galina V.; Teng, Lee-Jene; Salmina, Alla B.; Yamamoto, Tatsuo			Healthcare- and Community-Associated Methicillin-Resistant Staphylococcus aureus (MRSA) and Fatal Pneumonia with Pediatric Deaths in Krasnoyarsk, Siberian Russia: Unique MRSA's Multiple Virulence Factors, Genome, and Stepwise Evolution	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; TOXIC-SHOCK-SYNDROME; ANTIMICROBIAL RESISTANCE; GENETIC BACKGROUNDS; NUCLEOTIDE-SEQUENCE; BIOFILM FORMATION; USA300 CLONE; T-CELLS; STRAINS; IDENTIFICATION	Methicillin-resistant Staphylococcus aureus (MRSA) is a common multidrug-resistant (MDR) pathogen. We herein discussed MRSA and its infections in Krasnoyarsk, Siberian Russia between 2007 and 2011. The incidence of MRSA in 3,662 subjects was 22.0% and 2.9% for healthcare-and community-associated MRSA (HA-and CA-MRSA), respectively. The 15-day mortality rates for MRSA hospital-and community-acquired pneumonia (HAP and CAP) were 6.5% and 50%, respectively. MRSA CAP cases included pediatric deaths; of the MRSA pneumonia episodes available, >= 27.3% were associated with bacteremia. Most cases of HA-MRSA examined exhibited ST239/spa3(t037)/SCCmecIII.1.1.2 (designated as ST239(Kras)), while all CA-MRSA cases examined were ST8/spa1(t008)/SCCme-cIV.3.1.1(IVc) (designated as ST8(Kras)). ST239(Kras) and ST8(Kras) strongly expressed cytolytic peptide (phenol-soluble modulin a, PSMa; and delta-hemolysin, Hld) genes, similar to CA-MRSA. ST239(Kras) pneumonia may have been attributed to a unique set of multiple virulence factors (MVFs): toxic shock syndrome toxin-1 (TSST-1), elevated PSMa/Hld expression, alpha-hemolysin, the staphylococcal enterotoxin SEK/SEQ, the immune evasion factor SCIN/SAK, and collagen adhesin. Regarding ST8(Kras), SEA was included in MVFs, some of which were common to ST239(Kras). The ST239(Kras) (strain OC3) genome contained: a completely unique phage, phi Sa7-like (W), with no att repetition; S. aureus pathogenicity island SaPI2R, the first TSST-1 gene-positive (tst(+)) SaPI in the ST239 lineage; and a super copy of IS256 (>= 22 copies/genome). ST239(Kras) carried the Brazilian SCCmecIII.1.1.2 and United Kingdom-type tst. ST239(Kras) and ST8(Kras) were MDR, with the same levofloxacin resistance mutations; small, but transmissible chloramphenicol resistance plasmids spread widely enough to not be ignored. These results suggest that novel MDR and MVF+ HA-and CA-MRSA (ST239(Kras) and ST8(Kras)) emerged in Siberian Russia (Krasnoyarsk) associated with fatal pneumonia, and also with ST239(Kras), a new (Siberian Russian) clade of the ST239 lineage, which was created through stepwise evolution during its potential transmission route of Brazil-Europe-Russia/Krasnoyarsk, thereby selective advantages from unique MVFs and the MDR.	[Khokhlova, Olga E.; Iwao, Yasuhisa; Peryanova, Olga V.; Yamamoto, Tatsuo] Krasnoyarsk State Med Univ, Russia Japan Ctr Microbiol Metagen & Infect Dis, Krasnoyarsk, Russia; [Khokhlova, Olga E.; Peryanova, Olga V.] Krasnoyarsk State Med Univ, Dept Microbiol, Krasnoyarsk, Russia; [Khokhlova, Olga E.; Hung, Wei-Chun; Iwao, Yasuhisa; Takano, Tomomi; Higuchi, Wataru; Nishiyama, Akihito; Reva, Ivan V.; Yamamoto, Tatsuo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Infect Dis Control & Int Med, Div Bacteriol, Niigata, Japan; [Khokhlova, Olga E.; Hung, Wei-Chun; Wan, Tsai-Wen; Iwao, Yasuhisa; Reva, Ivan V.; Yamamoto, Tatsuo] Int Med Educ & Res Ctr, Dept Epidemiol Genom & Evolut, Niigata, Japan; [Wan, Tsai-Wen; Teng, Lee-Jene] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Hung, Wei-Chun] Kaohsiung Med Univ, Dept Microbiol & Immunol, Kaohsiung, Taiwan; [Yachenko, Svetlana V.] Krasnoyarsk Reg Ctr Prevent & Control AIDS & Infe, Krasnoyarsk, Russia; [Teplyakova, Olga V.] City Clin Hosp 7, Krasnoyarsk, Russia; [Teplyakova, Olga V.] Krasnoyarsk State Med Univ, Dept Gen Surg, Krasnoyarsk, Russia; [Kamshilova, Vera V.] Municipal Hosp Emergency Med Care, Krasnoyarsk, Russia; [Kotlovsky, Yuri V.] Krasnoyarsk State Med Univ, Cent Res Lab, Krasnoyarsk, Russia; [Reva, Ivan V.; Reva, Galina V.] Far Eastern Fed Univ, Sch Biomed, Vladivostok, Russia; [Sidorenko, Sergey V.] Res Inst Childrens Infect, St Petersburg, Russia; [Salmina, Alla B.] Krasnoyarsk State Med Univ, Res Inst Mol Med & Pathobiochem, Krasnoyarsk, Russia	Krasnoyarsk State Medical University; Krasnoyarsk State Medical University; Niigata University; National Taiwan University; Kaohsiung Medical University; Krasnoyarsk State Medical University; Krasnoyarsk State Medical University; Far Eastern Federal University; Krasnoyarsk State Medical University	Yamamoto, T (corresponding author), Krasnoyarsk State Med Univ, Russia Japan Ctr Microbiol Metagen & Infect Dis, Krasnoyarsk, Russia.	tatsuoy@imerc.jp	Teplyakova, Olga/AAE-5112-2019; Khokhlova, Olga/J-3119-2017; Teplyakova, Olga V./M-7060-2014; Salmina, Alla B./L-7977-2013; Sidorenko, Sergey/E-5870-2011; Olga, Peryanova/N-7432-2015	Teplyakova, Olga/0000-0003-0005-3316; Khokhlova, Olga/0000-0002-2829-5117; Teplyakova, Olga V./0000-0003-0005-3316; Sidorenko, Sergey/0000-0003-3550-7875; TENG, LEE-JENE/0000-0003-0104-741X; Reva, Galina/0000-0001-6502-4271; Reva, Ivan/0000-0002-3727-393X; Olga, Peryanova/0000-0001-7150-9670	Krasnoyarsk Regional Government (Russia); Japan-Russia Youth Exchange Center (Japan)	Krasnoyarsk Regional Government (Russia); Japan-Russia Youth Exchange Center (Japan)	This study was supported by a fund/grant from the Krasnoyarsk Regional Government (Russia) and Japan-Russia Youth Exchange Center (Japan), and by each institutional sources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; Alouf JE, 2003, INT J MED MICROBIOL, V292, P429, DOI 10.1078/1438-4221-00232; Arakere G, 2009, FEMS MICROBIOL LETT, V292, P141, DOI 10.1111/j.1574-6968.2008.01482.x; Bae T, 2006, MOL MICROBIOL, V62, P1035, DOI 10.1111/j.1365-2958.2006.05441.x; Baranovich T, 2007, EUROSURVEILLANCE, V12; Bartels MD, 2008, EUR J CLIN MICROBIOL, V27, P757, DOI 10.1007/s10096-008-0500-z; Becker EC, 2012, J BACTERIOL, V194, P5368, DOI 10.1128/JB.00818-12; Benson MA, 2014, MOL MICROBIOL, V93, P664, DOI 10.1111/mmi.12682; Berg T, 1998, J BACTERIOL, V180, P4350, DOI 10.1128/JB.180.17.4350-4359.1998; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Brusina EB, 2013, ANTIMICROB RESIST S1, V2, pP57; BYRNE ME, 1989, GENE, V81, P361, DOI 10.1016/0378-1119(89)90197-2; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P707; Costa MOC, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00576-13; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen FJ, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01011-13; Chen L, 2009, J CLIN MICROBIOL, V47, P3692, DOI 10.1128/JCM.00766-09; Cheung AL, 2008, INT J BIOCHEM CELL B, V40, P355, DOI 10.1016/j.biocel.2007.10.032; Cirlan Maria, 2005, Infection Genetics and Evolution, V5, P335, DOI 10.1016/j.meegid.2004.09.005; Clinical and Laboratory Standards Institute, 2012, M100S22 CLIN LAB STA; Committee for the Japanese Respiratory Society Guidelines in Management of Respiratory, 2004, Respirology, V9 Suppl 1, pS16; Conceicao T, 2007, CLIN MICROBIOL INFEC, V13, P971, DOI 10.1111/j.1469-0691.2007.01794.x; Coombs GW, 2013, COMMUN DIS INTELL, V37, pE210; Cue D, 2013, J BACTERIOL, V195, P1515, DOI 10.1128/JB.00012-13; de Bentzmann S, 2004, J INFECT DIS, V190, P1506, DOI 10.1086/424521; de Lencastre Herminia, 1997, Clin Microbiol Infect, V3, P289; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; de Sousa MA, 2004, FEMS IMMUNOL MED MIC, V40, P101, DOI 10.1016/S0928-8244(03)00370-5; de Sousa MA, 1998, J CLIN MICROBIOL, V36, P2590, DOI 10.1128/JCM.36.9.2590-2596.1998; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, J INFECT DIS, V197, P1523, DOI 10.1086/587907; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Espadinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059960; Ferry T, 2005, CLIN INFECT DIS, V41, P771, DOI 10.1086/432798; Foster TJ, 1998, TRENDS MICROBIOL, V6, P484, DOI 10.1016/S0966-842X(98)01400-0; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Gupta RK, 2013, J INFECT DIS, V208, P1841, DOI 10.1093/infdis/jit367; Hampele IC, 1997, J MOL BIOL, V268, P21, DOI 10.1006/jmbi.1997.0944; Harinstein L, 2011, J HOSP INFECT, V79, P194, DOI 10.1016/j.jhin.2011.03.017; Haroche J, 2002, ANTIMICROB AGENTS CH, V46, P2337, DOI 10.1128/AAC.46.8.2337-2343.2002; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Harro JM, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00037-12; Havaei SA, 2011, J CLIN MICROBIOL, V49, P3990, DOI 10.1128/JCM.05445-11; HIGUCHI W, 2010, J INFECT CHEMOTHER, V16, P144, DOI DOI 10.1007/s10156-010-0029-9; Holden MTG, 2010, J BACTERIOL, V192, P888, DOI 10.1128/JB.01255-09; Howden BP, 2010, J BACTERIOL, V192, P5848, DOI 10.1128/JB.00951-10; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Hung WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046987; Isobe H, 2012, BIOMED RES-TOKYO, V33, P97, DOI 10.2220/biomedres.33.97; Issa NC, 2001, POSTGRAD MED, V110, P55, DOI 10.3810/pgm.2001.10.1045; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Iwao Y, 2012, J INFECT CHEMOTHER, V18, P228, DOI 10.1007/s10156-012-0379-6; Iwao Y, 2012, JPN J INFECT DIS, V65, P184; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kadlec K, 2010, ANTIMICROB AGENTS CH, V54, P3475, DOI 10.1128/AAC.00464-10; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kalyan S, 2004, J INFECT DIS, V189, P1892, DOI 10.1086/383478; Kang MS, 2013, J BIOL CHEM, V288, P20520, DOI 10.1074/jbc.M113.454462; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; Khan SA, 1997, MICROBIOL MOL BIOL R, V61, P442, DOI 10.1128/.61.4.442-455.1997; Khokhlova O, 2015, J MICROBIOL IMMUNOL, V48, P335, DOI 10.1016/j.jmii.2012.09.004; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Kozitskaya S, 2004, INFECT IMMUN, V72, P1210, DOI 10.1128/IAI.72.2.1210-1215.2004; Krakauer T, 1999, IMMUNOL RES, V20, P163, DOI 10.1007/BF02786471; Kriegeskorte A, 2012, NAT MED, V18, P662, DOI 10.1038/nm.2765; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Li HM, 1998, IMMUNOL REV, V163, P177, DOI 10.1111/j.1600-065X.1998.tb01196.x; Li M, 2012, NAT MED, V18, P816, DOI 10.1038/nm.2692; Li Y, 2011, J BACTERIOL, V193, P3411, DOI 10.1128/JB.05135-11; Liu C, 2011, CLIN INFECT DIS, V52, P285, DOI 10.1093/cid/cir034; Loffler B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000715; Lucas AL, 2013, MICROB PATHOGENESIS, V57, P52, DOI 10.1016/j.micpath.2012.11.008; LYON BR, 1987, MICROBIOL REV, V51, P88, DOI 10.1128/MMBR.51.1.88-134.1987; McDougal LK, 2010, ANTIMICROB AGENTS CH, V54, P3804, DOI 10.1128/AAC.00351-10; Mendes RE, 2012, J CLIN MICROBIOL, V50, P3694, DOI 10.1128/JCM.02024-12; Mirzaii M, 2015, J INFECT PUBLIC HEAL, V8, P202, DOI 10.1016/j.jiph.2014.09.002; Monecke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097833; MURPHY E, 1984, NATURE, V307, P292, DOI 10.1038/307292a0; Murphy E., 1990, MOL BIOL STAPHYLOCOC, P123; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Nienaber JJC, 2011, J INFECT DIS, V204, P704, DOI 10.1093/infdis/jir389; Nishiyama A, 2012, FEMS IMMUNOL MED MIC, V66, P343, DOI 10.1111/j.1574-695X.2012.01027.x; Noto MJ, 2008, J BACTERIOL, V190, P1276, DOI 10.1128/JB.01128-07; Novick Richard P, 2007, Chem Immunol Allergy, V93, P42, DOI 10.1159/000100857; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Oliveira D., 1998, Clin Microbiol Infect, V4, P373, DOI 10.1111/j.1469-0691.1998.tb00081.x; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Pragman AA, 2004, J BACTERIOL, V186, P2430, DOI 10.1128/JB.186.8.2430-2438.2004; Robinson DA, 2004, J BACTERIOL, V186, P1060, DOI 10.1128/JB.186.4.1060-1064.2004; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Romanov AV, 2011, CLIN MICROBIOL ANTIM, V13, P169; [Романов Андрей Вячеславович Romanov А.V.], 2012, [Клиническая микробиология и антимикробная химиотерапия, Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya], V14, P201; Sawanobori E, 2015, J MICROBIOL IMMUNOL, V48, P565, DOI 10.1016/j.jmii.2014.04.015; SHALITA Z, 1980, PLASMID, V3, P291, DOI 10.1016/0147-619X(80)90042-6; Shi D, 2011, J CLIN MICROBIOL, V49, P1972, DOI 10.1128/JCM.01742-10; Shibuya Yasuhiro, 2008, Journal of Infection and Chemotherapy, V14, P439, DOI 10.1007/s10156-008-0640-1; Shore AC, 2010, ANTIMICROB AGENTS CH, V54, P4978, DOI 10.1128/AAC.01113-10; Simpson AE, 2003, J BACTERIOL, V185, P2143, DOI 10.1128/JB.185.7.2143-2152.2003; Smyth DS, 2009, J BACTERIOL, V191, P5964, DOI 10.1128/JB.00352-09; Stach CS, 2014, IMMUNOL RES, V59, P177, DOI 10.1007/s12026-014-8539-7; Stegger M, 2012, J BACTERIOL, V194, P1625, DOI 10.1128/JB.06653-11; Stratchounski LS, 2005, J CHEMOTHERAPY, V17, P54, DOI 10.1179/joc.2005.17.1.54; Takahashi N, 1998, LANCET, V351, P1614, DOI 10.1016/S0140-6736(97)11125-4; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Takano T, 2013, ANTIMICROB AGENTS CH, V57, P1589, DOI 10.1128/AAC.01147-12; Takano T, 2009, J INFECT CHEMOTHER, V15, P54, DOI 10.1007/s10156-008-0665-5; Takizawa Y, 2005, J CLIN MICROBIOL, V43, P3356, DOI 10.1128/JCM.43.7.3356-3363.2005; Tanaka T, 1995, J INFECT CHEMOTHER, V1, P40; Tenover FC, 2006, J CLIN MICROBIOL, V44, P108, DOI 10.1128/JCM.44.1.108-118.2006; Thurlow LR, 2012, FEMS IMMUNOL MED MIC, V65, P5, DOI 10.1111/j.1574-695X.2012.00937.x; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Vivoni AM, 2006, J CLIN MICROBIOL, V44, P1686, DOI 10.1128/JCM.44.5.1686-1691.2006; Vojtov N, 2002, P NATL ACAD SCI USA, V99, P10102, DOI 10.1073/pnas.152152499; Vorobieva V, 2008, APMIS, V116, P877, DOI 10.1111/j.1600-0463.2008.01092.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang T, 1998, ANTIMICROB AGENTS CH, V42, P236; Wang Z, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-529; WESTH H, 1995, ANTIMICROB AGENTS CH, V39, P369, DOI 10.1128/AAC.39.2.369; Wichelhaus TA, 1999, ANTIMICROB AGENTS CH, V43, P2813, DOI 10.1128/AAC.43.11.2813; Widdowson CA, 2000, ANTIMICROB AGENTS CH, V44, P393, DOI 10.1128/AAC.44.2.393-395.2000; World Health Organization, 2014, ANT RES GLOB REP SUR; Xia GQ, 2014, INFECT GENET EVOL, V21, P593, DOI 10.1016/j.meegid.2013.04.022; Xu SX, 2014, INFECT IMMUN, V82, P3588, DOI 10.1128/IAI.02110-14; Xu SX, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00052; Yamamoto T, 2013, BIOMEDICINE-TAIWAN, V3, P2, DOI 10.1016/j.biomed.2012.12.001; Yamamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029187; Zhang KY, 2008, J INFECT DIS, V197, P195, DOI 10.1086/523763; Zhang X, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00449-14; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	135	34	45	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128017	10.1371/journal.pone.0128017	http://dx.doi.org/10.1371/journal.pone.0128017			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047024	Green Submitted, gold, Green Published			2022-12-26	WOS:000355652200038
J	Mailath-Pokorny, M; Polterauer, S; Worda, K; Springer, S; Bettelheim, D				Mailath-Pokorny, Mariella; Polterauer, Stephan; Worda, Katharina; Springer, Stephanie; Bettelheim, Dieter			Isolated Short Fetal Femur Length in the Second Trimester and the Association with Adverse Perinatal Outcome: Experiences from a Tertiary Referral Center	PLOS ONE			English	Article							GROWTH RESTRICTION; GESTATIONAL-AGE; 2ND-TRIMESTER; PREGNANCY; FETUSES; LONG; BODY	Objective To determine the association between isolated mid-trimester short fetal femur length and adverse perinatal outcome. Methods This is a retrospective cohort study of patients with singleton gestations routinely assessed by second trimester ultrasound examination during 2006-2013. A fetal isolated short femur was defined as a femur length (FL) below the 5th percentile in a fetus with an abdominal circumference greater than the 10th percentile. Cases of aneuploidy, skeletal dysplasia and major anomalies were excluded. Primary outcomes of interest included the risk of small for gestational age neonates, low birth weight and preterm birth (PTB). Secondary outcome parameters were a 5-min Apgar score less than 7 and a neonatal intensive care unit admission. A control group of 200 fetuses with FL >= 5th percentile was used to compare primary and secondary outcome parameters within both groups. Chi-square and Student's t-tests were used where appropriate. Results Out of 608 eligible patients with a short FL, 117 met the inclusion criteria. Isolated short FL was associated with an increased risk for small for gestational age (19.7% versus 8.0%, p = 0.002) neonates, low birth weight (23.9% versus 8.5%, p<0.001), PTB (19.7% versus 6.0%, p<0.001) and neonatal intensive care unit admissions (13.7% versus 3.5%, p = 0.001). The incidence of a 5-min Apgar score less than 7 was similar in both groups. Conclusion Isolated short FL is associated with a subsequent delivery of small for gestational age and Low birth weight neonates as well as an increased risk for PTB. This information should be considered when counseling patients after mid-trimester isolated short FL is diagnosed.	[Mailath-Pokorny, Mariella; Worda, Katharina; Springer, Stephanie; Bettelheim, Dieter] Med Univ Vienna, Dept Obstet & Gynecol, Div Obstet & Fetomaternal Med, Vienna, Austria; [Polterauer, Stephan] Med Univ Vienna, Dept Obstet & Gynecol, Div Gen Gynecol & Gynecol Oncol, Comprehens Canc Ctr,Gynecol Canc Unit, Vienna, Austria; [Polterauer, Stephan] Karl Landsteiner Inst Gen Gynecol & Expt Gynecol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Mailath-Pokorny, M (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Div Obstet & Fetomaternal Med, Vienna, Austria.	mariella.mailath-pokorny@meduniwien.ac.at	Polterauer, Stephan/AAG-1331-2021	Polterauer, Stephan/0000-0002-9649-4505				ACOG committee opinion. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists, 1997, INT J GYNAECOL OBSTE, V59, P269; Bromley B, 2002, J ULTRAS MED, V21, P1087, DOI 10.7863/jum.2002.21.10.1087; Goetzinger KR, 2012, J ULTRAS MED, V31, P1935; HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4; KURTZ AB, 1990, RADIOLOGY, V177, P197, DOI 10.1148/radiology.177.1.2399317; Leung TY, 2006, ULTRASOUND OBST GYN, V27, P156, DOI 10.1002/uog.2656; Lindqvist PG, 2005, ULTRASOUND OBST GYN, V25, P258, DOI 10.1002/uog.1806; Mancilla EE, 1998, ENDOCRINOLOGY, V139, P2900, DOI 10.1210/en.139.6.2900; Mathiesen JM, 2014, ULTRASOUND OBST GYN, V44, P160, DOI 10.1002/uog.13286; Nyberg DA, 2008, ULTRASOUND OBST GYN, V31, P489, DOI 10.1002/uog.5358; NYBERG DA, 1993, AM J OBSTET GYNECOL, V168, P534, DOI 10.1016/0002-9378(93)90487-4; Ozlu T, 2013, PRENATAL DIAG, V33, P1063, DOI 10.1002/pd.4197; Papageorghiou AT, 2008, ULTRASOUND OBST GYN, V31, P507, DOI 10.1002/uog.5265; PEETERS LLH, 1979, AM J OBSTET GYNECOL, V135, P637, DOI 10.1016/S0002-9378(16)32989-1; Prefumo F, 2006, HUM REPROD, V21, P3019, DOI 10.1093/humrep/del058; Qin XZ, 2006, ENDOCRINOLOGY, V147, P5653, DOI 10.1210/en.2006-1055; SHELDON RE, 1979, AM J OBSTET GYNECOL, V135, P1071, DOI 10.1016/0002-9378(79)90739-7; Snijders RJM, 2000, ULTRASOUND OBST GYN, V16, P142, DOI 10.1046/j.1469-0705.2000.00198.x; SOGC Clinical Practice Guidelines, 2003, J OBSTET GYNECOL CAN, V25, P601; Todros T, 1996, EARLY HUM DEV, V45, P1, DOI 10.1016/0378-3782(95)01717-8; Todros T, 2004, BJOG-INT J OBSTET GY, V111, P83, DOI 10.1046/j.1471-0528.2003.00015.x; Ventura W, 2012, J CLIN ULTRASOUND, V40, P63, DOI 10.1002/jcu.20889; Vermeer N, 2013, PRENATAL DIAG, V33, P365, DOI 10.1002/pd.4068; Weisz B, 2008, ULTRASOUND OBST GYN, V31, P512, DOI 10.1002/uog.5349; Zalel Y, 2002, PRENATAL DIAG, V22, P553, DOI 10.1002/pd.364	25	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128820	10.1371/journal.pone.0128820	http://dx.doi.org/10.1371/journal.pone.0128820			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046665	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200105
J	Okigbo, CC; Speizer, IS				Okigbo, Chinelo C.; Speizer, Ilene S.			Determinants of Sexual Activity and Pregnancy among Unmarried Young Women in Urban Kenya: A Cross-Sectional Study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; UNINTENDED PREGNANCY; DEVELOPING-COUNTRIES; HEALTH; ADOLESCENTS; INITIATION; BEHAVIOR; OUTCOMES; YOUTH; TRANSITIONS	Objectives With age of marriage rising in Kenya, the period between onset of puberty and first marriage has increased, resulting in higher rates of premarital sexual activity and pregnancy. We assessed the determinants of sexual activity and pregnancy among young unmarried women in urban Kenya. Methods Baseline data from five urban areas in Kenya (Nairobi, Mombasa, Kisumu, Machakos, and Kakamega) collected in 2010 by the Measurement, Learning & Evaluation project were used. Women aged 15-24 years, who had never been married, and were not living with a male partner at the time of survey (weighted n=2020) were included. Using weighted, multivariate Cox proportional hazard regression and logistic regression analyses, we assessed factors associated with three outcome measures: time to first sex, time to first pregnancy, and teenage pregnancy. Results One-half of our sample had ever had sex; the mean age at first sex among the sexually-experienced was 17.7 (+/- 2.6) years. About 15% had ever been pregnant; mean age at first pregnancy was 18.3 (+/- 2.2) years. Approximately 11% had a teenage pregnancy. Three-quarters (76%) of those who had ever been pregnant (weighted n=306) reported the pregnancy was unwanted at the time. Having secondary education was associated with a later time to first sex and first pregnancy. In addition, religion, religiosity, and employment status were associated with time to first sex while city of residence, household size, characteristics of household head, family planning knowledge and misconceptions, and early sexual debut were significantly associated with time to first pregnancy. Education, city of residence, household wealth, early sexual debut, and contraceptive use at sexual debut were associated with teenage pregnancy for those 20-24 years. Conclusion Understanding risk and protective factors of youth sexual and reproductive health can inform programs to improve young people's long-term potential by avoiding early and unintended pregnancies.	[Okigbo, Chinelo C.; Speizer, Ilene S.] Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA; [Okigbo, Chinelo C.; Speizer, Ilene S.] Univ N Carolina, Carolina Populat Ctr, Measurement Learning & Evaluat Project, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Okigbo, CC (corresponding author), Univ N Carolina, Dept Maternal & Child Hlth, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27514 USA.	cokigbo@live.unc.edu	Okigbo, Chinelo/AAF-4505-2020; Okigbo, Chinelo C/F-3933-2015	Okigbo, Chinelo/0000-0002-4983-9339; Okigbo, Chinelo C/0000-0002-4983-9339	Bill & Melinda Gates Foundation; Carolina Population Center by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [5 R24 HD050924]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Carolina Population Center by the Eunice Kennedy Shriver National Institute of Child Health and Human Development	This research work was funded by the Bill & Melinda Gates Foundation (www.gatesfoundation.org/) and was supported by grant, 5 R24 HD050924, Carolina Population Center, awarded to the Carolina Population Center at The University of North Carolina at Chapel Hill by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (www.nichd.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. In addition, the contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the funders.	Agha S, 2009, ARCH SEX BEHAV, V38, P899, DOI 10.1007/s10508-008-9395-0; Beguy D, 2011, J URBAN HEALTH, V88, P318, DOI 10.1007/s11524-011-9547-8; Beguy D, 2009, J ADOLESCENT HEALTH, V45, P595, DOI 10.1016/j.jadohealth.2009.03.014; Blum RW, 2007, J ADOLESCENT HEALTH, V41, P230, DOI 10.1016/j.jadohealth.2007.04.005; Chandra-Mouli V, 2013, J ADOLESCENT HEALTH, V52, P517, DOI 10.1016/j.jadohealth.2013.03.002; Chiao C, 2009, AIDS CARE, V21, P881, DOI 10.1080/09540120802537856; Curtis SL, 2004, SEX TRANSM INFECT, V80, P22, DOI 10.1136/sti.2004.011650; Dodoo FNA, 2007, SOC SCI MED, V64, P1019, DOI 10.1016/j.socscimed.2006.10.007; Fatusi AO, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-136; Finer LB, 2014, WOMEN HEALTH ISS, V24, pE271, DOI 10.1016/j.whi.2014.02.002; GAGE AJ, 1994, SOC BIOL, V41, P44; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Gipson JD, 2008, STUD FAMILY PLANN, V39, P18, DOI 10.1111/j.1728-4465.2008.00148.x; Guo W, 2012, INT PERSPECT SEX R H, V38, P196, DOI 10.1363/3819612; Gupta N, 2003, STUD FAMILY PLANN, V34, P19, DOI 10.1111/j.1728-4465.2003.00019.x; Ikamari L, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-69; Jessor R, 1977, PROBLEM BEHAV PSYCHO, VXV, P281; Jessor R., 2001, RISIKOVERHALTENSWEIS, P61, DOI 10.1007/978-3-663-11310-2_3; Kabiru CW, 2009, J ADOLESCENCE, V32, P1023, DOI 10.1016/j.adolescence.2008.08.001; Kenya A, 2014, KEN AIDS IND SURV; Kenya National Bureau of Statistics (KNBS), 2010, 2009 KEN POP HOUS C, V1C; Khan S, 2008, 19 DHS MACR INT INC; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; Luke N, 2012, STUD FAMILY PLANN, V43, P115, DOI 10.1111/j.1728-4465.2012.00309.x; Magadi MA, 2009, J BIOSOC SCI, V41, P409, DOI 10.1017/S0021932008003210; Marston C, 2003, POP STUD-J DEMOG, V57, P77, DOI 10.1080/0032472032000061749; Marston C, 2006, LANCET, V368, P1581, DOI 10.1016/S0140-6736(06)69662-1; Marston M, 2013, INT PERSPECT SEX R H, V39, P22, DOI 10.1363/3902213; MCCARTHY J, 1992, STUD FAMILY PLANN, V23, P23, DOI 10.2307/1966825; Measurement Learning & Evaluation (MLE) Project Tupange KNBS, 2011, BAS HOUS SURV KEN UR; MEEKERS D, 1994, POP STUD-J DEMOG, V48, P47, DOI 10.1080/0032472031000147466; MLE Project, 2013, MEAS LEARN EV PROJ U; Nalugoda F, 2014, JAIDS-J ACQ IMM DEF, V65, P91, DOI 10.1097/QAI.0b013e3182a7f08a; Ndugwa RP, 2011, J URBAN HEALTH, V88, P298, DOI 10.1007/s11524-010-9462-4; Ngom P, 2003, J ADOLESCENT HEALTH, V33, P369, DOI 10.1016/S1054-139X(03)00213-1; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Rutstein SO, 2004, DHS COMP REPORTS, V6; Sanga K, 2014, AUST NZ J OBSTET GYN, V54, P360, DOI 10.1111/ajo.12219; Speizer IS, 2000, INT FAM PLAN PERSPEC, V26, P13, DOI 10.2307/2648285; StataCorp, 2013, STATA STAT SOFTW REL; Were M, 2007, ECON HUM BIOL, V5, P322, DOI 10.1016/j.ehb.2007.03.005	41	23	23	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129286	10.1371/journal.pone.0129286	http://dx.doi.org/10.1371/journal.pone.0129286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26047505	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200142
J	Tokuda, H; Kuroyanagi, G; Tsujimoto, M; Enomoto, Y; Matsushima-Nishiwaki, R; Onuma, T; Kojima, A; Doi, T; Tanabe, K; Akamatsu, S; Iida, H; Ogura, S; Otsuka, T; Iwama, T; Tanikawa, T; Ishikawa, K; Kojima, K; Kozawa, O				Tokuda, Haruhiko; Kuroyanagi, Gen; Tsujimoto, Masanori; Enomoto, Yukiko; Matsushima-Nishiwaki, Rie; Onuma, Takashi; Kojima, Akiko; Doi, Tomoaki; Tanabe, Kumiko; Akamatsu, Shigeru; Iida, Hiroki; Ogura, Shinji; Otsuka, Takanobu; Iwama, Toru; Tanikawa, Takahisa; Ishikawa, Kei; Kojima, Kumi; Kozawa, Osamu			Release of Phosphorylated HSP27 (HSPB1) from Platelets Is Accompanied with the Acceleration of Aggregation in Diabetic Patients	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; ALPHA-B-CRYSTALLIN; CARDIOVASCULAR-DISEASE; MAP KINASE; CELL-DEATH; COLLAGEN; RECEPTOR; ACTIVATION; HEAT-SHOCK-PROTEIN-27; MECHANISMS	We investigated the relationship between HSP27 phosphorylation and collagen-stimulated activation of platelets in patients with diabetes mellitus (DM). Platelet-rich plasma was prepared from blood of type 2 DM patients. The platelet aggregation was analyzed in size of aggregates by an aggregometer using a laser scattering method. The protein phosphorylation was analyzed by Western blotting. Phosphorylated-HSP27 and PDGF-AB released from platelets were measured by ELISA. The phosphorylated-HSP27 levels at Ser-78 and Ser-82 induced by collagen were directly proportional to the platelet aggregation. Total HSP27 levels in platelets were decreased concomitantly with the phosphorylation. The released HSP27 levels were significantly correlated with the phosphorylated levels of HSP27 in the platelets stimulated by 0.3 mu g/ml collagen. The low dose collagen-stimulated release of HSP27 was detected but relatively small in healthy donors. The released levels of PDGF-AB were in parallel with the levels of released HSP27. Area under the curve (AUC) of small aggregation (9-25 mu m)induced by 0.3 mu g/ml collagen was inversely proportional to the levels of released HSP27. AUC of large aggregation (50-70 mu m) was directly proportional to the levels of released HSP27. Exogenous recombinant phosphorylated-HSP27 hardly affected the aggregation or the released levels of PDGF-AB induced by collagen. These results strongly suggest that HSP27 is released from human platelets accompanied with its phosphorylation induced by collagen, which is correlated with the acceleration of platelet aggregation in type 2 DM patients.	[Tokuda, Haruhiko; Tanikawa, Takahisa; Ishikawa, Kei; Kojima, Kumi] Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi, Japan; [Tokuda, Haruhiko; Kuroyanagi, Gen; Tsujimoto, Masanori; Matsushima-Nishiwaki, Rie; Onuma, Takashi; Kojima, Akiko; Kozawa, Osamu] Gifu Univ, Grad Sch Med, Dept Pharmacol, Gifu, Japan; [Kuroyanagi, Gen; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthoped Surg, Nagoya, Aichi, Japan; [Tsujimoto, Masanori; Enomoto, Yukiko; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan; [Onuma, Takashi; Kojima, Akiko; Tanabe, Kumiko; Iida, Hiroki] Gifu Univ, Grad Sch Med, Dept Anesthesiol & Pain Med, Gifu, Japan; [Kojima, Akiko; Akamatsu, Shigeru] Matsunami Gen Hosp, Dept Anesthesiol & Crit Care Med, Gifu, Japan; [Doi, Tomoaki; Ogura, Shinji] Gifu Univ, Grad Sch Med, Dept Emergency & Disaster Med, Gifu, Japan	National Center for Geriatrics & Gerontology; Gifu University; Nagoya City University; Gifu University; Gifu University; Gifu University	Tokuda, H (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Clin Lab, Obu, Aichi, Japan.	tokuda@ncgg.go.jp		Iwama, Toru/0000-0002-9426-284X; Ogura, Shinji/0000-0001-7686-6001	Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (NCGG), Japan [25-4]; Ministry of Education, Science, Sports and Culture of Japan [23592249]	Research Funding for Longevity Sciences from National Center for Geriatrics and Gerontology (NCGG), Japan; Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This investigation was supported in part by the Research Funding for Longevity Sciences (25-4) from National Center for Geriatrics and Gerontology (NCGG), Japan, and a Grant-in-Aid for Scientific Research (23592249) from the Ministry of Education, Science, Sports and Culture of Japan.	Acunzo J, 2012, INT J BIOCHEM CELL B, V44, P1622, DOI 10.1016/j.biocel.2012.04.002; Arrigo AP, 2007, ADV EXP MED BIOL, V594, P14; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Hanai Y, 2009, LIFE SCI, V85, P386, DOI 10.1016/j.lfs.2009.07.003; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; INAGUMA Y, 1993, J BIOCHEM-TOKYO, V114, P378, DOI 10.1093/oxfordjournals.jbchem.a124184; Jin CH, 2014, MOL MED, V20, P280, DOI 10.2119/molmed.2014.00058; Kageyama Y, 2013, INT J MOL MED, V32, P813, DOI 10.3892/ijmm.2013.1455; Kardys I, 2008, CLIN CHEM, V54, P139, DOI 10.1373/clinchem.2007.094961; Kato K, 1996, J NEUROCHEM, V66, P946; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDRY J, 1992, J BIOL CHEM, V267, P794; Matsuno H, 2005, J CLIN ENDOCR METAB, V90, P920, DOI 10.1210/jc.2004-0137; Matsuno H, 1998, FEBS LETT, V429, P327, DOI 10.1016/S0014-5793(98)00626-7; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; Mymrikov EV, 2011, PHYSIOL REV, V91, P1123, DOI 10.1152/physrev.00023.2010; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Pockley AG, 2002, CIRCULATION, V105, P1012, DOI 10.1161/hc0802.103729; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Saklatvala J, 1996, J BIOL CHEM, V271, P6586, DOI 10.1074/jbc.271.12.6586; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	27	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128977	10.1371/journal.pone.0128977	http://dx.doi.org/10.1371/journal.pone.0128977			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046355	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200113
J	Tor, YS; Yazan, LS; Foo, JB; Wibowo, A; Ismail, N; Cheah, YK; Abdullah, R; Ismail, M; Ismail, IS; Yeap, SK				Tor, Yin Sim; Yazan, Latifah Saiful; Foo, Jhi Biau; Wibowo, Agustono; Ismail, Norsharina; Cheah, Yoke Kqueen; Abdullah, Rasedee; Ismail, Maznah; Ismail, Intan Safinar; Yeap, Swee Keong			Induction of Apoptosis in MCF-7 Cells via Oxidative Stress Generation, Mitochondria-Dependent and Caspase-Independent Pathway by Ethyl Acetate Extract of Dillenia suffruticosa and Its Chemical Profile	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; MEDIATED APOPTOSIS; ALPHA-TOCOPHEROL; REACTIVE OXYGEN; DOWN-REGULATION; CANCER CELLS; DEATH; FLAVONOIDS; ACID; ERK	Dillenia suffruticosa, which is locally known as Simpoh air, has been traditionally used to treat cancerous growth. The ethyl acetate extract of D. suffruticosa (EADs) has been shown to induce apoptosis in MCF-7 breast cancer cells in our previous study. The present study aimed to elucidate the molecular mechanisms involved in EADs-induced apoptosis and to identify the major compounds in the extract. EADs was found to promote oxidative stress in MCF-7 cells that led to cell death because the pre-treatment with antioxidants a-tocopherol and ascorbic acid significantly reduced the cytotoxicity of the extract (P<0.05). DCFH-DA assay revealed that treatment with EADs attenuated the generation of intracellular ROS. Apoptosis induced by EADs was not inhibited by the use of caspase-inhibitor Z-VAD-FMK, suggesting that the cell death is caspase-independent. The use of JC-1 dye reflected that EADs caused disruption in the mitochondrial membrane potential. The related molecular pathways involved in EADs-induced apoptosis were determined by GeXP multiplex system and Western blot analysis. EADs is postulated to induce cell cycle arrest that is p53- and p21-dependent based on the upregulated expression of p53- and p21 (P<0.05). The expression of Bax was upregulated with downregulation of Bcl-2 following treatment with EADs. The elevated Bax/Bcl-2 ratio and the depolarization of mitochondrial membrane potential suggest that EADs-induced apoptosis is mitochondria-dependent. The expression of oxidative stress-related AKT, p-AKT, ERK, and p-ERK was downregulated with upregulation of JNK and p-JNK. The data indicate that induction of oxidative-stress related apoptosis by EADs was mediated by inhibition of AKT and ERK, and activation of JNK. The isolation of compounds in EADs was carried out using column chromatography and elucidated using the nuclear resonance magnetic analysis producing a total of six compounds including 3-epimaslinic acid, kaempferol, kaempferide, protocatechuic acid, gallic acid and beta-sitosterol-3-O-a-D-glucopyranoside. The cytotoxicity of the isolated compounds was determined using MTT assay. Gallic acid was found to be most cytotoxic against MCF-7 cell line compared to others, with IC50 of 36 +/- 1.7 mu g/mL (P<0.05). In summary, EADs generated oxidative stress, induced cell cycle arrest and apoptosis in MCF-7 cells by regulating numerous genes and proteins that are involved in the apoptotic signal transduction pathway. Therefore, EADs has the potential to be developed as an anti-cancer agent against breast cancer.	[Tor, Yin Sim; Yazan, Latifah Saiful; Foo, Jhi Biau; Wibowo, Agustono; Ismail, Norsharina; Ismail, Maznah] Univ Putra Malaysia, Lab Mol Biomed, Inst Biosci, Serdang 43400, Selangor, Malaysia; [Yazan, Latifah Saiful; Cheah, Yoke Kqueen] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Selangor, Malaysia; [Abdullah, Rasedee] Univ Putra Malaysia, Fac Vet Med, Dept Vet Pathol & Microbiol, Serdang 43400, Selangor, Malaysia; [Ismail, Intan Safinar] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang 43400, Selangor, Malaysia; [Yeap, Swee Keong] Univ Putra Malaysia, Inst Biosci, Lab Vaccines & Immunotherapeut, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Yazan, LS (corresponding author), Univ Putra Malaysia, Lab Mol Biomed, Inst Biosci, Serdang 43400, Selangor, Malaysia.	latifahsy@upm.edu.my	Ismail, Intan Safinar/AAO-5386-2020; Wibowo, Agustono/U-8679-2019; Rasedee, Abdullah/E-9119-2013; Foo, Jhi Biau/J-2844-2019; Yeap, Swee Keong/H-9285-2013; sim, tor yin/M-6258-2017	Ismail, Intan Safinar/0000-0003-3960-0022; Wibowo, Agustono/0000-0001-6588-9507; Rasedee, Abdullah/0000-0001-6625-508X; Yeap, Swee Keong/0000-0002-4736-0674; sim, tor yin/0000-0002-4354-1486; Foo, Jhi Biau/0000-0002-5880-2220; ISMAIL, MAZNAH/0000-0002-2378-0519; Cheah, Yoke Kqueen/0000-0001-9258-3749	Ministry of Higher Education (MOHE), Malaysia [04-04-10-884FR]	Ministry of Higher Education (MOHE), Malaysia	The work was supported by Fundamental Research Grant Scheme (04-04-10-884FR) from Ministry of Higher Education (MOHE), Malaysia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2013, ANTIOXIDANT PRINCIPL; Armania N, 2013, J ETHNOPHARMACOL, V146, P525, DOI 10.1016/j.jep.2013.01.017; Bai L, 2006, J CANC MOL, V2, P141; Balasundram N, 2006, FOOD CHEM, V99, P191, DOI 10.1016/j.foodchem.2005.07.042; Batra P, 2013, 3 BIOTECH, V3, P439, DOI 10.1007/s13205-013-0117-5; Bayoumi SAL, 2010, PHYTOCHEMISTRY, V71, P598, DOI 10.1016/j.phytochem.2009.10.012; Bhatt AN, 2010, INDIAN J MED RES, V132, P129; Blagosklonny MV, 2000, LEUKEMIA, V14, P1502, DOI 10.1038/sj.leu.2401864; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Boulares AH, 1999, J BIOL CHEM, V274, P22932, DOI 10.1074/jbc.274.33.22932; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; BUETTNER GR, 1993, ARCH BIOCHEM BIOPHYS, V300, P535, DOI 10.1006/abbi.1993.1074; Burlacu A, 2003, J CELL MOL MED, V7, P249, DOI 10.1111/j.1582-4934.2003.tb00225.x; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Calderon-Montano JM, 2011, MINI-REV MED CHEM, V11, P298, DOI 10.2174/138955711795305335; Chen YR, 1996, J BIOL CHEM, V271, P631, DOI 10.1074/jbc.271.2.631; Constantinou C, 2009, CURR CANCER DRUG TAR, V9, P717, DOI 10.2174/156800909789271512; Nguyen DMC, 2013, MICROB PATHOGENESIS, V59-60, P52, DOI 10.1016/j.micpath.2013.04.005; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Eldahshan O. A., 2011, Current Research Journal of Biological Sciences, V3, P52; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Foo JB, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-197; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Gartel AL, 2002, MOL CANCER THER, V1, P639; Gomes CA, 2003, J MED CHEM, V46, P5395, DOI 10.1021/jm030956v; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halliwell B, 2004, BRIT J PHARMACOL, V142, P231, DOI 10.1038/sj.bjp.0705776; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu JD, 2011, J AGR FOOD CHEM, V59, P1996, DOI 10.1021/jf103656v; Hung H, 2004, J CELL PHYSIOL, V198, P197, DOI 10.1002/jcp.10398; Janicke RU, 2009, BREAST CANCER RES TR, V117, P219, DOI 10.1007/s10549-008-0217-9; Jiang GX, 2013, FOOD CHEM, V136, P563, DOI 10.1016/j.foodchem.2012.08.089; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; KamalEldin A, 1996, LIPIDS, V31, P671, DOI 10.1007/BF02522884; Kang GY, 2009, EUR J PHARMACOL, V611, P17, DOI 10.1016/j.ejphar.2009.03.068; Kasibhatla S, 2003, MOL CANCER THER, V2, P573; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Karamac Magdalena, 2006, Polish Journal of Food and Nutrition Sciences, V15, P55; Lee E, 2008, B KOREAN CHEM SOC, V29, P507; Lee HJ, 2010, J KOREAN SOC APPL BI, V53, P826, DOI 10.3839/jksabc.2010.125; Leist M, 2003, CASPASE INDEPENDENT; Li XC, 2011, FUNCT FOODS HEALTH D, V1, P232; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Lu ZM, 2006, IUBMB LIFE, V58, P621, DOI 10.1080/15216540600957438; Luo HT, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-16; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Ma XH, 2009, DRUG DISCOV TODAY, V14, P579, DOI 10.1016/j.drudis.2009.03.012; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mundhe K. S., 2011, Journal of Chemical and Pharmaceutical Research, V3, P764; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; Ohashi T, 2002, FEBS LETT, V511, P21, DOI 10.1016/S0014-5793(01)03262-8; Ostrakhovitch EA, 2005, J CELL BIOCHEM, V95, P1120, DOI 10.1002/jcb.20484; Otake Y, 2002, DRUG METAB DISPOS, V30, P103, DOI 10.1124/dmd.30.2.103; Patra RC, 2001, TOXICOLOGY, V162, P81, DOI 10.1016/S0300-483X(01)00345-6; PETIT PX, 1995, J CELL BIOL, V130, P157, DOI 10.1083/jcb.130.1.157; Petrelli A, 2008, CURR MED CHEM, V15, P422; Piccolo MT., 2012, J CAN RES UPDATES, V1, P189, DOI DOI 10.6000/1929-2279.2012.01.02.5; Ravishankar D, 2013, INT J BIOCHEM CELL B, V45, P2821, DOI 10.1016/j.biocel.2013.10.004; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roy Sanjit K, 2010, J Mol Signal, V5, P10, DOI 10.1186/1750-2187-5-10; Seo S Y T, 1981, JOURNAL OF THE AMERI, V101, P2075; Shim HY, 2007, MOL CELLS, V24, P95; SIES H, 1991, KLIN WOCHENSCHR, V69, P965, DOI 10.1007/BF01645140; SOULE HD, 1990, CANCER RES, V50, P6075; Tanaka T., 2011, Journal of Experimental and Clinical Medicine, V3, P27, DOI 10.1016/j.jecm.2010.12.005; TOR YS, 2014, BMC COMPLEM ALTERN M, V14, DOI DOI 10.1186/1472-6882-; vanAcker SABE, 1996, FREE RADICAL BIO MED, V20, P331, DOI 10.1016/0891-5849(95)02047-0; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang K, 2014, J BIOCHEM MOL TOXIC, V28, P387, DOI 10.1002/jbt.21575; Wardman P, 2002, J FLUORESC, V12, P65, DOI 10.1023/A:1015363220266; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060	78	61	63	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127441	10.1371/journal.pone.0127441	http://dx.doi.org/10.1371/journal.pone.0127441			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047480	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200021
J	Tourmente, M; Villar-Moya, P; Rial, E; Roldan, ERS				Tourmente, Maximiliano; Villar-Moya, Pilar; Rial, Eduardo; Roldan, Eduardo R. S.			Differences in ATP Generation Via Glycolysis and Oxidative Phosphorylation and Relationships with Sperm Motility in Mouse Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE-S; LDHC-NULL SPERM; LACTATE-DEHYDROGENASE; FIBROUS SHEATH; TYROSINE PHOSPHORYLATION; SPERMATOGENIC CELLS; MITOCHONDRIAL-DNA; SWIMMING VELOCITY; MALE-FERTILITY; TESTIS	Mouse sperm produce enough ATP to sustain motility by anaerobic glycolysis and respiration. However, previous studies indicated that an active glycolytic pathway is required to achieve normal sperm function and identified glycolysis as the main source of ATP to fuel the motility of mouse sperm. All the available evidence has been gathered from the studies performed using the laboratory mouse. However, comparative studies of closely related mouse species have revealed a wide range of variation in sperm motility and ATP production and that the laboratory mouse has comparatively low values in these traits. In this study, we compared the relative reliance on the usage of glycolysis or oxidative phosphorylation as ATP sources for sperm motility between mouse species that exhibit significantly different sperm performance parameters. We found that the sperm of species with higher oxygen consumption/lactate excretion rate ratios were able to produce higher amounts of ATP, achieving higher swimming velocities. Additionally, we show that the species with higher respiration/glycolysis ratios have a higher degree of dependence upon active oxidative phosphorylation. Moreover, we characterize for the first time two mouse species in which sperm depend on functional oxidative phosphorylation to achieve normal performance. Finally, we discuss that sexual selection could promote adaptations in sperm energetic metabolism tending to increase the usage of a more efficient pathway for the generation of ATP (and faster sperm).	[Tourmente, Maximiliano; Villar-Moya, Pilar; Roldan, Eduardo R. S.] CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, E-28006 Madrid, Spain; [Rial, Eduardo] CSIC, Ctr Invest Biol, Mitochondrial Bioenerget Res Grp, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Roldan, ERS (corresponding author), CSIC, Museo Nacl Ciencias Nat, Reprod Ecol & Biol Grp, C Jose Gutierrez Abascal 2, E-28006 Madrid, Spain.	roldane@mncn.csic.es	Rial, Eduardo/A-4242-2008; Roldan, Eduardo R.S./M-7947-2014; Tourmente, Maximiliano/I-2852-2019	Rial, Eduardo/0000-0001-8634-8902; Roldan, Eduardo R.S./0000-0002-7545-4248; Tourmente, Maximiliano/0000-0002-5833-9117	Spanish Ministry of Economy and Competitiveness; Junta para la Ampliacion de Estudios-Technicians Program (JAE-Tec) training scholarship	Spanish Ministry of Economy and Competitiveness(Spanish Government); Junta para la Ampliacion de Estudios-Technicians Program (JAE-Tec) training scholarship	This work was supported by the Spanish Ministry of Economy and Competitiveness. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a "Juan de la Cierva" postdoctoral fellowship from the Ministry of Economy and Competitiveness.; Recipient of a Junta para la Ampliacion de Estudios-Technicians Program (JAE-Tec) training scholarship.	Amaral A, 2013, REPRODUCTION, V146, pR163, DOI 10.1530/REP-13-0178; Anderson MJ, 2007, AM J PHYS ANTHROPOL, V134, P274, DOI 10.1002/ajpa.20674; BOER PH, 1987, MOL CELL BIOL, V7, P3107, DOI 10.1128/MCB.7.9.3107; BOHNENSACK R, 1986, BIOCHIM BIOPHYS ACTA, V850, P72, DOI 10.1016/0005-2728(86)90010-1; Boussouar F, 2003, BIOL REPROD, V69, P1069, DOI 10.1095/biolreprod.102.010074; Bunch DO, 1998, BIOL REPROD, V58, P834, DOI 10.1095/biolreprod58.3.834; BURGOS C, 1995, BIOL REPROD, V53, P84, DOI 10.1095/biolreprod53.1.84; Cazaux B, 2013, CHROMOSOMA, V122, P209, DOI 10.1007/s00412-013-0402-4; Cummins J, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P185, DOI 10.1016/B978-0-12-372568-4.00005-7; Danshina PV, 2010, BIOL REPROD, V82, P136, DOI 10.1095/biolreprod.109.079699; DEBURGOS NMG, 1994, ARCH BIOCHEM BIOPHYS, V308, P520, DOI 10.1006/abbi.1994.1073; Di Rienzo JA, 2002, J AGRIC BIOL ENVIR S, V7, P129, DOI 10.1198/10857110260141193; Eddy EM, 2003, MICROSC RES TECHNIQ, V61, P103, DOI 10.1002/jemt.10320; Ferramosca A, 2008, INT J ANDROL, V31, P337, DOI 10.1111/j.1365-2605.2007.00775.x; Ford WCL, 2006, HUM REPROD UPDATE, V12, P269, DOI 10.1093/humupd/dmi053; GALLINA FG, 1994, ARCH BIOCHEM BIOPHYS, V308, P515, DOI 10.1006/abbi.1994.1072; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; GARDNER DK, 1990, J REPROD FERTIL, V88, P361, DOI 10.1530/jrf.0.0880361; Gawlik V, 2008, MOL MEMBR BIOL, V25, P224, DOI 10.1080/09687680701855405; Montoto LG, 2011, REPRODUCTION, V142, P819, DOI 10.1530/REP-11-0232; Montoto LG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018173; Goodson SG, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102673; GOPALKRISHNAN K, 1995, INT J ANDROL, V18, P67, DOI 10.1111/j.1365-2605.1995.tb00642.x; HAMMERSTEDT RH, 1983, J BIOL CHEM, V258, P8759; Harris SE, 2005, THERIOGENOLOGY, V64, P992, DOI 10.1016/j.theriogenology.2005.01.004; HENNIG B, 1975, EUR J BIOCHEM, V55, P167, DOI 10.1111/j.1432-1033.1975.tb02149.x; Johnson AR, 2010, FASEB J, V24, P2752, DOI 10.1096/fj.09-153718; Krisfalusi M, 2006, BIOL REPROD, V75, P270, DOI 10.1095/biolreprod.105.049684; LI SSL, 1989, BIOL REPROD, V40, P173, DOI 10.1095/biolreprod40.1.173; Luke L, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115956; Mannowetz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041030; Miki K, 2004, P NATL ACAD SCI USA, V101, P16501, DOI 10.1073/pnas.0407708101; Miki Kiyoshi, 2007, Soc Reprod Fertil Suppl, V65, P309; Mitra K, 2005, J BIOL CHEM, V280, P25743, DOI 10.1074/jbc.M500310200; MONTAMAT EE, 1988, BIOCHEM J, V255, P1053, DOI 10.1042/bj2551053; Mori C, 1998, MOL REPROD DEV, V49, P374, DOI 10.1002/(SICI)1098-2795(199804)49:4&lt;374::AID-MRD4&gt;3.0.CO;2-K; Mukai C, 2004, BIOL REPROD, V71, P540, DOI 10.1095/biolreprod.103.026054; Mukai C, 2012, REPROD DOMEST ANIM, V47, P164, DOI 10.1111/j.1439-0531.2012.02071.x; Nakamura N, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107128; Nakamura N, 2010, BIOL REPROD, V82, P504, DOI 10.1095/biolreprod.109.080580; Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002; NEVO AC, 1970, J THEOR BIOL, V26, P11, DOI 10.1016/S0022-5193(70)80027-3; Odet F, 2008, BIOL REPROD, V79, P26, DOI 10.1095/biolreprod.108.068353; Odet F, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.108530; Odet F, 2011, BIOL REPROD, V85, P556, DOI 10.1095/biolreprod.111.091546; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pasupuleti V, 2007, THESIS KENT STATE U; Ruiz-Pesini E, 2007, CURR TOP DEV BIOL, V77, P3, DOI 10.1016/S0070-2153(06)77001-6; SHI QX, 1995, BIOL REPROD, V52, P540, DOI 10.1095/biolreprod52.3.540; Soulsbury CD, 2010, PLOS ONE, V5, pA152, DOI 10.1371/journal.pone.0009581; Storey BT, 2008, INT J DEV BIOL, V52, P427, DOI 10.1387/ijdb.072522bs; Suzuki H, 2013, HEREDITY, V111, P375, DOI 10.1038/hdy.2013.60; Takao D, 2008, J EXP BIOL, V211, P3594, DOI 10.1242/jeb.021923; Takei GL, 2014, J EXP BIOL, V217, P1876, DOI 10.1242/jeb.090985; Tanaka H, 2004, INT J ANDROL, V27, P172, DOI 10.1111/j.1365-2605.2004.00471.x; Tanaka H, 2003, INT J ANDROL, V26, P52, DOI 10.1046/j.1365-2605.2003.00389.x; Tang HH, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107011; Terrell KA, 2011, BIOL REPROD, V85, P473, DOI 10.1095/biolreprod.111.092106; Tourmente M, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.114.127621; Tourmente M, 2013, EVOLUTION, V67, P1838, DOI 10.1111/evo.12079; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Turner RM, 2006, REPROD FERT DEVELOP, V18, P25, DOI 10.1071/RD05120; Urner F, 2001, BIOL REPROD, V64, P1350, DOI 10.1095/biolreprod64.5.1350; VANDOP C, 1977, J BIOL CHEM, V252, P1303; Vemuganti SA, 2007, DEV BIOL, V309, P18, DOI 10.1016/j.ydbio.2007.06.010; Vicens A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-106; WELCH JE, 1992, BIOL REPROD, V46, P869, DOI 10.1095/biolreprod46.5.869	68	87	87	5	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20613	20626		10.1074/jbc.M115.664813	http://dx.doi.org/10.1074/jbc.M115.664813			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26048989	hybrid, Green Published			2022-12-26	WOS:000359608900056
J	Smith, KD; Gordon, PB; Rivetta, A; Allen, KE; Berbasova, T; Slayman, C; Strobel, SA				Smith, Kathryn D.; Gordon, Patricia B.; Rivetta, Alberto; Allen, Kenneth E.; Berbasova, Tetyana; Slayman, Clifford; Strobel, Scott A.			Yeast Fex1p Is a Constitutively Expressed Fluoride Channel with Functional Asymmetry of Its Two Homologous Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTING P-1B-TYPE ATPASE; SACCHAROMYCES-CEREVISIAE; RESISTANCE PROTEINS; MEMBRANE-PROTEINS; TOPOLOGY; SELECTIVITY; MODEL; NEUROSPORA; ANTIPORTER; MECHANISM	Fluoride is a ubiquitous environmental toxin with which all biological species must cope. A recently discovered family of fluoride export (FEX) proteins protects organisms from fluoride toxicity by removing it from the cell. We show here that FEX proteins in Saccharomyces cerevisiae function as ion channels that are selective for fluoride over chloride and that these proteins are constitutively expressed at the yeast plasma membrane. Continuous expression is in contrast to many other toxin exporters in yeast, and this, along with the fact that two nearly duplicate proteins are encoded in the yeast genome, suggests that the threat posed by fluoride ions is frequent and detrimental. Structurally, eukaryotic FEX proteins consist of two homologous four-transmembrane helix domains folded into an antiparallel dimer, where the orientation of the two domains is fixed by a single transmembrane linker helix. Using phylogenetic sequence conservation as a guide, we have identified several functionally important residues. There is substantial functional asymmetry in the effect of mutation at corresponding sites in the two domains. Specifically, mutations to residues in the C-terminal domain proved significantly more detrimental to function than did similar mutations in the N-terminal domain. Our data suggest particular residues that may be important to anion specificity, most notably the necessity of a positive charge near the end of TMH1 in the C-terminal domain. It is possible that a cationic charge at this location may create an electrostatic well for fluoride ions entering the channel from the cytoplasm.	[Smith, Kathryn D.; Gordon, Patricia B.; Berbasova, Tetyana; Strobel, Scott A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Rivetta, Alberto; Slayman, Clifford] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Allen, Kenneth E.] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Strobel, Scott A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Strobel, SA (corresponding author), Yale Univ, Dept Chem, Dept Mol Biophys & Biochem, POB 208114, New Haven, CT 06520 USA.	scott.strobel@yale.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [GM60696, GM022778]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060696, R01GM054839, P01GM022778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60696 (to C. S.) and GM022778 (to S. A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adamek Ewa, 2005, Roczniki Pomorskiej Akademii Medycznej w Szczecinie, V51, P69; Adle DJ, 2008, J BIOL CHEM, V283, P31460, DOI 10.1074/jbc.M806054200; Adle DJ, 2007, J BIOL CHEM, V282, P947, DOI 10.1074/jbc.M609535200; Adle DJ, 2009, P NATL ACAD SCI USA, V106, P10189, DOI 10.1073/pnas.0812114106; Agalakova NI, 2012, ISRN CELL BIOL, V2012, P1, DOI DOI 10.5402/2012/403835; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Baker JL, 2012, SCIENCE, V335, P233, DOI 10.1126/science.1215063; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Barrick JE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r239; Bertl A, 1998, PFLUG ARCH EUR J PHY, V436, P999, DOI 10.1007/s004240050735; Bihler H, 1999, FEBS LETT, V447, P115, DOI 10.1016/S0014-5793(99)00281-1; BLATT MR, 1987, J MEMBRANE BIOL, V98, P169, DOI 10.1007/BF01872129; Brachmann CB, 1998, YEAST, V14, P115; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; dos Santos SC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00180; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; IPCS UNEP ILO WHO, 1984, FLUOR FLUOR; Jagtap S, 2012, CHEM REV, V112, P2454, DOI 10.1021/cr2002855; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Ji CH, 2014, J GEN PHYSIOL, V144, P257, DOI 10.1085/jgp.201411243; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kaiser C., 1994, METHODS YEAST GENETI; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KROPF DL, 1986, J CELL BIOL, V102, P1209, DOI 10.1083/jcb.102.4.1209; Kuroda T, 2004, J MEMBRANE BIOL, V198, P177, DOI 10.1007/s00232-004-0671-1; Law CJ, 2009, BIOPHYS J, V97, P1346, DOI 10.1016/j.bpj.2009.06.026; LEBIODA L, 1993, PROTEINS, V16, P219, DOI 10.1002/prot.340160302; Lee H, 2012, BIOCHEM BIOPH RES CO, V427, P780, DOI 10.1016/j.bbrc.2012.09.138; LESHER RJ, 1977, ANTIMICROB AGENTS CH, V12, P339, DOI 10.1128/AAC.12.3.339; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; Li SS, 2013, P NATL ACAD SCI USA, V110, P19018, DOI 10.1073/pnas.1310439110; Lloris-Garcera P, 2014, J MOL BIOL, V426, P2246, DOI 10.1016/j.jmb.2014.03.012; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; Miranda M, 2001, J BIOL CHEM, V276, P22485, DOI 10.1074/jbc.M102332200; Modi N, 2013, BIOCHEMISTRY-US, V52, P5522, DOI 10.1021/bi400522b; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Muth TR, 2000, EMBO J, V19, P234, DOI 10.1093/emboj/19.2.234; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rapp M, 2006, NAT STRUCT MOL BIOL, V13, P112, DOI 10.1038/nsmb1057; Rivetta A, 2013, EUKARYOT CELL, V12, P684, DOI 10.1128/EC.00017-13; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; SMITH FA, 1978, CRIT REV ENV CONTR, V8, P293; Stefan CP, 2013, EUKARYOT CELL, V12, P204, DOI 10.1128/EC.00299-12; Stockbridge RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6120; Stockbridge RB, 2013, ELIFE, V2, DOI 10.7554/eLife.01084; Stockbridge RB, 2012, P NATL ACAD SCI USA, V109, P15289, DOI 10.1073/pnas.1210896109; Ubarretxena-Belandia I, 2001, CURR OPIN STRUC BIOL, V11, P370, DOI 10.1016/S0959-440X(00)00217-7; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Weinstein LH, 2004, FLUORIDES ENV EFFECT; WHO, 2006, FLUOR DRINK WAT; World Health Organization, 1970, WHO SWITZ MON SER, V59; Wright MB, 1996, J BACTERIOL, V178, P7197, DOI 10.1128/jb.178.24.7197-7205.1996; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Yang TT, 2014, SCIENCE, V346, P355, DOI 10.1126/science.1259723; Yerushalmi H, 2000, J BIOL CHEM, V275, P5264, DOI 10.1074/jbc.275.8.5264	60	23	26	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19874	19887		10.1074/jbc.M115.651976	http://dx.doi.org/10.1074/jbc.M115.651976			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26055717	Green Published, hybrid			2022-12-26	WOS:000359364600043
J	Crowder, JJ; Geigges, M; Gibson, RT; Fults, ES; Buchanan, BW; Sachs, N; Schink, A; Kreft, SG; Rubenstein, EM				Crowder, Justin J.; Geigges, Marco; Gibson, Ryan T.; Fults, Eric S.; Buchanan, Bryce W.; Sachs, Nadine; Schink, Andrea; Kreft, Stefan G.; Rubenstein, Eric M.			Rkr1/Ltn1 Ubiquitin Ligase-mediated Degradation of Translationally Stalled Endoplasmic Reticulum Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL PATHWAY; MESSENGER-RNAS LACKING; STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; TRIGGERS DEGRADATION; SHUTTLE VECTORS; HYGROMYCIN-B; STOP CODON; YEAST; RIBOSOME	Aberrant nonstop proteins arise from translation of mRNA molecules beyond the coding sequence into the 3'-untranslated region. If a stop codon is not encountered, translation continues into the poly(A) tail, resulting in C-terminal appendage of a polylysine tract and a terminally stalled ribosome. In Saccharomyces cerevisiae, the ubiquitin ligase Rkr1/Ltn1 has been implicated in the proteasomal degradation of soluble cytosolic nonstop and translationally stalled proteins. Rkr1 is essential for cellular fitness under conditions associated with increased prevalence of nonstop proteins. Mutation of the mammalian homolog causes significant neurological pathology, suggesting broad physiological significance of ribosome-associated quality control. It is not known whether and how soluble or transmembrane nonstop and translationally stalled proteins targeted to the endoplasmic reticulum (ER) are detected and degraded. We generated and characterized model soluble and transmembrane ER-targeted nonstop and translationally stalled proteins. We found that these proteins are indeed subject to proteasomal degradation. We tested three candidate ubiquitin ligases (Rkr1 and ER-associated Doa10 and Hrd1) for roles in regulating abundance of these proteins. Our results indicate that Rkr1 plays the primary role in targeting the tested model ER-targeted nonstop and translationally stalled proteins for degradation. These data expand the catalog of Rkr1 substrates and highlight a previously unappreciated role for this ubiquitin ligase at the ER membrane.	[Crowder, Justin J.; Gibson, Ryan T.; Fults, Eric S.; Buchanan, Bryce W.; Rubenstein, Eric M.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Geigges, Marco; Sachs, Nadine; Schink, Andrea; Kreft, Stefan G.] Univ Konstanz, Dept Biol, D-78457 Constance, Germany	Ball State University; University of Konstanz	Kreft, SG (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.	stefan.kreft@uni-konstanz.de; emrubenstein@bsu.edu	Regan, Clinton/E-6250-2012	Rubenstein, Eric/0000-0003-4983-1430; Geigges, Marco/0000-0001-9071-5162	National Institutes of Health [R15 GM111713]; Ball State University ASPiRE research awards; Indiana Academy of Science; Ball State University Provost's Office; Ball State University Department of Biology; Deutsche Forschungsgemeinschaft [SFB969]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM111713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ball State University ASPiRE research awards; Indiana Academy of Science; Ball State University Provost's Office; Ball State University Department of Biology; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R15 GM111713 (to E. M. R.). This work was also supported by Ball State University ASPiRE research awards (to J. J. C., E. S. F., and E. M. R.), an Indiana Academy of Science senior research award (to E. M. R.), funds from the Ball State University Provost's Office and Department of Biology (to E. M. R.), and Deutsche Forschungsgemeinschaft Grant SFB969 (to S. G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371; Brachmann CB, 1998, YEAST, V14, P115; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Braun MA, 2007, MOL CELL BIOL, V27, P2800, DOI 10.1128/MCB.01947-06; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Cacciottolo M, 2011, EUR J HUM GENET, V19, P974, DOI 10.1038/ejhg.2011.70; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106; Deak PM, 2001, J BIOL CHEM, V276, P10663, DOI 10.1074/jbc.M008608200; Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110; Dimitrova LN, 2009, J BIOL CHEM, V284, P10343, DOI 10.1074/jbc.M808840200; Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010; Ganoza MC, 2001, ANTIMICROB AGENTS CH, V45, P2813, DOI 10.1128/AAC.45.10.2813-2819.2001; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; GROLLMAN AP, 1966, P NATL ACAD SCI USA, V56, P1867, DOI 10.1073/pnas.56.6.1867; GROLLMAN AP, 1967, J BIOL CHEM, V242, P3226; Guthrie C., 2004, GUIDE YEAST GENETICS, P1; Habeck G, 2015, J CELL BIOL, V209, P261, DOI 10.1083/jcb.201408088; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; HJELM H, 1972, FEBS LETT, V28, P73, DOI 10.1016/0014-5793(72)80680-X; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Inada T, 2005, EMBO J, V24, P1584, DOI 10.1038/sj.emboj.7600636; Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207; Izawa T, 2012, CELL REPORTS, V2, P447, DOI 10.1016/j.celrep.2012.08.010; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Klucevsek KM, 2012, GENETICS, V191, P1107, DOI 10.1534/genetics.112.141713; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Lee HH, 2007, MOL CELL, V27, P938, DOI 10.1016/j.molcel.2007.07.019; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Lykke-Andersen J, 2014, J CELL BIOL, V204, P467, DOI 10.1083/jcb.201311103; Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111; Matsuda R, 2014, GENES CELLS, V19, P1, DOI 10.1111/gtc.12106; Metzger MB, 2008, J BIOL CHEM, V283, P32302, DOI 10.1074/jbc.M806424200; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; OOI CE, 1992, CELL, V71, P87, DOI 10.1016/0092-8674(92)90268-H; Pang SY, 2002, J CLIN ENDOCR METAB, V87, P2556, DOI 10.1210/jc.87.6.2556; Plemper RK, 1999, J CELL SCI, V112, P4123; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; REDDY VA, 1988, J BIOL CHEM, V263, P6978; Rubenstein EM, 2012, J CELL BIOL, V197, P761, DOI 10.1083/jcb.201203061; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Shao SC, 2015, MOL CELL, V57, P433, DOI 10.1016/j.molcel.2014.12.015; Shao SC, 2014, MOL CELL, V55, P880, DOI 10.1016/j.molcel.2014.07.006; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shen PS, 2015, SCIENCE, V347, P75, DOI 10.1126/science.1259724; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; SIKORSKI RS, 1989, GENETICS, V122, P19; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taniguchi A, 1998, HUM GENET, V102, P197, DOI 10.1007/s004390050677; Theodoraki MA, 2012, J BIOL CHEM, V287, P23911, DOI 10.1074/jbc.M112.341164; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Turner GC, 2000, SCIENCE, V289, P2117, DOI 10.1126/science.289.5487.2117; Tyson JR, 2000, EMBO J, V19, P6440, DOI 10.1093/emboj/19.23.6440; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Verma R, 2013, ELIFE, V2, DOI 10.7554/eLife.00308; von der Malsburg K, 2015, MOL BIOL CELL, V26, P2168, DOI 10.1091/mbc.E15-01-0040; Watts SG, 2015, JOVE-J VIS EXP, DOI 10.3791/52428; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; Wilson MA, 2007, GENETICS, V177, P773, DOI 10.1534/genetics.107.073205; Zattas D, 2015, CRIT REV BIOCHEM MOL, V50, P1, DOI 10.3109/10409238.2014.959889	73	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18454	18466		10.1074/jbc.M115.663559	http://dx.doi.org/10.1074/jbc.M115.663559			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055716	Green Published, hybrid			2022-12-26	WOS:000358512100017
J	Stival, C; La Spina, FA; Bar Graf, C; Arcelay, E; Arranz, SE; Ferreira, JJ; Le Grand, S; Dzikunu, VA; Santi, CM; Visconti, PE; Buffone, MG; Krapf, D				Stival, Cintia; La Spina, Florenza A.; Bar Graf, Carolina; Arcelay, Enid; Arranz, Silvia E.; Ferreira, Juan J.; Le Grand, Sibylle; Dzikunu, Victor A.; Santi, Celia M.; Visconti, Pablo E.; Buffone, Mariano G.; Krapf, Dario			Src Kinase Is the Connecting Player between Protein Kinase A (PKA) Activation and Hyperpolarization through SLO3 Potassium Channel Regulation in Mouse Sperm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATING AGENT BICARBONATE; TYROSINE KINASE; ACROSOME REACTION; PLASMA-MEMBRANE; ION CHANNELS; BOAR SPERM; K+ CHANNEL; PHOSPHORYLATION; SPERMATOZOA; DEPHOSPHORYLATION	Plasma membrane hyperpolarization is crucial for mammalian sperm to acquire acrosomal responsiveness during capacitation. Among the signaling events leading to mammalian sperm capacitation, the immediate activation of protein kinase A plays a pivotal role, promoting the subsequent stimulation of protein tyrosine phosphorylation that associates with fertilizing capacity. We have shown previously that mice deficient in the tyrosine kinase cSrc are infertile and exhibit improper cauda epididymis development. It is therefore not clear whether lack of sperm functionality is due to problems in epididymal maturation or to the absence of cSrc in sperm. To further address this problem, we investigated the kinetics of cSrc activation using anti-Tyr(P)-416-cSrc antibodies that only recognize active cSrc. Our results provide evidence that cSrc is activated downstream of PKA and that inhibition of its activity blocks the capacitation-induced hyperpolarization of the sperm plasma membrane without blocking the increase in tyrosine phosphorylation that accompanies capacitation. In addition, we show that cSrc inhibition also blocks the agonist-induced acrosome reaction and that this inhibition is overcome by pharmacological hyperpolarization. Considering that capacitation-induced hyperpolarization is mediated by SLO3, we evaluated the action of cSrc inhibitors on the heterologously expressed SLO3 channel. Our results indicate that, similar to SLO1 K+ channels, cSrc blockers significantly decreased SLO3-mediated currents. Together, these results are consistent with findings showing that hyperpolarization of the sperm plasma membrane is necessary and sufficient to prepare the sperm for the acrosome reaction and suggest that changes in sperm membrane potential are mediated by cSrc activation.	[Stival, Cintia; Bar Graf, Carolina; Arranz, Silvia E.; Krapf, Dario] CONICET UNR, Inst Biol Mol Celular Rosario, RA-2000 Rosario, Sf, Argentina; [Stival, Cintia; Bar Graf, Carolina; Arranz, Silvia E.; Krapf, Dario] UNR, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Sf, Argentina; [La Spina, Florenza A.; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn, Inst Biol & Med Expt, RA-1033 Buenos Aires, DF, Argentina; [Ferreira, Juan J.; Le Grand, Sibylle; Dzikunu, Victor A.; Santi, Celia M.] Washington Univ, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Arcelay, Enid; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Paige Labs, Amherst, MA 01003 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Washington University (WUSTL); University of Massachusetts System; University of Massachusetts Amherst	Krapf, D (corresponding author), CONICET UNR, Inst Biol Mol Celular Rosario, RA-2000 Rosario, Sf, Argentina.	krapf@ibr-conicet.gov.ar	Regan, Clinton/E-6250-2012; Ferreira, Juan/GNW-6445-2022	Ferreira, Juan/0000-0001-8175-9067; Baro Graf, Carolina/0000-0003-4490-9083; Krapf, Dario/0000-0001-7607-1954	National Institutes of Health [RO1TW008662, RO1 HD38082, HD440044, RO1 HD069631]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2011-0540, PICT 2014-2702, PICT 2013-1175]; CONICET [PIP 112-201101-00740]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044044, R01HD038082, R01HD069631] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [R01TW008662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1TW008662 (to M. G. B.), RO1 HD38082 and HD440044 (to P. E. V.), and RO1 HD069631 (to C. M. S.). This work was also supported by Agencia Nacional de Promocion Cientifica y Tecnologica Grants PICT 2011-0540 and PICT 2014-2702 (to D. K.) and PICT 2013-1175 (to M. G. B.) and CONICET Grant PIP 112-201101-00740 (to D. K. and M. G. B.). The authors declare that they have no conflicts of interest with the contents of this article.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Battistone MA, 2014, MOL HUM REPROD, V20, P1054, DOI 10.1093/molehr/gau073; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; Buffone MG, 2014, BBA-MOL BASIS DIS, V1842, P2610, DOI 10.1016/j.bbadis.2014.07.013; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chavez JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060578; Cho CH, 2005, J NEUROSCI, V25, P3712, DOI 10.1523/JNEUROSCI.5389-03.2005; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Davis MJ, 2001, AM J PHYSIOL-HEART C, V281, pH1835, DOI 10.1152/ajpheart.2001.281.5.H1835; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; Gadella BM, 2000, DEVELOPMENT, V127, P2407; Gonzalez-Fernandez L, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.107078; Goupil S, 2011, J ANDROL, V32, P95, DOI 10.2164/jandrol.110.010462; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Harrison RAP, 2000, MOL REPROD DEV, V55, P220, DOI 10.1002/(SICI)1098-2795(200002)55:2&lt;220::AID-MRD12&gt;3.0.CO;2-I; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Krapf D, 2012, DEV BIOL, V369, P43, DOI 10.1016/j.ydbio.2012.06.017; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Ling SZ, 2000, J BIOL CHEM, V275, P30683, DOI 10.1074/jbc.M004292200; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Luo JP, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093864; Michels S, 2013, CANCER RES, V73, P2518, DOI 10.1158/0008-5472.CAN-12-3023; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; Nikolic DS, 2011, BLOOD, V118, P4841, DOI 10.1182/blood-2010-09-305417; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Sato K, 1996, J BIOL CHEM, V271, P13250, DOI 10.1074/jbc.271.22.13250; STEELE RE, 1985, NUCLEIC ACIDS RES, V13, P1747, DOI 10.1093/nar/13.5.1747; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	41	32	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18855	18864		10.1074/jbc.M115.640326	http://dx.doi.org/10.1074/jbc.M115.640326			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26060254	Green Published, hybrid			2022-12-26	WOS:000358512100051
J	Westman, JS; Benktander, J; Storry, JR; Peyrard, T; Hult, AK; Hellberg, A; Teneberg, S; Olsson, ML				Westman, Julia S.; Benktander, John; Storry, Jill R.; Peyrard, Thierry; Hult, Annika K.; Hellberg, Asa; Teneberg, Susann; Olsson, Martin L.			Identification of the Molecular and Genetic Basis of PX2, a Glycosphingolipid Blood Group Antigen Lacking on Globoside-deficient Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGALACTOSAMINE; MASS-SPECTROMETRY; INTERNATIONAL-SOCIETY; EXPRESSION CLONING; SYNTHASE; GLYCOSYLTRANSFERASES; GLYCOLIPIDS; ANTIBODIES; GLYCOPROTEINS; PURIFICATION	The x(2) glycosphingolipid is expressed on erythrocytes from individuals of all common blood group phenotypes and elevated on cells of the rare P/P1/P-k-negative p blood group phenotype. Globoside or P antigen is synthesized by UDP-N-acetylgalactosamine: globotriaosyl-ceramide 3-beta-N-acetylgalactosaminyl-transferase encoded by B3GALNT1. It is the most abundant non-acid glycosphingolipid on erythrocytes and displays the same terminal disaccharide, GalNAc beta 3Gal, as x(2). We encountered a patient with mutations in B3GALNT1 causing the rare P-deficient P-1(k) phenotype and whose pretransfusion plasma was unexpectedly incompatible with p erythrocytes. The same phenomenon was also noted in seven other unrelated P-deficient individuals. Thin-layer chromatography, mass spectrometry, and flow cytometry were used to show that the naturally occurring antibodies made by p individuals recognize x(2) and sialylated forms of x(2), whereas x(2) is lacking on P-deficient erythrocytes. Overexpression of B3GALNT1 resulted in synthesis of both P and x(2). Knockdown experiments with siRNA against B3GALNT1 diminished x(2) levels. We conclude that x(2) fulfills blood group criteria and is synthesized by UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase. Based on this linkage, we proposed that x(2) joins P in the GLOB blood group system (ISBT 028) and is renamed PX2 (GLOB2). Thus, in the absence of a functional P synthase, neither P nor PX2 are formed. As a consequence, naturally occurring anti-P and anti-PX2 can be made. Until the clinical significance of anti-PX2 is known, we also recommend that rare P-1(k) or P-2(k) erythrocyte units are preferentially selected for transfusion to P-k patients because p erythrocytes may pose a risk for hemolytic transfusion reactions due to their elevated PX2 levels.	[Westman, Julia S.; Storry, Jill R.; Hult, Annika K.; Hellberg, Asa; Olsson, Martin L.] Lund Univ, Div Hematol & Transfus Med, Dept Lab Med, SE-22184 Lund, Sweden; [Benktander, John; Teneberg, Susann] Univ Gothenburg, Inst Biomed, Sahlgrenska Acad, SE-40530 Gothenburg, Sweden; [Storry, Jill R.; Hult, Annika K.; Hellberg, Asa; Olsson, Martin L.] Off Med Serv, Clin Immunol & Transfus Med, Lab Med, SE-22185 Lund, Sweden; [Peyrard, Thierry] INTS, Dept Ctr Natl Reference Grp Sanguins, F-75015 Paris, France; [Peyrard, Thierry] Lab Excellence GR Ex, F-75015 Paris, France	Lund University; University of Gothenburg	Teneberg, S (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, POB 440, SE-40530 Gothenburg, Sweden.	Susann.Teneberg@medkem.gu.se; Martin_L.Olsson@med.lu.se	Storry, Jill R/AAF-9130-2019	Storry, Jill R/0000-0003-2940-2604; Westman, Julia S./0000-0002-5506-1543; PEYRARD, THIERRY/0000-0002-7715-568X; Olsson, Martin L/0000-0003-1647-9610	Swedish Research Council [342-2004-4434]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	We express our gratitude to Sylvie Poupel in Paris, France for technical assistance with serological investigation and to Ulla Mandel in Copenhagen, Denmark for the generous donation of the monoclonal antibody TH2. We also acknowledge Rut Norda and Jan Safwenberg in Uppsala, Sweden; Birgitta Nilsson Sojka in Umea, Sweden; Marja-Kaisa Auvinen in Kuala Lumpur, Malaysia; and many others involved in the original clinical case that spurred our first interest. The use of the LTQ linear quadrupole ion trap mass spectrometer (obtained by Swedish Research Council Grant 342-2004-4434 to Gunnar Hansson), is gratefully acknowledged.	Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; ANDO S, 1973, J BIOCHEM-TOKYO, V73, P387; Breton C, 2012, CURR OPIN STRUC BIOL, V22, P540, DOI 10.1016/j.sbi.2012.06.007; Chai WG, 2001, ANAL CHEM, V73, P651, DOI 10.1021/ac0010126; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; Daniels G., 2013, HUMAN BLOOD GROUPS, P162; Daniels GL, 2004, VOX SANG, V87, P304, DOI 10.1111/j.1423-0410.2004.00564.x; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; FLETCHER KS, 1979, J BIOL CHEM, V254, P1196; FOLCH J, 1957, J BIOL CHEM, V226, P497; HANSSON GC, 1983, J BIOL CHEM, V258, P4091; Hellberg A, 2002, J BIOL CHEM, V277, P29455, DOI 10.1074/jbc.M203047200; KANNAGI R, 1982, J BIOL CHEM, V257, P4438; KANNAGI R, 1982, P NATL ACAD SCI-BIOL, V79, P3470, DOI 10.1073/pnas.79.11.3470; Karlsson H, 2010, GLYCOBIOLOGY, V20, P1103, DOI 10.1093/glycob/cwq070; KARLSSON KA, 1987, METHOD ENZYMOL, V138, P212; Keusch JJ, 2000, J BIOL CHEM, V275, P25308, DOI 10.1074/jbc.M002629200; Keusch JJ, 2000, J BIOL CHEM, V275, P25315, DOI 10.1074/jbc.M002630200; KOERNER TAW, 1983, BIOCHEMISTRY-US, V22, P2676, DOI 10.1021/bi00280a014; Kojima Y, 2000, J BIOL CHEM, V275, P15152, DOI 10.1074/jbc.M909620199; KOSCIELAK J, 1978, ARCH IMMUNOL THER EX, V26, P119; Kraft B, 2011, CELL MOL LIFE SCI, V68, P4091, DOI 10.1007/s00018-011-0725-3; KUNDU SK, 1983, J BIOL CHEM, V258, P3857; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; MARCUS DM, 1976, P NATL ACAD SCI USA, V73, P3263, DOI 10.1073/pnas.73.9.3263; Merrill AH, 2011, CHEM REV, V111, P6387, DOI 10.1021/cr2002917; NAIKI M, 1977, J IMMUNOL, V119, P537; Okajima T, 2000, J BIOL CHEM, V275, P40498, DOI 10.1074/jbc.M006902200; Olsson ML, 2011, VOX SANG, V6, P1; Palcic MM, 2011, CURR OPIN CHEM BIOL, V15, P226, DOI 10.1016/j.cbpa.2010.11.022; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Reid ME., 2012, BLOOD GROUP ANTIGEN, V3th, P135; Robbe C, 2004, RAPID COMMUN MASS SP, V18, P412, DOI 10.1002/rcm.1352; SAMUELSSON BE, 1990, METHOD ENZYMOL, V193, P623, DOI 10.1016/0076-6879(90)93442-N; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Storry JR, 2011, VOX SANG, V101, P77, DOI 10.1111/j.1423-0410.2010.01462.x; Suchanowska A, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.408286; Takematsu H, 2011, J BIOL CHEM, V286, P27214, DOI 10.1074/jbc.M111.234526; TANIGUCHI N, 1984, J BIOL CHEM, V259, P5637; THORN JJ, 1992, BIOCHEMISTRY-US, V31, P6509, DOI 10.1021/bi00143a022; Thuresson B, 2011, BLOOD, V117, P678, DOI 10.1182/blood-2010-08-301333; Toivonen S, 2001, J BIOL CHEM, V276, P37141, DOI 10.1074/jbc.M105715200; TONEGAWA Y, 1977, BIOCHEM BIOPH RES CO, V76, P9, DOI 10.1016/0006-291X(77)91661-8; Varki A., 2009, ESSENTIALS GLYCOBIOL; Waldi D., 1962, DUNNSCHICHT CHROMATO, P496; Westman JS, 2013, TRANSFUSION, V53, P2928, DOI 10.1111/trf.12355; Working Party for Red Cell Immunogenetics and Blood Group Terminology, 2014, C INT SOC BLOOD TRAN; YANG ZT, 1994, J BIOL CHEM, V269, P14620; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	49	12	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18505	18518		10.1074/jbc.M115.655308	http://dx.doi.org/10.1074/jbc.M115.655308			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055721	Green Published, hybrid			2022-12-26	WOS:000358512100023
J	Harris, SA; Boucher, BA; Cotterchio, M				Harris, Shelley A.; Boucher, Beatrice A.; Cotterchio, Michelle			Will Women Diagnosed with Breast Cancer Provide Biological Samples for Research Purposes?	PLOS ONE			English	Article							GENETIC-VARIANTS; RISK; ONTARIO; EXPOSURE; BIOBANK; PARTICIPATION	Background Little is known about the response rates for biological sample donation and attitudes towards control recruitment, especially in younger women. The goals of this pilot study were to determine in women recently diagnosed with breast cancer, the proportion of cases willing to provide biological samples and for purposes of control recruitment, contact information for friends or colleagues. Methods A population-based sample of breast cancer cases (n = 417, 25-74 years) was recruited from the Ontario Cancer Registry in 2010 and self-administered questionnaires were completed to determine willingness to provide samples (spot or 24-hr urine, saliva, blood) and contact information for friends/colleagues for control recruitment. Using X-2 analyses of contingency tables we evaluated if these proportions varied by age group (<45 and 45+) and other factors such as ethnicity, education, income, body mass index (BMI), smoking status and alcohol consumption. Results Cases were willing to provide blood samples, by visiting a clinic (62%) or by having a nurse visit the home (61%). Moreover, they would provide saliva (73%), and morning or 24-hr urine samples (66% and 52%). Younger cases (<= 45) were 3 times (OR) more likely more than older cases to agree to collect morning urine (95% CI: 1.15-8.35). Only 26% of cases indicated they would provide contact information of friends or work colleagues to act as controls. Educated cases were more likely to agree to provide samples, and cases who consumed alcohol were more willing to provide contact information. Ethnicity, income, BMI and smoking had little effect on response rates. Conclusions Reasonable response rates for biological sample collection should be expected in future case controls studies in younger women, but other methods of control selection must be devised.	[Harris, Shelley A.; Boucher, Beatrice A.; Cotterchio, Michelle] Canc Care Ontario, Prevent & Canc Control, Toronto, ON M5G 2L7, Canada; [Harris, Shelley A.; Cotterchio, Michelle] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5T 3M7, Canada; [Harris, Shelley A.] Occupat Canc Res Ctr, Toronto, ON M5G 1X3, Canada; [Boucher, Beatrice A.] Univ Toronto, Dept Nutr Sci, Toronto, ON M5S 3E2, Canada	Cancer Care Ontario; University of Toronto; University of Toronto	Harris, SA (corresponding author), Canc Care Ontario, Prevent & Canc Control, Toronto, ON M5G 2L7, Canada.	Shelley.Harris@cancercare.on.ca		Cotterchio, Michelle/0000-0003-2862-7895; Boucher, Beatrice/0000-0001-6909-3792; Harris, Shelley/0000-0003-2306-7921	Cancer Care Ontario, Population Studies Network	Cancer Care Ontario, Population Studies Network	This work was funded in part by a grant to MC from Cancer Care Ontario, Population Studies Network. The funder had no role in the study design, data collection or analysis, decision to publish or preparation of the manuscript.	Anderson LN, 2012, AM J EPIDEMIOL, V175, P289, DOI 10.1093/aje/kwr324; Anderson LN, 2011, CANCER EPIDEM BIOMAR, V20, P1708, DOI 10.1158/1055-9965.EPI-11-0300; Boucher BA, 2012, NUTR CANCER, V64, P695, DOI 10.1080/01635581.2012.687426; Colditz GA, 2010, CANCER CAUSE CONTROL, V21, P649, DOI 10.1007/s10552-009-9498-5; Colt JS, 2005, ANN EPIDEMIOL, V15, P700, DOI 10.1016/j.annepidem.2004.12.002; Gammon MD, 2002, BREAST CANCER RES TR, V74, P235, DOI 10.1023/A:1016387020854; Hainaut P, 2011, METHODS MOL BIOL, V675, P179, DOI 10.1007/978-1-59745-423-0_7; Harris SA, 2013, 2013 C INT SOC ENV E; Harris SA, 2009, RECRUITING YOUNG PEO, P34; Harris S, 2009, EPIDEMIOLOGY, V20, pS102, DOI 10.1097/01.ede.0000363020.36557.9c; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Knight JA, 2002, ANN EPIDEMIOL, V12, P27, DOI 10.1016/S1047-2797(01)00253-8; McElroy JA, 2008, CANCER EPIDEM BIOMAR, V17, P2311, DOI 10.1158/1055-9965.EPI-08-0263; Mordukhovich I, 2010, ENVIRON HEALTH PERSP, V118, P511, DOI 10.1289/ehp.0901233; Morton LM, 2006, AM J EPIDEMIOL, V163, P197, DOI 10.1093/aje/kwj036; Peakman TC, 2008, INT J EPIDEMIOL, V37, P2, DOI 10.1093/ije/dyn019; Zheng W, 2004, CANCER EPIDEM BIOMAR, V13, P709	17	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127994	10.1371/journal.pone.0127994	http://dx.doi.org/10.1371/journal.pone.0127994			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061089	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500069
J	Milet-Pinheiro, P; Ayasse, M; Dotterl, S				Milet-Pinheiro, Paulo; Ayasse, Manfred; Doetterl, Stefan			Visual and Olfactory Floral Cues of Campanula (Campanulaceae) and Their Significance for Host Recognition by an Oligolectic Bee Pollinator	PLOS ONE			English	Article							COLOR PREFERENCES; BOMBUS-TERRESTRIS; REWARDING FLOWERS; SPECIALIZED BEES; SOLITARY BEES; BARK BEETLES; EVOLUTION; POLLEN; HYMENOPTERA; BUMBLEBEES	Oligolectic bees collect pollen from a few plants within a genus or family to rear their offspring, and are known to rely on visual and olfactory floral cues to recognize host plants. However, studies investigating whether oligolectic bees recognize distinct host plants by using shared floral cues are scarce. In the present study, we investigated in a comparative approach the visual and olfactory floral cues of six Campanula species, of which only Campanula lactiflora has never been reported as a pollen source of the oligolectic bee Ch. rapunculi. We hypothesized that the flowers of Campanula species visited by Ch. rapunculi share visual (i.e. color) and/or olfactory cues (scents) that give them a host-specific signature. To test this hypothesis, floral color and scent were studied by spectrophotometric and chemical analyses, respectively. Additionally, we performed bioassays within a flight cage to test the innate color preference of Ch. rapunculi. Our results show that Campanula flowers reflect the light predominantly in the UV-blue/blue bee-color space and that Ch. rapunculi displays a strong innate preference for these two colors. Furthermore, we recorded spiroacetals in the floral scent of all Campanula species, but Ca. lactiflora. Spiroacetals, rarely found as floral scent constituents but quite common among Campanula species, were recently shown to play a key function for host-flower recognition by Ch. rapunculi. We conclude that Campanula species share some visual and olfactory floral cues, and that neurological adaptations (i.e. vision and olfaction) of Ch. rapunculi innately drive their foraging flights toward host flowers. The significance of our findings for the evolution of pollen diet breadth in bees is discussed.	[Milet-Pinheiro, Paulo; Ayasse, Manfred] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Doetterl, Stefan] Univ Bayreuth, Dept Plant Systemat, Bayreuth, Germany	Ulm University; University of Bayreuth	Dotterl, S (corresponding author), Salzburg Univ, Dept Organism Biol, A-5020 Salzburg, Austria.	miletpinheiro@hotmail.com	Pinheiro, Paulo Milet/P-7035-2015	Pinheiro, Paulo Milet/0000-0002-4929-2177	Deutsche Forschungsgemeinschaft [AY 12/5-1, DO 1250/6-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (AY 12/5-1; DO 1250/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RP, 2007, IDENTIFICATION OF ES, DOI [10.1002/cbdv.201100039, DOI 10.1002/CBDV.201100039]; Andrews ES, 2007, J CHEM ECOL, V33, P1682, DOI 10.1007/s10886-007-9337-7; Arnold SEJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014287; Ayasse M, 2000, EVOLUTION, V54, P1995, DOI 10.1111/j.0014-3820.2000.tb01243.x; Blionis GJ, 2001, ECOGRAPHY, V24, P287, DOI 10.1034/j.1600-0587.2001.240306.x; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Burger H, 2010, S AFR J BOT, V76, P788, DOI 10.1016/j.sajb.2010.08.003; Burger H, 2012, OECOLOGIA, V168, P727, DOI 10.1007/s00442-011-2136-4; Burger H, 2010, FUNCT ECOL, V24, P1234, DOI 10.1111/j.1365-2435.2010.01744.x; Cane JH, 2006, PLANT-POLLINATOR INTERACTIONS: FROM SPECIALIZATION TO GENERALIZATION, P99; Carvalho AT, 2014, J CHEM ECOL, V40, P1126, DOI 10.1007/s10886-014-0510-5; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; CHITTKA L, 1994, VISION RES, V34, P1489, DOI 10.1016/0042-6989(94)90151-1; Chittka L., 2005, PRACTICAL POLLINATIO, P157; Chittka L, 2006, CURR OPIN PLANT BIOL, V9, P428, DOI 10.1016/j.pbi.2006.05.002; CRESSWELL JE, 1994, OIKOS, V69, P304, DOI 10.2307/3546151; Dobson Heidi E.M., 1999, Plant Species Biology, V14, P153, DOI 10.1046/j.1442-1984.1999.00020.x; Dobson HEM, 1997, J INSECT PHYSIOL, V43, P89, DOI 10.1016/S0022-1910(96)00024-8; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; Dotterl S, 2010, CAN J ZOOL, V88, P668, DOI 10.1139/Z10-031; Dotterl S, 2011, J COMP PHYSIOL A, V197, P1119, DOI 10.1007/s00359-011-0673-2; Dotterl S, 2005, J CHEM ECOL, V31, P2993, DOI 10.1007/s10886-005-9152-y; Dotterl S, 2005, PLANT SYST EVOL, V255, P99, DOI 10.1007/s00606-005-0344-2; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; FRANCKE W, 1995, J CHEM ECOL, V21, P1043, DOI 10.1007/BF02033807; Francke W, 2001, CURR ORG CHEM, V5, P233, DOI 10.2174/1385272013375652; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Gorley C.K., 2006, GETTING STARTED PRIM; Goulson D, 2001, J INSECT BEHAV, V14, P669, DOI 10.1023/A:1012231419067; HEINRICH B, 1975, ANNU REV ECOL SYST, V6, P139, DOI 10.1146/annurev.es.06.110175.001035; Howell AD, 2007, ANIM BEHAV, V74, P199, DOI 10.1016/j.anbehav.2006.11.012; Huber DPW, 1999, J CHEM ECOL, V25, P805, DOI 10.1023/A:1020892700653; Knudsen JT, 2006, BOT REV, V72, P1, DOI 10.1663/0006-8101(2006)72[1:DADOFS]2.0.CO;2; Kovacic Sanja, 2004, Acta Botanica Croatica, V63, P171; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; Leonard AS, 2014, J COMP PHYSIOL A, V200, P463, DOI 10.1007/s00359-014-0904-4; LINSLEY E. GORTON, 1958, HILGARDIA, V27, P543; LUNAU K, 1995, J COMP PHYSIOL A, V177, P1; Mansion G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050076; McDonald J. H., 2009, HANDBOOK OF BIOLOGIC; Miiller A., 1997, BIENEN MITTELEUROPAI; Milet-Pinheiro P, 2013, J CHEM ECOL, V39, P1347, DOI 10.1007/s10886-013-0363-3; Milet-Pinheiro P, 2012, BEHAV ECOL, V23, P531, DOI 10.1093/beheco/arr219; Molet M, 2009, NATURWISSENSCHAFTEN, V96, P213, DOI 10.1007/s00114-008-0465-x; Muller A, 2006, BIOL CONSERV, V130, P604, DOI 10.1016/j.biocon.2006.01.023; NILSSON LA, 1983, NATURE, V305, P799, DOI 10.1038/305799a0; Papadopulos AST, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0960; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Praz CJ, 2008, APIDOLOGIE, V39, P547, DOI 10.1051/apido:2008034; Praz CJ, 2008, ECOLOGY, V89, P795, DOI 10.1890/07-0751.1; Raguso RA, 2004, ECOLOGY, V85, P1486, DOI 10.1890/03-0410; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; Robertson C, 1925, ECOLOGY, V6, P412, DOI 10.2307/1929107; Roquet C, 2008, SYST BOT, V33, P203, DOI 10.1600/036364408783887465; Rosenbauer A, 1996, DIE FARN UND BLUTENP, P417; Schaffler I, 2012, ANN BOT-LONDON, V110, P125, DOI 10.1093/aob/mcs101; Schlindwein C, 2014, BOT J LINN SOC, V176, P396, DOI 10.1111/boj.12212; Sedivy C, 2008, EVOLUTION, V62, P2487, DOI 10.1111/j.1558-5646.2008.00465.x; Simonds V, 2004, ANIM BEHAV, V67, P379, DOI 10.1016/j.anbehav.2003.03.020; Wcislo WT, 1996, ANNU REV ENTOMOL, V41, P257, DOI 10.1146/annurev.en.41.010196.001353; WEISS MR, 1991, NATURE, V354, P227, DOI 10.1038/354227a0; Westrich P, 1989, DIE WILDBIENEN BADEN, P437; Williams N.H., 1983, P50; Wright GA, 2009, FUNCT ECOL, V23, P841, DOI 10.1111/j.1365-2435.2009.01627.x; Zhang QH, 2000, CHEMOECOLOGY, V10, P69, DOI 10.1007/s000490050010	66	21	21	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128577	10.1371/journal.pone.0128577	http://dx.doi.org/10.1371/journal.pone.0128577			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26060994	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500090
J	Cui, YQ; Jia, FP; He, JF; Xie, XY; Li, ZH; Fu, MH; Hao, H; Liu, Y; Liu, DZ; Cowan, PJ; Zhu, H; Sun, QH; Liu, ZG				Cui, Yuqi; Jia, Fengpeng; He, Jianfeng; Xie, Xiaoyun; Li, Zhihong; Fu, Minghuan; Hao, Hong; Liu, Ying; Liu, Dylan Z.; Cowan, Peter J.; Zhu, Hua; Sun, Qinghua; Liu, Zhenguo			Ambient Fine Particulate Matter Suppresses In Vivo Proliferation of Bone Marrow Stem Cells through Reactive Oxygen Species Formation	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; AIR-POLLUTION EXPOSURE; OXIDATIVE STRESS; CIGARETTE-SMOKE; PREIMPLANTATION DEVELOPMENT; INHIBITS ANGIOGENESIS; NEOINTIMA FORMATION; SIGNALING PATHWAYS; REDOX REGULATION; STROMAL CELLS	Aims Some environmental insults, such as fine particulate matter (PM) exposure, significantly impair the function of stem cells. However, it is unknown if PM exposure could affect the population of bone marrow stem cells (BMSCs). The present study was to investigate the effects of PM on BMSCs population and related mechanism(s). Main Metheods PM was intranasally distilled into male C57BL/6 mice for one month. Flow cytometry with antibodies for BMSCs, Annexin V and BrdU ware used to determine the number of BMSCs and the levels of their apoptosis and proliferation in vivo. Phosphorylated Akt (P-Akt) level was determined in the BM cells with western blotting. Intracellular reactive oxygen species (ROS) formation was quantified using flow cytometry analysis. To determine the role of PM-induced ROS in BMSCs population, proliferation, and apotosis, experiments were repeated using N-acetylcysteine (NAC)-treated wild type mice or a triple transgenic mouse line with overexpression of antioxidant network (AON) composed of superoxide dismutase (SOD) 1, SOD3, and glutathione peroxidase-1 with decreased in vivo ROS production. Key Findings PM treatment significantly reduced BMSCs population in association with increased ROS formation, decreased P-Akt level, and inhibition of proliferation of BMSCs without induction of apoptosis. NAC treatment or AON overexpression with reduced ROS formation effectively prevented PM-induced reduction of BMSCs population and proliferation with partial recovery of P-Akt level. Significance PM exposure significantly decreased the population of BMSCs due to diminished proliferation via ROS-mediated mechanism (could be partially via inhibition of Akt signaling).	[Cui, Yuqi; Jia, Fengpeng; He, Jianfeng; Xie, Xiaoyun; Li, Zhihong; Fu, Minghuan; Hao, Hong; Liu, Ying; Liu, Dylan Z.; Zhu, Hua; Sun, Qinghua; Liu, Zhenguo] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Cardiovasc Med, Columbus, OH 43210 USA; [Cui, Yuqi] Shandong Univ, Shandong Prov Hosp, Dept Cardiol, Jinan 250021, Shandong, Peoples R China; [Zhu, Hua] Ohio State Univ, Dept Surg, Wexner Med Ctr, Columbus, OH 43210 USA; [Cowan, Peter J.] Univ Melbourne, St Vincents Hosp, Dept Med, Melbourne, Vic, Australia; [Jia, Fengpeng] Chongqing Med Univ, Affiliated Hosp 1, Dept Cardiovasc Med, Chongqing 400016, Peoples R China	University System of Ohio; Ohio State University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; University System of Ohio; Ohio State University; St Vincent's Hospital Melbourne; University of Melbourne; Chongqing Medical University	Liu, ZG (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Div Cardiovasc Med, Columbus, OH 43210 USA.	zhenguo.liu@osumc.edu	Cowan, Peter/AAH-7218-2020; Cui, Yuqi/U-5914-2017; Zhu, Hua/G-4409-2010	Zhu, Hua/0000-0001-7136-7326	US NIH grant [NIH R01 HL094650]; American Heart Association grant (AHA) [12SDG12070174]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026200] Funding Source: NIH RePORTER	US NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association grant (AHA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	US NIH grant to Zhenguo Liu (NIH R01 HL094650) for experiment design and American Heart Association grant to HZ (AHA 12SDG12070174) for experiment design.	Albrecht C, 2001, INHAL TOXICOL, V13, P191; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; BENEDICT WF, 1984, MUTAT RES, V136, P73, DOI 10.1016/0165-1218(84)90136-8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Chang JL, 2010, DIABETES, V59, P2949, DOI 10.2337/db10-0582; Cui YQ, 2015, CELL PHYSIOL BIOCHEM, V35, P353, DOI 10.1159/000369701; Daher N, 2014, SCI TOTAL ENVIRON, V470, P417, DOI 10.1016/j.scitotenv.2013.09.104; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; De Flora S, 2012, INT J CANCER, V131, P2763, DOI 10.1002/ijc.27814; Ebert R, 2006, STEM CELLS, V24, P1226, DOI 10.1634/stemcells.2005-0117; Gavett SH, 2003, ENVIRON HEALTH PERSP, V111, P981, DOI 10.1289/ehp.5931; Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313; Haberzettl P, 2012, ENVIRON HEALTH PERSP, V120, P848, DOI 10.1289/ehp.1104206; He SD, 2013, EXP LUNG RES, V39, P258, DOI 10.3109/01902148.2013.802828; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; Huang JJ, 2013, REPROD TOXICOL, V35, P89, DOI 10.1016/j.reprotox.2012.07.003; Huang JJ, 2009, FERTIL STERIL, V92, P1456, DOI 10.1016/j.fertnstert.2008.07.1781; Izzotti A, 2011, MUTAT RES-FUND MOL M, V717, P17, DOI 10.1016/j.mrfmmm.2010.10.003; Jurczyszyn A, 2014, J CANCER, V5, P480, DOI 10.7150/jca.8731; Khaldoyanidi S, 2001, BLOOD, V98, P303, DOI 10.1182/blood.V98.2.303; Khurshid SS, 2014, ENVIRON RES, V132, P46, DOI 10.1016/j.envres.2014.03.026; Kim GD, 2013, INT J ONCOL, V43, P600, DOI 10.3892/ijo.2013.1959; Kolanko Emanuel, 2013, Przegl Lek, V70, P858; Kondo T, 2009, J ATHEROSCLER THROMB, V16, P532, DOI 10.5551/jat.1255; Lee YJ, 2012, FOOD CHEM TOXICOL, V50, P116, DOI 10.1016/j.fct.2011.10.035; Li HL, 2011, FREE RADICAL BIO MED, V51, P30, DOI 10.1016/j.freeradbiomed.2011.04.016; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lin S, 2009, HUM REPROD, V24, P386, DOI 10.1093/humrep/den419; Lin S, 2010, TOXICOL SCI, V118, P202, DOI 10.1093/toxsci/kfq241; Liszewski W, 2012, DIFFERENTIATION, V83, P169, DOI 10.1016/j.diff.2011.12.005; Lu TW, 2010, ANTIOXID REDOX SIGN, V13, P1845, DOI 10.1089/ars.2010.3156; Madhubabu G, 2012, INHAL TOXICOL, V24, P143, DOI 10.3109/08958378.2011.649189; Mital R, 2011, AM J PHYSIOL-HEART C, V300, pH1960, DOI 10.1152/ajpheart.01285.2010; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Mysore TB, 2005, DIABETES, V54, P2109, DOI 10.2337/diabetes.54.7.2109; Nocun MS, 2013, ANAL BIOANAL CHEM, V405, P5583, DOI 10.1007/s00216-013-6957-3; O'Toole TE, 2010, CIRC RES, V107, P200, DOI 10.1161/CIRCRESAHA.110.222679; Ogasawara MA, 2009, ANTIOXID REDOX SIGN, V11, P1107, DOI [10.1089/ars.2008.2308, 10.1089/ARS.2008.2308]; Ohshima M, 2009, CIRC J, V73, P162, DOI 10.1253/circj.CJ-08-0123; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Rauscher FM, 2003, CIRCULATION, V108, P457, DOI 10.1161/01.CIR.0000082924.75945.48; ROSENKRANZ AR, 1992, J IMMUNOL METHODS, V156, P39, DOI 10.1016/0022-1759(92)90008-H; Shadie AM, 2014, CLIN EXP IMMUNOL, V177, P491, DOI 10.1111/cei.12348; Shafer MM, 2010, J ENVIRON MONITOR, V12, P704, DOI 10.1039/b915008k; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; Sugden PH, 2006, ANTIOXID REDOX SIGN, V8, P2111, DOI 10.1089/ars.2006.8.2111; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Talbot P, 2011, BIOL RES, V44, P189, DOI /S0716-97602011000200011; Traverse JH, 2013, JAMA-J AM MED ASSOC, V309, P343, DOI 10.1001/jama.2012.196454; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Wang TT, 2010, CHEM BIOL DRUG DES, V75, P214, DOI 10.1111/j.1747-0285.2009.00925.x; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Werner N, 2003, CIRC RES, V93, pE17, DOI 10.1161/01.RES.0000083812.30141.74; Xiao GG, 2003, J BIOL CHEM, V278, P50781, DOI 10.1074/jbc.M306423200; Xiao WK, 2015, INT J ONCOL, V46, P360, DOI 10.3892/ijo.2014.2735; Yauk CL, 2007, CANCER RES, V67, P5103, DOI 10.1158/0008-5472.CAN-07-0279; Zhang L, 2014, TOXICOL LETT, V228, P248, DOI 10.1016/j.toxlet.2014.05.015; Zhou YP, 2011, REPROD TOXICOL, V31, P123, DOI 10.1016/j.reprotox.2010.10.007	61	19	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0127309	10.1371/journal.pone.0127309	http://dx.doi.org/10.1371/journal.pone.0127309			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058063	gold, Green Published			2022-12-26	WOS:000356349000009
J	Konar, M; Rossi, R; Walter, H; Pajon, R; Beernink, PT				Konar, Monica; Rossi, Raffaella; Walter, Helen; Pajon, Rolando; Beernink, Peter T.			A Mutant Library Approach to Identify Improved Meningococcal Factor H Binding Protein Vaccine Antigens	PLOS ONE			English	Article							COMPLEMENT FACTOR-H; BACTERICIDAL ANTIBODY-RESPONSES; NEISSERIA-MENINGITIDIS; MONOCLONAL-ANTIBODIES; IMMUNOGENICITY; TRIAL; LIPOPROTEIN; FHBP; VARIANTS; RLP2086	Factor H binding protein (FHbp) is a virulence factor used by meningococci to evade the host complement system. FHbp elicits bactericidal antibodies in humans and is part of two recently licensed vaccines. Using human complement Factor H (FH) transgenic mice, we previously showed that binding of FH decreased the protective antibody responses to FHbp vaccination. Therefore, in the present study we devised a library-based method to identify mutant FHbp antigens with very low binding of FH. Using an FHbp sequence variant in one of the two licensed vaccines, we displayed an error-prone PCR mutant FHbp library on the surface of Escherichia coli. We used fluorescence-activated cell sorting to isolate FHbp mutants with very low binding of human FH and preserved binding of control anti-FHbp monoclonal antibodies. We sequenced the gene encoding FHbp from selected clones and introduced the mutations into a soluble FHbp construct. Using this approach, we identified several new mutant FHbp vaccine antigens that had very low binding of FH as measured by ELISA and surface plasmon resonance. The new mutant FHbp antigens elicited protective antibody responses in human FH transgenic mice that were up to 20-fold higher than those elicited by the wild-type FHbp antigen. This approach offers the potential to discover mutant antigens that might not be predictable even with protein structural information and potentially can be applied to other microbial vaccine antigens that bind host proteins.	[Konar, Monica; Rossi, Raffaella; Walter, Helen; Pajon, Rolando; Beernink, Peter T.] UCSF Benioff Childrens Hosp Oakland, Childrens Hosp Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA; [Walter, Helen] Mills Coll, Dept Biol, Oakland, CA 94613 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Beernink, PT (corresponding author), UCSF Benioff Childrens Hosp Oakland, Childrens Hosp Oakland Res Inst, Ctr Immunobiol & Vaccine Dev, Oakland, CA 94609 USA.	pbeernink@chori.org		Konar, Monica/0000-0002-8312-9699; Walter, Helen/0000-0003-2274-6172	Public Health Service grant from National Institute of Allergy and Infectious Diseases, NIH [R01 AI 099125]; Research Facilities Improvement Program grant from National Center for Research Resources, NIH [C06 RR 016226]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099125] Funding Source: NIH RePORTER	Public Health Service grant from National Institute of Allergy and Infectious Diseases, NIH; Research Facilities Improvement Program grant from National Center for Research Resources, NIH; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grant R01 AI 099125 (to P.T.B.) from the National Institute of Allergy and Infectious Diseases, NIH. The laboratory work at Children's Hospital Oakland Research Institute was performed in a facility funded by Research Facilities Improvement Program grant C06 RR 016226 from the National Center for Research Resources, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beernink PT, 2009, J INFECT DIS, V199, P1360, DOI 10.1086/597806; Beernink PT, 2008, INFECT IMMUN, V76, P4232, DOI 10.1128/IAI.00367-08; Beernink PT, 2008, INFECT IMMUN, V76, P2568, DOI 10.1128/IAI.00033-08; Beernink PT, 2014, CLIN VACCINE IMMUNOL, V21, P1505, DOI 10.1128/CVI.00517-14; Beernink PT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002688; Beernink PT, 2011, J IMMUNOL, V186, P3606, DOI 10.4049/jimmunol.1003470; Beernink PT, 2010, CLIN VACCINE IMMUNOL, V17, P1074, DOI 10.1128/CVI.00103-10; Beernink PT, 2009, MOL IMMUNOL, V46, P1647, DOI 10.1016/j.molimm.2009.02.021; Brunelli B, 2011, VACCINE, V29, P1072, DOI 10.1016/j.vaccine.2010.11.064; Cendron L, 2011, ACTA CRYSTALLOGR F, V67, P531, DOI 10.1107/S1744309111006154; Cohn AC, 2010, CLIN INFECT DIS, V50, P184, DOI 10.1086/649209; Costa I, 2014, MBIO, V5, DOI 10.1128/mBio.01625-14; Excler JL, 2013, CURR OPIN HIV AIDS, V8, P421, DOI 10.1097/COH.0b013e3283632c26; Findlow J, 2010, CLIN INFECT DIS, V51, P1127, DOI 10.1086/656741; Fletcher LD, 2004, INFECT IMMUN, V72, P2088, DOI 10.1128/IAI.72.4.2088-2100.2004; FROHOLM L O, 1991, NIPH (National Institute of Public Health) Annals (Oslo), V14, P139; Froholm LO, 1991, NIPH ANN, V14, P44; Giuliani MM, 2005, INFECT IMMUN, V73, P1151, DOI 10.1128/IAI.73.2.1151-1160.2005; Giuntini S, 2011, INFECT IMMUN, V79, P3751, DOI 10.1128/IAI.05182-11; Granoff DM, 2015, J INFECT DIS, V212, P784, DOI 10.1093/infdis/jiv081; Granoff DM, 2009, INFECT IMMUN, V77, P764, DOI 10.1128/IAI.01191-08; Halperin SA, 2007, VACCINE, V25, P450, DOI 10.1016/j.vaccine.2006.08.001; Jiang HQ, 2010, VACCINE, V28, P6086, DOI 10.1016/j.vaccine.2010.06.083; Johnson S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002981; Koeberling O, 2011, VACCINE, V29, P4728, DOI 10.1016/j.vaccine.2011.04.095; Konar M, 2013, J INFECT DIS, V208, P627, DOI 10.1093/infdis/jit239; Madico G, 2006, J IMMUNOL, V177, P501, DOI 10.4049/jimmunol.177.1.501; Marshall HS, 2012, PEDIATR INFECT DIS J, V31, P1061, DOI 10.1097/INF.0b013e31826327e4; Mascioni A, 2009, J BIOL CHEM, V284, P8729, DOI 10.1074/jbc.M808831200; Masignani V, 2003, J EXP MED, V197, P789, DOI 10.1084/jem.20021911; Meri S, 2008, VACCINE, V26, pI113, DOI 10.1016/j.vaccine.2008.11.058; Pajon R, 2012, INFECT IMMUN, V80, P2667, DOI 10.1128/IAI.00103-12; Pajon R, 2010, VACCINE, V28, P2122, DOI 10.1016/j.vaccine.2009.12.027; Piet JR, 2011, J BACTERIOL, V193, P2371, DOI 10.1128/JB.01331-10; Richmond PC, 2012, VACCINE, V30, P6163, DOI 10.1016/j.vaccine.2012.07.065; Richmond PC, 2012, LANCET INFECT DIS, V12, P597, DOI 10.1016/S1473-3099(12)70087-7; Rossi R, 2013, VACCINE, V31, P5451, DOI 10.1016/j.vaccine.2013.08.099; Scarselli M, 2009, J MOL BIOL, V386, P97, DOI 10.1016/j.jmb.2008.12.005; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Snape MD, 2010, PEDIATR INFECT DIS J, V29, pE71, DOI 10.1097/INF.0b013e3181f59f6d; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; van der Veen S, 2014, INFECT IMMUN, V82, P1157, DOI 10.1128/IAI.01183-13; Vandeputte-Rutten L, 2003, J BIOL CHEM, V278, P24825, DOI 10.1074/jbc.M302803200; Vu DM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00341; Welsch JA, 2004, J IMMUNOL, V172, P5606, DOI 10.4049/jimmunol.172.9.5606; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514	46	11	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128185	10.1371/journal.pone.0128185	http://dx.doi.org/10.1371/journal.pone.0128185			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057742	Green Submitted, Green Published, gold			2022-12-26	WOS:000356349000016
J	Ma, QG; Jin, J; Yuan, RX; Zhang, WK				Ma, Qingguo; Jin, Jia; Yuan, Ruixian; Zhang, Wuke			Who Are the True Fans? Evidence from an Event-Related Potential Study	PLOS ONE			English	Article							STIMULUS PROBABILITY; CELEBRITY WORSHIP; BRAIN POTENTIALS; FACES; AROUSAL; P300; P3A; ERP	Fans of celebrities commonly exist in modern society. Researchers from social science have been concerned with this problem for years. Furthermore, such researchers have attempted to measure people's involvement with celebrities in various ways. However, no study measured the degree of addiction to a specific celebrity at the neurological level. Therefore, the current study employed visually evoked event related potentials (ERPs) to examine people's attitude toward celebrities by comparing different brain activities of fans and non-fans when they were shown a set of photos. These photos include a specific celebrity, a familiar person, a stranger and a butterfly. Furthermore, to examine the validity of the detected neural index, we also investigated the correlation between brain activity and the score of the Celebrity Attitude Scale (CAS), which was a questionnaire used to explore people's attitude toward celebrities at behavioral level. Two groups of subjects were asked to complete an implicit task, i.e., to press a button when a picture of a butterfly appeared. Results revealed that fans showed significant positive N2 and P300 deflection when viewing the photos of their favorite celebrity, whereas in the non-fan group, the subjects only showed larger P300 amplitude as a response to the celebrity's photos. Furthermore, a positive correlation between P300 amplitude elicited by the stimuli of a celebrity face and CAS scores was also observed. These findings indicated fan attitude to a specific celebrity can also be observed at the neurological level and suggested the potential utility of using ERP component as an index of fandom involvement.	[Ma, Qingguo; Yuan, Ruixian; Zhang, Wuke] Zhejiang Univ, Sch Management, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Jia] Ningbo Univ, Sch Business, Ningbo 315211, Zhejiang, Peoples R China	Zhejiang University; Ningbo University	Jin, J (corresponding author), Ningbo Univ, Sch Business, Ningbo 315211, Zhejiang, Peoples R China.	jinjia@nbu.edu.cn		Jin, Jia/0000-0003-1124-2999	National Natural Science Foundation [71371167]; Natural Science Foundation of Zhejiang Province [LQ15G020003]; 211 Project from the State Education Ministry	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); 211 Project from the State Education Ministry	This work was supported by grant 71371167 from the National Natural Science Foundation and grant LQ15G020003 from the Natural Science Foundation of Zhejiang Province. Additional financial support was received from the 211 Project from the State Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, ADORING AUDIENCE FAN; Bobes MA, 2007, BIOL PSYCHOL, V75, P146, DOI 10.1016/j.biopsycho.2007.01.006; Bruin KJ, 2002, CLIN NEUROPHYSIOL, V113, P1172, DOI 10.1016/S1388-2457(02)00141-4; Couldry N, 2007, SET SOPRANOS INSIDE; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Delplanque S, 2006, INT J PSYCHOPHYSIOL, V60, P315, DOI 10.1016/j.ijpsycho.2005.06.006; EIMER M, 1993, BIOL PSYCHOL, V35, P123, DOI 10.1016/0301-0511(93)90009-W; Fairhall SL, 2007, CEREB CORTEX, V17, P2400, DOI 10.1093/cercor/bhl148; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Grasso DJ, 2009, BIOL PSYCHOL, V81, P95, DOI 10.1016/j.biopsycho.2009.03.001; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Guerra P, 2012, INT J PSYCHOPHYSIOL, V85, P79, DOI 10.1016/j.ijpsycho.2011.06.004; Keil A, 2002, PSYCHOPHYSIOLOGY, V39, P641, DOI 10.1017/S0048577202394162; Langeslag SJE, 2007, BIOL PSYCHOL, V76, P109, DOI 10.1016/j.biopsycho.2007.06.007; MADRIGAL R, 1995, J LEISURE RES, V27, P205, DOI 10.1080/00222216.1995.11949745; Maltby J, 2006, PERS INDIV DIFFER, V40, P273, DOI 10.1016/j.paid.2005.07.004; McCutcheon LE, 2002, BRIT J PSYCHOL, V93, P67, DOI 10.1348/000712602162454; Picton TW, 2000, PSYCHOPHYSIOLOGY, V37, P127, DOI 10.1111/1469-8986.3720127; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Soltani M, 2000, NEUROBIOLOGY, V14; SQUIRES NK, 1975, ELECTROEN CLIN NEURO, V38, P387, DOI 10.1016/0013-4694(75)90263-1; Vico C, 2010, NEUROPSYCHOLOGIA, V48, P2894, DOI 10.1016/j.neuropsychologia.2010.05.031	23	6	6	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129624	10.1371/journal.pone.0129624	http://dx.doi.org/10.1371/journal.pone.0129624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6PC	26057891	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000067
J	Thomson, RB; Alderman, RL; Tuck, GN; Hobday, AJ				Thomson, Robin B.; Alderman, Rachael L.; Tuck, Geoffrey N.; Hobday, Alistair J.			Effects of Climate Change and Fisheries Bycatch on Shy Albatross (Thalassarche cauta) in Southern Australia	PLOS ONE			English	Article							POPULATION-DYNAMICS; WANDERING ALBATROSS; LONGLINE FISHERY; DEMOGRAPHIC-MODELS; SEABIRD MORTALITY; DIOMEDEA-EXULANS; OCEAN; SURVIVAL; IMPACT; TRENDS	The impacts of climate change on marine species are often compounded by other stressors that make direct attribution and prediction difficult. Shy albatrosses (Thalassarche cauta) breeding on Albatross Island, Tasmania, show an unusually restricted foraging range, allowing easier discrimination between the influence of non-climate stressors (fisheries bycatch) and environmental variation. Local environmental conditions (rainfall, air temperature, and sea-surface height, an indicator of upwelling) during the vulnerable chick-rearing stage, have been correlated with breeding success of shy albatrosses. We use an age-, stage- and sex-structured population model to explore potential relationships between local environmental factors and albatross breeding success while accounting for fisheries bycatch by trawl and longline fisheries. The model uses time-series of observed breeding population counts, breeding success, adult and juvenile survival rates and a bycatch mortality observation for trawl fishing to estimate fisheries catchability, environmental influence, natural mortality rate, density dependence, and productivity. Observed at-sea distributions for adult and juvenile birds were coupled with reported fishing effort to estimate vulnerability to incidental bycatch. The inclusion of rainfall, temperature and sea-surface height as explanatory variables for annual chick mortality rate was statistically significant. Global climate models predict little change in future local average rainfall, however, increases are forecast in both temperatures and upwelling, which are predicted to have detrimental and beneficial effects, respectively, on breeding success. The model shows that mitigation of at least 50% of present bycatch is required to offset losses due to future temperature changes, even if upwelling increases substantially. Our results highlight the benefits of using an integrated modeling approach, which uses available demographic as well as environmental data within a single estimation framework, to provide future predictions. Such predictions inform the development of management options in the face of climate change.	[Thomson, Robin B.; Tuck, Geoffrey N.; Hobday, Alistair J.] CSIRO Marine & Atmospher Res, Oceans & Atmospheres Flagship, Hobart, Tas 7001, Australia; [Alderman, Rachael L.] Parks Water & Environm, Dept Primary Ind, Hobart, Tas 7001, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Thomson, RB (corresponding author), CSIRO Marine & Atmospher Res, Oceans & Atmospheres Flagship, GPO Box 1538, Hobart, Tas 7001, Australia.	robin.thomson@csiro.au	Hobday, Alistair/A-1460-2012; Tuck, Geoffrey/E-2356-2012	Hobday, Alistair/0000-0002-3194-8326; Tuck, Geoffrey/0000-0002-3640-6147	Department of Sustainability, Environment, Water, Population and Communities, Australia; Australia's CSIRO Climate Adaptation Flagship; Fisheries Research and Development Corporation-Department of Climate Change and Energy Efficiency of Australian Government (FRDC-DCCEE Marine National Adaptation Program) [2010/533]	Department of Sustainability, Environment, Water, Population and Communities, Australia; Australia's CSIRO Climate Adaptation Flagship; Fisheries Research and Development Corporation-Department of Climate Change and Energy Efficiency of Australian Government (FRDC-DCCEE Marine National Adaptation Program)	Continued funding support for the collection and analysis of demographic data came from the Department of Sustainability, Environment, Water, Population and Communities, Australia (www.environment.gov.au). Population modelling work was supported by Australia's CSIRO Climate Adaptation Flagship (www.csiro.au) and the Fisheries Research and Development Corporation-Department of Climate Change and Energy Efficiency on behalf of the Australian Government (FRDC-DCCEE Marine National Adaptation Program 2010/533). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CL, 2006, CONSERV GENET, V7, P531, DOI 10.1007/s10592-005-9064-y; Alderman R, 2011, WILDLIFE RES, V38, P672, DOI 10.1071/WR10199; Alderman R, 2010, MAR ECOL PROG SER, V405, P271, DOI 10.3354/meps08590; Alderman RL, 2012, THESIS U TASMANIA SA; [Anonymous], 2010, CLIMATE FUTURES TASM; Baker GB, 2007, BIOL CONSERV, V137, P319, DOI 10.1016/j.biocon.2007.02.012; Baker GB, 2002, EMU, V102, P71, DOI 10.1071/MU01036; Barbraud C, 2008, J APPL ECOL, V45, P1460, DOI 10.1111/j.1365-2664.2008.01537.x; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Barbraud C, 2011, J ANIM ECOL, V80, P89, DOI 10.1111/j.1365-2656.2010.01752.x; Brander K, 2011, NAT CLIM CHANGE, V1, P70, DOI 10.1038/nclimate1092; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Caswell, 2000, MATRIX POPULATION MO; Chambers LE, 2015, REG ENVIRON CHANGE, V15, P197, DOI 10.1007/s10113-014-0634-8; Chambers LE, 2011, EMU, V111, P235, DOI 10.1071/MU10033; Choquet R., 2004, Animal Biodiversity and Conservation, V27, P207; Crespin L, 2006, J ANIM ECOL, V75, P228, DOI 10.1111/j.1365-2656.2006.01035.x; Croxall JP, 2008, ANIM CONSERV, V11, P255, DOI 10.1111/j.1469-1795.2008.00196.x; Croxall JP, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P46; DEWR, 2006, THREAT AB PLAN INC C; Ducet N, 2000, J GEOPHYS RES-OCEANS, V105, P19477, DOI 10.1029/2000JC900063; Fordham DA, 2011, ECOL APPL, V21, P3317, DOI 10.1890/11-0314.1; Francis RIC, 2012, NEW ZEAL J ZOOL, V39, P3, DOI 10.1080/03014223.2011.600766; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Freitas C, 2010, ARGOSFILTER ARGOS LO; Gales R, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P20; Gedamke T, 2007, N AM J FISH MANAGE, V27, P605, DOI 10.1577/M05-157.1; Green RH, 1973, REC QUEEN VIC MUS, V51, P1; Hartog JR, 2011, DEEP-SEA RES PT II, V58, P746, DOI 10.1016/j.dsr2.2010.06.005; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hedd A, 2005, CONDOR, V107, P375, DOI 10.1650/7563; Hedd A, 2001, MAR ECOL PROG SER, V224, P267, DOI 10.3354/meps224267; Hobday AJ, 2013, 20110533 FRDCDCCEE; Hulme PE, 2005, J APPL ECOL, V42, P784, DOI 10.1111/j.1365-2664.2005.01082.x; Inchausti P, 2002, J ANIM ECOL, V71, P765, DOI 10.1046/j.1365-2656.2002.00638.x; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; JOHNSTONE G W, 1975, Emu, V75, P1, DOI 10.1071/MU9750001; Klaer N, 1997, EMU, V97, P150, DOI 10.1071/MU97019; Kostoglou P., 1996, SEALING TASMANIA HIS; MacDONALD DUNCAN, 1963, EMU, V63, P23; Maunder MN, 2013, FISH RES, V142, P61, DOI 10.1016/j.fishres.2012.07.025; Maunder MN, 2004, ACTA OECOL, V26, P85, DOI 10.1016/j.actao.2003.11.008; Nevoux M, 2010, ECOLOGY, V91, P2416, DOI 10.1890/09-0143.1; Oke PR, 2008, OCEAN MODEL, V21, P46, DOI 10.1016/j.ocemod.2007.11.002; Patterson TA, EXAMINING T IN PRESS; Phillips K., 2010, CUMULATIVE ASSESSMEN; Plomley N. J. B., 1966, FRIENDLY MISSION TAS, P92; Rolland V, 2009, ECOL APPL, V19, P1336, DOI 10.1890/08-1060.1; Rolland V, 2010, GLOBAL CHANGE BIOL, V16, P1910, DOI 10.1111/j.1365-2486.2009.02070.x; Rolland V, 2009, BIOL CONSERV, V142, P1084, DOI 10.1016/j.biocon.2008.12.030; Sandvik H, 2005, J ANIM ECOL, V74, P817, DOI 10.1111/j.1365-2656.2005.00981.x; Small C, 2006, CCAMLR SCI, V13, P143; Sullivan BJ, 2006, BIOL CONSERV, V131, P495, DOI 10.1016/j.biocon.2006.02.007; Sydeman WJ, 2012, MAR ECOL PROG SER, V454, P107, DOI 10.3354/meps09806; Thompson SA, 2012, MAR ECOL PROG SER, V454, P159, DOI 10.3354/meps09598; TICKELL WLN, 1968, ANTARCT BIRD STUD, P1; Tuck GN, 2003, BIOL CONSERV, V114, P1, DOI 10.1016/S0006-3207(02)00378-6; Tuck GN, 2001, J APPL ECOL, V38, P1182, DOI 10.1046/j.0021-8901.2001.00661.x; Tuck GN, 2004, HOBART CSIRO MARINE, P149; Watkins BP, 2008, ANIM CONSERV, V11, P247, DOI 10.1111/j.1469-1795.2008.00192.x; Webb LB, 2012, NAT CLIM CHANGE, V2, P259, DOI [10.1038/nclimate1417, 10.1038/NCLIMATE1417]; WEIMERSKIRCH H, 1992, OIKOS, V64, P464, DOI 10.2307/3545162; Weimerskirch H, 2004, POLAR BIOL, V27, P374, DOI 10.1007/s00300-004-0600-x; WEIMERSKIRCH H, 1987, OIKOS, V49, P315, DOI 10.2307/3565767; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Woods R., 2004, RESULTS PRELIMINARY, P98; Zador SG, 2008, BIOL CONSERV, V141, P872, DOI 10.1016/j.biocon.2008.01.001	70	15	15	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0127006	10.1371/journal.pone.0127006	http://dx.doi.org/10.1371/journal.pone.0127006			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057739	gold, Green Published			2022-12-26	WOS:000356349000006
J	Mason, SM; Prescott, J; Tworoger, SS; DeVivo, I; Rich-Edwards, JW				Mason, Susan M.; Prescott, Jennifer; Tworoger, Shelley S.; DeVivo, Immaculata; Rich-Edwards, Janet W.			Childhood Physical and Sexual Abuse History and Leukocyte Telomere Length among Women in Middle Adulthood	PLOS ONE			English	Article							EARLY-LIFE STRESS; CIGARETTE-SMOKING; OBESITY; ASSOCIATION; EXPERIENCES; CANCER; RISK; DYSFUNCTION; HEALTH	Objective Abuse victimization in childhood is associated with a variety of age-related cardiometabolic diseases, but the mechanisms remain unknown. Telomeres, which form the protective caps at the ends of chromosomes, have been proposed as measures of biological age, and a growing body of research suggests that telomere attrition may help to explain relationships between stress and cardiometabolic degradation. We examined the association between childhood abuse victimization and leukocyte telomere length among 1,135 participants in the Nurses' Health Study II (NHSII). Methods The NHSII ascertained physical and sexual child abuse histories in 2001. Telomere length was measured in genomic DNA extracted from peripheral blood leukocytes collected between 1996 and 1999. The ratio of telomere repeat copy number to a single gene copy number (T/S) was determined by a modified version of the quantitative real-time PCR telomere assay. Telomere length was log-transformed and corrected for assay variation across batch. We regressed telomere length on childhood abuse exposure variables and covariates using linear regression. Results We observed a reduction in telomere length associated with moderate physical abuse versus no physical abuse, but there was no evidence of a dose-response relationship for increased severity of physical abuse. No associations were noted for sexual abuse. Conclusions We found no evidence of an association between severity of childhood physical or sexual abuse and leukocyte telomere length in the NHSII.	[Mason, Susan M.; Rich-Edwards, Janet W.] Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, Boston, MA 02115 USA; [Mason, Susan M.; Prescott, Jennifer; Tworoger, Shelley S.; DeVivo, Immaculata; Rich-Edwards, Janet W.] Harvard Univ, Sch Med, Boston, MA USA; [Prescott, Jennifer; Tworoger, Shelley S.; DeVivo, Immaculata] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, Boston, MA 02115 USA; [Prescott, Jennifer; DeVivo, Immaculata] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Genet Epidemiol & Stat Genet, Boston, MA 02115 USA; [Tworoger, Shelley S.; Rich-Edwards, Janet W.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Mason, SM (corresponding author), Brigham & Womens Hosp, Connors Ctr Womens Hlth & Gender Biol, 75 Francis St, Boston, MA 02115 USA.	smmason@umn.edu		De Vivo, Immaculata/0000-0002-7185-7402; Mason, Susan/0000-0002-7635-9832	National Institutes of Health [RO1HL081557, UM1CA176726, R01CA67262]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grant RO1HL081557 from the National Institutes of Health. The Nurses' Health Study II infrastructure and blood collection are supported by grants UM1CA176726 and R01CA67262 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asok A, 2013, DEV PSYCHOPATHOL, V25, P577, DOI 10.1017/S0954579413000011; Bentley T, 2009, OBESITY, V17, P1900, DOI 10.1038/oby.2009.160; Black M.C., 2011, NATL INTIMATE PARTNE; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chen SH, 2014, J AFFECT DISORDERS, V169, P86, DOI 10.1016/j.jad.2014.07.035; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Drury SS, 2012, MOL PSYCHIATR, V17, P719, DOI 10.1038/mp.2011.53; Drury SS, 2014, PEDIATRICS, V134, pE128, DOI 10.1542/peds.2013-3415; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Fitzpatrick AL, 2011, J GERONTOL A-BIOL, V66, P421, DOI 10.1093/gerona/glq224; Fyhrquist F, 2012, ANN MED, V44, pS138, DOI 10.3109/07853890.2012.660497; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; Glass Daniel, 2010, Biol Psychiatry, V68, pe21, DOI 10.1016/j.biopsych.2010.02.026; Hofmann JN, 2011, BRIT J CANCER, V105, P1772, DOI 10.1038/bjc.2011.444; Houben JMJ, 2002, FREE RADIC BIOL MED, V44, P235; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Jun HJ, 2008, J ADOLESCENT HEALTH, V43, P55, DOI 10.1016/j.jadohealth.2007.12.003; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kendall-Tackett KA, 1999, CHILD ABUSE NEGLECT, V23, P593, DOI 10.1016/S0145-2134(99)00033-2; Kiecolt-Glaser JK, 2011, PSYCHOSOM MED, V73, P16, DOI 10.1097/PSY.0b013e31820573b6; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; KOSS MP, 1982, J CONSULT CLIN PSYCH, V50, P455, DOI 10.1037/0022-006X.50.3.455; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Noll JG, 2007, PEDIATRICS, V120, pE61, DOI 10.1542/peds.2006-3058; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; O'Donovan A, 2011, BIOL PSYCHIAT, V70, P465, DOI 10.1016/j.biopsych.2011.01.035; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Poole EM, 2011, AM J EPIDEMIOL, V174, P642, DOI 10.1093/aje/kwr123; Prescott J, 2012, HUM REPROD, V27, P3622, DOI 10.1093/humrep/des314; Prescott J, 2010, CANCER-AM CANCER SOC, V116, P4275, DOI 10.1002/cncr.25328; Rich-Edwards JW, 2012, CIRCULATION, V126, P920, DOI 10.1161/CIRCULATIONAHA.111.076877; Rich-Edwards JW, 2010, AM J PREV MED, V39, P529, DOI 10.1016/j.amepre.2010.09.007; Riley EH, 2010, J EPIDEMIOL COMMUN H, V64, P413, DOI 10.1136/jech.2009.095109; Rosner B, 2008, AM J EPIDEMIOL, V167, P653, DOI 10.1093/aje/kwm348; Savolainen K, 2014, BIOL PSYCHOL, V97, P35, DOI 10.1016/j.biopsycho.2014.02.002; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Straus M.A., 1990, PHYS VIOLENCE AM FAM, DOI DOI 10.4324/9781315126401; Stunkard A J, 1983, Res Publ Assoc Res Nerv Ment Dis, V60, P115; Surtees PG, 2011, J GERONTOL A-BIOL, V66, P1152, DOI 10.1093/gerona/glr112; Tjaden P, 2000, 183781 NCJ US DEP JU, DOI [10.1007/s10995-011-0819-4, DOI 10.1007/S10995-011-0819-4]; Tworoger SS, 2015, CANCER EPIDEM BIOMAR, V24, P73, DOI 10.1158/1055-9965.EPI-14-0896; Tworoger SS, 2006, CANCER RES, V66, P2476, DOI 10.1158/0008-5472.CAN-05-3369; Tyrka AR, 2010, BIOL PSYCHIAT, V67, P531, DOI 10.1016/j.biopsych.2009.08.014; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Zhu HD, 2011, J PEDIATR-US, V158, P215, DOI 10.1016/j.jpeds.2010.08.007	49	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0124493	10.1371/journal.pone.0124493	http://dx.doi.org/10.1371/journal.pone.0124493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053088	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300008
J	Mochizuki, H; Kennedy, K; Shapiro, SG; Breen, M				Mochizuki, Hiroyuki; Kennedy, Katherine; Shapiro, Susan G.; Breen, Matthew			BRAF Mutations in Canine Cancers	PLOS ONE			English	Article							HAIRY-CELL LEUKEMIA; PROSTATE-CANCER; THYROID-CARCINOMA; V600E MUTATION; RAPID RESPONSE; MELANOMA; VEMURAFENIB; PATHWAYS; GENE; REARRANGEMENTS	Activating mutations of the BRAF gene lead to constitutive activation of the MAPK pathway. Although many human cancers carry the mutated BRAF gene, this mutation has not yet been characterized in canine cancers. As human and canine cancers share molecular abnormalities, we hypothesized that BRAF gene mutations also exist in canine cancers. To test this hypothesis, we sequenced the exon 15 of BRAF, mutation hot spot of the gene, in 667 canine primary tumors and 38 control tissues. Sequencing analysis revealed that a single nucleotide T to A transversion at nucleotide 1349 occurred in 64 primary tumors (9.6%), with particularly high frequency in prostatic carcinoma (20/25, 80%) and urothelial carcinoma (30/45, 67%). This mutation results in the amino acid substitution of glutamic acid for valine at codon 450 (V450E) of canine BRAF, corresponding to the most common BRAF mutation in human cancer, V600E. The evolutional conservation of the BRAF V600E mutation highlights the importance of MAPK pathway activation in neoplasia and may offer opportunity for molecular diagnostics and targeted therapeutics for dogs bearing BRAF-mutated cancers.	[Mochizuki, Hiroyuki; Kennedy, Katherine; Shapiro, Susan G.; Breen, Matthew] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Breen, Matthew] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Breen, Matthew] N Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Breen, Matthew] N Carolina State Univ, Lineberger Comprehens Canc Ctr, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Breen, M (corresponding author), N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27695 USA.	Matthew_Breen@ncsu.edu	Mochizuki, Hiroyuki/L-9510-2015	Mochizuki, Hiroyuki/0000-0002-1520-0393; Breen, Matthew/0000-0002-8901-4155	North Carolina State University (NCSU); NATIONAL CENTER FOR RESEARCH RESOURCES [T35RR025837] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T35OD011070] Funding Source: NIH RePORTER	North Carolina State University (NCSU); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the North Carolina State University (NCSU) Cancer Genomics Fund (MB).	Boulalas I, 2009, INT J BIOL MARKER, V24, P17, DOI 10.1177/172460080902400103; Brose MS, 2002, CANCER RES, V62, P6997; Campos M, 2014, J VET INTERN MED, V28, P1814, DOI 10.1111/jvim.12435; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Cho NY, 2006, INT J CANCER, V119, P1858, DOI 10.1002/ijc.22071; Cohen J, 2003, J NATL CANCER I, V95, P625, DOI 10.1093/jnci/95.8.625; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Edwards RH, 2004, J MED GENET, V41, P270, DOI 10.1136/jmg.2003.016667; Follows GA, 2013, BRIT J HAEMATOL, V161, P150, DOI 10.1111/bjh.12201; Fowles J, VET COMP ON IN PRESS; Gao H, 2006, P NATL ACAD SCI USA, V103, P14477, DOI 10.1073/pnas.0606836103; Gillard M, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12170; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Hauschild A, 2012, LANCET, V380, P358, DOI 10.1016/S0140-6736(12)60868-X; Kimura ET, 2003, CANCER RES, V63, P1454; Knowles MA, 2015, NAT REV CANCER, V15, P25, DOI 10.1038/nrc3817; Kollermann J, 2010, ONCOL LETT, V1, P729, DOI 10.3892/ol_00000127; LeRoy BE, 2009, VET J, V180, P149, DOI 10.1016/j.tvjl.2008.07.012; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Munoz J, 2013, J CLIN ONCOL, V31, pE351, DOI 10.1200/JCO.2012.45.7739; Namba H, 2003, J CLIN ENDOCR METAB, V88, P4393, DOI 10.1210/jc.2003-030305; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Ren GP, 2012, GENE CHROMOSOME CANC, V51, P1014, DOI 10.1002/gcc.21984; Richter A, 2005, J HERED, V96, P764, DOI 10.1093/jhered/esi121; Roskoski R, 2010, BIOCHEM BIOPH RES CO, V399, P313, DOI 10.1016/j.bbrc.2010.07.092; Schulz WA, 2006, INT J CANCER, V119, P1513, DOI 10.1002/ijc.21852; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shelly S, 2005, MAMM GENOME, V16, P211, DOI 10.1007/s00335-004-2441-x; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Wang XS, 2011, CANCER DISCOV, V1, P35, DOI 10.1158/2159-8274.CD-10-0022; Xing M, 2005, ENDOCR-RELAT CANCER, V12, P245, DOI 10.1677/erc.1.0978	38	67	67	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129534	10.1371/journal.pone.0129534	http://dx.doi.org/10.1371/journal.pone.0129534			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053201	gold, Green Submitted, Green Published			2022-12-26	WOS:000355955300139
J	Ogata, Y; Mabuchi, Y; Yoshida, M; Suto, EG; Suzuki, N; Muneta, T; Sekiya, I; Akazawa, C				Ogata, Yusuke; Mabuchi, Yo; Yoshida, Mayu; Suto, Eriko Grace; Suzuki, Nobuharu; Muneta, Takeshi; Sekiya, Ichiro; Akazawa, Chihiro			Purified Human Synovium Mesenchymal Stem Cells as a Good Resource for Cartilage Regeneration	PLOS ONE			English	Article							HUMAN BONE-MARROW; ADIPOSE-TISSUE; STROMAL CELLS; DIFFERENTIATION; IDENTIFICATION; TENEURIN-4; REGULATOR	Mesenchymal stem cells (MSCs) have the ability to differentiate into a variety of lineages and to renew themselves without malignant changes, and thus hold potential for many clinical applications. However, it has not been well characterized how different the properties of MSCs are depending on the tissue source in which they resided. We previously reported a novel technique for the prospective MSC isolation from bone marrow, and revealed that a combination of cell surface markers (LNGFR and THY-1) allows the isolation of highly enriched MSC populations. In this study, we isolated LNGFR(+) THY-1(+) MSCs from synovium using flow cytometry. The results show that the synovium tissue contained a significantly larger percentage of LNGFR(+) THY-1(+) MSCs. We examined the colony formation and differentiation abilities of bone marrow-derived MSCs (BM-MSCs) and synovium-derived MSCs (SYN-MSCs) isolated from the same patients. Both types of MSCs exhibited a marked propensity to differentiate into specific lineages. BM-MSCs were preferentially differentiated into bone, while in the SYN-MSC culture, enhanced adipogenic and chondrogenic differentiation was observed. These data suggest that the tissue from which MSCs are isolated should be tailored according to their intended clinical therapeutic application.	[Ogata, Yusuke; Mabuchi, Yo; Yoshida, Mayu; Suto, Eriko Grace; Suzuki, Nobuharu; Akazawa, Chihiro] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Tokyo, Japan; [Muneta, Takeshi] Tokyo Med & Dent Univ, Grad Sch Med, Dept Joint Surg & Sport Med, Tokyo, Japan; [Sekiya, Ichiro] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Akazawa, C (corresponding author), Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Tokyo, Japan.	c.akazawa.bb@tmd.ac.jp	Ogata, Yusuke/X-9239-2019; Mabuchi, Yo/L-1535-2013	Ogata, Yusuke/0000-0002-5993-4356; Mabuchi, Yo/0000-0001-8008-3966; Muneta, Takeshi/0000-0003-1018-2939				Battula VL, 2007, DIFFERENTIATION, V75, P279, DOI 10.1111/j.1432-0436.2006.00139.x; Berenbaum F, 2013, OSTEOARTHR CARTILAGE, V21, P16, DOI 10.1016/j.joca.2012.11.012; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Civenni G, 2011, CANCER RES, V71, P3098, DOI 10.1158/0008-5472.CAN-10-3997; Conget PA, 1999, J CELL PHYSIOL, V181, P67, DOI 10.1002/(SICI)1097-4652(199910)181:1<67::AID-JCP7>3.0.CO;2-C; De Bari C, 2003, J CELL BIOL, V160, P909, DOI 10.1083/jcb.200212064; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gago-Lopez N, 2014, STEM CELL REP, V2, P576, DOI 10.1016/j.stemcr.2014.03.003; Hanley PJ, 2013, CYTOTHERAPY, V15, P416, DOI 10.1016/j.jcyt.2012.09.007; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Jackson WM, 2012, STEM CELL TRANSL MED, V1, P44, DOI 10.5966/sctm.2011-0024; Kobayashi S, 2011, P NATL ACAD SCI USA, V108, P14479, DOI 10.1073/pnas.1109767108; Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460; Liu TM, 2007, STEM CELLS, V25, P750, DOI 10.1634/stemcells.2006-0394; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001; Matsukura Y, 2015, J ORTHOP RES, V33, P246, DOI 10.1002/jor.22753; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Nimura A, 2008, ARTHRITIS RHEUM, V58, P501, DOI 10.1002/art.23219; Patil PB, 2014, CYTOTHERAPY, V16, P990, DOI 10.1016/j.jcyt.2014.03.001; PIERSMA AH, 1985, EXP HEMATOL, V13, P237; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 2001, CYTOTHERAPY, V3, P393, DOI 10.1080/146532401753277229; Quirici N, 2002, EXP HEMATOL, V30, P783, DOI 10.1016/S0301-472X(02)00812-3; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; SIMMONS PJ, 1991, BLOOD, V78, P55; Suzuki N, 2014, J ORTHOP RES, V32, P915, DOI 10.1002/jor.22616; Suzuki N, 2012, J NEUROSCI, V32, P11586, DOI 10.1523/JNEUROSCI.2045-11.2012; Truzzi F, 2014, J INVEST DERMATOL; van Strien ME, 2014, STEM CELL TRANSL MED, V3, P470, DOI 10.5966/sctm.2013-0038; Wang YW, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/652034; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813	36	60	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129096	10.1371/journal.pone.0129096	http://dx.doi.org/10.1371/journal.pone.0129096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053045	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300085
J	Wu, ZC; Xia, RW; Yin, XM; Huo, YJ; Zhu, GQ; Wu, SL; Bao, WB				Wu, Zhengchang; Xia, Riwei; Yin, Xuemei; Huo, Yongjiu; Zhu, Guoqiang; Wu, Shenglong; Bao, Wenbin			Proteomic Analysis of Duodenal Tissue from Escherichia coli F18-Resistant and -Susceptible Weaned Piglets	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; LAMININ RECEPTOR; EPITHELIAL-CELLS; EXPRESSION; F-18; GENE; FIMBRIAE; DIARRHEA; ANTIGEN; INNATE	Diarrhea and edema disease in weaned piglets due to infection by Escherichia coli F18 is a leading cause of economic loss in the pig industry. Resistance to E. coli F18 depends on expression of receptors on intestinal epithelial cells, and individual immunity. This study was conducted in Sutai pig E. coli F18-resistant and -susceptible full sib-pair individuals, identified on the basis of resource populations and verification of adhesion assays. The molecular mechanism underlying E. coli F18 resistance was investigated through analysis of the expression of E. coli F18 receptor associated and innate immunity proteins, using proteomics and bioinformatics techniques. Two-dimensional electrophoresis analysis revealed a total of 20 differentially expressed proteins in E. coli F18-resistant and -susceptible groups (10 upregulated and 10 downregulated). A total of 16 differentially expressed proteins were identified by MALDI TOF/TOF mass spectral analysis. According to gene ontology and pathway analysis, differentially expressed proteins were mainly involved in cell adhesion, immune response and other biologically relevant functions. Network analysis of interactions between differentially expressed proteins indicated a likelihood of their involvement in E. coli F18 infection. The expression levels of several important proteins including actin beta (ACTB), vinculin (VCL), heat stress proteins (HSPs) and transferrin (TF) in E. coli F18-resistant and -susceptible individuals were verified by Western blotting, supporting the identification of ACTB, VCL, HSPs and TF as promising candidate proteins for association with E. coli F18 susceptibility.	[Wu, Zhengchang; Xia, Riwei; Yin, Xuemei; Huo, Yongjiu; Wu, Shenglong; Bao, Wenbin] Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou 225009, Jiangsu, Peoples R China; [Zhu, Guoqiang] Yangzhou Univ, Coll Vet Med, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University	Bao, WB (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Key Lab Anim Genet Breeding Reprod & Mol Design J, Yangzhou 225009, Jiangsu, Peoples R China.	wbbao@yzu.edu.cn			National Natural Science Funds [31372285, 31172183]; Genetically Modified Organisms Technology Major Project [2014ZX08006-001B]; Science and Technology Supporting Project of Jiangsu Province [BE2012330, BY2012157, BE2013345]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Genetically Modified Organisms Technology Major Project; Science and Technology Supporting Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Funds (31372285, 31172183); Genetically Modified Organisms Technology Major Project (2014ZX08006-001B); Science and Technology Supporting Project of Jiangsu Province (BE2012330, BY2012157, BE2013345); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Alwan A, 1998, J MICROBIOL METH, V33, P163, DOI 10.1016/S0167-7012(98)00052-9; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Bao WB, 2008, J ANIM BREED GENET, V125, P427, DOI 10.1111/j.1439-0388.2008.00722.x; Bao WB, 2012, ANIM GENET, V43, P525, DOI 10.1111/j.1365-2052.2011.02287.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTIN AM, 1991, AM J VET RES, V52, P45; BERTSCHINGER HU, 1990, VET MICROBIOL, V25, P267, DOI 10.1016/0378-1135(90)90083-8; Bilsma IG, 1987, VET RES COMMUN, V11, P509, DOI [10.1007/BF00396368, DOI 10.1007/BF00396368]; Coddens A, 2007, VET MICROBIOL, V122, P332, DOI 10.1016/j.vetmic.2007.02.007; Coddens A, 2009, J BIOL CHEM, V284, P9713, DOI 10.1074/jbc.M807866200; David JC, 2000, J MOL NEUROSCI, V15, P109, DOI 10.1385/JMN:15:2:109; Dziarski R, 1996, J INFECT DIS, V174, P777, DOI 10.1093/infdis/174.4.777; EDFORSLILJA I, 1995, ANIM GENET, V26, P237, DOI 10.1111/j.1365-2052.1995.tb03250.x; Frydendahl K, 2003, VET MICROBIOL, V93, P39, DOI 10.1016/S0378-1135(02)00348-6; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Grange PA, 1996, INFECT IMMUN, V64, P606, DOI 10.1128/IAI.64.2.606-610.1996; HEUKESHOVEN J, 1985, ELECTROPHORESIS, V6, P103, DOI 10.1002/elps.1150060302; Jamieson KV, 2011, J MOL BIOL, V405, P24, DOI 10.1016/j.jmb.2010.10.028; Junghans P, 2004, J NUTR, V134, P43, DOI 10.1093/jn/134.1.43; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Mouricout M, 1997, ADV EXP MED BIOL, V412, P109; Mouricout M, 1997, P INT C AN BIOL, P47; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; OTTO BR, 1992, CRIT REV MICROBIOL, V18, P217, DOI 10.3109/10408419209114559; Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801; Varki A., 1999, ESSENTIALS GLYCOBIOL; Vogeli P, 1997, SCHWEIZ ARCH TIERH, V139, P479; Wallin RPA, 2002, TRENDS IMMUNOL, V23, P130, DOI 10.1016/S1471-4906(01)02168-8; Wu ShengLong, 2006, Chinese Journal of Veterinary Science, V26, P622; Ye L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043741; Yi Sun-Shin, 2013, Lab Anim Res, V29, P162, DOI 10.5625/lar.2013.29.3.162; Zhang Jian-jun, 2007, Weishengwu Xuebao, V47, P790; Zhu Li, 2010, Weishengwu Xuebao, V50, P1446	35	3	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0127164	10.1371/journal.pone.0127164	http://dx.doi.org/10.1371/journal.pone.0127164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053838	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300014
J	Bazmara, H; Soltani, M; Sefidgar, M; Bazargan, M; Naeenian, MM; Rahmim, A				Bazmara, Hossein; Soltani, Madjid; Sefidgar, Mostafa; Bazargan, Majid; Naeenian, Mojtaba Mousavi; Rahmim, Arman			The Vital Role of Blood Flow-Induced Proliferation and Migration in Capillary Network Formation in a Multiscale Model of Angiogenesis	PLOS ONE			English	Article							FLUID SHEAR-STRESS; FOCAL ADHESION KINASE; ENDOTHELIAL-CELLS; SIGNAL-TRANSDUCTION; DRUG-DELIVERY; VESSEL FUSION; TUMOR-GROWTH; MECHANISMS; EXPRESSION; MECHANOTRANSDUCTION	Sprouting angiogenesis and capillary network formation are tissue scale phenomena. There are also sub-scale phenomena involved in angiogenesis including at the cellular and intracellular (molecular) scales. In this work, a multiscale model of angiogenesis spanning intracellular, cellular, and tissue scales is developed in detail. The key events that are considered at the tissue scale are formation of closed flow path (that is called loop in this article) and blood flow initiation in the loop. At the cellular scale, growth, migration, and anastomosis of endothelial cells (ECs) are important. At the intracellular scale, cell phenotype determination as well as alteration due to blood flow is included, having pivotal roles in the model. The main feature of the model is to obtain the physical behavior of a closed loop at the tissue scale, relying on the events at the cellular and intracellular scales, and not by imposing physical behavior upon it. Results show that, when blood flow is considered in the loop, the anastomosed sprouts stabilize and elongate. By contrast, when the loop is modeled without consideration of blood flow, the loop collapses. The results obtained in this work show that proper determination of EC phenotype is the key for its survival.	[Bazmara, Hossein; Soltani, Madjid; Sefidgar, Mostafa; Bazargan, Majid; Naeenian, Mojtaba Mousavi] KNT Univ Technol, Dept Mech Engn, Tehran, Iran; [Soltani, Madjid; Rahmim, Arman] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Div Nucl Med, Baltimore, MD USA	Johns Hopkins University	Soltani, M (corresponding author), KNT Univ Technol, Dept Mech Engn, Tehran, Iran.	msoltani@jhu.edu	Bazmara, Hossein/AAO-8162-2021; Rahmim, Arman/ACS-4963-2022; Sefidgar, Mostafa/AAO-8634-2021; Bazargan, Majid/AAS-3204-2020	Rahmim, Arman/0000-0002-9980-2403; Bazargan, Majid/0000-0001-8747-664X				Anderson ARA, 2012, MODELING TUMOR VASCULATURE: MOLECULAR, CELLULAR, AND TISSUE LEVEL ASPECTS AND IMPLICATIONS, P105, DOI 10.1007/978-1-4614-0052-3_5; Ando J, 2013, CARDIOVASC RES, V99, P260, DOI 10.1093/cvr/cvt084; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; [Anonymous], EMBO J; Armer HEJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007716; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bauer AL, 2012, MODELING TUMOR VASCULATURE: MOLECULAR, CELLULAR, AND TISSUE LEVEL ASPECTS AND IMPLICATIONS, P79, DOI 10.1007/978-1-4614-0052-3_4; Bauer AL, 2010, J THEOR BIOL, V264, P838, DOI 10.1016/j.jtbi.2010.03.025; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; Berk BC, 2008, CIRCULATION, V117, P1082, DOI 10.1161/CIRCULATIONAHA.107.720730; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Chaplain MAJ, 2012, MODELING TUMOR VASCULATURE: MOLECULAR, CELLULAR, AND TISSUE LEVEL ASPECTS AND IMPLICATIONS, P167, DOI 10.1007/978-1-4614-0052-3_8; Chen KD, 1999, J BIOL CHEM, V274, P18393, DOI 10.1074/jbc.274.26.18393; Chien S, 1998, HYPERTENSION, V31, P162, DOI 10.1161/01.HYP.31.1.162; Chun TH, 1997, HYPERTENSION, V29, P1296, DOI 10.1161/01.HYP.29.6.1296; Clark ER, 1918, AM J ANAT, V23, P37, DOI 10.1002/aja.1000230103; COOKE JP, 1991, J CLIN INVEST, V88, P1663, DOI 10.1172/JCI115481; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; Dimmeler S, 1996, FEBS LETT, V399, P71, DOI 10.1016/S0014-5793(96)01289-6; Estrach S, 2011, CIRC RES, V109, P172, DOI 10.1161/CIRCRESAHA.111.240622; Garipcan B, 2011, ADV ENG MATER, V13, pB54, DOI 10.1002/adem.201080076; GERLOWSKI LE, 1986, MICROVASC RES, V31, P288, DOI 10.1016/0026-2862(86)90018-X; GIMBRONE MA, 1974, J NATL CANCER I, V52, P413, DOI 10.1093/jnci/52.2.413; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Herwig L, 2011, CURR BIOL, V21, P1942, DOI 10.1016/j.cub.2011.10.016; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Hsu PP, 2001, BIOCHEM BIOPH RES CO, V285, P751, DOI 10.1006/bbrc.2001.5221; Ishida T, 1996, CIRC RES, V79, P310, DOI 10.1161/01.RES.79.2.310; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Johnson BD, 2011, VASC MED, V16, P365, DOI 10.1177/1358863X11422109; Kaiser D, 1997, BIOCHEM BIOPH RES CO, V231, P586, DOI 10.1006/bbrc.1997.6146; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Lee HJ, 2003, BIOCHEM BIOPH RES CO, V304, P399, DOI 10.1016/S0006-291X(03)00592-8; Lehoux S, 1998, HYPERTENSION, V32, P338, DOI 10.1161/01.HYP.32.2.338; Lenard A, 2013, DEV CELL, V25, P492, DOI 10.1016/j.devcel.2013.05.010; LEVESQUE MJ, 1990, BIOMATERIALS, V11, P702, DOI 10.1016/0142-9612(90)90031-K; Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614; Li S, 2002, P NATL ACAD SCI USA, V99, P3546, DOI 10.1073/pnas.052018099; Li S, 1997, J BIOL CHEM, V272, P30455, DOI 10.1074/jbc.272.48.30455; Li YSJ, 2005, J BIOMECH, V38, P1949, DOI 10.1016/j.jbiomech.2004.09.030; Mahoney AW, 2012, IEEE ACM T COMPUT BI, V9, P169, DOI 10.1109/TCBB.2010.39; Mahoney AW, 2008, 2008 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY, P215; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Mariggi G, 2012, THESIS U COLL LONDON; Meeson A, 1996, DEVELOPMENT, V122, P3929; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Milde F, 2008, BIOPHYS J, V95, P3146, DOI 10.1529/biophysj.107.124511; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; MUTHUKKARUPPAN VR, 1982, J NATL CANCER I, V69, P699; Ngai C., 2010, OPEN CIRC VASC J, V3, P85; OKAHARA K, 1995, FEBS LETT, V373, P108, DOI 10.1016/0014-5793(95)01027-C; Osawa M, 2002, J CELL BIOL, V158, P773, DOI 10.1083/jcb.200205049; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Pan S, 2009, ANTIOXID REDOX SIGN, V11, P1669, DOI [10.1089/ars.2009.2487, 10.1089/ARS.2009.2487]; PAWELETZ N, 1989, CRIT REV ONCOL HEMAT, V9, P197, DOI 10.1016/S1040-8428(89)80002-2; Perfahl H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014790; Pries AR, 2001, HYPERTENSION, V38, P1476, DOI 10.1161/hy1201.100592; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Quitub AA, 2009, IEEE ENG MED BIOL, V28, P14, DOI 10.1109/MEMB.2009.931791; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Riaz A, 2013, THESIS UPPSALA U; Sefidgar M, 2015, MICROVASC RES, V99, P43, DOI 10.1016/j.mvr.2015.02.007; Sefidgar M, 2014, J TISSUE SCI ENG S, DOI [10.4172/2157-7552.S4-003, DOI 10.4172/2157-7552.S4-003]; Sefidgar M, 2014, J BIOL ENG, V8, DOI 10.1186/1754-1611-8-12; Shamloo A, 2010, LAB CHIP, V10, P3061, DOI 10.1039/c005069e; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Shirinifard A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007190; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Soltani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067025; Soltani M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020344; Song JW, 2012, INTEGR BIOL-UK, V4, P857, DOI 10.1039/c2ib20061a; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Stapor PC., 2011, CARDIOVASC ENG TECHN, V2, P124, DOI [10.1007/S13239-011-0041-Y, DOI 10.1007/S13239-011-0041-Y]; Stephanou A, 2006, MATH COMPUT MODEL, V44, P96, DOI 10.1016/j.mcm.2004.07.021; Stylianopoulos T, 2013, ANN BIOMED ENG, V41, P68, DOI 10.1007/s10439-012-0630-4; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Udan RS, 2013, DEVELOPMENT, V140, P4041, DOI 10.1242/dev.096255; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	85	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128878	10.1371/journal.pone.0128878	http://dx.doi.org/10.1371/journal.pone.0128878			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047145	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200109
J	Chan, CXJ; Joseph, IG; Huang, A; Jackson, DN; Lipke, PN				Chan, Cho X. J.; Joseph, Ivor G.; Huang, Andy; Jackson, Desmond N.; Lipke, Peter N.			Quantitative Analyses of Force-Induced Amyloid Formation in Candida albicans Als5p: Activation by Standard Laboratory Procedures	PLOS ONE			English	Article							THIN AGGREGATIVE FIMBRIAE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ADHESION NANODOMAINS; PROTEIN-STRUCTURE; FIBRIL FORMATION; SURFACE; CURLI; MOLECULE; FIBERS	Candida albicans adhesins have amyloid-forming sequences. In Als5p, these amyloid sequences cluster cell surface adhesins to create high avidity surface adhesion nanodomains. Such nanodomains form after force is applied to the cell surface by atomic force microscopy or laminar flow. Here we report centrifuging and resuspending S. cerevisiae cells expressing Als5p led to 1.7-fold increase in initial rate of adhesion to ligand coated beads. Furthermore, mechanical stress from vortex-mixing of Als5p cells or C. albicans cells also induced additional formation of amyloid nanodomains and consequent activation of adhesion. Vortex-mixing for 60 seconds increased the initial rate of adhesion 1.6-fold. The effects of vortex-mixing were replicated in heat-killed cells as well. Activation was accompanied by increases in thioflavin T cell surface fluorescence measured by flow cytometry or by confocal microscopy. There was no adhesion activation in cells expressing amyloid-impaired Als5p(V326N) or in cells incubated with inhibitory concentrations of anti-amyloid dyes. Together these results demonstrated the activation of cell surface amyloid nanodomains in yeast expressing Als adhesins, and further delineate the forces that can activate adhesion in vivo. Consequently there is quantitative support for the hypothesis that amyloid forming adhesins act as both force sensors and effectors.	[Chan, Cho X. J.; Joseph, Ivor G.; Huang, Andy; Jackson, Desmond N.; Lipke, Peter N.] CUNY Brooklyn Coll, Dept Biol, New York, NY 11210 USA; [Chan, Cho X. J.; Lipke, Peter N.] CUNY, Grad Ctr, New York, NY USA; [Chan, Cho X. J.] Pace Univ, Haskins Labs, New York, NY 10038 USA; [Chan, Cho X. J.] Pace Univ, Dept Chem & Phys Sci, New York, NY 10038 USA	City University of New York (CUNY) System; City University of New York (CUNY) System; Pace University; Pace University	Lipke, PN (corresponding author), CUNY Brooklyn Coll, Dept Biol, New York, NY 11210 USA.	plipke@brookyn.cuny.edu	Lipke, Peter N./AAW-4914-2020	Lipke, Peter N./0000-0003-1733-0690	National Institute of Health [R01 GM098616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098616] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health Grant# R01 GM098616 (http://grants.nih.gov/grants/funding/r01.htm) to PNL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsteens D, 2013, ANAL METHODS-UK, V5, P3657, DOI 10.1039/c3ay40473k; Alsteens D, 2012, ACS NANO, V6, P7703, DOI 10.1021/nn3025699; Alsteens D, 2010, P NATL ACAD SCI USA, V107, P20744, DOI 10.1073/pnas.1013893107; Alsteens D, 2009, ACS NANO, V3, P1677, DOI 10.1021/nn900078p; Austin JW, 1998, FEMS MICROBIOL LETT, V162, P295, DOI 10.1016/S0378-1097(98)00137-2; Bai G, 2012, INT J PHARMACEUT, V423, P264, DOI 10.1016/j.ijpharm.2011.11.044; Beaussart A, 2012, ACS NANO, V6, P10950, DOI 10.1021/nn304505s; BenNasr A, 1996, MOL MICROBIOL, V20, P927; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chan CXJ, 2014, EUKARYOT CELL, V13, P1136, DOI 10.1128/EC.00068-14; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; CHARM SE, 1969, BIBL ANAT, P85; Coleman DA, 2010, MICROBIOL-SGM, V156, P3645, DOI 10.1099/mic.0.043851-0; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dunstan DE, 2009, PROTEIN ENG DES SEL, V22, P741, DOI 10.1093/protein/gzp059; Dutton LC, 2014, MBIO, V5, DOI 10.1128/mBio.00911-14; Fandrich M, 2006, ACTA HISTOCHEM, V108, P215, DOI 10.1016/j.acthis.2006.03.012; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Garcia MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017632; Garcia-Herranz M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0092413, 10.1371/journal.pone.0086067]; Gaur NK, 1997, INFECT IMMUN, V65, P5289, DOI 10.1128/IAI.65.12.5289-5294.1997; Gilchrist KB, 2012, J INFECT DIS, V206, P1473, DOI 10.1093/infdis/jis464; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Hill EK, 2006, BIOMACROMOLECULES, V7, P10, DOI 10.1021/bm0505078; HOYER LL, 1995, MOL MICROBIOL, V15, P39, DOI 10.1111/j.1365-2958.1995.tb02219.x; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Ladner-Keay CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098753; Lipke PN, 2012, TRENDS MICROBIOL, V20, P59, DOI 10.1016/j.tim.2011.10.002; MCCUTCHEN SL, 1995, BIOCHEMISTRY-US, V34, P13527, DOI 10.1021/bi00041a032; Merlini G, 2005, CLIN CHIM ACTA, V357, P168, DOI 10.1016/j.cccn.2005.03.022; Morris KL, 2013, ANGEW CHEM INT EDIT, V52, P2279, DOI 10.1002/anie.201207699; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; OLSEN A, 1989, NATURE, V338, P652, DOI 10.1038/338652a0; Olsen A, 1998, INFECT IMMUN, V66, P944; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; Romero D, 2011, MOL MICROBIOL, V80, P1155, DOI 10.1111/j.1365-2958.2011.07653.x; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serpell LC, 2000, BBA-MOL BASIS DIS, V1502, P16, DOI 10.1016/S0925-4439(00)00029-6; SJOBRING U, 1994, MOL MICROBIOL, V14, P443, DOI 10.1111/j.1365-2958.1994.tb02179.x; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Vidal O, 1998, J BACTERIOL, V180, P2442, DOI 10.1128/JB.180.9.2442-2449.1998	44	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129152	10.1371/journal.pone.0129152	http://dx.doi.org/10.1371/journal.pone.0129152			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047318	Green Published, gold			2022-12-26	WOS:000355652200130
J	Huber, SKR; Camps, MGM; Jacobi, RHJ; Mouthaan, J; van Dijken, H; van Beek, J; Ossendorp, F; de Jonge, J				Huber, S. K. Rosendahl; Camps, M. G. M.; Jacobi, R. H. J.; Mouthaan, J.; van Dijken, H.; van Beek, J.; Ossendorp, F.; de Jonge, J.			Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets	PLOS ONE			English	Article							A VIRUS; PROTECTIVE IMMUNITY; TRANSGENIC MICE; FUSION PEPTIDE; H5N1 VIRUS; INFECTION; HUMANS; IDENTIFICATION; HEMAGGLUTININ; LYMPHOCYTES	Currently licensed influenza vaccines mainly induce antibodies against highly variable epitopes. Due to antigenic drift, protection is subtype or strain-specific and regular vaccine updates are required. In case of antigenic shifts, which have caused several pandemics in the past, completely new vaccines need to be developed. We set out to develop a vaccine that provides protection against a broad range of influenza viruses. Therefore, highly conserved parts of the influenza A virus (IAV) were selected of which we constructed antibody and T cell inducing peptide-based vaccines. The B epitope vaccine consists of the highly conserved HA2 fusion peptide and M2e peptide coupled to a CD4 helper epitope. The T epitope vaccine comprises 25 overlapping synthetic long peptides of 26-34 amino acids, thereby avoiding restriction for a certain MHC haplotype. These peptides are derived from nucleoprotein (NP), polymerase basic protein 1 (PB1) and matrix protein 1 (M1). C57BL/6 mice, BALB/c mice, and ferrets were vaccinated with the B epitopes, 25 SLP or a combination of both. Vaccine-specific antibodies were detected in sera of mice and ferrets and vaccine-specific cellular responses were measured in mice. Following challenge, both mice and ferrets showed a reduction of virus titers in the lungs in response to vaccination. Summarizing, a peptide-based vaccine directed against conserved parts of influenza virus containing B and T cell epitopes shows promising results for further development. Such a vaccine may reduce disease burden and virus transmission during pandemic outbreaks.	[Huber, S. K. Rosendahl; Jacobi, R. H. J.; Mouthaan, J.; van Dijken, H.; van Beek, J.; de Jonge, J.] Ctr Infect Dis Control Cib, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Camps, M. G. M.; Ossendorp, F.] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	de Jonge, J (corresponding author), Ctr Infect Dis Control Cib, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	Jorgen.de.Jonge@rivm.nl		de Jonge, Jorgen/0000-0003-3167-2435	European Union Seventh Framework Programme, Identification of Mechanisms Correlating with Susceptibility for Avian Influenza (IMECS) [201169]; Health Program of the European Union, Fast Vaccination (FASTVAC) [2009-1106]	European Union Seventh Framework Programme, Identification of Mechanisms Correlating with Susceptibility for Avian Influenza (IMECS); Health Program of the European Union, Fast Vaccination (FASTVAC)	Funding provided to FO, JvB, JdJ by the European Union Seventh Framework Programme under grant number 201169, Identification of Mechanisms Correlating with Susceptibility for Avian Influenza (IMECS), http://ec.europa.eu/research/health/infectious-diseases/emerging-epidemics/projects/175_en.html. Funding provided to JdJ, HvD, JM by the Health Program of the European Union under grant number 2009-1106, Fast Vaccination (FASTVAC), http://www.fastvac.eu/work-packages/liaison-for-vaccine-deployment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Alexander J, 2010, HUM IMMUNOL, V71, P468, DOI 10.1016/j.humimm.2010.02.014; [Anonymous], 2013, VACCINES; Assarsson E, 2008, J VIROL, V82, P12241, DOI 10.1128/JVI.01563-08; ATASSI MZ, 1983, P NATL ACAD SCI-BIOL, V80, P840, DOI 10.1073/pnas.80.3.840; Bijker MS, 2008, EUR J IMMUNOL, V38, P1033, DOI 10.1002/eji.200737995; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Bodewes R, 2010, EXPERT REV VACCINES, V9, P59, DOI [10.1586/erv.09.148, 10.1586/ERV.09.148]; Chun S, 2008, VACCINE, V26, P6068, DOI 10.1016/j.vaccine.2008.09.015; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Ebrahimi SM, 2011, VIRUS GENES, V42, P1, DOI 10.1007/s11262-010-0547-7; Fiers W, 2004, VIRUS RES, V103, P173, DOI 10.1016/j.virusres.2004.02.030; FINKELMAN FD, 1988, J IMMUNOL, V140, P1022; Francis JN, 2015, VACCINE, V33, P396, DOI 10.1016/j.vaccine.2014.06.006; Grant E, 2013, IMMUNOL CELL BIOL, V91, P184, DOI 10.1038/icb.2012.78; Hiemstra HS, 1997, P NATL ACAD SCI USA, V94, P10313, DOI 10.1073/pnas.94.19.10313; Hillaire MLB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939860; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Ichihashi T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024626; Jegaskanda S, 2013, J IMMUNOL, V190, P1837, DOI 10.4049/jimmunol.1201574; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; Kenter GG, 2009, NEW ENGL J MED, V361, P1838, DOI 10.1056/NEJMoa0810097; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lee LYH, 2008, J CLIN INVEST, V118, P3478, DOI 10.1172/JCI32460; Matsui M, 2010, BIOCHEM BIOPH RES CO, V391, P1494, DOI 10.1016/j.bbrc.2009.12.100; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Pica N, 2013, ANNU REV MED, V64, P189, DOI [10.1146/annurev-med-120611-145115, 10.1146/annure]; Pleguezuelos O, 2012, VACCINE, V30, P4655, DOI 10.1016/j.vaccine.2012.04.089; Plotnicky H, 2003, VIROLOGY, V309, P320, DOI 10.1016/S0042-6822(03)00072-2; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Quinones-Parra S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00285; REED L. J., 1938, AMER JOUR HYG, V27, P493; Schuurhuis DH, 2000, J EXP MED, V192, P145, DOI 10.1084/jem.192.1.145; SIGAL LJ, 1995, MOL IMMUNOL, V32, P623, DOI 10.1016/0161-5890(95)00031-9; SNAPPER CM, 1988, J EXP MED, V167, P183, DOI 10.1084/jem.167.1.183; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Stanekova Z, 2011, ACTA VIROL, V55, P61, DOI 10.4149/av_2011_01_61; Stanekova Z, 2012, INFLUENZA OTHER RESP, V6, P389, DOI 10.1111/j.1750-2659.2011.00328.x; Stanekova Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-351; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Stoloff GA, 2007, EUR J IMMUNOL, V37, P2441, DOI 10.1002/eji.200737254; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Suda T, 2011, ANTIVIR RES, V91, P252, DOI 10.1016/j.antiviral.2011.06.008; SUKENO N, 1979, TOHOKU J EXP MED, V128, P241, DOI 10.1620/tjem.128.241; Tan ACL, 2013, IMMUNOL CELL BIOL, V91, P96, DOI 10.1038/icb.2012.54; van den Brand JMA, 2010, J INFECT DIS, V201, P993, DOI 10.1086/651132; Wang MJ, 2007, VACCINE, V25, P2823, DOI 10.1016/j.vaccine.2006.12.038; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Wolf AI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028445	54	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127969	10.1371/journal.pone.0127969	http://dx.doi.org/10.1371/journal.pone.0127969			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046664	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200035
J	Kim, JI; Yoon, HS; Yi, G; Kim, HS; Yih, W; Shin, W				Kim, Jong Im; Yoon, Hwan Su; Yi, Gangman; Kim, Hyung Seop; Yih, Wonho; Shin, Woongghi			The Plastid Genome of the Cryptomonad Teleaulax amphioxeia	PLOS ONE			English	Article							CILIATE MESODINIUM-RUBRUM; DINOFLAGELLATE GENUS DINOPHYSIS; POLYMERASE-III HOLOENZYME; RED WATER-BLOOM; COMPLETE SEQUENCE; NUCLEOMORPH GENOME; CRYPTOPHYTE ALGA; PHYLOGENOMIC EVIDENCE; EVOLUTIONARY HISTORY; MITOCHONDRIAL GENOME	Teleaulax amphioxeia is a photosynthetic unicellular cryptophyte alga that is distributed throughout marine habitats worldwide. This alga is an important plastid donor to the dinoflagellate Dinophysis caudata through the ciliate Mesodinium rubrum in the marine food web. To better understand the genomic characteristics of T. amphioxeia, we have sequenced and analyzed its plastid genome. The plastid genome sequence of T. amphioxeia is similar to that of Rhodomonas salina, and they share significant synteny. This sequence exhibits less similarity to that of Guillardia theta, the representative plastid genome of photosynthetic cryptophytes. The gene content and order of the three photosynthetic cryptomonad plastid genomes studied is highly conserved. The plastid genome of T. amphioxeia is composed of 129,772 bp and includes 143 protein-coding genes, 2 rRNA operons and 30 tRNA sequences. The DNA polymerase III gene (dnaX) was most likely acquired via lateral gene transfer (LGT) from a firmicute bacterium, identical to what occurred in R. salina. On the other hand, the psbN gene was independently encoded by the plastid genome without a reverse transcriptase gene as an intron. To clarify the phylogenetic relationships of the algae with red-algal derived plastids, phylogenetic analyses of 32 taxa were performed, including three previously sequenced cryptophyte plastid genomes containing 93 protein-coding genes. The stramenopiles were found to have branched out from the Chromista taxa (cryptophytes, haptophytes, and stramenopiles), while the cryptophytes and haptophytes were consistently grouped into sister relationships with high resolution.	[Kim, Jong Im; Shin, Woongghi] Chungnam Natl Univ, Dept Biol, Taejon, South Korea; [Yoon, Hwan Su] Sungkyunkwan Univ, Dept Biol Sci, Suwon, South Korea; [Yi, Gangman] Gangneung Wonju Natl Univ, Dept Comp Sci, Wonju, South Korea; [Kim, Hyung Seop; Yih, Wonho] Kunsan Natl Univ, Dept Marine Biotechnol, Kunsan, South Korea	Chungnam National University; Sungkyunkwan University (SKKU); Kangnung Wonju National University; Kunsan National University	Yih, W (corresponding author), Kunsan Natl Univ, Dept Marine Biotechnol, Kunsan, South Korea.	ywonho@kunsan.ac.kr; shinw@cnu.ac.kr	Yoon, Hwan Su/A-2974-2013	Yoon, Hwan Su/0000-0001-9507-0105; shin, woongghi/0000-0001-7926-732X	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning, Basic Science Research Program (MSIP) [NRF-2013R1A1A3012539]; Ministry of Education [NRF-2013R1A1A2063006]; Mid-career Researcher Program by MSIP [NRF-C1ABA001-2010-0020700]; NRF [MEST: 2014R1A2A2A01003588]; Korean RDA Next-generation BioGreen21 [PJ009525]; Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea [PJT200620]; Korea Polar Research [PE15020]	National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning, Basic Science Research Program (MSIP); Ministry of Education; Mid-career Researcher Program by MSIP; NRF; Korean RDA Next-generation BioGreen21; Marine Biotechnology Program - Ministry of Oceans and Fisheries, Korea; Korea Polar Research	This research was supported by the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning, Basic Science Research Program (MSIP; NRF-2013R1A1A3012539) to J.I. Kim; the Ministry of Education (NRF-2013R1A1A2063006) to G. Yi; the Mid-career Researcher Program by MSIP (NRF-C1ABA001-2010-0020700) to W. Yih; NRF (MEST: 2014R1A2A2A01003588), Korean RDA Next-generation BioGreen21 (PJ009525), the Marine Biotechnology Program (PJT200620) funded by Ministry of Oceans and Fisheries, Korea, to H.S. Yoon; and the Korea Polar Research (Grant PE15020) to W. Shin.	Archibald JM, 2005, MICROBIAL PHYLOGENY, P238; Archibald JM, 2007, BIOESSAYS, V29, P392, DOI 10.1002/bies.20551; Barlow SB, 2002, HYDROBIOLOGIA, V473, P129, DOI 10.1023/A:1016585818665; Bary B. M., 1950, Transactions and Proceedings of the Royal Society of New Zealand, V78, P86; Baurain D, 2010, MOL BIOL EVOL, V27, P1698, DOI 10.1093/molbev/msq059; BHATTACHARYA D, 1995, J PHYCOL, V31, P489, DOI 10.1111/j.1529-8817.1995.tb02542.x; Bhattacharya D, 2013, MOL BIOL EVOL, V30, P1843, DOI 10.1093/molbev/mst084; Blankenship R. E., 2002, MOLECULAR MECHANISMS; BLINKOVA A, 1993, J BACTERIOL, V175, P6018, DOI 10.1128/JB.175.18.6018-6027.1993; BOOTH BC, 1982, DEEP-SEA RES, V29, P185, DOI 10.1016/0198-0149(82)90108-X; Borza T, 2005, EUKARYOT CELL, V4, P253, DOI 10.1128/EC.4.2.253-261.2005; Burki F, 2012, P ROY SOC B-BIOL SCI, V279, P2246, DOI 10.1098/rspb.2011.2301; Clemens WA, 1935, NATURE, V135, P473, DOI 10.1038/135473b0; Cruz S, 2013, J EXP BOT, V64, P3999, DOI 10.1093/jxb/ert197; Curtis BA, 2012, NATURE, V492, P59, DOI 10.1038/nature11681; DALLMANN HG, 1995, J BIOL CHEM, V270, P29563, DOI 10.1074/jbc.270.49.29563; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; de Vries J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2519; de Vries J, 2013, GENOME BIOL EVOL, V5, P2540, DOI 10.1093/gbe/evt205; Delwiche CF, 1996, MOL BIOL EVOL, V13, P873, DOI 10.1093/oxfordjournals.molbev.a025647; Donaher N, 2009, GENOME BIOL EVOL, V1, P439, DOI 10.1093/gbe/evp047; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; DOUGLAS SE, 1991, NATURE, V350, P148, DOI 10.1038/350148a0; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Gilson PR, 1997, CURR OPIN GENET DEV, V7, P800, DOI 10.1016/S0959-437X(97)80043-3; Gustafson DE, 2000, NATURE, V405, P1049, DOI 10.1038/35016570; Hackett JD, 2003, J PHYCOL, V39, P440, DOI 10.1046/j.1529-8817.2003.02100.x; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; HALLICK RB, 1993, NUCLEIC ACIDS RES, V21, P3537, DOI 10.1093/nar/21.15.3537; Hansen PJ, 2013, HARMFUL ALGAE, V28, P126, DOI 10.1016/j.hal.2013.06.004; Hart TJ, 1943, NATURE, V152, P661, DOI 10.1038/152661b0; Hart TJ, 1934, NATURE, V134, P459, DOI 10.1038/134459b0; Hauth AM, 2005, NUCLEIC ACIDS RES, V33, P4433, DOI 10.1093/nar/gki757; Hewes CD, 1998, J PHYCOL, V34, P945, DOI 10.1046/j.1529-8817.1998.340945.x; HILL DRA, 1991, PHYCOLOGIA, V30, P170, DOI 10.2216/i0031-8884-30-2-170.1; HILL DRA, 1992, ANN BOT FENN, V29, P173; Janouskovec J, 2010, P NATL ACAD SCI USA, V107, P10949, DOI 10.1073/pnas.1003335107; Janson S, 2003, PHYCOLOGIA, V42, P473, DOI 10.2216/i0031-8884-42-5-473.1; Janson S, 2004, ENVIRON MICROBIOL, V6, P1102, DOI 10.1111/j.1462-2920.2004.00646.x; Johnson MD, 2007, NATURE, V445, P426, DOI 10.1038/nature05496; Johnson MD, 2011, J EUKARYOT MICROBIOL, V58, P185, DOI 10.1111/j.1550-7408.2011.00545.x; Keeling PJ, 2004, AM J BOT, V91, P1481, DOI 10.3732/ajb.91.10.1481; Khan H, 2007, MOL BIOL EVOL, V24, P1832, DOI 10.1093/molbev/msm101; Kim E., 2009, V13, P1, DOI 10.1007/7089_2008_17; Kim E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-215; Kim M, 2014, J EUKARYOT MICROBIOL, V61, P354, DOI 10.1111/jeu.12115; Kim M, 2012, HARMFUL ALGAE, V13, P105, DOI 10.1016/j.hal.2011.10.010; Kowallik KV, 1995, PLANT MOL BIOL REP, V13, P336, DOI 10.1007/BF02669188; Lane CE, 2007, P NATL ACAD SCI USA, V104, P19908, DOI 10.1073/pnas.0707419104; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lindholm T., 1985, Advances in Aquatic Microbiology, V3, P1; LUCAS IAN, 1990, J PHYCOL, V26, P345, DOI 10.1111/j.0022-3646.1990.00345.x; MCFADDEN GI, 1993, ADV BOT RES, V19, P189, DOI 10.1016/S0065-2296(08)60205-0; Moeller HV, 2011, J PHYCOL, V47, P324, DOI 10.1111/j.1529-8817.2010.00954.x; Moore CE, 2012, GENOME BIOL EVOL, V4, P1162, DOI 10.1093/gbe/evs090; Myung G, 2011, HARMFUL ALGAE, V10, P536, DOI 10.1016/j.hal.2011.04.005; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Nishitani G, 2012, APPL ENVIRON MICROB, V78, P813, DOI 10.1128/AEM.06544-11; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; NOVARINO G, 1991, NORD J BOT, V11, P599, DOI 10.1111/j.1756-1051.1991.tb01269.x; Novarino G, 1997, J PLANKTON RES, V19, P1081, DOI 10.1093/plankt/19.8.1081; Ohta N, 2003, DNA RES, V10, P67, DOI 10.1093/dnares/10.2.67; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Pain A, 2005, SCIENCE, V309, P131, DOI 10.1126/science.1110418; Palmer JD, 2003, J PHYCOL, V39, P4, DOI 10.1046/j.1529-8817.2003.02185.x; Park MG, 2008, J PHYCOL, V44, P1154, DOI 10.1111/j.1529-8817.2008.00579.x; Park MG, 2006, AQUAT MICROB ECOL, V45, P101, DOI 10.3354/ame045101; Patron NJ, 2007, CURR BIOL, V17, P887, DOI 10.1016/j.cub.2007.03.069; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Puerta MVS, 2005, DNA RES, V12, P151, DOI 10.1093/dnares/12.2.151; Rice DW, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-31; Rogers MB, 2007, MOL BIOL EVOL, V24, P54, DOI 10.1093/molbev/msl129; RYTHER JH, 1967, NATURE, V214, P1318, DOI 10.1038/2141318a0; SCHNEPF E, 1988, BOT ACTA, V101, P196, DOI 10.1111/j.1438-8677.1988.tb00033.x; Seoane S, 2005, HYDROBIOLOGIA, V549, P1, DOI 10.1007/s10750-005-1736-6; Shi CL, 2006, BIOTECHNOL PROGR, V22, P1050, DOI 10.1021/bp060087d; Simpson CL, 2002, PLANT PHYSIOL, V129, P957, DOI 10.1104/pp.010908; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stiller JW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6764; Stoebe B, 1999, TRENDS GENET, V15, P344, DOI 10.1016/S0168-9525(99)01815-6; Takishita K, 2002, PROTIST, V153, P293, DOI 10.1078/1434-4610-00106; Tanifuji G, 2011, GENOME BIOL EVOL, V3, P44, DOI 10.1093/gbe/evq082; TAYLOR FJR, 1971, J FISH RES BOARD CAN, V28, P391, DOI 10.1139/f71-052; TAYLOR FJR, 1969, NATURE, V224, P819, DOI 10.1038/224819a0; Wagele H, 2011, MOL BIOL EVOL, V28, P699, DOI 10.1093/molbev/msq239; WANG SG, 1991, P NATL ACAD SCI USA, V88, P10783, DOI 10.1073/pnas.88.23.10783; WHITE AW, 1977, J FISH RES BOARD CAN, V34, P413, DOI 10.1139/f77-066; Wickett NJ, 2008, MOL BIOL EVOL, V25, P393, DOI 10.1093/molbev/msm267; Yih W, 2004, AQUAT MICROB ECOL, V36, P165, DOI 10.3354/ame036165; Yoon HS, 2002, P NATL ACAD SCI USA, V99, P15507, DOI 10.1073/pnas.242379899	93	25	26	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129284	10.1371/journal.pone.0129284	http://dx.doi.org/10.1371/journal.pone.0129284			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047475	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200141
J	Chen, B; Xu, X; Luo, J; Wang, HY; Zhou, SW				Chen, Bin; Xu, Xin; Luo, Jie; Wang, Heyong; Zhou, Songwen			Rapamycin Enhances the Anti-Cancer Effect of Dasatinib by Suppressing Src/PI3K/mTOR Pathway in NSCLC Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; SRC-FAMILY KINASES; LUNG-CANCER CELLS; CYCLE ARREST; PHASE-II; RADIATION SENSITIVITY; E-CADHERIN; C-SRC; MTOR	Src and the mammalian target of rapamycin ( mTOR) signaling are commonly activated in non-small cell lung cancer (NSCLC) and hence potential targets for chemotherapy. Although the combined use of Src inhibitor Dasatinib with other chemotherapeutic agents has shown superior efficacy for cancer treatment, the mechanisms that lead to enhanced sensitivity of Dasatinib are not completely understood. In this study, we found that Rapamycin dramatically enhanced Dasatinib-induced cell growth inhibition and cell cycle G1 arrest in human lung adenocarcinoma A549 cells without affecting apoptosis. The synergistic effects were consistently correlated with the up-regulation of cyclin-dependent kinases inhibitor proteins, including p16, p19, p21, and p27, as well as the repression of Cdk4 expression and nuclear translocation. Mechanistic investigations demonstrated that FoxO1/FoxO3a and p70S6K/4E-BP1, the molecules at downstream of Src-PI3K-Akt and mTOR signaling, were significantly suppressed by the combined use of Dasatinib and Rapamycin. Restraining Src and mTOR with small interfering RNA in A549 cells further confirmed that the Src/PI3K/mTOR Pathway played a crucial role in enhancing the anticancer effect of Dasatinib. In addition, this finding was also validated by a series of assays using another two NSCLC cell lines, NCI-H1706 and NCI-H460. Conclusively, our results suggested that the combinatory application of Src and mTOR inhibitors might be a promising therapeutic strategy for NSCLC treatment.	[Chen, Bin; Xu, Xin; Luo, Jie; Wang, Heyong; Zhou, Songwen] Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China; [Chen, Bin; Xu, Xin; Luo, Jie; Wang, Heyong; Zhou, Songwen] Tongji Univ, Sch Med, Inst Canc, Shanghai 200092, Peoples R China	Tongji University	Zhou, SW (corresponding author), Shanghai Pulm Hosp, Dept Med Oncol, Shanghai, Peoples R China.	zhou_songwen@126.com			Shanghai Municipal Natural Science Foundation [N0.13ZR1434700]; National Natural Science Foundation of China [N0.81301994]	Shanghai Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Shanghai Municipal Natural Science Foundation (Grant N0.13ZR1434700) and National Natural Science Foundation of China (Grant N0.81301994). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Boehrer S, 2011, CELL CYCLE, V10, P3168, DOI 10.4161/cc.10.18.16599; Brouxhon SM, 2014, ONCOGENE, V33, P225, DOI 10.1038/onc.2012.563; Cao DS, 2010, AM J RESP CELL MOL, V42, P88, DOI 10.1165/rcmb.2008-0455OC; Ceppi P, 2009, MOL CANCER THER, V8, P3066, DOI 10.1158/1535-7163.MCT-09-0151; Chan CM, 2012, CLIN CANCER RES, V18, P3580, DOI 10.1158/1078-0432.CCR-11-3359; Choudhury GG, 2006, CELL SIGNAL, V18, P1854, DOI 10.1016/j.cellsig.2006.02.003; Dalvai M, 2010, CELL CYCLE, V9, P3933, DOI 10.4161/cc.9.19.13154; Demers MJ, 2009, J CELL BIOCHEM, V107, P639, DOI 10.1002/jcb.22131; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gridelli C, 2008, ONCOLOGIST, V13, P139, DOI 10.1634/theoncologist.2007-0171; Haura EB, 2010, J CLIN ONCOL, V28, P1387, DOI 10.1200/JCO.2009.25.4029; Indovina P, 2012, ONCOGENE, V31, P929, DOI 10.1038/onc.2011.286; Inge LJ, 2013, J THORAC CARDIOV SUR, V145, P531, DOI 10.1016/j.jtcvs.2012.10.041; Jin W, 2008, J BIOL CHEM, V283, P1391, DOI 10.1074/jbc.M705052200; Johnson FM, 2010, J CLIN ONCOL, V28, P4609, DOI 10.1200/JCO.2010.30.5474; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Johnson ML, 2011, J THORAC ONCOL, V6, P1128, DOI 10.1097/JTO.0b013e3182161508; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Kopetz S, 2009, CANCER RES, V69, P3842, DOI 10.1158/0008-5472.CAN-08-2246; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lau MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059083; Lee H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050624; Leontieva OV, 2013, CELL CYCLE, V12, P3063, DOI 10.4161/cc.26130; Li CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091332; Li XY, 2014, MOL CELL, V53, P407, DOI 10.1016/j.molcel.2013.12.008; Marinov M, 2007, CRIT REV ONCOL HEMAT, V63, P172, DOI 10.1016/j.critrevonc.2007.04.002; Masaki T, 2003, EUR J CANCER, V39, P1447, DOI 10.1016/S0959-8049(03)00276-4; Miller AA, 2010, J THORAC ONCOL, V5, P380, DOI 10.1097/JTO.0b013e3181cee36e; Nagata Y, 2010, INT J ONCOL, V37, P1001, DOI 10.3892/ijo_00000751; Nautiyal J, 2009, CANCER LETT, V283, P143, DOI 10.1016/j.canlet.2009.03.035; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Papadimitrakopoulou V, 2012, J THORAC ONCOL, V7, P1315, DOI 10.1097/JTO.0b013e31825493eb; Raju U, 2012, RADIOTHER ONCOL, V105, P241, DOI 10.1016/j.radonc.2012.08.010; Roediger J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-214; Sarkar S, 2010, CANCER BIOL THER, V9, P592, DOI 10.4161/cbt.9.8.11103; Sen Banibrata, 2011, J Signal Transduct, V2011, P865819, DOI 10.1155/2011/865819; Simpkins F, 2012, CLIN CANCER RES, V18, P5911, DOI 10.1158/1078-0432.CCR-12-1257; Song JJ, 2010, CELL SIGNAL, V22, P377, DOI 10.1016/j.cellsig.2009.10.007; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tomioka H, 2012, INT J ONCOL, V41, P551, DOI 10.3892/ijo.2012.1485; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang X, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-106; Watanabe T, 2009, MOL CANCER RES, V7, P1582, DOI 10.1158/1541-7786.MCR-09-0064; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099763; Zhang J, 2007, AM J PATHOL, V170, P366, DOI 10.2353/ajpath.2007.060706	47	24	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129663	10.1371/journal.pone.0129663	http://dx.doi.org/10.1371/journal.pone.0129663			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061184	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500154
J	Meredith, A; Boroomand, S; Carthy, J; Luo, ZS; McManus, B				Meredith, Anna; Boroomand, Seti; Carthy, Jon; Luo, Zongshu; McManus, Bruce			1,25 Dihydroxyvitamin D-3 Inhibits TGF beta(1)-Mediated Primary Human Cardiac Myofibroblast Activation	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; NUTRITION EXAMINATION SURVEY; GROWTH-FACTOR BETA-1; 3RD NATIONAL-HEALTH; HEART-FAILURE; HYPOVITAMINOSIS-D; D DEFICIENCY; EXPRESSION; FIBROSIS; PATHWAY	Aims Epidemiological and interventional studies have suggested a protective role for vitamin D in cardiovascular disease, and basic research has implicated vitamin D as a potential inhibitor of fibrosis in a number of organ systems; yet little is known regarding direct effects of vitamin D on human cardiac cells. Given the critical role of fibrotic responses in end stage cardiac disease, we examined the effect of active vitamin D treatment on fibrotic responses in primary human adult ventricular cardiac fibroblasts (HCF-av), and investigated the relationship between circulating vitamin D (25(OH)D-3) and cardiac fibrosis in human myocardial samples. Methods and Results Interstitial cardiac fibrosis in end stage HF was evaluated by image analysis of picrosirius red stained myocardial sections. Serum 25(OH)D-3 levels were assayed using mass spectrometry. Commercially available HCF-av were treated with transforming growth factor (TGF)beta 1 to induce activation, in the presence or absence of active vitamin D (1,25(OH)(2)D-3). Functional responses of fibroblasts were analyzed by in vitro collagen gel contraction assay. 1,25(OH)(2)D-3 treatment significantly inhibited TGF alpha 1-mediated cell contraction, and confocal imaging demonstrated reduced stress fiber formation in the presence of 1,25 (OH)(2)D-3. Treatment with 1,25(OH)(2)D-3 reduced alpha-smooth muscle actin expression to control levels and inhibited SMAD2 phosphorylation. Conclusions Our results demonstrate that active vitamin D can prevent TGF beta 1-mediated biochemical and functional pro-fibrotic changes in human primary cardiac fibroblasts. An inverse relationship between vitamin D status and cardiac fibrosis in end stage heart failure was observed. Collectively, our data support an inhibitory role for vitamin D in cardiac fibrosis.	[Meredith, Anna; Boroomand, Seti; Luo, Zongshu; McManus, Bruce] Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada; [Meredith, Anna; Boroomand, Seti; McManus, Bruce] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Carthy, Jon] Ludwig Inst Canc Res, S-75124 Uppsala, Sweden; [McManus, Bruce] PROOF Ctr Excellence, Vancouver, BC, Canada	St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of British Columbia; Ludwig Institute for Cancer Research	McManus, B (corresponding author), Univ British Columbia, St Pauls Hosp, Ctr Heart Lung Innovat, Vancouver, BC V5Z 1M9, Canada.	bruce.mcmanus@hli.ubc.ca			Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Council of Canada; CIHR Strategic Training Program in Transplantation; British Columbia Proteomics Network; Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research	Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Council of Canada; CIHR Strategic Training Program in Transplantation(Canadian Institutes of Health Research (CIHR)); British Columbia Proteomics Network; Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	AM was supported by the Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Council of Canada, the CIHR Strategic Training Program in Transplantation, and funding from the British Columbia Proteomics Network. SB was supported by the Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research.	Bae S, 2013, J APPL PHYSIOL, V114, P979, DOI 10.1152/japplphysiol.01506.2012; Bae S, 2011, CARDIOVASC RES, V91, P632, DOI 10.1093/cvr/cvr133; Beildeck ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007872; Bodyak N, 2007, P NATL ACAD SCI USA, V104, P16810, DOI 10.1073/pnas.0611202104; Carthy JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019809; Chen S, 2008, HYPERTENSION, V52, P1106, DOI 10.1161/HYPERTENSIONAHA.108.119602; Chen SC, 2011, CIRCULATION, V124, P1838, DOI 10.1161/CIRCULATIONAHA.111.032680; Edgley AJ, 2012, CARDIOVASC THER, V30, pe30, DOI 10.1111/j.1755-5922.2010.00228.x; Firrincieli D, 2014, CLIN RES HEPATOL GAS, V38, P5, DOI 10.1016/j.clinre.2013.10.004; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Grant WB, 2010, J STEROID BIOCHEM, V121, P456, DOI 10.1016/j.jsbmb.2010.03.089; Grant WB, 2009, DERM-ENDOCRINOL, V1, P207, DOI 10.4161/derm.1.4.9841; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Ikeuchi M, 2004, CARDIOVASC RES, V64, P526, DOI 10.1016/j.cardiores.2004.07.017; Ito I, 2013, J CLIN INVEST, V123, P4579, DOI 10.1172/JCI67804; Larriba MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023524; KANE CJM, 1991, J CELL PHYSIOL, V148, P157, DOI 10.1002/jcp.1041480119; Kendrick J, 2009, ATHEROSCLEROSIS, V205, P255, DOI 10.1016/j.atherosclerosis.2008.10.033; Kim DH, 2008, AM J CARDIOL, V102, P1540, DOI 10.1016/j.amjcard.2008.06.067; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Lee JH, 2008, J AM COLL CARDIOL, V52, P1949, DOI 10.1016/j.jacc.2008.08.050; Li YJ, 2005, KIDNEY INT, V68, P1500, DOI 10.1111/j.1523-1755.2005.00562.x; Lijnen PJ, 2000, MOL GENET METAB, V71, P418, DOI 10.1006/mgme.2000.3032; Liu LCY, 2011, EUR J HEART FAIL, V13, P619, DOI 10.1093/eurjhf/hfr032; Nesby-O'Dell S, 2002, AM J CLIN NUTR, V76, P187, DOI 10.1093/ajcn/76.1.187; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Okada H, 2005, CIRCULATION, V111, P2430, DOI 10.1161/01.CIR.0000165066.71481.8E; Rahman A, 2007, J STEROID BIOCHEM, V103, P416, DOI 10.1016/j.jsbmb.2006.12.081; Ramirez AM, 2010, J STEROID BIOCHEM, V118, P142, DOI 10.1016/j.jsbmb.2009.11.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scragg RK, 2010, AM J CARDIOL, V105, P122, DOI 10.1016/j.amjcard.2009.08.661; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Stubbins RE, 2012, NUTR REV, V70, P721, DOI 10.1111/j.1753-4887.2012.00522.x; Tan SM, 2012, CLIN EXP PHARMACOL P, V39, P650, DOI 10.1111/j.1440-1681.2012.05726.x; VANDERWIELEN RPJ, 1995, LANCET, V346, P207, DOI 10.1016/S0140-6736(95)91266-5; Zerr P., 2014, ANN RHEUM DIS	39	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128655	10.1371/journal.pone.0128655	http://dx.doi.org/10.1371/journal.pone.0128655			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061181	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500093
J	Elnesr, MN; Alazba, AA; El-Abedein, AIZ; El-Adl, MM				Elnesr, Mohammad Nabil; Alazba, Abdurrahman Ali; El-Abedein, Assem Ibrahim Zein; El-Adl, Mahmoud Maher			Evaluating the Effect of Three Water Management Techniques on Tomato Crop	PLOS ONE			English	Article							SUBSURFACE DRIP IRRIGATION; DEFICIT IRRIGATION; PROCESSING TOMATO; SOIL; MICROIRRIGATION; PRODUCTIVITY; EFFICIENCY; EMITTERS; BIOMASS; FRUIT	The effects of three water management techniques were evaluated on subsurface drip irrigated tomatoes. The three techniques were the intermittent flow (3 pulses), the dual-lateral drip system (two lateral lines per row, at 15 and 25cm below soil surface), and the physical barrier (buried at 30 cm below soil surface). Field experiments were established for two successive seasons. Water movement in soil was monitored using continuously logging capacitance probes up to 60 cm depth. The results showed that the dual lateral technique positively increased the yield up to 50%, water use efficiency up to 54%, while the intermittent application improved some of the quality measures (fruit size, TSS, and Vitamin C), not the quantity of the yield that decreased in one season, and not affected in the other. The physical barrier has no significant effect on any of the important growth measures. The soil water patterns showed that the dual lateral method lead to uniform wetting pattern with depth up to 45 cm, the physical barrier appeared to increase lateral and upward water movement, while the intermittent application kept the wetting pattern at higher moisture level for longer time. The cost analysis showed also that the economic treatments were the dual lateral followed by the intermittent technique, while the physical barrier is not economical. The study recommends researching the effect of the dual lateral method on the root growth and performance. The intermittent application may be recommended to improve tomato quality but not quantity. The physical barrier is not recommended unless in high permeable soils.	[Elnesr, Mohammad Nabil; Alazba, Abdurrahman Ali; El-Abedein, Assem Ibrahim Zein; El-Adl, Mahmoud Maher] King Saud Univ, Alamoudi Chair Water Res, Riyadh, Saudi Arabia	King Saud University	Elnesr, MN (corresponding author), King Saud Univ, Alamoudi Chair Water Res, Riyadh, Saudi Arabia.	melnesr@ksu.edu.sa	ElNesr, Mohammad/A-8524-2011	ElNesr, Mohammad/0000-0002-0595-3092	National plan of science and technology in King Saud University [10-WAT985-02]; King Abdulaziz City for science and Technology [10-WAT985-02]	National plan of science and technology in King Saud University; King Abdulaziz City for science and Technology	The study was funded by the National plan of science and technology (http://npst.ksu.edu.sa/en) in the King Saud University along with King Abdulaziz City for science and Technology (kacst.edu.sa). This fund is for the two year project #10-WAT985-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Naeem Mushari A, 2008, Pak J Biol Sci, V11, P68, DOI 10.3923/pjbs.2008.68.73; Allan JA, 1998, GROUND WATER, V36, P545, DOI 10.1111/j.1745-6584.1998.tb02825.x; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Amosson S, 2011, B6113 KANS STAT U TE, P20; Arias R, 2000, J AGR FOOD CHEM, V48, P1697, DOI 10.1021/jf990974e; Awady M.N., 2008, 15 ANN C MISR SOC AG, V12, P477; Bakeer G A A, 2009, MISR J AGR ENG, V26, P736; Barth HK, 1995, ASAE PUBL, V95, P168; Ben-Gal A, 2003, SOIL SCI SOC AM J, V67, P1449, DOI 10.2136/sssaj2003.1449; Brown K. W., 1996, Evapotranspiration and irrigation scheduling. Proceedings of the International Conference, San Antonio, Texas, USA, November 3-6 1996., P806; Carvalho Wesley, 2005, Hortic. Bras., V23, P819, DOI 10.1590/S0102-05362005000300026; DSOUZA MC, 1992, HORTSCIENCE, V27, P465, DOI 10.21273/HORTSCI.27.5.465; EINesr Mohammad N., 2010, American Journal of Environmental Sciences, V6, P191, DOI 10.3844/ajessp.2010.191.203; El-Nesr MN, 2014, IRRIGATION SCI, V32, P111, DOI 10.1007/s00271-013-0417-x; Elmaloglou S, 2008, COMPUT ELECTRON AGR, V62, P266, DOI 10.1016/j.compag.2008.01.008; ElNesr M.N., 2011, SUBSURFACE DRIP IRRI; ELNESR MN, 2013, APPL ENVIRON SOIL SC, V2013, pNIL1, DOI DOI 10.1155/2013/530732; FAO, 1991, GENERAL GUIDELINES T; Gee G.W., 1996, METHODS SOIL ANAL, V3, P377; Harmanto, 2005, AGR WATER MANAGE, V71, P225, DOI 10.1016/j.agwat.2004.09.003; Horst MG, 2007, AGR WATER MANAGE, V87, P115, DOI 10.1016/j.agwat.2006.06.014; Ismail S., 2006, 14 ANN C MSIR SOC AG, P1001; Ityel E, 2012, IRRIGATION SCI, V30, P293, DOI 10.1007/s00271-011-0281-5; Kandelous MM, 2011, SOIL SCI SOC AM J, V75, P488, DOI 10.2136/sssaj2010.0181; Kenig E, 1995, ASAE PUBL, V95, P615; Kuscu H, 2014, AGR WATER MANAGE, V133, P92, DOI 10.1016/j.agwat.2013.11.008; Loeppert H.R., 1996, METHODS SOIL ANAL, P437, DOI DOI 10.2136/SSSAB00KSER5.3.C15; López Camelo Andrés F., 2004, Hortic. Bras., V22, P534, DOI 10.1590/S0102-05362004000300006; Maynard DN, 2006, KNOTTS HANDBOOK FOR; Mekonnen MM, 2011, HYDROL EARTH SYST SC, V15, P1577, DOI 10.5194/hess-15-1577-2011; Nakayama FS, 2012, TRICKLE IRRIGATION F; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Neshat A., 2012, Middle East Journal of Scientific Research, V11, P426; Netafim, 2011, RECOMMENDATIONS FOR; O'Brien DM, 1997, P 1997 CENTR PLAINS, P81; Patane C, 2011, SCI HORTIC-AMSTERDAM, V129, P590, DOI 10.1016/j.scienta.2011.04.030; Pek Z, 2011, J FOOD PHYS, V24-25, P43; Pek Z, 2014, CENT EUR J BIOL, V9, P383, DOI 10.2478/s11535-013-0279-5; PELLETIER G, 1993, HORTSCIENCE, V28, P338, DOI 10.21273/HORTSCI.28.4.338; Phene C. J., 1987, Acta Horticulturae, P101; Raoof M., 2013, Middle East Journal of Scientific Research, V13, P732; Rhoades J., 1996, METHODS SOIL ANAL 3, P417; Segal E, 2006, PLANT SOIL, V282, P333, DOI 10.1007/s11104-006-0003-6; Sparks D.L., 1996, METHODS SOIL ANAL 3; Stirzaker RJ, 2003, IRRIGATION SCI, V22, P177, DOI 10.1007/s00271-003-0083-5; Thomas G.W., 1996, SOIL PH SOIL ACIDI 3, P475, DOI DOI 10.2136/SSSABOOKSER5.3.C16; Thorburn PJ, 2003, IRRIGATION SCI, V22, P121, DOI 10.1007/s00271-003-0077-3; Vyrlas P, 2005, 2005 ASAE ANNUAL INT, DOI 10.13031/2013.19160; Welsh DF, 1995, ASAE PUBL, V95, P688; Zin El-Abedin T, 2006, MISR J AG ENG, V23; Zotarelli L, 2009, AGR WATER MANAGE, V96, P23, DOI 10.1016/j.agwat.2008.06.007	51	15	15	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129796	10.1371/journal.pone.0129796	http://dx.doi.org/10.1371/journal.pone.0129796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057380	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000073
J	Galappaththige, S; Roth, BJ				Galappaththige, Suran; Roth, Bradley J.			Electrical Pacing of Cardiac Tissue Including Potassium Inward Rectification	PLOS ONE			English	Article							DIASTOLIC FIELD STIMULATION; UNIPOLAR STIMULATION; VIRTUAL ELECTRODES; ACTIVATION; PROPAGATION; SIMULATIONS	In this study cardiac tissue is stimulated electrically through a small unipolar electrode. Numerical simulations predict that around an electrode are adjacent regions of depolarization and hyperpolarization. Experiments have shown that during pacing of resting cardiac tissue the hyperpolarization is often inhibited. Our goal is to determine if the inward rectifying potassium current (I-K1) causes the inhibition of hyperpolarization. Numerical simulations were carried out using the bidomain model with potassium dynamics specified to be inward rectifying. In the simulations, adjacent regions of depolarization and hyperpolarization were observed surrounding the electrode. For cathodal currents the virtual anode produces a hyperpolarization that decreases over time. For long duration pulses the current-voltage curve is non-linear, with very small hyperpolarization compared to depolarization. For short pulses, the hyperpolarization is more prominent. Without the inward potassium rectification, the current voltage curve is linear and the hyperpolarization is evident for both long and short pulses. In conclusion, the inward rectification of the potassium current explains the inhibition of hyperpolarization for long duration stimulus pulses, but not for short duration pulses.	[Galappaththige, Suran; Roth, Bradley J.] Oakland Univ, Dept Phys, Rochester, MI 48309 USA	Oakland University	Roth, BJ (corresponding author), Oakland Univ, Dept Phys, Rochester, MI 48309 USA.	roth@oakland.edu	Roth, Bradley J/A-4920-2008; Galappaththige, Suran/AAE-1623-2021	Roth, Bradley J/0000-0003-4321-9806; Galappaththige, Suran/0000-0001-5268-1838	National Institutes of Health [R01HL118392]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118392] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health R01HL118392. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anumonwo JMB, 2014, CARDIAC ELECTROPHYSI, P33; Efimov IR, 2003, J CARDIOVASC ELECTR, V14, P1223, DOI 10.1046/j.1540-8167.2003.03442.x; Henriquez CS, 1992, CRIT REV BIOMED ENG, V21, P1; KNISLEY SB, 1995, CIRC RES, V77, P1229, DOI 10.1161/01.RES.77.6.1229; LUO CH, 1994, CIRC RES, V74, P1071, DOI 10.1161/01.RES.74.6.1071; Maleckar MM, 2008, AM J PHYSIOL-HEART C, V295, pH1626, DOI 10.1152/ajpheart.00706.2008; NEUNLIST M, 1995, BIOPHYS J, V68, P2310, DOI 10.1016/S0006-3495(95)80413-3; Press W., 1992, NUMERICAL RECIPES FO; Puwal S, 2006, J BIOL SYST, V14, P101, DOI 10.1142/S0218339006001684; Roth BJ, 1998, J ELECTROCARDIOL, V31, P6, DOI 10.1016/S1053-0770(98)90272-5; ROTH BJ, 1991, CIRC RES, V68, P162, DOI 10.1161/01.RES.68.1.162; Roth BJ, 1993, ENG MED BIOL SOC 199, P857; Sambelashvili AT, 2003, AM J PHYSIOL-HEART C, V284, pH2368, DOI 10.1152/ajpheart.00988.2002; SEPULVEDA NG, 1989, BIOPHYS J, V55, P987, DOI 10.1016/S0006-3495(89)82897-8; Sharifov OF, 2003, J CARDIOVASC ELECTR, V14, P1215, DOI 10.1046/j.1540-8167.2003.03188.x; Wikswo JP, 1995, BIOPHYS J, V69, P2195, DOI 10.1016/S0006-3495(95)80115-3; Woods MC, 2013, BIOPHYS J, V105, P523, DOI 10.1016/j.bpj.2013.06.009	17	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0127837	10.1371/journal.pone.0127837	http://dx.doi.org/10.1371/journal.pone.0127837			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057242	Green Submitted, Green Published, gold			2022-12-26	WOS:000356349000012
J	Marentette, JO; Hurst, RE; McHowat, J				Marentette, John O.; Hurst, Robert E.; McHowat, Jane			Impaired Expression of Prostaglandin E-2 (PGE(2)) Synthesis and Degradation Enzymes during Differentiation of Immortalized Urothelial Cells from Patients with Interstitial Cystitis/Painful Bladder Syndrome	PLOS ONE			English	Article							EPITHELIAL-CELLS; IN-VITRO; PHOSPHOLIPASE A(2); MAST-CELL; CYCLOOXYGENASE-2; PROLIFERATION; PATHOGENESIS; INHIBITORS; MIGRATION; DIAGNOSIS	Purpose The differentiated superficial cells of the urothelium restrict urine flow into the bladder wall. We have demonstrated that urothelial cells isolated from bladders of patients with interstitial cystitis/painful bladder syndrome (IC/PBS) fail to release PGE(2) in response to tryptase. This study examines the expression of PGE(2) synthesis and degradation enzymes in urothelial cells during differentiation. Materials and Methods We measured immunoprotein expression of cyclooxygenase-2 (COX-2), prostaglandin E-2 synthase (PGES) and 15-hydroxyprostaglandin dehydrogenase (PGDH) in human urothelial cells and in immortalized urothelial cells isolated from the bladders of IC/PBS patients or normal subjects during stratification and differentiation produced by increased calcium and fetal bovine serum (Ca/FBS) in the culture medium for 1, 3 and 7 days. Results PGES immunoprotein expression increased during differentiation in normal and IC/PBS urothelial cells. COX-2 expression also increased in cells from normal patients following differentiation. Remarkably, no COX-2 expression was detectable in urothelial cells isolated from 3 out of 4 IC/PBS patients. PGDH immunoprotein expression decreased in normal cells after 1 and 3 days of Ca/FBS addition, but returned to normal after 7 days. PGDH expression was unchanged during differentiation at 1 and 3 days, but was more than 2-fold higher at 7 days compared to day 0 in the IC/PBS cells. Urothelial cells isolated from IC/PBS patients demonstrated no PGE2 release in response to tryptase under any of the experimental conditions studied. Conclusions Taken together, our results indicate that PGE2 release is compromised during stratification and differentiation in IC/PBS urothelium and may contribute to impaired barrier function.	[Marentette, John O.; McHowat, Jane] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Hurst, Robert E.] Univ Oklahoma, Hlth Sci Ctr, Dept Urol, Oklahoma City, OK 73104 USA	Saint Louis University; University of Oklahoma System; University of Oklahoma Health Sciences Center	McHowat, J (corresponding author), St Louis Univ, Sch Med, Dept Pathol, 1402 S Grand Blvd, St Louis, MO 63104 USA.	mchowaj@slu.edu		Hurst, Robert/0000-0003-0370-1817; McHowat, Jane/0000-0003-3133-3388	NIDDK [66119]; Saint Louis University President's Research Fund	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Saint Louis University President's Research Fund	This work was funded by NIDDK 66119 and Saint Louis University President's Research Fund (to JM).	Butrick CW, 2010, J WOMENS HEALTH, V19, P1185, DOI 10.1089/jwh.2009.1702; Carmean N, 2007, CELL PROLIFERAT, V40, P166, DOI 10.1111/j.1365-2184.2007.00428.x; Chai TC, 2004, NAT CLIN PRACT UROL, V1, P85, DOI 10.1038/ncpuro0057; Chen TC, 2011, CELL MICROBIOL, V13, P1703, DOI 10.1111/j.1462-5822.2011.01650.x; Dubois RN, 1998, FASEB J, V12, P1063, DOI 10.1096/fasebj.12.12.1063; Hauser PJ, 2009, J UROLOGY, V182, P2477, DOI 10.1016/j.juro.2009.07.013; Huan SKH, 2012, MOLECULES, V17, P6277, DOI 10.3390/molecules17066277; Iwanaga K, 2012, J PHARMACOL EXP THER, V340, P604, DOI 10.1124/jpet.111.189845; JOYCE NC, 1994, AM J PHYSIOL, V266, pC269, DOI 10.1152/ajpcell.1994.266.1.C269; Keay S, 2004, UROLOGY, V63, P22, DOI 10.1016/j.urology.2003.08.024; Keay S, 2003, UROLOGY, V61, P1278, DOI 10.1016/S0090-4295(03)00005-0; Kontos S, 2010, ADV UROL, DOI [10.1155/2010/136898, DOI 10.1155/2010/136898]; Marentette JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069948; Nazif O, 2007, UROLOGY, V69, P24, DOI 10.1016/j.urology.2006.08.1108; Nickel JC, 2000, CAN FAM PHYSICIAN, V46, P2430; Parsons CL, 2007, UROLOGY, V69, P9, DOI 10.1016/j.urology.2006.03.084; Rashid Hani H, 2004, BMC Urol, V4, P3, DOI 10.1186/1471-2490-4-3; Rastogi P, 2007, PROSTAG LEUKOTR ESS, V76, P205, DOI 10.1016/j.plefa.2006.12.004; Rastogi P, 2008, AM J PHYSIOL-LUNG C, V295, pL925, DOI 10.1152/ajplung.90230.2008; Rastogi P, 2008, AM J PHYSIOL-RENAL, V294, pF1129, DOI 10.1152/ajprenal.00572.2007; Rickard A, 2002, AM J PHYSIOL-RENAL, V283, pF944, DOI 10.1152/ajprenal.00072.2002; Ruan D, 2014, LIFE SCI, V116, P43, DOI 10.1016/j.lfs.2014.07.042; Sant GR, 2007, UROLOGY, V69, P34, DOI 10.1016/j.urology.2006.08.1109; Song T, 2011, ASIAN PAC J CANCER P, V12, P929; Theoharides T C, 1991, Semin Urol, V9, P74; Theoharides TC, 2001, UROLOGY, V57, P47, DOI 10.1016/S0090-4295(01)01129-3; Wibberley A, 2006, BRIT J PHARMACOL, V148, P154, DOI 10.1038/sj.bjp.0706715; Yang W, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007492; Zhang CO, 2005, J UROLOGY, V174, P2382, DOI 10.1097/01.ju.0000180417.11976.99	29	2	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129466	10.1371/journal.pone.0129466	http://dx.doi.org/10.1371/journal.pone.0129466			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057882	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000057
J	Yuan, X; Niu, HT; Wang, PL; Lu, J; Zhao, H; Liu, SH; Zheng, QS; Li, CG				Yuan, Xuan; Niu, Hai-tao; Wang, Peng-long; Lu, Jie; Zhao, Hong; Liu, Shi-han; Zheng, Qiu-sheng; Li, Chang-gui			Cardioprotective Effect of Licochalcone D against Myocardial Ischemia/Reperfusion Injury in Langendorff-Perfused Rat Hearts	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY RESPONSE; INHIBITS APOPTOSIS; NITRIC-OXIDE; FLAVONOIDS; QUERCETIN; PROTECTS; STRESS; ATHEROSCLEROSIS; SUPPRESSION	Flavonoids are important components of 'functional foods', with beneficial effects on cardiovascular function. The present study was designed to investigate whether licochalcone D (LD) could be a cardioprotective agent in ischemia/reperfusion (I/R) injury and to shed light on its possible mechanism. Compared with the I/R group, LD treatment enhanced myocardial function (increased LVDP, dp/dt(max), dp/dt(min), HR and CR) and suppressed cardiac injury (decreased LDH, CK and myocardial infarct size). Moreover, LD treatment reversed the I/R-induced cleavage of caspase-3 and PARP, resulting in a significant decrease in proinflammatory factors and an increase in antioxidant capacity in I/R myocardial tissue. The mechanisms underlying the antiapoptosis, antiinflammation and antioxidant effects were related to the activation of the AKT pathway and to the blockage of the NF-kappa B/p65 and p38 MAPK pathways in the I/R-injured heart. Additionally, LD treatment markedly activated endothelial nitric oxide synthase (eNOS) and reduced nitric oxide (NO) production. The findings indicated that LD had real cardioprotective potential and provided support for the use of LD in myocardial I/R injury.	[Yuan, Xuan; Niu, Hai-tao; Lu, Jie; Liu, Shi-han; Li, Chang-gui] Qingdao Univ, Affiliated Hosp, Qingdao 266003, Shandong, Peoples R China; [Zheng, Qiu-sheng] Binzhou Med Coll, Yantai 264000, Shandong, Peoples R China; [Wang, Peng-long; Zhao, Hong; Zheng, Qiu-sheng] Shihezi Univ, Sch Pharm, Key Lab Xinjiang Endem Phytomed Resources, Minist Educ, Shihezi 832002, Xinjiang, Peoples R China	Qingdao University; Binzhou Medical University; Shihezi University	Zheng, QS (corresponding author), Binzhou Med Coll, Yantai 264000, Shandong, Peoples R China.	zqsyt123@126.com; lichangguimed@163.com	Zheng, Qiusheng/E-1643-2013	Zheng, Qiusheng/0000-0001-6413-9878	National Natural Science Foundation of China [81260338]; Xinjiang Production and Construction Corps Funds for Distinguished Young Scientists [2011CD006]; International Cooperation Projects [2012BC001]; Postdoctoral Innovation Funds of Shandong Province [2014007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Xinjiang Production and Construction Corps Funds for Distinguished Young Scientists; International Cooperation Projects; Postdoctoral Innovation Funds of Shandong Province	This study was supported by the National Natural Science Foundation of China (No. 81260338), the Xinjiang Production and Construction Corps Funds for Distinguished Young Scientists (No. 2011CD006), and International Cooperation Projects (No. 2012BC001) to QZ. Postdoctoral Innovation Funds of Shandong Province to XY (No. 2014007).	Armstrong SC, 2004, CARDIOVASC RES, V61, P427, DOI 10.1016/j.cardiores.2003.09.031; Arumugam S, 2012, FREE RADICAL RES, V46, P154, DOI 10.3109/10715762.2011.647010; Baines CP, 2005, J MOL CELL CARDIOL, V38, P47, DOI 10.1016/j.yjmcc.2004.11.004; Bowden RA, 2002, CIRC RES, V90, P562, DOI 10.1161/01.RES.0000013835.53611.97; Chen ZY, 2000, FREE RADICAL BIO MED, V29, P589, DOI 10.1016/S0891-5849(00)00363-4; DAS DK, 1994, METHOD ENZYMOL, V233, P601; Dhalla NS, 2000, CARDIOVASC RES, V47, P446, DOI 10.1016/S0008-6363(00)00078-X; Ding HL, 2005, ACTA PHARMACOL SIN, V26, P315, DOI 10.1111/j.1745-7254.2005.00046.x; Dong LY, 2011, FOOD CHEM TOXICOL, V49, P3211, DOI 10.1016/j.fct.2011.09.040; Duarte J, 2001, BRIT J PHARMACOL, V133, P117, DOI 10.1038/sj.bjp.0704064; Duarte J, 2001, PLANTA MED, V67, P567, DOI 10.1055/s-2001-16492; DUARTE J, 1993, GEN PHARMACOL-VASC S, V24, P857, DOI 10.1016/0306-3623(93)90159-U; Edwards RL, 2007, J NUTR, V137, P2405, DOI 10.1093/jn/137.11.2405; Falchi M, 2006, J AGR FOOD CHEM, V54, P6613, DOI 10.1021/jf061048k; Fang F, 2011, PHARMACOLOGY, V88, P149, DOI 10.1159/000330068; Feng Y, 2008, AM J PHYSIOL-HEART C, V295, pH1311, DOI 10.1152/ajpheart.00119.2008; Ferdinandy P, 2003, BRIT J PHARMACOL, V138, P532, DOI 10.1038/sj.bjp.0705080; Furusawa JI, 2009, INT IMMUNOPHARMACOL, V9, P499, DOI 10.1016/j.intimp.2009.01.031; Guler A, 2011, MED SCI MONITOR, V17, pBR326, DOI 10.12659/MSM.882042; Han JC, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/134862; Haraguchi H, 1998, BIOORGAN MED CHEM, V6, P339, DOI 10.1016/S0968-0896(97)10034-7; Hayek T, 1997, ARTERIOSCL THROM VAS, V17, P2744, DOI 10.1161/01.ATV.17.11.2744; Huang CQ, 2010, AM J PHYSIOL-HEART C, V298, pH570, DOI 10.1152/ajpheart.00716.2009; Jeddi S, 2015, ARQ BRAS CARDIOL, V104, P136, DOI 10.5935/abc.20140181; Ji LL, 2010, AM J PHYSIOL-ENDOC M, V298, pE871, DOI 10.1152/ajpendo.00623.2009; Khalili H, 2012, J CARDIOVASC MED, V13, P708, DOI 10.2459/JCM.0b013e328356a3c6; Khan M, 2006, AM J PHYSIOL-HEART C, V290, pH2136, DOI 10.1152/ajpheart.01072.2005; Kim SJ, 2014, ARCH PHARM RES, V37, P1079, DOI 10.1007/s12272-013-0309-x; Kim SJ, 2014, BIOORG MED CHEM LETT, V24, P181, DOI 10.1016/j.bmcl.2013.11.044; Kleikers PWM, 2012, J MOL MED, V90, P1391, DOI 10.1007/s00109-012-0963-3; Lagneux C, 2000, LIFE SCI, V66, P503, DOI 10.1016/S0024-3205(99)00620-7; Liang F, 2004, CARDIOVASC RES, V62, P568, DOI 10.1016/j.cardiores.2004.01.025; Lim NR, 2013, BIOCHEM J, V456, P149, DOI 10.1042/BJ20121538; Loke WM, 2010, ARTERIOSCL THROM VAS, V30, P749, DOI 10.1161/ATVBAHA.109.199687; Lu N, 2011, PLANTA MED, V77, P984, DOI 10.1055/s-0030-1250718; Matsushima S, 2013, CIRC RES, V112, P1135, DOI 10.1161/CIRCRESAHA.111.300171; Murphy E, 2008, PHYSIOL REV, V88, P581, DOI 10.1152/physrev.00024.2007; Park HG, 2012, J NUTR BIOCHEM, V23, P759, DOI 10.1016/j.jnutbio.2011.03.021; Perez-Vizcaino F, 2010, MOL ASPECTS MED, V31, P478, DOI 10.1016/j.mam.2010.09.002; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Pogula BK, 2012, J PHYSIOL BIOCHEM, V68, P433, DOI 10.1007/s13105-012-0157-z; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Shen MY, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-31; Song LN, 2014, APOPTOSIS, V19, P567, DOI 10.1007/s10495-013-0946-z; Tanifuji S, 2010, INT IMMUNOPHARMACOL, V10, P769, DOI 10.1016/j.intimp.2010.04.007; Testai L, 2013, J PHARM PHARMACOL, V65, P750, DOI 10.1111/jphp.12032; Thomas CJ, 2011, EUR J PHARMACOL, V658, P160, DOI 10.1016/j.ejphar.2011.02.041; Wan LL, 2009, CARDIOVASC THER, V27, P28, DOI 10.1111/j.1755-5922.2009.00071.x; Wang MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE321, DOI 10.1152/ajpendo.00278.2004; Wang XL, 2007, APOPTOSIS, V12, P1209, DOI 10.1007/s10495-007-0055-y; Wright B, 2013, CARDIOVASC RES, V97, P13, DOI 10.1093/cvr/cvs304; Yap S, 2010, BIOFACTORS, V36, P350, DOI 10.1002/biof.111; Yin Y, 2013, EUR J PHARMACOL, V699, P219, DOI 10.1016/j.ejphar.2012.11.005; Zhang TP, 2009, APOPTOSIS, V14, P1245, DOI 10.1007/s10495-009-0391-1	54	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128375	10.1371/journal.pone.0128375	http://dx.doi.org/10.1371/journal.pone.0128375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058040	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000018
J	Kaasalainen, U; Heinrichs, J; Krings, M; Myllys, L; Grabenhorst, H; Rikkinen, J; Schmidt, AR				Kaasalainen, Ulla; Heinrichs, Jochen; Krings, Michael; Myllys, Leena; Grabenhorst, Heinrich; Rikkinen, Jouko; Schmidt, Alexander R.			Alectorioid Morphologies in Paleogene Lichens: New Evidence and Re-Evaluation of the Fossil Alectoria succini Magdefrau	PLOS ONE			English	Article							FORMING ASCOMYCOTA; PARMELIACEAE; LINEAGES; HISTORY; CALIBRATIONS; LECANORALES; DIVERGENCES; PHYLOGENY; BRYORIA; CLOCKS	One of the most important issues in molecular dating studies concerns the incorporation of reliable fossil taxa into the phylogenies reconstructed from DNA sequence variation in extant taxa. Lichens are symbiotic associations between fungi and algae and/or cyanobacteria. Several lichen fossils have been used as minimum age constraints in recent studies concerning the diversification of the Ascomycota. Recent evolutionary studies of Lecanoromycetes, an almost exclusively lichen-forming class in the Ascomycota, have utilized the Eocene amber inclusion Alectoria succinic as a minimum age constraint. However, a re-investigation of the type material revealed that this inclusion in fact represents poorly preserved plant remains, most probably of a root. Consequently, this fossil cannot be used as evidence of the presence of the genus Alectoria (Parmeliaceae, Lecanorales) or any other lichens in the Paleogene. However, newly discovered inclusions from Paleogene Baltic and Bitterfeld amber verify that alectorioid morphologies in lichens were in existence by the Paleogene. The new fossils represent either a lineage within the alectorioid group or belong to the genus Oropogon.	[Kaasalainen, Ulla; Schmidt, Alexander R.] Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany; [Heinrichs, Jochen] Univ Munich LMU, Dept Biol, Munich, Germany; [Heinrichs, Jochen] Univ Munich LMU, Geobioctr, Munich, Germany; [Krings, Michael] Univ Munich LMU, Dept Earth & Environm Sci, Munich, Germany; [Krings, Michael] Bavarian State Collect Palaeontol & Geol, Munich, Germany; [Myllys, Leena] Univ Helsinki, Finnish Museum Nat Hist, Helsinki, Finland; [Grabenhorst, Heinrich] Univ Hamburg, Amber Study Grp, Geol Palaeontol Inst & Museum, Hamburg, Germany; [Rikkinen, Jouko] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Gottingen; University of Munich; University of Munich; University of Munich; University of Helsinki; University of Hamburg; University of Helsinki	Kaasalainen, U (corresponding author), Univ Gottingen, Dept Geobiol, D-37073 Gottingen, Germany.	ulla.kaasalainen@geo.uni-goettingen.de	Krings, Michael/AAM-6436-2020; Kaasalainen, Ulla/AAG-8713-2021; Rikkinen, Jouko/AAM-8732-2021	Kaasalainen, Ulla/0000-0001-9899-4768; Myllys, Leena/0000-0002-9566-9473; Rikkinen, Jouko/0000-0002-4615-6639	Alexander von Humboldt foundation; German Research Foundation (DFG); Open Access Publication Fund of the University of Gottingen	Alexander von Humboldt foundation(Alexander von Humboldt Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Gottingen	This work was supported by the Alexander von Humboldt foundation (fellowship to UK): The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It also received support from the Open Access Grant Program of the German Research Foundation (DFG) and the Open Access Publication Fund of the University of Gottingen: The publication fee in an open access publication will be covered by the funders.	de Paz GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028161; Beimforde C, 2014, MOL PHYLOGENET EVOL, V78, P386, DOI 10.1016/j.ympev.2014.04.024; Bisulca C, 2012, AM MUS NOVIT, P1; Blumenstengel H., 2004, EXKURSIONSFUHRER VER, V224, P17; Brodo I.M., 1977, OPERA BOT, V42, P1; Bystrek J., 1971, ANN U M CURIE SKLODO, P265; Coiffard C, 2014, TAXON, V63, P1275, DOI 10.12705/636.17; Crespo A, 2010, TAXON, V59, P1735, DOI 10.1002/tax.596008; Donoghue MJ, 2003, INTEGR COMP BIOL, V43, P261, DOI 10.1093/icb/43.2.261; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Dunlop Jason A., 2010, P57; Esslinger T.L., 1989, SYST BOT MONOGR, V28, P1, DOI DOI 10.2307/25027728; GARGAS A, 1995, SCIENCE, V268, P1492, DOI 10.1126/science.7770775; Hedges S. Blair, 2009, P3; Hedman MM, 2010, PALEOBIOLOGY, V36, P16, DOI 10.1666/0094-8373-36.1.16; Honegger R, 2013, NEW PHYTOL, V197, P264, DOI 10.1111/nph.12009; Inoue J, 2010, SYST BIOL, V59, P74, DOI 10.1093/sysbio/syp078; Kirk PM., 2008, DICT FUNGI, V10th ed; Knuth G., 2002, HALLESCH JB GEOWISSE, V24, P35; Loriga J, 2014, AM J BOT, V101, P1466, DOI 10.3732/ajb.1400262; Lukoschek V, 2012, SYST BIOL, V61, P22, DOI 10.1093/sysbio/syr075; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Magallon S, 2010, SYST BIOL, V59, P384, DOI 10.1093/sysbio/syq027; MAGDEFRAU KARL, 1957, BER DUTCH BOT GES, V70, P433; Miadlikowska J, 2014, MOL PHYLOGENET EVOL, V79, P132, DOI 10.1016/j.ympev.2014.04.003; MYLLYS L., 2011, NORDIC LICHEN FLORA, V4, P26; Myllys L, 2014, LICHENOLOGIST, V46, P737, DOI 10.1017/S0024282914000346; Myllys L, 2011, LICHENOLOGIST, V43, P617, DOI 10.1017/S0024282911000132; Nascimbene Paul, 2000, P93; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Penney David, 2010, P22; Poinar GO, 2000, LICHENOLOGIST, V32, P263, DOI 10.1006/lich.1999.0258; Prieto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065576; Pyron RA, 2010, SYST BIOL, V59, P185, DOI 10.1093/sysbio/syp090; Rikkinen J, 2003, MYCOLOGIA, V95, P1032, DOI 10.2307/3761911; Rikkinen J, 2002, MYCOL RES, V106, P984, DOI 10.1017/S0953756202005907; Rikkinen J, 2008, J EXP BOT, V59, P1007, DOI 10.1093/jxb/ern004; Sauquet H, 2012, SYST BIOL, V61, P289, DOI 10.1093/sysbio/syr116; Schneider H, 2015, ORG DIVERS EVOL, DOI [10.1007/s13127-015-0200-3, DOI 10.1007/S13127-015-0200-]; Standke G., 2008, EXKURSIONSF HRER VER, V236, P11; Standke G., 1998, SCHRIFTENREIHE F R G, V7, P93; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Taylor TN, 1997, AM J BOT, V84, P992, DOI 10.2307/2446290; Thell A, 2012, NORD J BOT, V30, P641, DOI 10.1111/j.1756-1051.2012.00008.x; Velmala S., 2011, NORDIC LICHEN FLORA, V4, P14; Velmala S, 2014, ANN BOT FENN, V51, P345, DOI 10.5735/085.051.0601; Weitschat W., 1997, METALLA, V1, P71; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; YOSHIMURA I, 1987, BIBL LICHENOL, V25, P185; Yuan XL, 2005, SCIENCE, V308, P1017, DOI 10.1126/science.1111347	50	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129526	10.1371/journal.pone.0129526	http://dx.doi.org/10.1371/journal.pone.0129526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053106	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300138
J	Wang, C; Li, YF; Gao, SC; Cheng, DX; Zhao, SH; Liu, EQ				Wang, Chuan; Li, Yafeng; Gao, Shoucui; Cheng, Daxin; Zhao, Sihai; Liu, Enqi			Breviscapine Injection Improves the Therapeutic Effect of Western Medicine on Angina Pectoris Patients	PLOS ONE			English	Article							CORONARY-HEART-DISEASE	To evaluate the beneficial and adverse effects of breviscapine injection in combination with Western medicine on the treatment of patients with angina pectoris. The Cochrane Central Register of Controlled Trials, Medline, Science Citation Index, EMBASE, the China National Knowledge Infrastructure, the Wanfang Database, the Chongqing VIP Information Database and the China Biomedical Database were searched to identify randomized clinical trials (RCTs) that evaluated the effects of Western medicine compared to breviscapine injection plus Western medicine on angina pectoris patients. The included studies were analyzed using RevMan 5.1.0 software. The literature search yielded 460 studies, wherein 16 studies matched the selection criteria. The results showed that combined therapy using Breviscapine plus Western medicine was superior to Western medicine alone for improving angina pectoris symptoms (OR = 3.77, 95% Cl: 2.76 similar to 5.15) and also resulted in increased electrocardiogram (ECG) improvement (OR = 2.77, 95% Cl: 2.16 similar to 3.53). The current evidence suggests that Breviscapine plus Western medicine achieved a superior therapeutic effect compared to Western medicine alone.	[Wang, Chuan; Li, Yafeng; Gao, Shoucui; Cheng, Daxin; Zhao, Sihai; Liu, Enqi] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Res Inst Atherosclerot Dis, Xian, Shaanxi, Peoples R China; [Wang, Chuan] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Kofu, Yamanashi, Japan; [Cheng, Daxin] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 3, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; University of Yamanashi; Xi'an Jiaotong University	Zhao, SH (corresponding author), Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Res Inst Atherosclerot Dis, Xian, Shaanxi, Peoples R China.	sihaizhao@mail.xjtu.edu.cn; liuenqi@mail.xjtu.edu.cn	liu, enqi/S-7771-2019; Wang, Chuan/AAK-3148-2020	Zhao, Sihai/0000-0002-5845-6639; Wang, Chuan/0000-0002-8016-0113; Liu, Enqi/0000-0002-2092-3158	National Natural Science Foundation of China [81370379]; Fundamental Research Funds for the Central Universities; Natural Science Foundation of Shaanxi Province [2012KJXX-07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province)	This work was supported in part by the National Natural Science Foundation of China (No. 81370379), the Fundamental Research Funds for the Central Universities and the Natural Science Foundation of Shaanxi Province (2012KJXX-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1979, Circulation, V59, P607; [崔建梅 Cui Jianmei], 2003, [天然产物研究与开发, Natural Product R & D], V15, P255; Deng K, 2009, J ANHUI TRADITIONAL, V29, P14; FLAHERTY JT, 1984, AM J MED, V76, P52, DOI 10.1016/0002-9343(84)91043-X; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hemingway H, 2003, BRIT MED J, V327, P895, DOI 10.1136/bmj.327.7420.895; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hu S, 2011, J NEW MED, V21, P283; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Li HP, 2011, CHINESE J CLIN RES, V24, P944; Liang T, 2010, HENAN TRADITIONAL CH, V30, P998; Lin LL, 2007, J CARDIOVASC PHARM, V50, P327, DOI 10.1097/FJC.0b013e3180cbd0e7; Lu YJ, 2010, CLIN J CHINESE MED, V2, P30; Meng LC, 2010, GUIDING J TRADITIONA, V21, P283; Ministry of Health P, 2004, CHIN HLTH STAT YB; Peng Dayan GY., 2011, J HUBEI COLL TRADIT, V13, P15; PSATY BM, 1990, JAMA-J AM MED ASSOC, V263, P1653, DOI 10.1001/jama.263.12.1653; Ren YP, 2014, CHINESE MED J-PEKING, V127, P2991, DOI 10.3760/cma.j.issn.0366-6999.20140036; Saydah SH, 2006, J ALTERN COMPLEM MED, V12, P805, DOI 10.1089/acm.2006.12.805; Shao ZB, 2009, CLIN J TRADITIONAL C, V21, P119; Shi SH, 2011, QINDAO MED J, V43, P282; Tan ZH, 2009, CHINESE J ETHNOMEDIC, V18, P65; Wang Jin, 2006, ZHEJIANG SPORT SCIEN, V28, P41; Wang M, 2008, AM J CHINESE MED, V36, P1199, DOI 10.1142/S0192415X08006521; Wang M, 2010, ACTA DIABETOL, V47, pS209, DOI 10.1007/s00592-009-0164-x; Yan L, 2010, J CELL BIOCHEM, V109, P1158, DOI 10.1002/jcb.22495; Yu HW, 2001, J INFORM TRADITIONAL, V8, P68; Zhang QM, 2012, TIANJIN J TRADITIONA, V29, P133; Zhang XD, 2011, GUIDE CHINA MED, V19, P280; Zhao J.G., 2010, CHIN J INTEGR MED CA, V8, P396, DOI [10.3969/j.issn.1672-1349.2010.04.008, DOI 10.3969/J.ISSN.1672-1349.2010.04.008]; Zhao SH, 2011, ANTIVIR RES, V89, P156, DOI 10.1016/j.antiviral.2010.12.003; Zhou BX, 2007, MED WORLD, V8, P91	32	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129969	10.1371/journal.pone.0129969	http://dx.doi.org/10.1371/journal.pone.0129969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052709	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300173
J	Yin, SN; Song, C; Wu, HB; Chen, X; Zhang, Y				Yin, Songna; Song, Chao; Wu, Haibo; Chen, Xin; Zhang, Yong			Adverse Effects of High Concentrations of Fluoride on Characteristics of the Ovary and Mature Oocyte of Mouse	PLOS ONE			English	Article							GENE-EXPRESSION; CELLS; WATER; TRANSPLANTATION; ENVIRONMENT; APOPTOSIS; BEHAVIOR; PROTEIN; MODEL	Reproductive toxicity has been an exciting topic of research in reproductive biology in recent years. Soluble fluoride salts are toxic at high concentrations; their reproductive toxicity was assessed in this study by administering different fluoride salt concentrations to mice. Continuous feeding for five weeks resulted in damage to the histological architecture of ovaries. The expression of genes, including Dazl, Stra8, Nobox, Sohlh1, and ZP3 gene, associated with oocyte formation were much lower in the experimental group as compared with the control group. The number of in vitro fertilization of mature oocytes were also much lower in the experimental group as compared with control. Moreover, the fertility of female mice, as assessed by mating with normal male mice, was also lower in experimental compared with control groups. The expression of the oocyte-specific genes: Bmp15, Gdf9, H1oo, and ZP2, which are involved in oocyte growth and the induction of the acrosome reaction, decreased with the fluoride administration. DNA methylation and histone acetylation (H3K18ac and H3K9ac) are indispensable for germline development and genomic imprinting in mammals, and fluoride administration resulted in reduced levels of H3K9ac and H3K18ac in the experimental group as compared with the control group, as detected by immunostaining. Our results indicate that the administration of high concentrations of fluoride to female mice significantly reduced the number of mature oocytes and hampered their development and fertilization. Thus, this study lays a foundation for future studies on fluoride- induced reproductive disorders in women.	[Yin, Songna; Song, Chao; Wu, Haibo; Chen, Xin; Zhang, Yong] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Yin, Songna; Song, Chao; Wu, Haibo; Chen, Xin; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Zhang, Y (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	YongZhang1956@126.com	Zhang, Yong/K-7945-2016; chen, xiner/GVU-3933-2022	Zhang, Yong/0000-0001-8642-4071; 	National High Technology Research and Development Program of China (863 Program) [2011AA100303]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program of China (863 Program) (No. 2011AA100303) (http://www.most.gov.cn).	Barnett KR, 2006, HUM REPROD UPDATE, V12, P537, DOI 10.1093/humupd/dml022; Barrios F, 2012, J CELL SCI, V125, P1455, DOI 10.1242/jcs.092593; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; Brekhman V, 2000, MOL HUM REPROD, V6, P465, DOI 10.1093/molehr/6.5.465; Chattopadhyay A, 2011, ARCH TOXICOL, V85, P327, DOI 10.1007/s00204-010-0588-7; Chawla SL, 2012, FLUORIDE, V45, P125; Chen HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041683; Choi AL, 2012, ENVIRON HEALTH PERSP, V120, P1362, DOI 10.1289/ehp.1104912; Ding L, 2012, THERIOGENOLOGY, V78, P784, DOI 10.1016/j.theriogenology.2012.03.026; Evans EB, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.099978; FRENI SC, 1994, J TOXICOL ENV HEALTH, V42, P109, DOI 10.1080/15287399409531866; Hozumi S, 2003, BEHAV BRAIN RES, V138, P9, DOI 10.1016/S0166-4328(02)00183-3; Jha SK, 2011, REV ENVIRON CONTAM T, V211, P121, DOI 10.1007/978-1-4419-8011-3_4; Jhala DD, 2008, FOOD CHEM TOXICOL, V46, P1138, DOI 10.1016/j.fct.2007.11.009; Karube H, 2009, J DENT RES, V88, P461, DOI 10.1177/0022034509334771; Kim SY, 2014, ASIAN AUSTRAL J ANIM, V27, P266, DOI 10.5713/ajas.2013.13699; Kivrak Y, 2012, FLUORIDE, V45, P302; Niikura Y, 2009, AGING-US, V1, P971, DOI 10.18632/aging.100105; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pollick HF, 2004, INT J OCCUP ENV HEAL, V10, P343, DOI 10.1179/oeh.2004.10.3.343; Rajkovic A, 2004, SCIENCE, V305, P1157, DOI 10.1126/science.1099755; Rosalbino F, 2012, J MATER SCI-MATER M, V23, P1129, DOI 10.1007/s10856-012-4591-9; Shi JW, 2013, GENET MOL RES, V12, P5640, DOI 10.4238/2013.November.18.13; Smith ER, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00036; Song GH, 2014, J PHYSIOL BIOCHEM, V70, P761, DOI 10.1007/s13105-014-0344-1; Sun ZL, 2010, ARCH TOXICOL, V84, P353, DOI 10.1007/s00204-009-0508-x; Vitoria I, 2014, GAC SANIT, V28, P255, DOI 10.1016/j.gaceta.2013.10.010; Wang S, 2013, CELL TISSUE RES, V354, P609, DOI 10.1007/s00441-013-1678-7; Wurtz T, 2008, TOXICOLOGY, V249, P26, DOI 10.1016/j.tox.2008.04.013; Xiang Q, 2010, ENV HLTH, DOI [10.1289/ehp.1003171, DOI 10.1289/EHP.1003171]; Yin SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086330; Zeng FY, 2003, BIOL REPROD, V68, P31, DOI 10.1095/biolreprod.102.007674; Zhang M, 2008, TOXICOL LETT, V179, P1, DOI 10.1016/j.toxlet.2008.03.002	33	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129594	10.1371/journal.pone.0129594	http://dx.doi.org/10.1371/journal.pone.0129594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053026	gold, Green Submitted, Green Published			2022-12-26	WOS:000355955300149
J	Buse, J; Fassbender, S; Entling, MH; Pavlicek, T				Buse, Joern; Fassbender, Samuel; Entling, Martin H.; Pavlicek, Tomas			Microclimatic Divergence in a Mediterranean Canyon Affects Richness, Composition, and Body Size in Saproxylic Beetle Assemblages	PLOS ONE			English	Article							LOWER NAHAL-OREN; EVOLUTION-CANYON; CLIMATE-CHANGE; SPECIES-RICHNESS; MOUNT-CARMEL; INTERSLOPE DIVERGENCE; LATITUDINAL GRADIENTS; FOREST COMPOSITION; INSECT HERBIVORES; MT. CARMEL	Large valleys with opposing slopes may act as a model system with which the effects of strong climatic gradients on biodiversity can be evaluated. The advantage of such comparisons is that the impact of a change of climate can be studied on the same species pool without the need to consider regional differences. The aim of this study was to compare the assemblage of saproxylic beetles on such opposing slopes at Lower Nahal Oren, Mt. Carmel, Israel (also known as "Evolution Canyon") with a 200-800% higher solar radiation on the south-facing (SFS) compared to the north-facing slope (NFS). We tested specific hypotheses of species richness patterns, assemblage structure, and body size resulting from interslope differences in microclimate. Fifteen flight-interception traps per slope were distributed over three elevation levels ranging from 50 to 100 m a.s.l. Richness of saproxylic beetles was on average 34% higher on the SFS compared with the NFS, with no detected influence of elevation levels. Both assemblage structure and average body size were determined by slope aspect, with more small-bodied beetles found on the SFS. Both the increase in species richness and the higher prevalence of small species on the SFS reflect ecological rules present on larger spatial grain (species-energy hypothesis and community body size shift hypothesis), and both can be explained by the metabolic theory of ecology. This is encouraging for the complementary use of micro-and macroclimatic gradients to study impacts of climate warming on biodiversity.	[Buse, Joern; Fassbender, Samuel; Entling, Martin H.] Univ Koblenz Landau, Inst Environm Sci, Ecosyst Anal, Landau, Germany; [Pavlicek, Tomas] Univ Haifa, Inst Evolut, IL-31999 Haifa, Israel	University of Koblenz & Landau; University of Haifa	Buse, J (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Ecosyst Anal, Frt Str 7, Landau, Germany.	joernbuse@gmx.de	Buse, Joern/G-6588-2015; Entling, Martin H/C-6953-2008; Pavlicek, Tomas/C-4768-2008	Buse, Joern/0000-0001-8226-1893; 				Allen AP, 2002, SCIENCE, V297, P1545, DOI 10.1126/science.1072380; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, CONSERV BIOL, V26, P1082, DOI 10.1111/j.1523-1739.2012.01913.x; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Bassler C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065842; Bassler C, 2010, ECOL INDIC, V10, P341, DOI 10.1016/j.ecolind.2009.06.014; Baselga A, 2008, ECOGRAPHY, V31, P263, DOI 10.1111/j.0906-7590.2008.5335.x; Basset Y, 2001, J APPL ECOL, V38, P1045, DOI 10.1046/j.1365-2664.2001.00660.x; Blackburn Tim M., 1999, Diversity and Distributions, V5, P165, DOI 10.1046/j.1472-4642.1999.00046.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buse J, 2008, CONSERV BIOL, V22, P329, DOI 10.1111/j.1523-1739.2007.00880.x; Buse J, 2013, INSECT CONSERV DIVER, V6, P687, DOI 10.1111/icad.12023; Buse J, 2013, BIODIVERS CONSERV, V22, P1115, DOI 10.1007/s10531-012-0395-y; Chikatunov V, 2000, BIOL J LINN SOC, V69, P139, DOI 10.1006/bijl.1999.0322; Chikatunov V, 1997, J ARID ENVIRON, V37, P367, DOI 10.1006/jare.1997.0278; Chow E. D., 2007, ELLIPSE FUNCTIONS DR; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Clark JS, 2011, GLOBAL CHANGE BIOL, V17, P1834, DOI 10.1111/j.1365-2486.2010.02380.x; Colwell RK, 2013, DIVERS DISTRIB, V14, P1; Cudmore TJ, 2010, J APPL ECOL, V47, P1036, DOI 10.1111/j.1365-2664.2010.01848.x; CUSHMAN JH, 1993, OECOLOGIA, V95, P30, DOI 10.1007/BF00649503; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Entling MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045875; Entling W, 2010, J BIOGEOGR, V37, P477, DOI 10.1111/j.1365-2699.2009.02216.x; Evans JP, 2009, CLIMATIC CHANGE, V92, P417, DOI 10.1007/s10584-008-9438-5; Evans KL, 2005, BIOL REV, V80, P1, DOI 10.1017/S1464793104006517; Field R, 2009, J BIOGEOGR, V36, P132, DOI 10.1111/j.1365-2699.2008.01963.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; HAWKINS BA, 1995, OECOLOGIA, V102, P31, DOI 10.1007/BF00333307; Hawkins BA, 2003, ECOLOGY, V84, P3105, DOI 10.1890/03-8006; Horak J, 2014, FOREST ECOL MANAG, V315, P80, DOI 10.1016/j.foreco.2013.12.018; Hyvarinen E, 2006, EUR J ENTOMOL, V103, P397, DOI 10.14411/eje.2006.054; Kaniewski D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102090; Keena MA, 2006, ENVIRON ENTOMOL, V35, P912, DOI 10.1603/0046-225X-35.4.912; Koricheva J, 1998, ANNU REV ENTOMOL, V43, P195, DOI 10.1146/annurev.ento.43.1.195; Krams I, 2012, FOREST ECOL MANAG, V270, P147, DOI 10.1016/j.foreco.2012.01.012; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Melamud V, 2007, ACTA ZOOL ACAD SCI H, V53, P381; MENDEL Z, 1983, PHYTOPARASITICA, V11, P13, DOI 10.1007/BF02980707; Millien V, 2006, ECOL LETT, V9, P853, DOI 10.1111/j.1461-0248.2006.00928.x; Muller J, ECOGRAPHY IN PRESS, V37; Netherer S, 2010, FOREST ECOL MANAG, V259, P831, DOI 10.1016/j.foreco.2009.07.034; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; Nevo E, 1996, ISR J ZOOL, V42, P395; Nevo E, 2012, P NATL ACAD SCI USA, V109, P2960, DOI 10.1073/pnas.1120633109; Nevo E, 2011, GENOME BIOL EVOL, V3, P1039, DOI 10.1093/gbe/evr052; Newbold T, 2009, J BIOGEOGR, V36, P2085, DOI 10.1111/j.1365-2699.2009.02140.x; Novotny V, 2010, J ANIM ECOL, V79, P1193, DOI 10.1111/j.1365-2656.2010.01728.x; Nuche P, 2014, ECOL INDIC, V40, P68, DOI 10.1016/j.ecolind.2013.12.023; Oksanen J., 2016, R PACKAG; Oliver I, 1996, CONSERV BIOL, V10, P99, DOI 10.1046/j.1523-1739.1996.10010099.x; Palm T, 1959, HOLZ RINDENKAFER SUD; Pavlicek T, 2008, BIOL J LINN SOC, V93, P147; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Pavlicek Tomas, 2008, Ecologia Mediterranea, V34, P25; R-Core-Development-Team, 2011, R LANG ENV STAT COMP, DOI [10.1016/j.neuroimage.2011.01.013, DOI 10.1016/J.NEUROIMAGE.2011.01.013]; Ramirez-Hernandez A, 2014, BIODIVERS CONSERV, V23, P2069, DOI 10.1007/s10531-014-0705-7; Raz S, 2011, BIOL J LINN SOC, V102, P876; Raz S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005214; Reitalu T, 2013, J BIOGEOGR, V40, P1524, DOI 10.1111/jbi.12092; Roberts D.W., 2010, LABDSV ORDINATION MU; Rouault G, 2006, ANN FOREST SCI, V63, P613, DOI 10.1051/forest:2006044; Ruiz-Labourdette D, 2012, J BIOGEOGR, V39, P162, DOI 10.1111/j.1365-2699.2011.02592.x; Schmidl Juergen, 2004, Naturschutz und Landschaftsplanung, V36, P202; Schuldt A, 2009, ECOGRAPHY, V32, P1; Shepherd BL, 2008, J INSECT PHYSIOL, V54, P604, DOI 10.1016/j.jinsphys.2007.12.007; Stokland J.N., 2012, BIODIVERSITY DEAD WO; Sverdrup-Thygeson A, 2009, J INSECT CONSERV, V13, P183, DOI 10.1007/s10841-008-9141-x; Venables WN., 2002, MODERN APPL STAT S 4; Vodka S, 2009, J INSECT CONSERV, V13, P553, DOI 10.1007/s10841-008-9202-1; Volney WJA, 2000, AGR ECOSYST ENVIRON, V82, P283, DOI 10.1016/S0167-8809(00)00232-2; Walczynska A, 2012, B ENTOMOL RES, V102, P644, DOI 10.1017/S0007485312000296; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; Widerberg MK, 2012, BIODIVERS CONSERV, V21, P3035, DOI 10.1007/s10531-012-0353-8; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	80	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129323	10.1371/journal.pone.0129323	http://dx.doi.org/10.1371/journal.pone.0129323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047491	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200151
J	Dadheech, N; Srivastava, A; Paranjape, N; Gupta, S; Dave, A; Shah, GM; Bhonde, RR; Gupta, S				Dadheech, Nidheesh; Srivastava, Abhay; Paranjape, Neha; Gupta, Shivika; Dave, Arpita; Shah, Girish M.; Bhonde, Ramesh R.; Gupta, Sarita			Swertisin an Anti-Diabetic Compound Facilitate Islet Neogenesis from Pancreatic Stem/Progenitor Cells via p-38 MAP Kinase-SMAD Pathway: An In-Vitro and In-Vivo Study	PLOS ONE			English	Article							ENICOSTEMMA-LITTORALE BLUME; AQUEOUS EXTRACT; BETA-CELLS; STEM-CELLS; ACTIVIN-A; DIFFERENTIATION; EXPRESSION; INSULIN; IDENTIFICATION; CARCINOMA	Transplanting islets serves best option for restoring lost beta cell mass and function. Small bio-chemical agents do have the potential to generate new islets mass, however lack of understanding about mechanistic action of these small molecules eventually restricts their use in cell-based therapies for diabetes. We recently reported "Swertisin" as a novel islet differentiation inducer, generating new beta cells mass more effectively. Henceforth, in the present study we attempted to investigate the molecular signals that Swertisin generate for promoting differentiation of pancreatic progenitors into islet cells. To begin with, both human pancreatic progenitors (PANC-1 cells) and primary cultured mouse intra-islet progenitor cells (mIPC) were used and tested for Swertisin induced islet neogenesis mechanism, by monitoring immunoblot profile of key transcription factors in time dependent manner. We observed Swertisin follow Activin-A mediated MEPK-TKK pathway involving role of p38 MAPK via activating Neurogenin-3 (Ngn-3) and Smad Proteins cascade. This MAP Kinase intervention in differentiation of cells was confirmed using strong pharmacological inhibitor of p38 MAPK (SB203580), which effectively abrogated this process. We further confirmed this mechanism in-vivo in partial pancreatectomised (PPx) mice model, where we could show Swertisin exerted potential increase in insulin transcript levels with persistent down-regulation of progenitor markers like Nestin, Ngn-3 and Pancreatic Duodenal Homeobox Gene-1 (PDX-1) expression, within three days post PPx. With detailed molecular investigations here in, we first time report the molecular mode of action of Swertisin for islet neogenesis mediated through MAP Kinase (MEPK-TKK) pathway involving Ngn-3 and Smad transcriptional regulation. These findings held importance for developing Swertisin as potent pharmacological drug candidate for effective and endogenous differentiation of islets in cell based therapy for diabetes.	[Dadheech, Nidheesh; Srivastava, Abhay; Dave, Arpita; Gupta, Sarita] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Endocrinol & Stem Cell Res Lab, Vadodara, Gujarat, India; [Paranjape, Neha; Gupta, Shivika] Hislope Coll Biotechnol, Nagpur, Maharashtra, India; [Shah, Girish M.] Univ Laval, CHUQ, CHUL, Skin Canc Res Lab,Ctr Rech, Quebec City, PQ, Canada; [Bhonde, Ramesh R.] Manipal Hosp, Manipal Hosp & Regenerat Med Ctr, Manipal, Karnataka, India	Maharaja Sayajirao University Baroda; Laval University; Manipal Academy of Higher Education (MAHE)	Gupta, S (corresponding author), Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Biochem, Mol Endocrinol & Stem Cell Res Lab, Vadodara, Gujarat, India.	saritagupta9@gmail.com	Dadheech, Nidheesh/E-3142-2017	Dadheech, Nidheesh/0000-0002-7155-0486; Shah, Girish/0000-0002-9291-1164	Department of Biotechnology, Government of India, New Delhi, India [BT/TR-7721/MED/14/1071/2006, BT/PR3564/BRB/10/975/2011]; DBT-MSUB-ILSPARE programme [BT/PR14551/INF/22/122/2010]; Natural Sciences and Engineering Research Council of Canada [155257-2011]; Department of Biotechnology-HRD, MST Government of India, New Delhi, India; Canadian Government; Canadian Commonwealth Scholarship Program; India Studies Faculty Research Fellowship Award from Shastri Indo-Canadian Institute	Department of Biotechnology, Government of India, New Delhi, India(Department of Biotechnology (DBT) India); DBT-MSUB-ILSPARE programme; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Department of Biotechnology-HRD, MST Government of India, New Delhi, India; Canadian Government; Canadian Commonwealth Scholarship Program; India Studies Faculty Research Fellowship Award from Shastri Indo-Canadian Institute	The authors acknowledge the Department of Biotechnology, Government of India, New Delhi, India, for funding the project (grant no. BT/TR-7721/MED/14/1071/2006 and grant no. BT/PR3564/BRB/10/975/2011) and for establishing central instrumental facility for confocal microscopy at Maharaja Sayajirao University, Baroda, India under DBT-MSUB-ILSPARE programme (Grant no. BT/PR14551/INF/22/122/2010). The work carried out at Laval University was supported by the Discovery grant # 155257-2011 to Dr. Girish Shah from the Natural Sciences and Engineering Research Council of Canada. The authors also thank Department of Biotechnology-HRD, MST Government of India, New Delhi, India, for proving financial grant, and the Canadian Government for financially supporting Dr. Nidheesh Dadheech with Canadian Commonwealth Scholarship Program to carry out some part of study under the supervision of Dr. GM Shah, in Laval University, Quebec, Canada. Dr. GM Shah was recipient of the India Studies Faculty Research Fellowship Award from the Shastri Indo-Canadian Institute for his work in India and Canada on this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeyens L, 2006, CELL DEATH DIFFER, V13, P1892, DOI 10.1038/sj.cdd.4401883; Bonal C, 2008, BIOCHEM SOC T, V36, P286, DOI 10.1042/BST0360286; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Brown ML, 2010, TRENDS ENDOCRIN MET, V21, P441, DOI 10.1016/j.tem.2010.02.008; Dalvi MP, 2009, J BIOSCIENCES, V34, P523, DOI 10.1007/s12038-009-0071-x; Demeterco C, 2000, J CLIN ENDOCR METAB, V85, P3892, DOI 10.1210/jc.85.10.3892; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Granger A, 2009, J INTERN MED, V266, P325, DOI 10.1111/j.1365-2796.2009.02156.x; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Ilieva A, 1999, J ENDOCRINOL, V161, P357, DOI 10.1677/joe.0.1610357; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kojima I, 2006, INT J BIOCHEM CELL B, V38, P923, DOI 10.1016/j.biocel.2005.09.019; Kojima I, 1997, SER S US, P189; Lardon J, 2002, HISTOCHEM CELL BIOL, V117, P535, DOI 10.1007/s00418-002-0412-4; Lee SH, 2011, ISLETS, V3, P188, DOI 10.4161/isl.3.4.16338; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Maroo J, 2003, PHYTOMEDICINE, V10, P196, DOI 10.1078/094471103321659933; Maroo J, 2002, J ETHNOPHARMACOL, V81, P317, DOI 10.1016/S0378-8741(02)00095-8; Misfeldt AA, 2008, DIABETES, V57, P3069, DOI 10.2337/db08-0878; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nidheesh D, 2013, EVIDENCE BASED COMPL; Ogihara T, 2003, J BIOL CHEM, V278, P21693, DOI 10.1074/jbc.M302684200; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Penny C, 2002, CELL BIOL INT, V26, P1057, DOI 10.1006/cbir.2002.0965; Pittenger GL, 2009, DIABETOLOGIA, V52, P735, DOI 10.1007/s00125-009-1322-y; Sarita Gupta, 2010, International Journal of Integrative Biology, V9, P49; Selander L, 2002, MECH DEVELOP, V113, P189, DOI 10.1016/S0925-4773(02)00023-0; Soria B, 2001, DIABETOLOGIA, V44, P407, DOI 10.1007/s001250051636; Stratta RJ, 1999, ANN SURG, V229, P701, DOI 10.1097/00000658-199905000-00013; Swift GH, 1998, MOL CELL BIOL, V18, P5109, DOI 10.1128/MCB.18.9.5109; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Umezawa K, 2003, BIOMED PHARMACOTHER, V57, P341, DOI 10.1016/S0753-3322(03)00096-9; Uzan B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004734; Vasu VT, 2005, J ETHNOPHARMACOL, V101, P277, DOI 10.1016/j.jep.2005.05.007; Wu YX, 2010, LAB INVEST, V90, P1373, DOI 10.1038/labinvest.2010.106; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang YQ, 2005, J CELL MOL MED, V9, P331, DOI 10.1111/j.1582-4934.2005.tb00359.x; Zhang YQ, 2003, DIABETES-METAB RES, V19, P363, DOI 10.1002/dmrr.406; Zhang YQ, 2002, ENDOCRINOLOGY, V143, P3540, DOI 10.1210/en.2002-220089; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128244	10.1371/journal.pone.0128244	http://dx.doi.org/10.1371/journal.pone.0128244			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047129	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200049
J	Hargrove, JS; Weyl, OLF; Allen, MS; Deacon, NR				Hargrove, John S.; Weyl, Olaf L. F.; Allen, Micheal S.; Deacon, Neil R.			Using Tournament Angler Data to Rapidly Assess the Invasion Status of Alien Sport Fishes (Micropterus spp.) in Southern Africa	PLOS ONE			English	Article							FRESH-WATER FISH; INTRODUCTIONS; BIODIVERSITY; MANAGEMENT; CONFLICTS; IMPACT; RISK	Fishes are one of the most commonly introduced aquatic taxa worldwide, and invasive fish species pose threats to biodiversity and ecosystem function in recipient waters. Considerable research efforts have focused on predicting the invasibility of different fish taxa; however, accurate records detailing the establishment and spread of invasive fishes are lacking for large numbers of fish around the globe. In response to these data limitations, a low-cost method of cataloging and quantifying the temporal and spatial status of fish invasions was explored. Specifically, angler catch data derived from competitive bass angling tournaments was used to document the distribution of 66 non-native populations of black bass (Micropterus spp.) in southern Africa. Additionally, catch data from standardized tournament events were used to assess the abundance and growth of non-native bass populations in southern Africa relative to their native distribution (southern and eastern United States). Differences in metrics of catch per unit effort (average number of fish retained per angler per day), daily bag weights (the average weight of fish retained per angler), and average fish weight were assessed using catch data from 14,890 angler days of tournament fishing (11,045 days from South Africa and Zimbabwe; 3,845 days from the United States). No significant differences were found between catch rates, average daily bag weight, or the average fish weight between countries, suggesting that bass populations in southern Africa reach comparable sizes and numbers relative to waters in their native distribution. Given the minimal cost associated with data collection (i.e. records are collected by tournament organizers), the standardized nature of the events, and consistent bias (i.e. selection for the biggest fish in a population), the use of angler catch data represents a novel approach to infer the status and distribution of invasive sport fish.	[Hargrove, John S.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Weyl, Olaf L. F.; Deacon, Neil R.] South African Inst Aquat Biodivers, Grahamstown, South Africa; [Weyl, Olaf L. F.] SAIAB, Ctr Invas Biol, Grahamstown, South Africa; [Allen, Micheal S.] Univ Florida, Fisheries & Aquat Sci Program, Gainesville, FL USA	State University System of Florida; University of Florida; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; State University System of Florida; University of Florida	Hargrove, JS (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	tractor@ufl.edu; O.Weyl@saiab.ac.za		Hargrove, John/0000-0002-8643-7822; Weyl, Olaf/0000-0002-8935-3296	Institute of Food and Agricultural Sciences, University of Florida; National Research Foundation (N.R.F.); DST/NRF Centre of Excellence in Invasion Biology (CIB)	Institute of Food and Agricultural Sciences, University of Florida(University of Florida); National Research Foundation (N.R.F.); DST/NRF Centre of Excellence in Invasion Biology (CIB)	Financial support for JSH was provided by a graduate assistantship from the Institute of Food and Agricultural Sciences, University of Florida. The National Research Foundation (N.R.F.) and DST/NRF Centre of Excellence in Invasion Biology (CIB) contributed significantly to funding this research.	Beamesderfer Raymond C. P., 1995, North American Journal of Fisheries Management, V15, P688, DOI 10.1577/1548-8675(1995)015<0688:GNMAPR>2.3.CO;2; Blackburn TM, 2011, TRENDS ECOL EVOL, V26, P333, DOI 10.1016/j.tree.2011.03.023; Bonar SA, 2009, STANDARD METHODS FOR SAMPLING NORTH AMERICAN FRESHWATER FISHES, P1; Britton JR, 2011, FISH FISH, V12, P256, DOI 10.1111/j.1467-2979.2010.00390.x; Cambray JA, 2003, HYDROBIOLOGIA, V500, P217, DOI 10.1023/A:1024648719995; Carlander KD, 1977, HDB FRESHWATER FISH, V2; Casal CMV, 2006, BIOL INVASIONS, V8, P3, DOI 10.1007/s10530-005-0231-3; Clarkson RW, 2005, FISHERIES, V30, P20, DOI 10.1577/1548-8446(2005)30[20:CBNFAN]2.0.CO;2; DOLMAN W B, 1991, North American Journal of Fisheries Management, V11, P177, DOI 10.1577/1548-8675(1991)011<0177:COBCTR>2.3.CO;2; Driscoll M. Todd, 2012, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V66, P25; Ebbers M.A., 1987, North American Journal of Fisheries Management, V76, P252; Ellender BR, 2014, J FISH BIOL, V85, P1890, DOI 10.1111/jfb.12512; Ellender BR, 2014, AQUAT INVASIONS, V9, P117, DOI 10.3391/ai.2014.9.2.01; Farman R.S., 1982, North American Journal of Fisheries Management, V2, P249, DOI 10.1577/1548-8659(1982)2<249:ELBAUC>2.0.CO;2; GABELHOUSE D W JR, 1986, North American Journal of Fisheries Management, V6, P481, DOI 10.1577/1548-8659(1986)6<481:BAUOAC>2.0.CO;2; Garcia-Berthou E, 2007, J FISH BIOL, V71, P33, DOI 10.1111/j.1095-8649.2007.01668.x; Garcia-Berthou E, 2005, CAN J FISH AQUAT SCI, V62, P453, DOI 10.1139/F05-017; Gozlan RE, 2008, FISH FISH, V9, P106, DOI 10.1111/j.1467-2979.2007.00267.x; Hunt LM, 2011, ECOL APPL, V21, P2555, DOI 10.1890/10-1237.1; Jackson DA, 2002, AM FISH S S, V31, P221; Jackson ZJ, 2008, FISHERIES MANAG ECOL, V15, P107, DOI 10.1111/j.1365-2400.2007.00591.x; Jones JPG, 2011, J APPL ECOL, V48, P9, DOI 10.1111/j.1365-2664.2010.01917.x; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Maceina Michael J., 1998, North American Journal of Fisheries Management, V18, P998, DOI 10.1577/1548-8675(1998)018<0998:VILBRI>2.0.CO;2; Marchetti MP, 2004, ECOL APPL, V14, P587, DOI 10.1890/02-5301; Matthias BG, 2014, FISHERIES, V39, P261, DOI 10.1080/03632415.2014.903836; McCafferty JR, 2012, WATER SA, V38, P327, DOI 10.4314/wsa.v38i2.18; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Noble RL, 2002, AM FISH S S, V31, P419; Olson D.E., 1989, North American Journal of Fisheries Management, V9, P287, DOI 10.1577/1548-8675(1989)009<0287:SFTSBA>2.3.CO;2; Pita P, 2014, FISHERIES MANAG ECOL, V21, P454, DOI 10.1111/fme.12095; Pope KL, 2010, INLAND FISHERIES MANAGEMENT IN NORTH AMERICA, THIRD EDITION, P325; Post JR, 2008, ECOL APPL, V18, P1038, DOI 10.1890/07-0465.1; Powell KI, 2011, AM J BOT, V98, P539, DOI 10.3732/ajb.1000402; Quinn S., 2009, CENTRARCHID FISHES D, P312; R Core Team, 2021, R LANGUAGE ENV STAT; Ricciardi A, 1998, CAN J FISH AQUAT SCI, V55, P1759, DOI 10.1139/cjfas-55-7-1759; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; Robbins W.H., 1974, BLACKBASS AM OVERSEA; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00267.x-i1; Schramm HL, 2007, FISHERIES, V32, P234, DOI 10.1577/1548-8446(2007)32[234:IBAPAW]2.0.CO;2; SCHRAMM HL, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016<0004:TSOCSF>2.0.CO;2; Scott L. E. P., 2006, Smithiana Monograph, P1; Taylor GC, 2015, FISH RES, V162, P37, DOI 10.1016/j.fishres.2014.09.014; US Department of the Interior US Fish and Wildlife Service and US Department of Commerce US Census Bureau, 2011, NAT SURV FISH HUNT W; van Rensburg BJ, 2011, BIOLOGICAL INVASIONS: ECONOMIC AND ENVIRONMENTAL COSTS OF ALIEN PLANT, ANIMAL, AND MICROBE SPECIES, 2ND EDITION, P325; Welcomme RL, 1988, 294 FAO, P328; Wilde Gene R., 1998, North American Journal of Fisheries Management, V18, P972, DOI 10.1577/1548-8675(1998)018&lt;0972:COTBBF&gt;2.0.CO;2; Williamson M., 1996, BIOL INVASIONS, P15; WILLIS DW, 1986, FISHERIES, V11, P7, DOI 10.1577/1548-8446(1986)011<0007:TKBBTM>2.0.CO;2; Winker H, 2011, MAR FRESHWATER RES, V62, P1270, DOI 10.1071/MF11054	52	26	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0130056	10.1371/journal.pone.0130056	http://dx.doi.org/10.1371/journal.pone.0130056			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047487	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200171
J	Kamr, AM; Dembek, KA; Reed, SM; Slovis, NM; Zaghawa, AA; Rosol, TJ; Toribio, RE				Kamr, Ahmed M.; Dembek, Katarzyna A.; Reed, Stephen M.; Slovis, Nathan M.; Zaghawa, Ahmed A.; Rosol, Thomas J.; Toribio, Ramiro E.			Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates	PLOS ONE			English	Article							SERUM PARATHYROID-HORMONE; D DEFICIENCY; MAGNESIUM CONCENTRATIONS; D SUPPLEMENTATION; HORSES; FOALS; PREVALENCE; SEPSIS; HYPOCALCEMIA; EXPRESSION	Background Hypocalcemia is a frequent abnormality that has been associated with disease severity and outcome in hospitalized foals. However, the pathogenesis of equine neonatal hypocalcemia is poorly understood. Hypovitaminosis D in critically ill people has been linked to hypocalcemia and mortality; however, information on vitamin D metabolites and their association with clinical findings and outcome in critically ill foals is lacking. The goal of this study was to determine the prevalence of vitamin D deficiency (hypovitaminosis D) and its association with serum calcium, phosphorus, and parathyroid hormone (PTH) concentrations, disease severity, and mortality in hospitalized newborn foals. Methods and Results One hundred newborn foals <= 72 hours old divided into hospitalized (n = 83; 59 septic, 24 sick non-septic [SNS]) and healthy (n = 17) groups were included. Blood samples were collected on admission to measure serum 25-hydroxyvitamin D-3 [25(OH)D-3], 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3], and PTH concentrations. Data were analyzed by nonparametric methods and univariate logistic regression. The prevalence of hypovitaminosis D [defined as 25(OH)D-3 <9.51 ng/mL] was 63% for hospitalized, 64% for septic, and 63% for SNS foals. Serum 25(OH)D-3 and 1,25(OH)(2)D-3 concentrations were significantly lower in septic and SNS compared to healthy foals (P<0.0001; P = 0.037). Septic foals had significantly lower calcium and higher phosphorus and PTH concentrations than healthy and SNS foals (P<0.05). In hospitalized and septic foals, low 1,25(OH)(2)D-3 concentrations were associated with increased PTH but not with calcium or phosphorus concentrations. Septic foals with 25(OH)D-3 <9.51 ng/mL and 1,25(OH)(2)D-3 <7.09 pmol/L were more likely to die (OR=3.62; 95% CI = 1.1-12.40; OR = 5.41; 95% CI = 1.19-24.52, respectively). Conclusions Low 25(OH)D-3 and 1,25(OH)(2)D-3 concentrations are associated with disease severity and mortality in hospitalized foals. Vitamin D deficiency may contribute to a pro-inflammatory state in equine perinatal diseases. Hypocalcemia and hyperphosphatemia together with decreased 1,25(OH)(2)D-3 but increased PTH concentrations in septic foals indicates that PTH resistance may be associated with the development of these abnormalities.	[Kamr, Ahmed M.; Dembek, Katarzyna A.; Rosol, Thomas J.; Toribio, Ramiro E.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Reed, Stephen M.] Rood & Riddle Equine Hosp, Lexington, KY USA; [Slovis, Nathan M.] Hagyard Equine Med Inst, Lexington, KY USA; [Zaghawa, Ahmed A.] Univ Sadat City, Fac Vet Med, Sadat City, Egypt	University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); University of Sadat City	Toribio, RE (corresponding author), Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA.	toribio.1@osu.edu	Rosol, Thomas/G-9585-2011; Kamr, Ahmed/AAG-2904-2021; Toribio, Ramiro/H-7838-2013	Rosol, Thomas/0000-0003-3737-1190; Kamr, Ahmed/0000-0002-7409-0227; Toribio, Ramiro/0000-0002-9063-540X; zaghawa, ahmed/0000-0002-3263-2948	Ohio State University [520402]; United States Department of Agriculture; Egyptian Cultural and Educational Bureau	Ohio State University(Ohio State University); United States Department of Agriculture(United States Department of Agriculture (USDA)); Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau)	Equine Research Funds of The Ohio State University 520402 and The United States Department of Agriculture. Financial support was provided by the Egyptian Cultural and Educational Bureau to A. Kamr. Partial funding for Open Access provided by The Ohio State University Open Access Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrein K, 2014, CRIT CARE, V18, DOI 10.1186/cc13790; Amrein K, 2011, CRIT CARE, V15, DOI 10.1186/cc10120; Aygencel G, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/856747; Borella E, 2014, ANN NY ACAD SCI, V1317, P76, DOI 10.1111/nyas.12321; BREWER BD, 1988, EQUINE VET J, V20, P18, DOI 10.1111/j.2042-3306.1988.tb01445.x; Christensen EI, 2012, PHYSIOLOGY, V27, P223, DOI 10.1152/physiol.00022.2012; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; DiBartola SP, 2005, FLUID ELECTROLYTE AC, P195; Edfeldt K, 2010, P NATL ACAD SCI USA, V107, P22593, DOI 10.1073/pnas.1011624108; Garcia-Lopez JM, 2001, AM J VET RES, V62, P7, DOI 10.2460/ajvr.2001.62.7; Han JE, 2014, AM J RESP CRIT CARE, V190, P483, DOI 10.1164/rccm.201408-1443ED; Haroon M, 2012, CLIN RHEUMATOL, V31, P199, DOI 10.1007/s10067-011-1880-5; Hebbar KB, 2014, J CLIN TRANSL ENDOCR, V1, P170, DOI 10.1016/j.jcte.2014.09.002; HOLICK MF, 1990, J NUTR, V120, P1464, DOI 10.1093/jn/120.suppl_11.1464; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hurcombe SDA, 2009, J VET INTERN MED, V23, P335, DOI 10.1111/j.1939-1676.2009.0275.x; Izadpanah M, 2013, IMMUNOTHERAPY-UK, V5, P843, DOI [10.2217/imt.13.84, 10.2217/IMT.13.84]; Jeng L, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-28; Jones G, 2008, AM J CLIN NUTR, V88, p582S, DOI 10.1093/ajcn/88.2.582S; Karefylakis C, 2014, OBES SURG, V24, P343, DOI 10.1007/s11695-013-1104-y; Kuro-o M, 2010, PEDIATR NEPHROL, V25, P583, DOI 10.1007/s00467-009-1260-4; Lang C.-L., 2014, ISRN Endocrinol, V2014, P1, DOI [DOI 10.1155/2014/105456, 10.1155/2014/105456]; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Lee P, 2009, INTENS CARE MED, V35, P2028, DOI 10.1007/s00134-009-1642-x; Lind L, 2000, CRIT CARE MED, V28, P93, DOI 10.1097/00003246-200001000-00015; Madej JP, 2009, POL J VET SCI, V12, P499; Marzolo MP, 2011, BIOL RES, V44, P89, DOI 10.4067/S0716-97602011000100012; McKinney JD, 2011, J AM MED DIR ASSOC, V12, P208, DOI 10.1016/j.jamda.2010.04.004; Meier U, 2006, CLIN CHEM, V52, P1247, DOI 10.1373/clinchem.2005.065680; Nair P, 2013, INTENS CARE MED, V39, P267, DOI 10.1007/s00134-012-2713-y; Nguyen HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064348; Norman AW, 2008, AM J CLIN NUTR, V88, p491S, DOI 10.1093/ajcn/88.2.491S; Olauson H, 2014, SEMIN NEPHROL, V34, P586, DOI 10.1016/j.semnephrol.2014.09.005; Pozza ME, 2014, VET J, V199, P451, DOI 10.1016/j.tvjl.2014.01.002; Rippel C, 2012, INTENS CARE MED, V38, P2055, DOI 10.1007/s00134-012-2718-6; RUDE RK, 1976, CLIN ENDOCRINOL, V5, P209, DOI 10.1111/j.1365-2265.1976.tb01947.x; Salle BL, 2000, AM J CLIN NUTR, V71, p1317S, DOI 10.1093/ajcn/71.5.1317s; Meneses JFSE, 2009, PEDIATR CRIT CARE ME, V10, P234, DOI 10.1097/PCC.0b013e3181937042; Schreiber A, 2012, KIDNEY INT, V82, P53, DOI 10.1038/ki.2012.62; Speeckaert MM, 2014, ADV CLIN CHEM, V63, P1, DOI 10.1016/B978-0-12-800094-6.00001-7; Toribio RE, 2011, VET CLIN N AM-EQUINE, V27, P129, DOI 10.1016/j.cveq.2010.12.010; Toribio RE, 2011, VET CLIN N AM-EQUINE, V27, P35, DOI 10.1016/j.cveq.2010.12.011; Toribio RE, 2005, J VET INTERN MED, V19, P223, DOI 10.1892/0891-6640(2005)19&lt;223:AISPHA&gt;2.0.CO;2; Toribio RE, 2003, J MOL ENDOCRINOL, V31, P609, DOI 10.1677/jme.0.0310609; Toribio RE, 2001, AM J VET RES, V62, P938, DOI 10.2460/ajvr.2001.62.938; Venkatesh B, 2014, CRIT CARE, V18, DOI 10.1186/cc13863; Waldron JL, 2013, J CLIN PATHOL, V66, P620, DOI 10.1136/jclinpath-2012-201301; Watkins RR, 2011, J INFECTION, V63, P321, DOI 10.1016/j.jinf.2011.07.002	48	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127684	10.1371/journal.pone.0127684	http://dx.doi.org/10.1371/journal.pone.0127684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046642	gold, Green Submitted, Green Published			2022-12-26	WOS:000355652200025
J	Majaneva, M; Hyytiainen, K; Varvio, SL; Nagai, S; Blomster, J				Majaneva, Markus; Hyytiainen, Kirsi; Varvio, Sirkka Liisa; Nagai, Satoshi; Blomster, Jaanika			Bioinformatic Amplicon Read Processing Strategies Strongly Affect Eukaryotic Diversity and the Taxonomic Composition of Communities	PLOS ONE			English	Article							RARE BIOSPHERE; SPECIES RICHNESS; SEQUENCES; WRINKLES; SEARCH; FUNGI; UNITS	Amplicon read sequencing has revolutionized the field of microbial diversity studies. The technique has been developed for bacterial assemblages and has undergone rigorous testing with mock communities. However, due to the great complexity of eukaryotes and the numbers of different rDNA copies, analyzing eukaryotic diversity is more demanding than analyzing bacterial or mock communities, so studies are needed that test the methods of analyses on taxonomically diverse natural communities. In this study, we used 20 samples collected from the Baltic Sea ice, slush and under-ice water to investigate three program packages (UPARSE, mothur and QIIME) and 18 different bioinformatic strategies implemented in them. Our aim was to assess the impact of the initial steps of bioinformatic strategies on the results when analyzing natural eukaryotic communities. We found significant differences among the strategies in resulting read length, number of OTUs and estimates of diversity as well as clear differences in the taxonomic composition of communities. The differences arose mainly because of the variable number of chimeric reads that passed the pre-processing steps. Singleton removal and denoising substantially lowered the number of errors. Our study showed that the initial steps of the bioinformatic amplicon read processing strategies require careful consideration before applying them to eukaryotic communities.	[Majaneva, Markus; Hyytiainen, Kirsi; Blomster, Jaanika] Univ Helsinki, Dept Environm Sci, Helsinki, Finland; [Majaneva, Markus; Hyytiainen, Kirsi] Univ Helsinki, Tvarminne Zool Stn, Hango, Finland; [Varvio, Sirkka Liisa] Univ Helsinki, Dept Math & Stat, Helsinki, Finland; [Nagai, Satoshi] Natl Res Inst Fisheries Sci, Res Ctr Aquat Genom, Yokohama, Kanagawa, Japan	University of Helsinki; University of Helsinki; University of Helsinki; Japan Fisheries Research & Education Agency (FRA)	Majaneva, M (corresponding author), Univ Helsinki, Dept Environm Sci, Helsinki, Finland.	markus.majaneva@gmail.com		Blomster, Jaanika/0000-0003-1347-7919; Majaneva, Markus/0000-0003-3884-2548	Walter and Andree de Nottbeck Foundation; University of Helsinki 3-year grant; Onni Talas Foundation	Walter and Andree de Nottbeck Foundation; University of Helsinki 3-year grant; Onni Talas Foundation	This work was supported by Walter and Andree de Nottbeck Foundation (MM), University of Helsinki 3-year grant (JB, MM, KH) and Onni Talas Foundation (KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RI, 2013, MICROB ECOL, V66, P735, DOI 10.1007/s00248-013-0266-4; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashelford KE, 2005, APPL ENVIRON MICROB, V71, P7724, DOI 10.1128/AEM.71.12.7724-7736.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Bachy C, 2013, ISME J, V7, P244, DOI 10.1038/ismej.2012.106; Behnke A, 2011, ENVIRON MICROBIOL, V13, P340, DOI 10.1111/j.1462-2920.2010.02332.x; Behnke A, 2010, FEMS MICROBIOL ECOL, V72, P89, DOI 10.1111/j.1574-6941.2010.00836.x; Bragg L, 2012, NAT METHODS, V9, P425, DOI 10.1038/nmeth.1990; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Caron DA, 2009, APPL ENVIRON MICROB, V75, P5797, DOI 10.1128/AEM.00298-09; Cermeno P, 2013, MAR ECOL PROG SER, V488, P1, DOI 10.3354/meps10443; Comeau AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027492; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edgcomb V, 2011, ISME J, V5, P1344, DOI 10.1038/ismej.2011.6; Egge E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074371; Epstein S, 2008, BIODIVERS CONSERV, V17, P261, DOI 10.1007/s10531-007-9250-y; Erlich Y, 2008, NAT METHODS, V5, P679, DOI 10.1038/nmeth.1230; Fenchel T, 1997, OIKOS, V80, P220, DOI 10.2307/3546589; Finlay BJ, 2004, PROTIST, V155, P237, DOI 10.1078/143446104774199619; Finlay BJ, 1999, PROTIST, V150, P419, DOI 10.1016/S1434-4610(99)70042-8; Gaspar JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060458; Gong J, 2013, PROTIST, V164, P369, DOI 10.1016/j.protis.2012.11.006; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lie AAY, 2014, APPL ENVIRON MICROB, V80, P4363, DOI 10.1128/AEM.00057-14; Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x; Lucking R, 2014, J MOL EVOL, V78, P148, DOI 10.1007/s00239-013-9603-y; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; Maggs CA, 1996, J PHYCOL, V32, P176, DOI 10.1111/j.0022-3646.1996.00176.x; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; Majaneva M, 2012, POLAR BIOL, V35, P875, DOI 10.1007/s00300-011-1132-9; May A, 2014, BIOINFORMATICS, V30, P1530, DOI 10.1093/bioinformatics/btu085; Mohamed DJ, 2011, ISME J, V5, P379, DOI 10.1038/ismej.2010.137; Moon-van der Staay SY, 2001, NATURE, V409, P607, DOI 10.1038/35054541; Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0; Nebel M, 2011, ENV MICROBIOL REP, V3, P154, DOI 10.1111/j.1758-2229.2010.00200.x; NICKRENT DL, 1991, NUCLEIC ACIDS RES, V19, P227, DOI 10.1093/nar/19.2.227; Nilsson RH, 2010, MOL ECOL RESOUR, V10, P1076, DOI 10.1111/j.1755-0998.2010.02850.x; Nishitani G, 2012, APPL ENVIRON MICROB, V78, P813, DOI 10.1128/AEM.06544-11; Prokopowich CD, 2003, GENOME, V46, P48, DOI 10.1139/G02-103; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rodriguez-Ramos T, 2014, J PLANKTON RES, V36, P334, DOI 10.1093/plankt/fbt115; Santoferrara LF, 2014, ENVIRON MICROBIOL, V16, P2752, DOI 10.1111/1462-2920.12380; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Stoeck T, 2014, ENVIRON MICROBIOL, V16, P430, DOI 10.1111/1462-2920.12194; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Unterseher M, 2011, MOL ECOL, V20, P275, DOI 10.1111/j.1365-294X.2010.04948.x; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; Wuyts J, 2000, NUCLEIC ACIDS RES, V28, P4698, DOI 10.1093/nar/28.23.4698; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	63	47	49	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0130035	10.1371/journal.pone.0130035	http://dx.doi.org/10.1371/journal.pone.0130035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047335	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200170
J	Bhat, HB; Ishitsuka, R; Inaba, T; Murate, M; Abe, M; Makino, A; Kohyama-Koganeya, A; Nagao, K; Kurahashi, A; Kishimoto, T; Tahara, M; Yamano, A; Nagamune, K; Hirabayashi, Y; Juni, N; Umeda, M; Fujimori, F; Nishibori, K; Yamaji-Hasegawa, A; Greimel, P; Kobayashi, T				Bhat, Hema Balakrishna; Ishitsuka, Reiko; Inaba, Takehiko; Murate, Motohide; Abe, Mitsuhiro; Makino, Asami; Kohyama-Koganeya, Ayako; Nagao, Kohjiro; Kurahashi, Atsushi; Kishimoto, Takuma; Tahara, Michiru; Yamano, Akinori; Nagamune, Kisaburo; Hirabayashi, Yoshio; Juni, Naoto; Umeda, Masato; Fujimori, Fumihiro; Nishibori, Kozo; Yamaji-Hasegawa, Akiko; Greimel, Peter; Kobayashi, Toshihide			Evaluation of aegerolysins as novel tools to detect and visualize ceramide phosphoethanolamine, a major sphingolipid in invertebrates	FASEB JOURNAL			English	Article						lipid binding protein; membrane lipids; poreforming toxins	RICH MEMBRANE DOMAINS; LIPID DOMAINS; PLEUROTUS-ERYNGII; EDIBLE MUSHROOM; SPHINGOMYELIN; CHOLESTEROL; BINDING; DROSOPHILA; REVEALS; PROTEIN	Ceramide phosphoethanolamine (CPE), a sphingomyelin analog, is a major sphingolipid in invertebrates and parasites, whereas only trace amounts are present in mammalian cells. In this study, mushroom-derived proteins of the aegerolysin family-pleurotolysin A2 (PlyA2; K-D = 12 nM), ostreolysin (Oly; K-D = 1.3 nM), and erylysin A (EryA; K-D = 1.3 nM)-strongly associated with CPE/cholesterol (Chol)-containing membranes, whereas their low affinity to sphingomyelin/Chol precluded establishment of the binding kinetics. Binding specificity was determined by multilamellar liposome binding assays, supported bilayer assays, and solid-phase studies against a series of neutral and negatively charged lipid classes mixed 1:1 with Chol or phosphatidylcholine. No cross-reactivity was detected with phosphatidylethanolamine. Only PlyA2 also associated with CPE, independent of Chol content (K-D = 41 mu M), rendering it a suitable tool for visualizing CPE in lipid-blotting experiments and biologic samples from sterol auxotrophic organisms. Visualization of CPE enrichment in the CNS of Drosophila larvae (by PlyA2) and in the bloodstream form of the parasite Trypanosoma brucei (by EryA) by fluorescence imaging demonstrated the versatility of aegerolysin family proteins as efficient tools for detecting and visualizing CPE.	[Bhat, Hema Balakrishna; Ishitsuka, Reiko; Inaba, Takehiko; Murate, Motohide; Abe, Mitsuhiro; Makino, Asami; Kishimoto, Takuma; Yamaji-Hasegawa, Akiko; Greimel, Peter; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama 3510198, Japan; [Kohyama-Koganeya, Ayako; Hirabayashi, Yoshio] RIKEN, Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama 3510198, Japan; [Nagao, Kohjiro; Juni, Naoto; Umeda, Masato] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto, Japan; [Kurahashi, Atsushi; Nishibori, Kozo] Yukiguni Maitake Co Ltd, Niigata, Japan; [Tahara, Michiru; Nagamune, Kisaburo] Natl Inst Infect Dis, Dept Parasitol, Tokyo, Japan; [Yamano, Akinori; Nagamune, Kisaburo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Nagamune, Kisaburo] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki 305, Japan; [Fujimori, Fumihiro] Tokyo Kasei Univ, Fac Human Life Sci, Dept Environm Sci & Educ, Tokyo, Japan; [Kobayashi, Toshihide] Univ Lyon 1, INSERM, U1060, F-69622 Villeurbanne, France	RIKEN; RIKEN; Kyoto University; National Institute of Infectious Diseases (NIID); University of Tsukuba; University of Tsukuba; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Kobayashi, T (corresponding author), RIKEN, Lipid Biol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kobayasi@riken.jp	KOBAYASHI, TOSHIHIDE/S-8313-2019; 香山, 綾子/ABF-4396-2021; Abe, Mitsuhiro/C-3602-2017; Kishimoto, Takuma/AAP-1813-2021	KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; 香山, 綾子/0000-0002-7632-7953; Inaba, Takehiko/0000-0002-8770-4662; Hirabayashi, Yoshio/0000-0002-5774-7354; Murate, Motohide/0000-0001-5715-7947; Kurahashi, Atsushi/0000-0003-4427-193X; Abe, Mitsuhiro/0000-0002-6244-1771; Greimel, Peter/0000-0002-4931-6183	Integrated Lipidology Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan [24790104, 23590251, 23790115, 24770135, 22390018, 25293015]; Naito Foundation; Grants-in-Aid for Scientific Research [15H04726] Funding Source: KAKEN	Integrated Lipidology Program of RIKEN; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Integrated Lipidology Program of RIKEN; and by Grants in Aid for Scientific Research 24790104 (to R.I.), 23590251 (to M.M.), 23790115 (to A.M.), 24770135 (to T.Ki.), and 22390018 and 25293015 (to T.Ko.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and by the Naito Foundation.	Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Abeytunga DTU, 2004, J LIPID RES, V45, P1221, DOI 10.1194/jlr.M300392-JLR200; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Ghosh A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003980; HORI T, 1967, J BIOCHEM-TOKYO, V62, P67, DOI 10.1093/oxfordjournals.jbchem.a128637; Hursey B. S., 1995, World Animal Review, P67; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Ishitsuka R, 2011, J LIPID RES, V52, P2084, DOI 10.1194/jlr.D018184; Karlsson R, 2006, ANAL BIOCHEM, V349, P136, DOI 10.1016/j.ab.2005.09.034; Kellermann MY, 2012, ORG GEOCHEM, V43, P112, DOI 10.1016/j.orggeochem.2011.10.005; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Kraut R, 2011, J NEUROCHEM, V116, P764, DOI 10.1111/j.1471-4159.2010.07022.x; KUZOE FAS, 1993, ACTA TROP, V54, P153, DOI 10.1016/0001-706X(93)90089-T; Lebars I, 2008, NUCLEIC ACIDS RES, V36, P7146, DOI 10.1093/nar/gkn831; Lukoyanova N, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002049; Makino A, 2015, FASEB J, V29, P477, DOI 10.1096/fj.13-247585; Murate M, 2015, J CELL SCI, V128, P1627, DOI 10.1242/jcs.163105; Murate M, 2010, BIOCHEMISTRY-US, V49, P4732, DOI 10.1021/bi100007u; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; O'Connor J. D, 1970, Biochim. biophys. Acta, V202, P195, DOI 10.1016/0005-2760(70)90234-1; Sepcic K, 2004, FEBS LETT, V575, P81, DOI 10.1016/j.febslet.2004.07.093; Shibata T, 2010, TOXICON, V56, P1436, DOI 10.1016/j.toxicon.2010.08.010; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Skocaj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092783; Sutterwala SS, 2008, MOL MICROBIOL, V70, P281, DOI 10.1111/j.1365-2958.2008.06393.x; Ternes P, 2009, J LIPID RES, V50, P2270, DOI 10.1194/jlr.M900230-JLR200; Terova B, 2005, BIOPHYS J, V88, P2661, DOI 10.1529/biophysj.104.058149; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; Vacaru AM, 2013, J BIOL CHEM, V288, P11520, DOI 10.1074/jbc.M113.460972; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Weber DK, 2015, BIOPHYS J, V108, P1987, DOI 10.1016/j.bpj.2015.03.024; WHITE DC, 1969, BIOCHIM BIOPHYS ACTA, V187, P527, DOI 10.1016/0005-2760(69)90050-2; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; YANG TK, 1974, LIPIDS, V9, P1009, DOI 10.1007/BF02533827	40	36	36	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3920	3934		10.1096/fj.15-272112	http://dx.doi.org/10.1096/fj.15-272112			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26060215				2022-12-26	WOS:000359915600027
J	McLaughlin, JE; Bin-Umer, MA; Widiez, T; Finn, D; McCormick, S; Tumer, NE				McLaughlin, John E.; Bin-Umer, Mohamed Anwar; Widiez, Thomas; Finn, Daniel; McCormick, Susan; Tumer, Nilgun E.			A Lipid Transfer Protein Increases the Glutathione Content and Enhances Arabidopsis Resistance to a Trichothecene Mycotoxin	PLOS ONE			English	Article							FUSARIUM HEAD BLIGHT; CELL-DEATH; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; UDP-GLUCOSYLTRANSFERASE; DEFENSE RESPONSES; REDUCED VIRULENCE; GIBBERELLA-ZEAE; GENE-EXPRESSION; DEOXYNIVALENOL	Fusarium head blight (FHB) or scab is one of the most important plant diseases worldwide, affecting wheat, barley and other small grains. Trichothecene mycotoxins such as deoxynivalenol (DON) accumulate in the grain, presenting a food safety risk and health hazard to humans and animals. Despite considerable breeding efforts, highly resistant wheat or barley cultivars are not available. We screened an activation tagged Arabidopsis thaliana population for resistance to trichothecin (Tcin), a type B trichothecene in the same class as DON. Here we show that one of the resistant lines identified, trichothecene resistant 1 (trr1) contains a T-DNA insertion upstream of two nonspecific lipid transfer protein (nsLTP) genes, AtLTP4.4 and AtLTP4.5. Expression of both nsLTP genes was induced in trr1 over 10-fold relative to wild type. Overexpression of AtLTP4.4 provided greater resistance to Tcin than AtLTP4.5 in Arabidopsis thaliana and in Saccharomyces cerevisiae relative to wild type or vector transformed lines, suggesting a conserved protection mechanism. Tcin treatment increased reactive oxygen species (ROS) production in Arabidopsis and ROS stain was associated with the chloroplast, the cell wall and the apoplast. ROS levels were attenuated in Arabidopsis and in yeast overexpressing AtLTP4.4 relative to the controls. Exogenous addition of glutathione and other antioxidants enhanced resistance of Arabidopsis to Tcin while the addition of buthionine sulfoximine, an inhibitor of glutathione synthesis, increased sensitivity, suggesting that resistance was mediated by glutathione. Total glutathione content was significantly higher in Arabidopsis and in yeast overexpressing AtLTP4.4 relative to the controls, highlighting the importance of AtLTP4.4 in maintaining the redox state. These results demonstrate that trichothecenes cause ROS accumulation and overexpression of AtLTP4.4 protects against trichothecene-induced oxidative stress by increasing the glutathione-based antioxidant defense.	[McLaughlin, John E.; Bin-Umer, Mohamed Anwar; Widiez, Thomas; Finn, Daniel; Tumer, Nilgun E.] Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA; [McCormick, Susan] Agr Res Serv, Bacterial Foodborne Pathogens & Mycol Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL USA	Rutgers State University New Brunswick; United States Department of Agriculture (USDA)	Tumer, NE (corresponding author), Rutgers State Univ, Sch Environm & Biol Sci, Dept Plant Biol & Pathol, New Brunswick, NJ 08903 USA.	tumer@aesop.rutgers.edu	McLaughlin, John/AAE-5024-2019; WIDIEZ, Thomas/AAC-8313-2021	McLaughlin, John/0000-0003-4511-6202; WIDIEZ, Thomas/0000-0001-6002-2306; McCormick, Susan/0000-0002-7824-6372	United States Department of Agriculture [59-0206-1-121]; United States Wheat and Barley Scab initiative; National Institutes of Health [S10RR025424]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025424] Funding Source: NIH RePORTER	United States Department of Agriculture(United States Department of Agriculture (USDA)); United States Wheat and Barley Scab initiative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This is a cooperative project No. 59-0206-1-121 supported by the United States Department of Agriculture in cooperation with the United States Wheat and Barley Scab initiative and by the National Institutes of Health Grant S10RR025424 to Nilgun E. Tumer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari KI, 2014, TOXINS, V6, P679, DOI 10.3390/toxins6020679; Arunachalam C, 2013, TOXICOL LETT, V217, P149, DOI 10.1016/j.toxlet.2012.12.003; Audenaert K, 2014, TOXINS, V6, P1, DOI 10.3390/toxins6010001; Audenaert K, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-112; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; Bin-Umer MA, 2014, P NATL ACAD SCI USA, V111, P11798, DOI 10.1073/pnas.1403145111; Bin-Umer MA, 2011, TOXINS, V3, P1484, DOI 10.3390/toxins3121484; Boutrot F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-86; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Bushnell WR, 2010, PHYTOPATHOLOGY, V100, P33, DOI 10.1094/PHYTO-100-1-0033; Champigny MJ, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00230; Chen RQ, 2009, CELL RES, V19, P1377, DOI 10.1038/cr.2009.117; CUNDLIFFE E, 1974, P NATL ACAD SCI USA, V71, P30, DOI 10.1073/pnas.71.1.30; De Coninck B, 2013, J EXP BOT, V64, P5297, DOI 10.1093/jxb/ert295; Desjardins AE, 1996, MOL PLANT MICROBE IN, V9, P775, DOI 10.1094/MPMI-9-0775; DESJARDINS AE, 1993, MICROBIOL REV, V57, P595, DOI 10.1128/MMBR.57.3.595-604.1993; Desjardins AE, 2007, J AGR FOOD CHEM, V55, P6487, DOI 10.1021/jf0709193; Desmond OJ, 2008, MOL PLANT PATHOL, V9, P435, DOI 10.1111/J.1364-3703.2008.00475.X; Di R, 2005, MOL PLANT MICROBE IN, V18, P762, DOI 10.1094/MPMI-18-0762; Di R, 2010, PLANT SCI, V178, P374, DOI 10.1016/j.plantsci.2010.02.003; Ding LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019008; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Foroud NA, 2009, INT J MOL SCI, V10, P147, DOI 10.3390/ijms10010147; FRIED HM, 1981, P NATL ACAD SCI-BIOL, V78, P238, DOI 10.1073/pnas.78.1.238; Fruhmann P, 2014, ORG BIOMOL CHEM, V12, P5144, DOI 10.1039/c4ob00458b; Gardiner DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-289; Gardiner SA, 2010, MOL PLANT MICROBE IN, V23, P962, DOI 10.1094/MPMI-23-7-0962; Gossett DR, 1996, PLANT PHYSIOL, V112, P803, DOI 10.1104/pp.112.2.803; Harris LJ, 2001, PHYSIOL MOL PLANT P, V58, P173, DOI 10.1006/pmpp.2001.0326; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Jung HW, 2003, PLANT CELL ENVIRON, V26, P915, DOI 10.1046/j.1365-3040.2003.01024.x; Kader JC, 1996, ANNU REV PLANT PHYS, V47, P627, DOI 10.1146/annurev.arplant.47.1.627; Kluger B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119656; Kluger B, 2013, ANAL BIOANAL CHEM, V405, P5031, DOI 10.1007/s00216-012-6483-8; Kolb FL, 2001, CROP SCI, V41, P611, DOI 10.2135/cropsci2001.413611x; Lemmens M, 2005, MOL PLANT MICROBE IN, V18, P1318, DOI 10.1094/MPMI-18-1318; Mahajan N, 2013, J BIOL CHEM, V288, P11611, DOI 10.1074/jbc.M112.410852; Maldonado AM, 2002, NATURE, V419, P399, DOI 10.1038/nature00962; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; McCormick S. P, 2013, PHYTOCHEMICALS PLANT, V42, P1; McLaughlin JE, 2009, P NATL ACAD SCI USA, V106, P21883, DOI 10.1073/pnas.0909777106; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; McMullen M, 2012, PLANT DIS, V96, P1712, DOI 10.1094/PDIS-03-12-0291-FE; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Nomura H, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1926; Pestka JJ, 2010, TOXINS, V2, P1300, DOI 10.3390/toxins2061300; Ponts N, 2009, FEMS MICROBIOL LETT, V293, P255, DOI 10.1111/j.1574-6968.2009.01521.x; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Poppenberger B, 2003, J BIOL CHEM, V278, P47905, DOI 10.1074/jbc.M307552200; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Sarowar S, 2009, PLANT CELL REP, V28, P419, DOI 10.1007/s00299-008-0653-3; Schweiger W, 2013, MOL PLANT PATHOL, V14, P772, DOI 10.1111/mpp.12048; Shin S, 2012, J EXP BOT, V63, P4731, DOI 10.1093/jxb/ers141; Singer T, 2003, METH MOL B, V236, P241; Walter Stephanie, 2011, Mycotoxin Res, V27, P221, DOI 10.1007/s12550-011-0099-2; Wegulo SN, 2011, PLANT DIS, V95, P554, DOI 10.1094/PDIS-07-10-0495; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; WICKNER RB, 1982, P NATL ACAD SCI-BIOL, V79, P4706, DOI 10.1073/pnas.79.15.4706; Wu F, 2014, ANNU REV FOOD SCI T, V5, P351, DOI 10.1146/annurev-food-030713-092431; Xing FQ, 2013, FEBS LETT, V587, P2164, DOI 10.1016/j.febslet.2013.05.034; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zhang B, 2014, PLANT J, V77, P185, DOI 10.1111/tpj.12376; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zurbriggen MD, 2009, PLANT J, V60, P962, DOI 10.1111/j.1365-313X.2009.04010.x	64	21	23	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0130204	10.1371/journal.pone.0130204	http://dx.doi.org/10.1371/journal.pone.0130204			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057253	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000082
J	Shields, EJ; Lam, CJ; Cox, AR; Rankin, MM; Van Winkle, TJ; Hess, RS; Kushner, JA				Shields, Emily J.; Lam, Carol J.; Cox, Aaron R.; Rankin, Matthew M.; Van Winkle, Thomas J.; Hess, Rebecka S.; Kushner, Jake A.			Extreme Beta-Cell Deficiency in Pancreata of Dogs with Canine Diabetes	PLOS ONE			English	Article							SUSCEPTIBILITY GENES; CHRONIC-PANCREATITIS; YOUNG-DOGS; MELLITUS; PROLIFERATION; ONSET; HAPLOTYPES; HISTORY; DISEASE; ISLETS	The pathophysiology of canine diabetes remains poorly understood, in part due to enigmatic clinical features and the lack of detailed histopathology studies. Canine diabetes, similar to human type 1 diabetes, is frequently associated with diabetic ketoacidosis at onset or after insulin omission. However, notable differences exist. Whereas human type 1 diabetes often occurs in children, canine diabetes is typically described in middle age to elderly dogs. Many competing theories have been proposed regarding the underlying cause of canine diabetes, from pancreatic atrophy to chronic pancreatitis to autoimmune mediated beta-cell destruction. It remains unclear to what extent beta-cell loss contributes to canine diabetes, as precise quantifications of islet morphometry have not been performed. We used high-throughput microscopy and automated image processing to characterize islet histology in a large collection of pancreata of diabetic dogs. Diabetic pancreata displayed a profound reduction in beta-cells and islet endocrine cells. Unlike humans, canine non-diabetic islets are largely comprised of beta-cells. Very few beta-cells remained in islets of diabetic dogs, even in pancreata from new onset cases. Similarly, total islet endocrine cell number was sharply reduced in diabetic dogs. No compensatory proliferation or lymphocyte infiltration was detected. The majority of pancreata had no evidence of pancreatitis. Thus, canine diabetes is associated with extreme beta-cell deficiency in both new and longstanding disease. The beta-cell predominant composition of canine islets and the near-total absence of beta-cells in new onset elderly diabetic dogs strongly implies that similar to human type 1 diabetes, beta-cell loss underlies the pathophysiology of canine diabetes.	[Shields, Emily J.; Lam, Carol J.; Cox, Aaron R.; Kushner, Jake A.] Texas Childrens Hosp, Baylor Coll Med, McNair Med Inst, Pediat Diabet & Endocrinol, Houston, TX 77030 USA; [Rankin, Matthew M.] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Pediat Endocrinol & Diabet, Philadelphia, PA 19104 USA; [Van Winkle, Thomas J.; Hess, Rebecka S.] Univ Penn, Sch Vet Med, Matthew J Ryan Vet Hosp, Philadelphia, PA 19104 USA	Baylor College of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Kushner, JA (corresponding author), Texas Childrens Hosp, Baylor Coll Med, McNair Med Inst, Pediat Diabet & Endocrinol, Houston, TX 77030 USA.	kushner@bcm.edu	Kushner, Jake A/AAF-5049-2022; Kushner, Jake A/AFJ-8198-2022	Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744	NIH [1R01AG040110, NCI P30-CA125123]; Robert and Janice McNair Foundation; Pathology and Histology Core at Baylor College of Medicine; Diabetes Research Center of the Baylor College of Medicine [DRC-P30DK079638]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040110] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert and Janice McNair Foundation; Pathology and Histology Core at Baylor College of Medicine; Diabetes Research Center of the Baylor College of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the NIH (1R01AG040110), the Robert and Janice McNair Foundation, by the Pathology and Histology Core at Baylor College of Medicine with funding from the NIH (NCI P30-CA125123) and by the Diabetes Research Center of the Baylor College of Medicine (DRC-P30DK079638).	Ahlgren KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105473; ALEJANDRO R, 1988, J AM VET MED ASSOC, V193, P1050; ATKINS CE, 1988, AM J VET RES, V49, P1577; Atkinson MJ, 2009, MED RADIOL RADIAT ON, P1, DOI 10.1007/978-3-540-74386-6_1; Brenner K, 2009, J VET INTERN MED, V23, P67, DOI 10.1111/j.1939-1676.2008.0214.x; Catchpole B, 2008, J SMALL ANIM PRACT, V49, P4, DOI 10.1111/j.1748-5827.2007.00398.x; Catchpole B, 2005, DIABETOLOGIA, V48, P1948, DOI 10.1007/s00125-005-1921-1; Catchpole B, 2013, VET J, V195, P139, DOI 10.1016/j.tvjl.2012.11.013; COTTON RB, 1971, J AM VET MED ASSOC, V159, P863; Davison LJ, 2008, VET IMMUNOL IMMUNOP, V126, P83, DOI 10.1016/j.vetimm.2008.06.016; Davison LJ, 2005, VET REC, V156, P467, DOI 10.1136/vr.156.15.467; Fall T, 2010, J VET INTERN MED, V24, P1322, DOI 10.1111/j.1939-1676.2010.0630.x; FOULIS AK, 1984, DIABETOLOGIA, V26, P456; Gardner DSL, 2012, DIABETES METAB SYNDR, V5, P101, DOI 10.2147/DMSO.S23353; Gepts W, 1967, Diabetologia, V3, P249, DOI 10.1007/BF01222202; Guptill L, 2003, VET J, V165, P240, DOI 10.1016/S1090-0233(02)00242-3; HAWKINS KL, 1987, VET PATHOL, V24, P170, DOI 10.1177/030098588702400211; Hess RS, 2000, J AM VET MED ASSOC, V217, P1166, DOI 10.2460/javma.2000.217.1166; Hess RS, 2000, J AM VET MED ASSOC, V216, P1414, DOI 10.2460/javma.2000.216.1414; HOENIG M, 1992, VET IMMUNOL IMMUNOP, V32, P195, DOI 10.1016/0165-2427(92)90046-S; Hume DZ, 2006, J VET INTERN MED, V20, P547, DOI 10.1892/0891-6640(2006)20[547:OODWDK]2.0.CO;2; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P467, DOI 10.1111/j.1399-0039.2006.00716.x; KRAMER JW, 1980, DIABETES, V29, P558, DOI 10.2337/diabetes.29.7.558; Mansfield C, 2012, TOP COMPANION ANIM M, V27, P123, DOI 10.1053/j.tcam.2012.04.003; Mattin M, 2014, VET REC, V174, P349, DOI 10.1136/vr.101950; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Minkus G, 1997, VET PATHOL, V34, P164, DOI 10.1177/030098589703400212; Nelson RW, 2014, J ENDOCRINOL, V222, pT1, DOI 10.1530/JOE-14-0202; Pugliese A, 2014, PEDIATR DIABETES, V15, P1, DOI 10.1111/pedi.12097; Rankin MM, 2013, DIABETES, V62, P1634, DOI 10.2337/db12-0848; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Riedel MJ, 2012, DIABETOLOGIA, V55, P372, DOI 10.1007/s00125-011-2344-9; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Seddon JM, 2010, TISSUE ANTIGENS, V75, P218, DOI 10.1111/j.1399-0039.2009.01426.x; Short AD, 2010, TISSUE ANTIGENS, V75, P242, DOI 10.1111/j.1399-0039.2009.01434.x; Short AD, 2007, J HERED, V98, P518, DOI 10.1093/jhered/esm048; Son WC, 2010, TOXICOL LETT, V193, P179, DOI 10.1016/j.toxlet.2010.01.005; Spijker HS, 2013, DIABETES, V62, P2471, DOI 10.2337/db12-1001; Sreenan S, 1999, DIABETES, V48, P989, DOI 10.2337/diabetes.48.5.989; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; WARWICK WJ, 1963, CAN J COMP MED VET S, V27, P215; Watson PJ, 2011, J VET INTERN MED, V25, P797, DOI 10.1111/j.1939-1676.2011.0744.x; Watson P, 2012, TOP COMPANION ANIM M, V27, P133, DOI 10.1053/j.tcam.2012.04.006; Westermarck E, 2012, TOP COMPANION ANIM M, V27, P96, DOI 10.1053/j.tcam.2012.05.002	46	21	21	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129809	10.1371/journal.pone.0129809	http://dx.doi.org/10.1371/journal.pone.0129809			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057531	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000074
J	Borg, O; Casanova, R; Bootsma, RJ				Borg, Olivier; Casanova, Remy; Bootsma, Reinoud J.			Reading from a Head-Fixed Display during Walking: Adverse Effects of Gaze Stabilization Mechanisms	PLOS ONE			English	Article							VISUAL-VESTIBULAR INTERACTION; HUMAN VESTIBULOOCULAR REFLEX; EYE-MOVEMENTS; VIEWING DISTANCE; SMOOTH-PURSUIT; CONTRAST SENSITIVITY; TARGET DISTANCE; ROTATION; VISION; MICROSACCADES	Reading performance during standing and walking was assessed for information presented on earth-fixed and head-fixed displays by determining the minimal duration during which a numerical time stimulus needed to be presented for 50% correct naming answers. Reading from the earth-fixed display was comparable during standing and walking, with optimal performance being attained for visual character sizes in the range of 0.2 degrees to 1 degrees. Reading from the head-fixed display was impaired for small (0.2-0.3 degrees) and large (5 degrees) visual character sizes, especially during walking. Analysis of head and eye movements demonstrated that retinal slip was larger during walking than during standing, but remained within the functional acuity range when reading from the earth-fixed display. The detrimental effects on performance of reading from the head-fixed display during walking could be attributed to loss of acuity resulting from large retinal slip. Because walking activated the angular vestibulo-ocular reflex, the resulting compensatory eye movements acted to stabilize gaze on the information presented on the earth-fixed display but destabilized gaze from the information presented on the head-fixed display. We conclude that the gaze stabilization mechanisms that normally allow visual performance to be maintained during physical activity adversely affect reading performance when the information is presented on a display attached to the head.	[Borg, Olivier; Casanova, Remy; Bootsma, Reinoud J.] Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France; [Borg, Olivier] Oxylane R&D, Villeneuve Dascq, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Bootsma, RJ (corresponding author), Aix Marseille Univ, CNRS, Inst Sci Mouvement, Marseille, France.	reinoud.bootsma@univ-amu.fr	casanova, remy/U-3603-2017; Bootsma, Reinoud/B-1254-2008; casanova, rémy/AGK-6933-2022; Casanova, Remy/GSO-3393-2022	casanova, remy/0000-0002-7101-8043; Bootsma, Reinoud/0000-0002-3719-7586; casanova, rémy/0000-0002-7101-8043; 	Oxylane RD	Oxylane RD	Oxylane R&D provided support in the form of salary for author OB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES GR, 1993, PROG NEUROBIOL, V41, P435, DOI 10.1016/0301-0082(93)90026-O; Barnes GR, 2000, J NEUROPHYSIOL, V84, P2340, DOI 10.1152/jn.2000.84.5.2340; Borg O, 2015, DISPLAYS, V36, P30, DOI 10.1016/j.displa.2014.11.003; BURR DC, 1982, VISION RES, V22, P479, DOI 10.1016/0042-6989(82)90196-1; CARL JR, 1987, J NEUROPHYSIOL, V57, P1446, DOI 10.1152/jn.1987.57.5.1446; Chung STL, 1998, VISION RES, V38, P2949, DOI 10.1016/S0042-6989(98)00072-8; Clarke F.J.J, 1957, J MOD OPTIC, V4, P69; CLARKE FJJ, 1962, VISION RES, V2, P53, DOI 10.1016/0042-6989(62)90063-9; Collewijn H, 2000, J NEUROPHYSIOL, V84, P376, DOI 10.1152/jn.2000.84.1.376; COLLEWIJN H, 1981, ANN NY ACAD SCI, V374, P312, DOI 10.1111/j.1749-6632.1981.tb30879.x; Costela FM, 2013, PEERJ, V1, DOI 10.7717/peerj.119; Crane BT, 1997, J NEUROPHYSIOL, V78, P2129, DOI 10.1152/jn.1997.78.4.2129; DAS VE, 1995, J NEUROPHYSIOL, V74, P624, DOI 10.1152/jn.1995.74.2.624; DAS VE, 1995, AVIAT SPACE ENVIR MD, V66, P728; Demer JL, 1996, J VESTIBUL RES-EQUIL, V6, P295, DOI 10.1016/0957-4271(96)00025-0; DITCHBURN RW, 1959, J PHYSIOL-LONDON, V145, P98, DOI 10.1113/jphysiol.1959.sp006130; Engbert R, 2006, P NATL ACAD SCI USA, V103, P7192, DOI 10.1073/pnas.0509557103; GAUTHIER GM, 1990, EXP BRAIN RES, V81, P150; GROSSMAN GE, 1989, J NEUROPHYSIOL, V62, P264, DOI 10.1152/jn.1989.62.1.264; GROSSMAN GE, 1988, EXP BRAIN RES, V70, P470; Han YH, 2005, EXP BRAIN RES, V165, P294, DOI 10.1007/s00221-005-2305-y; HERSE PR, 1989, OPTOMETRY VISION SCI, V66, P774, DOI 10.1097/00006324-198911000-00009; HINE T, 1987, VISION RES, V27, P1639, DOI 10.1016/0042-6989(87)90171-4; Hirasaki E, 1999, EXP BRAIN RES, V127, P117, DOI 10.1007/s002210050781; Howarth PA, 1997, DISPLAYS, V18, P107, DOI 10.1016/S0141-9382(97)00011-5; HUEBNER WP, 1992, J NEUROPHYSIOL, V68, P1775, DOI 10.1152/jn.1992.68.5.1775; Imai T, 2001, EXP BRAIN RES, V136, P1, DOI 10.1007/s002210000533; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; LEIGH RJ, 1994, ANN NEUROL, V36, P129, DOI 10.1002/ana.410360204; MAAS EF, 1989, BRAIN RES, V499, P153, DOI 10.1016/0006-8993(89)91145-1; Marigold DS, 2007, NEUROSCIENCE, V144, P302, DOI 10.1016/j.neuroscience.2006.09.006; Marigold DS, 2008, EXP BRAIN RES, V188, P23, DOI 10.1007/s00221-008-1335-7; Martinez-Conde S, 2006, NEURON, V49, P297, DOI 10.1016/j.neuron.2005.11.033; McCamy MB, 2012, J NEUROSCI, V32, P9194, DOI 10.1523/JNEUROSCI.0515-12.2012; Moore ST, 2001, ANN NY ACAD SCI, V942, P139; Moore ST, 1999, EXP BRAIN RES, V129, P347, DOI 10.1007/s002210050903; Paige GD, 1998, J NEUROPHYSIOL, V80, P2391, DOI 10.1152/jn.1998.80.5.2391; PAIGE GD, 1989, EXP BRAIN RES, V77, P585; PAIGE GD, 1991, ACTA OTO-LARYNGOL, P282; Peng GCY, 1996, BIOL CYBERN, V75, P309, DOI 10.1007/s004220050297; POZZO T, 1990, EXP BRAIN RES, V82, P97; RIGGS LA, 1953, J OPT SOC AM, V43, P495, DOI 10.1364/JOSA.43.000495; RIGGS LA, 1952, J OPT SOC AM, V42, P872; ROBINSON DA, 1986, BIOL CYBERN, V55, P43, DOI 10.1007/BF00363977; Rucci M, 2003, J VISION, V3, P852, DOI 10.1167/3.11.18; Rucci M, 2007, NATURE, V447, P851, DOI 10.1038/nature05866; SCHWARZ U, 1991, J NEUROPHYSIOL, V66, P851, DOI 10.1152/jn.1991.66.3.851; Snaterse M, 2011, J APPL PHYSIOL, V110, P1682, DOI 10.1152/japplphysiol.00536.2010; SNYDER LH, 1992, J NEUROPHYSIOL, V67, P861, DOI 10.1152/jn.1992.67.4.861; Telford L, 1998, EXP BRAIN RES, V118, P115, DOI 10.1007/s002210050261; Watamaniuk SNJ, 2003, J VISION, V3, P698, DOI 10.1167/3.11.5; Wellenius GA, 2000, EXP BRAIN RES, V133, P139, DOI 10.1007/s002210000369; Xiang YQ, 2008, J NEUROPHYSIOL, V100, P763, DOI 10.1152/jn.90256.2008; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Yu DY, 2007, J VISION, V7, DOI 10.1167/7.2.2; ZANGEMEISTER WH, 1981, EXP NEUROL, V71, P76, DOI 10.1016/0014-4886(81)90072-8	58	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129902	10.1371/journal.pone.0129902	http://dx.doi.org/10.1371/journal.pone.0129902			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053622	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300168
J	Chen, JW; Lao, FY; Chen, XW; Deng, HH; Liu, R; He, HY; Fu, C; Chen, YS; Liu, FY; Li, QW; Jackson, P; Aitken, K				Chen, Jian-wen; Lao, Fang-ye; Chen, Xi-wen; Deng, Hai-hua; Liu, Rui; He, Hui-yi; Fu, Cheng; Chen, Yong-sheng; Liu, Fu-ye; Li, Qi-wei; Jackson, Phillip; Aitken, Karen			DNA Marker Transmission and Linkage Analysis in Populations Derived from a Sugarcane (Saccharum spp.) x Erianthus arundinaceus Hybrid	PLOS ONE			English	Article							GENETIC-MAP; INTERGENERIC HYBRIDS; GENOME ANALYSIS; AFLP; IDENTIFICATION; CONSTRUCTION; CHROMOSOMES; DIVERSITY; GERMPLASM; COVERAGE	Introgression of Erianthus arundinaceus has been the focus of several sugarcane breeding programs in the world, because the species has desirable traits such as high biomass production, vigour, ratooning ability and good resistance to environmental stresses and disease. In this study four genetic maps were constructed for two intergeneric populations. The first population (BC1) was generated from a cross between an Erianthus/Saccharum hybrid YC96-40 and a commercial sugarcane variety CP84-1198. The second population (BC2) was generated from a cross between YCE01-116, a progeny of the BC1 cross and NJ57-416, a commercial sugarcane cultivar. Markers across both populations were generated using 35 AFLP and 23 SSR primer pairs. A total of 756 and 728 polymorphic markers were scored in the BC1 and BC2 populations, respectively. In the BC1 population, a higher proportion of markers was derived from the Erianthus ancestor than those from the Saccharum ancestor Badila. In the BC2 population, both the number and proportion of markers derived from Erianthus were approximately half of those in the BC1 population. Linkage analysis led to the construction of 38, 57, 36 and 47 linkage groups (LGs) for YC96-40, CP84-1198, YCE01-116, and NJ57-416, encompassing 116, 174, 97 and 159 markers (including single dose, double dose and bi-parental markers), respectively. These LGs could be further placed into four, five, five and six homology groups (HGs), respectively, based on information from multi-allelic SSR markers and repulsion phase linkages detected between LGs. Analysis of repulsion phase linkage indicated that Erianthus behaved like a true autopolyploid.	[Chen, Jian-wen; Lao, Fang-ye; Chen, Xi-wen; Deng, Hai-hua; Liu, Rui; He, Hui-yi; Fu, Cheng; Chen, Yong-sheng; Liu, Fu-ye; Li, Qi-wei] Guangzhou Sugarcane Ind Res Inst, Guangdong Key Lab Sugarcane Improvement & Biorefi, Guangzhou, Guangdong, Peoples R China; [Jackson, Phillip; Aitken, Karen] CSIRO Agr, Queensland Biosci Precinct, Brisbane, Qld, Australia	Guangdong Academy of Sciences; Institute of Nanfan & Seed Industry, Guangdong Academy of Sciences; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Li, QW (corresponding author), Guangzhou Sugarcane Ind Res Inst, Guangdong Key Lab Sugarcane Improvement & Biorefi, Guangzhou, Guangdong, Peoples R China.	liqiwei66@163.com; Phillip.Jackson@csiro.au	aitken, karen/I-5817-2012; Chen, Yongsheng/D-3256-2011	aitken, karen/0000-0003-4372-0721; Chen, Yongsheng/0000-0003-1448-8177	Chinese National Ministry of Science and Technology; Australian Centre for International Agricultural Research [CS1/2000/038]; Science and Technology planning project of Guangdong Province, China [2003C50215]; China Agriculture Research System [CARS-20-1-4]	Chinese National Ministry of Science and Technology; Australian Centre for International Agricultural Research; Science and Technology planning project of Guangdong Province, China; China Agriculture Research System	Chinese National Ministry of Science and Technology, the Australian Centre for International Agricultural Research (project CS1/2000/038); the Science and Technology planning project of Guangdong Province, China (2003C50215); and China Agriculture Research System (Grant No. CARS-20-1-4).	Aitken K, 2005, THEOR APPL GENET, V110, P789, DOI 10.1007/s00122-004-1813-7; Aitken KS, 2007, GENOME, V50, P742, DOI 10.1139/G07-056; Aitken KS, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-152; ALJANABI SM, 1993, GENETICS, V134, P1249; ALJANABI SM, 1994, THEOR APPL GENET, V89, P959, DOI 10.1007/BF00224524; Alwala S, 2008, EUPHYTICA, V164, P37, DOI 10.1007/s10681-007-9634-9; Besse P, 1997, GENOME, V40, P428, DOI 10.1139/g97-057; Butterfield M. K., 2001, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P1; Cai Q, 2005, PLANT BREEDING, V124, P322, DOI 10.1111/j.1439-0523.2005.01099.x; Cai Q, 2012, GENET RESOUR CROP EV, V59, P1483, DOI 10.1007/s10722-011-9776-4; D'Hont A, 1998, GENOME, V41, P221, DOI 10.1139/gen-41-2-221; Daniels SJ, 1987, SUGARCANE IMPROVEMEN, V11, P7, DOI DOI 10.1016/B978-0-444-42769-4.50007-2; DASILVA J, 1995, MOL BREEDING, V1, P165, DOI 10.1007/BF01249701; DASILVA JAG, 1993, GENOME, V36, P782, DOI 10.1139/g93-103; Deng HH, 2002, SUGARCANE CANESUGAR, V1, P1, DOI DOI 10.3969/J.ISSN.1005-9695.2002.01.001; DHONT A, 1995, THEOR APPL GENET, V91, P320, DOI 10.1007/BF00220894; DHont A, 1996, MOL GEN GENET, V250, P405, DOI [10.1007/BF02174028, 10.1007/s004380050092]; Garcia AAF, 2006, THEOR APPL GENET, V112, P298, DOI 10.1007/s00122-005-0129-6; Grivet L, 2002, CURR OPIN PLANT BIOL, V5, P122, DOI 10.1016/S1369-5266(02)00234-0; Hoarau JY, 2001, THEOR APPL GENET, V103, P84, DOI 10.1007/s001220000390; Hoisngton D, 1992, LAB PROTOCOLS; Lao FY, 2006, SUGARCANE CANESUGAR, V1, P6; Lee M, 1995, ADV AGRON, V55, P265, DOI 10.1016/S0065-2113(08)60542-8; Matsuo K, 2001, JIRCAS RES HIGHLIGHT, P12; Ming R, 2002, CROP SCI, V42, P570, DOI 10.2135/cropsci2002.0570; Ming R, 1998, GENETICS, V150, P1663; Mukherjee S. K, 1957, BOT GAZ, V119, P55, DOI DOI 10.1086/335962; Nair Narayana V., 2006, Cytologia (Tokyo), V71, P107, DOI 10.1508/cytologia.71.107; Piperidis G, 2000, GENOME, V43, P1033, DOI 10.1139/gen-43-6-1033; Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]; SANGUINETTI CJ, 1994, BIOTECHNIQUES, V17, P914; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Van Ooijen JW, 2004, JOINMAP 4 SOFTWARE C; WU KK, 1992, THEOR APPL GENET, V83, P294, DOI 10.1007/BF00224274; Xu Shao-Bin, 2002, Yichuan, V24, P335	36	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128865	10.1371/journal.pone.0128865	http://dx.doi.org/10.1371/journal.pone.0128865			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053338	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300063
J	Li, DD; Li, L; Luo, ZS; Mou, WS; Mao, LC; Ying, TJ				Li, Dongdong; Li, Li; Luo, Zisheng; Mou, Wangshu; Mao, Linchun; Ying, Tiejin			Comparative Transcriptome Analysis Reveals the Influence of Abscisic Acid on the Metabolism of Pigments, Ascorbic Acid and Folic Acid during Strawberry Fruit Ripening	PLOS ONE			English	Article							TOMATO FRUIT; FOLATE BIOFORTIFICATION; ARABIDOPSIS-THALIANA; NUTRITIONAL QUALITY; RNA-SEQ; BIOSYNTHESIS; PLANTS; ABA; ANTHOCYANINS; DEFICIENCY	A comprehensive investigation of abscisic acid (ABA) biosynthesis and its influence on other important phytochemicals is critical for understanding the versatile roles that ABA plays during strawberry fruit ripening. Using RNA-seq technology, we sampled strawberry fruit in response to ABA or nordihydroguaiaretic acid (NDGA; an ABA biosynthesis blocker) treatment during ripening and assessed the expression changes of genes involved in the metabolism of pigments, ascorbic acid (AsA) and folic acid in the receptacles. The transcriptome analysis identified a lot of genes differentially expressed in response to ABA or NDGA treatment. In particular, genes in the anthocyanin biosynthesis pathway were actively regulated by ABA, with the exception of the gene encoding cinnamate 4-hydroxylase. Chlorophyll degradation was accelerated by ABA mainly owing to the higher expression of gene encoding pheide a oxygenase. The decrease of beta-carotene content was accelerated by ABA treatment and delayed by NDGA. A high negative correlation rate was found between ABA and beta-carotene content, indicating the importance of the requirement for ABA synthesis during fruit ripening. In addition, evaluation on the folate biosynthetic pathway indicate that ABA might have minor function in this nutrient's biosynthesis process, however, it might be involved in its homeostasis. Surprisingly, though AsA content accumulated during fruit ripening, expressions of genes involved in its biosynthesis in the receptacles were significantly lower in ABA-treated fruits. This transcriptome analysis expands our understanding of ABA's role in phytochemical metabolism during strawberry fruit ripening and the regulatory mechanisms of ABA on these pathways were discussed. Our study provides a wealth of genetic information in the metabolism pathways and may be helpful for molecular manipulation in the future.	[Li, Dongdong; Luo, Zisheng; Mou, Wangshu; Mao, Linchun; Ying, Tiejin] Zhejiang Univ, Key Lab Agrofood Proc, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Li] ARO, Volcani Ctr, Dept Postharvest Sci Fresh Produce, Bet Dagan, Israel	Zhejiang University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Luo, ZS (corresponding author), Zhejiang Univ, Key Lab Agrofood Proc, Coll Biosyst Engn & Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	luozisheng@zju.edu.cn		Li, Dongdong/0000-0001-7464-6478	National Basic Research Program of China [2013CB127101]; National Natural Science Foundation of China [31371856]; Zhejiang Provincial Natural Science Foundation of China [LR13C200001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	The research was financially supported by the National Basic Research Program of China (2013CB127101), the National Natural Science Foundation of China (31371856) and Zhejiang Provincial Natural Science Foundation of China (LR13C200001).	Araguez I, 2013, J PROTEOMICS, V83, P160, DOI 10.1016/j.jprot.2013.03.016; Arora A, 2008, INT J FOOD SCI TECH, V43, P1913, DOI 10.1111/j.1365-2621.2008.01743.x; Basu A, 2014, CRIT REV FOOD SCI, V54, P790, DOI 10.1080/10408398.2011.608174; Blancquaert D, 2014, J EXP BOT, V65, P895, DOI 10.1093/jxb/ert483; Blancquaert D, 2013, J EXP BOT, V64, P3899, DOI 10.1093/jxb/ert224; Chai YM, 2011, J EXP BOT, V62, P5079, DOI 10.1093/jxb/err207; CHENG GW, 1991, J AM SOC HORTIC SCI, V116, P865, DOI 10.21273/JASHS.116.5.865; Cruz-Rus E, 2011, J EXP BOT, V62, P4191, DOI 10.1093/jxb/err122; de La Garza RID, 2007, P NATL ACAD SCI USA, V104, P4218, DOI 10.1073/pnas.0700409104; Du H, 2013, PLANT MOL BIOL, V83, P475, DOI 10.1007/s11103-013-0103-7; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Gagne S, 2011, J PLANT GROWTH REGUL, V30, P1, DOI 10.1007/s00344-010-9165-9; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Giampieri F, 2012, NUTRITION, V28, P9, DOI 10.1016/j.nut.2011.08.009; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hanson AD, 2011, ANNU REV PLANT BIOL, V62, P105, DOI 10.1146/annurev-arplant-042110-103819; Imai T, 2009, PHYSIOL PLANTARUM, V136, P139, DOI 10.1111/j.1399-3054.2009.01213.x; Jeong ST, 2004, PLANT SCI, V167, P247, DOI 10.1016/j.plantsci.2004.03.021; Jia HF, 2013, J EXP BOT, V64, P1677, DOI 10.1093/jxb/ert028; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jia HF, 2013, NEW PHYTOL, V198, P453, DOI 10.1111/nph.12176; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Kang CY, 2013, PLANT CELL, V25, P1960, DOI 10.1105/tpc.113.111732; Li DD, 2014, POSTHARVEST BIOL TEC, V90, P56, DOI 10.1016/j.postharvbio.2013.12.006; Li GM, 2003, J NUTR BIOCHEM, V14, P568, DOI 10.1016/S0955-2863(03)00115-3; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Navarrete O, 2012, PHYTOCHEMISTRY, V73, P23, DOI 10.1016/j.phytochem.2011.09.008; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; PURVIS AC, 1981, PLANT PHYSIOL, V68, P854, DOI 10.1104/pp.68.4.854; Sandhu AK, 2011, FOOD CHEM, V126, P982, DOI 10.1016/j.foodchem.2010.11.105; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI DOI 10.1016/S1360-1385(01)02187-2; Severo J, 2011, FOOD CHEM, V126, P995, DOI 10.1016/j.foodchem.2010.11.107; Stralsjo LM, 2003, J AGR FOOD CHEM, V51, P128, DOI 10.1021/jf020699n; Sun L, 2012, J EXP BOT, V63, P3097, DOI 10.1093/jxb/ers026; Symons GM, 2012, J EXP BOT, V63, P4741, DOI 10.1093/jxb/ers147; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tulipani S, 2008, J AGR FOOD CHEM, V56, P696, DOI 10.1021/jf0719959; Wang HC, 2007, PLANT GROWTH REGUL, V52, P189, DOI 10.1007/s10725-007-9189-8; Yabuta Y, 2007, J EXP BOT, V58, P2661, DOI 10.1093/jxb/erm124; Yu LJ, 2012, NEW PHYTOL, V195, P97, DOI 10.1111/j.1469-8137.2012.04154.x; Zhang AY, 2006, PLANT PHYSIOL, V141, P475, DOI 10.1104/pp.105.075416; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026	44	40	42	4	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0130037	10.1371/journal.pone.0130037	http://dx.doi.org/10.1371/journal.pone.0130037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053069	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300176
J	Sun, QJ; Wu, M; Bu, XH; Xiong, L				Sun, Qingjie; Wu, Min; Bu, Xianghui; Xiong, Liu			Effect of the Amount and Particle Size of Wheat Fiber on the Physicochemical Properties and Gel Morphology of Starches	PLOS ONE			English	Article							GUM; MICROSTRUCTURE	Effects of added wheat fiber, with different levels and particle sizes, on the physicochemical properties and gel morphology of wheat starch and mung bean starch were investigated, using rapid visco analyzer (RVA), texture analyzer (TPA) and scanning electron microscopy (SEM). Each starch was added with wheat fiber at 10, 20, 30 and 40% (weight basis, g/100g), and different sizes of 60, 100 and 180 mesh, respectively. The peak viscosity (PV) of starches with wheat fiber were higher than the control. Starches had the highest PV with 40%, 60 mesh wheat fiber. The starches with wheat fiber showed higher hardness when compared to the control. Wheat starch and mung bean starch, with 40%, 60 mesh wheat fiber, had the highest hardnesses of 147.78 and 1032.11g, respectively. SEM showed that the dense honeycomb structure of starch gel was diminished with increasing wheat fiber. Additionally, the number of internal pores was reduced, and a large lamellar structure was formed.	[Sun, Qingjie; Wu, Min; Bu, Xianghui; Xiong, Liu] Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Peoples R China	Qingdao Agricultural University	Sun, QJ (corresponding author), Qingdao Agr Univ, Coll Food Sci & Engn, Qingdao, Peoples R China.	phdsun@163.com			Qingdao Municipal Science and Technology Plan Project [14-2-3-48-nsh]	Qingdao Municipal Science and Technology Plan Project	Financial support from the Qingdao Municipal Science and Technology Plan Project (grant number: 14-2-3-48-nsh) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamri MS, 2013, FOOD HYDROCOLLOID, V30, P541, DOI 10.1016/j.foodhyd.2012.07.003; Alvarez V, 2006, J COMPOS MATER, V40, P21, DOI 10.1177/0021998305053508; [Anonymous], 2001, CEREAL FOOD WORLD, V46, P112; Appelqvist IAM, 1997, FOOD REV INT, V13, P163, DOI 10.1080/87559129709541105; BeMiller JN, 2011, CARBOHYD POLYM, V86, P386, DOI 10.1016/j.carbpol.2011.05.064; Clodualdo CM, 2010, CEREAL CHEM, V87, P305; Debiagi F, 2010, CIENC AGROTEC, V34, P1522, DOI 10.1590/S1413-70542010000600024; Fabunmi OO, 2011, J POLYM ENVIRON, V19, P841, DOI 10.1007/s10924-011-0374-5; Fahrizio E, 2005, ANTIOXIDANT ACTIVITY; Feng T, 2012, CARBOHYD POLYM, V90, P667, DOI 10.1016/j.carbpol.2012.05.094; Gregory MG, 2008, STARCH, V60, P476; Huang CC, 2009, INT J FOOD SCI TECH, V44, P50, DOI 10.1111/j.1365-2621.2007.01634.x; Hung PV, 2006, TRENDS FOOD SCI TECH, V17, P448, DOI 10.1016/j.tifs.2005.12.006; Kaur L, 2008, FOOD CHEM, V111, P1, DOI 10.1016/j.foodchem.2008.03.027; Kim MJ, 2008, CARBOHYD POLYM, V74, P787, DOI 10.1016/j.carbpol.2008.04.043; Lai P, 2011, FOOD CHEM, V127, P153, DOI 10.1016/j.foodchem.2010.12.116; Li WH, 2011, INT J FOOD SCI TECH, V46, P1621, DOI 10.1111/j.1365-2621.2011.02663.x; Ramirez MGL, 2011, CARBOHYD POLYM, V86, P1712, DOI 10.1016/j.carbpol.2011.07.002; Mann JI, 2009, NUTR METAB CARDIOVAS, V19, P226, DOI 10.1016/j.numecd.2009.02.002; Pons M, 1996, J TEXTURE STUD, V27, P597, DOI 10.1111/j.1745-4603.1996.tb00996.x; Prachayawarakorn J, 2012, J POLYM ENVIRON, V20, P88, DOI 10.1007/s10924-011-0371-8; Rosa MF, 2009, BIORESOURCE TECHNOL, V100, P5196, DOI 10.1016/j.biortech.2009.03.085; Sharma P, 2011, J CEREAL SCI, V53, P25, DOI 10.1016/j.jcs.2010.08.005; Sharma R, 2009, J FOOD PROCESS PRES, V33, P401, DOI 10.1111/j.1745-4549.2008.00283.x; Singh H, 2009, INT J FOOD PROP, V12, P713, DOI 10.1080/10942910801995614; Symons LJ, 2004, J FOOD SCI, V69, pC257, DOI 10.1111/j.1365-2621.2004.tb06325.x; Tan HZ, 2009, FOOD RES INT, V42, P551, DOI 10.1016/j.foodres.2009.02.015; Zhang YC, 2011, CARBOHYD POLYM, V86, P700, DOI 10.1016/j.carbpol.2011.05.009; Zhu KX, 2010, FOOD RES INT, V43, P943, DOI 10.1016/j.foodres.2010.01.005	29	12	12	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128665	10.1371/journal.pone.0128665	http://dx.doi.org/10.1371/journal.pone.0128665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053534	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300051
J	Nokkari, A; Mouhieddine, TH; Itani, MM; Abou-Kheir, W; Daoud, G; Zhu, R; Meshref, Y; Soueid, J; Al Hariri, M; Mondello, S; Jaffa, AA; Kobeissy, F				Nokkari, Amaly; Mouhieddine, Tarek H.; Itani, Muhieddine M.; Abou-Kheir, Wassim; Daoud, Georges; Zhu, Rui; Meshref, Yehia; Soueid, Jihane; Al Hariri, Moustafa; Mondello, Stefania; Jaffa, Ayad A.; Kobeissy, Firas			Characterization of the Kallikrein-Kinin System Post Chemical Neuronal Injury: An In Vitro Biochemical and Neuroproteomics Assessment	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; BRADYKININ B-2 RECEPTOR; PC12 CELLS; PROTEOMIC ANALYSIS; INDUCED APOPTOSIS; PHOSPHOLIPASE-D; CALCIUM; BIOMARKERS; BIOLOGY; DEATH	Traumatic Brain Injury (TBI) is the result of a mechanical impact on the brain provoking mild, moderate or severe symptoms. It is acknowledged that TBI leads to apoptotic and necrotic cell death; however, the exact mechanism by which brain trauma leads to neural injury is not fully elucidated. Some studies have highlighted the pivotal role of the Kallikrein-Kinin System (KKS) in brain trauma but the results are still controversial and inconclusive. In this study, we investigated both the expression and the role of Bradykinin 1 and 2 receptors (B1R and B2R), in mediating neuronal injury under chemical neurotoxicity paradigm in PC12 cell lines. The neuronal cell line PC12 was treated with the apoptotic drug Staurosporine (STS) to induce cell death. Intracellular calcium release was evaluated by Fluo 4-AM staining and showed that inhibition of the B2R prevented calcium release following STS treatment. Differential analyses utilizing immunofluorescence, Western blot and Real-time Polymerase Chain Reaction revealed an upregulation of both bradykinin receptors occurring at 3h and 12h post-STS treatment, but with a higher induction of B2R compared to B1R. This implies that STS-mediated apoptosis in PC12 cells is mainly conducted through B2R and partly via B1R. Finally, a neuroproteomics approach was conducted to find relevant proteins associated to STS and KKS in PC12 cells. Neuroproteomics results confirmed the presence of an inflammatory response leading to cell death during apoptosis-mediated STS treatment; however, a "survival" capacity was shown following inhibition of B2R coupled with STS treatment. Our data suggest that B2R is a key player in the inflammatory pathway following STS-mediated apoptosis in PC12 cells and its inhibition may represent a potential therapeutic tool in TBI.	[Nokkari, Amaly; Soueid, Jihane; Al Hariri, Moustafa; Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Mouhieddine, Tarek H.] Amer Univ Beirut, Fac Med, Med Ctr, Beirut, Lebanon; [Itani, Muhieddine M.] St George Univ London, Fac Med, Nicosia, Cyprus; [Abou-Kheir, Wassim; Daoud, Georges] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol, Beirut, Lebanon; [Zhu, Rui; Meshref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy	American University of Beirut; American University of Beirut; American University of Beirut; Texas Tech University System; Texas Tech University; University of Messina	Nokkari, A (corresponding author), Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon.	amalyn.breizh@gmail.com; wa12@aub.edu.lb; firasko@gmail.com	Itani, Muhieddine/R-3826-2019; Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017; Abou-Kheir, Wassim/AAP-2587-2020	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; Abou-Kheir, Wassim/0000-0001-9719-9324; Daoud, Georges/0000-0001-8043-3882; Mouhieddine, Tarek/0000-0002-1190-5978; Soueid, Jihane/0000-0002-1973-8705	National Institutes of Health [HL077192, HL087986]; Medical Practice Grant faculty of Medicine; CNRS [10267]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087986, R01HL077192] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Practice Grant faculty of Medicine; CNRS(Centre National de la Recherche Scientifique (CNRS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by the National Institutes of Health grants HL077192 and HL087986, Medical Practice Grant faculty of Medicine, CNRS Award Number 10267 (AAJ). Grant recipient: Dr. Ayad Jaffa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert-Weissenberger C, 2013, PROG NEUROBIOL, V101, P65, DOI 10.1016/j.pneurobio.2012.11.004; Bal-Price A, 2006, NITRIC OXIDE-BIOL CH, V14, P238, DOI 10.1016/j.niox.2005.10.002; Ballesteros MA, 2007, INTENS CARE MED, V33, P58, DOI 10.1007/s00134-006-0361-9; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Boutte AM, 2012, ELECTROPHORESIS, V33, P3693, DOI 10.1002/elps.201200196; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Fischer H., 2014, GUIDE US MILITARY CA; Furuno T, 2006, NEUROSCI LETT, V392, P240, DOI 10.1016/j.neulet.2005.09.031; Guevara-Lora I, 2012, NEUROCHEM INT, V61, P72, DOI 10.1016/j.neuint.2012.04.013; Guingab-Cagmat JD, 2012, ELECTROPHORESIS, V33, P3786, DOI 10.1002/elps.201200326; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; Hellal F, 2003, J NEUROTRAUM, V20, P841, DOI 10.1089/089771503322385773; Hillmeister P, 2012, ACTA PHYSIOL, V206, P215, DOI 10.1111/apha.12007; HORWITZ J, 1991, J NEUROCHEM, V56, P509, DOI 10.1111/j.1471-4159.1991.tb08179.x; HORWITZ J, 1992, J NEUROCHEM, V59, P1474, DOI 10.1111/j.1471-4159.1992.tb08463.x; Jaffa MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044714; Jiang CY, 2014, BIOL TRACE ELEM RES, V158, P249, DOI 10.1007/s12011-014-9918-6; Jiang H, 2014, INT J MOL MED, V33, P1298, DOI 10.3892/ijmm.2014.1684; KLYSZCZNASKO H, 1993, ARCH BIOCHEM BIOPHYS, V306, P383, DOI 10.1006/abbi.1993.1527; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2010, METHODS MOL BIOL, V662, P303, DOI 10.1007/978-1-60761-800-3_15; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar S, 2015, LEUKEMIA LYMPHOMA, V56, P1846, DOI 10.3109/10428194.2014.974042; Liu Bo, 2003, V237, P99; Liu J, 2013, BIOL CHEM, V394, P319, DOI 10.1515/hsz-2012-0316; Malekinejad H, 2014, IRAN J PHARM RES, V13, P191; Marks J, 2003, J BIOL CHEM, V278, P34158, DOI 10.1074/jbc.M304543200; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Nakayama T, 2004, BIOCHEM J, V377, P299, DOI 10.1042/BJ20030599; NEUHAUS R, 1991, J NEUROSCI, V11, P3984; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Cunha MP, 2014, ASN NEURO, V6, DOI 10.1177/1759091414554945; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Rizzuto Rosario, 2004, Sci STKE, V2004, pre1, DOI 10.1126/stke.2152004re1; Shen S, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-11; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tang SCW, 2011, CONTRIB NEPHROL, V170, P145, DOI 10.1159/000325650; Tinetti ME, 2008, NEW ENGL J MED, V359, P252, DOI 10.1056/NEJMoa0801748; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128601	10.1371/journal.pone.0128601	http://dx.doi.org/10.1371/journal.pone.0128601			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047500	Green Published, gold			2022-12-26	WOS:000355652200082
J	Le Henaff, C; Mansouri, R; Modrowski, D; Zarka, M; Geoffroy, V; Marty, C; Tarantino, N; Laplantine, E; Marie, PJ				Le Henaff, Carole; Mansouri, Rafik; Modrowski, Dominique; Zarka, Mylene; Geoffroy, Valerie; Marty, Caroline; Tarantino, Nadine; Laplantine, Emmanuel; Marie, Pierre J.			Increased NF-kappa B Activity and Decreased Wnt/beta-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE-MINERAL DENSITY; OSTEOPENIA; SMURF1; DEGRADATION; INHIBITION; ADULTS; CELLS; PREVALENCE; ACTIVATION; DISEASE	The prevalent human Delta F508 mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) is associated with reduced bone formation and bone loss in mice. The molecular mechanisms by which the Delta F508-CFTR mutation causes alterations in bone formation are poorly known. In this study, we analyzed the osteoblast phenotype in Delta F508-CFTR mice and characterized the signaling mechanisms underlying this phenotype. Ex vivo studies showed that the Delta F508-CFTR mutation negatively impacted the differentiation of bone marrow stromal cells into osteoblasts and the activity of osteoblasts, demonstrating that the Delta F508-CFTR mutation alters both osteoblast differentiation and function. Treatment with a CFTR corrector rescued the abnormal collagen gene expression in Delta F508-CFTR osteoblasts. Mechanistic analysis revealed that NF-kappa B signaling and transcriptional activity were increased in mutant osteoblasts. Functional studies showed that the activation of NF-kappa B transcriptional activity in mutant osteoblasts resulted in increased beta-catenin phosphorylation, reduced osteoblast beta-catenin expression, and altered expression of Wnt/beta-catenin target genes. Pharmacological inhibition of NF-kappa B activity or activation of canonical Wnt signaling rescued Wnt target gene expression and corrected osteoblast differentiation and function in bone marrow stromal cells and osteoblasts from Delta F508-CFTR mice. Overall, the results show that the Delta F508-CFTR mutation impairs osteoblast differentiation and function as a result of overactive NF-kappa B and reduced Wnt/beta-catenin signaling. Moreover, the data indicate that pharmacological inhibition of NF-kappa B or activation of Wnt/beta-catenin signaling can rescue the abnormal osteoblast differentiation and function induced by the prevalent Delta F508-CFTR mutation, suggesting novel therapeutic strategies to correct the osteoblast dysfunctions in cystic fibrosis.	[Le Henaff, Carole; Mansouri, Rafik; Modrowski, Dominique; Zarka, Mylene; Geoffroy, Valerie; Marty, Caroline; Marie, Pierre J.] INSERM, UMR 1132, F-75475 Paris, France; [Le Henaff, Carole; Mansouri, Rafik; Modrowski, Dominique; Zarka, Mylene; Geoffroy, Valerie; Marty, Caroline; Marie, Pierre J.] Univ Paris Diderot, Sorbonne Paris Cite, F-75013 Paris, France; [Tarantino, Nadine; Laplantine, Emmanuel] Inst Pasteur, Lab Signalisat & Pathogenese, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Marie, PJ (corresponding author), Hop Lariboisiere, INSERM, UMR 1132, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	pierre.marie@inserm.fr	Geoffroy, Valerie/P-1521-2014; Modrowski, Dominique/N-6578-2018	Geoffroy, Valerie/0000-0003-3920-7482; Modrowski, Dominique/0000-0003-1103-7127; Zarka, Mylene/0000-0003-3179-4432	Association Prevention and Traitement des Decalcifications, Paris, France; Association Rhumatisme et Travail, Paris, France; Vaincre La Mucoviscidose (VLM) [RF20110600482]	Association Prevention and Traitement des Decalcifications, Paris, France; Association Rhumatisme et Travail, Paris, France; Vaincre La Mucoviscidose (VLM)	This work was supported by grants from the Association Prevention and Traitement des Decalcifications and the Association Rhumatisme et Travail (to P. J. M.), Paris, France, and by Grant RF20110600482 from Vaincre La Mucoviscidose (VLM 2012-2013, to C. L. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Becq F, 2010, DRUGS, V70, P241, DOI 10.2165/11316160-000000000-00000; Bodas M, 2010, DISCOV MED, V9, P346; Borot F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007116; Boyce BF, 2010, ANN NY ACAD SCI, V1192, P367, DOI 10.1111/j.1749-6632.2009.05315.x; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; Chang J, 2013, P NATL ACAD SCI USA, V110, P9469, DOI 10.1073/pnas.1300532110; Chang J, 2009, NAT MED, V15, P682, DOI 10.1038/nm.1954; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conway SP, 2000, THORAX, V55, P798, DOI 10.1136/thorax.55.9.798; Dif F, 2004, BONE, V35, P595, DOI 10.1016/j.bone.2004.05.021; Du Qiang, 2010, For Immunopathol Dis Therap, V1, P155; Edelman A, 2012, ARCH PEDIATRIE, V19, pS13, DOI 10.1016/S0929-693X(12)71101-6; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Guo R, 2008, J BIOL CHEM, V283, P23084, DOI 10.1074/jbc.M709848200; Haston CK, 2008, AM J RESP CRIT CARE, V177, P309, DOI 10.1164/rccm.200705-659OC; Haworth CS, 1999, THORAX, V54, P961, DOI 10.1136/thx.54.11.961; Hay E, 2005, J BIOL CHEM, V280, P13616, DOI 10.1074/jbc.M411999200; Hunter MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011598; Kaneki H, 2006, J BIOL CHEM, V281, P4326, DOI 10.1074/jbc.M509430200; Krum SA, 2010, NAT REV RHEUMATOL, V6, P607, DOI 10.1038/nrrheum.2010.133; Laplantine E, 2009, EMBO J, V28, P2885, DOI 10.1038/emboj.2009.241; Le Henaff C, 2014, AM J PATHOL, V184, P1132, DOI 10.1016/j.ajpath.2013.12.027; Le Henaff C, 2012, AM J PATHOL, V180, P2068, DOI 10.1016/j.ajpath.2012.01.039; Legroux-Gerot I, 2012, JOINT BONE SPINE, V79, P73, DOI 10.1016/j.jbspin.2011.05.009; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Miraoui H, 2009, J BIOL CHEM, V284, P4897, DOI 10.1074/jbc.M805432200; MODROWSKI D, 1993, CELL TISSUE RES, V271, P499, DOI 10.1007/BF02913733; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; Paccou J, 2010, CALCIFIED TISSUE INT, V86, P1, DOI 10.1007/s00223-009-9316-9; Pacifici R, 2010, ARCH BIOCHEM BIOPHYS, V503, P41, DOI 10.1016/j.abb.2010.05.027; Paradis J, 2010, J CYST FIBROS, V9, P239, DOI 10.1016/j.jcf.2010.05.001; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Pashuck TD, 2009, PEDIATR RES, V65, P311, DOI 10.1203/PDR.0b013e3181961e80; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Sermet-Gaudelus I, 2007, AM J RESP CRIT CARE, V175, P951, DOI 10.1164/rccm.200606-776OC; Shead EF, 2007, THORAX, V62, P650, DOI 10.1136/thx.2006.075887; Stalvey MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080098; Tabary O, 2006, CELL SIGNAL, V18, P652, DOI 10.1016/j.cellsig.2005.06.004; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; Weitzmann MN, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/125705; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200	45	28	31	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18009	18017		10.1074/jbc.M115.646208	http://dx.doi.org/10.1074/jbc.M115.646208			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26060255	hybrid, Green Published			2022-12-26	WOS:000358511700033
J	Wu, Y; Koharudin, LMI; Mehrens, J; DeLucia, M; Byeon, CH; Byeon, IJL; Calero, G; Ahn, J; Gronenborn, AM				Wu, Ying; Koharudin, Leonardus M. I.; Mehrens, Jennifer; DeLucia, Maria; Byeon, Chang-Hyeok; Byeon, In-Ja L.; Calero, Guillermo; Ahn, Jinwoo; Gronenborn, Angela M.			Structural Basis of Clade-specific Engagement of SAMHD1 (Sterile alpha Motif and Histidine/Aspartate-containing Protein 1) Restriction Factors by Lentiviral Viral Protein X (Vpx) Virulence Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 INFECTION; ACCESSORY PROTEINS; IMMUNE EVASION; INHIBITOR; RELEASE; MX2	Sterile alpha motif (SAM) and histidine/aspartate (HD)-containing protein 1 (SAMHD1) restricts human/simian immunodeficiency virus infection in certain cell types and is counteracted by the virulence factor Vpx. Current evidence indicates that Vpx recruits SAMHD1 to the Cullin4-Ring Finger E3 ubiquitin ligase (CRL4) by facilitating an interaction between SAMHD1 and the substrate receptor DDB1- and Cullin4-associated factor 1 (DCAF1), thereby targeting SAMHD1 for proteasome-dependent down-regulation. Host-pathogen co-evolution and positive selection at the interfaces of host-pathogen complexes are associated with sequence divergence and varying functional consequences. Two alternative interaction interfaces are used by SAMHD1 and Vpx: the SAMHD1 N-terminal tail and the adjacent SAM domain or the C-terminal tail proceeding the HD domain are targeted by different Vpx variants in a unique fashion. In contrast, the C-terminal WD40 domain of DCAF1 interfaces similarly with the two above complexes. Comprehensive biochemical and structural biology approaches permitted us to delineate details of clade-specific recognition of SAMHD1 by lentiviral Vpx proteins. We show that not only the SAM domain but also the N-terminal tail engages in the DCAF1-Vpx interaction. Furthermore, we show that changing the single Ser-52 in human SAMHD1 to Phe, the residue found in SAMHD1 of Red-capped monkey and Mandrill, allows it to be recognized by Vpx proteins of simian viruses infecting those primate species, which normally does not target wild type human SAMHD1 for degradation.	[Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ahn, J (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA.	jia12@pitt.edu; amg100@pitt.edu	Regan, Clinton/E-6250-2012	Gronenborn, Angela M/0000-0001-9072-3525	National Institutes of Health [P50GM082251]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50GM082251 (to A. M. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blanchet FP, 2012, CURR HIV RES, V10, P307, DOI 10.2174/157016212800792441; Bricogne G, 2011, AUTOBUSTER; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLucia M, 2013, J BIOL CHEM, V288, P19116, DOI 10.1074/jbc.M113.469007; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; Feng YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00450; Fregoso OI, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003496; Goujon C, 2013, NATURE, V502, P559, DOI 10.1038/nature12542; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kirchhoff F, 2010, CELL HOST MICROBE, V8, P55, DOI 10.1016/j.chom.2010.06.004; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Liu ZL, 2013, CELL HOST MICROBE, V14, P398, DOI 10.1016/j.chom.2013.08.015; Luban J, 2012, CELL HOST MICROBE, V12, P408, DOI 10.1016/j.chom.2012.10.002; Mashiba M, 2013, VIRUSES-BASEL, V5, P1, DOI 10.3390/v5010001; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Romani B, 2012, CURR OPIN VIROL, V2, P755, DOI 10.1016/j.coviro.2012.09.010; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schwefel D, 2014, NATURE, V505, P234, DOI 10.1038/nature12815; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Strebel K, 2013, CURR OPIN VIROL, V3, P692, DOI 10.1016/j.coviro.2013.08.004; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Wei W, 2014, J VIROL, V88, P583, DOI 10.1128/JVI.02866-13; Zhang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037477; Zheng YH, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-112	36	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17935	17945		10.1074/jbc.M115.665513	http://dx.doi.org/10.1074/jbc.M115.665513			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26045556	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000358511700027
J	Aceto, J; Nourizadeh-Lillabadi, R; Maree, R; Dardenne, N; Jeanray, N; Wehenkel, L; Alestrom, P; van Loon, JJWA; Muller, M				Aceto, Jessica; Nourizadeh-Lillabadi, Rasoul; Maree, Raphael; Dardenne, Nadia; Jeanray, Nathalie; Wehenkel, Louis; Alestrom, Peter; van Loon, Jack J. W. A.; Muller, Marc			Zebrafish Bone and General Physiology Are Differently Affected by Hormones or Changes in Gravity	PLOS ONE			English	Article							INNER-EAR OTOLITHS; MUTATIONS AFFECTING DEVELOPMENT; CYTOCHROME-OXIDASE ACTIVITY; BRANCHIAL ARCH MUTANTS; CENTRAL-NERVOUS-SYSTEM; ALTERED GRAVITY; DANIO-RERIO; MICE LACKING; SWIMMING BEHAVIOR; MOTION SICKNESS	Teleost fish such as zebrafish (Danio rerio) are increasingly used for physiological, genetic and developmental studies. Our understanding of the physiological consequences of altered gravity in an entire organism is still incomplete. We used altered gravity and drug treatment experiments to evaluate their effects specifically on bone formation and more generally on whole genome gene expression. By combining morphometric tools with an objective scoring system for the state of development for each element in the head skeleton and specific gene expression analysis, we confirmed and characterized in detail the decrease or increase of bone formation caused by a 5 day treatment (from 5dpf to 10 dpf) of, respectively parathyroid hormone (PTH) or vitamin D3 (VitD3). Microarray transcriptome analysis after 24 hours treatment reveals a general effect on physiology upon VitD3 treatment, while PTH causes more specifically developmental effects. Hypergravity (3g from 5dpf to 9 dpf) exposure results in a significantly larger head and a significant increase in bone formation for a subset of the cranial bones. Gene expression analysis after 24 hrs at 3g revealed differential expression of genes involved in the development and function of the skeletal, muscular, nervous, endocrine and cardiovascular systems. Finally, we propose a novel type of experimental approach, the "Reduced Gravity Paradigm", by keeping the developing larvae at 3g hypergravity for the first 5 days before returning them to 1g for one additional day. 5 days exposure to 3g during these early stages also caused increased bone formation, while gene expression analysis revealed a central network of regulatory genes (hes5, sox10, lgals3bp, egr1, edn1, fos, fosb, klf2, gadd45ba and socs3a) whose expression was consistently affected by the transition from hyper-to normal gravity.	[Aceto, Jessica; Jeanray, Nathalie; Muller, Marc] Univ Liege, GIGA Res, Lab Organogenesis & Regenerat, B-4000 Sart Tilman Par Liege, Belgium; [Nourizadeh-Lillabadi, Rasoul; Alestrom, Peter] Norwegian Univ Life Sci, BasAM, Vetbio, Dep 0033, Oslo, Norway; [Maree, Raphael; Wehenkel, Louis] Univ Liege, GIGA, Liege, Belgium; [Nourizadeh-Lillabadi, Rasoul; Wehenkel, Louis] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Dardenne, Nadia] Univ Liege, Unite Soutien Meth Biostat & Epidemiol, B23, Liege, Belgium; [van Loon, Jack J. W. A.] Vrije Univ Amsterdam, Med Ctr, Dept Oral & Maxillofacial Surg Oral Pathol, DESC, Amsterdam, Netherlands; [van Loon, Jack J. W. A.] Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [van Loon, Jack J. W. A.] ESA, Estec, TEC MMG, NL-2200 AG Noordwijk, Netherlands	University of Liege; Norwegian University of Life Sciences; University of Liege; University of Liege; University of Liege; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; European Space Agency	Muller, M (corresponding author), Univ Liege, GIGA Res, Lab Organogenesis & Regenerat, B-4000 Sart Tilman Par Liege, Belgium.	m.muller@ulg.ac.be		Maree, Raphael/0000-0002-9587-1954; van Loon, Jack/0000-0001-9051-6016	Fonds de la Recherche Fondamentale Collective; SSTC [2.4555.99/2.4542.00/2.4561.10]; University of Liege [PAI: P5/35]; GAME project; European Space Agency projects [AO-99-LSS-003, AO-99-LSS-006]; Belgian Space Agency Prodex project FISH-GSIM; Belgian Space Agency Prodex project FISH-SIM; Netherlands Organisation for Scientific (NWO) Research Earth and Life Sciences via the Netherlands Space Office NSO [MG-057]	Fonds de la Recherche Fondamentale Collective(Fonds de la Recherche Scientifique - FNRS); SSTC; University of Liege(University of Liege); GAME project; European Space Agency projects; Belgian Space Agency Prodex project FISH-GSIM; Belgian Space Agency Prodex project FISH-SIM; Netherlands Organisation for Scientific (NWO) Research Earth and Life Sciences via the Netherlands Space Office NSO(Netherlands Organization for Scientific Research (NWO))	This work was supported by the "Fonds de la Recherche Fondamentale Collective"; 2.4555.99/2.4542.00/2.4561.10, the SSTC; PAI: P5/35, the University of Liege; GAME project, the European Space Agency projects AO-99-LSS-003 and AO-99-LSS-006, the Belgian Space Agency Prodex projects FISH-GSIM and FISH-SIM. JvL received grant MG-057 from the Netherlands Organisation for Scientific (NWO) Research Earth and Life Sciences via the Netherlands Space Office NSO.	Aceto J, 2008, J GRAVIT PHYSL, V15, P111; Aceto J, 2009, J GRAVITATI IN PRESS, V16; Anjos L, 2013, GEN COMP ENDOCR, V191, P102, DOI 10.1016/j.ygcen.2013.05.014; Anken R, 2006, ADV SPACE RES, V38, P1032, DOI 10.1016/j.asr.2006.03.003; Anken RH, 2006, PROTOPLASMA, V229, P205, DOI 10.1007/s00709-006-0219-6; Anken RH, 2004, ADV SPACE RES-SERIES, V34, P1592, DOI 10.1016/j.asr.2004.01.023; Anken RH, 2004, J EXP ZOOL PART A, V301A, P815, DOI 10.1002/jez.a.97; [Anonymous], 2013, DIAGN PATHOL, DOI DOI 10.1186/1746-1596-8-S1-S26; Apschner A, 2014, DIS MODEL MECH, V7, P811, DOI 10.1242/dmm.015693; Apschner A, 2011, METHOD CELL BIOL, V105, P239, DOI 10.1016/B978-0-12-381320-6.00010-2; Arias JL, 1997, CONNECT TISSUE RES, V36, P21, DOI 10.3109/03008209709160211; Asai Y, 2005, FASEB J, V19, pA1367; Beier M, 1999, ACTA ASTRONAUT, V44, P585, DOI 10.1016/S0094-5765(99)00104-6; Beier M, 2002, ADV SPACE RES-SERIES, V30, P727, DOI 10.1016/S0273-1177(02)00387-3; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blaker-Lee A, 2012, DIS MODEL MECH, V5, P834, DOI 10.1242/dmm.009944; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Brittijn SA, 2009, INT J DEV BIOL, V53, P835, DOI 10.1387/ijdb.082615sb; Brown JR, 1996, CELL, V86, P297, DOI 10.1016/S0092-8674(00)80101-4; Cau E, 2000, DEVELOPMENT, V127, P2323; Chang WJ, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-46; Close R, 2002, MECH DEVELOP, V118, P269, DOI 10.1016/S0925-4773(02)00283-6; Craig TA, 2012, MOL ENDOCRINOL, V26, P1630, DOI 10.1210/me.2012-1113; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Dalcq J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050140; Danks JA, 2011, GEN COMP ENDOCR, V170, P79, DOI 10.1016/j.ygcen.2010.10.023; Dattani MT, 2005, CLIN ENDOCRINOL, V63, P121, DOI 10.1111/j.1365-2265.2005.02289.x; DEGROOT RP, 1991, EXP CELL RES, V197, P87, DOI 10.1016/0014-4827(91)90483-B; DEGROOT RP, 1990, J CELL SCI, V97, P33; deJong HAA, 1996, AVIAT SPACE ENVIR MD, V67, P463; Duflo SGD, 2000, BRAIN RES, V861, P333, DOI 10.1016/S0006-8993(00)02044-8; Dutton K, 2009, DIS MODEL MECH, V2, P68, DOI 10.1242/dmm.001164; Edelmann E, 2004, ADV SPACE RES-SERIES, V33, P1390, DOI 10.1016/j.asr.2003.09.042; Edsall SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089296; Farioli-Vecchioli S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008339; Fitzgerald J, 1996, EXP CELL RES, V228, P168, DOI 10.1006/excr.1996.0313; Fleming A, 2005, J BIOMOL SCREEN, V10, P823, DOI 10.1177/1087057105279952; Fleming A, 2004, J BONE MINER RES, V19, pS334; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Fong K, 2004, BMJ-BRIT MED J, V329, P1441, DOI 10.1136/bmj.329.7480.1441; Fuentes J, 2007, AM J PHYSIOL-REG I, V293, pR956, DOI 10.1152/ajpregu.00111.2007; Fuentes J, 2007, AM J PHYSIOL-REG I, V293, pR884, DOI 10.1152/ajpregu.00203.2007; Fuentes J, 2010, AM J PHYSIOL-REG I, V299, pR150, DOI 10.1152/ajpregu.00378.2009; Fuller C A, 1994, J Gravit Physiol, V1, pP69; Furukawa R, 2002, ADV SPACE RES, V30, P733, DOI 10.1016/S0273-1177(02)00388-5; Gavaia PJ, 2006, GENE EXPR PATTERNS, V6, P637, DOI 10.1016/j.modgep.2005.11.010; Goerlich R, 2005, J GRAVIT PHYSL, V12, pP279; Granet C, 2001, BIOCHEM BIOPH RES CO, V284, P622, DOI 10.1006/bbrc.2001.5023; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; Henrotin YE, 2003, OSTEOARTHR CARTILAGE, V11, P747, DOI 10.1016/S1063-4584(03)00150-X; Hilbig R, 2002, ESA SPEC PUBL, V501, P139; Hill A, 2003, TOXICOL SCI, V76, P392, DOI 10.1093/toxsci/kfg241; Hogan BM, 2005, ENDOCRINOLOGY, V146, P547, DOI 10.1210/en.2004-0296; Horn E, 2011, LAB SCI SPACE DATA, P123; Horn ER, 2003, ADV SPACE B, V9, P133, DOI 10.1016/S1569-2574(03)09006-3; Hughes-Fulford M, 1998, Gravit Space Biol Bull, V11, P51; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Hwang PP, 2013, PFLUG ARCH EUR J PHY, V465, P1233, DOI 10.1007/s00424-013-1269-1; Ijiri K, 2003, ADV SPACE RES-SERIES, V32, P1501, DOI 10.1016/S0273-1177(03)90388-7; Ijiri K, 1998, ADV SPACE RES, V21, P1155, DOI 10.1016/S0273-1177(97)00205-6; Jongen JWJM, 1996, J BONE MINER RES, V11, P1218; Karlsson C, 2007, CELL TISSUE RES, V327, P539, DOI 10.1007/s00441-006-0307-0; Kaufman GD, 2005, BRAIN RES REV, V50, P200, DOI 10.1016/j.brainresrev.2005.06.001; Kawane T, 2003, J ENDOCRINOL, V178, P247, DOI 10.1677/joe.0.1780247; Kim YI, 2013, MOL CELLS, V36, P145, DOI 10.1007/s10059-013-0117-7; Kimmel CB, 1998, DEV BIOL, V203, P245, DOI 10.1006/dbio.1998.9016; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kondrachuk AV, 2006, ARCH ITAL BIOL, V144, P75; KURIHARA Y, 1994, NATURE, V368, P703, DOI 10.1038/368703a0; Langheinrich U, 2003, BIOESSAYS, V25, P904, DOI 10.1002/bies.10326; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Larbuisson A, 2013, DIFFERENTIATION, V86, P192, DOI 10.1016/j.diff.2013.07.006; Lathers CM, 2001, ACTA ASTRONAUT, V49, P419, DOI 10.1016/S0094-5765(01)00117-5; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Liang J, 2012, J NEUROSCI, V32, P10662, DOI 10.1523/JNEUROSCI.5785-10.2012; Lin CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045650; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Mackay Eirinn W, 2013, Bonekey Rep, V2, P445, DOI 10.1038/bonekey.2013.179; Malicki J, 1996, DEVELOPMENT, V123, P275; Marthy HJ, 2002, VIE MILIEU, V52, P149; Miller CT, 2000, DEVELOPMENT, V127, P3815; Mitchell RE, 2013, OSTEOARTHR CARTILAGE, V21, P269, DOI 10.1016/j.joca.2012.11.004; Mizuno R, 2003, ADV SPACE RES-SERIES, V32, P1513, DOI 10.1016/S0273-1177(03)90389-9; Moorman SJ, 1999, J NEUROBIOL, V38, P247, DOI 10.1002/(SICI)1097-4695(19990205)38:2<247::AID-NEU7>3.3.CO;2-V; Moorman SJ, 2007, GRAVITATIONAL SPACE, V20, P79; Mori S, 1996, AVIAT SPACE ENVIR MD, V67, P256; Muller M, 2010, J APPL ICHTHYOL, V26, P239, DOI 10.1111/j.1439-0426.2010.01413.x; Muller M, 2009, J GRAVITATI IN PRESS, V16; Muller M, 2008, J GRAVIT PHYSL, V15, P253; Nakagawa A, 2003, BRAIN RES, V986, P114, DOI 10.1016/S0006-8993(03)03220-7; Niihori M, 2004, ZOOL SCI, V21, P923, DOI 10.2108/zsj.21.923; Nindl G, 1996, J BRAIN RES, V37, P291; NOSE K, 1994, EXP CELL RES, V211, P168, DOI 10.1006/excr.1994.1073; Nourizadeh-Lillabadi R, 2009, J TOXICOL ENV HEAL A, V72, P112, DOI 10.1080/15287390802537255; Ohnishi T, 1998, ADV SPACE RES, V21, P1077, DOI 10.1016/S0273-1177(98)00030-1; Okabe M, 2004, P NATL ACAD SCI USA, V101, P17716, DOI 10.1073/pnas.0406116101; Paulus U, 1996, J BRAIN RES, V37, P103; PAULUS U, 1995, ADV SPACE RES, V17, P285; Peterson RT, 2000, P NATL ACAD SCI USA, V97, P12965, DOI 10.1073/pnas.97.24.12965; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Piepenbreier K, 2006, ADV SPACE RES-SERIES, V38, P1016, DOI 10.1016/j.asr.2005.05.077; Pietsch J, 2011, CURR MOL MED, V11, P350, DOI 10.2174/156652411795976600; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Pompeiano O, 2002, NEUROSCIENCE, V114, P135, DOI 10.1016/S0306-4522(02)00202-6; Rahmann H, 2000, ADV SPACE RES-SERIES, V25, P1985, DOI 10.1016/S0273-1177(99)01007-8; RAHMANN H, 1990, ESA SP PUBL, V307, P259; Renn J, 2014, J APPL ICHTHYOL, V30, P701, DOI 10.1111/jai.12514; Renn J, 2009, DEV DYNAM, V238, P241, DOI 10.1002/dvdy.21836; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Salie R, 2010, BONE, V46, P680, DOI 10.1016/j.bone.2009.10.022; Sato A, 1999, ADV SPACE RES, V24, P807, DOI 10.1016/S0273-1177(99)00076-9; Saura M, 2010, THESCIENTIFICWORLDJO, V10, P624, DOI 10.1100/tsw.2010.58; Schein V, 2012, GEN COMP ENDOCR, V175, P344, DOI 10.1016/j.ygcen.2011.11.033; Schilling TF, 1996, DEVELOPMENT, V123, P329; Schilling Thomas F., 2002, P59; Sebastian C, 2001, J NEUROBIOL, V46, P59, DOI 10.1002/1097-4695(200101)46:1<59::AID-NEU6>3.0.CO;2-X; Seitz S, 2013, BONE, V53, P231, DOI 10.1016/j.bone.2012.12.009; Shih TH, 2012, AM J PHYSIOL-REG I, V302, pR84, DOI 10.1152/ajpregu.00318.2011; Shimada N, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-10; Shimada N, 2006, DEV DYNAM, V235, P2686, DOI 10.1002/dvdy.20901; Shimomura-Umemura S, 2006, ADV SPACE RES, V38, P1082, DOI 10.1016/j.asr.2005.02.093; Slenzka K, 2003, ADV SPACE RES-SERIES, V31, P1595, DOI 10.1016/S0273-1177(03)00011-5; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Suzuki N, 2007, ADV SPACE RES, V40, P1711, DOI 10.1016/j.asr.2007.04.104; Suzuki N, 2011, BONE, V48, P1186, DOI 10.1016/j.bone.2011.02.004; Takabayashi A, 2003, ADV SPACE RES-SERIES, V32, P1527, DOI 10.1016/S0273-1177(03)90391-7; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Trahey M, 1999, P NATL ACAD SCI USA, V96, P3006, DOI 10.1073/pnas.96.6.3006; Van Loon J, 2005, J GRAVITATIONAL PHYS, V12, pP5; Van Loon J., 2010, 38 ASS COMM SPAC RES; van Loon J J, 2001, J Gravit Physiol, V8, pP139; van Loon J.J.W.A., 2007, BIOL SPACE LIFE EART, P17; Vanloon J, 2008, P LIF SPAC LIF EARTH, P663; Vanoevelen J, 2011, FASEB J, V25, P3197, DOI 10.1096/fj.11-183145; VANSTRAATEN F, 1983, P NATL ACAD SCI-BIOL, V80, P3183; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Verreijdt L, 2006, DEV DYNAM, V235, P1371, DOI 10.1002/dvdy.20734; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Wang L, 2011, BLOOD, V118, P4102, DOI 10.1182/blood-2011-05-353235; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Watanabe S, 1989, Adv Space Res, V9, P231, DOI 10.1016/0273-1177(89)90078-1; Westerfield M, 2007, ZEBRAFISH BOOK; Whitfield TT, 1996, DEVELOPMENT, V123, P241; Wiederhold ML, 2003, J VESTIBUL RES-EQUIL, V13, P205; Williams D, 2009, CAN MED ASSOC J, V180, P1317, DOI 10.1503/cmaj.090628; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Yan YL, 2012, J ENDOCRINOL, V214, P421, DOI 10.1530/JOE-12-0110; Yang LX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r227; Zajac JD, 2008, CURR OPIN NEPHROL HY, V17, P353, DOI 10.1097/MNH.0b013e328304651c; Zheng CL, 2005, BIOCHEM BIOPH RES CO, V326, P100, DOI 10.1016/j.bbrc.2004.11.006	156	51	52	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0126928	10.1371/journal.pone.0126928	http://dx.doi.org/10.1371/journal.pone.0126928			42	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061167	gold, Green Published, Green Accepted			2022-12-26	WOS:000355979500021
J	Shah, NH; LePendu, P; Bauer-Mehren, A; Ghebremariam, YT; Iyer, SV; Marcus, J; Nead, KT; Cooke, JP; Leeper, NJ				Shah, Nigam H.; LePendu, Paea; Bauer-Mehren, Anna; Ghebremariam, Yohannes T.; Iyer, Srinivasan V.; Marcus, Jake; Nead, Kevin T.; Cooke, John P.; Leeper, Nicholas J.			Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population	PLOS ONE			English	Article							ADVERSE CARDIOVASCULAR EVENTS; PLASMA ASYMMETRIC DIMETHYLARGININE; CORONARY-ANGIOGRAPHY; CLOPIDOGREL; MORTALITY; DISEASE; ASPIRIN; PHARMACOVIGILANCE; ASSOCIATION; OMEPRAZOLE	Background and Aims Proton pump inhibitors (PPIs) have been associated with adverse clinical outcomes amongst clopidogrel users after an acute coronary syndrome. Recent pre-clinical results suggest that this risk might extend to subjects without any prior history of cardiovascular disease. We explore this potential risk in the general population via data-mining approaches. Methods Using a novel approach for mining clinical data for pharmacovigilance, we queried over 16 million clinical documents on 2.9 million individuals to examine whether PPI usage was associated with cardiovascular risk in the general population. Results In multiple data sources, we found gastroesophageal reflux disease (GERD) patients exposed to PPIs to have a 1.16 fold increased association (95% CI 1.09-1.24) with myocardial infarction (MI). Survival analysis in a prospective cohort found a two-fold (HR = 2.00; 95% CI 1.07-3.78; P = 0.031) increase in association with cardiovascular mortality. We found that this association exists regardless of clopidogrel use. We also found that H-2 blockers, an alternate treatment for GERD, were not associated with increased cardiovascular risk; had they been in place, such pharmacovigilance algorithms could have flagged this risk as early as the year 2000. Conclusions Consistent with our pre-clinical findings that PPIs may adversely impact vascular function, our data-mining study supports the association of PPI exposure with risk for MI in the general population. These data provide an example of how a combination of experimental studies and data-mining approaches can be applied to prioritize drug safety signals for further investigation.	[Shah, Nigam H.; LePendu, Paea; Bauer-Mehren, Anna; Iyer, Srinivasan V.] Stanford Univ, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Ghebremariam, Yohannes T.; Cooke, John P.] Houston Methodist Res Inst, Dept Cardiovasc Sci, Houston, TX USA; [Marcus, Jake] Practice Fus Inc, San Francisco, CA USA; [Nead, Kevin T.; Leeper, Nicholas J.] Stanford Univ, Div Cardiovasc Med & Vasc Surg, Stanford, CA 94305 USA	Stanford University; The Methodist Hospital System; The Methodist Hospital - Houston; Stanford University	Shah, NH (corresponding author), Stanford Univ, Stanford Ctr Biomed Informat Res, Stanford, CA 94305 USA.	nigam@stanford.edu		LePendu, Paea/0000-0001-7358-931X; Cooke, John/0000-0003-0033-9138	NIH grant [U54HG004028]; NLM grant [R01 LM011369]; NIGMS grant [R01 GM101430]; NIH [1U01HL100397]; Stanford School of Medicine Dean's fellowship [1049528-149-KAVFB]; Tobacco-Related Disease Research Program (TRDRP) of the University of California [20FT-0090]; NHLBI grant [5K01HL118683-04]; Houston Methodist Research Institute; Apixio, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397, K01HL118683] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004028] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101430] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM011369] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NLM grant; NIGMS grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford School of Medicine Dean's fellowship; Tobacco-Related Disease Research Program (TRDRP) of the University of California(University of California System); NHLBI grant; Houston Methodist Research Institute; Apixio, Inc.; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	PL, ABM, NHS and SVI acknowledge support from the NIH grant U54HG004028 for the National Center for Biomedical Ontology, NLM grant R01 LM011369, and NIGMS grant R01 GM101430. NHS also acknowledges research gift support from Apixio, Inc. This work was also supported in part by grants to JPC from the NIH (1U01HL100397), AHA (11IRG5180026), and the Stanford SPARK Translational Research Program. YTG was a recipient of the Stanford School of Medicine Dean's fellowship (1049528-149-KAVFB) and the Tobacco-Related Disease Research Program (TRDRP) of the University of California (20FT-0090). YTG is currently supported by the NHLBI grant 5K01HL118683-04 and by intramural funding from the Houston Methodist Research Institute. Practice Fusion provided support in the form of salaries for author JM, but did not have any additional role in the study design, and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section. Apixio, Inc., supported the project by providing an unrestricted research gift to Stanford University, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamopoulos AB, 2009, J CARDIOVASC PHARM, V54, P163, DOI 10.1097/FJC.0b013e3181af6d9c; Ari H, 2010, HEART VESSELS, V25, P19, DOI 10.1007/s00380-009-1158-x; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Charlot M, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d2690; Charlot M, 2010, ANN INTERN MED, V153, P378, DOI 10.7326/0003-4819-153-6-201009210-00005; Coloma PM, 2013, DRUG SAFETY, V36, P13, DOI 10.1007/s40264-012-0002-x; Committee CS., 1996, LANCET, V348, P1329; Cooke JP, 2011, ARTERIOSCL THROM VAS, V31, P1462, DOI 10.1161/ATVBAHA.111.228833; Cooke JP, 2010, VASC MED, V15, P235, DOI 10.1177/1358863X10362605; Cooke JP, 2004, CIRCULATION, V109, P1813, DOI 10.1161/01.CIR.0000126823.07732.D5; Dayal S, 2005, VASC MED, V10, pS27, DOI 10.1191/1358863x05vm599oa; Douglas IJ, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4388; Dunn SP, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.004564; Friedman CP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001456; Ghebremariam YT, 2013, CIRCULATION, V128, P845, DOI 10.1161/CIRCULATIONAHA.113.003602; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Goodman SG, 2012, CIRCULATION, V125, P978, DOI 10.1161/CIRCULATIONAHA.111.032912; Halevy A, 2009, IEEE INTELL SYST, V24, P8, DOI 10.1109/MIS.2009.36; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013; Honig PK, 2013, CLIN PHARMACOL THER, V93, P474, DOI 10.1038/clpt.2013.60; Ito Tetsuhide, 2010, Curr Gastroenterol Rep, V12, P448, DOI 10.1007/s11894-010-0141-0; Katz MH, 2010, ARCH INTERN MED, V170, P747, DOI 10.1001/archinternmed.2010.64; Leeper NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063499; LePendu P, 2013, CLIN PHARMACOL THER, V93, P547, DOI 10.1038/clpt.2013.47; LePendu P, 2013, LEARNING SIGNALS ADV, P83; Lowe Henry J, 2009, AMIA Annu Symp Proc, V2009, P391; Lu TM, 2011, INT J CARDIOL, V153, P135, DOI 10.1016/j.ijcard.2011.06.120; Madanick RD, 2011, CLEV CLIN J MED, V78, P39, DOI 10.3949/ccjm.77a.10087; Maggio M, 2013, JAMA INTERN MED, V173, P1559, DOI 10.1001/jamainternmed.2013.8459; Maggio M, 2013, JAMA INTERN MED, V173, P518, DOI 10.1001/jamainternmed.2013.2851; Mittermayer F, 2006, ARTERIOSCL THROM VAS, V26, P2536, DOI 10.1161/01.ATV.0000242801.38419.48; Nead KT, 2013, J AM COLL CARDIOL, V62, P553, DOI 10.1016/j.jacc.2013.04.061; Nead KT, 2013, AM J CARDIOL, V111, P851, DOI 10.1016/j.amjcard.2012.11.055; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Oudit GY, 2011, EUR J HEART FAIL, V13, P1211, DOI 10.1093/eurjhf/hfr104; Schillinger W, 2007, CIRCULATION, V116, P57, DOI 10.1161/CIRCULATIONAHA.106.666008; Shih CJ, 2014, INT J CARDIOL, V177, P292, DOI 10.1016/j.ijcard.2014.09.036; Simon T, 2011, CIRCULATION, V123, P474, DOI 10.1161/CIRCULATIONAHA.110.965640; Sossalla S, 2011, J CARDIOVASC SURG, V52, P437; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Tran CTL, 2003, ATHEROSCLEROSIS SUPP, V4, P33, DOI 10.1016/S1567-5688(03)00032-1; US Food and Drug Administration, FDA DRUG SAF PODC HE; Wilson AM, 2010, VASC MED, V15, P267, DOI 10.1177/1358863X10364552	47	222	235	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0124653	10.1371/journal.pone.0124653	http://dx.doi.org/10.1371/journal.pone.0124653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061035	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500007
J	Beguelini, MR; Goes, RM; Rahal, P; Morielle-Versute, E; Taboga, SR				Beguelini, Mateus R.; Goes, Rejane M.; Rahal, Paula; Morielle-Versute, Eliana; Taboga, Sebastiao R.			Impact of the Processes of Total Testicular Regression and Recrudescence on the Epididymal Physiology of the Bat Myotis nigricans (Chiroptera: Vespertilionidae)	PLOS ONE			English	Article							ANNUAL REPRODUCTIVE-CYCLE; ESTROGEN-RECEPTOR-ALPHA; FRUIT-EATING BAT; RAT EPIDIDYMIS; MORPHOLOGICAL-CHANGES; ANDROGEN RECEPTORS; BOAR EPIDIDYMIS; EXPRESSION; AROMATASE; PHYLLOSTOMIDAE	Myotis nigricans is a species of vespertilionid bat, whose males show two periods of total testicular regression within the same annual reproductive cycle in the northwest Sao Paulo State, Brazil. Studies have demonstrated that its epididymis has an elongation of the caudal portion, which stores spermatozoa during the period of testicular regression in July, but that they had no sperm during the regression in November. Thus, the aim of this study was to analyze the impact of the total testicular regression in the epididymal morphophysiology and patterns of its hormonal regulation. The results demonstrate a continuous activity of the epididymis from the Active to the Regressing periods; a morphofunctional regression of the epididymis in the Regressed period; and a slow recrudescence process. Thus, we concluded that the processes of total testicular regression and posterior recrudescence suffered by Myotis nigricans also impact the physiology of the epididymis, but with a delay in epididymal response. Epididymal physiology is regulated by testosterone and estrogen, through the production and secretion of testosterone by the testes, its conduction to the epididymis (mainly through luminal fluid), conversion of testosterone to dihydrotestosterone by the 5 alpha-reductase enzyme (mainly in epithelial cells) and to estrogen by aromatase; and through the activation/deactivation of the androgen receptor and estrogen receptor a in epithelial cells, which regulate the epithelial cell morphophysiology, prevents cell death and regulates their protein expression and secretion, which ensures the maturation and storage of the spermatozoa.	[Beguelini, Mateus R.; Goes, Rejane M.; Rahal, Paula; Taboga, Sebastiao R.] UNESP, Dept Biol, Sao Jose Do Rio Preto, SP, Brazil; [Morielle-Versute, Eliana] UNESP, Dept Bot & Zool, Sao Jose Do Rio Preto, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Beguelini, MR (corresponding author), UFOB, Ctr Biol & Hlth Sci, Barreiras, BA, Brazil.	mateus.beguelini@ufob.edu.br	Beguelini, Mateus Rodrigues/N-5063-2018; Góes, Rejane M/H-7954-2012; Rahal, Paula/D-3871-2012; Góes, Rejane Maira/AAY-5863-2020	Góes, Rejane M/0000-0002-3622-460X; Rahal, Paula/0000-0001-5693-6148; Góes, Rejane Maira/0000-0002-3622-460X; Beguelini, Mateus/0000-0002-9568-4446; Taboga, Sebastiao/0000-0002-0970-4288	Sao Paulo State Research Foundation (FAPESP) [Process: 2012/09194-0]; Brazilian National Research and Development Council (CNPq) [Process: 300163/2008-8, Process: 301596/2011-5, Process: 302008/2010-1]	Sao Paulo State Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Research and Development Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The scholarship awarded to Mateus Rodrigues Beguelini by the Sao Paulo State Research Foundation (FAPESP-Process: 2012/09194-0) is gratefully acknowledged. This work was also supported by Brazilian National Research and Development Council (CNPq) Processes: 300163/2008-8 and 301596/2011-5 research fellowships to Sebastiao R. Taboga and Process: 302008/2010-1 to Eliana Morielle-Versute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera-Merlo C, 2005, ANAT REC PART A, V282A, P83, DOI 10.1002/ar.a.20144; Ahmed MH, 2009, AUSTR J BASIC APPL S, V3, P2278; Avila DM, 1998, J ENDOCRINOL, V159, P403, DOI 10.1677/joe.0.1590403; Beguelini MR, 2014, GEN COMP ENDOCR, V201, P53, DOI 10.1016/j.ygcen.2014.03.044; Beguelini MR, 2014, REPROD FERT DEVELOP, V26, P834, DOI 10.1071/RD13109; Beguelini MR, 2013, MICROSC RES TECHNIQ, V76, P1035, DOI 10.1002/jemt.22264; Beguelini MR, 2013, GEN COMP ENDOCR, V185, P80, DOI 10.1016/j.ygcen.2012.12.009; Beguelini MR, 2013, ANAT REC, V296, P156, DOI 10.1002/ar.22613; Beguelini Mateus R., 2010, Chiroptera Neotropical, V16, P769; BENOIT JACQUES, 1926, ARCH ANAL HIST ET EMB, V5, P173; Beu CCL, 2009, ANAT HISTOL EMBRYOL, V38, P49, DOI 10.1111/j.1439-0264.2008.00891.x; Butenandt A., 1931, Z ANGEW CHEM, V44, P905, DOI [10.1002/ange.19310444602, DOI 10.1002/ANGE.19310444602]; Carpino A, 2004, J ANAT, V204, P217, DOI 10.1111/j.0021-8782.2004.00272.x; Crichton E. G., 2000, REPROD BIOL BATS; De Knegt LV, 2005, ARQ BRAS MED VET ZOO, V57, P576, DOI 10.1590/S0102-09352005000500002; Domeniconi RF, 2007, TISSUE CELL, V39, P47, DOI 10.1016/j.tice.2007.01.002; Ezer N., 2002, EPIDIDYMIS MOL CLIN, P297, DOI [10.1007/978-1-4615-0679-9_17, DOI 10.1007/978-1-4615-0679-9_17]; FELDEN F, 1992, J STEROID BIOCHEM, V42, P279, DOI 10.1016/0960-0760(92)90130-B; Hejmej A, 2005, DOMEST ANIM ENDOCRIN, V29, P534, DOI 10.1016/j.domaniend.2005.03.002; Hess R. A., 2004, Animal Reproduction, V1, P5; Hess RA, 1997, NATURE, V390, P509, DOI 10.1038/37352; Hosken DJ, 1996, J REPROD FERTIL, V108, P171; Jervis KM, 2001, BIOL REPROD, V65, P696, DOI 10.1095/biolreprod65.3.696; Joseph A, 2011, BIOL REPROD, V84, P207, DOI 10.1095/biolreprod.110.087353; KRUTZSCH PH, 1979, J REPROD FERTIL, V56, P333; Lambard S, 2003, MOL HUM REPROD, V9, P117, DOI 10.1093/molehr/gag020; Leon-Galvan MA, 2005, SOUTHWEST NAT, V50, P453, DOI 10.1894/0038-4909(2005)050[0453:MRCOMB]2.0.CO;2; Pearl CA, 2007, DOMEST ANIM ENDOCRIN, V33, P451, DOI 10.1016/j.domaniend.2006.09.003; Pelletier G, 2000, J ENDOCRINOL, V165, P359, DOI 10.1677/joe.0.1650359; Pereyra-Martinez AC, 2001, ENDOCRINE, V16, P15, DOI 10.1385/ENDO:16:1:15; Puga CCI, 2014, GEN COMP ENDOCR, V197, P33, DOI 10.1016/j.ygcen.2013.12.003; Puga CCI, 2013, REPROD FERT DEVELOP, V25, P558, DOI 10.1071/RD12029; Ribeiro MG, 2000, INICIACAO TECNICAS P; ROBAIRE B, 1977, ENDOCRINOLOGY, V101, P1379, DOI 10.1210/endo-101-5-1379; ROBAIRE B, 1995, BIOL REPROD, V52, P226, DOI 10.1095/biolreprod52.2.226; Robaire B, 1998, J REPROD FERTIL, P211; Robaire B, 2007, ASIAN J ANDROL, V9, P545, DOI 10.1111/j.1745-7262.2007.00316.x; Robaire B, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1071; Robaire B, 2011, J ANDROL, V32, P592, DOI 10.2164/jandrol.111.014266; Schimming BC, 2001, ANAT HISTOL EMBRYOL, V30, P327, DOI 10.1046/j.1439-0264.2001.00338.x; Schimming Bruno Cesar, 2002, Brazilian Journal of Veterinary Research and Animal Science, V39, P61; Serre V, 1998, BIOL REPROD, V58, P497, DOI 10.1095/biolreprod58.2.497; Shayu D, 2006, MOL CELL ENDOCRINOL, V249, P40, DOI 10.1016/j.mce.2006.01.016; Syntin P, 1999, BIOL REPROD, V61, P1622, DOI 10.1095/biolreprod61.6.1622; Tobon A. R., 2010, CONTACTOS, V78, P58; WEIBEL ER, 1966, J CELL BIOL, V30, P23, DOI 10.1083/jcb.30.1.23; WILSON DE, 1970, NATURE, V225, P1155, DOI 10.1038/2251155a0; Wimsatt WA, 1969, S SOC EXPT BIOL; Yamashita S, 2004, ANAT REC PART A, V279A, P768, DOI 10.1002/ar.a.20061	49	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128484	10.1371/journal.pone.0128484	http://dx.doi.org/10.1371/journal.pone.0128484			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057377	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000023
J	Dinga, JN; Wamalwa, M; Njimoh, DL; Njahira, MN; Djikeng, A; Skilton, R; Titanji, VPK; Pelle, R				Dinga, Jerome Nyhalah; Wamalwa, Mark; Njimoh, Dieudonne Lemuh; Njahira, Moses N.; Djikeng, Appolinaire; Skilton, Rob; Titanji, Vincent Pryde Kehdingha; Pelle, Roger			TpUB05, a Homologue of the Immunodominant Plasmodium falciparum Protein UB05, Is a Marker of Protective Immune Responses in Cattle Experimentally Vaccinated against East Coast Fever	PLOS ONE			English	Article							SPOROZOITES; PREDICTION; ANTIBODIES; ANTIGEN	Introduction East Coast fever, a devastating disease of cattle, can be controlled partially by vaccination with live T. parva sporozoites. The antigens responsible for conferring immunity are not fully characterized. Recently it was shown that the Plasmodium falciparum immunodominant protein UB05 is highly conserved in T. parva, the causative agent of East Coast fever. The aim of the present investigation was to determine the role of the homologue TpUB05 in protective immunity to East Coast fever. Methods The cloning, sequencing and expression of TpUB05 were done according to standard protocols. Bioinformatics analysis of TpUB05 gene was carried out using algorithms found in the public domain. Polyclonal antiserum against recombinant TpUB05 were raised in rabbits and used for further analysis by Western blotting, ELISA, immunolocalization and in vitro infection neutralization assay. The ability of recombinant TpUB05 (r-TpUB05) to stimulate bovine PBMCs ex-vivo to produce IFN-gamma or to proliferate was tested using ELISpot and [3H]-thymidine incorporation assays, respectively. Results All the 20 cattle immunised by the infection and treatment method (ITM) developed significantly higher levels of TpUB05 specific antibodies (p<0.0001) compared to the non-vaccinated ones. Similarly, r-TpUB05 highly stimulated bovine PMBCs from 8/12 (67%) of ITM-immunized cattle tested to produce IFN-gamma and proliferate (p<0.029) as compared to the 04 na ve cattle included as controls. Polyclonal TpUB05 antiserum raised against r-TpUB05 also marginally inhibited infection (p < 0.046) of bovine PBMCs by T. parva sporozoites. In further experiments RT-PCR showed that the TpUB05 gene is expressed by the parasite. This was confirmed by immunolocalization studies which revealed TpUB05 expression by schizonts and piroplasms. Bioinformatics analysis also revealed that this antigen possesses two transmembrane domains, a N-glycosylation site and several O-glycosylation sites. Conclusion It was concluded that TpUB05 is a potential marker of protective immunity in ECF worth investigating further.	[Dinga, Jerome Nyhalah; Njimoh, Dieudonne Lemuh; Titanji, Vincent Pryde Kehdingha] Univ Buea, Biotechnol Unit, Fac Sci, Buea, Cameroon; [Dinga, Jerome Nyhalah; Wamalwa, Mark; Njahira, Moses N.; Djikeng, Appolinaire; Skilton, Rob] Biosci Eastern & Cent Africa Int Livestock Res In, Nairobi, Kenya; [Dinga, Jerome Nyhalah; Pelle, Roger] Int Livestock Res Inst, Nairobi, Kenya	CGIAR; International Livestock Research Institute (ILRI)	Titanji, VPK (corresponding author), Univ Buea, Biotechnol Unit, Fac Sci, Buea, Cameroon.	vpk.titanji@yahoo.com		Djikeng, Appolinaire/0000-0001-9271-3419; Wamalwa, Mark/0000-0001-7714-2697; Dinga, Jerome/0000-0002-8457-4903	African Biosciences Challenge Fund from BecA-ILRI Hub, Nairobi, Kenya	African Biosciences Challenge Fund from BecA-ILRI Hub, Nairobi, Kenya	This work was supported by a fellowship awarded to Jerome Nyhalah Dinga through the African Biosciences Challenge Fund from BecA-ILRI Hub, Nairobi, Kenya. The authors also thank the University of Buea for time-off to carry out the research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Boulter N, 2000, ADV PARASIT, V44, P41; Fine P., 1999, ISSUES RELATING USE; Graham SP, 2006, P NATL ACAD SCI USA, V103, P3286, DOI 10.1073/pnas.0511273103; Harlow E., 1988, ANTIBODIES LAB MANUA; Hoof I, 2009, IMMUNOGENETICS, V61, P1, DOI 10.1007/s00251-008-0341-z; Kangethe RT, 2004, CLONING CHARACTERISA; Katende J, 1998, PARASITOL RES, V84, P408, DOI 10.1007/s004360050419; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Musoke A, 2005, VACCINE, V23, P3084, DOI 10.1016/j.vaccine.2004.09.039; MUSOKE AJ, 1984, IMMUNOLOGY, V52, P231; Nene V, 1996, INFECT IMMUN, V64, P2056, DOI 10.1128/IAI.64.6.2056-2061.1996; Norval RA, 1992, EPIDIMIOLOGY THEILER; Offit PA, 2008, VACCINES-BASEL, V2, P17, DOI 10.1016/b978-1-4557-0090-5.00004-5; Paranavitana C, 2005, CYTOKINE, V30, P86, DOI 10.1016/j.cyto.2004.12.009; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; RADLEY D E, 1975, Veterinary Parasitology, V1, P51, DOI 10.1016/0304-4017(75)90007-2; RADLEY D E, 1975, Veterinary Parasitology, V1, P35, DOI 10.1016/0304-4017(75)90005-9; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwartz L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-11; Strachan T, 1999, HUMAN MOL GENETICS; Thakur A, 2012, VACCINE, V30, P4907, DOI 10.1016/j.vaccine.2012.05.049; Titanji VPK, 2009, CLIN CHEM LAB MED, V47, P1147, DOI 10.1515/CCLM.2009.255; Titanji VPK, 2005, J CAMEROON ACAD SCI, V5, P49; Wahl G, 1998, PARASITOLOGY, V116, P349, DOI 10.1017/S003118209700228X; YOUNG AS, 1988, PARASITOLOGY, V96, P403, DOI 10.1017/S0031182000058388	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128040	10.1371/journal.pone.0128040	http://dx.doi.org/10.1371/journal.pone.0128040			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053064	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300021
J	Grieco, AJ; Billett, HH; Green, NS; Driscoll, MC; Bouhassira, EE				Grieco, Amanda J.; Billett, Henny H.; Green, Nancy S.; Driscoll, M. Catherine; Bouhassira, Eric E.			Variation in Gamma-Globin Expression before and after Induction with Hydroxyurea Associated with BCL11A, KLF1 and TAL1	PLOS ONE			English	Article							LOCUS-CONTROL REGION; SICKLE-CELL-ANEMIA; RED-BLOOD-CELLS; FETAL-HEMOGLOBIN; F-CELLS; PROTEIN; HYDROXYCARBAMIDE; HEREDITARY; MECHANISMS; HBS1L-MYB	The molecular mechanisms governing gamma-globin expression in a subset of fetal hemoglobin (alpha 2 gamma 2: HbF) expressing red blood cells (F-cells) and the mechanisms underlying the variability of response to hydroxyurea induced gamma-globin expression in the treatment of sickle cell disease are not completely understood. Here we analyzed intra-person clonal populations of basophilic erythroblasts (baso-Es) derived from bone marrow common myeloid progenitors in serum free cultures and report the level of fetal hemoglobin production in F-cells negatively correlates with expression of BCL11A, KLF1 and TAL1. We then examined the effects of hydroxyurea on these three transcription factors and conclude that a successful induction of gamma-globin includes a reduction in BCL11A, KLF1 and TAL1 expression. These data suggests that expression changes in this transcription factor network modulate gamma-globin expression in F-cells during steady state erythropoiesis and after induction with hydroxyurea.	[Grieco, Amanda J.; Bouhassira, Eric E.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA; [Billett, Henny H.] Albert Einstein Coll Med, Div Hematol, Dept Med, Montefiore Med Ctr, Bronx, NY 10467 USA; [Green, Nancy S.] Columbia Univ, Dept Pediat, Div Pediat Hematol Oncol Stem Cell Transplatat, New York, NY 10027 USA; [Driscoll, M. Catherine] AECOM, Dept Pediat, Div Hemato Oncol, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Yeshiva University; Albert Einstein College of Medicine	Bouhassira, EE (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10467 USA.	eric.bouhassira@einstein.yu.edu	Bouhassira, Eric/AAZ-4184-2021	Green, Nancy S./0000-0002-9877-1561	New York State Stem Cell Science [C024405, C024172]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER	New York State Stem Cell Science; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	EEB and AJG were supported by grants C024405 and C024172 from New York State Stem Cell Science [http://www.stemcell.ny.gov/].	[Anonymous], 2011, HEMATOL-AM SOC HEMAT, DOI DOI 10.1182/ASHEDUCATI0N-2011.1.459; Bauer DE, 2013, SCIENCE, V342, P253, DOI 10.1126/science.1242088; Bianchi E, 2010, BLOOD, V116, pE99, DOI 10.1182/blood-2009-08-238311; Borg J, 2010, NAT GENET, V42, P801, DOI 10.1038/ng.630; BOYER SH, 1975, SCIENCE, V188, P361, DOI 10.1126/science.804182; Charache S, 1995, N ENGL J MED, V332; Costa FC, 2007, BRIT J HAEMATOL, V136, P333, DOI 10.1111/j.1365-2141.2006.06424.x; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Elnitski L, 1997, J BIOL CHEM, V272, P369; Farrell JJ, 2011, BLOOD, V117, P4935, DOI 10.1182/blood-2010-11-317081; Flanagan JM, 2012, BRIT J HAEMATOL, V157, P240, DOI 10.1111/j.1365-2141.2012.09061.x; Ghatpande SS, 2010, J PROTEOMICS, V73, P619, DOI 10.1016/j.jprot.2009.11.003; Green NS, 2014, PEDIATR RES, V75, P196, DOI 10.1038/pr.2013.227; Green NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055709; Holmes ML, 1999, MOL CELL BIOL, V19, P4182; Lanzkron S, 2008, ANN INTERN MED, V148, P939, DOI 10.7326/0003-4819-148-12-200806170-00221; Lavelle D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036846; Lee M, 2003, ENVIRON MOL MUTAGEN, V42, P91, DOI 10.1002/em.10177; Lettre G, 2008, P NATL ACAD SCI USA, V105, P11869, DOI 10.1073/pnas.0804799105; Li LQ, 2010, J EXP MED, V207, P2543, DOI 10.1084/jem.20100504; MACKLIS RM, 1982, J CLIN INVEST, V70, P752, DOI 10.1172/JCI110671; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Menzel S, 2007, NAT GENET, V39, P1197, DOI 10.1038/ng2108; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Musallam KM, 2013, BLOOD, V121, P2199, DOI 10.1182/blood-2012-10-408021; NOGUCHI CT, 1988, NEW ENGL J MED, V318, P96, DOI 10.1056/NEJM198801143180207; NUEZ B, 1995, NATURE, V375, P316, DOI 10.1038/375316a0; Olivier EN, 2006, EXP HEMATOL, V34, P1635, DOI 10.1016/j.exphem.2006.07.003; Pace BS, 2006, DEV DYNAM, V235, P1727, DOI 10.1002/dvdy.20802; PAPAYANNOPOULOU T, 1977, P NATL ACAD SCI USA, V74, P2923, DOI 10.1073/pnas.74.7.2923; Pecoraro A, 2014, EUR J HAEMATOL, V92, P66, DOI 10.1111/ejh.12204; PERKINS AC, 1995, NATURE, V375, P318; PLATT OS, 1984, J CLIN INVEST, V74, P652, DOI 10.1172/JCI111464; Pourfarzad F, 2013, HAEMATOLOGICA, V98, P696, DOI 10.3324/haematol.2012.074492; POWARS DR, 1984, BLOOD, V63, P921, DOI 10.1182/blood.V63.4.921.921; Qiu CH, 2008, BLOOD, V111, P2400, DOI 10.1182/blood-2007-07-102087; RODGERS GP, 1990, NEW ENGL J MED, V322, P1037, DOI 10.1056/NEJM199004123221504; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Sedgewick AE, 2008, BLOOD CELL MOL DIS, V41, P255, DOI 10.1016/j.bcmd.2008.06.007; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Steinberg MH, 1997, BLOOD, V89, P1078, DOI 10.1182/blood.V89.3.1078; Suzuki M, 2013, MOL CELL BIOL, V33, P1687, DOI 10.1128/MCB.01617-12; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Walker AL, 2011, BLOOD, V118, P5664, DOI 10.1182/blood-2011-07-368746; Wang WC, 2011, LANCET, V377, P1663, DOI 10.1016/S0140-6736(11)60355-3; Ware RE, 2011, BLOOD, V118, P4985, DOI 10.1182/blood-2011-07-364190; WOOD WG, 1975, BLOOD, V46, P671; Xu J, 2010, GENE DEV, V24, P783, DOI 10.1101/gad.1897310; Yun WJ, 2014, NUCLEIC ACIDS RES, V42, P4283, DOI 10.1093/nar/gku072	51	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129431	10.1371/journal.pone.0129431	http://dx.doi.org/10.1371/journal.pone.0129431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053062	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300125
J	Kim, HW; Ryu, GW; Park, CH; Kang, EW; Park, JT; Han, SH; Yoo, TH; Shin, SK; Kang, SW; Choi, KH; Han, DS; Chang, TI				Kim, Hyung Woo; Ryu, Geun Woo; Park, Cheol Ho; Kang, Ea Wha; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Shin, Sug Kyun; Kang, Shin-Wook; Choi, Kyu Hun; Han, Dae Suk; Chang, Tae Ik			Hyponatremia Predicts New-Onset Cardiovascular Events in Peritoneal Dialysis Patients	PLOS ONE			English	Article							MAINTENANCE HEMODIALYSIS-PATIENTS; SERUM SODIUM CONCENTRATION; HEART-FAILURE; MORTALITY; RISK; INFLAMMATION; OUTCOMES; LEVEL	Background and Aim Cardiovascular (CV) disease is the leading cause of morbidity and mortality in patients on peritoneal dialysis (PD). Hyponatremia was recently shown to be a modifiable factor that is strongly associated with increased mortality in PD patients. However, the clinical impact of hyponatremia on CV outcomes in these patients is unclear. Methods To determine whether a low serum sodium level predicts the development of CV disease, we carried out a prospective observational study of 441 incident patients who started PD between January 2000 and December 2005. Time-averaged serum sodium (TA-Na) levels were determined to investigate the ability of hyponatremia to predict newly developed CV events in these patients. Results During a mean follow-up of 43.2 months, 106 (24.0%) patients developed new CV events. The cumulative incidence of new-onset CV events after the initiation of PD was significantly higher in patients with TA-Na levels <= 138 mEq/L than in those with a TA-Na > 138 mEq/L. After adjustment for multiple potentially confounding covariates, an increase in TA-Na level was found to be associated with a significantly lower risk of CV events (subdistribution hazard ratio per 1 mEq/L increase, 0.90; 95% confidence interval, 0.83-0.96; p = 0.003). Patients with a TA-Na <= 138 mEq/L had a 2.31-fold higher risk of suffering a CV event. Conclusions These results provide evidence of a clear association between low serum sodium and new-onset CV events after dialysis initiation in PD patients. Whether the correction of hyponatremia for this indication provides additional protection for the development of CV disease in these patients remains to be addressed in interventional studies.	[Kim, Hyung Woo; Ryu, Geun Woo; Park, Cheol Ho; Park, Jung Tak; Han, Seung Hyeok; Yoo, Tae-Hyun; Kang, Shin-Wook; Choi, Kyu Hun; Han, Dae Suk] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Severance Biomed Sci Inst, Brain Korea Med Sci 21, Seoul 120749, South Korea; [Kang, Ea Wha; Shin, Sug Kyun; Chang, Tae Ik] Ilsan Hosp, NHIS Med Ctr, Dept Internal Med, Goyangshi, Gyeonggi Do, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; NHIS Ilsan Hospital	Chang, TI (corresponding author), Ilsan Hosp, NHIS Med Ctr, Dept Internal Med, Goyangshi, Gyeonggi Do, South Korea.	tichang73@hanmail.net	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018; Kim, Hyung Woo/AAC-1448-2019	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635; Kim, Hyung Woo/0000-0002-6305-452X; Choi, Kyu Hun/0000-0003-0095-9011; Park, Jung Tak/0000-0002-2325-8982; Yoo, Tae-Hyun/0000-0002-9183-4507; Park, Cheol Ho/0000-0003-4636-5745; Kang, Shin-Wook/0000-0002-5677-4756	Brain Korea 21 Project for Medical Science, Yonsei University; National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2011-0030711]; Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [A102065]	Brain Korea 21 Project for Medical Science, Yonsei University(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Research Foundation of Korea (NRF) grant - Korean government (MEST); Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This work was supported by the Brain Korea 21 Project for Medical Science, Yonsei University, by a National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (No. 2011-0030711), and by a grant of the Korea Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; ARROYO V, 1976, AM J DIG DIS, V21, P249, DOI 10.1007/BF01095898; Bettari L, 2012, J CARD FAIL, V18, P74, DOI 10.1016/j.cardfail.2011.09.005; Bettari L, 2012, HEART FAIL REV, V17, P17, DOI 10.1007/s10741-010-9193-3; Chang TI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111373; Combs S, 2014, AM J KIDNEY DIS, V63, P294, DOI 10.1053/j.ajkd.2013.09.017; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Goldberg A, 2006, ARCH INTERN MED, V166, P781, DOI 10.1001/archinte.166.7.781; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Han SH, 2012, NAT REV NEPHROL, V8, P163, DOI 10.1038/nrneph.2012.12; Hecking M, 2012, AM J KIDNEY DIS, V59, P238, DOI 10.1053/j.ajkd.2011.07.013; Hoorn EJ, 2013, AM J KIDNEY DIS, V62, P139, DOI 10.1053/j.ajkd.2012.09.019; KATZ MA, 1973, NEW ENGL J MED, V289, P843, DOI 10.1056/NEJM197310182891607; Kovesdy CP, 2012, CIRCULATION, V125, P677, DOI 10.1161/CIRCULATIONAHA.111.065391; Krediet RT, 2010, NAT REV NEPHROL, V6, P451, DOI 10.1038/nrneph.2010.68; Kumar S, 1998, LANCET, V352, P220, DOI 10.1016/S0140-6736(97)12169-9; LEE WH, 1986, CIRCULATION, V73, P257, DOI 10.1161/01.CIR.73.2.257; Mandai S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-276; Mc Causland FR, 2012, NEPHROL DIAL TRANSPL, V27, P1613, DOI 10.1093/ndt/gfr497; Nigwekar SU, 2013, AM J KIDNEY DIS, V62, P755, DOI 10.1053/j.ajkd.2013.02.367; Pecoits R, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_11.28; SAXON LA, 1993, AM J CARDIOL, V72, P62, DOI 10.1016/0002-9149(93)90220-7; SCHAER GL, 1983, AM J CARDIOL, V51, P1635, DOI 10.1016/0002-9149(83)90200-X; Swart RM, 2011, NEPHRON PHYSIOL, V118, P45, DOI 10.1159/000322238; SZATALOWICZ VL, 1981, NEW ENGL J MED, V305, P263, DOI 10.1056/NEJM198107303050506; Upadhyay A, 2006, AM J MED, V119, pS30, DOI 10.1016/j.amjmed.2006.05.005; Vilar E, 2011, SEMIN DIALYSIS, V24, P487, DOI 10.1111/j.1525-139X.2011.00968.x; Waikar SS, 2011, AM J MED, V124, P77, DOI 10.1016/j.amjmed.2010.07.029; Wang AYM, 2011, SEMIN NEPHROL, V31, P159, DOI 10.1016/j.semnephrol.2011.01.005; WANNAMETHEE G, 1994, J HYPERTENS, V12, P971; Zevallos G, 2001, PERITON DIALYSIS INT, V21, P72	31	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129480	10.1371/journal.pone.0129480	http://dx.doi.org/10.1371/journal.pone.0129480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053619	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300130
J	Li, YS; Xi, Y; Li, XJ; Leng, CL; Jia, MM; Zhang, WK; Tang, HB				Li, Yu-Sang; Xi, Yang; Li, Xiao-Jun; Leng, Chang-Long; Jia, Mei-Mei; Zhang, Wei Kevin; Tang, He-Bin			Up-Regulation of the Biosynthesis and Release of Substance P through Wnt/beta-Catenin Signaling Pathway in Rat Dorsal Root Ganglion Cells	PLOS ONE			English	Article							NEUROKININ-1 RECEPTOR; PROSTAGLANDIN E-2; NEUROPATHIC PAIN; BETA-CATENIN; STEM-CELLS; NEURONS; ACTIVATION; DIFFERENTIATION; INHIBITION; EXPRESSION	To examine regulatory effects of beta-catenin on the biosynthesis and release of substance P, a rat chronic constriction injury (CCI) model and a rat dorsal root ganglion (DRG) cell culture model were used in the present study. The CCI treatment significantly induced the overall expression of beta-catenin (158 +/- 6% of sham) in the ipsilateral L5 DRGs in comparison with the sham group (109 +/- 4% of sham). The CCI-induced aberrant expression of beta-catenin was significantly attenuated by oral administration of diclofenac (119 +/- 6% of the sham value; 10 mg/kg). Importantly, aberrant nuclear accumulation of beta-catenin in cultured DRG cells resulted in up-regulation of the PPT-A mRNA expression and the substance P release. The up-regulation of both the PPT-A mRNA expression and the substance P release by either a GSK-3 beta inhibitor TWS119 (10 mu M) or a Wnt signaling agonist Wnt-3a (100 ng/ml) were significantly abolished by an inhibitor of cyclooxygenase-2 (COX-2; NS-398, 1 mu M). Collectively, these data suggest that nociceptive input-activated beta-catenin signaling plays an important role in regulating the biosynthesis and release of substance P, which may contribute to the inflammation responses related to chronic pain.	[Li, Yu-Sang; Li, Xiao-Jun; Leng, Chang-Long; Jia, Mei-Mei; Zhang, Wei Kevin; Tang, He-Bin] South Cent Univ Nationalities, Coll Pharm, Dept Pharmacol, Wuhan 430074, Peoples R China; [Xi, Yang] Ningbo Univ, Sch Med, Ningbo 315211, Zhejiang, Peoples R China	South Central Minzu University; Ningbo University	Tang, HB (corresponding author), South Cent Univ Nationalities, Coll Pharm, Dept Pharmacol, 182 Minyuan Rd, Wuhan 430074, Peoples R China.	hbtang2006@mail.scuec.edu.cn	Zhang, Wei/M-4241-2019	Zhang, Wei/0000-0003-4960-6137; Tang, He-Bin/0000-0002-2673-7882; Li, Yu-Sang/0000-0002-7508-0469	National Natural Science Foundation of China [81373842, 81101538]; Natural Science Foundation of China Hubei [2013CFB451]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China Hubei	Funding for this work was provided by the National Natural Science Foundation of China (81373842, 81101538), and Natural Science Foundation of China Hubei (2013CFB451).	Akaboshi S, 2009, AM J PATHOL, V175, P1675, DOI 10.2353/ajpath.2009.090069; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Gigliuto C, 2014, J PAIN RES, V7, P227, DOI 10.2147/JPR.S59161; Guan JS, 2005, CELL, V122, P619, DOI 10.1016/j.cell.2005.06.010; Halleskog C, 2013, J NEUROCHEM, V125, P803, DOI 10.1111/jnc.12250; Hillion J, 2012, PANCREATOLOGY, V12, P372, DOI 10.1016/j.pan.2012.05.005; Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363; Hua XY, 1999, NEUROSCIENCE, V89, P525, DOI 10.1016/S0306-4522(98)00488-6; Ji YS, 1998, CIRC RES, V83, P295, DOI 10.1161/01.RES.83.3.295; Li YS, 2012, J PHARMACOL SCI, V118, P43, DOI 10.1254/jphs.11160FP; Li YS, 2011, WORLD J GASTROENTERO, V17, P1772, DOI 10.3748/wjg.v17.i13.1772; Lim K, 2008, CANCER RES, V68, P553, DOI 10.1158/0008-5472.CAN-07-2295; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Mei G, 2013, CELL BIOL INT, V37, P1225, DOI 10.1002/cbin.10158; Monga SPS, 2011, INT J BIOCHEM CELL B, V43, P1021, DOI 10.1016/j.biocel.2009.09.001; Muralidharan S, 2011, J IMMUNOL, V187, P5221, DOI 10.4049/jimmunol.1101585; Nunez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018562; Ring A, 2014, STEM CELL REV REP, V10, P512, DOI 10.1007/s12015-014-9515-2; Shi YQ, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-47; St-Jacques B, 2011, J NEUROCHEM, V118, P841, DOI 10.1111/j.1471-4159.2011.07230.x; Tang HB, 2008, J PHARMACOL SCI, V108, P190, DOI 10.1254/jphs.08163FP; Tang HB, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-42; Tang HB, 2008, N-S ARCH PHARMACOL, V377, P325, DOI 10.1007/s00210-007-0211-5; Tang HB, 2007, J PHARMACOL SCI, V105, P264, DOI 10.1254/jphs.FP0071359; Tang HB, 2008, NEUROPHARMACOLOGY, V55, P1405, DOI 10.1016/j.neuropharm.2008.08.037; Tesfaye A, 2007, CANCER RES, V67, P3998, DOI 10.1158/0008-5472.CAN-05-1684; Van Hecken A, 2000, J CLIN PHARMACOL, V40, P1109; Xia XC, 2010, MOL CELL BIOL, V30, P206, DOI 10.1128/MCB.01844-08; Yaksh TL, 2001, J NEUROSCI, V21, P5847, DOI 10.1523/JNEUROSCI.21-16-05847.2001; Zhang XQ, 2010, CELL MOL NEUROBIOL, V30, P885, DOI 10.1007/s10571-010-9517-9; Zhang YK, 2013, J CLIN INVEST, V123, P2268, DOI 10.1172/JCI65364	32	8	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129701	10.1371/journal.pone.0129701	http://dx.doi.org/10.1371/journal.pone.0129701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26054011	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300159
J	Fergnani, PN; Ruggiero, A				Nilda Fergnani, Paula; Ruggiero, Adriana			Ecological Diversity in South American Mammals: Their Geographical Distribution Shows Variable Associations with Phylogenetic Diversity and Does Not Follow the Latitudinal Richness Gradient	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; NICHE CONSERVATISM; MORPHOLOGICAL DIVERSITY; HISTORICAL BIOGEOGRAPHY; SPECIES RICHNESS; GLOBAL PATTERNS; BODY-SIZE; EVOLUTION; TROPICS; BIODIVERSITY	The extent to which the latitudinal gradient in species richness may be paralleled by a similar gradient of increasing functional or phylogenetic diversity is a matter of controversy. We evaluated whether taxonomic richness (TR) is informative in terms of ecological diversity (ED, an approximation to functional diversity) and phylogenetic diversity (AvPD) using data on 531 mammal species representing South American old autochthonous (marsupials, xenarthrans), mid-Cenozoic immigrants (hystricognaths, primates) and newcomers (carnivorans, artiodactyls). If closely related species are ecologically more similar than distantly related species, AvPD will be a strong predictor of ED; however, lower ED than predicted from AvPD may be due to species retaining most of their ancestral characters, suggesting niche conservatism. This pattern could occur in tropical rainforests for taxa of tropical affinity (old autochthonous and mid-Cenozoic immigrants) and in open and arid habitats for newcomers. In contrast, higher ED than expected from AvPD could occur, possibly in association with niche evolution, in arid and open habitats for taxa of tropical affinity and in forested habitats for newcomers. We found that TR was a poor predictor of ED and AvPD. After controlling for TR, there was considerable variability in the extent to which AvPD accounted for ED. Taxa of tropical affinity did not support the prediction of ED deficit within tropical rainforests, rather, they showed a mosaic of regions with an excess of ED interspersed with zones of ED deficit within the tropics; newcomers showed ED deficit in arid and open regions. Some taxa of tropical affinity showed excess of ED in tropical desert areas (hystricognaths) or temperate semideserts (xenarthrans); newcomers showed excess of ED at cold-temperate latitudes in the Northern Hemisphere. This result suggests that extreme climatic conditions at both temperate and tropical latitudes may have promoted niche evolution in mammals.	[Nilda Fergnani, Paula; Ruggiero, Adriana] Univ Nacl Comahue, INIBIOMA, CONICET, Lab Ecotono,Ctr Reg Univ Bariloche, San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Fergnani, PN (corresponding author), Univ Nacl Comahue, INIBIOMA, CONICET, Lab Ecotono,Ctr Reg Univ Bariloche, San Carlos De Bariloche, Rio Negro, Argentina.	paulafergnani@gmail.com			CONICET (National Scientific and Technical Research Council Argentina) [PIP-114-200901-00089]; Universidad Nacional del Comahue	CONICET (National Scientific and Technical Research Council Argentina); Universidad Nacional del Comahue	This work was supported by PIP-114-200901-00089 - CONICET (www.conicet.gov.ar) (National Scientific and Technical Research Council Argentina) (AR); and Universidad Nacional del Comahue (http://www.uncoma.edu.ar/) (AR PNF).	Antoine PO, 2012, P ROY SOC B-BIOL SCI, V279, P1319, DOI 10.1098/rspb.2011.1732; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Baiser B, 2011, GLOBAL ECOL BIOGEOGR, V20, P134, DOI 10.1111/j.1466-8238.2010.00583.x; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Brown JH, 2014, J BIOGEOGR, V41, P8, DOI 10.1111/jbi.12228; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Cadotte M, 2013, ECOL LETT, V16, P1234, DOI 10.1111/ele.12161; Cooper N, 2011, P ROY SOC B-BIOL SCI, V278, P2384, DOI 10.1098/rspb.2010.2207; Davies TJ, 2008, P NATL ACAD SCI USA, V105, P11556, DOI 10.1073/pnas.0801917105; Davies TJ, 2011, PHILOS T R SOC B, V366, P2414, DOI 10.1098/rstb.2011.0058; de Carvalho RA, 2010, NAT CONSERVACAO, V8, P171, DOI 10.4322/natcon.00802011; Delsuc F, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-11; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; *ESRI, 2007, ARCGIS 9 2 SOFTW; Faith DP, 1996, CONSERV BIOL, V10, P1286, DOI 10.1046/j.1523-1739.1996.10041286.x; Fenker J, 2014, DIVERS DISTRIB, V20, P1108, DOI 10.1111/ddi.12217; Fritz SA, 2012, J BIOGEOGR, V39, P1373, DOI 10.1111/j.1365-2699.2012.02757.x; Fritz SA, 2010, P ROY SOC B-BIOL SCI, V277, P2435, DOI 10.1098/rspb.2010.0030; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Groves C, 2004, INT J PRIMATOL, V25, P1105, DOI 10.1023/B:IJOP.0000043354.36778.55; Harcourt AH, 2006, J BIOGEOGR, V33, P2077, DOI 10.1111/j.1365-2699.2006.01557.x; Hawkins BA, 2012, J BIOGEOGR, V39, P825, DOI 10.1111/j.1365-2699.2011.02655.x; Huang S, 2012, P ROY SOC B-BIOL SCI, V279, P4997, DOI 10.1098/rspb.2012.1981; Isaac NJB, 2004, DIVERS DISTRIB, V10, P275, DOI 10.1111/j.1366-9516.2004.00092.x; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Perez SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068029; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kozak KH, 2006, EVOLUTION, V60, P2604, DOI 10.1111/j.0014-3820.2006.tb01893.x; Kozak KH, 2010, ECOL LETT, V13, P1378, DOI 10.1111/j.1461-0248.2010.01530.x; Laliberte E, 2010, FD MEASURING FUNCTIO, DOI [10.1001/jamapsychiatry.2015.49, DOI 10.1001/JAMAPSYCHIATRY.2015.49]; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Marquet PA, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P191; Mayfield MM, 2010, GLOBAL ECOL BIOGEOGR, V19, P423, DOI 10.1111/j.1466-8238.2010.00532.x; Mazel F, 2014, GLOBAL ECOL BIOGEOGR, V23, P836, DOI 10.1111/geb.12158; Morales-Castilla I, 2012, AM NAT, V180, P246, DOI 10.1086/666608; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Fergnani PN, 2013, MEM I OSWALDO CRUZ, V108, P997, DOI 10.1590/0074-0276130369; Olalla-Tarraga MA, 2011, J BIOGEOGR, V38, P2237, DOI 10.1111/j.1365-2699.2011.02570.x; Ortiz-Jaureguizar E, 2006, J ARID ENVIRON, V66, P498, DOI 10.1016/j.jaridenv.2006.01.007; Pascual R, 2006, ANN MO BOT GARD, V93, P209, DOI 10.3417/0026-6493(2006)93[209:EAGTBH]2.0.CO;2; Patterson BD, 2003, DIGITAL DISTRIBUTION; Pausas JG, 2010, BIOSCIENCE, V60, P614, DOI 10.1525/bio.2010.60.8.7; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Podani J, 2006, OIKOS, V115, P179, DOI 10.1111/j.2006.0030-1299.15048.x; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rowe N, 1996, PICTORIAL GUIDE LIVI; Roy K, 2004, Frontiers of Biogeography: New Directions in the Geography of Nature, P151; Roy K, 2001, P ROY SOC B-BIOL SCI, V268, P2503, DOI 10.1098/rspb.2000.1428; Safi K, 2011, PHILOS T R SOC B, V366, P2536, DOI 10.1098/rstb.2011.0024; Schleuter D, 2010, ECOL MONOGR, V80, P469, DOI 10.1890/08-2225.1; Schweiger O, 2008, OECOLOGIA, V157, P485, DOI 10.1007/s00442-008-1082-2; Shepherd UL, 1998, J BIOGEOGR, V25, P19, DOI 10.1046/j.1365-2699.1998.251172.x; Springer MS, 2011, PHILOS T R SOC B, V366, P2478, DOI 10.1098/rstb.2011.0023; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stevens RD, 2003, ECOL LETT, V6, P1099, DOI 10.1046/j.1461-0248.2003.00541.x; Stevens RD, 2012, J ANIM ECOL, V81, P455, DOI 10.1111/j.1365-2656.2011.01900.x; Tucker CM, 2013, DIVERSITY DISTRIB; Verzi DH, 2014, ACTA PALAEONTOL POL, V59, P757, DOI 10.4202/app.2012.0135; Verzi Diego H., 2002, Mastozoologia Neotropical, V9, P309; Warwick RM, 1998, J APPL ECOL, V35, P532, DOI 10.1046/j.1365-2664.1998.3540532.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Woodburne MO, 2010, J MAMM EVOL, V17, P245, DOI 10.1007/s10914-010-9144-8	66	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128264	10.1371/journal.pone.0128264	http://dx.doi.org/10.1371/journal.pone.0128264			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053742	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300027
J	Omori, Y; Chaya, T; Yoshida, S; Irie, S; Tsujii, T; Furukawa, T				Omori, Yoshihiro; Chaya, Taro; Yoshida, Satoyo; Irie, Shoichi; Tsujii, Toshinori; Furukawa, Takahisa			Identification of G Protein-Coupled Receptors (GPCRs) in Primary Cilia and Their Possible Involvement in Body Weight Control	PLOS ONE			English	Article							PROLACTIN-RELEASING PEPTIDE; REDUCES FOOD-INTAKE; NEUROMEDIN-U; NEUROPEPTIDE FF; NEURONAL CILIA; MICE LEADS; MOUSE LINE; GPR10; INTRAFLAGELLAR; LOCALIZATION	Primary cilia are sensory organelles that harbor various receptors such as G protein-coupled receptors (GPCRs). We analyzed subcellular localization of 138 non-odorant GPCRs. We transfected GPCR expression vectors into NIH3T3 cells, induced ciliogenesis by serum starvation, and observed subcellular localization of GPCRs by immunofluorescent staining. We found that several GPCRs whose ligands are involved in feeding behavior, including prolactin-releasing hormone receptor (PRLHR), neuropeptide FF receptor 1 (NPFFR1), and neuromedin U receptor 1 (NMUR1), localized to the primary cilia. In addition, we found that a short form of dopamine receptor D2 (DRD2S) is efficiently transported to the primary cilia, while a long form of dopamine receptor D2 (DRD2L) is rarely transported to the primary cilia. Using an anti-Prlhr antibody, we found that Prlhr localized to the cilia on the surface of the third ventricle in the vicinity of the hypothalamic periventricular nucleus. We generated the Npy2r-Cre transgenic mouse line in which Cre-recombinase is expressed under the control of the promoter of Npy2r encoding a ciliary GPCR. By mating Npy2r-Cre mice with Ift80 flox mice, we generated Ift80 conditional knockout (CKO) mice in which Npy2r-positive cilia were diminished in number. We found that Ift80 CKO mice exhibited a body weight increase. Our results suggest that Npy2r-positive cilia are important for body weight control.	[Omori, Yoshihiro; Chaya, Taro; Yoshida, Satoyo; Irie, Shoichi; Tsujii, Toshinori; Furukawa, Takahisa] Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, Suita, Osaka, Japan; [Omori, Yoshihiro; Chaya, Taro] JST, PRESTO, Suita, Osaka, Japan	Osaka University; Japan Science & Technology Agency (JST)	Furukawa, T (corresponding author), Osaka Univ, Inst Prot Res, Lab Mol & Dev Biol, 3-2 Yamadaoka, Suita, Osaka, Japan.	takahisa.furukawa@protein.osaka-u.ac.jp			PRESTO from Japan Science and Technology Agency [4118]; Japan Society for the Promotion of Science [25113519, 23113728, 15H04669, 25293070]; Takeda Science Foundation; Uehara Memorial Foundation; Research Foundation for Opto-Science and Technology; Suzuken Memorial Foundation; Naito Foundation [220]; Hyogo Science and Technology Association; Osaka Community Foundation; Grants-in-Aid for Scientific Research [15K18955] Funding Source: KAKEN	PRESTO from Japan Science and Technology Agency; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Research Foundation for Opto-Science and Technology; Suzuken Memorial Foundation; Naito Foundation(Naito Memorial Foundation); Hyogo Science and Technology Association; Osaka Community Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by PRESTO (#4118 for YO) from Japan Science and Technology Agency (http://www.jst.go.jp/), Grants-in-Aid for Scientific Research on Innovative Areas (#25113519, #23113728 for YO), Grant-in-Aid for Scientific Research (B) (#15H04669 for TF, #25293070 for YO) from Japan Society for the Promotion of Science (http://www.jsps.go.jp/), The Takeda Science Foundation (for YO and TF) (http://www.takeda-sci.or.jp/), The Uehara Memorial Foundation (for YO) (http://www.ueharazaidan.or.jp/), Research Foundation for Opto-Science and Technology (for TF) (http://www.refost-hq.jp/gaiyo.html), Suzuken Memorial Foundation (for YO) (http://www.suzukenzaidan.or.jp/), Naito Foundation (#220 for YO) (https://www.naito-f.or.jp/), Hyogo Science and Technology Association (for TF) (http://www.hyogosta.jp/), The Osaka Community Foundation (for TF) (http://www.osaka-community.or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2005, EUR J NEUROSCI, V21, P2837, DOI 10.1111/j.1460-9568.2005.04100.x; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Beales PL, 2007, NAT GENET, V39, P727, DOI 10.1038/ng2038; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Berbari NF, 2007, J NEUROSCI RES, V85, P1095, DOI 10.1002/jnr.21209; Bjursell M, 2007, BIOCHEM BIOPH RES CO, V363, P633, DOI 10.1016/j.bbrc.2007.09.016; Bolborea M, 2013, TRENDS NEUROSCI, V36, P91, DOI 10.1016/j.tins.2012.12.008; Bonini JA, 2000, J BIOL CHEM, V275, P39324, DOI 10.1074/jbc.M004385200; Brailov I, 2000, BRAIN RES, V872, P271, DOI 10.1016/S0006-8993(00)02519-1; Butler A A, 2001, Trends Genet, V17, pS50, DOI 10.1016/S0168-9525(01)02481-7; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034; Desprat C, 1997, PHARMACOL BIOCHEM BE, V58, P559, DOI 10.1016/S0091-3057(97)00249-9; Domire JS, 2011, CELL MOL LIFE SCI, V68, P2951, DOI 10.1007/s00018-010-0603-4; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Fain GL, 2010, CURR BIOL, V20, pR114, DOI 10.1016/j.cub.2009.12.006; Fitzgerald Peter, 2008, J Psychopharmacol, V22, P12, DOI 10.1177/0269216307087148; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fukusumi S, 2006, PEPTIDES, V27, P1073, DOI 10.1016/j.peptides.2005.06.031; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; GICQUEL S, 1993, PEPTIDES, V14, P749, DOI 10.1016/0196-9781(93)90108-S; Gu W, 2004, J MOL NEUROSCI, V22, P93, DOI 10.1385/JMN:22:1-2:93; Hanada R, 2004, NAT MED, V10, P1067, DOI 10.1038/nm1106; Handel M, 1999, NEUROSCIENCE, V89, P909, DOI 10.1016/S0306-4522(98)00354-6; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Hinuma S, 2000, NAT CELL BIOL, V2, P703, DOI 10.1038/35036326; Howard AD, 2000, NATURE, V406, P70, DOI 10.1038/35017610; Imayoshi I, 2012, NEUROSCI RES, V73, P85, DOI 10.1016/j.neures.2012.02.003; JAINCHIL.JL, 1969, J VIROL, V4, P549, DOI 10.1128/JVI.4.5.549-553.1969; Jenkins PM, 2006, CURR BIOL, V16, P1211, DOI 10.1016/j.cub.2006.04.034; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kojima M, 2000, BIOCHEM BIOPH RES CO, V276, P435, DOI 10.1006/bbrc.2000.3502; Langford LA, 1997, ULTRASTRUCT PATHOL, V21, P135, DOI 10.3109/01913129709021312; Laurent P, 2005, NAT NEUROSCI, V8, P1735, DOI 10.1038/nn1585; Lawrence CB, 2000, NAT NEUROSCI, V3, P645, DOI 10.1038/76597; Lawrence CB, 2004, AM J PHYSIOL-REG I, V286, pR101, DOI 10.1152/ajpregu.00402.2003; Lin S, 2004, NEUROPEPTIDES, V38, P189, DOI 10.1016/j.npep.2004.05.005; Loktev AV, 2013, CELL REP, V5, P1316, DOI 10.1016/j.celrep.2013.11.011; Louvi A, 2011, NEURON, V69, P1046, DOI 10.1016/j.neuron.2011.03.002; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Maruyama M, 1999, NEUROSCI LETT, V276, P193, DOI 10.1016/S0304-3940(99)00831-9; Matsumoto H, 2000, NEUROSCI LETT, V285, P234, DOI 10.1016/S0304-3940(00)01077-6; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P1078, DOI 10.1016/0006-291X(85)91726-7; Mori K, 2005, EMBO J, V24, P325, DOI 10.1038/sj.emboj.7600526; Murase T, 1996, PEPTIDES, V17, P353, DOI 10.1016/0196-9781(95)02137-X; Nakazato M, 2000, BIOCHEM BIOPH RES CO, V277, P191, DOI 10.1006/bbrc.2000.3669; Naveilhan P, 1999, NAT MED, V5, P1188, DOI 10.1038/13514; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Onaka T, 2010, TRENDS ENDOCRIN MET, V21, P287, DOI 10.1016/j.tem.2010.01.005; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; Roland BL, 1999, ENDOCRINOLOGY, V140, P5736, DOI 10.1210/en.140.12.5736; Samson WK, 2000, BRAIN RES, V858, P19, DOI 10.1016/S0006-8993(99)02451-8; Sato S, 2007, GENESIS, V45, P502, DOI 10.1002/dvg.20318; Seal LJ, 2000, ENDOCRINOLOGY, V141, P1909, DOI 10.1210/en.141.5.1909; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; Sunter D, 2001, NEUROSCI LETT, V313, P145, DOI 10.1016/S0304-3940(01)02267-4; Tobin JL, 2009, GENET MED, V11, P386, DOI 10.1097/GIM.0b013e3181a02882; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Watanabe TK, 2005, CLIN EXP PHARMACOL P, V32, P355, DOI 10.1111/j.1440-1681.2005.04196.x; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zaghloul NA, 2010, TRENDS GENET, V26, P168, DOI 10.1016/j.tig.2010.01.006	62	34	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128422	10.1371/journal.pone.0128422	http://dx.doi.org/10.1371/journal.pone.0128422			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053317	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300037
J	Terai, T; Okumura, T; Imai, S; Nakao, M; Yamaji, K; Ito, M; Nagata, T; Kaneko, K; Miyazaki, K; Okada, A; Nomura, Y; Hanada, N				Terai, Tomohiko; Okumura, Takekazu; Imai, Susumu; Nakao, Masumi; Yamaji, Kazuaki; Ito, Masahiko; Nagata, Tsuyoshi; Kaneko, Kimiyuki; Miyazaki, Kouji; Okada, Ayako; Nomura, Yoshiaki; Hanada, Nobuhiro			Screening of Probiotic Candidates in Human Oral Bacteria for the Prevention of Dental Disease	PLOS ONE			English	Article							SALIVARY MUTANS STREPTOCOCCI; VOLATILE SULFUR-COMPOUNDS; PERIODONTAL-DISEASE; LACTOBACILLUS; STRAINS; BIFIDOBACTERIUM; COLONIZATION; ENDOCARDITIS; INFECTIONS; ADHERENCE	The oral cavity in healthy subjects has a well-balanced microbiota that consists of more than 700 species. However, a disturbance of this balance, with an increase of harmful microbes and a decrease of beneficial microbes, causes oral disorders such as periodontal disease or dental caries. Nowadays, probiotics are expected to confer oral health benefits by modulating the oral microbiota. This study screened new probiotic candidates with potential oral health benefits and no harmful effects on the oral cavity. We screened 14 lactobacillus strains and 36 streptococcus strains out of 896 oral isolates derived from healthy subjects. These bacteria did not produce volatile sulfur compounds or water-insoluble glucan, had higher antibacterial activity against periodontal bacteria, and had higher adherence activity to oral epithelial cells or salivary-coated hydroxyapatite in vitro. We then evaluated the risk of primary cariogenicity and infective endocarditis of the selected oral isolates. As a result, Lactobacillus crispatus YIT 12319, Lactobacillus fermentum YIT 12320, Lactobacillus gasseri YIT 12321, and Streptococcus mitis YIT 12322 were selected because they showed no cariogenic potential in an artificial mouth system and a lower risk of experimental infective endocarditis in a rat model. These candidates are expected as new probiotics with potential oral health benefits and no adverse effects on general health.	[Terai, Tomohiko; Okumura, Takekazu; Nakao, Masumi; Yamaji, Kazuaki; Ito, Masahiko; Nagata, Tsuyoshi; Kaneko, Kimiyuki; Miyazaki, Kouji] Yakult Cent Inst, Tokyo, Japan; [Imai, Susumu; Okada, Ayako; Nomura, Yoshiaki; Hanada, Nobuhiro] Tsurumi Univ, Sch Dent Med, Dept Translat Res, Yokohama, Kanagawa, Japan	Yakult Honsha Company, Limited; Tsurumi University	Terai, T (corresponding author), Yakult Cent Inst, Tokyo, Japan.	tomohiko-terai@yakult.co.jp	Hanada, Nobuhiro/C-5308-2011	Nomura, Yoshiaki/0000-0002-0814-0572	Yakult Central Institute; Grants-in-Aid for Scientific Research [15K20655] Funding Source: KAKEN	Yakult Central Institute; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was funded by the Yakult Central Institute (http://institute.yakult.co.jp/). The funder provided support in the form of salaries for authors TT, TO, MN, KY, MI, TN, KK, and KM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. SI and NH received research funds from the Yakult Central Institute. All remaining authors declare no potential conflicts of interest with respect to the authorship and publication of this article. The specific roles of the authors are detailed in the Author Contributions' section.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Allen BL, 2002, MICROB PATHOGENESIS, V32, P191, DOI 10.1006/mpat.2002.0496; Arihara K, 1996, LETT APPL MICROBIOL, V22, P420, DOI 10.1111/j.1472-765X.1996.tb01194.x; Asahara T, 2003, CLIN DIAGN LAB IMMUN, V10, P169, DOI 10.1128/CDLI.10.1.169-173.2003; Bosch M, 2012, ARCH ORAL BIOL, V57, P539, DOI 10.1016/j.archoralbio.2011.10.006; Burton JP, 2006, J APPL MICROBIOL, V100, P754, DOI 10.1111/j.1365-2672.2006.02837.x; Busscher HJ, 1999, CARIES RES, V33, P403, DOI 10.1159/000016541; Caglar E, 2008, ACTA ODONTOL SCAND, V66, P154, DOI 10.1080/00016350802089467; Caglar E, 2006, ACTA ODONTOL SCAND, V64, P314, DOI 10.1080/00016350600801709; Caglar E, 2009, INT J PAEDIATR DENT, V19, P377, DOI 10.1111/j.1365-263X.2009.00989.x; Cannon JP, 2005, EUR J CLIN MICROBIOL, V24, P31, DOI 10.1007/s10096-004-1253-y; Do T, 2013, CLIN COSMET INVESTIG, V5, P11, DOI 10.2147/CCIDE.S31005; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; GIBBONS RJ, 1976, INFECT IMMUN, V14, P1109, DOI 10.1128/IAI.14.4.1109-1112.1976; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Gulati M, 2013, INT J PREVENTIVE MED, V4, P988; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Han YW, 2013, J DENT RES, V92, P485, DOI 10.1177/0022034513487559; Hatakka K, 2007, J DENT RES, V86, P125, DOI 10.1177/154405910708600204; HERAIEF E, 1982, INFECT IMMUN, V37, P127; Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6; Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food, 2002, GUID EV PROB FOOD, P1; Kato H, 2005, Oral Dis, V11 Suppl 1, P67, DOI 10.1111/j.1601-0825.2005.01096.x; Kolenbrander PE, 2002, MICROBIOL MOL BIOL R, V66, P486, DOI 10.1128/MMBR.66.3.486-505.2002; Koll-Klais P, 2005, ORAL MICROBIOL IMMUN, V20, P354, DOI 10.1111/j.1399-302X.2005.00239.x; Makino H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078331; Makino Y, 2012, J PERIODONTOL, V83, P635, DOI 10.1902/jop.2011.110275; Masdea L, 2012, ARCH ORAL BIOL, V57, P1041, DOI 10.1016/j.archoralbio.2012.02.011; Matsuki T, 2004, APPL ENVIRON MICROB, V70, P167, DOI 10.1128/AEM.70.1.167-173.2004; Ministry of Health Labour and Welfare, 2011, SURV DENT DIS 2011; Miyake T, 1998, MICROBIOL IMMUNOL, V42, P661, DOI 10.1111/j.1348-0421.1998.tb02337.x; Morita E, 2004, ORAL MICROBIOL IMMUN, V19, P386, DOI 10.1111/j.1399-302x.2004.00173.x; Moriya S., 2011, Journal of the National Institute of Public Health, V60, P379; MUKASA H, 1973, INFECT IMMUN, V8, P555, DOI 10.1128/IAI.8.4.555-562.1973; Nase L, 2001, CARIES RES, V35, P412, DOI 10.1159/000047484; Nikawa H, 2011, J INVESTIG CLIN DENT, V2, P187, DOI 10.1111/j.2041-1626.2011.00056.x; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Nomoto K, 2005, J BIOSCI BIOENG, V100, P583, DOI 10.1263/jbb.100.583; Ochiai K, 2011, ANTIBIOT CHEMOTHER, V27, P18; Olivares M, 2006, J APPL MICROBIOL, V101, P72, DOI 10.1111/j.1365-2672.2006.02981.x; Salako NO, 2011, MED PRIN PRACT, V20, P75, DOI 10.1159/000319760; Santiago B, 2012, J BACTERIOL, V194, P2010, DOI 10.1128/JB.06737-11; Shimauchi H, 2008, J CLIN PERIODONTOL, V35, P897, DOI 10.1111/j.1600-051X.2008.01306.x; Sookkhee S, 2001, J APPL MICROBIOL, V90, P172, DOI 10.1046/j.1365-2672.2001.01229.x; Stephan Robert M., 1943, JOUR DENTAL RES, V22, P45, DOI 10.1177/00220345430220010601; Sun ZL, 2013, APPL MICROBIOL BIOT, V97, P1941, DOI 10.1007/s00253-012-4044-x; TAKAHASHI N, 1990, J DENT RES, V69, P1266, DOI 10.1177/00220345900690060801; Takemura H, 1996, ANTIMICROB AGENTS CH, V40, P2280, DOI 10.1128/AAC.40.10.2280; Tanaka M, 2004, MICROBES INFECT, V6, P1078, DOI 10.1016/j.micinf.2004.05.021; Tangerman A, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/1/017010; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; van Reenen CA, 1998, J APPL MICROBIOL, V84, P1131; Vanessa V, 2007, J MED MICROBIOL, V56, P1017; Xiong YQ, 2005, ANTIMICROB AGENTS CH, V49, P380, DOI 10.1128/AAC.49.1.380-387.2005; Yoshida E, 2013, J HARD TISSUE BIOL, V22, P419; Zahradnik RT, 2009, J APPL MICROBIOL, V107, P682, DOI 10.1111/j.1365-2672.2009.04243.x	56	40	44	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128657	10.1371/journal.pone.0128657	http://dx.doi.org/10.1371/journal.pone.0128657			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053410	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300050
J	Zhou, YN; Wu, YQ; Jiang, XQ; Zhang, XL; Xia, LG; Lin, KL; Xu, YJ				Zhou, Yuning; Wu, Yuqiong; Jiang, Xinquan; Zhang, Xiuli; Xia, Lunguo; Lin, Kaili; Xu, Yuanjin			The Effect of Quercetin on the Osteogenesic Differentiation and Angiogenic Factor Expression of Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; MAPK SIGNALING PATHWAYS; STROMAL CELLS; IN-VITRO; OSTEOBLAST DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; PROGENITOR CELLS; BLOOD-VESSELS; P38	Bone marrow-derived mesenchymal stem cells (BMSCs) are widely used in regenerative medicine in light of their ability to differentiate along the chondrogenic and osteogenic lineages. As a type of traditional Chinese medicine, quercetin has been preliminarily reported to promote osteogenic differentiation in osteoblasts. In the present study, the effects of quercetin on the proliferation, viability, cellular morphology, osteogenic differentiation and angiogenic factor secretion of rat BMSCs (rBMSCs) were examined by MTT assay, fluorescence activated cell sorter (FACS) analysis, real-time quantitative PCR (RT-PCR) analysis, alkaline phosphatase (ALP) activity and calcium deposition assays, and Enzyme-linked immunosorbent assay (ELISA). Moreover, whether mitogen-activated protein kinase (MAPK) signaling pathways were involved in these processes was also explored. The results showed that quercetin significantly enhanced the cell proliferation, osteogenic differentiation and angiogenic factor secretion of rBMSCs in a dose-dependent manner, with a concentration of 2 mu M achieving the greatest stimulatory effect. Moreover, the activation of the extracellular signal-regulated protein kinases (ERK) and p38 pathways was observed in quercetin-treated rBMSCs. Furthermore, these induction effects could be repressed by either the ERK inhibitor PD98059 or the p38 inhibitor SB202190, respectively. These data indicated that quercetin could promote the proliferation, osteogenic differentiation and angiogenic factor secretion of rBMSCs in vitro, partially through the ERK and p38 signaling pathways.	[Zhou, Yuning; Xu, Yuanjin] Shanghai Jiao Tong Univ, Shanghai Key Lab Stomatol, Shanghai Peoples Hosp 9, Dept Oral Surg,Sch Med, Shanghai 200030, Peoples R China; [Zhou, Yuning; Xu, Yuanjin] Shanghai Res Inst Stomatol, Shanghai, Peoples R China; [Wu, Yuqiong; Jiang, Xinquan] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Prosthodont, Sch Med, Shanghai 200030, Peoples R China; [Wu, Yuqiong; Jiang, Xinquan; Zhang, Xiuli] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Shanghai Res Inst Stomatol, Oral Bioengn Lab,Sch Med, Shanghai 200030, Peoples R China; [Xia, Lunguo] Shanghai Jiao Tong Univ, Dept Oral & Craniomaxillofacial Sci, Ctr Craniofacial Orthodont, Sch Med,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China; [Lin, Kaili] Chinese Acad Sci, Shanghai Inst Ceram, Biomat & Tissue Engn Res Ctr, Shanghai 200050, Peoples R China; [Lin, Kaili] Tongji Univ, Lab Oral Biomed Sci & Translat Med, Sch Stomatol, Shanghai 200092, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Ceramics, CAS; Tongji University	Xia, LG (corresponding author), Shanghai Jiao Tong Univ, Dept Oral & Craniomaxillofacial Sci, Ctr Craniofacial Orthodont, Sch Med,Shanghai Peoples Hosp 9, Shanghai 200030, Peoples R China.	xialunguo@hotmail.com; lklecnu@aliyun.com; xuyuanjin@hotmail.com			National Natural Science Foundation of China [81171458, 81470713, 81400554]; Specialized Research Fund for the Doctoral Program of Higher Education [20110073110076]; Science and Technology Committee of Shanghai Municipality [14140904100, 14YF1402400, 12nm0501600]; Medicine and Engineering Cross Project of Shanghai Jiao Tong University [YG2012SM29]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Science and Technology Committee of Shanghai Municipality(Shanghai Science & Technology Committee); Medicine and Engineering Cross Project of Shanghai Jiao Tong University	This work was funded by National Natural Science Foundation of China (81171458, 81470713 and 81400554), Specialized Research Fund for the Doctoral Program of Higher Education (20110073110076), Science and Technology Committee of Shanghai Municipality (14140904100, 14YF1402400 and 12nm0501600), Medicine and Engineering Cross Project of Shanghai Jiao Tong University (YG2012SM29).	Abiramasundari G, 2012, J ETHNOPHARMACOL, V141, P474, DOI 10.1016/j.jep.2012.03.015; AMBROSE ANTHONY M., 1949, JOUR NUTRITION, V38, P305; Anand K, 2011, ASIAN PAC J CANCER P, V12, P2829; Bai Y, 2013, BIOTECHNOL LETT, V35, P301, DOI 10.1007/s10529-012-1084-3; Bara JJ, 2014, TISSUE ENG PT A, V20, P147, DOI [10.1089/ten.tea.2013.0196, 10.1089/ten.TEA.2013.0196]; Bavaria MN, 2014, APOPTOSIS, V19, P467, DOI 10.1007/s10495-013-0944-1; BIKFALVI A, 1991, J CELL PHYSIOL, V149, P50, DOI 10.1002/jcp.1041490108; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Cancedda Ranieri, 2003, Novartis Found Symp, V249, P133; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Chen ML, 2011, INT J MOL MED, V27, P545, DOI 10.3892/ijmm.2011.619; Clark D, 2015, J BIOMED MATER RES A, V103, P639, DOI 10.1002/jbm.a.35215; DVORAK HF, 1991, J EXP MED, V174, P1275, DOI 10.1084/jem.174.5.1275; Feric NT, 2014, BIOMATER SCI-UK, V2, P1384, DOI 10.1039/c4bm00073k; Ferrara N, 1996, Curr Opin Nephrol Hypertens, V5, P35, DOI 10.1097/00041552-199601000-00008; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Glowacki J, 1998, CLIN ORTHOP RELAT R, pS82, DOI 10.1097/00003086-199810001-00010; Guicheux J, 2003, J BONE MINER RES, V18, P2060, DOI 10.1359/jbmr.2003.18.11.2060; Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606; Haynesworth SE, 1996, J CELL PHYSIOL, V166, P585, DOI 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6; Ho AWY, 2008, IMMUNOBIOLOGY, V213, P533, DOI 10.1016/j.imbio.2008.01.003; Hoch AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035579; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Hu YY, 2003, ENDOCRINOLOGY, V144, P2068, DOI 10.1210/en.2002-220863; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; Jadlowiec J, 2004, J BIOL CHEM, V279, P53323, DOI 10.1074/jbc.M404934200; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Jansen RG, 2009, J ORAL PATHOL MED, V38, P630, DOI 10.1111/j.1600-0714.2009.00763.x; Jiang XQ, 2009, BIOMATERIALS, V30, P4522, DOI 10.1016/j.biomaterials.2009.05.021; JOHNSON GL, 1994, CURR OPIN CELL BIOL, V6, P230, DOI 10.1016/0955-0674(94)90141-4; Kim KI, 2014, BIOMATERIALS, V35, P4792, DOI 10.1016/j.biomaterials.2014.02.048; Kim YJ, 2006, BIOCHEM PHARMACOL, V72, P1268, DOI 10.1016/j.bcp.2006.08.021; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Ko J, 2007, EXP MOL MED, V39, P129, DOI 10.1038/emm.2007.15; Krane SM, 2005, J EXP MED, V201, P841, DOI 10.1084/jem.20050354; Kuhnau J, 1976, World Rev Nutr Diet, V24, P117; Li ZH, 2014, INT J CLIN EXP MED, V7, P540; Lin KL, 2013, BIOMATERIALS, V34, P10028, DOI 10.1016/j.biomaterials.2013.09.056; Lin ZW, 2014, EXP THER MED, V7, P625, DOI 10.3892/etm.2013.1464; Liu MM, 2017, J TISSUE ENG REGEN M, V11, P276, DOI 10.1002/term.1911; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Marrony S, 2003, BONE, V33, P426, DOI 10.1016/S8756-3282(03)00195-9; Matsuoka F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055082; Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1; Miles SL, 2014, NUTR REV, V72, P720, DOI 10.1111/nure.12152; Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4; Neumann T, 2003, MICROVASC RES, V66, P59, DOI 10.1016/S0026-2862(03)00040-2; Oh SJ, 2010, FOOD CHEM TOXICOL, V48, P3227, DOI 10.1016/j.fct.2010.08.028; Peluso I, 2015, CRIT REV FOOD SCI, V55, P383, DOI 10.1080/10408398.2012.656770; Peng HR, 2002, J CLIN INVEST, V110, P751, DOI 10.1172/JCI200215153; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prouillet C, 2004, BIOCHEM PHARMACOL, V67, P1307, DOI 10.1016/j.bcp.2003.11.009; Satue M, 2013, BIOCHEM PHARMACOL, V86, P1476, DOI 10.1016/j.bcp.2013.09.009; Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Suehiro F, 2011, STEM CELLS DEV, V20, P1540, DOI 10.1089/scd.2010.0279; Suzuki A, 2006, J BONE MINER RES, V21, P674, DOI 10.1359/JBMR.020603; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; Taylor SC, 2013, MOL BIOTECHNOL, V55, P217, DOI 10.1007/s12033-013-9672-6; Utesch D, 2008, MUTAT RES-GEN TOX EN, V654, P38, DOI 10.1016/j.mrgentox.2008.04.008; Wanachewin O, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-71; Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953; Wang XT, 2006, PLAST RECONSTR SURG, V117, P129, DOI 10.1097/01.prs.0000185609.07293.3e; Wenger A, 2005, CELLS TISSUES ORGANS, V181, P80, DOI 10.1159/000091097; Winet H, 1996, BONE, V19, pS39, DOI 10.1016/S8756-3282(96)00133-0; Wu BY, 2000, J NEUROSCI RES, V62, P730, DOI 10.1002/1097-4547(20001201)62:5<730::AID-JNR13>3.3.CO;2-B; Wu YQ, 2015, CELL PROLIFERAT, V48, P375, DOI 10.1111/cpr.12185; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; ZEMANKOVA-KUNZOVA H, 1949, Lek List, V4, P401; Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022; Zhai YK, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/921954; Zhang LF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099946, 10.1371/journal.pone.0084950]; Zhang ZT, 2010, APOPTOSIS, V15, P105, DOI 10.1007/s10495-009-0425-8; Zhao YF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/637415; Zhou C, 2014, CELL PROLIFERAT, V47, P124, DOI 10.1111/cpr.12097	76	73	76	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129605	10.1371/journal.pone.0129605	http://dx.doi.org/10.1371/journal.pone.0129605			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053266	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300152
J	Kakimoto, Y; Kamiguchi, H; Ochiai, E; Satoh, F; Osawa, M				Kakimoto, Yu; Kamiguchi, Hiroshi; Ochiai, Eriko; Satoh, Fumiko; Osawa, Motoki			MicroRNA Stability in Postmortem FFPE Tissues: Quantitative Analysis Using Autoptic Samples from Acute Myocardial Infarction Patients	PLOS ONE			English	Article							CIRCULATING MICRORNAS; FRESH-FROZEN; RNA; EXPRESSION; BIOMARKERS; INTEGRITY; QUALITY; SERUM; PCR; ELECTROPHORESIS	MicroRNAs (miRNAs) are very short (18-24 nucleotides) nucleic acids that are expressed in a number of biological tissues and have been shown to be more resistant to extreme temperatures and pH compared to longer RNA molecules, like mRNAs. As miRNAs contribute to diverse biological process and respond to various kinds of cellular stress, their utility as diagnostic biomarkers and/or therapeutic targets has recently been explored. Here, we have evaluated the usefulness of miRNA quantification during postmortem examination of cardiac tissue from acute myocardial infarction (AMI) patients. Cardiac tissue was collected within one week of the patient's death and either frozen (19 samples) or fixed in formalin for up to three years (36 samples). RNA integrity was evaluated with an electropherogram, and it appears that longer RNAs are fragmented after death in the long-term fixed samples. Quantitative PCR was also performed for seven miRNAs and three other small RNAs in order to determine the appropriate controls for our postmortem analysis. Our data indicate that miR-191 and miR-26b are more suitable than the other types of small RNA molecules as they are stably detected after death and long-term fixation. Further, we also applied our quantitation method, using these endogenous controls, to evaluate the expression of three previously identified miRNA biomarkers, miR-1, miR-208b, and miR-499a, in formalin-fixed tissues from AMI patients. Although miR-1 and miR-208b decreased (1.4-fold) and increased (1.2-fold), respectively, in the AMI samples compared to the controls, the significance of these changes was limited by our sample size. In contrast, the relative level of miR-499a was significantly decreased in the AMI samples (2.1-fold). This study highlights the stability of miRNAs after death and long-term fixation, validating their use as reliable biomarkers for AMI during postmortem examination.	[Kakimoto, Yu; Ochiai, Eriko; Satoh, Fumiko; Osawa, Motoki] Tokai Univ, Sch Med, Dept Forens Med, Isehara, Kanagawa 25911, Japan; [Kamiguchi, Hiroshi] Tokai Univ, Support Ctr Med Res & Educ, Isehara, Kanagawa, Japan	Tokai University; Tokai University	Osawa, M (corresponding author), Tokai Univ, Sch Med, Dept Forens Med, Isehara, Kanagawa 25911, Japan.	osawa@is.icc.u-tokai.ac.jp			Tokai University Educational System General Research Organization [14NS289941]; JSPS KAKENHI Grant [26893278]	Tokai University Educational System General Research Organization; JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Research and Study Project of Tokai University Educational System General Research Organization (14NS289941) and JSPS KAKENHI Grant (26893278).	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Applied Biosystems, 2008, GUIDE TO PERFORMING; Becker C, 2010, METHODS, V50, P237, DOI 10.1016/j.ymeth.2010.01.010; Bostjancic E, 2010, CARDIOLOGY, V115, P163, DOI 10.1159/000268088; Bronze-da-Rocha E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/985408; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Deddens JC, 2013, J CARDIOVASC TRANSL, V6, P884, DOI 10.1007/s12265-013-9493-9; Di Leva G, 2013, CURR OPIN GENET DEV, V23, P3, DOI 10.1016/j.gde.2013.01.004; Guo ZY, 2014, SCI REP-UK, V4, DOI 10.1038/srep05150; Haile S, 2003, RNA, V9, P1491, DOI 10.1261/rna.5940703; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Kakimoto Y, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000565; Kakimoto Y, 2013, AM J FOREN MED PATH, V34, P242, DOI 10.1097/PAF.0b013e31828879cd; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar V, 2010, ROBBINS AND COTRAN P, P545; Kuwabara Y, 2011, CIRC-CARDIOVASC GENE, V4, P446, DOI 10.1161/CIRCGENETICS.110.958975; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long GW, 2012, INT J BIOL SCI, V8, P811, DOI 10.7150/ijbs.4439; Lv P, 2014, INT J MOL SCI, V15, P5774, DOI 10.3390/ijms15045774; Macabeo-Ong M, 2002, MODERN PATHOL, V15, P979, DOI 10.1097/01.MP.0000026054.62220.FC; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Micke P, 2006, LAB INVEST, V86, P202, DOI 10.1038/labinvest.3700372; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moret I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082753; Muciaccia B, 2015, INT J LEGAL MED, V129, P11, DOI 10.1007/s00414-014-1066-1; Olivieri F, 2013, INT J CARDIOL, V167, P531, DOI 10.1016/j.ijcard.2012.01.075; Peiro-Chova L, 2013, VIRCHOWS ARCH, V463, P765, DOI 10.1007/s00428-013-1485-2; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Plattner T, 2008, J Forensic Leg Med, V15, P325, DOI 10.1016/j.jflm.2007.12.019; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Satoh M, 2010, J CARD FAIL, V16, P404, DOI 10.1016/j.cardfail.2010.01.002; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Slagter-Jager JG, 2012, J PHARMACEUT BIOMED, V70, P657, DOI 10.1016/j.jpba.2012.04.031; Srinivasan M, 2002, AM J PATHOL, V161, P1961, DOI 10.1016/S0002-9440(10)64472-0; Turashvili G, 2012, EXP MOL PATHOL, V92, P33, DOI 10.1016/j.yexmp.2011.09.013; Wong L, 2007, PUBLICATION; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xiao JJ, 2014, INT J CLIN EXP MED, V7, P136; Zhang H, 2013, SCI JUSTICE, V53, P115, DOI 10.1016/j.scijus.2012.11.005	45	34	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129338	10.1371/journal.pone.0129338	http://dx.doi.org/10.1371/journal.pone.0129338			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046358	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200153
J	Madlala, HP; Van Heerden, FR; Mubagwa, K; Musabayane, CT				Madlala, Hlengiwe Pretty; Van Heerden, Fanie Retief; Mubagwa, Kanigula; Musabayane, Cephas Tagumirwa			Changes in Renal Function and Oxidative Status Associated with the Hypotensive Effects of Oleanolic Acid and Related Synthetic Derivatives in Experimental Animals	PLOS ONE			English	Article							BARK ETHANOLIC EXTRACT; ORUJO OLIVE OIL; NITRIC-OXIDE; URSOLIC ACIDS; BLOOD-GLUCOSE; TRITERPENOIDS; HYPERTENSION; ANTIOXIDANT; STRESS; KIDNEY	Purpose The triterpene oleanolic acid (OA) is known to possess antihypertensive actions. In the present study we to compared the effects of the triterpene on mean arterial blood pressure (MAP) and kidney function following acute administration in normotensive animals with those of its related oleanane synthetic derivatives (brominated oleanolic acid, Br-OA and oleanolic acid methyl ester, Me-OA). We also used experimental models of hypertension to further explore the effects of sub-chronic oral OA treatment and evaluated influences on oxidative status. Methods OA was extracted from dried flower buds of Syzygium aromaticum using a previously validated protocol in our laboratory. Me-OA and Br-OA were synthesized according to a method described. Rats were supplemented with lithium chloride (12 mmol L-1) prior to experimentation in order to raise plasma lithium to allow measurements of lithium clearance and fractional excretion (FELi) as indices of proximal tubular Na+ handling. Anaesthetized animals were continuously infused via the right jugular with 0.077M NaCl. MAP was measured via a cannula inserted in the carotid artery, and urine was collected through a cannula inserted in the bladder. After a 3.5 h equilibration, MAP, urine flow, electrolyte excretion rates were determined for 4 h of 1 h control, 1.5 h treatment and 1.5 h recovery periods. OA, Me-OA and Br-OA were added to the infusate during the treatment period. We evaluated sub-chronic effects on MAP and kidney function in normotensive Wistar rats and in two animal models of hypertension, spontaneously hypertensive rats (SHR) and Dahl salt-sensitive (DSS) rats, during 9-week administration of OA (p.o.). Tissue oxidative status was examined in these animals at the end of the study. Increasing evidence suggests that and renal function disturbances and oxidative stress play major roles in the pathogenesis of hypertension. Results Acute infusion OA and oleanane derivatives displayed qualitatively similar effects in decreasing MAP and increasing urinary Na+ outputs. The drugs increased the FENa and FELi without influencing GFR indicating that at least part of the overall natriuretic effect involved proximal tubular Na+ reabsorption. Sub-chronic OA administration (p.o.) also elicited hypotensive responses in Wistar, DSS and SHR rats. The MAP lowering effect was more marked in hypertensive animals and were positively correlated with increased urinary Na+ excretion. Compared with respective control rats, OA treatment reduced malondialdehyde (MDA, a marker of lipid peroxidation) and increased activities of antioxidant enzymes; superoxide dismutase and glutathione peroxidase in hepatic, cardiac and renal tissues. Conclusions OA and oleanane derivatives have similar effects on MAP, kidney function and oxidative stress. The amelioration of oxidative stress and blood pressure lowering effects by OA are more marked in hypertensive animals and correlated with an increased urinary Na+ output.	[Madlala, Hlengiwe Pretty; Musabayane, Cephas Tagumirwa] Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, Durban, South Africa; [Van Heerden, Fanie Retief] Univ KwaZulu Natal, Coll Sci Engn & Agr, Sch Chem & Phys, Pietermaritzburg, South Africa; [Mubagwa, Kanigula] Katholieke Univ Leuven, Fac Med, Dept Cardiovasc Med, Leuven, Belgium	University of Kwazulu Natal; University of Kwazulu Natal; KU Leuven	Musabayane, CT (corresponding author), Univ KwaZulu Natal, Coll Hlth Sci, Sch Lab Med & Med Sci, Durban, South Africa.	musabayanec@ukzn.ac.za	Van Heerden, Fanie R/A-5685-2008	Van Heerden, Fanie R/0000-0002-5710-7525	NRF; MRC South Africa; University of KwaZulu-Natal, Research Division	NRF; MRC South Africa; University of KwaZulu-Natal, Research Division	The authors are grateful to the NRF and MRC South Africa and the University of KwaZulu-Natal, Research Division for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo M, 2014, ANTIOXID REDOX SIGN, V20, P74, DOI 10.1089/ars.2013.5259; Ayyanar M, 2011, J ETHNOPHARMACOL, V134, P851, DOI 10.1016/j.jep.2011.01.029; Couch RD, 2005, BIOORG MED CHEM LETT, V15, P2215, DOI 10.1016/j.bmcl.2005.03.031; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Dongmo AB, 2011, J ETHNOPHARMACOL, V133, P204, DOI 10.1016/j.jep.2010.09.033; Drenjancevic-Peric I, 2011, KIDNEY BLOOD PRESS R, V34, P1, DOI 10.1159/000320387; Forstermann U, 2010, PFLUG ARCH EUR J PHY, V459, P923, DOI 10.1007/s00424-010-0808-2; Fu LF, 2013, ORG LETT, V15, P1622, DOI 10.1021/ol400399x; Gondwe M, 2008, PHYTOMEDICINE, V15, P699, DOI 10.1016/j.phymed.2008.02.004; Grossman E, 2008, DIABETES CARE, V31, pS185, DOI 10.2337/dc08-s246; Honda T, 2000, J MED CHEM, V43, P4233, DOI 10.1021/jm0002230; Kamadyaapa DR, 2009, CARDIOVASC J AFR, V20, P161; Kasapoglu M, 2001, EXP GERONTOL, V36, P209, DOI 10.1016/S0531-5565(00)00198-4; Khathi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081632; Liu JZ, 2014, CHEM-BIOL INTERACT, V221, P88, DOI 10.1016/j.cbi.2014.07.017; Madlala HP, 2012, RENAL FAILURE, V34, P767, DOI 10.3109/0886022X.2012.678172; MAHATO SB, 1994, PHYTOCHEMISTRY, V37, P1517, DOI 10.1016/S0031-9422(00)89569-2; Majid DSA, 2007, CLIN EXP PHARMACOL P, V34, P946, DOI 10.1111/j.1440-1681.2007.04642.x; Mapanga RF, 2009, RENAL FAILURE, V31, P481, DOI 10.1080/08860220902963558; Mizuno Yoshiko, 2010, Curr Cardiol Rep, V12, P472, DOI 10.1007/s11886-010-0142-5; Mkhwanazi BN, 2014, RENAL FAILURE, V36, P419, DOI 10.3109/0886022X.2013.867799; Musabayane CT, 2007, RENAL FAILURE, V29, P389, DOI 10.1080/08860220701260735; Musabayane CT, 2010, RENAL FAILURE, V32, P832, DOI 10.3109/0886022X.2010.494802; Musabayane CT, 2005, J ETHNOPHARMACOL, V97, P485, DOI 10.1016/j.jep.2004.12.005; Ngubane PS, 2011, RENAL FAILURE, V33, P434, DOI 10.3109/0886022X.2011.568147; Panza JA, 1997, CLIN CARDIOL, V20, P26; Perona JS, 2006, J NUTR BIOCHEM, V17, P429, DOI 10.1016/j.jnutbio.2005.11.007; Rahmani AH, 2014, INT J CLIN EXP MED, V7, P483; Rodriguez-Rodriguez R, 2008, BRIT J PHARMACOL, V155, P535, DOI 10.1038/bjp.2008.289; Rodriguez-Rodriguez R, 2006, J AGR FOOD CHEM, V54, P2096, DOI 10.1021/jf0528512; Rodriguez-Rodriguezl R, 2004, BRIT J NUTR, V92, P635, DOI 10.1079/BJN20041231; Somova LI, 2004, PHYTOMEDICINE, V11, P121, DOI 10.1078/0944-7113-00329; Somova LI, 1999, J S AFR VET ASSOC, V70, P14; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; Sporn MB, 2011, J NAT PROD, V74, P537, DOI 10.1021/np100826q; Thomsen K, 1990, KIDNEY INT, V37, P10; WEINBERGER MH, 1986, HYPERTENSION, V8, P127, DOI 10.1161/01.HYP.8.6_Pt_2.II127; [World Health Organization 2013], 2013, WHODCOWHD20132; Yates MS, 2007, MOL CANCER THER, V6, P154, DOI 10.1158/1535-7163.MCT-06-0516; Zicha J, 2012, PHYSIOL RES, V61, pS35, DOI 10.33549/physiolres.932363	40	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128192	10.1371/journal.pone.0128192	http://dx.doi.org/10.1371/journal.pone.0128192			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046776	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200046
J	Mets, OM; Roothaan, SM; Bronsveld, I; Luijk, B; van de Graaf, EA; Vink, A; de Jong, PA				Mets, Onno M.; Roothaan, Suzan M.; Bronsveld, Inez; Luijk, Bart; van de Graaf, Ed A.; Vink, Aryan; de Jong, Pim A.			Emphysema Is Common in Lungs of Cystic Fibrosis Lung Transplantation Patients: A Histopathological and Computed Tomography Study	PLOS ONE			English	Article							CT; DENSITY; DISEASE; MORPHOMETRY; MICE	Background Lung disease in cystic fibrosis (CF) involves excessive inflammation, repetitive infections and development of bronchiectasis. Recently, literature on emphysema in CF has emerged, which might become an increasingly important disease component due to the increased life expectancy. The purpose of this study was to assess the presence and extent of emphysema in endstage CF lungs. Methods In explanted lungs of 20 CF patients emphysema was semi-quantitatively assessed on histology specimens. Also, emphysema was automatically quantified on pre-transplantation computed tomography (CT) using the percentage of voxels below -950 Houndfield Units and was visually scored on CT. The relation between emphysema extent, pre-transplantation lung function and age was determined. Results All CF patients showed emphysema on histological examination: 3/20 (15%) showed mild, 15/20 (75%) moderate and 2/20 (10%) severe emphysema, defined as 0-20% emphysema, 20-50% emphysema and >50% emphysema in residual lung tissue, respectively. Visually upper lobe bullous emphysema was identified in 13/20 and more diffuse non-bullous emphysema in 18/20. Histology showed a significant correlation to quantified CT emphysema (p = 0.03) and visual emphysema score (p = 0.001). CT and visual emphysema extent were positively correlated with age (p = 0.045 and p = 0.04, respectively). Conclusions In conclusion, this study both pathologically and radiologically confirms that emphysema is common in end-stage CF lungs, and is age related. Emphysema might become an increasingly important disease component in the aging CF population.	[Mets, Onno M.; de Jong, Pim A.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Roothaan, Suzan M.; Vink, Aryan] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Bronsveld, Inez; Luijk, Bart; van de Graaf, Ed A.] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Mets, OM (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	o.m.mets@umcutrecht.nl	de Jong, Pim A/G-7220-2014	de Jong, Pim A/0000-0003-4840-6854				Bedrossian CW, 1976, LUNG CYSTIC FIBROSIS; Brody AS, 2006, J THORAC IMAG, V21, P14, DOI 10.1097/01.rti.0000203937.82276.ce; de Jong PA, 2004, RADIOLOGY, V231, P434, DOI 10.1148/radiol.2312021393; Gehrig S, 2014, AM J RESP CRIT CARE, V189, P1082, DOI 10.1164/rccm.201311-1932OC; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; Gianotti A, 2013, AM J RESP CELL MOL, V49, P445, DOI 10.1165/rcmb.2012-0408OC; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Hartl D, 2012, J CYST FIBROS, V11, P363, DOI 10.1016/j.jcf.2012.07.003; Helbich TH, 1999, RADIOLOGY, V213, P537, DOI 10.1148/radiology.213.2.r99nv04537; Helbich TH, 1999, AM J ROENTGENOL, V173, P81, DOI 10.2214/ajr.173.1.10397104; Loeve M, 2009, THORAX, V64, P876, DOI 10.1136/thx.2008.110908; Mall MA, 2008, AM J RESP CRIT CARE, V177, P730, DOI 10.1164/rccm.200708-1233OC; Mashefski JF, 2008, DAIL HAMMARS PULMONA, VI; MENEELY GR, 1962, AM REV RESPIR DIS, V85, P762; Mets OM, 2012, AM J ROENTGENOL, V199, P336, DOI 10.2214/AJR.11.7808; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MULLER NL, 1988, CHEST, V94, P782, DOI 10.1378/chest.94.4.782; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Salvatore D, 2011, J CYST FIBROS, V10, P71, DOI 10.1016/j.jcf.2010.12.005; SOBONYA RE, 1986, AM REV RESPIR DIS, V134, P290; TOMASHEFSKI JF, 1985, HUM PATHOL, V16, P253, DOI 10.1016/S0046-8177(85)80011-3; TOMASHEFSKI JF, 1986, AM REV RESPIR DIS, V133, P535; Trojanek JB, 2014, AM J RESP CELL MOL, V51, P709, DOI 10.1165/rcmb.2013-0407OC; Wielputz MO, 2011, EUR RESPIR J, V38, P1060, DOI 10.1183/09031936.00149810; Wielputz MO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073142	26	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128062	10.1371/journal.pone.0128062	http://dx.doi.org/10.1371/journal.pone.0128062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047144	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200039
J	Shukla, A; Singh, VK; Bharadwaj, DR; Kumar, R; Rai, A; Rai, AK; Mugasimangalam, R; Parameswaran, S; Singh, M; Naik, PS				Shukla, Anjali; Singh, V. K.; Bharadwaj, D. R.; Kumar, Rajesh; Rai, Ashutosh; Rai, A. K.; Mugasimangalam, Raja; Parameswaran, Sriram; Singh, Major; Naik, P. S.			De Novo Assembly of Bitter Gourd Transcriptomes: Gene Expression and Sequence Variations in Gynoecious and Monoecious Lines	PLOS ONE			English	Article							MELON MOMORDICA-CHARANTIA; RNA-SEQ; ARABIDOPSIS; MARKERS; ETHYLENE; GENOME; MICROSATELLITES; BIOINFORMATICS; IMPROVEMENT; ANNOTATION	Bitter gourd (Momordica charantia L.) is a nutritious vegetable crop of Asian origin, used as a medicinal herb in Indian and Chinese traditional medicine. Molecular breeding in bitter gourd is in its infancy, due to limited molecular resources, particularly on functional markers for traits such as gynoecy. We performed de novo transcriptome sequencing of bitter gourd using Illumina next-generation sequencer, from root, flower buds, stem and leaf samples of gynoecious line (Gy323) and a monoecious line (DRAR1). A total of 65,540 transcripts for Gy323 and 61,490 for DRAR1 were obtained. Comparisons revealed SNP and SSR variations between these lines and, identification of gene classes. Based on available transcripts we identified 80 WRKY transcription factors, several reported in responses to biotic and abiotic stresses; 56 ARF genes which play a pivotal role in auxin-regulated gene expression and development. The data presented will be useful in both functions studies and breeding programs in bitter gourd.	[Shukla, Anjali; Bharadwaj, D. R.; Kumar, Rajesh; Rai, Ashutosh; Singh, Major; Naik, P. S.] Indian Inst Vegetable Res, Div Crop Improvement, Varanasi 221305, Uttar Pradesh, India; [Singh, V. K.] Banaras Hindu Univ, Sch Biotechnol, Ctr Bioinformat, Varanasi 221005, Uttar Pradesh, India; [Rai, A. K.] Banaras Hindu Univ, Ctr Adv Studies, Dept Bot, Varanasi 221005, Uttar Pradesh, India; [Mugasimangalam, Raja; Parameswaran, Sriram] Genotyp Technol P Ltd, Bangalore 560094, Karnataka, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Vegetable Research; Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Singh, M (corresponding author), Indian Inst Vegetable Res, Div Crop Improvement, Post Bag 01, Varanasi 221305, Uttar Pradesh, India.	singhvns@gmail.com	Rai, Ashutosh/P-6120-2018; Niranjan, Vidya/AAF-5553-2019; Niranjan, Vidya/O-6464-2016; Singh, Major/P-9790-2019	Rai, Ashutosh/0000-0001-6136-6696; Niranjan, Vidya/0000-0001-9187-7753; Niranjan, Vidya/0000-0001-9187-7753; Singh, Major/0000-0002-0247-861X	Indian Council of Agricultural Research, New Delhi; Genotypic Technology (P) Ltd.	Indian Council of Agricultural Research, New Delhi(Indian Council of Agricultural Research (ICAR)); Genotypic Technology (P) Ltd.	Genotypic Technology (P) Ltd., provided indirect support in the form letting the authors from Genotypic RM & SP to work on this project, but did not provide any financial support or have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The Indian Council of Agricultural Research, New Delhi provided financial support for basic research facilities, infrastructure etc for Indian Institute of Vegetable Research, Varanasi. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baby Joseph, 2013, Asian Pacific Journal of Tropical Disease, V3, P93, DOI 10.1016/S2222-1808(13)60052-3; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Basch E, 2003, AM J HEALTH-SYST PH, V60, P356, DOI 10.1093/ajhp/60.4.356; Behera T. K., 2004, Journal of New Seeds, V6, P217; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Boualem A, 2008, SCIENCE, V321, P836, DOI 10.1126/science.1159023; Brennan VC, 2012, J MED FOOD, V15, P325, DOI 10.1089/jmf.2011.0158; BYERS RE, 1972, P NATL ACAD SCI USA, V69, P717, DOI 10.1073/pnas.69.3.717; Chan SMH, 2013, J PHARM PHARM SCI, V16, P207, DOI 10.18433/J3T60G; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Clarke K, 2013, SCI CHINA LIFE SCI, V56, P156, DOI 10.1007/s11427-013-4444-x; Da Maia LC, 2008, INT J SYSTEMATIC BIO, V4, P363; Dalamu, 2012, INDIAN J HORTIC, V69, P65; de Jong Mark, 2010, BMC Res Notes, V3, P73, DOI 10.1186/1756-0500-3-73; Dey SS, 2006, SCI HORTIC-AMSTERDAM, V109, P21, DOI 10.1016/j.scienta.2006.03.006; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Fang EF, 2011, CURR MOL MED, V11, P417; Filippi CV, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0360-x; Gaikwad AB, 2008, HORTSCIENCE, V43, P127, DOI 10.21273/HORTSCI.43.1.127; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Grover JK, 2004, J ETHNOPHARMACOL, V93, P123, DOI 10.1016/j.jep.2004.03.035; Guo DL, 2012, AM J BOT, V99, pE182, DOI 10.3732/ajb.1100277; Guo XY, 2007, FEBS LETT, V581, P1015, DOI 10.1016/j.febslet.2007.01.088; Gupta PK, 2002, PLANT CELL TISS ORG, V70, P229, DOI 10.1023/A:1016597404454; Gupta S, 2014, SUGAR TECH, V16, P372, DOI 10.1007/s12355-013-0288-8; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Iwamoto Eishin, 2006, Horticultural Research (Japan), V5, P101, DOI 10.2503/hrj.5.101; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kalloo G., 1988, VEGETABLE BREEDING, V1, P105; Katsaounis TI, 2008, J STAT PLAN INFER, V138, P245, DOI 10.1016/j.jspi.2007.05.008; Khan SA, 2007, WORLD J GASTROENTERO, V13, P1761, DOI 10.3748/wjg.v13.i11.1761; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; Kumar Sanjeet, 2004, Journal of New Seeds, V6, P383; Kushwaha H, 2013, MOL BIOTECHNOL, V54, P1, DOI 10.1007/s12033-012-9536-5; Kushwaha H, 2011, MOL BIOL REP, V38, P5037, DOI 10.1007/s11033-010-0650-9; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammadov J, 2012, INT J PLANT GENOMICS, V2012, DOI [DOI 10.1155/2012/728398, 10.1155/2012/728398]; Matsumura H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087138; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P2017, DOI 10.1093/pcp/pcr153; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morozova O, 2009, ANNU REV GENOM HUM G, V10, P135, DOI 10.1146/annurev-genom-082908-145957; Nemhauser JL, 2000, DEVELOPMENT, V127, P3877; Ooi CP, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007845.pub2; QUELLER DC, 1993, TRENDS ECOL EVOL, V8, P285, DOI 10.1016/0169-5347(93)90256-O; Ram D., 2002, Cucurbit Genetics Cooperative, P65; Ram D., 2002, Indian Journal of Agricultural Sciences, V72, P348; Ram D, 2006, J HERED, V97, P294, DOI 10.1093/jhered/esj028; Ramirez-Gonzalez RH, 2012, SOURCE CODE BIOL MED, V7, DOI 10.1186/1751-0473-7-6; Rhee SY, 2006, ANNU REV PLANT BIOL, V57, P335, DOI 10.1146/annurev.arplant.56.032604.144103; RUDICH J, 1972, PLANT PHYSIOL, V49, P998, DOI 10.1104/pp.49.6.998; Saeed MK., 2010, PHARMACOLOGYONLINE, V1, P252; Sathishsekar D, 2005, ASIA PAC J CLIN NUTR, V14, P153; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Sharma B, 2013, NEW PHYTOL, V197, P949, DOI 10.1111/nph.12078; Singh AK, 2007, J HORTIC SCI BIOTECH, V82, P217, DOI 10.1080/14620316.2007.11512222; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Singh VK, 2011, INT J BIOINFORM RES, V3, P221; Staub Jack E., 2008, V1, P241; Steve OO, 2008, AFR J BIOTECHNOL, V7, P2535; Stokes TL, 2002, GENE DEV, V16, P171, DOI 10.1101/gad.952102; Sundberg E, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001628; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Wang SZ, 2010, AM J BOT, V97, pE75, DOI 10.3732/ajb.1000153; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu P, 2014, PLANT J, V77, P430, DOI 10.1111/tpj.12370; Yang Peizhen, 2010, BMC Plant Biol, V10, P250, DOI 10.1186/1471-2229-10-250; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou WB, 1998, PLANT BREED ABSTR, V68, P1002	77	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128331	10.1371/journal.pone.0128331	http://dx.doi.org/10.1371/journal.pone.0128331			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047102	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200059
J	Takahashi-Niki, K; Kato-Ose, I; Murata, H; Maita, H; Iguchi-Ariga, SMM; Ariga, H				Takahashi-Niki, Kazuko; Kato-Ose, Izumi; Murata, Hiroaki; Maita, Hiroshi; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Epidermal Growth Factor-dependent Activation of the Extracellular Signal-regulated Kinase Pathway by DJ-1 Protein through Its Direct Binding to c-Raf Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; OXIDIZED DJ-1; CELL-DEATH; ANTIOXIDATIVE STRESS; PHOSPHORYLATION; IDENTIFICATION; GLYOXALASE; PTEN; TRANSFORMATION; OXIDATION	DJ-1 is an oncogene and also a causative gene for familial Parkinson disease. DJ-1 has various functions, and the oxidative status of cysteine at position 106 (Cys-106) is crucial for determination of the activation level of DJ-1. Although DJ-1 requires activated Ras for its oncogenic activity and although it activates the extracellular signal-regulated kinase (ERK) pathway, a cell growth pathway downstream of Ras, the precise mechanism underlying activation of the ERK pathway by DJ-1 is still not known. In this study, we found that DJ-1 directly bound to the kinase domain of c-Raf but not to Ras and that Cys-106 mutant DJ-1 bound to c-Raf more weakly than did wild-type DJ-1. Co-localization of DJ-1 with c-Raf in the cytoplasm was enhanced in epidermal growth factor (EGF)-treated cells. Knockdown of DJ-1 expression attenuated the phosphorylation level of c-Raf in EGF-treated cells, resulting in reduced activation of MEK and ERK1/2. Although EGF-treated DJ-1 knock-out cells also showed attenuated c-Raf activation, reintroduction of wild-type DJ-1, but not C106S DJ-1, into DJ-1 knock-out cells restored c-Raf activation in a DJ-1 binding activity in a c-Raf-dependent manner. DJ-1 was not responsible for activation of c-Raf in phorbol myristate acetate-treated cells. Furthermore, DJ-1 stimulated self-phosphorylation activity of c-Raf in vitro, but DJ-1 was not a target for Raf kinase. Oxidation of Cys-106 in DJ-1 was not affected by EGF treatment. These findings showed that DJ-1 is a positive regulator of the EGF/Ras/ERK pathway through targeting c-Raf.	[Takahashi-Niki, Kazuko; Kato-Ose, Izumi; Murata, Hiroaki; Maita, Hiroshi; Ariga, Hiroyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Fac Agr, Kita Ku, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan.	hiro@pharm.hokudai.ac.jp	Maita, Hiroshi/D-5495-2012		Ministry of Education, Culture, Sports, Science and Technology; Grants-in-Aid for Scientific Research [25830071] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology. The authors declare that they have no conflicts of interest with the contents of this article.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Ariga H, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/683920; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Barnard D, 1998, ONCOGENE, V17, P1539, DOI 10.1038/sj.onc.1202061; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; BRTVA TR, 1995, J BIOL CHEM, V270, P9809, DOI 10.1074/jbc.270.17.9809; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chen J, 2010, HUM MOL GENET, V19, P2395, DOI 10.1093/hmg/ddq113; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Choi MS, 2014, J NEUROSCI, V34, P15123, DOI 10.1523/JNEUROSCI.4751-13.2014; DAUM G, 1994, TRENDS BIOCHEM SCI, V19, P474, DOI 10.1016/0968-0004(94)90133-3; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Gu L, 2009, BIOCHEM BIOPH RES CO, V383, P469, DOI 10.1016/j.bbrc.2009.04.037; Hasim S, 2014, J BIOL CHEM, V289, P1662, DOI 10.1074/jbc.M113.505784; He XY, 2012, CARCINOGENESIS, V33, P555, DOI 10.1093/carcin/bgs002; Ito G, 2006, BIOCHEM BIOPH RES CO, V339, P667, DOI 10.1016/j.bbrc.2005.11.058; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kato I, 2013, MOL CELL BIOL, V33, P340, DOI 10.1128/MCB.01350-12; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim YC, 2010, FEBS LETT, V584, P3891, DOI 10.1016/j.febslet.2010.08.010; Kim YC, 2009, INT J ONCOL, V35, P1331, DOI 10.3892/ijo_00000451; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Koide-Yoshida S, 2007, INT J MOL MED, V19, P885; Lee JY, 2012, HUM MOL GENET, V21, P3215, DOI 10.1093/hmg/dds155; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Maita C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054087; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Mitsugi H, 2013, FEBS LETT, V587, P2493, DOI 10.1016/j.febslet.2013.06.032; Mitsumoto A, 2001, FREE RADICAL RES, V35, P301, DOI 10.1080/10715760100300831; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Oehrl W, 2003, J BIOL CHEM, V278, P17819, DOI 10.1074/jbc.M209951200; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Rahman-Roblick R, 2008, ONCOGENE, V27, P4854, DOI 10.1038/onc.2008.124; Saito Y, 2014, J NEUROPATH EXP NEUR, V73, P714, DOI 10.1097/NEN.0000000000000087; Saito Y, 2009, NEUROSCI LETT, V465, P1, DOI 10.1016/j.neulet.2009.08.074; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tang J, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/735618; Toyoda Y, 2014, BIOL OPEN, V3, P777, DOI 10.1242/bio.20149399; Waak J, 2009, J BIOL CHEM, V284, P14245, DOI 10.1074/jbc.M806902200; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Xuan YT, 2005, CIRCULATION, V112, P1971, DOI 10.1161/CIRCULATIONAHA.105.561522; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200; Zhao QQ, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-86	49	25	25	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17838	17847		10.1074/jbc.M115.666271	http://dx.doi.org/10.1074/jbc.M115.666271			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048984	hybrid, Green Published			2022-12-26	WOS:000358511700020
J	Hatano, A; Ueno, T; Kitagami, S; Kawaguchi, J				Hatano, Aya; Ueno, Taiji; Kitagami, Shinji; Kawaguchi, Jun			Why Verbalization of Non-Verbal Memory Reduces Recognition Accuracy: A Computational Approach to Verbal Overshadowing	PLOS ONE			English	Article							FUSIFORM FACE AREA; MULTIPLE FACE; WITHIN-CATEGORY; ACCOUNT; METAANALYSIS; PERCEPTION; MEDIATE; SYSTEM; WORDS	Verbal overshadowing refers to a phenomenon whereby verbalization of non-verbal stimuli (e.g., facial features) during the maintenance phase (after the target information is no longer available from the sensory inputs) impairs subsequent non-verbal recognition accuracy. Two primary mechanisms have been proposed for verbal overshadowing, namely the recoding interference hypothesis, and the transfer-inappropriate processing shift. The former assumes that verbalization renders non-verbal representations less accurate. In contrast, the latter assumes that verbalization shifts processing operations to a verbal mode and increases the chance of failing to return to non-verbal, face-specific processing operations (i.e., intact, yet inaccessible non-verbal representations). To date, certain psychological phenomena have been advocated as inconsistent with the recoding-interference hypothesis. These include a decline in non-verbal memory performance following verbalization of non-target faces, and occasional failures to detect a significant correlation between the accuracy of verbal descriptions and the non-verbal memory performance. Contrary to these arguments against the recoding interference hypothesis, however, the present computational model instantiated core processing principles of the recoding interference hypothesis to simulate face recognition, and nonetheless successfully reproduced these behavioral phenomena, as well as the standard verbal overshadowing. These results demonstrate the plausibility of the recoding interference hypothesis to account for verbal overshadowing, and suggest there is no need to implement separable mechanisms (e.g., operation-specific representations, different processing principles, etc.). In addition, detailed inspections of the internal processing of the model clarified how verbalization rendered internal representations less accurate and how such representations led to reduced recognition accuracy, thereby offering a computationally grounded explanation. Finally, the model also provided an explanation as to why some studies have failed to report verbal overshadowing. Thus, the present study suggests it is not constructive to discuss whether verbal overshadowing exists or not in an all-or-none manner, and instead suggests a better experimental paradigm to further explore this phenomenon.	[Hatano, Aya; Ueno, Taiji; Kitagami, Shinji; Kawaguchi, Jun] Nagoya Univ, Grad Sch Environm Studies, Dept Psychol, Nagoya, Aichi 4648601, Japan; [Ueno, Taiji] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [Ueno, Taiji] Japan Soc Promot Sci, Tokyo, Japan	Nagoya University; University of York - UK; Japan Society for the Promotion of Science	Ueno, T (corresponding author), Nagoya Univ, Grad Sch Environm Studies, Dept Psychol, Nagoya, Aichi 4648601, Japan.	ueno.taiji@d.mbox.nagoya-u.ac.jp			Japan Society for the Promotion of Science [262696, 14J02696, 23101006, 26380984, 21330168, 25285200]; Grants-in-Aid for Scientific Research [25284003] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	All of the funds below came from Japan Society for the Promotion of Science. The URL is as follows: https://www.jsps.go.jp/english/index.html. (1) Grants-in-Aid for JSPS fellow #262696 (14J02696) (to TU). (2) JSPS Grants-in-Aid for Scientific Research on Innovative Areas 23101006, JSPS Grants-in-Aid Scientific Research (C) 26380984 (to SK). (3) JSPS Grants-in-Aid for Scientific Research (B) 21330168 and 25285200 (to JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alogna VK, 2014, PERSPECT PSYCHOL SCI, V9, P556, DOI 10.1177/1745691614545653; BANKS WP, 1970, PSYCHOL BULL, V74, P81, DOI 10.1037/h0029531; Botvinick M, 2004, PSYCHOL REV, V111, P395, DOI 10.1037/0033-295X.111.2.395; Brown C, 2005, MEM COGNITION, V33, P1442, DOI 10.3758/BF03193377; Brown C, 2003, APPL COGNITIVE PSYCH, V17, P183, DOI 10.1002/acp.861; Brown C, 2002, APPL COGNITIVE PSYCH, V16, P873, DOI 10.1002/acp.919; Brown C, 2014, J EXP PSYCHOL LEARN; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; Dilkina K, 2008, COGN NEUROPSYCHOL, V25, P136, DOI 10.1080/02643290701723948; Dodson CS, 1997, MEM COGNITION, V25, P129, DOI 10.3758/BF03201107; FALLSHORE M, 1995, J EXP PSYCHOL LEARN, V21, P1608, DOI 10.1037/0278-7393.21.6.1608; Finger K, 2002, APPL COGNITIVE PSYCH, V16, P887, DOI 10.1002/acp.922; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hatano A, 2013, P 35 ANN C COGN SCI, P2494; Hills PJ, 2009, J EXP PSYCHOL HUMAN, V35, P1427, DOI 10.1037/a0015788; HINTON GE, 1989, ARTIF INTELL, V40, P185, DOI 10.1016/0004-3702(89)90049-0; Joanisse MF, 1999, P NATL ACAD SCI USA, V96, P7592, DOI 10.1073/pnas.96.13.7592; Jones TC, 2013, Q J EXP PSYCHOL, V66, P1818, DOI 10.1080/17470218.2013.771688; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; KINTSCH W, 1967, PSYCHOL REV, V74, P496, DOI 10.1037/h0025127; Kitagami S, 2002, APPL COGNITIVE PSYCH, V16, P963, DOI 10.1002/acp.917; Lane SM, 2004, PSYCHOL SCI, V15, P715, DOI 10.1111/j.0956-7976.2004.00747.x; Lloyd-Jones TJ, 2008, EUR J COGN PSYCHOL, V20, P456, DOI 10.1080/09541440701728425; Macrae CN, 2002, PSYCHOL SCI, V13, P194, DOI 10.1111/1467-9280.00436; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Meissner CA, 2001, APPL COGNITIVE PSYCH, V15, P603, DOI 10.1002/acp.728; Meissner CA, 2001, MEM COGNITION, V29, P176, DOI 10.3758/BF03195751; Meissner CA, 2008, EUR J COGN PSYCHOL, V20, P414, DOI 10.1080/09541440701728581; Melcher JM, 1996, J MEM LANG, V35, P231, DOI 10.1006/jmla.1996.0013; Melcher JM, 2004, MEM COGNITION, V32, P618, DOI 10.3758/BF03195853; MORRIS CD, 1977, J VERB LEARN VERB BE, V16, P519, DOI 10.1016/S0022-5371(77)80016-9; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; Perfect TJ, 2002, APPL COGNITIVE PSYCH, V16, P973, DOI 10.1002/acp.920; Pinker S, 2002, TRENDS COGN SCI, V6, P456, DOI 10.1016/S1364-6613(02)01990-3; Plaut DC, 2011, COGN NEUROPSYCHOL, V28, P251, DOI 10.1080/02643294.2011.609812; Plaut DC, 2000, PSYCHOL REV, V107, P786, DOI 10.1037//0033-295X.107.4.786; Plaut DC, 2002, COGN NEUROPSYCHOL, V19, P603, DOI 10.1080/02643290244000112; Plaut DC, 1997, LANG COGNITIVE PROC, V12, P765, DOI 10.1080/016909697386682; Plaut DC, 1996, PSYCHOL REV, V103, P56, DOI 10.1037/0033-295X.103.1.56; Schooler JW, 2002, APPL COGNITIVE PSYCH, V16, P989, DOI 10.1002/acp.930; SCHOOLER JW, 1990, COGNITIVE PSYCHOL, V22, P36, DOI 10.1016/0010-0285(90)90003-M; SCHOOLER JW, 1993, J EXP PSYCHOL GEN, V122, P166, DOI 10.1037/0096-3445.122.2.166; SPORER SL, 1991, J EXP PSYCHOL LEARN, V17, P323, DOI 10.1037/0278-7393.17.2.323; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; TULVING E, 1982, J EXP PSYCHOL LEARN, V8, P336, DOI 10.1037/0278-7393.8.4.336; Valentin D, 1996, J OPT SOC AM A, V13, P717, DOI 10.1364/JOSAA.13.000717; Vanags T, 2005, APPL COGNITIVE PSYCH, V19, P1127, DOI 10.1002/acp.1160; Westerman DL, 1997, AM J PSYCHOL, V110, P417, DOI 10.2307/1423566; Wickham LHV, 2006, APPL COGNITIVE PSYCH, V20, P157, DOI 10.1002/acp.1176; WILSON TD, 1991, J PERS SOC PSYCHOL, V60, P181, DOI 10.1037/0022-3514.60.2.181; WINOGRAD E, 1981, J EXP PSYCHOL-HUM L, V7, P181, DOI 10.1037/0278-7393.7.3.181; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; YOUNG R A, 1987, Spatial Vision, V2, P273, DOI 10.1163/156856887X00222	57	3	3	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127618	10.1371/journal.pone.0127618	http://dx.doi.org/10.1371/journal.pone.0127618			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26061046	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500044
J	Val, A; Dirks, PHGM; Backwell, LR; d'Errico, F; Berger, LR				Val, Aurore; Dirks, Paul H. G. M.; Backwell, Lucinda R.; d'Errico, Francesco; Berger, Lee R.			Taphonomic Analysis of the Faunal Assemblage Associated with the Hominins (Australopithecus sediba) from the Early Pleistocene Cave Deposits of Malapa, South Africa	PLOS ONE			English	Article							BONE ACCUMULATIONS; FOSSIL ASSEMBLAGE; STERKFONTEIN; HUMANKIND; LEOPARDS; SKELETON; DENSITY; CRADLE; SITE; REPRESENTATION	Here we present the results of a taphonomic study of the faunal assemblage associated with the hominin fossils (Australopithecus sediba) from the Malapa site. Results include estimation of body part representation, mortality profiles, type of fragmentation, identification of breakage patterns, and microscopic analysis of bone surfaces. The diversity of the faunal spectrum, presence of animals with climbing proclivities, abundance of complete and/or articulated specimens, occurrence of antimeric sets of elements, and lack of carnivore-modified bones, indicate that animals accumulated via a natural death trap leading to an area of the cave system with no access to mammalian scavengers. The co-occurrence of well preserved fossils, carnivore coprolites, deciduous teeth of brown hyaena, and some highly fragmented and poorly preserved remains supports the hypothesis of a mixing of sediments coming from distinct chambers, which collected at the bottom of the cave system through the action of periodic water flow. This combination of taphonomic features explains the remarkable state of preservation of the hominin fossils as well as some of the associated faunal material.	[Val, Aurore; Backwell, Lucinda R.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Val, Aurore; Backwell, Lucinda R.; Berger, Lee R.] Univ Witwatersrand, Dept Sci & Technol, Natl Res Fdn Ctr Excellence Palaeosci, Johannesburg, South Africa; [Dirks, Paul H. G. M.] James Cook Univ, Sch Earth & Environm Sci, Townsville, Qld 4811, Australia; [Dirks, Paul H. G. M.; Backwell, Lucinda R.] Univ Witwatersrand, Sch Geosci, Johannesburg, South Africa; [d'Errico, Francesco] Univ Bordeaux, CNRS, Unite Mixte Rech PACEA 5199, Talence, France; [d'Errico, Francesco] Univ Bergen, Dept Archaeol Hist Cultural Studies & Relig, Bergen, Norway	University of Witwatersrand; University of Witwatersrand; James Cook University; University of Witwatersrand; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Bergen	Val, A (corresponding author), Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa.	aurore_val@yahoo.com	Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629; Val, Aurore/0000-0001-5350-186X	National Geographic Society; Gauteng Provincial Government; National Research Foundation of South Africa; Evolutionary Studies Institute (University of the Witwatersrand); Carstens Trust; Australian Research Foundation [ARC DP140104282]; African Origins Program	National Geographic Society(National Geographic Society); Gauteng Provincial Government; National Research Foundation of South Africa(National Research Foundation - South Africa); Evolutionary Studies Institute (University of the Witwatersrand); Carstens Trust; Australian Research Foundation(Australian Research Council); African Origins Program	This paper was funded by the National Geographic Society, Gauteng Provincial Government, National Research Foundation of South Africa, African Origins Program, Evolutionary Studies Institute (University of the Witwatersrand), Carstens Trust, and the Australian Research Foundation (ARC DP140104282). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2007, J HUM EVOL, V53, P751, DOI 10.1016/j.jhevol.2007.08.009; Adams JW, 2007, QUATERNARY SCI REV, V26, P2526, DOI 10.1016/j.quascirev.2007.05.006; Adams JW, 2006, THESIS U WITWATERSRA; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Berger Lee R., 2012, J ANTHROPOL SCI, V90, P1; Brain C.K., 1993, Transvaal Museum Monograph, V8, P257; Brain C. K., 1969, Scientific Papers Namib Desert Research Station, VNo. 39, P13; BRAIN C. K, 1981, HUNTERS HUNTED INTRO; Brain C. K., 1976, HUMAN ORIGINS, P97; Bunn H.T., 1986, THESIS U CALIFORNIA; BUNN HT, 1986, CURR ANTHROPOL, V27, P431, DOI 10.1086/203467; Carlson KJ, 2003, J HUM EVOL, V44, P431, DOI 10.1016/S0047-2484(03)00025-3; Castel Jean-Christophe, 2010, Revue de Paleobiologie, V29, P411; Clarke RJ, 2008, S AFR J SCI, V104, P443, DOI 10.1590/s0038-23532008000600015; Clarke RJ, 1998, S AFR J SCI, V94, P460; Clarke Ron J., 2007, P199; COOKE H B S, 1991, Palaeontologia Africana, V28, P9; Costamagno Sandrine, 1999, Anthropozoologica, V29, P13; COUMONT M. -P., 2006, THESIS U AIX MARSEIL; Coumont MP, 2009, ANN PALEONTOL, V95, P1, DOI 10.1016/j.annpal.2008.12.002; Davis S.J.M., 1987, ARCHAEOLOGY ANIMALS; de Ruiter DJ, 2009, J HUM EVOL, V56, P497, DOI 10.1016/j.jhevol.2009.01.009; de Ruiter DJ, 2000, J ARCHAEOL SCI, V27, P665, DOI 10.1006/jasc.1999.0470; Dirks PHGM, 2013, J AFR EARTH SCI, V78, P109, DOI 10.1016/j.jafrearsci.2012.09.012; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Dominguez-Rodrigo Manuel, 2010, Journal of Taphonomy, V8, P155; Gilbert CC, PAPIO CRANIUM UNPUB; Gommery D., 2008, Annals of the Transvaal Museum, V45, P67; GRINE FE, 1989, AM J PHYS ANTHROPOL, V79, P409, DOI 10.1002/ajpa.1330790402; Grine Frederick E., 1993, Transvaal Museum Monograph, V8, P75; Keyser AW, 2000, S AFR J SCI, V96, P193; Klein R.G., 1984, ANAL ANIMAL BONES AR; Kos AM, 2003, J ARCHAEOL SCI, V30, P781, DOI 10.1016/S0305-4403(02)00252-2; KREUTZER LA, 1992, J ARCHAEOL SCI, V19, P271, DOI 10.1016/0305-4403(92)90017-W; Kuhn BF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026940; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; Lam YM, 1999, AM ANTIQUITY, V64, P343, DOI 10.2307/2694283; Lyman L.D., 1994, VERTEBRATE TAPHONOMY, DOI DOI 10.1017/CBO9781139878302; LYMAN RL, 1994, AM ANTIQUITY, V59, P36, DOI 10.2307/3085500; LYMAN RL, 1984, J ANTHROPOL ARCHAEOL, V3, P259, DOI 10.1016/0278-4165(84)90004-7; LYMAN RL, 1987, AM ANTIQUITY, V52, P125, DOI 10.2307/281064; Marean CW, 1995, J HUM EVOL, V29, P515, DOI 10.1006/jhev.1995.1074; Novecosky BJ, 2005, J ARCHAEOL SCI, V32, P1677, DOI 10.1016/j.jas.2005.05.009; Payne S., 1975, ARCHAEOZOOLOGICAL ST, P27; Pickering R, 2011, SCIENCE, V333, P1421, DOI 10.1126/science.1203697; Pickering TR, 2004, AM J PHYS ANTHROPOL, V125, P1, DOI 10.1002/ajpa.10278; Pickering TR, 2004, FORENSIC SCI INT, V144, P37, DOI 10.1016/j.forsciint.2004.03.003; Pickering TR, 2004, J HUM EVOL, V46, P595, DOI 10.1016/j.jhevol.2004.03.002; Pickering TR, 2004, J HUM EVOL, V46, P279, DOI 10.1016/j.jhevol.2003.12.001; Plug C., 1990, South African Archaeological Bulletin, V45, P53, DOI 10.2307/3887918; Reynolds Sally Christine, 2011, Palaeontologia Africana, V46, P59; SKINNER JD, 1991, J ARCHAEOL SCI, V18, P513, DOI 10.1016/0305-4403(91)90051-P; Tobias PV, 2000, OXFORD MGR GEOL GEOP, P252; Val A, 2014, S AFR ARCHAEOL BULL, V69, P49; Val Aurore, 2011, S. Afr. j. sci., V107, P01; VILLA P, 1991, J HUM EVOL, V21, P27, DOI 10.1016/0047-2484(91)90034-S; Wang X., 1993, NATL GEOGRAPHIC RES, V9, P422; Watson Virginia, 1993, Transvaal Museum Monograph, V8, P35	59	26	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0126904	10.1371/journal.pone.0126904	http://dx.doi.org/10.1371/journal.pone.0126904			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061082	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000355979500020
J	Waldbusser, GG; Hales, B; Langdon, CJ; Haley, BA; Schrader, P; Brunner, EL; Gray, MW; Miller, CA; Gimenez, I; Hutchinson, G				Waldbusser, George G.; Hales, Burke; Langdon, Chris J.; Haley, Brian A.; Schrader, Paul; Brunner, Elizabeth L.; Gray, Matthew W.; Miller, Cale A.; Gimenez, Iria; Hutchinson, Greg			Ocean Acidification Has Multiple Modes of Action on Bivalve Larvae	PLOS ONE			English	Article							OYSTERS CRASSOSTREA-GIGAS; PACIFIC OYSTER; MYTILUS-EDULIS; MERCENARIA-MERCENARIA; SHELL DIFFERENTIATION; ENERGY-METABOLISM; ANIMAL PHYSIOLOGY; COASTAL ZONE; SEA-WATER; CO2	Ocean acidification (OA) is altering the chemistry of the world's oceans at rates unparalleled in the past roughly 1 million years. Understanding the impacts of this rapid change in baseline carbonate chemistry on marine organisms needs a precise, mechanistic understanding of physiological responses to carbonate chemistry. Recent experimental work has shown shell development and growth in some bivalve larvae, have direct sensitivities to calcium carbonate saturation state that is not modulated through organismal acid-base chemistry. To understand different modes of action of OA on bivalve larvae, we experimentally tested how pH, P-CO2, and saturation state independently affect shell growth and development, respiration rate, and initiation of feeding in Mytilus californianus embryos and larvae. We found, as documented in other bivalve larvae, that shell development and growth were affected by aragonite saturation state, and not by pH or P-CO2. Respiration rate was elevated under very low pH (similar to 7.4) with no change between pH of similar to 8.3 to similar to 7.8. Initiation of feeding appeared to be most sensitive to P-CO2, and possibly minor response to pH under elevated P-CO2. Although different components of physiology responded to different carbonate system variables, the inability to normally develop a shell due to lower saturation state precludes pH or P-CO2 effects later in the life history. However, saturation state effects during early shell development will carry-over to later stages, where pH or P-CO2 effects can compound OA effects on bivalve larvae. Our findings suggest OA may be a multi-stressor unto itself. Shell development and growth of the native mussel, M. californianus, was indistinguishable from the Mediterranean mussel, Mytilus galloprovincialis, collected from the southern U.S. Pacific coast, an area not subjected to seasonal upwelling. The concordance in responses suggests a fundamental OA bottleneck during development of the first shell material affected only by saturation state.	[Waldbusser, George G.; Hales, Burke; Haley, Brian A.; Brunner, Elizabeth L.; Gimenez, Iria] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Langdon, Chris J.; Schrader, Paul; Gray, Matthew W.; Hutchinson, Greg] Oregon State Univ, Hatfield Marine Sci Ctr, Coastal Oregon Marine Expt Stn, Newport, OR 97365 USA; [Langdon, Chris J.; Schrader, Paul; Gray, Matthew W.; Hutchinson, Greg] Oregon State Univ, Hatfield Marine Sci Ctr, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Miller, Cale A.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University	Waldbusser, GG (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	waldbuss@coas.oregonstate.edu	Gray, Matthew W/AGV-0678-2022; /AAL-3738-2021	Gray, Matthew/0000-0003-0872-2449; Waldbusser, George/0000-0002-8334-580X; Gimenez, Iria/0000-0001-5916-4446	National Science Foundation OCE CRI-OA [1041267]; Directorate For Geosciences [1041267] Funding Source: National Science Foundation	National Science Foundation OCE CRI-OA; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation OCE CRI-OA #1041267 to GGW, BH, CJL, and BAH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alin SR, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007511; Allam B, 1998, DIS AQUAT ORGAN, V33, P123, DOI 10.3354/dao033123; Aranda-Burgos JA, 2014, J MOLLUS STUD, V80, P8, DOI 10.1093/mollus/eyt044; Armengol X, 2001, HYDROBIOLOGIA, V446, P107, DOI 10.1023/A:1017591004514; Arnold WS, 2009, AQUAT BIOL, V5, P49, DOI 10.3354/ab00137; ASTM International, 2004, STAND GUID COND STAT, pE724; BALDWIN BS, 1995, MAR ECOL PROG SER, V120, P135, DOI 10.3354/meps120135; Bandstra L, 2006, MAR CHEM, V100, P24, DOI 10.1016/j.marchem.2005.10.009; Barros P, 2013, J EXP MAR BIOL ECOL, V440, P200, DOI 10.1016/j.jembe.2012.12.014; Barton A, 2012, LIMNOL OCEANOGR, V57, P698, DOI 10.4319/lo.2012.57.3.0698; BAYNE BL, 1975, J MAR BIOL ASSOC UK, V55, P675, DOI 10.1017/S0025315400017343; Borges AV, 2010, LIMNOL OCEANOGR, V55, P346, DOI 10.4319/lo.2010.55.1.0346; BORRERO FJ, 1988, MAR ECOL PROG SER, V42, P9, DOI 10.3354/meps042009; Cai WJ, 2011, NAT GEOSCI, V4, P766, DOI [10.1038/ngeo1297, 10.1038/NGEO1297]; Carre M, 2006, GEOCHIM COSMOCHIM AC, V70, P4906, DOI 10.1016/j.gca.2006.07.019; CARRIKER MR, 1992, AM MALACOL BULL, V9, P193; Chan KYK, 2011, J EXP BIOL, V214, P3857, DOI 10.1242/jeb.054809; da Costa F, 2011, MAR BIOL, V158, P1829, DOI 10.1007/s00227-011-1695-6; DADD RH, 1971, ANN ENTOMOL SOC AM, V64, P687, DOI 10.1093/aesa/64.3.687; De Wit P, 2013, MOL ECOL, V22, P2884, DOI 10.1111/mec.12081; DEMOTT WR, 1988, LIMNOL OCEANOGR, V33, P397, DOI 10.4319/lo.1988.33.3.0397; DICKSON AG, 1990, J CHEM THERMODYN, V22, P113, DOI 10.1016/0021-9614(90)90074-Z; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Elvin DW, 1974, THESIS OREGON STATE; Eversole AG, 2001, DEV AQUAC FISH SCI, V31, P221; Feely RA, 2008, SCIENCE, V320, P1490, DOI 10.1126/science.1155676; Feely RA, 2010, ESTUAR COAST SHELF S, V88, P442, DOI 10.1016/j.ecss.2010.05.004; Flye-Sainte-Marie J, 2007, J EXP MAR BIOL ECOL, V349, P378, DOI 10.1016/j.jembe.2007.05.029; Freitas PS, 2009, BIOGEOSCIENCES, V6, P1209, DOI 10.5194/bg-6-1209-2009; Gagnon AC, 2012, EARTH PLANET SC LETT, V329, P150, DOI 10.1016/j.epsl.2012.03.005; Gaylord B, 2015, ECOLOGY, V96, P3, DOI 10.1890/14-0802.1; Gaylord B, 2011, J EXP BIOL, V214, P2586, DOI 10.1242/jeb.055939; Gazeau FDR, 2013, MAR BIOL, V160, P1; Gazeau F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023010; GERDES D, 1983, AQUACULTURE, V31, P221, DOI 10.1016/0044-8486(83)90314-9; GIAUME C, 1980, NEUROSCI LETT, V17, P197, DOI 10.1016/0304-3940(80)90084-1; Gobler CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083648; Goulletquer P, 2004, AQUAT LIVING RESOUR, V17, P195, DOI 10.1051/alr:2004018; Hales B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002295; Hales B, 2004, LIMNOL OCEANOGR-METH, V2, P356, DOI 10.4319/lom.2004.2.356; Harris KE, 2013, GEOPHYS RES LETT, V40, P2720, DOI 10.1002/grl.50460; HART MW, 1991, BIOL BULL, V180, P12, DOI 10.2307/1542425; Hettinger A, 2013, GLOBAL CHANGE BIOL, V19, P3317, DOI 10.1111/gcb.12307; Hettinger A, 2012, ECOLOGY, V93, P2758, DOI 10.1890/12-0567.1; Hinga KR, 2002, MAR ECOL PROG SER, V238, P281, DOI 10.3354/meps238281; His E, 1997, WATER RES, V31, P351, DOI 10.1016/S0043-1354(96)00244-8; HIS E, 1988, AQUACULTURE, V69, P185, DOI 10.1016/0044-8486(88)90195-0; Hochachka P. W., 2001, BIOCH ADAPTATION MEC; Honisch B, 2012, SCIENCE, V335, P1058, DOI 10.1126/science.1208277; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; Hopkinson C, 2004, RESP AQUATIC ECOSYST, P122; Jordey LH, 1953, BIOL BULL, V104, P398; Kelly MW, 2013, GLOBAL CHANGE BIOL, V19, P2536, DOI 10.1111/gcb.12251; Kelly RP, 2011, SCIENCE, V332, P1036, DOI 10.1126/science.1203815; KNIPRATH E, 1981, ZOOL SCR, V10, P61, DOI 10.1111/j.1463-6409.1981.tb00485.x; Kurihara H, 2004, MAR ECOL PROG SER, V274, P161, DOI 10.3354/meps274161; Kurihara H, 2004, J OCEANOGR, V60, P743, DOI 10.1007/s10872-004-5766-x; Kurihara H, 2007, AQUAT BIOL, V1, P91, DOI 10.3354/ab00009; LABARBERA M, 1974, MAR BIOL, V25, P233, DOI 10.1007/BF00394969; Langdon C, 2003, AQUACULTURE, V220, P227, DOI 10.1016/S0044-8486(02)00621-X; Lewis DE, 1998, OCEANOGRAPH LIT REV, V45; Loosanoff V. L., 1963, Advances in Marine Biology, V1, P1, DOI 10.1016/S0065-2881(08)60257-6; Lueker TJ, 2000, MAR CHEM, V70, P105, DOI 10.1016/S0304-4203(00)00022-0; Marshall DJ, 2008, OCEANOGR MAR BIOL, V46, P203, DOI 10.1201/9781420065756.ch5; Matias D, 2011, HELGOLAND MAR RES, V65, P369, DOI 10.1007/s10152-010-0230-3; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; McConnaughey TA, 2008, GEO-MAR LETT, V28, P287, DOI 10.1007/s00367-008-0116-4; McElhany P, 2013, MAR BIOL, V160, P1807, DOI 10.1007/s00227-012-2052-0; Melzner F, 2009, BIOGEOSCIENCES, V6, P2313, DOI 10.5194/bg-6-2313-2009; Michaelidis B, 2005, PHYSIOL BIOCHEM ZOOL, V78, P373, DOI 10.1086/430223; Miller AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005661; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; Millero FJ, 2010, MAR FRESHWATER RES, V61, P139, DOI 10.1071/MF09254; Moran AL, 2004, J EXP MAR BIOL ECOL, V306, P17, DOI 10.1016/j.jembe.2003.12.021; Moueza M, 2006, INVERTEBR BIOL, V125, P21, DOI 10.1111/j.1744-7410.2006.00036.x; Najjar RG, 2010, ESTUAR COAST SHELF S, V86, P1, DOI 10.1016/j.ecss.2009.09.026; Newell Roger I.E., 1996, P185; PACE ML, 1987, MAR ECOL PROG SER, V40, P185, DOI 10.3354/meps040185; Pane EF, 2007, MAR ECOL PROG SER, V334, P1, DOI 10.3354/meps334001; Parker Laura M., 2013, Biology - Basel, V2, P651, DOI 10.3390/biology2020651; Parker LM, 2012, GLOBAL CHANGE BIOL, V18, P82, DOI 10.1111/j.1365-2486.2011.02520.x; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Peracchia C, 2004, BBA-BIOMEMBRANES, V1662, P61, DOI 10.1016/j.bbamem.2003.10.020; Pernet F, 2006, J EXP MAR BIOL ECOL, V329, P265, DOI 10.1016/j.jembe.2005.09.008; Pespeni MH, 2013, INTEGR COMP BIOL, V53, P857, DOI 10.1093/icb/ict094; Phillips NE, 2002, ECOLOGY, V83, P2562, DOI 10.2307/3071815; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Powell EN, 2011, J SHELLFISH RES, V30, P403, DOI 10.2983/035.030.0228; Reum JCP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089619; RODRIGUEZ SR, 1993, MAR ECOL PROG SER, V97, P193, DOI 10.3354/meps097193; RUMRILL SS, 1990, OPHELIA, V32, P163, DOI 10.1080/00785236.1990.10422030; Sanchez-Lazo C, 2012, AQUACULTURE, V358, P71, DOI 10.1016/j.aquaculture.2012.06.021; Scanes E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093649; Schmid A, 2004, J GEN PHYS, V130, P99; SEDANO FJ, 1995, J EXP MAR BIOL ECOL, V192, P75, DOI 10.1016/0022-0981(95)00062-V; SPRUNG M, 1984, MAR ECOL PROG SER, V17, P283, DOI 10.3354/meps017283; Stumpp M, 2013, NAT CLIM CHANGE, V3, P1044, DOI 10.1038/NCLIMATE2028; Suzuki M, 2013, CAN J ZOOL, V91, P349, DOI 10.1139/cjz-2012-0333; Talmage SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026941; Talmage SC, 2009, LIMNOL OCEANOGR, V54, P2072, DOI 10.4319/lo.2009.54.6.2072; Tambutte E, 2012, P ROY SOC B-BIOL SCI, V279, P19, DOI 10.1098/rspb.2011.0733; THOMPSON PA, 1994, AQUACULTURE, V119, P237, DOI 10.1016/0044-8486(94)90178-3; Thomsen J, 2010, BIOGEOSCIENCES, V7, P3879, DOI 10.5194/bg-7-3879-2010; Thomsen J, 2015, BIOGEOSCIENCES DISCU, V12, P1543, DOI DOI 10.5194/BGD-12-1543-2015; Thomsen J, 2010, MAR BIOL, V157, P2667, DOI 10.1007/s00227-010-1527-0; Togo T, 1995, BIOL BULL-US, V189, P330, DOI 10.2307/1542150; VANDENBERG JI, 1994, AM J PHYSIOL, V266, pC489, DOI 10.1152/ajpcell.1994.266.2.C489; Vargas CA, 2013, J PLANKTON RES, V35, P1059, DOI 10.1093/plankt/fbt045; Videla JA, 1998, MAR BIOL, V132, P635, DOI 10.1007/s002270050428; Waldbusser GG, 2015, NAT CLIM CHANGE, V5, P273, DOI 10.1038/NCLIMATE2479; Waldbusser GG, 2014, ANNU REV MAR SCI, V6, P221, DOI 10.1146/annurev-marine-121211-172238; Waldbusser GG, 2013, GEOPHYS RES LETT, V40, P2171, DOI 10.1002/grl.50449; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Waldbusser GG, 2010, MAR ECOL PROG SER, V417, P171, DOI 10.3354/meps08809; Wallace RB, 2014, ESTUAR COAST SHELF S, V148, P1, DOI 10.1016/j.ecss.2014.05.027; White MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061065; Widdicombe S, 2008, J EXP MAR BIOL ECOL, V366, P187, DOI 10.1016/j.jembe.2008.07.024; WIDDOWS J, 1991, AQUACULTURE, V94, P147, DOI 10.1016/0044-8486(91)90115-N; WIDDOWS J, 1989, BIOL BULL, V177, P154, DOI 10.2307/1541843	121	116	118	4	157	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128376	10.1371/journal.pone.0128376	http://dx.doi.org/10.1371/journal.pone.0128376			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061095	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500079
J	Matias, ML; Romao, M; Weel, IC; Ribeiro, VR; Nunes, PR; Borges, VT; Araujo, JP; Peracoli, JC; de Oliveira, L; Peracoli, MT				Matias, Mariana Leticia; Romao, Mariana; Weel, Ingrid Cristina; Ribeiro, Vanessa Rocha; Nunes, Priscila Rezeck; Borges, Vera Therezinha; Araujo, Joao Pessoa, Jr.; Peracoli, Jose Carlos; de Oliveira, Leandro; Peracoli, Maria Terezinha			Endogenous and Uric Acid-Induced Activation of NLRP3 Inflammasome in Pregnant Women with Preeclampsia	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; MATERNAL-FETAL INTERFACE; CYTOKINE PRODUCTION; TRANSCRIPTION FACTORS; ONSET PREECLAMPSIA; NALP3 INFLAMMASOME; MONONUCLEAR-CELLS; IMMUNE-SYSTEM; MONOCYTES	Preeclampsia (PE) is a specific syndrome of pregnancy, characterized by hypertension and proteinuria. This pathology is associated with hyperuricemia and elevated serum levels of inflammatory cytokines. Uric acid crystals may activate an intracellular complex called inflammasome, which is important for processing and release of inflammatory cytokines. This study investigated the state of monocyte activation, both endogenous and stimulated with monosodium urate (MSU), by gene expression of NLRP1 and NLRP3 receptors as well as their association with inflammatory cytokines expression. Monocytes were obtained from peripheral blood of 23 preeclamptic pregnant women, 23 normotensive pregnant women (NT) and 23 healthy non-pregnant women (NP). Inflammasome activation was evaluated by the gene expression of NLRP1, NLRP3, caspase-1, IL-1 beta, IL-18 and TNF-alpha by RT-qPCR in unstimulated monocytes (endogenous expression), or after cell stimulation with MSU (stimulated expression). The concentration of cytokines was assessed by ELISA. In preeclamptic pregnant women, gene expression of NLRP1, NLRP3, caspase-1, IL-1 beta and TNF-alpha by monocytes stimulated or not with MSU was significantly higher than in NT and NP groups. Stimulation of monocytes from preeclamptic and non-pregnant women with MSU induced increased gene expression of NLRP3, caspase-1 and TNF-alpha in relation to the endogenous expression in these groups, while this was not observed in the NT group. The cytokine determination showed that monocytes from women with PE produced higher endogenous levels of IL-1 beta, IL-18 and TNF-alpha compared to the other groups, while the stimulus with MSU led to higher production of these cytokines in preeclamptic group than in the NT group. In conclusion, the results showed increased basal gene expression of NLRP1 and NLRP3 receptors in monocytes from PE group. These cells stimulation with MSU demonstrates that uric acid plays a role in NLRP3 inflammasome activation, suggesting the participation of this inflammatory complex in the pathogenesis of preeclampsia.	[Matias, Mariana Leticia; Borges, Vera Therezinha; Peracoli, Jose Carlos; de Oliveira, Leandro] Sao Paulo State Univ, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP, Brazil; [Romao, Mariana; Weel, Ingrid Cristina; Ribeiro, Vanessa Rocha; Nunes, Priscila Rezeck; Araujo, Joao Pessoa, Jr.; Peracoli, Maria Terezinha] Sao Paulo State Univ, Inst Biosci, Dept Microbiol & Immunol, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista	Peracoli, MT (corresponding author), Sao Paulo State Univ, Inst Biosci, Dept Microbiol & Immunol, Botucatu, SP, Brazil.	tperacoli@uol.com.br	Ribeiro Vasques, Vanessa Rocha/AAU-7634-2021; Araujo Jr, Joao Pessoa/Q-3043-2019; Araujo, Joao Pessoa/C-2444-2012; De Oliveira, Leandro/G-3476-2012; Veiga, Mariana Romão/J-1590-2015; Ribeiro, Vanessa Rocha/B-1460-2016; Nunes, Priscila/B-1457-2016; BORGES, VERA T/B-7363-2014; Peracoli, Jose Carlos/GME-1756-2022; Peracoli, Maria/AAD-2409-2019; Matias, Mariana/B-1458-2016	Ribeiro Vasques, Vanessa Rocha/0000-0001-7629-7689; Araujo Jr, Joao Pessoa/0000-0002-9153-1485; Araujo, Joao Pessoa/0000-0002-9153-1485; De Oliveira, Leandro/0000-0002-8422-9907; Veiga, Mariana Romão/0000-0002-8990-0237; Ribeiro, Vanessa Rocha/0000-0001-7629-7689; Nunes, Priscila/0000-0002-8041-5753; BORGES, VERA T/0000-0002-9347-9641; Matias, Mariana/0000-0001-7174-3336				[Anonymous], INF DNA DET CELL FUN; Azizieh F, 2005, AM J REPROD IMMUNOL, V54, P30, DOI 10.1111/j.1600-0897.2005.00278.x; Bainbridge SA, 2008, PLACENTA, V29, pS67, DOI 10.1016/j.placenta.2007.11.001; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Beckmann I, 2004, HYPERTENS PREGNANCY, V23, P319, DOI 10.1081/PRG-200030334; Borzychowski AM, 2006, SEMIN FETAL NEONAT M, V11, P309, DOI 10.1016/j.siny.2006.04.001; Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P77; Cartwright JE, 2010, REPRODUCTION, V140, P803, DOI 10.1530/REP-10-0294; Cheng SB, 2015, AM J REPROD IMMUNOL, V73, P487, DOI 10.1111/aji.12329; Ciraci C, 2012, MICROBES INFECT, V14, P1263, DOI 10.1016/j.micinf.2012.07.007; Conforti-Andreoni C, 2011, J IMMUNOL, V187, P5842, DOI 10.4049/jimmunol.1101408; Cristofalo R, 2013, FREE RADICAL RES, V47, P268, DOI 10.3109/10715762.2013.765951; Darmochwal-Kolarz D, 2012, J REPROD IMMUNOL, V93, P75, DOI 10.1016/j.jri.2012.01.006; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; de Oliveira LG, 2010, REV BRAS GINECOL OBS, V32, P609, DOI 10.1590/S0100-72032010001200008; Dinarello CA, 2003, J INFECT DIS, V187, pS370, DOI 10.1086/374751; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Grishman EK, 2012, PEDIATR RES, V71, P626, DOI 10.1038/pr.2012.24; Haneklaus M, 2013, CURR OPIN IMMUNOL, V25, P40, DOI 10.1016/j.coi.2012.12.004; Giorgi VSI, 2012, J REPROD IMMUNOL, V95, P67, DOI 10.1016/j.jri.2012.06.004; Johnson MR, 2002, BJOG-INT J OBSTET GY, V109, P836, DOI 10.1016/S1470-0328(02)01045-5; Kim YM, 2005, AM J OBSTET GYNECOL, V193, P921, DOI 10.1016/j.ajog.2005.06.053; Kingsbury SR, 2011, J INFLAMM RES, V4, P39, DOI 10.2147/JIR.S11330; Klimkiewicz-Blok D, 2013, ADV CLIN EXP MED, V22, P699; Koga K, 2008, REPROD SCI, V15, P231, DOI 10.1177/1933719108316391; Lamkanfi M, 2007, J LEUKOCYTE BIOL, V82, P220, DOI 10.1189/jlb.1206756; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lasiglie D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020014; LI CY, 1973, J HISTOCHEM CYTOCHEM, V21, P1; Lok CAR, 2009, AM J REPROD IMMUNOL, V61, P346, DOI 10.1111/j.1600-0897.2009.00701.x; Luppi P, 2006, CLIN IMMUNOL, V118, P268, DOI 10.1016/j.clim.2005.11.001; Martin AC, 2010, NAT REV NEPHROL, V6, P744, DOI 10.1038/nrneph.2010.125; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Marzi M, 1996, CLIN EXP IMMUNOL, V106, P127, DOI 10.1046/j.1365-2249.1996.d01-809.x; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mazouni C, 2008, J REPROD IMMUNOL, V78, P80, DOI 10.1016/j.jri.2007.10.002; Medeiros LTL, 2014, AM J REPROD IMMUNOL, V72, P5, DOI 10.1111/aji.12222; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mulla MJ, 2011, AM J REPROD IMMUNOL, V65, P542, DOI 10.1111/j.1600-0897.2010.00960.x; Novick D, 2013, SEMIN IMMUNOL, V25, P439, DOI 10.1016/j.smim.2013.10.014; Orange S, 2003, HYPERTENS PREGNANCY, V22, P1, DOI 10.1081/PRG-120016788; Peracoli JC, 2013, J REPROD IMMUNOL, V100, P129, DOI 10.1016/j.jri.2013.08.003; Peracoli JC, 2007, AM J REPROD IMMUNOL, V57, P177, DOI 10.1111/j.1600-0897.2006.00455.x; Peracoli MTS, 2011, AM J REPROD IMMUNOL, V66, P460, DOI 10.1111/j.1600-0897.2011.01016.x; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Pontillo A, 2015, AM J REPROD IMMUNOL, V73, P577, DOI 10.1111/aji.12353; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Redman CWG, 2003, PLACENTA, V24, pS21, DOI 10.1053/plac.2002.0930; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; Roberts JM, 1998, SEMIN REPROD ENDOCR, V16, P5, DOI 10.1055/s-2007-1016248; Rock KL, 2013, NAT REV RHEUMATOL, V9, P13, DOI 10.1038/nrrheum.2012.143; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Siljee JE, 2013, PRENATAL DIAG, V33, P1183, DOI 10.1002/pd.4219; Striz I, 2011, IMMUNOBIOLOGY, V216, P1110, DOI 10.1016/j.imbio.2011.04.009; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Toldi G, 2011, AM J REPROD IMMUNOL, V66, P223, DOI 10.1111/j.1600-0897.2011.00987.x; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Yang CS, 2012, INT NEUROUROL J, V16, P2, DOI 10.5213/inj.2012.16.1.2	65	73	76	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129095	10.1371/journal.pone.0129095	http://dx.doi.org/10.1371/journal.pone.0129095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053021	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300084
J	St George, M; Ayoub, AT; Banerjee, A; Churchill, CDM; Winter, P; Klobukowski, M; Cass, CE; Luduena, RF; Tuszynski, JA; Damaraju, S				St George, Marc; Ayoub, Ahmed T.; Banerjee, Asok; Churchill, Cassandra D. M.; Winter, Philip; Klobukowski, Mariusz; Cass, Carol E.; Luduena, Richard F.; Tuszynski, Jack A.; Damaraju, Sambasivarao			Designing and Testing of Novel Taxanes to Probe the Highly Complex Mechanisms by Which Taxanes Bind to Microtubules and Cause Cytotoxicity to Cancer Cells	PLOS ONE			English	Article							ALPHA-BETA-TUBULIN; LUNG-CANCER; TAXOL; RESISTANCE; MODEL; DIMER; LINE; DYNAMICS; SITE; DIFFERENTIATION	Our previous work identified an intermediate binding site for taxanes in the microtubule nanopore. The goal of this study was to test derivatives of paclitaxel designed to bind to this intermediate site differentially depending on the isotype of beta-tubulin. Since beta-tubulin isotypes have tissue-dependent expression-specifically, the beta III isotype is very abundant in aggressive tumors and much less common in normal tissues-this is expected to lead to tubulin targeted drugs that are more efficacious and have less side effects. Seven derivatives of paclitaxel were designed and four of these were amenable for synthesis in sufficient purity and yield for further testing in breast cancer model cell lines. None of the derivatives studied were superior to currently used taxanes, however computer simulations provided insights into the activity of the derivatives. Our results suggest that neither binding to the intermediate binding site nor the final binding site is sufficient to explain the activities of the derivative taxanes studied. These findings highlight the need to iteratively improve on the design of taxanes based on their activity in model systems. Knowledge gained on the ability of the engineered drugs to bind to targets and bring about activity in a predictable manner is a step towards personalizing therapies.	[St George, Marc; Damaraju, Sambasivarao] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Ayoub, Ahmed T.; Churchill, Cassandra D. M.; Klobukowski, Mariusz] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Banerjee, Asok; Luduena, Richard F.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Winter, Philip; Cass, Carol E.; Tuszynski, Jack A.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada; [Tuszynski, Jack A.] Univ Alberta, Dept Phys, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Texas System; University of Texas Health San Antonio; University of Alberta; University of Alberta	Tuszynski, JA (corresponding author), Univ Alberta, Dept Oncol, Edmonton, AB, Canada.	jackt@ualberta.ca; sambasivarao.damaraju@ualberta.ca	Tuszynski, Jack/AAA-2073-2020; Ayoub, Ahmed Taha/ABE-7048-2020; Churchill, Cassandra/E-6405-2015	Tuszynski, Jack/0000-0001-9976-0429; Ayoub, Ahmed Taha/0000-0001-9106-1076; Churchill, Cassandra/0000-0003-1754-2044	Canadian Breast Cancer Foundation grant [RES0010014]	Canadian Breast Cancer Foundation grant	Funded by the Canadian Breast Cancer Foundation grant awarded to JAT, number: RES0010014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alushin GM, 2014, CELL, V157, P1117, DOI 10.1016/j.cell.2014.03.053; BANERJEE A, 1992, J BIOL CHEM, V267, P5625; Barbier P, 2010, J BIOL CHEM, V285, P31672, DOI 10.1074/jbc.M110.141929; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Bennett MJ, 2009, BIOCHEMISTRY-US, V48, P4858, DOI 10.1021/bi900200q; Buey RM, 2005, CHEM BIOL, V12, P1269, DOI 10.1016/j.chembiol.2005.09.010; Buey RM, 2007, NAT CHEM BIOL, V3, P117, DOI 10.1038/nchembio853; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Case DA, 2012, AMBER 12; Clarke SJ, 1999, CLIN PHARMACOKINET, V36, P99, DOI 10.2165/00003088-199936020-00002; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Craik AC, 2010, ONCOGENE, V29, P5381, DOI 10.1038/onc.2010.272; DELMER A, 1989, J CLIN ONCOL, V7, P738, DOI 10.1200/JCO.1989.7.6.738; Derry WB, 1997, BIOCHEMISTRY-US, V36, P3554, DOI 10.1021/bi962724m; DERRY WB, 1995, BIOCHEMISTRY-US, V34, P2203, DOI 10.1021/bi00007a014; Fauzee NJS, 2011, ASIAN PAC J CANCER P, V12, P837; FELLOUS A, 1977, EUR J BIOCHEM, V78, P167, DOI 10.1111/j.1432-1033.1977.tb11726.x; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Freedman H, 2009, J CHEM INF MODEL, V49, P424, DOI 10.1021/ci8003336; Gebremichael Y, 2008, BIOPHYS J, V95, P2487, DOI 10.1529/biophysj.108.129072; Genheden S, 2012, J CHEM INF MODEL, V52, P2079, DOI 10.1021/ci3001919; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Grafmuller A, 2013, J MOL BIOL, V425, P2232, DOI 10.1016/j.jmb.2013.03.029; Grafmuller A, 2011, STRUCTURE, V19, P409, DOI 10.1016/j.str.2010.12.020; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; HARKER WG, 1985, CANCER RES, V45, P4091; HARKER WG, 1983, CANCER RES, V43, P4943; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huzil JT, 2006, NANOTECHNOLOGY, V17, pS90, DOI 10.1088/0957-4484/17/4/014; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JEANNESSON P, 1990, CANCER RES, V50, P1231; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Karki R, 2013, EXPERT OPIN THER TAR, V17, P461, DOI 10.1517/14728222.2013.766170; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Kelly K, 2001, J CLIN ONCOL, V19, P3210, DOI 10.1200/JCO.2001.19.13.3210; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; LOZZIO BB, 1981, P SOC EXP BIOL MED, V166, P546; Maccari G, 2013, J CHEM THEORY COMPUT, V9, P698, DOI 10.1021/ct3006612; Mane JY, 2013, CHEM BIOL DRUG DES, V82, P60, DOI 10.1111/cbdd.12132; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Mechetner E, 1998, CLIN CANCER RES, V4, P389; Mitra A, 2008, BIOPHYS J, V95, P3252, DOI 10.1529/biophysj.108.133884; Natarajan K, 2013, BIOPOLYMERS, V99, P282, DOI 10.1002/bip.22153; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Peng LLX, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003464; Prussia AJ, 2010, CHEMBIOCHEM, V11, P101, DOI 10.1002/cbic.200900538; Rao S, 1999, J BIOL CHEM, V274, P37990, DOI 10.1074/jbc.274.53.37990; Rigas JR, 2004, ONCOLOGIST, V9, P16, DOI 10.1634/theoncologist.9-suppl_2-16; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Sonnenblick A, 2014, CANCER TREAT REV, V40, P1089, DOI 10.1016/j.ctrv.2014.07.005; Trempe G L, 1976, Recent Results Cancer Res, P33; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang RX, 2005, J MED CHEM, V48, P4111, DOI 10.1021/jm048957q; Xiao H, 2006, P NATL ACAD SCI USA, V103, P10166, DOI 10.1073/pnas.0603704103; Yared JA, 2012, DRUG DES DEV THER, V6, P371, DOI 10.2147/DDDT.S28997; Yeh IT, 2004, CELL MOTIL CYTOSKEL, V57, P96, DOI 10.1002/cm.10157	63	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129168	10.1371/journal.pone.0129168	http://dx.doi.org/10.1371/journal.pone.0129168			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052950	gold, Green Submitted, Green Published			2022-12-26	WOS:000355955300096
J	Chen, C; Hu, KL; Li, H; Yun, AP; Li, BG				Chen, Chong; Hu, Kelin; Li, Hong; Yun, Anping; Li, Baoguo			Three-Dimensional Mapping of Soil Organic Carbon by Combining Kriging Method with Profile Depth Function	PLOS ONE			English	Article							TOTAL NITROGEN; LAND-USE; SPATIAL-DISTRIBUTION; LOESS PLATEAU; MATTER; VARIABILITY; STORAGE; TEXTURE; 3D; GRASSLAND	Understanding spatial variation of soil organic carbon (SOC) in three-dimensional direction is helpful for land use management. Due to the effect of profile depths and soil texture on vertical distribution of SOC, the stationary assumption for SOC cannot be met in the vertical direction. Therefore the three-dimensional (3D) ordinary kriging technique cannot be directly used to map the distribution of SOC at a regional scale. The objectives of this study were to map the 3D distribution of SOC at a regional scale by combining kriging method with the profile depth function of SOC (KPDF), and to explore the effects of soil texture and land use type on vertical distribution of SOC in a fluvial plain. A total of 605 samples were collected from 121 soil profiles (0.0 to 1.0 m, 0.20 m increment) in Quzhou County, China and SOC contents were determined for each soil sample. The KPDF method was used to obtain the 3D map of SOC at the county scale. The results showed that the exponential equation well described the vertical distribution of mean values of the SOC contents. The coefficients of determination, root mean squared error and mean prediction error between the measured and the predicted SOC contents were 0.52, 1.82 and -0.24 g kg(-1) respectively, suggesting that the KPDF method could be used to produce a 3D map of SOC content. The surface SOC contents were high in the mid-west and south regions, and low values lay in the southeast corner. The SOC contents showed significant positive correlations between the five different depths and the correlations of SOC contents were larger in adjacent layers than in non-adjacent layers. Soil texture and land use type had significant effects on the spatial distribution of SOC. The influence of land use type was more important than that of soil texture in the surface soil, and soil texture played a more important role in influencing the SOC levels for 0.2-0.4 m layer.	[Chen, Chong; Hu, Kelin; Yun, Anping; Li, Baoguo] China Agr Univ, Dept Soil & Water Sci, Beijing 100193, Peoples R China; [Li, Hong] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou 571101, Peoples R China; [Li, Hong] Nova Scotia Agr Coll, Dept Plant & Anim Sci, Truro, NS B2N 5E3, Canada	China Agricultural University; Chinese Academy of Tropical Agricultural Sciences; Dalhousie University	Hu, KL (corresponding author), China Agr Univ, Dept Soil & Water Sci, 2 Yuan Ming Yuan Xi Lu, Beijing 100193, Peoples R China.	hukel@cau.edu.cn	Yun, Anping/AAN-3643-2020	Yun, Anping/0000-0001-5783-0492	National Natural Science Foundation of China [41171184]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (41171184) (study design).	Arthur E, 2014, EUR J SOIL SCI, V65, P218, DOI 10.1111/ejss.12121; Arweiler Nicole Birgit, 2014, BASIC LINEAR GEOSTAT, V18, P2129, DOI [10.1007/s00784-014-1193-6, 10.1007/s00449-014-1169-6]; BURKE IC, 1989, SOIL SCI SOC AM J, V53, P800, DOI 10.2136/sssaj1989.03615995005300030029x; Caspersen JP, 2000, SCIENCE, V290, P1148, DOI 10.1126/science.290.5494.1148; Castrignano A, 2002, SOIL TILL RES, V65, P95, DOI 10.1016/S0167-1987(01)00288-4; Celik I, 2005, SOIL TILL RES, V83, P270, DOI 10.1016/j.still.2004.08.001; Chen C, 2015, ENVIRON EARTH SCI, V73, P4339, DOI 10.1007/s12665-014-3720-9; DEUTSCH CV, 1998, GSLIB GEOSTAT SOFTWA; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Du ZL, 2010, SOIL SCI SOC AM J, V74, P196, DOI 10.2136/sssaj2009.0048; Fang X, 2012, CATENA, V88, P6, DOI 10.1016/j.catena.2011.07.012; Flores C, 2009, CHEMOSPHERE, V74, P1544, DOI 10.1016/j.chemosphere.2008.10.060; Government of Quzhou County, 2009, AGR YB QUZH COUNT; He Y, 2009, AUST J SOIL RES, V47, P622, DOI 10.1071/SR08218; Hu KL, 2014, GEODERMA, V226, P54, DOI 10.1016/j.geoderma.2014.03.001; Huang B, 2007, GEODERMA, V139, P336, DOI 10.1016/j.geoderma.2007.02.012; Lacoste M, 2014, GEODERMA, V213, P296, DOI 10.1016/j.geoderma.2013.07.002; Li HY, 2013, GEODERMA, V195, P31, DOI 10.1016/j.geoderma.2012.11.005; Li MM, 2013, CATENA, V101, P11, DOI 10.1016/j.catena.2012.09.012; Liu F, 2013, SOIL SCI SOC AM J, V77, P1241, DOI 10.2136/sssaj2012.0317; Liu TL, 2006, SOIL SCI SOC AM J, V70, P1200, DOI 10.2136/sssaj2005.0126; Malone BP, 2009, GEODERMA, V154, P138, DOI 10.1016/j.geoderma.2009.10.007; McGrath D, 2003, APPL GEOCHEM, V18, P1629, DOI 10.1016/S0883-2927(03)00045-3; Meersmans J, 2008, GEODERMA, V143, P1, DOI 10.1016/j.geoderma.2007.08.025; Meersmans J, 2009, GEODERMA, V152, P43, DOI 10.1016/j.geoderma.2009.05.015; Minasny B, 2006, AUST J SOIL RES, V44, P233, DOI 10.1071/SR05136; Mishra U, 2009, SOIL SCI SOC AM J, V73, P614, DOI 10.2136/sssaj2007.0410; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Rawls WJ, 2003, GEODERMA, V116, P61, DOI 10.1016/S0016-7061(03)00094-6; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Soil Survey Staff, 2010, KEYS SOIL TAX; Van Meirvenne M, 2003, BIOL FERT SOILS, V37, P147; Veronesi F, 2012, SOIL TILL RES, V124, P111, DOI 10.1016/j.still.2012.05.009; Wang DD, 2010, PEDOSPHERE, V20, P525, DOI 10.1016/S1002-0160(10)60042-2; Wiesmeier M, 2012, GLOBAL CHANGE BIOL, V18, P2233, DOI 10.1111/j.1365-2486.2012.02699.x; Ye M, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006924; Yimer F, 2006, GEODERMA, V135, P335, DOI 10.1016/j.geoderma.2006.01.005; Zhang C, 2013, EUR J SOIL BIOL, V54, P16, DOI 10.1016/j.ejsobi.2012.10.007; Zhang SW, 2012, GEODERMA, V171, P35, DOI 10.1016/j.geoderma.2011.07.012; Zheng L, 2015, SOIL TILL RES, V145, P78, DOI 10.1016/j.still.2014.08.003; Zinn YL, 2005, GEODERMA, V127, P168, DOI 10.1016/j.geoderma.2005.02.010	41	16	17	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129038	10.1371/journal.pone.0129038	http://dx.doi.org/10.1371/journal.pone.0129038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047012	gold, Green Submitted, Green Published			2022-12-26	WOS:000355652200118
J	Lackey, B; Seas, C; Van der Stuyft, P; Otero, L				Lackey, Brian; Seas, Carlos; Van der Stuyft, Patrick; Otero, Larissa			Patient Characteristics Associated with Tuberculosis Treatment Default: A Cohort Study in a High-Incidence Area of Lima, Peru	PLOS ONE			English	Article							MULTIDRUG-RESISTANT TUBERCULOSIS; RISK-FACTORS; ADHERENCE; PREDICTORS; STRATEGIES; 5-YEAR	Background Although tuberculosis (TB) is usually curable with antibiotics, poor adherence to medication can lead to increased transmission, drug resistance, and death. Prior research has shown several factors to be associated with poor adherence, but this problem remains a substantial barrier to global TB control. We studied patients in a high-incidence district of Lima, Peru to identify factors associated with premature termination of treatment (treatment default). Methods We conducted a prospective cohort study of adult smear-positive TB patients enrolled between January 2010 and December 2011 with no history of TB disease. Descriptive statistics and multivariable logistic regression analyses were performed to determine risk factors associated with treatment default. Results Of the 1233 patients studied, 127 (10%) defaulted from treatment. Patients who defaulted were more likely to have used illegal drugs (OR = 4.78, 95% CI: 3.05-7.49), have multidrug-resistant TB (OR = 3.04, 95% CI: 1.58-5.85), not have been tested for HIV (OR = 2.30, 95% CI: 1.50-3.54), drink alcohol at least weekly (OR = 2.22, 95% CI: 1.40-3.52), be underweight (OR = 2.08, 95% CI: 1.21-3.56), or not have completed secondary education (OR = 1.55, 95% CI: 1.03-2.33). Conclusions Our study identified several factors associated with defaulting from treatment, suggesting a complex set of causes that might lead to default. Addressing these factors individually would be difficult, but they might help to identify certain high-risk patients for supplemental	[Lackey, Brian] Univ Texas Austin, Sch Publ Hlth Austin, Austin, TX 78712 USA; [Seas, Carlos; Otero, Larissa] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Seas, Carlos] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru; [Van der Stuyft, Patrick] Inst Trop Med, Dept Publ Hlth, Gen Epidemiol & Dis Control Unit, B-2000 Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Fac Med, Dept Publ Hlth, B-9000 Ghent, Belgium	University of Texas System; University of Texas Austin; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Institute of Tropical Medicine (ITM); Ghent University	Lackey, B (corresponding author), Univ Texas Austin, Sch Publ Hlth Austin, Reg Campus, Austin, TX 78712 USA.	brianwlackey@gmail.com		Otero, Larissa/0000-0002-8348-4340; Seas, Carlos/0000-0001-7067-9141	Belgian Cooperation; Institute of Tropical Medicine in Antwerp, Belgium (FA3); Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru	Belgian Cooperation; Institute of Tropical Medicine in Antwerp, Belgium (FA3); Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru	This study was funded by the Belgian Cooperation (www.dg-d.be) through a project of institutional collaboration between the Institute of Tropical Medicine in Antwerp, Belgium (FA3) and the Instituto de Medicina Tropical Alexander von Humboldt in Lima, Peru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS R H, 1960, Bull World Health Organ, V23, P463; [Anonymous], 1993, MMWR Recomm Rep, V42, P1; [Anonymous], 2011, TUB COUNTR PROF PER; Blackstone K, 2013, AIDS BEHAV, V17, P74, DOI 10.1007/s10461-012-0308-9; Brasil Pedro Emmanuel Alvarenga Americano do, 2008, Cad. Saúde Pública, V24, ps485, DOI 10.1590/S0102-311X2008001600003; Cayla JA, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-121; Chung-Delgado K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027610; Cramm JM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-72; Culqui DR, 2012, ARCH BRONCONEUMOL, V48, P150, DOI 10.1016/j.arbres.2011.12.008; DAWSON JJY, 1966, B WORLD HEALTH ORGAN, V34, P533; Finlay A, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-56; FOX W, 1958, Tubercle, V39, P269, DOI 10.1016/S0041-3879(58)80088-4; Franke MF, 2008, CLIN INFECT DIS, V46, P1844, DOI 10.1086/588292; Frieden T, 2004, TOMANS TUBERCULOSIS; Hasker E, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-97; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; ISEMAN MD, 1993, NEW ENGL J MED, V328, P576, DOI 10.1056/NEJM199302253280811; KAMAT SR, 1966, B WORLD HEALTH ORGAN, V34, P517; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Kruk ME, 2008, TROP MED INT HEALTH, V13, P703, DOI 10.1111/j.1365-3156.2008.02042.x; Kurbatova EV, 2012, TUBERCULOSIS, V92, P397, DOI 10.1016/j.tube.2012.06.003; Molfenter TD, 2012, PATIENT PREFER ADHER, V6, P643, DOI 10.2147/PPA.S34711; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Otero L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026276; PablosMendez A, 1997, AM J MED, V102, P164, DOI 10.1016/S0002-9343(96)00402-0; Sanders MJ, 2013, AM J OCCUP THER, V67, P91, DOI 10.5014/ajot.2013.005033; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20, DOI [10.1371/journal.pone.0108591, DOI 10.1371/JOURNAL.PONE.0108591]; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; Tuberculosis Chemotherapy Centre, 1959, Bull World Health Organ, V21, P51; Volmink J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003510.pub2; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1	31	27	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128541	10.1371/journal.pone.0128541	http://dx.doi.org/10.1371/journal.pone.0128541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046766	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200076
J	Li, Y; Chang, WQ; Zhang, M; Li, XB; Jiao, Y; Lou, HX				Li, Ying; Chang, Wenqiang; Zhang, Ming; Li, Xiaobin; Jiao, Yang; Lou, Hongxiang			Diorcinol D Exerts Fungicidal Action against Candida albicans through Cytoplasm Membrane Destruction and ROS Accumulation	PLOS ONE			English	Article							AMPHOTERICIN-B; CELL-DEATH; MITOCHONDRIAL; MECHANISMS; PATHWAY; EPIDEMIOLOGY; ENDOPHYTES; RESISTANCE; GROWTH; LEADS	Candida albicans, which is the most common human fungal pathogen, causes high mortality among immunocompromised patients. Antifungal drug resistance becomes a major challenge for the management of Candida infection. Diorcinol D (DD), a diphenyl ether derivative isolated from an endolichenic fungus, exerted fungicidal action against Candida species. In this study, we investigated the possible mechanism of its antifungal activity. The change of membrane dynamics and permeability suggested that the cell membrane was disrupted by the treatment of DD. This was further supported by the evidences of intracellular glycerol accumulation, alteration of cell ultrastructure, and down-regulation of genes involved in cell membrane synthesis. In addition, the treatment of Candida albicans with DD resulted in the elevation of reactive oxygen species (ROS), which caused the dysfunction of mitochondria. These altogether suggested that DD exerted its antifungal activity through cytoplasmic membrane destruction and ROS accumulation. This finding is helpful to uncover the underlying mechanisms for the diphenyl ether derivatives and provides a potential application in fighting clinical fungal infections.	[Li, Ying; Chang, Wenqiang; Zhang, Ming; Li, Xiaobin; Jiao, Yang; Lou, Hongxiang] Shandong Univ, Minist Educ, Key Lab Chem Biol, Dept Nat Prod Chem, Jinan 250100, Peoples R China	Shandong University	Lou, HX (corresponding author), Shandong Univ, Minist Educ, Key Lab Chem Biol, Dept Nat Prod Chem, 44 West Wenhua Rd, Jinan 250100, Peoples R China.	louhongxiang@sdu.edu.cn			Natural Scientific Foundation of China (NSFC) [81172956, 81273383, 81402804]	Natural Scientific Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Scientific Foundation of China (NSFC Nos, 81172956, 81273383, 81402804), http://www.nsfc.gov.cn/. The funder Hongxiang Lou conceived and designed the experiments for this manuscript.	Ahting U, 1999, J CELL BIOL, V147, P959, DOI 10.1083/jcb.147.5.959; Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Aly AH, 2010, FUNGAL DIVERS, V41, P1, DOI 10.1007/s13225-010-0034-4; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Chen L, 1982, PROBING MITOCHONDRIA, V123, P141; Choi H, 2012, BBA-BIOMEMBRANES, V1818, P1648, DOI 10.1016/j.bbamem.2012.02.026; Deray G, 2002, J ANTIMICROB CHEMOTH, V49, P37, DOI 10.1093/jac/49.suppl_1.37; Eisenberg T, 2007, APOPTOSIS, V12, P1011, DOI 10.1007/s10495-007-0758-0; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; FRASER VJ, 1992, CLIN INFECT DIS, V15, P414, DOI 10.1093/clind/15.3.414; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Gregori C, 2007, EUKARYOT CELL, V6, P1635, DOI 10.1128/EC.00106-07; Halama P, 2004, BIOCONTROL, V49, P95, DOI 10.1023/B:BICO.0000009378.31023.ba; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Keilin D, 1936, PROC R SOC SER B-BIO, V121, P165, DOI 10.1098/rspb.1936.0056; KINOSITA K, 1981, BIOCHEMISTRY-US, V20, P4270, DOI 10.1021/bi00518a006; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Li L, 2014, ACTA PHARM SINICA; Li Y, 2015, FEMS YEAST RES; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; Mishra Nagendra Nath, 2007, Acta Microbiologica et Immunologica Hungarica, V54, P201, DOI 10.1556/AMicr.54.2007.3.1; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nash TH., 1996, LICHEN BIOL; Newman DJ, 2008, J MED CHEM, V51, P2589, DOI 10.1021/jm0704090; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wang YY, 2013, CANCER LETT, V329, P207, DOI 10.1016/j.canlet.2012.10.042; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Wu XZ, 2010, BBA-GEN SUBJECTS, V1800, P439, DOI 10.1016/j.bbagen.2010.01.001; Wu XZ, 2009, BBA-GEN SUBJECTS, V1790, P770, DOI 10.1016/j.bbagen.2009.05.002; Wu XZ, 2008, ACTA PHARMACOL SIN, V29, P1478, DOI 10.1111/j.1745-7254.2008.00900.x; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028953; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	39	45	49	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128693	10.1371/journal.pone.0128693	http://dx.doi.org/10.1371/journal.pone.0128693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047493	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200091
J	[Anonymous]				[Anonymous]			Adjustments of the Pesticide Risk Index Used in Environmental Policy in Flanders	PLOS ONE			English	Article							SURFACE WATERS; RESIDUES; LOSSES	Indicators are used to quantify the pressure of pesticides on the environment. Pesticide risk indicators typically require weighting environmental exposure by a no effect concentration. An indicator based on spread equivalents (Sigma Seq) is used in environmental policy in Flanders (Belgium). The pesticide risk for aquatic life is estimated by weighting active ingredient usage by the ratio of their maximum allowable concentration and their soil halflife. Accurate estimates of total pesticide usage in the region are essential in such calculations. Up to 2012, the environmental impact of pesticides was estimated on sales figures provided by the Federal Government. Since 2013, pesticide use is calculated based on results from the Farm Accountancy Data Network (FADN). The estimation of pesticide use was supplemented with data for non-agricultural use based on sales figures of amateur use provided by industry and data obtained from public services. The Seq-indicator was modified to better reflect reality. This method was applied for the period 2009-2012 and showed differences between estimated use and sales figures of pesticides. The estimated use of pesticides based on accountancy data is more accurate compared to sales figures. This approach resulted in a better view on pesticide use and its respective environmental impact in Flanders.							Flemish Environment Agency (VMM)	Flemish Environment Agency (VMM)	This study was financed by the Flemish Environment Agency (VMM). The funder played a role in study design and decision to publish.	Adriaanse PI, 1997, SURFACE WATER MODELS; [Anonymous], OFFICIAL J EUROPEA L; [Anonymous], 2008, COMMISSION REGULATIO, VL250, P1; [Anonymous], 2009, OFFICIAL J EUROPEA L, V309/71, DOI DOI 10.3000/17252555.L_2009.309.ENG; [Anonymous], 2011, OFFICIAL J EUROPEA L, V180, P3; Bedos C, 2002, AGRONOMIE, V22, P21, DOI 10.1051/agro:2001003; Beernaerts S, 2005, INT J ENVIRON AN CH, V85, P41, DOI 10.1080/0306731042000303143; Carter A., 2000, Pesticide Outlook, V11, P149, DOI 10.1039/b006243j; Claeys D, 2005, BEPALING VERBRUIK GE; Claeys S, 2007, MILIEURAPPORT VLAAND; Council Directive 91/414/EE, 1991, OFFICIAL J L, V230; Darvas B, 1998, APPL AGR, P188; De Kraker J, 1994, TEELT SLA HAAR SOORT, V63; De Moel CP, 1993, TEELT VAN BLOEMKOOL; De Smet B, 2005, CROP PROT, V24, P363, DOI 10.1016/j.cropro.2004.09.005; De Smet B, 2002, MIRA200202 U GENT VA; De Wilde T, 2007, PEST MANAG SCI, V63, P111, DOI 10.1002/ps.1323; Dutry C, 2013, GEZINSWEEKBLAD BOND; EC (European Commission), AGR RUR DEV FARM ACC; Fytoweb, 2012, LIJST BELG ERK BESTR; Gray SM, 1996, CROP PROT, V15, P687, DOI 10.1016/S0261-2194(96)00040-3; Huber A, 1998, SCI TOTAL ENVIRON, V223, P177, DOI 10.1016/S0048-9697(98)00314-3; Lenders S., 2013, GEBRUIK ENERGIE GEWA; Lenders S, 2010, MILIEUDRUK VANUIT LA; Lenders S., 2012, BODEMBALANS VLAAMSE; LNE, ACT MIL 2003 2007 PE; Nault BA, 2004, CROP PROT, V23, P147, DOI 10.1016/j.cropro.2003.08.002; Niemeijer D, 2008, ECOL INDIC, V8, P14, DOI 10.1016/j.ecolind.2006.11.012; Niemeijer David, 2008, Environment Development and Sustainability, V10, P89, DOI 10.1007/s10668-006-9040-9; Nuyttens D, 2013, PEST MANAG SCI, V69, P564, DOI 10.1002/ps.3485; Pannecoucque J, 2013, BELGISCHE BESCHRIJVE; Peeters B, 2010, MILIEU EN NATUURRAPP; Pussemier L, 1997, LANDBOUW TOEGEPASTE, V62, P157; Reichenberger S, 2007, SCI TOTAL ENVIRON, V384, P1, DOI 10.1016/j.scitotenv.2007.04.046; Schulz R, 2002, ENVIRON TOXICOL CHEM, V21, P2172, DOI [10.1002/etc.5620211021, 10.1897/1551-5028(2002)021&lt;2172:ACMAFA&gt;2.0.CO;2]; Smeets E., 1999, 25 EUR ENV AG; Snoek NJ, 1987, TEELT AND; Taylor AG, 2001, HORTSCIENCE, V36, P199, DOI 10.21273/HORTSCI.36.2.199; Van den Bossche A, 2002, MIRA200205; Van den Bossche A, 2003, ONDERZOEK NAAR GEBRU; Vanparijs L, 1986, DE TEELT VAN PREI; Vercruysse F, 2002, CROP PROT, V21, P307, DOI 10.1016/S0261-2194(01)00102-8; Volksgezondheid FOD Veiligheid van de Voedselketen en Leefmilie. Directoraat Generaal Dier Plant en voeding: Dienst Pesticiden en Meststoffen, 2009, GIDS AANV ERK PROD A; Vryzas Z, 2009, WATER RES, V43, P1, DOI 10.1016/j.watres.2008.09.021; Vryzas Z, 2011, ECOTOX ENVIRON SAFE, V74, P174, DOI 10.1016/j.ecoenv.2010.04.011; Wustenberghs H, 2012, PEST MANAG SCI, V68, P1130, DOI 10.1002/ps.3332; OFFICIAL J EUROPEA L, V327	47	2	2	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129669	10.1371/journal.pone.0129669	http://dx.doi.org/10.1371/journal.pone.0129669			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046655	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200165
J	Le Billan, F; Khan, JA; Lamribet, K; Viengchareun, S; Bouligand, J; Fagart, J; Lombes, M				Le Billan, Florian; Khan, Junaid A.; Lamribet, Khadija; Viengchareun, Say; Bouligand, Jerome; Fagart, Jerome; Lombes, Marc			Cistrome of the aldosterone-activated mineralocorticoid receptor in human renal cells	FASEB JOURNAL			English	Article						chromatin immunoprecipitation sequencing; sodium; nuclear receptor; transcription factor	EPITHELIAL SODIUM-CHANNEL; TRANSCRIPTION FACTORS; GLUCOCORTICOID-RECEPTOR; ANDROGEN RECEPTOR; BREAST-CANCER; TARGET GENES; GENOME; BINDING; PROTEIN; ALPHA	Aldosterone exerts its effects mainly by activating the mineralocorticoid receptor (MR), a transcription factor that regulates gene expression through complex and dynamic interactions with coregulators and transcriptional machinery, leading to fine-tuned control of vectorial ionic transport in the distal nephron. To identify genome-wide aldosterone-regulated MR targets in human renal cells, we set up a chromatin immunoprecipitation (ChIP) assay by using a specific anti-MR antibody in a differentiated human renal cell line expressing green fluorescent protein (GFP)-MR. This approach, coupled with high-throughput sequencing, allowed identification of 974 genomic MR targets. Computational analysis identified an MR response element (MRE) including single or multiple half-sites and palindromic motifs in which the AGtA-CAgxatGTtCt sequence was the most prevalent motif. Most genomic MR-binding sites (MBSs) are located > 10 kb from the transcriptional start sites of target genes (84%). Specific aldosterone-induced recruitment of MR on the first most relevant genomic sequences was further validated by ChIP-quantitative (q) PCR and correlated with concomitant and positive aldosterone-activated transcriptional regulation of the corresponding gene, as assayed by RT-qPCR. It was notable that most MBSs lacked MREs but harbored DNA recognition motifs for other transcription factors (FOX, EGR1, AP1, PAX5) suggesting functional interaction. This work provides new insights into aldosterone MR-mediated renal signaling and opens relevant perspectives for mineralocorticoid-related pathophysiology.	[Le Billan, Florian; Khan, Junaid A.; Lamribet, Khadija; Viengchareun, Say; Bouligand, Jerome; Fagart, Jerome; Lombes, Marc] INSERM, U1185, F-94275 Le Kremlin Bicetre, France; [Le Billan, Florian; Khan, Junaid A.; Lamribet, Khadija; Viengchareun, Say; Bouligand, Jerome; Fagart, Jerome; Lombes, Marc] Univ Paris 11, Fac Med Paris Sud, Unite Mixte Rech S1185, F-94276 Le Kremlin Bicetre, France; [Bouligand, Jerome] Hop Bicetre, AP HP, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Lombes, Marc] Hop Bicetre, AP HP, Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Lombes, M (corresponding author), Univ Paris 11, Fac Med Paris Sud, INSERM, U1185, 63 Rue Gabriel Peri, F-94276 Le Kremlin Bicetre, France.	jerome.fagart@inserm.fr; marc.lombes@u-psud.fr	Khan, Junaid/AAE-3522-2019; Viengchareun, Say/GOV-6812-2022; Khan, Junaid Ali/ABG-2756-2020; Viengchareun, Say/M-6612-2017; Lombes, Marc/L-5933-2018; Khan, Junaid Ali/ABG-6129-2020; BOULIGAND, Jérôme/S-5716-2018; Fagart, Jerome/S-4581-2018	Khan, Junaid Ali/0000-0003-2630-1744; Lombes, Marc/0000-0003-3189-023X; Fagart, Jerome/0000-0002-7965-0553; Le Billan, Florian/0000-0002-3400-9295; viengchareun, say/0000-0003-4280-3250	INSERM, Universite Paris Sud; Agence Nationale de la Recherche (ANR) [11-BSV1-028-01]; France Genomique national infrastructure; ANR [11-BSV1-028-01, ANR-10-INBS-0009]; Ministere de l'Enseignement Superieur et de la Recherche (MESR)	INSERM, Universite Paris Sud; Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); France Genomique national infrastructure; ANR(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France)	The authors thank Stephane Le Crom (Ecole Normale Superieure, Institut de Biologie de l'ENS, IBENS, Plateforme Genomique, Paris, F-75005 France), Juliette Pouch (INSERM, U1024, Paris, F-75005 France), Sophie Lemoine (CNRS, UMR 8197, Paris, F-75005 France), and their genomic platform for their help in the genomic sequencing and initial analysis of the results; and Florian Nadal (INSERM U1185 and Assistance Publique-Hopitaux de Paris, Service de Pharmacogenetique, Genetique Moleculaire et Hormonologie, Hopital de Bicetre, F-94275 Le Kremlin Bicetre, France) for invaluable contributions to the initial analysis of the ChIP-seq data. This work was supported by grants from INSERM, Universite Paris Sud and by Grant 11-BSV1-028-01 Agence Nationale de la Recherche (ANR). The ChIP-Seq was supported by the France Genomique national infrastructure, funded as part of the "Investissements d'Avenir" program managed by ANR contract ANR-10-INBS-0009. F.L.B. is the recipient of a doctoral fellowship from Ministere de l'Enseignement Superieur et de la Recherche (MESR), and J.A.K. received ANR postdoctoral fellowship 11-BSV1-028-01. The authors declare no conflicts of interest.	Amasaki Y, 2000, J ALLERGY CLIN IMMUN, V106, pS1; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dakour J, 1997, GENE, V185, P153, DOI 10.1016/S0378-1119(96)00587-2; Deppe CE, 2002, ENDOCRINOLOGY, V143, P1932, DOI 10.1210/en.143.5.1932; Fagart J, 2010, J BIOL CHEM, V285, P29932, DOI 10.1074/jbc.M110.131342; Fakitsas P, 2007, J AM SOC NEPHROL, V18, P1084, DOI 10.1681/ASN.2006080902; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Gumz ML, 2009, J CLIN INVEST, V119, P2423, DOI 10.1172/JCI36908; Hellal-Levy C, 2000, MOL ENDOCRINOL, V14, P1210, DOI 10.1210/me.14.8.1210; Hou CH, 2012, CHROMOSOMA, V121, P107, DOI 10.1007/s00412-011-0352-7; Hu SG, 2010, MOL ENDOCRINOL, V24, P2392, DOI 10.1210/me.2010-0226; Hudson WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107000; JOHNSON JP, 1992, PHARMACOL THERAPEUT, V53, P1, DOI 10.1016/0163-7258(92)90042-X; Jourdren L, 2012, BIOINFORMATICS, V28, P1542, DOI 10.1093/bioinformatics/bts165; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li GL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S12-S11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Naray-Fejes-Toth A, 2008, AM J PHYSIOL-RENAL, V295, pF18, DOI 10.1152/ajprenal.00573.2007; Need EF, 2012, MOL ENDOCRINOL, V26, P1941, DOI 10.1210/me.2011-1314; PALMER LG, 1990, J GEN PHYSIOL, V96, P23, DOI 10.1085/jgp.96.1.23; Pan D, 2011, CANCER RES, V71, P6360, DOI 10.1158/0008-5472.CAN-11-0362; Pearce D, 2003, VITAM HORM, V66, P29, DOI 10.1016/S0083-6729(03)01002-1; Pearce D, 2001, TRENDS ENDOCRIN MET, V12, P341, DOI 10.1016/S1043-2760(01)00439-8; Petrovich E, 2014, J STEROID BIOCHEM, V139, P78, DOI 10.1016/j.jsbmb.2013.10.006; Polman JAE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-118; PRIE D, 1995, KIDNEY INT, V47, P1310, DOI 10.1038/ki.1995.186; Ratman D, 2013, MOL CELL ENDOCRINOL, V380, P41, DOI 10.1016/j.mce.2012.12.014; Richards J, 2014, J BIOL CHEM, V289, P11791, DOI 10.1074/jbc.M113.531095; Richards J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00253; Robert-Nicoud M, 2001, P NATL ACAD SCI USA, V98, P2712, DOI 10.1073/pnas.051603198; Rossier B C, 1994, Curr Opin Nephrol Hypertens, V3, P487, DOI 10.1097/00041552-199409000-00003; Rubel CA, 2012, MOL ENDOCRINOL, V26, P1428, DOI 10.1210/me.2011-1355; Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048; Sekizawa N, 2011, MOL CELL ENDOCRINOL, V341, P78, DOI 10.1016/j.mce.2011.05.029; Ueda K, 2014, BIOCHEM BIOPH RES CO, V445, P132, DOI 10.1016/j.bbrc.2014.01.125; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095; Wang XK, 2010, CANCER GENET CYTOGEN, V196, P64, DOI 10.1016/j.cancergencyto.2009.09.003; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	42	44	44	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3977	3989		10.1096/fj.15-274266	http://dx.doi.org/10.1096/fj.15-274266			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26054365	Green Submitted			2022-12-26	WOS:000359915600032
J	Bell, AJ; Frankel, LK; Bricker, TM				Bell, Adam J.; Frankel, Laurie K.; Bricker, Terry M.			High Yield Non-detergent Isolation of Photosystem I-Lightharvesting Chlorophyll II Membranes from Spinach Thylakoids IMPLICATIONS FOR THE ORGANIZATION OF THE PS I ANTENNAE IN HIGHER PLANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HARVESTING COMPLEX-II; ARABIDOPSIS-THALIANA; CHLAMYDOMONAS-REINHARDTII; STATE TRANSITIONS; PROTEIN COMPLEXES; ENERGY-TRANSFER; PORE-SIZE; CYANOBACTERIA; SUBUNITS; LIPODISQ	Styrene-maleic acid copolymer was used to effect a non-detergent partial solubilization of thylakoids from spinach. A high density membrane fraction, which was not solubilized by the copolymer, was isolated and was highly enriched in the Photosystem (PS) I-light-harvesting chlorophyll (LHC) II supercomplex and depleted of PS II, the cytochrome b(6)/f complex, and ATP synthase. The LHC II associated with the supercomplex appeared to be energetically coupled to PS I based on 77 K fluorescence, P-700 photooxidation, and PS I electron transport light saturation experiments. The chlorophyll (Chl) a/b ratio of the PS I-LHC II membranes was 3.2 +/- 0.9, indicating that on average, three LHC II trimers may associate with each PS I. The implication of these findings within the context of higher plant PS I antenna organization is discussed.	[Bell, Adam J.; Frankel, Laurie K.; Bricker, Terry M.] Louisiana State Univ, Dept Biol Sci, Biochem & Mol Biol Sect, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Bricker, TM (corresponding author), 202 Life Sci Bldg, Baton Rouge, LA 70803 USA.	btbric@lsu.edu			Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-98ER20310]	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE))	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grant DE-FG02-98ER20310 (to T. M. B. and L. K. F.). The authors declare that they have no conflicts of interest with the contents of this article.	ALBERTSSON PA, 1994, METHOD ENZYMOL, V228, P469; Amunts A, 2010, J BIOL CHEM, V285, P3478, DOI 10.1074/jbc.M109.072645; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bibby TS, 2001, NATURE, V413, P590, DOI 10.1038/35098153; Boekema EJ, 2001, NATURE, V412, P745, DOI 10.1038/35089104; BRUCE BD, 1988, J BIOL CHEM, V263, P7302; BURNAP RL, 1993, PLANT PHYSIOL, V103, P893, DOI 10.1104/pp.103.3.893; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; CALLAHAN FE, 1989, PLANT PHYSIOL, V91, P629, DOI 10.1104/pp.91.2.629; Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593; Croce R, 2013, PHOTOSYNTH RES, V116, P153, DOI 10.1007/s11120-013-9838-x; Danielsson R, 2004, BBA-BIOENERGETICS, V1608, P53, DOI 10.1016/j.bbabio.2003.10.005; Danielsson R, 2009, BBA-BIOENERGETICS, V1787, P25, DOI 10.1016/j.bbabio.2008.10.002; DELEPELAIRE P, 1979, P NATL ACAD SCI USA, V76, P111, DOI 10.1073/pnas.76.1.111; Drop B, 2014, PLANT J, V78, P181, DOI 10.1111/tpj.12459; Feissner R, 2003, ANAL BIOCHEM, V315, P90, DOI 10.1016/S0003-2697(02)00658-9; Galka P, 2012, PLANT CELL, V24, P2963, DOI 10.1105/tpc.112.100339; Ihalainen JA, 2002, BIOPHYS J, V83, P2190, DOI 10.1016/S0006-3495(02)73979-9; Kirchhoff H, 2013, PLANT PHYSIOL, V161, P497, DOI 10.1104/pp.112.207548; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Liu HJ, 2013, SCIENCE, V342, P1104, DOI 10.1126/science.1242321; Long AR, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-41; METZ JG, 1985, FEBS LETT, V185, P191, DOI 10.1016/0014-5793(85)80768-7; Narayanan J, 2006, J PHYS CONF SER, V28, P83, DOI 10.1088/1742-6596/28/1/017; Orwick MC, 2012, ANGEW CHEM INT EDIT, V51, P4653, DOI 10.1002/anie.201201355; Orwick-Rydmark M, 2012, NANO LETT, V12, P4687, DOI 10.1021/nl3020395; Pernodet N, 1997, ELECTROPHORESIS, V18, P55, DOI 10.1002/elps.1150180111; Qin XC, 2011, PHOTOCHEM PHOTOBIOL, V87, P143, DOI 10.1111/j.1751-1097.2010.00830.x; Raschle T, 2010, CURR OPIN STRUC BIOL, V20, P471, DOI 10.1016/j.sbi.2010.05.006; Ruban AV, 1997, BBA-BIOENERGETICS, V1321, P61, DOI 10.1016/S0005-2728(97)00047-9; Scheidelaar S, 2015, BIOPHYS J, V108, P279, DOI 10.1016/j.bpj.2014.11.3464; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Serebryany E, 2012, BBA-BIOMEMBRANES, V1818, P225, DOI 10.1016/j.bbamem.2011.07.047; Swainsbury DJK, 2014, ANGEW CHEM INT EDIT, V53, P11803, DOI 10.1002/anie.201406412; Takahashi H, 2014, PLANT CELL PHYSIOL, V55, P1437, DOI 10.1093/pcp/pcu071; TJUS SE, 1995, PHOTOSYNTH RES, V45, P41, DOI 10.1007/BF00032234; VALLON O, 1991, P NATL ACAD SCI USA, V88, P8262, DOI 10.1073/pnas.88.18.8262; van Oort B, 2010, BIOPHYS J, V98, P922, DOI 10.1016/j.bpj.2009.11.012; Wientjes E, 2013, BBA-BIOENERGETICS, V1827, P420, DOI 10.1016/j.bbabio.2012.12.009; Zhang SP, 2004, J BIOL CHEM, V279, P3180, DOI 10.1074/jbc.M311640200	40	58	58	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18429	18437		10.1074/jbc.M115.663872	http://dx.doi.org/10.1074/jbc.M115.663872			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055710	hybrid, Green Published			2022-12-26	WOS:000358512100015
J	Karch, J; Kanisicak, O; Brody, MJ; Sargent, MA; Michael, DM; Molkentin, JD				Karch, Jason; Kanisicak, Onur; Brody, Matthew J.; Sargent, Michelle A.; Michael, Demetria M.; Molkentin, Jeffery D.			Necroptosis Interfaces with MOMP and the MPTP in Mediating Cell Death	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; NECROSIS; BAX; TRANSLOCATION; COFILIN; FUSION; KINASE	During apoptosis the pro-death Bcl-2 family members Bax and Bak induce mitochondrial outer membrane permeabilization (MOMP) to mediate cell death. Recently, it was shown that Bax and Bak are also required for mitochondrial permeability transition pore (MPTP)dependent necrosis, where, in their non-oligomeric state, they enhance permeability characteristics of the outer mitochondrial membrane. Necroptosis is another form of regulated necrosis involving the death receptors and receptor interacting protein kinases (RIP proteins, by Ripk genes). Here, we show cells or mice deficient for Bax/Bak or cyclophilin D, a protein that regulates MPTP opening, are resistant to cell death induced by necroptotic mediators. We show that Bax/Bak oligomerization is required for necroptotic cell death and that this oligomerization reinforces MPTP opening. Mechanistically, we observe mixed lineage kinase domain-like (MLKL) protein and cofilin-1 translocation to the mitochondria following necroptosis induction, while expression of the mitochondrial matrix isoform of the antiapoptotic Bcl-2 family member, myeloid cell leukemia 1 (Mcl-1), is significantly reduced. Some of these effects are lost with necroptosis inhibition in Bax/Bak1 double null, Ppif(-/-), or Ripk3(-/-) fibroblasts. Hence, downstream mechanisms of cell death induced by necroptotic stimuli utilize both Bax/Bak to generate apoptotic pores in the outer mitochondrial membrane as well as MPTP opening in association with known mitochondrial death modifying proteins.	[Karch, Jason; Kanisicak, Onur; Brody, Matthew J.; Sargent, Michelle A.; Michael, Demetria M.; Molkentin, Jeffery D.] Univ Cincinnati, Dept Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45220 USA; [Molkentin, Jeffery D.] Howard Hughes Med Inst, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Howard Hughes Medical Institute	Molkentin, JD (corresponding author), Univ Cincinnati, Dept Med, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45220 USA.	Jeff.Molkentin@cchmc.org	Kanisicak, Onur/AAU-4586-2020	Kanisicak, Onur/0000-0002-8393-4874; Brody, Matthew/0000-0003-4904-7670; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health [P01 HL080101]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health (P01 HL080101) and the Howard Hughes Medical Institute (J.D.M.).	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chua BT, 2003, NAT CELL BIOL, V5, P1083, DOI 10.1038/ncb1070; De Marchi U, 2006, MOL MEMBR BIOL, V23, P521, DOI 10.1080/09687860600907644; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hoppins S, 2011, MOL CELL, V41, P150, DOI 10.1016/j.molcel.2010.11.030; Irrinki KM, 2011, MOL CELL BIOL, V31, P3745, DOI 10.1128/MCB.05303-11; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Karch J, 2015, CIRC RES, V116, P1800, DOI 10.1161/CIRCRESAHA.116.305421; Karch J, 2013, ELIFE, V2, DOI 10.7554/eLife.00772; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Klamt F, 2009, NAT CELL BIOL, V11, P1241, DOI 10.1038/ncb1968; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Li L, 2014, CIRCULATION, V114; Lim SY, 2007, CARDIOVASC DRUG THER, V21, P467, DOI 10.1007/s10557-007-6067-6; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Marshall KD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00323; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tait SWG, 2013, CELL REP, V5, P878, DOI 10.1016/j.celrep.2013.10.034; Tischner D, 2012, APOPTOSIS, V17, P1197, DOI 10.1007/s10495-012-0756-8; Vercammen D, 1998, J EXP MED, V187, P1477, DOI 10.1084/jem.187.9.1477; Wabnitz GH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.36; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wu JF, 2013, CELL RES, V23, P994, DOI 10.1038/cr.2013.91	29	63	63	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0130520	10.1371/journal.pone.0130520	http://dx.doi.org/10.1371/journal.pone.0130520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061004	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500174
J	Li, Y; Wang, K; Xie, H; Wang, YT; Wang, DW; Xu, CL; Huang, X; Wang, DS				Li, Yu; Wang, Ke; Xie, Hui; Wang, Yan-Tao; Wang, Dong-Wei; Xu, Chun-Lin; Huang, Xin; Wang, De-Sen			A Nematode Calreticulin, Rs-CRT, Is a Key Effector in Reproduction and Pathogenicity of Radopholus similis	PLOS ONE			English	Article							ROOT-KNOT NEMATODE; DOUBLE-STRANDED-RNA; PLANT-PARASITIC NEMATODES; HETERODERA-GLYCINES; TRANSGENIC PLANTS; CYST NEMATODES; INTERFERENCE; GENES; HOST; PROTEINS	Radopholus similis is a migratory plant-parasitic nematode that causes severe damage to many agricultural and horticultural crops. Calreticulin (CRT) is a Ca2+-binding multifunctional protein that plays key roles in the parasitism, immune evasion, reproduction and pathogenesis of many animal parasites and plant nematodes. Therefore, CRT is a promising target for controlling R. similis. In this study, we obtained the full-length sequence of the CRT gene from R. similis(Rs-crt), which is 1,527-bp long and includes a 1,206-bp ORF that encodes 401 amino acids. Rs-CRT and Mi-CRT from Meloidogyne incognita showed the highest similarity and were grouped on the same branch of the phylogenetic tree. Rs-crt is a multi-copy gene that is expressed in the oesophageal glands and gonads of females, the gonads of males, the intestines of juveniles and the eggs of R. similis. The highest Rs-crt expression was detected in females, followed by juveniles, eggs and males. The reproductive capability and pathogenicity of R. similis were significantly reduced after treatment with Rs-crt dsRNA for 36 h. Using plant-mediated RNAi, we confirmed that Rs-crt expression was significantly inhibited in the nematodes, and resistance to R. similis was significantly improved in transgenic tomato plants. Plant-mediated RNAi-induced silencing of Rs-crt could be effectively transmitted to the F2 generation of R. similis; however, the silencing effect of Rs-crt induced by in vitro RNAi was no longer detectable in F1 and F2 nematodes. Thus, Rs-crt is essential for the reproduction and pathogenicity of R. similis.	[Li, Yu; Wang, Ke; Xie, Hui; Wang, Yan-Tao; Wang, Dong-Wei; Xu, Chun-Lin; Huang, Xin] South China Agr Univ, Dept Plant Pathol, Lab Plant Nematol, Guangzhou 510642, Guangdong, Peoples R China; [Li, Yu; Wang, Ke; Xie, Hui; Wang, Yan-Tao; Wang, Dong-Wei; Xu, Chun-Lin; Huang, Xin] South China Agr Univ, Res Ctr Nematodes Plant Quarantine, Dept Plant Pathol, Guangzhou 510642, Guangdong, Peoples R China; [Wang, Yan-Tao] Paulownia Res & Dev Ctr State Forestry Adm, Zhengzhou 450003, Henan, Peoples R China; [Wang, De-Sen] Rutgers State Univ, Dept Entomol, New Brunswick, NJ 08901 USA	South China Agricultural University; South China Agricultural University; Chinese Academy of Forestry; Paulownia R&D Center of State Administration of Forestry & Grassland, CAF; Rutgers State University New Brunswick	Xie, H (corresponding author), South China Agr Univ, Dept Plant Pathol, Lab Plant Nematol, Guangzhou 510642, Guangdong, Peoples R China.	xiehui@scau.edu.cn	Wang, Dongwei/M-7768-2017	Wang, Dongwei/0000-0001-5226-4241	National Natural Science Foundation of China [31071665, 31371920]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China (Nos. 31071665 and 31371920). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arshad W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096979; Bakhetia M, 2007, MOL PLANT MICROBE IN, V20, P306, DOI 10.1094/MPMI-20-3-0306; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Blaxter M, 1996, INT J PARASITOL, V26, P1025, DOI 10.1016/S0020-7519(96)00060-4; Cabezon C, 2008, MOL IMMUNOL, V45, P1431, DOI 10.1016/j.molimm.2007.08.022; Chaudhury A, 2000, PLANT CELL TISS ORG, V60, P113, DOI 10.1023/A:1006456005961; CHEN H, 1994, BIOTECHNIQUES, V16, P664; Chen Q, 2005, MOL PLANT MICROBE IN, V18, P621, DOI 10.1094/MPMI-18-0621; Cheng X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066011; Cotten J., 1993, P593; Cottrell TR, 2003, TRENDS MICROBIOL, V11, P37, DOI 10.1016/S0966-842X(02)00004-5; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; de Boer JM, 1998, J NEMATOL, V30, P309; Dubreuil G, 2009, J EXP BOT, V60, P4041, DOI 10.1093/jxb/erp237; Fairbairn DJ, 2007, PLANTA, V226, P1525, DOI 10.1007/s00425-007-0588-x; FALLAS GA, 1994, NEMATROPICA, V24, P175; Ferreira V, 2004, MOL IMMUNOL, V40, P1279, DOI 10.1016/j.molimm.2003.11.018; Gao JL, 2008, PARASITOL RES, V102, P737, DOI 10.1007/s00436-007-0826-y; Haegeman A, 2010, MOL PLANT PATHOL, V11, P315, DOI [10.1111/J.1364-3703.2010.00614.X, 10.1111/j.1364-3703.2010.00614.x]; Hannon GJ., 2004, RNAI GUIDE GENE SILE; Hu LL, 2013, EXP PARASITOL, V135, P15, DOI 10.1016/j.exppara.2013.05.012; Huang GZ, 2006, P NATL ACAD SCI USA, V103, P14302, DOI 10.1073/pnas.0604698103; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Jacob J, 2007, GENE, V402, P9, DOI 10.1016/j.gene.2007.07.015; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Jaubert S, 2005, MOL PLANT MICROBE IN, V18, P1277, DOI 10.1094/MPMI-18-1277; Jaubert S, 2002, MOL BIOCHEM PARASIT, V121, P205, DOI 10.1016/S0166-6851(02)00034-8; Kaplan DT, 1997, J NEMATOL, V29, P421; Kasper G, 2001, PARASITE IMMUNOL, V23, P141, DOI 10.1046/j.1365-3024.2001.00366.x; Kerschen A, 2004, FEBS LETT, V566, P223, DOI 10.1016/j.febslet.2004.04.043; KHALIFE J, 1994, PARASITOLOGY, V108, P527, DOI 10.1017/S0031182000077398; Klink VP, 2009, PLANTA, V230, P53, DOI 10.1007/s00425-009-0926-2; Kovacs H, 1998, BIOCHEMISTRY-US, V37, P17865, DOI 10.1021/bi973197p; Li XD, 2011, EXP PARASITOL, V128, P121, DOI 10.1016/j.exppara.2011.02.017; Luc M, 2005, PLANT PARASIT NEMAT, p[365, 448, 467, 504]; Ma J, 2011, TRANSGENIC RES, V20, P1367, DOI 10.1007/s11248-011-9502-1; Mao JJ, 2014, TRANSGENIC RES, V23, P145, DOI 10.1007/s11248-013-9739-y; Park BJ, 2001, MOL BIOL CELL, V12, P2835, DOI 10.1091/mbc.12.9.2835; Peng Hao, 2006, Scientia Agricultura Sinica, V39, P1729; Richardson PN, 1993, PLANT PARASIT NEMAT, P515; Rosso MN, 2005, MOL PLANT MICROBE IN, V18, P615, DOI 10.1094/MPMI-18-0615; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smant G, 1997, PHYTOPATHOLOGY, V87, P839, DOI 10.1094/PHYTO.1997.87.8.839; Smith IM, 1998, DISTRIBUTION MAPS QU; Ssango F, 2004, FIELD CROP RES, V90, P177, DOI 10.1016/j.fcr.2004.02.018; Steeves RM, 2006, FUNCT PLANT BIOL, V33, P991, DOI 10.1071/FP06130; Suchitra S, 2005, BBA-GEN SUBJECTS, V1722, P293, DOI 10.1016/j.bbagen.2004.12.020; Tyagi H, 2008, TRANSGENIC RES, V17, P897, DOI 10.1007/s11248-008-9174-7; Urwin PE, 2002, MOL PLANT MICROBE IN, V15, P747, DOI 10.1094/MPMI.2002.15.8.747; Walawage SL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-668; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Yadav BC, 2006, MOL BIOCHEM PARASIT, V148, P219, DOI 10.1016/j.molbiopara.2006.03.013; Zha WJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020504; Zhang C, 2012, EUR J PLANT PATHOL, V133, P899, DOI 10.1007/s10658-012-0015-4; Zhu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038572	55	18	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129351	10.1371/journal.pone.0129351	http://dx.doi.org/10.1371/journal.pone.0129351			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061142	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500140
J	Malukiewicz, J; Boere, V; Fuzessy, LF; Grativol, AD; Silva, IDE; Pereira, LCM; Ruiz-Miranda, CR; Valenca, YM; Stone, AC				Malukiewicz, Joanna; Boere, Vanner; Fuzessy, Lisieux F.; Grativol, Adriana D.; de Oliveira e Silva, Ita; Pereira, Luiz C. M.; Ruiz-Miranda, Carlos R.; Valenca, Yuri M.; Stone, Anne C.			Natural and Anthropogenic Hybridization in Two Species of Eastern Brazilian Marmosets (Callithrix jacchus and C. penicillata)	PLOS ONE			English	Article							MICROSATELLITE NULL ALLELES; POPULATION-STRUCTURE; GENETIC DIVERSITY; HYBRID ZONE; SPECIATION; SOFTWARE; PROGRAM; COMMON; GENOTYPE; EVENTS	Animal hybridization is well documented, but evolutionary outcomes and conservation priorities often differ for natural and anthropogenic hybrids. Among primates, an order with many endangered species, the two contexts can be hard to disentangle from one another, which carries important conservation implications. Callithrix marmosets give us a unique glimpse of genetic hybridization effects under distinct natural and human-induced contexts. Here, we use a 44 autosomal microsatellite marker panel to examine genome-wide admixture levels and introgression at a natural C. jacchus and C. penicillata species border along the Sao Francisco River in NE Brazil and in an area of Rio de Janeiro state where humans introduced these species exotically. Additionally, we describe for the first time autosomal genetic diversity in wild C. penicillata and expand previous C. jacchus genetic data. We characterize admixture within the natural zone as bimodal where hybrid ancestry is biased toward one parental species or the other. We also show evidence that Sao Francisco River islands are gateways for bidirectional gene flow across the species border. In the anthropogenic zone, marmosets essentially form a hybrid swarm with intermediate levels of admixture, likely from the absence of strong physical barriers to interspecific breeding. Our data show that while hybridization can occur naturally, the presence of physical, even if leaky, barriers to hybridization is important for maintaining species genetic integrity. Thus, we suggest further study of hybridization under different contexts to set well informed conservation guidelines for hybrid populations that often fit somewhere between "natural" and "man-made."	[Malukiewicz, Joanna; Boere, Vanner] Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil; [Malukiewicz, Joanna; Stone, Anne C.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; [Fuzessy, Lisieux F.] Univ Fed Minas Gerais, Dept Plant Biol, Belo Horizonte, MG, Brazil; [Grativol, Adriana D.; Ruiz-Miranda, Carlos R.] Univ Estadual Norte Fluminense, Ctr Biociencias & Biotecnol, Ciencias Ambientias, Campos Dos Goytacazes, RJ, Brazil; [de Oliveira e Silva, Ita] Univ Fed Vicosa, Dept Biol Anim, Vicosa, MG, Brazil; [Pereira, Luiz C. M.] Univ Fed Vale Sao Francisco, Ctr Conservacao & Manejo Fauna Caatinga, Petrolina, PE, Brazil; [Valenca, Yuri M.] Ctr Reabilitacao Anim Silvestres Santuario Tres R, Recife, PE, Brazil	Universidade Federal de Vicosa; Arizona State University; Arizona State University-Tempe; Universidade Federal de Minas Gerais; Universidade Estadual do Norte Fluminense; Universidade Federal de Vicosa; Universidade Federal do Vale do Sao Francisco	Malukiewicz, J (corresponding author), Univ Fed Vicosa, Dept Bioquim & Biol Mol, Vicosa, MG, Brazil.	jmalukie@gmail.com	Ruiz-Miranda, Carlos R/H-7308-2015; Ruiz-Miranda, Carlos R/A-4719-2008; Malukiewicz, Joanna/AHD-5401-2022; Ruiz, Carlos R/I-4446-2016; Fuzessy, Lisieux/G-2488-2017	Ruiz-Miranda, Carlos R/0000-0001-7360-0304; Ruiz-Miranda, Carlos R/0000-0001-9786-5315; Malukiewicz, Joanna/0000-0003-0494-1089; Fuzessy, Lisieux/0000-0001-9599-9782; Stone, Anne/0000-0001-8021-8314	National Science Foundation DDIG Grant [1061508]; Fulbright Fellowship; Arizona State University SOLS FIGG grant; Arizona State University GPSA Jump Start and Research Grants; Arizona State University Chapter of Sigma Xi; International Primatological Society Research Grant	National Science Foundation DDIG Grant; Fulbright Fellowship; Arizona State University SOLS FIGG grant; Arizona State University GPSA Jump Start and Research Grants; Arizona State University Chapter of Sigma Xi; International Primatological Society Research Grant	This work was supported by the National Science Foundation DDIG Grant #1061508 to JM and ACS, Fulbright Fellowship to Brazil to JM, Arizona State University SOLS FIGG grant, Arizona State University GPSA Jump Start and Research Grants, Arizona State University Chapter of Sigma Xi, and an International Primatological Society Research Grant to JM.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; ALONSO C, 1987, Revista Brasileira de Biologia, V47, P465; Arias CF, 2008, MOL ECOL, V17, P4699, DOI 10.1111/j.1365-294X.2008.03934.x; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Benirshke K, 1962, SCIENCE, V138, P384; Bohling JH, 2013, MOL ECOL, V22, P74, DOI 10.1111/mec.12109; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Coimbra-Filho Adelmar F., 1993, P95; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Crispo E, 2011, BIOESSAYS, V33, P508, DOI 10.1002/bies.201000154; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Detwiler KM, 2005, INT J PRIMATOL, V26, P661, DOI 10.1007/s10764-005-4372-0; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Galbusera PHA, 2008, CONSERV GENET, V9, P731, DOI 10.1007/s10592-007-9370-7; Godinho R, 2011, MOL ECOL, V20, P5154, DOI 10.1111/j.1365-294X.2011.05345.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; HALDANE JBS, 1954, J GENET, V52, P631, DOI 10.1007/BF02985085; Hale ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045170; Hufbauer RA, 2008, CURR BIOL, V18, pR246, DOI 10.1016/j.cub.2008.01.038; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jiggins CD, 2000, TRENDS ECOL EVOL, V15, P250, DOI 10.1016/S0169-5347(00)01873-5; Katoh H, 2009, AM J PRIMATOL, V71, P912, DOI 10.1002/ajp.20729; Kelaita MA, 2013, AM J PHYS ANTHROPOL, V150, P223, DOI 10.1002/ajpa.22196; Lehman SM, 2006, DEV PRIMATOL, P1; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Malukiewicz J, 2014, AM J PHYS ANTHROPOL, V155, P522, DOI 10.1002/ajpa.22605; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; MENDES SL, 1997, THESIS U ESTADUAL CA; Nielsen EE, 2006, MOL ECOL NOTES, V6, P971, DOI 10.1111/j.1471-8286.2006.01433.x; Nievergelt CM, 1998, MOL ECOL, V7, P1432; Passamani Marcelo, 1997, Neotropical Primates, V5, P9; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pritchard JK, 2000, GENETICS, V155, P945; Raveendran M, 2008, AM J PRIMATOL, V70, P906, DOI 10.1002/ajp.20581; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Ross CN, 2007, P NATL ACAD SCI USA, V104, P6278, DOI 10.1073/pnas.0607426104; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ruiz-Miranda Carlos R., 2000, Neotropical Primates, V8, P98; Ruiz-Miranda CR, 2006, BRAZ ARCH BIOL TECHN, V49, P99, DOI 10.1590/S1516-89132006000100012; Rylands Anthony B., 1993, P262; Rylands Anthony B., 2009, P23, DOI 10.1007/978-0-387-78705-3_2; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Tang J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000455; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weir BS., 1996, GENETIC DATA ANAL; Zinner D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-83	60	33	35	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127268	10.1371/journal.pone.0127268	http://dx.doi.org/10.1371/journal.pone.0127268			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061111	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500032
J	Da Silva, JDF; Malo, DL; Bataglion, GA; Eberlin, MN; Ronconi, CM; Alves, S; de Sa, GF				Ferreira Da Silva, Janine dos Santos; Malo, Daniel Lopez; Bataglion, Giovana Anceski; Eberlin, Marcos Nogueira; Ronconi, Celia Machado; Alves Junior, Severino; de Sa, Gilberto Fernandes			Adsorption in a Fixed-Bed Column and Stability of the Antibiotic Oxytetracycline Supported on Zn(II)-[2-Methylimidazolate] Frameworks in Aqueous Media	PLOS ONE			English	Article							METAL-ORGANIC FRAMEWORKS; TETRACYCLINE ANTIBIOTICS; VETERINARY ANTIBIOTICS; WATER; PHARMACEUTICALS; REMOVAL; BEHAVIOR; ENVIRONMENT; RESISTANCE; RESIDUES	A metal-organic framework, Zn-[2-methylimidazolate] frameworks (ZIF-8), was used as adsorbent material to remove different concentrations of oxytetracycline (OTC) antibiotic in a fixed-bed column. The OTC was studied at concentrations of 10, 25 and 40 mg L-1. At 40 mg L-1, the breakthrough point was reached after approximately 10 minutes, while at 10 and 25 mg L-1 this point was reached in about 30 minutes. The highest removal rate of 60% for the 10 mg L-1 concentration was reached after 200 minutes. The highest adsorption capacity (28.3 mg g(-1)) was attained for 25 mg L-1 of OTC. After the adsorption process, a band shift was observed in the UV-Vis spectrum of the eluate. Additional studies were carried out to determine the cause of this band shift, involving a mass spectrometry (MS) analysis of the supernatant liquid during the process. This investigation revealed that the main route of adsorption consisted of the coordination of OTC with the metallic zinc centers of ZIF-8. The materials were characterized by thermal analysis (TA), scanning electron microscopy (SEM), powder X-ray diffraction (XRD), and infrared spectroscopy (IR) before and after adsorption, confirming the presence of OTC in the ZIF-8 and the latter's structural stability after the adsorption process.	[Ferreira Da Silva, Janine dos Santos; Malo, Daniel Lopez; Alves Junior, Severino; de Sa, Gilberto Fernandes] Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil; [Bataglion, Giovana Anceski; Eberlin, Marcos Nogueira] Univ Estadual Campinas, Inst Quim, Sao Paulo, Brazil; [Ronconi, Celia Machado] Univ Fed Fluminense, Inst Quim, Rio De Janeiro, Brazil	Universidade Federal de Pernambuco; Universidade Estadual de Campinas; Universidade Federal Fluminense	Da Silva, JDF (corresponding author), Univ Fed Pernambuco, Dept Quim Fundamental, Recife, PE, Brazil.	nanequimica@hotmail.com	Alves, Severino/L-8963-2013; Bataglion, Giovana A/G-9282-2018; Ronconi, Célia Machado/H-5704-2016; De Sa or DeSa or Sa, Gilberto/I-5766-2012; López-Malo, Daniel/F-7623-2015	Bataglion, Giovana A/0000-0001-6643-9268; Ronconi, Célia Machado/0000-0001-9736-9661; López-Malo, Daniel/0000-0003-2661-7570; Eberlin, Marcos Nogueira/0000-0003-4868-0618; Junior, Severino/0000-0002-8092-4224	Brazilian research funding agency CNPq (National Council for Scientific and Technological Development); Brazilian research funding agency INCT-INAMI (National Institute of Science and Technology - Nanotechnology for Integrated Markers); Brazilian research funding agency CAPES (Brazil Nanobiotec Network/Federal Agency for the Support and Improvement of Higher Education)	Brazilian research funding agency CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian research funding agency INCT-INAMI (National Institute of Science and Technology - Nanotechnology for Integrated Markers); Brazilian research funding agency CAPES (Brazil Nanobiotec Network/Federal Agency for the Support and Improvement of Higher Education)	The authors thank the Brazilian research funding agencies CNPq (National Council for Scientific and Technological Development) and INCT-INAMI (the National Institute of Science and Technology - Nanotechnology for Integrated Markers) for fellowships granted to J.F.S., and CAPES (Brazil Nanobiotec Network/Federal Agency for the Support and Improvement of Higher Education) for a fellowship granted to D.L.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu Z, 2004, PROCESS BIOCHEM, V39, P599, DOI 10.1016/S0032-9592(03)00132-8; Aristilde L, 2010, ENVIRON SCI TECHNOL, V44, P7839, DOI 10.1021/es102136y; Atkins P.J., 1999, INORGANIC CHEM; Bila DM, 2003, QUIM NOVA, V26, P523, DOI 10.1590/S0100-40422003000400015; Blackwell PA, 2009, CHEMOSPHERE, V75, P13, DOI 10.1016/j.chemosphere.2008.11.070; Blanco G, 2009, ENVIRON RES, V109, P405, DOI 10.1016/j.envres.2009.01.007; Calero M, 2009, J HAZARD MATER, V171, P886, DOI 10.1016/j.jhazmat.2009.06.082; Cao Y, 2007, MICROPOR MESOPOR MAT, V103, P352, DOI 10.1016/j.micromeso.2007.01.058; Chartone-Souza E, 2005, J INORG BIOCHEM, V99, P1001, DOI 10.1016/j.jinorgbio.2005.01.004; Chee-Sanford JC, 2001, APPL ENVIRON MICROB, V67, P1494, DOI 10.1128/AEM.67.4.1494-1502.2001; Chen C, 2012, CHEM ENG J, V183, P60, DOI 10.1016/j.cej.2011.12.021; Chen YC, 1998, J CHROMATOGR A, V802, P95, DOI 10.1016/S0021-9673(97)01181-3; Chopra I, 2001, MICROBIOL MOL BIOL R, V65, P232, DOI 10.1128/MMBR.65.2.232-260.2001; Cychosz KA, 2010, LANGMUIR, V26, P17198, DOI 10.1021/la103234u; Daughton CG, 1999, ENVIRON HEALTH PERSP, V107, P907, DOI 10.2307/3434573; Doskocil L, 2012, FUEL PROCESS TECHNOL, V101, P29, DOI 10.1016/j.fuproc.2012.02.010; Ehrampoosh MH, 2011, IRAN J ENVIRON HEALT, V8, P35; Fent K, 2006, AQUAT TOXICOL, V76, P122, DOI 10.1016/j.aquatox.2005.09.009; Guerra W, 2005, J INORG BIOCHEM, V99, P2348, DOI 10.1016/j.jinorgbio.2005.09.001; Halling-Sorensen B, 1998, CHEMOSPHERE, V36, P357, DOI 10.1016/S0045-6535(97)00354-8; Haque E, 2011, J HAZARD MATER, V185, P507, DOI 10.1016/j.jhazmat.2010.09.035; Hasan Z, 2012, J HAZARD MATER, V209, P151, DOI 10.1016/j.jhazmat.2012.01.005; Hayashi H, 2007, NAT MATER, V6, P501, DOI 10.1038/nmat1927; Henschel A, 2011, ADSORPTION, V17, P219, DOI 10.1007/s10450-010-9317-z; Huang XC, 2006, ANGEW CHEM INT EDIT, V45, P1557, DOI 10.1002/anie.200503778; James SL, 2003, CHEM SOC REV, V32, P276, DOI 10.1039/b200393g; Kallo D, 2001, REV MINERAL GEOCHEM, V45, P519, DOI 10.2138/rmg.2001.45.15; Kong WD, 2012, CHEMOSPHERE, V87, P542, DOI 10.1016/j.chemosphere.2011.12.062; Kostich MS, 2008, SCI TOTAL ENVIRON, V389, P329, DOI 10.1016/j.scitotenv.2007.09.008; Kusgens P, 2009, MICROPOR MESOPOR MAT, V120, P325, DOI 10.1016/j.micromeso.2008.11.020; Le Bris H, 2004, MAR POLLUT BULL, V48, P434, DOI 10.1016/j.marpolbul.2003.08.018; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Liao P, 2013, CHEM ENG J, V228, P496, DOI 10.1016/j.cej.2013.04.118; Ma FJ, 2011, J AM CHEM SOC, V133, P4178, DOI 10.1021/ja109659k; Maia PP, 2009, FOOD CONTROL, V20, P11, DOI 10.1016/j.foodcont.2008.01.007; Martinez-Carballo E, 2007, ENVIRON POLLUT, V148, P570, DOI 10.1016/j.envpol.2006.11.035; MCCORMICK JRD, 1957, J AM CHEM SOC, V79, P2848; Morley NJ, 2009, ENVIRON TOXICOL PHAR, V27, P161, DOI 10.1016/j.etap.2008.11.004; Ordonez MJC, 2010, J MEMBRANE SCI, V361, P28, DOI 10.1016/j.memsci.2010.06.017; Pan YC, 2011, CHEM COMMUN, V47, P2071, DOI 10.1039/c0cc05002d; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Patil DV, 2011, IND ENG CHEM RES, V50, P10516, DOI 10.1021/ie200429f; Pavia D.L., 2009, INTRO SPECTROSCOPY; Peralta D, 2013, MICROPOR MESOPOR MAT, V173, P1, DOI 10.1016/j.micromeso.2013.01.012; Reif R, 2008, DESALINATION, V221, P511, DOI 10.1016/j.desal.2007.01.111; Rowsell JLC, 2004, MICROPOR MESOPOR MAT, V73, P3, DOI 10.1016/j.micromeso.2004.03.034; SANDE M A, 1990, P1117; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Tan JC, 2010, P NATL ACAD SCI USA, V107, P9938, DOI 10.1073/pnas.1003205107; Tapia O, 2000, UNDERSTANDING CHEM R, V17; Ternes TA, 1999, SCI TOTAL ENVIRON, V225, P81, DOI 10.1016/S0048-9697(98)00334-9; Tian YQ, 2003, CHEM-EUR J, V9, P5673, DOI 10.1002/chem.200304957; van Eldik R, 1999, COORDIN CHEM REV, V182, P373, DOI 10.1016/S0010-8545(98)00213-6; van Eldik R, 2005, CHEM REV, V105, P1917, DOI 10.1021/cr050571f; Venglovsky J, 2009, BIORESOURCE TECHNOL, V100, P5386, DOI 10.1016/j.biortech.2009.03.068; von Mitscher LA, 1978, MED RES SERIES, V9; WILLIAMS RJP, 1990, COORDIN CHEM REV, V100, P573, DOI 10.1016/0010-8545(90)85020-S; Yang XQ, 2013, J CHROMATOGR A, V1304, P28, DOI 10.1016/j.chroma.2013.06.064; Zhou JL, 2009, J HAZARD MATER, V166, P655, DOI 10.1016/j.jhazmat.2008.11.070; Zuccato E, 2005, J HAZARD MATER, V122, P205, DOI 10.1016/j.jhazmat.2005.03.001	60	37	38	3	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128436	10.1371/journal.pone.0128436	http://dx.doi.org/10.1371/journal.pone.0128436			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057121	Green Published, gold			2022-12-26	WOS:000356349000021
J	Ibraheem, F; Hussain, MZ; Bhatti, AA				Ibraheem, Farheen; Hussain, Malik Zawwar; Bhatti, Akhlaq Ahmad			C-1 Positive Surface over Positive Scattered Data Sites	PLOS ONE			English	Article							INTERPOLATION	The aim of this paper is to develop a local positivity preserving scheme when the data amassed from different sources is positioned at sparse points. The proposed algorithm first triangulates the irregular data using Delauny triangulation method, therewith interpolates each boundary and radial curve of the triangle by C-1 rational trigonometric cubic function. Half of the parameters in the description of the interpolant are constrained to keep up the positive shape of data while the remaining half are set free for users' requirement. Orthogonality of trigonometric function assures much smoother surface as compared to polynomial functions. The proposed scheme can be of great use in areas of surface reconstruction and deformation, signal processing, CAD/CAM design, solving differential equations, and image restoration.	[Ibraheem, Farheen; Bhatti, Akhlaq Ahmad] Natl Univ Comp & Emerging Sci, Lahore, Pakistan; [Hussain, Malik Zawwar] Univ Punjab, Dept Math, Lahore, Pakistan	University of Punjab	Ibraheem, F (corresponding author), Natl Univ Comp & Emerging Sci, Lahore, Pakistan.	farheen.butt@gmail.com	Bhatti, Akhlaq Ahmad/AGL-8514-2022					Cao SJ, 2014, INFORM SCIENCES, V278, P22, DOI 10.1016/j.ins.2014.03.133; Davidson KR, 2006, EVOLUTION COOPERATIO; Dehmer M, 2014, PLOS ONE, V9; DOUGHERTY RL, 1989, MATH COMPUT, V52, P471, DOI 10.1090/S0025-5718-1989-0962209-1; FRANKE R, 1980, INT J NUMER METH ENG, V15, P1691, DOI 10.1002/nme.1620151110; GOODMAN TNT, 1995, APPL MATH COMPUT, V68, P41, DOI 10.1016/0096-3003(94)00086-J; Gupta MK, 2014, MATCH-COMMUN MATH CO, V72, P519; Herrmann M, 1996, J COMPUT APPL MATH, V73, P209, DOI 10.1016/0377-0427(96)00044-1; Hussain MZ, 2011, J APPL MATH COMPUT, V35, P281, DOI 10.1007/s12190-009-0356-0; Hussain MZ, 2009, EUROPEAN J SCI RES, V25, P151; Ibraheem F, 2012, J APPL MATH, DOI 10.1155/2012/247120; Jaun W, 2012, CHINESE SCI BULL, V57, P724, DOI [10.1007/s11434-011-4890-4, DOI 10.1007/S11434-011-4890-4]; Kraus V, 2014, INFORM SCIENCES, V288, P220, DOI 10.1016/j.ins.2014.07.018; Ma ZQ, 2011, INT J MOD PHYS C, V22, P1257, DOI 10.1142/S0129183111016877; NIELSON GM, 1979, J APPROX THEORY, V25, P318, DOI 10.1016/0021-9045(79)90020-0; Piah A. R. M., 2005, Mathematics of Surfaces XI 11th IMA International Conference. Proceedings (Lecture Notes in Computer Science Vol. 3604), P336, DOI 10.1007/11537908_20; Sarfraz M, 2012, APPL MATH COMPUT, V218, P7898, DOI 10.1016/j.amc.2012.01.072	18	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0120658	10.1371/journal.pone.0120658	http://dx.doi.org/10.1371/journal.pone.0120658			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057122	Green Submitted, Green Published, gold			2022-12-26	WOS:000356349000001
J	Wang, CY; He, NP; Zhang, JJ; Lv, YL; Wang, L				Wang, Chunyan; He, Nianpeng; Zhang, Jinjing; Lv, Yuliang; Wang, Li			Long-Term Grazing Exclusion Improves the Composition and Stability of Soil Organic Matter in Inner Mongolian Grasslands	PLOS ONE			English	Article							DIFFERENT LAND USES; HUMIC SUBSTANCES; NORTHERN CHINA; AGGREGATE STABILITY; FOREST ECOSYSTEMS; CARBON FRACTIONS; NITROGEN; DYNAMICS; STORAGE; DRIVEN	Alteration of the composition of soil organic matter (SOM) in Inner Mongolian grassland soils associated with the duration of grazing exclusion (GE) has been considered an important index for evaluating the restoring effects of GE practice. By using five plots from a grassland succession series from free grazing to 31-year GE, we measured the content of soil organic carbon (SOC), humic acid carbon (HAC), fulvic acid carbon (FAC), humin carbon (HUC), and humic acid structure to evaluate the changes in SOM composition. The results showed that SOC, HUC, and the ratios of HAC/FAC and HAC/extractable humus carbon (C) increased significantly with prolonged GE duration, and their relationships can be well fitted by positive exponential equations, except for FAC. In contrast, the HAC content increased logarithmically with prolonged GE duration. Long-term GE enhanced the content of SOC and soil humification, which was obvious after more than 10 years of GE. Solid-state C-13 nuclear magnetic resonance spectroscopy showed that the ratios of alkyl C/O- alkyl C first decreased, and then remained stable with prolonged GE. Alternately, the ratios of aromaticity and hydrophobicity first increased, and then were maintained at relatively stable levels. Thus, a decade of GE improved the composition and structure of SOM in semiarid grassland soil and made it more stable. These findings provide new evidence to support the positive effects of long-term GE on soil SOC sequestration in the Inner Mongolian grasslands, in view of the improvement of SOM structure and stability.	[Wang, Chunyan; He, Nianpeng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China; [Wang, Chunyan; Lv, Yuliang] Southwest Univ, Coll Geog Sci, Chongqing 400715, Peoples R China; [Zhang, Jinjing; Wang, Li] Jilin Agr Univ, Coll Resource & Environm Sci, Changchun 130118, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Southwest University - China; Jilin Agricultural University	He, NP (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing 100101, Peoples R China.	henp@igsnrr.ac.cn; zhangjinjing@126.com		he, nianpeng/0000-0002-0458-5953	Natural Science Foundation of China [31270519, 31470506]; Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Science [2013RC102]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Science	Funding for this work came from the Natural Science Foundation of China (31270519, 31470506), and the Program for Kezhen Distinguished Talents in Institute of Geographic Sciences and Natural Resources Research, Chinese Academy of Science (2013RC102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breshears DD, 2003, EARTH SURF PROC LAND, V28, P1189, DOI 10.1002/esp.1034; BURKE IC, 1995, ECOL APPL, V5, P793, DOI 10.2307/1941987; Conte P, 1997, GEODERMA, V80, P339, DOI 10.1016/S0016-7061(97)00059-1; Dai KH, 2001, BIOGEOCHEMISTRY, V54, P51, DOI 10.1023/A:1010697518227; Doane TA, 2003, GEODERMA, V114, P319, DOI 10.1016/S0016-7061(03)00047-8; DORAN JW, 1980, SOIL SCI SOC AM J, V44, P765, DOI 10.2136/sssaj1980.03615995004400040022x; Dou S, 2008, EUR J SOIL SCI, V59, P532, DOI 10.1111/j.1365-2389.2007.01012.x; DOU S, 1988, Acta Pedologica Sinica, V25, P252; Dou S., 2010, SOIL ORGANIC MATTERS; Dou S., 1991, PEDOSPHERE, V1, P345; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; Gao YZ, 2009, ECOL RES, V24, P627, DOI 10.1007/s11284-008-0532-y; Gao YZ, 2008, PLANT SOIL, V307, P41, DOI 10.1007/s11104-008-9579-3; Guimaraes DV, 2013, SOIL TILL RES, V126, P177, DOI 10.1016/j.still.2012.07.010; He NP, 2012, J GEOGR SCI, V22, P859, DOI 10.1007/s11442-012-0968-4; He NP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026506; He NP, 2009, GEODERMA, V150, P302, DOI 10.1016/j.geoderma.2009.02.004; He NP, 2008, SOIL BIOL BIOCHEM, V40, P2952, DOI 10.1016/j.soilbio.2008.08.018; He NP, 2013, ECOLOGY EVOLUTION, V3, DOI [10.1002/ece1003.1881, DOI 10.1002/ECE1003.1881]; Hoffmann C, 2008, J ARID ENVIRON, V72, P792, DOI 10.1016/j.jaridenv.2007.09.004; Hoffmann C, 2008, CATENA, V75, P182, DOI 10.1016/j.catena.2008.06.003; Huan ZQ, 2008, FOREST ECOL MANAG, V254, P46, DOI 10.1016/j.foreco.2007.07.021; Kumada K., 1988, CHEM SOIL ORGANIC MA; Kuo S, 1996, METHODS SOIL ANAL PA, V5, P869, DOI [10.2136/sssabookser5.3.c32, DOI 10.2136/SSSABOOKSER5.3.C32]; LAO JC, 1988, HDB SOIL AGROCHEMIST; Nelson D. W., 1982, METHODS SOIL ANAL 2; Papini R, 2011, AGR ECOSYST ENVIRON, V140, P68, DOI 10.1016/j.agee.2010.11.013; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; Peng F, 1965, ACTA PEDOLOGICA SINI, V13, P208; Piccolo A, 2005, EUR J SOIL SCI, V56, P343, DOI 10.1111/j.1365-2389.2004.00671.x; Piccolo A, 1999, SOIL SCI SOC AM J, V63, P1801, DOI 10.2136/sssaj1999.6361801x; PICCOLO A, 1992, BIORESOURCE TECHNOL, V40, P275, DOI 10.1016/0960-8524(92)90154-P; Seddaiu G, 2013, AGR ECOSYST ENVIRON, V167, P1, DOI 10.1016/j.agee.2013.01.002; Shang S, 2012, SOIL ORGANIC CARBON; Sheng XB., 1997, CHINESE J SOIL SCI, V6, P244; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Spaccini R, 2006, GEODERMA, V132, P9, DOI 10.1016/j.geoderma.2005.04.015; Steffens M, 2009, EUR J SOIL SCI, V60, P198, DOI 10.1111/j.1365-2389.2008.01104.x; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Tisdall JM, 1982, J SOIL SCI, V62, P141, DOI DOI 10.1111/J.1365-2389.1982.TB01755.X; Ussiri DAN, 2003, GEODERMA, V111, P123, DOI 10.1016/S0016-7061(02)00257-4; Watanabe A, 2001, EUR J SOIL SCI, V52, P599, DOI 10.1046/j.1365-2389.2001.00410.x; Wiesmeier M, 2012, EUR J SOIL SCI, V63, P22, DOI 10.1111/j.1365-2389.2011.01418.x; Wu L, 2008, J ENVIRON QUAL, V37, P663, DOI 10.2134/jeq2007.0196; Yang Z, 2004, NUTR CYCL AGROECOSYS, V70, P161, DOI 10.1023/B:FRES.0000048479.30593.ea; Yang ZH, 2004, COMMUN SOIL SCI PLAN, V35, P615, DOI 10.1081/CSS-120030347; Zhang JJ, 2009, EUR J SOIL SCI, V60, P966, DOI 10.1111/j.1365-2389.2009.01191.x; Zhang JJ, 2011, APPL SOIL ECOL, V51, P1, DOI 10.1016/j.apsoil.2011.08.004; Zhang T, 2013, PLANT SOIL, V367, P249, DOI 10.1007/s11104-012-1551-6; Zhou ZY, 2007, BIOGEOCHEMISTRY, V82, P127, DOI 10.1007/s10533-006-9058-y	50	13	16	7	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128837	10.1371/journal.pone.0128837	http://dx.doi.org/10.1371/journal.pone.0128837			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057249	gold, Green Submitted, Green Published			2022-12-26	WOS:000356349000032
J	Borin, GP; Sanchez, CC; de Souza, AP; de Santana, ES; de Souza, AT; Leme, AFP; Squina, FM; Buckeridge, M; Goldman, GH; Oliveira, JVD				Borin, Gustavo Pagotto; Sanchez, Camila Cristina; de Souza, Amanda Pereira; de Santana, Eliane Silva; de Souza, Aline Tieppo; Paes Leme, Adriana Franco; Squina, Fabio Marcio; Buckeridge, Marcos; Goldman, Gustavo Henrique; de Castro Oliveira, Juliana Velasco			Comparative Secretome Analysis of Trichoderma reesei and Aspergillus niger during Growth on Sugarcane Biomass	PLOS ONE			English	Article							SOLID-STATE FERMENTATION; ENZYME-PRODUCTION; ETHANOL; PROTEIN; CARBON; TRANSCRIPTION; EXPRESSION; PECTINASES; CELLULASE; FAMILY	Background Our dependence on fossil fuel sources and concern about the environment has generated a worldwide interest in establishing new sources of fuel and energy. Thus, the use of ethanol as a fuel is advantageous because it is an inexhaustible energy source and has minimal environmental impact. Currently, Brazil is the world's second largest producer of ethanol, which is produced from sugarcane juice fermentation. However, several studies suggest that Brazil could double its production per hectare by using sugarcane bagasse and straw, known as second-generation (2G) bioethanol. Nevertheless, the use of this biomass presents a challenge because the plant cell wall structure, which is composed of complex sugars (cellulose and hemicelluloses), must be broken down into fermentable sugar, such as glucose and xylose. To achieve this goal, several types of hydrolytic enzymes are necessary, and these enzymes represent the majority of the cost associated with 2G bioethanol processing. Reducing the cost of the saccharification process can be achieved via a comprehensive understanding of the hydrolytic mechanisms and enzyme secretion of polysaccharide-hydrolyzing microorganisms. In many natural habitats, several microorganisms degrade lignocellulosic biomass through a set of enzymes that act synergistically. In this study, two fungal species, Aspergillus niger and Trichoderma reesei, were grown on sugarcane biomass with two levels of cell wall complexity, culm in natura and pretreated bagasse. The production of enzymes related to biomass degradation was monitored using secretome analyses after 6, 12 and 24 hours. Concurrently, we analyzed the sugars in the supernatant. Results Analyzing the concentration of monosaccharides in the supernatant, we observed that both species are able to disassemble the polysaccharides of sugarcane cell walls since 6 hours post-inoculation. The sugars from the polysaccharides such as arabinoxylan and beta-glucan (that compose the most external part of the cell wall in sugarcane) are likely the first to be released and assimilated by both species of fungi. At all time points tested, Aspergillus niger produced more enzymes (quantitatively and qualitatively) than Trichoderma reesei. However, the most important enzymes related to biomass degradation, including cellobiohydrolases, endoglucanases, beta-glucosidases, beta-xylosidases, endoxylanases, xyloglucanases, and alpha-arabinofuranosidases, were identified in both secretomes. We also noticed that the both fungi produce more enzymes when grown in culm as a single carbon source. Conclusion Our work provides a detailed qualitative and semi-quantitative secretome analysis of Aspergillus niger and Trichoderma reesei grown on sugarcane biomass. Our data indicate that a combination of enzymes from both fungi is an interesting option to increase saccharification efficiency. In other words, these two fungal species might be combined for their usage in industrial processes.	[Borin, Gustavo Pagotto; Sanchez, Camila Cristina; de Santana, Eliane Silva; de Souza, Aline Tieppo; Squina, Fabio Marcio; Goldman, Gustavo Henrique; de Castro Oliveira, Juliana Velasco] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil; [de Souza, Amanda Pereira; Buckeridge, Marcos] Univ Sao Paulo, Inst Biociencias, Dept Bot, Lab Fisiol Ecol Plantas LAFIECO, Sao Paulo, Brazil; [Paes Leme, Adriana Franco] CNPEM, Lab Nacl Biociencias LNBio, Campinas, SP, Brazil; [Goldman, Gustavo Henrique] Fac Ciencias Farmaceut Ribeirao Preto, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Oliveira, JVD (corresponding author), CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol CTBE, Campinas, SP, Brazil.	juliana.velasco@bietanol.org.br	Goldman, Gustavo Henrique/F-1848-2013; Squina, Fabio/J-8130-2012; Buckeridge, Marcos Silveira/E-7773-2012; Leme, Adriana F Paes/C-9679-2012	Goldman, Gustavo Henrique/0000-0002-2986-350X; Squina, Fabio/0000-0002-8154-7459; Buckeridge, Marcos Silveira/0000-0002-5455-8136; Leme, Adriana F Paes/0000-0001-7959-147X; Pagotto Borin, Gustavo/0000-0001-7087-4780; De Souza, Amanda/0000-0002-7237-6483	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP) [2013/01071-9, 2013/09541-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP [2011/08945-9]	Fundacao de Amparo Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	GPB and CS hold Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) scholarships (2013/01071-9 and 2013/09541-4), and ESS holds a Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) scholarship. The authors thank the FAPESP (2011/08945-9) for financial support.	ACUNAARGUELLES ME, 1995, APPL MICROBIOL BIOT, V43, P808, DOI 10.1007/s002530050489; Adav SS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.012419; Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Borges TA, 2013, PROCESS BIOCH; Braaksma M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-584; Buckeridge MS, 2012, GCB BIOENERGY, V4, P119, DOI 10.1111/j.1757-1707.2011.01122.x; Bussamara R, 2010, BIORESOURCE TECHNOL, V101, P268, DOI 10.1016/j.biortech.2008.10.063; BUSSINK HJD, 1992, EUR J BIOCHEM, V208, P83, DOI 10.1111/j.1432-1033.1992.tb17161.x; CARPITA N, 1979, SCIENCE, V205, P1144, DOI 10.1126/science.205.4411.1144; Corbin RW, 2003, P NATL ACAD SCI USA, V100, P9232, DOI 10.1073/pnas.1533294100; COSTAFERREIRA M, 1994, APPL BIOCHEM BIOTECH, V44, P231, DOI 10.1007/BF02779659; de Souza AP, 2014, BIOENERG RES, V7, P24, DOI 10.1007/s12155-013-9366-8; de Souza WR, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-40; EPE, 2013, EPE BAL EN NAC 2013; Gao J, 2003, J PROTEOME RES, V2, P643, DOI 10.1021/pr034038x; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Hakkinen M, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-14; HARMSEN JAM, 1990, CURR GENET, V18, P161, DOI 10.1007/BF00312604; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Jun H, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-68; Leite DCC, 2013, BIOENERG RES, P1; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lin Y, 2006, APPL MICROBIOL BIOT, V69, P627, DOI 10.1007/s00253-005-0229-x; Lu X, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-23; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Maki M, 2009, INT J BIOL SCI, V5, P500; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Marx IJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-172; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mohanram S., 2013, SUSTAINABLE CHEM PRO, V1, P15, DOI [10.1186/2043-7129-1-15, DOI 10.1186/2043-7129-1-15]; Oliveira JM, 2011, PLOS ONE, V6, P1; Leme AFP, 2012, J PROTEOME RES, V11, P279, DOI 10.1021/pr2006439; Patel-Predd P, 2006, ENVIRON SCI TECHNOL, V40, P4052, DOI 10.1021/es062725u; Patil SR, 2006, BIORESOURCE TECHNOL, V97, P2340, DOI 10.1016/j.biortech.2005.10.025; PATTERSO.RK, 1973, ANAL CHEM, V45, P605, DOI 10.1021/ac60325a050; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Polizeli MLTM, 2005, APPL MICROBIOL BIOT, V67, P577, DOI 10.1007/s00253-005-1904-7; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Rodrigues RCLB, 2003, PROCESS BIOCHEM, V38, P1231, DOI 10.1016/S0032-9592(02)00290-X; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; SolisPereyra S, 1996, WORLD J MICROB BIOT, V12, P257, DOI 10.1007/BF00360924; Stricker AR, 2008, APPL MICROBIOL BIOT, V78, P211, DOI 10.1007/s00253-007-1322-0; Tani S, 2014, APPL MICROBIOL BIOTE; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; van der Kaaij RA, 2007, EUKARYOT CELL, V6, P1178, DOI 10.1128/EC.00354-06	45	70	71	1	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129275	10.1371/journal.pone.0129275	http://dx.doi.org/10.1371/journal.pone.0129275			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053961	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300107
J	Chen, YQ; Wei, J				Chen, Yunqin; Wei, Jia			Identification of Pathogen Signatures in Prostate Cancer Using RNA-seq	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CHRONIC-FATIGUE-SYNDROME; PROPIONIBACTERIUM-ACNES; HUMAN CYTOMEGALOVIRUS; HUMAN KERATINOCYTES; XMRV; INFLAMMATION; INFECTION; PREVALENCE; POLYOMAVIRUSES	Infections of the prostate by bacteria, human papillomaviruses, polyomaviruses, xenotropic murine leukemia virus (MLV)-related gammaretroviruses, human cytomegaloviruses and other members of the herpesvirus family have been widely researched. However, many studies have yielded conflicting and controversial results. In this study, we systematically investigated the transcriptomes of human prostate samples for the unique genomic signatures of these pathogens using RNA-seq data from both western and Chinese patients. Human and nonhuman RNA-seq reads were mapped onto human and pathogen reference genomes respectively using alignment tools Bowtie and BLAT. Pathogen infections and integrations were analyzed in adherence with the standards from published studies. Among the nine pathogens (Propionibacterium acnes, HPV, HCMV, XMRV, BKV, JCV, SV40, EBV, and HBV) we analyzed, Propionibacterium acnes genes were detected in all prostate tumor samples and all adjacent samples, but not in prostate samples from healthy individuals. SV40, HCMV, EBV and low-risk HPVs transcripts were detected in one tumor sample and two adjacent samples from Chinese prostate cancer patients, but not in any samples of western prostate cancer patients; XMRV, BKV and JCV sequences were not identified in our work; HBV, as a negative control, was absent from any samples. Moreover, no pathogen integration was identified in our study. While further validation is required, our analysis provides evidence of Propionibacterium acnes infections in human prostate tumors. Noted differences in viral infections across ethnicity remain to be confirmed with other large prostate cancer data sets. The effects of bacterial and viral infections and their contributions to prostate cancer pathogenesis will require continuous research on associated pathogens.	[Chen, Yunqin; Wei, Jia] AstraZeneca, R&D Informat, Shanghai 201203, Peoples R China	AstraZeneca	Wei, J (corresponding author), AstraZeneca, R&D Informat, 199 Liangjing Rd,Zhangjiang Hitech Pk, Shanghai 201203, Peoples R China.	Jenny.wei@astrazeneca.com			AstraZeneca	AstraZeneca(AstraZeneca)	AstraZeneca provided support in the form of salaries for authors JW and YC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Ahsan N, 2006, ADV EXP MED BIOL, V577, P1; Alexeyev OA, 2007, J CLIN MICROBIOL, V45, P3721, DOI 10.1128/JCM.01543-07; Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; Arnold RS, 2010, UROLOGY, V75, P755, DOI 10.1016/j.urology.2010.01.038; Ayub A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/810461; Bergh Drott J., 2012, THE ROLE OF MICROORG; Blaheta RA, 2006, NEOPLASIA, V8, P807, DOI 10.1593/neo.06379; Bojar RA, 2004, CLIN DERMATOL, V22, P375, DOI 10.1016/j.clindermatol.2004.03.005; Brooks MJ, 2011, MOL VIS, V17, P3034; Chandran UR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-45; Cingoz O, 2012, J VIROL, V86, P328, DOI 10.1128/JVI.06022-11; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Das D, 2008, J VIROL, V82, P2705, DOI 10.1128/JVI.02461-07; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Fehri LF, 2011, INT J MED MICROBIOL, V301, P69, DOI 10.1016/j.ijmm.2010.08.014; Fischer N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/603046; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Graham GM, 2004, BRIT J DERMATOL, V150, P421, DOI 10.1046/j.1365-2133.2004.05762.x; Groom HCT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034221; Holland C, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-230; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Katzourakis A, 2011, J VIROL, V85, P10909, DOI 10.1128/JVI.00827-11; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Khoury JD, 2013, J VIROL, V87, P8916, DOI 10.1128/JVI.00340-13; Kim J, 2002, J IMMUNOL, V169, P1535, DOI 10.4049/jimmunol.169.3.1535; Klein EA, 2008, CURR OPIN UROL, V18, P315, DOI 10.1097/MOU.0b013e3282f9b3b7; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lin Y, 2011, IRISH J MED SCI, V180, P497, DOI 10.1007/s11845-011-0692-6; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Mak TN, 2013, GENOME ANNOUNCEMENTS, V1, DOI [10.1128/genomeA01071-13, DOI 10.1128/GENOMEA01071-13]; McDowell A, 2005, J CLIN MICROBIOL, V43, P326, DOI 10.1128/JCM.43.1.326-334.2005; McDowell A, 2008, J MED MICROBIOL, V57, P218, DOI 10.1099/jmm.0.47489-0; McDowell A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/493564; Mendoza R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036073; Menendez-Arias L, 2011, REV MED VIROL, V21, P3, DOI 10.1002/rmv.673; Nagy I, 2005, J INVEST DERMATOL, V124, P931, DOI 10.1111/j.0022-202X.2005.23705.x; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nelson William G, 2004, J Urol, V172, pS6, DOI 10.1097/01.ju.0000142058.99614.ff; Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317; Pang KR, 2005, METH MOLEC MED, V116, P1; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Perry A, 2011, EXPERT REV ANTI-INFE, V9, P1149, DOI [10.1586/ERI.11.137, 10.1586/eri.11.137]; Ren SC, 2012, CELL RES, V22, P806, DOI 10.1038/cr.2012.30; Rui S, 2003, FRONT BIOSCI-LANDMRK, V8, pD256, DOI 10.2741/984; Saha A, 2010, CANCER BIOL THER, V10, P961, DOI 10.4161/cbt.10.10.13923; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Selth LA, 2014, ENDOCR-RELAT CANCER, V21, pL17, DOI 10.1530/ERC-14-0234; Sfanos KS, 2012, NAT REV UROL, V9, P111, DOI 10.1038/nrurol.2011.225; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Shannon Beverley A, 2006, Future Oncol, V2, P225, DOI 10.2217/14796694.2.2.225; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77; Simmons G, 2011, SCIENCE, V334, P814, DOI 10.1126/science.1213841; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WEBSTER GF, 1980, INFLAMMATION, V4, P261, DOI 10.1007/BF00915027; Whitaker NJ, 2013, PROSTATE, V73, P236, DOI 10.1002/pros.22562; Zambrano A, 2002, PROSTATE, V53, P263, DOI 10.1002/pros.10157	65	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128955	10.1371/journal.pone.0128955	http://dx.doi.org/10.1371/journal.pone.0128955			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053031	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300071
J	Huang, HB; Xiao, K; Lu, S; Yang, KL; Ansari, AR; Khaliq, H; Song, H; Zhong, JM; Liu, HZ; Peng, KM				Huang, Hai-bo; Xiao, Ke; Lu, Shun; Yang, Ke-li; Ansari, Abdur Rahman; Khaliq, Haseeb; Song, Hui; Zhong, Juming; Liu, Hua-zhen; Peng, Ke-mei			Increased Thymic Cell Turnover under Boron Stress May Bypass TLR3/4 Pathway in African Ostrich	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM INFECTION; CD4(+)CD8(+) THYMOCYTES; CUTTING EDGE; EXPRESSION; SURVIVAL; GENE; MICE; PROLIFERATION; APOPTOSIS; TLR4	Previous studies revealed that thymus is a targeted immune organ in malnutrition, and high-boron stress is harmful for immune organs. African ostrich is the living fossil of ancient birds and the food animals in modern life. There is no report about the effect of boron intake on thymus of ostrich. The purpose of present study was to evaluate the effect of excessive boron stress on ostrich thymus and the potential role of TLR3/4 signals in this process. Histological analysis demonstrated that long-term boron stress (640 mg/L for 90 days) did not disrupt ostrich thymic structure during postnatal development. However, the numbers of apoptotic cells showed an increased tendency, and the expression of autophagy and proliferation markers increased significantly in ostrich thymus after boron treatment. Next, we examined the expression of TLR3 and TLR4 with their downstream molecular in thymus under boron stress. Since ostrich genome was not available when we started the research, we first cloned ostrich TLR3 TLR4 cDNA from thymus. Ostrich TLR4 was close to white-throated Tinamou. Whole avian TLR4 codons were under purify selection during evolution, whereas 80 codons were under positive selection. TLR3 and TLR4 were expressed in ostrich thymus and bursa of fabricius as was revealed by quantitative real-time PCR (qRT-PCR). TLR4 expression increased with age but significantly decreased after boron treatment, whereas TLR3 expression showed the similar tendency. Their downstream molecular factors (IRF1, JNK, ERK, p38, IL-6 and IFN) did not change significantly in thymus, except that p100 was significantly increased under boron stress when analyzed by qRT-PCR or western blot. Taken together, these results suggest that ostrich thymus developed resistance against long-term excessive boron stress, possibly by accelerating intrathymic cell death and proliferation, which may bypass the TLR3/4 pathway. In addition, attenuated TLRs activity may explain the reduced inflammatory response to pathogens under boron stress.	[Huang, Hai-bo; Xiao, Ke; Lu, Shun; Yang, Ke-li; Ansari, Abdur Rahman; Khaliq, Haseeb; Song, Hui; Zhong, Juming; Liu, Hua-zhen; Peng, Ke-mei] Huazhong Agr Univ, Coll Anim Sci & Vet Med, Dept Anat Histol & Embryol, Wuhan, Hubei, Peoples R China; [Zhong, Juming] Auburn Univ, Coll Vet Med, Dept Anat Physiol & Pharmacol, Auburn, AL 36849 USA	Huazhong Agricultural University; Auburn University System; Auburn University	Peng, KM (corresponding author), Huazhong Agr Univ, Coll Anim Sci & Vet Med, Dept Anat Histol & Embryol, Wuhan, Hubei, Peoples R China.	kmpeng@mail.hzau.edu.cn	KHALIQ, HASEEB/GQP-7691-2022; ANSARI, ABDUR RAHMAN/C-2027-2015	KHALIQ, HASEEB/0000-0002-4806-7349; ANSARI, ABDUR RAHMAN/0000-0002-3583-6524	National Natural Science Foundation of China [31272517]; Fundamental Research Funds for the Central Universities [2013YB09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by grants from the National Natural Science Foundation of China (31272517) and the Fundamental Research Funds for the Central Universities (2013YB09).	Armstrong TA, 2001, J ANIM SCI, V79, P1549; Baron ML, 2008, J IMMUNOL, V180, P7134, DOI 10.4049/jimmunol.180.11.7134; Basak S, 2008, CYTOKINE GROWTH F R, V19, P187, DOI 10.1016/j.cytogfr.2008.04.005; Bernasconi P, 2005, AM J PATHOL, V167, P129, DOI 10.1016/S0002-9440(10)62960-4; Bourgeois AC, 2007, J NUTR, V137, P2080, DOI 10.1093/jn/137.9.2080; Cheng JY, 2011, BIOL TRACE ELEM RES, V144, P538, DOI 10.1007/s12011-011-9024-y; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Demoulins T, 2008, J IMMUNOL, V181, P6757, DOI 10.4049/jimmunol.181.10.6757; Deobagkar-Lele M, 2014, EUR J IMMUNOL, V44, P137, DOI 10.1002/eji.201343506; Deobagkar-Lele M, 2013, IMMUNOLOGY, V138, P307, DOI 10.1111/imm.12047; Ge Q, 2013, DEV COMP IMMUNOL, V39, P85, DOI 10.1016/j.dci.2012.01.002; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Gordy C, 2012, PROTEIN CELL, V3, P17, DOI 10.1007/s13238-011-1127-x; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; Grueber CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089632; Gruver AL, 2008, J LEUKOCYTE BIOL, V84, P915, DOI 10.1189/jlb.0108025; Gu YF, 2007, INDIAN VET J, V84, P584; Hale JS, 2006, P NATL ACAD SCI USA, V103, P8447, DOI 10.1073/pnas.0601040103; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hu QQ, 2014, BIOL TRACE ELEM RES, V158, P73, DOI 10.1007/s12011-014-9899-5; Huang HB, 2014, VET IMMUNOL IMMUNOP, V158, P182, DOI 10.1016/j.vetimm.2014.01.005; Huang HB, 2013, VET IMMUNOL IMMUNOP, V153, P123, DOI 10.1016/j.vetimm.2012.12.008; Iqbal M, 2005, VET IMMUNOL IMMUNOP, V104, P117, DOI 10.1016/j.vetimm.2004.11.003; Ito Y, 2006, J HISTOCHEM CYTOCHEM, V54, P683, DOI 10.1369/jhc.5A6799.2006; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Li XY, 2010, CYTOKINE, V49, P1, DOI 10.1016/j.cyto.2009.08.010; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; Nielsen FH, 2014, J TRACE ELEM MED BIO, V28, P383, DOI 10.1016/j.jtemb.2014.06.023; Paleari MA, 1998, MEAT SCI, V48, P205, DOI 10.1016/S0309-1740(97)00091-0; Pan ZY, 2011, J ANIM VET ADV, V10, P2312, DOI 10.3923/javaa.2011.2312.2316; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Qiao L, 2000, IN VITRO CELL DEV-AN, V36, P465; Ratcliffe MJH, 2006, DEV COMP IMMUNOL, V30, P101, DOI 10.1016/j.dci.2005.06.018; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Savino W, 2006, PLOS PATHOG, V2, P472, DOI 10.1371/journal.ppat.0020062; SCHAFFNER T, 1974, CELL IMMUNOL, V13, P304, DOI 10.1016/0008-8749(74)90247-0; Sidler Corinne, 2013, Frontiers in Genetics, V4, P211, DOI 10.3389/fgene.2013.00211; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Uddin MN, 2012, AGE, V34, P75, DOI 10.1007/s11357-011-9221-9; Uluisik I, 2011, GENOMICS, V97, P106, DOI 10.1016/j.ygeno.2010.10.006; Varga I, 2010, ANN ANAT, V192, P232, DOI 10.1016/j.aanat.2010.05.007; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wang W, 2014, J AGR FOOD CHEM, V62, P11024, DOI 10.1021/jf501789t; Yin YB, 2011, VET MICROBIOL, V149, P324, DOI 10.1016/j.vetmic.2010.12.004	48	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129596	10.1371/journal.pone.0129596	http://dx.doi.org/10.1371/journal.pone.0129596			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053067	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300150
J	Lochmann, TL; Thomas, RR; Bennett, JP; Taylor, SM				Lochmann, Timothy L.; Thomas, Ravindar R.; Bennett, James P., Jr.; Taylor, Shirley M.			Epigenetic Modifications of the PGC-1 alpha Promoter during Exercise Induced Expression in Mice	PLOS ONE			English	Article							DNA METHYLATION; MESSENGER-RNA; RECEPTOR ACTIVATION; GENE-EXPRESSION; WIDE; 5-HYDROXYMETHYLCYTOSINE; COACTIVATORS; ENHANCERS; INTENSITY; ISLANDS	The transcriptional coactivator, PGC-1 alpha, is known for its role in mitochondrial biogenesis. Although originally thought to exist as a single protein isoform, recent studies have identified additional promoters which produce multiple mRNA transcripts. One of these promoters (promoter B), approximately 13.7kb upstream of the canonical PGC-1 alpha promoter (promoter A), yields alternative transcripts present at levels much lower than the canonical PGC-1 alpha mRNA transcript. In skeletal muscle, exercise resulted in a substantial, rapid increase of mRNA of these alternative PGC-1 alpha transcripts. Although the beta(2)-adrenergic receptor was identified as a signaling pathway that activates transcription from PGC-1 alpha promoter B, it is not yet known what molecular changes occur to facilitate PGC-1 alpha promoter B activation following exercise. We sought to determine whether epigenetic modifications were involved in this exercise response in mouse skeletal muscle. We found that DNA hydroxymethylation correlated to increased basal mRNA levels from PGC-1 alpha promoter A, but that DNA methylation appeared to play no role in the exercise-induced activation of PGC-1 alpha promoter B. The level of the activating histone mark H3K4me3 increased with exercise 2-4 fold across PGC-1 alpha promoter B, but remained unaltered past the canonical PGC-1 alpha transcriptional start site. Together, these data show that epigenetic modifications partially explain exercise-induced changes in the skeletal muscle mRNA levels of PGC-1 alpha isoforms.	[Lochmann, Timothy L.; Taylor, Shirley M.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23284 USA; [Thomas, Ravindar R.; Bennett, James P., Jr.] Virginia Commonwealth Univ, Parkinsons Ctr, Richmond, VA USA; [Bennett, James P., Jr.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA; [Bennett, James P., Jr.] Virginia Commonwealth Univ, Dept Psychiat, Richmond, VA USA; [Bennett, James P., Jr.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA USA; [Taylor, Shirley M.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Taylor, SM (corresponding author), Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23284 USA.	smtaylor@vcu.edu		Lochmann, Timothy/0000-0002-3368-6067	National Science Foundation [NSF 1122018]; VCU Parkinson's and Movement Disorder Center; NIH-NCI Cancer Center [P30 CA016059]; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1122018] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); VCU Parkinson's and Movement Disorder Center; NIH-NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was funded by a grant from the National Science Foundation (www.nsf.gov) NSF 1122018 (TL, SMT) and by the VCU Parkinson's and Movement Disorder Center (parkinsons.vcu.edu) (JPP, RT and TL). Services and products in support of this research were generated by the VCU Massey Cancer Center Biological Macromolecule Shared Resource, supported, in part, with funding from NIH-NCI Cancer Center (www.nih.gov) Support Grant P30 CA016059.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrey G, 2013, SCIENCE, V340, P1195, DOI 10.1126/science.1234167; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chang JS, 2012, J BIOL CHEM, V287, P9100, DOI 10.1074/jbc.M111.320200; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Ding Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003111; Egan B, 2010, J PHYSIOL-LONDON, V588, P1779, DOI 10.1113/jphysiol.2010.188011; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gal-Yam EN, 2008, P NATL ACAD SCI USA, V105, P12979, DOI 10.1073/pnas.0806437105; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Han H, 2011, HUM MOL GENET, V20, P4299, DOI 10.1093/hmg/ddr356; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Maston GA, 2012, ANNU REV GENOM HUM G, V13, P29, DOI 10.1146/annurev-genom-090711-163723; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miura S, 2008, ENDOCRINOLOGY, V149, P4527, DOI 10.1210/en.2008-0466; Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646; Nader GA, 2014, J APPL PHYSIOL, V116, P693, DOI 10.1152/japplphysiol.01366.2013; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Norrbom J, 2011, AM J PHYSIOL-ENDOC M, V301, pE1092, DOI 10.1152/ajpendo.00119.2011; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Parrish R Ryley, 2012, Curr Protoc Neurosci, VChapter 7, DOI 10.1002/0471142301.ns0724s60; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Racanelli AC, 2008, MOL CELL BIOL, V28, P836, DOI 10.1128/MCB.01088-07; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ruas JL, 2012, CELL, V151, P1319, DOI 10.1016/j.cell.2012.10.050; Sakashita K, 2001, J CLIN INVEST, V108, P1195, DOI 10.1172/JCI200113030; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Soyal SM, 2012, HUM MOL GENET, V21, P3461, DOI 10.1093/hmg/dds177; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Tadaishi M, 2011, AM J PHYSIOL-ENDOC M, V300, pE341, DOI 10.1152/ajpendo.00400.2010; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; van Leeuwen F, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-113; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Yoshioka T, 2009, J MATER CYCLES WASTE, V11, P1, DOI 10.1007/s10163-008-0223-3; Yu M, 2012, NAT PROTOC, V7, P2159, DOI 10.1038/nprot.2012.137; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111; Zhang YB, 2009, J BIOL CHEM, V284, P32813, DOI 10.1074/jbc.M109.037556	52	27	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129647	10.1371/journal.pone.0129647	http://dx.doi.org/10.1371/journal.pone.0129647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053857	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300157
J	Siew, ML; van Vonderen, JJ; Hooper, SB; te Pas, AB				Siew, Melissa L.; van Vonderen, Jeroen J.; Hooper, Stuart B.; te Pas, Arjan B.			Very Preterm Infants Failing CPAP Show Signs of Fatigue Immediately after Birth	PLOS ONE			English	Article							INITIAL RESPIRATORY MANAGEMENT; AIRWAY PRESSURE FAILURE; STABLE MICROBUBBLE TEST; LUNG LIQUID CLEARANCE; CHEST-WALL; NASAL CPAP; NEWBORN-INFANTS; WEEKS GESTATION; FULL-TERM; SURFACTANT	Objective To investigate the differences in breathing pattern and effort in infants at birth who failed or succeeded on continuous positive airway pressure (CPAP) during the first 48 hours after birth. Methods Respiratory function recordings of 32 preterm infants were reviewed of which 15 infants with a gestational age of 28.6 (0.7) weeks failed CPAP and 17 infants with a GA of 30.1 (0.4) weeks did not fail CPAP. Frequency, duration and tidal volumes (VT) of expiratory holds (EHs), peak inspiratory flows, CPAP-level and FiO(2)-levels were analysed. Results EH incidence increased <6 minutes after birth and remained stable thereafter. EH peak inspiratory flows and VT were similar between CPAP-fail and CPAP-success infants. At 9-12 minutes, CPAP-fail infants more frequently used smaller VTs, 0-9 ml/kg and required higher peak inspiratory flows. However, CPAP-success infants often used large VTs (>9 ml/kg) with higher peak inspiratory flows than CPAP-fail infants (71.8 +/- 15.8 vs. 15.5 +/- 5.2 ml/kg. s, p < 0.05). CPAP-fail infants required higher FiO(2) (0.31 +/- 0.03 vs. 0.21 +/- 0.01), higher CPAP pressures (6.62 +/- 0.3 vs. 5.67 +/- 0.26 cm H2O) and more positive pressure-delivered breaths (45 +/- 12 vs. 19 +/- 9%) (p < 0.05) Conclusion At 9-12 minutes after birth, CPAP-fail infants more commonly used lower VTs and required higher peak inspiratory flow rates while receiving greater respiratory support. VT was less variable and larger VT was infrequently used reflecting early signs of fatigue.	[Siew, Melissa L.; Hooper, Stuart B.] Monash Univ, Ritchie Ctr, MIMR PHI, Clayton, Vic, Australia; [van Vonderen, Jeroen J.; te Pas, Arjan B.] Leiden Univ, Med Ctr, Dept Pediat, Div Neonatol, Leiden, Netherlands	Monash University; Prince Henry's Institute of Medical Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Siew, ML (corresponding author), Monash Univ, Ritchie Ctr, MIMR PHI, Clayton, Vic, Australia.	melissa.siew@monash.edu	van Vonderen, Jeroen J./L-4067-2019; pas, arjan te/AAA-9019-2020	van Vonderen, Jeroen J./0000-0002-1258-5224; pas, arjan te/0000-0001-7831-8797; Hooper, Stuart/0000-0003-1676-4825	Veni-grant, the Netherlands Organisation for Health Research and Development (ZonMw), Innovational Research Incentives Scheme Veni-Vidi-Vici [91612027]; Willem-Alexander Children's Foundation scholarship; David Henderson-Smart Travel Scholarship	Veni-grant, the Netherlands Organisation for Health Research and Development (ZonMw), Innovational Research Incentives Scheme Veni-Vidi-Vici; Willem-Alexander Children's Foundation scholarship; David Henderson-Smart Travel Scholarship	A.B. te Pas is recipient of a Veni-grant, the Netherlands Organisation for Health Research and Development (ZonMw), part of the Innovational Research Incentives Scheme Veni-Vidi-Vici, projectnumber 91612027. J.J. van Vonderen is recipient of a Willem-Alexander Children's Foundation scholarship. M.L. Siew was funded by the David Henderson-Smart Travel Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammari A, 2005, J PEDIATR-US, V147, P341, DOI 10.1016/j.jpeds.2005.04.062; Daniel IWBD, 2010, NEONATOLOGY, V98, P150, DOI 10.1159/000279887; Bien MY, 2011, CRIT CARE MED, V39, P2253, DOI 10.1097/CCM.0b013e31822279ed; Bushell T, 2013, J Neonatal Perinatal Med, V6, P53, DOI 10.3233/NPM-1363612; Dargaville PA, 2013, NEONATOLOGY, V104, P8, DOI 10.1159/000346460; De Jaegere AP, 2012, ACTA PAEDIATR, V101, P374, DOI 10.1111/j.1651-2227.2011.02558.x; Dimitriou G, 2011, EUR J PEDIATR, V170, P45, DOI 10.1007/s00431-010-1264-x; Dunn MS, 2011, PEDIATRICS, V128, pE1069, DOI 10.1542/peds.2010-3848; Elgellab A, 2001, INTENS CARE MED, V27, P1782, DOI 10.1007/s00134-001-1117-1; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Fiori HH, 2006, J PERINAT MED, V34, P66, DOI 10.1515/JPM.2006.008; FISHER JT, 1982, AM REV RESPIR DIS, V125, P650; Frappell PB, 2005, RESP PHYSIOL NEUROBI, V149, P143, DOI 10.1016/j.resp.2005.05.028; Fuchs H, 2011, ARCH DIS CHILD-FETAL, V96, pF343, DOI 10.1136/adc.2010.205898; GAULTIER C, 1995, EUR RESPIR J, V8, P150, DOI 10.1183/09031936.95.08010150; GERHARDT T, 1980, ACTA PAEDIATR SCAND, V69, P359, DOI 10.1111/j.1651-2227.1980.tb07093.x; HARDING R, 1980, SLEEP, V3, P307, DOI 10.1093/sleep/3.3-4.307; HELDT GP, 1987, J APPL PHYSIOL, V62, P164, DOI 10.1152/jappl.1987.62.1.164; Hooper SB, 2007, FASEB J, V21, P3329, DOI 10.1096/fj.07-8208com; Hutchison AA, 2000, BIOL NEONATE, V78, P139, DOI 10.1159/000014262; Kaczmarek J, 2013, ARCH DIS CHILD-FETAL, V98, pF70, DOI 10.1136/fetalneonatal-2011-301340; KELLY E, 1993, PEDIATR PULM, V15, P225, DOI 10.1002/ppul.1950150408; Khan N, 1996, CRIT CARE MED, V24, P1568, DOI 10.1097/00003246-199609000-00023; KOSCH PC, 1984, J APPL PHYSIOL, V57, P1126, DOI 10.1152/jappl.1984.57.4.1126; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; MORTOLA JP, 1982, J APPL PHYSIOL, V52, P716, DOI 10.1152/jappl.1982.52.3.716; MORTOLA JP, 1984, AM REV RESPIR DIS, V129, P49; NILSSON R, 1980, ACTA PAEDIATR SCAND, V69, P597, DOI 10.1111/j.1651-2227.1980.tb07328.x; Pas ABT, 2008, PEDIATR RES, V64, P281, DOI 10.1203/PDR.0b013e31817d9c35; Pillai MS, 2011, J TROP PEDIATRICS, V57, P274, DOI 10.1093/tropej/fmq047; Sandri F, 2010, PEDIATRICS, V125, pE1402, DOI 10.1542/peds.2009-2131; Lopez ES, 2011, CLINICS, V66, P823, DOI 10.1590/S1807-59322011000500019; Schilleman K, 2012, RESUSCITATION, V83, P1135, DOI 10.1016/j.resuscitation.2012.01.036; Schmolzer GM, 2010, ARCH DIS CHILD-FETAL, V95, pF295, DOI 10.1136/adc.2009.165878; Siew ML, 2011, PEDIATR RES, V70, P50, DOI 10.1203/PDR.0b013e31821be094; Siew ML, 2009, J APPL PHYSIOL, V106, P1888, DOI 10.1152/japplphysiol.91526.2008; te Pas AB, 2009, PEDIATR RES, V65, P352, DOI 10.1203/PDR.0b013e318193f117; VYAS H, 1986, PEDIATR PULM, V2, P189, DOI 10.1002/ppul.1950020403; Warren RH, 1997, EUR RESPIR J, V10, P2295, DOI 10.1183/09031936.97.10102295; Wong KA, 1998, J APPL PHYSIOL, V85, P849, DOI 10.1152/jappl.1998.85.3.849; Yost CC, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001456	41	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129592	10.1371/journal.pone.0129592	http://dx.doi.org/10.1371/journal.pone.0129592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052947	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300148
J	Vacondio, F; Bassi, M; Silva, C; Castelli, R; Carmi, C; Scalvini, L; Lodola, A; Vivo, V; Flammini, L; Barocelli, E; Mor, M; Rivara, S				Vacondio, Federica; Bassi, Michele; Silva, Claudia; Castelli, Riccardo; Carmi, Caterina; Scalvini, Laura; Lodola, Alessio; Vivo, Valentina; Flammini, Lisa; Barocelli, Elisabetta; Mor, Marco; Rivara, Silvia			Amino Acid Derivatives as Palmitoylethanolamide Prodrugs: Synthesis, In Vitro Metabolism and In Vivo Plasma Profile in Rats	PLOS ONE			English	Article							AMIDE HYDROLASE INHIBITORS; PHARMACOLOGICAL CHARACTERIZATION; ESTER PRODRUGS; STABILITY; HYDROLYSIS; RECEPTOR; PAIN; PEPTIDE; ENZYME; OLEOYLETHANOLAMIDE	Palmitoylethanolamide (PEA) has antinflammatory and antinociceptive properties widely exploited in veterinary and human medicine, despite its poor pharmacokinetics. Looking for prodrugs that could progressively release PEA to maintain effective plasma concentrations, we prepared carbonates, esters and carbamates at the hydroxyl group of PEA. Chemical stability (pH 7.4) and stability in rat plasma and liver homogenate were evaluated by in vitro assays. Carbonates and carbamates resulted too labile and too resistant in plasma, respectively. Ester derivatives, prepared by conjugating PEA with various amino acids, allowed to modulate the kinetics of PEA release in plasma and stability in liver homogenate. L-Val-PEA, with suitable PEA release in plasma, and D-Val-PEA, with high resistance to hepatic degradation, were orally administered to rats and plasma levels of prodrugs and PEA were measured at different time points. Both prodrugs showed significant release of PEA, but provided lower plasma concentrations than those obtained with equimolar doses of PEA. Amino-acid esters of PEA are a promising class to develop prodrugs, even if they need further chemical optimization.	[Vacondio, Federica; Bassi, Michele; Silva, Claudia; Castelli, Riccardo; Carmi, Caterina; Scalvini, Laura; Lodola, Alessio; Vivo, Valentina; Flammini, Lisa; Barocelli, Elisabetta; Mor, Marco; Rivara, Silvia] Univ Parma, Dipartimento Farm, I-43100 Parma, Italy	University of Parma	Rivara, S (corresponding author), Univ Parma, Dipartimento Farm, I-43100 Parma, Italy.	silvia.rivara@unipr.it	Mor, Marco/D-2394-2009; Rivara, Silvia/K-8104-2017; Lodola, Alessio/H-9078-2013; Vacondio, Federica/C-1295-2009	Mor, Marco/0000-0003-0199-1849; Rivara, Silvia/0000-0001-8058-4250; Lodola, Alessio/0000-0002-8675-1002; Vacondio, Federica/0000-0002-0729-4385; Scalvini, Laura/0000-0003-3610-527X; Bassi, Michele/0000-0001-6123-8221				ACEDO M, 1992, TETRAHEDRON LETT, V33, P4989, DOI 10.1016/S0040-4039(00)61253-4; [Anonymous], 2013, MAESTR VERS 9 6; [Anonymous], 2013, GLID VERS 6 1; Astarita G, 2006, J PHARMACOL EXP THER, V318, P563, DOI 10.1124/jpet.106.105221; Balvers MGJ, 2013, CNS NEUROL DISORD-DR, V12, P26; BENNION C, 1992, J MED CHEM, V35, P2939, DOI 10.1021/jm00094a003; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Buchwald P, 1999, J MED CHEM, V42, P5160, DOI 10.1021/jm990145k; Calignano A, 2001, EUR J PHARMACOL, V419, P191, DOI 10.1016/S0014-2999(01)00988-8; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Cerrato S, 2012, VET J, V191, P377, DOI 10.1016/j.tvjl.2011.04.002; Clapper JR, 2009, CHEMMEDCHEM, V4, P1505, DOI 10.1002/cmdc.200900210; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Della Valle F, 2013, United States patent, Patent No. [US8470373, 8470373]; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; Duranti A, 2012, J MED CHEM, V55, P4824, DOI 10.1021/jm300349j; Fleisher D, 1996, ADV DRUG DELIVER REV, V19, P115, DOI 10.1016/0169-409X(95)00103-E; Hong SY, 1999, BIOCHEM PHARMACOL, V58, P1775, DOI 10.1016/S0006-2952(99)00259-2; Ichikawa T, 2001, CHEM PHARM BULL, V49, P1102, DOI 10.1248/cpb.49.1102; Jaggar SI, 1998, PAIN, V76, P189, DOI 10.1016/S0304-3959(98)00041-4; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Liederer BM, 2006, J PHARM SCI-US, V95, P1177, DOI 10.1002/jps.20542; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Lo Verme J, 2005, MOL PHARMACOL, V67, P15, DOI 10.1124/mol.104.006353; Luongo E, 2014, EUR J PHARM SCI, V62, P33, DOI 10.1016/j.ejps.2014.05.009; Mazzari S, 1996, EUR J PHARMACOL, V300, P227, DOI 10.1016/0014-2999(96)00015-5; Moreno-Sanz G, 2012, BRIT J PHARMACOL, V167, P1620, DOI 10.1111/j.1476-5381.2012.02098.x; Oh D M, 1999, Pharm Biotechnol, V12, P59; Petrosino S, 2016, BRIT J PHARMACOL, V173, P1154, DOI 10.1111/bph.13084; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Rivara M, 2008, CHEM BIODIVERS, V5, P140, DOI 10.1002/cbdv.200890004; Russo R, 2007, J PHARMACOL EXP THER, V322, P236, DOI 10.1124/jpet.107.119941; Schrodinger LLC, 2013, MACROMODEL VERS 10 2; Silverman R, 2014, ORGANIC CHEM DRUG DE, V3rd, P423; Solorzano C, 2009, P NATL ACAD SCI USA, V106, P20966, DOI 10.1073/pnas.0907417106; Song XQ, 2005, MOL PHARMACEUT, V2, P157, DOI 10.1021/mp049888e; SOULLAWTON J, 1995, ANTIMICROB AGENTS CH, V39, P2759, DOI 10.1128/AAC.39.12.2759; Sugawara M, 2000, J PHARM SCI-US, V89, P781, DOI 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7; Tsume Y, 2014, EUR J PHARM BIOPHARM, V86, P514, DOI 10.1016/j.ejpb.2013.12.009; Ueda N, 2001, J BIOL CHEM, V276, P35552, DOI 10.1074/jbc.M106261200; USANSKY JI, 2001, PK FUNCTIONS MICROSO; Vacondio F, 2011, EUR J MED CHEM, V46, P4466, DOI 10.1016/j.ejmech.2011.07.021; Vacondio F, 2010, DRUG METAB REV, V42, P551, DOI 10.3109/03602531003745960; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; Vig BS, 2003, PHARM RES-DORDR, V20, P1381, DOI 10.1023/A:1025745824632; Wadkins RM, 2001, MOL PHARMACOL, V60, P355, DOI 10.1124/mol.60.2.355; Zhang D, 2007, NEUROPHARMACOLOGY, V52, P1095, DOI 10.1016/j.neuropharm.2006.11.009	48	19	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128699	10.1371/journal.pone.0128699	http://dx.doi.org/10.1371/journal.pone.0128699			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053855	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300054
J	Wagner, RG; Bottomley, C; Ngugi, AK; Ibinda, F; Gomez-Olive, FX; Kahn, K; Tollman, S; Newton, CR				Wagner, Ryan G.; Bottomley, Christian; Ngugi, Anthony K.; Ibinda, Fredrick; Gomez-Olive, F. Xavier; Kahn, Kathleen; Tollman, Stephen; Newton, Charles R.		SEEDS Writing Grp	Incidence, Remission and Mortality of Convulsive Epilepsy in Rural Northeast South Africa	PLOS ONE			English	Article							PREMATURE MORTALITY; HEALTH; PREVALENCE; BURDEN; AREA; ONCHOCERCIASIS; VALIDATION; REGIONS; PEOPLE; DEATH	Background Epilepsy is one of the most common neurological conditions globally, estimated to constitute 0.75% of the global burden of disease, with the majority of this burden found in low- and middle- income countries (LMICs). Few studies from LMICs, including much of sub-Saharan Africa, have described the incidence, remission or mortality rates due to epilepsy, which are needed to quantify the burden and inform policy. This study investigates the epidemiological parameters of convulsive epilepsy within a context of high HIV prevalence and an emerging burden of cardiovascular disease. Methods A cross-sectional population survey of 82,818 individuals, in the Agincourt Health and Socio-demographic Surveillance Site (HDSS) in rural northeast South Africa was conducted in 2008, from which 296 people were identified with active convulsive epilepsy. A follow-up survey was conducted in 2012. Incidence and mortality rates were estimated, with duration and remission rates calculated using the DISMOD II software package. Results The crude incidence for convulsive epilepsy was 17.4/100,000 per year (95%CI: 13.1-23.0). Remission was 4.6% and 3.9% per year for males and females, respectively. The standardized mortality ratio was 2.6 (95%CI: 1.7-3.5), with 33.3% of deaths directly related to epilepsy. Mortality was higher in men than women (adjusted rate ratio (aRR) 2.6 (95%CI: 1.2-5.4)), and was significantly associated with older ages (50+ years versus those 0-5 years old (RR 4.8 (95%CI: 0.6-36.4)). Conclusions The crude incidence was lower whilst mortality rates were similar to other African studies; however, this study found higher mortality amongst older males. Efforts aimed at further understanding what causes epilepsy in older people and developing interventions to reduce prolonged seizures are likely to reduce the overall burden of ACE in rural South Africa.	[Wagner, Ryan G.; Bottomley, Christian; Ngugi, Anthony K.; Kahn, Kathleen; Tollman, Stephen; Newton, Charles R.] Studies Epidemiol Epilepsy Demog Surveillance Sys, Accra, Ghana; [Wagner, Ryan G.; Gomez-Olive, F. Xavier; Kahn, Kathleen; Tollman, Stephen; Newton, Charles R.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Johannesburg, South Africa; [Wagner, Ryan G.; Kahn, Kathleen; Tollman, Stephen] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Publ Hlth Sci, Umea, Sweden; [Wagner, Ryan G.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Bottomley, Christian] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Fac Epidemiol & Populat Hlth, London WC1, England; [Bottomley, Christian] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, MRC Trop Epidemiol Grp, London WC1, England; [Ngugi, Anthony K.] Aga Khan Univ East Africa, Res Support Unit, Fac Hlth Sci, Nairobi, Kenya; [Ibinda, Fredrick; Newton, Charles R.] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Gomez-Olive, F. Xavier; Kahn, Kathleen; Tollman, Stephen] INDEPTH Network, Accra, Ghana; [Newton, Charles R.] UCL Inst Child Hlth, Neurosci Unit, London, England; [Newton, Charles R.] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England	University of Witwatersrand; Umea University; Umea University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; INDEPTH Network; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Wagner, RG (corresponding author), Studies Epidemiol Epilepsy Demog Surveillance Sys, Accra, Ghana.	Ryan.wagner@wits.ac.za	Newton, Charles RJC/B-7578-2014; Newton, Charles/V-7872-2019; Gómez-Olivé, Francesc Xavier/AAP-7673-2021; Wagner, Ryan G/AFK-7323-2022; Odermatt, Peter/K-7727-2015	Newton, Charles RJC/0000-0002-6999-5507; Newton, Charles/0000-0002-6999-5507; Gómez-Olivé, Francesc Xavier/0000-0002-4876-0848; Wagner, Ryan G/0000-0003-2741-3676; Odermatt, Peter/0000-0002-0296-2508; Kahn, Kathleen/0000-0003-3339-3931; Owusu-Agyei, Seth/0000-0002-0807-1781; Bottomley, Christian/0000-0002-5241-8412; Tollman, Stephen/0000-0003-0744-7588; Twine, Rhian/0000-0002-0766-6556; Odhiambo, Rachel/0000-0002-7525-0659; Akpalu, Albert/0000-0002-4802-9852	Wellcome Trust, UK [083744, 058893/Z/99/A, 069683/Z/02/Z, 085477/Z/08/Z]; Medical Research Council [MR/K012126/1] Funding Source: researchfish	Wellcome Trust, UK(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Support was provided by Wellcome Trust, UK: 083744; 058893/Z/99/A; 069683/Z/02/Z; 085477/Z/08/Z (www.wellcome.ac.uk). The funders has no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspray TJ, 2005, EPILEPSIA, V46, P15, DOI 10.1111/j.1528-1167.2005.00402.x; Barendregt Jan J, 2003, Popul Health Metr, V1, P4, DOI 10.1186/1478-7954-1-4; Belhocine M, 2004, EPILEPSY WHO AFRICAN; Chandramohan D, 1998, TROP MED INT HEALTH, V3, P436, DOI 10.1046/j.1365-3156.1998.00255.x; COCKERELL OC, 1994, LANCET, V344, P918, DOI 10.1016/S0140-6736(94)92270-5; Connor MD, 2007, LANCET NEUROL, V6, P269, DOI 10.1016/S1474-4422(07)70002-9; Debouverie M, 1993, NEUROLOGIE TROPICALE, P57; Ding D, 2006, LANCET NEUROL, V5, P823, DOI 10.1016/S1474-4422(06)70528-2; Diop AG, 2005, EPILEPSIA, V46, P33, DOI 10.1111/j.1528-1167.2005.00405.x; Forsgren L, 2005, EPILEPSIA, V46, P18, DOI 10.1111/j.1528-1167.2005.00403.x; Gomez-Olive FX, 2013, GLOBAL HEALTH ACTION, V6, P181, DOI 10.3402/gha.v6i0.19305; GRUNITZKY KE, 1991, EPILEPSIES, V3, P295; Houinato D, 2013, EPILEPSIA, V54, P757, DOI 10.1111/epi.12082; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kahn K, 2012, INT J EPIDEMIOL, V41, P988, DOI 10.1093/ije/dys115; Kahn K, 2011, J PUBLIC HEALTH POL, V32, pS30, DOI 10.1057/jphp.2011.27; Kaiser C, 2007, T ROY SOC TROP MED H, V101, P48, DOI 10.1016/j.trstmh.2006.06.003; Kaiser C, 1998, EPILEPSY RES, V30, P247, DOI 10.1016/S0920-1211(98)00007-2; Kotsopoulos I, 2005, SEIZURE-EUR J EPILEP, V14, P175, DOI 10.1016/j.seizure.2005.01.005; Kotsopoulos IAW, 2002, EPILEPSIA, V43, P1402, DOI 10.1046/j.1528-1157.2002.t01-1-26901.x; Kwan P, 2004, J NEUROL NEUROSUR PS, V75, P1376, DOI 10.1136/jnnp.2004.045690; Mu J, 2011, NEUROLOGY, V77, P132, DOI 10.1212/WNL.0b013e318223c784; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Newton CR, 2012, LANCET, V380, P1193, DOI 10.1016/S0140-6736(12)61381-6; Ngugi AK, 2011, NEUROLOGY, V77, P1005, DOI 10.1212/WNL.0b013e31822cfc90; Ngugi AK, 2013, LANCET NEUROL, V4422, P1; Ngugi AK, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-8; Ngugi AK, 2014, NEUROLOGY, V82, P582, DOI 10.1212/WNL.0000000000000123; Ngugi AK, 2013, EPILEPSIA, V54, P1352, DOI 10.1111/epi.12236; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Office for National Statistics UK, 2013, REV EUR STAND POP 20; Rwiza H, 2005, EPILEPSIA, V33, P1051; TekleHaimanot R, 1997, EPILEPSIA, V38, P541, DOI 10.1111/j.1528-1157.1997.tb01138.x; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Wagner RG, 2009, PARASITE IMMUNOL, V31, P697, DOI 10.1111/j.1365-3024.2009.01128.x; Wagner RG, 2014, EPILEPSY RES, V108, P782, DOI 10.1016/j.eplepsyres.2014.01.004; Winkler AS, 2009, EPILEPSIA, V50, P2310, DOI 10.1111/j.1528-1167.2009.02184.x	37	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129097	10.1371/journal.pone.0129097	http://dx.doi.org/10.1371/journal.pone.0129097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053071	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000355955300086
J	Zhou, FQ; Wu, L; Liu, XJ; Gong, HH; Luk, KDK; Hu, Y				Zhou, Fuqing; Wu, Lin; Liu, Xiaojia; Gong, Honghan; Luk, Keith Dip-Kei; Hu, Yong			Characterizing Thalamocortical Disturbances in Cervical Spondylotic Myelopathy: Revealed by Functional Connectivity under Two Slow Frequency Bands	PLOS ONE			English	Article							SPINAL-CORD-INJURY; CORTICAL REORGANIZATION; HUMAN THALAMUS; CORTEX; BRAIN; DECOMPRESSION; NETWORKS; DISEASE; RATS; FMRI	Background and Purpose Recent advanced MRI studies on cervical spondylotic myelopathy (CSM) revealed alterations of sensorimotor cortex, but the disturbances of large-scale thalamocortical systems remains elusive. The purpose of this study was to characterizing the CSM-related thalamocortical disturbances, which were associated with spinal cord structural injury, and clinical measures. Methods A total of 17 patients with degenerative CSM and well-matched control subjects participated. Thalamocortical disturbances were quantified using thalamus seed-based functional connectivity in two distinct low frequencies bands (slow-5 and slow-4), with different neural manifestations. The clinical measures were evaluated by Japanese Orthopaedic Association (JOA) score system and Neck Disability Index (NDI) questionnaires. Results Decreased functional connectivity was found in the thalamo-motor, -somatosensory, and -temporal circuits in the slow-5 band, indicating impairment of thalamo-cortical circuit degeneration or axon/synaptic impairment. By contrast, increased functional connectivity between thalami and the bilateral primary motor (M1), primary and secondary somatosensory (S1/S2), premotor cortex (PMC), and right temporal cortex was detected in the slow-4 band, and were associated with higher fractional anisotropy values in the cervical cord, corresponding to mild spinal cord structural injury. Conclusions These thalamocortical disturbances revealed by two slow frequency bands inform basic understanding and vital clues about the sensorimotor dysfunction in CSM. Further work is needed to evaluate its contribution in central functional reorganization during spinal cord degeneration.	[Zhou, Fuqing; Wu, Lin; Gong, Honghan] NanChang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang, Jiangxi, Peoples R China; [Zhou, Fuqing; Liu, Xiaojia; Luk, Keith Dip-Kei; Hu, Yong] Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China	Nanchang University; University of Hong Kong	Hu, Y (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Orthopaed & Traumatol, Pokfulam, Hong Kong, Peoples R China.	yhud@hku.hk	Hu, Yong/C-4276-2009	Hu, Yong/0000-0003-0305-5616				Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Dietz V, 2014, BRAIN, V137, P654, DOI 10.1093/brain/awt262; Dong Y, 2008, J NEUROSURG-SPINE, V9, P538, DOI 10.3171/SPI.2008.10.0831; Douaud G, 2011, BRAIN, V134, P3467, DOI 10.1093/brain/awr279; Duggal N, 2010, NEUROLOGY, V74, P1048, DOI 10.1212/WNL.0b013e3181d6b0ea; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Holly LT, 2007, J NEUROSURG-SPINE, V6, P544, DOI 10.3171/spi.2007.6.6.5; Johansen-Berg H, 2005, CEREB CORTEX, V15, P31, DOI 10.1093/cercor/bhh105; Kowalczyk I, 2012, BRAIN, V135, P461, DOI 10.1093/brain/awr328; Matz PG, 2009, J NEUROSURG-SPINE, V11, P104, DOI 10.3171/2009.1.SPINE08716; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Morel A, 1997, J COMP NEUROL, V387, P588, DOI 10.1002/(SICI)1096-9861(19971103)387:4<588::AID-CNE8>3.0.CO;2-Z; Salvi Frank J, 2006, Spine J, V6, p182S, DOI 10.1016/j.spinee.2006.05.006; Seminowicz DA, 2012, J NEUROSCI, V32, P15843, DOI 10.1523/JNEUROSCI.2927-12.2012; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Song XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086818; Sydekum E, 2009, NEUROIMAGE, V44, P1345, DOI 10.1016/j.neuroimage.2008.10.015; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tam S, 2010, NEUROSURGERY, V67, pE863, DOI 10.1227/01.NEU.0000374848.86299.17; Wager TD, 2005, NEUROIMAGE, V26, P99, DOI 10.1016/j.neuroimage.2005.01.011; Wee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037828; Wen CY, 2014, RADIOLOGY, V270, P197, DOI 10.1148/radiol.13121885; Wu CWW, 2008, NEUROIMAGE, V42, P1047, DOI 10.1016/j.neuroimage.2008.05.035; Xue SW, 2014, BRAIN CONNECT, V4, P242, DOI 10.1089/brain.2013.0182; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Yu RJ, 2014, HUM BRAIN MAPP, V35, P627, DOI 10.1002/hbm.22203; Zhang DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054512; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou FQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104442; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0125913	10.1371/journal.pone.0125913	http://dx.doi.org/10.1371/journal.pone.0125913			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053316	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300010
J	de Beco, S; Perney, JB; Coscoy, S; Amblard, F				de Beco, Simon; Perney, Jean-Baptiste; Coscoy, Sylvie; Amblard, Francois			Mechanosensitive Adaptation of E-Cadherin Turnover across adherens Junctions	PLOS ONE			English	Article							COLLECTIVE CELL-MIGRATION; ALPHA-CATENIN; ACTIN CYTOSKELETON; 2-PHOTON FRAP; F-ACTIN; VINCULIN; TENSION; ADHESION; BINDING; MECHANOTRANSDUCTION	In the natural and technological world, multi-agent systems strongly depend on how the interactions are ruled between their individual components, and the proper control of timescales and synchronization is a key issue. This certainly applies to living tissues when multicellular assemblies such as epithelial cells achieve complex morphogenetic processes. In epithelia, because cells are known to individually generate actomyosin contractile stress, each individual intercellular adhesive junction line is subjected to the opposed stresses independently generated by its two partner cells. Contact lines should thus move unless their two partner cells mechanically match. The geometric homeostasis of mature epithelia observed at short enough time-scale thus raises the problem to understand how cells, if considered as noisy individual actuators, do adapt across individual intercellular contacts to locally balance their time-average contractile stress. Structural components of adherens junctions, cytoskeleton (F-actin) and homophilic bonds (E-cadherin) are quickly renewed at steady-state. These turnovers, if they depend on forces exerted at contacts, may play a key role in the mechanical adaptation of epithelia. Here we focus on E-cadherin as a force transducer, and we study the local regulation and the mechanosensitivity of its turnover in junctions. We show that E-cadherin turnover rates match remarkably well on either side of mature intercellular contacts, despite the fact that they exhibit large fluctuations in time and variations from one junction to another. Using local mechanical and biochemical perturbations, we find faster turnover rates with increased tension, and asymmetric rates at unbalanced junctions. Together, the observations that E-cadherin turnover, and its local symmetry or asymmetry at each side of the junction, are mechanosensitive, support the hypothesis that E-cadherin turnover could be involved in mechanical homeostasis of epithelia.	[de Beco, Simon; Perney, Jean-Baptiste; Coscoy, Sylvie; Amblard, Francois] Inst Curie, Ctr Rech, Lab Physicochim, Paris, France; [de Beco, Simon; Perney, Jean-Baptiste; Coscoy, Sylvie; Amblard, Francois] CNRS, Unite Mixte Rech 168, Paris, France; [de Beco, Simon; Perney, Jean-Baptiste; Coscoy, Sylvie; Amblard, Francois] Univ Paris 06, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Amblard, F (corresponding author), Inst Curie, Ctr Rech, Lab Physicochim, Paris, France.	francois.amblard@curie.fr		de Beco, Simon/0000-0003-1730-3000; Coscoy, Sylvie/0000-0003-3963-3609	CNRS (Centre National de la Recherche Scientifique); Institut Curie; ANR (Agence Nationale de la Recherche) [ANR-08-pcvi-0012-02]; FRM (Fondation pour la Recherche Medicale) [FDT20090916704]; MENRT; CelTisPhyBio Labex [ANR-10-LBX-0038]	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); FRM (Fondation pour la Recherche Medicale)(Fondation pour la Recherche Medicale); MENRT; CelTisPhyBio Labex	This work was supported by CNRS (Centre National de la Recherche Scientifique) http://www.cnrs.fr/; (Institut Curie) http://www.curie.fr/; ANR (Agence Nationale de la Recherche) http://www.agence-nationale-recherche.fr/: Grant 3Dphotopol ANR-08-pcvi-0012-02; Grants for Simon de Beco: FRM (Fondation pour la Recherche Medicale) http://www.frm.org/, FDT20090916704, and MENRT http://www.education.gouv.fr/; CelTisPhyBio Labex (No ANR-10-LBX-0038).	Benazeraf B, 2013, ANNU REV CELL DEV BI, V29, P1, DOI 10.1146/annurev-cellbio-101011-155703; Quang BAT, 2013, CURR BIOL, V23, P2197, DOI 10.1016/j.cub.2013.09.015; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Cavey M, 2008, NATURE, V453, P751, DOI 10.1038/nature06953; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Coscoy S, 2002, P NATL ACAD SCI USA, V99, P12813, DOI 10.1073/pnas.192084599; de Beco S, 2012, INT REV CEL MOL BIO, V295, P63, DOI 10.1016/B978-0-12-394306-4.00008-3; de Beco S, 2009, P NATL ACAD SCI USA, V106, P7010, DOI 10.1073/pnas.0811253106; Dufour S, 2013, CELL ADHES MIGR, V7, P345, DOI 10.4161/cam.25139; Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Hong S, 2013, J CELL BIOL, V201, P131, DOI 10.1083/jcb.201211054; Hong S, 2010, P NATL ACAD SCI USA, V107, P3528, DOI 10.1073/pnas.0911027107; Iruela-Arispe ML, 2013, DEVELOPMENT, V140, P2851, DOI 10.1242/dev.070680; Kim TJ, 2015, CURR BIOL, V25, P218, DOI 10.1016/j.cub.2014.11.017; Kourakis MJ, 2014, DEV BIOL, V395, P120, DOI 10.1016/j.ydbio.2014.08.023; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Leckband DE, 2014, ANNU REV CELL DEV BI, V30, P291, DOI 10.1146/annurev-cellbio-100913-013212; Liu ZJ, 2010, P NATL ACAD SCI USA, V107, P9944, DOI 10.1073/pnas.0914547107; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Nanes BA, 2012, J CELL BIOL, V199, P365, DOI 10.1083/jcb.201205029; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Schwarz US, 2012, J CELL SCI, V125, P3051, DOI 10.1242/jcs.093716; Smutny M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022458; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; Twiss F, 2012, BIOL OPEN, V1, P1128, DOI 10.1242/bio.20122428; Waharte F, 2005, BIOPHYS J, V88, P1467, DOI 10.1529/biophysj.104.049619; Warner SJ, 2009, J CELL BIOL, V187, P119, DOI [10.1083/jcb.200906047, 10.1083/jcb.200901029]; Wu SK, 2013, CELL COMMUN ADHES, V20, P201, DOI 10.3109/15419061.2013.856889; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	33	19	19	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128281	10.1371/journal.pone.0128281	http://dx.doi.org/10.1371/journal.pone.0128281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046627	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200055
J	Esposito, S; Piralla, A; Zampiero, A; Bianchini, S; Di Pietro, G; Scala, A; Pinzani, R; Fossali, E; Baldanti, F; Principi, N				Esposito, Susanna; Piralla, Antonio; Zampiero, Alberto; Bianchini, Sonia; Di Pietro, Giada; Scala, Alessia; Pinzani, Raffaella; Fossali, Emilio; Baldanti, Fausto; Principi, Nicola			Characteristics and Their Clinical Relevance of Respiratory Syncytial Virus Types and Genotypes Circulating in Northern Italy in Five Consecutive Winter Seasons	PLOS ONE			English	Article							GLYCOPROTEIN G GENE; MOLECULAR EPIDEMIOLOGY; GROUP-A; PHYLOGENETIC ANALYSIS; RAPID SPREAD; ON1 GENOTYPE; B GENOTYPE; VARIABILITY; INFECTION; SEVERITY	In order to investigate the genetic diversity and patterns of the co-circulating genotypes of respiratory syncytial virus (RSV) and their possible relationships with the severity of RSV infection, we studied all of the RSV-positive nasopharyngeal samples collected from children during five consecutive winters (2009-2010, 2010-2011, 2011-2012, 2012-2013 and 2013-2014). The RSVs were detected using the respiratory virus panel fast assay and single-tube RT-PCR, their nucleotides were sequenced, and they were tested for positive selection. Of the 165 positive samples, 131 (79.4%) carried RSV-A and 34 (20.6%) RSV-B; both groups co-circulated in all of the study periods, with RSV-A predominating in all the seasons except for winter 2010-2011, which had a predominance of RSV-B. Phylogenetic analysis of the RSV-A sequences identified genotypes NA1 and ON1, the second replacing the first during the last two years of the study period. The RSV-B belonged to genotypes BA9 and BA10. BA9 was detected in all the years of the study whereas BA only desultorily. Comparison of the subjects infected by RSV-A and RSV-B types did not reveal any significant differences, but the children infected by genotype A/NA1 more frequently had lower respiratory tract infections (p<0.0001) and required hospitalisation (p = 0.007) more often than those infected by genotype A/ON1. These findings show that RSV has complex patterns of circulation characterised by the periodical replacement of the predominant genotypes, and indicate that the circulation and pathogenic role of the different RSV strains should be investigated as each may have a different impact on the host. A knowledge of the correlations between types, genotypes and disease severity may also be important in order to be able to include the more virulent strains in future vaccines.	[Esposito, Susanna; Zampiero, Alberto; Bianchini, Sonia; Di Pietro, Giada; Scala, Alessia; Pinzani, Raffaella; Principi, Nicola] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy; [Piralla, Antonio; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy; [Fossali, Emilio] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Emergency Unit, Milan, Italy; [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Microbiol Sect, I-27100 Pavia, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Fondazione San Matteo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pavia	Esposito, S (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy.	susanna.esposito@unimi.it	Fossali, Emilio/K-2200-2015; Esposito, Susanna/K-3475-2016; Baldanti, Fausto/J-4924-2018; Piralla, Antonio/K-4756-2018	Fossali, Emilio/0000-0002-3197-062X; Esposito, Susanna/0000-0003-4103-2837; Baldanti, Fausto/0000-0002-3358-8969; Piralla, Antonio/0000-0002-6062-2579	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The study was supported by a grant of the Italian Ministry of Health (Bando Giovani Ricercatori 2009).	Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Arnott A, 2011, J CLIN MICROBIOL, V49, P3504, DOI 10.1128/JCM.01131-11; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Balmaks R, 2014, J MED VIROL, V86, P1971, DOI 10.1002/jmv.23855; Blanc A, 2005, ARCH VIROL, V150, P603, DOI 10.1007/s00705-004-0412-x; Borchers AT, 2013, CLIN REV ALLERG IMMU, V45, P331, DOI 10.1007/s12016-013-8368-9; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; Choi EH, 2013, CURR TOP MICROBIOL, V372, P121, DOI 10.1007/978-3-642-38919-1_6; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Cui GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075020; Dapat IC, 2010, J CLIN MICROBIOL, V48, P3423, DOI 10.1128/JCM.00646-10; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Esposito S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-271; Fodha I, 2007, J MED VIROL, V79, P1951, DOI 10.1002/jmv.21026; Gilca R, 2006, J INFECT DIS, V193, P54, DOI 10.1086/498526; Hall CB, 2013, CURR TOP MICROBIOL, V372, P39, DOI 10.1007/978-3-642-38919-1_2; Hirano E, 2014, INFECT GENET EVOL, V28, P183, DOI 10.1016/j.meegid.2014.09.030; Hornsleth A, 1998, PEDIATR INFECT DIS J, V17, P1114, DOI 10.1097/00006454-199812000-00003; Imaz MS, 2000, J MED VIROL, V61, P76, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;76::AID-JMV12&gt;3.0.CO;2-P; Kaplan NM, 2008, J MED VIROL, V80, P168, DOI 10.1002/jmv.21067; Katzov-Eckert H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041953; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; MCCONNOCHIE KM, 1990, J PEDIATR-US, V117, P52, DOI 10.1016/S0022-3476(05)82443-6; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Paulus SC, 2007, CLIN IMMUNOL, V123, P252, DOI 10.1016/j.clim.2007.03.003; Peret TCT, 1998, J GEN VIROL, V79, P2221, DOI 10.1099/0022-1317-79-9-2221; Peret TCT, 2000, J INFECT DIS, V181, P1891, DOI 10.1086/315508; Pierangeli A, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.26.20843; Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105; Prifert C, 2013, EMERG INFECT DIS, V19, P1029, DOI 10.3201/eid1906.121582; Rebuffo-Scheer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025468; Ren L, 2014, INFECT GENET EVOL, V27, P339, DOI 10.1016/j.meegid.2014.07.030; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Shobugawa Y, 2009, J CLIN MICROBIOL, V47, P2475, DOI 10.1128/JCM.00115-09; SULLENDER WM, 1993, J CLIN MICROBIOL, V31, P1224, DOI 10.1128/JCM.31.5.1224-1231.1993; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tapia LI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090786; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; van Elden LJR, 2003, J CLIN MICROBIOL, V41, P4378, DOI 10.1128/JCM.41.9.4378-4381.2003; Venter M, 2001, J GEN VIROL, V82, P2117, DOI 10.1099/0022-1317-82-9-2117; Walsh EE, 1997, J INFECT DIS, V175, P814, DOI 10.1086/513976; Wu WN, 2012, MICROB PATHOGENESIS, V52, P184, DOI 10.1016/j.micpath.2011.12.006	48	78	81	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129369	10.1371/journal.pone.0129369	http://dx.doi.org/10.1371/journal.pone.0129369			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047100	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200159
J	Niu, G; Zhang, H; Liu, D; Chen, L; Belani, C; Wang, HG; Cheng, H				Niu, Ge; Zhang, Huan; Liu, Dan; Chen, Li; Belani, Chandra; Wang, Hong-Gang; Cheng, Hua			Tid1, the Mammalian Homologue of Drosophila Tumor Suppressor Tid56, Mediates Macroautophagy by Interacting with Beclin1-containing Autophagy Protein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DNAJ PROTEIN; NF-KAPPA-B; T-LYMPHOCYTES; CELL-SURVIVAL; HTID-1; CANCER; APOPTOSIS; DESTABILIZATION; OVEREXPRESSION; CONTRIBUTES	One of the fundamental functions of molecular chaperone proteins is to selectively conjugate cellular proteins, targeting them directly to lysosome. Some of chaperones, such as the stress-induced Hsp70, also play important roles in autophagosome-forming macroautophagy under various stress conditions. However, the role of their co-chaperones in autophagy regulation has not been well defined. We here show that Tid1, a DnaJ co-chaperone for Hsp70 and the mammalian homologue of the Drosophila tumor suppressor Tid56, is a key mediator of macroautophagy pathway. Ectopic expression of Tid1 induces autophagy by forming LC3+ autophagosome foci, whereas silencing Tid1 leads to drastic impairment of autophagy as induced by nutrient deprivation or rapamycin. In contrast, Hsp70 is dispensable for a role in nutrient deprivation-induced autophagy. The murine Tid1 can be replaced with human Tid1 in murine fibroblast cells for induction of autophagy. We further show that Tid1 increases autophagy flux by interacting with the Beclin1-PI3 kinase class III protein complex in response to autophagy inducing signal and that Tid1 is an essential mediator that connects I kappa B kinases to the Beclin1-containing autophagy protein complex. Together, these results reveal a crucial role of Tid1 as an evolutionarily conserved and essential mediator of canonical macroautophagy.	[Niu, Ge; Zhang, Huan; Liu, Dan; Chen, Li; Cheng, Hua] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Cheng, Hua] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Cheng, Hua] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Cheng, Hua] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Belani, Chandra; Wang, Hong-Gang] Penn State Univ, Coll Med, Penn State Hershey Canc Inst, Hershey, PA 17033 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Cheng, H (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	hcheng@ihv.umaryland.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R01AI090113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090113] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI090113 (to H. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn BY, 2010, ONCOGENE, V29, P1155, DOI 10.1038/onc.2009.413; Bae MK, 2005, CANCER RES, V65, P2520, DOI 10.1158/0008-5472.CAN-03-2735; Chen CY, 2013, CANCER RES, V73, P4009, DOI 10.1158/0008-5472.CAN-12-4066; Chen CY, 2009, J PATHOL, V219, P347, DOI 10.1002/path.2604; Cheng H, 2005, MOL CELL BIOL, V25, P44, DOI 10.1128/MCB.25.1.44-59.2005; Cheng H, 2002, J BIOL CHEM, V277, P20605, DOI 10.1074/jbc.M201204200; Cheng H, 2001, CURR BIOL, V11, P1771, DOI 10.1016/S0960-9822(01)00540-1; Copeland E, 2011, ONCOGENE, V30, P2252, DOI 10.1038/onc.2010.601; Criollo A, 2010, EMBO J, V29, P619, DOI 10.1038/emboj.2009.364; Cui JZ, 2013, BBA-REV CANCER, V1836, P15, DOI 10.1016/j.bbcan.2013.02.003; Dhennin-Duthille I, 2011, J BIOL CHEM, V286, P5034, DOI 10.1074/jbc.M110.155903; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Iosefson O, 2012, CELL STRESS CHAPERON, V17, P57, DOI 10.1007/s12192-011-0285-3; Janku F, 2011, NAT REV CLIN ONCOL, V8, P528, DOI 10.1038/nrclinonc.2011.71; Kim SW, 2005, CANCER RES, V65, P8784, DOI 10.1158/0008-5472.CAN-04-4422; Kim SW, 2004, CANCER RES, V64, P7732, DOI 10.1158/0008-5472.CAN-04-1323; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Kurzik-Dumke U, 2008, INT J MOL MED, V21, P19; KURZIKDUMKE U, 1995, DEV GENET, V16, P64, DOI 10.1002/dvg.1020160110; Linnoila J, 2008, NEURON, V60, P625, DOI 10.1016/j.neuron.2008.09.025; Liu HY, 2005, J BIOL CHEM, V280, P19461, DOI 10.1074/jbc.M500313200; Lo JF, 2004, MOL CELL BIOL, V24, P2226, DOI 10.1128/MCB.24.6.2226-2236.2004; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Ng ACH, 2014, MOL CELL BIOL, V34, P1427, DOI 10.1128/MCB.01021-13; Qian J, 2010, GASTROENTEROLOGY, V138, P1418, DOI 10.1053/j.gastro.2009.10.044; Ren T., 2015, ONCOGENE, P334; Ren T, 2012, J BIOL CHEM, V287, P34683, DOI 10.1074/jbc.M112.377143; Sarkar S, 2001, J BIOL CHEM, V276, P49034, DOI 10.1074/jbc.M103683200; Schilling B, 1998, VIROLOGY, V247, P74, DOI 10.1006/viro.1998.9220; Shin JY, 2013, LUNG CANCER, V81, P362, DOI 10.1016/j.lungcan.2013.05.009; Sohn SY, 2006, J GEN VIROL, V87, P1883, DOI 10.1099/vir.0.81684-0; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tarunina M, 2004, MOL CELL BIOL, V24, P10792, DOI 10.1128/MCB.24.24.10792-10801.2004; Trentin GA, 2001, J BIOL CHEM, V276, P13087, DOI 10.1074/jbc.M009267200; Wang L, 2006, ONCOGENE, V25, P4320, DOI 10.1038/sj.onc.1209458; Wei YJ, 2013, CELL, V154, P1269, DOI 10.1016/j.cell.2013.08.015; Yan G, 2008, J BIOL CHEM, V283, P12489, DOI 10.1074/jbc.M707988200; Yang YH, 2013, P NATL ACAD SCI USA, V110, P6841, DOI 10.1073/pnas.1217692110	42	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18102	18110		10.1074/jbc.M115.665950	http://dx.doi.org/10.1074/jbc.M115.665950			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26055714	hybrid, Green Published			2022-12-26	WOS:000358511700041
J	Bhattacharjee, S; Kumar, V; Chandrasekhar, M; Malviya, M; Ganswindt, A; Ramesh, K; Sankar, K; Umapathy, G				Bhattacharjee, Subhadeep; Kumar, Vinod; Chandrasekhar, Mithileshwari; Malviya, Manjari; Ganswindt, Andre; Ramesh, Krishnamurthy; Sankar, Kalyanasundaram; Umapathy, Govindhaswamy			Glucocorticoid Stress Responses of Reintroduced Tigers in Relation to Anthropogenic Disturbance in Sariska Tiger Reserve in India	PLOS ONE			English	Article							HORMONE; REPRODUCTION; CONSERVATION; ENDOCRINE; SEX; SUPPRESSION; METABOLISM; CARNIVORES; EXCRETION; SCIENCE	Tiger (Panthera tigris), an endangered species, is under severe threat from poaching, habitat loss, prey depletion and habitat disturbance. Such factors have been reported causing local extermination of tiger populations including in one of the most important reserves in India, namely Sariska Tiger Reserve (STR) in northwestern India. Consequently, tigers were reintroduced in STR between 2008 and 2010, but inadequate breeding success was observed over the years, thus invoking an investigation to ascertain physiological correlates. In the present study, we report glucocorticoid stress responses of the reintroduced tigers in relation to anthropogenic disturbance in the STR from 2011 to 2013. We found anthropogenic disturbance such as encounter rates of livestock and humans, distance to roads and efforts to kill domestic livestock associated with an elevation in fecal glucocorticoid metabolite (fGCM) concentrations in the monitored tigers. In this regard, female tigers seem more sensitive to such disturbance than males. It was possible to discern that tiger's fGCM levels were significantly positively related to the time spent in disturbed areas. Resulting management recommendations include relocation of villages from core areas and restriction of all anthropogenic activities in the entire STR.	[Bhattacharjee, Subhadeep; Malviya, Manjari; Ramesh, Krishnamurthy; Sankar, Kalyanasundaram] Wildlife Inst India, Dehra Dun, Uttarakhand, India; [Kumar, Vinod; Chandrasekhar, Mithileshwari; Umapathy, Govindhaswamy] CSIR, CCMB, Lab Conservat Endangered Species LaCONES, Hyderabad, Andhra Pradesh, India; [Ganswindt, Andre] Univ Pretoria, Dept Anat & Physiol, Endocrine Res Lab, ZA-0110 Onderstepoort, South Africa	Wildlife Institute of India; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); University of Pretoria	Umapathy, G (corresponding author), CSIR, CCMB, Lab Conservat Endangered Species LaCONES, Hyderabad, Andhra Pradesh, India.	guma@ccmb.res.in	Ganswindt, Andre/G-9856-2014	Ganswindt, Andre/0000-0002-1474-7602; Umapathy, Govindhaswamy/0000-0003-4086-7445; Kumar, Vinod/0000-0002-1409-770X; Bhattacharjee, Subhadeep/0000-0002-5110-151X; Malviya, Manjari/0000-0001-5076-2482	National Tiger Conservation Authority of India (NTCA); Central Zoo Authority of India, Ministry of Environment and Forests, Government of India; Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology	National Tiger Conservation Authority of India (NTCA); Central Zoo Authority of India, Ministry of Environment and Forests, Government of India; Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology	National Tiger Conservation Authority of India (NTCA) and Central Zoo Authority of India, Ministry of Environment and Forests, Government of India and Council of Scientific and Industrial Research (CSIR), Ministry of Science and Technology are acknowledged for providing financial support for the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bixby K, 1992, BALANCING BRINK EXTI, P199; BREITENMOSER U, 1990, NATURE ENV SERIES, V45; Brown JL, 2010, ZOO BIOL, V29, P274, DOI 10.1002/zoo.20268; BROWN JL, 1994, BIOL REPROD, V51, P776, DOI 10.1095/biolreprod51.4.776; Champion S.H., 1968, REVISED SURVEY FORES; Charbonnel N, 2008, PHYSIOL BIOCHEM ZOOL, V81, P63, DOI 10.1086/523306; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot021; Devineau O, 2010, J APPL ECOL, V47, P524, DOI 10.1111/j.1365-2664.2010.01805.x; Dinerstein E, 2006, SETTING PRIORITIES C; Dobson A, 2000, SCIENCE, V288, P985, DOI 10.1126/science.288.5468.985; Earnhardt JM, 1999, ANIM CONSERV, V2, P279, DOI 10.1111/j.1469-1795.1999.tb00074.x; French SS, 2010, HORM BEHAV, V58, P792, DOI 10.1016/j.yhbeh.2010.08.001; Fritts SH, 1997, RESTOR ECOL, V5, P7, DOI 10.1046/j.1526-100X.1997.09702.x; Ganswindt A, 2012, BIOL LETTERS, V8, P695, DOI 10.1098/rsbl.2011.1181; GRIFFITH B, 1989, SCIENCE, V245, P477, DOI 10.1126/science.245.4917.477; Hayward MW, 2007, ORYX, V41, P205, DOI 10.1017/S0030605307001767; Hunt KE, 2003, PHYSIOL BIOCHEM ZOOL, V76, P918, DOI 10.1086/380209; Janin A, 2011, BIOL CONSERV, V144, P1008, DOI 10.1016/j.biocon.2010.12.009; Jhala Y.V., 2011, STATUS TIGERS COPRED, P302; Knapp CR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot032; Kumar V, 2014, GEN COMP ENDOCR, V201, P37, DOI 10.1016/j.ygcen.2014.03.024; Mondol S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000585; Morell V, 2007, SCIENCE, V317, P1312, DOI 10.1126/science.317.5843.1312; Narayan EJ, 2013, GEN COMP ENDOCR, V194, P318, DOI 10.1016/j.ygcen.2013.10.002; Noss RF, 1996, CONSERV BIOL, V10, P949, DOI 10.1046/j.1523-1739.1996.10040949.x; Ramesh K, 2013, TIGER REINTRODUCTION; Rodgers W.A., 1988, PLANNING WILDLIFE PR; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Sankar K, 2010, TROP CONSERV SCI, V3, P301, DOI 10.1177/194008291000300305; Sankar K, 2013, 1 WILDL I IND, P141; Sankar K, 2005, ASSESSMENT STA UNPUB; Sankar K, 2008, ECOLOGICAL STUDIES S, P145; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; Sheriff MJ, 2011, OECOLOGIA, V166, P593, DOI 10.1007/s00442-011-1907-2; Strasser EH, 2013, J APPL ECOL, V50, P912, DOI 10.1111/1365-2664.12103; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Tilbrook AJ, 1999, J ENDOCRINOL, V160, P469, DOI 10.1677/joe.0.1600469; Tilbrook AJ, 2000, REV REPROD, V5, P105, DOI 10.1530/ror.0.0050105; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; Treves A, 2003, CONSERV BIOL, V17, P1491, DOI 10.1111/j.1523-1739.2003.00059.x; Umapathy G, 2013, GEN COMP ENDOCR, V180, P33, DOI 10.1016/j.ygcen.2012.10.009; Van Meter PE, 2009, HORM BEHAV, V55, P329, DOI 10.1016/j.yhbeh.2008.11.001; Walston J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000485; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; White G. C., 1990, ANAL WILDLIFE RADIO, P383, DOI 10.1016/B978-0-08-092657-5.50008-2; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Young AJ, 2006, P NATL ACAD SCI USA, V103, P12005, DOI 10.1073/pnas.0510038103; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016	51	37	38	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127626	10.1371/journal.pone.0127626	http://dx.doi.org/10.1371/journal.pone.0127626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061171	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500046
J	Jiang, XX; Chen, YP; Zhu, HT; Wang, B; Qu, P; Chen, RF; Sun, XQ				Jiang, Xiaoxiao; Chen, Yaping; Zhu, Haitao; Wang, Bo; Qu, Ping; Chen, Renfu; Sun, Xiaoqing			Sodium Tanshinone IIA Sulfonate Ameliorates Bladder Fibrosis in a Rat Model of Partial Bladder Outlet Obstruction by Inhibiting the TGF-beta/Smad Pathway Activation	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; FIBROBLASTS; EXPRESSION; MATRIX; MICE	Transforming growth factor (TGF)-beta 1 is known to play a pivotal role in a diverse range of biological systems including modulation of fibrosis in several organs. The precise role of TGF-beta/Smad signaling in the progression of bladder fibrosis secondary to partial bladder outlet obstruction (PBOO) is yet to be conclusively. Using a rat PBOO model, we investigated TGF-beta 1 expression and exaimined whether sodium tanshinone IIA sulfonate (STS) could inhibit TGF-beta/Smad signaling pathway activation and ameliorate bladder fibrosis. Forty-eight female Sprague-Dawley rats were randomly divided into three groups: sham operation group (n = 16), PBOO operation without STS treatment group (n = 16) and PBOO operation with STS treatment group (n = 16). Thirty-two rats underwent the operative procedure to create PBOO and subsequently received intraperitoneal injections of STS (10 mg/kg/d; n = 16) or vehicle (n = 16) two days after the surgery. Sham surgery was conducted on 16 rats, which received intraperitoneal vehicle injection two days later. In each of the three groups, an equal number of rats were sacrificed at weeks 4 and 8 after the PBOO or sham operation. The TGF-beta/Smad signaling pathway was analyzed using western blotting, immunohistochemical staining and reverse transcriptase polymerase chain reaction (RT-PCR). One-way analysis of variance was conducted to draw statistical inferences. At 4 and 8 weeks, the expression of TGF-beta 1 and phosphorylated Smad2 and Smad3 in STS-treated PBOO rats was significantly lower than in the PBOO rats not treated with STS. Alpha smooth muscle actin (alpha-SMA), collagen I and collagen III expression at 4 and 8 weeks post PBOO was lower in STS-treated PBOO rats when compared to that in PBOO rats not treated with STS. Our findings indicate that STS ameliorates bladder fibrosis by inhibiting TGF-beta/Smad signaling pathway activation, and may prove to be a potential therapeutic measure for preventing bladder fibrosis secondary to PBOO operation.	[Jiang, Xiaoxiao; Chen, Yaping; Zhu, Haitao; Wang, Bo; Sun, Xiaoqing] Xuzhou Med Coll, Xuzhou, Jiangsu, Peoples R China; [Zhu, Haitao; Chen, Renfu; Sun, Xiaoqing] Affiliated Hosp, Xuzhou Med Coll, Dept Urol Surg, Xuzhou, Jiangsu, Peoples R China; [Sun, Xiaoqing] Xuzhou Med Affiliated Hosp, Dept Urol Lab, Xuzhou, Jiangsu, Peoples R China; [Jiang, Xiaoxiao; Qu, Ping] Yancheng City 1 Peoples Hosp, Dept Urol Surg, Yancheng, Jiangsu, Peoples R China; [Chen, Yaping] Yancheng City 1 Peoples Hosp, Dept Oncol, Yancheng, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Zhu, HT (corresponding author), Xuzhou Med Coll, Xuzhou, Jiangsu, Peoples R China.	401774138@qq.com; sunheyao@163.com	zhu, HAITAO/GVL-0589-2022		Xuzhou Municipal Science and Technology development grant [XF11C066]	Xuzhou Municipal Science and Technology development grant	This study was funded by Xuzhou Municipal Science and Technology development grant XF11C066.	Altuntas CZ, 2012, AM J PHYSIOL-RENAL, V303, pF1363, DOI 10.1152/ajprenal.00273.2012; Amaro Joao L., 2005, Int. braz j urol., V31, P579, DOI 10.1590/S1677-55382005000600012; Anumanthan G, 2009, J UROLOGY, V182, P1775, DOI 10.1016/j.juro.2009.05.126; Baskin LS, 1999, ADV EXP MED BIOL, V462, P49; Buttyan R, 1997, EUR UROL, V32, P32; Chen Z, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/267976; Prado PSD, 2012, INT J EXP PATHOL, V93, P218, DOI 10.1111/j.1365-2613.2012.00813.x; Dennler S, 2002, J LEUKOCYTE BIOL, V71, P731; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; FANG J, 2010, DISCOVER, V31, P18, DOI DOI 10.1016/J.PHYMED.2010.06.002; Gao S, 2012, ATHEROSCLEROSIS, V220, P3, DOI 10.1016/j.atherosclerosis.2011.06.041; Imamura M, 2007, AM J PHYSIOL-RENAL, V293, pF1007, DOI 10.1152/ajprenal.00107.2007; Isaka Y, 2000, KIDNEY INT, V58, P1885, DOI 10.1046/j.1523-1755.2000.00360.x; Islam SS, 2014, J CELL COMMUN SIGNAL, V8, P39, DOI 10.1007/s12079-013-0216-4; Jiang CM, 2011, RENAL FAILURE, V33, P355, DOI 10.3109/0886022X.2011.559681; Kikuno N, 2009, BJU INT, V103, P1424, DOI 10.1111/j.1464-410X.2008.08129.x; LANDAU EH, 1994, J UROLOGY, V152, P702, DOI 10.1016/S0022-5347(17)32685-X; LEVIN RM, 1990, PROSTATE, P9; Matsumoto S, 2009, BJU INT, V103, P1436, DOI 10.1111/j.1464-410X.2008.08261.x; Rubinstein Mauricio, 2007, Int. braz j urol., V33, P33, DOI 10.1590/S1677-55382007000100006; Schnaper HW, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341126; Serban AI, 2015, J DIABETES, V7, P114, DOI 10.1111/1753-0407.12154; SHAPIRO E, 1991, J UROLOGY, V145, P1024, DOI 10.1016/S0022-5347(17)38521-X; Shi BK, 2009, UROL INT, V82, P43, DOI 10.1159/000176024; Tang JH, 2008, J HUAZHONG U SCI-MED, V28, P539, DOI 10.1007/s11596-008-0511-0; Tu XL, 2014, J PATHOL, V234, P46, DOI 10.1002/path.4373; Xu Y, 2008, J CLIN IMMUNOL, V28, P512, DOI 10.1007/s10875-008-9206-3; Yang L, 2015, INT J MOL MED; Yang L, 2009, EXP MOL MED, V41, P508, DOI 10.3858/emm.2009.41.7.056; Yoshizawa H, 2015, GENE THER; Zhang DS, 2010, LAB INVEST, V90, P436, DOI 10.1038/labinvest.2009.149; Zhang Y, 2013, J ETHNOPHARMACOL, V148, P671, DOI 10.1016/j.jep.2013.05.028; Zhou DX, 2012, J HUAZHONG U SCI-MED, V32, P829, DOI 10.1007/s11596-012-1042-2	33	33	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129655	10.1371/journal.pone.0129655	http://dx.doi.org/10.1371/journal.pone.0129655			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061047	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500152
J	Cuesta-Vargas, A; Hilgenkamp, T				Cuesta-Vargas, Antonio; Hilgenkamp, Thessa			Reference Values of Grip Strength Measured with a Jamar Dynamometer in 1526 Adults with Intellectual Disabilities and Compared to Adults without Intellectual Disability	PLOS ONE			English	Article							ACTIVITY READINESS QUESTIONNAIRE; HAND-HELD DYNAMOMETRY; OLDER-ADULTS; PHYSICAL-FITNESS; MUSCLE STRENGTH; DECLINE; INDIVIDUALS; MARKER	Aim The aim of this study was to investigate grip strength in a large sample of people with intellectual disabilities, to establish reference values for adults with intellectual disabilities (ID) and compare it to adults without intellectual disability. Methods This study analysed pooled baseline data from two independent studies for all 1526 adults with ID: Special Olympics Funfitness Spain (n = 801) and the Dutch cross-sectional study 'Healthy aging and intellectual disabilities' (n = 725). Results The grip strength result of people with ID across gender and age subgroups is presented with CI95% values from higher 25.5-31.0 kg in male younger to lower 4.3-21.6 kg in female older. Conclusion This study is the first to present grip strength results of a large sample of people with ID from 20-90 years of age. This study provides reference values for people with ID for use in clinical practice.	[Cuesta-Vargas, Antonio] Univ Malaga, Dept Psiquiatria & Fisioterapia, Facultad Ciencias Salud, Andalucia Tech,Inst Biomed Malaga IBIMA,Grp Clini, E-29071 Malaga, Spain; [Cuesta-Vargas, Antonio] Queensland Univ Technol, Sch Clin Sci, Fac Hlth, Brisbane, Qld 4001, Australia; [Hilgenkamp, Thessa] Erasmus MC, Dept Gen Practice, Intellectual Disabil Med, Rotterdam, Netherlands; [Hilgenkamp, Thessa] Abrona, Zeist, Netherlands	Universidad de Malaga; Queensland University of Technology (QUT); Erasmus University Rotterdam; Erasmus MC	Cuesta-Vargas, A (corresponding author), Univ Malaga, Dept Psiquiatria & Fisioterapia, Facultad Ciencias Salud, Andalucia Tech,Inst Biomed Malaga IBIMA,Grp Clini, E-29071 Malaga, Spain.	acuesta.var@gmail.com		Cuesta-Vargas, Antonio I/0000-0002-8880-4315; Hilgenkamp, Thessa/0000-0001-9882-163X				Abizanda P, 2012, ARCH GERONTOL GERIAT, V54, P21, DOI 10.1016/j.archger.2011.02.006; Alfaro-Acha A, 2006, J GERONTOL A-BIOL, V61, P859, DOI 10.1093/gerona/61.8.859; Alvares-da-Silva MR, 2005, NUTRITION, V21, P113, DOI 10.1016/j.nut.2004.02.002; Bohannon Richard W, 2007, J Geriatr Phys Ther, V30, P28; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Bohannon RW, 2006, PHYSIOTHERAPY, V92, P11, DOI 10.1016/j.physio.2005.05.003; Bohannon RW, 2001, PERCEPT MOTOR SKILL, V93, P323, DOI 10.2466/PMS.93.5.323-328; Cardinal BJ, 1996, MED SCI SPORT EXER, V28, P468, DOI 10.1097/00005768-199604000-00011; Carmeli E, 2012, ARCH GERONTOL GERIAT, V55, P181, DOI 10.1016/j.archger.2011.06.032; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Cuesta-Vargas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096529; de Winter CF, 2012, RES DEV DISABIL, V33, P1722, DOI 10.1016/j.ridd.2012.04.010; Dwyer G., 2008, ACSMS HLTH RELATED P, VSecond; Evenhuis HM, 2012, J AM GERIATR SOC, V60, P934, DOI 10.1111/j.1532-5415.2012.03925.x; Hilgenkamp TIM, 2014, RES DEV DISABIL, V35, P439, DOI 10.1016/j.ridd.2013.11.015; Hilgenkamp TIM, 2012, J INTELLECT DEV DIS, V37, P158, DOI 10.3109/13668250.2012.681773; Hilgenkamp TIM, 2011, RES DEV DISABIL, V32, P1097, DOI 10.1016/j.ridd.2011.01.018; Lantman-De Valk HMJV, 2000, FAM PRACT, V17, P405, DOI 10.1093/fampra/17.5.405; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; Moran C FE, 1981, CLIN ASSESSMENT RECO; Norman K, 2005, CLIN NUTR, V24, P143, DOI 10.1016/j.clnu.2004.08.007; Norman K, 2011, CLIN NUTR, V30, P135, DOI 10.1016/j.clnu.2010.09.010; Oppewal A, 2014, RES DEV DISABIL, V35, P2299, DOI 10.1016/j.ridd.2014.05.027; Oppewal A, 2014, RES DEV DISABIL, V35, P1317, DOI 10.1016/j.ridd.2014.03.022; Oppewal A, 2013, RES DEV DISABIL, V34, P3301, DOI 10.1016/j.ridd.2013.07.005; Oppewal A, 2013, RES DEV DISABIL, V34, P1623, DOI 10.1016/j.ridd.2013.02.013; Rimmer JH, 2012, PM&R, V4, P857, DOI 10.1016/j.pmrj.2012.08.008; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Syddall H, 2003, AGE AGEING, V32, P650, DOI 10.1093/ageing/afg111; Temple VA, 2006, AM J HEALTH PROMOT, V21, P2, DOI 10.4278/0890-1171-21.1.2; THOMAS S, 1992, CAN J SPORT SCI, V17, P338	33	24	25	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129585	10.1371/journal.pone.0129585	http://dx.doi.org/10.1371/journal.pone.0129585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1GM	26053852	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300145
J	Groussman, RD; Parker, MS; Armbrust, EV				Groussman, Ryan D.; Parker, Micaela S.; Armbrust, E. Virginia			Diversity and Evolutionary History of Iron Metabolism Genes in Diatoms	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; SACCHAROMYCES-CEREVISIAE; ELECTRON-TRANSPORT; COPPER; SEQUENCE; GENOME; PLASTOCYANIN; PHOTOSYNTHESIS; ACQUISITION; FLAVODOXIN	Ferroproteins arose early in Earth's history, prior to the emergence of oxygenic photosynthesis and the subsequent reduction of bioavailable iron. Today, iron availability limits primary productivity in about 30% of the world's oceans. Diatoms, responsible for nearly half of oceanic primary production, have evolved molecular strategies for coping with variable iron concentrations. Our understanding of the evolutionary breadth of these strategies has been restricted by the limited number of species for which molecular sequence data is available. To uncover the diversity of strategies marine diatoms employ to meet cellular iron demands, we analyzed 367 newly released marine microbial eukaryotic transcriptomes, which include 47 diatom species. We focused on genes encoding proteins previously identified as having a role in iron management: iron uptake (high-affinity ferric reductase, multi-copper oxidase, and Fe(III) permease); iron storage (ferritin); iron-induced protein substitutions (flavodoxin/ferredoxin, and plastocyanin/cytochrome c6) and defense against reactive oxygen species (superoxide dismutases). Homologs encoding the high-affinity iron uptake system components were detected across the four diatom Classes suggesting an ancient origin for this pathway. Ferritin transcripts were also detected in all Classes, revealing a more widespread utilization of ferritin throughout diatoms than previously recognized. Flavodoxin and plastocyanin transcripts indicate possible alternative redox metal strategies. Predicted localization signals for ferredoxin identify multiple examples of gene transfer from the plastid to the nuclear genome. Transcripts encoding four superoxide dismutase metalloforms were detected, including a putative nickel-coordinating isozyme. Taken together, our results suggest that the majority of iron metabolism genes in diatoms appear to be vertically inherited with functional diversity achieved via possible neofunctionalization of paralogs. This refined view of iron use strategies in diatoms elucidates the history of these adaptations, and provides potential molecular markers for determining the iron nutritional status of different diatom species in environmental samples.	[Groussman, Ryan D.; Parker, Micaela S.; Armbrust, E. Virginia] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	armbrust@u.washington.edu		Parker, Micaela/0000-0003-1007-4612	Gordon and Betty Moore Foundation [2637, 537.01]; National Science Foundation [DUE-0969603]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF))	This research was funded in part by the Gordon and Betty Moore Foundation [http://www.moore.org/] through Grant #2637 to the National Center for Genome Resources and through Grant #537.01 to EVA. RDG received support through the National Science Foundation [http://www.nsf.gov/] grant #DUE-0969603. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS SC, 1992, J INORG BIOCHEM, V47, P161, DOI 10.1016/0162-0134(92)84062-R; Armbrust EV, 2009, NATURE, V459, P185, DOI 10.1038/nature08057; BAKER RT, 1992, J BIOL CHEM, V267, P23364; Barondeau DP, 2004, BIOCHEMISTRY-US, V43, P8038, DOI 10.1021/bi0496081; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Berger SA, 2011, BIOINFORMATICS, V27, P2068, DOI 10.1093/bioinformatics/btr320; Bes MT, 1999, STRUCT FOLD DES, V7, P1201, DOI 10.1016/S0969-2126(00)80054-4; Blaby-Haas CE, 2012, BBA-MOL CELL RES, V1823, P1531, DOI 10.1016/j.bbamcr.2012.04.010; Bottger LH, 2012, J EXP BOT, V63, P5763, DOI 10.1093/jxb/ers225; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; DJINOVIC K, 1992, J MOL BIOL, V226, P227, DOI 10.1016/0022-2836(92)90135-7; Dupont CL, 2008, ENVIRON MICROBIOL, V10, P1831, DOI 10.1111/j.1462-2920.2008.01604.x; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Figueroa RI, 2009, PROTIST, V160, P285, DOI 10.1016/j.protis.2008.12.003; Fink RC, 2002, ARCH BIOCHEM BIOPHYS, V399, P19, DOI 10.1006/abbi.2001.2739; Fridovich I, 1998, J EXP BIOL, V201, P1203; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Gueneau P, 1998, EUR J PHYCOL, V33, P203, DOI 10.1080/09670269810001736703; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Imanian B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010711; Jin WL, 2001, BIOCHEMISTRY-US, V40, P7525, DOI 10.1021/bi002509c; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Keeling PJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001889; KITAGAWA Y, 1991, J BIOCHEM-TOKYO, V109, P477, DOI 10.1093/oxfordjournals.jbchem.a123407; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; LaRoche J, 1996, NATURE, V382, P802; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Lommer M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-718; Maldonado MT, 2006, LIMNOL OCEANOGR, V51, P1729, DOI 10.4319/lo.2006.51.4.1729; Maldonado MT, 2001, J PHYCOL, V37, P298, DOI 10.1046/j.1529-8817.2001.037002298.x; Marchetti A, 2012, P NATL ACAD SCI USA, V109, pE317, DOI 10.1073/pnas.1118408109; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; Morrissey J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00043; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nuester J, 2012, J PHYCOL, V48, P626, DOI 10.1111/j.1529-8817.2012.01165.x; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Pankowski A, 2009, AQUAT BIOL, V4, P273, DOI 10.3354/ab00116; Peers G, 2006, NATURE, V441, P341, DOI 10.1038/nature04630; PENFIELD KW, 1981, J AM CHEM SOC, V103, P4382, DOI 10.1021/ja00405a016; Pfaffen S, 2013, J BIOL CHEM, V288, P14917, DOI 10.1074/jbc.M113.454496; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; RAVEN JA, 1988, NEW PHYTOL, V109, P279, DOI 10.1111/j.1469-8137.1988.tb04196.x; Raven JA, 2013, J EXP BOT, V64, P2119, DOI 10.1093/jxb/ert121; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saito MA, 2003, INORG CHIM ACTA, V356, P308, DOI 10.1016/S0020-1693(03)00442-0; Schmidt A, 2009, J BASIC MICROB, V49, P109, DOI 10.1002/jobm.200800293; Severance S, 2004, BIOCHEM J, V380, P487, DOI 10.1042/BJ20031921; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; Shearer J, 2006, INORG CHEM, V45, P2358, DOI 10.1021/ic0514344; Sims PA, 2006, PHYCOLOGIA, V45, P361, DOI 10.2216/05-22.1; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weatherburn DC, 2001, HANDBOOK ON METALLOPROTEINS, P193; Whitney LP, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00234; Wolfe-Simon F, 2005, J PHYCOL, V41, P453, DOI 10.1111/j.1529-8817.2005.00086.x; WOOD PM, 1978, EUR J BIOCHEM, V87, P9, DOI 10.1111/j.1432-1033.1978.tb12346.x	60	40	40	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129081	10.1371/journal.pone.0129081	http://dx.doi.org/10.1371/journal.pone.0129081			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052941	gold, Green Submitted, Green Published			2022-12-26	WOS:000355955300083
J	Kim, NH; Yoshimaru, T; Chen, YA; Matsuo, T; Komatsu, M; Miyoshi, Y; Tanaka, E; Sasa, M; Mizuguchi, K; Katagiri, T				Kim, Nam-Hee; Yoshimaru, Tetsuro; Chen, Yi-An; Matsuo, Taisuke; Komatsu, Masato; Miyoshi, Yasuo; Tanaka, Eiji; Sasa, Mitsunori; Mizuguchi, Kenji; Katagiri, Toyomasa			BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer Cells	PLOS ONE			English	Article							RECEPTOR ACTIVITY; IMPORTIN-ALPHA; EXPRESSION; PROHIBITIN; TRANSPORT; REPRESSOR; SURVIVAL	We recently reported that brefeldin A-inhibited guanine nucleotide-exchange protein 3 (BIG3) binds Prohibitin 2 (PHB2) in cytoplasm, thereby causing a loss of function of the PHB2 tumor suppressor in the nuclei of breast cancer cells. However, little is known regarding the mechanism by which BIG3 inhibits the nuclear translocation of PHB2 into breast cancer cells. Here, we report that BIG3 blocks the estrogen (E2)-dependent nuclear import of PHB2 via the karyopherin alpha (KPNA) family in breast cancer cells. We found that over-expressed PHB2 interacted with KPNA1, KPNA5, and KPNA6, thereby leading to the E2-dependent translocation of PHB2 into the nuclei of breast cancer cells. More importantly, knockdown of each endogenous KPNA by siRNA caused a significant inhibition of E2-dependent translocation of PHB2 in BIG3-depleted breast cancer cells, thereby enhancing activation of estrogen receptor alpha (ER alpha). These data indicated that BIG3 may block the KPNAs (KPNA1, KPNA5, and KPNA6) binding region(s) of PHB2, thereby leading to inhibition of KPNAs-mediated PHB2 nuclear translocation in the presence of E2 in breast cancer cells. Understanding this regulation of PHB2 nuclear import may provide therapeutic strategies for controlling E2/ER alpha signals in breast cancer cells.	[Kim, Nam-Hee; Yoshimaru, Tetsuro; Matsuo, Taisuke; Komatsu, Masato; Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima 770, Japan; [Kim, Nam-Hee; Tanaka, Eiji] Univ Tokushima, Grad Sch, Inst Biomed Sci, Dept Orthodont & Dentofacial Orthoped, Tokushima 770, Japan; [Chen, Yi-An; Mizuguchi, Kenji] Natl Inst Biomed Innovat, Osaka, Japan; [Miyoshi, Yasuo] Hyogo Coll Med, Div Breast & Endocrine Surg, Dept Surg, Kobe, Hyogo, Japan; [Sasa, Mitsunori] Tokushima Breast Care Clin, Dept Surg, Tokushima, Japan	Tokushima University; Tokushima University; National Institute of Health Sciences - Japan; Hyogo College of Medicine; University of Hyogo	Katagiri, T (corresponding author), Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima 770, Japan.	tkatagi@genome.tokushima-u.ac.jp	Tanaka, Eiji/E-7105-2015; Mizuguchi, Kenji/GVS-5857-2022; Miyoshi, Yasuo/AAI-6321-2020; Yoshimaru, Tetsuro/AAE-5335-2020	Tanaka, Eiji/0000-0002-2707-1613; Mizuguchi, Kenji/0000-0003-3021-7078; Miyoshi, Yasuo/0000-0001-8535-4008; Yoshimaru, Tetsuro/0000-0001-8582-3011	Project Future of Relay For Life Japan; Tokushima Breast Care Clinic; MEXT KAKENHI Grant [251347212, 25293079, 26461948]; IMSUT Joint Research Project	Project Future of Relay For Life Japan; Tokushima Breast Care Clinic; MEXT KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); IMSUT Joint Research Project	This work was supported by the Project Future of Relay For Life Japan, grant/research support from Tokushima Breast Care Clinic, a Grant-in-Aid for Scientific Research on Innovative Areas (MEXT KAKENHI Grant Number 251347212), Grants-in-Aid for Scientific Research (MEXT KAKENHI Grant Numbers 25293079 and 26461948), an IMSUT Joint Research Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Yi-An, 2014, BMC Res Notes, V7, P435, DOI 10.1186/1756-0500-7-435; Dankof A, 2007, VIRCHOWS ARCH, V451, P877, DOI 10.1007/s00428-007-0513-5; Delage-Mourroux R, 2000, J BIOL CHEM, V275, P35848, DOI 10.1074/jbc.M001327200; Gluz O, 2008, INT J CANCER, V123, P1433, DOI 10.1002/ijc.23628; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kim JW, 2009, CANCER SCI, V100, P1468, DOI 10.1111/j.1349-7006.2009.01209.x; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kurebayashi J, 1996, BRIT J CANCER, V74, P200, DOI 10.1038/bjc.1996.338; Kurtev V, 2004, J BIOL CHEM, V279, P24834, DOI 10.1074/jbc.M312300200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lin JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-157; Mishra S, 2005, TRENDS MOL MED, V11, P192, DOI 10.1016/j.molmed.2005.02.004; Mishra S, 2006, J CELL MOL MED, V10, P353, DOI 10.1111/j.1582-4934.2006.tb00404.x; Mishra S, 2010, FEBS J, V277, P3937, DOI 10.1111/j.1742-4658.2010.07809.x; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Mortezavi A, 2011, CLIN CANCER RES, V17, P1111, DOI 10.1158/1078-0432.CCR-10-0081; Park JH, 2006, CANCER RES, V66, P9186, DOI 10.1158/0008-5472.CAN-06-1601; Sakai M, 2010, ANTICANCER RES, V30, P851; Shimo A, 2007, CANCER SCI, V98, P174, DOI 10.1111/j.1349-7006.2006.00381.x; Thuaud F, 2013, CHEM BIOL, V20, P316, DOI 10.1016/j.chembiol.2013.02.006; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; Yoshimaru T, 2014, SCI REP-UK, V4, DOI 10.1038/srep07355; Yoshimaru T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3443	28	16	21	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0127707	10.1371/journal.pone.0127707	http://dx.doi.org/10.1371/journal.pone.0127707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052702	gold, Green Submitted, Green Published			2022-12-26	WOS:000355955300017
J	Larson, S; Farrer, D; Lowry, D; Ebert, DA				Larson, Shawn; Farrer, Debbie; Lowry, Dayv; Ebert, David A.			Preliminary Observations of Population Genetics and Relatedness of the Broadnose Sevengill Shark, Notorynchus cepedianus, in Two Northeast Pacific Estuaries	PLOS ONE			English	Article							GULF-OF-MEXICO; CARCHARHINUS-LIMBATUS; MICROSATELLITE LOCI; COMPUTER-PROGRAM; BLACKTIP SHARK; LEMON SHARK; ATLANTIC; RECONSTRUCTION; POLYANDRY; EVOLUTION	The broadnose sevengill shark, Notorynchus cepedianus, a common coastal species in the eastern North Pacific, was sampled during routine capture and tagging operations conducted from 2005-2012. One hundred and thirty three biopsy samples were taken during these research operations in Willapa Bay, Washington and in San Francisco Bay, California. Genotypic data from seven polymorphic microsatellites (derived from the related sixgill shark, Hexanchus griseus) were used to describe Notorynchus cepedianus genetic diversity, population structure and relatedness. Diversity within Notorynchus cepedianus was found to be low to moderate with an average observed heterozygosity of 0.41, expected heterozygosity of 0.53, and an average of 5.1 alleles per microsatellite locus. There was no evidence of a recent population bottleneck based on genetic data. Analyses of genetic differences between the two sampled estuaries suggest two distinct populations with some genetic mixing of sharks sampled during 2005-2006. Relatedness within sampled populations was high, with percent relatedness among sharks caught in the same area indicating 42.30% first-order relative relationships (full or half siblings). Estuary-specific familial relationships suggest that management of Notorynchus cepedianus on the U.S. West Coast should incorporate stock-specific management goals to conserve this ecologically important predator.	[Larson, Shawn] Seattle Aquarium, Seattle, WA 98101 USA; [Farrer, Debbie; Lowry, Dayv] Washington Dept Fish & Wildlife, Washington, DC USA; [Ebert, David A.] Moss Landing Marine Labs, Pacific Shark Res Ctr, Moss Landing, CA 95039 USA	Washington Department of Fish & Wildlife (WDFW); Moss Landing Marine Laboratories	Larson, S (corresponding author), Seattle Aquarium, Seattle, WA 98101 USA.	s.larson@seattleaquarium.org		Lowry, Dayv/0000-0003-1159-3828	Seattle Aquarium; Foley Frischkorn Wildlife Conservation Fund	Seattle Aquarium; Foley Frischkorn Wildlife Conservation Fund	This research was supported by the Seattle Aquarium and the Foley Frischkorn Wildlife Conservation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen H, 2009, MOL ECOL, V18, P4409, DOI 10.1111/j.1365-294X.2009.04377.x; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Buston PM, 2009, MOL ECOL, V18, P4707, DOI 10.1111/j.1365-294X.2009.04383.x; Chapman DD, 2004, MOL ECOL, V13, P1965, DOI 10.1111/j.1365-294X.2004.02178.x; Daly-Engel TS, 2010, MAR ECOL PROG SER, V403, P255, DOI 10.3354/meps08417; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Ebert, 2003, SHARKS RAYS CHIMERAS; EBERT DA, 1989, CALIF FISH GAME, V75, P102; EBERT DA, 1991, S AFR J MARINE SCI, V11, P455, DOI 10.2989/025776191784287637; Ebert DA, 2001, CALIFORNIAS LIVING M, P470; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Feldheim KA, 2001, MOL ECOL, V10, P295, DOI 10.1046/j.1365-294x.2001.01182.x; Feldheim KA, 2004, EVOLUTION, V58, P2332, DOI 10.1111/j.0014-3820.2004.tb01607.x; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Heist EJ, 1999, COPEIA, P182, DOI 10.2307/1447399; Heist EJ, 2003, MOL ECOL NOTES, V3, P59, DOI 10.1046/j.1471-8286.2003.00348.x; HOENIG J M, 1990, NOAA Technical Report NMFS, P1; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keeney DB, 2003, MAR BIOL, V143, P1039, DOI 10.1007/s00227-003-1166-9; Keeney DB, 2005, MOL ECOL, V14, P1911, DOI 10.1111/j.1365-294X.2005.02549.x; Larson S, 2011, CONSERV GENET, V12, P679, DOI 10.1007/s10592-010-0174-9; Miller-Sims VC, 2008, MOL ECOL, V17, P5036, DOI 10.1111/j.1365-294X.2008.03986.x; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; Olsen KH, 2004, CAN J FISH AQUAT SCI, V61, P328, DOI [10.1139/f04-067, 10.1139/F04-067]; Ovenden JR, 2006, MOL ECOL NOTES, V6, P415, DOI 10.1111/j.1471-8286.2005.01254.x; Ovenden JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-40; Pardini AT, 2000, MOL ECOL, V9, P1176, DOI 10.1046/j.1365-294x.2000.00954-4.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; PLANES S, 1993, MAR BIOL, V117, P665, DOI 10.1007/BF00349779; Portnoy DS, 2007, MOL ECOL, V16, P187, DOI 10.1111/j.1365-294X.2006.03138.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Schindler DE, 2002, ECOL APPL, V12, P735, DOI 10.2307/3060985; Schmidt JV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004988; Selkoe KA, 2006, ECOLOGY, V87, P3082, DOI 10.1890/0012-9658(2006)87[3082:CSAKAE]2.0.CO;2; Sikkel PC, 2010, J FISH BIOL, V76, P1671, DOI 10.1111/j.1095-8649.2010.02607.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Williams GD, 2012, J FISH BIOL, V80, P1380, DOI 10.1111/j.1095-8649.2011.03179.x; Williams GD, 2011, ENVIRON BIOL FISH, V91, P379, DOI 10.1007/s10641-011-9797-z	46	9	9	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129278	10.1371/journal.pone.0129278	http://dx.doi.org/10.1371/journal.pone.0129278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052706	gold, Green Submitted, Green Published			2022-12-26	WOS:000355955300108
J	Mao, DW; Ding, ZX; Jia, WB; Liao, W; Li, X; Huang, HY; Yuan, JH; Zang, YF; Zhang, H				Mao, Dewang; Ding, Zhongxiang; Jia, Wenbin; Liao, Wei; Li, Xun; Huang, Huiyuan; Yuan, Jianhua; Zang, Yu-Feng; Zhang, Han			Low-Frequency Fluctuations of the Resting Brain: High Magnitude Does Not Equal High Reliability	PLOS ONE			English	Article							STATE FUNCTIONAL MRI; DEFAULT MODE NETWORK; SIGNAL FLUCTUATIONS; FMRI; AMPLITUDE; CONNECTIVITY; DISEASE; CORTEX; SCHIZOPHRENIA; IMPACT	The amplitude of low-frequency fluctuation (ALFF) measures low-frequency oscillations of the blood-oxygen-level-dependent signal, characterizing local spontaneous activity during the resting state. ALFF is a commonly used measure for resting-state functional magnetic resonance imaging (rs-fMRI) in numerous basic and clinical neuroscience studies. Using a test-retest rs-fMRI dataset consisting of 21 healthy subjects and three repetitive scans, we found that several key brain regions with high ALFF intensities (or magnitude) had poor reliability. Such regions included the posterior cingulate cortex, the medial prefrontal cortex in the default mode network, parts of the right and left thalami, and the primary visual and motor cortices. The above finding was robust with regard to different sample sizes (number of subjects), different scanning parameters (repetition time) and variations of test-retest intervals (i.e., intra-scan, intra-session, and inter-session reliability), as well as with different scanners. Moreover, the qualitative, map-wise results were validated further with a region-of-interest-based quantitative analysis using "canonical" coordinates as reported previously. Therefore, we suggest that the reliability assessments be incorporated in future ALFF studies, especially for the brain regions with a large ALFF magnitude as listed in our paper. Splitting single data into several segments and assessing within-scan "test-retest" reliability is an acceptable alternative if no "real" test-retest datasets are available. Such evaluations might become more necessary if the data are collected with clinical scanners whose performance is not as good as those that are used for scientific research purposes and are better maintained because the lower signal-to-noise ratio may further dampen ALFF reliability.	[Mao, Dewang; Ding, Zhongxiang; Yuan, Jianhua] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China; [Jia, Wenbin; Liao, Wei; Li, Xun; Huang, Huiyuan; Zang, Yu-Feng; Zhang, Han] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China; [Jia, Wenbin; Liao, Wei; Li, Xun; Huang, Huiyuan; Zang, Yu-Feng; Zhang, Han] Zhejiang Key Lab Res Assessment Cognit Impairment, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Hangzhou Normal University	Zhang, H (corresponding author), Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China.	napoleon1982@gmail.com		Zhang, Han/0000-0002-6645-8810	National Natural Science Foundation of China [81201156]; Zhejiang Provincial Natural Science Foundation of China [LY13H180016]; Science Foundation for Post Doctorate Research of China [2013M540501]; Science Foundation from Health Commission of Zhejiang Province [201342245]; "Qian Jiang Distinguished Professor" program; Science Foundation from Health Commission of Zhejiang Province Zhongxiang Ding [201342245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Science Foundation for Post Doctorate Research of China; Science Foundation from Health Commission of Zhejiang Province; "Qian Jiang Distinguished Professor" program; Science Foundation from Health Commission of Zhejiang Province Zhongxiang Ding	This work was partially supported by the National Natural Science Foundation of China (no. 81201156 to HZ); the Zhejiang Provincial Natural Science Foundation of China (no. LY13H180016 to DM); the Science Foundation for Post Doctorate Research of China (no. 2013M540501 to ZD) and the Science Foundation from Health Commission of Zhejiang Province (no. 201342245 to JY). Dr. Yu-Feng Zang acknowledges the support of the "Qian Jiang Distinguished Professor" program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Zhejiang Provincial Natural Science Foundation of China (no. LY13H180016), Dewang Mao. The funder had role in data collection and analysis. The Science Foundation for Post Doctorate Research of China (no. 2013M540501); and The Science Foundation from Health Commission of Zhejiang Province (no. 201342245), Zhongxiang Ding. The funder had role in study design, data collection and analysis.	Boubela RN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00168; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cui Y, 2014, DIABETES, V63, P749, DOI 10.2337/db13-0519; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; Liu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087880; Liu DQ, 2013, NEUROINFORMATICS, V11, P469, DOI 10.1007/s12021-013-9187-0; Liu YO, 2012, ACTA RADIOL, V53, P1073, DOI 10.1258/ar.2012.120269; Liu Y, 2011, EUR J RADIOL, V80, P407, DOI 10.1016/j.ejrad.2010.05.002; Liu YO, 2011, J NEUROL SCI, V304, P127, DOI 10.1016/j.jns.2011.01.023; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Lynch CJ, 2013, BIOL PSYCHIAT, V74, P212, DOI 10.1016/j.biopsych.2012.12.013; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Turner JA, 2012, PSYCHIAT RES-NEUROIM, V201, P253, DOI 10.1016/j.pscychresns.2011.09.012; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wen XY, 2013, BRAIN RES, V1509, P58, DOI 10.1016/j.brainres.2013.03.007; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054; Yuan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078708; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	42	15	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128117	10.1371/journal.pone.0128117	http://dx.doi.org/10.1371/journal.pone.0128117			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053265	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300023
J	Orlov, M; Smeaton, LM; Kumwenda, J; Hosseinipour, MC; Campbell, TB; Schooley, RT				Orlov, Marika; Smeaton, Laura M.; Kumwenda, Johnstone; Hosseinipour, Mina C.; Campbell, Thomas B.; Schooley, Robert T.			Presence of Plasmodium falciparum DNA in Plasma Does Not Predict Clinical Malaria in an HIV-1 Infected Population	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEASE INHIBITORS; ANTIMALARIAL ACTIVITY; SENEGALESE CHILDREN; UGANDAN CHILDREN; IN-VITRO; INFECTION; COHORT; ADULTS; HIV-1	Background HIV-1 and Plasmodium falciparum malaria cause substantial morbidity in Sub-Saharan Africa, especially as co-infecting pathogens. We examined the relationship between presence of P. falciparum DNA in plasma samples and clinical malaria as well as the impact of atazanavir, an HIV-1 protease inhibitor (PI), on P. falciparum PCR positivity. Methods ACTG study A5175 compared two NNRTI-based regimens and one PI-based anti-retroviral (ARV) regimen in antiretroviral therapy naive participants. We performed nested PCR on plasma samples for the P. falciparum 18s rRNA gene to detect the presence of malaria DNA in 215 of the 221 participants enrolled in Blantyre and Lilongwe, Malawi. We also studied the closest sample preceding the first malaria diagnosis from 102 persons with clinical malaria and randomly selected follow up samples from 88 persons without clinical malaria. Results PCR positivity was observed in 18 (8%) baseline samples and was not significantly associated with age, sex, screening CD4+ T-cell count, baseline HIV-1 RNA level or co-trimoxazole use within the first 8 weeks. Neither baseline PCR positivity (p = 0.45) nor PCR positivity after initiation of antiretroviral therapy (p = 1.0) were significantly associated with subsequent clinical malaria. Randomization to the PI versus NNRTI ARV regimens was not significantly associated with either PCR positivity (p = 0.5) or clinical malaria (p = 0.609). Clinical malaria was associated with a history of tuberculosis (p = 0.006) and a lower BMI (p = 0.004). Conclusion P. falciparum DNA was detected in 8% of participants at baseline, but was not significantly associated with subsequent development of clinical malaria. HIV PI therapy did not decrease the prevalence of PCR positivity or incidence of clinical disease.	[Orlov, Marika; Schooley, Robert T.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Smeaton, Laura M.] Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, Boston, MA 02115 USA; [Kumwenda, Johnstone] Johns Hopkins Univ, Res Project, Blantyre, Malawi; [Hosseinipour, Mina C.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Hosseinipour, Mina C.] Univ N Carolina Project, Lilongwe, Malawi; [Campbell, Thomas B.] Univ Colorado, Sch Med, Aurora, CO USA	University of California System; University of California San Diego; Harvard University; Harvard T.H. Chan School of Public Health; University of Malawi; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Anschutz Medical Campus	Schooley, RT (corresponding author), Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA.	rschooley@ucsd.edu		Orlov, Marika/0000-0003-1961-0813	NIH [1U01AI068636, 1U01AI068634, 1U01AI069432, 1U01AI069423]; UCSD Division of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069518, U01AI069432, U01AI068634, UM1AI069518, U01AI068636, UM1AI068634, UM1AI068636, U01AI069423] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSD Division of Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH Grants 1U01AI068636, 1U01AI068634, 1U01AI069432 and 1U01AI069423 and by unrestricted funds from the UCSD Division of Infectious Diseases. Dr. Schooley has utilized compensation for consultative services for Gilead Sciences that were paid to UCSD to support Dr. Orlov's graduate student stipend and for supplies for these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achan J, 2012, NEW ENGL J MED, V367, P2110, DOI 10.1056/NEJMoa1200501; Adriane A., 2011, SEX GEOGRAPHIC BASED; Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; Bharti AR, 2007, AM J TROP MED HYG, V77, P444, DOI 10.4269/ajtmh.2007.77.444; Campbell TB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001290; Chandramohan D, 1998, INT J EPIDEMIOL, V27, P296, DOI 10.1093/ije/27.2.296; Cuadros DF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023458; Cuadros DF, 2011, INT J EPIDEMIOL, V40, P931, DOI 10.1093/ije/dyq256; Dzinjalamala F., 2009, EPIDEMIOL MALAWI, P203; Gal S, 2001, ANN NY ACAD SCI, V945, P234; Grimwade K, 2004, AIDS, V18, P547, DOI 10.1097/00002030-200402200-00023; He ZX, 2008, ANTIMICROB AGENTS CH, V52, P2653, DOI 10.1128/AAC.01329-07; Kalyesubula I, 1997, PEDIATR INFECT DIS J, V16, P876, DOI 10.1097/00006454-199709000-00011; Kapiga SH, 2002, J ACQ IMMUN DEF SYND, V29, P409, DOI 10.1097/00126334-200204010-00013; Kublin JG, 2005, LANCET, V365, P233, DOI 10.1016/S0140-6736(05)17743-5; Ladeia-Andrade S, 2009, AM J TROP MED HYG, V80, P452, DOI 10.4269/ajtmh.2009.80.452; Lamikanra AA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-201; Le Port A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-193; Males S, 2008, CLIN INFECT DIS, V46, P516, DOI 10.1086/526529; Mwapasa V, 2004, AIDS, V18, P1051, DOI 10.1097/00002030-200404300-00014; Nakanjako D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-66; Noormahomed EV, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-252; Orlov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039000; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Porter KA, 2012, ANTIMICROB AGENTS CH, V56, P995, DOI 10.1128/AAC.05322-11; Redmond AM, 2007, AIDS, V21, P763, DOI 10.1097/QAD.0b013e328031f41a; Skinner-Adams TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034399; Toma H, 2001, AM J TROP MED HYG, V64, P257, DOI 10.4269/ajtmh.2001.64.257; Whitworth J, 2000, LANCET, V356, P1051, DOI 10.1016/S0140-6736(00)02727-6; World Health Organization, MALARIA	30	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129519	10.1371/journal.pone.0129519	http://dx.doi.org/10.1371/journal.pone.0129519			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053030	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300136
J	Robertoni, FSZ; Olivo, CR; Lourenco, JD; Goncalves, NG; Velosa, APP; Lin, CJ; Flo, CM; Saraiva-Romanholo, BM; Sasaki, SD; Martins, MA; Teodoro, WR; Lopes, FDTQS				Robertoni, Fabola S. Z.; Olivo, Clarice R.; Lourenco, Juliana D.; Goncalves, Natalia G.; Velosa, Ana Paula P.; Lin, Chin J.; Flo, Claudia M.; Saraiva-Romanholo, Beatriz M.; Sasaki, Sergio D.; Martins, Milton A.; Teodoro, Walcy R.; Lopes, Fernanda Degobbi T. Q. S.			Collagenase mRNA Overexpression and Decreased Extracellular Matrix Components Are Early Events in the Pathogenesis of Emphysema	PLOS ONE			English	Article							SMOKE-INDUCED EMPHYSEMA; OBSTRUCTIVE PULMONARY-DISEASE; ELASTASE-INDUCED EMPHYSEMA; ACUTE LUNG INJURY; CONNECTIVE-TISSUE; AEROBIC EXERCISE; III COLLAGEN; MICE; DEGRADATION; METALLOPROTEINASES	To describe the progression of parenchymal remodeling and metalloproteinases gene expression in earlier stages of emphysema, mice received porcine pancreatic elastase (PPE) instillation and Control groups received saline solution. After PPE instillation (1, 3, 6 hours, 3 and 21 days) we measured the mean linear intercept, the volume proportion of types I and III collagen, elastin, fibrillin and the MMP-1, -8, -12 and -13 gene expression. We observed an initial decrease in type I (at the 3rd day) and type III collagen (from the 6th hour until the 3rd day), in posterior time points in which we detected increased gene expression for MMP-8 and -13 in PPE groups. After 21 days, the type III collagen fibers increased and the type I collagen values returned to similar values compared to control groups. The MMP-12 gene expression was increased in earlier times (3 and 6 hours) to which we detected a reduced proportion of elastin (3 days) in PPE groups, reinforcing the already established importance of MMP-12 in the breakdown of ECM. Such findings will be useful to better elucidate the alterations in ECM components and the importance of not only metalloelastase but also collagenases in earlier emphysema stages, providing new clues to novel therapeutic targets.	[Robertoni, Fabola S. Z.; Olivo, Clarice R.; Lourenco, Juliana D.; Velosa, Ana Paula P.; Flo, Claudia M.; Saraiva-Romanholo, Beatriz M.; Martins, Milton A.; Teodoro, Walcy R.; Lopes, Fernanda Degobbi T. Q. S.] Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, Brazil; [Goncalves, Natalia G.; Lin, Chin J.] Univ Sao Paulo, Sch Med, Dept Phatol, Sao Paulo, Brazil; [Saraiva-Romanholo, Beatriz M.] Univ City Sao Paulo, Sao Paulo, Brazil; [Sasaki, Sergio D.] UFABC, Ctr Nat & Human Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Cidade de Sao Paulo; Universidade Federal do ABC (UFABC)	Lopes, FDTQS (corresponding author), Univ Sao Paulo, Sch Med, Dept Med, Sao Paulo, Brazil.	fernandadtqsl@gmail.com	Pereira Velosa, Ana Paula/AGH-4935-2022; Martins, Milton A/L-7541-2017; Teodoro, Walcy/H-5133-2017; Lourenço, Juliana D./C-5326-2013; Sasaki, Sergio Daishi/AAR-2928-2021; Lin, Chin J/B-7895-2013; Olivo, Clarice Rosa/K-2236-2012; GonÃalves, Natalia/AAE-7276-2022; teodoro, walcy/J-7602-2018; Saraiva-Romanholo, Beatriz Mangueira/I-5482-2013	Teodoro, Walcy/0000-0001-7559-4542; Lourenço, Juliana D./0000-0002-9291-5237; Sasaki, Sergio Daishi/0000-0002-6233-3316; Lin, Chin J/0000-0001-7489-560X; teodoro, walcy/0000-0001-7559-4542; Saraiva-Romanholo, Beatriz Mangueira/0000-0003-0853-9708; Pereira Velosa, Ana Paula/0000-0002-6465-0796; Gomes Goncalves, Natalia/0000-0002-5253-5483; DTQS Lopes, Fernanda/0000-0002-6402-3055	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/08584-6, 2012/02957-8]; Laboratorio de Investigacao Medica [LIM 20]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Laboratorio de Investigacao Medica	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Grant Numbers: 2011/08584-6 and 2012/02957-8); Laboratorio de Investigacao Medica (LIM 20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2000, J STRUCTURAL BIOL S2, P189; ABRAMS WR, 1988, EXP LUNG RES, V14, P459, DOI 10.3109/01902148809087821; Anciaes AM, 2011, CLINICS, V66, P1797, DOI 10.1590/S1807-59322011001000020; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Betsuyaku T, 1999, AM J RESP CRIT CARE, V159, P1985, DOI 10.1164/ajrccm.159.6.9809043; Cavarra E, 1996, LAB INVEST, V75, P273; Churg A, 2004, AM J RESP CRIT CARE, V170, P492, DOI 10.1164/rccm.200404-511OC; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; Churg A, 2007, THORAX, V62, P706, DOI 10.1136/thx.2006.068353; DARMIENTO J, 1992, CELL, V71, P955, DOI 10.1016/0092-8674(92)90391-O; Finlay GA, 1997, AM J RESP CRIT CARE, V156, P240, DOI 10.1164/ajrccm.156.1.9612018; GOLD, 2011, GLOB STRAT DIAGN MAN; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Ito S, 2005, J APPL PHYSIOL, V98, P503, DOI 10.1152/japplphysiol.00590.2004; Kawakami M, 2008, BIOL PHARM BULL, V31, P1434, DOI 10.1248/bpb.31.1434; Koenders MMJF, 2009, J PATHOL, V218, P446, DOI 10.1002/path.2548; Kononov S, 2001, AM J RESP CRIT CARE, V164, P1920, DOI 10.1164/ajrccm.164.10.2101083; KUHN C, 1976, LAB INVEST, V34, P372; Kurimoto E, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-5; LANG MR, 1994, THORAX, V49, P319, DOI 10.1136/thx.49.4.319; Lee EJ, 2009, CHEST, V135, P344, DOI 10.1378/chest.08-1583; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lourenco JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098216; Lucey EC, 1998, AM J RESP CRIT CARE, V158, P555, DOI 10.1164/ajrccm.158.2.9705021; MARGRAF LR, 1991, AM REV RESPIR DIS, V143, P391; Ramos DS, 2010, MED SCI SPORT EXER, V42, P113, DOI 10.1249/MSS.0b013e3181ad1c72; Goncalves CTR, 2012, CRIT CARE, V16, DOI 10.1186/cc11807; Rubio ML, 2004, CHEST, V125, P1500, DOI 10.1378/chest.125.4.1500; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; SHAPIRO SD, 1994, AM J RESP CRIT CARE, V150, pS160, DOI 10.1164/ajrccm/150.6_Pt_2.S160; Shapiro SD, 1999, AM J RESP CELL MOL, V20, P1100, DOI 10.1165/ajrcmb.20.6.f151; Shifren A, 2007, AM J PHYSIOL-LUNG C, V292, pL778, DOI 10.1152/ajplung.00352.2006; Shifren Adrian, 2006, Proc Am Thorac Soc, V3, P428, DOI 10.1513/pats.200601-009AW; Shiomi T, 2003, EXP LUNG RES, V29, P1, DOI 10.1080/01902140303761; Silver FH, 2002, J THEOR BIOL, V216, P243, DOI 10.1006/jtbi.2002.2542; SNIDER GL, 1986, AM REV RESPIR DIS, V133, P149, DOI 10.1164/arrd.1986.133.1.149; SNIDER GL, 1988, AM REV RESPIR DIS, V137, P918, DOI 10.1164/ajrccm/137.4.918; Spiess K, 2007, CONNECT TISSUE RES, V48, P99, DOI 10.1080/03008200601166194; Stockley RA, 2001, NOVART FDN SYMP, V234, P189; STOLK J, 1992, J PATHOL, V167, P349, DOI 10.1002/path.1711670314; STONE PJ, 1995, AM J RESP CRIT CARE, V151, P952; Suki B, 2008, RESP PHYSIOL NEUROBI, V163, P33, DOI 10.1016/j.resp.2008.03.015; Suki B, 2011, COMPR PHYSIOL, V1, P1317, DOI 10.1002/cphy.c100033; Takubo Y, 2002, AM J RESP CRIT CARE, V166, P1596, DOI 10.1164/rccm.2202001; Vieira RD, 2012, MED SCI SPORT EXER, V44, P1227, DOI 10.1249/MSS.0b013e31824b2877; Vlahovic G, 1999, AM J RESP CRIT CARE, V160, P2086, DOI 10.1164/ajrccm.160.6.9706031; WEIBEL ER, 1963, LAB INVEST, V12, P131	49	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129590	10.1371/journal.pone.0129590	http://dx.doi.org/10.1371/journal.pone.0129590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052708	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300147
J	Wang, TH; Kittipayak, S; Lin, YT; Lin, CH; Pan, LK				Wang, Tzu Hwei; Kittipayak, Samrit; Lin, Yu Ting; Lin, Cheng Hsun; Pan, Lung Kwang			Quantification of the In Vitro Radiosensitivity of Mung Bean Sprout Elongation to 6MV X-Ray: A Revised Target Model Study	PLOS ONE			English	Article							SURVIVAL	In this study, a revised target model for quantifying the in vitro radiosensitivity of mung bean sprout elongation to 6-MV X-rays was developed. The revised target model, which incorporated the Poisson prediction for a low probability of success, provided theoretical estimates that were highly consistent with the actual data measured in this study. The revised target model correlated different in vitro radiosensitivities to various effective target volumes and was successfully confirmed by exposing mung beans in various elongation states to various doses of 6-MV X-rays. For the experiment, 5,000 fresh mung beans were randomly distributed into 100 petri dishes, which were randomly divided into ten groups. Each group received an initial watering at a different time point prior to X-ray exposure, resulting in different effective target volumes. The bean sprouts were measured 70 hr after X-ray exposure, and the average length of the bean sprouts in each group was recorded as an index of the mung bean in vitro radiosensitivity. Mung beans that received an initial watering either six or sixteen hours before X-ray exposure had the shortest sprout length, indicating that the maximum effective target volume was formed within that specific time period. The revised target model could be also expanded to interpret the "two-hit" model of target theory, although the experimental data supported the "one-hit" model. If the "two-hit" model was sustained, theoretically, the target size would be 2.14 times larger than its original size to produce the same results.	[Wang, Tzu Hwei] Buddhist Tzu Chi Gen Hosp, Dept Radiotherapy Oncol, Taichung Branch, Taichung 427, Taiwan; [Wang, Tzu Hwei; Kittipayak, Samrit; Lin, Yu Ting; Lin, Cheng Hsun; Pan, Lung Kwang] Cent Taiwan Univ Sci & Technol Takun, Grad Inst Radiol Sci, Taichung 406, Taiwan; [Lin, Yu Ting] China Med Univ, Beigang Hosp, Dept Radiol, Yunlin 651, Taiwan	Buddhist Tzu Chi General Hospital; Taichung Tzu Chi Hospital; Central Taiwan University Science & Technology; China Medical University Taiwan	Pan, LK (corresponding author), Cent Taiwan Univ Sci & Technol Takun, Grad Inst Radiol Sci, Taichung 406, Taiwan.	lkpan@ctust.edu.tw		PAN, Lung-Kwang/0000-0002-9485-4722	National Science Council of the Republic of China [NSCsimilar to93-2213-E-166-004]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	The work was financially supported by the National Science Council of the Republic of China under Contract No. NSC similar to 93-2213-E-166-004. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah T. L., 2009, American Journal of Applied Sciences, V6, P1436; [Anonymous], 1969, J APPL POLYM SCI; Attix F.H., 2008, INTRO RADIOLOGICAL P; Aziz NH, 1997, APPL RADIAT ISOTOPES, V48, P71, DOI 10.1016/S0969-8043(96)00058-9; Balagamwala EH, 2012, TECHNOL CANCER RES T, V11, P3, DOI 10.7785/tcrt.2012.500229; Benedict SH, 1997, INT J RADIAT ONCOL, V37, P765, DOI 10.1016/S0360-3016(97)00023-0; Berg JM, 2002, BIOCHEMISTRY-US, V5th; Brenner DJ, 2002, INT J RADIAT ONCOL, V52, P6; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Hsieh CH, 2006, APPL RADIAT ISOTOPES, V64, P306, DOI 10.1016/j.apradiso.2005.08.018; Kamba C, 2007, 18 INT C JAP; Knoll G. F., 1989, RAD DETECTION MEASUR; O'Reilly C, 2007, SILVA FENN, V41, P235, DOI 10.14214/sf.293; Preuss SB, 2003, GENETICS, V164, P323; Ryu S, 1998, INT J RADIAT ONCOL, V41, P869, DOI 10.1016/S0360-3016(98)00111-4; Scott SL, 2004, INT J RADIAT ONCOL, V59, P219, DOI 10.1016/j.ijrobp.2004.01.027; Smolko EE, 2005, NUCL INSTRUM METH B, V236, P249, DOI 10.1016/j.nimb.2005.04.055; [苏家乐 SU Jia-le], 2009, [核农学报, Acta Agriculturae Nucleatae Sinica], V23, P990; Tavera L, 2003, RADIAT MEAS, V36, P591, DOI 10.1016/S1350-4487(03)00207-5; Turner J.E., 2000, ATOMS RAD RAD PROTEC, V2nd ed.; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0	21	3	3	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128384	10.1371/journal.pone.0128384	http://dx.doi.org/10.1371/journal.pone.0128384			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053016	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300032
J	Boyd, A; Almeida, JR; Darrah, PA; Sauce, D; Seder, RA; Appay, V; Gorochov, G; Larsen, M				Boyd, Anders; Almeida, Jorge R.; Darrah, Patricia A.; Sauce, Delphine; Seder, Robert A.; Appay, Victor; Gorochov, Guy; Larsen, Martin			Pathogen-Specific T Cell Polyfunctionality Is a Correlate of T Cell Efficacy and Immune Protection	PLOS ONE			English	Article							ANTIGEN-SENSITIVITY; VIRUS	Introduction Understanding the factors that delineate the efficacy of T cell responses towards pathogens is crucial for our ability to develop potent therapies against infectious diseases. Multidimensional evaluation of T cell functionality at the single-cell level enables exhaustive analysis of combinatorial functional properties, hence polyfunctionality. We have recently invented an algorithm that quantifies polyfunctionality, the Polyfunctionality Index (Larsen et al. PLoS One 2012). Here we demonstrate that quantitative assessment of T cell polyfunctionality correlates with T cell efficacy measured as the capacity to kill target cells in vitro and control infection in vivo. Methods We employed the polyfunctionality index on two datasets selected for their unique ability to evaluate the polyfunctional imprint on T cell efficacy. 1) HIV-specific CD8(+) T cells and 2) Leishmania major-specific CD4(+) T cells were analysed for their capacity to secrete multiple effector molecules, kill target cells and control infection. Briefly, employing the Polyfunctionality Index algorithm we determined the parameter estimates resulting in optimal correlation between T cell polyfunctionality and T cell efficacy. Results T cell polyfunctionality is correlated with T cell efficacy measured as 1) target killing (r=0.807, P<0.0001) and 2) lesion size upon challenge with Leishmania major (r=-0.50, P=0.004). Contrary to an approach relying on the Polyfunctionality Index algorithm, quantitative evaluation of T cell polyfunctionality traditionally ignores the gradual contribution of more or less polyfunctional T cells. Indeed, comparing both approaches we show that optimal description of T cell efficacy is obtained when gradually integrating all levels of polyfunctionality in accordance with the Polyfunctionality Index. Conclusions Our study presents a generalizable methodology to objectively evaluate the impact of polyfunctionality on T cell efficacy. We show that T cell polyfunctionality is a superior correlate of T cell efficacy both in vitro and in vivo as compared with response size. Therefore, future immunotherapies should aim to increase T cell polyfunctionality.	[Boyd, Anders] Inst Pierre Louis Epidemiol & Sante Publ, INSERM, UMR S1136, Paris, France; [Almeida, Jorge R.; Sauce, Delphine; Appay, Victor; Gorochov, Guy; Larsen, Martin] Ctr Immunol & Malad Infect CIMI Paris, INSERM, UMR S1135, Paris, France; [Darrah, Patricia A.; Seder, Robert A.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Gorochov, Guy; Larsen, Martin] Grp Hosp Pitie Salpetriere, AP HP, Dept Immunol, F-75634 Paris, France; [Gorochov, Guy; Larsen, Martin] Univ Paris 06, Sorbonne Univ, CR7, CIMI Paris, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Larsen, M (corresponding author), Ctr Immunol & Malad Infect CIMI Paris, INSERM, UMR S1135, Paris, France.	Martin.Larsen@upmc.fr	Boyd, Anders/GLQ-8906-2022; SAUCE, Delphine/ABE-5975-2020; Appay, Victor/M-4830-2017; Appay, Victor/AAM-7701-2021; Gorochov, Guy/P-2911-2017; Larsen, Martin/A-7316-2014	Boyd, Anders/0000-0001-9512-8928; SAUCE, Delphine/0000-0003-4596-7373; Larsen, Martin/0000-0003-1375-4816; Appay, Victor/0000-0001-5434-3963; Gorochov, Guy/0000-0003-2097-9677	INSERM; University Pierre et Marie Curie EMERGENCE" program; Fondation pour l'Aide a la Recherche sur la Sclerose En Plaques; ARTHRITIS Fondation COURTIN; Agence nationale de recherche sur le Sida et les hepatites	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Pierre et Marie Curie EMERGENCE" program; Fondation pour l'Aide a la Recherche sur la Sclerose En Plaques(Fondation pour la Recherche Medicale); ARTHRITIS Fondation COURTIN; Agence nationale de recherche sur le Sida et les hepatites	The study was funded by INSERM, the University Pierre et Marie Curie EMERGENCE" program (www.upmc.fr), "Fondation pour l'Aide a la Recherche sur la Sclerose En Plaques" (www.ARSEP.org) and ARTHRITIS Fondation COURTIN (http://www.fondation-arthritis.org). A.B. was awarded a post-doctoral fellowship with the "Agence nationale de recherche sur le Sida et les hepatites" (www.agence-nationale-recherche.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida JR, 2009, BLOOD, V113, P6351, DOI 10.1182/blood-2009-02-206557; Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Graw F, 2014, J VIROL, V88, P10134, DOI 10.1128/JVI.00647-14; Larsen M, 2011, TLS-TIMES LIT SUPPL, P6; Larsen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042403; Lissina A, 2014, AIDS, V28, P477, DOI 10.1097/QAD.0000000000000175; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Peters NC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004538; Radaelli A, 2007, VACCINE, V25, P2128, DOI 10.1016/j.vaccine.2006.11.009; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Smolen KK, 2014, J IMMUNOL, V193, P3003, DOI 10.4049/jimmunol.1400895; Swadling L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009185; Szaba FM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004142; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Yuan JD, 2008, P NATL ACAD SCI USA, V105, P20410, DOI 10.1073/pnas.0810114105	19	49	50	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128714	10.1371/journal.pone.0128714	http://dx.doi.org/10.1371/journal.pone.0128714			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046523	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200094
J	Dai, PS; Luo, HY; Sheng, HW; Zhao, YL; Li, L; Wu, J; Zhao, YQ; Suzuki, KJ				Dai, Peishan; Luo, Hanyuan; Sheng, Hanwei; Zhao, Yali; Li, Ling; Wu, Jing; Zhao, Yuqian; Suzuki, Kenji			A New Approach to Segment Both Main and Peripheral Retinal Vessels Based on Gray-Voting and Gaussian Mixture Model	PLOS ONE			English	Article							BLOOD-VESSELS; MATCHED-FILTER; IMAGES; EXTRACTION; WAVELET	Vessel segmentation in retinal fundus images is a preliminary step to clinical diagnosis for some systemic diseases and some eye diseases. The performances of existing methods for segmenting small vessels which are usually of more importance than the main vessels in a clinical diagnosis are not satisfactory in clinical use. In this paper, we present a method for both main and peripheral vessel segmentation. A local gray-level change enhancement algorithm called gray-voting is used to enhance the small vessels, while a two-dimensional Gabor wavelet is used to extract the main vessels. We fuse the gray-voting results with the 2D-Gabor filter results as pre-processing outcome. A Gaussian mixture model is then used to extract vessel clusters from the pre-processing outcome, while small vessels fragments are obtained using another gray-voting process, which complements the vessel cluster extraction already performed. At the last step, we eliminate the fragments that do not belong to the vessels based on the shape of the fragments. We evaluated the approach with two publicly available DRIVE (Staal et al., 2004) and STARE (Hoover et at., 2000) datasets with manually segmented results. For the STARE dataset, when using the second manually segmented results which include much more small vessels than the first manually segmented results as the "gold standard," this approach achieved an average sensitivity, accuracy and specificity of 65.0%, 92.1% and 97.0%, respectively. The sensitivities of this approach were much higher than those of the other existing methods, with comparable specificities; these results thus demonstrated that this approach was sensitive to detection of small vessels.	[Dai, Peishan; Luo, Hanyuan; Sheng, Hanwei; Zhao, Yali; Li, Ling; Wu, Jing; Zhao, Yuqian] Cent South Univ, Sch Geosci & Infophys, Dept Biomed Engn, Changsha, Hunan, Peoples R China; [Suzuki, Kenji] Univ Chicago, Dept Radiol, Chicago, IL 60637 USA	Central South University; University of Chicago	Dai, PS (corresponding author), Cent South Univ, Sch Geosci & Infophys, Dept Biomed Engn, Changsha, Hunan, Peoples R China.	daipeishan@163.com; kenjisuzuki00@gmail.com	Suzuki, Kenji/A-1284-2007	Suzuki, Kenji/0000-0002-3993-8309	National Natural Science Foundation of China [81171420]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grants 81171420.	Cheung CYL, 2014, ALZHEIMERS DEMENT, V10, P135, DOI 10.1016/j.jalz.2013.06.009; Fathi A, 2013, BIOMED SIGNAL PROCES, V8, P71, DOI 10.1016/j.bspc.2012.05.005; Fraz MM, 2012, COMPUT METH PROG BIO, V108, P600, DOI 10.1016/j.cmpb.2011.08.009; Fraz MM, 2012, IEEE T BIO-MED ENG, V59, P2538, DOI 10.1109/TBME.2012.2205687; Goatman KA, 2011, IEEE T MED IMAGING, V30, P972, DOI 10.1109/TMI.2010.2099236; Hoover A, 2000, IEEE T MED IMAGING, V19, P203, DOI 10.1109/42.845178; Kose C, 2011, EXPERT SYST APPL, V38, P13670, DOI 10.1016/j.eswa.2011.04.141; Li Q, 2012, EXPERT SYST APPL, V39, P7600, DOI 10.1016/j.eswa.2011.12.046; Marin D, 2011, IEEE T MED IMAGING, V30, P146, DOI 10.1109/TMI.2010.2064333; Martinez-Perez ME, 2007, MED IMAGE ANAL, V11, P47, DOI 10.1016/j.media.2006.11.004; Mendonca AM, 2006, IEEE T MED IMAGING, V25, P1200, DOI 10.1109/TMI.2006.879955; Nguyen UTV, 2011, LECT NOTES COMPUT SC, V7009, P117, DOI 10.1007/978-3-642-24319-6_15; Niemeijer M, 2004, PROC SPIE, V5370, P648, DOI 10.1117/12.535349; Ramlugun GS, 2012, EXPERT SYST APPL, V39, P1141, DOI 10.1016/j.eswa.2011.07.115; Ricci E, 2007, IEEE T MED IMAGING, V26, P1357, DOI 10.1109/TMI.2007.898551; Saleh MD, 2011, J DIGIT IMAGING, V24, P564, DOI 10.1007/s10278-010-9302-9; Shahbeig S, 2013, IMAGE PROCESSING IET, V7, DOI [10.1007/s10916-009-9337-y, DOI 10.1007/S10916-009-9337-Y]; Soares JVB, 2006, IEEE T MED IMAGING, V25, P1214, DOI 10.1109/TMI.2006.879967; Staal J, 2004, IEEE T MED IMAGING, V23, P501, DOI 10.1109/TMI.2004.825627; Suzuki K, 2012, QUANT IMAG MED SURG, V2, P163, DOI 10.3978/j.issn.2223-4292.2012.09.02; Xiao ZY, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/401413; Yin Y, 2012, PATTERN RECOGN, V45, P1235, DOI 10.1016/j.patcog.2011.09.019; You XG, 2011, PATTERN RECOGN, V44, P2314, DOI 10.1016/j.patcog.2011.01.007; Zhang B, 2010, COMPUT BIOL MED, V40, P438, DOI 10.1016/j.compbiomed.2010.02.008; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zheng J, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/927285	26	41	43	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127748	10.1371/journal.pone.0127748	http://dx.doi.org/10.1371/journal.pone.0127748			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047128	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200029
J	Natarajan, V; Madhan, B; Tiku, ML				Natarajan, Venkatachalam; Madhan, Balaraman; Tiku, Moti L.			Intra-Articular Injections of Polyphenols Protect Articular Cartilage from Inflammation-Induced Degradation: Suggesting a Potential Role in Cartilage Therapeutics	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; IN-VITRO EVALUATION; TANNIC-ACID; CROSS-LINKING; ELASTIN STABILIZATION; PLANT POLYPHENOLS; TISSUE; EXPRESSION; CURCUMIN	Arthritic diseases, such as osteoarthritis and rheumatoid arthritis, inflict an enormous health care burden on society. Osteoarthritis, a degenerative joint disease with high prevalence among older people, and rheumatoid arthritis, an autoimmune inflammatory disease, both lead to irreversible structural and functional damage to articular cartilage. The aim of this study was to investigate the effect of polyphenols such as catechin, quercetin, epigallocatechin gallate, and tannic acid, on crosslinking type II collagen and the roles of these agents in managing in vivo articular cartilage degradation. The thermal, enzymatic, and physical stability of bovine articular cartilage explants following polyphenolic treatment were assessed for efficiency. Epigallocatechin gallate and tannic acid-treated explants showed >12 degrees C increase over native cartilage in thermal stability, thereby confirming cartilage crosslinking. Polyphenol-treated cartilage also showed a significant reduction in the percentage of collagen degradation and the release of glycosaminoglycans against collagenase digestion, indicating the increase physical integrity and resistance of polyphenol crosslinked cartilage to enzymatic digestion. To examine the in vivo cartilage protective effects, polyphenols were injected intra-articularly before (prophylactic) and after (therapeutic) the induction of collagen-induced arthritis in rats. The hind paw volume and histomorphological scoring was done for cartilage damage. The intra-articular injection of epigallocatechin gallate and tannic acid did not significantly influence the time of onset or the intensity of joint inflammation. However, histomorphological scoring of the articular cartilage showed a significant reduction in cartilage degradation in prophylactic-and therapeutic-groups, indicating that intra-articular injections of polyphenols bind to articular cartilage and making it resistant to degradation despite ongoing inflammation. These studies establish the value of intra-articular injections of polyphenol in stabilization of cartilage collagen against degradation and indicate the unique beneficial role of injectable polyphenols in protecting the cartilage in arthritic conditions.	[Natarajan, Venkatachalam; Madhan, Balaraman] CSIR, Cent Leather Res Inst, Madras, Tamil Nadu, India; [Tiku, Moti L.] Rutgers State Univ, Robert Wood Johnson Med Sch, New Brunswick, NJ 08903 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Leather Research Institute (CLRI); Rutgers State University New Brunswick; Rutgers State University Medical Center	Madhan, B (corresponding author), CSIR, Cent Leather Res Inst, Madras, Tamil Nadu, India.	bmadhan76@yahoo.co.in	Balaraman, Madhan/B-3136-2009; Venkatachalam, Natarajan/B-7930-2009	Balaraman, Madhan/0000-0002-4198-8452; Venkatachalam, Natarajan/0000-0003-1491-8886	CSIR India under the CSIR-YSA Project of BM [1105]; CSIR	CSIR India under the CSIR-YSA Project of BM; CSIR(Council of Scientific & Industrial Research (CSIR) - India)	BM and VN are grateful to CSIR India for providing financial assistance under the CSIR-YSA Project of BM (CSIR-CLRI Communication No. 1105). Author VN thanks CSIR for providing a Senior Research Fellowship.	Adcocks C, 2002, J NUTR, V132, P341, DOI 10.1093/jn/132.3.341; Ahmed S, 2004, J PHARMACOL EXP THER, V308, P767, DOI 10.1124/jpet.103.059220; Ahmed S, 2009, ARTHRITIS RHEUM-US, V60, P1282, DOI 10.1002/art.24488; Aly Maha Nasr Sayed, 2008, Recent Pat Drug Deliv Formul, V2, P231; Athens AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060719; Avila MY, 2010, J CATARACT REFR SURG, V36, P659, DOI 10.1016/j.jcrs.2009.11.003; Barker MK, 2001, RHEUMATOLOGY, V40, P274, DOI 10.1093/rheumatology/40.3.274; Baxter NJ, 1997, BIOCHEMISTRY-US, V36, P5566, DOI 10.1021/bi9700328; Bhosale AM, 2008, BRIT MED BULL, V87, P77, DOI 10.1093/bmb/ldn025; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487; Chang TL, 2013, BIOL CHEM, V394, P561, DOI 10.1515/hsz-2012-0277; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Chen X, 2003, CLIN CANCER RES, V9, P3115; Cheng DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091571; Chuang TH, 2009, TISSUE ENG PT A, V15, P2837, DOI [10.1089/ten.tea.2008.0394, 10.1089/ten.TEA.2008.0394]; Clutterbuck AL, 2009, ANN NY ACAD SCI, V1171, P428, DOI 10.1111/j.1749-6632.2009.04687.x; Covington AD, 2009, TANNING CHEMISTRY: THE SCIENCE OF LEATHER, P1; Csotye J, 2009, J THERM ANAL CALORIM, V95, P805, DOI 10.1007/s10973-008-9414-3; Fessel G, 2014, ACTA BIOMATER, V10, P1897, DOI 10.1016/j.actbio.2013.12.048; Fox AJS, 2009, SPORTS HEALTH, V1, P461, DOI 10.1177/1941738109350438; Ganesan K, 2008, RHEUMATOL INT, V28, P345, DOI 10.1007/s00296-007-0446-y; Henrotin Y, 2010, OSTEOARTHR CARTILAGE, V18, P141, DOI 10.1016/j.joca.2009.10.002; Hiraishi N, 2013, DENT MATER, V29, P1048, DOI 10.1016/j.dental.2013.07.015; Htay HH, 2013, GREEN TEA POLYPHENOL, P139; Isenburg JC, 2007, CIRCULATION, V115, P1729, DOI 10.1161/CIRCULATIONAHA.106.672873; Isenburg JC, 2006, BIOMATERIALS, V27, P3645, DOI 10.1016/j.biomaterials.2006.02.016; Isenburg JC, 2005, BIOMATERIALS, V26, P1237, DOI 10.1016/j.biomaterials.2004.04.034; Isenburg JC, 2004, BIOMATERIALS, V25, P3293, DOI 10.1016/j.biomaterials.2003.10.001; Jackson JK, 2010, J MATER SCI-MATER M, V21, P1435, DOI 10.1007/s10856-010-4019-3; Jean-Gilles D, 2012, J AGR FOOD CHEM, V60, P5755, DOI 10.1021/jf203456w; Kasyanov V, 2006, BIOMATERIALS, V27, P745, DOI 10.1016/j.biomaterials.2005.06.022; Kona FR, 2014, REC ADV POLYPHEN RES, V4, P209; Larsen C, 2008, J PHARM SCI-US, V97, P4622, DOI 10.1002/jps.21346; Lay E, 2012, J NUTR BIOCHEM, V23, P106, DOI 10.1016/j.jnutbio.2010.11.004; Liu XQ, 2005, J NUTR, V135, P165, DOI 10.1093/jn/135.2.165; Liu Z, 2012, BIOMATERIALS, V33, P7336, DOI 10.1016/j.biomaterials.2012.06.080; Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005; Madhan B, 2002, BIOMATERIALS, V23, P2841, DOI 10.1016/S0142-9612(01)00410-0; Madhan B, 2001, CHEM PHYS LETT, V346, P334, DOI 10.1016/S0009-2614(01)00910-1; Makris EA, 2014, P NATL ACAD SCI USA, V111, pE4832, DOI 10.1073/pnas.1414271111; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mohan A, 2013, ANTI-CANCER AGENT ME, V13, P281, DOI 10.2174/1871520611313020015; Morinobu A, 2008, ARTHRITIS RHEUM, V58, P2012, DOI 10.1002/art.23594; Mort JS, 2001, ARTHRITIS RES, V3, P337, DOI 10.1186/ar325; Naumov I, 2012, J THERM ANAL CALORIM, V108, P59, DOI 10.1007/s10973-011-1532-7; Ofek G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002795; Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498; Pearson W, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-19; Rasheed Z, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2700; Satyam A, 2014, J TISSUE ENG REGEN M, V8, P233, DOI 10.1002/term.1522; SCHLEBUSCH H, 1972, ANGIOLOGICA, V9, P248; Shen CL, 2012, J NUTR BIOCHEM, V23, P1367, DOI 10.1016/j.jnutbio.2012.04.001; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Sung HW, 1999, BIOMATERIALS, V20, P1759, DOI 10.1016/S0142-9612(99)00069-1; Svelander L, 2009, EUR J PHARMACOL, V613, P155, DOI 10.1016/j.ejphar.2009.03.074; Tang HR, 2003, J AGR FOOD CHEM, V51, P6652, DOI 10.1021/jf034380u; Tedder ME, 2009, TISSUE ENG PT A, V15, P1257, DOI 10.1089/ten.tea.2008.0263; Than P, 2005, J THERM ANAL CALORIM, V82, P213, DOI 10.1007/s10973-005-0868-2; Tiku ML, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2274; Tyyni A, 2000, SCAND J MED SCI SPOR, V10, P249, DOI 10.1034/j.1600-0838.2000.010005249.x; Ulrich-Vinther Michael, 2003, J Am Acad Orthop Surg, V11, P421; Verzijl N, 2000, J BIOL CHEM, V275, P39027, DOI 10.1074/jbc.M006700200; WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0; Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717; Yun HJ, 2008, RHEUMATOL INT, V29, P23, DOI 10.1007/s00296-008-0597-5	65	33	33	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127165	10.1371/journal.pone.0127165	http://dx.doi.org/10.1371/journal.pone.0127165			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046639	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200015
J	Wang, SY; Hu, BL; Si, WY; Jia, L; Zheng, XJ; Zhou, JY				Wang, Sanying; Hu, Boli; Si, Weiying; Jia, Lu; Zheng, Xiaojuan; Zhou, Jiyong			Avibirnavirus VP4 Protein Is a Phosphoprotein and Partially Contributes to the Cleavage of Intermediate Precursor VP4-VP3 Polyprotein	PLOS ONE			English	Article							BURSAL DISEASE VIRUS; N-TERMINAL PHOSPHORYLATION; DEPENDENT RNA-POLYMERASE; HOST-CELLS; CATALYTIC DYAD; DOMAIN; CONTAINS; GENOME; IDENTIFICATION; NUCLEOPROTEIN	Birnavirus-encoded viral protein 4 (VP4) utilizes a Ser/Lys catalytic dyad mechanism to process polyprotein. Here three phosphorylated amino acid residues Ser538, Tyr611 and Thr674 within the VP4 protein of the infectious bursal disease virus (IBDV), a member of the genus Avibirnavirus of the family Birnaviridae, were identified by mass spectrometry. Anti-VP4 monoclonal antibodies finely mapping to phosphorylated (p) Ser538 and the epitope motif (530)PVVDGIL(536) were generated and verified. Proteomic analysis showed that in IBDV-infected cells the VP4 was distributed mainly in the cytoskeletal fraction and existed with different isoelectric points and several phosphorylation modifications. Phosphorylation of VP4 did not influence the aggregation of VP4 molecules. The proteolytic activity analysis verified that the pTyr611 and pThr674 sites within VP4 are involved in the cleavage of viral intermediate precursor VP4-VP3. This study demonstrates that IBDV-encoded VP4 protein is a unique phosphoprotein and that phosphorylation of Tyr611 and Thr674 of VP4 affects its serine-protease activity.	[Wang, Sanying; Si, Weiying; Jia, Lu; Zheng, Xiaojuan; Zhou, Jiyong] Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China; [Hu, Boli; Zhou, Jiyong] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China; [Zheng, Xiaojuan; Zhou, Jiyong] Zhejiang Univ, Affiliated Hosp 1, State Key Lab & Collaborat Innovat, Ctr Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Sanying] Shaoxing Ctr Dis Control & Prevent, Shaoxing, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Nanjing Agricultural University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Zheng, XJ (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China.	zhengxiaojuan@zju.edu.cn; jyzhou@njau.edu.cn			China Agriculture Research System [CARS-41-K11]; National Natural Science Foundation of China [30870117, 30800825]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from China Agriculture Research System (Grant No. CARS-41-K11) and National Natural Science Foundation of China (Grant No. 30870117 and 30800825). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnitz RA, 2010, J VIROL, V84, P6410, DOI 10.1128/JVI.02273-09; Bhuvanakantham R, 2010, MICROBES INFECT, V12, P615, DOI 10.1016/j.micinf.2010.04.005; Birghan C, 2000, EMBO J, V19, P114, DOI 10.1093/emboj/19.1.114; Brandt M, 2001, J VIROL, V75, P11974, DOI 10.1128/JVI.75.24.11974-11982.2001; Chang GRL, 2012, PROTEIN ENG DES SEL, V25, P789, DOI 10.1093/protein/gzs087; Chen LY, 2013, J VIROL, V87, P3177, DOI 10.1128/JVI.02761-12; Chung IYW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.198812; Da Costa B, 2002, J VIROL, V76, P2393, DOI 10.1128/JVI.76.5.2393-2402.2002; Da Costa B, 2003, J VIROL, V77, P719, DOI 10.1128/JVI.77.1.719-725.2003; Escaffre O, 2013, J VIROL, V87, P2767, DOI 10.1128/JVI.02360-12; Feldman AR, 2006, J MOL BIOL, V358, P1378, DOI 10.1016/j.jmb.2006.02.045; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Granzow H, 1997, J VIROL, V71, P8879, DOI 10.1128/JVI.71.11.8879-8885.1997; Hagiwara K, 2008, PROTEOMICS, V8, P1871, DOI 10.1002/pmic.200701051; Irigoyen N, 2012, J BIOL CHEM, V287, P24473, DOI 10.1074/jbc.M112.356113; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; Jackwood DJ, 2008, VIROLOGY, V377, P110, DOI 10.1016/j.virol.2008.04.018; Kibenge FSB, 1997, ARCH VIROL, V142, P1227, DOI 10.1007/s007050050154; Kolesnikova L, 2012, CELL MICROBIOL, V14, P182, DOI 10.1111/j.1462-5822.2011.01709.x; Lappalainen P, 1998, MOL BIOL CELL, V9, P1951, DOI 10.1091/mbc.9.8.1951; Le Nouen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028064; Lee J, 2006, ACTA CRYSTALLOGR F, V62, P1235, DOI 10.1107/S1744309106046070; Lejal N, 2000, J GEN VIROL, V81, P983, DOI 10.1099/0022-1317-81-4-983; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Letzel T, 2007, J VIROL, V81, P12827, DOI 10.1128/JVI.01501-07; Li WG, 2011, PHYS RES INT, V2011, P1, DOI [10.1155/2011/791545, DOI 10.1155/2011/791545]; Li ZH, 2013, J VIROL, V87, P1221, DOI 10.1128/JVI.02421-12; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Liu MH, 2004, VIROLOGY, V330, P62, DOI 10.1016/j.virol.2004.09.009; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Machesky LM, 2001, TRENDS CELL BIOL, V11, P286, DOI 10.1016/S0962-8924(01)02009-8; Maraver A, 2003, J VIROL, V77, P6438, DOI 10.1128/JVI.77.11.6438-6449.2003; Mostafa HH, 2013, J VIROL, V87, P2109, DOI 10.1128/JVI.02588-12; MULLER H, 1987, VIROLOGY, V159, P174, DOI 10.1016/0042-6822(87)90363-1; OPPLING V, 1991, J GEN VIROL, V72, P2275, DOI 10.1099/0022-1317-72-9-2275; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Petit S, 2000, J VIROL, V74, P2057, DOI 10.1128/JVI.74.5.2057-2066.2000; Rodriguez-Lecompte JC, 2002, VIROLOGY, V292, P241, DOI 10.1006/viro.2001.1260; Sanchez AB, 1999, VIROLOGY, V262, P190, DOI 10.1006/viro.1999.9910; SCHNITZLER D, 1993, J GEN VIROL, V74, P1563, DOI 10.1099/0022-1317-74-8-1563; Shang SB, 2009, MOL IMMUNOL, V46, P327, DOI 10.1016/j.molimm.2008.10.028; SPIES U, 1989, NUCLEIC ACIDS RES, V17, P7982, DOI 10.1093/nar/17.19.7982; Stradal T, 1998, FEBS LETT, V431, P134, DOI 10.1016/S0014-5793(98)00751-0; Tacken MGJ, 2004, ARCH VIROL, V149, P2245, DOI 10.1007/s00705-004-0365-0; Tacken MGJ, 2002, J VIROL, V76, P11301, DOI 10.1128/JVI.76.22.11301-11311.2002; Wang SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084503; Wang YZ, 2009, MOL IMMUNOL, V46, P1964, DOI 10.1016/j.molimm.2009.03.011; Weeds A, 1993, CURR OPIN CELL BIOL, V5, P63, DOI 10.1016/S0955-0674(05)80009-2; Wu YP, 2012, PROTEOMICS, V12, P1844, DOI 10.1002/pmic.201100479; Wu YP, 2009, ARCH VIROL, V154, P1873, DOI 10.1007/s00705-009-0524-4; Yamaguchi T, 1996, VIROLOGY, V223, P219, DOI 10.1006/viro.1996.0470; Zhang X, 2009, J PROTEOME RES, V8, P5111, DOI 10.1021/pr900488q; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200; Zhou JY, 2005, PROG BIOCHEM BIOPHYS, V32, P37	54	7	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128828	10.1371/journal.pone.0128828	http://dx.doi.org/10.1371/journal.pone.0128828			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046798	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200106
J	O'Day, E; Le, MTN; Imai, S; Tan, SM; Kirchner, R; Arthanari, H; Hofmann, O; Wagner, G; Lieberman, J				O'Day, Elizabeth; Le, Minh T. N.; Imai, Shunsuke; Tan, Shen Mynn; Kirchner, Rory; Arthanari, Haribabu; Hofmann, Oliver; Wagner, Gerhard; Lieberman, Judy			An RNA-binding Protein, Lin28, Recognizes and Remodels G-quartets in the MicroRNAs (miRNAs) and mRNAs It Regulates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-QUADRUPLEX STRUCTURE; NMR-SPECTROSCOPY; PROMOTER REGION; DNA; TRANSLATION; EXPRESSION; LIN-28; INHIBITION; MYC; TELOMERASE	Lin28 is an evolutionarily conserved RNA-binding protein that inhibits processing of pre-let-7 microRNAs (miRNAs) and regulates translation of mRNAs that control developmental timing, pluripotency, metabolism, and tumorigenesis. The RNA features that mediate Lin28 binding to the terminal loops of let-7 pre-miRNAs and to Lin28-responsive elements (LREs) in mRNAs are not well defined. Here we show that Lin28 target datasets are enriched for RNA sequences predicted to contain stable planar structures of 4 guanines known as G-quartets (G4s). The imino NMR spectra of pre-let-7 loops and LREs contain resonances characteristic of G4 hydrogen bonds. These sequences bind to a G4-binding fluorescent dye, N-methyl-mesoporphyrin IX (NMM). Mutations and truncations in the RNA sequence that prevent G4 formation also prevent Lin28 binding. The addition of Lin28 to a pre-let-7 loop or an LRE reduces G4 resonance intensity and NMM binding, suggesting that Lin28 may function to remodel G4s. Further, we show that NMM inhibits Lin28 binding. Incubation of a human embryonal carcinoma cell line with NMM reduces its stem cell traits. In particular it increases mature let-7 levels, decreases OCT4, HMGA1, CCNB1, CDK4, and Lin28A protein, decreases sphere formation, and inhibits colony formation. Our results suggest a previously unknown structural feature of Lin28 targets and a new strategy for manipulating Lin28 function.	[O'Day, Elizabeth; Imai, Shunsuke; Arthanari, Haribabu; Wagner, Gerhard] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [O'Day, Elizabeth; Le, Minh T. N.; Tan, Shen Mynn; Lieberman, Judy] Boston Childrens Hosp, Cellular & Mol Med Program, Boston, MA 02115 USA; [Kirchner, Rory; Hofmann, Oliver] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Wagner, G (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	Gerhard_wagner@hms.harvard.edu; Judy.Lieberman@childrens.harvard.edu	Regan, Clinton/E-6250-2012; Lieberman, Judy/A-2717-2015; Hofmann, Oliver/F-1800-2013	LE, Thi Nguyet Minh/0000-0002-6077-1566; Imai, Shunsuke/0000-0001-9346-2359; Arthanari, Haribabu/0000-0002-7281-1289; Kirchner, Rory/0000-0003-4814-5885; Wagner, Gerhard/0000-0002-2063-4401; Hofmann, Oliver/0000-0002-7738-1513	Department of Defense Breast Cancer Research Program [W81 XWH-09-1-0058]; National Institutes of Health [GM047467]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	Department of Defense Breast Cancer Research Program(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Department of Defense Breast Cancer Research Program Grant W81 XWH-09-1-0058 (to J. L.) and National Institutes of Health Grant GM047467 (to G. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Adrian M, 2012, METHODS, V57, P11, DOI 10.1016/j.ymeth.2012.05.003; AMBROS V, 1989, CELL, V57, P49, DOI 10.1016/0092-8674(89)90171-2; AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Arthanari H, 1998, NUCLEIC ACIDS RES, V26, P3724, DOI 10.1093/nar/26.16.3724; Bole M, 2008, MOL BIOSYST, V4, P1212, DOI 10.1039/b812537f; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bugaut A, 2010, ORG BIOMOL CHEM, V8, P2771, DOI 10.1039/c002418j; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; da Silva MW, 2007, METHODS, V43, P264, DOI 10.1016/j.ymeth.2007.05.007; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Drygin D, 2009, CANCER RES, V69, P7653, DOI 10.1158/0008-5472.CAN-09-1304; Furtig B, 2003, CHEMBIOCHEM, V4, P936, DOI 10.1002/cbic.200300700; Grand CL, 2002, MOL CANCER THER, V1, P565; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; HENDERSON E, 1987, CELL, V51, P899, DOI 10.1016/0092-8674(87)90577-0; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Ivanov P, 2014, P NATL ACAD SCI USA, V111, P18201, DOI 10.1073/pnas.1407361111; Jin JY, 2011, NUCLEIC ACIDS RES, V39, P3724, DOI 10.1093/nar/gkq1350; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; King CE, 2011, CANCER RES, V71, P4260, DOI 10.1158/0008-5472.CAN-10-4637; Krishnan-Ghosh Y, 2004, J AM CHEM SOC, V126, P11009, DOI 10.1021/ja049259y; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lightfoot HL, 2011, BIOCHEMISTRY-US, V50, P7514, DOI 10.1021/bi200851d; LIU ZC, 1989, GENE DEV, V3, P2039, DOI 10.1101/gad.3.12b.2039; Loughlin FE, 2012, NAT STRUCT MOL BIOL, V19, P84, DOI 10.1038/nsmb.2202; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; MARSH TC, 1994, BIOCHEMISTRY-US, V33, P10718, DOI 10.1021/bi00201a020; Mayr F, 2012, NUCLEIC ACIDS RES, V40, P7492, DOI 10.1093/nar/gks355; Meirelles K, 2012, P NATL ACAD SCI USA, V109, P2358, DOI 10.1073/pnas.1120733109; Mikami-Terao Y, 2008, CANCER LETT, V261, P226, DOI 10.1016/j.canlet.2007.11.017; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nam Y, 2011, CELL, V147, P1080, DOI 10.1016/j.cell.2011.10.020; Nicoludis JM, 2012, J AM CHEM SOC, V134, P20446, DOI 10.1021/ja3088746; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Palumbo SL, 2009, J AM CHEM SOC, V131, P10878, DOI 10.1021/ja902281d; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Phan AT, 2005, NAT CHEM BIOL, V1, P167, DOI 10.1038/nchembio723; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Simonsson T, 1998, NUCLEIC ACIDS RES, V26, P1167, DOI 10.1093/nar/26.5.1167; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; West JA, 2009, NATURE, V460, P909, DOI 10.1038/nature08210; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Xu Y, 2006, NUCLEIC ACIDS RES, V34, P949, DOI 10.1093/nar/gkj485; Xue DB, 2011, HISTOPATHOLOGY, V59, P452, DOI 10.1111/j.1365-2559.2011.03949.x; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	70	25	26	4	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17909	17922		10.1074/jbc.M115.665521	http://dx.doi.org/10.1074/jbc.M115.665521			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26045559	hybrid, Green Published			2022-12-26	WOS:000358511700025
J	Haase, AT; Rakasz, E; Schultz-Darken, N; Nephew, K; Weisgrau, KL; Reilly, CS; Li, QS; Southern, PJ; Rothenberger, M; Peterson, ML; Schlievert, PM				Haase, Ashley T.; Rakasz, Eva; Schultz-Darken, Nancy; Nephew, Karla; Weisgrau, Kimberly L.; Reilly, Cavan S.; Li, Qingsheng; Southern, Peter J.; Rothenberger, Meghan; Peterson, Marnie L.; Schlievert, Patrick M.			Glycerol Monolaurate Microbicide Protection against Repeat High-Dose SIV Vaginal Challenge	PLOS ONE			English	Article							IMMUNE-RESPONSES; RHESUS MACAQUES; INFECTION; HIV; TRANSMISSION; INOCULATION; WOMEN	Measures to prevent sexual mucosal transmission are critically needed, particularly to prevent transmission to young women at high risk in the microepidemics in South Africa that disproportionally contribute to the continued pandemic. To that end, microbicides containing anti-retroviral (ARV) agents have been shown to prevent transmission, but with efficacy limited both by adherence and pre-existing innate immune and inflammatory conditions in the female reproductive tract (FRT). Glycerol monolaurate (GML) has been proposed as a microbicide component to enhance efficacy by blocking these transmission-facilitating innate immune response to vaginal exposure. We show here in an especially rigorous test of protection in the SIV-rhesus macaque model of HIV-1 transmission to women, that GML used daily and before vaginal challenge protects against repeat high doses of SIV by criteria that include virological and immunological assays to detect occult infection. We also provide evidence for indirect mechanisms of action in GML-mediated protection. Developing a sustained formulation for GML delivery could contribute an independent, complementary protective component to an ARV-containing microbicide.	[Haase, Ashley T.; Li, Qingsheng; Southern, Peter J.; Schlievert, Patrick M.] Univ Minnesota, Sch Med, Dept Microbiol & Immunobiol, Minneapolis, MN 55455 USA; [Rakasz, Eva; Schultz-Darken, Nancy; Nephew, Karla; Weisgrau, Kimberly L.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Reilly, Cavan S.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Rothenberger, Meghan] Univ Minnesota, Sch Med, Dept Med, Div Infect Dis, Minneapolis, MN 55455 USA; [Peterson, Marnie L.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Haase, AT (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol & Immunobiol, Minneapolis, MN 55455 USA.	haase001@umn.edu	Rakasz, Eva G/H-9197-2019	Schlievert, Patrick/0000-0001-8314-9369	National Institutes of Health [AI071976]; Office of the Director, National Institutes of Health [P51OD011106]; Research Facilities Improvement Program [RR15459-01, RR020141-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR020141, C06RR015459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071976, R33AI071976] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Facilities Improvement Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research reported in this publication was supported by National Institutes of Health grant AI071976 and in part by the Office of the Director, National Institutes of Health under Award Number P51OD011106 to the Wisconsin National Primate Research Center, University of Wisconsin-Madison. This research was conducted in part at a facility constructed with support from Research Facilities Improvement Program grant numbers RR15459-01 and RR020141-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, MTN 003 VOICE; Baeten JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001888; Cline AN, 2005, J MED PRIMATOL, V34, P303; Dobard C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007701; Fauci AS, 2008, NATURE, V453, P289, DOI 10.1038/453289a; Friedrich TC, 2004, NAT MED, V10, P275, DOI 10.1038/nm998; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Jones A, 2014, LANCET, V384, P272, DOI 10.1016/S0140-6736(13)62230-8; KARIM QA, 1992, AIDS, V6, P1535, DOI 10.1097/00002030-199212000-00018; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Kaul R, 2008, J REPROD IMMUNOL, V77, P32, DOI 10.1016/j.jri.2007.02.002; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Ma ZM, 2004, J VIROL, V78, P14048, DOI 10.1128/JVI.78.24.14048-14052.2004; Marthas ML, 2001, AIDS RES HUM RETROV, V17, P1455, DOI 10.1089/088922201753197123; McChesney MB, 1998, J VIROL, V72, P10029, DOI 10.1128/JVI.72.12.10029-10035.1998; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; PROJAN SJ, 1994, J BACTERIOL, V176, P4204, DOI 10.1128/jb.176.14.4204-4209.1994; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Schlievert PM, 2008, ANTIMICROB AGENTS CH, V52, P4448, DOI 10.1128/AAC.00989-08; Urdaneta S, 2005, 3 INT AIDS SOC C HIV; Wilson NA, 2006, J VIROL, V80, P5875, DOI 10.1128/JVI.00171-06; Witcher KJ, 1996, CLIN DIAGN LAB IMMUN, V3, P10, DOI 10.1128/CDLI.3.1.10-13.1996	27	23	23	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129465	10.1371/journal.pone.0129465	http://dx.doi.org/10.1371/journal.pone.0129465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057743	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000056
J	Hou, J; Liu, CY; Yao, P; Chen, WH; He, MA; Wang, YJ; Liang, Y; Miao, XP; Wei, S; Xu, T; Fang, WM; Zhu, J; Li, XL; Hu, FB; Wu, TC; Yang, HD; Yuan, J				Hou, Jian; Liu, Chuanyao; Yao, Ping; Chen, Weihong; He, Meian; Wang, Youjie; Liang, Yuan; Miao, Xiaoping; Wei, Sheng; Xu, Tian; Fang, Weimin; Zhu, Jiang; Li, Xiulou; Hu, Frank B.; Wu, Tangchun; Yang, Handong; Yuan, Jing			Association of Adiposity Indices with Platelet Distribution Width and Mean Platelet Volume in Chinese Adults	PLOS ONE			English	Article							BODY-MASS INDEX; TO-HEIGHT RATIO; WAIST CIRCUMFERENCE; METABOLIC SYNDROME; CARDIOMETABOLIC RISK; ABDOMINAL OBESITY; OXIDATIVE STRESS; INFLAMMATION; PREVALENCE; DYSFUNCTION	Hypoxia is a prominent characteristic of inflammatory tissue lesions. It can affect platelet function. While mean platelet volume (MPV) and platelet distribution width (PDW) are sample platelet indices, they may reflect subcinical platelet activation. To investigated associations between adiposity indices and platelet indices, 17327 eligible individuals (7677 males and 9650 females) from the Dongfeng-Tongji Cohort Study (DFTJ-Cohort Study, n=27009) were included in this study, except for 9682 individuals with missing data on demographical, lifestyle, physical indicators and diseases relative to PDW and MPV. Associations between adiposity indices including waist circumstance (WC), waist-to-height ratio (WHtR), body mass index (BMI), and MPV or PDW in the participants were analyzed using multiple logistic regressions. There were significantly negative associations between abnormal PDW and WC or WHtR for both sexes (p(trend)<0.001 for all), as well as abnormal MPV and WC or WHtR among female participants (p(trend)<0.05 for all). In the highest BMI groups, only females with low MPV or PDW were at greater risk for having low MPV (OR=1.33, 95% CI=1.10, 1.62 p(trend)<0.001) or PDW (OR=1.34, 95% CI=1.14, 1.58, p(trend)<0.001) than those who had low MPV or PDW in the corresponding lowest BMI group. The change of PDW seems more sensitive than MPV to oxidative stress and hypoxia. Associations between reduced PDW and MPV values and WC, WHtR and BMI values in Chinese female adults may help us to further investigate early changes in human body.	[Hou, Jian; Liu, Chuanyao; Chen, Weihong; He, Meian; Xu, Tian; Wu, Tangchun; Yuan, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Occupat & Environm Hlth, Wuhan 430030, Hubei, Peoples R China; [Hou, Jian; Liu, Chuanyao; Yao, Ping; Chen, Weihong; He, Meian; Wang, Youjie; Liang, Yuan; Xu, Tian; Wu, Tangchun; Yuan, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, MOE Key Lab Environm & Hlth, Wuhan 430030, Hubei, Peoples R China; [Yao, Ping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg, Wuhan 430030, Hubei, Peoples R China; [Wang, Youjie; Fang, Weimin] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth, Wuhan 430030, Hubei, Peoples R China; [Liang, Yuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Social Med & Hlth Management, Wuhan 430030, Hubei, Peoples R China; [Miao, Xiaoping; Wei, Sheng] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat, Wuhan 430030, Hubei, Peoples R China; [Zhu, Jiang] Dongfeng Motor Corp, Dongfeng Cent Hosp, Phys Examinat Ctr, Shiyan 442008, Hubei, Peoples R China; [Li, Xiulou] Dongfeng Motor Corp, Dongfeng Cent Hosp, Dept Clin Teaching & Sci, Shiyan 442008, Hubei, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA; [Yang, Handong] Dongfeng Motor Corp, Dongfeng Cent Hosp, Dept Cardiol, Shiyan 442008, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Dongfeng Motor; Dongfeng Motor; Harvard University; Harvard T.H. Chan School of Public Health; Dongfeng Motor	Yang, HD (corresponding author), Dongfeng Motor Corp, Dongfeng Cent Hosp, Dept Cardiol, Shiyan 442008, Hubei, Peoples R China.	yanghand@139.com; jyuan@tjh.tjmu.edu.cn	Hou, Jian/AAC-1400-2022; miao, xiaoping/C-4336-2011	Hou, Jian/0000-0002-8478-0416; miao, xiaoping/0000-0002-6818-9722	National Key Basic Research and Development Program [2011CB503800, 2011CB5038004]; 111 Project [B12004]; Program for Changjiang Scholars; Innovative Research Team in University of Ministry of Education of China [IRT1246]; China Medical Board [12-113]; Dongfeng Motor Corporation	National Key Basic Research and Development Program(National Basic Research Program of China); 111 Project(Ministry of Education, China - 111 Project); Program for Changjiang Scholars(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Innovative Research Team in University of Ministry of Education of China(Ministry of Education, China); China Medical Board; Dongfeng Motor Corporation	This work was supported by research funds from the National Key Basic Research and Development Program (2011CB503800, TC, Wu and 2011CB5038004, WH, Chen); the 111 Project (No. B12004, TC, Wu); the Program for Changjiang Scholars (TC, Wu); Innovative Research Team in University of Ministry of Education of China (NO. IRT1246), China Medical Board (No. 12-113, TC, Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dongfeng Motor Corporation only provided support in the form of salaries for authors [J Zhu, XL Li, and HD Yang], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Akbal A, 2014, OSTEOPOROSIS INT, V25, P2291, DOI 10.1007/s00198-014-2764-8; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Anfossi G, 2009, NUTR METAB CARDIOVAS, V19, P440, DOI 10.1016/j.numecd.2009.01.006; Arslan D, 2013, PEDIATR CARDIOL, V34, P1013, DOI 10.1007/s00246-012-0600-5; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2; Chen S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.253; Chen WB, 2013, DIAGNOSTICS; de Gonzalo-Calvo D, 2012, JOURNAL OF CLINICAL, V4, P12; De Luca G, 2014, BLOOD COAGUL FIBRIN, V25, P86, DOI 10.1097/MBC.0b013e32836577a8; Fernandez-Sanchez A, 2011, INT J MOL SCI, V12, P3117, DOI 10.3390/ijms12053117; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Gasparyan AY, 2011, CURR PHARM DESIGN, V17, P47; Gupta S, 2012, INDIAN J CARDIOL, V15, P22; Gutierrez-Fisac JL, 2012, OBES REV, V13, P388, DOI 10.1111/j.1467-789X.2011.00964.x; Jindal S, 2011, HEMATOLOGY, V16, P86, DOI 10.1179/102453311X12902908412110; Kaito K, 2005, BRIT J HAEMATOL, V128, P698, DOI 10.1111/j.1365-2141.2004.05357.x; Khode Vitthal, 2012, J Cardiovasc Dis Res, V3, P272, DOI 10.4103/0975-3583.102694; Lebedeva EV, 2003, B EXP BIOL MED+, V136, P554, DOI 10.1023/B:BEBM.0000020201.51742.28; Li WC, 2013, EUR J NUTR, V52, P57, DOI 10.1007/s00394-011-0286-0; Liang QC, 2014, PLATELETS, V25, P433, DOI 10.3109/09537104.2013.831064; Loef M, 2013, OBESITY, V21, pE51, DOI 10.1002/oby.20037; Nielson CM, 2012, J BONE MINER RES, V27, P1, DOI 10.1002/jbmr.1486; Nurjono M, 2013, ANN ACAD MED SINGAP, V42, P241; Ozturk ZA, 2013, EUR REV MED PHARMACO, V17, P334; Park BJ, 2012, PLATELETS, V23, P45, DOI 10.3109/09537104.2011.589014; Popkin BM, 2014, OBES REV, V15, P60, DOI 10.1111/obr.12120; Popkin BM, 2013, OBES REV, V14, P11, DOI 10.1111/obr.12102; Qadri S, 2013, HIV MED, V14, P549, DOI 10.1111/hiv.12048; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Ravetti MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003111; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Santilli F, 2012, OBES REV, V13, P27, DOI 10.1111/j.1467-789X.2011.00930.x; Santimone I, 2011, HAEMATOL-HEMATOL J, V96, P1180, DOI 10.3324/haematol.2011.043042; Trayhurn P, 2013, PHYSIOL REV, V93, P1, DOI 10.1152/physrev.00017.2012; Vagdatli E, 2010, HIPPOKRATIA, V14, P28; Wang F, 2013, INT J EPIDEMIOL, V42, P731, DOI 10.1093/ije/dys053; Wang RT, 2013, J PSYCHIATR RES, V47, P644, DOI 10.1016/j.jpsychires.2013.01.014; Ware LJ, 2014, NUTR METAB CARDIOVAS, V24, P900, DOI 10.1016/j.numecd.2014.02.005; Xi B, 2012, OBES REV, V13, P287, DOI 10.1111/j.1467-789X.2011.00944.x; Yang F, 2006, CLIN NUTR, V25, P1030, DOI 10.1016/j.clnu.2006.04.009; Zhang J, 2015, J CLIN DENSITOM, V18, P44, DOI 10.1016/j.jocd.2014.03.001; Zhang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104361	43	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129677	10.1371/journal.pone.0129677	http://dx.doi.org/10.1371/journal.pone.0129677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058081	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000069
J	Brennan, RB; Healy, MG; Fenton, O; Lanigan, GJ				Brennan, Raymond B.; Healy, Mark G.; Fenton, Owen; Lanigan, Gary J.			The Effect of Chemical Amendments Used for Phosphorus Abatement on Greenhouse Gas and Ammonia Emissions from Dairy Cattle Slurry: Synergies and Pollution	PLOS ONE			English	Article							NITROUS-OXIDE EMISSION; METHANE EMISSIONS; LIVESTOCK SLURRY; N2O EMISSIONS; CHARCOAL; BIOCHAR; SOIL; VOLATILIZATION; MANURE; MANAGEMENT	Land application of cattle slurry can result in incidental and chronic phosphorus (P) loss to waterbodies, leading to eutrophication. Chemical amendment of slurry has been proposed as a management practice, allowing slurry nutrients to remain available to plants whilst mitigating P losses in runoff. The effectiveness of amendments is well understood but their impacts on other loss pathways (so-called 'pollution swapping' potential) and therefore the feasibility of using such amendments has not been examined to date. The aim of this laboratory scale study was to determine how the chemical amendment of slurry affects losses of NH3, CH4, N2O, and CO2. Alum, FeCl2, Polyaluminium chloride (PAC)-and biochar reduced NH3 emissions by 92, 54, 65 and 77% compared to the slurry control, while lime increased emissions by 114%. Cumulative N2O emissions of cattle slurry increased when amended with alum and FeCl2 by 202% and 154% compared to the slurry only treatment. Lime, PAC and biochar resulted in a reduction of 44, 29 and 63% in cumulative N2O loss compared to the slurry only treatment. Addition of amendments to slurry did not significantly affect soil CO2 release during the study while CH4 emissions followed a similar trend for all of the amended slurries applied, with an initial increase in losses followed by a rapid decrease for the duration of the study. All of the amendments examined reduced the initial peak in CH4 emissions compared to the slurry only treatment. There was no significant effect of slurry amendments on global warming potential (GWP) caused by slurry land application, with the exception of biochar. After considering pollution swapping in conjunction with amendment effectiveness, the amendments recommended for further field study are PAC, alum and lime. This study has also shown that biochar has potential to reduce GHG losses arising from slurry application.	[Brennan, Raymond B.; Healy, Mark G.] Natl Univ Ireland, Civil Engn, Galway, Co Galway, Ireland; [Fenton, Owen; Lanigan, Gary J.] TEAGASC, Environm Res Ctr, Johnstown Castle, Co Wexford, Ireland	Ollscoil na Gaillimhe-University of Galway; Teagasc	Lanigan, GJ (corresponding author), TEAGASC, Environm Res Ctr, Johnstown Castle, Co Wexford, Ireland.	gary.lanigan@teagasc.ie	Brennan, Raymond/K-7363-2014; Fenton, Owen/D-4377-2009; Lanigan, Gary J/C-6864-2012; Healy, Mark/C-1400-2009	Fenton, Owen/0000-0001-7119-2538; Lanigan, Gary J/0000-0003-0813-3097; Healy, Mark/0000-0003-0869-5225	Teagasc Walsh Fellowship Scheme; Anima\Change Framework 7 Project [FP7-KBBE-2010-4]	Teagasc Walsh Fellowship Scheme; Anima\Change Framework 7 Project	This research was funded by the Teagasc Walsh Fellowship Scheme and the Anima vertical bar Change Framework 7 Project (FP7-KBBE-2010-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon B, 2006, AGR ECOSYST ENVIRON, V112, P153, DOI 10.1016/j.agee.2005.08.030; Asada T, 2002, J HEALTH SCI, V48, P473, DOI 10.1248/jhs.48.473; Bol R, 2003, SOIL BIOL BIOCHEM, V35, P1411, DOI 10.1016/S0038-0717(03)00235-9; Bourdin F, 2014, AGR ECOSYST ENVIRON, V188, P122, DOI 10.1016/j.agee.2014.02.025; Brennan RB, 2011, SCI TOTAL ENVIRON, V409, P5111, DOI 10.1016/j.scitotenv.2011.08.016; Brennan RB, 2011, SOIL USE MANAGE, V27, P238, DOI 10.1111/j.1475-2743.2011.00326.x; British Standards, 1990, 1377 BS, P2; British Standards Determination by mass-loss on ignition, 1990, BRIT STAND DET MASS, P3; Bruun EW, 2011, EUR J SOIL SCI, V62, P581, DOI 10.1111/j.1365-2389.2011.01377.x; Buda AR, 2009, J ENVIRON QUAL, V38, P2273, DOI 10.2134/jeq2008.0501; Byrne E., 1979, CHEM ANAL AGR MAT ME; Carpenter SR, 1998, ECOL APPL, V8, P559, DOI 10.1890/1051-0761(1998)008[0559:NPOSWW]2.0.CO;2; Chadwick D, AGR ECOSYST ENV, V197, P51; Chadwick DR, 2000, J ENVIRON QUAL, V29, P277, DOI 10.2134/jeq2000.00472425002900010035x; Clough TJ, 2010, J ENVIRON QUAL, V39, P1218, DOI 10.2134/jeq2010.0204; Correll DL, 1998, J ENVIRON QUAL, V27, P261, DOI 10.2134/jeq1998.00472425002700020004x; Crutzen P.J., 1981, DENITRIFICATION NITR, P17; Dao TH, 2002, J ENVIRON QUAL, V31, P1388, DOI 10.2134/jeq2002.1388; Dao TH, 1999, J ENVIRON QUAL, V28, P1114, DOI 10.2134/jeq1999.00472425002800040008x; Ding Y, 2010, WATER AIR SOIL POLL, V213, P47, DOI 10.1007/s11270-010-0366-4; Duffy P., 2012, IRELAND NATL INVENTO; Ellis S, 1998, PLANT SOIL, V202, P15, DOI 10.1023/A:1004332209345; EPA, 2010, ENV PROT AG TRENDS N; Ferm M, 1998, NUTR CYCL AGROECOSYS, V51, P5, DOI 10.1023/A:1009780030477; Goulding KWT, 1998, NEW PHYTOL, V139, P49, DOI 10.1046/j.1469-8137.1998.00182.x; Hyde BP, 2003, ATMOS ENVIRON, V37, P55, DOI 10.1016/S1352-2310(02)00692-1; Intergovernmental Panel on Climate Change, 1996, IPCC GUIDELINES NATL, V2, P335; Iyobe T, 2004, J HEALTH SCI, V50, P148; Kammann C, 2012, J ENVIRON QUAL, V41, P1052, DOI 10.2134/jeq2011.0132; Kasimir-Klemedtsson A, 1997, SOIL USE MANAGE, V13, P245, DOI 10.1111/j.1475-2743.1997.tb00595.x; KISSEL DE, 1977, SOIL SCI SOC AM J, V41, P1133, DOI 10.2136/sssaj1977.03615995004100060024x; Lalor S, 2012, COSTS AMMONIA ABATEM; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Meade G, 2011, AGR ECOSYST ENVIRON, V140, P208, DOI 10.1016/j.agee.2010.12.007; Meisinger John J., 2001, TheScientificWorldJOURNAL, V1, P860, DOI 10.1100/tsw.2001.100; Misselbrook TH, 2002, BIOSYST ENG, V81, P313, DOI 10.1006/bioe.2001.0017; Misselbrook TH, 2000, ATMOS ENVIRON, V34, P871, DOI 10.1016/S1352-2310(99)00350-7; Moore PA, 1999, POULTRY SCI, V78, P692, DOI 10.1093/ps/78.5.692; Oya A, 2002, CARBON, V40, P1391, DOI 10.1016/S0008-6223(01)00273-1; PAIN BF, 1989, J SCI FOOD AGR, V47, P1, DOI 10.1002/jsfa.2740470102; Rodhe L, 2006, SOIL USE MANAGE, V22, P229, DOI 10.1111/j.1475-2743.2006.00043.x; SAS, 2004, SAS WIND VERS 9 1 SA; Sherlock RR, 2002, J ENVIRON QUAL, V31, P1491, DOI 10.2134/jeq2002.1491; Shi Y, 2001, T ASAE, V44, P677; Smith E, 2009, J ENVIRON MANAGE, V90, P2531, DOI 10.1016/j.jenvman.2009.01.012; Smith KA, 2000, J AGR ENG RES, V77, P277, DOI 10.1006/jaer.2000.0604; Sogaard HT, 2002, ATMOS ENVIRON, V36, P3309, DOI 10.1016/S1352-2310(02)00300-X; Sommer SG, 2006, J AGR SCI, V144, P229, DOI 10.1017/S0021859606006022; Sommer SG, 2003, EUR J AGRON, V19, P465, DOI 10.1016/S1161-0301(03)00037-6; Spokas K. A., 2009, Annals of Environmental Science, V3, P179; Stark C.H., 2008, DYN SOIL DYN PLANT, V2, P1; Steiner C, 2008, J PLANT NUTR SOIL SC, V171, P893, DOI 10.1002/jpln.200625199; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Steiner C, 2010, J ENVIRON QUAL, V39, P1236, DOI 10.2134/jeq2009.0337; Stevens CJ, 2009, PHYS CHEM EARTH, V34, P589, DOI 10.1016/j.pce.2008.01.001; Streubel J, 2010, ASA CSSA SSSA 2010 I; Velthof GL, 1997, NETH J AGR SCI, V45, P347; Velthof GL, 2002, NUTR CYCL AGROECOSYS, V62, P249, DOI 10.1023/A:1021259107244; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Wardle DA, 2008, SCIENCE, V320, P629, DOI 10.1126/science.1154960; Wulf S, 2002, J ENVIRON QUAL, V31, P1795, DOI 10.2134/jeq2002.1795; Yanai Y, 2007, SOIL SCI PLANT NUTR, V53, P181, DOI 10.1111/j.1747-0765.2007.00123.x	62	23	23	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0111965	10.1371/journal.pone.0111965	http://dx.doi.org/10.1371/journal.pone.0111965			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053923	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300002
J	Gella, L; Raman, R; Kulothungan, V; Pal, SS; Ganesan, S; Sharma, T				Gella, Laxmi; Raman, Rajiv; Kulothungan, Vaitheeswaran; Pal, Swakshyar Saumya; Ganesan, Suganeswari; Sharma, Tarun			Impairment of Colour Vision in Diabetes with No Retinopathy: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetics Study (SNDREAMS-II, Report 3)	PLOS ONE			English	Article							RISK-FACTORS; CATARACT; NEPHROPATHY; MELLITUS	Purpose To assess impairment of colour vision in type 2 diabetics with no diabetic retinopathy and elucidate associated risk factors in a population-based cross-sectional study. Methods This is part of Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular-genetics Study (SN-DREAMS II) which was conducted between 2007-2010. FM 100 hue-test was performed in 253 subjects with no clinical evidence of diabetic retinopathy. All subjects underwent detailed ophthalmic evaluation including cataract grading using LOCS III and 45 degrees 4-field stereoscopic fundus photography. Various ocular and systemic risk factors for impairment of colour vision (ICV) were assessed in subjects with diabetes but no retinopathy. P value of < 0.05 was considered statistically significant. Results The mean age of the study sample was 57.08 +/- 9.21 (range: 44-86 years). Gender adjusted prevalence of ICV among subjects with diabetes with no retinopathy was 39.5% (CI: 33.5-45.5). The mean total error score in the study sample was 197.77 +/- 100 (range: 19-583). The risk factors for ICV in the study were women OR: 1.79 (1.00-3.18), increased resting heart rate OR: 1.04 (1.01-1.07) and increased intraocular pressure OR: 1.12 (1.00-1.24). Significant protective factor was serum high-density lipoprotein OR: 0.96 (0.93-0.99). Conclusions Acquired ICV is an early indicator of neurodegenerative changes in the retina. ICV found in diabetic subjects without retinopathy may be of non-vascular etiology.	[Gella, Laxmi] Elite Sch Optometry, Madras, Tamil Nadu, India; [Gella, Laxmi] Birla Inst Technol & Sci, Pilani, Rajasthan, India; [Raman, Rajiv; Pal, Swakshyar Saumya; Ganesan, Suganeswari; Sharma, Tarun] Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India; [Kulothungan, Vaitheeswaran] Manonmaniam Sundaranar Univ, Tirunelveli, Tamilnadu, India	Birla Institute of Technology & Science Pilani (BITS Pilani); Manonmaniam Sundaranar University	Sharma, T (corresponding author), Sankara Nethralaya, Shri Bhagwan Mahavir Vitreoretinal Serv, Madras, Tamil Nadu, India.	drtaruns@gmail.com	Kulothungan, Vaitheeswaran/HGB-7707-2022; Raman, Rajiv/A-7234-2009	Raman, Rajiv/0000-0001-5842-0233	Jamshetji Tata trust, Mumbai	Jamshetji Tata trust, Mumbai	Jamshetji Tata trust, Mumbai. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Agarwal S, 2005, OPHTHAL EPIDEMIOL, V12, P143, DOI 10.1080/09286580590932734; Anandaraja S, 2005, INT J CARDIOL, V102, P117, DOI 10.1016/j.ijcard.2004.05.009; Andrade LCO, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-104; Bosman DR, 2001, DIABETES CARE, V24, P495, DOI 10.2337/diacare.24.3.495; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; Eisner A, 2008, VISION RES, V48, P2663, DOI 10.1016/j.visres.2008.01.029; Feitosa-Santana C, 2010, OPHTHAL PHYSL OPT, V30, P717, DOI 10.1111/j.1475-1313.2010.00776.x; Fong DS, 1999, AM J OPHTHALMOL, V128, P612, DOI 10.1016/S0002-9394(99)00227-5; Giuffre G, 2007, OPHTHALMOLOGICA, V221, P47, DOI 10.1159/000096522; Kessel L, 1999, BRIT J OPHTHALMOL, V83, P1042, DOI 10.1136/bjo.83.9.1042; Leske MC, 1997, OPHTHALMOLOGY, V104, P1987, DOI 10.1016/S0161-6420(97)30043-8; Namperumalsamy P, 2003, DIABETES CARE, V26, P1831, DOI 10.2337/diacare.26.6.1831; Nork T M, 2000, Trans Am Ophthalmol Soc, V98, P331; Ong GL, 2003, BRIT J OPHTHALMOL, V87, P747, DOI 10.1136/bjo.87.6.747; Papaconstantinou D, 2009, CLIN OPHTHALMOL, V3, P251; Raman R, 2011, INVEST OPHTH VIS SCI, V52, P4592, DOI 10.1167/iovs.10-6903; Raman R, 2010, INVEST OPHTH VIS SCI, V51, P6253, DOI 10.1167/iovs.10-5414; Shaw JE, 1998, DIABETES RES CLIN PR, V39, P55, DOI 10.1016/S0168-8227(97)00122-8; Shin YJ, 2005, J KOREAN OPHTHALMOL, V46, P78; Shin YJ, 2014, INVEST OPHTH VIS SCI, V55, P25, DOI 10.1167/iovs.13-11698; Shoji T, 2011, DIABETIC MED, V28, P865, DOI 10.1111/j.1464-5491.2011.03290.x; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Ventruba J, 2006, Cesk Slov Oftalmol, V62, P133; Verma A, 2009, EYE, V23, P1824, DOI 10.1038/eye.2009.184; VERRIEST G, 1982, AM J OPHTHALMOL, V93, P635, DOI 10.1016/S0002-9394(14)77380-5; Zahiruddin Kowser, 2010, Korean J Ophthalmol, V24, P159, DOI 10.3341/kjo.2010.24.3.159	26	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129391	10.1371/journal.pone.0129391	http://dx.doi.org/10.1371/journal.pone.0129391			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053017	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300123
J	Gomez, AV; Cordova, G; Munita, R; Parada, GE; Barrios, AP; Cancino, GI; Alvarez, AR; Andres, ME				Gomez, Andrea V.; Cordova, Gonzalo; Munita, Roberto; Parada, Guillermo E.; Barrios, Alvaro P.; Cancino, Gonzalo I.; Alvarez, Alejandra R.; Andres, Maria E.			Characterizing HSF1 Binding and Post-Translational Modifications of hsp70 Promoter in Cultured Cortical Neurons: Implications in the Heat-Shock Response	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITION; STRESS-RESPONSE; DIFFERENT MECHANISMS; GENE-TRANSCRIPTION; PROTEIN INDUCTION; MOTOR-NEURONS; PC12 CELLS; RAT-BRAIN; IN-VIVO; EXPRESSION	Causes of lower induction of Hsp70 in neurons during heat shock are still a matter of debate. To further inquire into the mechanisms regulating Hsp70 expression in neurons, we studied the activity of Heat Shock Factor 1 (HSF1) and histone posttranslational modifications (PTMs) at the hsp70 promoter in rat cortical neurons. Heat shock induced a transient and efficient translocation of HSF1 to neuronal nuclei. However, no binding of HSF1 at the hsp70 promoter was detected while it bound to the hsp25 promoter in cortical neurons during heat shock. Histone PTMs analysis showed that the hsp70 promoter harbors lower levels of histone H3 and H4 acetylation in cortical neurons compared to PC12 cells under basal conditions. Transcriptomic profiling data analysis showed a predominant usage of cryptic transcriptional start sites at hsp70 gene in the rat cerebral cortex, compared with the whole brain. These data support a weaker activation of hsp70 canonical promoter. Heat shock increased H3Ac at the hsp70 promoter in PC12 cells, which correlated with increased Hsp70 expression while no modifications occurred at the hsp70 promoter in cortical neurons. Increased histone H3 acetylation by Trichostatin A led to hsp70 mRNA and protein induction in cortical neurons. In conclusion, we found that two independent mechanisms maintain a lower induction of Hsp70 in cortical neurons. First, HSF1 fails to bind specifically to the hsp70 promoter in cortical neurons during heat shock and, second, the hsp70 promoter is less accessible in neurons compared to non-neuronal cells due to histone deacetylases repression.	[Gomez, Andrea V.; Cordova, Gonzalo; Munita, Roberto; Parada, Guillermo E.; Barrios, Alvaro P.; Cancino, Gonzalo I.; Alvarez, Alejandra R.; Andres, Maria E.] Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Santiago, Chile	Pontificia Universidad Catolica de Chile	Gomez, AV (corresponding author), Pontificia Univ Catolica Chile, Dept Cellular & Mol Biol, Fac Biol Sci, Ave Libertador Bernardo OHiggins, Santiago, Chile.	andreagomez.z@gmail.com; mandres@bio.puc.cl	Córdova, Gonzalo/AAQ-8784-2020; Munita, Roberto/B-3143-2010; Cancino, Gonzalo/ABF-6049-2021	Parada, Guillermo/0000-0003-1018-9882; Cancino, Gonzalo/0000-0001-8697-7282; Munita, Roberto/0000-0002-6605-7160; Alvarez Rojas, Alejandra/0000-0002-8129-9280; Cordova, Gonzalo/0000-0002-9585-4740	Fondo Nacional de Desarrollo Cientifico y Tecnologico [1110352]; Millennium Scientific Initiative [N P10/063-F]	Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Scientific Initiative	This work was supported by the Fondo Nacional de Desarrollo Cientifico y Tecnologico (http://www.conicyt.cl/fondecyt/sobre-fondecyt/quees-fondecyt/) Grant # 1110352 to MEA and Millennium Scientific Initiative ( http://www.iniciativamilenio.cl) grant N P10/063-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerfelt M, 2010, NAT REV MOL CELL BIO, V11, P545, DOI 10.1038/nrm2938; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Atanur SS, 2010, GENOME RES, V20, P791, DOI 10.1101/gr.103499.109; Barrios AP, 2014, MOL CELL BIOL, V34, P2760, DOI 10.1128/MCB.00083-14; Batulan Z, 2003, J NEUROSCI, V23, P5789; Blanco EH, 2011, NEUROPEPTIDES, V45, P273, DOI 10.1016/j.npep.2011.05.002; Calderwood S K, 2010, Sign Transduct Insights, V2, P13; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Drujan D, 1999, SHOCK, V12, P443, DOI 10.1097/00024382-199912000-00005; Dwyer DS, 1996, NEUROCHEM RES, V21, P659, DOI 10.1007/BF02527722; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Galleguillos D, 2010, J NEUROCHEM, V114, P1158, DOI 10.1111/j.1471-4159.2010.06841.x; Gomez AV, 2008, MOL CELL, V31, P222, DOI 10.1016/j.molcel.2008.06.015; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guertin MJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002610; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hatayama T, 1997, J BIOCHEM-TOKYO, V122, P904; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Marcuccilli CJ, 1996, J NEUROSCI, V16, P478; MARINI AM, 1990, J NEUROCHEM, V54, P1509, DOI 10.1111/j.1471-4159.1990.tb01198.x; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; MATHUR SK, 1994, P NATL ACAD SCI USA, V91, P8695, DOI 10.1073/pnas.91.18.8695; Merkin J, 2012, SCIENCE, V338, P1593, DOI 10.1126/science.1228186; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Moloney TC, 2014, CNS NEUROSCI THER, V20, P50, DOI 10.1111/cns.12200; MORRISONBOGORAD M, 1994, J NEUROCHEM, V63, P857; NISHIMURA RN, 1991, MOL BRAIN RES, V9, P39, DOI 10.1016/0169-328X(91)90128-K; Nishimura RN, 1996, MOL BRAIN RES, V36, P227, DOI 10.1016/0169-328X(95)00261-P; Oza J, 2008, CELL STRESS CHAPERON, V13, P73, DOI 10.1007/s12192-008-0013-9; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; SCHILLER P, 1988, J MOL BIOL, V203, P97, DOI 10.1016/0022-2836(88)90094-0; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Tagawa K, 2007, J NEUROSCI, V27, P868, DOI 10.1523/JNEUROSCI.4522-06.2007; Taylor DM, 2007, MOL CELL NEUROSCI, V34, P20, DOI 10.1016/j.mcn.2006.09.007; Tonkiss J, 2005, INT J HYPERTHER, V21, P433, DOI 10.1080/02656730500165514; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Verma P, 2014, J NEUROSCI, V34, P1599, DOI 10.1523/JNEUROSCI.3039-13.2014; Walsh D, 1997, CELL MOL LIFE SCI, V53, P198, DOI 10.1007/PL00000592; Wang HM, 2004, J NEUROSCI, V24, P10963, DOI 10.1523/JNEUROSCI.3461-04.2004; Wang Y, 2014, GENOMICS, V103, P222, DOI 10.1016/j.ygeno.2014.02.002; Wood SH, 2013, AGE, V35, P763, DOI 10.1007/s11357-012-9410-1; Yang JX, 2008, BRAIN RES, V1203, P39, DOI 10.1016/j.brainres.2008.01.082; Zhang Y, 2002, J CELL BIOCHEM, V86, P376, DOI 10.1002/jcb.10232; Zhang Z, 2014, SCI WORLD J, DOI 10.1155/2014/938348	55	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129329	10.1371/journal.pone.0129329	http://dx.doi.org/10.1371/journal.pone.0129329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053851	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300119
J	Taraszkiewicz, A; Szewczyk, G; Sarna, T; Bielawski, KP; Nakonieczna, J				Taraszkiewicz, Aleksandra; Szewczyk, Grzegorz; Sarna, Tadeusz; Bielawski, Krzysztof P.; Nakonieczna, Joanna			Photodynamic Inactivation of Candida albicans with Imidazoacridinones: Influence of Irradiance, Photosensitizer Uptake and Reactive Oxygen Species Generation	PLOS ONE			English	Article							CATIONIC PORPHYRINS; ANTINEOPLASTIC AGENTS; ESCHERICHIA-COLI; THERAPY; RESISTANCE; VIABILITY; BACTERIAL; LIGHT; SUSCEPTIBILITY; EPIDEMIOLOGY	The increasing applicability of antifungal treatments, the limited range of available drug classes and the emergence of drug resistance in Candida spp. suggest the need for new treatment options. To explore the applicability of C. albicans photoinactivation, we examined nine structurally different imidazoacridinone derivatives as photosensitizing agents. The most effective derivatives showed a > 10(4)-fold reduction of viable cell numbers. The fungicidal action of the three most active compounds was compared at different radiant powers (3.5 to 63 mW/cm(2)),and this analysis indicated that 7 mW/cm2 was the most efficient. The intracellular accumulation of these compounds in fungal cells correlated with the fungicidal activity of all 9 derivatives. The lack of effect of verapamil, an inhibitor targeting Candida ABC efflux pumps, suggests that these imidazoacridinones are not substrates for ABC transporters. Thus, unlike azoles, a major class of antifungals used against Candida, ABC transporter-mediated resistance is unlikely. Electron paramagnetic resonance (EPR)-spin trapping data suggested that the fungicidal light-induced action of these derivatives might depend on the production of superoxide anion. The highest generation rate of superoxide anion was observed for 1330H, 1610H, and 1611. Singlet oxygen production was also detected upon the irradiation of imidazoacridinone derivatives with UV laser light, with a low to moderate yield, depending on the type of compound. Thus, imidazoacridinone derivatives examined in the present study might act via mixed type I/type II photodynamic mechanism. The presented data indicate lack of direct correlation between the structures of studied imidazoacridinones, cell killing ability, and ROS production. However, we showed for the first time that for imidazoacridinones not only intracellular accumulation is necessary prerequisite of lethal photosensitization of C. albicans, but also localization within particular cellular structures. Our findings present IA derivatives as efficient antifungal photosensitizers with a potential to be used in local treatment of Candida infection.	[Taraszkiewicz, Aleksandra; Bielawski, Krzysztof P.; Nakonieczna, Joanna] Univ Gdansk, Lab Mol Diagnost, Intercollegiate Fac Biotechnol, PL-80952 Gdansk, Poland; [Taraszkiewicz, Aleksandra; Szewczyk, Grzegorz; Bielawski, Krzysztof P.; Nakonieczna, Joanna] Med Univ Gdansk, Gdansk, Poland; [Szewczyk, Grzegorz; Sarna, Tadeusz] Jagiellonian Univ, Dept Biophys, Fac Biochem Biophys & Biotechnol, Krakow, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Jagiellonian University	Nakonieczna, J (corresponding author), Univ Gdansk, Lab Mol Diagnost, Intercollegiate Fac Biotechnol, PL-80952 Gdansk, Poland.	joanna.nakonieczna@biotech.ug.edu.pl	Bielawski, Krzysztof/ABA-6143-2021; Szewczyk, Grzegorz/AAL-7326-2020	Bielawski, Krzysztof/0000-0002-5812-6314; Szewczyk, Grzegorz/0000-0003-0834-1080; Nakonieczna, Joanna/0000-0002-2420-664X	National Science Center [NCN 2013/09/B/NZ7.00410, 2011/03/B/NZ1/00007, NCN 2013/09/N/NZ1/00188]; LiSMIDoS-Life Sciences and Mathematics Interdisciplinary Doctoral Studies	National Science Center(National Science Centre, Poland); LiSMIDoS-Life Sciences and Mathematics Interdisciplinary Doctoral Studies	Financial support for this work was obtained from the National Science Center grant no: NCN 2013/09/B/NZ7.00410 (JN), 2011/03/B/NZ1/00007 (TS), and NCN 2013/09/N/NZ1/00188 (AT). AT is supported by LiSMIDoS-Life Sciences and Mathematics Interdisciplinary Doctoral Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adar Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.30; Alves E, 2008, J IND MICROBIOL BIOT, V35, P1447, DOI 10.1007/s10295-008-0446-2; Alves E, 2014, FUTURE MED CHEM, V6, P141, DOI 10.4155/fmc.13.211; [Anonymous], 2010, [No title captured], Patent No. 20100137351; Arendrup MC, 2010, CURR OPIN CRIT CARE, V16, P445, DOI 10.1097/MCC.0b013e32833e84d2; Beirao S, 2014, PHOTOCHEM PHOTOBIOL, V90, P1387, DOI 10.1111/php.12331; Bliss JM, 2004, ANTIMICROB AGENTS CH, V48, P2000, DOI 10.1128/AAC.48.6.2000-2006.2004; Chibebe J, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-217; Cholody W. M., 1993, United Staes Patent, Patent No. [5,231,100, 5231100]; CHOLODY WM, 1990, J MED CHEM, V33, P2852, DOI 10.1021/jm00172a028; CHOLODY WM, 1990, J MED CHEM, V33, P49, DOI 10.1021/jm00163a009; Cholody WM, 1996, J MED CHEM, V39, P1028, DOI 10.1021/jm950564r; Cizekova L, 2014, BIOORGAN MED CHEM, V22, P4684, DOI 10.1016/j.bmc.2014.07.013; Clennan EL, 2005, TETRAHEDRON, V61, P6665, DOI 10.1016/j.tet.2005.04.017; Costa L, 2010, PHOTOCH PHOTOBIO SCI, V9, P1126, DOI 10.1039/c0pp00051e; Costa L, 2011, ANTIVIR RES, V91, P278, DOI 10.1016/j.antiviral.2011.06.007; Dai TH, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00120, 10.3389/fmicb.2012.00417]; Dai TH, 2011, ANTIMICROB AGENTS CH, V55, P5710, DOI 10.1128/AAC.05404-11; Mima EGD, 2010, ORAL SURG ORAL MED O, V109, P392, DOI 10.1016/j.tripleo.2009.10.006; Eichner A, 2013, PHOTOCH PHOTOBIO SCI, V12, P135, DOI 10.1039/c2pp25164g; Milanesio ME, 2013, PHOTODIAGN PHOTODYN, V10, P320, DOI 10.1016/j.pdpdt.2013.01.007; Felgentrager A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.4.045002; Giuliani F, 2010, ANTIMICROB AGENTS CH, V54, P637, DOI 10.1128/AAC.00603-09; Gonzales FP, 2013, FUTURE MICROBIOL, V8, P785, DOI [10.2217/FMB.13.44, 10.2217/fmb.13.44]; Gonzales FP, 2012, FUNGAL BIOL-UK, V116, P1, DOI 10.1016/j.funbio.2011.10.001; Halliwell B, 2000, FREE RADICALS IN BIO; Henderson BW, 2006, LASER SURG MED, V38, P489, DOI 10.1002/lsm.20327; Junqueira JC, 2009, LASER MED SCI, V24, P877, DOI 10.1007/s10103-009-0673-4; Kozinska A, 2012, ISR J CHEM, V52, P745, DOI 10.1002/ijch.201200019; KRISHNA CM, 1991, PHOTOCHEM PHOTOBIOL, V54, P51, DOI 10.1111/j.1751-1097.1991.tb01984.x; Lam M, 2011, PHOTOCHEM PHOTOBIOL, V87, P904, DOI 10.1111/j.1751-1097.2011.00938.x; Lambrechts SAG, 2005, ANTIMICROB AGENTS CH, V49, P2026, DOI 10.1128/AAC.49.5.2026-2034.2005; Lopez-Chicon P, 2012, PHOTOCH PHOTOBIO SCI, V11, P1099, DOI 10.1039/c2pp25105a; Machado-de-Sena RM, 2014, PHOTODIAGN PHOTODYN, V11, P275, DOI 10.1016/j.pdpdt.2014.03.013; Mantareva V, 2011, EUR J MED CHEM, V46, P4430, DOI 10.1016/j.ejmech.2011.07.015; MARTIN JP, 1987, ARCH BIOCHEM BIOPHYS, V256, P39, DOI 10.1016/0003-9861(87)90423-1; Martins JD, 2011, ORAL SURG ORAL MED O, V111, P71, DOI 10.1016/j.tripleo.2010.08.012; Maubon D, 2014, INTENS CARE MED, V40, P1241, DOI 10.1007/s00134-014-3404-7; Mroz P, 2007, PHOTOCH PHOTOBIO SCI, V6, P1139, DOI 10.1039/b711141j; Munin E, 2007, J PHOTOCH PHOTOBIO B, V88, P16, DOI 10.1016/j.jphotobiol.2007.04.011; Cormick MP, 2011, PHOTOCH PHOTOBIO SCI, V10, P1556, DOI 10.1039/c1pp05074e; Pereira CA, 2011, LASER MED SCI, V26, P341, DOI 10.1007/s10103-010-0852-3; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; PRASAD R, 1995, CURR GENET, V27, P320, DOI 10.1007/BF00352101; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Prates RA, 2011, J ANTIMICROB CHEMOTH, V66, P1525, DOI 10.1093/jac/dkr160; Prates RA, 2009, LASER PHYS, V19, P1038, DOI 10.1134/S1054660X09050284; Rodrigues MCO, 2014, J NEUROIMMUNOL, V269, P1, DOI [10.1016/j.jneuroim.2013.09.020, 10.1016/iineuroim.2013.09.020]; Schindl A, 2001, HAUTARZT, V52, P779, DOI 10.1007/s001050170065; Souza RC, 2010, LASER MED SCI, V25, P385, DOI 10.1007/s10103-009-0706-z; Taraszkiewicz A, 2013, APPL ENVIRON MICROB, V79, P3692, DOI 10.1128/AEM.00748-13; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; Teichert MC, 2002, ORAL SURG ORAL MED O, V93, P155, DOI 10.1067/moe.2002.120051; Wainwright M, 2010, INT J ANTIMICROB AG, V36, P14, DOI 10.1016/j.ijantimicag.2010.03.002; Yang YT, 2013, LASER SURG MED, V45, P175, DOI 10.1002/lsm.22124; Zeina B, 2003, BRIT J DERMATOL, V148, P229, DOI 10.1046/j.1365-2133.2003.05091.x; Zeina B, 2001, BRIT J DERMATOL, V144, P274, DOI 10.1046/j.1365-2133.2001.04013.x	57	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129301	10.1371/journal.pone.0129301	http://dx.doi.org/10.1371/journal.pone.0129301			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053272	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300114
J	Tsubokura, M; Kato, S; Morita, T; Nomura, S; Kami, M; Sakaihara, K; Hanai, T; Oikawa, T; Kanazawa, Y				Tsubokura, Masaharu; Kato, Shigeaki; Morita, Tomohiro; Nomura, Shuhei; Kami, Masahiro; Sakaihara, Kikugoro; Hanai, Tatsuo; Oikawa, Tomoyoshi; Kanazawa, Yukio			Assessment of the Annual Additional Effective Doses amongst Minamisoma Children during the Second Year after the Fukushima Daiichi Nuclear Power Plant Disaster	PLOS ONE			English	Article							CHERNOBYL ACCIDENT; INTERNAL EXPOSURE; CS-137; CONTAMINATION; RADIOCESIUM; INGESTION; UKRAINE; ADULTS; OBLAST	An assessment of the external and internal radiation exposure levels, which includes calculation of effective doses from chronic radiation exposure and assessment of long-term radiation-related health risks, has become mandatory for residents living near the nuclear power plant in Fukushima, Japan. Data for all primary and secondary children in Minamisoma who participated in both external and internal screening programs were employed to assess the annual additional effective dose acquired due to the Fukushima Daiichi nuclear power plant disaster. In total, 881 children took part in both internal and external radiation exposure screening programs between 1st April 2012 to 31st March 2013. The level of additional effective doses ranged from 0.025 to 3.49 mSv/year with the median of 0.70 mSv/year. While 99.7% of the children (n = 878) were not detected with internal contamination, 90.3% of the additional effective doses was the result of external radiation exposure. This finding is relatively consistent with the doses estimated by the United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR). The present study showed that the level of annual additional effective doses among children in Minamisoma has been low, even after the inter-individual differences were taken into account. The dose from internal radiation exposure was negligible presumably due to the success of contaminated food control.	[Tsubokura, Masaharu; Kami, Masahiro] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan; [Tsubokura, Masaharu; Sakaihara, Kikugoro; Hanai, Tatsuo; Oikawa, Tomoyoshi; Kanazawa, Yukio] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, Fukushima, Japan; [Tsubokura, Masaharu; Kato, Shigeaki; Morita, Tomohiro] Soma Cent Hosp, Dept Radiat Protect, Soma, Fukushima, Japan; [Nomura, Shuhei] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England	University of Tokyo; Imperial College London	Tsubokura, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan.	tsubokura-tky@umin.ac.jp	Tsubokura, Masaharu/D-7300-2017; Nomura, Shuhei/HCH-5356-2022; Tsubokura, Masaharu/AAV-4364-2021; Hayano, Ryugo/F-7889-2012	Tsubokura, Masaharu/0000-0001-8027-202X; Tsubokura, Masaharu/0000-0001-8027-202X; Hayano, Ryugo/0000-0002-1214-7806; Nomura, Shuhei/0000-0002-2963-7297	Japan Health Foundation [145100000258]	Japan Health Foundation(Japan Health Foundation)	This work was supported by Japan Health Foundation Grant Number 145100000258.	Atomic Energy Society of Japan T, 2013, NIPPON GENSHIRYOKU G, V55, P91; Balonov MI, 2007, RADIAT PROT DOSIM, V127, P491, DOI 10.1093/rpd/ncm301; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; Hirayama Hideo, 2013, Radioisotopes, V62, P335; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; International_Commission_on_Radiological_Protection, 1992, ANN ICRP, V67; Kurihara O, 2014, CURR STAT ISSU; Likhtarev IA, 1996, HEALTH PHYS, V70, P297, DOI 10.1097/00004032-199603000-00001; Likhtarev IA, 2000, HEALTH PHYS, V79, P341, DOI 10.1097/00004032-200010000-00002; Nomura S, 2015, ENVIRON SCI TECHNOL, V49, P1009, DOI 10.1021/es503504y; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Sugimoto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065331; Sugimoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106377; Tonnessen A, 2002, J TRAUMA STRESS, V15, P453, DOI 10.1023/A:1020961604434; Toohey RE, 2008, HEALTH PHYS, V95, P26, DOI 10.1097/01.HP.0000285798.55584.6d; Tsubokura M, 2015, HEALTH PHYS, V108, P39, DOI 10.1097/HP.0000000000000167; Tsubokura M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100302; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR, 2014, ANN A LEV EFF RAD EX; UNSCEAR, 1988, ANN D EXP CHERN ACC; World Health Organization. International Expert Working G, 2013, HLTH RISK ASS NUCL A, DOI [10.2471/BLT.13.030613, DOI 10.2471/BLT.13.030613]; Yoshida K, 2012, RADIAT PROT DOSIM, V151, P144, DOI 10.1093/rpd/ncr466; Yoshida-Ohuchi H, 2013, RADIAT PROT DOSIM, V154, P385, DOI 10.1093/rpd/ncs245; Zhang H, 2014, INT J ENV RES PUB HE, V11, P9286, DOI 10.3390/ijerph110909286	24	27	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129114	10.1371/journal.pone.0129114	http://dx.doi.org/10.1371/journal.pone.0129114			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053271	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300088
J	Beltra, A; Addison, P; Avalos, JA; Crochard, D; Garcia-Mari, F; Guerrieri, E; Giliomee, JH; Malausa, T; Navarro-Campos, C; Palero, F; Soto, A				Beltra, Aleixandre; Addison, Pia; Avalos, Juan Antonio; Crochard, Didier; Garcia-Mari, Ferran; Guerrieri, Emilio; Giliomee, Jan H.; Malausa, Thibaut; Navarro-Campos, Cristina; Palero, Ferran; Soto, Antonia			Guiding Classical Biological Control of an Invasive Mealybug Using Integrative Taxonomy	PLOS ONE			English	Article							PARACOCCUS-MARGINATUS HEMIPTERA; GYRANUSOIDEA-TEBYGI NOYES; MOLECULAR-IDENTIFICATION; SCALE INSECTS; MORPHOLOGICAL CHARACTERIZATION; BIOTYPE B; PSEUDOCOCCIDAE; HYMENOPTERA; PARASITOIDS; HOMOPTERA	Delottococcus aberiae De Lotto (Hemiptera: Pseudococcidae) is a mealybug of Southern African origin that has recently been introduced into Eastern Spain. It causes severe distortions on young citrus fruits and represents a growing threat to Mediterranean citrus production. So far, biological control has proven unsatisfactory due to the absence of efficient natural enemies in Spain. Hence, the management of this pest currently relies only on chemical control. The introduction of natural enemies of Delottococcus aberiae from the native area of the pest represents a sustainable and economically viable alternative to reduce the risks linked to pesticide applications. Since biological control of mealybugs has been traditionally challenged by taxonomic misidentification, an intensive survey of Delottococcus spp. and their associated parasitoids in South Africa was required as a first step towards a classical biological control programme. Combining morphological and molecular characterization (integrative taxonomy) a total of nine mealybug species were identified in this study, including three species of Delottococcus. Different populations of Delottococcus aberiae were found on wild olive trees, in citrus orchards and on plants of Chrysanthemoides monilifera, showing intra-specific divergences according to their host plants. Interestingly, the invasive mealybug populations from Spanish orchards clustered together with the population on citrus from Limpopo Province (South Africa), sharing COI haplotypes. This result pointed to an optimum location to collect natural enemies against the invasive mealybug. A total of 14 parasitoid species were recovered from Delottococcus spp. and identified to genus and species level, by integrating morphological and molecular data. A parasitoid belonging to the genus Anagyrus, collected from Delottococcus aberiae in citrus orchards in Limpopo, is proposed here as a good biological control agent to be introduced into Spain.	[Beltra, Aleixandre; Avalos, Juan Antonio; Garcia-Mari, Ferran; Navarro-Campos, Cristina; Soto, Antonia] Univ Politecn Valencia, Inst Agroforestal Mediterrani, E-46022 Valencia, Spain; [Addison, Pia] Univ Stellenbosch, Dept Conservat Ecol & Entomol, ZA-7600 Stellenbosch, South Africa; [Crochard, Didier; Malausa, Thibaut; Palero, Ferran] Univ Nice Sophia Antipolis, CNRS, UMR 1355 7254, INRA,Inst Sophia Agrobiotech, F-06900 Sophia Antipolis, France; [Guerrieri, Emilio] CNR, Ist Protez Sostenibile Piante, Portici, Italy; [Giliomee, Jan H.] Univ Stellenbosch, Dept Bot & Zool, Ctr Invas Biol, ZA-7600 Stellenbosch, South Africa	Universitat Politecnica de Valencia; Stellenbosch University; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); Stellenbosch University	Soto, A (corresponding author), Univ Politecn Valencia, Inst Agroforestal Mediterrani, E-46022 Valencia, Spain.	asoto@eaf.upv.es	Malausa, Thibaut/X-1614-2018; Guerrieri, Emilio/ABB-7498-2020; Addison, Pia/G-9372-2012; Palero, Feran/L-7186-2019; Palero, Ferran/A-7830-2012	Malausa, Thibaut/0000-0003-1681-7958; Addison, Pia/0000-0002-8227-339X; Palero, Feran/0000-0002-0343-8329; Palero, Ferran/0000-0002-0343-8329	European Union Seventh Framework Programme FP7-IRSES "IPRABIO" [269196]; European Union Seventh Framework Programme FP7-IAPP "COLBICS" [324475]; European Union Seventh Framework Programme FP7-IRSES "BIOMODICS" [612566]	European Union Seventh Framework Programme FP7-IRSES "IPRABIO"; European Union Seventh Framework Programme FP7-IAPP "COLBICS"; European Union Seventh Framework Programme FP7-IRSES "BIOMODICS"	This work was supported by the European Union Seventh Framework Programme FP7-IRSES #269196 "IPRABIO" and FP7-IAPP #324475 "COLBICS" and FP7-IRSES #612566 "BIOMODICS". The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRICOLA U, 1989, B ENTOMOL RES, V79, P671, DOI 10.1017/S0007485300018824; Amarasekare KG, 2009, BIOL CONTROL, V51, P91, DOI 10.1016/j.biocontrol.2009.07.005; Anga Jean-Marc, 1999, Bulletin of the Natural History Museum Entomology Series, V68, P93; [Anonymous], 1999, HDB BIOL CONTROL; Jacas JA, 2010, INTEGR MANAG PLANT P, V5, P61, DOI 10.1007/978-90-481-8606-8_3; Bartlett BR., 1978, INTRO PARASITES PRED, P137; Baumann L, 2002, APPL ENVIRON MICROB, V68, P3198, DOI 10.1128/AEM.68.7.3198-3205.2002; Beltra A, 2012, B ENTOMOL RES, V102, P165, DOI 10.1017/S0007485311000514; Beltra A, 2013, LEVANTE AGRICOLA, V419, P348; Blumberg D, 1997, BIOL CONTROL, V8, P225, DOI 10.1006/bcon.1997.0502; BRAIN C. K., 1915, Trans. R. Soc. South Africa, V5, P65; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charles JG, 2011, BIOCONTROL, V56, P155, DOI 10.1007/s10526-010-9322-x; Correa MCG, 2012, B ENTOMOL RES, V102, P524, DOI 10.1017/S0007485312000053; COX JM, 1986, B ENTOMOL RES, V76, P481, DOI 10.1017/S0007485300014966; DANKS HV, 1988, ANNU REV ENTOMOL, V33, P271, DOI 10.1146/annurev.en.33.010188.001415; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; de Lotto G., 1977, Journal of the Entomological Society of Southern Africa, V40, P13; DE LOTTO G., 1964, Bull. Brit. Mus (nat. Hist.) Ent., V14, P343; De Lotto G., 1961, Bulletin of the British Museum (Natural History) Entomology, V10, P211; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Foldi Imre, 1997, Memoires du Museum National d'Histoire Naturelle, V173, P203; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Garcia-Mari F, 2012, PLAGAS CITRICOS GEST; Goolsby JA, 1998, BIOL CONTROL, V12, P127, DOI 10.1006/bcon.1998.0624; GROSS P, 1993, ANNU REV ENTOMOL, V38, P251, DOI 10.1146/annurev.en.38.010193.001343; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hardy NB, 2008, SYST ENTOMOL, V33, P51, DOI 10.1111/j.1365-3113.2007.00408.x; HATTINGH V, 1998, CITRUS PESTS REPUBLI, P112; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heraty J, 2004, SYST ENTOMOL, V29, P544, DOI 10.1111/j.0307-6970.2004.00267.x; Hufbauer RA, 2005, BIOL CONTROL, V35, P227, DOI 10.1016/j.biocontrol.2005.04.004; Japoshvili G., 2010, Entomologia Hellenica, V19, P132; Kairo M. T. K., 2000, Integrated Pest Management Reviews, V5, P241, DOI 10.1023/A:1012997619132; KERRICH G. J., 1967, Bulletin of the British Museum (Natural History), B. Entomology, V20, P143; Kirk AA, 2000, B ENTOMOL RES, V90, P317, DOI 10.1017/S0007485300000444; Malausa T, 2011, J APPL ENTOMOL, V135, P142, DOI 10.1111/j.1439-0418.2009.01495.x; McKenzie H.L., 1967, MEALYBUGS CALIFORNIA; Miller DR, 2011, AFR ENTOMOL, V19, P614, DOI 10.4001/003.019.0306; Miller DR, 2002, P ENTOMOL SOC WASH, V104, P825; Moore D., 1988, Biocontrol News and Information, V9, P209; Muniappan R, 2006, FLA ENTOMOL, V89, P212, DOI 10.1653/0015-4040(2006)89[212:CBCOTP]2.0.CO;2; NEUENSCHWANDER P, 1994, BIOCONTROL SCI TECHN, V4, P61, DOI 10.1080/09583159409355313; Neuenschwander P, 2001, BIOL CONTROL, V21, P214, DOI 10.1006/bcon.2001.0937; NOYES JS, 1982, J NAT HIST, V16, P315, DOI 10.1080/00222938200770261; Noyes JS, 1994, ORIENTAL MEALYBUG PA; da Silva VCP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103480, 10.1371/journal.pone.0093049, 10.1371/journal.pone.0105072, 10.1371/journal.pone.0087588, 10.1371/journal.pone.0103267, 10.1371/journal.pone.0091910, 10.1371/journal.pone.0107196, 10.1371/journal.pone.0110033, 10.1371/journal.pone.0096514, 10.1371/journal.pone.0087348, 10.1371/journal.pone.0103535, 10.1371/journal.pone.0095536, 10.1371/journal.pone.0099366, 10.1371/journal.pone.0113637, 10.1371/journal.pone.0095422]; Park DS, 2011, B ENTOMOL RES, V101, P429, DOI 10.1017/S0007485310000714; Park DS, 2010, J ECON ENTOMOL, V103, P25, DOI 10.1603/EC09144; Pellizzari Giuseppina, 2010, BioRisk, V4, P475; Pieterse W, 2010, AFR ENTOMOL, V18, P23, DOI 10.4001/003.018.0104; Prinsloo G.L., 1998, African Plant Protection, V4, P81; Prinsloo G.L., 2001, Journal of Hymenoptera Research, V10, P145; PRINSLOO GL, 1988, J NAT HIST, V22, P1465, DOI 10.1080/00222938800770891; Prinsloo GL, 2003, AFR ENTOMOL, V11, P77; PRINSLOO GL, 1983, J ENTOMOL SOC S AFR, V46, P103; Prinsloo GL, 1983, ENTOMOL MEM DEP AGR, V60, P1; Prinsloo GL, 1976, J ENTOMOL SOC S AFR, V39, P190; Rosen D., 1973, Entomophaga, V18, P215, DOI 10.1007/BF02371468; Rugman-Jones PF, 2011, BIOCONTROL, V56, P265, DOI 10.1007/s10526-010-9328-4; Rung A, 2008, ANN ENTOMOL SOC AM, V101, P525, DOI 10.1603/0013-8746(2008)101[525:MIOTCR]2.0.CO;2; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Sequeira AS, 2000, P ROY SOC B-BIOL SCI, V267, P2359, DOI 10.1098/rspb.2000.1292; Sethusa MT, 2014, AFR ENTOMOL, V22, P257, DOI 10.4001/003.022.0218; Sforza R, 2013, P 4 INT S BIOL CONTR, P46; Stiling Peter, 1993, American Entomologist, V39, P31; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Triapitsyn SV, 2007, BIOL CONTROL, V41, P14, DOI 10.1016/j.biocontrol.2006.12.013; Trjapitzin V.A., 1989, Opredeliteli po Faune SSSR, V158, P1; Wakgari WM, 2005, AFR ENTOMOL, V13, P281; Williams D. J., 1992, Mealybugs of Central and South America.; Zhang YZ, 2011, BIOL CONTROL, V58, P182, DOI 10.1016/j.biocontrol.2011.05.006	75	25	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128685	10.1371/journal.pone.0128685	http://dx.doi.org/10.1371/journal.pone.0128685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047349	Green Published, gold			2022-12-26	WOS:000355652200090
J	Fogelgren, B; Polgar, N; Lui, VH; Lee, AJ; Tamashiro, KKA; Napoli, JA; Walton, CB; Zuo, XF; Lipschutz, JH				Fogelgren, Ben; Polgar, Noemi; Lui, Vanessa H.; Lee, Amanda J.; Tamashiro, Kadee-Kalia A.; Napoli, Josephine Andrea; Walton, Chad B.; Zuo, Xiaofeng; Lipschutz, Joshua H.			Urothelial Defects from Targeted Inactivation of Exocyst Sec10 in Mice Cause Ureteropelvic Junction Obstructions	PLOS ONE			English	Article							CADHERIN GENE PROMOTER; CHRONIC-RENAL-FAILURE; PRIMARY CILIOGENESIS; DEVELOPING KIDNEY; PLASMA-MEMBRANE; CELL BIOLOGY; PROTEIN SEC8; MOUSE; EXOCYTOSIS; EXPRESSION	Most cases of congenital obstructive nephropathy are the result of ureteropelvic junction obstructions, and despite their high prevalence, we have a poor understanding of their etiology and scarcity of genetic models. The eight-protein exocyst complex regulates polarized exocytosis of intracellular vesicles in a large variety of cell types. Here we report generation of a conditional knockout mouse for Sec10, a central component of the exocyst, which is the first conditional allele for any exocyst gene. Inactivation of Sec10 in ureteric bud-derived cells using Ksp1.3-Cre mice resulted in severe bilateral hydronephrosis and complete anuria in newborns, with death occurring 6-14 hours after birth. Sec10(FL/FL); Ksp-Cre embryos developed ureteropelvic junction obstructions between E17.5 and E18.5 as a result of degeneration of the urothelium and subsequent overgrowth by surrounding mesenchymal cells. The urothelial cell layer that lines the urinary tract must maintain a hydrophobic luminal barrier again urine while remaining highly stretchable. This barrier is largely established by production of uroplakin proteins that are transported to the apical surface to establish large plaques. By E16.5, Sec10(FL/FL); Ksp-Cre ureter and pelvic urothelium showed decreased uroplakin-3 protein at the luminal surface, and complete absence of uroplakin-3 by E17.5. Affected urothelium at the UPJ showed irregular barriers that exposed the smooth muscle layer to urine, suggesting this may trigger the surrounding mesenchymal cells to overgrow the lumen. Findings from this novel mouse model show Sec10 is critical for the development of the urothelium in ureters, and provides experimental evidence that failure of this urothelial barrier may contribute to human congenital urinary tract obstructions.	[Fogelgren, Ben; Polgar, Noemi; Lui, Vanessa H.; Lee, Amanda J.; Tamashiro, Kadee-Kalia A.; Napoli, Josephine Andrea] Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA; [Walton, Chad B.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA; [Zuo, Xiaofeng; Lipschutz, Joshua H.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Fogelgren, B (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Anat Biochem & Physiol, Honolulu, HI 96822 USA.	fogelgre@hawaii.edu		Polgar, Noemi/0000-0002-8400-162X	National Institutes of Health [K01DK087852, R03DK100738, P20GM103457-06A1-8293, R01DK069909, R21DK070980]; United States Department of Veteran's Affairs [I01 BX000820]; Satellite Healthcare Norman S. Coplon Extramural Research Grant; Hawaii Community Foundation [12ADVC-51347]; University of Alabama at Birmingham Hepato/Renal Fibrocystic Diseases Core Center [5P30DK074038]; March of Dimes: Basil O'Connor Starter Scholar Research Award [5-FY14-56]; University of Hawaii at Manoa Research Centers in Minority Institute, BRIDGES program [5G12MD007601]; NATIONAL CANCER INSTITUTE [P30CA013148] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK070980, R03DK100738, P60DK079626, P30DK074038, R01DK069909, K01DK087852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103457, P30GM103341] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007601] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000820] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veteran's Affairs(US Department of Veterans Affairs); Satellite Healthcare Norman S. Coplon Extramural Research Grant; Hawaii Community Foundation; University of Alabama at Birmingham Hepato/Renal Fibrocystic Diseases Core Center; March of Dimes: Basil O'Connor Starter Scholar Research Award(March of Dimes); University of Hawaii at Manoa Research Centers in Minority Institute, BRIDGES program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by 1) National Institutes of Health: Grant # K01DK087852 to BF; http://www.nih.gov/. 2) National Institutes of Health: Grant # R03DK100738 to BF; http://www.nih.gov/. 3) National Institutes of Health: Grant # P20GM103457-06A1-8293 to BF; http://www.nih.gov/. 4) National Institutes of Health: Grant # R01DK069909 to JL; http://www.nih.gov/. 5) National Institutes of Health: Grant # R21DK070980 to JL; http://www.nih.gov/. 6) United States Department of Veteran's Affairs: Merit Award # I01 BX000820 to JL; http://www.research.va.gov/funding/. 7) Satellite Healthcare Norman S. Coplon Extramural Research Grant to JL; http://www.satellitehealth.com/about_satellite/philanthropy/coplon_grants/. 8) Hawaii Community Foundation: Grant # 12ADVC-51347 to BF; http://www.hawaiicommunityfoundation.org/. 9) University of Alabama at Birmingham Hepato/Renal Fibrocystic Diseases Core Center: Pilot Award # 5P30DK074038 to BF; http://www.uab.edu/medicine/hrfdcc/. 10) March of Dimes: Basil O'Connor Starter Scholar Research Award #5-FY14-56 to BF; http://www.marchofdimes.org/. 11) University of Hawaii at Manoa Research Centers in Minority Institute, BRIDGES program: Pilot Award # 5G12MD007601 to BF; http://rcmi-bridges.jabsom.hawaii.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airik R, 2007, KIDNEY INT, V72, P1459, DOI 10.1038/sj.ki.5002589; Aoki Y, 2004, GENES CELLS, V9, P1287, DOI 10.1111/j.1365-2443.2004.00805.x; Bakris G, 2008, AM J KIDNEY DIS, V51, pS1, DOI 10.1053/j.ajkd.2008.01.015; Bartoli FA, 1996, UROL RES, V24, P9, DOI 10.1007/BF00296726; Bascands JL, 2005, KIDNEY INT, V68, P925, DOI 10.1111/j.1523-1755.2005.00486.x; Benfield MR, 2003, PEDIATR TRANSPLANT, V7, P321, DOI 10.1034/j.1399-3046.2003.00029.x; Bodemann BO, 2011, CELL, V144, P253, DOI 10.1016/j.cell.2010.12.018; Cain JE, 2011, J CLIN INVEST, V121, P1199, DOI 10.1172/JCI45523; Chang CP, 2004, J CLIN INVEST, V113, P1051, DOI 10.1172/JCI200420049; Chen XW, 2011, NAT CELL BIOL, V13, P580, DOI 10.1038/ncb2226; Chevalier RL, 2010, PEDIATR NEPHROL, V25, P687, DOI 10.1007/s00467-009-1316-5; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Erman A, 2006, TISSUE CELL, V38, P293, DOI 10.1016/j.tice.2006.07.001; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fogelgren B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001361; Fogelgren B, 2009, AM J PHYSIOL-RENAL, V296, pF1166, DOI 10.1152/ajprenal.90550.2008; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; Gandhi D, 2013, DEV CELL, V26, P469, DOI 10.1016/j.devcel.2013.07.017; Guichard A, 2013, CELL HOST MICROBE, V14, P294, DOI 10.1016/j.chom.2013.08.001; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; Haraguchi R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042245; Heider MR, 2012, EXORCISING EXOCYST C; Hu CCA, 2005, MOL BIOL CELL, V16, P3937, DOI 10.1091/mbc.E05-02-0136; Hu P, 2000, J CELL BIOL, V151, P961, DOI 10.1083/jcb.151.5.961; Igarashi P, 2003, NEPHRON EXP NEPHROL, V94, pE1, DOI 10.1159/000070812; Igarashi P, 1999, AM J PHYSIOL-RENAL, V277, pF599, DOI 10.1152/ajprenal.1999.277.4.F599; Ingraham SE, 2011, PEDIATR NEPHROL, V26, P1453, DOI 10.1007/s00467-011-1799-8; Ingraham SE, 2010, PEDIATR RES, V68, P500, DOI 10.1203/PDR.0b013e3181f82f15; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Khandelwal P, 2008, P NATL ACAD SCI USA, V105, P15773, DOI 10.1073/pnas.0805636105; Khandelwal P, 2013, MOL BIOL CELL, V24, P1007, DOI 10.1091/mbc.E12-08-0568; Khandelwal P, 2009, AM J PHYSIOL-RENAL, V297, pF1477, DOI 10.1152/ajprenal.00327.2009; Klein J, 2011, INT J EXP PATHOL, V92, P168, DOI 10.1111/j.1365-2613.2010.00727.x; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Letinic K, 2009, P NATL ACAD SCI USA, V106, P11342, DOI 10.1073/pnas.0904244106; Li L, 2009, AM J PHYSIOL-RENAL, V297, pF1526, DOI 10.1152/ajprenal.00318.2009; Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Liu JL, 2009, MOL BIOL CELL, V20, P3763, DOI 10.1091/mbc.E08-09-0967; Lloyd KCK, 2011, ANN NY ACAD SCI, V1245, P24, DOI 10.1111/j.1749-6632.2011.06311.x; Lu HZ, 2013, DEV CELL, V27, P560, DOI 10.1016/j.devcel.2013.10.020; Lyons PD, 2009, BIOSCIENCE REP, V29, P229, DOI 10.1042/BSR20080162; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mathai JC, 2014, BIOPHYS J, V107, P1273, DOI 10.1016/j.bpj.2014.07.047; Mesrobian HGO, 2012, PEDIATR CLIN N AM, V59, P839, DOI 10.1016/j.pcl.2012.05.008; Nichols CD, 2010, CURR BIOL, V20, P1316, DOI 10.1016/j.cub.2010.05.065; NOVICK P, 1979, P NATL ACAD SCI USA, V76, P1858, DOI 10.1073/pnas.76.4.1858; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Park KM, 2010, AM J PHYSIOL-RENAL, V298, pF818, DOI 10.1152/ajprenal.00596.2009; Ren JQ, 2012, DEV CELL, V22, P967, DOI 10.1016/j.devcel.2012.03.005; Roth D, 1998, MOL BIOL CELL, V9, P1725, DOI 10.1091/mbc.9.7.1725; Roth JA, 2001, CURR OPIN PEDIATR, V13, P138, DOI 10.1097/00008480-200104000-00009; Roth KS, 2002, CLIN PEDIATR, V41, P309, DOI 10.1177/000992280204100503; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016443.50138.CD; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Singh S, 2007, J AM SOC NEPHROL, V18, P461, DOI 10.1681/ASN.2006040405; Thapa N, 2012, DEV CELL, V22, P116, DOI 10.1016/j.devcel.2011.10.030; Tripathi P, 2012, J AM SOC NEPHROL, V23, P618, DOI 10.1681/ASN.2011060566; Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001; Whyte DA, 1999, AM J PHYSIOL-RENAL, V277, pF587, DOI 10.1152/ajprenal.1999.277.4.F587; Woodward M, 2002, BJU INT, V89, P149, DOI 10.1046/j.1464-4096.2001.woodward.2578.x; Woolf AS, 2013, J AM SOC NEPHROL, V24, P19, DOI 10.1681/ASN.2012020127; Woolf AS, 2001, ADV RENAL REPLACE TH, V8, P157, DOI 10.1053/jarr.2001.26348; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Yamany T, 2014, CURR OPIN ORGAN TRAN, V19, P323, DOI 10.1097/MOT.0000000000000084; Yu J, 2002, DEVELOPMENT, V129, P5301; Zuo XF, 2011, J BIOL CHEM, V286, P22469, DOI 10.1074/jbc.M111.238469; Zuo XF, 2009, MOL BIOL CELL, V20, P2522, DOI 10.1091/mbc.E08-07-0772	73	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129346	10.1371/journal.pone.0129346	http://dx.doi.org/10.1371/journal.pone.0129346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046524	gold, Green Submitted, Green Published			2022-12-26	WOS:000355652200154
J	Quashie, PK; Han, YS; Hassounah, S; Mesplede, T; Wainberg, MA				Quashie, Peter K.; Han, Ying-Shan; Hassounah, Said; Mesplede, Thibault; Wainberg, Mark A.			Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor	PLOS ONE			English	Article							STRAND TRANSFER; I-TASSER; STRUCTURE PREDICTION; BIOCHEMICAL-ANALYSIS; HOMOLOGY DETECTION; CRYSTAL-STRUCTURE; TERMINAL DOMAINS; CATALYTIC DOMAIN; NUCLEAR IMPORT; VIRAL-DNA	Understanding the HIV integrase protein and mechanisms of resistance to HIV integrase inhibitors is complicated by the lack of a full length HIV integrase crystal structure. Moreover, a lentiviral integrase structure with co-crystallised DNA has not been described. For these reasons, we have developed a structural method that utilizes free software to create quaternary HIV integrase homology models, based partially on available full-length prototype foamy virus integrase structures as well as several structures of truncated HIV integrase. We have tested the utility of these models in screening of small anti-integrase compounds using randomly selected molecules from the ZINC database as well as a well characterized IN: DNA binding inhibitor, FZ41, and a putative IN: DNA binding inhibitor, HDS1. Docking studies showed that the ZINC compounds that had the best binding energies bound at the IN: IN dimer interface and that the FZ41 and HDS1 compounds docked at approximately the same location in integrase, i.e. behind the DNA binding domain, although there is some overlap with the IN: IN dimer interface to which the ZINC compounds bind. Thus, we have revealed two possible locations in integrase that could potentially be targeted by allosteric integrase inhibitors, that are distinct from the binding sites of other allosteric molecules such as LEDGF inhibitors. Virological and biochemical studies confirmed that HDS1 and FZ41 share a similar activity profile and that both can inhibit each of integrase and reverse transcriptase activities. The inhibitory mechanism of HDS1 for HIV integrase seems to be at the DNA binding step and not at either of the strand transfer or 3' processing steps of the integrase reaction. Furthermore, HDS1 does not directly interact with DNA. The modeling and docking methodology described here will be useful for future screening of integrase inhibitors as well as for the generation of models for the study of integrase drug resistance.	[Quashie, Peter K.; Han, Ying-Shan; Hassounah, Said; Mesplede, Thibault; Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, AIDS Ctr, Lady Davis Med Res, Montreal, PQ H3T 1E2, Canada; [Quashie, Peter K.; Hassounah, Said; Wainberg, Mark A.] McGill Univ, Fac Med, Div Expt Med, Montreal, PQ H3T 1E2, Canada; [Wainberg, Mark A.] McGill Univ, Fac Med, Dept Microbiol & Immunol, Montreal, PQ H3T 1E2, Canada	McGill University; McGill University; McGill University	Wainberg, MA (corresponding author), McGill Univ, Jewish Gen Hosp, AIDS Ctr, Lady Davis Med Res, Montreal, PQ H3T 1E2, Canada.	mark.wainberg@mcgill.ca	Mesplède, Thibault/E-8550-2014	Mesplède, Thibault/0000-0003-0515-9128; Quashie, Peter/0000-0003-4114-5460; Hassounah, Said/0000-0002-9712-1313	Canadian Institutes of Health Research (CIHR) [CCM104886]; Reseau SIDA of the Fonds de Recherche du Quebec; CAHR/CIHR; Bristol Myers Squibb/Canadian HIV Trials Network (BMS/CTN); Fonds de la Recherche du Quebec en Sante (FRQS)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau SIDA of the Fonds de Recherche du Quebec; CAHR/CIHR; Bristol Myers Squibb/Canadian HIV Trials Network (BMS/CTN); Fonds de la Recherche du Quebec en Sante (FRQS)	This work was supported by research grants from the Canadian Institutes of Health Research (CIHR grant number CCM104886) and the Reseau SIDA of the Fonds de Recherche du Quebec. P.K.Q. was the recipient of a doctoral scholarship from CAHR/CIHR. T.M. was a recipient of a Postdoctoral Fellowship from Bristol Myers Squibb/Canadian HIV Trials Network (BMS/CTN). S.A.H. is the recipient of a doctoral studentship from the Fonds de la Recherche du Quebec en Sante (FRQS).	[Anonymous], PYMOL MOL GRAPHICS S; Baldi P, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P39; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Blanco JL, 2011, J INFECT DIS, V203, P1204, DOI 10.1093/infdis/jir025; Bonnenfant S, 2004, J VIROL, V78, P5728, DOI 10.1128/JVI.78.11.5728-5736.2004; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Buenavista MT, 2012, BIOINFORMATICS, V28, P1851, DOI 10.1093/bioinformatics/bts292; Ceccherini-Silberstein F, 2009, AIDS REV, V11, P17; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Christ F, 2010, NAT CHEM BIOL, V6, P442, DOI 10.1038/nchembio.370; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; De Luca L, 2011, CHEMMEDCHEM, V6, P1184, DOI 10.1002/cmdc.201100071; Desimmie BA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-57; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dicker IB, 2008, J BIOL CHEM, V283, P23599, DOI 10.1074/jbc.M804213200; DUNBRACK RL, 1994, NAT STRUCT BIOL, V1, P334, DOI 10.1038/nsb0594-334; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Engelman A, 1997, J VIROL, V71, P3507, DOI 10.1128/JVI.71.5.3507-3514.1997; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; FDA, FDA APPR IS RALT; Goethals O, 2008, J VIROL, V82, P10366, DOI 10.1128/JVI.00470-08; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Han YS, 2013, ANTIVIR RES, V98, P441, DOI 10.1016/j.antiviral.2013.04.001; Han YS, 2012, J VIROL METHODS, V184, P34, DOI 10.1016/j.jviromet.2012.05.003; Hare S, 2012, EMBO J, V31, P3020, DOI 10.1038/emboj.2012.118; Hare S, 2011, MOL PHARMACOL, V80, P565, DOI 10.1124/mol.111.073189; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Jenkins TM, 1996, J BIOL CHEM, V271, P7712, DOI 10.1074/jbc.271.13.7712; Johnson BC, 2013, J MOL BIOL, V425, P2133, DOI 10.1016/j.jmb.2013.03.027; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kessl JJ, 2011, NUCLEIC ACIDS RES, V39, P9009, DOI 10.1093/nar/gkr581; Kessl JJ, 2009, VIRUSES-BASEL, V1, P713, DOI 10.3390/v1030713; KOLTUN WL, 1965, BIOPOLYMERS, V3, P665, DOI 10.1002/bip.360030606; Kramer VG, 2012, ANTIMICROB AGENTS CH, V56, P4154, DOI 10.1128/AAC.00409-12; Krishnan L, 2010, P NATL ACAD SCI USA, V107, P15910, DOI 10.1073/pnas.1002346107; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Levin A, 2010, NUCLEUS-PHILA, V1, P422, DOI 10.4161/nucl.1.5.12903; Li XA, 2011, VIROLOGY, V411, P194, DOI 10.1016/j.virol.2010.12.008; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187; Mesplede T, 2014, J ANTIMICROB CHEMOTH, V69, P2733, DOI 10.1093/jac/dku199; Mesplede T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-22; Mesplede T, 2012, CURR OPIN HIV AIDS, V7, P401, DOI 10.1097/COH.0b013e328356db89; Mousnier A, 2004, MOL PHARMACOL, V66, P783, DOI 10.1124/mol.104.001735; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Prlic A, 2010, BIOINFORMATICS, V26, P2983, DOI 10.1093/bioinformatics/btq572; Quashie PK, 2015, J VIROL, V89, P3163, DOI 10.1128/JVI.03353-14; Quashie PK, 2013, ANTIMICROB AGENTS CH, V57, P6223, DOI 10.1128/AAC.01835-13; Quashie PK, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-34; Quashie PK, 2012, J VIROL, V86, P2696, DOI 10.1128/JVI.06591-11; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rhodes David I., 2011, Antiviral Chemistry & Chemotherapy, V21, P155, DOI 10.3851/IMP1716; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Serrao E, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-25; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sun R, 2011, BIOORG MED CHEM LETT, V21, P961, DOI 10.1016/j.bmcl.2010.12.055; Sussman JL, 1998, ACTA CRYSTALLOGR D, V54, P1078, DOI 10.1107/S0907444998009378; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Wainberg MA, 2012, CURR OPIN VIROL, V2, P656, DOI 10.1016/j.coviro.2012.08.007; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wang Q, 2008, NAT PROTOC, V3, P1832, DOI 10.1038/nprot.2008.184; Xu HT, 2011, J VIROL, V85, P11300, DOI 10.1128/JVI.05584-11; Yan Hua, 2005, Antiviral Chemistry & Chemotherapy, V16, P363; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	74	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128310	10.1371/journal.pone.0128310	http://dx.doi.org/10.1371/journal.pone.0128310			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046987	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200058
J	Pierron, R; Gorfer, M; Berger, H; Jacques, A; Sessitsch, A; Strauss, J; Compant, S				Pierron, Romain; Gorfer, Markus; Berger, Harald; Jacques, Alban; Sessitsch, Angela; Strauss, Joseph; Compant, Stephane			Deciphering the Niches of Colonisation of Vitis vinifera L. by the Esca-Associated Fungus Phaeoacremonium aleophilum Using a gfp Marked Strain and Cutting Systems	PLOS ONE			English	Article							PHAEOMONIELLA-CHLAMYDOSPORA; STAINING TECHNIQUE; TRUNK DISEASES; GRAPEVINE; WOOD; PATHOGENS; TRANSFORMATION; DECLINE; AGENT	Introduction Esca disease has become a major threat for viticulture. Phaeoacremonium aleophilum is considered a pioneer of the esca complex pathosystem, but its colonisation behaviour inside plants remains poorly investigated. Material and Methods In this study, P. aleophilum::gfp7 colonisation was assessed six and twelve weeks post-inoculation in two different types of tissues: in the node and the internode of one year-old rooted cuttings of Cabernet Sauvignon. These processes of colonisation were compared with the colonisation by the wild-type strain using a non-specific lectin probe Alexa Fluor 488-WGA. Results Data showed that six weeks post-inoculation of the internode, the fungus had colonised the inoculation point, the bark and xylem fibres. Bark, pith and xylem fibres were strongly colonised by the fungus twelve weeks post-inoculation and it can progress up to 8 mm from the point of inoculation using pith, bark and fibres. P. aleophilum was additionally detected in the lumen of xylem vessels in which tyloses blocked its progression. Different plant responses in specific tissues were additionally visualised. Inoculation of nodes led to restricted colonisation of P. aleophilum and this colonisation was associated with a plant response six weeks post-inoculation. The fungus was however detected in xylem vessels, bark and inside the pith twelve weeks post-inoculation. Conclusions These results demonstrate that P. aleophilum colonisation can vary according to the type of tissues and the type of spread using pith, bark and fibres. Woody tissues can respond to the injury and to the presence of this fungus, and xylem fibres play a key role in the early colonisation of the internode by P. aleophilum before the fungus can colonise xylem vessels.	[Pierron, Romain; Jacques, Alban] Univ Toulouse, Equipe Vins Viticulture & Enol, Dept Sci Agron & Agroalimentaires, INP EI Purpan, Toulouse, France; [Pierron, Romain; Gorfer, Markus; Strauss, Joseph] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Tulln, Austria; [Gorfer, Markus; Berger, Harald; Sessitsch, Angela; Strauss, Joseph; Compant, Stephane] AIT Austrian Inst Technol GmbH, Hlth & Environm Dept, Bioresources Unit, Tulln, Austria	Universite de Toulouse; University of Natural Resources & Life Sciences, Vienna; Austrian Institute of Technology (AIT)	Compant, S (corresponding author), AIT Austrian Inst Technol GmbH, Hlth & Environm Dept, Bioresources Unit, Tulln, Austria.	stephane.compant@ait.ac.at	Compant, Stephane/ABG-1032-2020; Sessitsch, Angela/AAW-3191-2020; rolshausen, philippe/F-7999-2011; Compant, Stéphane/P-8342-2018; Gorfer, Markus/AIB-4801-2022; Romain, Pierron/AAI-7972-2020	Compant, Stephane/0000-0003-0709-6087; Sessitsch, Angela/0000-0003-0137-930X; Compant, Stéphane/0000-0003-0709-6087; Gorfer, Markus/0000-0003-3010-6044; Romain, Pierron/0000-0001-6969-0263; Berger, Harald/0000-0001-7974-3058; Strauss, Joseph/0000-0003-0474-6267	French ministry, Region Midi-Pyrenees [12050499]; European Cost action [FA1303]; AIT Austrian Institute of Technology GmbH	French ministry, Region Midi-Pyrenees(Region Occitanie); European Cost action; AIT Austrian Institute of Technology GmbH	The authors are grateful to French ministry, Region Midi-Pyrenees (project no 12050499), as well as European Cost action FA1303 and to Dr. Brian Murphy (Trinity College Dublin, Ireland) for English correction of the manuscript. AIT Austrian Institute of Technology GmbH provided support in the form of salaries for authors (MG, HB, AS, JS and SC), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adalat K., 2000, PHYTOPATHOL MEDITERR, V39, P92, DOI DOI 10.14601/PHYT0PATH0L_; [Anonymous], 2005, PHYTOPATHOL MEDITERR, V44, P162; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Blanchette R.A., 1992, DEFENSE MECH WOODY P; Campisano A, 2014, MOL BIOL EVOL, V31, P1059, DOI 10.1093/molbev/msu075; Compant S, 2008, FEMS MICROBIOL ECOL, V63, P84, DOI 10.1111/j.1574-6941.2007.00410.x; Crous P. W., 2000, Phytopathologia Mediterranea, V39, P112; Crous PW, 1996, MYCOLOGIA, V88, P786, DOI 10.2307/3760973; Del Rio J.A., 2001, PHYTOPATHOL MEDITERR, V40, P394; del Rio JA, 2004, PHYTOPATHOL MEDITERR, V43, P87; Feliciano A.J., 2001, PHYTOPATHOL MEDITERR, V40, P387, DOI 10.14601/Phytopathol_Mediterr-1623; Fife DJ, 2000, APPL ENVIRON MICROB, V66, P2208, DOI 10.1128/AEM.66.5.2208-2210.2000; Fleurat-Lessard P, 2014, EUR J PLANT PATHOL, V139, P137, DOI 10.1007/s10658-013-0372-7; Gorfer M, 2007, MYCOL RES, V111, P850, DOI 10.1016/j.mycres.2007.05.002; Gramaje D, 2011, PLANT DIS, V95, P1040, DOI 10.1094/PDIS-01-11-0025; Grosman J., 2012, PHYTOMA, V651, P31; Halleen F, 2003, AUSTRALAS PLANT PATH, V32, P47, DOI 10.1071/AP02062; Iriti M., 2008, Acta Phytopathologica et Entomologica Hungarica, V43, P15, DOI 10.1556/APhyt.43.2008.1.2; Landi L, 2012, PHYTOPATHOLOGY, V102, P290, DOI 10.1094/PHYTO-06-11-0165; Larignon P, 2009, CR BIOL, V332, P765, DOI 10.1016/j.crvi.2009.05.005; Lecomte P, 2012, PLANT DIS, V96, P924, DOI 10.1094/PDIS-09-11-0776-RE; Leveau JHJ, 2002, CURR OPIN MICROBIOL, V5, P259, DOI 10.1016/S1369-5274(02)00321-1; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Lorena T., 2001, PHYTOPATHOL MEDITERR, V40, P400, DOI [10.14601/Phytopathol_Mediterr-1610, DOI 10.14601/PHYTOPATHOL_MEDITERR-1610]; McLean T, 2009, AUSTRALAS PLANT PATH, V38, P153, DOI 10.1071/AP08090; Mugnai L, 1999, PLANT DIS, V83, P404, DOI 10.1094/PDIS.1999.83.5.404; Mutawila C, 2011, PHYTOPATHOL MEDITERR, V50, pS46; Pancher M, 2012, APPL ENVIRON MICROB, V78, P4308, DOI 10.1128/AEM.07655-11; Pearce R. B., 2000, Journal of Arboriculture, V26, P1; Pearce RB, 1996, NEW PHYTOL, V132, P203, DOI 10.1111/j.1469-8137.1996.tb01842.x; Pontini S, 2014, PHYSIOL MOL PLANT P, V87, P51, DOI 10.1016/j.pmpp.2014.06.002; Pouzoulet J, 2013, PHYTOPATHOL MEDITERR, V52, P313; ROBIN JB, 1989, OPHTHALMOLOGY, V96, P1198; Romanazzi G, 2009, EUR J PLANT PATHOL, V125, P277, DOI 10.1007/s10658-009-9481-8; Rooney-Latham S, 2005, PLANT DIS, V89, P867, DOI 10.1094/PD-89-0867; Shigo A. L., 1977, USDA Forest Service Agriculture Information Bulletin; SIZEMORE RK, 1990, APPL ENVIRON MICROB, V56, P2245, DOI 10.1128/AEM.56.7.2245-2247.1990; Tippett J, 1981, IAWA B, V2, P2; Urbez-Torres JR, 2014, PLANT DIS, V98, P469, DOI 10.1094/PDIS-05-13-0523-RE; Urbez-Torres JR, 2011, PHYTOPATHOL MEDITERR, V50, pS5; Valtaud C, 2009, J PLANT PATHOL, V91, P37	41	14	14	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0126851	10.1371/journal.pone.0126851	http://dx.doi.org/10.1371/journal.pone.0126851			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061034	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500019
J	Cugno, M; Tedeschi, A; Borghi, A; Bucciarelli, P; Asero, R; Venegoni, L; Griffini, S; Grovetti, E; Berti, E; Marzano, AV				Cugno, Massimo; Tedeschi, Alberto; Borghi, Alessandro; Bucciarelli, Paolo; Asero, Riccardo; Venegoni, Luigia; Griffini, Samantha; Grovetti, Elena; Berti, Emilio; Marzano, Angelo Valerio			Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk	PLOS ONE			English	Article							CHRONIC URTICARIA; PLASMA-LEVELS; TISSUE FACTOR; BLISTERING DISEASES; PEMPHIGOID DISEASES; ANTI-IGE; AUTOANTIBODIES; FIBRINOLYSIS; PATHOGENESIS; EOSINOPHILS	Coagulation activation has been demonstrated in two prototypic autoimmune skin diseases, chronic autoimmune urticaria and bullous pemphigoid, but only the latter is associated with increased thrombotic risk. Two markers of coagulation activation (prothrombin fragment F1 + 2 and fibrin fragment D-dimer) were measured by immunoenzymatic methods in plasma samples from 30 patients with active chronic autoimmune urticaria, positive for autologous serum skin test, 30 patients with active bullous pemphigoid and 30 healthy subjects. In skin biopsies, tissue factor expression was evaluated by both immunohistochemistry and in situ hybridization. F1+2 and D-dimer levels were higher in active chronic autoimmune urticaria (276.5 +/- 89.8 pmol/L and 5.56 +/- 4.40 nmol/L, respectively) than in controls (145.2 +/- 38.0 pmol/L and 1.06 +/- 0.25 nmol/L; P=0.029 and P=0.011) and were much higher in active bullous pemphigoid (691.7 +/- 318.7 pmol/L and 15.24 +/- 9.09 nmol/L, respectively) (P<0.0001). Tissue factor positivity was evident in skin biopsies of both disorders with higher intensity in bullous pemphigoid. F1+2 and D-dimer, during remission, were markedly reduced in both disorders. These findings support the involvement of coagulation activation in the pathophysiology of both diseases. The strong systemic activation of coagulation in bullous pemphigoid may contribute to increase the thrombotic risk and provides the rationale for clinical trials on anticoagulant treatments in this disease.	[Cugno, Massimo; Griffini, Samantha; Grovetti, Elena] Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Dipartimento Fisiopatol Med Chirurg & Trapianti,M, Milan, Italy; [Tedeschi, Alberto] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Unita Operat Allergol & Immunol Clin, Milan, Italy; [Borghi, Alessandro] Univ Ferrara, Dept Med Sci, Dermatol Sect, I-44100 Ferrara, Italy; [Bucciarelli, Paolo] Fdn IRCCS Ca Granda, Osped Maggiore Policlin, A Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy; [Asero, Riccardo] Clin San Carlo, Ambulatorio Allergol, Paderno Dugnano, MI, Italy; [Venegoni, Luigia; Berti, Emilio; Marzano, Angelo Valerio] Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Dipartimento Fisiopatol Med Chirurg & Trapianti,U, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Ferrara; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Cugno, M (corresponding author), Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Dipartimento Fisiopatol Med Chirurg & Trapianti,M, Milan, Italy.	massimo.cugno@unimi.it	Borghi, Alessandro/K-5412-2015; Cugno, Massimo/K-8106-2016; Venegoni, Luigia/K-6085-2018; Bucciarelli, Paolo/J-1907-2015; Bucciarelli, Paolo/AAB-5024-2019	Borghi, Alessandro/0000-0001-9163-9691; Cugno, Massimo/0000-0002-9918-0763; Venegoni, Luigia/0000-0002-1846-1206; Bucciarelli, Paolo/0000-0003-0877-365X; Bucciarelli, Paolo/0000-0003-0877-365X; Berti, Emilio/0000-0001-6753-4910	"Ricerca corrente", Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy	"Ricerca corrente", Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy	This work was supported by "Ricerca corrente", Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 2011, EXP DERMATOL, V20, P1022, DOI 10.1111/j.1600-0625.2011.01378.x; Asero R, 2008, ALLERGY, V63, P176, DOI 10.1111/j.1398-9995.2007.01514.x; Asero R, 2006, J ALLERGY CLIN IMMUN, V117, P1113, DOI 10.1016/j.jaci.2005.12.1343; Asero R, 2007, J ALLERGY CLIN IMMUN, V119, P705, DOI 10.1016/j.jaci.2006.08.043; Bernstein JA, 2014, J ALLERGY CLIN IMMUN, V133, P1270, DOI 10.1016/j.jaci.2014.02.036; Borrego L, 1996, AM J PATHOL, V148, P897; Cirino G, 1996, J EXP MED, V183, P821, DOI 10.1084/jem.183.3.821; Cugno M, 2010, AUTOIMMUNITY, V43, P189, DOI 10.3109/08916930903293086; Cugno M, 2009, INT ARCH ALLERGY IMM, V148, P170, DOI 10.1159/000155748; Echigo T, 2006, ARCH DERMATOL RES, V298, P38, DOI 10.1007/s00403-006-0661-5; Feliciani C, 1999, INT J IMMUNOPATH PH, V12, P55; GRATTAN CEH, 1986, BRIT J DERMATOL, V114, P583, DOI 10.1111/j.1365-2133.1986.tb04065.x; GRATTAN CEH, 1991, CLIN EXP ALLERGY, V21, P695, DOI 10.1111/j.1365-2222.1991.tb03198.x; Greaves MW, 2014, IMMUNOL ALLERGY CLIN, V34, P1, DOI 10.1016/j.iac.2013.07.009; GRUBER BL, 1988, J INVEST DERMATOL, V90, P213, DOI 10.1111/1523-1747.ep12462239; Hertl M, 2006, J CLIN INVEST, V116, P1159, DOI 10.1172/JCI28547; HIDE M, 1993, NEW ENGL J MED, V328, P1599, DOI 10.1056/NEJM199306033282204; Ingegnoli F, 2010, CLIN EXP RHEUMATOL, V28, P254; Joly P, 2005, ARCH DERMATOL, V141, P691, DOI 10.1001/archderm.141.6.691; Joly P, 2012, J INVEST DERMATOL, V132, P1998, DOI 10.1038/jid.2012.35; Kessel A, 2005, CLIN EXP ALLERGY, V35, P221, DOI 10.1111/j.1365-2222.2005.02168.x; Le Jan S, 2014, J INVEST DERMATOL, V134, P2908, DOI 10.1038/jid.2014.263; Lo Schiavo A, 2013, CLIN DERMATOL, V31, P391, DOI 10.1016/j.clindermatol.2013.01.006; Ludwig RJ, 2013, TRENDS MOL MED, V19, P501, DOI 10.1016/j.molmed.2013.06.003; Maino A, 2012, CURR VASC PHARMACOL, V10, P670, DOI 10.2174/157016112801784594; Marzano AV, 2013, CLIN EXP IMMUNOL, V171, P76, DOI 10.1111/j.1365-2249.2012.04674.x; Marzano AV, 2011, CLIN EXP IMMUNOL, V165, P44, DOI 10.1111/j.1365-2249.2011.04391.x; Marzano AV, 2009, BRIT J DERMATOL, V160, P266, DOI 10.1111/j.1365-2133.2008.08880.x; Moosbauer C, 2007, BLOOD, V109, P995, DOI 10.1182/blood-2006-02-004945; Nobe K, 2005, J PHARMACOL SCI, V99, P252, DOI 10.1254/jphs.FP0050679; Opal SM, 2000, CRIT CARE MED, V28, pS77, DOI 10.1097/00003246-200009001-00017; Rosendaal FR, 2007, J THROMB HAEMOST, V5, P310, DOI 10.1111/j.1538-7836.2007.02489.x; Saibeni S, 2006, J THROMB HAEMOST, V4, P1510, DOI 10.1111/j.1538-7836.2006.01970.x; Saini SS, 2014, IMMUNOL ALLERGY CLIN, V34, P33, DOI 10.1016/j.iac.2013.09.012; Savioli M, 2009, CRIT CARE MED, V37, P424, DOI 10.1097/CCM.0b013e31819542da; SCHAEFFER RC, 1993, AM J PHYSIOL, V264, pH1798, DOI 10.1152/ajpheart.1993.264.6.H1798; Schmidt E, 2013, LANCET, V381, P320, DOI 10.1016/S0140-6736(12)61140-4; Tedeschi A, 2014, ALLERGY, V69, P683, DOI 10.1111/all.12389; Tedeschi A, 2010, CLIN EXP ALLERGY, V40, P875, DOI 10.1111/j.1365-2222.2010.03473.x; Tong LJ, 1997, J ALLERGY CLIN IMMUN, V99, P461, DOI 10.1016/S0091-6749(97)70071-X; Ujiie H, 2010, J DERMATOL, V37, P194, DOI 10.1111/j.1346-8138.2009.00792.x; van der Poll T, 2012, CURR VASC PHARMACOL, V10, P632, DOI 10.2174/157016112801784549; Yancey KB, 2005, J CLIN INVEST, V115, P825, DOI 10.1172/JCI200524855; Yang YW, 2011, STROKE, V42, P319, DOI 10.1161/STROKEAHA.110.596361; Zuberbier T, 2014, ALLERGY, V69, P868, DOI 10.1111/all.12313	45	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129456	10.1371/journal.pone.0129456	http://dx.doi.org/10.1371/journal.pone.0129456			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057532	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000054
J	Hori, A; Wada, K; Smith, DR				Hori, Ai; Wada, Koji; Smith, Derek R.			A Socio-Demographic Examination of Adults Responding to Governmental Vaccination Recommendations during the Japanese Rubella Outbreak of 2013	PLOS ONE			English	Article							RISK; INFLUENZA; HEALTH	Background In 2013 a rubella outbreak occurred among Japanese people of working-age which resulted in 14,357 reported cases. The Japanese government subsequently recommended voluntary vaccination or rubella antibody testing for young women (15-49 years of age) who were planning to conceive and for adult men, children, and other persons in potential contact with pregnant women at home. However, the expense and time involved for vaccination, antibody testing and visiting a clinic may represent a major barrier to voluntary compliance among this busy demographic. The aim of the current study was, therefore, to examine potential relationships between the social background of Japanese working-age individuals affected by the 2013 voluntary vaccination campaign. Methods A web-based survey of 1,889 Japanese men and women aged 20-49 years was conducted in early 2014. Statistical analyses were used to explore the associations between social background and testing for rubella antibody and/or vaccination uptake during the previous year. Results Twenty-four percent of respondents who were planning a pregnancy had been tested for rubella antibody or vaccinated in 2013. However, among those without a current desire for pregnancy, 3% of men and 7% of women, respectively, were tested or vaccinated. Regardless of whether they were planning to conceive, testing for rubella antibodies or vaccination was statistically associated with having acquaintances who had been vaccinated, understanding the government recommendations, and being able to confirm their lack of rubella vaccination history using Maternal and Child Health Handbook records in both men and women. Conclusion To help eliminate rubella in Japan, additional initiatives need to target Japanese individuals who cannot envisage a direct benefit from vaccination. The results of this study suggest that disseminating the government recommendation to all potentially affected subpopulations, along with maintaining life-time vaccination records might offer a solution to encourage vaccination uptake among working-age adults in Japan, as elsewhere.	[Hori, Ai] Natl Inst Global Hlth & Med, Clin Res Ctr, Dept Epidemiol & Prevent, Tokyo, Japan; [Wada, Koji] Bur Int Hlth Cooperat, Natl Inst Global Hlth & Med, Tokyo, Japan; [Smith, Derek R.] Univ Newcastle, Fac Hlth & Med, Sch Hlth Sci, Ourimbah, Australia	University of Newcastle	Wada, K (corresponding author), Bur Int Hlth Cooperat, Natl Inst Global Hlth & Med, Tokyo, Japan.	kwada-sgy@umin.ac.jp	Hori, Ai/G-5277-2019	Hori, Ai/0000-0002-0191-5996; Smith, Derek/0000-0002-8202-2523	Health Labour Sciences Research Grant of Ministry of Health, Labour and Welfare, Tokyo, Japan; National Center for Global Health and Medicine [27-4]	Health Labour Sciences Research Grant of Ministry of Health, Labour and Welfare, Tokyo, Japan; National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was funded by the Health Labour Sciences Research Grant of the Ministry of Health, Labour and Welfare, Tokyo, Japan and the research fund of National Center for Global Health and Medicine (27-4). The funders had no role in the study design, data collection or analysis, the decision to publish, or in manuscript preparation.	Babigumira JB, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-406; Castillo-Solorzano C, 2011, J INFECT DIS, V204, pS683, DOI 10.1093/infdis/jir471; Fujimoto S, 2001, Nihon Koshu Eisei Zasshi, V48, P486; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Japan Pediatric Society, 2013, PET COUNT RUB OUTBR; Japan Society of Obstetrics and Gynecology, 2014, PET STRAT PREV PER R; Johnson DR, 2008, AM J MED, V121, pS28, DOI 10.1016/j.amjmed.2008.05.005; Ministry of Health, 2014, NAT IN RUB; Ministry of Health Labour and Welfare, 2013, REQ LOC GOV TEST RUB; Ministry of Health Labour and Welfare, 2013, INF PREV RUB CONG RU; National Institute of Infectious Diseases, 2014, CUM NUMB RUB CAS WEE; National Institute of Infectious Diseases, 2014, DIAGN CAS CONG RUB S; National Institute of Infectious Diseases and Tuberculosis and Infectious Diseases Control Division Ministry of Health Labour and Welfare, 2013, INFECT AGENTS SURVEI, V34, P87; Ndiaye SM, 2005, AM J PREV MED, V28, P248, DOI 10.1016/j.amepre.2005.02.016; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Smith DR, 2012, IND HEALTH, V50, P463; Tanaka-Taya K, 2013, MMWR-MORBID MORTAL W, V62, P457; Ueda K, 2009, VACCINE, V27, P3232, DOI 10.1016/j.vaccine.2009.02.076; Vieira JC, 2011, REV PANAM SALUD PUBL, V30, P335; Wada K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1065; Who Publication, 2011, Vaccine, V29, P8767, DOI 10.1016/j.vaccine.2011.08.061; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	22	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129900	10.1371/journal.pone.0129900	http://dx.doi.org/10.1371/journal.pone.0129900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057740	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000076
J	Navarrete, AA; Diniz, TR; Braga, LPP; Silva, GGZ; Franchini, JC; Rossetto, R; Edwards, RA; Tsai, SM				Navarrete, Acacio Aparecido; Diniz, Tatiana Rosa; Perez Braga, Lucas Palma; Silva, Genivaldo Gueiros Zacarias; Franchini, Julio Cezar; Rossetto, Raffaella; Edwards, Robert Alan; Tsai, Siu Mui			Multi-Analytical Approach Reveals Potential Microbial Indicators in Soil for Sugarcane Model Systems	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; TRASH RETENTION; ORGANIC-MATTER; NITROGEN; BIOMASS; MANAGEMENT; DIVERSITY; RESPONSES; QUALITY; CARBON	This study focused on the effects of organic and inorganic amendments and straw retention on the microbial biomass (MB) and taxonomic groups of bacteria in sugarcane-cultivated soils in a greenhouse mesocosm experiment monitored for gas emissions and chemical factors. The experiment consisted of combinations of synthetic nitrogen (N), vinasse (V; a liquid waste from ethanol production), and sugarcane-straw blankets. Increases in CO2-C and N2O-N emissions were identified shortly after the addition of both N and V to the soils, thus increasing MB nitrogen (MB-N) and decreasing MB carbon (MB-C) in the N+V-amended soils and altering soil chemical factors that were correlated with the MB. Across 57 soil metagenomic datasets, Actinobacteria (31.5%), Planctomycetes (12.3%), Deltaproteobacteria (12.3%), Alphaproteobacteria (12.0%) and Betaproteobacteria (11.1%) were the most dominant bacterial groups during the experiment. Differences in relative abundance of metagenomic sequences were mainly revealed for Acidobacteria, Actinobacteria, Gammaproteobacteria and Verrucomicrobia with regard to N+V fertilization and straw retention. Differential abundances in bacterial groups were confirmed using 16S rRNA gene-targeted phylum-specific primers for real-time PCR analysis in all soil samples, whose results were in accordance with sequence data, except for Gammaproteobacteria. Actinobacteria were more responsive to straw retention with Rubrobacterales, Bifidobacteriales and Actinomycetales related to the chemical factors of N+V-amended soils. Acidobacteria subgroup 7 and Opitutae, a verrucomicrobial class, were related to the chemical factors of soils without straw retention as a surface blanket. Taken together, the results showed that MB-C and MB-N responded to changes in soil chemical factors and CO2-C and N2O-N emissions, especially for N+V-amended soils. The results also indicated that several taxonomic groups of bacteria, such as Acidobacteria, Actinobacteria and Verrucomicrobia, and their subgroups acted as early-warning indicators of N+V amendments and straw retention in sugarcane-cultivated soils, which can alter the soil chemical factors.	[Navarrete, Acacio Aparecido; Diniz, Tatiana Rosa; Perez Braga, Lucas Palma; Tsai, Siu Mui] Univ Sao Paulo, Ctr Nucl Energy Agr CENA, Cell & Mol Biol Lab, Piracicaba, SP, Brazil; [Silva, Genivaldo Gueiros Zacarias; Edwards, Robert Alan] San Diego State Univ, Computat Sci Res Ctr, San Diego, CA 92182 USA; [Franchini, Julio Cezar] Brazilian Agr Res Corp, Londrina, PR, Brazil; [Rossetto, Raffaella] Sao Paulos Agcy Agribusiness Technol, Piracicaba, SP, Brazil; [Edwards, Robert Alan] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Edwards, Robert Alan] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	Universidade de Sao Paulo; California State University System; San Diego State University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Tsai, SM (corresponding author), Univ Sao Paulo, Ctr Nucl Energy Agr CENA, Cell & Mol Biol Lab, Piracicaba, SP, Brazil.	tsai@cena.usp.br	Navarrete, Acacio A/K-5257-2014; Edwards, Robert/Q-1691-2019; FRANCHINI, JULIO C/C-5777-2016; Tsai, Siu Mui/C-2793-2012	Navarrete, Acacio A/0000-0001-6204-8702; Edwards, Robert/0000-0001-8383-8949; FRANCHINI, JULIO C/0000-0002-8686-3012; Tsai, Siu Mui/0000-0002-3733-6312; Palma Perez Braga, Lucas/0000-0003-2789-7252	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [12/13321-7, 14/06077-8, 11/51749-6]; CNPq-Brazilian National Council for Scientific and Technological Development (CNPq) [485801-2011-6]; Nucleo de Pesquisa em Tecnologia e Inovacao para Sustentabilidade da Agricultura (NAPTISA); Direct For Biological Sciences [1330800] Funding Source: National Science Foundation	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq-Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Nucleo de Pesquisa em Tecnologia e Inovacao para Sustentabilidade da Agricultura (NAPTISA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP 12/13321-7, 14/06077-8 and 11/51749-6) and CNPq-Brazilian National Council for Scientific and Technological Development (CNPq 485801-2011-6). Small funds were also provided by Nucleo de Pesquisa em Tecnologia e Inovacao para Sustentabilidade da Agricultura (NAPTISA).	Aleixo AP, 2014, CIENC RURAL, V44, P588, DOI 10.1590/S0103-84782014000400002; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barns SM, 1999, APPL ENVIRON MICROB, V65, P1731; Barros R. P., 2010, PESQUISA AGROPECUARI, V40, P341, DOI [DOI 10.5216/PAT.V40I3.5841, 10.5216/pat.v40i3.5841]; BARTLETT RJ, 1988, SOIL SCI SOC AM J, V52, P1191, DOI 10.2136/sssaj1988.03615995005200040055x; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Camargo AO, 2009, METHODS CHEM ANAL PH; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; Craine JM, 2007, ECOLOGY, V88, P2105, DOI 10.1890/06-1847.1; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; do Carmo JB, 2012, GCB BIOENERGY, V5, P267; Feije F, 1972, ANAL CHIM ACTA, V149, P363; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Franchini JC, 2007, SOIL TILL RES, V92, P18, DOI 10.1016/j.still.2005.12.010; Garcia-Gil JC, 2000, SOIL BIOL BIOCHEM, V32, P1907, DOI 10.1016/S0038-0717(00)00165-6; Graham MH, 2002, SOIL BIOL BIOCHEM, V34, P93, DOI 10.1016/S0038-0717(01)00160-2; Hargreaves PR, 2003, SOIL BIOL BIOCHEM, V41, P249; Hartmann M, 2006, FEMS MICROBIOL ECOL, V57, P378, DOI 10.1111/j.1574-6941.2006.00132.x; Heffer P, 2008, MEDIUM TERM OUTLOOK, DOI [10.1007/BF03187121, DOI 10.1007/BF03187121]; Hidalgo K, 2009, FEED TECH, V13, P18; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Hurney AP, 2013, INT SUGAR J, V115, P212; Isanapong J, 2012, J BACTERIOL, V194, P2744, DOI 10.1128/JB.00264-12; Jackson LE, 2003, GEODERMA, V114, P305, DOI 10.1016/S0016-7061(03)00046-6; Jenkinson DS, 1981, SOIL BIOCH, V5, P415; Jiang ZP, 2012, SUGAR TECH, V14, P412, DOI 10.1007/s12355-012-0174-9; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lazcano C, 2013, BIOL FERT SOILS, V49, P723, DOI 10.1007/s00374-012-0761-7; Leita L, 1999, BIOL FERT SOILS, V28, P371, DOI 10.1007/s003740050506; Li YangRui, 2008, Southwest China Journal of Agricultural Sciences, V21, P749; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Meier EA, 2006, NUTR CYCL AGROECOSYS, V75, P101, DOI 10.1007/s10705-006-9015-0; Meng YanCheng, 2009, Southwest China Journal of Agricultural Sciences, V22, P389; Montenegro Gómez Sandra Patricia, 2009, Acta Agron., V58, P41; Mooshammer M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4694; Mutton MA, 2010, SUGARCANE BIOETHANOL, V1, P423, DOI DOI 10.5151/BLUCHER0A-SUGARCANE-SUGARCANEBI0ETHAN0L_; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Noll M, 2005, ENVIRON MICROBIOL, V7, P382, DOI 10.1111/j.1462-2920.2005.00700.x; Trivelin PCO, 2013, SCI AGR, V70, P345, DOI 10.1590/S0103-90162013000500009; Pan Y, 2014, FEMS MICROBIOL ECOL, V90, P195, DOI 10.1111/1574-6941.12384; Penatti CP, 1988, B TECNICO COPERSUCAR, V44, P32; Pisa G, 2011, BRAZ J MED BIOL RES, V44, P1215, DOI [10.1590/S0100-879X2011007500148, 10.1590/S0100-879X2011001200004]; POWLSON DS, 1981, J AGR SCI-CAMBRIDGE, V97, P713, DOI 10.1017/S0021859600037084; Rachid CTCC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059342; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Rawat SR, 2012, FEMS MICROBIOL ECOL, V82, P341, DOI 10.1111/j.1574-6941.2012.01381.x; Ribeiro BT, 2012, BIOSCI J, V28, P25; Robertson FA, 2007, AUST J SOIL RES, V45, P13, DOI 10.1071/SR06080; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Shange RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040338; Silva GGZ, 2014, PEERJ, V2, DOI 10.7717/peerj.425; SPARLING GP, 1992, AUST J SOIL RES, V30, P195, DOI 10.1071/SR9920195; STEUDLER PA, 1989, NATURE, V341, P314, DOI 10.1038/341314a0; Stevenson BS, 2004, APPL ENVIRON MICROB, V70, P4748, DOI 10.1128/AEM.70.8.4748-4755.2004; Sul WJ, 2013, SOIL BIOL BIOCHEM, V65, P33, DOI 10.1016/j.soilbio.2013.05.007; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Thrash J Cameron, 2010, J Bacteriol, V192, P3838, DOI 10.1128/JB.00510-10; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Ventura M, 2007, MICROBIOL MOL BIOL R, V71, P495, DOI 10.1128/MMBR.00005-07; Ward NL, 2009, APPL ENVIRON MICROB, V75, P2046, DOI 10.1128/AEM.02294-08; Wessen E, 2010, SOIL BIOL BIOCHEM, V42, P1759, DOI 10.1016/j.soilbio.2010.06.013; Yang SD, 2013, SUGAR TECH, V15, P152, DOI 10.1007/s12355-012-0200-y; Zhang Y.L., 2008, GUANGXI TROPICAL AGR, V2, P28	69	35	36	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129765	10.1371/journal.pone.0129765	http://dx.doi.org/10.1371/journal.pone.0129765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057123	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000071
J	Paleczny, M; Hammill, E; Pauly, D; Pauly, D				Paleczny, Michelle; Hammill, Edd; Karpouzi, Vasiliki; Pauly, Daniel			Population Trend of the World's Monitored Seabirds, 1950-2010	PLOS ONE			English	Article							PREDATORS; FISHERIES; IMPACT; BIRDS; FOOD	Seabird population changes are good indicators of long-term and large-scale change in marine ecosystems, and important because of their many impacts on marine ecosystems. We assessed the population trend of the world's monitored seabirds (1950-2010) by compiling a global database of seabird population size records and applying multivariate autoregressive state-space (MARSS) modeling to estimate the overall population trend of the portion of the population with sufficient data (i.e., at least five records). This monitored population represented approximately 19% of the global seabird population. We found the monitored portion of the global seabird population to have declined overall by 69.7% between 1950 and 2010. This declining trend may reflect the global seabird population trend, given the large and apparently representative sample. Furthermore, the largest declines were observed in families containing wide-ranging pelagic species, suggesting that pan-global populations may be more at risk than shorter-ranging coastal populations.	[Paleczny, Michelle; Hammill, Edd; Karpouzi, Vasiliki; Pauly, Daniel] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Hammill, Edd] Univ Technol Sydney, Sch Environm, Ultimo, NSW 2007, Australia	University of British Columbia; University of Technology Sydney	Paleczny, M (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	m.paleczny@fisheries.ubc.ca	Pauly, Daniel Marc/AAY-2316-2021	Pauly, Daniel/0000-0003-3756-4793	University of British Columbia; Pew Environment Group	University of British Columbia; Pew Environment Group	This work was supported by the Sea Around Us project, a collaboration between the University of British Columbia and the Pew Environment Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2010, PROG OCEANOGR, V84, P242, DOI 10.1016/j.pocean.2009.10.001; Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; BENGTSON SA, 1984, AUK, V101, P1; Brooke MD, 2004, P ROY SOC B-BIOL SCI, V271, pS246, DOI 10.1098/rsbl.2003.0153; Croll DA, 2005, SCIENCE, V307, P1959, DOI 10.1126/science.1108485; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; CROXALL JP, 1984, STATUS CONSERVATION; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Freedman B, 2010, ECOLOGY CANADIAN CON; Furness RW, 2000, MAR ECOL PROG SER, V202, P253, DOI 10.3354/meps202253; Goya E, 2002, INVESTIGACIONES MARI, V30; Gremillet D, 2015, BIOL CONSERV, V182, P143, DOI 10.1016/j.biocon.2014.12.001; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; HASEGAWA H, 1982, American Birds, V36, P806; Hilton GM, 2010, IBIS, V152, P443, DOI 10.1111/j.1474-919X.2010.01031.x; Holmes E, MULTIVARIATE AUTOREG; Irons DB, 2008, GLOBAL CHANGE BIOL, V14, P1455, DOI 10.1111/j.1365-2486.2008.01581.x; Jones HP, 2012, J WILDLIFE MANAGE, V76, P2, DOI 10.1002/jwmg.240; Karpouzi VS, 2007, MAR ECOL PROG SER, V343, P87, DOI 10.3354/meps06860; Kolb GS, 2010, MAR ECOL PROG SER, V417, P287, DOI 10.3354/meps08791; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Moore-Colyer R. J., 2000, RURAL HIST, V11.1, P57, DOI DOI 10.1017/S0956793300001904; Mulder CPH, 2011, SEABIRD ISLANDS ECOL; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; Osterblom H, 2008, OIKOS, V117, P967, DOI 10.1111/j.2008.0030-1299.16501.x; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Peters JL, 1979, CHECKLIST BIRDS WORL; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Riddick SN, 2012, ATMOS ENVIRON, V55, P319, DOI 10.1016/j.atmosenv.2012.02.052; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123	35	202	212	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129342	10.1371/journal.pone.0129342	http://dx.doi.org/10.1371/journal.pone.0129342			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058068	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000049
J	Parker, JC; Douglas, I; Bell, J; Comer, D; Bailie, K; Skibinski, G; Heaney, LG; Shields, MD				Parker, Jeremy C.; Douglas, Isobel; Bell, Jennifer; Comer, David; Bailie, Keith; Skibinski, Grzegorz; Heaney, Liam G.; Shields, Michael D.			Epidermal Growth Factor Removal or Tyrphostin AG1478 Treatment Reduces Goblet Cells & Mucus Secretion of Epithelial Cells from Asthmatic Children Using the Air-Liquid Interface Model	PLOS ONE			English	Article							INTRACELLULAR SIGNALING PATHWAYS; FACTOR RECEPTOR; BRONCHIAL EPITHELIUM; MUCIN PRODUCTION; EGF RECEPTOR; HYPERSECRETION; INFLAMMATION; PHARMACOTHERAPY; AMPHIREGULIN; CULTURE	Rationale Epithelial remodelling in asthma is characterised by goblet cell hyperplasia and mucus hypersecretion for which no therapies exist. Differentiated bronchial air-liquid interface cultures from asthmatic children display high goblet cell numbers. Epidermal growth factor and its receptor have been implicated in goblet cell hyperplasia. Objectives We hypothesised that EGF removal or tyrphostin AG1478 treatment of differentiating air-liquid interface cultures from asthmatic children would result in a reduction of epithelial goblet cells and mucus secretion. Methods In Aim 1 primary bronchial epithelial cells from non-asthmatic (n = 5) and asthmatic (n = 5) children were differentiated under EGF-positive (10ng/ml EGF) and EGF-negative culture conditions for 28 days. In Aim 2, cultures from a further group of asthmatic children (n = 5) were grown under tyrphostin AG1478, a tyrosine kinase inhibitor, conditions. All cultures were analysed for epithelial resistance, markers of differentiation using immunocytochemistry, ELISA for MUC5AC mucin secretion and qPCR for MUC5AC mRNA. Results In cultures from asthmatic children the goblet cell number was reduced in the EGF negative group (p = 0.01). Tyrphostin AG1478 treatment of cultures from asthmatic children had significant reductions in goblet cells at 0.2 mu g/ml (p = 0.03) and 2 mu g/ml (p = 0.003) as well as mucus secretion at 2 mu g/ml (p = 0.04). Conclusions We have shown in this preliminary study that through EGF removal and tyrphostin AG1478 treatment the goblet cell number and mucus hypersecretion in differentiating air-liquid interface cultures from asthmatic children is significantly reduced. This further highlights the epidermal growth factor receptor as a potential therapeutic target to inhibit goblet cell hyperplasia and mucus hypersecretion in asthma.	[Parker, Jeremy C.; Bell, Jennifer; Comer, David; Skibinski, Grzegorz; Heaney, Liam G.; Shields, Michael D.] Queens Univ Belfast, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Douglas, Isobel; Bailie, Keith; Shields, Michael D.] Royal Belfast Hosp Sick Children, Belfast, Antrim, North Ireland	Queens University Belfast	Heaney, LG (corresponding author), Queens Univ Belfast, Ctr Infect & Immun, Hlth Sci Bldg, Belfast, Antrim, North Ireland.	l.heaney@qub.ac.uk			Northern Ireland Chest Heart and Stroke Association [200942]; Public Health Agency [RRG/3244/05] Funding Source: researchfish	Northern Ireland Chest Heart and Stroke Association; Public Health Agency	Northern Ireland Chest Heart and Stroke Association (grant number 200942) provided funding for this study. The funders had no involvement in the design, data collection, analysis, decision to publish or preparation of the manuscript.	Amishima M, 1998, AM J RESP CRIT CARE, V157, P1907, DOI 10.1164/ajrccm.157.6.9609040; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Coyle PV, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-41; Cutz E, 2002, Histopathology, V41, P22; Denker BM, 1998, AM J PHYSIOL-RENAL, V274, pF1, DOI 10.1152/ajprenal.1998.274.1.F1; Doherty GM, 2003, CLIN EXP ALLERGY, V33, P1221, DOI 10.1046/j.1365-2222.2003.01752.x; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Hovenberg HW, 1996, BIOCHEM J, V318, P319, DOI 10.1042/bj3180319; Hur GY, 2007, EXP MOL MED, V39, P367, DOI 10.1038/emm.2007.41; Lai H, 2010, J AEROSOL MED PULM D, V23, P219, DOI 10.1089/jamp.2009.0802; Lai HY, 2010, CURR OPIN ALLERGY CL, V10, P67, DOI 10.1097/ACI.0b013e328334643a; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Manzo ND, 2012, AM J RESP CELL MOL, V47, P349, DOI 10.1165/rcmb.2011-0257OC; Parker J, 2010, PEDIATR RES, V67, P17, DOI 10.1203/PDR.0b013e3181c0b200; Perrais M, 2002, J BIOL CHEM, V277, P32258, DOI 10.1074/jbc.M204862200; Pohunek P, 2005, PEDIAT ALLERG IMM-UK, V16, P43, DOI 10.1111/j.1399-3038.2005.00239.x; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Raymond E, 2000, DRUGS, V60, P15, DOI 10.2165/00003495-200060001-00002; Rogers DF, 2007, RESP CARE, V52, P1134; Saglani S, 2014, THORAX, V69, P887, DOI 10.1136/thoraxjnl-2014-205561; Shaykhiev R, 2013, P NATL ACAD SCI USA, V110, P12102, DOI 10.1073/pnas.1303058110; Stevenson EC, 1997, CLIN EXP ALLERGY, V27, P1027, DOI 10.1111/j.1365-2222.1997.tb01254.x; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Tamaoka M, 2008, EUR RESPIR J, V32, P1213, DOI 10.1183/09031936.00166907; Thavagnanam S, 2011, PEDIATR RES, V69, P95, DOI 10.1203/PDR.0b013e318204edb5; Vargaftig BB, 2003, AM J PHYSIOL-LUNG C, V285, pL808, DOI 10.1152/ajplung.00377.2002; Zudhi-Alimam M, 2000, AM J RESP CELL MOL B, V22, P253; Zwick E, 1999, TRENDS PHARMACOL SCI, V20, P408, DOI 10.1016/S0165-6147(99)01373-5	31	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129546	10.1371/journal.pone.0129546	http://dx.doi.org/10.1371/journal.pone.0129546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057128	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000061
J	Iyomasa, MM; Fernandes, FS; Iyomasa, DM; Pereira, YCL; Fernandez, RAR; Calzzani, RA; Nascimento, GC; Leite-Panissi, CRA; Issa, JPM				Iyomasa, Mamie Mizusaki; Fernandes, Fernanda Silva; Iyomasa, Daniela Mizusaki; Lara Pereira, Yamba Carla; Restrepo Fernandez, Rodrigo Alberto; Calzzani, Ricardo Alexandre; Nascimento, Glauce Crivelaro; Andrade Leite-Panissi, Christie Ramos; Mardegan Issa, Joao Paulo			Metabolic Changes in Masseter Muscle of Rats Submitted to Acute Stress Associated with Exodontia	PLOS ONE			English	Article							SKELETAL-MUSCLE; REACTIVE OXYGEN; TEMPOROMANDIBULAR DISORDERS; UNILATERAL EXTRACTION; OXIDATIVE STRESS; PAIN; RESPONSES; INTERFERENCE; MITOCHONDRIA; PREVALENCE	Clinical evidence has shown that stress may be associated with alterations in masticatory muscle functions. Morphological changes in masticatory muscles induced by occlusal alterations and associated with emotional stress are still lacking in the literature. The objective of this study was to evaluate the influence of acute stress on metabolic activity and oxidative stress of masseter muscles of rats subjected to occlusal modification through morphological and histochemical analyses. In this study, adult Wistar rats were divided into 4 groups: a group with extraction and acute stress (E+A); group with extraction and without stress (E+C); group without extraction and with acute stress (NO+A); and control group without both extraction and stress (NO+C). Masseter muscles were analyzed by Succinate Dehydrogenase (SDH), Nicotinamide Adenine Dinucleotide Diaphorase (NADH) and Reactive Oxygen Species (ROS) techniques. Statistical analyses and two-way ANOVA were applied, followed by Tukey-Kramer tests. In the SDH test, the E+C, E+A and NO+A groups showed a decrease in high desidrogenase activities fibers (P < 0.05), compared to the NO+C group. In the NADH test, there was no difference among the different groups. In the ROS test, in contrast, E+A, E+C and NO+A groups showed a decrease in ROS expression, compared to NO+C groups (P < 0.05). Modified dental occlusion and acute stress - which are important and prevalent problems that affect the general population - are important etiologic factors in metabolic plasticity and ROS levels of masseter muscles.	[Iyomasa, Mamie Mizusaki; Fernandes, Fernanda Silva; Iyomasa, Daniela Mizusaki; Calzzani, Ricardo Alexandre; Nascimento, Glauce Crivelaro; Andrade Leite-Panissi, Christie Ramos; Mardegan Issa, Joao Paulo] Univ Sao Paulo, Ribeirao Preto Dent Fac, Dept Morphol Physiol & Basic Pathol, BR-14040904 Ribeirao Preto, SP, Brazil; [Lara Pereira, Yamba Carla] Univ Estadual Campinas, Sch Dent Piracicaba, Biol Dent Buco Grad Program, BR-13414903 Piracicaba, SP, Brazil; [Restrepo Fernandez, Rodrigo Alberto] Univ Sao Paulo, Sch Med, Dept Physiol, BR-14040900 Ribeirao Preto, SP, Brazil; [Nascimento, Glauce Crivelaro; Andrade Leite-Panissi, Christie Ramos] Univ Sao Paulo, Sch Philosophy Sci & Literature Ribeirao Preto, Psychobiol Grad Program, BR-14040901 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade de Sao Paulo	Nascimento, GC (corresponding author), Univ Sao Paulo, Ribeirao Preto Dent Fac, Dept Morphol Physiol & Basic Pathol, BR-14040904 Ribeirao Preto, SP, Brazil.	glau_nascimento@yahoo.com.br	Issa, João Paulo/A-2505-2011; Leite-Panissi, Christie Ramos Andrade/A-2011-2013; Nascimento, Glauce C/G-2307-2014; Fernandez, Rodrigo/GRF-1350-2022; Iyomasa, Daniela M/I-8245-2014	Issa, João Paulo/0000-0002-1056-0795; Leite-Panissi, Christie Ramos Andrade/0000-0003-1762-2730; Nascimento, Glauce C/0000-0001-5116-2200; Iyomasa, Daniela M/0000-0002-2013-9240	FAPESP [2011/00856-7, 2011/15209-7, 2011/18889-9]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP (Grant numbers 2011/00856-7; 2011/15209-7 and 2011/18889-9; URL: http://fapesp.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvenshine Ronald C, 2007, Dent Clin North Am, V51, P105, DOI 10.1016/j.cden.2006.10.005; Avni D, 2005, PHOTOMED LASER SURG, V23, P273, DOI 10.1089/pho.2005.23.273; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Basi DL, 2012, J ORAL REHABIL, V39, P326, DOI 10.1111/j.1365-2842.2011.02271.x; Bazan E, 2008, MICRON, V39, P536, DOI 10.1016/j.micron.2007.07.006; Carvalho Andréa Lúcia de Almeida, 2008, Braz. oral res., V22, P31, DOI 10.1590/S1806-83242008000100006; CHRISTENSEN LV, 1995, J ORAL REHABIL, V22, P521, DOI 10.1111/j.1365-2842.1995.tb01198.x; Cutando A, 2007, J PINEAL RES, V42, P419, DOI 10.1111/j.1600-079X.2007.00425.x; Dicker GJ, 2012, INT J ORAL MAX SURG, V41, P922, DOI 10.1016/j.ijom.2012.01.007; do Nascimento GC, 2014, PHYSIOL BEHAV, V125, P1, DOI 10.1016/j.physbeh.2013.11.009; Glaros AG, 2005, J AM DENT ASSOC, V136, P451, DOI 10.14219/jada.archive.2005.0200; Guyton A, 2006, TEXB MED PHYSL; Hajjawi O., 2011, EJSR, V51, P133; Hao L, 2006, ARTERIOSCL THROM VAS, V26, P819, DOI 10.1161/01.ATV.0000204344.90301.7c; Iyomasa MM, 2008, MICRON, V39, P1111, DOI 10.1016/j.micron.2008.07.002; Iyomasa MM, 2009, MICRON, V40, P206, DOI 10.1016/j.micron.2008.09.002; Kebede B, 2011, ETHIOP J HEALTH SCI, V21, P209; Kindler S, 2012, J PAIN, V13, P1188, DOI 10.1016/j.jpain.2012.09.004; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Pereira YCL, 2015, ACTA ODONTOL SCAND, V73, P81, DOI 10.3109/00016357.2014.954267; Li Q, 2011, PHYSIOL BEHAV, V104, P365, DOI 10.1016/j.physbeh.2011.04.012; Macfarlane TV, 2002, COMMUNITY DENT ORAL, V30, P52, DOI 10.1034/j.1600-0528.2002.300108.x; MAEDA N, 1990, ACTA ANAT, V137, P19, DOI 10.1159/000146852; Mammucari C, 2010, MECH AGEING DEV, V131, P536, DOI 10.1016/j.mad.2010.07.003; MAXWELL LC, 1973, AM J PHYSIOL, V224, P356, DOI 10.1152/ajplegacy.1973.224.2.356; Miehe B, 1999, ANN ANAT, V181, P37, DOI 10.1016/S0940-9602(99)80084-3; Murrant CL, 2001, MICROSC RES TECHNIQ, V55, P236, DOI 10.1002/jemt.1173; Pacak K, 2001, ENDOCR REV, V22, P502, DOI 10.1210/er.22.4.502; Pedroni Cristiane Rodrigues, 2006, J. Appl. Oral Sci., V14, P388, DOI 10.1590/S1678-77572006000500016; PETER JB, 1972, BIOCHEMISTRY-US, V11, P2627, DOI 10.1021/bi00764a013; Piao YJ, 2005, FREE RADICAL BIO MED, V38, P989, DOI 10.1016/j.freeradbiomed.2004.11.011; Powers SK, 2012, CURR OPIN CLIN NUTR, V15, P240, DOI 10.1097/MCO.0b013e328352b4c2; RICHARDIN P, 1995, J ORAL REHABIL, V22, P775, DOI 10.1111/j.1365-2842.1995.tb00222.x; Rispoli Daniel Zeni, 2008, Braz J Otorhinolaryngol, V74, P790, DOI 10.1016/S1808-8694(15)31393-8; Roy M, 2009, P NATL ACAD SCI USA, V106, P20900, DOI 10.1073/pnas.0904706106; Rustin P, 2002, NAT GENET, V30, P352, DOI 10.1038/ng0402-352; Sipila K, 2011, EUR J PAIN, V15, P1061, DOI 10.1016/j.ejpain.2011.05.001; Takeda H, 2009, J ORAL MAXIL SURG, V67, P1844, DOI 10.1016/j.joms.2009.04.027; Throckmorton GS, 2001, J ORAL MAXIL SURG, V59, P620, DOI 10.1053/joms.2001.23373; Tsai CY, 2012, INT J ORAL MAX SURG, V41, P394, DOI 10.1016/j.ijom.2011.10.016; Tsai CY, 2010, INT J ORAL MAX SURG, V39, P593, DOI 10.1016/j.ijom.2010.02.011; Tsai CM, 2002, J ORAL REHABIL, V29, P44, DOI 10.1046/j.1365-2842.2002.00810.x; Uhac I, 2003, J ORAL REHABIL, V30, P211, DOI 10.1046/j.1365-2842.2003.01030.x; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Viel EC, 2008, AM J PHYSIOL-HEART C, V295, pH281, DOI 10.1152/ajpheart.00304.2008; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; White AT, 2012, AM J PHYSIOL-ENDOC M, V303, pE308, DOI 10.1152/ajpendo.00054.2012; Wiech K, 2008, TRENDS COGN SCI, V12, P306, DOI 10.1016/j.tics.2008.05.005; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097	49	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128397	10.1371/journal.pone.0128397	http://dx.doi.org/10.1371/journal.pone.0128397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053038	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300033
J	Klein, J; Pierscionek, BK; Lauritzen, J; Derntl, K; Grzybowski, A; Zlatkova, MB				Klein, Johann; Pierscionek, Barbara K.; Lauritzen, Jan; Derntl, Karin; Grzybowski, Andrzej; Zlatkova, Margarita B.			The Effect of Cataract on Early Stage Glaucoma Detection Using Spatial and Temporal Contrast Sensitivity Tests	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; VISUAL-ACUITY; AUTOMATED-ANALYSIS; OPTIC DISC; PERIMETRY; FLICKER; DISABILITY; EXTRACTION; FIELD; RESPONSES	Background To investigate the effect of cataract on the ability of spatial and temporal contrast sensitivity tests used to detect early glaucoma. Methods Twenty-seven glaucoma subjects with early cataract (mean age 60 +/- 10.2 years) which constituted the test group were recruited together with twenty-seven controls (cataract only) matched for age and cataract type from a primary eye care setting. Contrast sensitivity to flickering gratings at 20 Hz and stationary gratings with and without glare, were measured for 0.5, 1.5 and 3 cycles per degree (cpd) in central vision. Perimetry and structural measurements with the Heidelberg Retinal Tomograph (HRT) were also performed. Results After considering the effect of cataract, contrast sensitivity to stationary gratings was reduced in the test group compared with controls with a statistically significant mean difference of 0.2 log units independent of spatial frequency. The flicker test showed a significant difference between test and control group at 1.5 and 3 cpd (p = 0.019 and p = 0.011 respectively). The percentage of glaucoma patients who could not see the temporal modulation was much higher compared with their cataract only counterparts. A significant correlation was found between the reduction of contrast sensitivity caused by glare and the Glaucoma Probability Score (GPS) as measured with the HRT (p<0.005). Conclusions These findings indicate that both spatial and temporal contrast sensitivity tests are suitable for distinguishing between vision loss as a consequence of glaucoma and vision loss caused by cataract only. The correlation between glare factor and GPS suggests that there may be an increase in intraocular stray light in glaucoma.	[Klein, Johann; Zlatkova, Margarita B.] Univ Ulster, Sch Biomed Sci, Coleraine BT52 1SA, Londonderry, North Ireland; [Pierscionek, Barbara K.; Lauritzen, Jan] Univ Kingston, Fac Sci Engn & Comp, Kingston Upon Thames KT1 2EE, Surrey, England; [Derntl, Karin] Ordinat Dr Karin Derntl, A-4840 Vocklabruck, Austria; [Grzybowski, Andrzej] Poznan City Hosp, Dept Ophthalmol, Poznan, Poland; [Grzybowski, Andrzej] Univ Warmia & Mazury, Dept Ophthalmol, Olsztyn, Poland	Ulster University; Kingston University; University of Warmia & Mazury	Pierscionek, BK (corresponding author), Univ Kingston, Fac Sci Engn & Comp, Penrhyn Rd, Kingston Upon Thames KT1 2EE, Surrey, England.	b.pierscionek@kingston.ac.uk	Pierscionek, Barbara/AAK-5760-2021; Grzybowski, A/E-4486-2010	Grzybowski, A/0000-0002-3724-2391				ABRAHAMSSON M, 1986, INVEST OPHTH VIS SCI, V27, P1131; Anderson RS, 2009, INVEST OPHTH VIS SCI, V50, P4022, DOI 10.1167/iovs.08-2934; Ansari EA, 2002, BRIT J OPHTHALMOL, V86, P1131, DOI 10.1136/bjo.86.10.1131; ARDEN GB, 1978, INVEST OPHTH VIS SCI, V171, P23; Artes PH, 2002, INVEST OPHTH VIS SCI, V43, P2654; ATKIN A, 1979, AM J OPHTHALMOL, V88, P205, DOI 10.1016/0002-9394(79)90467-7; Bergin C, 2011, INVEST OPHTH VIS SCI, V52, P3676, DOI 10.1167/iovs.10-6642; BRETON ME, 1991, INVEST OPHTH VIS SCI, V32, P2931; Carrillo MM, 2005, ARCH OPHTHALMOL-CHIC, V123, P929, DOI 10.1001/archopht.123.7.929; Casser L., 1997, ATLAS PRIMARY EYECAR; CASSON EJ, 1993, J OPT SOC AM A, V10, P1792, DOI 10.1364/JOSAA.10.001792; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Coops A, 2006, INVEST OPHTH VIS SCI, V47, P5348, DOI 10.1167/iovs.06-0579; Crawford MLJ, 2000, INVEST OPHTH VIS SCI, V41, P1791; DEWAARD PWT, 1992, INVEST OPHTH VIS SCI, V33, P618; El-Gohary AA., 2009, RES J MED MED SCI, V4, P85; ELLIOTT DB, 1993, INVEST OPHTH VIS SCI, V34, P108; Garway-Heath DF, 2000, OPHTHALMOLOGY, V107, P1809, DOI 10.1016/S0161-6420(00)00284-0; Harwerth RS, 2003, VISION RES, V43, P505, DOI 10.1016/S0042-6989(02)00653-3; Hashemi H, 2012, OPHTHALMOLOGY, V119, P541, DOI 10.1016/j.ophtha.2011.08.030; Hayashi K, 2001, AM J OPHTHALMOL, V132, P41, DOI 10.1016/S0002-9394(01)00920-5; HEIJL A, 1984, ACTA OPHTHALMOL, V62, P658; HICKS TP, 1983, J PHYSIOL-LONDON, V337, P183, DOI 10.1113/jphysiol.1983.sp014619; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Hot A, 2008, INVEST OPHTH VIS SCI, V49, P3049, DOI 10.1167/iovs.07-1205; JANKELOVITS ER, 1988, APPL OPTICS, V27, P1057, DOI 10.1364/AO.27.001057; Johnson C A, 1994, J Glaucoma, V3 Suppl 1, pS32; Junemann AGM, 2000, GRAEF ARCH CLIN EXP, V238, P427, DOI 10.1007/s004170050374; KEESEY UT, 1972, J OPT SOC AM, V62, P446, DOI 10.1364/JOSA.62.000446; KELLY DH, 1966, J OPT SOC AM, V56, P1628, DOI 10.1364/JOSA.56.001628; Kook MS, 2004, AM J OPHTHALMOL, V138, P85, DOI 10.1016/j.ajo.2004.03.020; Korth MJ, 2000, KLIN MONATSBL AUGENH, V216, P360, DOI 10.1055/s-2000-10582; LACHENMAYR BJ, 1991, GRAEF ARCH CLIN EXP, V229, P246, DOI 10.1007/BF00167877; LACHENMAYR BJ, 1992, INVEST OPHTH VIS SCI, V33, P3539; Lahav K, 2011, ARCH OPHTHALMOL-CHIC, V129, P16, DOI 10.1001/archophthalmol.2010.332; LAM BL, 1991, OPHTHALMOLOGY, V98, P1066; Langerhorst CT, PERIMETRY UPDATE 199, P67; LUNDH BL, 1985, ACTA OPHTHALMOL, V63, P487; LUNTINEN O, 1995, VISION RES, V35, P2339, DOI 10.1016/0042-6989(94)00309-A; Martus P, 1998, INVEST OPHTH VIS SCI, V39, P1567; Membrey L, 2001, PERIMETRY UPDATE 2000/2001, P259; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Mitov D L, 2005, Neurosci Behav Physiol, V35, P417, DOI 10.1007/s11055-005-0042-0; Morgan JE, 2000, BRIT J OPHTHALMOL, V84, P303, DOI 10.1136/bjo.84.3.303; Owsley Cynthia, 2003, Ophthalmol Clin North Am, V16, P171, DOI 10.1016/S0896-1549(03)00003-8; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; REGAN D, 1984, BRIT J OPHTHALMOL, V68, P310, DOI 10.1136/bjo.68.5.310; Richman J, 2010, ARCH OPHTHALMOL-CHIC, V128, P1576, DOI 10.1001/archophthalmol.2010.275; Robson JG, J OPT SOC AM A, V6, P1141; ROSS JE, 1984, BRIT J OPHTHALMOL, V68, P821, DOI 10.1136/bjo.68.11.821; Russell RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083595; Schiefer U, 2010, INVEST OPHTH VIS SCI, V51, P5685, DOI 10.1167/iovs.09-5067; Siddiqui MAR, 2005, BRIT J OPHTHALMOL, V89, P1569, DOI 10.1136/bjo.2005.080655; Swanson WH, 2014, INVEST OPHTH VIS SCI, V55, P353, DOI 10.1167/iovs.13-11640; Swanson WH, 2011, INVEST OPHTH VIS SCI, V52, P764, DOI 10.1167/iovs.10-6158; Swindale NV, 2000, INVEST OPHTH VIS SCI, V41, P1730; Swindale NV, 1996, J GLAUCOMA, V5, P156; Tanna AP, 2004, OPHTHALMOLOGY, V111, P1504, DOI 10.1016/j.ophtha.2004.01.035; Tochel C M, 2005, BMC Ophthalmol, V5, P22, DOI 10.1186/1471-2415-5-22; TYLER CW, 1981, INVEST OPHTH VIS SCI, V20, P204; VANDENBERG TJTP, 1986, DOC OPHTHALMOL, V61, P327, DOI 10.1007/BF00142360; Velten IM, 1999, BRIT J OPHTHALMOL, V83, P199, DOI 10.1136/bjo.83.2.199; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Willis A, 2000, INVEST OPHTH VIS SCI, V41, P325; Woods RL, 1998, OPHTHALMOLOGY, V105, P2318, DOI 10.1016/S0161-6420(98)91235-0; Yucel YH, 2003, PROG RETIN EYE RES, V22, P465, DOI 10.1016/S1350-9462(03)00026-0; Zhu HG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085654	68	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128681	10.1371/journal.pone.0128681	http://dx.doi.org/10.1371/journal.pone.0128681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053793	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000355955300053
J	Bratanov, D; Balandin, T; Round, E; Shevchenko, V; Gushchin, I; Polovinkin, V; Borshchevskiy, V; Gordeliy, V				Bratanov, Dmitry; Balandin, Taras; Round, Ekaterina; Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Borshchevskiy, Valentin; Gordeliy, Valentin			An Approach to Heterologous Expression of Membrane Proteins. The Case of Bacteriorhodopsin	PLOS ONE			English	Article							SENSORY RHODOPSIN-II; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PHARAONIS PHOBORHODOPSIN; FUNCTIONAL EXPRESSION; GENE-EXPRESSION; PROTON PUMP; BACTERIOOPSIN; DETERMINANTS; PURIFICATION	Heterologous overexpression of functional membrane proteins is a major bottleneck of structural biology. Bacteriorhodopsin from Halobium salinarum (bR) is a striking example of the difficulties in membrane protein overexpression. We suggest a general approach with a finite number of steps which allows one to localize the underlying problem of poor expression of a membrane protein using bR as an example. Our approach is based on constructing chimeric proteins comprising parts of a protein of interest and complementary parts of a homologous protein demonstrating advantageous expression. This complementary protein approach allowed us to increase bR expression by two orders of magnitude through the introduction of two silent mutations into bR coding DNA. For the first time the high quality crystals of bR expressed in E. Coli were obtained using the produced protein. The crystals obtained with in meso nanovolume crystallization diffracted to 1.67 angstrom.	[Bratanov, Dmitry; Balandin, Taras; Round, Ekaterina; Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Borshchevskiy, Valentin; Gordeliy, Valentin] Res Ctr Julich, ICS Struct Biochem 6, Inst Complex Syst, Julich, Germany; [Bratanov, Dmitry] Univ Aachen RWTH, Inst Crystallog, Aachen, Germany; [Round, Ekaterina; Gushchin, Ivan; Polovinkin, Vitaly; Gordeliy, Valentin] Univ Grenoble Alpes, IBS, Grenoble, France; [Round, Ekaterina; Gushchin, Ivan; Polovinkin, Vitaly; Gordeliy, Valentin] CNRS, IBS, Grenoble, France; [Round, Ekaterina; Gushchin, Ivan; Polovinkin, Vitaly; Gordeliy, Valentin] CEA, IBS, Grenoble, France; [Shevchenko, Vitaly; Gushchin, Ivan; Polovinkin, Vitaly; Borshchevskiy, Valentin; Gordeliy, Valentin] Moscow Inst Phys & Technol, Res Educ Ctr Bionanophys, Dolgoprudnyi, Russia	Helmholtz Association; Research Center Julich; RWTH Aachen University; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Moscow Institute of Physics & Technology	Gordeliy, V (corresponding author), Res Ctr Julich, ICS Struct Biochem 6, Inst Complex Syst, Julich, Germany.	valentin.gordeliy@ibs.fr	Bratanov, Dmitry/J-6865-2015; Borshchevskiy, Valentin I./F-2287-2014; Shevchenko, Vitaly/F-2956-2014; Polovinkin, Vitaly/G-6627-2017; Gushchin, Ivan/K-9197-2015; Gordeliy, Valentin I/J-3636-2013; Gushchin, Ivan/AAO-8829-2020	Borshchevskiy, Valentin I./0000-0003-4398-9712; Polovinkin, Vitaly/0000-0002-3630-5565; Gushchin, Ivan/0000-0002-5348-6070; Gordeliy, Valentin I/0000-0001-5782-5896; Gushchin, Ivan/0000-0002-5348-6070	program "Chaires d'excellence" of ANR France, CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement; MC grant (Marie Curie, project SBMPs) [FP7-PEOPLE-2007-1-1-ITN]; EC FP7 grant [HEALTH-201924]; BMBF (PhoNa - Photonic Nanomaterials); 5 top 100-program of the Ministry for science and education of Russia; RFBR [13-04-91320]; ONEXIM, Russia; FRISBI [ANR-10-INSB-05-02]; GRAL within Grenoble Partnership for Structural Biology (PSB) [ANR-10-LABX-49-01]	program "Chaires d'excellence" of ANR France, CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement(French National Research Agency (ANR)); MC grant (Marie Curie, project SBMPs); EC FP7 grant; BMBF (PhoNa - Photonic Nanomaterials)(Federal Ministry of Education & Research (BMBF)); 5 top 100-program of the Ministry for science and education of Russia; RFBR(Russian Foundation for Basic Research (RFBR)); ONEXIM, Russia; FRISBI; GRAL within Grenoble Partnership for Structural Biology (PSB)	The work was supported by the program "Chaires d'excellence" edition 2008 of ANR France, CEA(IBS) - HGF(FZJ) STC 5.1 specific agreement; the MC grant (Marie Curie, FP7-PEOPLE-2007-1-1-ITN, project SBMPs); and an EC FP7 grant for the EDICTconsortium (HEALTH-201924). Part of this work was supported by BMBF (PhoNa - Photonic Nanomaterials). The work was partially supported by the 5 top 100-program of the Ministry for science and education of Russia and by RFBR, research project No. 13-04-91320. The authors greatly acknowledge support of this work by ONEXIM, Russia. The work used the platforms of the Grenoble Instruct centre (ISBG; UMS 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble Partnership for Structural Biology (PSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belrhali H, 1999, STRUCTURE, V7, P909, DOI 10.1016/S0969-2126(99)80118-X; Birge RR, 1999, J PHYS CHEM B, V103, P10746, DOI 10.1021/jp991883n; Bogdanov M, 2010, P NATL ACAD SCI USA, V107, P15057, DOI 10.1073/pnas.1006286107; Booth PJ, 2010, P NATL ACAD SCI USA, V107, P3947, DOI 10.1073/pnas.0914478107; Booth PJ, 1997, BIOCHEMISTRY-US, V36, P197, DOI 10.1021/bi962200m; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; BROUILLETTE CG, 1989, PROTEINS, V5, P38, DOI 10.1002/prot.340050106; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cartailler JP, 2003, ANNU REV BIOPH BIOM, V32, P285, DOI 10.1146/annurev.biophys.32.110601.142516; Chen GQ, 1996, PROTEIN SCI, V5, P456; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Curran AR, 1999, BIOCHEMISTRY-US, V38, P9328, DOI 10.1021/bi982322+; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; FERRANDO E, 1993, GENE, V125, P41, DOI 10.1016/0378-1119(93)90743-M; Francis Dana M, 2010, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0524s61; Fu HY, 2010, J BACTERIOL, V192, P5866, DOI 10.1128/JB.00642-10; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Gushchin I, 2013, P NATL ACAD SCI USA, V110, P12631, DOI 10.1073/pnas.1221629110; Hampp N, 2000, CHEM REV, V100, P1755, DOI 10.1021/cr980072x; Hohenfeld IP, 1999, FEBS LETT, V442, P198, DOI 10.1016/S0014-5793(98)01659-7; Hsu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056363; HUANG KS, 1982, J BIOL CHEM, V257, P8596; Hunt JF, 1997, BIOCHEMISTRY-US, V36, P15177, DOI 10.1021/bi970147b; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamo N, 2006, BIOCHEM BIOPH RES CO, V341, P285, DOI 10.1016/j.bbrc.2005.12.181; KARNIK S, 1990, P NATL ACAD SCI USA, V87, P8955, DOI 10.1073/pnas.87.22.8955; KARNIK SS, 1987, J BIOL CHEM, V262, P9255; Kato HE, 2012, NATURE, V482, P369, DOI 10.1038/nature10870; KAYUSHIN LP, 1974, FEBS LETT, V39, P39, DOI 10.1016/0014-5793(74)80011-6; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Landau EM, 1996, P NATL ACAD SCI USA, V93, P14532, DOI 10.1073/pnas.93.25.14532; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; LORBER B, 1990, FEBS LETT, V261, P14, DOI 10.1016/0014-5793(90)80625-S; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MIERCKE LJW, 1989, J BIOL CHEM, V264, P7531; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nekrasova OV, 2010, J BIOTECHNOL, V147, P145, DOI 10.1016/j.jbiotec.2010.03.019; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Petrovskaya LE, 2010, FEBS LETT, V584, P4193, DOI 10.1016/j.febslet.2010.09.005; POMPEJUS M, 1993, EUR J BIOCHEM, V211, P27, DOI 10.1111/j.1432-1033.1993.tb19866.x; Raine A, 2003, BIOCHIMIE, V85, P659, DOI 10.1016/S0300-9084(03)00130-5; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Samuelson J, 2011, PRODUCTION OF MEMBRANE PROTEINS: STRATEGIES FOR EXPRESSION AND ISOLATION, P13; SHAND RF, 1991, BIOCHEMISTRY-US, V30, P3082, DOI 10.1021/bi00226a015; Shevchenko V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112873; Shimono K, 2003, J BIOL CHEM, V278, P23882, DOI 10.1074/jbc.M301200200; Shimono K, 1997, FEBS LETT, V420, P54, DOI 10.1016/S0014-5793(97)01487-7; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szpirer CY, 2005, BIOTECHNIQUES, V38, P775, DOI 10.2144/05385RR02; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]	58	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128390	10.1371/journal.pone.0128390	http://dx.doi.org/10.1371/journal.pone.0128390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046789	Green Published, gold			2022-12-26	WOS:000355652200066
J	Calinger, K; Calhoon, E; Chang, HC; Whitacre, J; Wenzel, J; Comita, L; Queenborough, S				Calinger, Kellen; Calhoon, Elisabeth; Chang, Hsiao-chi; Whitacre, James; Wenzel, John; Comita, Liza; Queenborough, Simon			Historic Mining and Agriculture as Indicators of Occurrence and Abundance of Widespread Invasive Plant Species	PLOS ONE			English	Article							LAND-USE HISTORY; FOREST; MINE; ROADS; LANDSCAPE; PATTERNS; NITROGEN; CARBON; SHRUB; FIELD	Anthropogenic disturbances often change ecological communities and provide opportunities for non-native species invasion. Understanding the impacts of disturbances on species invasion is therefore crucial for invasive species management. We used generalized linear mixed effects models to explore the influence of land-use history and distance to roads on the occurrence and abundance of two invasive plant species (Rosa multiflora and Berberis thunbergii) in a 900-ha deciduous forest in the eastern U.S.A., the Powdermill Nature Reserve. Although much of the reserve has been continuously forested since at least 1939, aerial photos revealed a variety of land-uses since then including agriculture, mining, logging, and development. By 2008, both Rosa multiflora and Berberis thunbergii were widespread throughout the reserve (occurring in 24% and 13% of 4417 10-m diameter regularly-placed vegetation plots, respectively) with occurrence and abundance of each varying significantly with land-use history. Rosa multiflora was more likely to occur in historically farmed, mined, logged or developed plots than in plots that remained forested, (log odds of 1.8 to 3.0); Berberis thunbergii was more likely to occur in plots with agricultural, mining, or logging history than in plots without disturbance (log odds of 1.4 to 2.1). Mining, logging, and agriculture increased the probability that Rosa multiflora had >10% cover while only past agriculture was related to cover of Berberis thunbergii. Proximity to roads was positively correlated with the occurrence of Rosa multiflora (a 0.26 increase in the log odds for every 1-m closer) but not Berberis thunbergii, and roads had no impact on the abundance of either species. Our results indicated that a wide variety of disturbances may aid the introduction of invasive species into new habitats, while high-impact disturbances such as agriculture and mining increase the likelihood of high abundance post-introduction.	[Calinger, Kellen; Calhoon, Elisabeth; Chang, Hsiao-chi; Comita, Liza; Queenborough, Simon] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Columbus, OH 43210 USA; [Whitacre, James; Wenzel, John] Carnegie Museum Nat Hist, Powdermill Nat Reserve, Rector, PA 15677 USA; [Comita, Liza] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Whitacre, James] Univ Illinois, Univ Lib, Urbana, IL 61801 USA	University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Illinois System; University of Illinois Urbana-Champaign	Calinger, K (corresponding author), Ohio State Univ, Dept Evolut Ecol & Organismal Biol, 318 W 12th Ave, Columbus, OH 43210 USA.	kcalinger@gmail.com		Whitacre, James/0000-0003-3464-9337	Heinz Endowment	Heinz Endowment	The vegetation survey was made possible through a grant from the Heinz Endowment, http://www.heinz.org/.	Amrine J, 2002, BIOL CONTROL INVASIV, P265; Anderson JR, 1976, GEOL SURV PROF PAP; Bates D, 2013, NO LME4 LINEAR MIXED; Bravo M, 2011, MULTIFLORA ROSE; Brown CD, 2009, BIOL CONSERV, V142, P1647, DOI 10.1016/j.biocon.2009.02.035; Burgess CH, 1948, FARM Q, V3, P50; Cassidy TM, 2004, BIOL INVASIONS, V6, P113, DOI 10.1023/B:BINV.0000010128.44332.0f; Compton JE, 2000, ECOLOGY, V81, P2314, DOI 10.1890/0012-9658(2000)081[2314:LTIOAO]2.0.CO;2; Corbett EA, 1996, RESTOR ECOL, V4, P346, DOI 10.1111/j.1526-100X.1996.tb00187.x; DeGasperis BG, 2007, ECOLOGY, V88, P3115, DOI 10.1890/06-2014.1; Drummond MA, 2010, BIOSCIENCE, V60, P286, DOI 10.1525/bio.2010.60.4.7; E.S.R.I, 2012, ARCGIS; Ehrenfeld JG, 1997, J TORREY BOT SOC, V124, P210, DOI 10.2307/2996586; Ekka NJ, 2011, TROP ECOL, V52, P337; Evans DM, 2013, ECOL ENG, V51, P16, DOI 10.1016/j.ecoleng.2012.12.065; Flory SL, 2006, PLANT ECOL, V184, P131, DOI 10.1007/s11258-005-9057-4; Gray AN, 2005, ENVIRON MONIT ASSESS, V100, P109, DOI 10.1007/s10661-005-7060-9; Klimstra WD, 1956, T ILL STATE ACAD SCI, V58, P66; Kuhman TR, 2011, CAN J FOREST RES, V41, P920, DOI [10.1139/X11-026, 10.1139/x11-026]; Kuhman TR, 2010, LANDSCAPE ECOL, V25, P1433, DOI 10.1007/s10980-010-9500-3; Lee TD, 2012, FOREST ECOL MANAG, V265, P201, DOI 10.1016/j.foreco.2011.10.035; Lemke D, 2013, INT J MIN RECLAM ENV, V27, P275, DOI 10.1080/17480930.2012.699215; Lundgren MR, 2004, NORTHEAST NAT, V11, P313, DOI 10.1656/1092-6194(2004)011[0313:IOLUAS]2.0.CO;2; McDonald RI, 2008, J TORREY BOT SOC, V135, P260, DOI 10.3159/08-RA-012.1; McDonald RI, 2008, FOREST ECOL MANAG, V255, P4021, DOI 10.1016/j.foreco.2008.03.054; Meiners SJ, 2002, ECOGRAPHY, V25, P215, DOI 10.1034/j.1600-0587.2002.250209.x; Mosher ES, 2009, BIOL INVASIONS, V11, P2317, DOI 10.1007/s10530-008-9418-8; Norland MR, 1993, SOIL FACTORS AFFECTI, P9345; Parendes LA, 2000, CONSERV BIOL, V14, P64, DOI 10.1046/j.1523-1739.2000.99089.x; Parker JD, 2010, BIOL INVASIONS, V12, P1557, DOI 10.1007/s10530-009-9568-3; Pauchard A, 2004, CONSERV BIOL, V18, P238, DOI 10.1111/j.1523-1739.2004.00300.x; R Core Team, 2018, R LANG ENV STAT COMP; Silander J. A., 1999, Biological Invasions, V1, P189, DOI 10.1023/A:1010024202294; Silva LCR, 2013, ECOL APPL, V23, P1345, DOI 10.1890/12-1957.1; STEFFEY J, 1985, AM HORTIC, V64, P4; SYLVIA DM, 1990, AGR ECOSYST ENVIRON, V31, P253, DOI 10.1016/0167-8809(90)90224-2; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; USDA Forest Service Forest Health Staff, 2006, MULT ROS; Von Holle B, 2007, BIOL CONSERV, V136, P33, DOI 10.1016/j.biocon.2006.10.044; Zipper CE, 2011, J ENVIRON QUAL, V40, P1567, DOI 10.2134/jeq2011.0040	40	14	14	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128161	10.1371/journal.pone.0128161	http://dx.doi.org/10.1371/journal.pone.0128161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046534	gold, Green Published			2022-12-26	WOS:000355652200044
J	D'Agata, F; Cicerale, A; Mingolla, A; Caroppo, P; Orsi, L; Mortara, P; Troni, W; Pinessi, L				D'Agata, Federico; Cicerale, Alessandro; Mingolla, Arianna; Caroppo, Paola; Orsi, Laura; Mortara, Paolo; Troni, Walter; Pinessi, Lorenzo			Double-Cone Coil TMS Stimulation of the Medial Cortex Inhibits Central Pain Habituation	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; ANTERIOR CINGULATE CORTEX; DEEP BRAIN-STIMULATION; FRONTAL-CORTEX; PLACEBO ANALGESIA; EVOKED-POTENTIALS; PERCEPTION; MODULATION; HUMANS; CONNECTIVITY	Objective The aim of this study was to investigate whether Transcranial Magnetic Stimulation (TMS) applied over the medial line of the scalp affects the subjective perception of continuous pain induced by means of electric stimulation. In addition, we wanted to identify the point of stimulation where this effect was maximum. Methods Superficial electrical stimulation was used to induce continuous pain on the dominant hand. At the beginning of the experiment we reached a pain rating of 5 on an 11-point numeric rating scale (NRS; 0 = no pain and 10 = maximum tolerable pain) for each subject by setting individually the current intensity. The TMS (five pulses at increasing intensities) was applied on 5 equidistant points (one per session) over the medial line of the scalp in 13 healthy volunteers using a double-cone coil to stimulate underlying parts of the brain cortex. In every experimental session the painful stimulation lasted 45 minutes, during which pain and distress intensities NRS were recorded continuously. We calculated the effect of adaptation and the immediate effect of the TMS stimulation for all locations. Additionally, an ALE (Activation Likelihood Estimation) meta-analysis was performed to compare our results with the neuroimaging literature on subjective pain rating. Results TMS stimulation temporarily decreased the pain ratings, and pain adaptation was suppressed when applying the TMS over the FCz site on the scalp. No effect was found for distress ratings. Conclusions The present data suggest that the medial cortex in proximity of the cingulated gyrus has a causal role in adaptation mechanisms and in processing ongoing pain and subjective sensation of pain intensity.	[D'Agata, Federico; Cicerale, Alessandro; Mingolla, Arianna] Univ Turin, LabNI, Turin, Italy; [D'Agata, Federico; Cicerale, Alessandro; Mortara, Paolo; Troni, Walter; Pinessi, Lorenzo] Univ Turin, Neurosci Dept, Turin, Italy; [Caroppo, Paola] Hop La Pitie Salpetriere, Inst Cerveau & Moelle Epiniere, ICM, Paris, France; [Orsi, Laura; Mortara, Paolo; Pinessi, Lorenzo] AOU Citta Salute & Sci Presidio Molinette, Neurosci Dept, Turin, Italy	University of Turin; University of Turin; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Cicerale, A (corresponding author), Univ Turin, LabNI, Turin, Italy.	alessandro.cicerale@unito.it	Caroppo, Paola/J-5044-2018; D'Agata, Federico/ABG-8839-2021	Caroppo, Paola/0000-0003-4274-9004; D'Agata, Federico/0000-0001-9432-0248				Amanzio M, 2013, HUM BRAIN MAPP, V34, P738, DOI 10.1002/hbm.21471; Bingel U, 2007, PAIN, V131, P21, DOI 10.1016/j.pain.2006.12.005; Bingel U, 2006, PAIN, V120, P8, DOI 10.1016/j.pain.2005.08.027; Bittar RG, 2005, J CLIN NEUROSCI, V12, P515, DOI 10.1016/j.jocn.2004.10.005; Buhle JT, 2012, PSYCHOL SCI, V23, P246, DOI 10.1177/0956797611427919; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; de Tommaso M, 2005, CLIN NEUROPHYSIOL, V116, P1254, DOI 10.1016/j.clinph.2005.02.018; Deng ZD, 2013, BRAIN STIMUL, V6, P1, DOI 10.1016/j.brs.2012.02.005; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Ferreira-Valente MA, 2011, PAIN, V152, P2399, DOI 10.1016/j.pain.2011.07.005; Fields HL, 2005, TXB PAIN, P125; FINNER H, 1993, J AM STAT ASSOC, V88, P920, DOI 10.2307/2290782; Frot M, 2008, J NEUROSCI, V28, P944, DOI 10.1523/JNEUROSCI.2934-07.2008; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Gersner R, 2011, J NEUROSCI, V31, P7521, DOI 10.1523/JNEUROSCI.6751-10.2011; Greffrath W, 2007, PAIN, V132, P301, DOI 10.1016/j.pain.2007.04.026; Hayward G, 2007, EUR J NEUROSCI, V25, P2224, DOI 10.1111/j.1460-9568.2007.05430.x; Kanda M, 2003, CLIN NEUROPHYSIOL, V114, P860, DOI 10.1016/S1388-2457(03)00034-8; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Laird AR, 2005, NEUROINFORMATICS, V3, P65, DOI 10.1385/NI:3:1:065; LEBLANC J, 1966, CAN J PHYSIOL PHARM, V44, P287, DOI 10.1139/y66-033; Lenz FA, 1998, J NEUROPHYSIOL, V79, P2231, DOI 10.1152/jn.1998.79.4.2231; Lozano AM, 2012, J NEUROSURG, V116, P315, DOI 10.3171/2011.10.JNS102122; Machii K, 1999, CLIN NEUROPHYSIOL, V110, P1315, DOI 10.1016/S1388-2457(99)00065-6; Melzack R, 1999, PAIN, pS121, DOI 10.1016/S0304-3959(99)00145-1; Mobascher A, 2010, INT J PSYCHOPHYSIOL, V75, P16, DOI 10.1016/j.ijpsycho.2009.10.008; Mylius V, 2006, CLIN NEUROPHYSIOL, V117, P1814, DOI 10.1016/j.clinph.2006.04.013; Mylius V, 2012, PAIN, V153, P1350, DOI 10.1016/j.pain.2012.04.009; Nuwer M R, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P11; Petrovic P, 2002, SCIENCE, V295, P1737, DOI 10.1126/science.1067176; Rennefeld C, 2010, PAIN, V148, P503, DOI 10.1016/j.pain.2009.12.014; Roth Y, 2002, J CLIN NEUROPHYSIOL, V19, P361, DOI 10.1097/00004691-200208000-00008; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Tracey I, 2007, NEURON, V55, P377, DOI 10.1016/j.neuron.2007.07.012; Valeriani M, 2000, CLIN NEUROPHYSIOL, V111, P1103, DOI 10.1016/S1388-2457(00)00273-X; Valeriani M, 2003, PAIN, V105, P57, DOI 10.1016/S0304-3959(03)00137-4; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; Vogt B. A., 2009, CINGULATE NEUROBIOLO; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wang G, 2014, PAIN, V155, P755, DOI 10.1016/j.pain.2014.01.005; Wood BM, 2010, J PAIN, V11, P1259, DOI 10.1016/j.jpain.2010.02.025; Yoo WK, 2006, NEUROREPORT, V17, P141, DOI 10.1097/01.wnr.0000198438.37012.d6	42	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128765	10.1371/journal.pone.0128765	http://dx.doi.org/10.1371/journal.pone.0128765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046985	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200098
J	Hu, DM; Hu, SY; Wan, W; Xu, M; Du, RK; Zhao, W; Gao, XL; Liu, J; Liu, HY; Hong, J				Hu, Dongmei; Hu, Siyi; Wan, Wen; Xu, Man; Du, Ruikai; Zhao, Wei; Gao, Xiaolian; Liu, Jing; Liu, Haiyan; Hong, Jiong			Effective Optimization of Antibody Affinity by Phage Display Integrated with High-Throughput DNA Synthesis and Sequencing Technologies	PLOS ONE			English	Article							MATURATION; LIBRARIES; CONSTRUCTION; MUTAGENESIS; ANTIGEN; DIVERSITY; REGIONS; PROTEIN; A21	Phage display technology has been widely used for antibody affinity maturation for decades. The limited library sequence diversity together with excessive redundancy and labour-consuming procedure for candidate identification are two major obstacles to widespread adoption of this technology. We hereby describe a novel library generation and screening approach to address the problems. The approach started with the targeted diversification of multiple complementarity determining regions (CDRs) of a humanized anti-ErbB2 antibody, HuA21, with a small perturbation mutagenesis strategy. A combination of three degenerate codons, NWG, NWC, and NSG, were chosen for amino acid saturation mutagenesis without introducing cysteine and stop residues. In total, 7,749 degenerate oligonucleotides were synthesized on two microchips and released to construct five single-chain antibody fragment (scFv) gene libraries with 4 x 106 DNA sequences. Deep sequencing of the unselected and selected phage libraries using the Illumina platform allowed for an in-depth evaluation of the enrichment landscapes in CDR sequences and amino acid substitutions. Potent candidates were identified according to their high frequencies using NGS analysis, by-passing the need for the primary screening of target-binding clones. Furthermore, a subsequent library by recombination of the 10 most abundant variants from four CDRs was constructed and screened, and a mutant with 158-fold increased affinity (K-d = 25.5 pM) was obtained. These results suggest the potential application of the developed methodology for optimizing the binding properties of other antibodies and biomolecules.	[Hu, Dongmei; Hu, Siyi; Wan, Wen; Xu, Man; Du, Ruikai; Zhao, Wei; Gao, Xiaolian; Liu, Jing; Liu, Haiyan; Hong, Jiong] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Gao, Xiaolian] Univ Houston, Dept Biol & Biochem, Houston, TX USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Houston System; University of Houston	Liu, HY (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China.	hjiong@ustc.edu.cn; hyliu@ustc.edu.cn	Liu, Haiyan/O-9637-2014; HONG, Jiong/N-1996-2013	HONG, Jiong/0000-0002-4592-7083; Liu, Haiyan/0000-0002-5926-820X	Ministry of Science and Technology of Major Projects; National Natural Science Foundation of China; National High Technology Research and Development Program; National Basic Research Program of China	Ministry of Science and Technology of Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work received funding from these sources: Ministry of Science and Technology of Major Projects [http://www.nmp.gov.cn] (JL). National Natural Science Foundation of China [http://www.nsfc.gov.cn] (JH). National High Technology Research and Development Program [http://www.863.gov.cn] (HYL, JH). National Basic Research Program of China [http://program.most.gov.cn] (JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borovkov AY, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq677; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Chang L, 2010, J COMPUT AID MOL DES, V24, P37, DOI 10.1007/s10822-009-9312-1; Cheng LS, 2003, CELL RES, V13, P35, DOI 10.1038/sj.cr.7290149; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Derda R, 2011, MOLECULES, V16, P1776, DOI 10.3390/molecules16021776; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fowler DM, 2010, NAT METHODS, V7, P741, DOI 10.1038/nmeth.1492; Ge X, 2010, BIOTECHNOL BIOENG, V106, P347, DOI 10.1002/bit.22712; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; Gonzalez-Munoz A, 2012, MABS-AUSTIN, V4, P664, DOI 10.4161/mabs.21728; Hu SY, 2008, PROTEINS, V70, P938, DOI 10.1002/prot.21551; Irving RA, 1996, IMMUNOTECHNOLOGY, V2, P127, DOI 10.1016/1380-2933(96)00044-9; JONES PT, 1986, NATURE, V321, P522, DOI 10.1038/321522a0; Kunik V, 2012, NUCLEIC ACIDS RES, V40, pW521, DOI 10.1093/nar/gks480; Laffly E, 2008, J MOL BIOL, V378, P1094, DOI 10.1016/j.jmb.2008.03.045; Larman HB, 2012, P NATL ACAD SCI USA, V109, P18523, DOI 10.1073/pnas.1215549109; Larman HB, 2011, NAT BIOTECHNOL, V29, P535, DOI 10.1038/nbt.1856; Low NM, 1996, J MOL BIOL, V260, P359, DOI 10.1006/jmbi.1996.0406; Martineau Pierre, 2002, Methods Mol Biol, V178, P287; Rajpal A, 2005, P NATL ACAD SCI USA, V102, P8466, DOI 10.1073/pnas.0503543102; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Ravn U, 2013, METHODS, V60, P99, DOI 10.1016/j.ymeth.2013.03.001; Schier R, 1996, J MOL BIOL, V255, P28, DOI 10.1006/jmbi.1996.0004; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Wan W, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku405; Wark KL, 2006, ADV DRUG DELIVER REV, V58, P657, DOI 10.1016/j.addr.2006.01.025; Whitehead TA, 2012, NAT BIOTECHNOL, V30, P543, DOI 10.1038/nbt.2214; Wu HR, 1998, P NATL ACAD SCI USA, V95, P6037, DOI 10.1073/pnas.95.11.6037; Xu M, 2015, J BIOTECHNOL, V194, P27, DOI 10.1016/j.jbiotec.2014.11.007; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626; Zhou HH, 2011, J BIOL CHEM, V286, P31676, DOI 10.1074/jbc.M111.235184; Zhou XC, 2004, NUCLEIC ACIDS RES, V32, P5409, DOI 10.1093/nar/gkh879	34	47	50	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129125	10.1371/journal.pone.0129125	http://dx.doi.org/10.1371/journal.pone.0129125			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046845	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200127
J	Kassab, MA; Mudassir, M; Singh, A; Muthuraman, N; Bhagat, M; Palanichamy, JK; Ramalingam, P; Chosdol, K; Sinha, S; Chattopadhyay, P				Kassab, Muzaffer Ahmad; Mudassir, Madeeha; Singh, Anand; Muthuraman, N.; Bhagat, Mohita; Palanichamy, Jayanth Kumar; Ramalingam, Pradeep; Chosdol, Kunzang; Sinha, Subrata; Chattopadhyay, Parthaprasad			Gene Silencing and Activation of Human Papillomavirus 18 Is Modulated by Sense Promoter Associated RNA in Bidirectionally Transcribed Long Control Region	PLOS ONE			English	Article							TERM SUPPRESSION; CANCER-CELLS; TIME PCR; E6; INTERFERENCE; EXPRESSION	Background Recently various studies have demonstrated the role of promoter associated non-coding RNAs (pRNA) in dsRNA induced transcriptional gene silencing and activation. However the exact mechanistic details of these processes with respect to the orientation of pRNAs are poorly defined. Methodology/Principal Findings We have identified novel sense and antisense long control region (LCR) associated RNAs (pRNAs) in HPV18 positive cervical cancer cell lines HeLa, C-4 I and C-4 II. Using dsRNAs against these pRNAs, we were able to achieve upregulation or downregulation of the sense and antisense pRNAs and the downstream E6 and E7 oncogenes. We present evidence that knockdown of the sense pRNA is associated with reduction in E6 and E7 oncogenes and an upregulation of antisense pRNA. Conversely upregulation of sense pRNA is accompanied by an induction of the oncogenes and a concomitant reduction in antisense pRNA. Moreover, the exact role of sense and antisense pRNAs in dsRNA mediated gene modulation was confirmed by their selective degradation using antisense phosphorothioate oligodeoxynucleotides (ODN). Degradation of sense pRNA with antisense ODN led to loss of dsRNA induced silencing and activation, suggesting that dsRNA mediated gene modulation requires sense pRNA. Both processes were accompanied with congruent changes in the methylation pattern of activating and repressive histones. Conclusion/Significance Thus this data identifies and demonstrates the role of previously unknown important regulatory transcripts in HPV18 gene expression which can prove valuable targets in cervical cancer therapeutics. This mode of gene regulation by bidirectional transcription could be operational in other promoters as well and serve as a mechanism of regulating gene expression.	[Kassab, Muzaffer Ahmad; Mudassir, Madeeha; Bhagat, Mohita; Palanichamy, Jayanth Kumar; Chosdol, Kunzang; Chattopadhyay, Parthaprasad] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India; [Singh, Anand] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Muthuraman, N.] Inst Liver & Biliary Sci, Dept Biochem, New Delhi, Vasant Kunj, India; [Ramalingam, Pradeep] Weill Cornell Med Coll, New York, NY USA; [Sinha, Subrata] Natl Brain Res Ctr, Gurgaon, Haryana, India	All India Institute of Medical Sciences (AIIMS) New Delhi; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Institute of Liver & Biliary Sciences (ILBS); Cornell University; Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Chattopadhyay, P (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	parthoaiims@hotmail.com	Kassab, Muzaffer Ahmad/AAH-7977-2019; Ramalingam, Pradeep/AAO-3210-2020; Palanichamy, Jayanth Kumar/B-5715-2009	Ramalingam, Pradeep/0000-0002-5943-9670; Palanichamy, Jayanth Kumar/0000-0002-3903-7252; chosdol, kunzang/0000-0002-7065-3395	Department of Biotechnology (DBT), Govt. of India [BT/01/COE/05/13, BT/PR13733/AGR/36/667/2010]; ICMR JRF	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); ICMR JRF	This work was supported by a grant from the Department of Biotechnology (DBT), Govt. of India, Sanction No. BT/01/COE/05/13, BT/PR13733/AGR/36/667/2010 to Parthaprasad Chattopadhyay and ICMR JRF to Muzaffer Ahmad Kassab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2001, CURR CANCER DRUG TAR, V1, P197, DOI 10.2174/1568009013334160; Alvarez-Salas LM, 1998, P NATL ACAD SCI USA, V95, P1189, DOI 10.1073/pnas.95.3.1189; AUERSPERG N, 1962, J NATL CANCER I, V28, P605; Bernard HU, 2002, ANTIVIR THER, V7, P219; Butz K, 2003, ONCOGENE, V22, P5938, DOI 10.1038/sj.onc.1206894; Chang JTC, 2010, CANCER GENE THER, V17, P827, DOI 10.1038/cgt.2010.38; CHEN JJ, 1995, SCIENCE, V269, P529, DOI 10.1126/science.7624774; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Graffmann N, 2006, ANAL BIOCHEM, V354, P308, DOI 10.1016/j.ab.2006.03.039; Hall AHS, 2003, J VIROL, V77, P6066, DOI 10.1128/JVI.77.10.6066-6069.2003; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Hawkins PG, 2009, NUCLEIC ACIDS RES, V37, P2984, DOI 10.1093/nar/gkp127; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Koivusalo R, 2006, CANCER RES, V66, P11817, DOI 10.1158/0008-5472.CAN-06-2185; LAIMINS LA, 1993, INFECT AGENT DIS, V2, P74; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Palanichamy JK, 2010, MOL CANCER THER, V9, P2114, DOI 10.1158/1535-7163.MCT-09-0977; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Singh A, 2014, J ANTIMICROB CHEMOTH, V69, P404, DOI 10.1093/jac/dkt348; Suzuki K, 2008, J BIOL CHEM, V283, P23353, DOI 10.1074/jbc.M709651200; Tang S, 2006, ONCOGENE, V25, P2094, DOI 10.1038/sj.onc.1209244; Ting AH, 2005, NAT GENET, V37, P906, DOI 10.1038/ng1611; Zelkowitz R, 2009, SCIENCE, V323, P580, DOI 10.1126/science.323.5914.580; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	31	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128416	10.1371/journal.pone.0128416	http://dx.doi.org/10.1371/journal.pone.0128416			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047143	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200069
J	Xavier, AL; Guedes, TB; Napoli, MF				Xavier, Ariane Lima; Guedes, Thais Barreto; Napoli, Marcelo Felgueiras			Biogeography of Anurans from the Poorly Known and Threatened Coastal Sandplains of Eastern Brazil	PLOS ONE			English	Article							BIOTIC ELEMENT ANALYSIS; DISTRIBUTION PATTERNS; ATLANTIC FOREST; CONSERVATION; VICARIANCE; AREAS; BIODIVERSITY; DIVERSITY; COMMUNITY; ENDEMISM	The east coast of Brazil comprises an extensive area inserted in the Tropical Atlantic Domain and is represented by sandy plains of beach ridges commonly known as Restingas. The coastal environments are unique and house a rich amphibian fauna, the geographical distribution patterns of which are incipient. Biogeographical studies can explain the current distributional patterns and provide the identification of natural biogeographical units. These areas are important in elucidating the evolutionary history of the taxa and the areas where they occur. The aim of this study was to seek natural biogeographical units in the Brazilian sandy plains of beach ridges by means of distribution data of amphibians and to test the main predictions of the vicariance model to explain the patterns found. We revised and georeferenced data on the geographical distribution of 63 anuran species. We performed a search for latitudinal distribution patterns along the sandy coastal plains of Brazil using the non-metric multidimensional scaling method (NMDS) and the biotic element analysis to identify natural biogeographical units. The results showed a monotonic variation in anuran species composition along the latitudinal gradient with a break in the clinal pattern from 23 degrees S to 25 degrees S latitude (states of Rio de Janeiro to Sao Paulo). The major predictions of the vicariance model were corroborated by the detection of four biotic elements with significantly clustered distribution and by the presence of congeneric species distributed in distinct biotic elements. The results support the hypothesis that vicariance could be one of the factors responsible for the distribution patterns of the anuran communities along the sandy coastal plains of eastern Brazil. The results of the clusters are also congruent with the predictions of paleoclimatic models made for the Last Glacial Maximum of the Pleistocene, such as the presence of historical forest refugia and biogeographical patterns already detected for amphibians in the Atlantic Rainforest.	[Xavier, Ariane Lima; Napoli, Marcelo Felgueiras] Univ Fed Bahia, Programa Posgrad Ecol & Biomonitoramento, Inst Biol, Salvador, BA, Brazil; [Xavier, Ariane Lima] Inst Fed Educ Ciencia & Tecnol Baiano, Valenca, BA, Brazil; [Guedes, Thais Barreto] Univ Fed Sao Paulo, Programa Posgrad Ecol & Evolucao, Sao Paulo, Brazil; [Guedes, Thais Barreto] Univ Sao Paulo, Museu Zool, Sao Paulo, SP, Brazil; [Napoli, Marcelo Felgueiras] Univ Fed Bahia, Inst Biol, Dept Zool, Museu Zool, Salvador, BA, Brazil; [Napoli, Marcelo Felgueiras] Univ Fed Rio de Janeiro, Museu Nacl, Dept Vertebrados, Rio De Janeiro, RJ, Brazil	Universidade Federal da Bahia; Instituto Federal Baiano (IFBAIANO); Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Federal da Bahia; Universidade Federal do Rio de Janeiro	Napoli, MF (corresponding author), Univ Fed Bahia, Programa Posgrad Ecol & Biomonitoramento, Inst Biol, Salvador, BA, Brazil.	napoli@ufba.br	Napoli, Marcelo/G-3720-2012; Guedes, Thaís B./U-9342-2017	Napoli, Marcelo/0000-0003-3843-0543; Guedes, Thaís B./0000-0003-3318-7193	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [21/2008]; Fundacao O Boticario de Protecao a Natureza [0844-20092]	Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); Fundacao O Boticario de Protecao a Natureza	This study was supported by the Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB, grant 21/2008 to MFN; http://www.fapesb.ba.gov.br/) for financial support to the project "Adequacao da Pos-Graduacao em Diversidade Animal ao uso de metodos e ferramentas de analise espacial;" the Fundacao O Boticario de Protecao a Natureza (grant 0844-20092 to MFN; http://www.fundacaogrupoboticario.org.br) for financial support to the project "Areas prioritarias para a conservacao de anfibios anuros nas restingas do litoral brasileiro."	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; AbSaber AN, 1977, PALEOCLIMAS, V3, P1; ABSABER Aziz, 2003, DOMINIOS NATUREZA BR; Almeida E. A. B., 2010, BIOGEOGRAFIA AM PADR, P52; Amorim DS, 1996, NEOTROPICAL BIOGEOGR, P183; Bastazini CV, 2007, HERPETOLOGICA, V63, P459, DOI 10.1655/0018-0831(2007)63[459:WEVBEC]2.0.CO;2; Bates JM, 1998, J BIOGEOGR, V25, P783, DOI 10.1046/j.1365-2699.1998.2540783.x; Becker FG, 2006, BIODIVERSIDADE REGIO, P10; Brown J. H., 1998, BIOGEOGRAPHY; Caldas Francis Luiz Santos, 2011, Check List, V7, P55; Camardelli M, 2012, HERPETOLOGICA, V68, P31, DOI 10.1655/HERPETOLOGICA-D-10-00033.1; Caramaschi U, 2004, AMPHIBIA-REPTILIA, V25, P1, DOI 10.1163/156853804322992788; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1461; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carvalho SB, 2011, DIVERS DISTRIB, V17, P408, DOI 10.1111/j.1472-4642.2011.00752.x; Casagranda MD, 2012, CLADISTICS, V28, P645, DOI 10.1111/j.1096-0031.2012.00410.x; Casazza G, 2009, J BIOGEOGR, V36, P2056, DOI 10.1111/j.1365-2699.2009.02156.x; Chen YH, 2013, CURR ZOOL, V59, P449, DOI 10.1093/czoolo/59.4.449; Condamine FL, 2013, CLADISTICS, V29, P88, DOI 10.1111/j.1096-0031.2012.00412.x; Costa LP, 2000, BIOTROPICA, V32, P872; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; CROIZAT L, 1974, SYST ZOOL, V23, P265, DOI 10.2307/2412139; da Silva JMC, 2004, GLOBAL ECOL BIOGEOGR, V13, P85, DOI 10.1111/j.1466-882X.2004.00077.x; Dabes L, 2012, HERPETOLOGICA, V68, P443, DOI 10.1655/HERPETOLOGICA-D-10-00058; de Sa RO, 2014, S AM J HERPETOL, V9, pS1, DOI 10.2994/SAJH-D-13-00022.1; Duellman WE, 1999, PATTERNS DISTRIBUTIO; Ficetola GF, 2013, J BIOGEOGR, V40, P1202, DOI [10.1111/jbi.12060, 10.1111/jbi.12206]; FRANCO A. C, 1984, RESTINGAS ORIGEM EST, P413; Frost D.R., 2021, AMPHIBIAN SPECIES WO; Garcia P, 2004, IUCN RED LIST THREAT; Garcia P.C.A., 2007, CIENCIA AMBIENTE, V35, P65; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Guedes TB, 2014, J BIOGEOGR, V41, P919, DOI 10.1111/jbi.12272; Hausdorf B, 2004, J BIOGEOGR, V31, P1751, DOI 10.1111/j.1365-2699.2004.01090.x; Hausdorf B, 2003, SYST BIOL, V52, P717, DOI 10.1080/10635150390235584; Hausdorf B, 2002, SYST BIOL, V51, P648, DOI 10.1080/10635150290102320; Hennig C, 2006, SYST BIOL, V55, P170, DOI 10.1080/10635150500481523; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Humphries C.J., 1999, CLADISTIC BIOGEOGRAP; IBGE-Instituto Brasileiro de Geografia e Estatistica & USGS-United States Geological Survey, 1992, MAP VEG BRAS VECT DI; Langone J.A., 1987, Comunicaciones Zoologicas del Museo de Historia Natural de Montevideo, V11, P1; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; Lomolino M.V., 2010, BIOGEOGRAPHY, Vfourth; Maciel Daniel Bastos, 2010, Zootaxa, V2640, P53; McCune B, 2002, ANAL ECOLOGICAL COMM; McLennan DA, 2002, J BIOGEOGR, V29, P1055, DOI 10.1046/j.1365-2699.2002.00733.x; Morrone J.J., 2009, EVOLUTIONARY BIOGEOG; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; Morrone JJ, 2014, J BIOGEOGR, V41, P842, DOI 10.1111/jbi.12251; Muller P, 1973, BIOGEOGRAPHICA; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Napoli Marcelo Felgueiras, 1999, Alytes (Paris), V16, P165; Nelson G., 1981, SYSTEMATICS BIOGEORA; Nogueira C, 2011, J BIOGEOGR, V38, P1907, DOI 10.1111/j.1365-2699.2011.02538.x; Nunes I, 2011, HERPETOLOGICA, V67, P80, DOI 10.1655/HERPETOLOGICA-D-10-00026.1; Pellegrino KCM, 2005, BIOL J LINN SOC, V85, P13, DOI 10.1111/j.1095-8312.2005.00472.x; Pereira de Andrade Sheila, 2012, Check List, V8, P149; PLATNICK NI, 1978, SYST ZOOL, V27, P1, DOI 10.2307/2412808; Prance G.T., 1982, BIOL DIVERSIFICATION, P137; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rocha CFD., 2007, Braz. J. Biol., V67, P263, DOI 10.1590/S1519-69842007000200011; ROSEN DE, 1978, SYST ZOOL, V27, P159, DOI 10.2307/2412970; Sigrist Mário Sérgio, 2008, Biota Neotrop., V8, P0, DOI 10.1590/S1676-06032008000400002; Silva J. M. C., 2005, MATA ATLANTICA BIODI, P43; Silva MB, 2008, THESIS U SAO PAULO S; Sondersom TR, 1988, P WORKSH NEOTR DISTR, P121; Souza CRG, 2008, RESTINGA CONCEITOS E; Stevaux Maria Nazaré, 2002, Rev. Bras. Zool., V19, P235, DOI 10.1590/S0101-81752002000500018; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Vasconcelos TS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104130; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Wronski T, 2008, J BIOGEOGR, V35, P1759, DOI 10.1111/j.1365-2699.2008.01933.x; Zina Juliana, 2010, Check List, V6, P230	74	10	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128268	10.1371/journal.pone.0128268	http://dx.doi.org/10.1371/journal.pone.0128268			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047484	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200051
J	Wood, ER; Bledsoe, R; Chai, J; Daka, P; Deng, HF; Ding, Y; Harris-Gurley, S; Kryn, LH; Nartey, E; Nichols, J; Nolte, RT; Prabhu, N; Rise, C; Sheahan, T; Shotwell, JB; Smith, D; Tai, V; Taylor, JD; Tomberlin, G; Wang, LP; Wisely, B; You, SY; Xia, B; Dickson, H				Wood, Edgar R.; Bledsoe, Randy; Chai, Jing; Daka, Philias; Deng, Hongfeng; Ding, Yun; Harris-Gurley, Sarah; Kryn, Luz Helena; Nartey, Eldridge; Nichols, James; Nolte, Robert T.; Prabhu, Ninad; Rise, Cecil; Sheahan, Timothy; Shotwell, J. Brad; Smith, Danielle; Tai, Vince; Taylor, J. David; Tomberlin, Ginger; Wang, Liping; Wisely, Bruce; You, Shihyun; Xia, Bing; Dickson, Hamilton			The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNASE-L; 2-5A SYSTEM; L PATHWAY; INTERFERON; PROTEIN; APOPTOSIS; BINDING; PURIFICATION; MITOCHONDRIA; REPLICATION	2',5'-Oligoadenylate synthetase (OAS) enzymes and RNase-L constitute a major effector arm of interferon (IFN)-mediated antiviral defense. OAS produces a unique oligonucleotide second messenger, 2',5'-oligoadenylate (2-5A), that binds and activates RNase-L. This pathway is down-regulated by virus- and host-encoded enzymes that degrade 2-5A. Phosphodiesterase 12 (PDE12) was the first cellular 2-5A-degrading enzyme to be purified and described at a molecular level. Inhibition of PDE12 may up-regulate the OAS/RNase-L pathway in response to viral infection resulting in increased resistance to a variety of viral pathogens. We generated a PDE12-null cell line, HeLa Delta PDE12, using transcription activator-like effector nuclease-mediated gene inactivation. This cell line has increased 2-5A levels in response to IFN and poly(I-C), a double-stranded RNA mimic compared with the parental cell line. Moreover, HeLa Delta PDE12 cells were resistant to viral pathogens, including encephalomyocarditis virus, human rhinovirus, and respiratory syncytial virus. Based on these results, we used DNA-encoded chemical library screening to identify starting points for inhibitor lead optimization. Compounds derived from this effort raise 2-5A levels and exhibit antiviral activity comparable with the effects observed with PDE12 gene inactivation. The crystal structure of PDE12 complexed with an inhibitor was solved providing insights into the structure-activity relationships of inhibitor potency and selectivity.	[Wood, Edgar R.; Bledsoe, Randy; Harris-Gurley, Sarah; Kryn, Luz Helena; Nartey, Eldridge; Nichols, James; Smith, Danielle; Taylor, J. David; Tomberlin, Ginger; Wisely, Bruce] GlaxoSmithKline, Dept Biol Sci, Res Triangle Pk, NC 27709 USA; [Nolte, Robert T.; Wang, Liping] GlaxoSmithKline, Dept Chem Sci, Res Triangle Pk, NC 27709 USA; [Daka, Philias; Sheahan, Timothy; Shotwell, J. Brad; Tai, Vince; You, Shihyun; Dickson, Hamilton] GlaxoSmithKline, Antiviral Discovery Performance Unit, Res Triangle Pk, NC 27709 USA; [Chai, Jing; Deng, Hongfeng; Ding, Yun; Prabhu, Ninad; Rise, Cecil; Xia, Bing] GlaxoSmithKline, ELT Boston, Waltham, MA 02451 USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Wood, ER (corresponding author), GlaxoSmithKline, Biol Sci, 5 Moore Dr, Res Triangle Pk, NC 27709 USA.	edgar.r.wood@mindspring.com	Sheahan, Timothy/J-8201-2019	Sheahan, Timothy/0000-0001-9181-2183; Taylor, J. David/0000-0001-6113-465X				Clark MA, 2009, NAT CHEM BIOL, V5, P647, DOI 10.1038/nchembio.211; Copeland R. A., 2004, ENZYMES PRACTICAL IN; Deng HF, 2012, J MED CHEM, V55, P7061, DOI 10.1021/jm300449x; Disch JS, 2013, J MED CHEM, V56, P3666, DOI 10.1021/jm400204k; Domingo-Gil E, 2006, APOPTOSIS, V11, P725, DOI 10.1007/s10495-006-5541-0; Drappier M, 2014, VIROLOGIE, V18, P264, DOI 10.1684/vir.2014.0578; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Elbahesh H, 2011, VIROLOGY, V409, P262, DOI 10.1016/j.virol.2010.10.016; Ezelle Heather J, 2012, Front Biosci (Schol Ed), V4, P767; Flodstrom-Tullberg M, 2005, J IMMUNOL, V174, P1171, DOI 10.4049/jimmunol.174.3.1171; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Gusho E, 2014, MBIO, V5, DOI 10.1128/mBio.01312-14; Han JQ, 2007, J VIROL, V81, P5561, DOI 10.1128/JVI.01857-06; Kay Brian K., 2009, V498, P185, DOI 10.1007/978-1-59745-196-3_13; Kjaer KH, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-33; Kubota K, 2004, J BIOL CHEM, V279, P37832, DOI 10.1074/jbc.M400089200; Le Roy F, 2007, CELL DEATH DIFFER, V14, P1406, DOI 10.1038/sj.cdd.4402130; Li XL, 2011, WIRES RNA, V2, P58, DOI 10.1002/wrna.32; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; Lou ZY, 2014, TRENDS PHARMACOL SCI, V35, P86, DOI 10.1016/j.tips.2013.11.006; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Mol CD, 2000, NATURE, V403, P451, DOI 10.1038/35000249; Morin B, 2010, ANTIVIR RES, V87, P345, DOI 10.1016/j.antiviral.2010.06.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Poulsen JB, 2011, NUCLEIC ACIDS RES, V39, P3754, DOI 10.1093/nar/gkq1282; Reema KT, 2013, BIOORG MED CHEM LETT, V23, P3584, DOI 10.1016/j.bmcl.2013.04.019; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06; Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Silverman RH, 2014, J INTERF CYTOK RES, V34, P455, DOI 10.1089/jir.2014.0007; Sorgeloos F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003474; TORRENCE PF, 1983, ANAL BIOCHEM, V129, P103, DOI 10.1016/0003-2697(83)90058-1; Wang H, 2010, EMBO J, V29, P2566, DOI 10.1038/emboj.2010.152; WILLIAMS BRG, 1978, EUR J BIOCHEM, V92, P455, DOI 10.1111/j.1432-1033.1978.tb12767.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang R, 2013, P NATL ACAD SCI USA, V110, P13114, DOI 10.1073/pnas.1306917110; Zhang W, 2012, J BIOL CHEM, V287, P11981, DOI 10.1074/jbc.M111.338525; Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	47	46	47	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19681	19696		10.1074/jbc.M115.653113	http://dx.doi.org/10.1074/jbc.M115.653113			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26055709	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000359364600028
J	Lontay, B; Bodoor, K; Sipos, A; Weitzel, DH; Loiselle, D; Safi, R; Zheng, DH; Devente, J; Hickner, RC; McDonnell, DP; Ribar, T; Haystead, TA				Lontay, Beata; Bodoor, Khaldon; Sipos, Adrienn; Weitzel, Douglas H.; Loiselle, David; Safi, Rachid; Zheng, Donghai; Devente, James; Hickner, Robert C.; McDonnell, Donald P.; Ribar, Thomas; Haystead, Timothy A.			Pregnancy and Smoothelin-like Protein 1 (SMTNL1) Deletion Promote the Switching of Skeletal Muscle to a Glycolytic Phenotype in Human and Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GESTATIONAL DIABETES-MELLITUS; HORMONE REPLACEMENT THERAPY; INSULIN-RESISTANCE; PROGESTERONE-RECEPTOR; POSTMENOPAUSAL WOMEN; ADDUCTOR POLLICIS; ESTROGEN; EXERCISE; ADAPTATION; EXPRESSION	Pregnancy promotes physiological adaptations throughout the body, mediated by the female sex hormones progesterone and estrogen. Changes in the metabolic properties of skeletal muscle enable the female body to cope with the physiological challenges of pregnancy and may also be linked to the development of insulin resistance. We conducted global microarray, proteomic, and metabolic analyses to study the role of the progesterone receptor and its transcriptional regulator, smoothelin-like protein 1 (SMTNL1) in the adaptation of skeletal muscle to pregnancy. We demonstrate that pregnancy promotes fiber-type changes from an oxidative to glycolytic isoform in skeletal muscle. This phenomenon is regulated through an interaction between SMTNL1 and progesterone receptor, which alters the expression of contractile and metabolic proteins. smtnl1(-/-) mice are metabolically less efficient and show impaired glucose tolerance. Pregnancy antagonizes these effects by inducing metabolic activity and increasing glucose tolerance. Our results suggest that SMTNL1 has a role in mediating the actions of steroid hormones to promote fiber switching in skeletal muscle during pregnancy. Our findings also bear on the management of gestational diabetes that develops as a complication of pregnancy in similar to 4% of women.	[Lontay, Beata; Bodoor, Khaldon; Weitzel, Douglas H.; Loiselle, David; Safi, Rachid; McDonnell, Donald P.; Haystead, Timothy A.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; [Lontay, Beata; Sipos, Adrienn] Univ Debrecen, Fac Med, Dept Med Chem, H-4032 Debrecen, Hungary; [Zheng, Donghai; Hickner, Robert C.] E Carolina Univ, Dept Kinesiol, Greenville, NC 27858 USA; [Devente, James] E Carolina Univ, Dept Obstet & Gynecol, Greenville, NC 27834 USA; [Hickner, Robert C.] Univ KwaZulu Natal, Dept Biokinet Exercise & Leisure Sci, ZA-4000 Durban, South Africa; [Ribar, Thomas] Duke Univ, Med Ctr, Duke iPSC Shared Resource Facil, Durham, NC 27710 USA	Duke University; University of Debrecen; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Kwazulu Natal; Duke University	Haystead, TA (corresponding author), Duke Univ, Sch Med, C118 LSRC Box 3813, Durham, NC 27710 USA.	timothy.haystead@duke.edu	Regan, Clinton/E-6250-2012; Safi, Rachid/A-5909-2010	hickner, Robert/0000-0002-2683-1617	National Institutes of Health [R01DK065954-05]; University of Debrecen [RH/751/2015]; King Hussein fellowship;  [OTKA PD107898];  [TAMOP-4.2.2.A-11/1/KONV-2012-0025];  [TAMOP 4.2.4.A/2-11-1-2012-0001]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Debrecen; King Hussein fellowship; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK065954-05 (to T. A. H.). This work was also supported by Grants OTKA PD107898, TAMOP-4.2.2.A-11/1/KONV-2012-0025, and TAMOP 4.2.4.A/2-11-1-2012-0001, the University of Debrecen (RH/751/2015) (to B. L.), and by The King Hussein fellowship (to K. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC1311, DOI 10.1152/ajpcell.00248.2004; Bodoor K, 2011, J BIOL CHEM, V286, P31839, DOI 10.1074/jbc.M111.270397; BOOTH FW, 1991, PHYSIOL REV, V71, P541, DOI 10.1152/physrev.1991.71.2.541; Borman MA, 2004, FEBS LETT, V573, P207, DOI 10.1016/j.febslet.2004.08.002; BRADSHAW MS, 1991, J BIOL CHEM, V266, P16684; Branisteanu DD, 2003, TRENDS ENDOCRIN MET, V14, P54, DOI 10.1016/S1043-2760(03)00003-1; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Carey AL, 2009, DIABETOLOGIA, V52, P2015, DOI 10.1007/s00125-009-1420-x; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; Coleman KM, 2003, J BIOL CHEM, V278, P12834, DOI 10.1074/jbc.M212312200; Barros RPD, 2008, MOL CELL ENDOCRINOL, V295, P24, DOI 10.1016/j.mce.2008.07.008; Edwards DP, 2005, ANNU REV PHYSIOL, V67, P335, DOI 10.1146/annurev.physiol.67.040403.120151; Fitts RH, 2003, AM J PHYS MED REHAB, V82, P320, DOI 10.1097/01.PHM.0000059336.40487.9C; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hamilton MT, 2000, J APPL PHYSIOL, V88, P327, DOI 10.1152/jappl.2000.88.1.327; Kirwan JP, 2004, J CLIN ENDOCR METAB, V89, P4678, DOI 10.1210/jc.2004-0749; Lontay B, 2004, J COMP NEUROL, V478, P72, DOI 10.1002/cne.20273; Lontay B, 2010, J BIOL CHEM, V285, P29357, DOI 10.1074/jbc.M110.143966; Onambele NGL, 2001, CLIN SCI, V100, P421, DOI 10.1042/CS20000264; Rowan BG, 2000, MOL CELL BIOL, V20, P8720, DOI 10.1128/MCB.20.23.8720-8730.2000; Schmidt Carla, 2009, Methods Mol Biol, V564, P207, DOI 10.1007/978-1-60761-157-8_12; Shadforth IP, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-145; Shao JH, 2002, DIABETES, V51, P19, DOI 10.2337/diabetes.51.1.19; Skelton DA, 1999, CLIN SCI, V96, P357, DOI 10.1042/CS19980318; Solomon CG, 2001, HYPERTENSION, V37, P232, DOI 10.1161/01.HYP.37.2.232; Sugaya A, 2000, LIFE SCI, V66, P641, DOI 10.1016/S0024-3205(99)00636-0; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Ulke-Lemee A, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-10; Wooldridge AA, 2008, J BIOL CHEM, V283, P11850, DOI 10.1074/jbc.M708628200	29	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17985	17998		10.1074/jbc.M115.658120	http://dx.doi.org/10.1074/jbc.M115.658120			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048986	hybrid, Green Published			2022-12-26	WOS:000358511700031
J	Bellaloui, N; Bruns, HA; Abbas, HK; Mengistu, A; Fisher, DK; Reddy, KN				Bellaloui, Nacer; Bruns, Herbert A.; Abbas, Hamed K.; Mengistu, Alemu; Fisher, Daniel K.; Reddy, Krishna N.			Effects of Row-Type, Row-Spacing, Seeding Rate, Soil-Type, and Cultivar Differences on Soybean Seed Nutrition under US Mississippi Delta Conditions	PLOS ONE			English	Article							AZOMETHINE-H METHOD; CHEMICAL-COMPOSITION; PRODUCTION SYSTEM; SOLAR-RADIATION; NARROW ROWS; SINGLE-ROW; YIELD; MATURITY; DROUGHT; QUALITY	The new Early Soybean Production System (ESPS), developed in the Midsouth USA, including the Mississippi delta, resulted in higher yield under irrigated and non-irrigated conditions. However, information on the effects of the agricultural practices such as row-type (RT: twin-vs. single-row), row-spacing, (RS), seeding rate (SR), soil-type (ST) on seed nutrition under the ESPS environment in the Mississippi delta is very limited. Our previous research in the Mississippi delta showed these agricultural practices altered seed nutrients in one cultivar only. However, whether these effects on seed nutrients will be exhibited by other soybean cultivars with earlier and later maturities across multiple years are not yet known. Therefore, the objective of this research was to evaluate the effects of agricultural practices and cultivar (Cv) differences on seed nutrition in clay and sandy soils under ESPS environment of high heat and drought. Two field experiments were conducted; one experiment was conducted in 2009 and 2010, and the other in 2008, 2009, and 2010 under irrigated conditions. Soybean were grown on 102 cm single-rows and on 25 cmtwin-rows with 102 cm centers at seeding rates of 20, 30, 40, and 50 seeds m-2. Two soybean cultivars (94M80 with earlier maturity; and GP 533 with later maturity) were used. Results showed that increasing seeding rate resulted in increases of protein, sucrose, glucose, raffinose, B, and P concentrations on both single-and twin-rows. However, this increase became either constant or declined at the higher rates (40 and 50 seeds m(-2)). Protein and linolenic acid concentrations were higher in GP 533 than in 94M80 on both row-types, but oil and oleic acid concentrations were in 94M80 than GP 533. Generally, cultivar GP 533 accumulated more seed constituents in seeds than 94M80. In 2010, there were no clear responses of seed nutrients to SR increase in both cultivars, perhaps due to drier year and high heat in 2010. It is concluded that RT and SR can alter seed nutrition under clay and sandy soils, especially under high heat and drought conditions as in the Mississippi delta.	[Bellaloui, Nacer] USDA ARS, Crop Genet Res Unit, Stoneville, MS 38776 USA; [Bruns, Herbert A.; Fisher, Daniel K.; Reddy, Krishna N.] USDA ARS, Crop Prod Syst Res Unit, Stoneville, MS 38776 USA; [Abbas, Hamed K.] USDA ARS, Biol Control Pests Res Unit, Stoneville, MS 38776 USA; [Mengistu, Alemu] USDA ARS, Crop Genet Res Unit, Jackson, TN 38301 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Bellaloui, N (corresponding author), USDA ARS, Crop Genet Res Unit, Stoneville, MS 38776 USA.	nacer.bellaloui@ars.usda.gov		Reddy, Krishna/0000-0002-2807-834X	USDA-ARS (US federal agency); Agricultural Research Service Project [6402-21220-012-00D]	USDA-ARS (US federal agency); Agricultural Research Service Project	This study was funded by USDA-ARS (US federal agency). The grant number is: Agricultural Research Service Project 6402-21220-012-00D. Website: http://www.ars.usda.gov/pandp/people/people.htm?personid=37050.	Abbasi MK, 2012, AGRON J, V104, P1476, DOI 10.2134/agronj2011.0379; Alpaslan M, 2001, J AM OIL CHEM SOC, V78, P933, DOI 10.1007/s11746-001-0366-0; Amoghein R. S., 2012, Journal of Medicinal Plants Research, V6, P2493; Andrade FH, 2002, AGRON J, V94, P975, DOI 10.2134/agronj2002.0975; [Anonymous], 1990, AOAC OFFICIAL METHOD, V15th ed., DOI [10.1016/b0-12-765490-9/00006-9, DOI 10.1016/B0-12-765490-9/00006-9]; Ball RA, 2000, CROP SCI, V40, P757, DOI 10.2135/cropsci2000.403757x; Ball RA, 2000, CROP SCI, V40, P1070, DOI 10.2135/cropsci2000.4041070x; BANDEMER S. L., 1944, Industrial and Engineering Chemistry. Analytical edition, V16, P317, DOI 10.1021/i560129a013; Bellaloui B, 2015, FRONT PLANT IN PRESS; Bellaloui N., 2010, Agricultural Sciences, V1, P110; Bellaloui N., 2009, Crop Management, pCM; Bellaloui N, 2010, CROP SCI, V50, P1978, DOI 10.2135/cropsci2009.10.0596; Bellaloui N, 2014, CROP SCI, V54, P1782, DOI 10.2135/cropsci2013.07.0463; Bellaloui N, 2009, CROP SCI, V49, P608, DOI 10.2135/cropsci2008.04.0192; BHARATI M P, 1977, Nepalese Journal of Agriculture, V12, P239; Boydak E, 2002, J AGR FOOD CHEM, V50, P4718, DOI 10.1021/jf0255331; Bruns HA, 2011, AGRON J, V103, P1308, DOI 10.2134/agronj2011.0076; Bruns HA, 2011, AGRON J, V103, P702, DOI 10.2134/agronj2010.0475; Burkey KO, 1997, PHYSIOL PLANTARUM, V101, P591, DOI 10.1111/j.1399-3054.1997.tb01042.x; CAVELL A. J., 1955, Journal of the Science of Food and Agriculture, V6, P479, DOI 10.1002/jsfa.2740060814; CHAPMAN GW, 1976, J AM OIL CHEM SOC, V53, P54, DOI 10.1007/BF02637391; CHU WS, 1979, J AM OIL CHEM SOC, V56, P71, DOI 10.1007/BF02914271; COOPER RL, 1977, AGRON J, V69, P89, DOI 10.2134/agronj1977.00021962006900010023x; Dardanelli JL, 2006, CROP SCI, V46, P1939, DOI 10.2135/cropsci2005.12-0480; Dordas C, 2007, J AGR SCI-CAMBRIDGE, V145, P377, DOI 10.1017/S0021859607006879; Dwivedi SL, 1996, FIELD CROP RES, V48, P125, DOI 10.1016/S0378-4290(96)01027-1; FEHR W. R., 1977, STAGES SOYBEAN DEV; GUBBELS GH, 1986, CAN J PLANT SCI, V66, P521, DOI 10.4141/cjps86-071; Harue T, 1971, P CROP SCI SOC JPN, V40, P530, DOI DOI 10.1626/JCS.40.530; Heatherly L. G., 1999, SOYBEAN PRODUCTION M, P103; Inskeep W.P., 1996, METHODS SOIL ANAL, V3; JAMIESON PD, 1995, FIELD CROP RES, V43, P77, DOI 10.1016/0378-4290(95)00042-O; JOHN MK, 1975, ANAL LETT, V8, P559, DOI 10.1080/00032717508058240; KONDRA ZP, 1975, CAN J PLANT SCI, V55, P339, DOI 10.4141/cjps75-052; Krueger K, 2013, CROP SCI, V53, P602, DOI 10.2135/cropsci2012.06.0372; Levy R, 2008, LOUISIANA SOYBEAN FE; Liu K., 1997, SOYBEAN CHEM TECHNOL, P25, DOI 10.1007/978-1-4615-1763-4_2; LOHSE G, 1982, COMMUN SOIL SCI PLAN, V13, P127, DOI 10.1080/00103628209367251; Mascagni HJR, 2008, COMP SINGLE ROW TWIN; Mousavi S. J., 2011, Australian Journal of Basic and Applied Sciences, V5, P2625; Obendorf RL, 1998, CROP SCI, V38, P78, DOI 10.2135/cropsci1998.0011183X003800010014x; Ray JD, 2006, CROP SCI, V46, P52, DOI 10.2135/cropsci2005.0043; SAS, 2002, SAS 2002 2010 STAT A; Shibles R., 1975, CROP PHYSIOL, P151; SHIBLES R. M., 1965, CROP SCI, V5, P575, DOI 10.2135/cropsci1965.0011183X000500060027x; SHIBLES RM, 1966, CROP SCI, V6, P55, DOI 10.2135/cropsci1966.0011183X000600010017x; Smith JR, 2008, CROP SCI, V48, P2279, DOI 10.2135/cropsci2008.01.0026; SPAETH SC, 1984, AGRON J, V76, P128, DOI 10.2134/agronj1984.00021962007600010031x; SPAETH SC, 1984, AGRON J, V76, P123, DOI 10.2134/agronj1984.00021962007600010030x; Specht JE, 2001, CROP SCI, V41, P493, DOI 10.2135/cropsci2001.412493x; TAYLOR HM, 1982, FIELD CROP RES, V5, P1, DOI 10.1016/0378-4290(82)90002-8; Vyn TJ, 2002, J AGR FOOD CHEM, V50, P3501, DOI 10.1021/jf0200671; Wilcox JR, 2001, CROP SCI, V41, P11, DOI 10.2135/cropsci2001.41111x	53	21	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129913	10.1371/journal.pone.0129913	http://dx.doi.org/10.1371/journal.pone.0129913			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061182	gold, Green Published			2022-12-26	WOS:000355979500166
J	Malcolm, HA; Schultz, AL; Sachs, P; Johnstone, N; Jordan, A				Malcolm, Hamish A.; Schultz, Arthur L.; Sachs, Patrick; Johnstone, Nicola; Jordan, Alan			Decadal Changes in the Abundance and Length of Snapper (Chrysophrys auratus) in Subtropical Marine Sanctuaries	PLOS ONE			English	Article							STEREO-VIDEO SYSTEM; GREAT-BARRIER-REEF; PAGRUS-AURATUS; LIFE-HISTORY; RESERVE BOUNDARIES; TEMPORAL VARIATION; FISH ASSEMBLAGES; PROTECTION; SPARIDAE; DENSITY	Abundance and length of the highly-targeted snapper Chysophrys auratus were compared between sites in 'no take' areas (Sanctuary Zones: SZ), partial protected areas which are fished (Habitat Protection Zones: HPZ), and areas outside (Outside) the Solitary Islands Marine Park (SIMP), Australia. Baited Remote Underwater Video (BRUV) sampling on shallow rocky reef (15 - 25 m) was conducted annually from 2002 until 2014 in the Austral-winter, covering the decade after these marine park zones were established (2002). Additional deeper sites (25 - 40 m) were sampled in 2010-2011 to assess if findings were more-broadly applicable. Lengths were measured using stereo-BRUVs from 2011-2014. Snapper were significantly more abundant in SZ overall and in most years compared with the other two management types, which did not significantly differ. Snapper rapidly increased after 2 - 3 years protection in all management types, especially SZ. Snapper were present on more SZ deployments than HPZ and Outside after the same period. The positive SZ response in snapper abundance on shallower reef was also found at a broader spatial scale on deeper sites. Again the two fished management types did not show significant differences among each other. There was considerable variation in snapper abundance between years, with strong peaks in 2005, 2009 and 2014 especially in SZ. Abundances remained higher in SZ in the year or two following a strong peak, but decreased to similar abundances to fished areas before the next peak. Snapper length frequency distribution significantly differed between SZ and both fished management types, with more larger snapper within SZ including a higher proportion (58%) that were legal-sized (>25.7 cm FL). HPZ and Outside did not significantly differ from each other, and were dominated by individuals below legal size. Overall, SZ's have positively influenced abundance and length of snapper on these subtropical rocky reefs.	[Malcolm, Hamish A.] NSW Dept Primary Ind, Marine Ecosyst Res, Coffs Harbour, NSW 2450, Australia; [Schultz, Arthur L.] Southswell Marine, Urunga, NSW 2455, Australia; [Sachs, Patrick] Australian Fisheries Management Author, Canberra, ACT 2610, Australia; [Johnstone, Nicola] NSW Dept Primary Ind, Coffs Harbour, NSW 2450, Australia; [Jordan, Alan] NSW Dept Primary Ind, Marine Ecosyst Res, Nelson Bay, NSW 2315, Australia	NSW Department of Primary Industries; NSW Department of Primary Industries; NSW Department of Primary Industries	Malcolm, HA (corresponding author), NSW Dept Primary Ind, Marine Ecosyst Res, POB 4297, Coffs Harbour, NSW 2450, Australia.	hamish.malcolm@dpi.nsw.gov.au			NSW Government	NSW Government	The authors received no specific funding for this work. It was undertaken as part of core funding for marine parks research by the NSW Government.	Abesamis RA, 2005, ECOL APPL, V15, P1798, DOI 10.1890/05-0174; Abesamis RA, 2006, AQUAT CONSERV, V16, P349, DOI 10.1002/aqc.730; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Babcock RC, 1999, MAR ECOL PROG SER, V189, P125, DOI 10.3354/meps189125; Banks SA, 2010, MAR POLICY, V34, P197, DOI 10.1016/j.marpol.2009.06.006; Barrett NS, 2007, J EXP MAR BIOL ECOL, V345, P141, DOI 10.1016/j.jembe.2007.02.007; Bergseth BJ, 2015, FISH FISH, V16, P240, DOI 10.1111/faf.12051; Cappo M, 2003, AQUATIC PROTECTED AR, P455; Chapman MR, 1999, MAR ECOL PROG SER, V181, P81, DOI 10.3354/meps181081; Claudet J, 2010, ECOL APPL, V20, P830, DOI 10.1890/08-2131.1; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Cote IM, 2001, J FISH BIOL, V59, P178, DOI 10.1006/jfbi.2001.1752; Curley BG, 2013, REV FISH BIOL FISHER, V23, P435, DOI 10.1007/s11160-013-9309-7; Denny CM, 2004, MAR ECOL PROG SER, V272, P183, DOI 10.3354/meps272183; Denny CM, 2004, BIOL CONSERV, V116, P119, DOI 10.1016/S0006-3207(03)00183-6; Edgar GJ, 2009, ECOL APPL, V19, P1967, DOI 10.1890/09-0610.1; Edgar GJ, 2009, MAR ECOL PROG SER, V388, P51, DOI 10.3354/meps08149; Egli DP, 2004, ICES J MAR SCI, V61, P1137, DOI 10.1016/j.icesjms.2004.07.004; Evans RD, 2004, AQUAT CONSERV, V14, P505, DOI 10.1002/aqc.631; Ferrell D., 1997, ASSESSMENT FISHERY S; Forcada A, 2008, MAR ENVIRON RES, V66, P536, DOI 10.1016/j.marenvres.2008.08.003; Garcia-Charton JA, 2004, MAR BIOL, V144, P161, DOI 10.1007/s00227-003-1170-0; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Halpern BS, 2003, ECOL APPL, V13, pS117; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hamer PA, 2004, MAR FRESHWATER RES, V55, P663, DOI 10.1071/MF04024; Hamer PA, 2006, ESTUAR COAST SHELF S, V68, P686, DOI 10.1016/j.ecss.2006.03.017; Harasti D, 2015, J EXP MAR BIOL ECOL, V463, P173, DOI 10.1016/j.jembe.2014.12.003; Hardinge J, 2013, J EXP MAR BIOL ECOL, V449, P250, DOI 10.1016/j.jembe.2013.09.018; Harvey E, 2004, MAR FRESHWATER RES, V55, P573, DOI 10.1071/MF03130; Harvey E, 2002, FISH RES, V57, P255, DOI 10.1016/S0165-7836(01)00356-3; Harvey ES, 1998, MAR TECHNOL SOC J, V32, P3; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Henry G, 1999, SNAPPER YELLOWTAIL K; Henry GW, 2003, 99158 FRDC TAFI; Hixon MA, 2014, ICES J MAR SCI, V71, P2171, DOI 10.1093/icesjms/fst200; Jordan A., 2010, NSW DEP ENV CLIMATE, V209; Kelaher BP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085825; Langlois TJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045973; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Malcolm HA, 2005, RECREATIONAL F UNPUB; Malcolm HA, 2007, MAR ECOL PROG SER, V350, P277, DOI 10.3354/meps07195; Malcolm HA, 2011, AQUAT CONSERV, V21, P173, DOI 10.1002/aqc.1165; McClanahan TR, 2012, MAR ECOL PROG SER, V469, P121, DOI 10.3354/meps10009; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Molloy PP, 2009, J APPL ECOL, V46, P743, DOI 10.1111/j.1365-2664.2009.01662.x; Moran MJ, 1990, RELATIONSHIP PARTIAL; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Nagelkerken I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036906; NSWMPA, 2009, SOL ISL MAR PARK ZON; Parsons DM, 2014, NEW ZEAL J MAR FRESH, V48, P256, DOI 10.1080/00288330.2014.892013; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Ross PM, 2007, MAR FRESHWATER RES, V58, P1144, DOI 10.1071/MF07017; Rowling K, 2010, STATUS FISHERIES RES; Russ GR, 2004, OECOLOGIA, V138, P622, DOI 10.1007/s00442-003-1456-4; Russ GR, 2003, MAR ECOL PROG SER, V264, P15, DOI 10.3354/meps264015; Schultz AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049437; Shears NT, 2006, BIOL CONSERV, V132, P222, DOI 10.1016/j.biocon.2006.04.001; Smith ANH, 2014, MAR ECOL PROG SER, V499, P203, DOI 10.3354/meps10653; Stewart J, 2010, NSW FISHERIES RES RE; Stewart J, 2011, FISH RES, V108, P209, DOI 10.1016/j.fishres.2010.11.017; Sumpton WD, 2008, FISH RES, V94, P92, DOI 10.1016/j.fishres.2008.07.001; Sumpton WD, 2003, MAR FRESHWATER RES, V54, P923, DOI 10.1071/MF02119; Watson DL, 2009, MAR ECOL PROG SER, V384, P241, DOI 10.3354/meps08009; Willis TJ, 2003, J APPL ECOL, V40, P214, DOI 10.1046/j.1365-2664.2003.00775.x; Zeller D, 2003, MAR ECOL PROG SER, V254, P269, DOI 10.3354/meps254269	70	33	35	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127616	10.1371/journal.pone.0127616	http://dx.doi.org/10.1371/journal.pone.0127616			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061036	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500043
J	Ultsch, A; Lotsch, J				Ultsch, Alfred; Loetsch, Joern			Computed ABC Analysis for Rational Selection of Most Informative Variables in Multivariate Data	PLOS ONE			English	Article							LORENTZ CURVE; PAIN; INEQUALITY; CHANNELS	Objective Multivariate data sets often differ in several factors or derived statistical parameters, which have to be selected for a valid interpretation. Basing this selection on traditional statistical limits leads occasionally to the perception of losing information from a data set. This paper proposes a novel method for calculating precise limits for the selection of parameter sets. Methods The algorithm is based on an ABC analysis and calculates these limits on the basis of the mathematical properties of the distribution of the analyzed items. The limits im-plement the aim of any ABC analysis, i.e., comparing the increase in yield to the required additional effort. In particular, the limit for set A, the "important few", is optimized in a way that both, the effort and the yield for the other sets (B and C), are minimized and the additional gain is optimized. Results As a typical example from biomedical research, the feasibility of the ABC analysis as an objective replacement for classical subjective limits to select highly relevant variance components of pain thresholds is presented. The proposed method improved the biological interpretation of the results and increased the fraction of valid information that was obtained from the experimental data. Conclusions The method is applicable to many further biomedical problems in-cluding the creation of diagnostic complex biomarkers or short screening tests from comprehensive test batteries. Thus, the ABC analysis can be proposed as a mathematically valid replacement for traditional limits to maximize the information obtained from multivariate research data.	[Ultsch, Alfred] Univ Marburg, DataBion Res Grp, D-35032 Marburg, Germany; [Loetsch, Joern] Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60054 Frankfurt, Germany; [Loetsch, Joern] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, D-60590 Frankfurt, Germany	Philipps University Marburg; Goethe University Frankfurt; Fraunhofer Gesellschaft	Lotsch, J (corresponding author), Goethe Univ Frankfurt, Inst Clin Pharmacol, D-60054 Frankfurt, Germany.	j.loetsch@em.uni-frankfurt.de		Lotsch, Jorn/0000-0002-5818-6958	European Union Seventh Framework Programme (FP7) [602919]	European Union Seventh Framework Programme (FP7)	The research received funding, in particular the necessary computation equipment, from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement no. 602919 (JL). The funders had no role in method design, data selection and analysis, decision to publish, or preparation of the manuscript.	Arnold BC., 1983, PARETO DISTRIBUTIONS; ATKINSON AB, 1970, J ECON THEORY, V2, P244, DOI 10.1016/0022-0531(70)90039-6; Behnisch M, 2010, CLUSTERING POPULATIO; Dickie HF, 1951, FACTORY MANAGEMENT M, V109, P92; Doehring A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017724; Farber Ines, 2010, USING CLASS LABELS E; Farrington B., 2012, PURCHASING SUPPLY CH; GASTWIRTH JL, 1976, ECONOMETRICA, V44, P479, DOI 10.2307/1913977; GASTWIRTH JL, 1971, ECONOMETRICA, V39, P1037, DOI 10.2307/1909675; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Guttman L., 1954, PSYCHOMETRIKA, V19, P149, DOI 10.1007/BF02289162; Hardy M, 2010, MATH INTELL, V32, P38, DOI 10.1007/s00283-010-9159-2; Hummel T, 2010, J NEUROL; Juran J., 1975, QUAL PROG, V8, P8; KAISER HF, 1959, AM PSYCHOL, V14, P425; Knoblauch J, 2009, BESTEN MITARBEITER F; Krause E.F., 1988, TAXICAB GEOMETRY ADV; Krause M, 2014, REV INCOME WEALTH, V60, P905, DOI 10.1111/roiw.12047; Krzanowski WJ, 2000, PRINCIPLES MULTIVARI; Lotsch J, 2013, J BIOMED INFORM, V46, P921, DOI 10.1016/j.jbi.2013.07.010; Neddermeyer TJ, 2008, PAIN, V138, P286, DOI 10.1016/j.pain.2007.12.015; Novotny J, 2007, ANN REGIONAL SCI, V41, P563, DOI 10.1007/s00168-007-0113-y; Pareto V., 1909, MANUEL EC POLITIQUE; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Schuler M, 2002, EIDEGENOSSISCHE VOLK; Sudbury JR, 2013, J NEUROSCI, V 33, P17160, DOI 10.1523/JNEUROSCI.1048-13.2013; Wild T., 2002, BEST PRACTICE INVENT, V2nd ed	27	42	46	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129767	10.1371/journal.pone.0129767	http://dx.doi.org/10.1371/journal.pone.0129767			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061064	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500164
J	Gao, YF; Yuan, F; Liu, JB; Li, LP; He, YC; Gao, RJ; Cai, YD; Jiang, Y				Gao, Yu-Fei; Yuan, Fei; Liu, Junbao; Li, Li-Peng; He, Yi-Chun; Gao, Ru-Jian; Cai, Yu-Dong; Jiang, Yang			Identification of New Candidate Genes and Chemicals Related to Esophageal Cancer Using a Hybrid Interaction Network of Chemicals and Proteins	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; KAPPA-B; LIPID-PEROXIDATION; SODIUM-CHANNELS; BETA-CATENIN; DNA-DAMAGE; EXPRESSION; PATHWAY; CELLS; PREDICTION	Cancer is a serious disease responsible for many deaths every year in both developed and developing countries. One reason is that the mechanisms underlying most types of cancer are still mysterious, creating a great block for the design of effective treatments. In this study, we attempted to clarify the mechanism underlying esophageal cancer by searching for novel genes and chemicals. To this end, we constructed a hybrid network containing both proteins and chemicals, and generalized an existing computational method previously used to identify disease genes to identify new candidate genes and chemicals simultaneously. Based on jackknife test, our generalized method outperforms or at least performs at the same level as those obtained by a widely used method - the Random Walk with Restart (RWR). The analysis results of the final obtained genes and chemicals demonstrated that they highly shared gene ontology (GO) terms and KEGG pathways with direct and indirect associations with esophageal cancer. In addition, we also discussed the likelihood of selected candidate genes and chemicals being novel genes and chemicals related to esophageal cancer.	[Gao, Yu-Fei; Liu, Junbao; Li, Li-Peng; He, Yi-Chun; Gao, Ru-Jian; Jiang, Yang] Jilin Univ, China Japan Union Hosp, Dept Surg, Changchun 130033, Peoples R China; [Yuan, Fei] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Coll Life Sci, Shanghai 200444, Peoples R China	Jilin University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University	Jiang, Y (corresponding author), Jilin Univ, China Japan Union Hosp, Dept Surg, Changchun 130033, Peoples R China.	jy7555@163.com		cai, yudong/0000-0001-5664-7979	National Natural Science Foundation of China [81372696, 31371335]; China Postdoctoral Science Foundation [2013 M541314]; Jilin Provincial Science AMP; Technology Department [20090175, 20100733]; Natural Science Fund Projects of Jilin province [201215059]; Development of Science and Technology Plan Projects of Jilin province [20100733, 201101074]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry [2009-36]; Scientific Research Foundation (Jilin Department of Science Technology) [20090175, 20100733, 200705314]; Health and Family Planning Commission of Jilin Province [2010Z068]; Human resources and Social Security Department of Jilin Province; Postdoctoral Science Foundation of Jilin Province; National Basic Research Program of China [2011CB510101, 2011CB510102]; Jilin province key scientific research project [20150204026YY]; Basic scientific research funding of Jilin university [450060501520]; Innovation Program of the Shanghai Municipal Education Commission [12ZZ087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jilin Provincial Science AMP; Technology Department; Natural Science Fund Projects of Jilin province; Development of Science and Technology Plan Projects of Jilin province; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Scientific Research Foundation (Jilin Department of Science Technology); Health and Family Planning Commission of Jilin Province; Human resources and Social Security Department of Jilin Province; Postdoctoral Science Foundation of Jilin Province; National Basic Research Program of China(National Basic Research Program of China); Jilin province key scientific research project; Basic scientific research funding of Jilin university; Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	National Natural Science Foundation of China (81372696), China Postdoctoral Science Foundation (2013 M541314), Jilin Provincial Science & Technology Department (20090175, 20100733), Natural Science Fund Projects of Jilin province (201215059), Development of Science and Technology Plan Projects of Jilin province (20100733, 201101074), Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (2009-36), Scientific Research Foundation (Jilin Department of Science & Technology, 200705314, 20090175, 20100733), Health and Family Planning Commission of Jilin Province (2010Z068), Human resources and Social Security Department of Jilin Province (2012-2014), Postdoctoral Science Foundation of Jilin Province, and Human resources and Social Security Department of Jilin Province (2012), National Basic Research Program of China (2011CB510101, 2011CB510102), Jilin province key scientific research project (20150204026YY), Basic scientific research funding of Jilin university (450060501520), National Natural Science Foundation of China (31371335), the Innovation Program of the Shanghai Municipal Education Commission (12ZZ087). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2014, BRIT J CANCER, V110, P1088, DOI 10.1038/bjc.2013.769; Alexandre J, 2006, INT J CANCER, V119, P41, DOI 10.1002/ijc.21685; [Anonymous], 1979, IARC Monogr Eval Carcinog Risk Chem Hum, V20, P575; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arcangeli A., 2005, NOVARTIS FDN S; Ashcroft F. M., 1999, ION CHANNELS DIS; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Berger AJ, 2003, CANCER RES, V63, P8103; BLUM A, 1977, SCIENCE, V195, P17, DOI 10.1126/science.831254; Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P269, DOI 10.1023/A:1026028303196; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107767; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen X, 2012, MOL BIOSYST, V8, P1970, DOI 10.1039/c2mb00002d; CHURCH SL, 1993, P NATL ACAD SCI USA, V90, P3113, DOI 10.1073/pnas.90.7.3113; Commission CPS, 1977, FED REGISTER, V42, P6; Dahmen RP, 2001, CANCER RES, V61, P7039; Danielsson BR, 2003, EPILEPSY RES, V55, P147, DOI 10.1016/S0920-1211(03)00119-0; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Derek JC, 2008, NOVARTIS FDN S, V266; FERNANDEZPOL JA, 1982, CANCER RES, V42, P609; Gu JA, 2010, CANCER PREV RES, V3, P1176, DOI 10.1158/1940-6207.CAPR-09-0265; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; HOLLSTEIN MC, 1990, P NATL ACAD SCI USA, V87, P9958, DOI 10.1073/pnas.87.24.9958; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025297; Huang YP, 2011, INT J CANCER, V128, P2261, DOI 10.1002/ijc.25569; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang M, 2013, MOL BIOSYST, V9, P2720, DOI 10.1039/c3mb70089e; Jiang R, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S2; Ju W, 2007, MOL PHARMACOL, V71, P1381, DOI 10.1124/mol.106.032185; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Kawanishi S, 2002, FREE RADICAL BIO MED, V32, P822, DOI 10.1016/S0891-5849(02)00779-7; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kobayashi Y, 2008, CANCER SCI, V99, P1546, DOI 10.1111/j.1349-7006.2008.00856.x; Kohler S, 2008, AM J HUM GENET, V82, P949, DOI 10.1016/j.ajhg.2008.02.013; Konopka JB, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/489208; Koppert LB, 2004, BRIT J CANCER, V90, P892, DOI 10.1038/sj.bjc.6601589; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Lastraioli E, 2006, J CELL PHYSIOL, V209, P398, DOI 10.1002/jcp.20748; Layke JC, 2006, AM FAM PHYSICIAN, V73, P2187; LeBlanc RB, 1973, WHATS AVAILABLE FLAM; Li BQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/267375; Li YJ, 2010, BIOINFORMATICS, V26, P1219, DOI 10.1093/bioinformatics/btq108; Lim SD, 2005, PROSTATE, V62, P200, DOI 10.1002/pros.20137; LO YYC, 1995, J BIOL CHEM, V270, P11727, DOI 10.1074/jbc.270.20.11727; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; Luo W, 2004, NEUROSIGNALS, V13, P99, DOI 10.1159/000076563; Macropol K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-283; Maekawa T, 2007, MOL CELL BIOL, V27, P1730, DOI 10.1128/MCB.01579-06; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Mayer RJ, 2008, HARRISONS PRINCIPLES, P764; McNeil S., 2013, IMAGING; Meng XR, 2014, BRAZ J MED BIOL RES, V47, P811, DOI 10.1590/1414-431X20143906; Mimori K, 2003, ONCOGENE, V22, P3463, DOI 10.1038/sj.onc.1206378; Ming ZZ, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0153-4; MOMPARLER RL, 1976, CANCER RES, V36, P2891; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Muller JM, 1997, METHODS, V11, P301, DOI 10.1006/meth.1996.0424; Myhren L, 2014, EUR J PHARM BIOPHARM, V88, P186, DOI 10.1016/j.ejpb.2014.04.002; Nakajima M, 2003, BRIT J CANCER, V88, P1734, DOI 10.1038/sj.bjc.6600941; National Cancer Institute, 2014, SEER STAT FACT SHEET; National Toxicology Program, 1978, Natl Cancer Inst Carcinog Tech Rep Ser, V76, P1; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Onganer PU, 2005, J MEMBRANE BIOL, V204, P67, DOI 10.1007/s00232-005-0747-6; OSTERBERG RE, 1977, J TOXICOL ENV HEALTH, V3, P979, DOI 10.1080/15287397709529632; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Pitkanen A, 2011, LANCET NEUROL, V10, P173, DOI 10.1016/S1474-4422(10)70310-0; Prival MJ, SCIENCE, V195, P76; PURI PL, 1995, J BIOL CHEM, V270, P22129, DOI 10.1074/jbc.270.38.22129; Qin X, 2014, MOL CARCINOGEN, V53, P526, DOI 10.1002/mc.22004; RAGSDALE DS, 1991, MOL PHARMACOL, V40, P756; Ray G, 2000, BREAST CANCER RES TR, V59, P163, DOI 10.1023/A:1006357330486; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sagara M, 1999, INT J CANCER, V84, P251, DOI 10.1002/(SICI)1097-0215(19990621)84:3<251::AID-IJC9>3.3.CO;2-Z; Satoh S, 2000, NAT GENET, V24, P245, DOI 10.1038/73448; Schoenwolf GC, 2015, LARSENS HUMAN EMBRYO; Shi HB, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-101; Slawson C, 2010, TRENDS BIOCHEM SCI, V35, P547, DOI 10.1016/j.tibs.2010.04.005; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Sudo T, 2007, EJSO-EUR J SURG ONC, V33, P44, DOI 10.1016/j.ejso.2006.10.034; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; SZATROWSKI TP, 1991, CANCER RES, V51, P794; TAN C, 1967, CANCER-AM CANCER SOC, V20, P333, DOI 10.1002/1097-0142(1967)20:3<333::AID-CNCR2820200302>3.0.CO;2-K; Tasioudi KE, 2012, PATHOL RES PRACT, V208, P398, DOI 10.1016/j.prp.2012.05.009; van Hagen P, 2012, NEW ENGL J MED, V366, P2074, DOI 10.1056/NEJMoa1112088; Veeramachaneni NK, 2014, J THORACIC CARDIOVAS, V127, P92; Wang JS, 2012, ASIAN PAC J CANCER P, V13, P2527, DOI 10.7314/APJCP.2012.13.6.2527; [王金胜 Wang Jinsheng], 2011, [中国组织化学与细胞化学杂志, Chinese Journal of Histochemistry and Cytochemistry], V20, P124; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Wu JX, 2014, TUMOR BIOL, V35, P3709, DOI 10.1007/s13277-013-1490-8; Yan T, 1996, CANCER RES, V56, P2864; Yang M, 2012, BREAST CANCER RES TR, V134, P603, DOI 10.1007/s10549-012-2102-9; Zhang HZ, 2012, CHIN J CANCER, V31, P281, DOI 10.5732/cjc.011.10390; Zhang J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/523415; Zhao HG, 2014, SCI REP-UK, V4, DOI 10.1038/srep03866; Zhao M, 2013, NUCLEIC ACIDS RES, V41, pD970, DOI 10.1093/nar/gks937; Zhou JH, 2008, TOXICOL APPL PHARM, V230, P33, DOI 10.1016/j.taap.2008.01.041; Zieba M, 2000, RESP MED, V94, P800, DOI 10.1053/rmed.2000.0825	112	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129474	10.1371/journal.pone.0129474	http://dx.doi.org/10.1371/journal.pone.0129474			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058041	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000058
J	Gasperov, NM; Sabol, I; Planinic, P; Grubisic, G; Fistonic, I; Corusic, A; Grce, M				Gasperov, Nina Milutin; Sabol, Ivan; Planinic, Pavao; Grubisic, Goran; Fistonic, Ivan; Corusic, Ante; Grce, Magdalena			Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer	PLOS ONE			English	Article							ABERRANT DNA METHYLATION; INTRAEPITHELIAL NEOPLASIA; CPG METHYLATION; CANDIDATE BIOMARKER; HPV INFECTION; L1 GENE; PROGRESSION; LINES; PATTERNS; GENOME	Change in the host and/or human papillomavirus (HPV) DNA methylation profile is probably one of the main factors responsible for the malignant progression of cervical lesions to cancer. To investigate those changes we studied 173 cervical samples with different grades of cervical lesion, from normal to cervical cancer. The methylation status of nine cellular gene promoters, CCNA1, CDH1, C13ORF18, DAPK1, HIC1, RAR beta 2, hTERT1, hTERT2 and TWIST1, was investigated by Methylation Specific Polymerase Chain Reaction (MSP). The methylation of HPV18 L1-gene was also investigated by MSP, while the methylated cytosines within four regions, L1, 5'LCR, enhancer, and promoter of the HPV16 genome covering 19 CpG sites were evaluated by bisulfite sequencing. Statistically significant methylation biomarkers distinguishing between cervical precursor lesions from normal cervix were primarily C13ORF18and secondly CCNA1, and those distinguishing cervical cancer from normal or cervical precursor lesions were CCNA1, C13ORF18, hTERT1, hTERT2 and TWIST1. In addition, the methylation analysis of individual CpG sites of the HPV16 genome in different sample groups, notably the 7455 and 7694 sites, proved to be more important than the overall methylation frequency. The majority of HPV18 positive samples contained both methylated and unmethylated L1 gene, and samples with L1-gene methylated forms alone had better prognosis when correlated with the host cell gene promoters' methylation profiles. In conclusion, both cellular and viral methylation biomarkers should be used for monitoring cervical lesion progression to prevent invasive cervical cancer.	[Gasperov, Nina Milutin; Sabol, Ivan; Grce, Magdalena] Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia; [Planinic, Pavao; Corusic, Ante] Clin Hosp Ctr Zagreb, Clin Gynecol & Obstet, Dept Gynecol Oncol, Zagreb, Croatia; [Grubisic, Goran] Clin Hosp Sestre Milosrdnice, Obstet & Gynaecol Clin, Zagreb, Croatia; [Fistonic, Ivan] Private Gynaecol Clin, Zagreb, Croatia	Rudjer Boskovic Institute; University of Zagreb	Grce, M (corresponding author), Rudjer Boskovic Inst, Div Mol Med, Zagreb, Croatia.	grce@irb.hr	Sabol, Ivan/B-7455-2012; GRCE, MAGDALENA/ABD-2768-2020; Fistonic, Ivan/V-7013-2017	Sabol, Ivan/0000-0002-5753-8528; Fistonic, Ivan/0000-0003-3295-9390; Grce, Magdalena/0000-0001-6178-8418	Croatian Ministry of Science, Education and Sport [098-0982464-2510]; European Union's Seventh Framework Programme for research, technological development and demonstration [316289]	Croatian Ministry of Science, Education and Sport(Ministry of Science, Education and Sports, Republic of Croatia); European Union's Seventh Framework Programme for research, technological development and demonstration	This work was supported by the Croatian Ministry of Science, Education and Sport (grant 098-0982464-2510). MG was also supported by the European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement No 316289. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1982, MOL CLONING LAB MANU; Badal S, 2004, VIROLOGY, V324, P483, DOI 10.1016/j.virol.2004.04.002; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Burchell AN, 2014, J INFECT DIS, V210, P846, DOI 10.1093/infdis/jiu200; Clarke MA, 2012, CANCER EPIDEM BIOMAR, V21, P2125, DOI 10.1158/1055-9965.EPI-12-0905; Cuzick J, 2012, VACCINE, V30, pF107, DOI 10.1016/j.vaccine.2012.05.088; de Sanjose S, 2010, LANCET ONCOL, V11, P1048, DOI 10.1016/S1470-2045(10)70230-8; de Wilde J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-271; Dessain SK, 2000, CANCER RES, V60, P537; Duenas-Gonzalez A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-38; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Eijsink JJH, 2011, GYNECOL ONCOL, V120, P280, DOI 10.1016/j.ygyno.2010.10.029; Farkas SA, 2013, EPIGENETICS-US, V8, P1213, DOI 10.4161/epi.26346; Feng QH, 2005, JNCI-J NATL CANCER I, V97, P273, DOI 10.1093/jnci/dji041; Flatley JE, 2009, CANCER EPIDEM BIOMAR, V18, P2782, DOI 10.1158/1055-9965.EPI-09-0493; Iliopoulos D, 2009, ONCOL REP, V22, P199, DOI 10.3892/or_00000425; Ivanova T, 2002, BMC CANCER, V2, DOI 10.1186/1471-2407-2-4; Kalantari M, 2004, J VIROL, V78, P12762, DOI 10.1128/JVI.78.23.12762-12772.2004; Kalantari M, 2008, VIROLOGY, V374, P292, DOI 10.1016/j.virol.2007.12.016; Kalantari M, 2014, VIROLOGY, V448, P314, DOI 10.1016/j.virol.2013.10.032; Kitkumthorn N, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-55; Kumari A, 2009, PANCREATOLOGY, V9, P360, DOI 10.1159/000212094; Lorincz AT, 2013, INT J CANCER, V133, P637, DOI 10.1002/ijc.28050; Matovina M, 2009, GYNECOL ONCOL, V113, P120, DOI 10.1016/j.ygyno.2008.12.004; Milutin-Gagperov N, 2007, COLLEGIUM ANTROPOL, V31, P89; Mirabello L, 2013, INT J CANCER, V132, P1412, DOI 10.1002/ijc.27750; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; OVANINRAKIC A, 2003, GYNAECOL PERINATOL, V12, P148; Patel DA, 2012, J VIROL METHODS, V184, P84, DOI 10.1016/j.jviromet.2012.05.022; Remus R, 1999, J VIROL, V73, P1010, DOI 10.1128/JVI.73.2.1010-1022.1999; Schiffman M, 2007, LANCET, V370, P890, DOI [10.1016/S0140-6736(07)61416-0, 10.1016/S0140-6736(13)60022-7]; Steenbergen RDM, 2004, JNCI-J NATL CANCER I, V96, P294, DOI 10.1093/jnci/djh031; Sun C, 2011, GYNECOL ONCOL; Turan T, 2007, VIROLOGY, V361, P185, DOI 10.1016/j.virol.2006.11.010; Turan T, 2006, VIROLOGY, V349, P175, DOI 10.1016/j.virol.2005.12.033; Virmani AK, 2001, CLIN CANCER RES, V7, P584; Vrdoljak Eduard, 2013, Lijec Vjesn, V135, P225; Wentzensen N, 2009, GYNECOL ONCOL, V112, P293, DOI 10.1016/j.ygyno.2008.10.012; Wentzensen N, 2012, JNCI-J NATL CANCER I, V104, P1738, DOI 10.1093/jnci/djs425; Widschwendter A, 2004, CLIN CANCER RES, V10, P3396, DOI 10.1158/1078-0432.CCR-03-0143; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050; Yang HJ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-212; Yang N, 2009, CANCER EPIDEM BIOMAR, V18, P3000, DOI 10.1158/1055-9965.EPI-09-0405; Zinn RL, 2007, CANCER RES, V67, P194, DOI 10.1158/0008-5472.CAN-06-3396	47	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129452	10.1371/journal.pone.0129452	http://dx.doi.org/10.1371/journal.pone.0129452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057381	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000053
J	Bogner, B; Boye, SL; Min, SH; Peterson, JJ; Ruan, Q; Zhang, ZH; Reitsamer, HA; Hauswirth, WW; Boye, SE				Bogner, Barbara; Boye, Sanford L.; Min, Seok Hong; Peterson, James J.; Ruan, Qing; Zhang, Zhonghong; Reitsamer, Herbert A.; Hauswirth, William W.; Boye, Shannon E.			Capsid Mutated Adeno-Associated Virus Delivered to the Anterior Chamber Results in Efficient Transduction of Trabecular Meshwork in Mouse and Rat	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; GLUCOCORTICOID-INDUCIBLE MMP1; LEBER CONGENITAL AMAUROSIS; GENE-THERAPY; TISSUE TRANSGLUTAMINASE; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; GLAUCOMATOUS EYES; OUTFLOW FACILITY; RPE65 MUTATIONS	Background Adeno associated virus (AAV) is well known for its ability to deliver transgenes to retina and to mediate improvements in animal models and patients with inherited retinal disease. Although the field is less advanced, there is growing interest in AAV's ability to target cells of the anterior segment. The purpose of our study was to fully articulate a reliable and reproducible method for injecting the anterior chamber (AC) of mice and rats and to investigate the transduction profiles of AAV2- and AAV8-based capsid mutants containing self-complementary (sc) genomes in the anterior segment of the eye. Methodology/Principle Findings AC injections were performed in C57BL/6 mice and Sprague Dawley rats. The cornea was punctured anterior of the iridocorneal angle. To seal the puncture site and to prevent reflux an air bubble was created in the AC. scAAVs expressing GFP were injected and transduction was evaluated by immunohistochemistry. Both parent serotype and capsid modifications affected expression. scAAV2-based vectors mediated efficient GFP-signal in the corneal endothelium, ciliary non-pigmented epithelium (NPE), iris and chamber angle including trabecular meshwork, with scAAV2(Y444F) and scAAV2(triple) being the most efficient. Conclusions/Significance This is the first study to semi quantitatively evaluate transduction of anterior segment tissues following injection of capsid-mutated AAV vectors. scAAV2-based vectors transduced corneal endothelium, ciliary NPE, iris and trabecular meshwork more effectively than scAAV8-based vectors. Mutagenesis of surface-exposed tyrosine residues greatly enhanced transduction efficiency of scAAV2 in these tissues. The number of Y-F mutations was not directly proportional to transduction efficiency, however, suggesting that proteosomal avoidance alone may not be sufficient. These results are applicable to the development of targeted, gene-based strategies to investigate pathological processes of the anterior segment and may be applied toward the development of gene-based therapies for glaucoma and acquired or inherited corneal anomalies.	[Bogner, Barbara; Zhang, Zhonghong; Reitsamer, Herbert A.] SALK Paracelsus Med Univ, Dept Ophthalmol & Optometry, Salzburg, Austria; [Boye, Sanford L.; Min, Seok Hong; Peterson, James J.; Ruan, Qing; Hauswirth, William W.; Boye, Shannon E.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32611 USA	Paracelsus Private Medical University; State University System of Florida; University of Florida	Boye, SE (corresponding author), Univ Florida, Dept Ophthalmol, Gainesville, FL 32611 USA.	Shannon.Boye@eye.ufl.edu		hauswirth, william/0000-0002-3244-4947; Boye, Shannon/0000-0002-7312-3197	Austrian Academy of Sciences [Doc-fFORTE-22966]; PMU-FFF [S-12/02/006-BOG]; Lotte Schwarz Endowment for Experimental Ophthalmology and Glaucoma Research; Research to Prevent Blindness; Fuchs Endowment; Institutional Grant of University Eye Clinic Salzburg [RO1 EY024280, P30-EY021721]; NATIONAL EYE INSTITUTE [P30EY021721, R01EY024280] Funding Source: NIH RePORTER	Austrian Academy of Sciences; PMU-FFF; Lotte Schwarz Endowment for Experimental Ophthalmology and Glaucoma Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Fuchs Endowment; Institutional Grant of University Eye Clinic Salzburg; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by: Doc-fFORTE-22966 (Austrian Academy of Sciences), PMU-FFF S-12/02/006-BOG, Lotte Schwarz Endowment for Experimental Ophthalmology and Glaucoma Research, Fuchs Endowment, Institutional Grant of the University Eye Clinic Salzburg, RO1 EY024280 (SEB), P30-EY021721 (WWH), and Research to Prevent Blindness.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Ashtari M, 2011, J CLIN INVEST, V121, P2160, DOI 10.1172/JCI57377; Aslanidi GV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059142; Aslanidi GV, 2012, VACCINE, V30, P3908, DOI 10.1016/j.vaccine.2012.03.079; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Balaggan KS, 2012, GENE THER, V19, P145, DOI 10.1038/gt.2011.153; Barraza RA, 2010, MOL THER, V18, P491, DOI 10.1038/mt.2009.278; Bennett J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002865; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Borras T, 2006, J GENE MED, V8, P589, DOI 10.1002/jgm.886; Borras T, 2012, INVEST OPHTH VIS SCI, V53, P2506, DOI 10.1167/iovs.12-9483o; Bowles DE, 2012, MOL THER, V20, P443, DOI 10.1038/mt.2011.237; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Boye SL, 2011, INVEST OPHTH VIS SCI, V52, P7098, DOI 10.1167/iovs.11-7867; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Buie LK, 2013, INVEST OPHTH VIS SCI, V54, P5441, DOI 10.1167/iovs.13-11651; Buie LK, 2010, INVEST OPHTH VIS SCI, V51, P236, DOI 10.1167/iovs.09-3847; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; DiMattia M, 2005, ACTA CRYSTALLOGR F, V61, P917, DOI 10.1107/S1744309105028514; DiMattia MA, 2012, J VIROL, V86, P6947, DOI 10.1128/JVI.07232-11; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Flugel-Koch C, 2004, EXP EYE RES, V79, P649, DOI 10.1016/j.exer.2004.07.005; Gabriel N, 2013, HUM GENE THER METHOD, V24, P80, DOI 10.1089/hgtb.2012.194; Gerometta R, 2010, INVEST OPHTH VIS SCI, V51, P3042, DOI 10.1167/iovs.09-4920; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Haire SE, 2006, INVEST OPHTH VIS SCI, V47, P3745, DOI 10.1167/iovs.06-0086; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Hippert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035318; Hiscott P, 2006, PROG RETIN EYE RES, V25, P1, DOI 10.1016/j.preteyeres.2005.05.001; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Junglas B, 2012, AM J PATHOL, V180, P2386, DOI 10.1016/j.ajpath.2012.02.030; Junglas B, 2009, EXP EYE RES, V88, P1065, DOI 10.1016/j.exer.2009.01.008; Kampik D, 2012, EXP EYE RES, V95, P54, DOI 10.1016/j.exer.2011.07.001; Kay CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062097; Klimczak RR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007467; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Koilkonda RD, 2009, MOL VIS, V15; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Kumar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072447; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Lee ES, 2014, CURR EYE RES, V39, P859, DOI 10.3109/02713683.2014.884593; Li G, 2013, EXP EYE RES, V109, P8, DOI 10.1016/j.exer.2013.01.005; Lipinski DM, 2014, HUM GENE THER, V25, P50, DOI 10.1089/hum.2013.009; Liu J, 2008, MOL VIS, V14, P2087; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Markusic DM, 2010, MOL THER, V18, P2048, DOI 10.1038/mt.2010.172; McCarty DM, 2008, MOL THER, V16, P1648, DOI 10.1038/mt.2008.171; Medina-Ortiz WE, 2013, INVEST OPHTH VIS SCI, V54, P6779, DOI 10.1167/iovs.13-12298; Mohan RR, 2013, OCUL SURF, V11, P150, DOI 10.1016/j.jtos.2012.10.004; Mohan RR, 2012, PROG RETIN EYE RES, V31, P43, DOI 10.1016/j.preteyeres.2011.09.001; Mohan RR, 2011, INVEST OPHTH VIS SCI, V52, P4833, DOI 10.1167/iovs.11-7357; Mohan RR, 2010, MOL VIS, V16, P2494; Nam HJ, 2007, J VIROL, V81, P12260, DOI 10.1128/JVI.01304-07; Opie SR, 2003, J VIROL, V77, P6995, DOI 10.1128/JVI.77.12.6995-7006.2003; Padron E, 2005, J VIROL, V79, P5047, DOI 10.1128/JVI.79.8.5047-5058.2005; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Parker DGA, 2007, GENE THER, V14, P760, DOI 10.1038/sj.gt.3302921; Peterson JJ, 2003, EXP EYE RES, V76, P553, DOI 10.1016/S0014-4835(03)00032-0; Petrs-Silva H, 2011, MOL THER, V19, P293, DOI 10.1038/mt.2010.234; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Prendes MA, 2013, BRIT J OPHTHALMOL, V97, P680, DOI 10.1136/bjophthalmol-2011-301132; Puppo A, 2014, GENE THER, V21, P855, DOI 10.1038/gt.2014.57; Qi XP, 2007, INVEST OPHTH VIS SCI, V48, P1, DOI 10.1167/iovs.06-0789; Rasmussen Carol A, 2014, J Glaucoma, V23, pS15, DOI 10.1097/IJG.0000000000000106; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Sacca SC, 2015, J CELL PHYSIOL, V230, P510, DOI 10.1002/jcp.24826; SCHITTNY JC, 1988, J CELL BIOL, V107, P1599, DOI 10.1083/jcb.107.4.1599; Seo SJ, 2012, EXP EYE RES, V101, P60, DOI 10.1016/j.exer.2012.05.013; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Spiga MG, 2010, INVEST OPHTH VIS SCI, V51, P3029, DOI 10.1167/iovs.09-4918; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tamm ER, 2009, EXP EYE RES, V88, P648, DOI 10.1016/j.exer.2009.02.007; Tektas OY, 2009, EXP EYE RES, V88, P769, DOI 10.1016/j.exer.2008.11.025; Tovar-Vidales T, 2008, INVEST OPHTH VIS SCI, V49, P622, DOI 10.1167/iovs.07-0835; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; Vemuganti GK, 2011, DEV OPHTHALMOL, V48, P24, DOI 10.1159/000324261; Vittitow JL, 2002, MOL VIS, V8, P32; Wang WH, 2008, J CLIN INVEST, V118, P1056, DOI 10.1172/JCI33871; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Weitz AC, 2013, J NEUROPHYSIOL, V109, P1979, DOI 10.1152/jn.00852.2012; Welge-Lussen U, 2000, INVEST OPHTH VIS SCI, V41, P2229; Williams KA, 2012, CURR OPIN OPHTHALMOL, V23, P276, DOI 10.1097/ICU.0b013e3283541eb6; Wordinger RJ, 2007, INVEST OPHTH VIS SCI, V48, P1191, DOI 10.1167/iovs.06-0296; Xiang Y, 2014, INT J OPHTHALMOL-CHI, V7, P924, DOI 10.3980/j.issn.2222-3959.2014.06.02; Xiao W, 2002, J VIROL, V76, P11505, DOI 10.1128/JVI.76.22.11505-11517.2002; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899; Xue W, 2006, INVEST OPHTH VIS SCI, V47, P997, DOI 10.1167/iovs.05-1106; Zhang Z, 2014, INVEST OPHTH VIS SCI, V55, P935, DOI 10.1167/iovs.13-12890; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	96	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128759	10.1371/journal.pone.0128759	http://dx.doi.org/10.1371/journal.pone.0128759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052939	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300057
J	Guo, W; Zhang, WX; Liu, CS; Song, YY; Bai, O				Guo, Wei; Zhang, Wenxian; Liu, Chunshui; Song, Yuanyuan; Bai, Ou			Clinical Analysis of the HBV Infection Status of 135 Patients with Diffuse Large B Cell Lymphoma Treated with R-CHOP or CHOP/CHOP-Like Chemotherapy	PLOS ONE			English	Article							NON-HODGKIN-LYMPHOMA; HEPATITIS-B; VIRUS REACTIVATION; HIGH PREVALENCE; RITUXIMAB; COMBINATION; TRIAL; RISK	Objectives This study aimed to determine the HBV infection status of 135 patients with DLBCL (diffuse large B cell lymphoma), to analyze the overall survival (OS) and progression-free survival (PFS) of the different HBV infection status groups, and to discuss the relationship between HBV serological test results and the prognosis of DLBCL patients. Methods A retrospective analysis was performed of the clinical data, HBV serological test results, and PFS/OS of 135 DLBCL patients who were initially diagnosed and treated with more than 3 cycles of an R-CHOP/CHOP/CHOP-like regimen at our center from January 1, 2008 to December 31, 2012. Results The patients in the HBV infection group were older at disease onset (>= 60 years old) and were more likely to present with stage 3-4 disease compared with the HBV-free group (P = 0.030 and P = 0.025, respectively). Approximately 50% of the patients with an active HBV infection required a reduction in the chemotherapy dose, and 66.7% of the patients in this group received more than 1 line of therapy; these rates were significantly higher than those in the no infection group (P = 0.003 and P = 0.011, respectively). Although HBV infection had no obvious influence on the outcome of first-line therapy, patients with an inactive infection had a higher relapse/progression rate within 3 months after a CR/PR than patients with an active infection (14/20 vs. 1/12, P = 0.001). The PFS at 1 year, 3 years and OS rates at 1 year, 3 years were significantly lower in the active HBV infection group than in the HBV-free group (P = 0.008, P = 0.002, P = 0.004, and P = 0.002, respectively). The PFS rates at 1 year and 3 year in HBV-free group were higher than those in the HBV infection group (80.5% and 52.9% P = 0.001, 78.1% and 44.4% P = 0.002). The lymphoma-related mortality rates were 2.7% in the no infection group, 19.2% in the HBV infection group (P = 0.004), and 28.6% in the active HBV infection group (P = 0.001). Among the patients treated with MabThera, the PFS in the HBV infection group was 11 months in the HBV infection group and 67 months in the infection-free group (P = 0.000). A Cox regression model of PFS revealed that age >= 60 years and HBV infection were independent prognostic factors (age: P = 0.019, HR = 2.002, 95% CI 1.123-3.567; HBV infection: P = 0.026, HR = 0.494, 95% CI 0.265-0.919). Conclusion Compared with the patients in HBV-free group, those in the HBV infection group were older at disease onset, and the active infection patients presented with more advanced disease and had a lower PFS at 1, 3 years as well as a lower OS at 3 years. The patients in the inactive infection group had a higher progression/relapse rate within 3 months after a CR/PR than those in the active infection group. HBV infection was an unfavorable factor for PFS in the MabThera group. An age >= 60 years and HBV infection were independent unfavorable prognostic factors for PFS.	[Guo, Wei; Zhang, Wenxian; Liu, Chunshui; Bai, Ou] Jilin Univ, Hosp 1, Dept Tumor Ctr, Changchun 130023, Jilin, Peoples R China; [Song, Yuanyuan] Jilin Univ, Hosp 1, Dept Lab Med, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University	Bai, O (corresponding author), Jilin Univ, Hosp 1, Dept Tumor Ctr, Changchun 130023, Jilin, Peoples R China.	oubai16@163.com			Science and Technology Department of Jilin Province, China [20140414004]	Science and Technology Department of Jilin Province, China	This work was supported by Science and Technology Department of Jilin Province, China, grant number 20140414004 to OB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker N, 2012, J CANCER RES CLIN, V138, P1993, DOI 10.1007/s00432-012-1279-y; Chen MH, 2008, ANN HEMATOL, V87, P475, DOI 10.1007/s00277-008-0469-9; Cheson BD, 2007, J CLIN ONCOL, V25, P579, DOI 10.1200/JCO.2006.09.2403; Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese Medical Association, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P405; Coiffier B, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.32749; Coiffier B, 2010, BLOOD, V116, P2040, DOI 10.1182/blood-2010-03-276246; Dalia S, 2013, LEUKEMIA RES, V37, P1107, DOI 10.1016/j.leukres.2013.06.007; Elbedewy TA, 2015, J EGYPT NATL CANCER, V27, P11, DOI 10.1016/j.jnci.2015.01.004; Fukushima N, 2009, ANN ONCOL, V20, P2013, DOI 10.1093/annonc/mdp230; Hsu C, 2014, HEPATOLOGY, V59, P2092, DOI 10.1002/hep.26718; Huang H, 2014, JAMA-J AM MED ASSOC, V312, P2521, DOI 10.1001/jama.2014.15704; Kang J, 2011, ANN HEMATOL, V90, P159, DOI 10.1007/s00277-010-1055-5; Kusumoto S, 2011, J SYN ORG CHEM JPN, V69, P1, DOI 10.5059/yukigoseikyokaishi.69.1; Lu S, 2015, LEUKEMIA LYMPHOMA, V56; Marcucci F, 2011, BLOOD, V117, P1792, DOI 10.1182/blood-2010-06-275818; Niitsu N, 2010, J CLIN ONCOL, V28, P5097, DOI 10.1200/JCO.2010.29.7531; Pfreundschuh M, 2011, LANCET ONCOL, V12, P1013, DOI 10.1016/S1470-2045(11)70235-2; Rubio J, 2014, LEUKEMIA LYMPHOMA, P1; Swerdlow SH, 2008, WHO CLASSIFICATION T; Visco C, 2012, LEUKEMIA, V26, P2103, DOI 10.1038/leu.2012.83; Wei Z, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0845-3; Xiaofeng L, 2005, ZHONGHUA LIUXINGBING, V26; Xie WZ, 2013, EXP THER MED, V6, P109, DOI 10.3892/etm.2013.1079; Zurawska U, 2012, J CLIN ONCOL, V30, P3167, DOI 10.1200/JCO.2011.40.7510	24	9	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129064	10.1371/journal.pone.0129064	http://dx.doi.org/10.1371/journal.pone.0129064			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053951	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300081
J	Mohapatra, SK; Sandhu, A; Singh, KP; Singla, SK; Chauhan, MS; Manik, R; Palta, P				Mohapatra, Sushil Kumar; Sandhu, Anjit; Singh, Karn Pratap; Singla, Suresh Kumar; Chauhan, Manmohan Singh; Manik, Radheysham; Palta, Prabhat			Establishment of Trophectoderm Cell Lines from Buffalo (Bubalus bubalis) Embryos of Different Sources and Examination of In Vitro Developmental Competence, Quality, Epigenetic Status and Gene Expression in Cloned Embryos Derived from Them	PLOS ONE			English	Article							INTERFERON-TAU EXPRESSION; MESSENGER-RNA EXPRESSION; NUCLEAR TRANSFER; BOVINE EMBRYOS; BLASTOCYSTS; SECRETION; CULTURE; VIVO; PATTERN; MOUSE	Despite being successfully used to produce live offspring in many species, somatic cell nuclear transfer (NT) has had a limited applicability due to very low (>1%) live birth rate because of a high incidence of pregnancy failure, which is mainly due to placental dysfunction. Since this may be due to abnormalities in the trophectoderm (TE) cell lineage, TE cells can be a model to understand the placental growth disorders seen after NT. We isolated and characterized buffalo TE cells from blastocysts produced by in vitro fertilization (TE-IVF) and Hand-made cloning (TE-HMC), and compared their growth characteristics and gene expression, and developed a feeder-free culture system for their long-term culture. The TE-IVF cells were then used as donor cells to produce HMC embryos following which their developmental competence, quality, epigenetic status and gene expression were compared with those of HMC embryos produced using fetal or adult fibroblasts as donor cells. We found that although TE-HMC and TE-IVF cells have a similar capability to grow in culture, significant differences exist in gene expression levels between them and between IVF and HMC embryos from which they are derived, which may have a role in the placental abnormalities associated with NT pregnancies. Although TE cells can be used as donor cells for producing HMC blastocysts, their developmental competence and quality is lower than that of blastocysts produced from fetal or adult fibroblasts. The epigenetic status and expression level of many important genes is different in HMC blastocysts produced using TE cells or fetal or adult fibroblasts or those produced by IVF.	[Mohapatra, Sushil Kumar; Sandhu, Anjit; Singh, Karn Pratap; Singla, Suresh Kumar; Chauhan, Manmohan Singh; Manik, Radheysham; Palta, Prabhat] Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute	Palta, P (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Karnal, India.	prabhatpalta@yahoo.com	Singh, Karn Pratap/AAW-8398-2021	MOHAPATRA, SUSHIL KUMAR/0000-0003-1416-4359	National Agriculture Innovative Project (NAIP) [C2-1-(5)/2007, C-2067, 075]; Dept. of Biotechnology, Ministry of Science and Technology, Govt. of India; ICAR-SRF; CSIR-SRF	National Agriculture Innovative Project (NAIP); Dept. of Biotechnology, Ministry of Science and Technology, Govt. of India; ICAR-SRF; CSIR-SRF(Council of Scientific & Industrial Research (CSIR) - India)	The present work was funded partly by National Agriculture Innovative Project (NAIP) grant to S.K.S. (C2-1-(5)/2007) and M.S.C. (C-2067 and 075), and partly by the Dept. of Biotechnology, Ministry of Science and Technology, Govt. of India. S.K.M. and A.S. are recipients of ICAR-SRF and CSIR-SRF, respectively.	Arnold DR, 2006, REPRODUCTION, V132, P279, DOI 10.1530/rep.1.01217; Bai H, 2013, J REPROD DEVELOP, V59, P1, DOI 10.1262/jrd.2012-100; Bai H, 2011, J REPROD DEVELOP, V57, P518, DOI 10.1262/jrd.10-186K; Bazer FW, 1997, AM J REPROD IMMUNOL, V37, P412; Chavatte-Palmer P, 2012, PLACENTA, V33, pS99, DOI 10.1016/j.placenta.2011.09.012; Chen TP, 2004, CURR TOP DEV BIOL, V60, P55; Constant F, 2006, BIOL REPROD, V75, P122, DOI 10.1095/biolreprod.106.051581; Das P, 2008, MOL ENDOCRINOL, V22, P331, DOI 10.1210/me.2007-0300; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; FARIA TN, 1991, ENDOCRINOLOGY, V129, P2895, DOI 10.1210/endo-129-6-2895; FLECHON JE, 1995, PLACENTA, V16, P643, DOI 10.1016/0143-4004(95)90033-0; Fletcher CJ, 2007, REPRODUCTION, V133, P243, DOI 10.1530/rep.1.01203; George A, 2011, CELL REPROGRAM, V13, P263, DOI 10.1089/cell.2010.0094; Golding MC, 2011, MOL REPROD DEV, V78, P306, DOI 10.1002/mrd.21306; Golla K, 2012, REPROD DOMEST ANIM, V47, P842, DOI 10.1111/j.1439-0531.2011.01978.x; HERNANDEZLEDEZMA JJ, 1992, BIOL REPROD, V47, P374, DOI 10.1095/biolreprod47.3.374; Kim MS, 2013, ASIAN AUSTRAL J ANIM, V26, P638, DOI 10.5713/ajas.2012.12462; Kubisch HM, 2003, MOL REPROD DEV, V64, P79, DOI 10.1002/mrd.10211; Kubisch HM, 2001, ANIM REPROD SCI, V66, P1, DOI 10.1016/S0378-4320(01)00086-0; Laurincik J, 2007, ADV EXP MED BIOL, V591, P84; Li RH, 1996, HUM REPROD, V11, P1328; Miyazaki H, 2002, PLACENTA, V23, P613, DOI 10.1053/plac.2002.0846; Neira JA, 2007, REPROD DOMEST ANIM, V42, P68, DOI 10.1111/j.1439-0531.2006.00732.x; Novakovic B, 2010, J BIOL CHEM, V285, P9583, DOI 10.1074/jbc.M109.064956; Odiatis C, 2010, PLACENTA, V31, P630, DOI 10.1016/j.placenta.2010.05.001; Panarace M, 2007, THERIOGENOLOGY, V67, P142, DOI 10.1016/j.theriogenology.2006.09.036; REIMA I, 1993, DIFFERENTIATION, V54, P35; Rizos D, 2002, BIOL REPROD, V66, P589, DOI 10.1095/biolreprod66.3.589; Saadeldin IM, 2012, J REPROD DEVELOP, V58, P425, DOI 10.1262/jrd.11-112H; Saadeldin IM, 2011, THERIOGENOLOGY, V75, P995, DOI 10.1016/j.theriogenology.2010.11.006; Schiffmacher AT, 2013, MOL REPROD DEV, V80, P826, DOI 10.1002/mrd.22212; Selokar NL, 2012, THERIOGENOLOGY, V78, P930, DOI 10.1016/j.theriogenology.2012.03.018; Selokar NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090755; Selokar NL, 2012, CELL REPROGRAM, V14, P146, DOI 10.1089/cell.2011.0076; Shah RA, 2009, THERIOGENOLOGY, V71, P1215, DOI 10.1016/j.theriogenology.2008.10.004; Sharma R, 2012, REPROD FERT DEVELOP, V24, P1098, DOI 10.1071/RD11298; Sharma R, 2011, CELL REPROGRAM, V13, P539, DOI 10.1089/cell.2011.0041; Shimada A, 2001, PLACENTA, V22, P652, DOI 10.1053/plac.2001.0702; Stojkovic M, 1999, ANIM REPROD SCI, V55, P151, DOI 10.1016/S0378-4320(99)00015-9; Szafranska B, 2007, ANIM REPROD SCI, V99, P269, DOI 10.1016/j.anireprosci.2006.05.012; Talbot NC, 2000, BIOL REPROD, V62, P235, DOI 10.1095/biolreprod62.2.235; Talbot NC, 2008, MOL REPROD DEV, V75, P299, DOI 10.1002/mrd.20741; Talbot NC, 2007, IN VITRO CELL DEV-AN, V43, P59, DOI 10.1007/s11626-007-9013-9; Talbot NC, 2010, ANIM REPROD SCI, V120, P187, DOI 10.1016/j.anireprosci.2010.03.009; Tsunoda Y, 1998, J REPROD FERTIL, V113, P181, DOI 10.1530/jrf.0.1130181; Ushizawa K, 2005, J REPROD DEVELOP, V51, P211, DOI 10.1262/jrd.16072; Wrenzycki C, 2001, BIOL REPROD, V65, P309, DOI 10.1095/biolreprod65.1.309; Yao N, 2009, REPROD DOMEST ANIM, V44, P132, DOI 10.1111/j.1439-0531.2007.01009.x	48	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129235	10.1371/journal.pone.0129235	http://dx.doi.org/10.1371/journal.pone.0129235			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053554	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300103
J	Tsai, MC; Chen, CH; Lee, HC; Lin, HC; Lee, CZ				Tsai, Ming-Chieh; Chen, Chao-Hung; Lee, Hsin-Chien; Lin, Herng-Ching; Lee, Cha-Ze			Increased Risk of Depressive Disorder following Cholecystectomy for Gallstones	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; QUALITY-OF-LIFE; LAPAROSCOPIC CHOLECYSTECTOMY; INSULIN-RESISTANCE; POSTCHOLECYSTECTOMY; SYMPTOMS; EPIDEMIOLOGY; PREVALENCE; DISEASE; PAIN	Background Prior studies indicate a possible association between depression and cholecystectomy, but no study has compared the risk of post-operative depressive disorders (DD) after cholecystectomy. This retrospective follow-up study aimed to examine the relationship between cholecystectomy and the risk of DD in patients with gallstones in a population-based database. Methods Using ambulatory care data from the Longitudinal Health Insurance Database 2000, 6755 patients who received a first-time principal diagnosis of gallstones at the emergency room (ER) were identified. Among them, 1197 underwent cholecystectomy. Each patient was then individually followed-up for two years to identify those who were later diagnosed with DD. Cox proportional hazards regressions were performed to estimate the risk of developing DD between patients with gallstone who did and those who did not undergo cholecystectomy. Results Of 6755 patients with gallstones, 173 (2.56%) were diagnosed with DD during the two-year follow-up. Among patients who did and those who did not undergo cholecystectomy, 3.51% and 2.36% later developed depressive disorder, respectively. After adjusting for the patient's sex, age and geographic location, the hazard ratio (HR) of DD within two years of gallstone diagnosis was 1.43 (95% CI, 1.02-2.04) for patients who underwent cholecystectomy compared to those who did not. Females, but not males, had a higher the adjusted HR of DD (1.61; 95% CI, 1.08-2.41) for patients who underwent cholecystectomy compared to those who did not. Conclusions There is an association between cholecystectomy and subsequent risk of DD among females, but not in males.	[Tsai, Ming-Chieh] Cathay Gen Hosp, Div Gastroenterol, Dept Internal Med, Taipei, Taiwan; [Tsai, Ming-Chieh; Lin, Herng-Ching] Taipei Med Univ, Sch Hlth Care Adm, Taipei, Taiwan; [Chen, Chao-Hung] Mackay Jr Coll Med Nursing & Management, Dept Cosmet Applicat & Management, Taipei, Taiwan; [Chen, Chao-Hung] MacKay Mem Hosp, Dept Thorac Surg, Taipei, Taiwan; [Lee, Hsin-Chien; Lin, Herng-Ching] Taipei Med Univ Hosp, Sleep Res Ctr, Taipei, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ Hosp, Dept Psychiat, Taipei, Taiwan; [Lee, Cha-Ze] Natl Taiwan Univ Hosp & Coll Med, Dept Internal Med, Taipei, Taiwan	Cathay General Hospital; Taipei Medical University; Mackay Junior College of Medicine, Nursing & Management; Mackay Memorial Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; National Taiwan University; National Taiwan University Hospital	Lee, CZ (corresponding author), Natl Taiwan Univ Hosp & Coll Med, Dept Internal Med, Taipei, Taiwan.	czl@ntu.edu.tw		lee, hsin-chien/0000-0002-7557-8259				Asghar S., 2012, INT J CLIN MED, V3, P7, DOI [10.4236/ijcm.2012.37104, DOI 10.4236/IJCM.2012.37104]; BARKER MG, 1968, BRIT MED J, V2, P91, DOI 10.1136/bmj.2.5597.91; Brawman-Mintzer O, 2014, AM J GASTROENTEROL, V109, P436, DOI 10.1038/ajg.2013.467; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Girometti R, 2010, BRIT J RADIOL, V83, P351, DOI 10.1259/bjr/99865290; Hsueh LN, 2011, KAOHSIUNG J MED SCI, V27, P280, DOI 10.1016/j.kjms.2011.03.002; Huang J, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-63; Jaunoo SS, 2010, INT J SURG, V8, P15, DOI 10.1016/j.ijsu.2009.10.008; JORGENSEN T, 1991, SCAND J GASTROENTERO, V26, P124, DOI 10.3109/00365529108996493; Kahokehr A, 2012, SURG ENDOSC, V26, P1730, DOI 10.1007/s00464-011-2101-7; Kang JH, 2010, ANN RHEUM DIS, V69, P1165, DOI 10.1136/ard.2009.116178; Kemp JA, 2008, J AM COLL SURGEONS, V206, P28, DOI 10.1016/j.jamcollsurg.2007.06.289; Levy RL, 2006, GASTROENTEROLOGY, V130, P1447, DOI 10.1053/j.gastro.2005.11.057; Liao SC, 2012, PSYCHOL MED, V42, P1227, DOI 10.1017/S0033291711002364; Lien HH, 2010, J GASTROINTEST SURG, V14, P126, DOI 10.1007/s11605-009-1062-9; Lorusso D, 2003, SCAND J GASTROENTERO, V38, P653, DOI 10.1080/00365520310002995; LOWENFELS AB, 1992, SCAND J GASTROENTERO, V27, P984, DOI 10.3109/00365529209000175; Luman W, 1996, GUT, V39, P863, DOI 10.1136/gut.39.6.863; MCCARTY MF, 1994, MED HYPOTHESES, V43, P247, DOI 10.1016/0306-9877(94)90075-2; MCMAHON AJ, 1995, BRIT J SURG, V82, P1378, DOI 10.1002/bjs.1800821028; Mertens MC, 2009, J GASTROINTEST SURG, V13, P304, DOI 10.1007/s11605-008-0718-1; Mertz HR, 2003, NEW ENGL J MED, V349, P2136, DOI 10.1056/NEJMra035579; Nilsson E, 2004, INT J QUAL HEALTH C, V16, P473, DOI 10.1093/intqhc/mzh077; Palsson SH, 2015, SCAND J GASTROENTERO, V50, P211, DOI 10.3109/00365521.2014.978818; Parkman HP, 2013, DIGEST DIS SCI, V58, P1062, DOI 10.1007/s10620-013-2596-y; Pearson S, 2010, DIABETES CARE, V33, P1128, DOI 10.2337/dc09-1940; Rahman Ganiyu A, 2005, J Natl Med Assoc, V97, P1534; Ramasubbu R, 2002, MED HYPOTHESES, V59, P537, DOI 10.1016/S0306-9877(02)00244-X; ROS E, 1987, GUT, V28, P1500, DOI 10.1136/gut.28.11.1500; Ruhi CE, 2013, AM J GASTROENTEROL, V108, P952, DOI [10.1038/ajg.2013.70, DOI 10.1038/AJG.2013.70]; Schmidt M, 2012, WORLD J GASTROENTERO, V18, P1365, DOI 10.3748/wjg.v18.i12.1365; Schoenemann J, 1997, Z GASTROENTEROL, V35, P139; Schofer JM, 2010, J EMERG MED, V39, P406, DOI 10.1016/j.jemermed.2007.11.090; Scriven M W, 1993, J R Coll Surg Edinb, V38, P79; Sehlo GM, 2010, CURR PSYCHIAT, V17, P1; Shen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088189; Shi HY, 2009, J GASTROINTEST SURG, V13, P1651, DOI 10.1007/s11605-009-0962-z; Stefaniak T, 2004, SCAND J GASTROENTERO, V39, P127, DOI 10.1080/00365520310007990; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; VANDERVELPEN GC, 1993, GUT, V34, P1448, DOI 10.1136/gut.34.10.1448; Weinert CR, 2000, ARCH INTERN MED, V160, P989, DOI 10.1001/archinte.160.7.989; Weissman MM, 1996, JAMA-J AM MED ASSOC, V276, P293, DOI 10.1001/jama.276.4.293; WOMACK NA, 1947, ANN SURG, V126, P31, DOI 10.1097/00000658-194707000-00004	45	7	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129962	10.1371/journal.pone.0129962	http://dx.doi.org/10.1371/journal.pone.0129962			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053886	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300172
J	Umeki, D; Ohnuki, Y; Mototani, Y; Shiozawa, K; Suita, K; Fujita, T; Nakamura, Y; Saeki, Y; Okumura, S				Umeki, Daisuke; Ohnuki, Yoshiki; Mototani, Yasumasa; Shiozawa, Kouichi; Suita, Kenji; Fujita, Takayuki; Nakamura, Yoshiki; Saeki, Yasutake; Okumura, Satoshi			Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED ATROPHY; SKELETAL-MUSCLE; CYCLOSPORINE-A; RAT GROWTH; HEART-RATE; HYPERTROPHY; DISRUPTION; EXPRESSION; RAPAMYCIN; RECEPTOR	Background Glucocorticoid has a direct catabolic effect on skeletal muscle, leading to muscle atrophy, but no effective pharmacotherapy is available. We reported that clenbuterol (CB) induced masseter muscle hypertrophy and slow-to-fast myosin heavy chain (MHC) isoform transition through direct muscle beta 2-adrenergic receptor stimulation. Thus, we hypothesized that CB would antagonize glucocorticoid (dexamethasone; DEX)-induced muscle atrophy and fast-to-slow MHC isoform transition. Methodology We examined the effect of CB on DEX-induced masseter muscle atrophy by measuring masseter muscle weight, fiber diameter, cross-sectional area, and myosin heavy chain (MHC) composition. To elucidate the mechanisms involved, we used immunoblotting to study the effects of CB on muscle hypertrophic signaling (insulin growth factor 1 (IGF1) expression, Akt/mammalian target of rapamycin (mTOR) pathway, and calcineurin pathway) and atrophic signaling (Akt/Forkhead box-O (FOXO) pathway and myostatin expression) in masseter muscle of rats treated with DEX and/or CB. Results and Conclusion Masseter muscle weight in the DEX-treated group was significantly lower than that in the Control group, as expected, but co-treatment with CB suppressed the DEX-induced masseter muscle atrophy, concomitantly with inhibition of fast-to-slow MHC isoforms transition. Activation of the Akt/mTOR pathway in masseter muscle of the DEX-treated group was significantly inhibited compared to that of the Control group, and CB suppressed this inhibition. DEX also suppressed expression of IGF1 (positive regulator of muscle growth), and CB attenuated this inhibition. Myostatin protein expression was unchanged. CB had no effect on activation of the Akt/FOXO pathway. These results indicate that CB antagonizes DEX-induced muscle atrophy and fast-to-slow MHC isoform transition via modulation of Akt/mTOR activity and IGF1 expression. CB might be a useful pharmacological agent for treatment of glucocorticoid-induced muscle atrophy.	[Umeki, Daisuke; Ohnuki, Yoshiki; Mototani, Yasumasa; Shiozawa, Kouichi; Saeki, Yasutake; Okumura, Satoshi] Tsurumi Univ, Sch Dent Med, Dept Physiol, Yokohama, Kanagawa 2308501, Japan; [Umeki, Daisuke; Nakamura, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Orthodont, Yokohama, Kanagawa 2308501, Japan; [Suita, Kenji; Fujita, Takayuki; Okumura, Satoshi] Yokohama City Univ, Grad Sch Med, Cardiovasc Res Inst, Yokohama, Kanagawa 2360004, Japan	Tsurumi University; Tsurumi University; Yokohama City University	Okumura, S (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Physiol, Yokohama, Kanagawa 2308501, Japan.	okumura-s@tsurumi-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [26861803, 22791147, 24790219, 25460296, 23593052, 23591087]; Takeda Science Foundation; Yokohama Foundation for Advancement of Medical Science; Yokohama Academic Foundation; Research Foundation for Community Medicine; Suzuken Memorial Foundation [14-014];  [22136009]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yokohama Foundation for Advancement of Medical Science; Yokohama Academic Foundation; Research Foundation for Community Medicine; Suzuken Memorial Foundation; 	This study was supported in part by grants from a Grant-in-Aid for Scientific Research on Innovative Areas (22136009: Dr. Okumura), and grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology [Drs. Umeki (26861803), Mototani (22791147), Suita (24790219), Fujita (25460296), Nakamura (23593052), Okumura (23591087)], Takeda Science Foundation (Dr. Okumura), Yokohama Foundation for Advancement of Medical Science (Dr. Okumura), Yokohama Academic Foundation (Dr. Ohnuki), Research Foundation for Community Medicine (Dr. Okumura), and Suzuken Memorial Foundation (14-014: Dr. Okumura).	Abo T, 2012, CELL BIOCHEM FUNCT, V30, P671, DOI 10.1002/cbf.2848; AGBENYEGA ET, 1992, COMP BIOCHEM PHYS A, V102, P141, DOI 10.1016/0300-9629(92)90026-M; Arai C, 2005, JPN J PHYSIOL, V55, P173, DOI 10.2170/jjphysiol.R2123; Arai C, 2006, J PHYSIOL SCI, V56, P205, DOI 10.2170/physiolsci.RP002206; Bai YZ, 2012, J PHARMACOL SCI, V119, P381, DOI 10.1254/jphs.12102FP; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Dasarathy S, 2004, AM J PHYSIOL-GASTR L, V287, pG1124, DOI 10.1152/ajpgi.00202.2004; Delling U, 2000, MOL CELL BIOL, V20, P6600, DOI 10.1128/MCB.20.17.6600-6611.2000; Deyl Z, 1975, Adv Exp Med Biol, V53, P359; Feng Q, 2014, BRAIN RES, V1589, P37, DOI 10.1016/j.brainres.2014.09.029; Fuentes EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044256; Huang H, 2000, J ANIM SCI, V78, P604; Jiang TX, 1996, AM J RESP CRIT CARE, V154, P1778, DOI 10.1164/ajrccm.154.6.8970370; Kamide T, 2015, J PHYSIOL SCI, V65, P195, DOI 10.1007/s12576-014-0354-3; Kawakami E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064719; KILIARIDIS S, 1988, ARCH ORAL BIOL, V33, P187, DOI 10.1016/0003-9969(88)90044-1; Latres E, 2005, J BIOL CHEM, V280, P2737, DOI 10.1074/jbc.M407517200; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Macedo AG, 2014, J STEROID BIOCHEM, V143, P357, DOI 10.1016/j.jsbmb.2014.05.010; MCELLIGOTT MA, 1989, COMP BIOCHEM PHYS C, V92, P135, DOI 10.1016/0742-8413(89)90215-6; MILLER MF, 1988, J ANIM SCI, V66, P12, DOI 10.2527/jas1988.66112x; MOORE NG, 1994, AM J PHYSIOL, V267, pE475, DOI 10.1152/ajpendo.1994.267.3.E475; Nakamura S, 2013, J ORAL REHABIL, V40, P205, DOI 10.1111/joor.12030; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Oddera S, 1998, RESPIRATION, V65, P199, DOI 10.1159/000029260; Ohnuki Y, 2014, J PHYSIOL-LONDON, V592, P5461, DOI 10.1113/jphysiol.2014.282996; Ohnuki Y, 2013, J PHARMACOL SCI, V123, P36, DOI 10.1254/jphs.12271FP; Ohnuki Y, 2009, ARCH ORAL BIOL, V54, P783, DOI 10.1016/j.archoralbio.2009.05.008; Okumura S, 2003, P NATL ACAD SCI USA, V100, P9986, DOI 10.1073/pnas.1733772100; Okumura S, 2003, CIRC RES, V93, P364, DOI 10.1161/01.RES.0000086986.35568.63; Okumura S, 2008, J APPL PHYSIOL, V105, P173, DOI 10.1152/japplphysiol.01166.2007; Okumura S, 2014, J CLIN INVEST, V124, P2785, DOI 10.1172/JCI64784; Okumura S, 2009, J PHARMACOL SCI, V109, P354, DOI 10.1254/jphs.08R26FM; Pang LH, 2000, AM J RESP CELL MOL, V23, P79, DOI 10.1165/ajrcmb.23.1.3985; Pellegrino MA, 2004, EXP PHYSIOL, V89, P89, DOI 10.1113/expphysiol.2003.002609; PETERS MJ, 1995, EUR J PHARM-MOLEC PH, V289, P275, DOI 10.1016/0922-4106(95)90104-3; Ricart-Firinga C, 2000, AM J PHYSIOL-CELL PH, V278, pC582, DOI 10.1152/ajpcell.2000.278.3.C582; Pereira RMR, 2011, JOINT BONE SPINE, V78, P41, DOI 10.1016/j.jbspin.2010.02.025; ROY RR, 1983, ARCH ORAL BIOL, V28, P639, DOI 10.1016/0003-9969(83)90012-2; Rozengurt E, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00357; Sacheck JM, 2004, AM J PHYSIOL-ENDOC M, V287, pE591, DOI 10.1152/ajpendo.00073.2004; Schakman O, 2013, INT J BIOCHEM CELL B, V45, P2163, DOI 10.1016/j.biocel.2013.05.036; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Shimizu N, 2011, CELL METAB, V13, P170, DOI 10.1016/j.cmet.2011.01.001; Stevens L, 2000, AM J PHYSIOL-CELL PH, V279, pC1558, DOI 10.1152/ajpcell.2000.279.5.C1558; Taylor DR, 2000, THORAX, V55, P595, DOI 10.1136/thorax.55.7.595; TUCKER MJ, 1979, INT J CANCER, V23, P803, DOI 10.1002/ijc.2910230611; Umeki D, 2013, J PHARMACOL SCI, V122, P278, DOI 10.1254/jphs.12195FP; Yu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020334	49	27	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128263	10.1371/journal.pone.0128263	http://dx.doi.org/10.1371/journal.pone.0128263			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053620	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300026
J	Vollbrecht, C; Mairinger, FD; Koitzsch, U; Peifer, M; Koenig, K; Heukamp, LC; Crispatzu, G; Wilden, L; Kreuzer, KA; Hallek, M; Odenthal, M; Herling, CD; Buettner, R				Vollbrecht, Claudia; Mairinger, Fabian Dominik; Koitzsch, Ulrike; Peifer, Martin; Koenig, Katharina; Heukamp, Lukas Carl; Crispatzu, Giuliano; Wilden, Laura; Kreuzer, Karl-Anton; Hallek, Michael; Odenthal, Margarete; Herling, Carmen Diana; Buettner, Reinhard			Comprehensive Analysis of Disease-Related Genes in Chronic Lymphocytic Leukemia by Multiplex PCR-Based Next Generation Sequencing	PLOS ONE			English	Article							SF3B1 MUTATIONS; HIGH-THROUGHPUT; ATM GENE; NOTCH1; TP53; SURVIVAL; RESISTANCE; EVOLUTION; ALIGNMENT; IDENTIFY	Background High resolution molecular studies have demonstrated that the clonal acquisition of gene mutations is an important mechanism that may promote rapid disease progression and drug resistance in chronic lymphocytic leukemia (CLL). Therefore, the early and sensitive detection of such mutations is an important prerequisite for future predictive CLL diagnostics in the clinical setting. Material & Methods Here, we describe a novel, target-specific next generation sequencing (NGS) approach, which combines multiplex PCR-based target enrichment and library generation with ultradeep high-throughput parallel sequencing using a MiSeq platform. We designed a CLL specific target panel, covering hotspots or complete coding regions of 15 genes known to be recurrently mutated and/or related to B-cell receptor signaling. Results High-throughput sequencing was performed using as little as 40 ng of peripheral blood B-cell DNA from 136 CLL patients and a dilution series of two ATM- or TP53-mutated cell lines, the latter of which demonstrated a limit of mutation detection below 5%. Using a stringent functional assessment algorithm, 102 mutations in 8 genes were identified in CLL patients, including hotspot regions of TP53, SF3B1, NOTCH1, ATM, XPO1, MYD88, DDX3X and the B- cell receptor signaling regulator PTPN6. The presence of mutations was significantly associated with an advanced disease status und molecular markers of an inferior prognosis, such as an unmutated IGHV mutation status or positivity for ZAP70 by flow cytometry. Conclusion In summary, targeted sequencing using an amplicon based library technology allows a resource- efficient and sensitive mutation analysis for diagnostic or exploratory purposes and facilitates molecular subtyping of patient sets with adverse prognosis.	[Vollbrecht, Claudia; Koitzsch, Ulrike; Koenig, Katharina; Heukamp, Lukas Carl; Odenthal, Margarete; Buettner, Reinhard] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Vollbrecht, Claudia; Koitzsch, Ulrike; Koenig, Katharina; Heukamp, Lukas Carl; Crispatzu, Giuliano; Wilden, Laura; Kreuzer, Karl-Anton; Hallek, Michael; Odenthal, Margarete; Herling, Carmen Diana; Buettner, Reinhard] Univ Hosp Cologne, CIO Cologne Bonn, Cologne, Germany; [Vollbrecht, Claudia; Koitzsch, Ulrike; Peifer, Martin; Koenig, Katharina; Odenthal, Margarete; Buettner, Reinhard] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Mairinger, Fabian Dominik] Univ Duisburg Essen, Univ Hosp Essen, Inst Pathol, Essen, Germany; [Peifer, Martin] Univ Cologne, Cologne Ctr Gen, Dept Translat Gen, D-50931 Cologne, Germany; [Crispatzu, Giuliano; Wilden, Laura; Kreuzer, Karl-Anton; Hallek, Michael; Herling, Carmen Diana] Univ Hosp Cologne, Dept Internal Med, Cologne, Germany; [Crispatzu, Giuliano] Univ Cologne, Excellence Cluster Cellular Stress Response & Agi, D-50931 Cologne, Germany	University of Cologne; University of Cologne; University of Cologne; University of Duisburg Essen; University of Cologne; University of Cologne; University of Cologne	Herling, CD (corresponding author), Univ Hosp Cologne, CIO Cologne Bonn, Cologne, Germany.	carmen.herling@uk-koeln.de; reinhard.buettner@uk-koeln.de	Hallek, Michael/Y-3191-2019; Heukamp, Lukas/G-9967-2012; Hatzis, Christos/M-3867-2015	Hallek, Michael/0000-0002-7425-4455; Peifer, Martin/0000-0002-5243-5503; Heukamp, Lukas/0000-0002-3388-3482; Hatzis, Christos/0000-0002-8120-2290; Crispatzu, Giuliano/0000-0001-8041-2125; Mairinger, Fabian/0000-0003-1067-0051; Vollbrecht, Claudia/0000-0002-0861-001X	Deutsche Forschungsgemeinschaft [KFO 286]; German Cancer AID (Onkologisches Spitzenzentrum Koln-Bonn)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Cancer AID (Onkologisches Spitzenzentrum Koln-Bonn)	This study was supported by the Deutsche Forschungsgemeinschaft (KFO 286, Speaker MH) to RB, KAK, CDH, and by the German Cancer AID (Onkologisches Spitzenzentrum Koln-Bonn).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Austen B, 2005, BLOOD, V106, P3175, DOI 10.1182/blood-2004-11-4516; Baliakas P, 2015, LEUKEMIA, V29, P329, DOI 10.1038/leu.2014.196; Bhagwat M., 2012, CURR PROTOC BIOINFOR, V10, DOI [10.1002/0471250953.bi1008s37, DOI 10.1002/0471250953.BI1008S37]; Chang FQ, 2013, CANCER GENET-NY, V206, P413, DOI 10.1016/j.cancergen.2013.10.003; Cortese D, 2014, LEUKEMIA, V28, P710, DOI 10.1038/leu.2013.333; Cramer P, 2011, NAT REV CLIN ONCOL, V8, P38, DOI 10.1038/nrclinonc.2010.167; Dighiero G, 2008, LANCET, V371, P1017, DOI 10.1016/S0140-6736(08)60456-0; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Gruber M, 2014, SEMIN HEMATOL, V51, P177, DOI 10.1053/j.seminhematol.2014.05.004; Gunnarsson R, 2013, LEUKEMIA LYMPHOMA, V54, P1583, DOI 10.3109/10428194.2012.751530; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Jeromin S, 2014, LEUKEMIA, V28, P108, DOI 10.1038/leu.2013.263; Jethwa A, 2013, BRIT J HAEMATOL, V163, P496, DOI 10.1111/bjh.12539; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lai R, 2002, LEUKEMIA RES, V26, P849, DOI 10.1016/S0145-2126(02)00013-9; Landau DA, 2014, LEUKEMIA, V28, P34, DOI 10.1038/leu.2013.248; Landau DA, 2013, GENOME MED, V5, DOI 10.1186/gm451; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Magliozzi M, 2006, DIS MARKERS, V22, P257, DOI 10.1155/2006/740493; Malecki MJ, 2006, MOL CELL BIOL, V26, P4642, DOI 10.1128/MCB.01655-05; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rossi D, 2012, BLOOD, V119, P2854, DOI 10.1182/blood-2011-12-395673; Rossi D, 2012, BLOOD, V119, P521, DOI 10.1182/blood-2011-09-379966; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Schweighofer CD, 2011, INT J CANCER, V128, P2759, DOI 10.1002/ijc.25605; Sutton LA, 2015, HAEMATOLOGICA, V100, P370, DOI 10.3324/haematol.2014.109777; Thompson AA, 1997, BLOOD, V90, P1387, DOI 10.1182/blood.V90.4.1387.1387_1387_1394; Tibaldi E, 2011, LEUKEMIA, V25, P1768, DOI 10.1038/leu.2011.152; Villamor N, 2013, LEUKEMIA, V27, P1100, DOI 10.1038/leu.2012.357; Villamor N, 2013, SEMIN HEMATOL, V50, P286, DOI 10.1053/j.seminhematol.2013.09.005; Wan YZ, 2013, BLOOD, V121, P4627, DOI 10.1182/blood-2013-02-427641; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Woyach JA, 2014, NEW ENGL J MED, V370, P2286, DOI 10.1056/NEJMoa1400029; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Zenz T, 2010, J CLIN ONCOL, V28, P4473, DOI 10.1200/JCO.2009.27.8762	42	21	22	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129544	10.1371/journal.pone.0129544	http://dx.doi.org/10.1371/journal.pone.0129544			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053404	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300141
J	Chen, YY; Wang, JP; Jiang, YY; Li, H; Hu, YH; Lee, KO; Li, GW				Chen, Yan Yan; Wang, Jin Ping; Jiang, Ya Yun; Li, Hui; Hu, Ying Hua; Lee, Kok Onn; Li, Guang Wei			Fasting Plasma Insulin at 5 Years of Age Predicted Subsequent Weight Increase in Early Childhood over a 5-Year Period-The Da Qing Children Cohort Study	PLOS ONE			English	Article							BODY-MASS INDEX; METABOLIC-SYNDROME; RESISTANCE; OBESITY; RISK; HYPERINSULINEMIA; GAIN; SENSITIVITY; OVERWEIGHT; ADIPOSITY	Background The association between hyperinsulinemia and obesity is well known. However, it is uncertain especially in childhood obesity, if initial fasting hyperinsulinemia predicts obesity, or obesity leads to hyperinsulinemia through insulin resistance. Objective To investigate the predictive effect of fasting plasma insulin on subsequent weight change after a 5-year interval in childhood. Methods 424 Children from Da Qing city, China, were recruited at 5 years of age and followed up for 5 years. Blood pressure, anthropometric measurements, fasting plasma insulin, glucose and triglycerides were measured at baseline and 5 years later. Results Fasting plasma insulin at 5 years of age was significantly correlated with change of weight from 5 to 10 years (Delta Weight). Children in the lowest insulin quartile had Delta Weight of 13.08 +/- 0.73 kg compare to 18.39 +/- 0.86 in the highest insulin quartile (P<0.0001) in boys, and similarly 12.03 +/- 0.71 vs 15.80 +/- 0.60 kg (P<0.0001) in girls. Multivariate analysis showed that the predictive effect of insulin at 5 years of age on subsequent weight gain over 5 years remained statistically significant even after the adjustment for age, sex, birth weight, TV-viewing time and weight (or body mass index) at baseline. By contrast, the initial weight at 5 years of age did not predict subsequent changes in insulin level 5 years later. Children who had both higher fasting insulin and weight at 5 years of age showed much higher levels of systolic blood pressures, fasting plasma glucose, the homeostasis model assessment for insulin resistance (HOMA-IR) and triglycerides at 10 years of age. Conclusions Fasting plasma insulin at 5 years of age predicts weight gain and cardiovascular risk factors 5 year later in Chinese children of early childhood, but the absolute weight at 5 years of age did not predict subsequent change in fasting insulin.	[Chen, Yan Yan; Li, Guang Wei] Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Endocrinol & Cardiovasc Dis Ctr, Fuwai Hosp, Beijing 100730, Peoples R China; [Chen, Yan Yan; Li, Guang Wei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Wang, Jin Ping; Jiang, Ya Yun; Li, Hui; Hu, Ying Hua] Da Qing First Hosp, Cardiol, Da Qing, Peoples R China; [Lee, Kok Onn] Natl Univ Singapore, Dept Med, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Li, Guang Wei] China Japan Friendship Hosp, Endocrinol, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; National University of Singapore; China-Japan Friendship Hospital	Chen, YY (corresponding author), Chinese Acad Med Sci, Natl Ctr Cardiovasc Dis, Endocrinol & Cardiovasc Dis Ctr, Fuwai Hosp, Beijing 100730, Peoples R China.	doc.yan@medmail.com.cn	Lee, Kok-Onn/E-9874-2011	Lee, Kok-Onn/0000-0002-3040-1185; Chen, Yanyan/0000-0002-4697-149X	Scientific Research Foundation of Ministry of Health of China [98-1-080]	Scientific Research Foundation of Ministry of Health of China	This work was supported by Grant 98-1-080 from the Scientific Research Foundation of Ministry of Health of China.	Adam TC, 2009, DIABETES CARE, V32, P2114, DOI 10.2337/dc09-0833; Anthony K, 2006, DIABETES, V55, P2986, DOI 10.2337/db06-0376; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Chen YY, 2011, PEDIATR RES, V70, P307, DOI 10.1203/PDR.0b013e318225f8a9; Folsom AR, 1996, AM J EPIDEMIOL, V144, P235, DOI 10.1093/oxfordjournals.aje.a008918; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Han JC, 2008, J PEDIATR-US, V152, P612, DOI 10.1016/j.jpeds.2007.12.036; Ji CY, 2009, INT J CARDIOL, V132, P1, DOI 10.1016/j.ijcard.2008.07.003; Johnson MS, 2001, J CLIN ENDOCR METAB, V86, P3182, DOI 10.1210/jc.86.7.3182; Labayen I, 2011, INT J OBESITY, V35, P1284, DOI 10.1038/ijo.2011.98; Li Hui, 2009, Zhonghua Er Ke Za Zhi, V47, P493; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Maffeis C, 2002, J CLIN ENDOCR METAB, V87, P71, DOI 10.1210/jc.87.1.71; Maffeis C, 2008, J CLIN ENDOCR METAB, V93, P2122, DOI 10.1210/jc.2007-2089; Matteis C, 2010, NUTR METAB CARDIOVAS, V20, P266, DOI 10.1016/j.numecd.2009.04.005; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; Morrison JA, 2008, AM J CLIN NUTR, V88, P778, DOI 10.1093/ajcn/88.3.778; Morrison JA, 2009, METABOLISM, V58, P290, DOI 10.1016/j.metabol.2008.09.027; NEEL JV, 1962, AM J HUM GENET, V14, P353; Odeleye OE, 1997, DIABETES, V46, P1341, DOI 10.2337/diabetes.46.8.1341; Powell LM, 2007, ARCH PEDIAT ADOL MED, V161, P553, DOI 10.1001/archpedi.161.6.553; Shaikh MG, 2008, EUR J ENDOCRINOL, V159, P791, DOI 10.1530/EJE-08-0533; Wedick NM, 2009, OBESITY, V17, P1609, DOI 10.1038/oby.2008.666; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942	25	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127389	10.1371/journal.pone.0127389	http://dx.doi.org/10.1371/journal.pone.0127389			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047327	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200020
J	Flemming, A; Huang, QQ; Jin, JP; Jumaa, H; Herzog, S				Flemming, Alexandra; Huang, Qi-Quan; Jin, Jian-Ping; Jumaa, Hassan; Herzog, Sebastian			A Conditional Knockout Mouse Model Reveals That Calponin-3 Is Dispensable for Early B Cell Development	PLOS ONE			English	Article							PRE-BCR; ACIDIC CALPONIN; SMOOTH-MUSCLE; RAT-BRAIN; ACTIN CYTOSKELETON; NONMUSCLE CELLS; LIGHT-CHAIN; H2-CALPONIN; EXPRESSION; RECEPTOR	Calponins form an evolutionary highly conserved family of actin filament-associated proteins expressed in both smooth muscle and non-muscle cells. Whereas calponin-1 and calponin- 2 have already been studied to some extent, little is known about the role of calponin3 under physiological conditions due to the lack of an appropriate animal model. Here, we have used an unbiased screen to identify novel proteins implicated in signal transduction downstream of the precursor B cell receptor (pre-BCR) in B cells. We find that calponin-3 is expressed throughout early B cell development, localizes to the plasma membrane and is phosphorylated in a Syk-dependent manner, suggesting a putative role in pre-BCR signaling. To investigate this in vivo, we generated a floxed calponin-3-GFP knock-in mouse model that enables tracking of cells expressing calponin-3 from its endogenous promoter and allows its tissue-specific deletion. Using the knock-in allele as a reporter, we show that calponin-3 expression is initiated in early B cells and increases with their maturation, peaking in the periphery. Surprisingly, conditional deletion of the Cnn3 revealed no gross defects in B cell development despite this regulated expression pattern and the in vitro evidence, raising the question whether other components may compensate for its loss in lymphocytes. Together, our work identifies calponin-3 as a putative novel mediator downstream of the pre-BCR. Beyond B cells, the mouse model we generated will help to increase our understanding of calponin-3 in muscle and non-muscle cells under physiological conditions.	[Flemming, Alexandra; Jumaa, Hassan; Herzog, Sebastian] Max Planck Inst Immunobiol & Epigenet, Dept Mol Immunol, Freiburg, Germany; [Flemming, Alexandra; Jumaa, Hassan; Herzog, Sebastian] Univ Freiburg, Fac Biol, Biol 3, D-79106 Freiburg, Germany; [Huang, Qi-Quan] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Jin, Jian-Ping] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Jumaa, Hassan; Herzog, Sebastian] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Herzog, Sebastian] Med Univ Innsbruck, Div Dev Immunol, A-6020 Innsbruck, Austria	Max Planck Society; University of Freiburg; Northwestern University; Feinberg School of Medicine; Wayne State University; University of Freiburg; Medical University of Innsbruck	Jumaa, H (corresponding author), Univ Clin Ulm, Inst Immunol, Ulm, Germany.	hassan.jumaa@uni-ulm.de; sebastian.herzog@i-med.ac.at	Jin, Jian-Ping/AAD-1149-2020	Jin, JP/0000-0001-9932-1063; Herzog, Sebastian/0000-0001-7167-3489	Deutsche Forschungsgemeinschaft (Centre for Biological Signalling Studies, BIOSS) [EXC294]; Deutsche Forschungsgemeinschaft through Transregio Grant [TRR130]	Deutsche Forschungsgemeinschaft (Centre for Biological Signalling Studies, BIOSS); Deutsche Forschungsgemeinschaft through Transregio Grant	This work was funded by the Deutsche Forschungsgemeinschaft Grant EXC294 (the Centre for Biological Signalling Studies, BIOSS) and through Transregio Grant TRR130 to HJ.	Agassandian C, 2000, BRAIN RES, V887, P444, DOI 10.1016/S0006-8993(00)03030-4; Appel S, 2010, MOL BIOL CELL, V21, P1409, DOI 10.1091/mbc.E09-06-0451; APPLEGATE D, 1994, J BIOL CHEM, V269, P10683; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Baba Y, 2001, P NATL ACAD SCI USA, V98, P2582, DOI 10.1073/pnas.051626198; Conley ME, 2000, IMMUNOL REV, V178, P75, DOI 10.1034/j.1600-065X.2000.17809.x; Daimon E, 2013, ARCH DERMATOL RES, V305, P571, DOI 10.1007/s00403-013-1343-8; Ferhat L, 1996, EUR J NEUROSCI, V8, P1501, DOI 10.1111/j.1460-9568.1996.tb01612.x; Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862; FUJII T, 1995, J BIOCHEM-TOKYO, V117, P999, DOI 10.1093/oxfordjournals.jbchem.a124833; Fukui Y, 1997, J DERMATOL SCI, V14, P29, DOI 10.1016/S0923-1811(96)00545-2; Geier JK, 2006, SEMIN IMMUNOL, V18, P31, DOI 10.1016/j.smim.2005.11.001; GIMONA M, 1992, EUR J BIOCHEM, V205, P1067, DOI 10.1111/j.1432-1033.1992.tb16875.x; Haag J, 2007, EXP CELL RES, V313, P3386, DOI 10.1016/j.yexcr.2007.08.003; Harwood NE, 2010, ANNU REV IMMUNOL, V28, P185, DOI 10.1146/annurev-immunol-030409-101216; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hossain MM, 2006, BIOCHEMISTRY-US, V45, P15670, DOI 10.1021/bi061718f; Huang QQ, 2008, J BIOL CHEM, V283, P25887, DOI 10.1074/jbc.M801163200; Jiang WR, 2014, J BIOL CHEM, V289, P1617, DOI 10.1074/jbc.M113.498147; Leinweber BD, 1999, BIOCHEM J, V344, P117, DOI 10.1042/0264-6021:3440117; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Matthew JD, 2000, J PHYSIOL-LONDON, V529, P811, DOI 10.1111/j.1469-7793.2000.00811.x; Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649; Plantier M, 1999, EUR J NEUROSCI, V11, P2801, DOI 10.1046/j.1460-9568.1999.00702.x; Rami G, 2006, HIPPOCAMPUS, V16, P183, DOI 10.1002/hipo.20145; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Rodriguez R, 2001, J BIOL CHEM, V276, P47982, DOI 10.1074/jbc.M107577200; Rolli V, 2002, MOL CELL, V10, P1057, DOI 10.1016/S1097-2765(02)00739-6; Rozenblum GT, 2008, INT J BIOCHEM CELL B, V40, P1990, DOI 10.1016/j.biocel.2007.07.010; Shibukawa Y, 2013, EXP CELL RES, V319, P633, DOI 10.1016/j.yexcr.2012.12.022; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; So L, 2012, BIOCHEM J, V442, P465, DOI 10.1042/BJ20112092; Su YW, 2003, J EXP MED, V198, P1699, DOI 10.1084/jem.20031428; Takahashi K, 2000, BIOCHEM BIOPH RES CO, V279, P150, DOI 10.1006/bbrc.2000.3909; Tang J, 2006, J BIOL CHEM, V281, P6664, DOI 10.1074/jbc.M506991200; TRABELSITERZIDIS H, 1995, BIOCHEM J, V306, P211, DOI 10.1042/bj3060211; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Winder SJ, 1998, ACTA PHYSIOL SCAND, V164, P415, DOI 10.1111/j.1365-201X.1998.tb10697.x; Wu KC, 2008, CELL BIOCHEM BIOPHYS, V52, P139, DOI 10.1007/s12013-008-9031-6; Yamamoto M, 2006, BLOOD, V108, P2703, DOI 10.1182/blood-2006-05-024968; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015; Yoshikawa H, 1998, GENES CELLS, V3, P685, DOI 10.1046/j.1365-2443.1998.00214.x	44	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128385	10.1371/journal.pone.0128385	http://dx.doi.org/10.1371/journal.pone.0128385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046660	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200065
J	Monaghan, K; McNaughten, J; McGahon, MK; Kelly, C; Kyle, D; Yong, PH; McGeown, JG; Curtis, TM				Monaghan, Kevin; McNaughten, Jennifer; McGahon, Mary K.; Kelly, Catriona; Kyle, Daniel; Yong, Phaik Har; McGeown, J. Graham; Curtis, Tim M.			Hyperglycemia and Diabetes Downregulate the Functional Expression of TRPV4 Channels in Retinal Microvascular Endothelium	PLOS ONE			English	Article							HEAT-EVOKED ACTIVATION; RECEPTOR POTENTIAL V4; CA2+ ENTRY; RETINOPATHY; FLOW; AUTOREGULATION; DILATION; LESIONS; ARTERIOLES; MELLITUS	Retinal endothelial cell dysfunction is believed to play a key role in the etiology and pathogenesis of diabetic retinopathy. Numerous studies have shown that TRPV4 channels are critically involved in maintaining normal endothelial cell function. In the current paper, we demonstrate that TRPV4 is functionally expressed in the endothelium of the retinal microcirculation and that both channel expression and activity is downregulated by hyperglycaemia. Quantitative PCR and immunostaining demonstrated molecular expression of TRPV4 in cultured bovine retinal microvascular endothelial cells (RMECs). Functional TRPV4 activity was assessed in cultured RMECs from endothelial Ca2+-responses recorded using fura-2 microfluorimetry and electrophysiological recordings of membrane currents. The TRPV4 agonist 4 alpha-phorbol 12,13-didecanoate (4-alpha PDD) increased [Ca2+](i) in RMECs and this response was largely abolished using siRNA targeted against TRPV4. These Ca2+-signals were completely inhibited by removal of extracellular Ca2+, confirming their dependence on influx of extracellular Ca2+. The 4-alpha PDD Ca2+-response recorded in the presence of cyclopiazonic acid (CPA), which depletes the intracellular stores preventing any signal amplification through store release, was used as a measure of Ca2+-influx across the cell membrane. This response was blocked by HC067047, a TRPV4 antagonist. Under voltage clamp conditions, the TRPV4 agonist GSK1016790A stimulated a membrane current, which was again inhibited by HC067047. Following incubation with 25mM D-glucose TRPV4 expression was reduced in comparison with RMECs cultured under control conditions, as were 4 alpha PDD-induced Ca2+-responses in the presence of CPA and ion currents evoked by GSK1016790A. Molecular expression of TRPV4 in the retinal vascular endothelium of 3 months' streptozotocin-induced diabetic rats was also reduced in comparison with that in age-matched controls. We conclude that hyperglycaemia and diabetes reduce the molecular and functional expression of TRPV4 channels in retinal microvascular endothelial cells. These changes may contribute to diabetes induced endothelial dysfunction and retinopathy.	[Monaghan, Kevin; McNaughten, Jennifer; McGahon, Mary K.; Kelly, Catriona; Kyle, Daniel; Yong, Phaik Har; McGeown, J. Graham; Curtis, Tim M.] Queens Univ Belfast, Ctr Med Expt, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	Curtis, TM (corresponding author), Queens Univ Belfast, Ctr Med Expt, Belfast BT7 1NN, Antrim, North Ireland.	t.curtis@qub.ac.uk	Curtis, Tim/AEU-9750-2022	Curtis, Tim/0000-0003-1543-2781; Yong, Phaik Har/0000-0002-5888-9856	European Foundation for the Study of Diabetes; Department of Education and Learning Northern Ireland; Biotechnology and Biological Sciences Research Council (UK) [BB/I026359/1]; BBSRC [BB/I026359/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I026359/1] Funding Source: researchfish	European Foundation for the Study of Diabetes; Department of Education and Learning Northern Ireland; Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The European Foundation for the Study of Diabetes (TC), the Department of Education and Learning Northern Ireland (TC and GM), and the Biotechnology and Biological Sciences Research Council (UK) (Grant Ref: BB/I026359/1; TC and GM). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2001, AM J OPHTHALMOL, V132, P760, DOI 10.1016/S0002-9394(01)01124-2; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Bagher P, 2012, P NATL ACAD SCI USA, V109, P18174, DOI 10.1073/pnas.1211946109; Banumathi E, 2011, INVEST OPHTH VIS SCI, V52, P3103, DOI 10.1167/iovs.10-6574; Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Blum M, 2008, OPHTHALMOLOGICA, V222, P373, DOI 10.1159/000151278; Brayden JE, 2008, CLIN EXP PHARMACOL P, V35, P1116, DOI 10.1111/j.1440-1681.2007.04855.x; Bubolz AH, 2012, AM J PHYSIOL-HEART C, V302, pH634, DOI 10.1152/ajpheart.00717.2011; Chakravarthy U, 2013, LANCET, V382, P1258, DOI 10.1016/S0140-6736(13)61501-9; Cioffi DL, 2009, ANTIOXID REDOX SIGN, V11, P765, DOI 10.1089/ARS.2008.2221; Curtis TM, 2009, EYE, V23, P1496, DOI 10.1038/eye.2009.108; Curtis TM, 2003, DIABETOLOGIA, V46, P1252, DOI 10.1007/s00125-003-1178-5; Dunn KM, 2013, P NATL ACAD SCI USA, V110, P6157, DOI 10.1073/pnas.1216514110; Earley S, 2005, CIRC RES, V97, P1270, DOI 10.1161/01.RES.0000194321.60300.d6; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; ERNEST JT, 1983, INVEST OPHTH VIS SCI, V24, P985; Gao F, 2010, J HYPERTENS, V28, P102, DOI 10.1097/HJH.0b013e328332b865; Gardiner TA, 2007, MICROCIRCULATION, V14, P25, DOI 10.1080/10739680601072123; Guler AD, 2002, J NEUROSCI, V22, P6408; Hamanaka K, 2007, AM J PHYSIOL-LUNG C, V293, pL923, DOI 10.1152/ajplung.00221.2007; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Hatano N, 2013, LIFE SCI, V92, P317, DOI 10.1016/j.lfs.2013.01.002; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kern TS, 2010, MOL VIS, V16, P1629; Kohler R, 2006, ARTERIOSCL THROM VAS, V26, P1495, DOI 10.1161/01.ATV.0000225698.36212.6a; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Loot AE, 2008, CARDIOVASC RES, V80, P445, DOI 10.1093/cvr/cvn207; Ma X, 2013, HYPERTENSION, V62, P134, DOI 10.1161/HYPERTENSIONAHA.113.01500; Ma X, 2011, CELL CALCIUM, V50, P502, DOI 10.1016/j.ceca.2011.08.006; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; McGahon MK, 2007, CIRC RES, V100, P703, DOI 10.1161/01.RES.0000260182.36481.c9; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Ng LC, 2009, J PHYSIOL-LONDON, V587, P2429, DOI 10.1113/jphysiol.2009.172254; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2001, PHYSIOL REV, V81, P1415, DOI 10.1152/physrev.2001.81.4.1415; PATEL V, 1994, CLIN SCI, V86, P689, DOI 10.1042/cs0860689; Pla AF, 2012, ONCOGENE, V31, P200, DOI 10.1038/onc.2011.231; Pournaras CJ, 2008, PROG RETIN EYE RES, V27, P284, DOI 10.1016/j.preteyeres.2008.02.002; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robinson R, 2012, DIS MODEL MECH, V5, P444, DOI 10.1242/dmm.009597; Roy S, 2010, BIOGERONTOLOGY, V11, P447, DOI 10.1007/s10522-010-9263-x; SHARMA NK, 1985, AM J OPHTHALMOL, V100, P51, DOI 10.1016/S0002-9394(14)74982-7; SINCLAIR SH, 1982, OPHTHALMOLOGY, V89, P748, DOI 10.1016/s0161-6420(82)34720-x; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; Vriens J, 2005, CIRC RES, V97, P908, DOI 10.1161/01.RES.0000187474.47805.30; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Wu SW, 2009, AM J PHYSIOL-LUNG C, V297, pL650, DOI 10.1152/ajplung.00015.2009; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100; Zhang LQ, 2013, BRIT J PHARMACOL, V170, P661, DOI 10.1111/bph.12315	55	53	59	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128359	10.1371/journal.pone.0128359	http://dx.doi.org/10.1371/journal.pone.0128359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047504	Green Submitted, gold, Green Published			2022-12-26	WOS:000355652200062
J	Sasaki, JI; Hashimoto, M; Yamaguchi, S; Itoh, Y; Yoshimoto, I; Matsumoto, T; Imazato, S				Sasaki, Jun-Ichi; Hashimoto, Masanori; Yamaguchi, Satoshi; Itoh, Yoshihiro; Yoshimoto, Itsumi; Matsumoto, Takuya; Imazato, Satoshi			Fabrication of Biomimetic Bone Tissue Using Mesenchymal Stem Cell-Derived Three-Dimensional Constructs Incorporating Endothelial Cells	PLOS ONE			English	Article							IN-VITRO; REGENERATIVE MEDICINE; ANGIOGENIC FACTORS; VASCULARIZATION; DIFFERENTIATION; OSTEOGENESIS; COCULTURES	The development of technologies to promote vascularization of engineered tissue would drive major developments in tissue engineering and regenerative medicine. Recently, we succeeded in fabricating three-dimensional (3D) cell constructs composed of mesenchymal stem cells (MSCs). However, the majority of cells within the constructs underwent necrosis due to a lack of nutrients and oxygen. We hypothesized that incorporation of vascular endothelial cells would improve the cell survival rate and aid in the fabrication of biomimetic bone tissues in vitro. The purpose of this study was to assess the impact of endothelial cells combined with the MSC constructs (MSC/HUVEC constructs) during short-and long-term culture. When human umbilical vein endothelial cells (HUVECs) were incorporated into the cell constructs, cell viability and growth factor production were increased after 7 days. Furthermore, HUVECs were observed to proliferate and self-organize into reticulate porous structures by interacting with the MSCs. After long-term culture, MSC/HUVEC constructs formed abundant mineralized matrices compared with those composed of MSCs alone. Transmission electron microscopy and qualitative analysis revealed that the mineralized matrices comprised porous cancellous bone-like tissues. These results demonstrate that highly biomimetic bone tissue can be fabricated in vitro by 3D MSC constructs incorporated with HUVECs.	[Sasaki, Jun-Ichi; Hashimoto, Masanori; Yamaguchi, Satoshi; Itoh, Yoshihiro; Yoshimoto, Itsumi; Imazato, Satoshi] Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Osaka, Japan; [Itoh, Yoshihiro] Osaka Univ, Grad Sch Dent, Dept Restorat Dent & Endodontol, Osaka, Japan; [Matsumoto, Takuya] Okayama Univ, Dept Biomat, Okayama, Japan	Osaka University; Osaka University; Okayama University	Sasaki, JI (corresponding author), Osaka Univ, Grad Sch Dent, Dept Biomat Sci, Osaka, Japan.	jun1-s@dent.osaka-u.ac.jp	Yamaguchi, Satoshi/R-1812-2018	Yamaguchi, Satoshi/0000-0002-4661-8821; Imazato, Satoshi/0000-0003-3655-4809	Japan Society for the Promotion of Science [26462969, 24659846]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This project was funded by Grants-in-Aid for Scientific Research (Grant nos. 26462969 and 24659846) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/english/e-grants/index.html). The funding source did not play a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082085; Bajaj P, 2014, ANNU REV BIOMED ENG, V16, P247, DOI 10.1146/annurev-bioeng-071813-105155; Bidarra SJ, 2011, STEM CELL RES, V7, P186, DOI 10.1016/j.scr.2011.05.006; Bitar KN, 2013, CURR OPIN BIOTECH, V24, P909, DOI 10.1016/j.copbio.2013.03.021; Boas SEM, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1049; Boskey A, 2007, BIOMATERIALS, V28, P2465, DOI 10.1016/j.biomaterials.2006.11.043; Chan CY, 2013, LAB CHIP, V13, P4697, DOI 10.1039/c3lc90115g; Chim SM, 2013, CYTOKINE GROWTH F R, V24, P297, DOI 10.1016/j.cytogfr.2013.03.008; de Almeida Danilo C, 2013, Clin Biochem Rev, V34, P131; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Lantada AD, 2013, EXPERT REV MED DEVIC, V10, P629, DOI 10.1586/17434440.2013.827506; Drasdo D, 2003, MATH COMPUT MODEL, V37, P1163, DOI 10.1016/S0895-7177(03)00128-6; Garg T, 2014, EXPERT OPIN DRUG DEL, V11, P767, DOI 10.1517/17425247.2014.891014; Gershovich JG, 2013, TISSUE ENG PT A, V19, P2565, DOI [10.1089/ten.tea.2013.0256, 10.1089/ten.TEA.2013.0256]; Haraguchi Y, 2012, NAT PROTOC, V7, P850, DOI 10.1038/nprot.2012.027; Hasan A, 2014, BIOMATERIALS, V35, P7308, DOI 10.1016/j.biomaterials.2014.04.091; Hashimoto M, 2014, J BIOMED MATER RES A, V102, P1838, DOI 10.1002/jbm.a.34854; Kim J, 2013, BIOMATERIALS, V34, P7257, DOI 10.1016/j.biomaterials.2013.06.029; Koob S, 2011, TISSUE ENG PT A, V17, P311, DOI [10.1089/ten.tea.2010.0338, 10.1089/ten.TEA.2010.0338]; Lee JH, 2013, ARTIF ORGANS, V37, P637, DOI 10.1111/aor.12027; LEITH JT, 1995, CELL PROLIFERAT, V28, P415, DOI 10.1111/j.1365-2184.1995.tb00082.x; Ma JL, 2014, J BIOMED MATER RES A, V102, P1026, DOI 10.1002/jbm.a.34775; MacNeil S, 2007, NATURE, V445, P874, DOI 10.1038/nature05664; Malinen MM, 2014, BIOMATERIALS, V35, P5110, DOI 10.1016/j.biomaterials.2014.03.020; Mason SL, 2011, REGEN MED, V6, P767, DOI [10.2217/rme.11.94, 10.2217/RME.11.94]; Michelini E, 2010, ANAL BIOANAL CHEM, V398, P227, DOI 10.1007/s00216-010-3933-z; Murphy CM, 2013, EUR CELLS MATER, V26, P120, DOI 10.22203/eCM.v026a09; Nishiguchi A, 2014, BIOMATERIALS, V35, P4739, DOI 10.1016/j.biomaterials.2014.01.079; Novosel EC, 2011, ADV DRUG DELIVER REV, V63, P300, DOI 10.1016/j.addr.2011.03.004; Orabi H, 2013, SCI WORLD J, DOI 10.1155/2013/154564; Portalska KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046842; Rao RR, 2013, CYTOTHERAPY, V15, P1309, DOI 10.1016/j.jcyt.2013.06.005; Ribatti D, 2013, EXPERT OPIN INV DRUG, V22, P1157, DOI 10.1517/13543784.2013.813933; Ruano-Ravina A, 2006, OSTEOARTHR CARTILAGE, V14, P47, DOI 10.1016/j.joca.2005.07.017; Salgado AJ, 2013, INT REV NEUROBIOL, V108, P1, DOI 10.1016/B978-0-12-410499-0.00001-0; Sasaki JI, 2010, TISSUE ENG PT A, V16, P2497, DOI [10.1089/ten.tea.2009.0523, 10.1089/ten.TEA.2009.0523]; Sasaki JI, 2012, INTEGR BIOL-UK, V4, P1207, DOI 10.1039/c2ib20027a; Sekine H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2406; Sekiya S, 2013, REGEN MED, V8, P371, DOI [10.2217/RME.13.16, 10.2217/rme.13.16]; Steiner D, 2012, J ORTHOP RES, V30, P1682, DOI 10.1002/jor.22130; Swat MH, 2012, METHOD CELL BIOL, V110, P325, DOI 10.1016/B978-0-12-388403-9.00013-8; Theveneau E, 2012, CURR OPIN CELL BIOL, V24, P677, DOI 10.1016/j.ceb.2012.08.002; Twiss F, 2013, CELL MOL LIFE SCI, V70, P4101, DOI 10.1007/s00018-013-1329-x; Xue Y, 2009, BIOMED ENG ONLINE, V8, DOI 10.1186/1475-925X-8-34; Ye K, 2013, REGEN MED, V8, P333, DOI [10.2217/RME.13.28, 10.2217/rme.13.28]; Yildirimer L, 2014, BIOTECHNOL ADV, V32, P984, DOI 10.1016/j.biotechadv.2014.04.014; Zeitlin BD, 2012, LAB INVEST, V92, P988, DOI 10.1038/labinvest.2012.77; Zhou JA, 2011, ACTA BIOMATER, V7, P3999, DOI 10.1016/j.actbio.2011.06.040	48	23	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129266	10.1371/journal.pone.0129266	http://dx.doi.org/10.1371/journal.pone.0129266			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047122	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200139
J	Yang, BY; Zhang, MM; Li, LL; Pu, F; You, WW; Ke, CH				Yang, Bingye; Zhang, Mingming; Li, Lingling; Pu, Fei; You, Weiwei; Ke, Caihuan			Molecular Analysis of Atypical Family 18 Chitinase from Fujian Oyster Crassostrea angulata and Its Physiological Role in the Digestive System	PLOS ONE			English	Article							CRYSTALLINE STYLE; PROTEINS; EXPRESSION; IDENTIFICATION; PREDICTION; RECEPTOR; DISTINCT; CG-CLP1; RHYTHMS; MUSSEL	Chitinolytic enzymes have an important physiological significance in immune and digestive systems in plants and animals, but chitinase has not been identified as having a role in the digestive system in molluscan. In our study, a novel chitinase homologue, named Ca-Chit, has been cloned and characterized as the oyster Crassostrea angulate. The 3998bp fulllength cDNA of Ca-Chit consisted of 23bp 5-UTR, 3288 ORF and 688bp 3-UTR. The deduced amino acids sequence shares homologue with the chitinase of family 18. The molecular weight of the protein was predicted to be 119.389 kDa, with a pI of 6.74. The Ca-Chit protein was a modular enzyme composed of a glycosyl hydrolase family 18 domain, threonine- rich region profile and a putative membrane anchor domain. Gene expression profiles monitored by quantitative RT-PCR in different adult tissues showed that the mRNA of CaChit expressed markedly higher visceral mass than any other tissues. The results of the whole mount in-situ hybridization displayed that Ca-Chit starts to express the visceral mass of D-veliger larvae and then the digestive gland forms a crystalline structure during larval development. Furthermore, the adult oysters challenged by starvation indicated that the CaChit expression would be regulated by feed. All the observations made suggest that Ca-Chit plays an important role in the digestive system of the oyster, Crassostrea angulate.	[Yang, Bingye] Xiamen Med Coll, Xiamen 361008, Peoples R China; [Yang, Bingye; Pu, Fei; Ke, Caihuan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China; [Yang, Bingye; Pu, Fei; You, Weiwei; Ke, Caihuan] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen 361005, Peoples R China; [Zhang, Mingming; Li, Lingling] Xiamen Univ, Coll Life Sci, Xiamen 361005, Peoples R China	Xiamen Medical College; Xiamen University; Xiamen University; Xiamen University	Ke, CH (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen 361005, Peoples R China.	chke@xmu.edu.cn			NSFC [41176113]; National Basic Research Program of China [2010CB126403]; Special Fund for Marine Scientific Research in the Public Interest [201305016]; Earmarked Fund for Modern Agro-industry Technology Research System [CARS-48]	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Special Fund for Marine Scientific Research in the Public Interest; Earmarked Fund for Modern Agro-industry Technology Research System	This study was funded by NSFC (41176113), The National Basic Research Program of China (No. 2010CB126403), the Special Fund for Marine Scientific Research in the Public Interest (201305016) and the Earmarked Fund for Modern Agro-industry Technology Research System (CARS-48).	Aliakrinskaia I O, 2001, Izv Akad Nauk Ser Biol, P613; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arakane Y, 2003, INSECT BIOCHEM MOLEC, V33, P631, DOI 10.1016/S0965-1748(03)00049-3; Aronson NN, 1997, J CHEM INF COMP SCI, V37, P999, DOI 10.1021/ci970236v; Badariotti F, 2007, FEBS J, V274, P3646, DOI 10.1111/j.1742-4658.2007.05898.x; Badariotti F, 2007, DEV COMP IMMUNOL, V31, P559, DOI 10.1016/j.dci.2006.09.002; Badariotti F, 2006, J BIOL CHEM, V281, P29583, DOI 10.1074/jbc.M605687200; BIRKBECK TH, 1984, COMP BIOCHEM PHYS B, V77, P861, DOI 10.1016/0305-0491(84)90325-0; Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Chuang GY, 2012, BIOINFORMATICS, V28, P2249, DOI 10.1093/bioinformatics/bts426; Daimon T, 2003, INSECT BIOCHEM MOLEC, V33, P749, DOI 10.1016/S0965-1748(03)00084-5; Dorit R.L., 1991, ZOOLOGY, P925; Dziarski R, 2004, MOL IMMUNOL, V40, P877, DOI 10.1016/j.molimm.2003.10.011; Galtsoff P.S., 1964, FISHERY B FISH WILDL, V64, P1, DOI DOI 10.1111/J.1439-0388.2007.00702.X; Gonzalez M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-213; Gooday GW, 1990, BIODEGRADATION, V1, P177, DOI 10.1007/BF00058835; GRISLEY MS, 1990, COMP BIOCHEM PHYS B, V95, P311, DOI 10.1016/0305-0491(90)90081-4; Hinman VF, 2000, DEV GENES EVOL, V210, P129, DOI 10.1007/s004270050019; JENNER CE, 1956, BIOL BULL, V111, P304; KRISTENSEN J H, 1972, Ophelia, V10, P91; LANGTON RW, 1977, MAR BIOL, V41, P53, DOI 10.1007/BF00390581; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUNDBLAD G, 1976, ACTA CHEM SCAND B, V30, P889, DOI 10.3891/acta.chem.scand.30b-0889; MORTON B, 1971, Biological Journal of the Linnean Society, V3, P329, DOI 10.1111/j.1095-8312.1971.tb00526.x; MORTON JE, 1956, J MAR BIOL ASSOC UK, V35, P563, DOI 10.1017/S0025315400010420; NAKAI K, 1988, J BIOCHEM-TOKYO, V104, P693, DOI 10.1093/oxfordjournals.jbchem.a122535; Nichols S. Jerrine, 1993, P315; Qin J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043653; Renkema GH, 1997, EUR J BIOCHEM, V244, P279, DOI 10.1111/j.1432-1033.1997.00279.x; Richard F, 2007, CRASSOSTREA VIRGINIC; ROBERTSON JR, 1979, NAUTILUS, V93, P38; SMUCKER RA, 1984, COMP BIOCHEM PHYS A, V77, P239, DOI 10.1016/0300-9629(84)90054-9; Suzuki M, 2002, J HISTOCHEM CYTOCHEM, V50, P1081, DOI 10.1177/002215540205000810; WATANABE T, 1993, J BIOL CHEM, V268, P18567; Yang BY, 2013, COMP BIOCHEM PHYS B, V164, P168, DOI 10.1016/j.cbpb.2012.12.006; Yang BY, 2012, AQUACULTURE, V366, P54, DOI 10.1016/j.aquaculture.2012.08.040; Yonge C. M., 1932, Scientific Reports Great Barrier Reef Expedition, V1, P259	37	6	6	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129261	10.1371/journal.pone.0129261	http://dx.doi.org/10.1371/journal.pone.0129261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046992	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200138
J	Zhang, HF; Gao, N; Liu, TT; Fang, Y; Qi, B; Wen, Q; Zhou, J; Jia, LJ; Qiao, HL				Zhang, Haifeng; Gao, Na; Liu, Tingting; Fang, Yan; Qi, Bing; Wen, Qiang; Zhou, Jun; Jia, Linjing; Qiao, Hailing			Effect of Cytochrome b5 Content on the Activity of Polymorphic CYP1A2, 2B6, and 2E1 in Human Liver Microsomes	PLOS ONE			English	Article							DRUG-METABOLISM; B(5) REDUCTASE; P450 REDUCTASE; ROLES; OXIDATION; 3A4; PURIFICATION; CYP2E1	Human cytochrome b5 (Cyt b5) plays important roles in cytochrome P450 (CYP)-mediated drug metabolism. However, the expression level of Cyt b5 in normal human liver remains largely unknown. The effect of Cyt b5 on overall CYP activity in human liver microsomes (HLM) has rarely been reported and the relationship between Cyt b5 and the activity of polymorphic CYP has not been systematically investigated. In this study, we found that the median value of Cyt b5 protein was 270.01 pmol/ mg from 123 HLM samples, and 12- and 19fold individual variation was observed in Cyt b5 mRNA and protein levels, respectively. Gender and smoking clearly influenced Cyt b5 content. In addition, we found that Cyt b5 protein levels significantly correlated with the overall activity of CYP1A2, 2B6, and 2E1 in HLM. However, when the CYP activities were sorted by single nucleotide polymorphisms (SNP), the effect of Cyt b5 protein on the kinetic parameters varied greatly. There were significant correlations between Cyt b5 content and Vmax and CLint of CYP1A2 wild-types (3860GG, 2159GG, and 5347CC) as well as homozygous mutants (163AA and 3113GG). In contrast to V-max and C-Lint, the K-m of CYP2B6 516GG and 785AA genotypes was inversely associated with Cyt b5 content. Correlations between Cyt b5 content and V-max and CLint of CYP2E1 -1293GG, -1293GC, 7632TT, 7632TA, -333TT, and -352AA genotypes were also observed. In conclusion, Cyt b5 expression levels varied considerably in the Chinese cohort from this study. Cyt b5 had significant impact on the overall activity of CYP1A2, 2B6, and 2E1 in HLM and the effects of Cyt b5 protein on polymorphic CYP1A2, 2B6, and 2E1 activity were SNP-dependent. These findings suggest that Cyt b5 plays an important role in CYP-mediated activities in HLM and may possibly be a contributing factor for the individual variation observed in CYP enzyme activities.	[Zhang, Haifeng; Gao, Na; Liu, Tingting; Fang, Yan; Qi, Bing; Wen, Qiang; Zhou, Jun; Jia, Linjing; Qiao, Hailing] Zhengzhou Univ, Inst Clin Pharmacol, Zhengzhou 450052, Peoples R China	Zhengzhou University	Qiao, HL (corresponding author), Zhengzhou Univ, Inst Clin Pharmacol, Zhengzhou 450052, Peoples R China.	qiaohl@zzu.edu.cn		qi, bing/0000-0001-8025-493X	National Natural Science Foundation of China [81473279]; Science and Technology Innovative Scholar Program of Henan Province [134200510019]; Scientific and Technical Innovation Team of Zhengzhou City [131PCXTD604]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovative Scholar Program of Henan Province; Scientific and Technical Innovation Team of Zhengzhou City	This work was partly supported by the National Natural Science Foundation of China (No. 81473279), Science and Technology Innovative Scholar Program of Henan Province (No. 134200510019) and Scientific and Technical Innovation Team of Zhengzhou City (No. 131PCXTD604). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; Djordjevic N, 2010, EUR J CLIN PHARMACOL, V66, P697, DOI 10.1007/s00228-010-0823-4; Finn RD, 2008, J BIOL CHEM, V283, P31385, DOI 10.1074/jbc.M803496200; Gan L, 2009, DRUG METAB DISPOS, V37, P90, DOI 10.1124/dmd.108.023424; GIORDANO SJ, 1991, BIOCHEM BIOPH RES CO, V178, P38, DOI 10.1016/0006-291X(91)91776-9; Henderson CJ, 2014, DRUG METAB DISPOS, V42, P70, DOI 10.1124/dmd.113.055277; HILDEBRANDT A, 1971, ARCH BIOCHEM BIOPHYS, V143, P66, DOI 10.1016/0003-9861(71)90186-X; Im SC, 2011, ARCH BIOCHEM BIOPHYS, V507, P144, DOI 10.1016/j.abb.2010.10.023; Jerabek P, 2014, BIOCHEMISTRY-US, V53, P6695, DOI 10.1021/bi500814t; Kandel SE, 2014, CHEM RES TOXICOL, V27, P1474, DOI 10.1021/tx500203s; Kaspera R, 2011, BIOCHEM PHARMACOL, V82, P681, DOI 10.1016/j.bcp.2011.06.027; Kurian JR, 2004, J PHARMACOL EXP THER, V311, P1171, DOI 10.1124/jpet.104.072389; Laki Szilvia, 2013, Acta Pharm Hung, V83, P107; Martiny VY, 2013, J MOL BIOL, V425, P3978, DOI 10.1016/j.jmb.2013.07.010; Meyer UA, 2004, NAT REV GENET, V5, P669, DOI 10.1038/nrg1428; Nebert DW, 2006, NAT REV CANCER, V6, P947, DOI 10.1038/nrc2015; OZOLS J, 1989, BIOCHIM BIOPHYS ACTA, V997, P121, DOI 10.1016/0167-4838(89)90143-X; Palma BB, 2013, PHARMACOGENET GENOM, V23, P41, DOI 10.1097/FPC.0b013e32835c2ddf; PATTEN CJ, 1986, ARCH BIOCHEM BIOPHYS, V251, P629, DOI 10.1016/0003-9861(86)90373-5; Peng HM, 2014, J BIOL CHEM, V289, P33838, DOI 10.1074/jbc.M114.608919; Peng HM, 2013, BIOCHEMISTRY-US, V52, P210, DOI 10.1021/bi301384n; Sacco JC, 2010, PHARMACOGENET GENOM, V20, P26, DOI 10.1097/FPC.0b013e3283343296; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; SHIMADA T, 1986, J BIOL CHEM, V261, P909; SNYDER R, 1993, TOXICOL APPL PHARM, V122, P172, DOI 10.1006/taap.1993.1185; Soyama Akiko, 2005, Drug Metab Pharmacokinet, V20, P24, DOI 10.2133/dmpk.20.24; Storbeck KH, 2013, MOL CELL ENDOCRINOL, V371, P87, DOI 10.1016/j.mce.2012.11.020; Takahashi K, 2014, PHARM RES-DORDR, V31, P780, DOI 10.1007/s11095-013-1200-7; Trafalis DT, 2010, EXPERT OPIN DRUG MET, V6, P307, DOI 10.1517/17425250903540238; VERGERES G, 1995, BIOCHIMIE, V77, P604, DOI 10.1016/0300-9084(96)88176-4; Xie HJ, 2003, PHARMACOGENOMICS J, V3, P53, DOI 10.1038/sj.tpj.6500157; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, ARCH BIOCHEM BIOPHYS, V325, P174, DOI 10.1006/abbi.1996.0022; Yamazaki H, 1996, BIOCHEM PHARMACOL, V52, P301, DOI 10.1016/0006-2952(96)00208-0; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Zanger UM, 2008, ANAL BIOANAL CHEM, V392, P1093, DOI 10.1007/s00216-008-2291-6; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r	40	32	35	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128547	10.1371/journal.pone.0128547	http://dx.doi.org/10.1371/journal.pone.0128547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046844	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200077
J	Batista, CM; Kessler, RL; Eger, I; Soares, MJ				Batista, Cassiano Martin; Kessler, Rafael Luis; Eger, Iriane; Soares, Maurilio Jose			Trypanosoma cruzi Intracellular Amastigotes Isolated by Nitrogen Decompression Are Capable of Endocytosis and Cargo Storage in Reservosomes	PLOS ONE			English	Article							IN-VITRO; CYTOSTOME; GROWTH; TRYPOMASTIGOTES; TRANSFERRIN; FORMS; IRON	Epimastigote forms of Trypanosoma cruzi (the etiologic agent of Chagas disease) internalize and store extracellular macromolecules in lysosome-related organelles (LROs) called reservosomes, which are positive for the cysteine protease cruzipain. Despite the importance of endocytosis for cell proliferation, macromolecule internalization remains poorly understood in the most clinically relevant proliferative form, the intracellular amastigotes found in mammalian hosts. The main obstacle was the lack of a simple method to isolate viable intracellular amastigotes from host cells. In this work we describe the fast and efficient isolation of viable intracellular amastigotes by nitrogen decompression (cavitation), which allowed the analysis of amastigote endocytosis, with direct visualization of internalized cargo inside the cells. The method routinely yielded 5x10(7) amastigotes-with typical shape and positive for the amastigote marker Ssp4-from 5x10(6) infected Vero cells (48h post-infection). We could visualize the endocytosis of fluorescently-labeled transferrin and albumin by isolated intracellular amastigotes using immunofluorescence microscopy; however, only transferrin endocytosis was detected by flow cytometry (and was also analyzed by western blotting), suggesting that amastigotes internalized relatively low levels of albumin. Transferrin binding to the surface of amastigotes (at 4 degrees C) and its uptake (at 37 degrees C) were confirmed by binding dissociation assays using acetic acid. Importantly, both transferrin and albumin colocalized with cruzipain in amastigote LROs. Our data show that isolated Trypanosoma cruzi intracellular amastigotes actively ingest macromolecules from the environment and store them in cruzipain-positive LROs functionally related to epimastigote reservosomes.	[Batista, Cassiano Martin; Eger, Iriane; Soares, Maurilio Jose] Inst Carlos Chagas Fiocruz PR, Lab Biol Celular, Curitiba, Parana, Brazil; [Kessler, Rafael Luis] Inst Carlos Chagas Fiocruz PR, Lab Genom Func, Curitiba, Parana, Brazil; [Eger, Iriane] Univ Estadual Ponta Grossa, Dept Biol Geral, Ponta Grossa, Parana, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Estadual de Ponta Grossa	Batista, CM (corresponding author), Inst Carlos Chagas Fiocruz PR, Lab Biol Celular, Curitiba, Parana, Brazil.	cassianombatista@gmail.com	Soares, Maurilio J/I-4627-2016; Batista, C.M./D-1396-2013; Kessler, Rafael/E-9291-2018	Soares, Maurilio J/0000-0001-9701-836X; Batista, C.M./0000-0002-3947-5914; Kessler, Rafael/0000-0002-6365-8251	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Oswaldo Cruz (Fiocruz)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Oswaldo Cruz (Fiocruz)	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Oswaldo Cruz (Fiocruz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSOHN IA, 1983, J PARASITOL, V69, P437, DOI 10.2307/3281260; Alcantara CL, 2014, J CELL SCI, V127, P2227, DOI 10.1242/jcs.135491; ANDREWS NW, 1987, EXP PARASITOL, V64, P474, DOI 10.1016/0014-4894(87)90062-2; Auxiliadora de Sousa M., 1983, Memorias do Instituto Oswaldo Cruz, V78, P317, DOI 10.1590/S0074-02761983000300009; Batista CM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/714749; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; CAZZULO JJ, 1990, BIOCHIM BIOPHYS ACTA, V1037, P186, DOI 10.1016/0167-4838(90)90166-D; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; CONTRERAS VT, 1994, MEM I OSWALDO CRUZ, V89, P253, DOI 10.1590/S0074-02761994000200026; Correa JR, 2008, EXP PARASITOL, V119, P58, DOI 10.1016/j.exppara.2007.12.010; de Figueiredo RCBQ, 2000, PARASITOL RES, V86, P413, DOI 10.1007/s004360050686; de Souza W, 2008, MEM I OSWALDO CRUZ, V103, P313, DOI 10.1590/S0074-02762008000400001; de Souza W, 2009, PROG HISTOCHEM CYTO, V44, P67, DOI 10.1016/j.proghi.2009.01.001; DECARVALHO TU, 1983, Z PARASITENKD, V69, P571; Gradia DF, 2009, INT J PARASITOL, V39, P49, DOI 10.1016/j.ijpara.2008.05.019; Hernandez-Osorio LA, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/283842; Kalb LC, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-23; Kessler RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067441; Kessler RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055497; Kirchhausen T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016725; LALONDE RG, 1984, J CLIN INVEST, V73, P470, DOI 10.1172/JCI111233; LIMA MF, 1990, MOL BIOCHEM PARASIT, V38, P245, DOI 10.1016/0166-6851(90)90027-J; LOO VG, 1984, INFECT IMMUN, V45, P726, DOI 10.1128/IAI.45.3.726-730.1984; Lundmark R, 2010, SEMIN CELL DEV BIOL, V21, P363, DOI 10.1016/j.semcdb.2009.11.014; Marques A, 2011, PURIFICATION EXTRACE, DOI [10.1038/PROTEX.2011.265, DOI 10.1038/PROTEX.2011.265]; Mayle Kristine M, 2012, Biochim Biophys Acta, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; MEYER H, 1973, J PROTOZOOL, V20, P590, DOI 10.1111/j.1550-7408.1973.tb03580.x; MILDER R, 1969, J PROTOZOOL, V16, P730, DOI 10.1111/j.1550-7408.1969.tb02335.x; Porto-Carreiro I, 2000, EUR J CELL BIOL, V79, P858, DOI 10.1078/0171-9335-00112; Ramos TCP, 2011, CYTOM PART A, V79A, P538, DOI 10.1002/cyto.a.21077; Sambrook J, 1989, MOL CLONING LAB MANU, V2; Sant'Anna C, 2008, HISTOCHEM CELL BIOL, V130, P1187, DOI 10.1007/s00418-008-0486-8; Sant'Anna C, 2008, MICROSC RES TECHNIQ, V71, P599, DOI 10.1002/jemt.20592; Simpson Richard J, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5513; SIMPSON RJ, 2010, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.PROT5513; SOARES MJ, 1991, PARASITOL RES, V77, P461, DOI 10.1007/BF00928410; SOARES MJ, 1992, J CELL SCI, V102, P157; Taylor MC, 2010, PARASITOLOGY, V137, P899, DOI 10.1017/S0031182009991880; Thomas T.H.B, 1979, IRON METABOLISM MAN; Urbina JA, 2010, ACTA TROP, V115, P55, DOI 10.1016/j.actatropica.2009.10.023; VILLALTA F, 1982, J PROTOZOOL, V29, P570, DOI 10.1111/j.1550-7408.1982.tb01338.x; Waghabi MC, 2005, AM J PATHOL, V167, P993, DOI 10.1016/S0002-9440(10)61189-3	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0130165	10.1371/journal.pone.0130165	http://dx.doi.org/10.1371/journal.pone.0130165			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057131	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000081
J	Fuellgrabe, MW; Herrmann, D; Knecht, H; Kuenzel, S; Kneba, M; Pott, C; Brugemann, M				Fuellgrabe, Marc W.; Herrmann, Dietrich; Knecht, Henrik; Kuenzel, Sven; Kneba, Michael; Pott, Christiane; Bruegemann, Monika			High-Throughput, Amplicon-Based Sequencing of the CREBBP Gene as a Tool to Develop a Universal Platform-Independent Assay	PLOS ONE			English	Article							BURROWS-WHEELER TRANSFORM; PACIFIC BIOSCIENCES; READ ALIGNMENT; DNA; ERROR; QUALITY; TECHNOLOGY; MUTATIONS; ACCURACY; NANOPORE	High-throughput sequencing technologies are widely used to analyse genomic variants or rare mutational events in different fields of genomic research, with a fast development of new or adapted platforms and technologies, enabling amplicon-based analysis of single target genes or even whole genome sequencing within a short period of time. Each sequencing platform is characterized by well-defined types of errors, resulting from different steps in the sequencing workflow. Here we describe a universal method to prepare amplicon libraries that can be used for sequencing on different high-throughput sequencing platforms. We have sequenced distinct exons of the CREB binding protein (CREBBP) gene and analysed the output resulting from three major deep-sequencing platforms. platform-specific errors were adjusted according to the result of sequence analysis from the remaining platforms. Additionally, bioinformatic methods are described to determine platform dependent errors. Summarizing the results we present a platform-independent cost-efficient and timesaving method that can be used as an alternative to commercially available sample-preparation kits.	[Fuellgrabe, Marc W.; Herrmann, Dietrich; Knecht, Henrik; Kneba, Michael; Pott, Christiane; Bruegemann, Monika] Univ Hosp Schleswig Holstein, Dept Med 2, Kiel, Germany; [Kuenzel, Sven] Max Planck Inst Evolutionary Biol, Plon, Germany	University of Kiel; Schleswig Holstein University Hospital; Max Planck Society	Fuellgrabe, MW (corresponding author), Univ Hosp Schleswig Holstein, Dept Med 2, Kiel, Germany.	m.fuellgrabe@med2.uni-kiel.de						Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bolotin DA, 2012, EUR J IMMUNOL, V42, P3073, DOI 10.1002/eji.201242517; Bragg LM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003031; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; Carneiro MO, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-375; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Elliott Aaron M, 2012, J Biomol Tech, V23, P24, DOI 10.7171/jbt.12-2301-003; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Gilles A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-245; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Junemann S, 2013, NAT BIOTECHNOL, V31, P294, DOI 10.1038/nbt.2522; Ku CS, 2013, EXPERT REV MED DEVIC, V10, P1, DOI [10.1586/erd.12.63, 10.1586/ERD.12.63]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Nakamura K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr344; Olasagasti F, 2010, NAT NANOTECHNOL, V5, P798, DOI [10.1038/nnano.2010.177, 10.1038/NNANO.2010.177]; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shao W, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-18; Turcatti G, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn021; Vandenbroucke I, 2011, BIOTECHNIQUES, V51, P167, DOI 10.2144/000113733	30	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129195	10.1371/journal.pone.0129195	http://dx.doi.org/10.1371/journal.pone.0129195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057250	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000042
J	Liang, E; Brower, JV; Rice, SR; Buehler, DG; Saha, S; Kimple, RJ				Liang, Evan; Brower, Jeffrey V.; Rice, Stephanie R.; Buehler, Darya G.; Saha, Sandeep; Kimple, Randall J.			Merkel Cell Carcinoma Analysis of Outcomes: A 30-Year Experience	PLOS ONE			English	Article							LARGE T-ANTIGEN; RADIATION-THERAPY; P63 EXPRESSION; STAGE-I; POSTOPERATIVE RADIATION; POLYOMAVIRUS INFECTION; TRABECULAR CARCINOMA; PROGNOSTIC-FACTORS; LYMPH-NODE; SURVIVAL	Background Merkel cell carcinoma (MCC) is an aggressive cutaneous malignancy with poor prognosis. Limited data exists to guide treatment decisions. Here we report on our institutional experience and outcomes treating patients with MCC. Methods A database search (1984-2014) of patients treated at the University of Wisconsin Hospital and Clinics was used to identify patients with histologically confirmed MCC. Patient, tumor, and treatment characteristics were examined via review of medical records. Statistical analyses were performed to assess outcomes and associated prognostic factors. Results A total of 87 patients with MCC were identified with a median follow-up of 17 months (mean: 38, range: 0-210 months). Two and five-year overall survival rates were 53.9% and 32.8%, respectively. Recurrence was documented in 31.0% of patients (85.2% locoregional, 48.1% distant and 33.3% both). Patients with a history of immunosuppression exhibited significantly worse survival (hazard ratio, 2.01; 95% CI, 1.1-3.7) when compared to immune-competent individuals. The head and neck region was the most common location of primary lesion (N=49) followed by the extremities (N=31). Upper extremity primaries predicted significantly better overall survival (hazard ratio, 0.48; 95% CI, 0.23-0.99) while lower extremity primaries did not have significantly better results (hazard ratio, 0.5; 95% CI, 0.21-1.2) in comparison to head and neck site of primary. Nodal involvement (hazard ratio, 2.95; 95% CI, 1.5-5.79) was also a negative prognostic factor associated with poor overall survival when compared with clinically node negative patients. Primary tumor size > 2 cm (hazard ratio, 1.76; 95% CI, 0.91-3.4) was not associated with survival. Conclusions This study highlights the role of various factors in determining prognosis of Merkel cell carcinoma; history of immunosuppression, nodal involvement, and head/neck primary predicted worse overall survival. These findings suggest that improvements in both distant and locoregionally directed therapies might play an important role in control of MCC and identify areas for future study.	[Liang, Evan; Brower, Jeffrey V.; Rice, Stephanie R.; Kimple, Randall J.] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Buehler, Darya G.] Univ Wisconsin, Dept Pathol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Saha, Sandeep] Univ Wisconsin, Dept Biostat, Sch Med & Publ Hlth, Madison, WI USA; [Kimple, Randall J.] Univ Wisconsin, Sch Med & Publ Hlth, Carbone Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Kimple, RJ (corresponding author), Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rkimple@humonc.wisc.edu	Kimple, Randall/L-6460-2019; Rice, Stephanie/GZA-4791-2022; Rice, Stephanie/L-8734-2019	Kimple, Randall/0000-0001-8336-8000; Rice, Stephanie/0000-0002-2661-935X; Liang, Evan/0000-0002-6323-5523	Shapiro Summer Research Fellowship; NIH/NCI [CA160639]; NATIONAL CANCER INSTITUTE [R00CA160639, K99CA160639] Funding Source: NIH RePORTER	Shapiro Summer Research Fellowship; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a Shapiro Summer Research Fellowship (Evan Liang) and by NIH/NCI CA160639 (Randall Kimple). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelli M, 2003, J AM ACAD DERMATOL, V49, P832, DOI 10.1016/S0190-9622(03)02108-X; Agelli M, 2010, CURR PROB CANCER, V34, P14, DOI 10.1016/j.currproblcancer.2010.01.001; Albores-Saavedra J, 2010, J CUTAN PATHOL, V37, P20, DOI 10.1111/j.1600-0560.2009.01370.x; Allen PJ, 2005, J CLIN ONCOL, V23, P2300, DOI 10.1200/JCO.2005.02.329; Andea AA, 2010, HUM PATHOL, V41, P1405, DOI 10.1016/j.humpath.2010.02.010; Asgari MM, 2014, JAMA DERMATOL, V150, P716, DOI 10.1001/jamadermatol.2013.8116; Asioli S, 2007, CANCER-AM CANCER SOC, V110, P640, DOI 10.1002/cncr.22828; Asioli S, 2011, MODERN PATHOL, V24, P1451, DOI 10.1038/modpathol.2011.100; Bhatia K, 2010, INT J CANCER, V127, P1493, DOI 10.1002/ijc.25136; Bichakjian CK, 2014, J NATL COMPR CANC NE, V12, P410, DOI 10.6004/jnccn.2014.0041; DEWOLFPEETERS C, 1980, CANCER, V46, P1810, DOI 10.1002/1097-0142(19801015)46:8<1810::AID-CNCR2820460819>3.0.CO;2-7; Edge S, 2010, AJCC CANC STAGING HD; Engels EA, 2002, LANCET, V359, P497, DOI 10.1016/S0140-6736(02)07668-7; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Fields RC, 2012, CANCER-AM CANCER SOC, V118, P3311, DOI 10.1002/cncr.26626; Fields RC, 2011, ANN SURG, V254, P465, DOI 10.1097/SLA.0b013e31822c5fc1; Foote M, 2010, INT J RADIAT ONCOL, V77, P677, DOI 10.1016/j.ijrobp.2009.05.067; Hall BJ, 2012, J CUTAN PATHOL, V39, P911, DOI 10.1111/j.1600-0560.2012.01964.x; Hasan S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00276; Heath M, 2008, J AM ACAD DERMATOL, V58, P375, DOI 10.1016/j.jaad.2007.11.020; Hodgson NC, 2005, J SURG ONCOL, V89, P1, DOI 10.1002/jso.20167; Hui AC, 2011, INT J RADIAT ONCOL, V80, P1430, DOI 10.1016/j.ijrobp.2010.04.061; Iyer JG, 2014, J AM ACAD DERMATOL, V70, P637, DOI 10.1016/j.jaad.2013.11.031; Jabbour J, 2007, ANN SURG ONCOL, V14, P1943, DOI 10.1245/s10434-006-9327-y; Kaae J, 2010, JNCI-J NATL CANCER I, V102, P793, DOI 10.1093/jnci/djq120; Kim JA, 2013, JAMA DERMATOL, V149, P831, DOI 10.1001/jamadermatol.2013.409; Knapp CF, 2012, AM J DERMATOPATH, V34, P592, DOI 10.1097/DAD.0b013e31823e25d3; Kokoska ER, 1997, AM J SURG, V174, P688, DOI 10.1016/S0002-9610(97)00193-1; Laude HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001076; Lemos BD, 2010, J AM ACAD DERMATOL, V63, P751, DOI 10.1016/j.jaad.2010.02.056; MEEUWISSEN JA, 1995, INT J RADIAT ONCOL, V31, P325, DOI 10.1016/0360-3016(94)E0145-A; Mojica P, 2007, J CLIN ONCOL, V25, P1043, DOI 10.1200/JCO.2006.07.9319; MORRISON WH, 1990, INT J RADIAT ONCOL, V19, P583, DOI 10.1016/0360-3016(90)90484-2; Ott MJ, 1999, ARCH SURG-CHICAGO, V134, P388, DOI 10.1001/archsurg.134.4.388; Paulson KG, 2010, CANCER RES, V70, P8388, DOI 10.1158/0008-5472.CAN-10-2128; Sahi H, 2012, VIRCHOWS ARCH, V461, P553, DOI 10.1007/s00428-012-1310-3; Santamaria-Barria JA, 2013, ANN SURG ONCOL, V20, P1365, DOI 10.1245/s10434-012-2779-3; Sattler E, 2013, J DERMATOL, V40, P374, DOI 10.1111/1346-8138.12072; Schrama D, 2011, J INVEST DERMATOL, V131, P1631, DOI 10.1038/jid.2011.115; Schwartz JL, 2011, J CLIN ONCOL, V29, P1036, DOI 10.1200/JCO.2010.33.4136; Shatland E, 2005, P 29 ANN SAS US GR I, P206; Sihto H, 2011, CLIN CANCER RES, V17, P4806, DOI 10.1158/1078-0432.CCR-10-3363; Smith VA, 2012, LARYNGOSCOPE, V122, P1283, DOI 10.1002/lary.23222; Smith VA, 2012, OTOLARYNG HEAD NECK, V146, P403, DOI 10.1177/0194599811431789; Stetsenko GY, 2013, AM J CLIN PATHOL, V140, P838, DOI 10.1309/AJCPE4PK6CTBNQJY; Tadmor T, 2012, BRIT J HAEMATOL, V157, P457, DOI 10.1111/j.1365-2141.2012.09087.x; TANG CK, 1978, CANCER, V42, P2311, DOI 10.1002/1097-0142(197811)42:5<2311::AID-CNCR2820420531>3.0.CO;2-L; Tarantola TI, 2013, J AM ACAD DERMATOL, V68, P425, DOI 10.1016/j.jaad.2012.09.036; Tilling T, 2012, J SKIN CANCER, V2012, DOI 10.1155/2012/680410; TOKER C, 1972, ARCH DERMATOL, V105, P107, DOI 10.1001/archderm.105.1.107; Touze A, 2011, J CLIN ONCOL, V29, P1612, DOI 10.1200/JCO.2010.31.1704; Veness MJ, 2005, J CLIN ONCOL, V23, P7235, DOI 10.1200/JCO.2005.02.2814; Waltari M, 2011, INT J CANCER, V129, P619, DOI 10.1002/ijc.25720; Zager JS, 2014, J NATL COMPR CANC NE, V12, P425, DOI 10.6004/jnccn.2014.0042	54	29	31	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129476	10.1371/journal.pone.0129476	http://dx.doi.org/10.1371/journal.pone.0129476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053480	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300129
J	Qiu, W; Liesa, M; Carpenter, EP; Shirihai, OS				Qiu, Wei; Liesa, Marc; Carpenter, Elizabeth P.; Shirihai, Orian S.			ATP Binding and Hydrolysis Properties of ABCB10 and Their Regulation by Glutathione	PLOS ONE			English	Article							CASSETTE TRANSPORTER; MUTATIONS; ME; MITOCHONDRIA; MECHANISM; MUTANTS; CLUSTER; GATA-1; DOMAIN; EXPORT	ABCB10 (ATP binding cassette sub-family B10) is a mitochondrial inner-membrane ABC transporter. ABCB10 has been shown to protect the heart from the impact of ROS during ischemia-reperfusion and to allow for proper hemoglobin synthesis during erythroid development. ABC transporters are proteins that increase ATP binding and hydrolysis activity in the presence of the transported substrate. However, molecular entities transported by ABCB10 and its regulatory mechanisms are currently unknown. Here we characterized ATP binding and hydrolysis properties of ABCB10 by using the 8-azido-ATP photolabeling technique. This technique can identify potential ABCB10 regulators, transported substrates and amino-acidic residues required for ATP binding and hydrolysis. We confirmed that Gly497 and Lys498 in the Walker A motif, Glu624 in the Walker B motif and Gly602 in the C-Loopmotif of ABCB10 are required for proper ATP binding and hydrolysis activity, as their mutation changed ABCB10 8-Azido-ATP photo-labeling. In addition, we show that the potential ABCB10 transported entity and heme precursor delta-aminolevulinic acid (dALA) does not alter 8-azidoATP photo-labeling. In contrast, oxidized glutathione (GSSG) stimulates ATP hydrolysis without affecting ATP binding, whereas reduced glutathione (GSH) inhibits ATP binding and hydrolysis. Indeed, we detectABCB10 glutathionylation in Cys547 and show that it is one of the exposed cysteine residues within ABCB10 structure. In all, we characterize essential residues for ABCB10 ATPase activity and we provide evidence that supports the exclusion of dALA as a potential substrate directly transported by ABCB10. Last, we show the first molecular mechanism by which mitochondrial oxidative status, through GSH/GSSG, can regulate ABCB10.	[Qiu, Wei; Liesa, Marc; Shirihai, Orian S.] Boston Univ, Sch Med, Evans Biomed Res Ctr, Dept Med,Obes & Nutr Sect,Mitochondria ARC, Boston, MA 02118 USA; [Carpenter, Elizabeth P.] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford, England; [Shirihai, Orian S.] Ben Gurion Univ Negev, Dept Clin Biochem, Sch Med, IL-84105 Beer Sheva, Israel	Boston University; University of Oxford; Ben Gurion University	Liesa, M (corresponding author), Boston Univ, Sch Med, Evans Biomed Res Ctr, Dept Med,Obes & Nutr Sect,Mitochondria ARC, Boston, MA 02118 USA.	liesa@bu.edu; shirihai@bu.edu	Liesa, Marc/K-8590-2019	Liesa, Marc/0000-0002-5909-8570; Carpenter, Liz/0000-0001-9138-2937	National Institutes of Health [R01HL071629-03 534, R01DK074778]; Fundacion Ramon Areces [535]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacion Ramon Areces; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grants R01HL071629-03 534 and R01DK074778 (to OSS). ML was a recipient of a post-doctoral fellowship from 535 Fundacion Ramon Areces and is an Evans Center Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksandrov L, 2001, J BIOL CHEM, V276, P12918, DOI 10.1074/jbc.M100515200; Aleksandrov L, 2008, BIOCHEM J, V416, P129, DOI 10.1042/BJ20081068; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Baker MA, 2004, J CELL SCI, V117, P211, DOI 10.1242/jcs.00842; Balakrishnan L, 2004, J BIOL CHEM, V279, P11273, DOI 10.1074/jbc.M308494200; Bayeva M, 2013, CIRC RES, V113, P279, DOI 10.1161/CIRCRESAHA.113.301552; Biswas EE, 2001, BIOCHEMISTRY-US, V40, P8181, DOI 10.1021/bi0106686; Brannd M., 1994, MOL BIOL CELL, V3rd, P672; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Crooks DR, 2010, BLOOD, V115, P860, DOI 10.1182/blood-2009-09-243105; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Geourjon C, 2001, TRENDS BIOCHEM SCI, V26, P539, DOI 10.1016/S0968-0004(01)01907-7; Guernsey DL, 2009, NAT GENET, V41, P651, DOI 10.1038/ng.359; Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Hu JJ, 2008, J BIOL CHEM, V283, P29126, DOI 10.1074/jbc.M803028200; Hyde BB, 2012, CELL DEATH DIFFER, V19, P1117, DOI 10.1038/cdd.2011.195; Jungsuwadee P, 2009, MOL PHARMACOL, V75, P1117, DOI 10.1124/mol.108.052209; Li CH, 1996, J BIOL CHEM, V271, P28463, DOI 10.1074/jbc.271.45.28463; Liesa M, 2012, BBA-MOL CELL RES, V1823, P1945, DOI 10.1016/j.bbamcr.2012.07.013; Liesa M, 2011, CIRCULATION, V124, P806, DOI 10.1161/CIRCULATIONAHA.110.003418; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Lushchak Volodymyr I, 2012, J Amino Acids, V2012, P736837, DOI 10.1155/2012/736837; Mari M, 2009, ANTIOXID REDOX SIGN, V11, P2685, DOI [10.1089/ars.2009.2695, 10.1089/ARS.2009.2695]; Matsumura Y, 2008, AM J PHYSIOL-LUNG C, V295, pL698, DOI 10.1152/ajplung.90352.2008; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; Minich T, 2006, J NEUROCHEM, V97, P373, DOI 10.1111/j.1471-4159.2006.03737.x; Muller M, 1996, J BIOL CHEM, V271, P1877; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Shirihai OS, 2000, EMBO J, V19, P2492, DOI 10.1093/emboj/19.11.2492; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tang LL, 2012, BRIT J HAEMATOL, V157, P151, DOI 10.1111/j.1365-2141.2011.08936.x; Ueda K, 1997, J BIOL CHEM, V272, P22983, DOI 10.1074/jbc.272.37.22983; Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Yamamoto M, 2014, MOL CELL BIOL, V34, P1077, DOI 10.1128/MCB.00865-13; Yao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005315	42	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129772	10.1371/journal.pone.0129772	http://dx.doi.org/10.1371/journal.pone.0129772			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053025	Green Published, gold			2022-12-26	WOS:000355955300162
J	Yang, C; Yang, ZY; Chen, XL; Liu, T; Gou, SM; Chen, CZ; Xiao, J; Jin, X; He, ZQ; Dong, LM; Zhang, YS; Luo, N; Wu, HS; Wang, CY				Yang, Chong; Yang, Zhiyong; Chen, Xinglin; Liu, Tao; Gou, Shanmiao; Chen, Changzhong; Xiao, Jun; Jin, Xin; He, Zhiqiang; Dong, Liming; Zhang, Yushun; Luo, Na; Wu, Heshui; Wang, Chunyou			Inverted U-Shaped Relationship between Central Venous Pressure and Intra-Abdominal Pressure in the Early Phase of Severe Acute Pancreatitis: A Retrospective Study	PLOS ONE			English	Article							ABDOMINAL COMPARTMENT SYNDROME; PREDICT FLUID RESPONSIVENESS; SURVIVING SEPSIS CAMPAIGN; RECEPTOR BLOCKADE; HYPERTENSION; MANAGEMENT; RESUSCITATION; GUIDELINES; CARE; ENDOTHELIN	Objective Many studies have indicated that intra-abdominal pressure (IAP) is positively correlated with central venous pressure (CVP) in severe cases. However, although elevated IAP is common in patients with severe acute pancreatitis (SAP), its relationship with CVP remains unclear. Our study aimed to investigate the association of IAP with CVP in early-phase SAP patients. Methods In total, 116 SAP patients were included in this retrospective study. On the first day of hospitalization, blood samples were collected for biochemical examination and cytokine concentration monitoring. Additionally, a urinary catheter and right subclavian vein catheter were inserted for IAP and CVP measurement, respectively. Other routine clinical data were also recorded. Results Within 24 hours after hospitalization, CVP fluctuated and increased with increasing IAP up to 15.7 mmHg (P = 0.054) but decreased with increasing IAP when the IAP was > 15.7 mmHg (P < 0.001). After adjusting for abdominal perfusion pressure (APP) and mean arterial pressure (MAP), a similar distribution was observed. An inverted U-shaped trend between IAP and CVP was also present in the groups classified according to the patient's sex, local complications, ascites, and serum amylase levels. Conclusions CVP and IAP have an inverted U-shaped relationship, with a peak at an IAP of 15.7 mmHg in the early phase of SAP. After this peak, CVP decreases as IAP increases. These results have crucial implications for clinical fluid resuscitation in SAP patients. In particular, because one CVP value might be correlated with different IAP values in patients with the same CVP, the volume of fluid needed might be different.	[Yang, Chong; Yang, Zhiyong; Gou, Shanmiao; He, Zhiqiang; Dong, Liming; Zhang, Yushun; Wu, Heshui; Wang, Chunyou] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Dis Inst, Wuhan 430074, Hubei Province, Peoples R China; [Yang, Chong] Sichuan Acad Med Sci, Organ Transplant Ctr, Chengdu, Sichuan Provinc, Peoples R China; [Yang, Chong] Sichuan Prov Peoples Hosp, Chengdu, Sichuan Provinc, Peoples R China; [Yang, Chong] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Sichuan Provinc, Peoples R China; [Chen, Xinglin] Huazhong Univ Sci & Technol, Key Lab Geriatr, Minist Hlth, Dept Geriatr,Union Hosp,Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Xiao, Jun; Jin, Xin] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Surg Oncol Abdominal Dept,Canc Ctr, Wuhan 430074, Hubei Province, Peoples R China; [Chen, Changzhong] Dana Farber Canc Inst, Microarray Core Facil, Boston, MA 02115 USA; [Luo, Na] Univ Hong Kong, Ctr Appl English Studies, Hong Kong, Hong Kong, Peoples R China	Huazhong University of Science & Technology; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Harvard University; Dana-Farber Cancer Institute; University of Hong Kong	Wu, HS (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Pancreat Dis Inst, Wuhan 430074, Hubei Province, Peoples R China.	heshuiwu@163.com; chunyouwang52@126.com		Yang, Chong/0000-0002-0060-706X; Jin, Xin/0000-0001-6461-6005; Chen, Xinglin/0000-0002-5820-9224	National Natural Science Foundation of China [81171840]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (No. 81171840). This funder did not participate in the development of the study or the manuscript, including study design, collection, analysis, or interpretation of the data; writing of the manuscript; or the decision to submit the paper for publication.	Aitken EL, 2014, SURGERY, V155, P910, DOI 10.1016/j.surg.2013.12.028; Al-Bahrani AZ, 2008, PANCREAS, V36, P39, DOI 10.1097/mpa.0b013e318149f5bf; Balthazar EJ, 2002, RADIOLOGY, V223, P603, DOI 10.1148/radiol.2233010680; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; BASSI D, 1994, J AM COLL SURGEONS, V179, P257; Bezmarevic M, 2012, PANCREATOLOGY, V12, P337, DOI 10.1016/j.pan.2012.05.007; Boldt J, 1998, INTENS CARE MED, V24, P147, DOI 10.1007/s001340050536; Boyd JH, 2011, CRIT CARE MED, V39, P259, DOI 10.1097/CCM.0b013e3181feeb15; BURCHARD KW, 1990, CRIT CARE MED, V18, P120, DOI 10.1097/00003246-199001000-00027; Chen H, 2008, WORLD J GASTROENTERO, V14, P3541, DOI 10.3748/wjg.14.3541; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; De Waele JJ, 2009, WORLD J SURG, V33, P1128, DOI 10.1007/s00268-009-9994-5; De Waele JJ, 2005, CRIT CARE, V9, pR452, DOI 10.1186/cc3754; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Eibl G, 2000, GUT, V46, P390, DOI 10.1136/gut.46.3.390; Forgacs B, 2000, EUR SURG RES, V32, P162, DOI 10.1159/000008758; Forsmark CE, 2007, GASTROENTEROLOGY, V132, P2022, DOI 10.1053/j.gastro.2007.03.065; Group of Pancreas Surgery Chinese Society of Surgery Chinese Medical Association, 2007, Zhonghua Wai Ke Za Zhi, V45, P727; Rosas JMH, 2007, SURGERY, V141, P173, DOI 10.1016/j.surg.2006.04.016; Hunter JD, 2004, ANAESTHESIA, V59, P899, DOI 10.1111/j.1365-2044.2004.03712.x; Johnson CD, 2005, GUT, V54, P1, DOI 10.1136/gut.200A.057026; Ke L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033125; Ke L, 2012, WORLD J SURG, V36, P171, DOI 10.1007/s00268-011-1295-0; Kuntscher MV, 2006, RESUSCITATION, V70, P37, DOI 10.1016/j.resuscitation.2005.12.001; Magder Sheldon, 2007, J Intensive Care Med, V22, P44, DOI 10.1177/0885066606295303; Magder S, 2006, CRIT CARE MED, V34, P2224, DOI 10.1097/01.CCM.0000227646.98423.98; Malbrain MLNG, 2006, INTENS CARE MED, V32, P1722, DOI 10.1007/s00134-006-0349-5; Marik PE, 2008, CHEST, V134, P172, DOI 10.1378/chest.07-2331; Marik PE, 2013, CRIT CARE MED, V41, P1774, DOI 10.1097/CCM.0b013e31828a25fd; Mayerle J, 2005, NAT CLIN PRACT GASTR, V2, P473, DOI 10.1038/ncpgasthep0293; McKinley BA, 2009, SHOCK, V32, P463, DOI 10.1097/SHK.0b013e3181a20ba9; Mitchell RM, 2013, LANCET, V9367, P1447; Otsuki M, 2006, WORLD J GASTROENTERO, V12, P3314, DOI 10.3748/wjg.v12.i21.3314; Pupelis G, 2006, HPB, V8, P227, DOI 10.1080/13651820500540956; Tenner S, 2013, AM J GASTROENTEROL, V108, P1400, DOI 10.1038/ajg.2013.218; Uhl W, 2003, PANCREATOLOGY, V3, DOI 10.1159/000067684; Valenza F, 2007, CRIT CARE MED, V35, P1575, DOI 10.1097/01.CCM.0000266589.58118.F0; Wang MD, 2013, CHINESE MED J-PEKING, V126, P1987, DOI 10.3760/cma.j.issn.0366-6999.20130194; Warndorf MG, 2011, CLIN GASTROENTEROL H, V9, P705, DOI 10.1016/j.cgh.2011.03.032; Yang Zhi-Yong, 2009, Zhonghua Wai Ke Za Zhi, V47, P1450; Yu XD, 2013, ENVIRON RES, V121, P79, DOI 10.1016/j.envres.2012.11.002	42	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128493	10.1371/journal.pone.0128493	http://dx.doi.org/10.1371/journal.pone.0128493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053865	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300042
J	Moreira, LAA; de Oliveira, DGR; de Sousa, MBC; Pessoa, DMA				Antonio Moreira, Lais Alves; Rodrigues de Oliveira, Danilo Gustavo; Cordeiro de Sousa, Maria Bernardete; Almeida Pessoa, Daniel Marques			Parturition Signaling by Visual Cues in Female Marmosets (Callithrix jacchus)	PLOS ONE			English	Article							COMMON MARMOSETS; COLOR-VISION; PRIMATE; EVOLUTION; PREGNANCY; SUPPRESSION; MONKEYS; FRUIT; SKIN	New World monkeys have polymorphic color vision, in which all males and some females are dichromats, while most females are trichromats. There is little consensus about which selective pressures fashioned primate color vision, although detection of food, mates and predators has been hypothesized. Behavioral evidence shows that males from different species of Neotropical primates seem to perceive the timing of female conception and gestation, although, no signals fulfilling this function have been identified. Therefore, we used visual models to test the hypothesis that female marmosets show chromatic and/or achromatic cues that may indicate the time of parturition for male and female conspecifics. By recording the reflectance spectra of female marmosets' (Callithrix jacchus) sexual skin, and running chromatic and achromatic discrimination models, we found that both variables fluctuate during the weeks that precede and succeed parturition, forming "U" and inverted "U" patterns for chromatic and achromatic contrast, respectively. We suggest that variation in skin chroma and luminance might be used by female helpers and dominant females to identify the timing of birth, while achromatic variations may be used as clues by potential fathers to identify pregnancy stage in females and prepare for paternal burdens as well as to detect oestrus in the early post-partum period.	[Antonio Moreira, Lais Alves; Almeida Pessoa, Daniel Marques] Univ Fed Rio Grande do Norte, Dept Physiol, Lab Sensory Ecol, BR-59072970 Natal, RN, Brazil; [Antonio Moreira, Lais Alves; Cordeiro de Sousa, Maria Bernardete] Univ Fed Rio Grande do Norte, Dept Physiol, Lab Behav Endocrinol, BR-59072970 Natal, RN, Brazil; [Antonio Moreira, Lais Alves; Cordeiro de Sousa, Maria Bernardete; Almeida Pessoa, Daniel Marques] Univ Fed Rio Grande do Norte, Dept Physiol, Lab Adv Study Primates, BR-59072970 Natal, RN, Brazil; [Rodrigues de Oliveira, Danilo Gustavo] Univ Brasilia, Dept Physiol Sci, Lab Neurosci & Behav, Brasilia, DF, Brazil; [Cordeiro de Sousa, Maria Bernardete] Univ Fed Rio Grande do Norte, Inst Brain, BR-59072970 Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade de Brasilia; Universidade Federal do Rio Grande do Norte	Pessoa, DMA (corresponding author), Univ Fed Rio Grande do Norte, Dept Physiol, Lab Sensory Ecol, BR-59072970 Natal, RN, Brazil.	pessoadma@cb.ufrn.br	Pessoa, Daniel Marques Almeida/G-4302-2011	Pessoa, Daniel Marques Almeida/0000-0002-2516-6766; Alves Antonio Moreira, Lais/0000-0001-8182-4551	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [478222/2006-8, 25674/2009, 302592/2009-1, 800074/2010-6, 306018/2013-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	LAAM received a M.Sc. scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). DMAP and MBCS were financed by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Proc. No.: 478222/2006-8 (DMAP), 25674/2009 (DMAP), 302592/2009-1 (MBCS), 800074/2010-6 (MBCS) and 306018/2013-6 (MBCS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT DH, 1984, AM J PRIMATOL, V6, P169, DOI 10.1002/ajp.1350060305; Pessoa DMA, 2014, AM J PRIMATOL, V76, P721, DOI 10.1002/ajp.22264; Antonio Moreira Lais Alves, 2013, Oecologia Australis, V17, P303; Baker AJ, 1996, AM J PRIMATOL, V38, P47, DOI 10.1002/(SICI)1098-2345(1996)38:1<47::AID-AJP5>3.0.CO;2-T; Barreto CE, 1996, THESIS FEDERAL U RIO; BARRETT J, 1990, J REPROD FERTIL, V90, P411; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Bradley BJ, 2008, EVOL ANTHROPOL, V17, P97, DOI 10.1002/evan.20164; Buchanan-Smith HM, 2005, AM J PRIMATOL, V67, P393, DOI 10.1002/ajp.20194; Caine NG, 2000, P ROY SOC B-BIOL SCI, V267, P439, DOI 10.1098/rspb.2000.1019; Castro DC, 2005, BRAZ J MED BIOL RES, V38, P65, DOI 10.1590/S0100-879X2005000100011; Changizi MA, 2006, BIOL LETT-UK, V2, P217, DOI 10.1098/rsbl.2006.0440; Clough D, 2009, INT J PRIMATOL, V30, P859, DOI 10.1007/s10764-009-9379-5; DIXSON AF, 1987, PHYSIOL BEHAV, V41, P577, DOI 10.1016/0031-9384(87)90314-3; Dominy NJ, 2001, NATURE, V410, P363, DOI 10.1038/35066567; dusenbery d. b, 1992, SENSORY ECOLOGY ORGA; Fedigan LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084872; French JA, 2007, COOPERATIVE BREEDING, P34; GARBER PA, 1994, AM J PRIMATOL, V34, P199, DOI 10.1002/ajp.1350340210; Gerald MS, 2010, NATURWISSENSCHAFTEN, V97, P89, DOI 10.1007/s00114-009-0619-5; Gerald MS, 2009, BEHAV PROCESS, V80, P7, DOI 10.1016/j.beproc.2008.08.001; Higham JP, 2013, BEHAV ECOL SOCIOBIOL, V67, P1381, DOI 10.1007/s00265-013-1590-x; Higham JP, 2011, P ROY SOC B-BIOL SCI, V278, P3452, DOI 10.1098/rspb.2011.0052; Higham JP, 2010, BEHAV ECOL, V21, P739, DOI 10.1093/beheco/arq047; Jacobs GH, 2007, INT J PRIMATOL, V28, P729, DOI 10.1007/s10764-007-9168-y; Jacobs GH, 2010, OPHTHAL PHYSL OPT, V30, P422, DOI 10.1111/j.1475-1313.2010.00719.x; KOENIG A, 1995, AM J PRIMATOL, V35, P311, DOI 10.1002/ajp.1350350407; Maia R, 2013, METHODS ECOL EVOL, V4, P906, DOI 10.1111/2041-210X.12069; Maryanski Alexandra, 1997, NONVERBAL COMMUNICAT, P191; Melin AD, 2014, INT J PRIMATOL, V35, P258, DOI 10.1007/s10764-013-9730-8; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Mota MTD, 2006, HORM BEHAV, V49, P293, DOI 10.1016/j.yhbeh.2005.07.012; Osorio D, 2004, AM NAT, V164, P696, DOI 10.1086/425332; Perini ES, 2009, J EXP ZOOL PART A, V311A, P289, DOI 10.1002/jez.531; PHILLIPS IR, 1975, J REPROD FERTIL, V43, P103; Russell WMS, 2005, ANIM WELFARE, V14, P279; Rylands Anthony B., 2009, P23, DOI 10.1007/978-0-387-78705-3_2; Saltzman W, 1997, AM J PRIMATOL, V41, P1, DOI 10.1002/(SICI)1098-2345(1997)41:1<1::AID-AJP1>3.0.CO;2-0; Saltzman W, 2009, P ROY SOC B-BIOL SCI, V276, P389, DOI 10.1098/rspb.2008.1374; Semple S, 2013, AM J PRIMATOL, V75, P613, DOI 10.1002/ajp.22139; Setchell JM, 2009, INT J PRIMATOL, V30, P825, DOI 10.1007/s10764-009-9371-0; Smith AC, 2005, INT J PRIMATOL, V26, P337, DOI 10.1007/s10764-005-2928-7; Sousa MBC, 2005, AM J PRIMATOL, V67, P37, DOI 10.1002/ajp.20168; Sousa MBC, 1997, PRIMATOLOGIA BRASIL, P155; SPERLING HC, 1971, SCIENCE, V172, P180, DOI 10.1126/science.172.3979.180; Stevens M, 2009, INT J PRIMATOL, V30, P893, DOI 10.1007/s10764-009-9356-z; Sumner P, 2000, J EXP BIOL, V203, P1963; Sumner P, 2003, AM J PRIMATOL, V59, P67, DOI 10.1002/ajp.10066; Tardif SD, 2003, COMPARATIVE MED, V53, P364; Waitt C, 2003, P ROY SOC B-BIOL SCI, V270, pS144, DOI 10.1098/rsbl.2003.0065; Yamamoto ME, 2009, DEV PRIMATOL-PROG PR, P119, DOI 10.1007/978-1-4419-0293-1_6; Ziegler TE, 2005, HORM BEHAV, V47, P56, DOI 10.1016/j.yhbeh.2004.08.009; Ziegler TE, 2006, BIOL LETT-UK, V2, P181, DOI 10.1098/rsbl.2005.0426	53	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129319	10.1371/journal.pone.0129319	http://dx.doi.org/10.1371/journal.pone.0129319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047350	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200150
J	Kaehler, N; Adhikar, B; Raut, S; Marahatta, SB; Chapman, RS				Kaehler, Nils; Adhikar, Bipin; Raut, Shristi; Marahatta, Sujan Babu; Chapman, Robert Sedgwick			Perceived Stigma towards Leprosy among Community Members Living Close to Nonsomboon Leprosy Colony in Thailand	PLOS ONE			English	Article							AFFECTED PERSONS; SOCIAL STIGMA; DIMENSIONS; PROVINCE; QUALITY; HEALTH	Background Interpretation of Leprosy as a sickness differs among society. The set of beliefs, knowledge and perceptions towards a disease play a vital role in the construction of stigma towards a disease. The main purpose of this study was to explore the extent and correlates of the perceived stigma towards leprosy in the community living close to the leprosy colony in Non Somboon region of Khon Kaen Province of Thailand. Methods A cross-sectional study was conducted among 257 leprosy unaffected community participants, above the age of 18 who were living close to the Leprosy colony in Non Somboon region of Thailand. Each participant was asked a questionnaire containing characteristics of the participants in terms of socio-demographic background and knowledge regarding the disease. In addition perceived stigma towards leprosy was measured using EMIC (Explanatory Model Interview Catalogue) questionnaire. Results Among EMIC items, shame or embarrassment in the community due to leprosy was felt by 54.5%, dislike to buy food from leprosy affected persons were 49.8% and difficulty to find work for leprosy affected persons were perceived by 47.1%. Higher total EMIC score was found in participants age 61 years or older (p = 0.021), staying longer in the community (p = 0.005), attending fewer years of education (p = 0.024) and who were unemployed (p = 0.08). Similarly, perceptions about leprosy such as difficult to treat (p = 0.015), severe disease (p = 0.004) and punishment by God (p = 0.011) were significantly associated with higher perceived stigma. Conclusions Perceived stigma towards leprosy was found highest among participants with age 61 years or older, longer duration of stay in community close to the leprosy colony, lower duration of education and participants who were unemployed had higher perceived stigma. Similarly, participants with perceptions of leprosy such as difficult to treat, severe disease and punishment by God had higher perceived stigma towards leprosy. There is an urgent need of stigma reduction strategies focused on education and awareness concerning leprosy.	[Kaehler, Nils] Sandefjord Helsepark, Sandefjord, Norway; [Adhikar, Bipin] Nepal Community Hlth & Dev Ctr, Kahmandu, Nepal; [Raut, Shristi] Lumbini Med Coll, Dept Microbiol, Palpa, Nepal; [Marahatta, Sujan Babu] Manmohan Mem Med Coll, Dept Community Med, Kathmandu, Nepal; [Chapman, Robert Sedgwick] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand	Chulalongkorn University	Adhikar, B (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand.	biopion@gmail.com	Adhikari, Bipin/X-3110-2019	Adhikari, Bipin/0000-0001-8981-3910				Adhikari B, 2013, J Nepal Health Res Counc, V11, P264; Adhikari B, 2013, J MANMOHAN MEMORIAL, V1, P3; Adhikari B, 2013, J HEALTH RES, V27, P295; Adhikari B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002940; Arole S, 2002, LEPROSY REV, V73, P186; Bainson KA, 1998, LEPROSY REV, V69, P341; Calcraft J.H., 2006, ASIA PACIFIC DIABILI, V17, P73; Chen SM, 2005, LEPROSY REV, V76, P335; de Stigter DH, 2000, LEPROSY REV, V71, P492; Ebenso B., 2007, ASIAN PAC DISAB REHA, V18, P98; Heijnders ML, 2004, INT J LEPROSY, V72, P437, DOI 10.1489/1544-581X(2004)72&lt;437:TDOSIL&gt;2.0.CO;2; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000230; Kaehler N, 2013, J HEALTH RES, V27, P359; Kampirapap K, 2005, LEPROSY REV, V76, P325; Kushwah S S, 1981, Lepr India, V53, P221; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Myint T, 1992, Indian J Lepr, V64, P313; Nagaraja V, 2011, STIGMA LEPROSY PATIE, V10; Navon L, 1998, SOC HIST MED, V11, P89, DOI 10.1093/shm/11.1.89; Paoli RD, 2004, BOOK REPORT STIGMA N, P1; Peters RMH, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003274; Pieri FM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003324; Predaswat P, 1992, THESIS U CALIFORNIA; Primkaew W, 2005, DIS PREVENTION CONTR, V2005; Rafferty J, 2005, LEPROSY REV, V76, P119; Rao PSS, 2009, INDIAN J LEPR, V80, P167; Rensen C, 2011, DISABIL REHABIL, V33, P711, DOI 10.3109/09638288.2010.506942; Rinaldi A, 2005, PLOS MED, V2, P1222, DOI 10.1371/journal.pmed.0020341; Sermrittirong S, 2014, LEPROSY REV, V85, P36; Nardi SMT, 2011, LEPROSY REV, V82, P55; Try L., 2006, ASIA PAC DISABIL REH, V17, P55; Tsutsumi A, 2007, SOC SCI MED, V64, P2443, DOI 10.1016/j.socscimed.2007.02.014; VALENCIA LB, 1989, INT J LEPROSY, V57, P847; van Brakel WH, 2003, INT J LEPROSY, V71, P190, DOI 10.1489/1544-581X(2003)71&lt;190:MLSPRO&gt;2.0.CO;2; van Brakel WH, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.18394; WEISS MG, 1992, BRIT J PSYCHIAT, V160, P819, DOI 10.1192/bjp.160.6.819; Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237	37	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129086	10.1371/journal.pone.0129086	http://dx.doi.org/10.1371/journal.pone.0129086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26047512	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200122
J	Kersemans, V; Kannan, P; Beech, JS; Bates, R; Irving, B; Gilchrist, S; Allen, PD; Thompson, J; Kinchesh, P; Casteleyn, C; Schnabel, J; Partridge, M; Muschel, RJ; Smart, SC				Kersemans, Veerle; Kannan, Pavitra; Beech, John S.; Bates, Russell; Irving, Benjamin; Gilchrist, Stuart; Allen, Philip D.; Thompson, James; Kinchesh, Paul; Casteleyn, Christophe; Schnabel, Julia; Partridge, Mike; Muschel, Ruth J.; Smart, Sean C.			Improving In Vivo High-Resolution CT Imaging of the Tumour Vasculature in Xenograft Mouse Models through Reduction of Motion and Bone-Streak Artefacts	PLOS ONE			English	Article							VOLUME COMPUTED-TOMOGRAPHY; MICRO-CT; MAMMARY CARCINOMAS; ANGIOGENESIS; VISUALIZATION; ENHANCEMENT; MULTISCALE	Introduction Preclinical in vivo CT is commonly used to visualise vessels at a macroscopic scale. However, it is prone to many artefacts which can degrade the quality of CT images significantly. Although some artefacts can be partially corrected for during image processing, they are best avoided during acquisition. Here, a novel imaging cradle and tumour holder was designed to maximise CT resolution. This approach was used to improve preclinical in vivo imaging of the tumour vasculature. Procedures A custom built cradle containing a tumour holder was developed and fix-mounted to the CT system gantry to avoid artefacts arising from scanner vibrations and out-of-field sample positioning. The tumour holder separated the tumour from bones along the axis of rotation of the CT scanner to avoid bone-streaking. It also kept the tumour stationary and insensitive to respiratory motion. System performance was evaluated in terms of tumour immobilisation and reduction of motion and bone artefacts. Pre- and post-contrast CT followed by sequential DCE-MRI of the tumour vasculature in xenograft transplanted mice was performed to confirm vessel patency and demonstrate the multimodal capacity of the new cradle. Vessel characteristics such as diameter, and branching were quantified. Results Image artefacts originating from bones and out-of-field sample positioning were avoided whilst those resulting from motions were reduced significantly, thereby maximising the resolution that can be achieved with CT imaging in vivo. Tumour vessels >= 77 mu m could be resolved and blood flow to the tumour remained functional. The diameter of each tumour vessel was determined and plotted as histograms and vessel branching maps were created. Multimodal imaging using this cradle assembly was preserved and demonstrated. Conclusions The presented imaging workflow minimised image artefacts arising from scanner induced vibrations, respiratory motion and radiopaque structures and enabled in vivo CT imaging and quantitative analysis of the tumour vasculature at higher resolution than was possible before. Moreover, it can be applied in a multimodal setting, therefore combining anatomical and dynamic information.	[Kersemans, Veerle; Kannan, Pavitra; Beech, John S.; Gilchrist, Stuart; Allen, Philip D.; Thompson, James; Kinchesh, Paul; Partridge, Mike; Muschel, Ruth J.; Smart, Sean C.] Univ Oxford, Canc Res UK, Oxford, England; [Kersemans, Veerle; Kannan, Pavitra; Beech, John S.; Gilchrist, Stuart; Allen, Philip D.; Thompson, James; Kinchesh, Paul; Partridge, Mike; Muschel, Ruth J.; Smart, Sean C.] Univ Oxford, MRC, Dept Oncol, Oxford Inst Radiat Oncol, Oxford, England; [Bates, Russell; Irving, Benjamin; Schnabel, Julia] Univ Oxford, Dept Engn Sci, Inst Biomed Engn, Oxford OX1 3PJ, England; [Casteleyn, Christophe] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Dept Vet Sci, Lab Appl Vet Morphol, Antwerp, Belgium	Cancer Research UK; University of Oxford; University of Oxford; University of Oxford; University of Antwerp	Kersemans, V (corresponding author), Univ Oxford, Canc Res UK, Oxford, England.	Veerle.Kersemans@oncology.ox.ac.uk	Irving, Benjamin/AAP-3317-2020; Kannan, Pavitra/I-2796-2019; Schnabel, Julia/ACE-6863-2022; Kersemans, Veerle/AAG-3005-2020	Irving, Benjamin/0000-0003-3879-2050; Kannan, Pavitra/0000-0002-9170-6062; Kersemans, Veerle/0000-0002-4669-236X; Allen, Danny/0000-0002-6200-0925; Schnabel, Julia Anne/0000-0001-6107-3009	Medical Research Council (MRC); Cancer Research United Kingdom (CRUK) [C5255/A12678, C2522/A10339]; Cancer Research UK [20407, 16049, 16466] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/M000133/1, 1363937] Funding Source: researchfish; EPSRC [EP/M000133/1] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research United Kingdom (CRUK)(Cancer Research UK); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors received funding for this study from both the Medical Research Council (MRC; http://www.mrc.ac.uk/) and Cancer Research United Kingdom (CRUK; www.cancerresearchuk.org/) (VK, PK, JSB, BI, SG, PDA, JT, PK, JS, MP, RJM, SCS); CRUK grant numbers: C5255/A12678 and C2522/A10339.	Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Boas EF, 2012, IMAGING MED, V4, P229, DOI DOI 10.2217/IIM.12.13; Cebulla J, 2014, ANGIOGENESIS, V17, P695, DOI 10.1007/s10456-014-9429-2; Choyke PL, 2003, J MAGN RESON IMAGING, V17, P509, DOI 10.1002/jmri.10304; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; Ehling J, 2014, AM J PATHOL, V184, P431, DOI 10.1016/j.ajpath.2013.10.014; Ehling J, 2013, THROMB HAEMOSTASIS, V109, P375, DOI 10.1160/TH12-10-0721; Eisa F, 2012, EUR RADIOL, V22, P900, DOI 10.1007/s00330-011-2318-9; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Jannasch K, 2009, INT J CANCER, V125, P62, DOI 10.1002/ijc.24332; Kersemans V, 2011, J NUCL MED, V52, P1827, DOI 10.2967/jnumed.111.089151; Kiessling F, 2004, NAT MED, V10, P1133, DOI 10.1038/nm1101; Kindlmann Gordon L, 2005, Mol Imaging, V4, P417; Lim E, 2011, JOVE-J VIS EXP, DOI 10.3791/2775; Missbach-Guentner J, 2008, NEOPLASIA, V10, P663, DOI 10.1593/neo.08270; Missbach-Guentner J, 2011, INT J DEV BIOL, V55, P535, DOI 10.1387/ijdb.103229jm; Mondy WL, 2013, MICROSC MICROANAL, V19, P1416, DOI 10.1017/S1431927613013421; Nebuloni L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086562; Nebuloni L, 2013, ACAD RADIOL, V20, P1247, DOI 10.1016/j.acra.2013.06.003; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seong JM, 2013, J KOREAN MED SCI, V28, P1703, DOI 10.3346/jkms.2013.28.12.1703; Toy R, 2013, ACS NANO, V7, P3118, DOI 10.1021/nn3053439; Trachet B, 2009, COMPUT METHOD BIOMEC, V12, P491, DOI 10.1080/10255840802695445; Vandeghinste B, 2011, MOL IMAGING BIOL, V13, P78, DOI 10.1007/s11307-010-0335-8; Willekens I, 2010, CONTRAST MEDIA MOL I, V5, P201, DOI 10.1002/cmmi.394; Zhu WL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086583	27	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128537	10.1371/journal.pone.0128537	http://dx.doi.org/10.1371/journal.pone.0128537			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046526	Green Published, gold			2022-12-26	WOS:000355652200074
J	Kurland, IJ; Broin, PO; Golden, A; Su, G; Meng, F; Liu, LB; Mohney, R; Kulkarni, S; Guha, C				Kurland, Irwin Jack; Broin, Pilib O.; Golden, Aaron; Su, Gang; Meng, Fan; Liu, Laibin; Mohney, Robert; Kulkarni, Shilpa; Guha, Chandan			Integrative Metabolic Signatures for Hepatic Radiation Injury	PLOS ONE			English	Article							INDUCED LIVER-DISEASE; INDOXYL SULFATE; BIOMARKERS; TOXICITY; IDENTIFICATION; RADIOTHERAPY; THERAPY; DAMAGE; CELLS; CYCLE	Background Radiation-induced liver disease (RILD) is a dose-limiting factor in curative radiation therapy (RT) for liver cancers, making early detection of radiation-associated liver injury absolutely essential for medical intervention. A metabolomic approach was used to determine metabolic signatures that could serve as biomarkers for early detection of RILD in mice. Methods Anesthetized C57BL/6 mice received 0, 10 or 50 Gy Whole Liver Irradiation (WLI) and were contrasted to mice, which received 10 Gy whole body irradiation (WBI). Liver and plasma samples were collected at 24 hours after irradiation. The samples were processed using Gas Chromatography/Mass Spectrometry and Liquid Chromatography/Mass Spectrometry. Results Twenty four hours after WLI, 407 metabolites were detected in liver samples while 347 metabolites were detected in plasma. Plasma metabolites associated with 50 Gy WLI included several amino acids, purine and pyrimidine metabolites, microbial metabolites, and most prominently bradykinin and 3-indoxyl-sulfate. Liver metabolites associated with 50 Gy WLI included pentose phosphate, purine, and pyrimidine metabolites in liver. Plasma biomarkers in common between WLI and WBI were enriched in microbial metabolites such as 3 indoxyl sulfate, indole-3-lactic acid, phenyllactic acid, pipecolic acid, hippuric acid, and markers of DNA damage such as 2-deoxyuridine. Metabolites associated with tryptophan and indoles may reflect radiation-induced gut microbiome effects. Predominant liver biomarkers in common between WBI and WLI were amino acids, sugars, TCA metabolites (fumarate), fatty acids (lineolate, n-hexadecanoic acid) and DNA damage markers (uridine). Conclusions We identified a set of metabolomic markers that may prove useful as plasma biomarkers of RILD and WBI. Pathway analysis also suggested that the unique metabolic changes observed after liver irradiation was an integrative response of the intestine, liver and kidney.	[Kurland, Irwin Jack] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Diabet Ctr,Stable Isotope & Metabol Core Facil, Bronx, NY 10467 USA; [Broin, Pilib O.; Golden, Aaron] Albert Einstein Coll Med, Dept Genet, Div Computat Genet, Bronx, NY 10467 USA; [Su, Gang; Meng, Fan] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Liu, Laibin; Kulkarni, Shilpa; Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Mohney, Robert] Metabolon, Durham, NC USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Michigan System; University of Michigan; Yeshiva University; Albert Einstein College of Medicine; Metabolon	Guha, C (corresponding author), Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA.	cguhamd@gmail.com		O Broin, Pilib/0000-0002-6702-8564	NIH [R01 DK064670, R33 CA121051, U19 AI091175]; Einstein DRTC [P60DK020541]; Einstein CMCR [1U19AI091175]; Metabolon; NATIONAL CANCER INSTITUTE [R33CA121051] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI091175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R01DK064670, P30DK041296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein DRTC; Einstein CMCR; Metabolon; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research was supported by NIH grants, R01 DK064670, R33 CA121051 and U19 AI091175 to CG. IJK was supported by P60DK020541 (Einstein DRTC) and 1U19AI091175 (Einstein CMCR). OB, AG, LL and CG were supported by 1U19AI091175 (Einstein CMCR). Additionally, Metabolon provided support in the form of salaries for author [RPM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Caruso JC, 1997, EDUC PSYCHOL MEAS, V57, P637, DOI 10.1177/0013164497057004009; Cheng JCH, 2004, INT J RADIAT ONCOL, V60, P1502, DOI 10.1016/j.ijrobp.2004.05.048; Coy SL, 2011, INT J RADIAT BIOL, V87, P802, DOI 10.3109/09553002.2011.556177; Dawson LA, 2005, SEMIN RADIAT ONCOL, V15, P279, DOI 10.1016/j.semradonc.2005.04.005; Deguchi T, 2002, KIDNEY INT, V61, P1760, DOI 10.1046/j.1523-1755.2002.00318.x; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; FAJARDO LF, 1980, ARCH PATHOL LAB MED, V104, P584; Gallazzini M, 2009, PHYSIOLOGY, V24, P245, DOI 10.1152/physiol.00009.2009; GERACI JP, 1994, RADIAT RES, V140, P249, DOI 10.2307/3578909; Guha C, 2002, HEPATOLOGY, V36, P354, DOI 10.1053/jhep.2002.34516; Guha C, 2001, INT J RADIAT ONCOL, V49, P451, DOI 10.1016/S0360-3016(00)01495-4; Guha C, 1999, CANCER RES, V59, P5871; Guha C, 2011, SEMIN RADIAT ONCOL, V21, P256, DOI 10.1016/j.semradonc.2011.05.003; HELD KD, 1993, RADIAT RES, V134, P383, DOI 10.2307/3578201; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Huang KC, 2003, KIDNEY INT, V64, P704, DOI 10.1046/j.1523-1755.2003.00118.x; INGOLD JA, 1965, AMER J ROENTGENOL RA, V93, P200; Johnson CH, 2012, RADIAT RES, V178, P328, DOI 10.1667/RR2950.1; Johnson CH, 2011, RADIAT RES, V175, P473, DOI 10.1667/RR2437.1; Kennedy AS, 2009, INT J RADIAT ONCOL, V74, P1494, DOI 10.1016/j.ijrobp.2008.10.005; Kohonen T, 2002, NEURAL NETWORKS, V15, P945, DOI 10.1016/S0893-6080(02)00069-2; Kurland IJ, 2013, ANN NY ACAD SCI, V1287, P1, DOI 10.1111/nyas.12116; LAWRENCE TS, 1995, INT J RADIAT ONCOL, V31, P1237, DOI 10.1016/0360-3016(94)00418-K; LAWRENCE TS, 1992, INT J RADIAT ONCOL, V23, P781, DOI 10.1016/0360-3016(92)90651-W; Lee MT, 2009, J CLIN ONCOL, V27, P1585, DOI 10.1200/JCO.2008.20.0600; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; Liang SX, 2005, CANCER-AM CANCER SOC, V103, P2181, DOI 10.1002/cncr.21012; Liu MC, 2008, J AM SOC NEPHROL, V19, P1360, DOI 10.1681/ASN.2007080901; Manna SK, 2013, J PROTEOME RES, V12, P2269, DOI 10.1021/pr400161k; Manna SK, 2011, J PROTEOME RES, V10, P4120, DOI 10.1021/pr200310s; McGinn CJ, 1998, J CLIN ONCOL, V16, P2246, DOI 10.1200/JCO.1998.16.6.2246; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Patterson AD, 2010, MASS SPECTROM REV, V29, P503, DOI 10.1002/mas.20272; REED GB, 1966, AM J PATHOL, V48, P597; Sempoux C, 1997, HEPATOLOGY, V26, P128; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Takayama F, 2003, AM J KIDNEY DIS, V41, pS142, DOI 10.1053/ajkd.2003.50104; Takemura K, 1998, NEPHRON, V78, P82, DOI 10.1159/000044886; Tuttle S, 2000, RADIAT RES, V153, P781, DOI 10.1667/0033-7587(2000)153[0781:GPDATO]2.0.CO;2; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Yannam GR, 2014, INT J RADIAT ONCOL, V88, P404, DOI 10.1016/j.ijrobp.2013.10.037	43	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0124795	10.1371/journal.pone.0124795	http://dx.doi.org/10.1371/journal.pone.0124795			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046990	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200008
J	Oh, MG; Han, MA; Park, J; Ryu, SY; Choi, SW				Oh, Myueng Guen; Han, Mi Ah; Park, Jong; Ryu, So Yeon; Choi, Seong-Woo			The Prevalence of Vitamin D Deficiency among Cancer Survivors in a Nationwide Survey of the Korean Population	PLOS ONE			English	Article							D INSUFFICIENCY; 25-HYDROXYVITAMIN D; CARDIOVASCULAR-DISEASE; SUNLIGHT EXPOSURE; BREAST; HEALTH; RISK; PROGNOSIS	Background Recent studies have shown that inadequate vitamin D levels are associated with a poor cancer prognosis, but data regarding actual vitamin D levels in cancer survivors are limited. This study investigated the vitamin D levels and prevalence of vitamin D deficiency among Korean cancer survivors compared with non-cancer controls, and identified the factors associated with vitamin D deficiency. Methods Using the Korea National Health and Nutrition Examination Survey (KNHANES), 915 cancer survivors and 29,694 controls without a history of cancer were selected. Serum 25(OH) D levels were measured; vitamin D deficiency was defined as 25(OH) D levels less than 20 ng/mL. Chi-square tests and multiple logistic regression analyses were used to evaluate the prevalence of vitamin D deficiency and associated factors. Results Vitamin D deficiency was observed in 62.7% of cancer survivors and 67.1% of controls. Among cancer survivors, vitamin D deficiency was most prevalent among 19-44 year olds (76.2%) and among managers, professionals, and related workers (79.3%). Multiple logistic regression analysis revealed that younger cancer survivors and those who work indoors were predisposed to vitamin D deficiency. Conclusion Vitamin D deficiency was prevalent among both cancer survivors and controls in Korea. The regular evaluation and management of vitamin D levels is needed for both bone health and general health in cancer survivors.	[Oh, Myueng Guen] Jeongup Asan Hosp, Dept Internal Med, Jeongup, South Korea; [Han, Mi Ah; Park, Jong; Ryu, So Yeon; Choi, Seong-Woo] Chosun Univ, Coll Med, Dept Prevent Med, Gwangju, South Korea	Chosun University	Han, MA (corresponding author), Jeongup Asan Hosp, Dept Internal Med, Jeongup, South Korea.	mahan@chosun.ac.kr						Anderson LN, 2011, AM J EPIDEMIOL, V174, P293, DOI 10.1093/aje/kwr091; Bachhel Rachna, 2015, Int J Appl Basic Med Res, V5, P7, DOI 10.4103/2229-516X.149220; Beloyartseva Maria, 2012, Arch Osteoporos, V7, P187, DOI 10.1007/s11657-012-0096-x; Blackmore KM, 2008, AM J EPIDEMIOL, V168, P915, DOI 10.1093/aje/kwn198; Choi HS, 2013, ENDOCRINOL METAB, V28, P12, DOI 10.3803/EnM.2013.28.1.12; Choi HS, 2011, J CLIN ENDOCR METAB, V96, P643, DOI 10.1210/jc.2010-2133; Choudhary A, 2013, PEDIATR BLOOD CANCER, V60, P1237, DOI 10.1002/pbc.24403; Christodoulou S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/396541; Chung JY, 2013, NUTR RES PRACT, V7, P495, DOI 10.4162/nrp.2013.7.6.495; El Hayek J, 2010, J NUTR, V140, P1839, DOI 10.3945/jn.110.124644; Finkelmeier F, 2014, ALIMENT PHARM THER, V39, P1204, DOI 10.1111/apt.12731; Forrest KYZ, 2011, NUTR RES, V31, P48, DOI 10.1016/j.nutres.2010.12.001; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3757, DOI 10.1200/JCO.2008.20.0725; Grant WB, 2012, DERM-ENDOCRINOL, V4, P203, DOI 10.4161/derm.20965; Guise TA, 2006, ONCOLOGIST, V11, P1121, DOI 10.1634/theoncologist.11-10-1121; Gupta D, 2011, EXP THER MED, V2, P181, DOI 10.3892/etm.2011.205; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Jang H, 2013, WOMEN HEALTH, V53, P504, DOI 10.1080/03630242.2013.806386; Jeong H, 2014, ANN OCCUP ENVIRON ME, V26, DOI 10.1186/s40557-014-0028-x; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Neuhouser ML, 2008, AM J CLIN NUTR, V88, P133, DOI 10.1093/ajcn/88.1.133; Park S, 2012, NUTR RES PRACT, V6, P162, DOI 10.4162/nrp.2012.6.2.162; Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Rose AAN, 2013, BREAST CANCER RES TR, V141, P331, DOI 10.1007/s10549-013-2713-9; Sinha A, 2011, PEDIATR BLOOD CANCER, V57, P594, DOI 10.1002/pbc.22963; Tang JY, 2012, J AM ACAD DERMATOL, V67, DOI [10.1016/j.jaad.2012.05.044, 10.1016/j.jaad.2012.07.022]; Tretli S, 2012, CANCER CAUSE CONTROL, V23, P363, DOI 10.1007/s10552-011-9885-6; Trukova KP, 2012, NUTR CLIN PRACT, V27, P122, DOI 10.1177/0884533611431461; Wesa KM, 2015, NUTR CANCER, V67, P424, DOI 10.1080/01635581.2015.998838	32	6	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129901	10.1371/journal.pone.0129901	http://dx.doi.org/10.1371/journal.pone.0129901			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047013	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200168
J	Tilleman, L; Abbruzzetti, S; Ciaccio, C; De Sanctis, G; Nardini, M; Pesce, A; Desmet, F; Moens, L; Van Doorslaer, S; Bruno, S; Bolognesi, M; Ascenzi, P; Coletta, M; Viappiani, C; Dewilde, S				Tilleman, Lesley; Abbruzzetti, Stefania; Ciaccio, Chiara; De Sanctis, Giampiero; Nardini, Marco; Pesce, Alessandra; Desmet, Filip; Moens, Luc; Van Doorslaer, Sabine; Bruno, Stefano; Bolognesi, Martino; Ascenzi, Paolo; Coletta, Massimo; Viappiani, Cristiano; Dewilde, Sylvia			Structural Bases for the Regulation of CO Binding in the Archaeal Protoglobin from Methanosarcina acetivorans	PLOS ONE			English	Article							LIGAND-BINDING; MYOGLOBIN; MIGRATION; METHANE; LIFE	Studies of CO ligand binding revealed that two protein states with different ligand affinities exist in the protoglobin from Methanosarcina acetivorans (in MaPgb*, residue Cys(E20)101 was mutated to Ser). The switch between the two states occurs upon the ligation of MaPgb*. In this work, site-directed mutagenesis was used to explore the role of selected amino acids in ligand sensing and stabilization and in affecting the equilibrium between the "more reactive" and "less reactive" conformational states of MaPgb*. A combination of experimental data obtained from electronic and resonance Raman absorption spectra, CO ligand-binding kinetics, and X-ray crystallography was employed. Three amino acids were assigned a critical role: Trp(60)B9, Tyr(61)B10, and Phe(93)E11. Trp(60)B9 and Tyr(61) B10 are involved in ligand stabilization in the distal heme pocket; the strength of their interaction was reflected by the spectra of the CO-ligated MaPgb* and by the CO dissociation rate constants. In contrast, Phe(93)E11 is a key player in sensing the heme-bound ligand and promotes the rotation of the Trp(60)B9 side chain, thus favoring ligand stabilization. Although the structural bases of the fast CO binding rate constant of MaPgb* are still unclear, Trp(60)B9, Tyr(61)B10, and Phe(93)E11 play a role in regulating heme/ligand affinity.	[Tilleman, Lesley; Moens, Luc; Dewilde, Sylvia] Univ Antwerp, Dept Biomed Sci, B-2020 Antwerp, Belgium; [Abbruzzetti, Stefania; Viappiani, Cristiano] Univ Parma, Dept Phys & Earth Sci, I-43100 Parma, Italy; [Ciaccio, Chiara; Coletta, Massimo] Univ Roma Tor Vergata, Dept Clin Sci & Translat Med, Rome, Italy; [Ciaccio, Chiara; Coletta, Massimo] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Nardini, Marco; Bolognesi, Martino] Univ Milan, Dept Biosci, Milan, Italy; [Pesce, Alessandra] Univ Genoa, Dept Phys, Genoa, Italy; [Ascenzi, Paolo] Univ Roma Tre, Interdept Lab Electron Microscopy, Rome, Italy; [Desmet, Filip; Van Doorslaer, Sabine] Univ Antwerp, Dept Phys, B-2020 Antwerp, Belgium; [Bruno, Stefano] Univ Parma, Dept Pharm, Parma, Italy	University of Antwerp; University of Parma; University of Rome Tor Vergata; University of Milan; University of Genoa; Roma Tre University; University of Antwerp; University of Parma	Viappiani, C (corresponding author), Univ Parma, Dept Phys & Earth Sci, I-43100 Parma, Italy.	cristiano.viappiani@fis.unipr.it; sylvia.dewilde@ua.ac.be	abbruzzetti, stefania/AAE-5518-2020; Bolognesi, Martino/B-7924-2017; abbruzzetti, stefania/M-8640-2015; Coletta, Massimiliano/GSN-5927-2022; Nardini, Marco/B-7842-2017; Coletta, Massimo/N-9049-2015; Bruno, Stefano/A-4582-2011; Van Doorslaer, Sabine/E-5050-2017; Viappiani, Cristiano/AAC-7579-2019	abbruzzetti, stefania/0000-0001-7685-8554; Bolognesi, Martino/0000-0002-9253-5170; abbruzzetti, stefania/0000-0001-7685-8554; Nardini, Marco/0000-0002-3718-2165; Bruno, Stefano/0000-0002-7890-2472; Van Doorslaer, Sabine/0000-0002-1685-9202; Viappiani, Cristiano/0000-0001-7470-4770; COLETTA, Massimiliano/0000-0002-5489-9467	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (Azioni Integrate Italia Spagna) [2008BFJ34R, IT10L1M59M]; Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina); University of Antwerp; Fund for Scientific Research, Flanders, Belgium [G.0247.09]; Ministry for University and Research of Italy (University Roma Tre, Roma, Italy); University of Milano	Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (Azioni Integrate Italia Spagna); Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina); University of Antwerp; Fund for Scientific Research, Flanders, Belgium(FWO); Ministry for University and Research of Italy (University Roma Tre, Roma, Italy); University of Milano	The authors acknowledge the Italian Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2008, 2008BFJ34R, and Azioni Integrate Italia Spagna 2009, IT10L1M59M), and Ministero degli Affari Esteri, Direzione generale per la promozione del sistema Paese (Progetti di Grande Rilevanza, Italia-Argentina 2011-2013), the University of Antwerp and the Fund for Scientific Research, Flanders, Belgium (Grant No G.0247.09) for financial support. This work was partially supported by grants from the Ministry for University and Research of Italy (University Roma Tre, Roma, Italy, "CLAR 2012") and by institutional funds from University of Milano (FIRST-2007 and PUR-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzetti S, 2006, PHOTOCH PHOTOBIO SCI, V5, P1109, DOI 10.1039/b610236k; Abbruzzetti S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033614; Cerda J, 1999, BIOSPECTROSCOPY, V5, P289; Ciaccio C, 2013, BBA-PROTEINS PROTEOM, V1834, P1813, DOI 10.1016/j.bbapap.2013.02.026; Das TK, 2000, BIOCHEMISTRY-US, V39, P837, DOI 10.1021/bi9922087; Das TK, 1999, J BIOL CHEM, V274, P4207, DOI 10.1074/jbc.274.7.4207; Dewilde S, 2001, J BIOL CHEM, V276, P38949, DOI 10.1074/jbc.M106438200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114; Ferry JG, 2006, MOL BIOL EVOL, V23, P1286, DOI 10.1093/molbev/msk014; Forti F, 2011, J PHYS CHEM B, V115, P13771, DOI 10.1021/jp208562b; Freitas TAK, 2004, P NATL ACAD SCI USA, V101, P6675, DOI 10.1073/pnas.0308657101; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGM, 2003, MOSFLM USER GUIDE MO; Lessner DJ, 2006, P NATL ACAD SCI USA, V103, P17921, DOI 10.1073/pnas.0608833103; Lou BS, 2000, BIOCHEMISTRY-US, V39, P12424, DOI 10.1021/bi001257c; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nardini M, 2008, EMBO REP, V9, P157, DOI 10.1038/sj.embor.7401153; Pesce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066144; Rother M, 2004, P NATL ACAD SCI USA, V101, P16929, DOI 10.1073/pnas.0407486101; Sottini S, 2005, J PHYS CHEM B, V109, P19523, DOI 10.1021/jp0540981; Sottini S, 2005, J PHYS CHEM B, V109, P11411, DOI 10.1021/jp0514224; SOWERS KR, 1984, APPL ENVIRON MICROB, V47, P971, DOI 10.1128/AEM.47.5.971-978.1984; Spiro TG, 2005, J INORG BIOCHEM, V99, P34, DOI 10.1016/j.jinorgbio.2004.09.026; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Van Doorslaer S, 2012, INORG CHEM, V51, P8834, DOI 10.1021/ic3007074	28	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0125959	10.1371/journal.pone.0125959	http://dx.doi.org/10.1371/journal.pone.0125959			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047471	Green Published, gold			2022-12-26	WOS:000355652200011
J	Wideman, JG; Moore, BP				Wideman, Jeremy G.; Moore, Blake P.			The Evolutionary History of MAPL (Mitochondria-Associated Protein Ligase) and Other Eukaryotic BAM/GIDE Domain Proteins	PLOS ONE			English	Article							E3 UBIQUITIN LIGASE; SALMON SALMO-SALAR; MAXIMUM-LIKELIHOOD; MIXED MODELS; MULAN; MITOPHAGY; REPLACEMENT; PEROXISOMES; BIOGENESIS; ACTIVATOR	MAPL (mitochondria-associated protein ligase, also called MULAN/GIDE/MUL1) is a multifunctional mitochondrial outer membrane protein found in human cells that contains a unique BAM (beside a membrane) domain and a C-terminal RING-finger domain. MAPL has been implicated in several processes that occur in animal cells such as NF-kB activation, innate immunity and antiviral signaling, suppression of PINK1/parkin defects, mitophagy in skeletal muscle, and caspase-dependent apoptosis. Previous studies demonstrated that the BAM domain is present in diverse organisms in which most of these processes do not occur, including plants, archaea, and bacteria. Thus the conserved function of MAPL and its BAM domain remains an open question. In order to gain insight into its conserved function, we investigated the evolutionary origins of MAPL by searching for homologues in predicted proteomes of diverse eukaryotes. We show that MAPL proteins with a conserved BAM-RING architecture are present in most animals, protists closely related to animals, a single species of fungus, and several multicellular plants and related green algae. Phylogenetic analysis demonstrated that eukaryotic MAPL proteins originate from a common ancestor and not from independent horizontal gene transfers from bacteria. We also determined that two independent duplications of MAPL occurred, one at the base of multicellular plants and another at the base of vertebrates. Although no other eukaryote genome examined contained a verifiable MAPL orthologue, BAM domain-containing proteins were identified in the protists Bigelowiella natans and Ectocarpus siliculosis. Phylogenetic analyses demonstrated that these proteins are more closely related to prokaryotic BAM proteins and therefore likely arose from independent horizontal gene transfers from bacteria. We conclude that MAPL proteins with BAM-RING architectures have been present in the holozoan and viridiplantae lineages since their very beginnings. Our work paves the way for future studies into MAPL function in alternative model organisms like Capsaspora owczarzaki and Chlamydomonas reinhardtii that will help to answer the question of MAPL's ancestral function in ways that cannot be answered by studying animal cells alone.	[Wideman, Jeremy G.; Moore, Blake P.] Univ Alberta, Augustana Fac, Dept Sci, Camrose, AB T4V 2R3, Canada; [Wideman, Jeremy G.] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB T6G 2H7, Canada	University of Alberta; University of Alberta	Wideman, JG (corresponding author), Univ Alberta, Augustana Fac, Dept Sci, Camrose, AB T4V 2R3, Canada.	jeremy.grant.wideman@gmail.com		Wideman, Jeremy/0000-0002-4426-9533				Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambivero CT, 2014, CELL SIGNAL, V26, P2921, DOI 10.1016/j.cellsig.2014.09.004; Andrade-Navarro MA, 2009, CURR OPIN CELL BIOL, V21, P560, DOI 10.1016/j.ceb.2009.04.005; Bae SH, 2012, CELL RES, V22, P873, DOI 10.1038/cr.2012.38; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Cilenti L, 2014, BBA-MOL CELL RES, V1843, P1295, DOI 10.1016/j.bbamcr.2014.03.027; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gray MW, 2014, COLD SPRING HARB PER, V6; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huynen MA, 2013, BBA-BIOENERGETICS, V1827, P224, DOI 10.1016/j.bbabio.2012.08.001; Jenkins K, 2013, IMMUNOL CELL BIOL, V91, P321, DOI 10.1038/icb.2013.7; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lokireddy S, 2012, CELL METAB, V16, P613, DOI 10.1016/j.cmet.2012.10.005; McLelland GL, 2014, EMBO J, V33, P282, DOI 10.1002/embj.201385902; Mohanty A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00268; Neuspiel M, 2008, CURR BIOL, V18, P102, DOI 10.1016/j.cub.2007.12.038; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Soubannier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052830; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sugiura A., 2014, EMBO J; Tacchi L, 2012, DEV COMP IMMUNOL, V38, P545, DOI 10.1016/j.dci.2012.08.004; Tacchi L, 2011, MOL IMMUNOL, V49, P558, DOI 10.1016/j.molimm.2011.10.005; Yun JN, 2014, ELIFE, V3, DOI 10.7554/eLife.01958; Zemirli N, 2014, FEBS J, V281, P3095, DOI 10.1111/febs.12846; Zhang BC, 2008, CELL RES, V18, P900, DOI 10.1038/cr.2008.75	29	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128795	10.1371/journal.pone.0128795	http://dx.doi.org/10.1371/journal.pone.0128795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047467	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200101
J	Zamparo, P; Zorzi, E; Marcantoni, S; Cesari, P				Zamparo, Paola; Zorzi, Elena; Marcantoni, Sara; Cesari, Paola			Is Beauty in the Eyes of the Beholder? Aesthetic Quality versus Technical Skill in Movement Evaluation of Tai Chi	PLOS ONE			English	Article							ACTION ANTICIPATION; BASKETBALL PLAYERS; VISUAL-PERCEPTION; BIOLOGICAL MOTION; DANCE PERCEPTION; RESONANCE; ACCURACY; SOCCER; SPEED	The aim of this study was to compare experts to naive practitioners in rating the beauty and the technical quality of a Tai Chi sequence observed in video-clips (of high and middle level performances). Our hypothesis are: i) movement evaluation will correlate with the level of skill expressed in the kinematics of the observed action but ii) only experts will be able to unravel the technical component from the aesthetic component of the observed action. The judgments delivered indicate that both expert and non-expert observers are able to discern a good from a mediocre performance; however, as expected, only experts discriminate the technical from the aesthetic component of the action evaluated and do this independently of the level of skill shown by the model (high or middle level performances). Furthermore, the judgments delivered were strongly related to the kinematic variables measured in the observed model, indicating that observers rely on specific movement kinematics (e.g. movement amplitude, jerk and duration) for action evaluation. These results provide evidence of the complementary functional role of visual and motor action representation in movement evaluation and underline the role of expertise in judging the aesthetic quality of movements.	[Zamparo, Paola; Zorzi, Elena; Marcantoni, Sara; Cesari, Paola] Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy	University of Verona	Zamparo, P (corresponding author), Univ Verona, Dept Neurol & Movement Sci, I-37100 Verona, Italy.	paola.zamparo@univr.it	Zamparo, Paola/AAF-7700-2020	Zamparo, Paola/0000-0002-6919-6721; Cesari, Paola/0000-0002-1705-6065				Abreu AM, 2012, EUR J NEUROSCI, V35, P1646, DOI 10.1111/j.1460-9568.2012.08104.x; Aglioti SM, 2008, NAT NEUROSCI, V11, P1109, DOI 10.1038/nn.2182; ALLARD F, 1980, Journal of Sport Psychology, V2, P14; Almasbakk B., 2000, ENERGETICS HUMAN ACT, P228; Basmajian JV, 1977, MUSCLES MOVEMENTS BA; Bertucco M, 2010, NEUROSCIENCE, V171, P205, DOI 10.1016/j.neuroscience.2010.08.023; Best D., 1974, BRIT J AESTHET, V14, P197, DOI DOI 10.1093/BJAESTHETICS/14.3.197; Blasing B, 2012, ACTA PSYCHOL, V139, P300, DOI 10.1016/j.actpsy.2011.12.005; Brown WM, 2005, NATURE, V438, P1148, DOI 10.1038/nature04344; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Chase W., 1973, VISUAL INFORM PROCES, P215, DOI [10.1016/b978-0-12-170150-5.50011-1, DOI 10.1016/B978-0-12-170150-5.50011-1, 10.1016/B978-0-12-170150-5.50011-1]; Cross ES, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00102; Didierjean A, 2005, VIS COGN, V12, P265, DOI 10.1080/13506280444000021A; Duarte M, 2007, EXP BRAIN RES, V180, P457, DOI 10.1007/s00221-007-0871-x; ENOKA RM, 1994, NEUROMECHANICAL BASI; Grafton ST, 2009, ANN NY ACAD SCI, V1156, P97, DOI 10.1111/j.1749-6632.2009.04425.x; Humphrey D R, 1983, Adv Neurol, V39, P347; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Knoblich G, 2001, PSYCHOL SCI, V12, P467, DOI 10.1111/1467-9280.00387; Makris S, 2015, SOC COGN AFFECT NEUR, V10, P342, DOI 10.1093/scan/nsu052; McPherson SL, 1999, RES Q EXERCISE SPORT, V70, P369, DOI 10.1080/02701367.1999.10608057; Naeve N, 2011, BIOL LETT, V7, P221, DOI [10.1098/rsbl.2010.0619, DOI 10.1098/RSBL.2010.0619]; Newell K.M, 1993, VARIABILITY MOTOR CO; Opacic T, 2009, J EXP PSYCHOL LEARN, V35, P1570, DOI 10.1037/a0017244; Orgs G, 2013, CONSCIOUS COGN, V22, P603, DOI 10.1016/j.concog.2013.03.010; Penrose JMT, 1995, J HUM MOVEMENT STUD, V29, P199; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; SCULLY DM, 1986, HUM MOVEMENT SCI, V5, P185, DOI 10.1016/0167-9457(86)90024-2; Tomeo E, 2013, CEREB CORTEX, V23, P2765, DOI 10.1093/cercor/bhs279; Torrents C, 2013, PERCEPTION, V42, P447, DOI 10.1068/p7117; WEWERS ME, 1990, RES NURS HEALTH, V13, P227, DOI 10.1002/nur.4770130405	31	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128357	10.1371/journal.pone.0128357	http://dx.doi.org/10.1371/journal.pone.0128357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26047473	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200061
J	Cruz, J; Sarmento, P; Carretero, MA; White, PCL				Cruz, Joana; Sarmento, Pedro; Carretero, Miguel A.; White, Piran C. L.			Exotic Fish in Exotic Plantations: A Multi-Scale Approach to Understand Amphibian Occurrence in the Mediterranean Region	PLOS ONE			English	Article							POND OCCUPANCY; TEMPORARY PONDS; PALMATE NEWT; LAND-USE; LANDSCAPE; HABITAT; FOREST; CONSERVATION; DIVERSITY; RESPONSES	Globally, amphibian populations are threatened by a diverse range of factors including habitat destruction and alteration. Forestry practices have been linked with low diversity and abundance of amphibians. The effect of exotic Eucalyptus spp. plantations on amphibian communities has been studied in a number of biodiversity hotspots, but little is known of its impact in the Mediterranean region. Here, we identify the environmental factors influencing the presence of six species of amphibians (the Caudata Pleurodeles waltl, Salamandra salamandra, Lissotriton boscai, Triturus marmoratus and the anurans Pelobates cultripes and Hyla arborea/meridionalis) occupying 88 ponds. The study was conducted in a Mediterranean landscape dominated by eucalypt plantations alternated with traditional use (agricultural, montados and native forest) at three different scales: local (pond), intermediate (400 metres radius buffer) and broad (1000 metres radius buffer). Using the Akaike Information Criterion for small samples (AICc), we selected the top-ranked models for estimating the probability of occurrence of each species at each spatial scale separately and across all three spatial scales, using a combination of covariates from the different magnitudes. Models with a combination of covariates at the different spatial scales had a stronger support than those at individual scales. The presence of predatory fish in a pond had a strong effect on Caudata presence. Permanent ponds were selected by Hyla arborea/meridionalis over temporary ponds. Species occurrence was not increased by a higher density of streams, but the density of ponds impacted negatively on Lissotriton boscai. The proximity of ponds occupied by their conspecifics had a positive effect on the occurrence of Lissotriton boscai and Pleurodeles waltl. Eucalypt plantations had a negative effect on the occurrence of the newt Lissotriton boscai and anurans Hyla arborea/meridionalis, but had a positive effect on the presence of Salamandra salamandra, while no effect on any of the other species was detected. In conclusion, eucalypts had limited effects on the amphibian community at the intermediate and broad scales, but predatory fish had a major impact when considering all the scales combined. The over-riding importance of introduced fish as a negative impact suggests that forest managers should prevent new fish introductions and eradicate fish from already-occupied ponds whenever possible.	[Cruz, Joana; White, Piran C. L.] Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England; [Cruz, Joana; Carretero, Miguel A.] Univ Porto, InBIO, CIBIO Res Ctr Biodivers & Genet Resources, P-4485661 Vairao, Vila Do Conde, Portugal; [Sarmento, Pedro] Univ Aveiro, CESAM, P-3810193 Aveiro, Portugal	University of York - UK; Universidade do Porto; Universidade de Aveiro	Cruz, J (corresponding author), Univ York, Dept Environm, York YO10 5DD, N Yorkshire, England.	terraetudo@gmail.com	Carretero, Miguel A/A-1472-2013; Cruz, Joana/M-5072-2013; White, Piran Crawfurd Limond/AAH-6851-2021	Carretero, Miguel A/0000-0002-2335-7198; White, Piran Crawfurd Limond/0000-0002-7496-5775; Cruz, Joana/0000-0001-5431-0520; Sarmento, Pedro/0000-0002-9215-4626	Fundacao para Ciencia e Tecnologia [SFRH/BD/63885/2009]	Fundacao para Ciencia e Tecnologia(Portuguese Foundation for Science and Technology)	Joana Cruz had financial support provided by Fundacao para Ciencia e Tecnologia (grant SFRH/ BD/63885/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003187; Aben J, 2012, ANIM CONSERV, V15, P658, DOI 10.1111/j.1469-1795.2012.00562.x; Adams MJ, 2011, J WILDLIFE MANAGE, V75, P30, DOI 10.1002/jwmg.29; Adams MJ, 2000, ECOL APPL, V10, P559, DOI 10.1890/1051-0761(2000)010[0559:PPATEO]2.0.CO;2; Adum GB, 2012, CONSERV BIOL, V27, P354, DOI [10.1111/cobi.120065152, DOI 10.1111/COBI.120065152]; Alarcos G, 2003, COLONIZATION AMPHIBI; Altmoos M, 2010, ACTA OECOL, V36, P548, DOI 10.1016/j.actao.2010.08.001; [Anonymous], [No title captured]; Aragon P, 2000, COPEIA, P874, DOI 10.1643/0045-8511(2000)000[0874:CCCIPS]2.0.CO;2; Barton K., 2013, MUMIN MULTI MODEL IN; Beja P, 2003, BIOL CONSERV, V114, P317, DOI 10.1016/S0006-3207(03)00051-X; Bosch J, 2006, CONSERV BIOL, V20, P180, DOI 10.1111/j.1523-1739.2005.00296.x; BRONMARK C, 1994, CONSERV BIOL, V8, P841, DOI 10.1046/j.1523-1739.1994.08030841.x; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burnham K.P., 2003, MODEL SELECTION MULT; Burton EC, 2009, J WILDLIFE MANAGE, V73, P269, DOI 10.2193/2007-562; Caetano M, 2007, MANUAL NOVA COS CART; Caetano MH, 1999, J HERPETOL, V33, P192, DOI 10.2307/1565714; Canhoto C, 2007, INT REV HYDROBIOL, V92, P173, DOI 10.1002/iroh.200510956; Chan-McLeod ACA, 2003, J WILDLIFE MANAGE, V67, P663, DOI 10.2307/3802673; da Silva FR, 2012, BIODIVERS CONSERV, V21, P1411, DOI 10.1007/s10531-012-0252-z; Denoel M, 2005, CONSERV BIOL, V19, P162, DOI 10.1111/j.1523-1739.2005.00001.x; DIAZ-PANIAGUA C, 1988, Amphibia-Reptilia, V9, P15, DOI 10.1163/156853888X00161; DIAZ-PANIAGUA C, 1985, Amphibia-Reptilia, V6, P307, DOI 10.1163/156853885X00317; DIAZPANIAGUA C, 1992, ECOGRAPHY, V15, P267, DOI 10.1111/j.1600-0587.1992.tb00034.x; Diego-Rasilla FJ, 2004, BEHAV ECOL SOCIOBIOL, V55, P556, DOI 10.1007/s00265-003-0740-y; Diego-Rasilla FJ, 2008, ETHOLOGY, V114, P808, DOI 10.1111/j.1439-0310.2008.01532.x; Diego-Rasilla FJ, 2007, BEHAV ECOL SOCIOBIOL, V61, P1329, DOI 10.1007/s00265-007-0363-9; Dodd C. K. J., 2010, AMPHIBIAN ECOLOGY CO; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; DUPUIS LA, 1995, CONSERV BIOL, V9, P645, DOI 10.1046/j.1523-1739.1995.09030645.x; Escoriza D, 2012, HYDROBIOLOGIA, V680, P233, DOI 10.1007/s10750-011-0936-5; Evans J, 2009, PLANTED FORESTS: USES, IMPACTS AND SUSTAINABILITY, P1, DOI 10.1079/9781845935641.0000; Fahrig L, 2001, BIOL CONSERV, V100, P65, DOI 10.1016/S0006-3207(00)00208-1; FAO, 2010, GLOB FOR RES ASS 201, DOI [10.1073/pnas.0910467107, DOI 10.1073/PNAS.0910467107]; Ferreira M, 2013, BIOL CONSERV, V165, P179, DOI 10.1016/j.biocon.2013.05.029; Ficetola GF, 2012, ECOGRAPHY, V35, P693, DOI 10.1111/j.1600-0587.2011.06483.x; Fife D.A., 2014, PACKAGE FIFER; Fogarty JH, 2003, J WILDLIFE MANAGE, V67, P186, DOI 10.2307/3803074; Freidenfelds NA, 2011, FOREST ECOL MANAG, V261, P2115, DOI 10.1016/j.foreco.2011.03.005; Garcia-Munoz E, 2013, ACTA OECOL, V49, P45, DOI 10.1016/j.actao.2013.02.013; Gardner TA, 2007, CONSERV BIOL, V21, P775, DOI 10.1111/j.1523-1739.2007.00659.x; Goiti U, 2008, J MAMMAL, V89, P493, DOI 10.1644/07-MAMM-A-054R2.1; Gomez-Rodriguez C, 2012, DIVERS DISTRIB, V18, P260, DOI 10.1111/j.1472-4642.2011.00837.x; Guerry AD, 2002, CONSERV BIOL, V16, P745, DOI 10.1046/j.1523-1739.2002.00557.x; Guthlin D, 2012, WILDLIFE BIOL, V18, P374, DOI 10.2981/11-065; Hakkinen J, 2001, CHEMOSPHERE, V44, P441, DOI 10.1016/S0045-6535(00)00295-2; Hamer AJ, 2004, AGR ECOSYST ENVIRON, V102, P299, DOI 10.1016/j.agee.2003.09.027; Hamer AJ, 2011, ECOL APPL, V21, P378, DOI 10.1890/10-0390.1; Hartel T, 2007, HYDROBIOLOGIA, V583, P173, DOI 10.1007/s10750-006-0490-8; Hecnar SJ, 1997, BIOL CONSERV, V79, P123, DOI 10.1016/S0006-3207(96)00113-9; Humbert JY, 2009, AGR ECOSYST ENVIRON, V130, P1, DOI 10.1016/j.agee.2008.11.014; IPMA/MAMAOT P, 2013, TEMP MED AR MED AN P; Jakob C, 2003, HYDROBIOLOGIA, V499, P51, DOI 10.1023/A:1026343618150; Janin A, 2012, CONSERV BIOL, V26, P923, DOI 10.1111/j.1523-1739.2012.01910.x; Jobbagy EG, 2003, BIOGEOCHEMISTRY, V64, P205, DOI 10.1023/A:1024985629259; Johnson PTJ, 2011, CONSERV BIOL, V25, P556, DOI 10.1111/j.1523-1739.2010.01645.x; Joly P, 2001, CONSERV BIOL, V15, P239, DOI 10.1046/j.1523-1739.2001.99200.x; Karraker NE, 2006, BIOL CONSERV, V131, P132, DOI 10.1016/j.biocon.2006.02.013; Kats LB, 2003, DIVERS DISTRIB, V9, P99, DOI 10.1046/j.1472-4642.2003.00013.x; KATS LB, 1988, ECOLOGY, V69, P1865, DOI 10.2307/1941163; Keller D, 2012, FRESHWATER BIOL, V57, P1373, DOI 10.1111/j.1365-2427.2012.02797.x; Kiesecker JM, 2001, CONSERV BIOL, V15, P1064, DOI 10.1046/j.1523-1739.2001.0150041064.x; Klug P, 2009, ECOGRAPHY, V32, P973, DOI 10.1111/j.1600-0587.2009.05857.x; Knapp RA, 2000, CONSERV BIOL, V14, P428, DOI 10.1046/j.1523-1739.2000.99099.x; Kovar R, 2009, AMPHIBIA-REPTILIA, V30, P367, DOI 10.1163/156853809788795236; Lemckert Francis L., 2004, Applied Herpetology, V1, P165, DOI 10.1163/157075403323012179; Lenhardt PP, 2013, BASIC APPL ECOL, V14, P442, DOI 10.1016/j.baae.2013.05.004; Manenti R, 2009, AMPHIBIA-REPTILIA, V30, P7, DOI 10.1163/156853809787392766; Mann RM, 2009, ENVIRON POLLUT, V157, P2903, DOI 10.1016/j.envpol.2009.05.015; Mazerolle MJ, 2005, ECOL APPL, V15, P824, DOI 10.1890/04-0502; Mazerolle MJ, 2005, CAN J ZOOL, V83, P455, DOI 10.1139/Z05-032; Mendham DS, 2011, AGR FOREST METEOROL, V151, P1568, DOI 10.1016/j.agrformet.2011.06.014; Montori A., 1997, HERPETOLOGIA BONNENS, P273; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Orizaola G, 2006, ANIM CONSERV, V9, P171, DOI 10.1111/j.1469-1795.2006.00023.x; PAVIGNANO I, 1990, Amphibia-Reptilia, V11, P311, DOI 10.1163/156853890X00014; Payne CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107862; Petitot M, 2014, ECOL EVOL, V4, P3538, DOI 10.1002/ece3.1207; PETRANKA JW, 1994, FOREST ECOL MANAG, V67, P135, DOI 10.1016/0378-1127(94)90012-4; Pilliod DS, 2010, DIVERS DISTRIB, V16, P959, DOI 10.1111/j.1472-4642.2010.00699.x; Popescu VD, 2012, FOREST ECOL MANAG, V270, P163, DOI 10.1016/j.foreco.2012.01.027; Popescu VD, 2011, ECOL APPL, V21, P1283, DOI 10.1890/10-0658.1; Pujol-Buxo E, 2013, OIKOS, V122, P19, DOI 10.1111/j.1600-0706.2012.20617.x; Reshetnikov AN, 2003, HYDROBIOLOGIA, V510, P83, DOI 10.1023/B:HYDR.0000008634.92659.b4; Ribeiro R, 2011, LANDSCAPE ECOL, V26, P673, DOI 10.1007/s10980-011-9592-4; Russell Anthony P., 2005, P151, DOI 10.1007/3-540-26604-6_7; Russell C, 2012, APPL GEOGR, V35, P247, DOI 10.1016/j.apgeog.2012.07.003; Sax DF, 2002, GLOBAL ECOL BIOGEOGR, V11, P49, DOI 10.1046/j.1466-822X.2001.00262.x; Scherer RD, 2012, POPUL ECOL, V54, P487, DOI 10.1007/s10144-012-0324-7; Schmutzer AC, 2008, FRESHWATER BIOL, V53, P2613, DOI 10.1111/j.1365-2427.2008.02072.x; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Semlitsch RD, 2009, BIOSCIENCE, V59, P853, DOI 10.1525/bio.2009.59.10.7; Semlitsch RD, 1998, CONSERV BIOL, V12, P1113, DOI 10.1046/j.1523-1739.1998.97274.x; Skaug H., 2011, GLMMADMB GEN LINEAR, V5, pr143; TEJEDO M, 1993, HERPETOLOGICA, V49, P287; Teplitsky C, 2003, OECOLOGIA, V134, P270, DOI 10.1007/s00442-002-1106-2; Todd BD, 2006, BIOL CONSERV, V133, P178, DOI 10.1016/j.biocon.2006.06.003; Todd BD, 2009, J APPL ECOL, V46, P554, DOI 10.1111/j.1365-2664.2009.01645.x; Trochet Audrey, 2014, Biodivers Data J, pe4123, DOI 10.3897/BDJ.2.e4123; Trumbo DR, 2012, LANDSCAPE ECOL, V27, P1183, DOI 10.1007/s10980-012-9770-z; Vallan D, 2002, J TROP ECOL, V18, P725, DOI 10.1017/S026646740200247X; Van Buskirk J, 2005, ECOLOGY, V86, P1936, DOI 10.1890/04-1237; van Strien MJ, 2014, ECOL APPL, V24, P327, DOI 10.1890/13-0442.1; Veysey JS, 2011, LANDSCAPE ECOL, V26, P661, DOI 10.1007/s10980-011-9590-6; Vie J-C, 2009, WILDLIFE CHANGING WO; Villero JMB, 1995, ANFIBIOS REPTILES PR; Waringer L, 1988, AMPHIBIA-REPTILIA, V9, P1723; WARINGER-LOSCHENKOHL A, 1988, Amphibia-Reptilia, V9, P219, DOI 10.1163/156853888X00314; Watt PJ, 1997, ANIM BEHAV, V54, P865, DOI 10.1006/anbe.1996.0512; Yonekura R, 2004, ICHTHYOL RES, V51, P176, DOI 10.1007/s10228-003-0200-8; Zanini F, 2009, DIVERS DISTRIB, V15, P469, DOI 10.1111/j.1472-4642.2008.00556.x; Zuur A. F., 2013, BEGINNERS GUIDE GLM; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	116	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129891	10.1371/journal.pone.0129891	http://dx.doi.org/10.1371/journal.pone.0129891			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061096	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500165
J	Huang, SS; Huang, BQ; Wang, GJ; Yuan, YY; Dai, P				Huang, Shasha; Huang, Bangqing; Wang, Guojian; Yuan, Yongyi; Dai, Pu			The Relationship between the p.V37I Mutation in GJB2 and Hearing Phenotypes in Chinese Individuals	PLOS ONE			English	Article							26 GENE GJB2; DEAFNESS	The most common cause of nonsyndromic autosomal recessive hearing loss is mutations in GJB2. The mutation spectrum and prevalence of mutations vary significantly among ethnic groups, and the relationship between p.V37I mutation in GJB2 and the hearing phenotype is controversial. Among the 3,864 patients in this study, 106 (2.74%) had a homozygous p.V37I variation or a compound p.V37I plus other GJB2 pathogenic mutation, a frequency that was significantly higher than that in the control group (600 individuals, 0%). The hearing loss phenotype ranged from mild to profound in all patients with the homozygous p.V37I variation or compound p.V37I plus other GJB2 pathogenic mutation. There was no difference in the distribution of the hearing level in the group with the homozygous p.V37I variation and the group with the compound p.V37I variation plus pathogenic mutation. Most patients (66.04%) with the V37I-homozygous variation or p.V37I plus other pathogenic mutation had a mild or moderate hearing level. This study found a definite relationship between p.V37I and deafness, and most patients who carried the pathogenic combination with p.V37I mutation had mild or moderate hearing loss. Therefore, otolaryngologists should consider that the milder phenotype might be caused by the GJB2 p.V37I mutation.	[Huang, Shasha; Wang, Guojian; Yuan, Yongyi; Dai, Pu] Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Huang, Bangqing; Yuan, Yongyi] Peoples Liberat Army Gen Hosp, Hainan Branch, Dept Otolaryngol, Haitang Bay, Sanya, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Dai, P (corresponding author), Peoples Liberat Army Gen Hosp, Dept Otolaryngol, Do 28 Fuxing Rd, Beijing, Peoples R China.	daipu301@vip.sina.com		Yuan, Yongyi/0000-0002-7936-4776	National Key Basic Research Development Plan (973) [2014CB541701, 2014CB541706]; Minister of Science and Technology of China [2012BAI09B00]; Chinese National Nature Science Foundation Research Grants [81230020, 81200751, 81371096]; State 863 High Technology R&D Key Project of China [2012AA020101]; Postdoctoral Science Foundation Grant of China [2013M542450]	National Key Basic Research Development Plan (973); Minister of Science and Technology of China; Chinese National Nature Science Foundation Research Grants; State 863 High Technology R&D Key Project of China; Postdoctoral Science Foundation Grant of China	This work was supported by National Key Basic Research Development Plan (973) (2014CB541701, 2014CB541706), the Minister of Science and Technology of China (2012BAI09B00), Chinese National Nature Science Foundation Research Grants (81230020, 81200751, 81371096), State 863 High Technology R&D Key Project of China (2012AA020101), Postdoctoral Science Foundation Grant of China (2013M542450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruzzone R, 2003, FEBS LETT, V533, P79, DOI 10.1016/S0014-5793(02)03755-9; Chai Y, 2015, CLIN GENET, V87, P350, DOI 10.1111/cge.12387; Dahl HHM, 2006, J MED GENET, V43, P850, DOI 10.1136/jmg.2006.042051; Dai P, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-26; Estivill X, 1998, LANCET, V351, P394, DOI 10.1016/S0140-6736(97)11124-2; Gabriel H, 2001, Hum Mutat, V17, P521, DOI 10.1002/humu.1138; Hilgert N, 2009, EUR J HUM GENET, V17, P517, DOI 10.1038/ejhg.2008.201; Huang SS, 2013, MITOCHONDRION, V13, P791, DOI 10.1016/j.mito.2013.05.004; Huang SS, 2013, INT J PEDIATR OTORHI, V77, P379, DOI 10.1016/j.ijporl.2012.11.031; Kelley PM, 1998, AM J HUM GENET, V62, P792, DOI 10.1086/301807; Kim SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061592; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036621; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Snoeckx RL, 2005, AM J HUM GENET, V77, P945, DOI 10.1086/497996; Tsukada K, 2010, CLIN GENET, V78, P464, DOI 10.1111/j.1399-0004.2010.01407.x; Wattanasirichaigoon D, 2004, CLIN GENET, V66, P452, DOI 10.1111/j.1399-0004.2004.00325.x; Welch KO, 2007, AM J MED GENET A, V143A, P1567, DOI 10.1002/ajmg.a.31701; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79; Yuan YY, 2009, AM J MED GENET A, V149A, P689, DOI 10.1002/ajmg.a.32461	20	16	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129662	10.1371/journal.pone.0129662	http://dx.doi.org/10.1371/journal.pone.0129662			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061099	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500153
J	Robson, RL; Jones, R; Robson, RM; Schwartz, A; Richardson, TH				Robson, Robert L.; Jones, Robert; Robson, R. Moyra; Schwartz, Ariel; Richardson, Toby H.			Azotobacter Genomes: The Genome of Azotobacter chroococcum NCIMB 8003 (ATCC 4412)	PLOS ONE			English	Article							AEROBIC NITROGEN-FIXATION; RIBONUCLEOTIDE REDUCTASE; PSEUDOMONAS-AERUGINOSA; VANADIUM NITROGENASE; STRUCTURAL GENES; VINELANDII; OXYGEN; HYDROGENASE; SYSTEM; BIOSYNTHESIS	The genome of the soil-dwelling heterotrophic N-2-fixing Gram-negative bacterium Azotobacter chroococcum NCIMB 8003 (ATCC 4412) (Ac-8003) has been determined. It consists of 7 circular replicons totalling 5,192,291 bp comprising a circular chromosome of 4,591,803 bp and six plasmids pAcX50a, b, c, d, e, f of 10,435 bp, 13,852, 62,783, 69,713, 132,724, and 311,724 bp respectively. The chromosome has a G+C content of 66.27% and the six plasmids have G+C contents of 58.1, 55.3, 56.7, 59.2, 61.9, and 62.6% respectively. The methylome has also been determined and 5 methylation motifs have been identified. The genome also contains a very high number of transposase/inactivated transposase genes from at least 12 of the 17 recognised insertion sequence families. The Ac-8003 genome has been compared with that of Azotobacter vinelandii ATCC BAA-1303 (Av-DJ), a derivative of strain O, the only other member of the Azotobacteraceae determined so far which has a single chromosome of 5,365,318 bp and no plasmids. The chromosomes show significant stretches of synteny throughout but also reveal a history of many deletion/insertion events. The Ac-8003 genome encodes 4628 predicted protein-encoding genes of which 568 (12.2%) are plasmid borne. 3048 (65%) of these show > 85% identity to the 5050 protein-encoding genes identified in Av-DJ, and of these 99 are plasmid-borne. The core biosynthetic and metabolic pathways and macromolecular architectures and machineries of these organisms appear largely conserved including genes for CO-dehydrogenase, formate dehydrogenase and a soluble NiFe-hydrogenase. The genetic bases for many of the detailed phenotypic differences reported for these organisms have also been identified. Also many other potential phenotypic differences have been uncovered. Properties endowed by the plasmids are described including the presence of an entire aerobic corrin synthesis pathway in pAcX50f and the presence of genes for retro-conjugation in pAcX50c. All these findings are related to the potentially different environmental niches from which these organisms were isolated and to emerging theories about how microbes contribute to their communities.	[Robson, Robert L.; Robson, R. Moyra] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Jones, Robert] Craic Comp LLC, Seattle, WA USA; [Schwartz, Ariel; Richardson, Toby H.] Synthet Genom, La Jolla, CA USA	University of Reading	Robson, RL (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	r.l.robson@reading.ac.uk						Al-Attar S, 2011, BIOL CHEM, V392, P277, DOI 10.1515/BC.2011.042; Aleem A, 2003, BIORESOURCE TECHNOL, V86, P7, DOI 10.1016/S0960-8524(02)00134-7; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahl MI, 2007, PLASMID, V58, P31, DOI 10.1016/j.plasmid.2006.11.007; BALAJEE S, 1990, INDIAN J EXP BIOL, V28, P1082; Banerjee A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084574; Becking JH, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P759, DOI 10.1007/0-387-30746-x_26; Beijerinck MW, 1901, ARCH NEERL SCI 2, V8, P190; Bertsova YV, 2001, J BACTERIOL, V183, P6869, DOI 10.1128/JB.183.23.6869-6874.2001; Bertsova YV, 1998, BBA-BIOENERGETICS, V1363, P125, DOI 10.1016/S0005-2728(97)00094-7; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; BINGLE WH, 1987, J BACTERIOL, V169, P802, DOI 10.1128/jb.169.2.802-810.1987; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Boyd ES, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00201; BROWN ME, 1970, PLANT SOIL, V32, P250, DOI 10.1007/BF01372864; Cornish AS, 1998, MICROBIOL-UK, V144, P1747, DOI 10.1099/00221287-144-7-1747; DALTON H, 1968, J GEN MICROBIOL, V54, P463, DOI 10.1099/00221287-54-3-463; DALTON H, 1969, J GEN MICROBIOL, V56, P307, DOI 10.1099/00221287-56-3-307; DEINEMA MH, 1971, ARCH MIKROBIOL, V78, P42, DOI 10.1007/BF00409087; Demange P, 1986, IRON SIDEROPHORES PL, P131; DROZD J, 1970, Journal of General Microbiology, V63, P63; DU LS, 1994, J MOL BIOL, V243, P549, DOI 10.1016/0022-2836(94)90029-9; DUFF JT, 1961, J GEN MICROBIOL, V24, P273, DOI 10.1099/00221287-24-2-273; Eisen JA, 2000, GENOME BIOL, V1; ELESSAWY AA, 1984, ZBL MIKROBIOL, V139, P335, DOI 10.1016/S0232-4393(84)80011-6; FALLIK E, 1990, NUCLEIC ACIDS RES, V18, P4616, DOI 10.1093/nar/18.15.4616; FEKETE FA, 1989, APPL ENVIRON MICROB, V55, P298, DOI 10.1128/AEM.55.2.298-305.1989; FITZMAURICE WP, 1989, MOL GEN GENET, V218, P340, DOI 10.1007/BF00331287; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; FORD CM, 1990, MOL MICROBIOL, V4, P999, DOI 10.1111/j.1365-2958.1990.tb00672.x; FU HI, 1989, J BACTERIOL, V171, P4679, DOI 10.1128/jb.171.9.4679-4685.1989; Gimmestad M, 2006, J BACTERIOL, V188, P5551, DOI 10.1128/JB.00236-06; Gleason FK, 2002, J BACTERIOL, V184, P6544, DOI 10.1128/JB.184.23.6544-6550.2002; GUERRERO MG, 1975, ARCH MICROBIOL, V102, P91, DOI 10.1007/BF00428351; Guerrero MG, 1973, ARCH MICROBIOL, V102, P91; Haines AS, 2006, MICROBIOL-SGM, V152, P2689, DOI 10.1099/mic.0.28941-0; HARDISSO.C, 1969, J GEN MICROBIOL, V59, P1; Herter S, 2011, APPL MICROBIOL BIOT, V90, P1037, DOI 10.1007/s00253-011-3093-x; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hoeser J, 2014, FEBS LETT, V588, P1537, DOI 10.1016/j.febslet.2014.03.036; Hoidal HK, 2000, ENVIRON MICROBIOL, V2, P27, DOI 10.1046/j.1462-2920.2000.00074.x; KELLY M, 1969, BIOCHIM BIOPHYS ACTA, V171, P9, DOI 10.1016/0005-2744(69)90101-6; KELLY M, 1968, BIOCHEM J, V107, P1, DOI 10.1042/bj1070001; KENNEDY C, 1987, ANNU REV MICROBIOL, V41, P227, DOI 10.1146/annurev.mi.41.100187.001303; Kennedy CJ, 2007, BERGEYS MANUAL SYS B, P385; Kirakosyan AV, 1964, DOKLADY AKAD NAUK AR, V17, P33; Klassen JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011257; KRAKOW JS, 1963, BIOCHEM Z, V338, P796; Krasil'nikov NA, 1949, GUIDE BACTERIA ACTIO; Kummerli R, 2009, P ROY SOC B-BIOL SCI, V276, P3531, DOI 10.1098/rspb.2009.0861; Lau WWY, 2006, ENVIRON MICROBIOL, V8, P1688, DOI 10.1111/j.1462-2920.2006.01092.x; Lipman JG, 1903, REP NJ ST AGR EXP ST, P217; MADKOUR MA, 1990, APPL ENVIRON MICROB, V56, P2876, DOI 10.1128/AEM.56.9.2876-2881.1990; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MAIA M, 1988, J BACTERIOL, V170, P1984, DOI 10.1128/jb.170.4.1984-1985.1988; MartinezSalazar JM, 1996, J BACTERIOL, V178, P1800, DOI 10.1128/jb.178.7.1800-1808.1996; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; MERGEAY M, 1987, MOL GEN GENET, V209, P61, DOI 10.1007/BF00329837; Michel F, 2007, BIOCHIMIE, V89, P542, DOI 10.1016/j.biochi.2007.01.017; MOSHIRI F, 1994, MOL MICROBIOL, V14, P101, DOI 10.1111/j.1365-2958.1994.tb01270.x; Munoz-Centeno MC, 1996, BIOCHEM J, V298, P641; Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x; NIETO KF, 1989, SOIL BIOL BIOCHEM, V21, P967, DOI 10.1016/0038-0717(89)90089-8; Noar JD, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00313-13; Norberg P, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1267; Nunez C, 1999, J BACTERIOL, V181, P141; Ozen AI, 2012, MICROB ECOL, V63, P239, DOI 10.1007/s00248-011-9914-8; Ozer EA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-737; PAGE WJ, 1986, APPL ENVIRON MICROB, V51, P510, DOI 10.1128/AEM.51.3.510-514.1986; PAGE WJ, 1987, APPL ENVIRON MICROB, V53, P1418, DOI 10.1128/AEM.53.7.1418-1424.1987; PAGE WJ, 1991, INT J SYST BACTERIOL, V41, P369, DOI 10.1099/00207713-41-3-369; PARTRIDGE CDP, 1980, J GEN MICROBIOL, V119, P313; Pecina A, 1999, J BACTERIOL, V181, P1409; Perez JFC, 2007, ARCH LATINOAM NUTR, V57, P211; Poole RK, 1977, BIOSCIENCE REP, V17, P303; PROSSER J, 1988, J BACTERIOL, V170, P1990, DOI 10.1128/jb.170.4.1990-1993.1988; RAMOS JL, 1985, J BACTERIOL, V162, P746, DOI 10.1128/JB.162.2.746-751.1985; Rankin DJ, 2011, HEREDITY, V106, P1, DOI 10.1038/hdy.2010.24; Rediers H, 2004, MICROBIOL-SGM, V150, P1117, DOI 10.1099/mic.0.27096-0; Riera J, 1997, P NATL ACAD SCI USA, V94, P475, DOI 10.1073/pnas.94.2.475; ROBSON RL, 1984, J GEN MICROBIOL, V130, P1603; ROBSON RL, 1979, BIOCHEM J, V181, P569, DOI 10.1042/bj1810569; ROBSON RL, 1986, NATURE, V322, P388, DOI 10.1038/322388a0; ROBSON RL, 1989, EMBO J, V8, P1217, DOI 10.1002/j.1460-2075.1989.tb03495.x; Rodionov DA, 2003, J BIOL CHEM, V278, P41148, DOI 10.1074/jbc.M305837200; Romling U, 2002, RES MICROBIOL, V153, P205, DOI 10.1016/S0923-2508(02)01316-5; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Rubenchik LI, 1960, AZOTOBACTER ITS USES; Ryan MP, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-242; Sabra W, 2000, APPL ENVIRON MICROB, V66, P4037, DOI 10.1128/AEM.66.9.4037-4044.2000; SADOFF HL, 1975, BACTERIOL REV, V39, P516, DOI 10.1128/MMBR.39.4.516-539.1975; SAITIA S, 1989, BIOTECHNOL LETT, V11, P713, DOI 10.1007/BF01044103; SCHERINGS G, 1983, EUR J BIOCHEM, V135, P591, DOI 10.1111/j.1432-1033.1983.tb07693.x; Setubal JC, 2009, J BACTERIOL, V191, P4534, DOI 10.1128/JB.00504-09; Shapiro JA, 1999, GENETICA, V107, P171, DOI 10.1023/A:1003977827511; SHIVPRASAD S, 1989, APPL ENVIRON MICROB, V55, P1811, DOI 10.1128/AEM.55.7.1811-1817.1989; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; SINDHU SS, 1989, ZBL MIKROBIOL, V144, P97, DOI 10.1016/S0232-4393(89)80071-X; Smith NR, 1935, J BACTERIOL, V30, P323, DOI 10.1128/JB.30.3.323-328.1935; Steinberg RA, 1938, J AGRIC RES, V57, P0461; STOCKDALE H, 1968, J BACTERIOL, V95, P1798, DOI 10.1128/JB.95.5.1798-1803.1968; Tanabe T, 2003, J BACTERIOL, V185, P6938, DOI 10.1128/JB.185.23.6938-6949.2003; Taylor DE, 1999, TRENDS MICROBIOL, V7, P111, DOI 10.1016/S0966-842X(99)01454-7; Thompson JP, 1979, AZOTOBACTERACEAE TAX; TIBELIUS KH, 1993, GENE, V127, P53, DOI 10.1016/0378-1119(93)90616-B; Tillier ERM, 2000, NAT GENET, V26, P195, DOI 10.1038/79918; Tindale AE, 2000, MICROBIOL-SGM, V146, P1617, DOI 10.1099/00221287-146-7-1617; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Touchon M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011126; Turner RJ, 2001, CAN J MICROBIOL, V47, P33, DOI 10.1139/cjm-47-1-33; TYNDALL C, 1994, J MOL BIOL, V237, P266, DOI 10.1006/jmbi.1994.1230; VanOrsdel CE, 2013, J BACTERIOL, V195, P3640, DOI 10.1128/JB.00324-13; VEGA JM, 1973, BIOCHEM J, V133, P701, DOI 10.1042/bj1330701; WALKER CC, 1978, BIOCHIMIE, V60, P225, DOI 10.1016/S0300-9084(78)80818-9; Wu GH, 2000, J BIOL CHEM, V275, P4679, DOI 10.1074/jbc.275.7.4679; YATES MG, 1975, EUR J BIOCHEM, V60, P467, DOI 10.1111/j.1432-1033.1975.tb21025.x; Yoneyama F, 2011, J APPL MICROBIOL, V111, P932, DOI 10.1111/j.1365-2672.2011.05109.x; Young JM, 2007, INT J SYST EVOL MICR, V57, P2894, DOI 10.1099/ijs.0.64969-0; Zhang Y, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-78; Zhang Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00110	122	29	32	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127997	10.1371/journal.pone.0127997	http://dx.doi.org/10.1371/journal.pone.0127997			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061173	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000355979500070
J	Hove, RM; Ziemann, M; Bhave, M				Hove, Runyararo M.; Ziemann, Mark; Bhave, Mrinal			Identification and Expression Analysis of the Barley (Hordeum vulgare L.) Aquaporin Gene Family	PLOS ONE			English	Article							MEMBRANE INTRINSIC PROTEINS; FUNCTIONAL-CHARACTERIZATION; SILICON TRANSPORTER; PLANT AQUAPORINS; PIP AQUAPORINS; WATER CHANNELS; STRESS; RICE; MECHANISMS; BORON	Aquaporins (AQPs) are major intrinsic proteins (MIPs) that mediate bidirectional flux of water and other substrates across cell membranes, and play critical roles in plant-water relations, dehydration stress responses and crop productivity. However, limited data are available as yet on the contributions of these proteins to the physiology of the major crop barley (Hordeum vulgare). The present work reports the identification and expression analysis of the barley MIP family. A comprehensive search of publicly available leaf mRNA-seq data, draft barley genome data, GenBank transcripts and sixteen new annotations together revealed that the barley MIP family is comprised of at least forty AQPs. Alternative splicing events were likely in two plasma membrane intrinsic protein (PIP) AQPs. Analyses of the AQP signature sequences and specificity determining positions indicated a potential of several putative AQP isoforms to transport non-aqua substrates including physiological important substrates, and respond to abiotic stresses. Analysis of our publicly available leaf mRNA-seq data identified notable differential expression of HvPIP1;2 and HvTIP4;1 under salt stress. Analyses of other gene expression resources also confirmed isoform-specific responses in different tissues and/or in response to salinity, as well as some potentially inter-cultivar differences. The work reports systematic and comprehensive analysis of most, if not all, barley AQP genes, their sequences, expression patterns in different tissues, potential transport and stress response functions, and a strong framework for selection and/or development of stress tolerant barley varieties. In addition, the barley data would be highly valuable for genetic studies of the evolutionarily closely related wheat (Triticum aestivum L.).	[Hove, Runyararo M.; Bhave, Mrinal] Swinburne Univ Technol, Fac Sci Engn & Technol, Hawthorn, Vic 3122, Australia; [Ziemann, Mark] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia	Swinburne University of Technology; Baker Heart and Diabetes Institute	Hove, RM (corresponding author), Swinburne Univ Technol, Fac Sci Engn & Technol, POB 218, Hawthorn, Vic 3122, Australia.	mbhave@swin.edu.au	Ziemann, Mark Daniel/AAE-8466-2019	Nyadzayo, Runyararo/0000-0001-9294-5682				Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; Besse M, 2011, J EXP BOT, V62, P4127, DOI 10.1093/jxb/err175; Bienert GP, 2014, BBA-GEN SUBJECTS, V1840, P1596, DOI 10.1016/j.bbagen.2013.09.017; Bienert GP, 2012, BIOCHEM J, V445, P101, DOI 10.1042/BJ20111704; Bienert GP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-26; Bienert GP, 2011, PLANT J, V66, P306, DOI 10.1111/j.1365-313X.2011.04496.x; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Chiba Y, 2009, PLANT J, V57, P810, DOI 10.1111/j.1365-313X.2008.03728.x; Danielson JAH, 2010, ADV EXP MED BIOL, V679, P19; Danielson JAH, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-45; Fitzpatrick KL, 2009, PLANT CELL ENVIRON, V32, P1357, DOI 10.1111/j.1365-3040.2009.02003.x; Forrest KL, 2008, FUNCT INTEGR GENOMIC, V8, P115, DOI 10.1007/s10142-007-0065-4; Forrest KL, 2007, FUNCT INTEGR GENOMIC, V7, P263, DOI 10.1007/s10142-007-0049-4; Fricke W, 2014, FUNCT PLANT BIOL, V41, P366, DOI 10.1071/FP13219; Froger A, 1998, PROTEIN SCI, V7, P1458, DOI 10.1002/pro.5560070623; Gao ZX, 2010, PLANT CELL PHYSIOL, V51, P767, DOI 10.1093/pcp/pcq036; Guenther JF, 2003, PLANT CELL, V15, P981, DOI 10.1105/tpc.009787; Guo SW, 2007, J PLANT NUTR SOIL SC, V170, P73, DOI 10.1002/jpln.200625073; Gustavsson S, 2005, PLANT PHYSIOL, V139, P287, DOI 10.1104/pp.105.063198; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; Horie T, 2011, PLANT CELL PHYSIOL, V52, P663, DOI 10.1093/pcp/pcr027; Hove RM, 2011, PLANT MOL BIOL, V75, P413, DOI 10.1007/s11103-011-9737-5; Katsuhara M, 2002, PLANT CELL PHYSIOL, V43, P885, DOI 10.1093/pcp/pcf102; Katsuhara M, 2008, PFLUG ARCH EUR J PHY, V456, P687, DOI 10.1007/s00424-007-0434-9; Katsuhara M, 2014, J PLANT RES, V127, P787, DOI 10.1007/s10265-014-0662-y; Katsuhara M, 2014, PLANT BIOTECHNOL-NAR, V31, P213, DOI 10.5511/plantbiotechnology.14.0421a; Knipfer T, 2011, J EXP BOT, V62, P4115, DOI 10.1093/jxb/err075; Kvam VM, 2012, AM J BOT, V99, P248, DOI 10.3732/ajb.1100340; Li GW, 2008, J PLANT PHYSIOL, V165, P1879, DOI 10.1016/j.jplph.2008.05.002; Li LG, 2000, PLANT SCI, V154, P43, DOI 10.1016/S0168-9452(99)00269-1; Lian HL, 2004, PLANT CELL PHYSIOL, V45, P481, DOI 10.1093/pcp/pch058; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Mitani N, 2008, PFLUG ARCH EUR J PHY, V456, P679, DOI 10.1007/s00424-007-0408-y; Mori IC, 2014, PLANT CELL PHYSIOL, V55, P251, DOI 10.1093/pcp/pcu003; Perez-Lopez U, 2009, PHYSIOL PLANTARUM, V135, P29, DOI 10.1111/j.1399-3054.2008.01174.x; Prak S, 2008, MOL CELL PROTEOMICS, V7, P1019, DOI 10.1074/mcp.M700566-MCP200; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Schnurbusch T, 2010, PLANT PHYSIOL, V153, P1706, DOI 10.1104/pp.110.158832; Shibasaka M, 2012, PLANT SIGNAL BEHAV, V7, P1648, DOI 10.4161/psb.22294; Sorieul M, 2011, TRAFFIC, V12, P473, DOI 10.1111/j.1600-0854.2010.01154.x; Suga S, 2004, PLANT CELL PHYSIOL, V45, P823, DOI 10.1093/pcp/pch120; Tanaka M, 2008, PFLUG ARCH EUR J PHY, V456, P671, DOI 10.1007/s00424-007-0370-8; The International Barley Genome Sequencing Consortium, 2012, Nature (London), V491, P711; Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316; Ullrich SE., 2011, BARLEY PROD IMPROV U, P3, DOI DOI 10.1002/9780470958636.CH1; Walia H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-87; Yamaji N, 2012, PLANT PHYSIOL, V160, P1491, DOI 10.1104/pp.112.204578; Zelazny E, 2009, PLANT J, V57, P346, DOI 10.1111/j.1365-313X.2008.03691.x; Zhang DY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056312, 10.1371/journal.pone.0077345]; Zhang MH, 2010, J BIOL CHEM, V285, P41982, DOI 10.1074/jbc.M110.101790; Zhou LG, 2010, J EXP BOT, V61, P4157, DOI 10.1093/jxb/erq237; Zhu CF, 2005, J EXP BOT, V56, P2971, DOI 10.1093/jxb/eri294; Ziemann M, 2013, ACTA PHYSIOL PLANT, V35, P1915, DOI 10.1007/s11738-013-1230-0; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley	55	52	59	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128025	10.1371/journal.pone.0128025	http://dx.doi.org/10.1371/journal.pone.0128025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057533	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000014
J	Macia, M; Pecchi, E; Vilmen, C; Desrois, M; Lan, C; Portha, B; Bernard, M; Bendahan, D; Giannesini, B				Macia, Michael; Pecchi, Emilie; Vilmen, Christophe; Desrois, Martine; Lan, Carole; Portha, Bernard; Bernard, Monique; Bendahan, David; Giannesini, Benoit			Insulin Resistance Is Not Associated with an Impaired Mitochondrial Function in Contracting Gastrocnemius Muscle of Goto-Kakizaki Diabetic Rats In Vivo	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; GK-RAT; P-31-MR SPECTROSCOPY; OXIDATIVE STRESS; LIPID-CONTENT; TYPE-2; DYSFUNCTION; NEUROPATHY; HUMANS; METABOLISM	Insulin resistance, altered lipid metabolism and mitochondrial dysfunction in skeletal muscle would play a major role in type 2 diabetes mellitus (T2DM) development, but the causal relationships between these events remain conflicting. To clarify this issue, gastrocnemius muscle function and energetics were investigated throughout a multidisciplinary approach combining in vivo and in vitro measurements in Goto-Kakizaki (GK) rats, a non-obese T2DM model developing peripheral insulin resistant without abnormal level of plasma non-esterified fatty acids (NEFA). Wistar rats were used as controls. Mechanical performance and energy metabolism were assessed strictly non-invasively using magnetic resonance (MR) imaging and 31-phosphorus MR spectroscopy (P-31-MRS). Compared with control group, plasma insulin and glucose were respectively lower and higher in GK rats, but plasma NEFA level was normal. In resting GK muscle, phosphocreatine content was reduced whereas glucose content and intracellular pH were both higher. However, there were not differences between both groups for basal oxidative ATP synthesis rate, citrate synthase activity, and intramyocellular contents for lipids, glycogen, ATP and ADP (an important in vivo mitochondrial regulator). During a standardized fatiguing protocol (6 min of maximal repeated isometric contractions electrically induced at a frequency of 1.7 Hz), mechanical performance and glycolytic ATP production rate were reduced in diabetic animals whereas oxidative ATP production rate, maximal mitochondrial capacity and ATP cost of contraction were not changed. These findings provide in vivo evidence that insulin resistance is not caused by an impairment of mitochondrial function in this diabetic model.	[Macia, Michael; Pecchi, Emilie; Vilmen, Christophe; Desrois, Martine; Lan, Carole; Bernard, Monique; Bendahan, David; Giannesini, Benoit] Aix Marseille Univ, CNRS, CRMBM UMR 7339, F-13385 Marseille, France; [Portha, Bernard] Univ Paris Diderot, Sorbonne Paris Cite, CNRS EAC 4413, Lab B2PE,Unite BFA, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Macia, M (corresponding author), Aix Marseille Univ, CNRS, CRMBM UMR 7339, F-13385 Marseille, France.	michael.macia@live.fr	Portha, Bernard/AAW-3021-2021; Bernard, Monique/Q-7254-2017; Bendahan, David/AAU-1420-2020	Bernard, Monique/0000-0002-3179-8698; 				ADAMS GR, 1990, J APPL PHYSIOL, V69, P968, DOI 10.1152/jappl.1990.69.3.968; Allen MD, 2013, MUSCLE NERVE, V48, P298, DOI 10.1002/mus.23792; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Andersen H, 1997, DIABETOLOGIA, V40, P1062, DOI 10.1007/s001250050788; Andreassen CS, 2009, BRAIN, V132, P2724, DOI 10.1093/brain/awp208; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; BISBIS S, 1993, AM J PHYSIOL, V265, pE807, DOI 10.1152/ajpendo.1993.265.5.E807; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Boutilier RG, 2001, J EXP BIOL, V204, P3171; Desrois M, 2004, CARDIOVASC RES, V61, P288, DOI 10.1016/j.cardiores.2003.11.021; Desrois M, 2010, AM J PHYSIOL-HEART C, V299, pH1679, DOI 10.1152/ajpheart.00998.2009; FARESE RV, 1994, P NATL ACAD SCI USA, V91, P11040, DOI 10.1073/pnas.91.23.11040; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Giannesini B, 2005, MAGN RESON MED, V54, P1058, DOI 10.1002/mrm.20637; Giannesini B, 2003, BIOCHIMIE, V85, P873, DOI 10.1016/S0300-9084(03)00124-X; Giannesini B, 2001, J PHYSIOL-LONDON, V536, P905, DOI 10.1111/j.1469-7793.2001.00905.x; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Goto Y, 1988, Adv Exp Med Biol, V246, P29; Greenman RL, 2005, DIABETES CARE, V28, P1425, DOI 10.2337/diacare.28.6.1425; GROOP LC, 1992, AM J PHYSIOL, V263, pE79, DOI 10.1152/ajpendo.1992.263.1.E79; Han DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019739; Hancock CR, 2008, P NATL ACAD SCI USA, V105, P7815, DOI 10.1073/pnas.0802057105; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; Hinder LM, 2013, J ENDOCRINOL, V216, P1, DOI 10.1530/JOE-12-0356; Hochachka PW, 1997, J EXP BIOL, V200, P381; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; Holloszy JO, 2013, DIABETES, V62, P1036, DOI 10.2337/db12-1107; Holloszy JO, 2009, AM J CLIN NUTR, V89, p463S, DOI 10.3945/ajcn.2008.26717C; Holloway GP, 2010, DIABETES, V59, P819, DOI 10.2337/db09-1519; Holloway GP, 2009, AM J CLIN NUTR, V89, p455S, DOI 10.3945/ajcn.2008.26717B; Huang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081464; Jorgensen W, 2012, AM J PHYSIOL-ENDOC M, V303, pE515, DOI 10.1152/ajpendo.00103.2012; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Lanza IR, 2011, J MAGN RESON IMAGING, V34, P1143, DOI 10.1002/jmri.22733; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Mattei JP, 2006, MAGN RESON MATER PHY, V19, P275, DOI 10.1007/s10334-006-0051-1; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murakawa Y, 2002, DIABETES-METAB RES, V18, P473, DOI 10.1002/dmrr.326; Padilla DJ, 2006, AM J PHYSIOL-HEART C, V291, pH2439, DOI 10.1152/ajpheart.00290.2006; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Phillips DIW, 1996, METABOLISM, V45, P947, DOI 10.1016/S0026-0495(96)90260-7; Portha B, 2005, DIABETES-METAB RES, V21, P495, DOI 10.1002/dmrr.566; PORTHA B, 1991, DIABETES, V40, P486, DOI 10.2337/diabetes.40.4.486; Prompers JJ, 2014, INT J BIOCHEM CELL B, V50, P67, DOI 10.1016/j.biocel.2014.02.014; Rabol R, 2006, APPL PHYSIOL NUTR ME, V31, P675, DOI 10.1139/h06-071; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; Schrauwen-Hinderling VB, 2007, DIABETOLOGIA, V50, P113, DOI 10.1007/s00125-006-0475-1; Sleigh A, 2011, J CLIN INVEST, V121, P2457, DOI 10.1172/JCI46405; THOMPSON CH, 1995, J APPL PHYSIOL, V78, P2131, DOI 10.1152/jappl.1995.78.6.2131; Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Wang X, 2014, DIABETES METAB SYNDR, V7, P381, DOI 10.2147/DMSO.S65818; WOLFE CL, 1988, BIOCHIM BIOPHYS ACTA, V971, P9, DOI 10.1016/S0005-2728(88)80003-3	64	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129579	10.1371/journal.pone.0129579	http://dx.doi.org/10.1371/journal.pone.0129579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057538	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000064
J	Seimetz, M; Parajuli, N; Pichl, A; Bednorz, M; Ghofrani, HA; Schermuly, RT; Seeger, W; Grimminger, F; Weissmann, N				Seimetz, Michael; Parajuli, Nirmal; Pichl, Alexandra; Bednorz, Mariola; Ghofrani, Hossein Ardeschir; Schermuly, Ralph Theo; Seeger, Werner; Grimminger, Friedrich; Weissmann, Norbert			Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice	PLOS ONE			English	Article							SOLUBLE GUANYLATE-CYCLASE; SILDENAFIL TREATMENT; INHALED ILOPROST; CYCLIC-AMP; DISEASE; COPD; ROFLUMILAST; CELLS; TADALAFIL; NO	Rationale Chronic obstructive pulmonary disease (COPD) is a widespread disease, with no curative therapies available. Recent findings suggest a key role of NO and sGC-cGMP signaling for the pathogenesis of the disease. Previous data suggest a downregulation/inactivation of the cGMP producing soluble guanylate cyclase, and sGC stimulation prevented cigarette smoke-induced emphysema and pulmonary hypertension (PH) in mice. We thus aimed to investigate if the inhibition of the cGMP degrading phosphodiesterase (PDE)5 has similar effects. Results were compared to the effects of a PDE 4 inhibitor (cAMP elevating) and a combination of both. Methods C57BL6/J mice were chronically exposed to cigarette smoke and in parallel either treated with Tadalafil (PDE5 inhibitor), Piclamilast (PDE4 inhibitor) or both. Functional measurements (lung compliance, hemodynamics) and structural investigations (alveolar and vascular morphometry) as well as the heart ratio were determined after 6 months of tobacco smoke exposure. In addition, the number of alveolar macrophages in the respective lungs was counted. Results Preventive treatment with Tadalafil, Piclamilast or a combination of both almost completely prevented the development of emphysema, the increase in lung compliance, tidal volume, structural remodeling of the lung vasculature, right ventricular systolic pressure, and right ventricular hypertrophy induced by cigarette smoke exposure. Single, but not combination treatment prevented or reduced smoke-induced increase in alveolar macrophages. Conclusion Cigarette smoke-induced emphysema and PH could be prevented by inhibition of the phosphodiesterases 4 and 5 in mice.	[Seimetz, Michael; Parajuli, Nirmal; Pichl, Alexandra; Bednorz, Mariola; Ghofrani, Hossein Ardeschir; Schermuly, Ralph Theo; Seeger, Werner; Grimminger, Friedrich; Weissmann, Norbert] Univ Giessen & Marburg Lung Ctr, Excellence Cluster Cardiopulm Syst ECCPS, Giessen, Germany		Weissmann, N (corresponding author), Univ Giessen & Marburg Lung Ctr, Excellence Cluster Cardiopulm Syst ECCPS, Giessen, Germany.	Norbert.Weissmann@innere.med.uni-giessen.de	Ghofrani, Ardeschir/AAD-5293-2020; Ghofrani, Hossein Ardeschir/AAD-2856-2022; Parajuli, Nirmal/E-2536-2016	Ghofrani, Ardeschir/0000-0002-2029-4419; Grimminger, Friedrich/0000-0001-8725-6276; Weissmann, Norbert/0000-0003-2675-3871; Schermuly, Ralph/0000-0002-5167-6970; Seeger, Werner/0000-0003-1946-0894; Parajuli, Nirmal/0000-0002-0799-6301	German Research Foundation (DFG), Excellence Cluster Cardio-Pulmonary System (ECCPS); Alberta Innovates [201500354] Funding Source: researchfish	German Research Foundation (DFG), Excellence Cluster Cardio-Pulmonary System (ECCPS)(German Research Foundation (DFG)); Alberta Innovates	This work was supported by German Research Foundation (DFG), Excellence Cluster Cardio-Pulmonary System (ECCPS).	Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Alp S, 2006, PULM PHARMACOL THER, V19, P386, DOI 10.1016/j.pupt.2005.09.006; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Beeh KM, 2004, LUNG, V182, P369, DOI 10.1007/s00408-004-2518-z; Black PN, 2008, EUR RESPIR J, V31, P998, DOI 10.1183/09031936.00017207; Blanco I, 2013, EUR RESPIR J, V42, P982, DOI 10.1183/09031936.00176312; Blanco I, 2010, AM J RESP CRIT CARE, V181, P270, DOI 10.1164/rccm.200907-0988OC; Brown William M, 2007, Int J Chron Obstruct Pulmon Dis, V2, P517; Bull T, 2012, COPD, V9, P211, DOI 10.3109/15412555.2012.683966; Bundschuh DS, 2001, J PHARMACOL EXP THER, V297, P280; Chin KM, 2005, CORONARY ARTERY DIS, V16, P13, DOI 10.1097/00019501-200502000-00003; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Cowan C, 2005, Issues Emerg Health Technol, P1; de Visser YP, 2012, AM J PHYSIOL-LUNG C, V302, pL56, DOI 10.1152/ajplung.00041.2011; Dony E, 2008, EUR RESPIR J, V31, P599, DOI 10.1183/09031936.00002007; Dumitrascu R, 2006, CIRCULATION, V113, P286, DOI 10.1161/CIRCULATIONAHA.105.581405; Evgenov OV, 2006, NAT REV DRUG DISCOV, V5, P755, DOI 10.1038/nrd2038; Ferrer E, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-76; Fukao M, 1999, J BIOL CHEM, V274, P10927, DOI 10.1074/jbc.274.16.10927; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Goudie AR, 2014, LANCET RESP MED, V2, P293, DOI 10.1016/S2213-2600(14)70013-X; Grootendorst DC, 2007, THORAX, V62, P1081, DOI 10.1136/thx.2006.075937; Hertz AL, 2009, P NATL ACAD SCI USA, V106, P21978, DOI 10.1073/pnas.0911684106; Hoeper MM, 2013, EUR RESPIR J, V41, P853, DOI 10.1183/09031936.00213911; Hofmann F, 2000, J CELL SCI, V113, P1671; Holverda S, 2008, PULM PHARMACOL THER, V21, P558, DOI 10.1016/j.pupt.2008.01.012; Huang Z, 2006, CURR MED CHEM, V13, P3253, DOI 10.2174/092986706778773040; Izikki M, 2009, J PHARMACOL EXP THER, V330, P54, DOI 10.1124/jpet.108.148742; Lederer DJ, 2012, COPD, V9, P268, DOI 10.3109/15412555.2011.651180; Mata M, 2012, FREE RADICAL RES, V46, P690, DOI 10.3109/10715762.2012.669040; Minai OA, 2010, CHEST, V137, p39S, DOI 10.1378/chest.10-0087; MURAD F, 1986, J CLIN INVEST, V78, P1, DOI 10.1172/JCI112536; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Olschewski H, 2009, EUR RESPIR REV, V18, P29, DOI 10.1183/09059180.00011111; Olschewski H, 2002, NEW ENGL J MED, V347, P322, DOI 10.1056/NEJMoa020204; Osinski MT, 2001, MOL PHARMACOL, V59, P1044, DOI 10.1124/mol.59.5.1044; Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820; Rabe KF, 2005, LANCET, V366, P563, DOI 10.1016/S0140-6736(05)67100-0; Rao Ravinder Singh, 2011, Indian J Chest Dis Allied Sci, V53, P81; Repine JE, 1997, AM J RESP CRIT CARE, V156, P341, DOI 10.1164/ajrccm.156.2.9611013; Rietema H, 2008, EUR RESPIR J, V31, P759, DOI 10.1183/09031936.00114207; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; Sanz MJ, 2005, PHARMACOL THERAPEUT, V106, P269, DOI 10.1016/j.pharmthera.2004.12.001; Schermuly RT, 2008, EUR RESPIR J, V32, P881, DOI 10.1183/09031936.00114407; Schermuly RT, 2011, EXPERT OPIN INV DRUG, V20, P567, DOI 10.1517/13543784.2011.565048; Schermuly RT, 2004, CIRC RES, V94, P1101, DOI 10.1161/01.RES.0000126050.41296.8E; Schermuly RT, 2004, AM J RESP CRIT CARE, V169, P39, DOI 10.1164/rccm.200302-282OC; Schlossmann J, 2003, ANN MED, V35, P21, DOI 10.1080/07853890310004093; Schlossmann J, 2000, NATURE, V404, P197, DOI 10.1038/35004606; Seimetz M, 2011, CELL, V147, P293, DOI 10.1016/j.cell.2011.08.035; Selige J, 2010, J CELL PHYSIOL, V223, P317, DOI 10.1002/jcp.22037; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Teixeira CE, 2006, J PHARMACOL EXP THER, V316, P654, DOI 10.1124/jpet.105.092544; Udalov S, 2010, BMC PULM MED, V10, DOI 10.1186/1471-2466-10-26; Weissmann N, 2007, RESP MED, V101, P2125, DOI 10.1016/j.rmed.2007.05.025; Weissmann N, 2006, P NATL ACAD SCI USA, V103, P19093, DOI 10.1073/pnas.0606728103; Weissmann N, 2014, AM J RESP CRIT CARE, V189, P1359, DOI 10.1164/rccm.201311-2037OC; Weissmann N, 2014, AM J PHYSIOL-LUNG C, V306, pL986, DOI 10.1152/ajplung.00275.2013; Woyda K, 2009, EUR RESPIR J, V33, P861, DOI 10.1183/09031936.00109008; Wright JL, 2005, THORAX, V60, P605, DOI 10.1136/thx.2005.042994; WRIGHT JL, 1991, EXP LUNG RES, V17, P997, DOI 10.3109/01902149109064331; WRIGHT JL, 1990, AM REV RESPIR DIS, V142, P1422, DOI 10.1164/ajrccm/142.6_Pt_1.1422; Yang J, 2013, ARTERIOSCL THROM VAS, V33, P34, DOI 10.1161/ATVBAHA.112.300121	64	25	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129327	10.1371/journal.pone.0129327	http://dx.doi.org/10.1371/journal.pone.0129327			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058042	gold, Green Published			2022-12-26	WOS:000356349000048
J	Di Bari, G; Gentile, E; Latronico, T; Corriero, G; Fasano, A; Marzano, CN; Liuzzi, GM				Di Bari, Gaetano; Gentile, Eugenia; Latronico, Tiziana; Corriero, Giuseppe; Fasano, Anna; Marzano, Carlotta Nonnis; Liuzzi, Grazia Maria			Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures	PLOS ONE			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; NATURAL-PRODUCTS; DISEASES; METABOLITES; THERAPY; PROTEIN; TRIALS; CANCER; STRATEGIES; BINDING	The aim of this study was to evaluate whether water soluble compounds present in aqueous extracts from seven Mediterranean demosponges exert biological activity towards matrix metalloproteinases (MMPs), which represent important pathogenic factors of human diseases. Aqueous extracts were tested on LPS-activated cultured rat astrocytes, and levels and expression of MMP-2 and MMP-9 were assessed by zymography and RT-PCR, respectively. Our results demonstrated that the studied extracts contain water soluble compounds able to inhibit MMP-2 and MMP-9 activity and expression. We also compared the anti-MMP activities present in aqueous extracts from wild and reared specimens of Tethya aurantium and T. citrina. The results obtained revealed that the reared sponges maintain the production of bioactive compounds with inhibitory effect on MMP-2 and MMP-9 for all the duration of the rearing period. Taken together, our results indicate that the aqueous extracts from the selected Mediterranean demosponges possess a variety of water-soluble bioactive compounds, which are able to inhibit MMPs at different levels. The presence of biological activity in aqueous extracts from reared specimens of T. aurantium and T. citrina strongly encourage sponge aquaculture as a valid option to supply sponge biomass for drug development on a large scale.	[Di Bari, Gaetano; Gentile, Eugenia; Latronico, Tiziana; Fasano, Anna; Liuzzi, Grazia Maria] Aldo Moro Univ, Dept Biosci, Biotechnol & Biopharmaceut, Bari, Italy; [Corriero, Giuseppe; Marzano, Carlotta Nonnis] Aldo Moro Univ, Dept Biol, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Liuzzi, GM (corresponding author), Aldo Moro Univ, Dept Biosci, Biotechnol & Biopharmaceut, Bari, Italy.	graziamaria.liuzzi@uniba.it	Gentile, Eugenia/T-4465-2018; Liuzzi, Grazia Maria/GVR-7164-2022; Gentile, Eugenia/GQA-5514-2022	Gentile, Eugenia/0000-0001-9066-0245; Gentile, Eugenia/0000-0001-9066-0245; Liuzzi, Grazia Maria/0000-0001-5692-9335; Latronico, Tiziana/0000-0001-6971-5416; Nonnis Marzano, Carlotta/0000-0003-1284-9610				ALLAN JA, 1995, BIOCHEM J, V309, P299, DOI 10.1042/bj3090299; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Blunt JW, 2014, NAT PROD REP, V31, P160, DOI 10.1039/c3np70117d; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cardone F, 2010, J EXP MAR BIOL ECOL, V389, P93, DOI 10.1016/j.jembe.2010.03.012; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Di Bari G, 2015, MEDITERR MAR SCI, V16, P73, DOI 10.12681/mms.872; Di Bari G, 2014, ENVIRON TOXICOL PHAR, V38, P1007, DOI 10.1016/j.etap.2014.10.021; Duckworth A, 2003, AQUACULTURE, V221, P311, DOI 10.1016/S0044-8486(03)00070-X; Duckworth AR, 2003, AQUACULTURE, V217, P139, DOI 10.1016/S0044-8486(02)00038-8; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fujita M, 2003, J AM CHEM SOC, V125, P15700, DOI 10.1021/ja038025w; Fujita M, 2001, TETRAHEDRON, V57, P1229, DOI 10.1016/S0040-4020(00)01128-5; Gramegna P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028499; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Hu JL, 2007, NAT REV DRUG DISCOV, V6, P480, DOI 10.1038/nrd2308; Koopmans M, 2009, MAR DRUGS, V7, P787, DOI 10.3390/md7040787; Latronico T, 2007, AIDS, V21, P677, DOI 10.1097/QAD.0b013e328018751d; Latronico T, 2013, TOXICOL SCI, V135, P218, DOI 10.1093/toxsci/kft146; Latronico T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049656; Leal MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030580; Lee WJ, 2003, GLIA, V41, P15, DOI 10.1002/glia.10131; Liuzzi GM, 2004, MULT SCLER, V10, P290, DOI 10.1191/1352458504ms1016oa; Liuzzi GM, 2004, BRAIN, V127, P398, DOI 10.1093/brain/awh049; Liuzzi GM, 2007, NEUROCHEM RES, V32, P2184, DOI 10.1007/s11064-007-9415-9; Liuzzi GM, 2011, NEUROCHEM RES, V36, P518, DOI 10.1007/s11064-010-0373-2; Lodemel JB, 2004, COMP BIOCHEM PHYS B, V139, P253, DOI 10.1016/j.cbpc.2004.08.004; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Mannello F, 2006, RECENT PAT ANTI-CANC, V1, P91, DOI 10.2174/157489206775246421; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; Munro MHG, 1999, J BIOTECHNOL, V70, P15, DOI 10.1016/S0168-1656(99)00052-8; Newman DJ, 2004, J NAT PROD, V67, P1216, DOI 10.1021/np040031y; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pavlaki M, 2003, CANCER METAST REV, V22, P177, DOI 10.1023/A:1023047431869; Rodriguez-Nieto S, 2001, FASEB J, V15, P261, DOI 10.1096/fj.01-0427fje; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Sang QXA, 2006, CURR TOP MED CHEM, V6, P289, DOI 10.2174/156802606776287045; Sipkema D, 2005, MAR BIOTECHNOL, V7, P142, DOI 10.1007/s10126-004-0405-5; Skiles JW, 2004, CURR MED CHEM, V11, P2911, DOI 10.2174/0929867043364018; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang C, 2009, MAR DRUGS, V7, P71, DOI 10.3390/md7020071	44	11	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129322	10.1371/journal.pone.0129322	http://dx.doi.org/10.1371/journal.pone.0129322			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053757	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300118
J	Diaz-Vegas, A; Campos, CA; Contreras-Ferrat, A; Casas, M; Buvinic, S; Jaimovich, E; Espinosa, A				Diaz-Vegas, Alexis; Campos, Cristian A.; Contreras-Ferrat, Ariel; Casas, Mariana; Buvinic, Sonja; Jaimovich, Enrique; Espinosa, Alejandra			ROS Production via P2Y(1)-PKC-NOX2 Is Triggered by Extracellular ATP after Electrical Stimulation of Skeletal Muscle Cells	PLOS ONE			English	Article							SIGNALING MOLECULES; NAD(P)H OXIDASE; CALCIUM-RELEASE; NADPH OXIDASE; CA2+ RELEASE; RECEPTORS; TRANSDUCTION; CONTRACTION; MECHANISMS; CHANNELS	During exercise, skeletal muscle produces reactive oxygen species (ROS) via NADPH oxidase (NOX2) while inducing cellular adaptations associated with contractile activity. The signals involved in this mechanism are still a matter of study. ATP is released from skeletal muscle during electrical stimulation and can autocrinely signal through purinergic receptors; we searched for an influence of this signal in ROS production. The aim of this work was to characterize ROS production induced by electrical stimulation and extracellular ATP. ROS production was measured using two alternative probes; chloromethyl-2,7-dichlorodihydrofluorescein diacetate or electroporation to express the hydrogen peroxide-sensitive protein Hyper. Electrical stimulation (ES) triggered a transient ROS increase in muscle fibers which was mimicked by extracellular ATP and was prevented by both carbenoxolone and suramin; antagonists of pannexin channel and purinergic receptors respectively. In addition, transient ROS increase was prevented by apyrase, an ecto-nucleotidase. MRS2365, a P2Y(1) receptor agonist, induced a large signal while UTPyS (P2Y(2) agonist) elicited a much smaller signal, similar to the one seen when using ATP plus MRS2179, an antagonist of P2Y(1). Protein kinase C (PKC) inhibitors also blocked ES-induced ROS production. Our results indicate that physiological levels of electrical stimulation induce ROS production in skeletal muscle cells through release of extracellular ATP and activation of P2Y(1) receptors. Use of selective NOX2 and PKC inhibitors suggests that ROS production induced by ES or extracellular ATP is mediated by NOX2 activated by PKC.	[Diaz-Vegas, Alexis; Campos, Cristian A.; Espinosa, Alejandra] Univ Chile, Fac Med, Dept Tecnol Med, Santiago 7, Chile; [Diaz-Vegas, Alexis; Contreras-Ferrat, Ariel; Casas, Mariana; Jaimovich, Enrique; Espinosa, Alejandra] Univ Chile, Fac Med, ICBM, Ctr Estudios Mol Celula, Santiago 7, Chile; [Buvinic, Sonja] Univ Chile, Fac Odontol, Inst Invest Ciencias Odontol, Santiago, Chile; [Jaimovich, Enrique] Univ Chile, Fac Med, Programa Fisiol & Biofis, Inst Ciencias Biomed, Santiago 7, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Espinosa, A (corresponding author), Univ Chile, Fac Med, Dept Tecnol Med, Santiago 7, Chile.	bespinosa@med.uchile.cl	Diaz-Vegas, Alexis/Z-4026-2019; Jaimovich, Enrique/AAY-7632-2020; Diaz Vegas, Alexis/I-1941-2013	Diaz Vegas, Alexis/0000-0001-5227-4482	CONICYT-PIA [ACT111]; FONDECYT [1110467]	CONICYT-PIA; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The study was supported by CONICYT-PIA ACT111, FONDECYT 1110467 (AE and EJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Araya R, 2003, J GEN PHYSIOL, V121, P3, DOI 10.1085/jgp.20028671; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Burnstock G, 2013, PURINERG SIGNAL, V9, P541, DOI 10.1007/s11302-013-9381-4; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Cheng SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054125; Choi RCY, 2003, J NEUROSCI, V23, P4445; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Contreras-Ferrat A, 2014, J CELL SCI, V127, P1911, DOI 10.1242/jcs.138982; Crow JP, 1997, NITRIC OXIDE-BIOL CH, V1, P145, DOI 10.1006/niox.1996.0113; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; D' Ambrosi N, 2013, CURR MED CHEM, V20, P56; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Eltit JM, 2006, J BIOL CHEM, V281, P12143, DOI 10.1074/jbc.M511218200; Eltit JM, 2004, BIOPHYS J, V86, P3042, DOI 10.1016/S0006-3495(04)74353-2; Espinosa A, 2006, J CELL PHYSIOL, V209, P379, DOI 10.1002/jcp.20745; Espinosa A, 2013, INT J MOL SCI, V14, P15740, DOI 10.3390/ijms140815740; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; Fernandez-Verdejo R, 2014, INT J SPORTS MED, V35, P273, DOI 10.1055/s-0033-1353147; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Flores RV, 2005, MOL CELL BIOCHEM, V280, P35, DOI 10.1007/s11010-005-8050-5; Haendeler J, 2004, FEBS LETT, V577, P427, DOI 10.1016/j.febslet.2004.10.041; Hellsten Y, 1998, CIRCULATION, V98, P6, DOI 10.1161/01.CIR.98.1.6; Hidalgo C, 2005, IUBMB LIFE, V57, P315, DOI 10.1080/15216540500092328; Hidalgo C, 2006, J BIOL CHEM, V281, P26473, DOI 10.1074/jbc.M600451200; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Jackson MJ, 2011, ANTIOXID REDOX SIGN, V15, P2477, DOI 10.1089/ars.2011.3976; Jaimovich E, 2000, AM J PHYSIOL-CELL PH, V278, pC998, DOI 10.1152/ajpcell.2000.278.5.C998; Jorquera G, 2013, J CELL SCI, V126, P1189, DOI 10.1242/jcs.116855; Jorquera G, 2009, AM J PHYSIOL-CELL PH, V297, pC581, DOI 10.1152/ajpcell.00167.2009; Khairallah RJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002829; Mortensen SP, 2009, J APPL PHYSIOL, V107, P1757, DOI 10.1152/japplphysiol.00638.2009; Osorio-Fuentealba C, 2013, DIABETES, V62, P1519, DOI 10.2337/db12-1066; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Prosser BL, 2013, J MOL CELL CARDIOL, V58, P172, DOI 10.1016/j.yjmcc.2012.11.011; Prosser BL, 2011, SCIENCE, V333, P1440, DOI 10.1126/science.1202768; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Riquelme MA, 2013, NEUROPHARMACOLOGY, V75, P594, DOI 10.1016/j.neuropharm.2013.03.022; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Scheele C, 2009, TRENDS ENDOCRIN MET, V20, P95, DOI 10.1016/j.tem.2008.12.002; Sciancalepore M, 2012, FREE RADICAL BIO MED, V53, P1392, DOI 10.1016/j.freeradbiomed.2012.08.002; Sohn HY, 2000, J BIOL CHEM, V275, P18745, DOI 10.1074/jbc.M000026200; Sun QA, 2013, J BIOL CHEM, V288, P22961, DOI 10.1074/jbc.M113.480228; Vejrazka M, 2005, BBA-GEN SUBJECTS, V1722, P143, DOI 10.1016/j.bbagen.2004.12.008; Voss AA, 2009, J PHYSIOL-LONDON, V587, P5739, DOI 10.1113/jphysiol.2009.179275; Walas H, 2012, PFLUG ARCH EUR J PHY, V463, P319, DOI 10.1007/s00424-011-1050-2	49	57	57	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129882	10.1371/journal.pone.0129882	http://dx.doi.org/10.1371/journal.pone.0129882			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053483	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300167
J	Park, SL; Carmella, SG; Chen, ML; Patel, Y; Stram, DO; Haiman, CA; Le Marchand, L; Hecht, SS				Park, Sungshim L.; Carmella, Steven G.; Chen, Menglan; Patel, Yesha; Stram, Daniel O.; Haiman, Christopher A.; Le Marchand, Loic; Hecht, Stephen S.			Mercapturic Acids Derived from the Toxicants Acrolein and Crotonaldehyde in the Urine of Cigarette Smokers from Five Ethnic Groups with Differing Risks for Lung Cancer	PLOS ONE			English	Article							1,N-2-PROPANODEOXYGUANOSINE ADDUCTS; ALPHA,BETA-UNSATURATED ALDEHYDE; CHEMICAL CARCINOGENESIS; LIPID-PEROXIDATION; JAPANESE MEN; DNA-ADDUCTS; FATTY-ACIDS; F344 RATS; SMOKING; BIOMARKERS	The Multiethnic Cohort epidemiology study has clearly demonstrated that, compared to Whites and for the same number of cigarettes smoked, African Americans and Native Hawaiians have a higher risk for lung cancer whereas Latinos and Japanese Americans have a lower risk. Acrolein and crotonaldehyde are two important constituents of cigarette smoke which have well documented toxic effects and could play a role in lung cancer etiology. Their urinary metabolites 3-hydroxypropylmercapturic acid (3-HPMA) and 3-hydroxy-1-methylpropylmercapturic acid (HMPMA), respectively, are validated biomarkers of acrolein and crotonaldehyde exposure. We quantified levels of 3-HPMA and HMPMA in the urine of more than 2200 smokers from these five ethnic groups, and also carried out a genome wide association study using blood samples from these subjects. After adjusting for age, sex, creatinine, and total nicotine equivalents, geometric mean levels of 3-HPMA and HMPMA were significantly different in the five groups (P<0.0001). Native Hawaiians had the highest and Latinos the lowest geometric mean levels of both 3-HPMA and HMPMA. Levels of 3HPMA and HMPMA were 3787 and 2759 pmol/ml urine, respectively, in Native Hawaiians and 1720 and 2210 pmol/ml urine in Latinos. These results suggest that acrolein and crotonaldehyde may be involved in lung cancer etiology, and that their divergent levels may partially explain the differing risks of Native Hawaiian and Latino smokers. No strong signals were associated with 3-HPMA in the genome wide association study, suggesting that formation of the glutathione conjugate of acrolein is mainly non-enzymatic, while the top significant association with HMPMA was located on chromosome 12 near the TBX3 gene, but its relationship to HMPMA excretion is not clear.	[Park, Sungshim L.; Patel, Yesha; Stram, Daniel O.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Dept Prevent Med, Los Angeles, CA 90033 USA; [Carmella, Steven G.; Chen, Menglan; Hecht, Stephen S.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA	University of Southern California; University of Minnesota System; University of Minnesota Twin Cities; Cancer Research Center of Hawaii; University of Hawaii System	Hecht, SS (corresponding author), Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA.	hecht002@umn.edu		Hecht, Stephen/0000-0001-7228-1356	U.S. National Cancer Institute [CA-138338, CA-14089]; National Cancer Institute Cancer Center Support [CA-77598]; NATIONAL CANCER INSTITUTE [P01CA138338, P30CA014089, UM1CA164973, U01CA164973, P30CA077598] Funding Source: NIH RePORTER	U.S. National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grant no. CA-138338 and in part by grant no. CA-14089 from the U.S. National Cancer Institute (http://www.cancer.gov). Mass spectrometry was carried out in the Analytical Biochemistry Shared Resource of the Masonic Cancer Center, supported in part by National Cancer Institute Cancer Center Support grant no. CA-77598.	[Anonymous], 1995, IARC Monogr Eval Carcinog Risks Hum, V63, P337; Balbo S, 2014, CARCINOGENESIS, V35, P2798, DOI 10.1093/carcin/bgu204; BEAUCHAMP RO, 1985, CRC CR REV TOXICOL, V14, P309, DOI 10.3109/10408448509037461; BERHANE K, 1994, P NATL ACAD SCI USA, V91, P1480, DOI 10.1073/pnas.91.4.1480; BERHANE K, 1990, MOL PHARMACOL, V37, P251; Blot WJ, 2011, JNCI-J NATL CANCER I, V103, P810, DOI 10.1093/jnci/djr102; Bui LC, 2013, DRUG METAB DISPOS, V41, P1300, DOI 10.1124/dmd.113.052258; Cai J, 2009, CHEM RES TOXICOL, V22, P708, DOI 10.1021/tx800465m; Carmella SG, 2013, J CHROMATOGR B, V935, P36, DOI 10.1016/j.jchromb.2013.07.004; Carmella SG, 2009, CHEM RES TOXICOL, V22, P734, DOI 10.1021/tx800479s; CHUNG FL, 1983, CANCER RES, V43, P1230; CHUNG FL, 1986, CANCER RES, V46, P1285; Chung FL, 1999, MUTAT RES-FUND MOL M, V424, P71, DOI 10.1016/S0027-5107(99)00009-3; CHUNG FL, 1984, CANCER RES, V44, P990; Chung FL, 1996, CARCINOGENESIS, V17, P2105, DOI 10.1093/carcin/17.10.2105; Conklin DJ, 2009, J PHARMACOL EXP THER, V331, P456, DOI 10.1124/jpet.109.156513; Cote F, 2011, REGUL TOXICOL PHARM, V61, pS51, DOI 10.1016/j.yrtph.2010.03.004; Counts ME, 2004, REGUL TOXICOL PHARM, V39, P111, DOI 10.1016/j.yrtph.2003.12.005; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Gadgeel SM, 2001, CHEST, V120, P55, DOI 10.1378/chest.120.1.55; Haiman CA, 2006, NEW ENGL J MED, V354, P333, DOI 10.1056/NEJMoa033250; HARRIS RE, 1993, INT J EPIDEMIOL, V22, P592, DOI 10.1093/ije/22.4.592; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; Hecht SS, 1999, JNCI-J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Hecht SS, 2010, CHEM RES TOXICOL, V23, P1001, DOI 10.1021/tx100056m; HEE J, 1995, PHARMACOL BIOCHEM BE, V52, P195, DOI 10.1016/0091-3057(95)00089-F; HINDS MW, 1981, INT J CANCER, V27, P297, DOI 10.1002/ijc.2910270307; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Hukkanen J, 2005, PHARMACOL REV, V57, P79, DOI 10.1124/pr.57.1.3; International Agency for Research on Cancer, 1995, IARC MON EV CARC RIS, V63, P373; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Lee HW, 2014, ONCOTARGET, V5, P3526, DOI 10.18632/oncotarget.1954; LEMARCHAND L, 1992, CANCER EPIDEM BIOMAR, V1, P103; Mascher DG, 2001, J CHROMATOGR B, V750, P163, DOI 10.1016/S0378-4347(00)00385-6; Melikian AA, 2007, NICOTINE TOB RES, V9, P377, DOI 10.1080/14622200701188836; Minko IG, 2009, CHEM RES TOXICOL, V22, P759, DOI 10.1021/tx9000489; Morin A, 2011, REGUL TOXICOL PHARM, V61, pS3, DOI 10.1016/j.yrtph.2010.09.020; Murphy Sharon E, 2014, Carcinogenesis, V35, P2526, DOI 10.1093/carcin/bgu191; Myers CR, 2009, TOXICOLOGY, V257, P95, DOI 10.1016/j.tox.2008.12.013; Pal A, 2000, CANCER LETT, V154, P39, DOI 10.1016/S0304-3835(00)00390-6; Pan J, 2002, CHEM RES TOXICOL, V15, P367, DOI 10.1021/tx010136q; Pan JS, 2012, CHEM RES TOXICOL, V25, P2788, DOI 10.1021/tx3004104; Parent RA, 1998, TOXICOL SCI, V43, P110, DOI 10.1006/toxs.1998.2462; Park SL, 2015, CANCER EPIDEM BIOMAR, V24, P561, DOI 10.1158/1055-9965.EPI-14-1054; Patel YM, 2015, CANCER EPIDEM BIOMAR, V24, P119, DOI 10.1158/1055-9965.EPI-14-0815; RIVENSON A, 1988, CANCER RES, V48, P6912; Roethig HJ, 2009, NICOTINE TOB RES, V11, P1216, DOI 10.1093/ntr/ntp126; Sarkar P, 2007, MOL CELL BIOCHEM, V301, P191, DOI 10.1007/s11010-007-9411-z; Scherer G, 2007, HUM EXP TOXICOL, V26, P37, DOI 10.1177/0960327107073829; Schettgen T, 2008, RAPID COMMUN MASS SP, V22, P2629, DOI 10.1002/rcm.3659; Schwartz AG, 1997, CANCER, V79, P45, DOI 10.1002/(SICI)1097-0142(19970101)79:1<45::AID-CNCR7>3.0.CO;2-L; Seaman VY, 2009, ATMOS ENVIRON, V43, P6199, DOI 10.1016/j.atmosenv.2009.08.043; Shafey O, 2009, TOBACCO ATLAS, V3, P37; Shepperd CJ, 2009, REGUL TOXICOL PHARM, V55, P97, DOI 10.1016/j.yrtph.2009.06.006; Bastos LCS, 2010, J AGR FOOD CHEM, V58, P12777, DOI 10.1021/jf1028575; Sobue T, 2002, INT J CANCER, V99, P245, DOI 10.1002/ijc.10308; Spiess PC, 2011, J PROTEOMICS, V74, P2380, DOI 10.1016/j.jprot.2011.05.039; Stellman SD, 2003, ANN EPIDEMIOL, V13, P294, DOI 10.1016/S1047-2797(02)00420-9; Stellman SD, 2001, CANCER EPIDEM BIOMAR, V10, P1193; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Stewart BW, 2014, WORLD CANC REPORT 20, P16, DOI DOI 10.1136/oemed-2019-106012; U.S. Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Wang HT, 2012, J BIOL CHEM, V287, P12379, DOI 10.1074/jbc.M111.329623; Yan WY, 2010, J CHROMATOGR SCI, V48, P194, DOI 10.1093/chromsci/48.3.194; Yin RC, 2013, ANAL CHEM, V85, P3190, DOI 10.1021/ac3034695; Yuan JM, 2014, CARCINOGENESIS, V35, P339, DOI 10.1093/carcin/bgt352; Yuan JM, 2012, CARCINOGENESIS, V33, P804, DOI 10.1093/carcin/bgs026; Yuan Y, 2011, J STAT SOFTW, V45, P1; Zhang SY, 2007, CHEM RES TOXICOL, V20, P565, DOI 10.1021/tx700023z; Zhang S, 2006, CHEM RES TOXICOL, V19, P1386, DOI 10.1021/tx060154d; Zhang SY, 2011, CHEM RES TOXICOL, V24, P119, DOI 10.1021/tx100321y	74	40	40	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0124841	10.1371/journal.pone.0124841	http://dx.doi.org/10.1371/journal.pone.0124841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053186	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300009
J	Peng, XB; Thevathasan, NV; Gordon, AM; Mohammed, I; Gao, PX				Peng, Xiaobang; Thevathasan, Naresh V.; Gordon, Andrew M.; Mohammed, Idris; Gao, Pengxiang			Photosynthetic Response of Soybean to Microclimate in 26-Year-Old Tree-Based Intercropping Systems in Southern Ontario, Canada	PLOS ONE			English	Article							AGROFORESTRY; COMPETITION; GROWTH; POLICY; YIELD; MAIZE	In order to study the effect of light competition and microclimatic modifications on the net assimilation (NA), growth and yield of soybean (Glycine max L.) as an understory crop, three 26-year-old soybean-tree (Acer saccharinum Marsh., Populus deltoides X nigra, Juglans nigra L.) intercropping systems were examined. Tree competition reduced photosynthetically active radiation (PAR) incident on soybeans and reduced net assimilation, growth and yield of soybean. Soil moisture of 20 cm depth close (< 3 m) to the tree rows was also reduced. Correlation analysis showed that NA and soil water content were highly correlated with growth and yield of soybean. When compared with the monoculture soybean system, the relative humidity (RH) of the poplar-soybean, silver maple-soybean, and black walnut-soybean intercropped systems was increased by 7.1%, 8.0% and 5.9%, soil water content was reduced by 37.8%, 26.3% and 30.9%, ambient temperature was reduced by 1.3 degrees C, 1.4 degrees C and 1.0 degrees C, PAR was reduced by 53.6%, 57.9% and 39.9%, and air CO2 concentration was reduced by 3.7 mu mol.mol(-1), 4.2 mu mol.mol(-1) and 2.8 mu mol.mol(-1), respectively. Compared to the monoculture, the average NA of soybean in poplar, maple and walnut treatments was also reduced by 53.1%, 67.5% and 46.5%, respectively. Multivariate step-wise regression analysis showed that PAR, ambient temperature and CO2 concentration were the dominant factors influencing net photosynthetic rate.	[Peng, Xiaobang] Shangluo Univ, Dept Biol & Med Engn, Shangluo, Shaanxi, Peoples R China; [Peng, Xiaobang; Thevathasan, Naresh V.; Gordon, Andrew M.; Mohammed, Idris] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Gao, Pengxiang] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China	Shangluo University; University of Guelph; Northwest A&F University - China	Peng, XB (corresponding author), Shangluo Univ, Dept Biol & Med Engn, Shangluo, Shaanxi, Peoples R China.	xbpeng1898@sina.com			Science and technology project of Shaanxi, Science and Technology Department of Shaanxi Province [2014KJXX-79]; Chinese Scholarship Council	Science and technology project of Shaanxi, Science and Technology Department of Shaanxi Province; Chinese Scholarship Council(China Scholarship Council)	This work was supported by Science and technology project of Shaanxi, Science and Technology Department of Shaanxi Province (www.sninfo.gov.cn). The grant number is 2014KJXX-79. XP received the grant. The authors also wish to express their gratitude to the Chinese Scholarship Council for providing the scholarship to Dr. Peng Xiaobang, which enabled him to undertake this study in the School of Environmental Sciences, University of Guelph, Guelph, Ontario, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLENKINSOP PG, 1974, J EXP BOT, V25, P899, DOI 10.1093/jxb/25.5.899; BUCK LE, 1995, AGROFOREST SYST, V30, P57, DOI 10.1007/BF00708913; Garrett HEG, 1997, FOREST ECOL MANAG, V91, P5, DOI 10.1016/S0378-1127(96)03884-4; Garrity DP, 2004, AGROFOREST SYST, V61-2, P5, DOI 10.1023/B:AGFO.0000028986.37502.7c; GOLD MA, 1987, AGROFOREST SYST, V5, P109, DOI 10.1007/BF00047516; KANG BT, 1981, PLANT SOIL, V63, P165, DOI 10.1007/BF02374595; Lowan TL, 1990, AGR FOR METERE, V52, P49; Nerlich K., 2012, AGROFOREST SYST, V87, P475, DOI [10.1007/s10457-012-9560-2, DOI 10.1007/S10457-012-9560-2]; Newman SM, 1997, AGROFOREST SYST, V39, P23, DOI 10.1023/A:1005938310106; Peng Xiao-bang, 2008, Yingyong Shengtai Xuebao, V19, P2414; [彭晓邦 PENG Xiaobang], 2010, [生态学报, Acta Ecologica Sinica], V30, P710; Peng XB, 2009, AGROFOREST SYST, V76, P569, DOI 10.1007/s10457-009-9227-9; RASCHKE K, 1986, PLANTA, V168, P546, DOI 10.1007/BF00392275; Reynolds PE, 2007, ECOL ENG, V29, P362, DOI 10.1016/j.ecoleng.2006.09.024; SANKAR C R, 1988, Journal of Maharashtra Agricultural Universities, V13, P216; SIMPSON JA, 1999, THESIS U GUELPH GUEL; Tamang B, 2010, AGROFOREST SYST, V79, P111, DOI 10.1007/s10457-010-9280-4; Thevathasan N. V., 2004, Journal of Crop Improvement, V12, P339, DOI 10.1300/J411v12n01_04; Thevathasan NV, 2004, AGROFOREST SYST, V61-2, P257, DOI 10.1023/B:AGFO.0000029003.00933.6d; Wu YungYing, 1997, Temperate agroforestry systems., P149; Zhang JinSong, 2001, Scientia Silvae Sinicae, V37, P74; Zinkhan FC, 1997, AGROFOREST SYST, V35, P303, DOI 10.1007/BF00044460	22	13	16	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129467	10.1371/journal.pone.0129467	http://dx.doi.org/10.1371/journal.pone.0129467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053375	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300128
J	Yan, FX; Wu, CWW; Chao, YP; Chen, CJ; Tseng, YC				Yan, Feng-Xian; Wu, Changwei W.; Chao, Yi-Ping; Chen, Chi-Jen; Tseng, Ying-Chi			APOE-epsilon 4 Allele Altered the Rest-Stimulus Interactions in Healthy Middle-Aged Adults	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; E EPSILON-4 ALLELE; WORKING-MEMORY; FUNCTIONAL CONNECTIVITY; NETWORK CONNECTIVITY; ALZHEIMERS-DISEASE; BRAIN ACTIVATION; APOE GENOTYPE; STATE; HIPPOCAMPAL	The apolipoprotein E-epsilon 4 allele is a well-known genetic risk factor for late-onset Alzheimer's disease, which also impacts the cognitive functions and brain network connectivity in healthy middle-aged adults without dementia. Previous studies mainly focused on the effects of apolipoprotein E-epsilon 4 allele on single index using task or resting-state fMRI. However, how these evoked and spontaneous BOLD indices interact with each other remains largely unknown. Therefore, we evaluated the 'rest-stimulus interaction' between working-memory activation and resting-state connectivity in middle-aged apolipoprotein E-epsilon 4 carriers (n=9) and non-carriers (n=8). Four n-back task scans (n=0, 1, 2, 3) and one resting-state scan were acquired at a 3T clinical MRI scanner. The working-memory beta maps of low-, moderate-, and high-memory loads and resting-state connectivity maps of default mode, executive control, and hippocampal networks were derived and compared between groups. Apolipoprotein E-epsilon 4 carriers presented declined working-memory activation in the high-memory load across whole brain regions and reduced hippocampal connectivity compared with non-carriers. In addition, disrupted rest-stimulus interactions were found in the right anterior insula and bilateral parahippocampal regions for middle-aged adults with apolipoprotein E-epsilon 4 allele. The rest-stimulus interaction improved the detectability of network integrity changes in apolipoprotein E-epsilon 4 carriers, demonstrating the disrupted intrinsic connectivity within the executive-functional regions and the modulated memory-encoding capability within hippocampus-related regions.	[Yan, Feng-Xian; Chen, Chi-Jen; Tseng, Ying-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, New Taipei City, Taiwan; [Wu, Changwei W.] Natl Cent Univ, Dept Biomed Sci & Engn, Taoyuan, Taiwan; [Yan, Feng-Xian; Wu, Changwei W.; Tseng, Ying-Chi] Taipei Med Univ, Brain & Consciousness Res Ctr, Taipei, Taiwan; [Chao, Yi-Ping] Chang Gung Univ, Grad Inst Med Mechatron, Taoyuan, Taiwan	Taipei Medical University; National Central University; Taipei Medical University; Chang Gung University	Tseng, YC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, New Taipei City, Taiwan.	x2mickey@yahoo.com.tw	Chao, Yi-Ping/GOP-0833-2022	Chao, Yi-Ping/0000-0002-1681-5410; Wu, Changwei W./0000-0001-8968-9366				Anand A, 2007, J NEUROPSYCH CLIN N, V19, P274, DOI 10.1176/appi.neuropsych.19.3.274; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; Bokde ALW, 2010, J ALZHEIMERS DIS, V21, P103, DOI 10.3233/JAD-2010-091054; Bondi MW, 1995, NEUROLOGY, V45, P2203, DOI 10.1212/WNL.45.12.2203; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Chen CJ, 2013, AM J NEURORADIOL, V34, P1197, DOI 10.3174/ajnr.A3369; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Evans S, 2014, NEUROBIOL AGING, V35, P1615, DOI 10.1016/j.neurobiolaging.2014.01.145; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Filbey FM, 2010, BRAIN IMAGING BEHAV, V4, P177, DOI 10.1007/s11682-010-9097-9; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galvin JE, 2005, NEUROLOGY, V65, P559, DOI 10.1212/01.wnl.0000172958.95282.2a; Goveas JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055902; Greenwood PM, 2014, SCAND J PSYCHOL, V55, P268, DOI 10.1111/sjop.12123; Greenwood PM, 2005, NEUROPSYCHOLOGY, V19, P199, DOI 10.1037/0894-4105.19.2.199; Greenwood PM, 2000, P NATL ACAD SCI USA, V97, P11661, DOI 10.1073/pnas.97.21.11661; Greicius MD, 2007, BIOL PSYCHIAT, V62, P429, DOI 10.1016/j.biopsych.2006.09.020; Hahn K, 2013, NEUROIMAGE, V81, P96, DOI 10.1016/j.neuroimage.2013.05.011; Haller S, 2013, NEUROIMAGE, V81, P243, DOI 10.1016/j.neuroimage.2013.05.019; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Hasselmo ME, 2006, TRENDS COGN SCI, V10, P487, DOI 10.1016/j.tics.2006.09.005; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; HIXSON JE, 1990, J LIPID RES, V31, P545; Kljajevic V, 2014, ALZHEIMERS DEMENT, V10, P401, DOI 10.1016/j.jalz.2013.02.008; Lee TW, 2013, PSYCHIAT RES-NEUROIM, V213, P133, DOI 10.1016/j.pscychresns.2012.04.010; Lim HK, 2008, NEUROPSYCHOBIOLOGY, V57, P181, DOI 10.1159/000147471; Machulda MM, 2011, ARCH NEUROL-CHICAGO, V68, P1131, DOI 10.1001/archneurol.2011.108; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Parasuraman R, 2002, NEUROPSYCHOLOGY, V16, P254, DOI 10.1037//0894-4105.16.2.254; Pike KE, 2007, BRAIN, V130, P2837, DOI 10.1093/brain/awm238; Reiman EM, 2009, P NATL ACAD SCI USA, V106, P6820, DOI 10.1073/pnas.0900345106; Shu H, 2014, J AFFECT DISORDERS, V164, P5, DOI 10.1016/j.jad.2014.03.048; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Talairach J., 1988, COPLANAR STEREOTAXIC, P122; Tiraboschi P, 2004, NEUROLOGY, V62, P1977, DOI 10.1212/01.WNL.0000128091.92139.0F; Trachtenberg AJ, 2012, NEUROIMAGE, V59, P565, DOI 10.1016/j.neuroimage.2011.07.059; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wilson RS, 2011, ARCH NEUROL-CHICAGO, V68, P351, DOI 10.1001/archneurol.2011.31; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; Xie CM, 2012, NEUROIMAGE, V63, P320, DOI 10.1016/j.neuroimage.2012.06.062; Yan FX, 2013, BRAIN CONNECT, V3, P438, DOI 10.1089/brain.2013.0164; Yetkin FZ, 2006, EUR RADIOL, V16, P193, DOI 10.1007/s00330-005-2794-x; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zou QH, 2009, NEUROIMAGE, V48, P515, DOI 10.1016/j.neuroimage.2009.07.006	53	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128442	10.1371/journal.pone.0128442	http://dx.doi.org/10.1371/journal.pone.0128442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053677	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300040
J	Jafarian, A; Taghikani, M; Abroun, S; Allahverdi, A; Lamei, M; Lakpour, N; Soleimani, M				Jafarian, Arefeh; Taghikani, Mohammad; Abroun, Saeid; Allahverdi, Amir; Lamei, Maryam; Lakpour, Niknam; Soleimani, Masoud			The Generation of Insulin Producing Cells from Human Mesenchymal Stem Cells by MiR-375 and Anti-MiR-9	PLOS ONE			English	Article							CHONDROGENIC DIFFERENTIATION; BONE-MARROW; MICRORNA; EXPRESSION; TRANSPLANTATION; IDENTIFICATION; PROLIFERATION; BIOGENESIS; MECHANISMS; PLAYERS	Background MicroRNAs (miRNAs) are a group of endogenous small non-coding RNAs that regulate gene expression at the post-transcriptional level. A number of studies have led to the notion that some miRNAs have key roles in control of pancreatic islet development and insulin secretion. Based on some studies on miRNAs pattern, the researchers in this paper investigated the pancreatic differentiation of human bone marrow mesenchymal stem cells (hBM-MSCs) by up-regulation of miR-375 and down-regulation of miR-9 by lentiviruses containing miR-375 and anti-miR-9. Methodology After 21 days of induction, islet-like clusters containing insulin producing cells (IPCs) were confirmed by dithizone (DTZ) staining. The IPCs and beta cell specific related genes and proteins were detected using qRT-PCR and immunofluorescence on days 7, 14 and 21 of differentiation. Glucose challenge test was performed at different concentrations of glucose so extracellular and intracellular insulin and C-peptide were assayed using ELISA kit. Although derived IPCs by miR-375 alone were capable to express insulin and other endocrine specific transcription factors, the cells lacked the machinery to respond to glucose. Conclusion It was found that over-expression of miR-375 led to a reduction in levels of Mtpn protein in derived IPCs, while treatment with anti-miR-9 following miR-375 over-expression had synergistic effects on MSCs differentiation and insulin secretion in a glucose-regulated manner. The researchers reported that silencing of miR-9 increased OC-2 protein in IPCs that may contribute to the observed glucose-regulated insulin secretion. Although the roles of miR-375 and miR-9 are well known in pancreatic development and insulin secretion, the use of these miRNAs in transdifferentiation was never demonstrated. These findings highlight miRNAs functions in stem cells differentiation and suggest that they could be used as therapeutic tools for gene-based therapy in diabetes mellitus.	[Jafarian, Arefeh; Taghikani, Mohammad] Tarbiat Modares Univ, Dept Clin Biochem, Fac Med Sci, Tehran, Iran; [Abroun, Saeid; Allahverdi, Amir; Lamei, Maryam; Soleimani, Masoud] Tarbiat Modares Univ, Dept Hematol, Fac Med Sci, Tehran, Iran; [Lakpour, Niknam] Avicenna Res Inst, Nanobiotechnol Res Ctr, ACECR, Tehran, Iran	Tarbiat Modares University; Tarbiat Modares University; Academic Center for Education, Culture & Research (ACECR)	Soleimani, M (corresponding author), Tarbiat Modares Univ, Dept Hematol, Fac Med Sci, Tehran, Iran.	soleim_m@modares.ac.ir	ABROUN, SAEID/GPF-5006-2022	Jafarian, Arefeh/0000-0003-0576-087X	INSF: Iranian National Science Foundation [90006892]	INSF: Iranian National Science Foundation(Iran National Science Foundation (INSF))	The authors would like to thank the INSF: Iranian National Science Foundation for supporting of this project under contract No: 90006892.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bobis S, 2006, FOLIA HISTOCHEM CYTO, V44, P215; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen LB, 2004, WORLD J GASTROENTERO, V10, P3016; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; Kantharidis P, 2011, DIABETES, V60, P1832, DOI 10.2337/db11-0082; Kato T, 2006, CELL METAB, V4, P143, DOI 10.1016/j.cmet.2006.06.009; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Krampera M, 2006, BONE, V39, P678, DOI 10.1016/j.bone.2006.04.020; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Li Y, 2010, INT J CLIN EXP PATHO, V3, P254; Li YH, 2007, J CELL PHYSIOL, V211, P36, DOI 10.1002/jcp.20897; Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252; Marappagounder D, 2013, CELL MOL BIOL LETT, V18, P75, DOI 10.2478/s11658-012-0040-5; Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Pandey AK, 2009, CELL PHYSIOL BIOCHEM, V23, P221, DOI 10.1159/000218169; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plaisance V, 2006, J BIOL CHEM, V281, P26932, DOI 10.1074/jbc.M601225200; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Saba R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003652; Shantikumar S, 2012, CARDIOVASC RES, V93, P583, DOI 10.1093/cvr/cvr300; Shim JH, 2007, DIABETOLOGIA, V50, P1228, DOI 10.1007/s00125-007-0634-z; Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Tan Z, 2007, AM J HUM GENET, V81, P829, DOI 10.1086/521200; Tang XQ, 2008, BBA-GENE REGUL MECH, V1779, P697, DOI 10.1016/j.bbagrm.2008.06.010; Zhang BH, 2008, J CELL MOL MED, V12, P3, DOI 10.1111/j.1582-4934.2007.00196.x; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	45	48	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128650	10.1371/journal.pone.0128650	http://dx.doi.org/10.1371/journal.pone.0128650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047014	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200088
J	Pereira-Neves, A; Gonzaga, L; Menna-Barreto, RFS; Benchimol, M				Pereira-Neves, Antonio; Gonzaga, Luiz; Menna-Barreto, Rubem F. S.; Benchimol, Marlene			Characterisation of 20S Proteasome in Tritrichomonas foetus and Its Role during the Cell Cycle and Transformation into Endoflagellar Form	PLOS ONE			English	Article							TRICHOMONAS-VAGINALIS; GENE FAMILY; INTRACELLULAR-LOCALIZATION; ENTAMOEBA-HISTOLYTICA; S PROTEASOME; INHIBITORS; SUBUNIT; GROWTH; IDENTIFICATION; EXPRESSION	Proteasomes are intracellular complexes that control selective protein degradation in organisms ranging from Archaea to higher eukaryotes. These structures have multiple proteolytic activities that are required for cell differentiation, replication and maintaining cellular homeostasis. Here, we document the presence of the 20S proteasome in the protist parasite Tritrichomonas foetus. Complementary techniques, such as a combination of whole genome sequencing technologies, bioinformatics algorithms, cell fractionation and biochemistry and microscopy approaches were used to characterise the 20S proteasome of T. foetus. The 14 homologues of the typical eukaryotic proteasome subunits were identified in the T. foetus genome. Alignment analyses showed that the main regulatory and catalytic domains of the proteasome were conserved in the predicted amino acid sequences from T. foetus-proteasome subunits. Immunofluorescence assays using an anti-proteasome antibody revealed a labelling distributed throughout the cytosol as punctate cytoplasmic structures and in the perinuclear region. Electron microscopy of a T. foetus-proteasome-enriched fraction confirmed the presence of particles that resembled the typical eukaryotic 20S proteasome. Fluorogenic assays using specific peptidyl substrates detected presence of the three typical peptidase activities of eukaryotic proteasomes in T. foetus. As expected, these peptidase activities were inhibited by lactacystin, a well-known specific proteasome inhibitor, and were not affected by inhibitors of serine or cysteine proteases. During the transformation of T. foetus to endoflagellar form (EFF), also known as pseudocyst, we observed correlations between the EFF formation rates, increases in the proteasome activities and reduced levels of ubiquitin-protein conjugates. The growth, cell cycle and EFF transformation of T. foetus were inhibited after treatment with lactacystin in a dose-dependent manner. Lactacystin treatment also resulted in an accumulation of ubiquitinated proteins and caused increase in the amount of endoplasmic reticulum membranes in the parasite. Taken together, our results suggest that the ubiquitin-proteasome pathway is required for cell cycle and EFF transformation in T. foetus.	[Pereira-Neves, Antonio] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Programa Posgrad Ciencias Morfol, Rio De Janeiro, RJ, Brazil; [Pereira-Neves, Antonio; Benchimol, Marlene] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, RJ, Brazil; [Pereira-Neves, Antonio] Fiocruz MS, Ctr Pesquisa Aggeu Magalhaes, Dept Microbiol, Lab Microbiol & Biol Celular, Recife, PE, Brazil; [Gonzaga, Luiz] MCT, LNCC, Petropolis, RJ, Brazil; [Menna-Barreto, Rubem F. S.] Fiocruz MS, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Benchimol, Marlene] UNIGRANRIO, Univ Grande Rio, Duque De Caxias, RJ, Brazil; [Benchimol, Marlene] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Laboratorio Nacional de Computacao Cientifica (LNCC); Fundacao Oswaldo Cruz; Universidade do Grande Rio; Universidade Federal do Rio de Janeiro	Benchimol, M (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, RJ, Brazil.	marlenebenchimol@gmail.com	Pereira-Neves, Antonio/B-8989-2015; Menna-Barreto, Rubem/O-7325-2019; Almeida, Luiz GP/G-5829-2012	Menna-Barreto, Rubem/0000-0002-1352-0641; Almeida, Luiz GP/0000-0002-7124-2715; Pereira-Neves, Antonio/0000-0001-6629-568X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa de Nucleos de Excelencia (PRONEX); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Associacao Universitaria Santa Ursula (AUSU)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa de Nucleos de Excelencia (PRONEX)(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Associacao Universitaria Santa Ursula (AUSU)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Programa de Nucleos de Excelencia (PRONEX), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Associacao Universitaria Santa Ursula (AUSU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramova EB, 2004, BIOL BULL+, V31, P115, DOI 10.1023/B:BIBU.0000022464.37305.b4; Agrawal S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003426; Angeloni F, 2011, MOL ECOL RESOUR, V11, P662, DOI 10.1111/j.1755-0998.2011.02990.x; Balasubramanian S, 2012, J BIOL CHEM, V287, P36179, DOI 10.1074/jbc.M112.359281; Bartholomeu DC, 2001, MOL GENET GENOMICS, V265, P986, DOI 10.1007/s004380100493; Belote JM, 2009, HEREDITY, V103, P23, DOI 10.1038/hdy.2009.23; Benchimol M, 2004, MICROSC MICROANAL, V10, P528, DOI 10.1017/S1431927604040905; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bouzat JL, 2000, J MOL EVOL, V51, P532, DOI 10.1007/s002390010117; Cahais V, 2012, MOL ECOL RESOUR, V12, P834, DOI 10.1111/j.1755-0998.2012.03148.x; Cardoso J, 2008, PARASITOL RES, V103, P941, DOI 10.1007/s00436-008-1081-6; Cardoso J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021027; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Cascio P, 2002, EMBO J, V21, P2636, DOI 10.1093/emboj/21.11.2636; CHEN P, 1995, EMBO J, V14, P2620, DOI 10.1002/j.1460-2075.1995.tb07260.x; Chung DWD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043477; Dahan J, 2001, J EXP BOT, V52, P1947, DOI 10.1093/jexbot/52.362.1947; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; De Jesus JB, 2007, PROTEOMICS, V7, P1961, DOI 10.1002/pmic.200600797; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; Emmerlich V, 1999, MOL BIOCHEM PARASIT, V100, P131, DOI 10.1016/S0166-6851(99)00022-5; Fabre B, 2013, MOL CELL PROTEOMICS, V12, P687, DOI 10.1074/mcp.M112.023317; Fang CH, 2000, CLIN SCI, V99, P181, DOI 10.1042/CS20000032; Fang YK, 2014, J MICROBIOL IMMUNOL; Finley D, 2012, GENETICS, V192, P319, DOI 10.1534/genetics.112.140467; Fornai F, 2003, J NEUROSCI, V23, P8955; Fu HY, 1998, GENETICS, V149, P677; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gille C, 2003, J MOL BIOL, V326, P1437, DOI 10.1016/S0022-2836(02)01470-5; Glenn RJ, 2004, INT J ANTIMICROB AG, V24, P286, DOI 10.1016/j.ijantimicag.2004.02.023; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Gonzalez J, 1999, EUR J BIOCHEM, V264, P897, DOI 10.1046/j.1432-1327.1999.00682.x; Groll M, 2004, BBA-MOL CELL RES, V1695, P33, DOI 10.1016/j.bbamcr.2004.09.025; Heinemeyer W, 1997, J BIOL CHEM, V272, P25200, DOI 10.1074/jbc.272.40.25200; Hua SB, 1996, MOL BIOCHEM PARASIT, V78, P33, DOI 10.1016/S0166-6851(96)02599-6; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Kreidenweiss A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-187; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lamarre SG, 2009, J EXP BIOL, V212, P1294, DOI 10.1242/jeb.028290; Lilburn TG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S9; Torres-Machorro AL, 2009, CURR GENET, V55, P199, DOI 10.1007/s00294-009-0237-y; Lin WC, 2009, GENOMICS, V93, P487, DOI 10.1016/j.ygeno.2009.01.004; Makioka A, 2002, PARASITOL RES, V88, P454, DOI 10.1007/s00436-002-0601-z; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; Manning K, 2010, TOP COMPANION ANIM M, V25, P145, DOI 10.1053/j.tcam.2010.08.001; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Munoz C, 2012, INT J PARASITOL, V42, P715, DOI 10.1016/j.ijpara.2012.03.012; Nederlof PM, 1995, P NATL ACAD SCI USA, V92, P12060, DOI 10.1073/pnas.92.26.12060; Nino CA, 2013, MICROBIOLOGYOPEN, V2, P525, DOI 10.1002/mbo3.88; Noel CJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-99; Paugam A, 2003, TRENDS PARASITOL, V19, P55, DOI 10.1016/S1471-4922(02)00064-8; Paugam A, 2001, PARASITE, V8, P267, DOI 10.1051/parasite/2001084267; Pereira-Neves A, 2012, PROTIST, V163, P529, DOI 10.1016/j.protis.2011.11.005; Pereira-Neves A, 2011, VET PARASITOL, V175, P1, DOI 10.1016/j.vetpar.2010.10.007; Pereira-Neves A, 2009, PROTIST, V160, P536, DOI 10.1016/j.protis.2009.05.001; Perepechaeva ML, 2006, B EXP BIOL MED+, V142, P182, DOI 10.1007/s10517-006-0322-x; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Robertson CD, 1999, MOL BIOCHEM PARASIT, V103, P49, DOI 10.1016/S0166-6851(99)00110-3; Sanchez R, 2002, EXP PARASITOL, V102, P187, DOI 10.1016/S0014-4894(03)00055-9; Selman C, 2002, FREE RADICAL BIO MED, V33, P259, DOI 10.1016/S0891-5849(02)00874-2; Shaw MK, 2000, PARASITOLOGY, V121, P35, DOI 10.1017/S0031182099006071; Silva-Jardim I, 2004, ACTA TROP, V91, P121, DOI 10.1016/j.actatropica.2004.03.007; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Steverding D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-29; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; Tanaka K, 2012, BIOL CHEM, V393, P217, DOI 10.1515/hsz-2011-0285; To WY, 1997, FEBS LETT, V404, P253, DOI 10.1016/S0014-5793(97)00116-6; Wang CC, 2003, J BIOL CHEM, V278, P15800, DOI 10.1074/jbc.M300195200; Wenger Y, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-204; Wojcik C, 2003, INT J BIOCHEM CELL B, V35, P579, DOI 10.1016/S1357-2725(02)00380-1; Wolf DH, 2004, BBA-MOL CELL RES, V1695, P19, DOI 10.1016/j.bbamcr.2004.10.007; Yao CQ, 2013, J MED MICROBIOL, V62, P1, DOI 10.1099/jmm.0.047365-0; Zubacova Z, 2008, MOL BIOCHEM PARASIT, V161, P49, DOI 10.1016/j.molbiopara.2008.06.004	74	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129165	10.1371/journal.pone.0129165	http://dx.doi.org/10.1371/journal.pone.0129165			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047503	gold, Green Submitted, Green Published			2022-12-26	WOS:000355652200132
J	Wang, G; Yu, Y; Tu, YB; Tong, J; Liu, YG; Zhang, C; Chang, YF; Wang, SJ; Jiang, CG; Zhou, EM; Cai, XH				Wang, Gang; Yu, Ying; Tu, Yabin; Tong, Jie; Liu, Yonggang; Zhang, Chong; Chang, Yafei; Wang, Shujie; Jiang, Chenggang; Zhou, En-Min; Cai, Xuehui			Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Infection Induced Apoptosis and Autophagy in Thymi of Infected Piglets	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; MOLECULAR DISSECTION; REPLICATION; CHINA; NIDOVIRALES; THERAPIES; EMERGENCE; CYTOKINES; PROTEIN; ROLES	Previously, we demonstrated that the highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) HuN4 strain causes obvious thymic atrophy and thymocytes apoptosis in infected piglets after birth, which is more severe than that induced by classical PRRSV. In this study, we investigated apoptosis and autophagy in the thymus of piglets infected with the HP-PRRSV HuN4 strain, and found that both apoptosis and autophagy occurred in the thymus of piglets infected with HP-PRRSV. In addition to a few virus-infected cells, CD14(+) cells, the main autophagic cells in the thymus were thymic epithelial cells. These findings demonstrated that HP-PRRSV induces apoptosis in bystander cells, and induces autophagy in both infected and bystander cells in the thymus of infected piglets. Herein, we first present new data on the thymic lesions induced by HP-PRRSV, and show that apoptosis and autophagy are key mechanisms involved in cell survival and determinants of the severity of thymic atrophy in infected piglets. Finally, future studies of the mechanism underlying immune responses are proposed based on our current understanding of PRRSV-host interactions.	[Wang, Gang; Yu, Ying; Tu, Yabin; Tong, Jie; Liu, Yonggang; Zhang, Chong; Chang, Yafei; Wang, Shujie; Jiang, Chenggang; Cai, Xuehui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Yu, Ying; Zhou, En-Min] Northwest A&F Univ, Coll Vet Med, Dept Vet Prevent Med, Yangling 712100, Shaanxi, Peoples R China; [Zhang, Chong] Jilin Agr Univ, Changchun 130118, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Northwest A&F University - China; Jilin Agricultural University	Zhou, EM (corresponding author), Northwest A&F Univ, Coll Vet Med, Dept Vet Prevent Med, Yangling 712100, Shaanxi, Peoples R China.	zhouem@nwsuaf.edu.cn; cai139@hvri.ac.cn			National Science Foundation for Young Scholars of China [31201885]; State Key Laboratory of Veterinary Biotechnology, China [SKLVBF201301, SKLVBF201410]; National High Technology Research and Development Program of China [2011AA10A213]	National Science Foundation for Young Scholars of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Veterinary Biotechnology, China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by grants from the National Science Foundation for Young Scholars of China [grant number 31201885], the State Key Laboratory of Veterinary Biotechnology, China [grant numbers SKLVBF201301, SKLVBF201410] and the National High Technology Research and Development Program of China [grant number 2011AA10A213].	Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chang HC, 2008, VET MICROBIOL, V129, P281, DOI 10.1016/j.vetmic.2007.12.002; Chen QG, 2012, VIRUS RES, V163, P650, DOI 10.1016/j.virusres.2011.11.008; COLLINS M, 1995, AM J RESP CRIT CARE, V152, pS20, DOI 10.1164/ajrccm/152.4_Pt_2.S20; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Fernandez A, 2002, VIRUS RES, V83, P103, DOI 10.1016/S0168-1702(01)00426-9; Guo BQ, 2013, VIROLOGY, V435, P372, DOI 10.1016/j.virol.2012.09.013; Han Z, 2013, TRANSBOUND EMERG DIS; He YL, 2012, VET MICROBIOL, V160, P455, DOI 10.1016/j.vetmic.2012.05.040; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kirkegaard K, 2004, NAT REV MICROBIOL, V2, P301, DOI 10.1038/nrmicro865; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Li YF, 2007, VET J, V174, P577, DOI 10.1016/j.tvjl.2007.07.032; Li YM, 2014, VIRUS RES, V189, P29, DOI 10.1016/j.virusres.2014.04.011; Liu QH, 2012, VIROLOGY, V429, P136, DOI 10.1016/j.virol.2012.03.022; Liu YG, 2010, CLIN VACCINE IMMUNOL, V17, P1439, DOI 10.1128/CVI.00517-09; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Miller LC, 2004, ARCH VIROL, V149, P2453, DOI 10.1007/s00705-004-0377-9; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Oleksiewicz MB, 1999, VET MICROBIOL, V66, P15, DOI 10.1016/S0378-1135(98)00309-5; Patel D, 2009, ANTIVIR THER, V14, P899, DOI 10.3851/IMP1409; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Reed JC, 2005, BLOOD, V106, P408, DOI 10.1182/blood-2004-07-2761; Rossman JS, 2009, CELL HOST MICROBE, V6, P299, DOI 10.1016/j.chom.2009.09.009; Sedger LM, 2002, J IMMUNOL, V169, P6193, DOI 10.4049/jimmunol.169.11.6193; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Sun MX, 2012, AUTOPHAGY, V8, P1434, DOI 10.4161/auto.21159; Tian KG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000526; Tong GZ, 2007, EMERG INFECT DIS, V13, P1434, DOI 10.3201/eid1309.070399; Wang G, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-2; Wang G, 2011, VET IMMUNOL IMMUNOP, V142, P170, DOI 10.1016/j.vetimm.2011.05.004; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Xu GW, 2007, CELL RES, V17, P759, DOI 10.1038/cr.2007.52; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	42	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128292	10.1371/journal.pone.0128292	http://dx.doi.org/10.1371/journal.pone.0128292			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046751	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200056
J	Tong, T; Kim, N; Park, T				Tong, Tao; Kim, Nahyun; Park, Taesun			Topical Application of Oleuropein Induces Anagen Hair Growth in Telogen Mouse Skin	PLOS ONE			English	Article							DERMAL PAPILLA; BETA-CATENIN; FOLLICLE MORPHOGENESIS; WNT/BETA-CATENIN; CELLS; MICE; RAT; PROLIFERATION; ANGIOGENESIS; REGENERATION	We observed that oleuropein, the main constituent of the leaves and unprocessed olive drupes of Olea europaea, protected mice from high-fat diet-induced adiposity by up-regulation of genes involved in Wnt10b-mediated signaling in adipose tissue. The activation of Wnt/beta-catenin pathway is also well established to positively regulate the anagen phase of hair growth cycle in mice skin. Methodology and Principal Findings Oleuropein promoted cultured human follicle dermal papilla cell proliferation and induced LEF1 and Cyc-D1 mRNA expression and beta-catenin protein expression in dermal papilla cells. Nuclear accumulation of beta-catenin in dermal papilla cells was observed after oleuropein treatment. Topical application of oleuropein (0.4 mg/mouse/day) to C57BL/6N mice accelerated the hair-growth induction and increased the size of hair follicles in telogenic mouse skin. The oleuropein-treated mouse skin showed substantial upregulation of Wnt10b, FZDR1, LRP5, LEF1, Cyc-D1, IGF-1, KGF, HGF, and VEGF mRNA expression and beta-catenin protein expression. Conclusions and Significance These results demonstrate that topical oleuroepin administration induced anagenic hair growth in telogenic C57BL/6N mouse skin. The hair-growth promoting effect of oleuropein in mice appeared to be associated with the stimulation of the Wnt10b/beta-catenin signaling pathway and the upregulation of IGF-1, KGF, HGF, and VEGF gene expression in mouse skin tissue.	[Tong, Tao; Kim, Nahyun; Park, Taesun] Yonsei Univ, Dept Food & Nutr, Brain Korea PLUS Project 21, Seoul 120749, South Korea	Yonsei University	Park, T (corresponding author), Yonsei Univ, Dept Food & Nutr, Brain Korea PLUS Project 21, Seoul 120749, South Korea.	tspark@yonsei.ac.kr	Tong, Tao/Q-8856-2016	Tong, Tao/0000-0002-9309-2893; Park, Taesun/0000-0002-9752-9407	MOTIE (The Ministry of Trade, Industry and Energy), Republic of Korea, under the Research and Business Development (R&BD) support program [N0000869]; SRC program (Center for Food & Nutritional Genomics) of the National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology [2015R1A5A6001906]	MOTIE (The Ministry of Trade, Industry and Energy), Republic of Korea, under the Research and Business Development (R&BD) support program; SRC program (Center for Food & Nutritional Genomics) of the National Research Foundation (NRF) of Korea - Ministry of Education, Science and Technology	This work was supported by the MOTIE (The Ministry of Trade, Industry and Energy), Republic of Korea, under the Research and Business Development (R&BD) support program (Grant no. N0000869) supervised by the KIAT (Korea Institute for Advancement of Technology), and by the SRC program (Center for Food & Nutritional Genomics: Grant no. 2015R1A5A6001906) of the National Research Foundation (NRF) of Korea funded by the Ministry of Education, Science and Technology.	Andreadou I, 2006, J NUTR, V136, P2213, DOI 10.1093/jn/136.8.2213; Avci P, 2013, EXPERT OPIN DRUG DIS, V8, P331, DOI 10.1517/17460441.2013.761202; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; CARMICHAEL J, 1987, CANCER RES, V47, P936; Choi YS, 2013, CELL STEM CELL, V13, P720, DOI 10.1016/j.stem.2013.10.003; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cotsarelis G, 2001, TRENDS MOL MED, V7, P293, DOI 10.1016/S1471-4914(01)02027-5; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Datta K, 2009, J ETHNOPHARMACOL, V124, P450, DOI 10.1016/j.jep.2009.05.023; de la Puerta R, 2000, Z NATURFORSCH C, V55, P814; Enshell-Seijffers D, 2010, DEV CELL, V18, P633, DOI 10.1016/j.devcel.2010.01.016; Foulstone E, 2005, J PATHOL, V205, P145, DOI 10.1002/path.1712; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Han J, 2009, CYTOTECHNOLOGY, V59, P45, DOI 10.1007/s10616-009-9191-2; HOUSLEY RM, 1994, J CLIN INVEST, V94, P1764, DOI 10.1172/JCI117524; IBRAHIM L, 1982, J EMBRYOL EXP MORPH, V72, P209; Jo SJ, 2014, J DERMATOL, V41, P285, DOI 10.1111/1346-8138.12422; Kimura Y, 2009, J NUTR, V139, P2079, DOI 10.3945/jn.109.104992; Kuem N, 2014, MOL NUTR FOOD RES, V58, P2166, DOI 10.1002/mnfr.201400159; Kwack MH, 2012, J INVEST DERMATOL, V132, P1554, DOI 10.1038/jid.2012.24; Li YH, 2013, J INVEST DERMATOL, V133, P42, DOI 10.1038/jid.2012.235; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Lindner G, 2000, FASEB J, V14, P319, DOI 10.1096/fasebj.14.2.319; Mecklenburg L, 2000, J INVEST DERMATOL, V114, P909, DOI 10.1046/j.1523-1747.2000.00954.x; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Millar SE, 1999, DEV BIOL, V207, P133, DOI 10.1006/dbio.1998.9140; OLIVER R F, 1970, Journal of Embryology and Experimental Morphology, V23, P219; OLIVER RF, 1988, CLIN DERMATOL, V6, P74, DOI 10.1016/0738-081X(88)90069-7; OLIVER RF, 1966, J EMBRYOL EXP MORPH, V15, P331; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Park S, 2011, J HEPATOL, V54, P984, DOI 10.1016/j.jhep.2010.08.019; PETKOV V, 1972, ARZNEI-FORSCHUNG, V22, P1476; Peus D, 1996, DERMATOL CLIN, V14, P559, DOI 10.1016/S0733-8635(05)70384-3; PIERCE GF, 1994, J EXP MED, V179, P831, DOI 10.1084/jem.179.3.831; SATO C, 1995, J INVEST DERMATOL, V104, P958, DOI 10.1111/1523-1747.ep12606221; Schneider MR, 2009, CURR BIOL, V19, pR132, DOI 10.1016/j.cub.2008.12.005; Sirotkin AV, 2003, J REPROD DEVELOP, V49, P141, DOI 10.1262/jrd.49.141; Stenn KS, 2001, PHYSIOL REV, V81, P449, DOI 10.1152/physrev.2001.81.1.449; Stenn KS, 1996, DERMATOL CLIN, V14, P543, DOI 10.1016/S0733-8635(05)70383-1; Susalit E, 2011, PHYTOMEDICINE, V18, P251, DOI 10.1016/j.phymed.2010.08.016; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tsang Michael, 2004, Sci STKE, V2004, ppe17, DOI 10.1126/stke.2282004pe17; VANSCOTT EJ, 1958, J INVEST DERMATOL, V31, P281, DOI 10.1038/jid.1958.121; YAMAMOTO S, 1994, J INVEST DERMATOL, V102, P160, DOI 10.1111/1523-1747.ep12371755; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yano K, 2001, J CLIN INVEST, V107, P409, DOI 10.1172/JCI11317; Zachary I, 2003, BIOCHEM SOC T, V31, P1171	47	29	33	6	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129578	10.1371/journal.pone.0129578	http://dx.doi.org/10.1371/journal.pone.0129578			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26060936	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500150
J	Chanet, R; Kienda, G; Heneman-Masurel, A; Vernis, L; Cassinat, B; Guardiola, P; Fenaux, P; Chomienne, C; Huang, ME				Chanet, Roland; Kienda, Guy; Heneman-Masurel, Amelie; Vernis, Laurence; Cassinat, Bruno; Guardiola, Philippe; Fenaux, Pierre; Chomienne, Christine; Huang, Meng-Er			Yeast Assay Highlights the Intrinsic Genomic Instability of Human PML Intron 6 over Intron 3 and the Role of Replication Fork Proteins	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; GROSS-CHROMOSOMAL REARRANGEMENTS; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; TOPOISOMERASE-II; MAINTENANCE; MECHANISMS; PATHWAYS; MOTIFS; GENE	Human acute promyelocytic leukemia (APL) is characterized by a specific balanced translocation t(15;17)(q22;q21) involving the PML and RARA genes. In both de novo and therapy-related APL, the most frequent PML breakpoints are located within intron 6, and less frequently in intron 3; the precise mechanisms by which these breakpoints arise and preferentially in PML intron 6 remain unsolved. To investigate the intrinsic properties of the PML intron sequences in vivo, we designed Saccharomyces cerevisiae strains containing human PML intron 6 or intron 3 sequences inserted in yeast chromosome V and measured gross chromosomal rearrangements (GCR). This approach provided evidence that intron 6 had a superior instability over intron 3 due to an intrinsic property of the sequence and identified the 3' end of intron 6 as the most susceptible to break. Using yeast strains invalidated for genes that control DNA replication, we show that this differential instability depended at least upon Rrm3, a DNA helicase, and Mrc1, the human claspin homolog. GCR induction by hydrogen peroxide, a general genotoxic agent, was also dependent on genetic context. We conclude that: 1) this yeast system provides an alternative approach to study in detail the properties of human sequences in a genetically controlled situation and 2) the different susceptibility to produce DNA breaks in intron 6 versus intron 3 of the human PML gene is likely due to an intrinsic property of the sequence and is under replication fork genetic control.	[Chanet, Roland; Kienda, Guy; Heneman-Masurel, Amelie; Vernis, Laurence; Huang, Meng-Er] CNRS, Genotox Stress & Canc UMR3348, F-91405 Orsay, France; [Chanet, Roland; Kienda, Guy; Heneman-Masurel, Amelie; Vernis, Laurence; Huang, Meng-Er] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Cassinat, Bruno; Fenaux, Pierre; Chomienne, Christine] Hop St Louis, AP HP, Paris, France; [Cassinat, Bruno; Fenaux, Pierre; Chomienne, Christine] Univ Paris Diderot, Hop St Louis, INSERM, UMRS 1131, Paris, France; [Guardiola, Philippe] CHU Angers, Plateforme SNP Transcriptome & Epigenom, Angers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Huang, ME (corresponding author), CNRS, Genotox Stress & Canc UMR3348, F-91405 Orsay, France.	meng-er.huang@curie.fr	Vernis, Laurence/B-7414-2019; guardiola, philippe/L-2910-2015; CASSINAT, BRUNO/N-2752-2017; /L-1666-2018	CASSINAT, BRUNO/0000-0002-6514-3905; /0000-0001-7878-0877; CHOMIENNE, Christine/0000-0001-5513-5752	Centre National de la Recherche Scientifique; Institut Curie; Association Laurette Fugain	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Institut Curie; Association Laurette Fugain	The work was supported by Centre National de la Recherche Scientifique (MEH), Institut Curie (MEH), and Association Laurette Fugain (CC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Aze A, 2013, CHROMOSOMA, V122, P401, DOI 10.1007/s00412-013-0411-3; Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; de The H, 2010, NAT REV CANCER, V10, P775, DOI 10.1038/nrc2943; Debatisse M, 2012, TRENDS GENET, V28, P22, DOI 10.1016/j.tig.2011.10.003; DONG S, 1993, GENE CHROMOSOME CANC, V6, P133, DOI 10.1002/gcc.2870060302; Gordenin DA, 1998, MUTAT RES-FUND MOL M, V400, P45, DOI 10.1016/S0027-5107(98)00047-5; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hasan SK, 2008, BLOOD, V112, P3383, DOI 10.1182/blood-2007-10-115600; Hasan SK, 2010, GENE CHROMOSOME CANC, V49, P726, DOI 10.1002/gcc.20783; Ivessa AS, 2003, MOL CELL, V12, P1525, DOI 10.1016/S1097-2765(03)00456-8; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; Lee KY, 2010, J BIOL CHEM, V285, P10362, DOI 10.1074/jbc.M109.092544; Lobachev KS, 2000, EMBO J, V19, P3822, DOI 10.1093/emboj/19.14.3822; Lopes J, 2002, EMBO J, V21, P3201, DOI 10.1093/emboj/cdf310; Lou HQ, 2008, MOL CELL, V32, P106, DOI 10.1016/j.molcel.2008.08.020; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Maizels N, 2013, PLOS GENET, V9, DOI [10.1371/journal.pgen.1038/nature12149, DOI 10.1371/JOURNAL.PGEN.1038/NATURE12149]; Mays AN, 2010, BLOOD, V115, P326, DOI 10.1182/blood-2009-07-235051; Meczes EL, 1997, CANCER CHEMOTH PHARM, V39, P367, DOI 10.1007/s002800050585; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Mistry AR, 2005, NEW ENGL J MED, V352, P1529, DOI 10.1056/NEJMoa042715; Motea EA, 2010, BBA-PROTEINS PROTEOM, V1804, P1151, DOI 10.1016/j.bbapap.2009.06.030; Motegi A, 2006, MOL CELL BIOL, V26, P1424, DOI 10.1128/MCB.26.4.1424-1433.2006; Niu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040572; Paeschke K, 2013, NATURE, V497, P458, DOI 10.1038/nature12149; Panwar SL, 2008, BIOSCIENCE REP, V28, P217, DOI 10.1042/BSR20080071; Prasad R, 2012, ANNU REV MICROBIOL, V66, P39, DOI 10.1146/annurev-micro-092611-150111; Putnam CD, 2005, MOL CELL BIOL, V25, P7226, DOI 10.1128/MCB.25.16.7226-7238.2005; Putnam CD, 2012, P NATL ACAD SCI USA, V109, pE3251, DOI 10.1073/pnas.1216733109; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-107; Schmidt KH, 2006, P NATL ACAD SCI USA, V103, P18196, DOI 10.1073/pnas.0608566103; Schmidt KH, 2006, METHOD ENZYMOL, V409, P462, DOI 10.1016/S0076-6879(05)09027-0; Sia EA, 1997, MUTAT RES-DNA REPAIR, V383, P61, DOI 10.1016/S0921-8777(96)00046-8; Zhang H, 2007, MOL CELL, V27, P367, DOI 10.1016/j.molcel.2007.06.012; Zhang Y, 2012, MOL CELL, V48, P254, DOI 10.1016/j.molcel.2012.08.002	41	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129222	10.1371/journal.pone.0129222	http://dx.doi.org/10.1371/journal.pone.0129222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053431	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300102
J	Jharap, B; van Asseldonk, DP; de Boer, NKH; Bedossa, P; Diebold, J; Jonker, AM; Leteurtre, E; Verheij, J; Wendum, D; Wrba, F; Zondervan, PE; Colombel, JF; Reinisch, W; Mulder, CJJ; Bloemena, E; van Bodegraven, AA				Jharap, Bindia; van Asseldonk, Dirk P.; de Boer, Nanne K. H.; Bedossa, Pierre; Diebold, Joachim; Jonker, A. Mieke; Leteurtre, Emmanuelle; Verheij, Joanne; Wendum, Dominique; Wrba, Fritz; Zondervan, Pieter E.; Colombel, Jean-Frederic; Reinisch, Walter; Mulder, Chris J. J.; Bloemena, Elisabeth; van Bodegraven, Adriaan A.		NRH-Pathology Investigators	Diagnosing Nodular Regenerative Hyperplasia of the Liver Is Thwarted by Low Interobserver Agreement	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NONCIRRHOTIC PORTAL-HYPERTENSION; SINUSOIDAL OBSTRUCTION SYNDROME; COMBINATION THERAPY; 6-THIOGUANINE; AZATHIOPRINE; HEPATOTOXICITY; INFLIXIMAB; FEATURES	Background and Aims Nodular regenerative hyperplasia (NRH) of the liver is associated with several diseases and drugs. Clinical symptoms of NRH may vary from absence of symptoms to full-blown (non-cirrhotic) portal hypertension. However, diagnosing NRH is challenging. The objective of this study was to determine inter-and intraobserver agreement on the histopathologic diagnosis of NRH. Methods Liver specimens (n=48) previously diagnosed as NRH, were reviewed for the presence of NRH by seven pathologists without prior knowledge of the original diagnosis or clinical background. The majority of the liver specimens were from thiopurine using inflammatory bowel disease patients. Histopathologic features contributing to NRH were also assessed. Criteria for NRH were modified by consensus and subsequently validated. Interobserver agreement was evaluated by using the standard kappa index. Results After review, definite NRH, inconclusive NRH and no NRH were found in 35% (23-40%), 21% (13-27%) and 44% (38-56%), respectively (median, IQR). The median interobserver agreement for NRH was poor (kappa = 0.20, IQR 0.14-0.28). The intraobserver variability on NRH ranged between 14% and 71%. After modification of the criteria and exclusion of biopsies with technical shortcomings, the interobserver agreement on the diagnosis NRH was fair (kappa = 0.45). Conclusions The interobserver agreement on the histopathologic diagnosis of NRH was poor, even when assessed by well-experienced liver pathologists. Modification of the criteria of NRH based on consensus effort and exclusion of biopsies of poor quality led to a fairly increased interobserver agreement. The main conclusion of this study is that NRH is a clinicopathologic diagnosis that cannot reliably be based on histopathology alone.	[Jharap, Bindia; van Asseldonk, Dirk P.; de Boer, Nanne K. H.; Mulder, Chris J. J.; van Bodegraven, Adriaan A.] Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [Bedossa, Pierre] Beaujon Hosp, Dept Pathol, Paris, France; [Diebold, Joachim] Cantonal Hosp, Dept Pathol, Luzern, Switzerland; [Jonker, A. Mieke] Refaja Hosp, Dept Pathol, Stadskanaal, Netherlands; [Leteurtre, Emmanuelle] CHRU Lille, Dept Pathol, F-59037 Lille, France; [Verheij, Joanne] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Wendum, Dominique] Hop St Antoine, Dept Pathol, F-75571 Paris, France; [Wrba, Fritz] Univ Med Ctr Vienna, Dept Pathol, Vienna, Austria; [Zondervan, Pieter E.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Colombel, Jean-Frederic] Icahn Sch Med Mt Sinai, Dept Gastroenterol, New York, NY 10029 USA; [Reinisch, Walter] Univ Med Ctr Vienna, Dept Gastroenterol & Hepatol, Vienna, Austria; [Bloemena, Elisabeth] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [van Bodegraven, Adriaan A.] ORBIS Med Ctr, Dept Internal Med Gastroenterol & Geriatr, Sittard Geleen, Netherlands	Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Lucerne Cantonal Hospital; Universite de Lille - ISITE; CHU Lille; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Erasmus University Rotterdam; Erasmus MC; Icahn School of Medicine at Mount Sinai; Vrije Universiteit Amsterdam; Orbis Medical Center	Jharap, B (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands.	b.jharap@vumc.nl	de Boer, Nanne/AAE-8731-2022; van Bodegraven, Ad A/L-3180-2013; van Bodegraven, Ad/ABG-4367-2020; Bloemena, Elisabeth/V-1095-2018; Bloemena, Elisabeth/AAZ-1247-2021	Bloemena, Elisabeth/0000-0002-0221-9538; Verheij, Joanne/0000-0003-1283-630X; Bedossa, Pierre/0000-0002-8487-7322; de Boer, Nanne/0000-0001-8357-9887				Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Cotte L, 2011, J HEPATOL, V54, P489, DOI 10.1016/j.jhep.2010.07.030; De Boer NKH, 2008, SCAND J GASTROENTERO, V43, P604, DOI 10.1080/00365520701800266; Dubinsky MC, 2003, GASTROENTEROLOGY, V125, P298, DOI 10.1016/S0016-5085(03)00938-7; Ferlitsch A, 2007, AM J GASTROENTEROL, V102, P2495, DOI 10.1111/j.1572-0241.2007.01530.x; Force J, 2014, J CLIN ONCOL; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Laharie D, 2010, EUR J GASTROEN HEPAT, V22, P487, DOI 10.1097/MEG.0b013e328334098f; Minervini MI, 2009, J HEPATOL, V50, P501, DOI 10.1016/j.jhep.2008.10.030; Morris JM, 2010, EUR J GASTROEN HEPAT, V22, P1001, DOI 10.1097/MEG.0b013e3283360021; Nunez M, 2010, HEPATOLOGY, V52, P1143, DOI 10.1002/hep.23716; Panaccione R, 2014, GASTROENTEROLOGY, V146, P392, DOI 10.1053/j.gastro.2013.10.052; Reshamwala PA, 2006, HEPATOLOGY, V44, P7, DOI 10.1002/hep.21258; Rousselet MC, 2005, HEPATOLOGY, V41, P257, DOI 10.1002/hep.20535; Rubbia-Brandt L, 2010, CLIN LIVER DIS, V14, P651, DOI 10.1016/j.cld.2010.07.009; Rubbia-Brandt L, 2010, HISTOPATHOLOGY, V56, P430, DOI 10.1111/j.1365-2559.2010.03511.x; Schouten JNL, 2011, HEPATOLOGY, V54, P1071, DOI 10.1002/hep.24422; Seiderer J, 2005, J HEPATOL, V43, P303, DOI 10.1016/j.jhep.2005.02.051; Seksik P, 2011, INFLAMM BOWEL DIS, V17, P565, DOI 10.1002/ibd.21330; Sood A, 2014, HEPATOL RES, V44, P689, DOI 10.1111/hepr.12136; Teml A, 2007, WIEN KLIN WOCHENSCHR, V119, P519, DOI 10.1007/s00508-007-0841-0; Verheij J, 2013, HISTOPATHOLOGY, V62, P1083, DOI 10.1111/his.12114; Vernier-Massouille G, 2007, GUT, V56, P1404, DOI 10.1136/gut.2006.114363; WANLESS IR, 1990, HEPATOLOGY, V11, P787, DOI 10.1002/hep.1840110512; Zech CJ, 2007, EUR RADIOL, V17, P1898, DOI 10.1007/s00330-006-0544-3	25	36	36	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0120299	10.1371/journal.pone.0120299	http://dx.doi.org/10.1371/journal.pone.0120299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26054009	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300003
J	Nunes, PALD; Loureiro, ML; Pinol, L; Sastre, S; Voltaire, L; Canepa, A				Nunes, Paulo A. L. D.; Loureiro, Maria L.; Pinol, Laia; Sastre, Sergio; Voltaire, Louinord; Canepa, Antonio			Analyzing Beach Recreationists' Preferences for the Reduction of Jellyfish Blooms: Economic Results from a Stated-Choice Experiment in Catalonia, Spain	PLOS ONE			English	Article							VALUATION	Jellyfish outbreaks and their consequences appear to be on the increase around the world, and are becoming particularly relevant in the Mediterranean. No previous studies have quantified tourism losses caused by jellyfish outbreaks. We used a stated-choice questionnaire and a Random Utility Model to estimate the amount of time respondents would be willing to add to their journey, in terms of reported extra travel time, in order to reduce the risk of encountering jellyfish blooms in the Catalan coast. The estimation results indicated that the respondents were willing to spend on average an additional 23.8% of their travel time to enjoy beach recreation in areas with a lower risk of jellyfish blooms. Using as a reference the opportunity cost of time, we found that the subsample of individuals who made a tradeoff between the disutility generated by travelling longer in order to lower the risk of jellyfish blooms, and the utility gained from reducing this risk, are willing to pay on average (sic)3.20 per beach visit. This estimate, combined with the respondents' mean income, yielded annual economic gains associated with reduction of jellyfish blooms on the Catalan coast around (sic)422.57 million, or about 11.95% of the tourism expenditures in 2012. From a policy-making perspective, this study confirms the importance of the economic impacts of jellyfish blooms and the need for mitigation strategies. In particular, providing daily information using social media applications or other technical devices may reduce these social costs. The current lack of knowledge about jellyfish suggests that providing this information to beach recreationists may be a substantially effective policy instrument for minimising the impact of jellyfish blooms.	[Nunes, Paulo A. L. D.] UNEP, Div Environm Policy Implementat, Ecosyst Serv Econ Unit, Nairobi 00100, Kenya; [Loureiro, Maria L.] Univ Santiago de Compostela, Dept Fundamentos Anal Econ, Fac Ciencias Econ, Santiago De Compostela 15704, Spain; [Pinol, Laia] LEITAT Technol Ctr, Maritime Div, Terrassa 08225, Spain; [Sastre, Sergio; Canepa, Antonio] CSIC, Inst Ciencies Mar, Barcelona 08013, Spain; [Voltaire, Louinord] UBO, UMR AMURE, F-29200 Brest, France	Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Ifremer; Universite de Bretagne Occidentale	Loureiro, ML (corresponding author), Univ Santiago de Compostela, Dept Fundamentos Anal Econ, Fac Ciencias Econ, 15782 Campus Norte,Avda Burgo Nac, Santiago De Compostela 15704, Spain.	maria.loureiro@usc.es	Canepa, Antonio/R-5260-2018; Ferré, Laia Piñol/AAO-6979-2021; Loureiro, Maria L./Q-2384-2015	Canepa, Antonio/0000-0002-0608-2743; Loureiro, Maria L./0000-0002-7082-3980; Sastre, Sergio/0000-0002-7444-7425	European Commission [266445]; CONICYT [72120016]; Spanish Ministry of Economy and Competitiveness [ECO2012-39553-C04-02]	European Commission(European CommissionEuropean Commission Joint Research Centre); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Spanish Ministry of Economy and Competitiveness(Spanish Government)	The authors are also grateful to the European Commission, under contract agreement no. 266445 Vectors-Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors, for its financial support. A. Canepa was funded by CONICYT (PFCHA/Doctorado al Extranjero 4a Convocatoria, 72120016). Maria L. Loureiro would like to thank the Spanish Ministry of Economy and Competitiveness for its support through project number ECO2012-39553-C04-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamowicz W., 1998, INTRO ATTRIBUTE BASE; [Anonymous], 2012, CATALUNYA TURISTICA; Beaumont NJ, 2008, MAR POLLUT BULL, V56, P386, DOI 10.1016/j.marpolbul.2007.11.013; Canepa A, 2013, 4 INT JELL BLOOM S 2; Carson RT, 2009, AM J AGR ECON, V91, P1056, DOI 10.1111/j.1467-8276.2009.01309.x; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Graham WM, 2003, BIOL INVASIONS, V5, P53, DOI 10.1023/A:1024046707234; HANEMANN WM, 1989, AM J AGR ECON, V71, P1057, DOI 10.2307/1242685; Hanemman M, 1996, STAT ANAL DISCRETE R; Hearne RR, 2002, J ENVIRON MANAGE, V65, P153, DOI 10.1006/jema.2001.0541; Kim DH, 2012, FISHERIES SCI, V78, P1147, DOI 10.1007/s12562-012-0533-1; Knowler D, 2005, ECOL ECON, V52, P187, DOI 10.1016/j.ecolecon.2004.06.013; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Marambio M., 2013, 4 INT JELL BLOOM S H; Mariottini GL, 2010, MAR DRUGS, V8, P1122, DOI 10.3390/md8041122; McFadden D, 1973, FRONTIERS ECONOMETRI; Nastav B, 2013, MEDITERR MAR SCI, V14, P214, DOI 10.12681/mms.382; Nunes PALD, 2004, ENVIRON RESOUR ECON, V28, P517, DOI 10.1023/B:EARE.0000036777.83060.b6; Nunes PALD, 2008, ICES J MAR SCI, V65, P775, DOI 10.1093/icesjms/fsn078; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2012, ANNU REV MAR SCI, V4, P209, DOI 10.1146/annurev-marine-120709-142751; Quinones J, 2013, FISH RES, V139, P47, DOI 10.1016/j.fishres.2012.04.014; Remoundou K, 2009, ENVIRON SCI POLICY, V12, P1040, DOI 10.1016/j.envsci.2009.06.006; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; Sarda R, 2009, TOURISM MANAGE, V30, P158, DOI 10.1016/j.tourman.2008.05.011; Walsh R. G., 1990, Journal of Travel Research, V29, P17, DOI 10.1177/004728759002900105	26	30	30	5	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0126681	10.1371/journal.pone.0126681	http://dx.doi.org/10.1371/journal.pone.0126681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1GM	26053674	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300013
J	Saukkonen, K; Hagstrom, J; Mustonen, H; Juuti, A; Nordling, S; Fermer, C; Nilsson, O; Seppanen, H; Haglund, C				Saukkonen, Kapo; Hagstrom, Jaana; Mustonen, Harri; Juuti, Anne; Nordling, Stig; Fermer, Christian; Nilsson, Olle; Seppanen, Hanna; Haglund, Caj			Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma	PLOS ONE			English	Article							PROTEIN-1 EXPRESSION; INDEPENDENT FACTOR; CANCER; BIOMARKERS; OVEREXPRESSION	Aim of the Study Podocalyxin-like 1 is a transmembrane glyco-protein whose overexpression associates in many cancers with poor prognosis and unfavorable clinicopathological characteristics. Until now, its prognostic value has never been studied in pancreatic ductal adenocarcinoma (PDAC). The aim of this study was to investigate podocalyxin expression in PDAC by a novel monoclonal antibody and a commercially available polyclonal antibody. Patients and Materials With tissue microarrays and immuno-histochemistry, podocalyxin expression evaluation involved 168 PDAC patients. The associa-tions of the podocalyxin tumor expression with clinicopathological variables were explored by Fisher's exact test and the linear-by-linear test. Survival analyses were by Kaplan-Meier anal-ysis and the Cox proportional hazard model. Results The polyclonal antibody revealed membranous podocalyxin expression in 73 (44.0%) specimens and the monoclonal antibody was highly expressed in 36 (21.8%) cases. Membranous expression by the polyclonal antibody was associated with T classification (p=0.045) and perineural invasion (p=0.005), and high expression by the mono-clonal antibody with poor differentiation (p=0.033). High podocalyxin expression associated significantly with higher risk of death from PDAC by both the polyclonal antibody (hazard ratio (HR) = 1.62; 95% confidence interval (CI) 1.12-2.33; p=0.01) and the monoclonal antibody (HR = 2.10, 95% CI 1.38-3.20; p<0.001). The results remained significant in multivariate analysis, adjusted for age, gender, stage, lymph node ratio (>=/< 20%), and perivascular invasion (respectively as HR = 2.03; 95% CI 1.32-3.13, p=0.001; and as HR = 2.36; 95% CI 1.47-3.80, p<0.001). Conclusion We found podocalyxin to be an independent factor for poor prognosis in PDAC. To our knowledge, this is the first such report of its prognostic value.	[Saukkonen, Kapo; Mustonen, Harri; Juuti, Anne; Seppanen, Hanna; Haglund, Caj] Univ Helsinki, Dept Surg, FIN-00029 Helsinki, Finland; [Saukkonen, Kapo; Mustonen, Harri; Juuti, Anne; Seppanen, Hanna; Haglund, Caj] Helsinki Univ Hosp, FIN-00029 Helsinki, Finland; [Saukkonen, Kapo; Hagstrom, Jaana; Haglund, Caj] Univ Helsinki, Translat Canc Biol, Res Programs Unit, FIN-00014 Helsinki, Finland; [Hagstrom, Jaana; Nordling, Stig] Univ Helsinki, Dept Pathol, Haartman Inst, FIN-00014 Helsinki, Finland; [Hagstrom, Jaana; Nordling, Stig] Univ Helsinki, HUSLAB, FIN-00014 Helsinki, Finland; [Hagstrom, Jaana; Nordling, Stig] Univ Helsinki, Helsinki Univ Hosp, FIN-00014 Helsinki, Finland; [Fermer, Christian] Fujirebio Diagnost AB, SE-41458 Gothenburg, Sweden; [Nilsson, Olle] Onson Consulting, SE-41254 Gothenburg, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; H.U. Group Holdings Inc	Saukkonen, K (corresponding author), Univ Helsinki, Dept Surg, POB 440, FIN-00029 Helsinki, Finland.	kapo.saukkonen@helsinki.fi	Haglund, Caj/N-1240-2019; Hagström, Jaana/G-1468-2018; Seppänen, Hanna/AER-1337-2022	Hagström, Jaana/0000-0001-6079-7881; Mustonen, Harri Kalevi/0000-0001-5632-6796	Sigrid Juselius Foundation; Finska Lakaresallskapet; Liv och Halsa; Kurt och Doris Palander Foundation; K Albin Johansson Foundation; Fujirebio Diagnostics AB; Onson Consulting	Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Liv och Halsa; Kurt och Doris Palander Foundation; K Albin Johansson Foundation; Fujirebio Diagnostics AB; Onson Consulting	This study was supported by grants from Sigrid Juselius Foundation, Finska Lakaresallskapet, Liv och Halsa, Kurt och Doris Palander Foundation and K Albin Johansson Foundation. Fujirebio Diagnostics AB and Onson Consulting provided support in the form of salaries for authors CF and ON, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ansari D, 2011, BRIT J SURG, V98, P1041, DOI 10.1002/bjs.7574; Boman K, 2013, BRIT J CANCER, V108, P2321, DOI 10.1038/bjc.2013.215; Casey G, 2006, HUM MOL GENET, V15, P735, DOI 10.1093/hmg/ddi487; Cipollone JA, 2012, CLIN EXP METASTAS, V29, P239, DOI 10.1007/s10585-011-9446-0; Dallas MR, 2012, AM J PHYSIOL-CELL PH, V303, pC616, DOI 10.1152/ajpcell.00149.2012; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; Finnish cancer registry, 2014, CANCER STATISTICS; Fong ZV, 2012, CANCER J, V18, P530, DOI 10.1097/PPO.0b013e31827654ea; Heukamp LC, 2006, HISTOPATHOLOGY, V49, P242, DOI 10.1111/j.1365-2559.2006.02489.x; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Hsu YH, 2010, AM J PATHOL, V176, P3050, DOI 10.2353/ajpath.2010.090539; Jamieson NB, 2011, CLIN CANCER RES, V17, P3316, DOI 10.1158/1078-0432.CCR-10-3284; Kaprio T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-493; Kaprio T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-494; Kavoura E, 2011, HUM PATHOL, V42, P227, DOI 10.1016/j.humpath.2010.05.028; Kelley TW, 2005, AM J CLIN PATHOL, V124, P134, DOI 10.1309/7BHLAHHU0N4MHT7Q; KERJASCHKI D, 1984, J CELL BIOL, V98, P1505, DOI 10.1083/jcb.98.4.1505; Larsson A, 2011, BRIT J CANCER, V105, P666, DOI 10.1038/bjc.2011.295; Larsson A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-282; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Ney JT, 2007, HUM PATHOL, V38, P359, DOI 10.1016/j.humpath.2006.08.025; Nielsen JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000237; Nielsen JS, 2009, J AM SOC NEPHROL, V20, P1669, DOI 10.1681/ASN.2008070782; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Takeda T, 2000, MOL BIOL CELL, V11, P3219, DOI 10.1091/mbc.11.9.3219; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200	28	24	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129012	10.1371/journal.pone.0129012	http://dx.doi.org/10.1371/journal.pone.0129012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053486	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300076
J	Shumar, SA; Fagone, P; Alfonso-Pecchio, A; Gray, JT; Rehg, JE; Jackowski, S; Leonardi, R				Shumar, Stephanie A.; Fagone, Paolo; Alfonso-Pecchio, Adolfo; Gray, John T.; Rehg, Jerold E.; Jackowski, Suzanne; Leonardi, Roberta			Induction of Neuron-Specific Degradation of Coenzyme A Models Pantothenate Kinase-Associated Neurodegeneration by Reducing Motor Coordination in Mice	PLOS ONE			English	Article							ADENOASSOCIATED VIRAL VECTORS; PEROXISOMAL NUDIX HYDROLASE; MOUSE MODEL; INTRACEREBROVENTRICULAR INJECTION; FEEDBACK-REGULATION; PARKINSONS-DISEASE; COA BIOSYNTHESIS; NERVOUS-SYSTEM; AAV VECTORS; METABOLISM	Background Pantothenate kinase-associated neurodegeneration, PKAN, is an inherited disorder characterized by progressive impairment in motor coordination and caused by mutations in PANK2, a human gene that encodes one of four pantothenate kinase (PanK) isoforms. PanK initiates the synthesis of coenzyme A (CoA), an essential cofactor that plays a key role in energy metabolism and lipid synthesis. Most of the mutations in PANK2 reduce or abolish the activity of the enzyme. This evidence has led to the hypothesis that lower CoA might be the underlying cause of the neurodegeneration in PKAN patients; however, no mouse model of the disease is currently available to investigate the connection between neuronal CoA levels and neurodegeneration. Indeed, genetic and/or dietary manipulations aimed at reducing whole-body CoA synthesis have not produced a desirable PKAN model, and this has greatly hindered the discovery of a treatment for the disease. Objective, Methods, Results and Conclusions Cellular CoA levels are tightly regulated by a balance between synthesis and degradation. CoA degradation is catalyzed by two peroxisomal nudix hydrolases, Nudt7 and Nudt19. In this study we sought to reduce neuronal CoA in mice through the alternative approach of increasing Nudt7-mediated CoA degradation. This was achieved by combining the use of an adeno-associated virus-based expression system with the synapsin (Syn) promoter. We show that mice with neuronal overexpression of a cytosolic version of Nudt7 (scAAV9-Syn-Nudt7cyt) exhibit a significant decrease in brain CoA levels in conjunction with a reduction in motor coordination. These results strongly support the existence of a link between CoA levels and neuronal function and show that scAAV9-Syn-Nudt7cyt mice can be used to model PKAN.	[Shumar, Stephanie A.; Leonardi, Roberta] W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA; [Fagone, Paolo; Gray, John T.] St Jude Childrens Res Hosp, Dept Hematol, Memphis, TN 38105 USA; [Alfonso-Pecchio, Adolfo; Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Rehg, Jerold E.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	West Virginia University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Leonardi, R (corresponding author), W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26506 USA.	roleonardi@hsc.wvu.edu	Gray, John T/D-2916-2016; Rehg, Jerold E/N-8111-2018; Jackowski, Suzanne/N-8168-2018	Gray, John T/0000-0002-1888-4612; Jackowski, Suzanne/0000-0002-6855-1429; Fagone, Paolo/0000-0002-0102-3701	NBIA Disorders Association research grant; West Virginia University's School of Medicine startup foundation; National Institutes of Health NIH [GM062896]; American Lebanese Syrian Associated Charities (ALSAC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER	NBIA Disorders Association research grant; West Virginia University's School of Medicine startup foundation; National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NBIA Disorders Association research grant (http://www.nbiadisorders.org/) and West Virginia University's School of Medicine startup foundation funding to Roberta Leonardi and by the National Institutes of Health NIH GM062896 (http://www.nih.gov/) and the American Lebanese Syrian Associated Charities (ALSAC) to Suzanne Jackowski. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso-Pecchio A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049509; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bosveld F, 2008, HUM MOL GENET, V17, P2058, DOI 10.1093/hmg/ddn105; Brunetti D, 2014, BRAIN, V137, P57, DOI 10.1093/brain/awt325; Brunetti D, 2012, HUM MOL GENET, V21, P5294, DOI 10.1093/hmg/dds380; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Dusi S, 2014, AM J HUM GENET, V94, P11, DOI 10.1016/j.ajhg.2013.11.008; Fagone P, 2012, HUM GENE THER METHOD, V23, P1, DOI 10.1089/hgtb.2011.104; Foust KD, 2009, NAT BIOTECHNOL, V27, P59, DOI 10.1038/nbt.1515; Garcia M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040871; Gasmi L, 2001, BIOCHEM J, V357, P33, DOI 10.1042/0264-6021:3570033; Gholizadeh S, 2013, HUM GENE THER METHOD, V24, P205, DOI 10.1089/hgtb.2013.076; Glaab E, 2015, NEUROBIOL DIS, V74, P1, DOI 10.1016/j.nbd.2014.11.002; Gray JT, 2011, METHODS MOL BIOL, V807, P25, DOI 10.1007/978-1-61779-370-7_2; Gregory A, 2011, CURR NEUROL NEUROSCI, V11, P254, DOI 10.1007/s11910-011-0181-3; HOESCHE C, 1993, J BIOL CHEM, V268, P26494; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; HORIE S, 1986, J BIOCHEM, V99, P1345, DOI 10.1093/oxfordjournals.jbchem.a135602; Kim JM, 2006, DNA RES, V13, P275, DOI 10.1093/dnares/dsl016; Klepper J, 2013, HAND CLINIC, V113, P1689, DOI 10.1016/B978-0-444-59565-2.00036-8; Kuo YM, 2007, J INHERIT METAB DIS, V30, P310, DOI 10.1007/s10545-007-0560-8; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2005, J BIOL CHEM, V280, P3314, DOI 10.1074/jbc.M411608200; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Leonardi R, 2014, DIABETOLOGIA, V57, P1466, DOI 10.1007/s00125-014-3245-5; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Leonardi R, 2009, J BIOL CHEM, V284, P27077, DOI 10.1074/jbc.M109.031336; Leoni V, 2012, MOL GENET METAB, V105, P463, DOI 10.1016/j.ymgme.2011.12.005; McLean JR, 2014, NEUROSCI LETT, V576, P73, DOI 10.1016/j.neulet.2014.05.044; Minkler PE, 2008, ANAL BIOCHEM, V376, P275, DOI 10.1016/j.ab.2008.02.022; Miyake N, 2011, BRAIN RES, V1389, P19, DOI 10.1016/j.brainres.2011.03.014; Ofman R, 2006, BIOCHEM J, V393, P537, DOI 10.1042/BJ20050893; Olpin SE, 2013, J INHERIT METAB DIS, V36, P645, DOI 10.1007/s10545-013-9611-5; Reilly SJ, 2008, J BIOCHEM, V144, P655, DOI 10.1093/jb/mvn114; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; SHIMADA K, 1994, J CHROMATOGR B, V659, P227, DOI 10.1016/0378-4347(93)E0444-U; Siudeja K, 2011, EMBO MOL MED, V3, P755, DOI 10.1002/emmm.201100180; van Adel Brian A, 2009, J Clin Neuromuscul Dis, V10, P97, DOI 10.1097/CND.0b013e3181903126; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; White T, 1998, ANAL BIOCHEM, V258, P109, DOI 10.1006/abio.1997.2545; Williams S, 2013, MOL GENET METAB, V110, P336, DOI 10.1016/j.ymgme.2013.06.017; Williamson J R, 1979, Methods Enzymol, V55, P200; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Zhang YM, 2006, J BIOL CHEM, V281, P107, DOI 10.1074/jbc.M508825200; Zhang YM, 2005, J BIOL CHEM, V280, P32594, DOI 10.1074/jbc.M506275200; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200; Zhyvoloup A, 2002, J BIOL CHEM, V277, P22107, DOI 10.1074/jbc.C200195200; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	51	18	18	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0130013	10.1371/journal.pone.0130013	http://dx.doi.org/10.1371/journal.pone.0130013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052948	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300174
J	Stefani, FOP; Bell, TH; Marchand, C; de la Providencia, IE; El Yassimi, A; St-Arnaud, M; Hijri, M				Stefani, Franck O. P.; Bell, Terrence H.; Marchand, Charlotte; de la Providencia, Ivan E.; El Yassimi, Abdel; St-Arnaud, Marc; Hijri, Mohamed			Culture-Dependent and -Independent Methods Capture Different Microbial Community Fractions in Hydrocarbon-Contaminated Soils	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; BACTERIAL COMMUNITY; BIOREMEDIATION; OIL; DIVERSITY; FUNGI; BIOAUGMENTATION; IDENTIFICATION; PHYTOREMEDIATION; BIODEGRADATION	Bioremediation is a cost-effective and sustainable approach for treating polluted soils, but our ability to improve on current bioremediation strategies depends on our ability to isolate microorganisms from these soils. Although culturing is widely used in bioremediation research and applications, it is unknown whether the composition of cultured isolates closely mirrors the indigenous microbial community from contaminated soils. To assess this, we paired culture-independent (454-pyrosequencing of total soil DNA) with culture-dependent (isolation using seven different growth media) techniques to analyse the bacterial and fungal communities from hydrocarbon-contaminated soils. Although bacterial and fungal rarefaction curves were saturated for both methods, only 2.4% and 8.2% of the bacterial and fungal OTUs, respectively, were shared between datasets. Isolated taxa increased the total recovered species richness by only 2% for bacteria and 5% for fungi. Interestingly, none of the bacteria that we isolated were representative of the major bacterial OTUs recovered by 454-pyrosequencing. Isolation of fungi was moderately more effective at capturing the dominant OTUs observed by culture-independent analysis, as 3 of 31 cultured fungal strains ranked among the 20 most abundant fungal OTUs in the 454-pyrosequencing dataset. This study is one of the most comprehensive comparisons of microbial communities from hydrocarbon-contaminated soils using both isolation and high-throughput sequencing methods.	[Stefani, Franck O. P.; Bell, Terrence H.; Marchand, Charlotte; de la Providencia, Ivan E.; El Yassimi, Abdel; St-Arnaud, Marc; Hijri, Mohamed] Univ Montreal, Dept Biol Sci, Ctr Biodivers, Montreal, PQ, Canada	Universite de Montreal	Hijri, M (corresponding author), Univ Montreal, Dept Biol Sci, Ctr Biodivers, Montreal, PQ, Canada.	mohamed.hijri@umontreal.ca	St-Arnaud, Marc/D-1184-2017; Hijri, Mohamed/AAL-5737-2021; Hijri, Mohamed/ABC-5969-2021	St-Arnaud, Marc/0000-0002-7181-9895; Hijri, Mohamed/0000-0001-6112-8372; Bell, Terrence/0000-0003-3603-7270	Genome Quebec; Genome Canada	Genome Quebec; Genome Canada(Genome Canada)	This work was supported by the Genome Quebec and Genome Canada funded GenoRem Project.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Aislabie J, 2006, EXTREMOPHILES, V10, P171, DOI 10.1007/s00792-005-0498-4; ATLAS RM, 1995, INT BIODETER BIODEGR, V35, P317, DOI 10.1016/0964-8305(95)00030-9; Barreto MC, 2012, FEMS MICROBIOL ECOL, V82, P202, DOI 10.1111/j.1574-6941.2012.01419.x; Bell TH, 2014, TRENDS BIOTECHNOL, V32, P271, DOI 10.1016/j.tibtech.2014.02.008; Bell TH, 2014, ISME J, V8, P331, DOI 10.1038/ismej.2013.149; Bell TH, 2013, ISME J, V7, P1200, DOI 10.1038/ismej.2013.1; Billiard SM, 2008, TOXICOL SCI, V105, P5, DOI 10.1093/toxsci/kfm303; Bispo A, 1999, ORG GEOCHEM, V30, P947, DOI 10.1016/S0146-6380(99)00078-9; Bridge P, 2001, PLANT SOIL, V232, P147, DOI 10.1023/A:1010346305799; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Carraro L, 2011, RES MICROBIOL, V162, P231, DOI 10.1016/j.resmic.2011.01.002; Chaerun SK, 2004, ENVIRON INT, V30, P911, DOI 10.1016/j.envint.2004.02.007; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Collado J, 2007, FEMS MICROBIOL ECOL, V60, P521, DOI 10.1111/j.1574-6941.2007.00294.x; Cornforth DM, 2013, NAT REV MICROBIOL, V11, P285, DOI 10.1038/nrmicro2977; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; Daghino S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044233; Das K, 2007, BIORESOURCE TECHNOL, V98, P1339, DOI 10.1016/j.biortech.2006.05.032; dos Santos HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016943; Echeveste P, 2010, CHEMOSPHERE, V81, P161, DOI 10.1016/j.chemosphere.2010.06.072; Eckle P, 2012, ENVIRON SCI TECHNOL, V46, P13002, DOI 10.1021/es3029523; Fan MY, 2014, ENVIRON TECHNOL, V35, P391, DOI 10.1080/09593330.2013.829504; Ferrari BC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00217; Foster KR, 2012, CURR BIOL, V22, P1845, DOI 10.1016/j.cub.2012.08.005; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Gentry TJ, 2004, CRIT REV ENV SCI TEC, V34, P447, DOI 10.1080/10643380490452362; Guidi W, 2012, CHEM ECOL, V28, P49, DOI 10.1080/02757540.2011.627857; Haegeman B, 2013, ISME J, V7, P1092, DOI 10.1038/ismej.2013.10; Harms H, 2011, NAT REV MICROBIOL, V9, P177, DOI 10.1038/nrmicro2519; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; Janssen PH, 2002, APPL ENVIRON MICROB, V68, P2391, DOI 10.1128/AEM.68.5.2391-2396.2002; Kanaly RA, 2000, J BACTERIOL, V182, P2059, DOI 10.1128/JB.182.8.2059-2067.2000; Kopke B, 2005, APPL ENVIRON MICROB, V71, P7819, DOI 10.1128/AEM.71.12.7819-7830.2005; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Liu WX, 2010, ENVIRON GEOCHEM HLTH, V32, P23, DOI 10.1007/s10653-009-9262-5; Malaviya P, 2007, BIORESOURCE TECHNOL, V98, P3647, DOI 10.1016/j.biortech.2006.11.021; Martin F, 2012, ENVIRON POLLUT, V162, P345, DOI 10.1016/j.envpol.2011.11.032; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Mbadinga SM, 2011, INT BIODETER BIODEGR, V65, P1, DOI 10.1016/j.ibiod.2010.11.009; Mishra S, 2001, APPL ENVIRON MICROB, V67, P1675, DOI 10.1128/AEM.67.4.1675-1681.2001; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Olusola SA, 2010, J BIOREMED BIODEGRAD, V1, P111, DOI DOI 10.4172/2155-6199.1000113; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Perez-Leblic MI, 2012, J ENVIRON MANAGE, V95, pS285, DOI 10.1016/j.jenvman.2010.07.017; Pham VHT, 2012, TRENDS BIOTECHNOL, V30, P475, DOI 10.1016/j.tibtech.2012.05.007; PHILLIPS DH, 1983, NATURE, V303, P468, DOI 10.1038/303468a0; Pitkaranta M, 2008, APPL ENVIRON MICROB, V74, P233, DOI 10.1128/AEM.00692-07; Potin O, 2004, INT BIODETER BIODEGR, V54, P45, DOI 10.1016/j.ibiod.2004.01.003; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; R Development Core Team, R LANG ENV STAT COMP; Rafin C, 2013, ENVIRON SCI POLLUT R, V20, P3280, DOI 10.1007/s11356-012-1255-8; Regonne RK, 2013, ENVIRON POLLUT, V180, P145, DOI 10.1016/j.envpol.2013.04.038; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Saul DJ, 2005, FEMS MICROBIOL ECOL, V53, P141, DOI 10.1016/j.femsec.2004.11.007; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Shade A, 2012, ENVIRON MICROBIOL, V14, P2247, DOI 10.1111/j.1462-2920.2012.02817.x; Shahsavari E, 2013, J ENVIRON MANAGE, V122, P105, DOI 10.1016/j.jenvman.2013.02.050; Shokralla S, 2012, MOL ECOL, V21, P1794, DOI 10.1111/j.1365-294X.2012.05538.x; Shrestha P, 2011, APPL ENVIRON MICROB, V77, P5490, DOI 10.1128/AEM.02996-10; Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12; Suhara H, 2011, MYCOSCIENCE, V52, P48, DOI 10.1007/s10267-010-0062-7; Sutton NB, 2013, APPL ENVIRON MICROB, V79, P619, DOI 10.1128/AEM.02747-12; Thompson IP, 2005, ENVIRON MICROBIOL, V7, P909, DOI 10.1111/j.1462-2920.2005.00804.x; Toledo FL, 2006, SYST APPL MICROBIOL, V29, P244, DOI 10.1016/j.syapm.2005.09.003; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Tyagi M, 2011, BIODEGRADATION, V22, P231, DOI 10.1007/s10532-010-9394-4; Vartoukian SR, 2010, FEMS MICROBIOL LETT, V309, P1, DOI 10.1111/j.1574-6968.2010.02000.x; Vasudevan N, 2001, ENVIRON INT, V26, P409, DOI 10.1016/S0160-4120(01)00020-4; Vaz-Moreira I, 2011, ANTON LEEUW INT J G, V100, P245, DOI 10.1007/s10482-011-9583-0; Warnes GR, 2013, GPLOTS VARIOUS R PRO; Watanabe K, 2001, CURR OPIN BIOTECH, V12, P237, DOI 10.1016/S0958-1669(00)00205-6; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Wong JWC, 2002, WATER AIR SOIL POLL, V139, P1, DOI 10.1023/A:1015883924901; Yakimov MM, 2007, CURR OPIN BIOTECH, V18, P257, DOI 10.1016/j.copbio.2007.04.006; Zheng ZM, 2003, ENVIRON SCI POLLUT R, V10, P173, DOI 10.1065/espr2002.07.126	81	109	112	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128272	10.1371/journal.pone.0128272	http://dx.doi.org/10.1371/journal.pone.0128272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053848	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300028
J	Wang, CP; Jin, R; Nanda, A; Yan, JC; Li, GH				Wang, Cuiping; Jin, Rong; Nanda, Anil; Yan, Jinchuan; Li, Guohong			Platelet PI3K gamma Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions	PLOS ONE			English	Article							NEOINTIMA FORMATION; VASCULAR INJURY; DISTURBED FLOW; INFLAMMATION; ADHESION; ATHEROSCLEROSIS; ACTIVATION; GAMMA; ENDOTHELIUM; THICKNESS	Studies have begun to focus on the emerging function of platelets as immune and inflammatory cells that initiate and accelerate vascular inflammation. Phosphoinositide 3-kinase gamma (PI3K gamma) is critically involved in a number of inflammatory and autoimmune diseases. This study aims to investigate the contribution of platelet PI3K gamma to vascular remodeling under flow severely reduced conditions. Mouse partial left carotid artery ligation with adoptive transfer of activated, washed wild-type or PI3K gamma(-/-) platelets was used as the model. Intima-media area, leukocyte recruitment, and proinflammatory mediator expression were assessed. In vitro PI3K gamma(-/-) platelets were used to verify the effect of PI3K gamma. on platelet activation, interaction with leukocytes, and endothelial cells. Mice injected with activated platelets showed a significant increase in intima-media thickening, recruitment of neutrophils (at 3 d) and macrophages (at 21 d), and intercellular adhesion molecule-1, vascular cell adhesion molecule-1, tumor necrosis factor alpha, and interleukin-6 expression (at 3 d) in the flow-reduced area. These effects were abrogated by platelet PI3K gamma deficiency. Circulating platelet-leukocyte aggregates were reduced in PI3K gamma(-/-) mice after partial ligation. In vivo data confirmed that PI3K gamma mediated Adenine di-Phosphate -induced platelet activation through the Akt and p38 MAP kinase signaling pathways. Moreover, platelet PI3K gamma deficiency reduced platelet-leukocyte aggregation and platelet-endothelial cell (EC) interaction. These findings indicate that platelet PI3K gamma contributes to platelet-mediated vascular inflammation and carotid intima-media thickening after flow severely reduced. Platelet PI3K gamma may be a new target in the treatment of vascular diseases.	[Wang, Cuiping; Yan, Jinchuan] Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang 212001, Jiangsu, Peoples R China; [Wang, Cuiping; Jin, Rong; Nanda, Anil; Li, Guohong] LSU Hlth Sci Ctr, Dept Neurosurg, Shreveport, LA 71103 USA	Jiangsu University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Yan, JC (corresponding author), Jiangsu Univ, Affiliated Hosp, Dept Cardiol, Zhenjiang 212001, Jiangsu, Peoples R China.	yanjinchuan@hotmail.com; gli@lsuhsc.edu			National Natural Science Foundation of China [81370409, 81400269]; Development Health Engineering of Jiangsu Province [LJ201116]; Key Laboratory of Cardiovascular Disease of Zhenjiang [SS2012002]; National Institutes of Health [NS088719, HL087990]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088719] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Health Engineering of Jiangsu Province; Key Laboratory of Cardiovascular Disease of Zhenjiang; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by National Natural Science Foundation of China [No. 81370409] and Development Health Engineering of Jiangsu Province [LJ201116] and the Key Laboratory of Cardiovascular Disease of Zhenjiang [No. SS2012002] to JY and National Natural Science Foundation of China [No. 81400269] to CW and by grants from the National Institutes of Health [Grant No. NS088719; HL087990] to GL.	Bienvenu JG, 2001, CIRCULATION, V103, P1128, DOI 10.1161/01.CIR.103.8.1128; Chakrabarti S, 2005, ARTERIOSCL THROM VAS, V25, P2428, DOI 10.1161/01.ATV.0000184765.59207.f3; Cooper D, 2004, AM J PHYSIOL-HEART C, V286, pH1895, DOI 10.1152/ajpheart.01000.2003; Davis C, 2003, J THROMB HAEMOST, V1, P1699, DOI 10.1046/j.1538-7836.2003.00292.x; Davis PH, 2001, CIRCULATION, V104, P2815, DOI 10.1161/hc4601.099486; Donners MMPC, 2008, BLOOD, V111, P4596, DOI 10.1182/blood-2007-05-088906; Furman MI, 1998, J AM COLL CARDIOL, V31, P352, DOI 10.1016/S0735-1097(97)00510-X; Furman MI, 2001, J AM COLL CARDIOL, V38, P1002, DOI 10.1016/S0735-1097(01)01485-1; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hirsch E, 2001, FASEB J, V15, P2019, DOI 10.1096/fj.00-0810fje; Huo YQ, 2003, NAT MED, V9, P61, DOI 10.1038/nm810; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Korshunov VA, 2003, ARTERIOSCL THROM VAS, V23, P2185, DOI 10.1161/01.ATV.0000103120.06092.14; Li G, 2008, AM J PATHOL, V172, P1141, DOI 10.2353/ajpath.2008.070633; Lievens D, 2010, BLOOD, V116, P4317, DOI 10.1182/blood-2010-01-261206; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Martins PD, 2004, ARTERIOSCL THROM VAS, V24, P193, DOI 10.1161/01.ATV.0000106320.40933.E5; May AE, 2008, ARTERIOSCL THROM VAS, V28, pS5, DOI 10.1161/ATVBAHA.107.158915; Morrell CN, 2014, BLOOD, V123, P2759, DOI 10.1182/blood-2013-11-462432; Nam D, 2009, AM J PHYSIOL-HEART C, V297, pH1535, DOI 10.1152/ajpheart.00510.2009; Ni CW, 2010, BLOOD, V116, pE66, DOI 10.1182/blood-2010-04-278192; Ott I, 1996, CIRCULATION, V94, P1239, DOI 10.1161/01.CIR.94.6.1239; Projahn D, 2012, J LEUKOCYTE BIOL, V92, P1167, DOI 10.1189/jlb.0312151; Puri KD, 2005, BLOOD, V106, P150, DOI 10.1182/blood-2005-01-0023; Quinn MJ, 1999, CIRCULATION, V100, P1667, DOI 10.1161/01.CIR.100.15.1667; Rittenhouse SE, 1996, BLOOD, V88, P4401, DOI 10.1182/blood.V88.12.4401.bloodjournal88124401; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Schmidt R, 2008, CIRC RES, V102, P302, DOI 10.1161/CIRCRESAHA.107.157990; Schror K, 1998, Vasc Med, V3, P247, DOI 10.1191/135886398676216245; Seizer P, 2009, THROMB HAEMOSTASIS, V101, P682, DOI 10.1160/TH08-06-0368; Smirnova NF, 2014, J EXP MED, V211, P1779, DOI 10.1084/jem.20131276; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; TRIP MD, 1990, NEW ENGL J MED, V322, P1549, DOI 10.1056/NEJM199005313222201; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; VANZANTEN GH, 1994, J CLIN INVEST, V93, P615, DOI 10.1172/JCI117014; ZHANG J, 1995, J BIOL CHEM, V270, P6589, DOI 10.1074/jbc.270.12.6589	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129265	10.1371/journal.pone.0129265	http://dx.doi.org/10.1371/journal.pone.0129265			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053836	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300105
J	Gong, GC; Fan, WZ; Li, DZ; Tian, X; Chen, SJ; Fu, YC; Xu, WC; Wei, CJ				Gong, Gen-cheng; Fan, Wen-zhu; Li, Di-zheng; Tian, Xiong; Chen, Shao-jun; Fu, Yu-cai; Xu, Wen-can; Wei, Chi-ju			Increased Specific Labeling of INS-1 Pancreatic Beta-Cell by Using RIP-Driven Cre Mutants with Reduced Activity	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; PROMOTER INTERFERENCE; TRANSGENE EXPRESSION; EFFECTOR NUCLEASES; RECOMBINASE; GENE; BRAIN; VECTORS; MICE; PROGENITORS	Ectopically expressed Cre recombinase in extrapancreatic tissues in RIP-Cre mice has been well documented. The objective of this study was to find a simple solution that allows for improved beta-cell specific targeting. To this end, the RIP-Cre and reporter CMV-loxP-DsRed-loxP-EGFP expression cassettes were configurated into a one-plasmid and two-plasmid systems, which labeled approximately 80% insulin-positive INS-1 cells after 48 h transfection. However, off-target labeling was robustly found in more than 15% insulin-negative Ad293 cells. When an IRES element was inserted in front of Cre to reduce the translation efficiency, the ratio of recombination between INS-1 and Ad293 cells increased 3-4-fold. Further, a series of Cre mutants were generated by site-directed mutagenesis. When one of the mutants, Cre(H289P) in both configurations, was used in the experiment, the percentage of recombination dropped to background levels in a number of insulin-negative cell lines, but decreased only slightly in INS-1 cells. Consistently, DNA substrate digestion assay showed that the enzymatic activity of Cre(H289P) was reduced by 30-fold as compared to that of wild-type. In this study, we reported the generation of constructs containing RIP and Cre mutants, which enabled enhanced beta-cell specific labeling in vitro. These tools could be invaluable for beta-cell targeting and to the study of islet development.	[Gong, Gen-cheng; Fan, Wen-zhu; Li, Di-zheng; Tian, Xiong; Chen, Shao-jun; Wei, Chi-ju] Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China; [Fu, Yu-cai] Shantou Univ, Coll Med, Lab Cell Senescence, Shantou 515041, Guangdong, Peoples R China; [Xu, Wen-can] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Endocrinol, Shantou 515041, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University	Wei, CJ (corresponding author), Shantou Univ, Multidisciplinary Res Ctr, Shantou 515063, Guangdong, Peoples R China.	chijuwei@stu.edu.cn			Li Ka Shing Foundation; Natural Science Foundation of China [30971665, 81172894, 81370925]; Education Department of Guangdong [cxzd1123]	Li Ka Shing Foundation; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department of Guangdong	This research was supported by the Li Ka Shing Foundation, the Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant Nos. 30971665, 81172894, 81370925), and the Education Department of Guangdong (http://www.gdhed.edu.cn/) (Grant No. cxzd1123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Cradick TJ, 2013, NUCLEIC ACIDS RES, V41, P9584, DOI 10.1093/nar/gkt714; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Fukazawa T, 2006, EXP CELL RES, V312, P3404, DOI 10.1016/j.yexcr.2006.07.015; Gabriel R, 2011, NAT BIOTECHNOL, V29, P816, DOI 10.1038/nbt.1948; Gannon M, 2000, GENESIS, V26, P143, DOI 10.1002/(SICI)1526-968X(200002)26:2<143::AID-GENE13>3.0.CO;2-L; Gibb B, 2010, NUCLEIC ACIDS RES, V38, P5817, DOI 10.1093/nar/gkq384; Ginn SL, 2003, HUM GENE THER, V14, P1127, DOI 10.1089/104303403322167975; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Guilinger JP, 2014, NAT METHODS, V11, P429, DOI 10.1038/nmeth.2845; Gustafsson E, 2001, J CELL SCI, V114, P671; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Hasegawa Y, 2014, EXP ANIM TOKYO, V63, P183, DOI 10.1538/expanim.63.183; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hsieh J, 2012, GENE DEV, V26, P1010, DOI 10.1101/gad.187336.112; Johnson JD, 2014, ISLETS, V6, DOI 10.4161/19382014.2014.944439; Juillerat A, 2014, NUCLEIC ACIDS RES, V42, P5390, DOI 10.1093/nar/gku155; Kaczmarczyk SJ, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e56; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kyriaki G, 2003, CELL MOL NEUROBIOL, V23, P1, DOI 10.1023/A:1022598900246; Lamotte L, 2004, TRANSGENIC RES, V13, P463, DOI 10.1007/s11248-004-9587-x; Lee JY, 2006, J BIOL CHEM, V281, P2649, DOI 10.1074/jbc.M512373200; Lei Y, 2012, P NATL ACAD SCI USA, V109, P17484, DOI 10.1073/pnas.1215421109; Liu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013533; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; Lu S, 2012, NEUROBIOL DIS, V45, P219, DOI 10.1016/j.nbd.2011.08.006; Machida M, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/959737; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Martin M, 2007, ENDOCR DEV, V12, P24, DOI 10.1159/000109602; Mathijs Iris, 2012, Methods Mol Biol, V933, P317, DOI 10.1007/978-1-62703-068-7_21; Mehran AE, 2012, CELL METAB, V16, P723, DOI 10.1016/j.cmet.2012.10.019; Nunes-Duby SE, 1998, NUCLEIC ACIDS RES, V26, P391, DOI 10.1093/nar/26.2.391; Pattanayak V, 2011, NAT METHODS, V8, P765, DOI 10.1038/nmeth.1670; Pomplun D, 2007, HORM METAB RES, V39, P336, DOI 10.1055/s-2007-976538; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Salpeter SJ, 2006, METHOD ENZYMOL, V419, P322, DOI 10.1016/S0076-6879(06)19013-8; Semprini S, 2007, NUCLEIC ACIDS RES, V35, P1402, DOI 10.1093/nar/gkl1108; Silver DP, 2001, MOL CELL, V8, P233, DOI 10.1016/S1097-2765(01)00295-7; Song JH, 2010, GENESIS, V48, P628, DOI 10.1002/dvg.20672; Tang MM, 2011, MOL THER, V19, P60, DOI 10.1038/mt.2010.187; Uchida N, 2013, HUM GENE THER METHOD, V24, P117, DOI 10.1089/hgtb.2012.152; Wicksteed B, 2010, DIABETES, V59, P3090, DOI 10.2337/db10-0624; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036	48	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129092	10.1371/journal.pone.0129092	http://dx.doi.org/10.1371/journal.pone.0129092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046525	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200124
J	Gurecka, R; Koborova, I; Sebek, J; Sebekova, K				Gurecka, Radana; Koborova, Ivana; Sebek, Jozef; Sebekova, Katarina			Presence of Cardiometabolic Risk Factors Is Not Associated with Microalbuminuria in 14-to-20-Years Old Slovak Adolescents: A Cross-Sectional, Population Study	PLOS ONE			English	Article							URINARY ALBUMIN EXCRETION; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR RISK; ORTHOSTATIC PROTEINURIA; ESSENTIAL-HYPERTENSION; DIABETES-MELLITUS; SCHOOL-CHILDREN; ACCURATE METHOD; OBESITY; OVERWEIGHT	Introduction In adults, microalbuminuria indicates generalized endothelial dysfunction, and is an independent risk factor for cardiovascular and all cause mortality. Slovak adults present one of the highest cardiovascular mortality rates in Europe. Thus Slovak adolescents are on a high-risk to develop cardiovascular afflictions early, and screening for microalbuminuria might be useful in early assessment of their cardiovascular risk. We aimed to study the prevalence of microalbuminuria in Slovak adolescents, and the association of urinary albumin-to-creatinine ratio (ACR) to cardiovascular risk factors. Subjects and methods Anthropometric data, blood pressure, blood count, glucose homeostasis, lipid profile, renal function, inflammatory status, concentrations of homocysteine and uric acid were determined and associated with ACR in 2 666 adolescents (49.4% boys, 51.6% girls) aged 14-to-20 years. Microalbuminuria was classified as ACR 2.5-25.0 mg/mmol in boys and 3.5-35.0 mg/mmol in girls. Results Prevalence of microalbuminuria in both genders reached 3.3%, and did not differ significantly between lean and centrally obese subjects. Girls presented higher ACR than boys (normoalbuminuric: 0.6 +/- 0.5 mg/mmol vs. 0.5 +/- 0.4 mg/mmol, p>0.001; microalbuminuric: 9.3 +/- 7.3 mg/mmol vs. 5.0 +/- 3.8 mg/mmol; p>0.001). Microalbuminuric adolescents and those presenting normoalbuminuria within the upper ACR quartile were slimmer than their normoalbuminuric counterparts or adolescents with normoalbuminuria within the lower quartile, respectively. No association between microalbuminuria and cardiovascular risk markers was revealed. Conclusion Results obtained in this study do not support our assumption that ACR associates with cardiometabolic risk factors in apparently healthy adolescents. Follow-up studies until adulthood are needed to estimate the potential cardiometabolic risk of apparently healthy microalbuminuric adolescents.	[Gurecka, Radana; Koborova, Ivana; Sebekova, Katarina] Comenius Univ, Fac Med, Inst Mol BioMed, Bratislava, Slovakia; [Sebek, Jozef] Slovak Acad Sci, Inst Technol, Bratislava, Slovakia	Comenius University Bratislava; Slovak Academy of Sciences	Gurecka, R (corresponding author), Comenius Univ, Fac Med, Inst Mol BioMed, Bratislava, Slovakia.	radana.kollarova@gmail.com	Gurecka, Radana/AAX-6744-2021; Sebekova, Katarina/H-4906-2016; Sebekova, Katarina/GSD-7056-2022; Stefanadis, Christodoulos/ABH-2232-2020	Sebekova, Katarina/0000-0002-9641-9265; Sebekova, Katarina/0000-0002-9641-9265; Stefanadis, Christodoulos/0000-0001-5974-6454	Bratislava Self-governing Region; Regional Public Health Authority of the Slovak Republic in Bratislava; VEGA [1/0637/13]; APVV [0447-12]	Bratislava Self-governing Region; Regional Public Health Authority of the Slovak Republic in Bratislava; VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); APVV(Slovak Research and Development Agency)	This study was supported by the Bratislava Self-governing Region and the Regional Public Health Authority of the Slovak Republic in Bratislava, these funders participated in the design of "Respect for Health" study and data collection; and partially from VEGA No. 1/0637/13 and APVV No. 0447-12 grants (to KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2011, CURR OPIN ENDOCRINOL, V18, P23, DOI 10.1097/MED.0b013e3283424b37; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; BANGSTAD HJ, 1993, ACTA PAEDIATR, V82, P857, DOI 10.1111/j.1651-2227.1993.tb17628.x; Barzilay JI, 2004, AM J KIDNEY DIS, V44, P25, DOI 10.1053/j.ajkd.2004.03.022; Bigazzi R, 1998, J HYPERTENS, V16, P1325, DOI 10.1097/00004872-199816090-00014; Brandle E, 1996, EUR J CLIN NUTR, V50, P734; Brandt JR, 2010, PEDIATR NEPHROL, V25, P1131, DOI 10.1007/s00467-010-1451-z; DAVIES AG, 1984, ARCH DIS CHILD, V59, P625, DOI 10.1136/adc.59.7.625; Deckert T, 1989, STENO HYPOTHESES DIA, V32, P219; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Hanevold CD, 2008, HYPERTENSION, V51, P334, DOI 10.1161/HYPERTENSIONAHA.107.098095; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Hirschler V, 2010, PEDIATR DIABETES, V11, P322, DOI 10.1111/j.1399-5448.2009.00599.x; Hoogeveen EK, 1998, KIDNEY INT, V54, P203, DOI 10.1038/sj.ki.4495353; Johnson DW, 2012, MED J AUSTRALIA, V197, P224, DOI 10.5694/mja11.11468; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kelsey MM, 2014, GERONTOLOGY, V60, P222, DOI 10.1159/000356023; Kollarova R, 2013, CES SLOV PEDIAT, V68, P211; Krakauer NY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039504; Kwak BO, 2011, YONSEI MED J, V52, P476, DOI 10.3349/ymj.2011.52.3.476; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mazaraki A, 2011, EUR J CLIN NUTR, V65, P219, DOI 10.1038/ejcn.2010.244; Mazzoni MBM, 2011, NEPHROL DIAL TRANSPL, V26, P562, DOI 10.1093/ndt/gfq444; Mueller PW, 1999, RENAL FAILURE, V21, P293, DOI 10.3109/08860229909085091; Nguyen S, 2008, PEDIATRICS, V121, P37, DOI 10.1542/peds.2007-3594; NHANES, 2002, TECHNICAL REPORT; Nichols M., 2012, EUROPEAN CARDIOVASCU; Rademacher E, 2008, CLIN J AM SOC NEPHRO, V3, P998, DOI 10.2215/CJN.04631007; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; ROBINSON RR, 1980, KIDNEY INT, V18, P395, DOI 10.1038/ki.1980.151; Rutkowski B, 2013, NEPHROL DIAL TRANSPL, V28, P204, DOI 10.1093/ndt/gft328; Rutkowski P, 2006, J RENAL NUTR, V16, P216, DOI 10.1053/j.jrn.2006.04.017; SANCHEZBAYLE M, 1995, PEDIATR NEPHROL, V9, P428, DOI 10.1007/BF00866717; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schmieder RE, 2007, CLIN RES CARDIOL, V96, P247, DOI 10.1007/s00392-007-0510-3; Schwartz G, 2007, PEDIATR NEPHROL, V22, P1457; Sebekova K, 2012, Vnitr Lek, V58, P544; Singh A, 2011, PEDIATR NEPHROL, V26, P1957, DOI 10.1007/s00467-011-1777-1; Tsioufis C, 2005, AM J CARDIOL, V96, P946, DOI 10.1016/j.amjcard.2005.05.052; Tsioufis C, 2009, HELL J CARDIOL, V50, P476; World Health Organization, 2013, EUR HLTH REP 2012 CH; YOSHIOKA T, 1986, KIDNEY INT, V30, P538, DOI 10.1038/ki.1986.219	45	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129311	10.1371/journal.pone.0129311	http://dx.doi.org/10.1371/journal.pone.0129311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046923	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200147
J	Tut, TG; Lim, SHS; Dissanayake, IU; Descallar, J; Chua, W; Ng, W; de Souza, P; Shin, JS; Lee, CS				Tut, T. G.; Lim, S. H. S.; Dissanayake, I. U.; Descallar, J.; Chua, W.; Ng, W.; de Souza, P.; Shin, J-S.; Lee, C. S.			Upregulated Polo-Like Kinase 1 Expression Correlates with Inferior Survival Outcomes in Rectal Cancer	PLOS ONE			English	Article							COLON-CANCER; COLORECTAL-CANCER; PROGNOSTIC-FACTOR; MAMMALIAN-CELLS; PLK1; CHEMORADIOTHERAPY; CHECKPOINT; CARCINOMA; APOPTOSIS; TARGET	Background Human polo-like kinase 1 (PLK1) expression has been associated with inferior outcomes in colorectal cancer. Our aims were to analyse PLK1 in rectal cancer, and its association with clinicopathological variables, overall survival as well as tumour regression to neoadjuvant treatment. Methods PLK1 expression was quantified with immunohistochemistry in the centre and periphery (invasive front) of rectal cancers, as well as in the involved regional lymph nodes from 286 patients. Scores were based on staining intensity and percentage of positive cells, multiplied to give weighted scores from 1-12, dichotomised into low (0-5) or high (6-12). Results PLK1 scores in the tumour periphery were significantly different to adjacent normal mucosa. Survival analysis revealed that low PLK1 score in the tumour periphery had a hazard ratio of death of 0.59 in multivariate analysis. Other predictors of survival included age, tumour depth, metastatic status, vascular and perineural invasion and adjuvant chemotherapy. There was no statistically significant correlation between PLK1 score and histological tumour regression in the neoadjuvant cohort. Conclusion Low PLK1 score was an independent predictor of superior overall survival, adjusting for multiple clinicopathological variables including treatment.	[Tut, T. G.; Dissanayake, I. U.; de Souza, P.; Shin, J-S.; Lee, C. S.] Univ Western Sydney, Sch Med, Liverpool, NSW 2170, Australia; [Tut, T. G.; Lim, S. H. S.; Descallar, J.; Chua, W.; Ng, W.; de Souza, P.; Shin, J-S.; Lee, C. S.] Ingham Inst Appl Med Res, Liverpool, NSW 2170, Australia; [Lim, S. H. S.; Descallar, J.; de Souza, P.; Lee, C. S.] Univ New S Wales, Kensington, NSW 2052, Australia; [Lim, S. H. S.; Chua, W.; Ng, W.; de Souza, P.] Liverpool Hosp, Dept Med Oncol, Liverpool, NSW 2170, Australia; [Dissanayake, I. U.; Shin, J-S.; Lee, C. S.] Liverpool Hosp, Dept Anat Pathol, Liverpool, NSW 2170, Australia; [Lee, C. S.] Univ Sydney, Bosch Inst, Camperdown, NSW 2006, Australia	Western Sydney University; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; Liverpool Hospital; Liverpool Hospital; University of Sydney	Lim, SHS (corresponding author), Ingham Inst Appl Med Res, Liverpool, NSW 2170, Australia.	stephanie.lim@sswahs.nsw.gov.au	de Souza, Paul/P-5069-2019	Lee, C. Soon/0000-0003-1058-5826; Ng, Weng/0000-0003-2354-1857; Tut, Thein Ga/0000-0002-1608-9092; Lim, Stephanie Hui-Su/0000-0001-5940-7137				Francescangeli F, 2012, STEM CELLS, V30, P1819, DOI 10.1002/stem.1163; Han DP, 2012, MED SCI MONITOR, V18, pBR237, DOI 10.12659/MSM.882900; Ito Y, 2004, BRIT J CANCER, V90, P414, DOI 10.1038/sj.bjc.6601540; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Lund-Andersen C, 2014, RADIOTHER ONCOLOGY; Qin B, 2013, J BIOL CHEM, V288, P16139, DOI 10.1074/jbc.M113.456780; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rodel F, 2010, AM J PATHOL, V177, P918, DOI 10.2353/ajpath.2010.100040; Ryan R, 2005, HISTOPATHOLOGY, V47, P141, DOI 10.1111/j.1365-2559.2005.02176.x; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Spaekuch B, 2008, NEOPLASIA, V10, P223, DOI 10.1593/neo.07916; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Strebhardt K, 2010, NAT REV DRUG DISCOV, V9, P643, DOI 10.1038/nrd3184; Takahashi T, 2003, CANCER SCI, V94, P148, DOI 10.1111/j.1349-7006.2003.tb01411.x; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2001, J BIOL CHEM, V276, P41656, DOI 10.1074/jbc.M101831200; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; Weichert W, 2004, BRIT J CANCER, V90, P815, DOI 10.1038/sj.bjc.6601610; Weichert W, 2005, WORLD J GASTROENTERO, V11, P5644, DOI 10.3748/wjg.v11.i36.5644	24	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129313	10.1371/journal.pone.0129313	http://dx.doi.org/10.1371/journal.pone.0129313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047016	Green Submitted, gold, Green Published			2022-12-26	WOS:000355652200148
J	Vasilyeva, A; Sanches, IS; Florindo, C; Dmitriev, A				Vasilyeva, Anastasia; Sanches, Ilda Santos; Florindo, Carlos; Dmitriev, Alexander			Natural Mutations in Streptococcus agalactiae Resulting in Abrogation of beta Antigen Production	PLOS ONE			English	Article							GROUP-B-STREPTOCOCCUS; SEPARATE BINDING-SITES; C-PROTEIN; GENOME SEQUENCE; BAC GENE; VIRULENCE; IDENTIFICATION; SYSTEM; STRAINS; DETERMINANTS	Streptococcus agalactiae genome encodes 21 two-component systems (TCS) and a variety of regulatory proteins in order to control gene expression. One of the TCS, BgrRS, comprising the BgrR DNA-binding regulatory protein and BgrS sensor histidine kinase, was discovered within a putative virulence island. BgrRS influences cell metabolism and positively control the expression of bac gene, coding for beta antigen at transcriptional level. Inactivation of bgrR abrogated bac gene expression and increased virulence properties of Streptococcus agalactiae In this study, a total of 140 strains were screened for the presence of bac gene, and the TCS bgrR and bgrS genes. A total of 53 strains carried the bac, bgrR and bgrS genes. Most of them (48 strains) expressed beta antigen, while five strains did not express beta antigen. Three strains, in which bac gene sequence was intact, while bgrR and/or bgrS genes had mutations, and expression of beta antigen was absent, were complemented with a constructed plasmid pBgrRS(P) encoding functionally active bgrR and bgrS gene alleles. This procedure restored expression of beta antigen indicating the crucial regulatory role of TCS BgrRS The complemented strain A49V/BgrRS demonstrated attenuated virulence in intraperitoneal mice model of Streptococcus agalactiae infection compared to parental strain A49V. In conclusion we showed that disruption of beta antigen expression is associated with: i) insertion of ISSa4 upstream the bac gene just after the ribosomal binding site; ii) point mutation G342A resulting a stop codon TGA within the bac gene and a truncated form of beta antigen; iii) single deletion (G) in position 439 of the bgrR gene resulting in a frameshift and the loss of DNA-binding domain of the BgrR protein, and iv) single base substitutions in bgrR and bgrS genes causing single amino acid substitutions in BgrR (Arg187Lys) and BgrS (Arg252Gln). The fact that BgrRS negatively controls virulent properties of Streptococcus agalactiae gives a novel clue for understanding of Streptococcus agalactiae adaptation to the human.	[Vasilyeva, Anastasia; Dmitriev, Alexander] Russian Acad Med Sci, Inst Expt Med, Dept Mol Microbiol, St Petersburg P-22, Russia; [Sanches, Ilda Santos] Univ Nova Lisboa, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Dept Life Sci, Caparica, Portugal; [Sanches, Ilda Santos] Univ Nova Lisboa, Fac Ciencias & Tecnol, Res Unit Appl Mol Biosci UCIBIO, REQUIMTE, Caparica, Portugal; [Florindo, Carlos] Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal; [Dmitriev, Alexander] St Petersburg State Univ, Dept Fundamental Problems Med & Med Technol, St Petersburg 199034, Russia	Institute of Experimental Medicine; Russian Academy of Medical Sciences; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Saint Petersburg State University	Sanches, IS (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Dept Life Sci, Caparica, Portugal.	isanches@fct.unl.pt	Santos Sanches, Ilda/C-5693-2011	Santos Sanches, Ilda/0000-0002-0079-2672	Russian Federal Agency of Scientific Organization; RFBR [12-04-31431, 13-04-01864a]; NANO_GUARD; Fullerene-based systems for oxidative inactivation of airborne microbial pathogens FP7-MC-IRSES [269138]; Fundacao para a Ciencia e a Tecnologia/Ministerio da Educacao e Ciencia (FCT/MEC), Portugal [PTDC/SAU-MII/105114/2008, Pest-OE/BIA/UI0457/2011-CREM]; Fundacao para a Cincia e Tecnologia, Portugal [SFRH/BD/48231/2008]	Russian Federal Agency of Scientific Organization; RFBR(Russian Foundation for Basic Research (RFBR)); NANO_GUARD; Fullerene-based systems for oxidative inactivation of airborne microbial pathogens FP7-MC-IRSES; Fundacao para a Ciencia e a Tecnologia/Ministerio da Educacao e Ciencia (FCT/MEC), Portugal; Fundacao para a Cincia e Tecnologia, Portugal	This work was supported by i) the Russian Federal Agency of Scientific Organization; ii) RFBR projects. N<SUP>o</SUP> 12-04-31431 and. N<SUP>o</SUP> 13-04-01864a; iii) NANO_GUARD. Fullerene-based systems for oxidative inactivation of airborne microbial pathogens. Project No: 269138. FP7-MC-IRSES; iv) projects PTDC/SAU-MII/105114/2008 and Pest-OE/BIA/UI0457/2011-CREM, both funded by Fundacao para a Ciencia e a Tecnologia/Ministerio da Educacao e Ciencia (FCT/MEC), Portugal. CF is supported by research grant ref SFRH/BD/48231/2008 from Fundacao para a Cincia e Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areschoug T, 2002, J BIOL CHEM, V277, P12642, DOI 10.1074/jbc.M112072200; Berardi A, 2014, J CHEMOTHER, V19, P24; BRADY LJ, 1989, INFECT IMMUN, V57, P1573, DOI 10.1128/IAI.57.5.1573-1581.1989; Dmitriev A, 2006, FOLIA MICROBIOL, V51, P229, DOI 10.1007/BF02932127; Dmitriev A, 2004, J BACTERIOL, V186, P1106, DOI 10.1128/JB.186.4.1106-1109.2004; Dmitriev A, 2002, FEMS MICROBIOL LETT, V208, P93, DOI 10.1111/j.1574-6968.2002.tb11066.x; Dmitriev A, 1998, FEMS MICROBIOL LETT, V167, P33, DOI 10.1111/j.1574-6968.1998.tb13204.x; [ДМИТРИЕВ А.В. Dmitriev A.V.], 2009, [Медицинский академический журнал, Meditsinskii akademicheskii zhurnal], V9, P50; Dutra VG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-323; Eskandarian N, 2015, EUR J CLIN MICROBIOL, V34, P579, DOI 10.1007/s10096-014-2265-x; Faralla C, 2014, MBIO, V5, DOI 10.1128/mBio.00870-14; Flechard M, 2013, FEMS MICROBIOL LETT, V340, P65, DOI 10.1111/1574-6968.12076; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Grabovskaya K. B., 2007, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P44; Granlund M, 1998, J INFECT DIS, V177, P967, DOI 10.1086/515233; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jiang SM, 2008, J BACTERIOL, V190, P1956, DOI 10.1128/JB.01677-07; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Kong FR, 2006, J MED MICROBIOL, V55, P829, DOI 10.1099/jmm.0.46307-0; Kong FR, 2002, J CLIN MICROBIOL, V40, P620, DOI 10.1128/JCM.40.2.620-626.2002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Larsen JW, 2008, AM J OBSTET GYNECOL, V198, P440, DOI 10.1016/j.ajog.2007.11.030; Lindahl G, 2005, CLIN MICROBIOL REV, V18, P102, DOI 10.1128/CMR.18.1.102-127.2005; Lupo A, 2014, INT J MED MICROBIOL, V304, P717, DOI 10.1016/j.ijmm.2014.05.003; Maniatis T., 1982, MOL CLONING; Nagano N, 2006, MICROBIOL-SGM, V152, P771, DOI 10.1099/mic.0.28535-0; Nitschke H, 2014, J CLIN MICROBIOL, V52, P3933, DOI 10.1128/JCM.02411-14; Nordstrom T, 2011, J BIOL CHEM, V286, P33981, DOI 10.1074/jbc.M111.251728; Poyart C, 2001, J BACTERIOL, V183, P6324, DOI 10.1128/JB.183.21.6324-6334.2001; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; Rozhdestvenskaya AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010212; Sadowy E, 2010, J ANTIMICROB CHEMOTH, V65, P1907, DOI 10.1093/jac/dkq230; Santi I, 2009, J BACTERIOL, V191, P5387, DOI 10.1128/JB.00370-09; Sendi P, 2008, INFECTION, V36, P100, DOI 10.1007/s15010-007-7251-0; Spellerberg B, 2002, INFECT IMMUN, V70, P2434, DOI 10.1128/IAI.70.5.2434-2440.2002; Spellerberg B, 2000, GENE, V241, P51, DOI 10.1016/S0378-1119(99)00469-2; Tamura GS, 2000, J INFECT DIS, V181, P364, DOI 10.1086/315205; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tettelin H, 2002, P NATL ACAD SCI USA, V99, P12391, DOI 10.1073/pnas.182380799; Towbin H, 1992, Biotechnology, V24, P145; Yang HI, 2007, INFECT IMMUN, V75, P3455, DOI 10.1128/IAI.00332-07; Yang Q, 2011, MICROBES INFECT, V13, P757, DOI 10.1016/j.micinf.2011.03.001; Zutkis AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114784	44	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128426	10.1371/journal.pone.0128426	http://dx.doi.org/10.1371/journal.pone.0128426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047354	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200070
J	Xu, DH; Liu, DX; Wang, BQ; Chen, C; Chen, ZY; Li, D; Yang, YJ; Chen, HL; Kong, MG				Xu, Dehui; Liu, Dingxing; Wang, Biqing; Chen, Chen; Chen, Zeyu; Li, Dong; Yang, Yanjie; Chen, Hailan; Kong, Michael G.			In Situ OH Generation from O-2(-) and H2O2 Plays a Critical Role in Plasma-Induced Cell Death	PLOS ONE			English	Article							HABER-WEISS REACTION; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; IRON TRANSPORTER; TRANSFERRIN; FERRITIN; DMT1; FERROPORTIN; SUPEROXIDE; MECHANISMS	Reactive oxygen and nitrogen species produced by cold atmospheric plasma (CAP) are considered to be the most important species for biomedical applications, including cancer treatment. However, it is not known which species exert the greatest biological effects, and the nature of their interactions with tumor cells remains ill-defined. These questions were addressed in the present study by exposing human mesenchymal stromal and LP-1 cells to reactive oxygen and nitrogen species produced by CAP and evaluating cell viability. Superoxide anion (O-2(-)) and hydrogen peroxide (H2O2) were the two major species present in plasma, but their respective concentrations were not sufficient to cause cell death when used in isolation; however, in the presence of iron, both species enhanced the cell death-inducing effects of plasma. We propose that iron containing proteins in cells catalyze O-2(-) and H2O2 into the highly reactive OH radical that can induce cell death. The results demonstrate how reactive species are transferred to liquid and converted into the OH radical to mediate cytotoxicity and provide mechanistic insight into the molecular mechanisms underlying tumor cell death by plasma treatment.	[Xu, Dehui; Liu, Dingxing; Wang, Biqing; Chen, Chen; Chen, Zeyu; Li, Dong; Yang, Yanjie; Kong, Michael G.] Xi An Jiao Tong Univ, Ctr Plasma Biomed, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Peoples R China; [Chen, Hailan; Kong, Michael G.] Old Dominion Univ, Frank Reidy Ctr Bioelect, Norfolk, VA USA; [Kong, Michael G.] Old Dominion Univ, Dept Elect & Comp Engn, Norfolk, VA USA	Xi'an Jiaotong University; Old Dominion University; Old Dominion University	Xu, DH (corresponding author), Xi An Jiao Tong Univ, Ctr Plasma Biomed, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Peoples R China.	dehuixu@hotmail.com; mkong@odu.edu	Kong, Michael Gangyu/AAC-9728-2020; Xu, Dehui/K-3811-2016	Chen, Hai-Lan/0000-0002-5766-0531; Kong, Michael/0000-0001-8142-4726	National Natural Science Foundation of China [51307135, 51221005, 51307134]; Fundamental Research Funds for Central Universities [08143069, EIPE 14123]; Scientific Research Foundation for Returned from Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); Scientific Research Foundation for Returned from Overseas Chinese Scholars, State Education Ministry	This research was supported by the National Natural Science Foundation of China (nos. 51307135, 51221005, and 51307134), the Fundamental Research Funds for Central Universities (nos. 08143069 and EIPE 14123), and the Scientific Research Foundation for Returned from Overseas Chinese Scholars, State Education Ministry.	Ahn HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086173; Al-Qenaei A, 2014, FREE RADICAL BIO MED, V68, P87, DOI 10.1016/j.freeradbiomed.2013.12.006; Andrews NC, 1999, INT J BIOCHEM CELL B, V31, P991, DOI 10.1016/S1357-2725(99)00065-5; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Blanksby SJ, 2007, ANGEW CHEM INT EDIT, V46, P4948, DOI 10.1002/anie.200700219; Bleeke T, 2004, CIRC RES, V94, P37, DOI 10.1161/01.RES.0000109412.80157.7D; BRIELAND JK, 1991, ARCH BIOCHEM BIOPHYS, V284, P78, DOI 10.1016/0003-9861(91)90266-L; Brun P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033245; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chen C, 2014, PLASMA CHEM PLASMA P, V34, P403, DOI 10.1007/s11090-014-9545-1; Chen SX, 1999, EUR J BIOCHEM, V260, P726, DOI 10.1046/j.1432-1327.1999.00199.x; Fenton HJH, 1894, J CHEM SOC, V65; Franco R, 2007, J BIOL CHEM, V282, P30452, DOI 10.1074/jbc.M703091200; Garrick MD, 2003, BIOMETALS, V16, P41, DOI 10.1023/A:1020702213099; Graves DB, 2014, PLASMA PROCESS POLYM, V11, P1120, DOI 10.1002/ppap.201400068; Graves DB, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/26/263001; Hippeli S, 1997, Z NATURFORSCH C, V52, P555; Kanazawa S, MEASUREMENT OH RADIC; Kehrer JP, 2000, TOXICOLOGY, V149, P43, DOI 10.1016/S0300-483X(00)00231-6; Keidar M, 2013, PHYS PLASMAS, V20, DOI 10.1063/1.4801516; Kong MG, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115012; Koppenol WH, 2002, REDOX REP, V7, P59, DOI 10.1179/135100002125000208; Li YX, 2013, NEURAL REGEN RES, V8, P6, DOI 10.3969/j.issn.1673-5374.2013.01.001; Lortz S, 2014, J MOL ENDOCRINOL, V52, P301, DOI 10.1530/JME-13-0261; Luck AN, 2013, BIOCHEMISTRY-US, V52, P8333, DOI 10.1021/bi401190m; Nicolescu AC, 2006, NITRIC OXIDE-BIOL CH, V15, P163, DOI 10.1016/j.niox.2006.01.010; PEDEN DB, 1993, AM REV RESPIR DIS, V148, P455, DOI 10.1164/ajrccm/148.2.455; Plewa JM, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/4/043027; Prousek J, 2007, PURE APPL CHEM, V79, P2325, DOI 10.1351/pac200779122325; Shpyleva SI, 2011, BREAST CANCER RES TR, V126, P63, DOI 10.1007/s10549-010-0849-4; Suzuki YA, 2005, CELL MOL LIFE SCI, V62, P2560, DOI 10.1007/s00018-005-5371-1; Tani A, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729889; Tian W, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/16/165201; Tresp H, 2014, PLASMAMED, DOI [10.1615/ PlasmaMed. 2014009711 doi: Doi 10.1021/ Ja00242a038, DOI 10.1615/PLASMAMED.2014009711]; Wang Q, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-59; Wende K, 2014, CELL BIOL INT, V38, P412, DOI 10.1002/cbin.10200; Wu XN, 2014, EUR J CANCER PREV, V23, P122, DOI 10.1097/CEJ.0b013e3283627f14; Xu D, 2012, LEUKEMIA, V26, P1402, DOI 10.1038/leu.2011.332; Yi YH, 2013, ANGEW CHEM INT EDIT, V52, P8446, DOI 10.1002/anie.201304134; Yusupov M, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/2/025205	40	116	121	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128205	10.1371/journal.pone.0128205	http://dx.doi.org/10.1371/journal.pone.0128205			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046915	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200047
J	Burmeister, WP; Tarbouriech, N; Fender, P; Contesto-Richefeu, C; Peyrefitte, CN; Iseni, F				Burmeister, Wim P.; Tarbouriech, Nicolas; Fender, Pascal; Contesto-Richefeu, Celine; Peyrefitte, Christophe N.; Iseni, Frederic			Crystal Structure of the Vaccinia Virus Uracil-DNA Glycosylase in Complex with DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; INHIBITOR PROTEIN; ESCHERICHIA-COLI; REPAIR ENZYME; REPLICATION; SUBSTRATE; MIMICRY; CELLS; A20; TRANSLOCATION	Vaccinia virus polymerase holoenzyme is composed of the DNA polymerase catalytic subunit E9 associated with its heterodimeric co-factor A20.D4 required for processive genome synthesis. Although A20 has no known enzymatic activity, D4 is an active uracil-DNA glycosylase (UNG). The presence of a repair enzyme as a component of the viral replication machinery suggests that, for poxviruses, DNA synthesis and base excision repair is coupled. We present the 2.7 A crystal structure of the complex formed by D4 and the first 50 amino acids of A20 (D4.A20(1-50)) bound to a 10-mer DNA duplex containing an abasic site resulting from the cleavage of a uracil base. Comparison of the viral complex with its human counterpart revealed major divergences in the contacts between protein and DNA and in the enzyme orientation on the DNA. However, the conformation of the dsDNA within both structures is very similar, suggesting a dominant role of the DNA conformation for UNG function. In contrast to human UNG, D4 appears rigid, and we do not observe a conformational change upon DNA binding. We also studied the interaction of D4.A20(1-50) with different DNA oligomers by surface plasmon resonance. D4 binds weakly to nonspecific DNA and to uracil-containing substrates but binds abasic sites with a K-d of <1.4 mu M. This second DNA complex structure of a family I UNG gives new insight into the role of D4 as a co-factor of vaccinia virus DNA polymerase and allows a better understanding of the structural determinants required for UNG action.	[Burmeister, Wim P.; Tarbouriech, Nicolas; Fender, Pascal] Univ Grenoble Alpes, UVHCI, F-38000 Grenoble, France; [Burmeister, Wim P.; Tarbouriech, Nicolas; Fender, Pascal] CNRS, UVHCI, F-38000 Grenoble, France; [Contesto-Richefeu, Celine; Peyrefitte, Christophe N.; Iseni, Frederic] Inst Rech Biomed Armees, Unite Virol, F-91223 Bretigny Sur Orge, France; [Peyrefitte, Christophe N.] Fdn Merieux, Emerging Pathogens Lab, F-69007 Lyon, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS)	Burmeister, WP (corresponding author), Unit Virus Host Cell Interact, 71 Ave Martyrs, F-38042 Grenoble 9, France.	wim.burmeister@ujf-grenoble.fr; fredericiseni@gmail.com		Burmeister, Wim/0000-0003-0876-6118; tarbouriech, nicolas/0000-0002-0206-3959; Fender, Pascal/0000-0002-6698-3367	ANR [ANR-13-BSV8-0014]; Service de Sante des Armees; Delegation Generale pour l'Armement	ANR(French National Research Agency (ANR)); Service de Sante des Armees; Delegation Generale pour l'Armement	This work was supported by ANR Grant ANR-13-BSV8-0014 (REPLIPOX) and by research grants from the Service de Sante des Armees and the Delegation Generale pour l'Armement. The authors declare that they have no conflicts of interest with the contents of this article.	Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Boyle KA, 2011, J BIOL CHEM, V286, P24702, DOI 10.1074/jbc.M111.222216; Chen RX, 2002, J GEN VIROL, V83, P2339, DOI 10.1099/0022-1317-83-10-2339; Contesto-Richefeu C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003978; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; Dimasi N, 2007, ACTA CRYSTALLOGR F, V63, P204, DOI 10.1107/S1744309107004903; Ellison KS, 1996, J VIROL, V70, P7965, DOI 10.1128/JVI.70.11.7965-7973.1996; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Geoui T, 2007, J MOL BIOL, V366, P117, DOI 10.1016/j.jmb.2006.11.007; Handa P, 2001, J BIOL CHEM, V276, P17324, DOI 10.1074/jbc.M011166200; Holzer GW, 1997, J VIROL, V71, P4997, DOI 10.1128/JVI.71.7.4997-5002.1997; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavli B, 2002, J BIOL CHEM, V277, P39926, DOI 10.1074/jbc.M207107200; Kim Yun-Jeong, 2012, Curr Mol Pharmacol, V5, P3; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krusong K, 2006, J BIOL CHEM, V281, P4983, DOI 10.1074/jbc.M509137200; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; MULLANEY J, 1989, J GEN VIROL, V70, P449, DOI 10.1099/0022-1317-70-2-449; Panayotou G, 1998, J BIOL CHEM, V273, P45, DOI 10.1074/jbc.273.1.45; Parikh SS, 2000, P NATL ACAD SCI USA, V97, P5083, DOI 10.1073/pnas.97.10.5083; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Porecha RH, 2008, P NATL ACAD SCI USA, V105, P10791, DOI 10.1073/pnas.0801612105; Prichard MN, 1996, J VIROL, V70, P3018, DOI 10.1128/JVI.70.5.3018-3025.1996; Putnam CD, 1999, J MOL BIOL, V287, P331, DOI 10.1006/jmbi.1999.2605; Reddy SM, 1998, VIROLOGY, V251, P393, DOI 10.1006/viro.1998.9428; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; SAVVA R, 1995, NAT STRUCT BIOL, V2, P752, DOI 10.1038/nsb0995-752; Scaramozzino N, 2003, NUCLEIC ACIDS RES, V31, P4950, DOI 10.1093/nar/gkg672; Schonhoft JD, 2013, BIOCHEMISTRY-US, V52, P2536, DOI 10.1021/bi301562n; Schonhoft JD, 2013, BIOCHEMISTRY-US, V52, P2526, DOI 10.1021/bi301561d; Schormann N, 2014, PROTEIN SCI, V23, P1667, DOI 10.1002/pro.2554; Schormann N, 2013, ACTA CRYSTALLOGR F, V69, P1328, DOI 10.1107/S1744309113030613; Schormann N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-45; Sele C, 2013, J VIROL, V87, P1679, DOI 10.1128/JVI.01533-12; Shudofsky AMD, 2010, J VIROL, V84, P12325, DOI 10.1128/JVI.01435-10; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200; Ward TM, 2009, VIRUS RES, V142, P78, DOI 10.1016/j.virusres.2009.01.013; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zharkov DO, 2010, MUTAT RES-FUND MOL M, V685, P11, DOI 10.1016/j.mrfmmm.2009.10.017	45	16	17	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17923	17934		10.1074/jbc.M115.648352	http://dx.doi.org/10.1074/jbc.M115.648352			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26045555	Green Published, hybrid			2022-12-26	WOS:000358511700026
J	Ramby, AL; Goodman, DM; Wald, EL; Weiss, SL				Ramby, Alexis L.; Goodman, Denise M.; Wald, Eric L.; Weiss, Scott L.			Red Blood Cell Distribution Width as a Pragmatic Marker for Outcome in Pediatric Critical Illness	PLOS ONE			English	Article							PROGNOSTIC MARKER; HEART-FAILURE; MORTALITY; PREDICTION; PHYSIOLOGY; INDEX; RISK	Background Red cell distribution width (RDW) is a routine laboratory measure associated with poor outcomes in adult critical illness. Objective We determined the utility of RDW as an early pragmatic biomarker for outcome in pediatric critical illness. Methods We used multivariable logistic regression to test the association of RDW on the first day of pediatric intensive care unit (PICU) admission with prolonged PICU length of stay (LOS) >48 hours and mortality. The area under the receiver operating characteristic curve (AUROC) for RDW was compared to the Pediatric Index of Mortality (PIM)-2 score. Results Over a 13-month period, 596 unique patients had RDW measured on the first day of PICU admission. Sepsis was an effect modifier for LOS > 48 hours but not mortality. In sepsis, RDW was not associated with LOS > 48 hours. For patients without sepsis, each 1% increase in RDW was associated with 1.17 (95% CI 1.06, 1.30) increased odds of LOS > 48 hours. In all patients, RDW was independently associated with PICU mortality (OR 1.25, 95% CI 1.09, 1.43). The AUROC for RDW to predict LOS > 48 hours and mortality was 0.61 (95% CI 0.56, 0.66) and 0.65 (95% CI 0.55, 0.75), respectively. Although the AUROC for mortality was comparable to PIM-2 (0.75, 95% CI 0.66, 0.83; p = 0.18), RDW did not increase the discriminative utility when added to PIM-2. Despite the moderate AUROC, RDW <13.4% (upper limit of lower quartile) had 53% risk of LOS >48 hours and 3.3% risk of mortality compared to patients with an RDW >15.7% (lower limit of upper quartile) who had 78% risk of LOS >48 hours and 12.9% risk of mortality (p<0.001 for both outcomes). Conclusions Elevated RDW was associated with outcome in pediatric critical illness and provided similar prognostic information as the more complex PIM-2 severity of illness score. Distinct RDW thresholds best discriminate low-versus high-risk patients.	[Ramby, Alexis L.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Crit Care Med, Cincinnati, OH 45229 USA; [Goodman, Denise M.; Wald, Eric L.] Northwestern Univ, Feinberg Sch Med, Div Crit Care, Dept Pediat,Ann & Robert H Lurie Childrens Hosp C, Chicago, IL 60611 USA; [Weiss, Scott L.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Crit Care,Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA	Cincinnati Children's Hospital Medical Center; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Weiss, SL (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Crit Care,Dept Anesthesia & Crit Care Med, Philadelphia, PA 19104 USA.	WeissS@email.chop.edu		Goodman, Denise/0000-0001-9766-9453; Weiss, Scott/0000-0002-7040-3281	Division of Critical Care, Department of Pediatrics at Ann & Robert H. Lurie Children's Hospital of Chicago; Pediatric Critical Care and Trauma Scientist Development Program (PCCTSDP) [NICHD K12HD047349]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD047349] Funding Source: NIH RePORTER	Division of Critical Care, Department of Pediatrics at Ann & Robert H. Lurie Children's Hospital of Chicago; Pediatric Critical Care and Trauma Scientist Development Program (PCCTSDP); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Financial support was provided by the Division of Critical Care, Department of Pediatrics at Ann & Robert H. Lurie Children's Hospital of Chicago. SLW also receives funding through the Pediatric Critical Care and Trauma Scientist Development Program (PCCTSDP; NICHD K12HD047349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar Y, 2009, EUR J HEART FAIL, V11, P1155, DOI 10.1093/eurjhf/hfp147; Allen LA, 2010, J CARD FAIL, V16, P230, DOI 10.1016/j.cardfail.2009.11.003; Bazick HS, 2011, CRIT CARE MED, V39, P1913, DOI 10.1097/CCM.0b013e31821b85c6; Cleves MA, 2002, STATA J, V2, P301, DOI 10.1177/1536867X0200200307; DeSouza CM, 2009, J BIOPHARM STAT, V19, P1055, DOI 10.1080/10543400903242795; Edwards JD, 2012, CRIT CARE MED, V40, P2196, DOI 10.1097/CCM.0b013e31824e68cf; Felker GM, 2007, J AM COLL CARDIOL, V50, P40, DOI 10.1016/j.jacc.2007.02.067; Forhecz Z, 2009, AM HEART J, V158, P659, DOI 10.1016/j.ahj.2009.07.024; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Herridge MS, 2003, CLIN CHEST MED, V24, P751, DOI 10.1016/S0272-5231(03)00094-7; Hunziker S, 2012, CRIT CARE, V16, DOI 10.1186/cc11351; Jo YH, 2013, AM J EMERG MED, V31, P545, DOI 10.1016/j.ajem.2012.10.017; Koma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080240; Ku NS, 2012, SHOCK, V38, P123, DOI 10.1097/SHK.0b013e31825e2a85; Lacroix Jacques, 2005, Pediatr Crit Care Med, V6, pS126, DOI 10.1097/01.PCC.0000161287.61028.D4; Lippi G, 2009, ARCH PATHOL LAB MED, V133, P628, DOI 10.1043/1543-2165-133.4.628; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Massin MM, 2012, PEDIATR CARDIOL, V33, P1021, DOI 10.1007/s00246-012-0220-0; Meynaar IA, 2013, NETH J MED, V71, P488; Pollack MM, 2013, PEDIATR CRIT CARE ME, V14, P448, DOI 10.1097/PCC.0b013e31828a7270; PREGIBON D, 1981, ANN STAT, V9, P705, DOI 10.1214/aos/1176345513; Purtle SW, 2014, CRIT CARE MED, V42, P918, DOI 10.1097/CCM.0000000000000118; QURTOM HA, 1989, EUR J PEDIATR, V148, P745, DOI 10.1007/BF00443100; Sadaka Farid, 2013, J Intensive Care Med, V28, P307, DOI 10.1177/0885066612452838; Scharte M, 2003, CRIT CARE MED, V31, pS651, DOI 10.1097/01.CCM.0000098036.90796.ED; Sipahi T, 2004, PEDIATR HEMAT ONCOL, V21, P513, DOI 10.1080/08880010490477301; Slater A, 2003, INTENS CARE MED, V29, P278, DOI 10.1007/s00134-002-1601-2; Straney L, 2013, PEDIATR CRIT CARE ME, V14, P673, DOI 10.1097/PCC.0b013e31829760cf; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Weiss SL, 2012, PEDIATR CRIT CARE ME, V13, pE210, DOI 10.1097/PCC.0b013e318238b5cd; Wong HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086242; World Health Organization, 2010, WHONHD013	32	33	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129258	10.1371/journal.pone.0129258	http://dx.doi.org/10.1371/journal.pone.0129258			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057629	Green Submitted, Green Published, gold			2022-12-26	WOS:000356349000045
J	Stateva, SR; Salas, V; Anguita, E; Benaim, G; Villalobo, A				Stateva, Silviya R.; Salas, Valentina; Anguita, Estefania; Benaim, Gustavo; Villalobo, Antonio			Ca2+/Calmodulin and Apo-Calmodulin Both Bind to and Enhance the Tyrosine Kinase Activity of c-Src	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CACO-2 CELL MONOLAYERS; PROTEIN-KINASE; DEPENDENT ACTIVATION; TARGET RECOGNITION; PHOSPHORYLATION; DIVERSITY; DOMAINS; FAMILY; N-(6-AMINOHEXYL)-5-CHLORO-1-NAPHTHALENESULFONAMIDE	Src family non-receptor tyrosine kinases play a prominent role in multiple cellular processes, including: cell proliferation, differentiation, cell survival, stress response, and cell adhesion and migration, among others. And when deregulated by mutations, overexpression, and/or the arrival of faulty incoming signals, its hyperactivity contributes to the development of hematological and solid tumors. c-Src is a prototypical member of this family of kinases, which is highly regulated by a set of phosphorylation events. Other factor contributing to the regulation of Src activity appears to be mediated by the Ca2+ signal generated in cells by different effectors, where the Ca2+-receptor protein calmodulin (CaM) plays a key role. In this report we demonstrate that CaM directly interacts with Src in both Ca2+-dependent and Ca-2 (+)-independent manners in vitro and in living cells, and that the CaM antagonist N-(6-amino-hexyl)- 5-chloro-1-naphthalenesulfonamide (W-7) inhibits the activation of this kinase induced by the upstream activation of the epidermal growth factor receptor (EGFR), in human carcinoma epidermoide A431 cells, and by hydrogen peroxide-induced oxidative stress, in both A431 cells and human breast adenocarcinoma SK-BR-3 cells. Furthermore, we show that the Ca2+/CaM complex strongly activates the auto-phosphorylation and tyrosine kinase activity of c-Src toward exogenous substrates, but most relevantly and for the first time, we demonstrate that Ca2+-free CaM (apo-CaM) exerts a far higher activatory action on Src auto-phosphorylation and kinase activity toward exogenous substrates than the one exerted by the Ca2+/CaM complex. This suggests that a transient increase in the cytosolic concentration of free Ca2+ is not an absolute requirement for CaM-mediated activation of Src in living cells, and that a direct regulation of Src by apo-CaM could be inferred.	[Stateva, Silviya R.; Salas, Valentina; Anguita, Estefania; Villalobo, Antonio] CSIC, Inst Invest Biomed, Dept Canc Biol, E-28029 Madrid, Spain; [Stateva, Silviya R.; Salas, Valentina; Anguita, Estefania; Villalobo, Antonio] Univ Autonoma Madrid, E-28029 Madrid, Spain; [Salas, Valentina; Benaim, Gustavo] Cent Univ Venezuela, Fac Ciencias, Inst Expt Biol, Caracas, Venezuela; [Benaim, Gustavo] Inst Estudios Avanzados IDEA, Caracas, Venezuela	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Autonomous University of Madrid; University of Central Venezuela	Villalobo, A (corresponding author), CSIC, Inst Invest Biomed, Dept Canc Biol, E-28029 Madrid, Spain.	antonio.villalobo@iib.uam.es	Villalobo, Antonio/O-9621-2019; Benaim, Gustavo/H-5552-2019; Villalobo, Antonio/K-2902-2017	Villalobo, Antonio/0000-0002-4200-374X; Benaim, Gustavo/0000-0002-9359-5546; 	Secretaria de Estado de Investigacion, Desarrollo e Innovacion [SAF2011-23494, SAF2014-52048-R]; Consejeria de Educacion de la Comunidad de Madrid [S2011/BMD-2349]; CSIC program i-COOP+ [COOPA20053]; European Commission [PITN-GA-2011-289033]; People Program (Marie Curie Actions) of European Union's Seventh Framework Program FP7 under REA grant [PITN-GA-2011-289033]; Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela [03-00-6057-2005, PG-03-8728-2013]; Fondo Nacional de Ciencia, Tecnologia e Innovacion [P-2011000884]	Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Consejeria de Educacion de la Comunidad de Madrid; CSIC program i-COOP+; European Commission(European CommissionEuropean Commission Joint Research Centre); People Program (Marie Curie Actions) of European Union's Seventh Framework Program FP7 under REA grant; Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela; Fondo Nacional de Ciencia, Tecnologia e Innovacion	This work was funded by grants to AV from the Secretaria de Estado de Investigacion, Desarrollo e Innovacion (SAF2011-23494 & SAF2014-52048-R), the Consejeria de Educacion de la Comunidad de Madrid (S2011/BMD-2349), the CSIC program i-COOP+ 2014 (COOPA20053), and the European Commission (contract PITN-GA-2011-289033). SRS received funding from the People Program (Marie Curie Actions) of the European Union's Seventh Framework Program FP7/2007-2013 under REA grant agreement no PITN-GA-2011-289033. VS and GB were supported by fellowship and grants from the Consejo de Desarrollo Cientifico y Humanistico de la Universidad Central de Venezuela (03-00-6057-2005 & PG-03-8728-2013) and Fondo Nacional de Ciencia, Tecnologia e Innovacion (P-2011000884). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; Bahler M, 2002, FEBS LETT, V513, P107, DOI 10.1016/S0014-5793(01)03239-2; Basuroy S, 2010, AM J PHYSIOL-GASTR L, V299, pG186, DOI 10.1152/ajpgi.00368.2009; Benaim G, 2002, EUR J BIOCHEM, V269, P3619, DOI 10.1046/j.1432-1033.2002.03038.x; Berchtold MW, 2014, BBA-MOL CELL RES, V1843, P398, DOI 10.1016/j.bbamcr.2013.10.021; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Bobe R, 2003, AM J PHYSIOL-HEART C, V285, pH745, DOI 10.1152/ajpheart.01042.2002; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Fedida-Metula S, 2012, CARCINOGENESIS, V33, P740, DOI 10.1093/carcin/bgs021; Gao YL, 2001, J PHARMACOL EXP THER, V296, P426; GRAVES CB, 1986, J BIOL CHEM, V261, P429; Hayashi N, 2004, J MOL BIOL, V338, P169, DOI 10.1016/j.jmb.2004.02.041; HIDAKA H, 1983, METHOD ENZYMOL, V102, P185; HIDAKA H, 1981, P NATL ACAD SCI-BIOL, V78, P4354, DOI 10.1073/pnas.78.7.4354; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Irtegun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071035; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li HB, 2004, BIOCHEM J, V381, P257, DOI 10.1042/BJ20040515; Li HB, 2004, FEBS LETT, V559, P175, DOI 10.1016/S0014-5793(04)00067-5; Li HB, 2012, J BIOL CHEM, V287, P3273, DOI 10.1074/jbc.M111.317529; Llovera M, 2004, J NEUROCHEM, V88, P422, DOI 10.1046/j.1471-4159.2003.02178.x; Lombardo CR, 1995, BIOCHEMISTRY-US, V34, P16456, DOI 10.1021/bi00050a029; MacDougall DA, 2009, J BIOL CHEM, V284, P15573, DOI 10.1074/jbc.M809585200; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; OKADA M, 1989, J BIOL CHEM, V264, P20886; Osawa M, 1998, J MOL BIOL, V276, P165, DOI 10.1006/jmbi.1997.1524; Parks EE, 2014, J BIOL CHEM, V289, P25537, DOI 10.1074/jbc.M114.579581; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Perez Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep01295; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Salas V, 2005, PROTEIN EXPRES PURIF, V41, P384, DOI 10.1016/j.pep.2005.01.004; Samak G, 2011, J BIOL CHEM, V286, P30232, DOI 10.1074/jbc.M111.240358; Sato K, 2001, DEV GROWTH DIFFER, V43, P55; SATO KI, 1995, BIOCHEM BIOPH RES CO, V210, P844, DOI 10.1006/bbrc.1995.1735; Saucerman JJ, 2012, J MOL CELL CARDIOL, V52, P312, DOI 10.1016/j.yjmcc.2011.06.005; SCHATZMAN RC, 1983, BIOCHIM BIOPHYS ACTA, V755, P144, DOI 10.1016/0304-4165(83)90284-2; Sengupta P, 2007, J BIOL CHEM, V282, P8474, DOI 10.1074/jbc.M607211200; Stateva SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120798; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Wu JH, 2015, CELL SIGNAL, V27, P15, DOI 10.1016/j.cellsig.2014.10.001; Yamniuk AP, 2004, MOL BIOTECHNOL, V27, P33, DOI 10.1385/MB:27:1:33; Yang W, 2013, NEUROCHEM INT, V63, P180, DOI 10.1016/j.neuint.2013.06.010; Yuan KY, 2011, J BIOL CHEM, V286, P24776, DOI 10.1074/jbc.M110.202804; Zhougang SG, 2004, AM J PHYSIOL-RENAL, V286, pF858, DOI 10.1152/ajprenal.00282.2003	49	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128783	10.1371/journal.pone.0128783	http://dx.doi.org/10.1371/journal.pone.0128783			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058065	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000029
J	Wang, K; Long, SY; Tian, P				Wang, Kai; Long, Shiyang; Tian, Pu			Hierarchical Conformational Analysis of Native Lysozyme Based on Sub-Millisecond Molecular Dynamics Simulations	PLOS ONE			English	Article							TRANSITION PATH TIMES; FAST-FOLDING PROTEINS; ENERGY LANDSCAPE; MOTIONS; FLEXIBILITY; BINDING; FLUCTUATIONS; TRAJECTORIES; PREDICTION; ENSEMBLES	Hierarchical organization of free energy landscape (FEL) for native globular proteins has been widely accepted by the biophysics community. However, FEL of native proteins is usually projected onto one or a few dimensions. Here we generated collectively 0.2 milli-second molecular dynamics simulation trajectories in explicit solvent for hen egg white lysozyme (HEWL), and carried out detailed conformational analysis based on backbone torsional degrees of freedom (DOF). Our results demonstrated that at micro-second and coarser temporal resolutions, FEL of HEWL exhibits hub-like topology with crystal structures occupying the dominant structural ensemble that serves as the hub of conformational transitions. However, at 100ns and finer temporal resolutions, conformational substates of HEWL exhibit network-like topology, crystal structures are associated with kinetic traps that are important but not dominant ensembles. Backbone torsional state transitions on time scales ranging from nanoseconds to beyond microseconds were found to be associated with various types of molecular interactions. Even at nanoseconds temporal resolution, the number of conformational substates that are of statistical significance is quite limited. These observations suggest that detailed analysis of conformational substates at multiple temporal resolutions is both important and feasible. Transition state ensembles among various conformational substates at microsecond temporal resolution were observed to be considerably disordered. Life times of these transition state ensembles are found to be nearly independent of the time scales of the participating torsional DOFs.	[Wang, Kai; Long, Shiyang; Tian, Pu] Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China; [Tian, Pu] Jilin Univ, MOE Key Lab Mol Enzymol & Engn, Changchun 130023, Peoples R China	Jilin University; Jilin University	Tian, P (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China.	tianpu@jlu.edu.cn			Jilin University; National Natural Science Foundation of China [31270758]; High Performance Computing Center of Jilin University, China	Jilin University(Jilin University); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Performance Computing Center of Jilin University, China	This research was partially funded by a start-up fund from Jilin University and by 481 National Natural Science Foundation of China under grant number 31270758. 482 Computational resources were partially supported by High Performance Computing 483 Center of Jilin University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1981, BIOPOLYMERS, V20, P1013, DOI 10.1002/bip.1981.360200512; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Best RB, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.228104; Best RB, 2011, P NATL ACAD SCI USA, V108, P11087, DOI 10.1073/pnas.1016685108; Biehl R, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.138102; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Bolhuis PG, 2002, ANNU REV PHYS CHEM, V53, P291, DOI 10.1146/annurev.physchem.53.082301.113146; Bonneau R, 2001, ANNU REV BIOPH BIOM, V30, P173, DOI 10.1146/annurev.biophys.30.1.173; Fenwick RB, 2011, J AM CHEM SOC, V133, P10336, DOI 10.1021/ja200461n; Chodera JD, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2714538; Chodera JD, 2014, CURR OPIN STRUC BIOL, V25, P135, DOI 10.1016/j.sbi.2014.04.002; Chung HS, 2012, SCIENCE, V335, P981, DOI 10.1126/science.1215768; Chung HS, 2009, P NATL ACAD SCI USA, V106, P11837, DOI 10.1073/pnas.0901178106; Cormen T., 2009, INTRO ALGORITHMS; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Dickson A, 2013, J AM CHEM SOC, V135, P4729, DOI 10.1021/ja311077u; Dong MD, 2009, NAT NANOTECHNOL, V4, P514, DOI [10.1038/NNANO.2009.156, 10.1038/nnano.2009.156]; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gallicchio E, 2012, J COMPUT AID MOL DES, V26, P505, DOI 10.1007/s10822-012-9552-3; GO N, 1981, BIOPOLYMERS, V20, P991, DOI 10.1002/bip.1981.360200511; Gora A, 2013, CHEM REV, V113, P5871, DOI 10.1021/cr300384w; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Gur M, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4816375; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hildebrandt AK, 2014, J COMPUT CHEM, V35, P765, DOI 10.1002/jcc.23513; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Huang XH, 2010, BIOCOMPUT-PAC SYM, P228; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung Ling-Hong, 2011, BMC Res Notes, V4, P97, DOI 10.1186/1756-0500-4-97; Inoue R, 2010, BIOPHYS J, V99, P2309, DOI 10.1016/j.bpj.2010.08.017; Lane TJ, 2013, CURR OPIN STRUC BIOL, V23, P58, DOI 10.1016/j.sbi.2012.11.002; Lane TJ, 2011, J AM CHEM SOC, V133, P18413, DOI 10.1021/ja207470h; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Lexa KW, 2012, Q REV BIOPHYS, V45, P301, DOI 10.1017/S0033583512000066; Li DW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.118108; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Magis C, 2013, NUCLEIC ACIDS RES, V41, pW358, DOI 10.1093/nar/gkt383; Mirny L, 2001, ANNU REV BIOPH BIOM, V30, P361, DOI 10.1146/annurev.biophys.30.1.361; Mu YG, 2005, PROTEINS, V58, P45, DOI 10.1002/prot.20310; Pons C, 2013, J CHEM THEORY COMPUT, V9, P1830, DOI 10.1021/ct300990h; Sbreveali A, 1995, NATURE, V5, P248; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Sinko W, 2013, CHEM BIOL DRUG DES, V81, P41, DOI 10.1111/cbdd.12051; Sosnick TR, 2011, SCIENCE, V334, P464, DOI 10.1126/science.1214018; Stone JE, 2007, J COMPUT CHEM, V28, P2618, DOI 10.1002/jcc.20829; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tirion MM, 1996, PHYS REV LETT, V77, P1905, DOI 10.1103/PhysRevLett.77.1905; Vreede J, 2010, P NATL ACAD SCI USA, V107, P2397, DOI 10.1073/pnas.0908754107; Vymetal J, 2013, J CHEM THEORY COMPUT, V9, P441, DOI 10.1021/ct300794a; Wang Y, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002471; Winn PJ, 2002, P NATL ACAD SCI USA, V99, P5361, DOI 10.1073/pnas.082522999; Yao Y, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4802007; Zhou XB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-40; Zhuravlev PI, 2010, CURR OPIN STRUC BIOL, V20, P16, DOI 10.1016/j.sbi.2009.12.010	57	4	4	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129846	10.1371/journal.pone.0129846	http://dx.doi.org/10.1371/journal.pone.0129846			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057625	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000075
J	Bonanomi, M; Visentin, C; Invernizzi, G; Tortora, P; Regonesi, ME				Bonanomi, Marcella; Visentin, Cristina; Invernizzi, Gaetano; Tortora, Paolo; Regonesi, Maria Elena			The Toxic Effects of Pathogenic Ataxin-3 Variants in a Yeast Cellular Model	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; SOLUBLE AMYLOID OLIGOMERS; PROTEIN MISFOLDING DISEASES; POLYGLUTAMINE EXPANSION; SPINOCEREBELLAR ATAXIA; ALZHEIMERS-DISEASE; LIPID-PEROXIDATION; COMMON MECHANISM; ALPHA-SYNUCLEIN; CAG EXPANSIONS	Ataxin-3 (AT3) is a deubiquitinating enzyme that triggers an inherited neurodegenerative disorder, spinocerebellar ataxia type 3, when its polyglutamine (polyQ) stretch close to the C-terminus exceeds a critical length. AT3 variants carrying the expanded polyQ are prone to associate with each other into amyloid toxic aggregates, which are responsible for neuronal death with ensuing neurodegeneration. We employed Saccharomyces cerevisiae as a eukaryotic cellular model to better clarify the mechanism by which AT3 triggers the disease. We expressed three variants: one normal (Q26), one expanded (Q85) and one truncated for a region lying from the beginning of its polyQ stretch to the end of the protein (291 Delta). We found that the expression of the expanded form caused reduction in viability, accumulation of reactive oxygen species, imbalance of the antioxidant defense system and loss in cell membrane integrity, leading to necrotic death. The truncated variant also exerted a qualitatively similar, albeit milder, effect on cell growth and cytotoxicity, which points to the involvement of also non-polyQ regions in cytotoxicity. Guanidine hydrochloride, a well-known inhibitor of the chaperone Hsp104, almost completely restored wild-type survival rate of both 291 Delta-and Q85-expressing strains. This suggests that AT3 aggregation and toxicity is mediated by prion forms of yeast proteins, as this chaperone plays a key role in their propagation.	[Bonanomi, Marcella; Visentin, Cristina; Invernizzi, Gaetano; Tortora, Paolo] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Tortora, Paolo; Regonesi, Maria Elena] Milan Ctr Neurosci NeuroMI, Milan, Italy; [Regonesi, Maria Elena] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy	University of Milano-Bicocca; University of Milano-Bicocca	Tortora, P (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	paolo.tortora@unimib.it		Tortora, Paolo/0000-0001-5234-601X	Regione Lombardia, Italy (Network-Enabled Drug Design); Fondazione Cariplo, Italy (progetto Nobel: Network Operativo per la Biomedicina di Eccellenza in Lombardia)	Regione Lombardia, Italy (Network-Enabled Drug Design); Fondazione Cariplo, Italy (progetto Nobel: Network Operativo per la Biomedicina di Eccellenza in Lombardia)	This work was supported by grants from Regione Lombardia, Italy (Network-Enabled Drug Design), from Fondazione Cariplo, Italy (progetto Nobel: Network Operativo per la Biomedicina di Eccellenza in Lombardia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Bevivino AE, 2001, P NATL ACAD SCI USA, V98, P11955, DOI 10.1073/pnas.211305198; Bonanomi M, 2014, HUM MOL GENET, V23, P6542, DOI 10.1093/hmg/ddu373; BOYNE AF, 1972, ANAL BIOCHEM, V46, P639, DOI 10.1016/0003-2697(72)90335-1; Braun RJ, 2010, TRENDS BIOCHEM SCI, V35, P135, DOI 10.1016/j.tibs.2009.10.005; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Butterfield DA, 2002, NEUROBIOL AGING, V23, P655; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chow MKM, 2004, J MOL BIOL, V335, P333, DOI 10.1016/j.jmb.2003.08.064; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cushman-Nick M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003781; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Duennwald Martin L, 2013, Methods Mol Biol, V1017, P153, DOI 10.1007/978-1-62703-438-8_11; Duennwald ML, 2011, PRION, V5, P285, DOI [10.4161/pri.5.4.18071, 10.4161/pri.18071]; Duennwald ML, 2008, GENE DEV, V22, P3308, DOI 10.1101/gad.1673408; Ellisdon AM, 2006, J BIOL CHEM, V281, P16888, DOI 10.1074/jbc.M601470200; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; Giannattasio S, 2008, FEBS LETT, V582, P1519, DOI 10.1016/j.febslet.2008.03.048; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gitler AD, 2009, NAT GENET, V41, P308, DOI 10.1038/ng.300; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Heinicke S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000766; Hubener J, 2011, BRAIN, V134, P1925, DOI 10.1093/brain/awr118; Invernizzi G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051890; Jayasinghe SA, 2007, BBA-BIOMEMBRANES, V1768, P2002, DOI 10.1016/j.bbamem.2007.01.022; Johnson BS, 2008, P NATL ACAD SCI USA, V105, P6439, DOI 10.1073/pnas.0802082105; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; Khurana V, 2010, NAT REV NEUROSCI, V11, P436, DOI 10.1038/nrn2809; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; Lajoie P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015245; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lindgren M, 2010, FEBS J, V277, P1380, DOI 10.1111/j.1742-4658.2010.07571.x; Lippuner AD, 2014, FEMS MICROBIOL REV, V38, P300, DOI 10.1111/1574-6976.12060; Macedo-Ribeiro S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005834; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Matos CA, 2011, PROG NEUROBIOL, V95, P26, DOI 10.1016/j.pneurobio.2011.06.007; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; McLaurin J, 1997, EUR J BIOCHEM, V245, P355, DOI 10.1111/j.1432-1033.1997.t01-2-00355.x; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; Miller-Fleming Leonor, 2008, Biotechnol J, V3, P325, DOI 10.1002/biot.200700217; Natalello A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018789; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Pacheco LS, 2013, MUTAT RES-GEN TOX EN, V757, P99, DOI 10.1016/j.mrgentox.2013.06.023; Pellistri F, 2013, BBA-MOL CELL RES, V1833, P3155, DOI 10.1016/j.bbamcr.2013.08.019; Porzoor A, 2013, J ALZHEIMERS DIS, V35, P217, DOI 10.3233/JAD-122035; RANUM LPW, 1995, AM J HUM GENET, V57, P603; RICHTER C, 1987, CHEM PHYS LIPIDS, V44, P175, DOI 10.1016/0009-3084(87)90049-1; Riess O, 2008, CEREBELLUM, V7, P125, DOI 10.1007/s12311-008-0013-4; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Shangari Nandita, 2006, Curr Protoc Toxicol, VChapter 7, DOI 10.1002/0471140856.tx0707s27; Shehi E, 2003, BIOCHEMISTRY-US, V42, P14626, DOI 10.1021/bi0352825; Teparic R, 2004, MICROBIOL-SGM, V150, P3145, DOI 10.1099/mic.0.27296-0; Trottier Y, 1998, NEUROBIOL DIS, V5, P335, DOI 10.1006/nbdi.1998.0208; Uversky VN, 2010, FEBS J, V277, P2940, DOI 10.1111/j.1742-4658.2010.07721.x; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Yu YC, 2009, J NEUROSCI RES, V87, P1884, DOI 10.1002/jnr.22011; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	67	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129727	10.1371/journal.pone.0129727	http://dx.doi.org/10.1371/journal.pone.0129727			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052945	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300161
J	Fang, L; Wang, D; Li, YT; Cheng, ZL; Pine, MK; Wang, KX; Li, SH				Fang, Liang; Wang, Ding; Li, Yongtao; Cheng, Zhaolong; Pine, Matthew K.; Wang, Kexiong; Li, Songhai			The Source Parameters of Echolocation Clicks from Captive and Free-Ranging Yangtze Finless Porpoises (Neophocaena asiaeorientalis asiaeorientalis)	PLOS ONE			English	Article							DOLPHINS LAGENORHYNCHUS-ALBIROSTRIS; TRANSMISSION BEAM PATTERN; WHALES MESOPLODON-DENSIROSTRIS; HIGH-FREQUENCY CLICKS; PHOCOENA-PHOCOENA; PSEUDORCA-CRASSIDENS; TURSIOPS-TRUNCATUS; HARBOR PORPOISES; GAIN-CONTROL; NARROW-BAND	The clicks of Yangtze finless porpoises (Neophocaena asiaeorientalis asiaeorientalis) from 7 individuals in the tank of Baiji aquarium, 2 individuals in a netted pen at Shishou Tian-ezhou Reserve and 4 free-ranging individuals at Tianxingzhou were recorded using a broadband digital recording system with four element hydrophones. The peak-to-peak apparent source level (ASL_(pp)) of clicks from individuals at the Baiji aquarium was 167 dB re 1 mu Pa with mean center frequency of 133 kHz, -3dB bandwidth of 18 kHz and -10 dB duration of 58 mu s. The ASL_(pp) of clicks from individuals at the Shishou Tian-e-zhou Reserve was 180 dB re 1 mu Pa with mean center frequency of 128 kHz, -3dB bandwidth of 20 kHz and -10 dB duration of 39 mu s. The ASL_(pp) of clicks from individuals at Tianxingzhou was 176 dB re 1 mu Pa with mean center frequency of 129 kHz, -3dB bandwidth of 15 kHz and -10 dB duration of 48 mu s. Differences between the source parameters of clicks among the three groups of finless porpoises suggest these animals adapt to their echolocation signals depending on their surroundings.	[Fang, Liang; Wang, Ding; Li, Yongtao; Cheng, Zhaolong; Pine, Matthew K.; Wang, Kexiong] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China; [Fang, Liang; Li, Yongtao; Cheng, Zhaolong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Songhai] Chinese Acad Sci, Sanya Inst Deep Sea Sci & Engn, Sanya Key Lab Marine Mammal & Marine Bioacoust, Sanya 572000, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Deep-Sea Science & Engineering, CAS	Wang, KX (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan 430072, Peoples R China.	Wangk@ihb.ac.cn; lish@sidsse.ac.cn	Li, Songhai/A-2652-2012	Li, Songhai/0000-0003-4977-1722	National Natural Science Foundation of China [31170501, 31430080, 41306169, 41422604]; "Hundred Talents Program" of the Chinese Academy of Sciences [SIDSSE-BR-315 201201, Y410012]; Knowledge Innovation Program of the Chinese Academy of Sciences [SIDSSE-316 201210]; Sanya Key Laboratory of Marine Mammal and Marine Bioacoustics [L1402]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Sanya Key Laboratory of Marine Mammal and Marine Bioacoustics	This research was supported by the National Natural Science Foundation of China (No. 31170501 and No. 31430080). The data analysis and writing of the manuscript were supported by National Natural Science Foundation of China (Nos. 41306169 and 41422604), the "Hundred Talents Program" of the Chinese Academy of Sciences (SIDSSE-BR-315 201201, Y410012), the Knowledge Innovation Program of the Chinese Academy of Sciences (SIDSSE-316 201210), and Sanya Key Laboratory of Marine Mammal and Marine Bioacoustics (L1402).	Akamatsu T, 2007, DEEP-SEA RES PT II, V54, P290, DOI 10.1016/j.dsr2.2006.11.006; Atem ACG, 2009, BIOACOUSTICS, V19, P49, DOI 10.1080/09524622.2009.9753614; Au W. W., 1993, SONAR DOLPHINS; Au W.W.L., 2008, PRINCIPLES MARINE BI; Au WWL, 2004, ACOUST PHYS+, V50, P454, DOI 10.1134/1.1776224; Au WWL, 2003, NATURE, V423, P861, DOI 10.1038/nature01727; Au WWL, 2003, J ACOUST SOC AM, V113, P598, DOI 10.1121/1.1518980; AU WWL, 1986, J ACOUST SOC AM, V80, P688, DOI 10.1121/1.394012; AU WWL, 1995, J ACOUST SOC AM, V98, P51, DOI 10.1121/1.413643; Au WWL, 1999, J ACOUST SOC AM, V106, P3699, DOI 10.1121/1.428221; Au WWL, 2000, HEARING WHALES DOLPH; Gao Anli, 1993, Aquatic Mammals, V19, P3; Gotz T, 2010, J ACOUST SOC AM, V128, P563, DOI 10.1121/1.3353078; Jensen FH, 2009, J EXP BIOL, V212, P1078, DOI 10.1242/jeb.025619; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Kimura S, 2009, J ACOUST SOC AM, V125, P547, DOI 10.1121/1.3021302; Kyhn LA, 2010, J EXP BIOL, V213, P1940, DOI 10.1242/jeb.042440; Kyhn LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063763; Kyhn LA, 2009, J ACOUST SOC AM, V125, P1783, DOI 10.1121/1.3075600; Li SH, 2005, J ACOUST SOC AM, V117, P3288, DOI 10.1121/1.1882945; Li SH, 2006, J ACOUST SOC AM, V120, P1803, DOI 10.1121/1.2335674; Li SH, 2009, J ACOUST SOC AM, V126, P468, DOI 10.1121/1.3147507; Madsen PT, 2007, DEEP-SEA RES PT I, V54, P1421, DOI 10.1016/j.dsr.2007.04.020; Madsen PT, 2005, BIOACOUSTICS, V15, P195, DOI 10.1080/09524622.2005.9753547; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Madsen PT, 2004, J EXP BIOL, V207, P1811, DOI 10.1242/jeb.00966; Mei ZG, 2014, BIOL CONSERV, V172, P117, DOI 10.1016/j.biocon.2014.02.033; Mei ZG, 2012, BIOL CONSERV, V153, P192, DOI 10.1016/j.biocon.2012.04.029; Mohl B, 2000, J ACOUST SOC AM, V107, P638, DOI 10.1121/1.428329; Morisaka T, 2011, J ACOUST SOC AM, V129, P449, DOI 10.1121/1.3519401; Nowacek DP, 2005, MAR MAMMAL SCI, V21, P587, DOI 10.1111/j.1748-7692.2005.tb01253.x; Rasmussen MH, 2004, J ACOUST SOC AM, V116, P1826, DOI 10.1121/1.1775274; Rasmussen MH, 2002, J ACOUST SOC AM, V111, P1122, DOI 10.1121/1.1433814; Schotten M., 2004, ECHOLOCATION BATS DO, P393; Surlykke A, 2014, SPRINGER HANDB AUDIT, V51, P1, DOI 10.1007/978-1-4614-9146-0; Thomas JA, 2004, ECHOLOCATION BATS DO; Villadsgaard A, 2007, J EXP BIOL, V210, P56, DOI 10.1242/jeb.02618; Wahlberg M, 2011, J ACOUST SOC AM, V130, P2263, DOI 10.1121/1.3624822; Wang D, 2009, CHINESE SCI BULL, V54, P3473, DOI 10.1007/s11434-009-0522-7; Wang JY, 2012, NEOPHOCAENA ASIAORIE; Zhang X., 1992, Acta Hydrobiologica Sinica, V16, P289	42	9	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129143	10.1371/journal.pone.0129143	http://dx.doi.org/10.1371/journal.pone.0129143			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053758	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300092
J	Kamiza, AB; Hsieh, LL; Tang, RP; Chien, HT; Lai, CH; Chiu, LL; Lo, TP; Hung, KY; Wang, CY; You, JF; Hsiung, CA; Yeh, CC				Kamiza, Abram Bunya; Hsieh, Ling-Ling; Tang, Reiping; Chien, Huei-Tzu; Lai, Chih-Hsiung; Chiu, Li-Ling; Lo, Tsai-Ping; Hung, Kuan-Yi; Wang, Chun-Yi; You, Jeng-Fu; Hsiung, Chao A.; Yeh, Chih-Ching			Risk Factors Associated with Colorectal Cancer in a Subset of Patients with Mutations in MLH1 and MSH2 in Taiwan Fulfilling the Amsterdam II Criteria for Lynch Syndrome	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ADENOMAS; PREVALENCE; INCREASES; HISTORY; FRUIT; GENE; ABO	Background and Aim Lynch syndrome, caused by germline mutations in mismatch repair genes, is a predisposing factor for colorectal cancer (CRC). This retrospective cohort study investigated the risk factors associated with the development of CRC in patients with MLH1 and MSH2 germline mutations. Methods In total, 301 MLH1 and MSH2 germline mutation carriers were identified from the Amsterdam criteria family registry provided by the Taiwan Hereditary Nonpolyposis Colorectal Cancer Consortium. A Cox proportional hazard model was used to calculate the hazard ratios (HRs) and 95% confidence intervals (CIs) to determine the association between the risk factors and CRC development. A robust sandwich covariance estimation model was used to evaluate family dependence. Results Among the total cohort, subjects of the Hakka ethnicity exhibited an increased CRC risk (HR = 1.62, 95% CI = 1.09-2.34); however, those who performed regular physical activity exhibited a decreased CRC risk (HR = 0.62, 95% CI = 0.41-0.88). The CRC risk was enhanced in MLH1 germline mutation carriers, with corresponding HRs of 1.72 (95% CI = 1.16-2.55) and 0.54 (95% CI = 0.34-0.83) among subjects of the Hakka ethnicity and those who performed regular physical activity, respectively. In addition, the total cohort with a manual occupation had a 1.56 times higher CRC risk (95% CI = 1.07-2.27) than did that with a skilled occupation. Moreover, MSH2 germline mutation carriers with blood group type B exhibited an increased risk of CRC development (HR = 2.64, 95% CI = 1.06-6.58) compared with those with blood group type O. Conclusion The present study revealed that Hakka ethnicity, manual occupation, and blood group type B were associated with an increased CRC risk, whereas regular physical activity was associated with a decreased CRC risk in MLH1 and MSH2 germline mutation carriers.	[Kamiza, Abram Bunya; Yeh, Chih-Ching] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan; [Hsieh, Ling-Ling; Chien, Huei-Tzu; Lai, Chih-Hsiung; Chiu, Li-Ling] Chang Gung Univ, Dept Publ Hlth, Coll Med, Tao Yuan, Taiwan; [Tang, Reiping; You, Jeng-Fu] Chang Gung Mem Hosp, Colorectal Sect, Tao Yuan, Taiwan; [Chiu, Li-Ling] Chang Gung Univ Sci & Technol, Dept Nutr & Hlth Sci, Tao Yuan, Taiwan; [Lo, Tsai-Ping; Hung, Kuan-Yi; Hsiung, Chao A.] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Wang, Chun-Yi] Chang Gung Univ, Grad Inst Biomed Sci, Tao Yuan, Taiwan; [Yeh, Chih-Ching] China Med Univ, Dept Publ Hlth, Taichung, Taiwan	Taipei Medical University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; National Health Research Institutes - Taiwan; Chang Gung University; China Medical University Taiwan	Hsiung, CA (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan.	hsiung@nhri.org.tw; ccyeh@tmu.edu.tw		Kamiza, Abram Bunya/0000-0002-3919-7651	National Sciences Council, Executive Yuan, Taiwan [NSC 101-2314-B-038-057]	National Sciences Council, Executive Yuan, Taiwan	This study was supported by the National Sciences Council, Executive Yuan, Taiwan (grant NSC 101-2314-B-038-057). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AO, 2009, GENET MED, V11, P35, DOI [10.1097/GIM.0b013e318181fa2ff, 10.1097/GIM.0b013e31818fa2ff]; Botma A, 2013, CANCER-AM CANCER SOC, V119, P512, DOI 10.1002/cncr.27726; Botma A, 2010, J CLIN ONCOL, V28, P4346, DOI 10.1200/JCO.2010.28.0453; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; De Jong AE, 2004, GASTROENTEROLOGY, V126, P42, DOI 10.1053/j.gastro.2003.10.043; de la Chapelle A, 2005, FAM CANCER, V4, P233, DOI 10.1007/s10689-004-5811-3; Friedenreich CM, 2002, J NUTR, V132, p3456S, DOI 10.1093/jn/132.11.3456S; Hermann S, 2009, CANCER CAUSE CONTROL, V20, P1397, DOI 10.1007/s10552-009-9366-3; Kuiper RP, 2011, HUM MUTAT, V32, P407, DOI 10.1002/humu.21446; Limburg PJ, 2011, CLIN GASTROENTEROL H, V9, P497, DOI 10.1016/j.cgh.2010.10.021; Lynch HT, 2009, CLIN GENET, V76, P1, DOI 10.1111/j.1399-0004.2009.01230.x; Nasca PC, 2008, FUNDAMENTALS CANC EP; Pan SX, 2011, BIOMED ENVIRON SCI, V24, P491, DOI 10.3967/0895-3988.2011.05.006; Pfizer medical division, 2008, BURD CANC AS PFIZ FA; Sanchez Nelson F, 2012, BMC Res Notes, V5, P312, DOI 10.1186/1756-0500-5-312; Simons CCJM, 2013, AM J EPIDEMIOL, V177, P514, DOI 10.1093/aje/kws280; Song JH, 2013, CANCER CAUSE CONTROL, V24, P1717, DOI 10.1007/s10552-013-0247-4; Stellman JHL, 1996, CA-CANCER J CLIN, V46, P70, DOI 10.3322/canjclin.46.2.70; Syngal S, 2000, J MED GENET, V37, P641, DOI 10.1136/jmg.37.9.641; Tang R, 2009, CLIN GENET, V75, P334, DOI 10.1111/j.1399-0004.2009.01162.x; Tang RP, 1999, INT J CANCER, V82, P484, DOI 10.1002/(SICI)1097-0215(19990812)82:4&lt;484::AID-IJC3&gt;3.0.CO;2-A; Tang RP, 2004, CARCINOGENESIS, V25, P841, DOI 10.1093/carcin/bgh074; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Tutlewska K, 2013, HERED CANCER CLIN PR, V11, DOI 10.1186/1897-4287-11-9; Urun Y, 2012, ASIAN PAC J CANCER P, V13, P6097, DOI 10.7314/APJCP.2012.13.12.6097; Vogtmann E, 2013, CANCER CAUSE CONTROL, V24, P1935, DOI 10.1007/s10552-013-0268-z; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Winkels RM, 2012, GASTROENTEROLOGY, V142, P241, DOI 10.1053/j.gastro.2011.10.033; Wolpin BM, 2009, J NATL CANCER I, V101, P424, DOI 10.1093/jnci/djp020; World Cancer Research Fund, 2007, FOOD NUTR PREV CANC; Yeh CC, 2003, J FORMOS MED ASSOC, V102, P305	31	15	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0130018	10.1371/journal.pone.0130018	http://dx.doi.org/10.1371/journal.pone.0130018			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053027	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300175
J	Morscher, RJ; Aminzadeh-Gohari, S; Feichtinger, RG; Mayr, JA; Lang, R; Neureiter, D; Sperl, W; Kofler, B				Morscher, Raphael Johannes; Aminzadeh-Gohari, Sepideh; Feichtinger, Rene Gunther; Mayr, Johannes Adalbert; Lang, Roland; Neureiter, Daniel; Sperl, Wolfgang; Kofler, Barbara			Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model	PLOS ONE			English	Article							TARGETING CANCER METABOLISM; MITOCHONDRIAL-DNA; KETONE-BODIES; TRANSLATION INITIATION; RESPIRATORY-CHAIN; ENERGY-METABOLISM; OXIDATIVE STRESS; H2O2 MEDIATE; COMPLEX-I; GLUCOSE	Introduction Neuroblastoma is a malignant pediatric cancer derived from neural crest cells. It is characterized by a generalized reduction of mitochondrial oxidative phosphorylation. The goal of the present study was to investigate the effects of calorie restriction and ketogenic diet on neuroblastoma tumor growth and monitor potential adaptive mechanisms of the cancer's oxidative phosphorylation system. Methods Xenografts were established in CD-1 nude mice by subcutaneous injection of two neuroblastoma cell lines having distinct genetic characteristics and therapeutic sensitivity [SHSY5Y and SK-N-BE(2)]. Mice were randomized to four treatment groups receiving standard diet, calorie-restricted standard diet, long chain fatty acid based ketogenic diet or calorie-restricted ketogenic diet. Tumor growth, survival, metabolic parameters and weight of the mice were monitored. Cancer tissue was evaluated for diet-induced changes of proliferation indices and multiple oxidative phosphorylation system parameters (respiratory chain enzyme activities, western blot analysis, immunohistochemistry and mitochondrial DNA content). Results Ketogenic diet and/or calorie restriction significantly reduced tumor growth and prolonged survival in the xenograft model. Neuroblastoma growth reduction correlated with decreased blood glucose concentrations and was characterized by a significant decrease in Ki-67 and phospho-histone H3 levels in the diet groups with low tumor growth. As in human tumor tissue, neuroblastoma xenografts showed distinctly low mitochondrial complex II activity in combination with a generalized low level of mitochondrial oxidative phosphorylation, validating the tumor model. Neuroblastoma showed no ability to adapt its mitochondrial oxidative phosphorylation activity to the change in nutrient supply induced by dietary intervention. Conclusions Our data suggest that targeting the metabolic characteristics of neuroblastoma could open a new front in supporting standard therapy regimens. Therefore, we propose that a ketogenic diet and/or calorie restriction should be further evaluated as a possible adjuvant therapy for patients undergoing treatment for neuroblastoma.	[Morscher, Raphael Johannes; Aminzadeh-Gohari, Sepideh; Feichtinger, Rene Gunther; Kofler, Barbara] Paracelsus Med Univ, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria; [Mayr, Johannes Adalbert; Sperl, Wolfgang] Paracelsus Med Univ, Dept Pediat, Salzburg, Austria; [Lang, Roland] Paracelsus Med Univ, Dept Dermatol, Salzburg, Austria; [Neureiter, Daniel] Paracelsus Med Univ, Dept Pathol, Salzburg, Austria; [Morscher, Raphael Johannes] Med Univ Innsbruck, Div Med Genet, A-6020 Innsbruck, Tirol, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Paracelsus Private Medical University; Medical University of Innsbruck	Morscher, RJ (corresponding author), Paracelsus Med Univ, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria.	raphael.morscher@pmu.ac.at	Aminzadeh-Gohari, Sepideh/AAS-4529-2021	Kofler, Barbara/0000-0002-1198-4776; Aminzadeh-Gohari, Sepideh/0000-0003-3976-4297; Morscher, Raphael Johannes/0000-0003-3378-9266; Mayr, Johannes/0000-0001-6970-336X	Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung Salzburg; Children's Cancer Foundation Salzburg; Paracelsus Medical University Salzburg [E-10/12/061-KOF]	Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung Salzburg; Children's Cancer Foundation Salzburg(Swedish Cancer Society); Paracelsus Medical University Salzburg	This work was supported by the Vereinigung zur Forderung der padiatrischen Forschung und Fortbildung Salzburg, the Children's Cancer Foundation Salzburg and the Paracelsus Medical University Salzburg, single project grant No.: E-10/12/061-KOF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acham-Roschitz B, 2009, MOL GENET METAB, V98, P300, DOI 10.1016/j.ymgme.2009.06.012; Ahmad IM, 2005, J BIOL CHEM, V280, P4254, DOI 10.1074/jbc.M411662200; Allen BG, 2013, CLIN CANCER RES, V19, P3905, DOI 10.1158/1078-0432.CCR-12-0287; Amar L, 2005, J CLIN ONCOL, V23, P8812, DOI 10.1200/JCO.2005.03.1484; Astuti D, 2004, BRIT J CANCER, V91, P1835, DOI 10.1038/sj.bjc.6602202; Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1; Bough KJ, 2006, ANN NEUROL, V60, P223, DOI 10.1002/ana.20899; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Butler EB, 2013, CANCER RES, V73, P2709, DOI 10.1158/0008-5472.CAN-12-3009; Chang HT, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-47; Chiang MC, 2014, MITOCHONDRION, V14, P7, DOI 10.1016/j.mito.2013.12.003; Chu-Shore CJ, 2010, BRAIN DEV-JPN, V32, P318, DOI 10.1016/j.braindev.2009.04.009; Dang CV, 2011, J MOL MED, V89, P205, DOI 10.1007/s00109-011-0730-x; De Preter K, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-55; Dey R, 2000, J BIOL CHEM, V275, P7087, DOI 10.1074/jbc.275.10.7087; Dickinson A, 2013, CELL DEATH DIFFER, V20, P1644, DOI 10.1038/cdd.2013.115; Facucho-Oliveira JM, 2009, STEM CELL REV REP, V5, P140, DOI 10.1007/s12015-009-9058-0; Feichtinger Rene G, 2011, Front Biosci (Elite Ed), V3, P194, DOI 10.2741/e233; Feichtinger Rene G, 2011, Front Biosci (Elite Ed), V3, P187, DOI 10.2741/e232; Feichtinger RG, 2014, GLIA, V62, P514, DOI 10.1002/glia.22621; Feichtinger Rene' G, 2011, Front Biosci (Elite Ed), V3, P179, DOI 10.2741/e231; Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Freedland SJ, 2008, PROSTATE, V68, P11, DOI 10.1002/pros.20683; Freeman JM, 2007, PEDIATRICS, V119, P535, DOI 10.1542/peds.2006-2447; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hartman AL, 2007, EPILEPSIA, V48, P31, DOI 10.1111/j.1528-1167.2007.00914.x; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HOLLOSZY JO, 1970, BIOCHEM BIOPH RES CO, V40, P1368, DOI 10.1016/0006-291X(70)90017-3; Huffman J, 2006, CURR NEUROL NEUROSCI, V6, P332, DOI 10.1007/s11910-006-0027-6; Hughes SD, 2014, J NEUROCHEM, V129, P426, DOI 10.1111/jnc.12646; Igney FH, 2002, NAT REV CANCER, V2, P277, DOI 10.1038/nrc776; Jones NP, 2012, DRUG DISCOV TODAY, V17, P232, DOI 10.1016/j.drudis.2011.12.017; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kim JY, 2002, ONCOGENE, V21, P3139, DOI 10.1038/sj.onc.1205406; Kimberly MM, 2006, CLIN CHIM ACTA, V364, P292, DOI 10.1016/j.cca.2005.07.027; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Kollberg G, 2009, NEUROMUSCULAR DISORD, V19, P147, DOI 10.1016/j.nmd.2008.11.014; Kristensen GBB, 2005, CLIN CHEM, V51, P1632, DOI 10.1373/clinchem.2005.049080; Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059; Laffel L, 1999, DIABETES-METAB RES, V15, P412, DOI 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8; Li ZJ, 2012, CLIN CANCER RES, V18, P3603, DOI 10.1158/1078-0432.CCR-11-3321; Liang JY, 2007, NAT CELL BIOL, V9, P218, DOI 10.1038/ncb1537; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lv MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115147; Maroon J, 2013, J CHILD NEUROL, V28, P1002, DOI 10.1177/0883073813488670; Mayr JA, 2008, CLIN CANCER RES, V14, P2270, DOI 10.1158/1078-0432.CCR-07-4131; Mayr JA, 2011, AM J HUM GENET, V89, P792, DOI 10.1016/j.ajhg.2011.11.011; Meidenbauer JJ, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0009-2; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; Mukherjee P, 2004, CLIN CANCER RES, V10, P5622, DOI 10.1158/1078-0432.CCR-04-0308; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; NEBELING LC, 1995, J AM COLL NUTR, V14, P202; Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122; Paoli A, 2013, EUR J CLIN NUTR, V67, P789, DOI 10.1038/ejcn.2013.116; Park JR, 2013, PEDIATR BLOOD CANCER, V60, P985, DOI 10.1002/pbc.24433; Payne NE, 2011, EPILEPSIA, V52, P1941, DOI 10.1111/j.1528-1167.2011.03287.x; Pon LA, 2007, MITOCHONDRIA, Vxxiv; Qing GL, 2012, CANCER CELL, V22, P631, DOI 10.1016/j.ccr.2012.09.021; Raez LE, 2013, CANCER CHEMOTH PHARM, V71, P523, DOI 10.1007/s00280-012-2045-1; Rieger J, 2014, INT J ONCOL, V44, P1843, DOI 10.3892/ijo.2014.2382; ROEDER LM, 1982, J NEUROSCI RES, V8, P671, DOI 10.1002/jnr.490080412; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Schmidt M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-54; Schneider L, 2011, FREE RADICAL BIO MED, V51, P2007, DOI 10.1016/j.freeradbiomed.2011.08.030; Seyfried Thomas N, 2005, Nutr Metab (Lond), V2, P30, DOI 10.1186/1743-7075-2-30; Seyfried TN, 2011, BBA-BIOENERGETICS, V1807, P577, DOI 10.1016/j.bbabio.2010.08.009; Seyfried TN, 2010, LANCET ONCOL, V11, P811, DOI 10.1016/S1470-2045(10)70166-2; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Shidara Y, 2005, CANCER RES, V65, P1655, DOI 10.1158/0008-5472.CAN-04-2012; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Skinner R, 2009, J PEDIATR SURG, V44, P212, DOI 10.1016/j.jpedsurg.2008.10.042; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; TISDALE MJ, 1983, BRIT J CANCER, V47, P293, DOI 10.1038/bjc.1983.38; Vander Heiden MG, 2011, NAT REV DRUG DISCOV, V10, P671, DOI 10.1038/nrd3504; Venkateswaran V, 2007, J NATL CANCER I, V99, P1793, DOI 10.1093/jnci/djm231; Warburg O, 1924, NATURWISSENSCHAFTEN, V12, P1131, DOI 10.1007/BF01504608; Xun Z, 2012, MECH AGEING DEV, V133, P176, DOI 10.1016/j.mad.2012.01.008; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zimmermann FA, 2009, BRIT J CANCER, V100, P1434, DOI 10.1038/sj.bjc.6605028; Zimmermann Franz A, 2011, Front Biosci (Elite Ed), V3, P315; Zuccoli G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-33	88	63	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129802	10.1371/journal.pone.0129802	http://dx.doi.org/10.1371/journal.pone.0129802			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053068	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000355955300163
J	Patterson, C; McDaid, LM; Hilton, S				Patterson, Chris; McDaid, Lisa M.; Hilton, Shona			Gay and Bisexual Men's Perceptions of the Donation and Use of Human Biological Samples for Research: A Qualitative Study	PLOS ONE			English	Article							OBSERVATIONAL RESEARCH; ADULT OUTPATIENTS; GENETIC RESEARCH; HUMAN TISSUE; CONSENT; BLOOD; OWNERSHIP; BIOBANKS; DONORS; SALIVA	Human biological samples (biosamples) are increasingly important in diagnosing, treating and measuring the prevalence of illnesses. For the gay and bisexual population, biosample research is particularly important for measuring the prevalence of human immunodeficiency virus (HIV). By determining people's understandings of, and attitudes towards, the donation and use of biosamples, researchers can design studies to maximise acceptability and participation. In this study we examine gay and bisexual men's attitudes towards donating biosamples for HIV research. Semi-structured telephone interviews were conducted with 46 gay and bisexual men aged between 18 and 63 recruited in commercial gay scene venues in two Scottish cities. Interview transcripts were analysed thematically using the framework approach. Most men interviewed seemed to have given little prior consideration to the issues. Participants were largely supportive of donating tissue for medical research purposes, and often favourable towards samples being stored, reused and shared. Support was often conditional, with common concerns related to: informed consent; the protection of anonymity and confidentiality; the right to withdraw from research; and ownership of samples. Many participants were in favour of the storage and reuse of samples, but expressed concerns related to data security and potential misuse of samples, particularly by commercial organisations. The sensitivity of tissue collection varied between tissue types and collection contexts. Blood, urine, semen and bowel tissue were commonly identified as sensitive, and donating saliva and as unlikely to cause discomfort. To our knowledge, this is the first in-depth study of gay and bisexual men's attitudes towards donating biosamples for HIV research. While most men in this study were supportive of donating tissue for research, some clear areas of concern were identified. We suggest that these minority concerns should be accounted for to develop inclusive, evidence-informed research protocols that balance collective benefits with individual concerns.	[Patterson, Chris; McDaid, Lisa M.; Hilton, Shona] Univ Glasgow, MRC, CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Patterson, C (corresponding author), Univ Glasgow, MRC, CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	chris.patterson@glasgow.ac.uk	; Patterson, Chris/P-5947-2014	Hilton, Shona/0000-0003-0633-8152; Patterson, Chris/0000-0002-5914-8718; McDaid, Lisa/0000-0002-7711-8723	UK Medical Research Council, Understandings and Uses of Public Health Research programme at the MRC/CSO Social Public Health Sciences Unit, University of Glasgow [MC_U130085862/MC_UU_12017/6]; UK Medical Research Council, Sexual Health programme at the MRC/CSO Social Public Health Sciences Unit, University of Glasgow [MC_U130031238/MC_UU_12017/2]; MRC [MC_UU_12017/6, MC_U130031238, MC_UU_12017/11, MC_U130085862, MC_UU_12017/15, MC_UU_12017/2] Funding Source: UKRI; Medical Research Council [MC_UU_12017/6, MC_U130085862, MC_UU_12017/2, MC_UU_12017/15, MC_UU_12017/11, MC_U130031238] Funding Source: researchfish; Chief Scientist Office [SPHSU15, SPHSU11] Funding Source: researchfish	UK Medical Research Council, Understandings and Uses of Public Health Research programme at the MRC/CSO Social Public Health Sciences Unit, University of Glasgow; UK Medical Research Council, Sexual Health programme at the MRC/CSO Social Public Health Sciences Unit, University of Glasgow; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	CP and SH are funded by the UK Medical Research Council as part of the Understandings and Uses of Public Health Research programme (MC_U130085862/MC_UU_12017/6) at the MRC/CSO Social Public Health Sciences Unit, University of Glasgow. LM is funded by the UK Medical Research Council as part of the Sexual Health programme (MC_U130031238/MC_UU_12017/2) at the MRC/CSO Social Public Health Sciences Unit, University of Glasgow. The funding body had no role in the design, collection, analysis or interpretation of this study.	Al-Shahi R, 2005, BRIT MED J, V331, P942, DOI 10.1136/bmj.38624.397569.68; Aldridge S, 2005, GEN ENG NEWS, V25; Bryant RJ, 2008, J CLIN PATHOL, V61, P322, DOI 10.1136/jcp.2007.053173; Busby Helen, 2010, Clin Ethics, V5, P22; Charo RA, 2006, NEW ENGL J MED, V355, P1517, DOI 10.1056/NEJMp068192; Datta J, 2013, CULT HEALTH SEX, V15, P896, DOI 10.1080/13691058.2013.790075; Dhima M, 2013, J PROSTHODONT RES, V57, P51, DOI 10.1016/j.jpor.2012.09.004; Dixon-Woods M, 2008, MED LAW INT, V9, P131, DOI [DOI 10.1177/096853320800900203, 10.1177/096853320800900203]; Dunn KM, 2004, AM J EPIDEMIOL, V159, P1087, DOI 10.1093/aje/kwh141; Eriksson S, 2005, EUR J HUM GENET, V13, P1071, DOI 10.1038/sj.ejhg.5201458; Granger DA, 2007, PHYSIOL BEHAV, V92, P583, DOI 10.1016/j.physbeh.2007.05.004; Haga SB, 2008, ADV GENET, V60, P505, DOI 10.1016/S0065-2660(07)00418-X; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Hill EM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-72; Hoeyer K, 2003, NEW GENET SOC, V22, P229, DOI 10.1080/1463677032000147199; Ingelfinger FJ, 1979, INFORM UNEDUCATED CO, P265; Jack AL, 2003, BRIT MED J, V327, P262, DOI 10.1136/bmj.327.7409.262; Kettis-Lindblad A, 2006, EUR J PUBLIC HEALTH, V16, P433, DOI 10.1093/eurpub/cki198; Kho ME, 2009, WRITTEN INFORMED CON; Koka S, 2008, J AM DENT ASSOC, V139, P735, DOI 10.14219/jada.archive.2008.0255; Lemke AA, 2010, PUBLIC HEALTH GENOM, V13, P368, DOI 10.1159/000276767; Lewis C., 2013, BMJ OPEN, V3; Lewis C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003022; Macintyre S., 1995, PUBLIC UNDERST SCI, V4, P223, DOI DOI 10.1088/0963-6625/4/3/001; Macleod U, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-15; MALAMUD D, 1992, BRIT MED J, V305, P207, DOI 10.1136/bmj.305.6847.207; McGuire AL, 2008, AM J BIOETHICS, V8, P75, DOI 10.1080/15265160802478511; Medical Research Council, 2001, HUMAN TISSUE AND BIO; Nuffield Council on Bioethics, 1995, HUM TISS ETH LEG ISS; Ogloff James R P, 1991, Ethics Behav, V1, P239; Ritchie J., 2003, QUALITATIVE RES PRAC; Secko DM, 2009, SOC SCI MED, V68, P781, DOI 10.1016/j.socscimed.2008.11.020; Sindall C, 1998, HEALTH PROMOT INT, V13, P174, DOI 10.1093/heapro/13.2.174; Start RD, 1996, BRIT MED J, V313, P1366, DOI 10.1136/bmj.313.7069.1366; Tupasela A, 2010, SCAND J PUBLIC HEALT, V38, P46, DOI 10.1177/1403494809353824; Waldby C, 2004, SOC SCI MED, V59, P1461, DOI 10.1016/j.socscimed.2004.01.012; Wallace LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090805; Wendler D, 2002, ARCH INTERN MED, V162, P1457, DOI 10.1001/archinte.162.13.1457; White C., 2003, QUALITATIVE RES PRAC, V1st ed., P287	39	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129924	10.1371/journal.pone.0129924	http://dx.doi.org/10.1371/journal.pone.0129924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1GM	26053741	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000355955300169
J	Wang, JJ; Ding, GW; Zhu, ZB; Zhou, CL; Wang, N				Wang, Junjie; Ding, Guowei; Zhu, Zhibin; Zhou, Chunlian; Wang, Ning			Analysis of HIV Correlated Factors in Chinese and Vietnamese Female Sex Workers in Hekou, Yunnan Province, a Chinese Border Region	PLOS ONE			English	Article							INJECTION-DRUG USERS; SOUTHERN CHINA; RISK-FACTORS; YOUNG-WOMEN; CONDOM USE; INFECTION; PREVALENCE; METAANALYSIS; SYPHILIS; RECOMBINANT	Objectives To assess the prevalence and correlated factors of HIV-1 among Chinese and Vietnamese female sex workers (FSW) in the border county of Hekou, Yunnan province, China. Methods A cross-sectional survey was conducted collecting information on demographics, sexual behavior, medical history, and drug use. Blood samples were obtained to test for HIV/STIs. Multivariate logistic regression model was used to examine associations between factors and HIV-1 infection. Results Of 345 FSWs who participated in this study, 112 (32.5%) were Chinese and 233 (67.5) were Vietnamese. Vietnamese FSWs were significantly more likely to be HIV-1 positive (7.7%) compared with Chinese FSWs (0.9%) (p = 0.009). In multivariate analysis, sexual debut at age <= 16 (OR 3.8: 95% CI: 1.4, 10.6), last client's payment < 150 RMB ($22 USD) (OR: 5.2, 95% CI; 1.7, 16.6), and HSV-2 (OR: 12.3; 95% CI: 1.6, 94.8) were significant for HIV-1 infection. Conclusions Differences in HIV prevalence in Vietnamese and Chinese FSWs may be indicative of differential risk. It is important to characterize the nature of trans-border transmission in order to gain a better understanding of the potential impact on the international HIV epidemic. Understanding the correlated factors for HIV in Vietnamese and Chinese FSWs is important for designing interventions for this vulnerable population.	[Wang, Junjie; Ding, Guowei; Wang, Ning] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Zhu, Zhibin] Hekou Ctr Dis Control & Prevent, Hekou, Yunnan, Peoples R China; [Zhou, Chunlian] Capital Med Univ, Dept Nosocomial Infect Prevent & Control, Beijing Friendship Hosp, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Capital Medical University	Wang, N (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	wangnbj@163.com			mega-projects of national science research for the 12th Five-Year Plan [2012ZX10001-001]; 11th Five-Year Plan of China [2008ZX10001-003]	mega-projects of national science research for the 12th Five-Year Plan; 11th Five-Year Plan of China(National Key Technology R&D Program)	This work was supported by the mega-projects of national science research for the 12th Five-Year Plan (2012ZX10001-001) and 11th Five-Year Plan of China (2008ZX10001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; [Anonymous], 2002, PERSPECT SEX REPRO H; Bachanas PJ, 2002, J PEDIATR PSYCHOL, V27, P373, DOI 10.1093/jpepsy/27.4.373; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Beyrer C, 2001, WASH QUART, V24, P211, DOI 10.1162/016366001561483; Brady S, 2002, AIDS PATIENT CARE ST, V16, P121, DOI 10.1089/108729102317330463; CELENTANO DD, 1994, AIDS, V8, P533, DOI 10.1097/00002030-199404000-00018; Dada AJ, 1998, SEX TRANSM DIS, V25, P237, DOI 10.1097/00007435-199805000-00004; Des Jarlais DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087993; Espinoza L, 2009, AIDS EDUC PREV, V21, P19, DOI 10.1521/aeap.2009.21.5_supp.19; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; He Z., 2003, MIGRATION SEX IND HE; Hekou Bureau of Statistics, 2008, HEK YAO AUT COUNT AL; Huda S, 2006, INT J GYNECOL OBSTET, V94, P374, DOI 10.1016/j.ijgo.2006.04.027; Jia MH, 2010, JAIDS-J ACQ IMM DEF, V53, pS34, DOI 10.1097/QAI.0b013e3181c7d6ff; Kaneko N, 2007, NURS HEALTH SCI, V9, P284, DOI 10.1111/j.1442-2018.2007.00338.x; Kilmarx PH, 1998, AIDS, V12, P1889, DOI 10.1097/00002030-199814000-00021; Li DM, 2014, CHINESE MED J-PEKING, V127, P707, DOI 10.3760/cma.j.issn.0366-6999.20131502; Liang Y, 2009, CHIN J AIDS STD, V15, P457; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Manning WD, 2000, FAM PLANN PERSPECT, V32, P104, DOI 10.2307/2648158; Nepal B, 2007, J HEALTH POPUL NUTR, V25, P267; Patterson TL, 2008, J INFECT DIS, V197, P728, DOI 10.1086/527379; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Pettifor A, 2009, INT PERSPECT SEX R H, V35, P82, DOI [10.1363/3508209, 10.1363/ifpp.35.082.09]; Piyasirisilp S, 2000, J VIROL, V74, P11286, DOI 10.1128/JVI.74.23.11286-11295.2000; Poshyachina V., 1993, Bulletin on Narcotics, V45, P77; Poudel P, 2000, Gend Dev, V8, P74, DOI 10.1080/741923626; Resl V, 2003, SEX TRANSM INFECT, V79, DOI 10.1136/sti.79.6.e3; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; State Council AIDS Working Committee Office and UN Theme Group on AIDS in China, 2007, JOINT ASS HIV AIDS P; Thuong NV, 2005, SEX TRANSM INFECT, V81, P477, DOI 10.1136/sti.2005.016097; Thuy NTT, 1998, AIDS, V12, P425, DOI 10.1097/00002030-199804000-00012; United Nations General Assembly Special Session on HIV/AIDS (UNGASS), 2008, VIETN 3 COUNTR REP F; Uribe-Salas F, 2003, SEX TRANSM DIS, V30, P266, DOI 10.1097/00007435-200303000-00018; Varga C.A., 1997, HLTH TRANSITION R S3, V7, P45; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang L, 2014, CLIN INFECT DIS, V59, pE1, DOI 10.1093/cid/ciu245; Wong WCW, 2003, AIDS PATIENT CARE ST, V17, P417, DOI 10.1089/108729103322277439; Xu JJ, 2008, SEX TRANSM DIS, V35, P558, DOI 10.1097/OLQ.0b013e318165926b; Yu XF, 1999, J ACQ IMMUN DEF SYND, V22, P180; Yu XF, 2002, AIDS RES HUM RETROV, V18, P167, DOI 10.1089/08892220252779719; Yu XF, 1998, LANCET, V351, P1250, DOI 10.1016/S0140-6736(05)79316-8; ZHANG LB, 2013, LANCET INFECT DIS, V2, P13, DOI DOI 10.1016/S1473-3099(13)70245-7; Zimmerman C., 2003, HLTH RISKS CONSEQUEN	47	22	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129430	10.1371/journal.pone.0129430	http://dx.doi.org/10.1371/journal.pone.0129430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053040	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300124
J	Yang, WX; Zhang, YH; Zhou, XJ; Zhang, W; Xu, XL; Chen, RM; Meng, QC; Yuan, JH; Yang, PL; Yao, B				Yang, Wenxia; Zhang, Yuhong; Zhou, Xiaojin; Zhang, Wei; Xu, Xiaolu; Chen, Rumei; Meng, Qingchang; Yuan, Jianhua; Yang, Peilong; Yao, Bin			Production of a Highly Protease-Resistant Fungal alpha-Galactosidase in Transgenic Maize Seeds for Simplified Feed Processing	PLOS ONE			English	Article							SOYBEAN-MEAL; EXPRESSION; PLANTS; OLIGOSACCHARIDES; PURIFICATION; CLONING	Raffinose-family oligosaccharide (RFO) in soybeans is one of the major anti-nutritional factors for poultry and livestocks. alpha-Galactosidase is commonly supplemented into the animal feed to hydrolyze alpha-1,6-galactosidic bonds on the RFOs. To simplify the feed processing, a protease-resistant alpha-galactosidase encoding gene from Gibberella sp. strain F75, aga-F75, was modified by codon optimization and heterologously expressed in the embryos of transgentic maize driven by the embryo-specific promoter ZM-leg1A. The progenies were produced by backcrossing with the commercial inbred variety Zheng58. PCR, southern blot and western blot analysis confirmed the stable integration and tissue specific expression of the modified gene, aga-F75m, in seeds over four generations. The expression level of Aga-F75M reached up to 10,000 units per kilogram of maize seeds. In comparison with its counterpart produced in Pichia pastoris strain GS115, maize seed-derived Aga-F75M showed a lower temperature optimum (50 degrees C) and lower stability over alkaline pH range, but better thermal stability at 60 degrees C to 70 degrees C and resistance to feed pelleting inactivation (80 degrees C). This is the first report of producing alpha-galactosidase in transgenic plant. The study offers an effective and economic approach for direct utilization of alpha-galactosidase-producing maize without any purification or supplementation procedures in the feed processing.	[Yang, Wenxia; Xu, Xiaolu; Yang, Peilong; Yao, Bin] Chinese Acad Agr Sci, Feed Res Inst, Beijing 100193, Peoples R China; [Zhang, Yuhong; Zhou, Xiaojin; Zhang, Wei; Chen, Rumei] Chinese Acad Agr Sci, Inst Biotechnol, Beijing 100193, Peoples R China; [Meng, Qingchang; Yuan, Jianhua] Jiangsu Acad Agr Sci, Inst Food Crops, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Feed Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Jiangsu Academy of Agricultural Sciences	Yang, PL (corresponding author), Chinese Acad Agr Sci, Feed Res Inst, Beijing 100193, Peoples R China.	yangpeilong@caas.cn; binyao@caas.cn			Key Program of Transgenic Plant Breeding of China [2014ZX08003-002]; National High-Tech Research and Development Program of China [2012AA022208]; China Modern Agriculture Research System [CARS-42]	Key Program of Transgenic Plant Breeding of China; National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); China Modern Agriculture Research System	This work was supported by the Key Program of Transgenic Plant Breeding of China (2014ZX08003-002), and the National High-Tech Research and Development Program of China (2012AA022208), and the China Modern Agriculture Research System (CARS-42).	Armstrong C. L., 1991, Maize Genetics Cooperation News Letter, P92; Baik SH, 2000, J BIOSCI BIOENG, V90, P168, DOI 10.1016/S1389-1723(00)80105-X; BOWER R, 1992, PLANT J, V2, P409, DOI 10.1111/j.1365-313X.1992.00409.x; Cao YN, 2007, ENZYME MICROB TECH, V41, P835, DOI 10.1016/j.enzmictec.2007.07.005; Cao YN, 2009, APPL MICROBIOL BIOT, V83, P875, DOI 10.1007/s00253-009-1939-2; Cervera-Tison M, 2012, APPL ENVIRON MICROB, V78, P7720, DOI 10.1128/AEM.01350-12; Chen RM, 2008, TRANSGENIC RES, V17, P633, DOI 10.1007/s11248-007-9138-3; Chen YS, 2000, PROTEIN EXPRES PURIF, V20, P472, DOI 10.1006/prep.2000.1325; Cletus J, 2013, BIOTECHNOL LETT, V35, P1719, DOI 10.1007/s10529-013-1269-4; Deng LF, 2009, CHIN AGR SCI B, V25, P7; DENHERDER IF, 1992, MOL GEN GENET, V233, P404, DOI 10.1007/BF00265437; DEY PM, 1972, ADV ENZYMOL RAMB, V36, P91; Du F, 2013, PLANT PHYSIOL BIOCH, V69, P49, DOI 10.1016/j.plaphy.2013.04.017; Frame BR, 2006, METH MOL B, V343, P185; Ghazi S, 2003, BRIT POULTRY SCI, V44, P410, DOI 10.1080/00071660310001598283; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; James C., 2012, CHINA BIOTECHNOL, V32, P1; Kim SW, 2003, J ANIM SCI, V81, P2496; Kimura T, 2010, BIOSCI BIOTECH BIOCH, V74, P954, DOI 10.1271/bbb.90774; KLEIN TM, 1988, P NATL ACAD SCI USA, V85, P4305, DOI 10.1073/pnas.85.12.4305; Kotiguda, 2007, J MICROBIOL BIOTECHN, V17, P1430; Kurakake M, 2011, FOOD CHEM, V126, P177, DOI 10.1016/j.foodchem.2010.10.095; Liu HM, 2010, MOL BIOL REP, V37, P677, DOI 10.1007/s11033-009-9521-7; Meissle M, 2011, PEST MANAG SCI, V67, P807, DOI 10.1002/ps.2117; Messina MJ, 1999, AM J CLIN NUTR, V70, p439S, DOI 10.1093/ajcn/70.3.439s; Que Qiudeng, 2014, Front Plant Sci, V5, P379, DOI 10.3389/fpls.2014.00379; Reis AP, 2010, BRAZ ARCH BIOL TECHN, V53, P719, DOI 10.1590/S1516-89132010000300029; Smits CHM, 1996, WORLD POULTRY SCI J, V52, P203, DOI 10.1079/WPS19960016; Songstad DD, 1996, IN VITRO CELL DEV-PL, V32, P179; Tomes D. T., 1995, P197; Wang H, 2010, BIORESOURCE TECHNOL, V101, P8376, DOI 10.1016/j.biortech.2010.06.045; Whittle CA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-169; Xu XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056146; Zeyland J, 2014, ARCH IMMUNOL THER EX, V62, P411, DOI 10.1007/s00005-014-0280-3; Zhang YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081993	35	6	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129294	10.1371/journal.pone.0129294	http://dx.doi.org/10.1371/journal.pone.0129294			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053048	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300111
J	Yu, TH; Tung, YC; Chung, KP				Yu, Tsung-Hsien; Tung, Yu-Chi; Chung, Kuo-Piao			Which Kind of Provider's Operation Volumes Matters? Associations between CABG Surgical Site Infection Risk and Hospital and Surgeon Operation Volumes among Medical Centers in Taiwan	PLOS ONE			English	Article							BYPASS GRAFT-SURGERY; CARE-ASSOCIATED INFECTIONS; ADMINISTRATIVE CODING DATA; TOTAL HIP-REPLACEMENT; HEALTH-CARE; OUTCOME RELATIONSHIP; RECTAL-CANCER; SURVEILLANCE; IMPACT; COMPLICATIONS	Background Volume-infection relationships have been examined for high-risk surgical procedures, but the conclusions remain controversial. The inconsistency might be due to inaccurate identification of cases of infection and different methods of categorizing service volumes. This study takes coronary artery bypass graft (CABG) surgical site infections (SSIs) as an example to examine whether a relationship exists between operation volumes and SSIs, when different SSIs case identification, definitions and categorization methods of operation volumes were implemented. Methods A population-based cross-sectional multilevel study was conducted. A total of 7,007 patients who received CABG surgery between 2006 and 2008 from19 medical centers in Taiwan were recruited. SSIs associated with CABG surgery were identified using International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9 CM) codes and a Classification and Regression Trees (CART) model. Two definitions of surgeon and hospital operation volumes were used: (1) the cumulative CABG operation volumes within the study period; and (2) the cumulative CABG operation volumes in the previous one year before each CABG surgery. Operation volumes were further treated in three different ways: (1) a continuous variable; (2) a categorical variable based on the quartile; and (3) a data-driven categorical variable based on k-means clustering algorithm. Furthermore, subgroup analysis for comorbidities was also conducted. Results This study showed that hospital volumes were not significantly associated with SSIs, no matter which definitions or categorization methods of operation volume, or SSIs case identification approaches were used. On the contrary, the relationships between surgeon's volumes varied. Most of the models demonstrated that the low-volume surgeons had higher risk than high-volume surgeons. Conclusion Surgeon volumes were more important than hospital volumes in exploring the relationship between CABG operation volumes and SSIs in Taiwan. However, the relationships were not robust. Definitions and categorization methods of operation volume and correct identification of SSIs are important issues for future research.	[Yu, Tsung-Hsien; Tung, Yu-Chi; Chung, Kuo-Piao] Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei 10764, Taiwan	National Taiwan University	Chung, KP (corresponding author), Natl Taiwan Univ, Inst Hlth Policy & Management, Taipei 10764, Taiwan.	kpchung@ntu.edu.tw	Tung, Yu-Chi/V-1036-2019	Tung, Yu-Chi/0000-0001-9031-8749; CHUNG, KUO-PIAO/0000-0001-9482-7065; Yu, Tsung-Hsien/0000-0002-6874-989X				Al-Khatib SM, 2005, J AM COLL CARDIOL, V46, P1536, DOI 10.1016/j.jacc.2005.04.063; Bratzler DW, 2005, ARCH SURG-CHICAGO, V140, P174, DOI 10.1001/archsurg.140.2.174; Browne JA, 2009, J TRAUMA, V66, P809, DOI 10.1097/TA.0b013e31816166bb; Campbell PG, 2011, J NEUROSURG-SPINE, V14, P16, DOI 10.3171/2010.9.SPINE10151; Chowdhury MM, 2007, BRIT J SURG, V94, P145, DOI 10.1002/bjs.5714; Cristofolini M, 2012, INFECTION, V40, P397, DOI 10.1007/s15010-012-0275-0; Everitt B., 2003, MODERN MED STAT PRAC; Everitt B. S, 2011, CLUSTER ANAL, DOI DOI 10.1002/9780470977811; Friedman ND, 2007, INFECT CONT HOSP EP, V28, P1162, DOI 10.1086/519534; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Harrington G, 2004, INFECT CONT HOSP EP, V25, P472, DOI 10.1086/502424; Hervey SL, 2003, J BONE JOINT SURG AM, V85A, P1775, DOI 10.2106/00004623-200309000-00017; Hodgson DC, 2003, J NATL CANCER I, V95, P708, DOI 10.1093/jnci/95.10.708; Hogan AM, 2008, ANN SURG ONCOL, V15, P1267, DOI 10.1245/s10434-007-9804-y; Hollenbeak CS, 2000, CHEST, V118, P397, DOI 10.1378/chest.118.2.397; Hollenbeck BK, 2007, SURG INNOV, V14, P192, DOI 10.1177/1553350607307274; Huang CS, 2011, J FORMOS MED ASSOC, V110, P401, DOI 10.1016/S0929-6646(11)60059-4; Huang SS, 2011, INFECT CONT HOSP EP, V32, P775, DOI 10.1086/660874; Jhung MA, 2009, CLIN INFECT DIS, V49, P949, DOI 10.1086/605086; Katz JN, 2001, J BONE JOINT SURG AM, V83A, P1622, DOI 10.2106/00004623-200111000-00002; Klompas M, 2009, CLIN INFECT DIS, V48, P1268, DOI 10.1086/597591; Korol E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083743; Laudani L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074227; Lee J, 2011, J HOSP INFECT, V77, P316, DOI 10.1016/j.jhin.2010.11.013; Lee PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110732; Lemon SC, 2003, ANN BEHAV MED, V26, P172, DOI 10.1207/S15324796ABM2603_02; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Sands KE, 2003, INFECT CONT HOSP EP, V24, P741, DOI 10.1086/502123; Solomon DH, 2002, ARTHRITIS RHEUM, V46, P2436, DOI 10.1002/art.10478; Song XY, 2008, AM J INFECT CONTROL, V36, pS32, DOI 10.1016/j.ajic.2007.10.008; Stevenson KB, 2008, AM J INFECT CONTROL, V36, P155, DOI 10.1016/j.ajic.2008.01.004; Vogel TR, 2011, VASC ENDOVASC SURG, V45, P317, DOI 10.1177/1538574411403167; Walker N, 2013, LANCET, V382, P1029, DOI 10.1016/S0140-6736(13)61748-1; Wei MH, 2010, J ARTHROPLASTY, V25, P906, DOI 10.1016/j.arth.2009.06.033; Wu SC, 2006, INFECT CONT HOSP EP, V27, P308, DOI 10.1086/503015; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Yasunaga H, 2009, SURG TODAY, V39, P663, DOI 10.1007/s00595-008-3848-x; Yu TH, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/s12939-014-0064-8; Yu TH, 2014, BMC MED INFORM DECIS, V14, DOI 10.1186/1472-6947-14-42	40	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129178	10.1371/journal.pone.0129178	http://dx.doi.org/10.1371/journal.pone.0129178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053035	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300097
J	England, CG; Huang, JS; James, KT; Zhang, GD; Gobin, AM; Frieboes, HB				England, Christopher G.; Huang, Justin S.; James, Kurtis T.; Zhang, Guandong; Gobin, Andre M.; Frieboes, Hermann B.			Detection of Phosphatidylcholine-Coated Gold Nanoparticles in Orthotopic Pancreatic Adenocarcinoma using Hyperspectral Imaging	PLOS ONE			English	Article							PHOTOTHERMAL ABLATION; INTERSTITIAL PRESSURE; ELECTRON-MICROSCOPY; PARTICLE-SIZE; CANCER-CELLS; LUNG-CANCER; DELIVERY; TUMORS; PENETRATION; TRANSPORT	Nanoparticle uptake and distribution to solid tumors are limited by reticuloendothelial system systemic filtering and transport limitations induced by irregular intra-tumoral vascularization. Although vascular enhanced permeability and retention can aid targeting, high interstitial fluid pressure and dense extracellular matrix may hinder local penetration. Extravascular diffusivity depends upon nanoparticle size, surface modifications, and tissue vascularization. Gold nanoparticles functionalized with biologically-compatible layers may achieve improved uptake and distribution while enabling cytotoxicity through synergistic combination of chemotherapy and thermal ablation. Evaluation of nanoparticle uptake in vivo remains difficult, as detection methods are limited. We employ hyperspectral imaging of histology sections to analyze uptake and distribution of phosphatidylcholine-coated citrate gold nanoparticles (CGN) and silica-gold nanoshells (SGN) after tail-vein injection in mice bearing orthotopic pancreatic adenocarcinoma. For CGN, the liver and tumor showed 26.5 +/- 8.2 and 23.3 +/- 4.1 particles/100 mu m(2) within 10 mu m from the nearest source and few nanoparticles beyond 50 mu m, respectively. The spleen had 35.5 +/- 9.3 particles/100 mu m(2) within 10 mu m with penetration also limited to 50 mu m. For SGN, the liver showed 31.1 +/- 4.1 particles/100 mu m(2) within 10 mu m of the nearest source with penetration hindered beyond 30 mu m. The spleen and tumor showed uptake of 22.1 +/- 6.2 and 15.8 +/- 6.1 particles/100 mu m(2) within 10 mu m, respectively, with penetration similarly hindered. CGH average concentration (nanoparticles/mu m(2)) was 1.09 +/- 0.14 in the liver, 0.74 +/- 0.12 in the spleen, and 0.43 +/- 0.07 in the tumor. SGN average concentration (nanoparticles/mu m(2)) was 0.43 +/- 0.07 in the liver, 0.30 +/- 0.06 in the spleen, and 0.20 +/- 0.04 in the tumor. Hyperspectral imaging of histology sections enables analysis of phosphatidylcholine-coated gold-based nanoparticles in pancreatic tumors with the goal to improve nanotherapeutic efficacy.	[England, Christopher G.; Frieboes, Hermann B.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA; [England, Christopher G.; Frieboes, Hermann B.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Huang, Justin S.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [James, Kurtis T.; Zhang, Guandong; Gobin, Andre M.; Frieboes, Hermann B.] Univ Louisville, Dept Bioengn, Louisville, KY 40292 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Frieboes, HB (corresponding author), Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA.	hbfrie01@louisville.edu			IPIBS fellowship at the University of Louisville (CGE); NIH (National Institutes of Health (US) [CA139050]; Department of Pharmacology and Toxicology; Department of Bioengineering; James Graham Brown Cancer Center at the University of Louisville; NATIONAL CANCER INSTITUTE [R00CA139050, K99CA139050] Funding Source: NIH RePORTER	IPIBS fellowship at the University of Louisville (CGE); NIH (National Institutes of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pharmacology and Toxicology; Department of Bioengineering; James Graham Brown Cancer Center at the University of Louisville; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge Dr. Lacey R. McNally (Dept. of Medicine) for helping to design and guide the in vivo experiments. We acknowledge the IPIBS fellowship at the University of Louisville (CGE), NIH (National Institutes of Health (US)) grant CA139050 (McNally via JSH), and the support from the Department of Pharmacology and Toxicology, the Department of Bioengineering and the James Graham Brown Cancer Center at the University of Louisville. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAXTER LT, 1989, MICROVASC RES, V37, P77, DOI 10.1016/0026-2862(89)90074-5; BAXTER LT, 1990, MICROVASC RES, V40, P246, DOI 10.1016/0026-2862(90)90023-K; Bootz A, 2004, EUR J PHARM BIOPHARM, V57, P369, DOI 10.1016/S0939-6411(03)00193-0; Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Costa PM, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.30; Darwiche K, 2013, INT J NANOMED, V8, P4533, DOI 10.2147/IJN.S54418; De Jong WH, 2008, BIOMATERIALS, V29, P1912, DOI 10.1016/j.biomaterials.2007.12.037; England CG, 2015, EUR J PHARM BIOPHARM, V92, P120, DOI 10.1016/j.ejpb.2015.02.017; England Christopher G, 2013, Int J Nanomedicine, V8, P3603, DOI 10.2147/IJN.S51668; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Frieboes HB, 2006, CANCER RES, V66, P1597, DOI 10.1158/0008-5472.CAN-05-3166; Frieboes HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056876; Gobin AM, 2007, NANO LETT, V7, P1929, DOI 10.1021/nl070610y; Goodman TT, 2007, INT J NANOMED, V2, P265; Grosges T, 2011, BIOMED OPT EXPRESS, V2, P1584, DOI 10.1364/BOE.2.001584; Guo CS, 2013, NANOSCALE, V5, P6469, DOI 10.1039/c3nr01025b; Guo Y, 2013, INT J NANOMED, V8, P3437, DOI 10.2147/IJN.S47585; Heindryckx F, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-219; Huang KY, 2012, ACS NANO, V6, P4483, DOI 10.1021/nn301282m; Huo SD, 2013, CANCER RES, V73, P319, DOI 10.1158/0008-5472.CAN-12-2071; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; Jeon SO, 2012, J MICROENCAPSUL, V29, P234, DOI 10.3109/02652048.2011.646327; Kempen PJ, 2013, MICROSC MICROANAL, V19, P1290, DOI 10.1017/S143192761300192X; Kitamura N, 2001, CLIN EXP METASTAS, V18, P561, DOI 10.1023/A:1011900818419; Li SD, 2009, BBA-BIOMEMBRANES, V1788, P2259, DOI 10.1016/j.bbamem.2009.06.022; Li YB, 2010, NANOMEDICINE-UK, V5, P1161, DOI 10.2217/NNM.10.85; Luo J, 2013, PLOS ONE, V8; MAYROVITZ HN, 1992, MICROVASC RES, V43, P46, DOI 10.1016/0026-2862(92)90005-A; McNally LR, 2010, CLIN EXP METASTAS, V27, P591, DOI 10.1007/s10585-010-9349-5; Patra CR, 2008, CANCER RES, V68, P1970, DOI 10.1158/0008-5472.CAN-07-6102; Pisal DS, 2010, THROMB HAEMOSTASIS, V104, P1073, DOI 10.1160/TH10-06-0422; Preston TC, 2009, ACS NANO, V3, P3696, DOI 10.1021/nn900883d; Raghunand N, 2003, BRIT J RADIOL, V76, pS11, DOI 10.1259/bjr/12913493; Sadauskas Evaldas, 2007, Part Fibre Toxicol, V4, P10, DOI 10.1186/1743-8977-4-10; Schellekens H, 2013, PHARM RES-DORDR, V30, P1729, DOI 10.1007/s11095-013-1067-7; Society AC, 2013, CANC FACTS FIG 2013; Stober W, 1968, J COLLOID INTERFACE, V21; Straubinger R M, 1993, J Natl Cancer Inst Monogr, P69; Takahashi H, 2006, LANGMUIR, V22, P2, DOI 10.1021/la0520029; Taruttis A, 2010, OPT EXPRESS, V18, P19592, DOI 10.1364/OE.18.019592; van de Ven AL, 2013, NEW J PHYS, V15, DOI [10.1088/1367-2630/15/10/105021, DOI 10.1088/1367-2630/15/10/105021]; van de Ven AL, 2012, AIP ADV, V2, DOI 10.1063/1.3699060; VOGEL W, 1995, LANGMUIR, V11, P401, DOI 10.1021/la00002a005; Wang H, 2011, BIOMATERIALS, V32, P2979, DOI 10.1016/j.biomaterials.2011.01.001; Wang J, 2011, NANOMEDICINE-UK, V6, P1605, DOI [10.2217/nnm.11.141, 10.2217/NNM.11.141]; Wang K, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-23; Weinkauf Heidi, 2009, Biotechnology Journal, V4, P871, DOI 10.1002/biot.200800358; Wu M, 2014, J THEOR BIOL, V355, P194, DOI 10.1016/j.jtbi.2014.04.012; Wu M, 2013, J THEOR BIOL, V320, P131, DOI 10.1016/j.jtbi.2012.11.031; Zarogoulidis P, 2013, FUTURE ONCOL, V9, P1171, DOI [10.2217/fon.13.67, 10.2217/FON.13.67]; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhang XM, 2011, INT J NANOMED, V6, P437, DOI 10.2147/IJN.S15997; Zhang ZH, 2010, SMALL, V6, P430, DOI 10.1002/smll.200901515; Zheng JW, 2011, METHODS MOL BIOL, V697, P93, DOI 10.1007/978-1-60327-198-1_9	55	27	27	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129172	10.1371/journal.pone.0129172	http://dx.doi.org/10.1371/journal.pone.0129172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046360	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200133
J	Newell-Fugate, AE; Taibl, JN; Alloosh, M; Sturek, M; Bahr, JM; Nowak, RA; Krisher, RL				Newell-Fugate, Annie E.; Taibl, Jessica N.; Alloosh, Mouhamad; Sturek, Michael; Bahr, Janice M.; Nowak, Romana A.; Krisher, Rebecca L.			Effects of Obesity and Metabolic Syndrome on Steroidogenesis and Folliculogenesis in the Female Ossabaw Mini-Pig	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; POLYCYSTIC-OVARY-SYNDROME; TYPE-2 DIABETES-MELLITUS; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; MINIATURE SWINE; ADIPOSE-TISSUE; OVERWEIGHT/OBESE WOMEN; DIFFERENT PROPENSITIES; ANDROGEN PRODUCTION	The discrete effects of obesity on infertility in females remain undefined to date. To investigate obesity-induced ovarian dysfunction, we characterized metabolic parameters, steroidogenesis, and folliculogenesis in obese and lean female Ossabaw mini-pigs. Nineteen nulliparous, sexually mature female Ossabaw pigs were fed a high fat/cholesterol/fructose diet (n=10) or a control diet (n=9) for eight months. After a three-month diet-induction period, pigs remained on their respective diets and had ovarian ultrasound and blood collection conducted during a five-month study period after which ovaries were collected for histology, cell culture, and gene transcript level analysis. Blood was assayed for steroid and protein hormones. Obese pigs developed abdominal obesity and metabolic syndrome, including hyperglycemia, hypertension, insulin resistance and dyslipidemia. Obese pigs had elongated estrous cycles and hyperandrogenemia with decreased LH, increased FSH and luteal phase progesterone, and increased numbers of medium, ovulatory, and cystic follicles. Theca cells of obese, compared to control, pigs displayed androstenedione hypersecretion in response to in vitro treatment with LH, and up-regulated 3-beta-hydroxysteroid dehydrogenase 1 and 17-beta-hydroxysteroid dehydrogenase 4 transcript levels in response to in vitro treatment with LH or LH + insulin. Granulosa cells of obese pigs had increased 3-beta-hydroxysteroid dehydrogenase 1 transcript levels. In summary, obese Ossabaw pigs have increased transcript levels and function of ovarian enzymes in the delta 4 steroidogenic pathway. Alterations in LH, FSH, and progesterone, coupled with theca cell dysfunction, contribute to the hyperandrogenemia and disrupted folliculogenesis patterns observed in obese pigs. The obese Ossabaw mini-pig is a useful animal model in which to study the effects of obesity and metabolic syndrome on ovarian function and steroidogenesis. Ultimately, this animal model may be useful toward the development of therapies to improve fertility in obese and/or hyperandrogenemic females or in which to examine the effects of obesity on the maternal-fetal environment and offspring health.	[Newell-Fugate, Annie E.; Taibl, Jessica N.; Bahr, Janice M.; Nowak, Romana A.; Krisher, Rebecca L.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Alloosh, Mouhamad; Sturek, Michael] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	University of Illinois System; University of Illinois Urbana-Champaign; Indiana University System; Indiana University Bloomington	Newell-Fugate, AE (corresponding author), Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA.	anewell-fugate@cvm.tamu.edu	Newell-Fugate, Anne/AAD-5499-2019; Sturek, Michael/CAH-2948-2022	Newell-Fugate, Anne/0000-0002-1878-5892; 	National Institutes of Health [R21 HD060105, K01 OD011177]; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060105] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K01RR031274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK097512] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD011177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health R21 HD060105 and K01 OD011177 (www.nih.gov). The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUIDE CARE USE LAB A; BAHR JM, 1983, BIOL REPROD, V29, P326, DOI 10.1095/biolreprod29.2.326; Bellinger DA, 2006, ILAR J, V47, P243, DOI 10.1093/ilar.47.3.243; Blouin K, 2003, J CLIN ENDOCR METAB, V88, P5944, DOI 10.1210/jc.2003-030535; Blouin K, 2009, MOL CELL ENDOCRINOL, V301, P97, DOI 10.1016/j.mce.2008.10.035; Boots C, 2011, SEMIN REPROD MED, V29, P507, DOI 10.1055/s-0031-1293204; CARA JF, 1994, HORM RES, V42, P49, DOI 10.1159/000184145; Castillo-Martinez L, 2003, NUTRITION, V19, P317, DOI 10.1016/S0899-9007(02)00998-X; Chavarro JE, 2007, OBSTET GYNECOL, V110, P1050, DOI 10.1097/01.AOG.0000287293.25465.e1; CONLEY AJ, 1994, BIOL REPROD, V51, P655, DOI 10.1095/biolreprod51.4.655; Dechaud H, 2006, EUR J OBSTET GYN R B, V127, P88, DOI 10.1016/j.ejogrb.2005.12.009; Diamanti-Kandarakis E, 2001, Obes Rev, V2, P231, DOI 10.1046/j.1467-789X.2001.00041.x; Douchi T, 2002, ACTA OBSTET GYN SCAN, V81, P147, DOI 10.1034/j.1600-0412.2002.810210.x; DUBEY AK, 1985, BIOL REPROD, V33, P423, DOI 10.1095/biolreprod33.2.423; Dyson MC, 2006, COMPARATIVE MED, V56, P35; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Edwards JM, 2010, CARDIOVASC RES, V85, P631, DOI 10.1093/cvr/cvp308; Eisner JR, 2002, FERTIL STERIL, V77, P167, DOI 10.1016/S0015-0282(01)02947-8; Esinler I, 2008, REPROD BIOMED ONLINE, V17, P583, DOI 10.1016/S1472-6483(10)60249-0; ETHERTON TD, 1980, GROWTH, V44, P182; ETHERTON TD, 1980, LIPIDS, V15, P823, DOI 10.1007/BF02534372; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Jungheim ES, 2010, AM J OBSTET GYNECOL, V203, P525, DOI 10.1016/j.ajog.2010.06.043; Knox R, 2009, Soc Reprod Fertil Suppl, V66, P199; Knox RV, 2005, DOMEST ANIM ENDOCRIN, V29, P385, DOI 10.1016/j.domaniend.2005.02.025; Kreutz RP, 2011, DIABET METAB SYND OB, V4, P99, DOI 10.2147/DMSO.S17105; Lado-Abeal J, 1998, J CLIN ENDOCR METAB, V83, P3083, DOI 10.1210/jc.83.9.3083; Lee L, 2009, HEPATOLOGY, V50, P56, DOI 10.1002/hep.22904; Lindheim SR, 2000, FERTIL STERIL, V73, P493, DOI 10.1016/S0015-0282(99)00578-6; Lloyd PG, 2006, FASEB J, V20, pA299; MCNATTY KP, 1979, J CLIN ENDOCR METAB, V49, P851, DOI 10.1210/jcem-49-6-851; Moran L, 2011, AUST NZ J OBSTET GYN, V51, P455, DOI 10.1111/j.1479-828X.2011.01343.x; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Newell-Fugate AE, 2014, COMPARATIVE MED, V64, P44; Norman RJ, 2004, HUM REPROD UPDATE, V10, P267, DOI 10.1093/humupd/dmh018; Otis CR, 2003, COMPARATIVE MED, V53, P53; PANEPINTO LM, 1983, LAB ANIM SCI, V33, P95; Rainey WE, 2002, TRENDS ENDOCRIN MET, V13, P234, DOI 10.1016/S1043-2760(02)00609-4; Rondanelli M, 2014, ARCH GYNECOL OBSTET, V290, P1079, DOI 10.1007/s00404-014-3433-z; Rosenfield RL, 2010, BRAIN RES, V1364, P186, DOI 10.1016/j.brainres.2010.08.088; San Millan JL, 2004, J CLIN ENDOCR METAB, V89, P2640, DOI 10.1210/jc.2003-031252; SELBY C, 1990, ANN CLIN BIOCHEM, V27, P532, DOI 10.1177/000456329002700603; Silva JRV, 2009, THERIOGENOLOGY, V71, P1193, DOI 10.1016/j.theriogenology.2008.12.015; Sivalingam VN, 2014, HUM REPROD UPDATE, V20, P853, DOI 10.1093/humupd/dmu037; Spandorfer SD, 2004, J REPROD MED, V49, P973; Spurlock ME, 2008, J NUTR, V138, P397, DOI 10.1093/jn/138.2.397; Srivastava RK, 2011, MOL CELL ENDOCRINOL, V337, P24, DOI 10.1016/j.mce.2011.01.017; Sturek M, 2007, SWINE LAB SURG ANEST, P397; Van Laere AS, 2003, NATURE, V425, P832, DOI 10.1038/nature02064; van Swieten ECAM, 2005, GYNECOL OBSTET INVES, V59, P220, DOI 10.1159/000084347; Varga O, 2010, OBES REV, V11, P792, DOI 10.1111/j.1467-789X.2009.00667.x; Welsh Michael J, 2009, Trans Am Clin Climatol Assoc, V120, P149; WIESAK T, 1990, J REPROD FERTIL, V89, P633, DOI 10.1530/jrf.0.0890633; Young JM, 2010, REPRODUCTION, V140, P489, DOI 10.1530/REP-10-0094; Zhang D, 2010, GYNECOL ENDOCRINOL, V26, P325, DOI 10.3109/09513591003632100; Ziecik AJ, 2001, SEMIN REPROD MED, V19, P19, DOI 10.1055/s-2001-13907	56	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128749	10.1371/journal.pone.0128749	http://dx.doi.org/10.1371/journal.pone.0128749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046837	gold, Green Published			2022-12-26	WOS:000355652200097
J	Ran, Y; Ladd, GZ; Ceballos-Diaz, C; Jung, JI; Greenbaum, D; Felsenstein, KM; Golde, TE				Ran, Yong; Ladd, Gabriela Z.; Ceballos-Diaz, Carolina; Jung, Joo In; Greenbaum, Doron; Felsenstein, Kevin M.; Golde, Todd E.			Differential Inhibition of Signal Peptide Peptidase Family Members by Established gamma-Secretase Inhibitors	PLOS ONE			English	Article							VIRUS CORE PROTEIN; AMYLOID PRECURSOR PROTEIN; INTRAMEMBRANE PROTEOLYSIS; B-CELL; ENDOPLASMIC-RETICULUM; TRANSMEMBRANE DOMAIN; TRANSFERRIN RECEPTOR; PRESENILIN HOMOLOGS; ASPARTIC PROTEASE; INVARIANT CHAIN	The signal peptide peptidases (SPPs) are biomedically important proteases implicated as therapeutic targets for hepatitis C (human SPP, (hSPP)), plasmodium (Plasmodium SPP (pSPP)), and B-cell immunomodulation and neoplasia (signal peptide peptidase like 2a, (SPPL2a)). To date, no drug-like, selective inhibitors have been reported. We use a recombinant substrate based on the amino-terminus of BRI2 fused to amyloid beta 1-25 (A beta(1-25)) (FBA) to develop facile, cost-effective SPP/SPPL protease assays. Co-transfection of expression plasmids expressing the FBA substrate with SPP/SPPLs were conducted to evaluate cleavage, which was monitored by ELISA, Western Blot and immunoprecipitation/MALDI-TOF Mass spectrometry (IP/MS). No cleavage is detected in the absence of SPP/SPPL overexpression. Multiple gamma-secretase inhibitors (GSIs) and (Z-LL)(2) ketone differentially inhibited SPP/SPPL activity; for example, IC50 of LY-411,575 varied from 51 +/- 79 nM (on SPPL2a) to 5499 +/- 122 nM (on SPPL2b), while Compound E showed inhibition only on hSPP with IC50 of 1465 +/- 93 nM. Data generated were predictive of effects observed for endogenous SPPL2a cleavage of CD74 in a murine B-Cell line. Thus, it is possible to differentially inhibit SPP family members. These SPP/SPPL cleavage assays will expedite the search for selective inhibitors. The data also reinforce similarities between SPP family member cleavage and cleavage catalyzed by gamma-secretase.	[Ran, Yong; Ceballos-Diaz, Carolina; Jung, Joo In; Felsenstein, Kevin M.; Golde, Todd E.] Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA; [Ladd, Gabriela Z.] Univ Florida, Coll Pharm, Gainesville, FL 32610 USA; [Greenbaum, Doron] Pennsylvania Drug Discovery Inst, Philadelphia, PA USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ran, Y (corresponding author), Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32610 USA.	yran@ufl.edu; tgolde@ufl.edu			National Institutes of Healt [AG20206]; National Cancer Institute [CA166009]; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020206] Funding Source: NIH RePORTER	National Institutes of Healt(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health (http://www.nih.gov/) grants to TEG (AG20206) and National Cancer Institute CA166009 (http://www.cancer.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisner DR, 2013, J EXP MED, V210, P23, DOI 10.1084/jem.20121072; Bergmann H, 2013, J EXP MED, V210, P31, DOI 10.1084/jem.20121076; Casso DJ, 2005, GENETICS, V170, P139, DOI 10.1534/genetics.104.039933; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; De Strooper B, 2010, NAT REV NEUROL, V6, P99, DOI 10.1038/nrneurol.2009.218; Dev KK, 2006, EUR J PHARMACOL, V540, P10, DOI 10.1016/j.ejphar.2006.04.011; El Hage F, 2008, P NATL ACAD SCI USA, V105, P10119, DOI 10.1073/pnas.0802753105; Fluhrer R, 2006, NAT CELL BIOL, V8, P894, DOI 10.1038/ncb1450; Fluhrer R, 2012, J BIOL CHEM, V287, P5156, DOI 10.1074/jbc.M111.328104; Friedmann E, 2006, NAT CELL BIOL, V8, P843, DOI 10.1038/ncb1440; Golde TE, 2013, BBA-BIOMEMBRANES, V1828, P2898, DOI 10.1016/j.bbamem.2013.06.005; Golde Todd E, 2003, Sci STKE, V2003, pRE4, DOI 10.1126/stke.2003.172.re4; Golde TE, 2009, SEMIN CELL DEV BIOL, V20, P225, DOI 10.1016/j.semcdb.2009.02.003; Grigorenko AP, 2004, P NATL ACAD SCI USA, V101, P14955, DOI 10.1073/pnas.0406462101; Grigorenko AP, 2002, BIOCHEMISTRY-MOSCOW+, V67, P826, DOI 10.1023/A:1016365227942; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Harbut MB, 2012, P NATL ACAD SCI USA, V109, P21486, DOI 10.1073/pnas.1216016110; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510; Jonas MC, 2010, J CELL SCI, V123, P3378, DOI 10.1242/jcs.068841; Kaup M, 2002, J BIOL CHEM, V277, P38494, DOI 10.1074/jbc.M203461200; Kirkin V, 2007, CELL DEATH DIFFER, V14, P1678, DOI 10.1038/sj.cdd.4402175; Krawitz P, 2005, J BIOL CHEM, V280, P39515, DOI 10.1074/jbc.M501645200; Lemberg MK, 2002, MOL CELL, V10, P735, DOI 10.1016/S1097-2765(02)00655-X; Lemberg MK, 2001, J IMMUNOL, V167, P6441, DOI 10.4049/jimmunol.167.11.6441; Li XC, 2013, NATURE, V493, P56, DOI 10.1038/nature11801; Li XR, 2009, BIOCHEM BIOPH RES CO, V380, P454, DOI 10.1016/j.bbrc.2009.01.083; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Marapana DS, 2012, TRAFFIC, V13, P1457, DOI 10.1111/j.1600-0854.2012.01402.x; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Meyer EL, 2003, J BIOL CHEM, V278, P23786, DOI 10.1074/jbc.M301360200; Mitani Y, 2012, J NEUROSCI, V32, P2037, DOI 10.1523/JNEUROSCI.4264-11.2012; Nakahara S, 2006, FASEB J, V20, P2451, DOI 10.1096/fj.05-5066com; Nyborg AC, 2004, J BIOL CHEM, V279, P43148, DOI 10.1074/jbc.M405879200; Nyborg AC, 2004, J BIOL CHEM, V279, P15153, DOI 10.1074/jbc.M309305200; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-16; Nyborg AC, 2006, FASEB J, V20, P1671, DOI 10.1096/fj.06-5762com; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Parvanova I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005078; Pehar M, 2012, J BIOL CHEM, V287, P29921, DOI 10.1074/jbc.M112.363911; Ponting CP, 2002, HUM MOL GENET, V11, P1037, DOI 10.1093/hmg/11.9.1037; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Robakis T, 2008, J BIOL CHEM, V283, P36369, DOI 10.1074/jbc.M807527200; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2006, BIOCHEMISTRY-US, V45, P8649, DOI 10.1021/bi060597g; Schneppenheim J, 2014, MOL CELL BIOL, V34, P1398, DOI 10.1128/MCB.00038-14; Schneppenheim J, 2013, J EXP MED, V210, P41, DOI 10.1084/jem.20121069; SHIH YJ, 1990, J BIOL CHEM, V265, P19077; Steiner H, 2008, J BIOL CHEM, V283, P29627, DOI 10.1074/jbc.R800010200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Targett-Adams P, 2008, J BIOL CHEM, V283, P16850, DOI 10.1074/jbc.M802273200; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Voss M, 2012, J BIOL CHEM, V287, P43401, DOI 10.1074/jbc.M112.371369; Weihofen A, 2003, J BIOL CHEM, V278, P16528, DOI 10.1074/jbc.M301372200; Weihofen A, 2003, TRENDS CELL BIOL, V13, P71, DOI 10.1016/S0962-8924(02)00041-7; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 2004, SCIENCE, V305, P1119, DOI 10.1126/science.1096187; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Zahn C, 2013, FEBS J, V280, P1653, DOI 10.1111/febs.12176	62	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128619	10.1371/journal.pone.0128619	http://dx.doi.org/10.1371/journal.pone.0128619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046535	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200084
J	Tomar, S; Johnston, ML; John, SES; Osswald, HL; Nyalapatla, PR; Paul, LN; Ghosh, AK; Denison, MR; Mesecar, AD				Tomar, Sakshi; Johnston, Melanie L.; John, Sarah E. St.; Osswald, Heather L.; Nyalapatla, Prasanth R.; Paul, Lake N.; Ghosh, Arun K.; Denison, Mark R.; Mesecar, Andrew D.			Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CL(pro)) IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS-CORONAVIRUS; MAIN PROTEASE; 3C-LIKE PROTEASE; BIOLOGICAL EVALUATION; CATALYTIC-ACTIVITY; DIFFRACTION DATA; DIMER INTERFACE; DESIGN; INHIBITORS; MECHANISM	All coronaviruses, including the recently emerged Middle East respiratory syndrome coronavirus (MERS-CoV) from the beta-CoV subgroup, require the proteolytic activity of the nsp5 protease (also known as 3C-like protease, 3CL(pro)) during virus replication, making it a high value target for the development of anti-coronavirus therapeutics. Kinetic studies indicate that in contrast to 3CL(pro) from other beta-CoV 2c members, including HKU4 and HKU5, MERS-CoV 3CL(pro) is less efficient at processing a peptide substrate due to MERS-CoV 3CL(pro) being a weakly associated dimer. Conversely, HKU4, HKU5, and SARS-CoV 3CL(pro) enzymes are tightly associated dimers. Analytical ultracentrifugation studies support that MERS-CoV 3CL(pro) is a weakly associated dimer (K-d similar to 52 mu M) with a slow off-rate. Peptidomimetic inhibitors of MERS-CoV 3CL(pro) were synthesized and utilized in analytical ultracentrifugation experiments and demonstrate that MERS-CoV 3CL(pro) undergoes significant ligand-induced dimerization. Kinetic studies also revealed that designed reversible inhibitors act as activators at a low compound concentration as a result of induced dimerization. Primary sequence comparisons and x-ray structural analyses of two MERS-CoV 3CL(pro) and inhibitor complexes, determined to 1.6 angstrom, reveal remarkable structural similarity of the dimer interface with 3CL(pro) from HKU4-CoV and HKU5-CoV. Despite this structural similarity, substantial differences in the dimerization ability suggest that long range interactions by the nonconserved amino acids distant from the dimer interface may control MERS-CoV 3CL(pro) dimerization. Activation of MERS-CoV 3CL(pro) through ligand-induced dimerization appears to be unique within the genogroup 2c and may potentially increase the complexity in the development of MERS-CoV 3CL(pro) inhibitors as antiviral agents.	[Tomar, Sakshi; John, Sarah E. St.; Mesecar, Andrew D.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Johnston, Melanie L.; Osswald, Heather L.; Nyalapatla, Prasanth R.; Ghosh, Arun K.; Mesecar, Andrew D.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA; [Paul, Lake N.] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Denison, Mark R.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA; [Denison, Mark R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Vanderbilt University; Vanderbilt University	Mesecar, AD (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	amesecar@purdue.edu	Tomar, Sakshi/H-3283-2018; Tomar, Sakshi/AAL-6766-2020; Nyalapatla, Prasanth Reddy/Q-1111-2019; Regan, Clinton/E-6250-2012; Denison, Mark R/O-7258-2018	Tomar, Sakshi/0000-0001-5994-4178; Tomar, Sakshi/0000-0001-5994-4178; Denison, Mark R/0000-0003-2655-0900; Mesecar, Andrew/0000-0002-1241-2577; St. John, Sarah/0000-0001-6564-7081; Nyalapatla, Prasanth Reddy/0000-0003-1048-5841	National Institutes of Health [P30 CA023168]; United States Department of Energy [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor Grant [085P1000817]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI026603, R01AI026603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Crystallization and DNA sequencing were partially supported by the Purdue Center for Cancer Research Macromolecular Crystallography and DNA Sequencing Shared Resources, which are partially supported by National Institutes of Health Grant P30 CA023168. We acknowledge the LS-CAT and LRL-CAT beam line staff for their help in acquiring x-ray data. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy Office of Science by Argonne National Laboratory, was supported by the United States Department of Energy under Contract DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corp. and the Michigan Technology Tri-Corridor Grant 085P1000817. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Co., which operates the facility. We thank Yahira Baez-Santos, Dia Beachboard and Sergey Savinov for their helpful suggestions during manuscript preparation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agnihothram S, 2014, MBIO, V5, DOI 10.1128/mBio.00047-14; ALENIUS S, 1991, ACTA VET SCAND, V32, P163; Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Assiri A, 2013, NEW ENGL J MED, V369, P407, DOI 10.1056/NEJMoa1306742; Baez-Santos YM, 2014, J MED CHEM, V57, P2393, DOI 10.1021/jm401712t; BARBER DML, 1985, VET REC, V117, P459, DOI 10.1136/vr.117.18.459; Barrila J, 2006, BIOCHEMISTRY-US, V45, P14908, DOI 10.1021/bi0616302; Blanchard JE, 2004, CHEM BIOL, V11, P1445, DOI 10.1016/j.chembiol.2004.08.011; Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Butler D, 2012, NATURE, V492, P166, DOI 10.1038/492166a; Cauchemez S, 2013, EUROSURVEILLANCE, V18, P18; CAVALLARO JJ, 1970, J INFECT DIS, V122, P272, DOI 10.1093/infdis/122.4.272; Centers for Disease Control, 2014, MERS IN THE US; Chan JFW, 2012, J INFECTION, V65, P477, DOI 10.1016/j.jinf.2012.10.002; Chen S, 2008, J BIOCHEM, V143, P525, DOI 10.1093/jb/mvm246; Chen S, 2010, PROTEIN CELL, V1, P59, DOI 10.1007/s13238-010-0011-4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cheng SC, 2010, BIOPHYS J, V98, P1327, DOI 10.1016/j.bpj.2009.12.4272; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Cotten M, 2013, LANCET, V382, P1993, DOI 10.1016/S0140-6736(13)61887-5; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui LJ, 2011, ADV VIROL, V2011, DOI 10.1155/2011/129134; DeLano W. L., 2002, PYMOL MOL GRAPHICS S, DOI 10.1038/hr.2014.17; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan KQ, 2004, J BIOL CHEM, V279, P1637, DOI 10.1074/jbc.M310875200; Ghosh AK, 2005, J MED CHEM, V48, P6767, DOI 10.1021/JM050548m; Ghosh AK, 2008, BIOORG MED CHEM LETT, V18, P5684, DOI 10.1016/j.bmcl.2008.08.082; Ghosh AK, 2007, BIOORG MED CHEM LETT, V17, P5876, DOI 10.1016/j.bmcl.2007.08.031; Grum-Tokars V, 2008, VIRUS RES, V133, P63, DOI 10.1016/j.virusres.2007.02.015; HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Jacobs J, 2013, J MED CHEM, V56, P534, DOI 10.1021/jm301580n; Kaeppler U, 2005, J MED CHEM, V48, P6832, DOI 10.1021/jm0501782; Lai LH, 2006, CURR PHARM DESIGN, V12, P4555, DOI 10.2174/138161206779010396; Lai MMC, 1997, ADV VIRUS RES, V48, P1, DOI 10.1016/S0065-3527(08)60286-9; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; Li CM, 2010, J BIOL CHEM, V285, P28134, DOI 10.1074/jbc.M109.095851; Lim LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101941; LU YQ, 1995, J VIROL, V69, P3554, DOI 10.1128/JVI.69.6.3554-3559.1995; MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268; Memish ZA, 2013, EMERG INFECT DIS, V19, P1819, DOI 10.3201/eid1911.131172; Myers DP, 2001, BIOCHEMISTRY-US, V40, P13230, DOI 10.1021/bi0155908; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perera RA, 2013, EUROSURVEILLANCE, V18, P8, DOI 10.2807/1560-7917.ES2013.18.36.20574; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shen Y, 2006, MOL CELL, V22, P807, DOI 10.1016/j.molcel.2006.04.026; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Shi JH, 2008, J VIROL, V82, P4620, DOI 10.1128/JVI.02680-07; Shi JH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001084; Stobart CC, 2012, J VIROL, V86, P4801, DOI 10.1128/JVI.06754-11; Turlington M, 2013, BIOORG MED CHEM LETT, V23, P6172, DOI 10.1016/j.bmcl.2013.08.112; van Boheemen S, 2012, MBIO, V3, DOI 10.1128/mBio.00473-12; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; World Health Organization, 2014, MIDDL E RESP SYNDR C; Wu CG, 2013, ACTA CRYSTALLOGR D, V69, P747, DOI 10.1107/S0907444913001315; Yang HT, 2006, CURR PHARM DESIGN, V12, P4573, DOI 10.2174/138161206779010369; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Ziebuhr J, 2000, J GEN VIROL, V81, P853, DOI 10.1099/0022-1317-81-4-853	65	88	94	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 7	2015	290	32					19403	19422		10.1074/jbc.M115.651463	http://dx.doi.org/10.1074/jbc.M115.651463			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CO7TL	26055715	hybrid, Green Published			2022-12-26	WOS:000359364600002
J	Ozawa, R; Fujii, K; Kouzaki, M				Ozawa, Ryosuke; Fujii, Keisuke; Kouzaki, Motoki			The Return Trip Is Felt Longer Only Postdictively: A Psychophysiological Study of the Return Trip Effect	PLOS ONE			English	Article							SPECTRAL-ANALYSIS; TIME PERCEPTION; R-R; DURATIONS; JUDGMENT	The return trip often seems shorter than the outward trip even when the distance and actual time are identical. To date, studies on the return trip effect have failed to confirm its existence in a situation that is ecologically valid in terms of environment and duration. In addition, physiological influences as part of fundamental timing mechanisms in daily activities have not been investigated in the time perception literature. The present study compared round-trip and non-round-trip conditions in an ecological situation. Time estimation in real time and postdictive estimation were used to clarify the situations where the return trip effect occurs. Autonomic nervous system activity was evaluated from the electrocardiogram using the Lorenz plot to demonstrate the relationship between time perception and physiological indices. The results suggest that the return trip effect is caused only postdictively. Electrocardiographic analysis revealed that the two experimental conditions induced different responses in the autonomic nervous system, particularly in sympathetic nervous function, and that parasympathetic function correlated with postdictive timing. To account for the main findings, the discrepancy between the two time estimates is discussed in the light of timing strategies, i.e., prospective and retrospective timing, which reflect different emphasis on attention and memory processes. Also each timing method, i.e., the verbal estimation, production or comparative judgment, has different characteristics such as the quantification of duration in time units or knowledge of the target duration, which may be responsible for the discrepancy. The relationship between postdictive time estimation and the parasympathetic nervous system is also discussed.	[Ozawa, Ryosuke; Fujii, Keisuke; Kouzaki, Motoki] Kyoto Univ, Grad Sch Human & Environm Studies, Neurophysiol Lab, Kyoto, Japan; [Fujii, Keisuke] Japan Soc Promot Sci, Tokyo, Japan	Kyoto University; Japan Society for the Promotion of Science	Kouzaki, M (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Neurophysiol Lab, Kyoto, Japan.	kouzaki.motoki.4x@kyoto-u.ac.jp						Bar-Haim Y, 2010, COGNITION EMOTION, V24, P255, DOI 10.1080/02699930903387603; Bisson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033049; BLOCK RA, 1982, J EXP PSYCHOL LEARN, V8, P530, DOI 10.1037/0278-7393.8.6.530; Bos MGN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062661; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; BURT CDB, 1994, APPL COGNITIVE PSYCH, V8, P155, DOI 10.1002/acp.2350080206; Camm AJ, 1996, EUR HEART J, V17, P354; Coelho M, 2004, J INT NEUROPSYCH SOC, V10, P332, DOI 10.1017/S1355617704103019; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Glicksohn J, 2001, CONSCIOUS COGN, V10, P1, DOI 10.1006/ccog.2000.0468; HILL AB, 1985, BRIT J PSYCHOL, V76, P235, DOI 10.1111/j.2044-8295.1985.tb01947.x; Joulia TJF, 2004, AVIAT SPACE ENVIR MD, V75, P876; Kubota Y, 2001, COGNITIVE BRAIN RES, V11, P281, DOI 10.1016/S0926-6410(00)00086-0; LEDIETT V, 1972, PERCEPT MOTOR SKILL, V34, P759, DOI 10.2466/pms.1972.34.3.759; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Meissner K, 2011, BIOL PSYCHOL, V86, P289, DOI 10.1016/j.biopsycho.2011.01.001; PAGANI M, 1989, J HYPERTENS, V7, pS14, DOI 10.1097/00004872-198900076-00004; POYNTER WD, 1983, MEM COGNITION, V11, P77, DOI 10.3758/BF03197664; Rau PLP, 2006, CYBERPSYCHOL BEHAV, V9, P396, DOI 10.1089/cpb.2006.9.396; Roy MM, 2008, J EXP PSYCHOL-APPL, V14, P266, DOI 10.1037/1076-898X.14.3.266; Roy MM, 2013, Q J EXP PSYCHOL, V66, P121, DOI 10.1080/17470218.2012.699973; Seno T, 2011, PERCEPTION, V40, P497, DOI 10.1068/p6885; Smith Anne-Louise, 2006, Australasian Physical & Engineering Sciences in Medicine, V29, P97; Tobin S, 2012, MEM COGNITION, V40, P1339, DOI 10.3758/s13421-012-0231-3; Tobin S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009271; Tobin S, 2009, COMPUT HUM BEHAV, V25, P554, DOI 10.1016/j.chb.2008.12.002; Toichi M, 1999, INT J PSYCHOPHYSIOL, V31, P147, DOI 10.1016/S0167-8760(98)00047-6; Toichi M, 1997, J AUTONOM NERV SYST, V62, P79, DOI 10.1016/S0165-1838(96)00112-9; van de Ven N, 2011, PSYCHON B REV, V18, P827, DOI 10.3758/s13423-011-0150-5; VERCRUYSSEN M, 1989, Journal of Human Ergology, V18, P169; Wearden JH, 2008, LANG LEARN, V58, P149, DOI 10.1111/j.1467-9922.2008.00468.x; WEARDEN JH, 1995, Q J EXP PSYCHOL-B, V48, P129; YAMAMOTO Y, 1991, J APPL PHYSIOL, V71, P1143, DOI 10.1152/jappl.1991.71.3.1143; Zakay D, 2012, PSYCHOLOGIST, V25, P578	35	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127779	10.1371/journal.pone.0127779	http://dx.doi.org/10.1371/journal.pone.0127779			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26061138	Green Published, gold			2022-12-26	WOS:000355979500057
J	Carneiro, RGD; Pacheco, P; Isaias, RMD				da Silva Carneiro, Rene Gonalves; Pacheco, Priscilla; dos Santos Isaias, Rosy Mary			Could the Extended Phenotype Extend to the Cellular and Subcellular Levels in Insect-Induced Galls?	PLOS ONE			English	Article							ARABINOGALACTAN-PROTEINS; HEMIPTERA PSYLLOIDEA; WALLS; PECTIN; ANATOMY; RICH; ONTOGENY; BIOLOGY; TISSUES; MATRIX	Neo-ontogenesis of plant galls involves redifferentiation of host plant tissues to express new phenotypes, when new cell properties are established via structural-functional remodeling. Herein, Psidium cattleianum leaves and Nothotrioza cattleiani galls are analyzed by developmental anatomy, cytometry and immunocytochemistry of cell walls. We address hypothesis- driven questions concerning the organogenesis of globoid galls in the association of P. cattleianum -N. cattleianum, and P. myrtoides -N. myrtoidis. These double co-generic systems represent good models for comparing final gall shapes and cell lineages functionalities under the perspective of convergent plant-dependent or divergent insect-induced characteristics. Gall induction, and growth and development are similar in both galls, but homologous cell lineages exhibit divergent degrees of cell hypertrophy and directions of elongation. Median cortical cells in P. cattleianum galls hypertrophy the most, while in P. myrtoides galls there is a centrifugal gradient of cell hypertrophy. Cortical cells in P. cattleianum galls tend to anisotropy, while P. myrtoidis galls have isotropically hypertrophied cells. Immunocytochemistry evidences the chemical identity and functional traits of cell lineages: epidermal cells walls have homogalacturonans (HGAs) and galactans, which confer rigidity to sites of enhanced cell division; oil gland cell walls have arabinogalactan proteins (AGPs) that help avoiding cell death; and parenchyma cell walls have HGAs, galactans and arabinans, which confer porosity. Variations in such chemical identities are related to specific sites of hypertrophy. Even though the double co-generic models have the same macroscopic phenotype, the globoid morphotype, current analyses indicate that the extended phenotype of N. cattleiani is substantiated by cellular and subcellular specificities.	[da Silva Carneiro, Rene Gonalves; Pacheco, Priscilla; dos Santos Isaias, Rosy Mary] Univ Fed Minas Gerais, Inst Ciencias Biol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais	Isaias, RMD (corresponding author), Inst Ciencias Biol, Dept Bot, Bloco I2,165 Belo Horizonte, BR-165 Belo Horizonte, MG, Brazil.	rosy@icb.ufmg.br	Carneiro, Renê G. S./B-6216-2014; Isaias, Rosy MS/C-3736-2013	Carneiro, Renê G. S./0000-0002-4766-3851; Isaias, Rosy MS/0000-0001-8500-3320	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [307007/2012-2]; Empresa Brasileira de Pesquisa Agropecuaria [02.12.01.028.00.00]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Empresa Brasileira de Pesquisa Agropecuaria(Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA))	RGSC received scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (BR - www.capes.gov.br). PP received scholarship from Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (BR - www.fapemig.br). RMSI received funding from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (BR - www.cnpq.br) (grant number 307007/2012-2). RGSC, PP and RMSI had financial support from Empresa Brasileira de Pesquisa Agropecuaria (BR - www.embrapa.br) (grant number 02.12.01.028.00.00). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albersheim P, 2011, PLANT CELL WALLS: FROM CHEMISTRY TO BIOLOGY, P1; Arduim, 1997, MANUAL BASICO METODO; ARDUIN M, 1991, Revista Brasileira de Botanica, V14, P147; ARDUIN M, 1989, Revista Brasileira de Biologia, V49, P817; Arduin M., 1995, B BOT U SAO PAULO, V14, P109, DOI [10.11606/issn.2316-9052.v14i0p109-130, DOI 10.11606/ISSN.2316-9052.V14I0P109-130]; Bailey R, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000179; Baskin TI, 2005, ANNU REV CELL DEV BI, V21, P203, DOI 10.1146/annurev.cellbio.20.082503.103053; Bedetti CS, 2014, BIOCHEM SYST ECOL, V55, P53, DOI 10.1016/j.bse.2014.02.016; BUKATSCH F, 1972, Mikrokosmos, V61, P255; Burckhardt D, 2005, BIOL ECOLOGY EVOLUTI; Butignol C. A., 2003, Rev. Bras. entomol., V47, P1, DOI 10.1590/S0085-56262003000100001; Buvat R., 1989, ONTOGENY CELL DIFFER, DOI [10.1007/978-3-642-73635-3, DOI 10.1007/978-3-642-73635-3]; Carneiro RGS, 2014, S AFR J BOT, V92, P97, DOI 10.1016/j.sajb.2014.02.011; Carneiro RGS, 2014, PLANT CELL REP, V33, P2093, DOI 10.1007/s00299-014-1683-7; Carneiro RGS, 2013, ZOOTAXA, V3620, P129, DOI 10.11646/zootaxa.3620.1.6; Cassab GI, 1998, ANNU REV PLANT PHYS, V49, P281, DOI 10.1146/annurev.arplant.49.1.281; Chaves I, 2002, PHYSIOL PLANTARUM, V116, P548, DOI 10.1034/j.1399-3054.2002.1160414.x; Clausen MH, 2004, PLANTA, V219, P1036, DOI 10.1007/s00425-004-1309-3; Moura MZD, 2008, AUST J BOT, V56, P153, DOI 10.1071/BT07131; Moura MZD, 2009, BIOCHEM SYST ECOL, V37, P541, DOI 10.1016/j.bse.2009.08.007; Dawkins R., 1982, pi; de Oliveira DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094588; Dias GG, 2013, AN ACAD BRAS CIENC, V85, P187, DOI 10.1590/S0001-37652013000100010; Isaias RMD, 2011, BOTANY, V89, P581, DOI [10.1139/B11-048, 10.1139/b11-048]; Ferreira BG, 2013, BOTANY, V91, P752, DOI 10.1139/cjb-2013-0125; Formiga A. T., 2011, American Journal of Plant Sciences, V2, P823, DOI 10.4236/ajps.2011.26097; Formiga AT, 2013, PROTOPLASMA, V250, P899, DOI 10.1007/s00709-012-0473-8; Foster TJ, 1996, BIOPOLYMERS, V39, P51, DOI 10.1002/(SICI)1097-0282(199607)39:1<51::AID-BIP6>3.3.CO;2-7; Goncalves SJMR, 2005, TROP ZOOL, V18, P161, DOI 10.1080/03946975.2005.10531219; Guan Y, 2004, PLANT PHYSIOL, V135, P1346, DOI 10.1104/pp.104.039370; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hara N., 1957, BOT MAG TOKYO, V70, P108, DOI [10.1007/s00709-014-0673-5, DOI 10.1007/S00709-014-0673-5]; Hori K., 1992, P157; Isaias RMS, 2013, NEOTROP ENTOMOL, V42, P230, DOI 10.1007/s13744-013-0115-7; Isaias RMS., 2014, NEOTROPICAL INSECT G, P15, DOI [10.1007/978-94-017-8783-3_2, DOI 10.1007/978-94-017-8783-3_2]; JOHANSEN DONALD ALEXANDER, 1940; Jones L, 1997, PLANT PHYSIOL, V113, P1405, DOI 10.1104/pp.113.4.1405; KNOX JP, 1990, PLANTA, V181, P512, DOI 10.1007/BF00193004; KRISHNAN HB, 1988, AM J BOT, V75, P369, DOI 10.2307/2443984; Leroux O, 2011, ANN BOT-LONDON, V108, P307, DOI 10.1093/aob/mcr161; Lev-Yadun S., 2003, Current Topics in Plant Biology, Volume 4, P93; Magalhaes TA, 2014, PROTOPLASMA, V251, P747, DOI 10.1007/s00709-013-0574-z; Mastroberti Alexandra Antunes, 2008, Braz. J. Bot., V31, P1, DOI 10.1590/S0100-84042008000100002; McCartney L, 2002, J EXP BOT, V53, P707, DOI 10.1093/jexbot/53.369.707; McCartney L, 2000, PLANT J, V22, P105, DOI 10.1046/j.1365-313x.2000.00719.x; Meyer J., 1983, ANATOMIE DES GALLES; Meyer J., 1987, PLANT GALLS GALL IND; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; OBrien TP, 1981, STUDY PLANT STRUCTUR; Oliveira DC, 2010, S AFR J BOT, V76, P239, DOI 10.1016/j.sajb.2009.10.011; Oliveira D.C., 2008, REV BIOL NEOTROP, V5, P31, DOI [10.5216/rbn.v5i1.5625, DOI 10.5216/RBN.V5I1.5625]; Oliveira DC, 2014, NEOTROPICAL INSECT G, P35; Oliveira DC, 2010, PROTOPLASMA, V242, P81, DOI 10.1007/s00709-010-0128-6; PRICE PW, 1987, ENVIRON ENTOMOL, V16, P15, DOI 10.1093/ee/16.1.15; QI XY, 1995, PLANT PHYSIOL, V108, P1691, DOI 10.1104/pp.108.4.1691; Rohfritsch O., 1992, P60; Sabba RP, 2005, J AM SOC HORTIC SCI, V130, P936, DOI 10.21273/JASHS.130.6.936; SMALLWOOD M, 1995, PLANTA, V196, P510, DOI 10.1007/BF00203651; Smallwood M, 1996, PLANTA, V198, P452, DOI 10.1007/BF00620063; STERN DL, 1995, P ROY SOC B-BIOL SCI, V260, P85, DOI 10.1098/rspb.1995.0063; Stone GN, 2003, TRENDS ECOL EVOL, V18, P512, DOI 10.1016/S0169-5347(03)00247-7; SWORDS KMM, 1993, PLANT PHYSIOL, V102, P891, DOI 10.1104/pp.102.3.891; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P79, DOI 10.4161/psb.2.2.4176; VANDENBOSCH KA, 1989, EMBO J, V8, P335, DOI 10.1002/j.1460-2075.1989.tb03382.x; Verhertbruggen Y, 2009, CARBOHYD RES, V344, P1858, DOI 10.1016/j.carres.2008.11.010; WEIS AE, 1986, AM NAT, V127, P681, DOI 10.1086/284513; Willats WGT, 2001, PLANT MOL BIOL, V47, P9, DOI 10.1023/A:1010662911148; Willats WGT, 2000, CARBOHYD RES, V327, P309, DOI 10.1016/S0008-6215(00)00039-2; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022992; Zebelo SA, 2015, J EXP BOT, V66, P435, DOI 10.1093/jxb/eru480; Zeiss C, 2008, C ZEISS IMAGING SYST	72	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129331	10.1371/journal.pone.0129331	http://dx.doi.org/10.1371/journal.pone.0129331			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053863	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300120
J	Opala-Berdzik, A; Blaszczyk, JW; Bacik, B; Cieslinska-Swider, J; Swider, D; Sobota, G; Markiewicz, A				Opala-Berdzik, Agnieszka; Blaszczyk, Janusz W.; Bacik, Bogdan; Cieslinska-Swider, Joanna; Swider, Dariusz; Sobota, Grzegorz; Markiewicz, Andrzej			Static Postural Stability in Women during and after Pregnancy: A Prospective Longitudinal Study	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; PRESSURE MEASURES; BALANCE; PEOPLE; STANCE; FALLS; PAIN	This longitudinal study aimed to compare static postural stability in women between early pregnancy, advanced pregnancy, and at 2 and 6 months postpartum. Forty-five pregnant women were enrolled and 31 completed the protocol. Data were collected at 7-16 and 34-39 weeks gestation, and at 6-10 and 26-30 weeks postpartum. For each subject, the center of foot pressure path length and mean velocity (with directional subcomponents) were computed from 30-s long quiet-standing trials on a stationary force plate with eyes open or closed. The body mass, stance width, and sleep duration within 24 h before testing were also recorded. Static postural stability was not different between pregnancy and postpartum, except for the anterior posterior sway tested in the eyes-closed condition, which was significantly increased in late pregnancy compared to that at 2 and 6 months postpartum. Pregnant/postpartum women's body mass weakly positively correlated with anterior-posterior sway in the eyes-closed condition and their stance width weakly positively correlated with the anterior-posterior sway in the eyes-open condition. No effect of sleep duration on postural sway was found. Our findings indicate that under visual deprivation conditions women in advanced pregnancy may have decreased static stability compared to their nonpregnant state.	[Opala-Berdzik, Agnieszka; Markiewicz, Andrzej] Acad Phys Educ, Dept Physiotherapy Internal Dis, Katowice, Poland; [Blaszczyk, Janusz W.; Bacik, Bogdan; Sobota, Grzegorz] Acad Phys Educ, Dept Human Motor Behav, Katowice, Poland; [Blaszczyk, Janusz W.] Polish Acad Sci, M Nencki Inst Expt Biol, Warsaw, Poland; [Cieslinska-Swider, Joanna] Acad Phys Educ, Dept Physiotherapy Nervous & Locomotor Syst, Katowice, Poland; [Swider, Dariusz] Silesian Tech Univ, Inst Comp Sci, Gliwice, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Silesian University of Technology	Opala-Berdzik, A (corresponding author), Acad Phys Educ, Dept Physiotherapy Internal Dis, Katowice, Poland.	a.opala-berdzik@awf.katowice.pl	Cieślińska-Świder, Joanna/P-5512-2016; Blaszczyk, Janusz/N-8452-2013; Opala-Berdzik, Agnieszka/X-1794-2018; Błaszczyk, Janusz/AAK-4465-2021; Sobota, Grzegorz/W-1150-2018	Cieślińska-Świder, Joanna/0000-0003-1477-8641; Blaszczyk, Janusz/0000-0003-1073-9629; Opala-Berdzik, Agnieszka/0000-0002-2051-0185; Sobota, Grzegorz/0000-0002-8281-0431; Bacik, Bogdan/0000-0002-9894-3474	Polish Ministry of Science and Higher Education [2 P05D 052 27]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This study was funded by a Polish Ministry of Science and Higher Education grant 2 P05D 052 27. The funding was received by AM.	Baratto L, 2002, MOTOR CONTROL, V6, P246, DOI 10.1123/mcj.6.3.246; Butler EE, 2006, AM J OBSTET GYNECOL, V195, P1104, DOI 10.1016/j.ajog.2006.06.015; Dunning K, 2010, MATERN CHILD HLTH J, V14, P720, DOI 10.1007/s10995-009-0511-0; Gilleard WL, 2002, ARCH PHYS MED REHAB, V83, P1739, DOI 10.1053/apmr.2002.36069; Jang J, 2008, CLIN BIOMECH, V23, P468, DOI 10.1016/j.clinbiomech.2007.11.011; Jensen RK, 1996, J BIOMECH, V29, P251, DOI 10.1016/0021-9290(95)00042-9; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Ma J, 2009, J INT MED RES, V37, P1311, DOI 10.1177/147323000903700506; Marnach ML, 2003, OBSTET GYNECOL, V101, P331, DOI 10.1016/S0029-7844(02)02447-X; McCrory JL, 2010, J BIOMECH, V43, P2434, DOI 10.1016/j.jbiomech.2009.09.058; McCrory JL, 2010, BJOG-INT J OBSTET GY, V117, P954, DOI 10.1111/j.1471-0528.2010.02589.x; Mens JMA, 2009, OBSTET GYNECOL SURV, V64, P200, DOI 10.1097/OGX.0b013e3181950f1b; Nagai M, 2009, NEUROSCI LETT, V462, P130, DOI 10.1016/j.neulet.2009.06.091; Nyska M, 1997, ISRAEL J MED SCI, V33, P139; Oliveira LF, 2009, EUR J OBSTET GYN R B, V147, P25, DOI 10.1016/j.ejogrb.2009.06.027; Opala-Berdzik A, 2010, J HUM KINET, V26, P5, DOI 10.2478/v10078-010-0042-1; PEARLMAN MD, 1990, AM J OBSTET GYNECOL, V162, P1502, DOI 10.1016/0002-9378(90)90913-R; Pinsault N, 2009, MED ENG PHYS, V31, P276, DOI 10.1016/j.medengphy.2008.08.003; Pollock AS, 2000, CLIN REHABIL, V14, P402, DOI 10.1191/0269215500cr342oa; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Salavati M, 2009, GAIT POSTURE, V29, P460, DOI 10.1016/j.gaitpost.2008.11.016; Schiff MA, 2008, BJOG-INT J OBSTET GY, V115, P1648, DOI 10.1111/j.1471-0528.2008.01905.x; Slomka K, 2013, GAIT POSTURE, V37, P210, DOI 10.1016/j.gaitpost.2012.07.005; Swift CG, 2001, BRIT MED J, V322, P855, DOI 10.1136/bmj.322.7290.855; Vollestad NK, 2012, MANUAL THER, V17, P225, DOI 10.1016/j.math.2012.01.003; Whitcome KK, 2007, NATURE, V450, P1075, DOI 10.1038/nature06342; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	27	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0124207	10.1371/journal.pone.0124207	http://dx.doi.org/10.1371/journal.pone.0124207			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053046	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300007
J	Wang, S; Dong, RJ; Liu, DX; Wang, Y; Liu, B; Zhang, L; Xu, L				Wang, Shuo; Dong, Ruijuan; Liu, Dongxin; Wang, Yuan; Liu, Bo; Zhang, Luo; Xu, Li			The Role of Temporal Envelope and Fine Structure in Mandarin Lexical Tone Perception in Auditory Neuropathy Spectrum Disorder	PLOS ONE			English	Article							COCHLEAR HEARING-LOSS; SPEECH-PERCEPTION; STRUCTURE INFORMATION; FREQUENCY-SELECTIVITY; PITCH DISCRIMINATION; GAP DETECTION; INDIVIDUALS; CHILDREN; ABILITY; IMPLANTATION	Temporal information in a signal can be partitioned into temporal envelope (E) and fine structure (FS). Fine structure is important for lexical tone perception for normal-hearing (NH) listeners, and listeners with sensorineural hearing loss (SNHL) have an impaired ability to use FS in lexical tone perception due to the reduced frequency resolution. The present study was aimed to assess which of the acoustic aspects (E or FS) played a more important role in lexical tone perception in subjects with auditory neuropathy spectrum disorder (ANSD) and to determine whether it was the deficit in temporal resolution or frequency resolution that might lead to more detrimental effects on FS processing in pitch perception. Fifty-eight native Mandarin Chinese-speaking subjects (27 with ANSD, 16 with SNHL, and 15 with NH) were assessed for (1) their ability to recognize lexical tones using acoustic E or FS cues with the "auditory chimera" technique, (2) temporal resolution as measured with temporal gap detection (TGD) threshold, and (3) frequency resolution as measured with the Q(10dB) values of the psychophysical tuning curves. Overall, 26.5%, 60.2%, and 92.1% of lexical tone responses were consistent with FS cues for tone perception for listeners with ANSD, SNHL, and NH, respectively. The mean TGD threshold was significantly higher for listeners with ANSD (11.9 ms) than for SNHL (4.0 ms; p < 0.001) and NH (3.9 ms; p < 0.001) listeners, with no significant difference between SNHL and NH listeners. In contrast, the mean Q10dB for listeners with SNHL (1.8 +/- 0.4) was significantly lower than that for ANSD (3.5 +/- 1.0; p < 0.001) and NH (3.4 +/- 0.9; p < 0.001) listeners, with no significant difference between ANSD and NH listeners. These results suggest that reduced temporal resolution, as opposed to reduced frequency selectivity, in ANSD subjects leads to greater degradation of FS processing for pitch perception.	[Wang, Shuo; Dong, Ruijuan; Liu, Dongxin; Wang, Yuan; Liu, Bo; Zhang, Luo] Capital Med Univ, Beijing Inst Otolaryngol, Beijing Tongren Hosp, Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Xu, Li] Ohio Univ, Sch Rehabil & Commun Sci, Athens, OH 45701 USA	Capital Medical University; University System of Ohio; Ohio University	Zhang, L (corresponding author), Capital Med Univ, Beijing Inst Otolaryngol, Beijing Tongren Hosp, Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	dr.luozhang@gmail.com; xul@ohio.edu	Xu, Li/C-5908-2008	Xu, Li/0000-0002-0988-7934; Zhang, Luo/0000-0002-0910-9884	National Natural Science Foundation of China [81200754]; Beijing Nova Program [Z121107002512033]; Beijing Natural Science Foundation [7122034]; Capital Health Research and Development of Special from Beijing Municipal Health Bureau [2011-1017-04]; Basic-Clinical Cooperative Research Foundation of Capital Medical University [12JL46]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Capital Health Research and Development of Special from Beijing Municipal Health Bureau; Basic-Clinical Cooperative Research Foundation of Capital Medical University	This work was funded in part by grants from the National Natural Science Foundation of China (81200754), the 2012 Beijing Nova Program (Z121107002512033), Beijing Natural Science Foundation (7122034), the Capital Health Research and Development of Special from the Beijing Municipal Health Bureau (2011-1017-04), and the Basic-Clinical Cooperative Research Foundation of Capital Medical University (12JL46). The authors declare no competing financial interests in the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apoux F, 2013, ADV EXP MED BIOL, V787, P119, DOI 10.1007/978-1-4614-1590-9_14; Berlin CI, 2003, MENT RETARD DEV D R, V9, P225, DOI 10.1002/mrdd.10084; Bernstein JGW, 2006, J ACOUST SOC AM, V120, P3929, DOI 10.1121/1.2372452; GLASBERG BR, 1992, HEARING RES, V64, P81, DOI 10.1016/0378-5955(92)90170-R; GLASBERG BR, 1987, J ACOUST SOC AM, V81, P1546, DOI 10.1121/1.394507; GREENWOOD DD, 1990, J ACOUST SOC AM, V87, P2592, DOI 10.1121/1.399052; HARRISON RV, 1979, ARCH OTO-RHINO-LARYN, V224, P71, DOI 10.1007/BF00455226; Heinz MG, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P621, DOI 10.1007/978-1-4419-5686-6_56; Heinz MG, 2009, JARO-J ASSOC RES OTO, V10, P407, DOI 10.1007/s10162-009-0169-8; Henry KS, 2012, NAT NEUROSCI, V15, P1362, DOI 10.1038/nn.3216; Hopkins K, 2008, J ACOUST SOC AM, V123, P1140, DOI 10.1121/1.2824018; Hopkins K, 2007, J ACOUST SOC AM, V122, P1055, DOI 10.1121/1.2749457; Hopkins K, 2010, J ACOUST SOC AM, V127, P1595, DOI 10.1121/1.3293003; Hopkins K, 2009, J ACOUST SOC AM, V125, P442, DOI 10.1121/1.3037233; Humphriss R, 2013, INT J AUDIOL, V52, P442, DOI 10.3109/14992027.2013.786190; Kale S, 2010, JARO-J ASSOC RES OTO, V11, P657, DOI 10.1007/s10162-010-0223-6; Kong YY, 2006, J ACOUST SOC AM, V120, P2830, DOI 10.1121/1.2346009; Kumar UA, 2006, INT J AUDIOL, V45, P360, DOI 10.1080/14992020600624893; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LIN MC, 1988, ZHONGGUO YUWEN, V3, P182; Lorenzi C, 2006, P NATL ACAD SCI USA, V103, P18866, DOI 10.1073/pnas.0607364103; Lorenzi C, 2009, J ACOUST SOC AM, V125, P27, DOI 10.1121/1.2939125; Mason JC, 2003, LARYNGOSCOPE, V113, P45, DOI 10.1097/00005537-200301000-00009; Miller RL, 1997, J ACOUST SOC AM, V101, P3602, DOI 10.1121/1.418321; MOORE BCJ, 1992, J ACOUST SOC AM, V91, P2881, DOI 10.1121/1.402925; Moore BCJ, 1996, J ACOUST SOC AM, V100, P481, DOI 10.1121/1.415861; MOORE BCJ, 1988, J ACOUST SOC AM, V83, P1093, DOI 10.1121/1.396054; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; Moore BCJ, 2006, HEARING RES, V222, P16, DOI 10.1016/j.heares.2006.08.007; Narne VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055995; Narne VK, 2009, INT J AUDIOL, V48, P700, DOI 10.1080/14992020902931574; Narne VK, 2009, EAR HEARING, V30, P136, DOI 10.1097/AUD.0b013e3181926545; Nelson PB, 1997, J SPEECH LANG HEAR R, V40, P1387, DOI 10.1044/jslhr.4006.1387; Nikolopoulos TP, 2014, INT J PEDIATR OTORHI, V78, P171, DOI 10.1016/j.ijporl.2013.12.021; Peterson Ann, 2003, J Am Acad Audiol, V14, P188; Rance G, 2004, EAR HEARING, V25, P34, DOI 10.1097/01.AUD.0000111259.59690.B8; Rance G, 2008, OTOL NEUROTOL, V29, P179, DOI 10.1097/mao.0b013e31815e92fd; Sek A, 2011, INT J AUDIOL, V50, P237, DOI 10.3109/14992027.2010.550636; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Strelcyk O, 2009, J ACOUST SOC AM, V125, P3328, DOI 10.1121/1.3097469; TURNER CW, 1995, J ACOUST SOC AM, V97, P2568, DOI 10.1121/1.411911; Turner CW, 1999, J SPEECH LANG HEAR R, V42, P773, DOI 10.1044/jslhr.4204.773; Vinay, 2007, INT J AUDIOL, V46, P39, DOI 10.1080/14992020601077992; Wang S, 2011, JARO-J ASSOC RES OTO, V12, P783, DOI 10.1007/s10162-011-0285-0; Xu L, 2003, J ACOUST SOC AM, V114, P3024, DOI 10.1121/1.1623786; Xu L, 2002, J ACOUST SOC AM, V112, P247, DOI 10.1121/1.1487843; Zeng FG, 2006, J SPEECH LANG HEAR R, V49, P367, DOI 10.1044/1092-4388(2006/029); Zeng FG, 2005, J NEUROPHYSIOL, V93, P3050, DOI 10.1152/jn.00985.2004; Zeng FG, 1999, NEUROREPORT, V10, P3429, DOI 10.1097/00001756-199911080-00031; Zhong ZW, 2014, HEARING RES, V309, P55, DOI 10.1016/j.heares.2013.11.006	51	7	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129710	10.1371/journal.pone.0129710	http://dx.doi.org/10.1371/journal.pone.0129710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052707	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300160
J	Kwiatkowski, F; Arbre, M; Bidet, Y; Laquet, C; Uhrhammer, N; Bignon, YJ				Kwiatkowski, Fabrice; Arbre, Marie; Bidet, Yannick; Laquet, Claire; Uhrhammer, Nancy; Bignon, Yves-Jean			BRCA Mutations Increase Fertility in Families at Hereditary Breast/Ovarian Cancer Risk	PLOS ONE			English	Article							BREAST-CANCER; CARRIER PROBABILITIES; FEMALE FERTILITY; EARLY-ONSET; POPULATION; SUSCEPTIBILITY; PREGNANCY; DISEASE; GENES; AGE	Background Deleterious mutations in the BRCA genes are responsible for a small, but significant, proportion of breast and ovarian cancers (5 - 10 %). Proof of de novo mutations in hereditary breast/ovarian cancer (HBOC) families is rare, in contrast to founder mutations, thousands of years old, that may be carried by as much as 1% of a population. Thus, if mutations favoring cancer survive selection pressure through time, they must provide advantages that compensate for the loss of life expectancy. Method This hypothesis was tested within 2,150 HBOC families encompassing 96,325 individuals. Parameters included counts of breast/ovarian cancer, age at diagnosis, male breast cancer and other cancer locations. As expected, well-known clinical parameters discriminated between BRCA-mutated families and others: young age at breast cancer, ovarian cancer, pancreatic cancer and male breast cancer. The major fertility differences concerned men in BRCA-mutated families: they had lower first and mean age at paternity, and fewer remained childless. For women in BRCA families, the miscarriage rate was lower. In a logistic regression including clinical factors, the different miscarriage rate and men's mean age at paternity remained significant. Results Fertility advantages were confirmed in a subgroup of 746 BRCA mutation carriers and 483 non-carriers from BRCA mutated families. In particular, female carriers were less often nulliparous (9.1 % of carriers versus 16.0 %, p = 0.003) and had more children (1.8 +/- 1.4 SD versus 1.5 +/- 1.3, p = 0.002) as well as male carriers (1.7 +/- 1.3 versus 1.4 +/- 1.3, p = 0.024). Conclusion Although BRCA mutations shorten the reproductive period due to cancer mortality, they compensate by improving fertility both in male and female carriers.	[Kwiatkowski, Fabrice; Arbre, Marie; Laquet, Claire; Uhrhammer, Nancy; Bignon, Yves-Jean] Ctr Jean Perrin, Oncol Mol Lab, F-63011 Clermont Ferrand, France; [Kwiatkowski, Fabrice] Univ Clermont Ferrand, Math Lab, CNRS, UMR 6620, F-63171 Aubiere, France; [Bidet, Yannick; Bignon, Yves-Jean] Univ Auvergne, Univ Clermont Auvergne, F-63000 Clermont Ferrand, France	UNICANCER; Centre Jean Perrin; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite Clermont Auvergne (UCA); Universite Clermont Auvergne (UCA)	Kwiatkowski, F (corresponding author), Ctr Jean Perrin, Oncol Mol Lab, F-63011 Clermont Ferrand, France.	Fabrice.Kwiatkowski@CJP.fr	Bidet, Yannick/O-5753-2019; , bignon/Y-3243-2019	Bidet, Yannick/0000-0002-9624-8195; 	Centre Jean Perrin	Centre Jean Perrin	This study received no external funding. This research was totally financed by Centre Jean Perrin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas S, 2012, BREAST CANCER RES TR, V133, P347, DOI 10.1007/s10549-012-1958-z; Bonaiti B, 2011, B CANCER, V98, P779, DOI 10.1684/bdc.2011.1397; Buss L, 2006, ACTA OBSTET GYN SCAN, V85, P467, DOI 10.1080/00016340500494887; Caputo S, 2012, NUCLEIC ACIDS RES, V40, pD992, DOI 10.1093/nar/gkr1160; Diez O, 2010, BREAST CANCER RES TR, V121, P221, DOI 10.1007/s10549-009-0494-y; Eisinger F, 2004, B CANCER, V91, P219; Fischer C, 2013, J MED GENET, V50, P360, DOI 10.1136/jmedgenet-2012-101415; Friedman E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1387; Harboe TL, 2009, FAM CANCER, V8, P413, DOI 10.1007/s10689-009-9257-5; Hinkula M, 2002, INT J CANCER, V98, P912, DOI 10.1002/ijc.10267; Im KM, 2011, HUM GENET, V130, P685, DOI 10.1007/s00439-011-1003-z; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Kwiatkowski F, 2000, B CANCER, V87, P715; Laraqui A, 2013, INT J MED SCI, V10, P60, DOI 10.7150/ijms.5014; Lawn JE, 2011, LANCET, V377, P1448, DOI 10.1016/S0140-6736(10)62187-3; LAYDE PM, 1989, J CLIN EPIDEMIOL, V42, P963, DOI 10.1016/0895-4356(89)90161-3; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Moslehi R, 2010, AM J HUM BIOL, V22, P201, DOI 10.1002/ajhb.20978; Oktay K, 2010, J CLIN ONCOL, V28, P240, DOI 10.1200/JCO.2009.24.2057; Pal T, 2010, FERTIL STERIL, V93, P1805, DOI 10.1016/j.fertnstert.2008.12.052; Parmigiani G, 1998, AM J HUM GENET, V62, P145, DOI 10.1086/301670; Plon SE, 2005, CANCER J, V11, P255, DOI 10.1097/00130404-200507000-00002; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Russo J, 2000, J Natl Cancer Inst Monogr, P17; Smith KR, 2012, P ROY SOC B-BIOL SCI, V279, P1389, DOI 10.1098/rspb.2011.1697; Tyrer J, 2004, STAT MED, V23, P1111, DOI 10.1002/sim.1668; van der Luijt RB, 2001, J MED GENET, V38, P102, DOI 10.1136/jmg.38.2.102; Zinaman MJ, 1996, FERTIL STERIL, V65, P503, DOI 10.1016/S0015-0282(16)58144-8	28	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127363	10.1371/journal.pone.0127363	http://dx.doi.org/10.1371/journal.pone.0127363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047126	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200019
J	Warsi, J; Hosseinzadeh, Z; Elvira, B; Pelzl, L; Shumilina, E; Zhang, DE; Lang, KS; Lang, PA; Lang, F				Warsi, Jamshed; Hosseinzadeh, Zohreh; Elvira, Bernat; Pelzl, Lisann; Shumilina, Ekaterina; Zhang, Dong-Er; Lang, Karl S.; Lang, Philipp A.; Lang, Florian			USP18 Sensitivity of Peptide Transporters PEPT1 and PEPT2	PLOS ONE			English	Article							NF-KAPPA-B; UP-REGULATION; UBP43 USP18; OLIGOPEPTIDE TRANSPORTER; DOWN-REGULATION; KINASE; GROWTH; CELLS; ISG15; DRUG	USP18 (Ubiquitin-like specific protease 18) is an enzyme cleaving ubiquitin from target proteins. USP18 plays a pivotal role in antiviral and antibacterial immune responses. On the other hand, ubiquitination participates in the regulation of several ion channels and transporters. USP18 sensitivity of transporters has, however, never been reported. The present study thus explored, whether USP18 modifies the activity of the peptide transporters PEPT1 and PEPT2, and whether the peptide transporters are sensitive to the ubiquitin ligase Nedd4-2. To this end, cRNA encoding PEPT1 or PEPT2 was injected into Xenopus laevis oocytes without or with additional injection of cRNA encoding USP18. Electrogenic peptide (glycine-glycine) transport was determined by dual electrode voltage clamp. As a result, in Xenopus laevis oocytes injected with cRNA encoding PEPT1 or PEPT2, but not in oocytes injected with water or with USP18 alone, application of the dipeptide gly-gly (2 mM) was followed by the appearance of an inward current (Igly-gly). Coexpression of USP18 significantly increased Igly-gly in both PEPT1 and PEPT2 expressing oocytes. Kinetic analysis revealed that coexpression of USP18 increased maximal Igly-gly. Conversely, overexpression of the ubiquitin ligase Nedd4-2 decreased Igly-gly. Coexpression of USP30 similarly increased Igly-gly in PEPT1 expressing oocytes. In conclusion, USP18 sensitive cellular functions include activity of the peptide transporters PEPT1 and PEPT2.	[Warsi, Jamshed; Hosseinzadeh, Zohreh; Elvira, Bernat; Pelzl, Lisann; Shumilina, Ekaterina; Lang, Florian] Univ Tubingen, Dept Physiol 1, Tubingen, Germany; [Zhang, Dong-Er] Univ Calif San Diego, Moores UCSD Canc Ctr, Dept Pathol, La Jolla, CA 92093 USA; [Zhang, Dong-Er] Univ Calif San Diego, Moores UCSD Canc Ctr, Div Biol Sci, La Jolla, CA 92093 USA; [Lang, Karl S.] Univ Duisburg Essen, Fac Med, Inst Immunol, Essen, Germany; [Lang, Philipp A.] Univ Duesseldorf, Dept Mol Med 2, Dusseldorf, Germany	Eberhard Karls University of Tubingen; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Duisburg Essen	Lang, F (corresponding author), Univ Tubingen, Dept Physiol 1, Tubingen, Germany.	florian.lang@uni-tuebingen.de	Hosseinzadeh, Zohreh/X-8548-2019; Lang, Karl S/R-2505-2016; Elvira, Bernat/A-2404-2017	Hosseinzadeh, Zohreh/0000-0003-3407-7754; Lang, Karl/0000-0001-9783-7605; Elvira, Bernat/0000-0003-0434-2238	Deutsche Forschungsgemeinschaft [GRK 1302, SFB 773 B4/A1, La 315/13-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft (URL: http://www.dfg.de/): GRK 1302, SFB 773 B4/A1, La 315/13-3. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Ali T, 2009, GENE, V439, P35, DOI 10.1016/j.gene.2009.02.021; Almilaji A, 2014, KIDNEY BLOOD PRESS R, V39, P516, DOI 10.1159/000368462; Alteheld B, 2005, J NUTR, V135, P19, DOI 10.1093/jn/135.1.19; Ayyadurai S, 2013, LAB INVEST, V93, P888, DOI 10.1038/labinvest.2013.77; Baines Deborah, 2013, Curr Mol Pharmacol, V6, P50; Boehmer C, 2008, CELL PHYSIOL BIOCHEM, V22, P705, DOI 10.1159/000185554; Bongiorno D, 2011, CHANNELS, V5, P79, DOI 10.4161/chan.5.1.13967; Brandsch M, 2009, EXPERT OPIN DRUG MET, V5, P887, DOI 10.1517/17425250903042292; Burkart C, 2013, EMBO MOL MED, V5, P1035, DOI 10.1002/emmm.201201864; Burkart C, 2012, J BIOL CHEM, V287, P4883, DOI 10.1074/jbc.M111.255570; Cunningham CN, 2015, NAT CELL BIOL, V17, P160, DOI 10.1038/ncb3097; Dauphinee SM, 2014, GENES IMMUN, V15, P282, DOI 10.1038/gene.2014.17; Duex JE, 2011, J BIOL CHEM, V286, P25377, DOI 10.1074/jbc.M111.222760; Duex JE, 2009, MOL BIOL CELL, V20, P1833, DOI 10.1091/mbc.E08-08-0880; Eaton Douglas C, 2010, Proc Am Thorac Soc, V7, P54, DOI 10.1513/pats.200909-096JS; Elvira B, 2014, KIDNEY BLOOD PRESS R, V39, P353, DOI 10.1159/000355812; Fezai M, 2014, KIDNEY BLOOD PRESS R, V39, P546, DOI 10.1159/000368465; Francois-Newton V, 2012, BIOCHEM J, V446, P509, DOI 10.1042/BJ20120541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Gonzalez DE, 1998, CANCER RES, V58, P519; Hong BX, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-132; Honke N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003650; Hosseinzadeh Z, 2013, CELL PHYSIOL BIOCHEM, V31, P673, DOI 10.1159/000350086; Ingersoll SA, 2012, AM J PHYSIOL-GASTR L, V302, pG484, DOI 10.1152/ajpgi.00477.2011; Inoue M, 2005, CANCER LETT, V230, P72, DOI 10.1016/j.canlet.2004.12.023; Kamal MA, 2008, DRUG METAB PHARMACOK, V23, P236, DOI 10.2133/dmpk.23.236; Kim JH, 2008, J IMMUNOL, V181, P6467, DOI 10.4049/jimmunol.181.9.6467; Kim YH, 2014, J KOREAN MED SCI, V29, P351, DOI 10.3346/jkms.2014.29.3.351; Laedermann Cedric J, 2014, Handb Exp Pharmacol, V221, P231, DOI 10.1007/978-3-642-41588-3_11; Lang F, 2012, CELL CALCIUM, V52, P347, DOI 10.1016/j.ceca.2012.05.005; Liu XK, 2013, J EXP MED, V210, P1575, DOI 10.1084/jem.20122327; Makki MS, 2013, EXP CELL RES, V319, P612, DOI 10.1016/j.yexcr.2012.12.021; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Malhotra S, 2013, EUR J NEUROL, V20, P1390, DOI 10.1111/ene.12193; Manini I, 2013, CANCER BIOL THER, V14, P1158, DOI 10.4161/cbt.26525; Meredith D, 2009, PHILOS T R SOC B, V364, P203, DOI 10.1098/rstb.2008.0139; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Mitsuoka K, 2010, EUR J PHARM SCI, V40, P202, DOI 10.1016/j.ejps.2010.03.010; Munoz C, 2014, CELL PHYSIOL BIOCHEM, V33, P491, DOI 10.1159/000358629; Murray EJ, 2011, ANTIMICROB AGENTS CH, V55, P4311, DOI 10.1128/AAC.00644-11; Nakamura Tsutomu, 2008, Current Drug Delivery, V5, P153, DOI 10.2174/156720108784911749; Newstead S, 2011, BIOCHEM SOC T, V39, P1353, DOI 10.1042/BST0391353; Pakladok T, 2013, CELL PHYSIOL BIOCHEM, V31, P785, DOI 10.1159/000350096; Pieri M, 2010, AM J PHYSIOL-GASTR L, V299, pG136, DOI 10.1152/ajpgi.00014.2010; Potu H, 2010, CANCER RES, V70, P655, DOI 10.1158/0008-5472.CAN-09-1942; Rexhepaj R, 2010, CELL PHYSIOL BIOCHEM, V26, P641, DOI 10.1159/000322331; Rexhepaj R, 2010, CELL PHYSIOL BIOCHEM, V25, P715, DOI 10.1159/000315091; Richer E, 2011, GENES IMMUN, V12, P531, DOI 10.1038/gene.2011.38; Ritchie KJ, 2004, NAT MED, V10, P1374, DOI 10.1038/nm1133; Rotin D, 2011, PFLUG ARCH EUR J PHY, V461, P1, DOI 10.1007/s00424-010-0893-2; Rubio-Aliaga I, 2008, XENOBIOTICA, V38, P1022, DOI [10.1080/00498250701875254, 10.1080/00498250701875254 ]; Santin I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.158; Sarasin-Filipowicz M, 2009, MOL CELL BIOL, V29, P4841, DOI 10.1128/MCB.00224-09; Schwer H, 2000, GENOMICS, V65, P44, DOI 10.1006/geno.2000.6148; Snyder PM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.279pe41; Soundararajan R, 2012, CRIT REV BIOCHEM MOL, V47, P349, DOI 10.3109/10409238.2012.678285; Stokes A, 2006, CELL SIGNAL, V18, P1584, DOI 10.1016/j.cellsig.2005.12.009; Strutz-Seebohm N, 2013, CELL PHYSIOL BIOCHEM, V31, P968, DOI 10.1159/000350115; Sun DL, 2013, MOL PHARMACEUT, V10, P1409, DOI 10.1021/mp300700p; Tai W, 2012, MOL PHARM; Terada T, 2012, CURR TOP MEMBR, V70, P257, DOI 10.1016/B978-0-12-394316-3.00008-9; Tsume Y, 2008, MOL PHARMACEUT, V5, P717, DOI 10.1021/mp800008c; Warsi J, 2014, KIDNEY BLOOD PRESS R, V39, P591, DOI 10.1159/000368469; Warsi J, 2014, KIDNEY BLOOD PRESS R, V39, P378, DOI 10.1159/000355816; Warsi J, 2014, KIDNEY BLOOD PRESS R, V39, P388, DOI 10.1159/000368451; Xu DQ, 2012, VIRUS RES, V169, P264, DOI 10.1016/j.virusres.2012.07.002; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yang XD, 2002, PHARMACEUT RES, V19, P825, DOI 10.1023/A:1016132200104; Yarandi SS, 2011, NUTRITION, V27, P269, DOI 10.1016/j.nut.2010.07.004	69	6	8	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129365	10.1371/journal.pone.0129365	http://dx.doi.org/10.1371/journal.pone.0129365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046984	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200158
J	Cavalheri, H; Both, C; Martins, M				Cavalheri, Hamanda; Both, Camila; Martins, Marcio			The Interplay between Environmental Filtering and Spatial Processes in Structuring Communities: The Case of Neotropical Snake Communities	PLOS ONE			English	Article							PHYLOGENETIC STRUCTURE; ASSEMBLY PATTERNS; MORPHOLOGY; DIVERSITY; EVOLUTIONARY; SIMILARITY; FRAMEWORK; GRADIENT; ECOLOGY; LIZARDS	Both habitat filters and spatial processes can influence community structure. Space alone affects species immigration from the regional species pool, whereas habitat filters affect species distribution and inter-specific interactions. This study aimed to understand how the interplay between environmental and geographical processes influenced the structure of Neotropical snake communities in different habitat types. We selected six studies that sampled snakes in forests, four conducted in savannas and two in grasslands (the latter two are grouped in a non-forest category). We used the net relatedness and nearest taxon indices to assess phylogenetic structure within forest and non-forest areas. We also used the phylogenetic fuzzy-weighting algorithm to characterize phylogenetic structure across communities and the relation of phylogenetic composition patterns to habitat type, structure, and latitude. Finally, we tested for morphological trait convergence and phylogenetic niche conservatism using four forest and four non-forest areas for which morphological data were available. Community phylogenetic composition changed across forest and non-forest areas suggesting that environmental filtering influences community structure. Species traits were affected by habitat type, indicating convergence at the metacommunity level. Tail length, robustness, and number of ventral scales maximized community convergence among forest and non-forest areas. The observed patterns suggested environmental filtering, indicating that less vertically structured habitats represent a strong filter. Despite the fact that phylogenetic structure was not detected individually for each community, we observed a trend towards communities composed by more closely related species in higher latitudes and more overdispersed compositions in lower latitudes. Such pattern suggests that the limited distribution of major snake lineages constrained species distributions. Structure indices for each community were also related to habitat type, showing that communities from non-forest areas tend to be more clustered. Our study showed that both environmental filtering and spatial gradients play important roles in shaping the composition of Neotropical snake communities.	[Cavalheri, Hamanda; Martins, Marcio] Univ Sao Paulo, Inst Biociencias, Dept Ecol, BR-05508090 Sao Paulo, SP, Brazil; [Both, Camila] Univ Fed Santa Maria, Programa Posgrad Biodiversidade Anim, BR-97105900 Santa Maria, RS, Brazil	Universidade de Sao Paulo; Universidade Federal de Santa Maria (UFSM)	Cavalheri, H (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA.	hbadonac@ucsd.edu	Martins, Marcio/C-1150-2011	Martins, Marcio/0000-0001-8108-6309; Both, Camila/0000-0002-4590-7242	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [10/50146-3]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was funded by a Master's fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to H.C., and was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) to M.M. (10/50146-3). Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2013, ECOL LETT, V16, P1294, DOI 10.1111/ele.12157; Argolo A.J.S., 2004, SERPENTES CACAUAIS S; Barton PS, 2011, BIOL J LINN SOC, V102, P301, DOI 10.1111/j.1095-8312.2010.01580.x; Bernarde Paulo Sergio, 2006, South American Journal of Herpetology, V1, P102, DOI 10.2994/1808-9798(2006)1[102:ASCAED]2.0.CO;2; Bernarde PS, 2004, THESIS U ESTADUAL PA; Bernils RS, 1990, CIENCIA AMBIENTE, V1, P101; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Brum FT, 2012, OIKOS, V121, P899, DOI 10.1111/j.1600-0706.2011.19978.x; Cadle John E., 1993, P281; Carlucci MB, 2012, J VEG SCI, V23, P176, DOI 10.1111/j.1654-1103.2011.01339.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Cechin STZ, 1999, THESIS PONTIFICIA U; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Costa HC, 2014, HERPETOL BRAS, V3, P74; Dal Vechio Francisco, 2013, Pap. Avulsos Zool. (São Paulo), V53, P225, DOI 10.1590/S0031-10492013001600001; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Debastiani VJ, 2012, BIOINFORMATICS, V28, P2067, DOI 10.1093/bioinformatics/bts325; Di-Bernardo M., 1998, THESIS U ESTADUAL PA; Diamond J.M., 1975, P342; Duarte LDS, 2014, GLOBAL ECOL BIOGEOGR, V23, P213, DOI 10.1111/geb.12089; Duarte LDS, 2012, ECOGRAPHY, V35, P952, DOI 10.1111/j.1600-0587.2011.07193.x; Duarte LD, 2011, OIKOS, V120, P208, DOI 10.1111/j.1600-0706.2010.18898.x; Franca FGR, 2008, COPEIA, P23, DOI 10.1643/CH-05-034; Gianuca AT, 2014, AUSTRAL ECOL, V39, P29, DOI 10.1111/aec.12042; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; GUYER C, 1990, J TROP ECOL, V6, P65, DOI 10.1017/S0266467400004041; Herrera-MacBryde O, 2000, SI MAB SERIES, V4; Hubbell Stephen P., 2001, V32, pi; Instituto Ambiental do Parana, 2002, PLAN MAN PARQ EST MO; Irschick DJ, 1999, AM NAT, V154, P293, DOI 10.1086/303239; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Killeen TJ, 1998, BIOL ASSESSMENT PARQ; Klingenberg CP, 1996, BIOL J LINN SOC, V59, P143; Legendre P., 2012, NUMERICAL ECOLOGY; Leibold MA, 2010, ECOL LETT, V13, P1290, DOI 10.1111/j.1461-0248.2010.01523.x; Lillywhite Harvey B., 1993, P1; LOSOS JB, 1990, ECOL MONOGR, V60, P369, DOI 10.2307/1943062; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; Maddison WP, 2011, MESQUITE MODULAR SYS; Marques O.A.V., 1998, THESIS U SAO PAULO; Marques OA V., 2001, SERPENTES MATA ATL N; Martins M, 2001, J ZOOL, V254, P529, DOI 10.1017/S0952836901001030; Martins Marcio, 1999, Herpetological Natural History, V6, P78; MILES DB, 1984, ECOLOGY, V65, P1629, DOI 10.2307/1939141; MOERMOND TC, 1979, ECOLOGY, V60, P152, DOI 10.2307/1936477; Myers JA, 2009, ECOL LETT, V12, P1250, DOI 10.1111/j.1461-0248.2009.01373.x; Oksanen J, 2014, VEGAN COMMUNITY ECOL, DOI [10.1186/1471-2164-15-862, DOI 10.1186/1471-2164-15-862]; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pausas JG, 2010, BIOSCIENCE, V60, P614, DOI 10.1525/bio.2010.60.8.7; Pillar VD, 2010, ECOL LETT, V13, P587, DOI 10.1111/j.1461-0248.2010.01456.x; Pillar VD, 2009, J VEG SCI, V20, P334, DOI 10.1111/j.1654-1103.2009.05666.x; Pizzatto Ligia, 2007, P35; Purves Drew W., 2005, P107, DOI 10.1017/CBO9780511541971.006; R Development Core Team, 2012, R LANG ENV STAT COMP; Recoder RS, 2011, BIOTA NEOTROP, V11, P263, DOI 10.1590/S1676-06032011000100026; Ricklefs R.E., 1993, J EVOLUTION BIOL, DOI DOI 10.1046/J.1420-9101.1993.6020171.X; Ricklefs RE, 2004, ECOL LETT, V7, P1, DOI 10.1046/j.1461-0248.2003.00554.x; RICKLEFS RE, 1980, AUK, V97, P321; RICKLEFS RE, 1981, ECOLOGY, V62, P1474, DOI 10.2307/1941504; Sawaya Ricardo Jannini, 2008, Biota Neotropica, V8, P127; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882; Zanella N, 2006, REV BRAS ZOOL, V23, P211, DOI 10.1590/S0101-81752006000100013	66	11	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127959	10.1371/journal.pone.0127959	http://dx.doi.org/10.1371/journal.pone.0127959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061038	gold, Green Submitted, Green Published			2022-12-26	WOS:000355979500067
J	Yu, F; Bracken, CP; Pillman, KA; Lawrence, DM; Goodall, GJ; Callen, DF; Neilsen, PM				Yu, Feng; Bracken, Cameron P.; Pillman, Katherine A.; Lawrence, David M.; Goodall, Gregory J.; Callen, David F.; Neilsen, Paul M.			p53 Represses the Oncogenic Sno-MiR-28 Derived from a SnoRNA	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; CELL-CYCLE; GENE-EXPRESSION; P53-INDUCIBLE MICRORNAS; DOWN-REGULATION; FEEDBACK LOOP; IDENTIFICATION; TARGETS; ACTIVATION	p53 is a master tumour repressor that participates in vast regulatory networks, including feedback loops involving microRNAs (miRNAs) that regulate p53 and that themselves are direct p53 transcriptional targets. We show here that a group of polycistronic miRNA-like non-coding RNAs derived from small nucleolar RNAs (sno-miRNAs) are transcriptionally repressed by p53 through their host gene, SNHG1. The most abundant of these, sno-miR-28, directly targets the p53-stabilizing gene, TAF9B. Collectively, p53, SNHG1, sno-miR-28 and TAF9B form a regulatory loop which affects p53 stability and downstream p53-regulated pathways. In addition, SNHG1, SNORD28 and sno-miR-28 are all significantly upregulated in breast tumours and the overexpression of sno-miR-28 promotes breast epithelial cell proliferation. This research has broadened our knowledge of the crosstalk between small non-coding RNA pathways and roles of sno-miRNAs in p53 regulation.	[Yu, Feng; Callen, David F.; Neilsen, Paul M.] Univ Adelaide, Ctr Personalized Canc Med, Adelaide, SA, Australia; [Yu, Feng; Bracken, Cameron P.; Goodall, Gregory J.; Callen, David F.; Neilsen, Paul M.] Univ Adelaide, Discipline Med, Adelaide, SA, Australia; [Yu, Feng; Bracken, Cameron P.; Goodall, Gregory J.] SA Pathol, Ctr Canc Biol, Adelaide, SA, Australia; [Pillman, Katherine A.; Lawrence, David M.] SA Pathol, Ctr Canc Biol, ACRF Canc Genom Facil, Adelaide, SA, Australia; [Pillman, Katherine A.; Lawrence, David M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Neilsen, Paul M.] Swinburne Univ Technol, Kuching, Sarawak, Malaysia	University of Adelaide; University of Adelaide; Centre for Cancer Biology; SA Pathology; Centre for Cancer Biology; SA Pathology; University of Adelaide; Swinburne University of Technology; Swinburne University of Technology Sarawak	Bracken, CP (corresponding author), Univ Adelaide, Discipline Med, Adelaide, SA, Australia.	Cameron.Bracken@health.sa.gov.au	Pillman, Katherine A/M-5723-2019	Pillman, Katherine A/0000-0002-5869-889X; Lawrence, David/0000-0001-5464-5830; Bracken, Cameron/0000-0001-7722-625X; Callen, David/0000-0002-6189-9991; Neilsen, Paul/0000-0001-7937-3675; Goodall, Gregory/0000-0003-1294-0692	National Health and Medical Research Council of Australia (NHMRC) [44112162]; NHMRC grant [GNT1034633]; National Breast Cancer Foundation Australia; Adelaide Scholarships International	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC grant(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation Australia; Adelaide Scholarships International	This research received funding from National Health and Medical Research Council of Australia (NHMRC) grant 44112162, NHMRC grant GNT1034633 (http://www.nhmrc.gov.au), and from the National Breast Cancer Foundation Australia (http://www.nbcf.org.au), all assigned to DC. CB is supported by a Fellowship from the National Breast Cancer Foundation Australia, and FY is supported by Adelaide Scholarships International (http://www.adelaide.edu.au).	Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Beckerman R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000935; Bracken CP, 2014, EMBO J, V33, P2040, DOI 10.15252/embj.201488641; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brosh R, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.65; Budde A, 1999, ONCOGENE, V18, P1119, DOI 10.1038/sj.onc.1202402; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Burroughs AM, 2011, RNA BIOL, V8, P158, DOI 10.4161/rna.8.1.14300; Cao WJ, 2013, WORLD J GASTROENTERO, V19, P3658, DOI 10.3748/wjg.v19.i23.3658; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chen Z, 2003, J BIOL CHEM, V278, P35172, DOI 10.1074/jbc.M304241200; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Date DA, 2007, CELL BIOL INT, V31, P1470, DOI 10.1016/j.cellbi.2007.06.013; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Frontini M, 2005, MOL CELL BIOL, V25, P4638, DOI 10.1128/MCB.25.11.4638-4649.2005; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jin L, 2011, P NATL ACAD SCI USA, V108, P15840, DOI 10.1073/pnas.1019312108; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kho PS, 2004, J BIOL CHEM, V279, P21183, DOI 10.1074/jbc.M311912200; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li BQ, 2001, J BIOL CHEM, V276, P29729, DOI 10.1074/jbc.M101167200; Lin JP, 2014, ARTHRITIS RHEUMATOL, V66, P49, DOI 10.1002/art.38142; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; LU H, 1995, P NATL ACAD SCI USA, V92, P5154, DOI 10.1073/pnas.92.11.5154; Nakamura T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2752; Nakazawa K, 2014, FEBS J, V281, P2937, DOI 10.1111/febs.12831; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; Neilsen PM, 2011, ONCOTARGET, V2, P1203; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Noll JE, 2012, ONCOGENE, V31, P2836, DOI 10.1038/onc.2011.456; Nowak JS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4687; Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113; Ono M, 2011, NUCLEIC ACIDS RES, V39, P3879, DOI 10.1093/nar/gkq1355; Pichiorri F, 2010, CANCER CELL, V18, P367, DOI 10.1016/j.ccr.2010.09.005; Pishas KI, 2014, CANCER RES, V74, P921, DOI 10.1158/0008-5472.CAN-13-2424; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Ren ZJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.327; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224; Shi M, 2010, BBA-REV CANCER, V1805, P218, DOI 10.1016/j.bbcan.2009.12.001; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Su H, 2014, ONCOGENE, V33, P1348, DOI 10.1038/onc.2013.89; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Thorenoor N, 2015, TUMOR BIOL, V36, P41, DOI 10.1007/s13277-014-2818-8; van Valen F, 1999, HUMAN CELL CULTURE, V1, P55; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Vera J, 2013, ADV EXP MED BIOL, V774, P55, DOI 10.1007/978-94-007-5590-1_4; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Wiebusch L, 2010, ONCOGENE, V29, P3477, DOI 10.1038/onc.2010.99; Xiao JN, 2011, EMBO J, V30, P5021, DOI 10.1038/emboj.2011.463; Xu XL, 2001, NAT GENET, V28, P266, DOI 10.1038/90108; Yan HL, 2009, EMBO J, V28, P2719, DOI 10.1038/emboj.2009.214; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000	66	47	49	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129190	10.1371/journal.pone.0129190	http://dx.doi.org/10.1371/journal.pone.0129190			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061048	Green Published, gold			2022-12-26	WOS:000355979500128
J	Kromer, C; Schaarschmidt, ML; Schmieder, A; Herr, R; Goerdt, S; Peitsch, WK				Kromer, Christian; Schaarschmidt, Marthe-Lisa; Schmieder, Astrid; Herr, Raphael; Goerdt, Sergij; Peitsch, Wiebke K.			Patient Preferences for Treatment of Psoriasis with Biologicals: A Discrete Choice Experiment	PLOS ONE			English	Article							QUALITY-OF-LIFE; DRUG-TREATMENT; DOUBLE-BLIND; ARTHRITIS; THERAPIES; EFFICACY; METAANALYSIS; MODERATE; IMPACT; SAFETY	Treatment dissatisfaction and non-adherence are common among patients with psoriasis, partly due to discordance between individual preferences and recommended treatments. However, patients are more satisfied with biologicals than with other treatments. The aim of our study was to assess patient preferences for treatment of psoriasis with biologicals by using computer-based conjoint analysis. Biologicals approved for psoriasis in Germany were decomposed into outcome (probability of 50% and 90% improvement, time until response, sustainability of success, probability ofmild and severe adverse events (AE), probability of American College of Rheumatology (ACR) 20 response) and process attributes (treatment location, frequency, duration and delivery method). Impact of sociodemographic and socioeconomic characteristics and disease severity on Relative Importance Scores (RIS) of each attribute was assessed with analyses of variance, post hoc tests, and multivariate regression. Averaged across the cohort of 200 participants with moderate-to-severe psoriasis, preferences were highest for avoiding severe AE (RIS = 17.3), followed by 90% improvement (RIS = 14.0) and avoidingmild AE (RIS = 10.5). Process attributes reached intermediate RIS (8.2-8.8). Men were more concerned about efficacy than women (50% improvement: RIS = 6.9 vs. 9.5, p = 0.008; beta = -0.191, p = 0.011 inmultivariatemodels; 90% improvement: RIS = 12.1 vs. 15.4, p = 0.002; beta = -0.197, p = 0.009). Older participants judged the probability of 50% and 90% improvement less relevant than younger ones (50% improvement: Pearson's Correlation (PC) = -0.161, p = 0.022; beta = -0.219, p = 0.017; 90% improvement: PC = -0.155, p = 0.028; beta = -0.264, p = 0.004) but worried more about severe AE (PC = 0.175, p = 0.013; beta = 0.166, p = 0.082). In summary, participants with moderate-to-severe psoriasis were most interested in safety of biologicals, followed by efficacy, but preferences varied with sociodemographic characteristics and working status. Based on this knowledge, physicians should identify preferences of each individual patient during shared decision-making in order to optimize treatment satisfaction, adherence and outcome.	[Kromer, Christian; Schaarschmidt, Marthe-Lisa; Schmieder, Astrid; Goerdt, Sergij; Peitsch, Wiebke K.] Heidelberg Univ, Dept Dermatol, Univ Med Ctr Mannheim, Mannheim, Germany; [Herr, Raphael] Heidelberg Univ, Med Fac Mannheim, Mannheim Inst Publ Hlth Social & Prevent Med, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Peitsch, WK (corresponding author), Heidelberg Univ, Dept Dermatol, Univ Med Ctr Mannheim, Mannheim, Germany.	wiebke.ludwig@umm.de	Herr, Raphael/GYU-5115-2022	Herr, Raphael/0000-0003-0079-2792	scientists' program of the German network "Health Services Research Baden-Wurttemberg" of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg; Deutsche Forschungsgemeinschaft; University of Heidelberg within the funding program Open Access Publishing	scientists' program of the German network "Health Services Research Baden-Wurttemberg" of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Heidelberg within the funding program Open Access Publishing	The study was funded by the young scientists' program of the German network "Health Services Research Baden-Wurttemberg" of the Ministry of Science, Research and Arts in collaboration with the Ministry of Employment and Social Order, Family, Women and Senior Citizens, Baden-Wurttemberg (grant to Marthe-Lisa Schaarschmidt). In addition, the authors acknowledge the financial support of the Deutsche Forschungsgemeinschaft and the University of Heidelberg within the funding program Open Access Publishing.	Armstrong AW, 2013, JAMA DERMATOL, V149, P1180, DOI 10.1001/jamadermatol.2013.5264; Ash Z, 2012, ANN RHEUM DIS, V71, P319, DOI 10.1136/ard.2011.150995; Ashcroft DM, 2006, BRIT J DERMATOL, V155, P1236, DOI 10.1111/j.1365-2133.2006.07535.x; Augustin M, 2011, DERMATOLOGY, V222, P363, DOI 10.1159/000329026; Blome C, 2010, DERMATOLOGY, V221, P154, DOI 10.1159/000313825; Boyd CM, 2008, AGING CLIN EXP RES, V20, P181; de Korte J, 2004, J INVEST DERM SYMP P, V9, P140, DOI 10.1046/j.1087-0024.2003.09110.x; Dubertret L, 2006, BRIT J DERMATOL, V155, P729, DOI 10.1111/j.1365-2133.2006.07405.x; Finlay AY, 2004, J CUTAN MED SURG, V8, P310, DOI 10.1007/s10227-005-0030-6; Gniadecki R, 2015, BRIT J DERMATOL, V172, P244, DOI 10.1111/bjd.13343; Gong JJ, 2013, PSYCHOL HEALTH MED, V18, P645, DOI 10.1080/13548506.2013.766352; Grozdev I, 2012, J INVEST DERMATOL, V132, P1111, DOI 10.1038/jid.2011.427; Harris DL, 2001, BRIT J PLAST SURG, V54, P223, DOI 10.1054/bjps.2001.3550; Hovstadius Bo, 2010, BMC Clin Pharmacol, V10, P16, DOI 10.1186/1472-6904-10-16; Kimball Alexa Boer, 2012, J Am Acad Dermatol, V66, pe67, DOI 10.1016/j.jaad.2010.10.020; Kjaer T, 2006, HEALTH ECON, V15, P1217, DOI 10.1002/hec.1117; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; McInnes IB, 2013, LANCET, V382, P780, DOI 10.1016/S0140-6736(13)60594-2; Menter A, 2008, J AM ACAD DERMATOL, V58, P826, DOI 10.1016/j.jaad.2008.02.039; Nast A, 2012, J DTSCH DERMATOL S2, V10, pS1, DOI 10.1111/ j. 1610- 0387.2012.07919. x PMID: 22386073; Nast A, 2013, J INVEST DERMATOL, V133, P1963, DOI 10.1038/jid.2013.78; Opmeer BC, 2007, J CLIN EPIDEMIOL, V60, P696, DOI 10.1016/j.jclinepi.2006.10.011; Paul C, 2012, J EUR ACAD DERMATOL, V26, P448, DOI 10.1111/j.1468-3083.2011.04093.x; Reich K, 2012, BRIT J DERMATOL, V166, P179, DOI 10.1111/j.1365-2133.2011.10583.x; Reich K, 2008, CURR MED RES OPIN, V24, P1237, DOI [10.1185/030079908X291985, 10.1185/030079908X291985 ]; Schaarschmidt ML, 2013, J EUR ACAD DERMATOL, V27, P187, DOI 10.1111/j.1468-3083.2011.04440.x; Schaarschmidt ML, 2011, ARCH DERMATOL, V147, P1285, DOI 10.1001/archdermatol.2011.309; Schmieder A, 2012, J AM ACAD DERMATOL, V67, P363, DOI 10.1016/j.jaad.2011.08.023; Schmitt J, 2008, BRIT J DERMATOL, V159, P513, DOI 10.1111/j.1365-2133.2008.08732.x; Seston EM, 2007, ARCH DERMATOL, V143, P1175, DOI 10.1001/archderm.143.9.1175; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Umar N, 2013, J EUR ACAD DERMATOL, V27, P763, DOI 10.1111/j.1468-3083.2012.04569.x; Umar N, 2012, ACTA DERM-VENEREOL, V92, P341, DOI 10.2340/00015555-1304; van Cranenburgh OD, 2013, BRIT J DERMATOL, V169, P398, DOI 10.1111/bjd.12372; van Lumig PPM, 2012, J EUR ACAD DERMATOL, V26, P283, DOI 10.1111/j.1468-3083.2011.04044.x	35	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129120	10.1371/journal.pone.0129120	http://dx.doi.org/10.1371/journal.pone.0129120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058083	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000039
J	Ma, XY; Wu, HW; Jiang, WL; Ma, YJ; Ma, Y				Ma, Xiaoyan; Wu, Hanwen; Jiang, Weili; Ma, Yajie; Ma, Yan			Interference between Redroot Pigweed (Amaranthus retroflexus L.) and Cotton (Gossypium hirsutum L.): Growth Analysis	PLOS ONE			English	Article							WEED COMPETITION; SMARTWEED INTERFERENCE; MORNINGGLORY IPOMOEA; ACHENE PRODUCTION; CYNODON-DACTYLON; SEED PRODUCTION; PALMERI; COCKLEBUR; EMERGENCE; SICKLEPOD	Redroot pigweed is one of the injurious agricultural weeds on a worldwide basis. Understanding of its interference impact in crop field will provide useful information for weed control programs. The effects of redroot pigweed on cotton at densities of 0, 0.125, 0.25, 0.5, 1, 2, 4, and 8 plants m(-1) of row were evaluated in field experiments conducted in 2013 and 2014 at Institute of Cotton Research, CAAS in China. Redroot pigweed remained taller and thicker than cotton and heavily shaded cotton throughout the growing season. Both cotton height and stem diameter reduced with increasing redroot pigweed density. Moreover, the interference of redroot pigweed resulted in a delay in cotton maturity especially at the densities of 1 to 8 weed plants m(-1) of row, and cotton boll weight and seed numbers per boll were reduced. The relationship between redroot pigweed density and seed cotton yield was described by the hyperbolic decay regression model, which estimated that a density of 0.20-0.33 weed plant m(-1) of row would result in a 50% seed cotton yield loss from the maximum yield. Redroot pigweed seed production per plant or per square meter was indicated by logarithmic response. At a density of 1 plant m(-1) of cotton row, redroot pigweed produced about 626,000 seeds m(-2). Intraspecific competition resulted in density-dependent effects on weed biomass per plant, a range of 430-2,250 g dry weight by harvest. Redroot pigweed biomass ha(-1) tended to increase with increasing weed density as indicated by a logarithmic response. Fiber quality was not significantly influenced by weed density when analyzed over two years; however, the fiber length uniformity and micronaire were adversely affected at density of 1 weed plant m(-1) of row in 2014. The adverse impact of redroot pigweed on cotton growth and development identified in this study has indicated the need of effective redroot pigweed management.	[Ma, Xiaoyan; Jiang, Weili; Ma, Yajie; Ma, Yan] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China; [Wu, Hanwen] NSW Dept Primary Ind, Wagga Wagga Agr Inst, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; NSW Department of Primary Industries	Ma, Y (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	aymayan@126.com	MA, XIAO/HHN-5611-2022; Wu, Hanwen/B-7901-2010	Wu, Hanwen/0000-0001-5157-4977; Ma, Yan/0000-0001-6897-5064; Ma, Xiaoyan/0000-0002-8879-6175	Fundamental Research Funds for Central Public Welfare Research Institutes, China [SJ1312]	Fundamental Research Funds for Central Public Welfare Research Institutes, China	Fundamental Research Funds for Central Public Welfare Research Institutes, China (SJ1312), Xiaoyan Ma.	Aguyoh JN, 2003, WEED SCI, V51, P202, DOI 10.1614/0043-1745(2003)051[0202:IORPAR]2.0.CO;2; Amini R, 2014, EUR J AGRON, V60, P13, DOI 10.1016/j.eja.2014.07.002; Arle HF, 1973, WEED SCI, V22, P496; Askew SD, 2002, WEED SCI, V50, P357, DOI 10.1614/0043-1745(2002)050[0357:PSIAAP]2.0.CO;2; Askew SD, 2002, WEED SCI, V50, P350, DOI 10.1614/0043-1745(2002)050[0350:PSIAAP]2.0.CO;2; Askew SD, 2002, WEED SCI, V50, P326, DOI 10.1614/0043-1745(2002)050[0326:LIASPI]2.0.CO;2; Bailey WA, 1999, P S WEED SCI SOC, V52, P163; Barnett KA, 2013, WEED SCI, V61, P543, DOI 10.1614/WS-D-12-00169.1; Bensch CN, 2003, WEED SCI, V51, P37, DOI 10.1614/0043-1745(2003)051[0037:IORPAR]2.0.CO;2; BLACK CC, 1969, WEED SCI, V17, P338, DOI 10.1017/S0043174500054187; BUCHANAN GA, 1970, WEED SCI, V18, P149, DOI 10.1017/S0043174500077560; BUCHANAN GA, 1980, WEED SCI, V28, P258, DOI 10.1017/S0043174500055259; BUCHANAN GA, 1971, WEED SCI, V19, P580, DOI 10.1017/S0043174500050736; BUCHANAN GA, 1971, WEED SCI, V19, P576, DOI 10.1017/S0043174500050724; BUCHANAN GA, 1975, WEED SCI, V23, P324, DOI 10.1017/S004317450005311X; Burnside OC, 1996, WEED SCI, V44, P74, DOI 10.1017/S0043174500093589; CASTNER EP, 1989, WEED SCI, V37, P688, DOI 10.1017/S0043174500072647; CHANDLER JM, 1977, WEED SCI, V25, P151, DOI 10.1017/S0043174500033154; Christidis BG, 1955, COTTON GROWING PROBL, P435; Cortes JA, 2010, SPAN J AGRIC RES, V8, P391, DOI 10.5424/sjar/2010082-1184; CROWLEY RH, 1978, WEED SCI, V26, P484, DOI 10.1017/S0043174500050372; DONALD C. M., 1958, Australian Journal of Agricultural Research, V9, P421, DOI 10.1071/AR9580421; Ghanizadeh H, 2014, WEED BIOL MANAG, V14, P133, DOI 10.1111/wbm.12041; Heap I, INT SURVEY HERBICIDE; Holm L., 1997, WORLDS WEEDS NATURAL, P51; Horak MJ, 2000, WEED SCI, V48, P347, DOI 10.1614/0043-1745(2000)048[0347:GAOFAS]2.0.CO;2; Jalali M., 2012, International Journal of Agriculture: Research and Review, V2, P357; Karimmojeni H, 2014, PLANT SPEC BIOL, V29, pE1, DOI 10.1111/1442-1984.12022; KEELEY PE, 1991, WEED SCI, V39, P570, DOI 10.1017/S0043174500088391; Knezevic SZ, 1997, WEED SCI, V45, P502, DOI 10.1017/S0043174500088731; Knezevic SZ, 1998, WEED SCI, V46, P665, DOI 10.1017/S0043174500089694; KNEZEVIC SZ, 1994, WEED SCI, V42, P568, DOI 10.1017/S0043174500076967; KROPFF MJ, 1991, WEED RES, V31, P97, DOI 10.1111/j.1365-3180.1991.tb01748.x; Liu JG, 2009, WEED RES, V49, P217, DOI 10.1111/j.1365-3180.2008.00687.x; MacRae A. W., 2013, Journal of Cotton Science, V17, P227; MERCER KL, 1987, WEED SCI, V35, P807, DOI 10.1017/S0043174500079388; Meyers SL, 2010, WEED SCI, V58, P199, DOI 10.1614/WS-D-09-00048.1; Mirshekari B, 2010, WEED BIOL MANAG, V10, P120, DOI 10.1111/j.1445-6664.2010.00371.x; MOHLER CL, 1995, J APPL ECOL, V32, P627, DOI 10.2307/2404658; Morgan GD, 2001, WEED TECHNOL, V15, P408, DOI 10.1614/0890-037X(2001)015[0408:CIOPAA]2.0.CO;2; Munger P. H., 1986, Dissertation Abstracts International, B (Sciences and Engineering), V47, P1337; PATTERSON DT, 1982, WEED SCI, V30, P692, DOI 10.1017/S0043174500041448; [彭军 Peng Jun], 2012, [棉花学报, Cotton Science], V24, P272; Poonguzhalan P. A. R., 2013, Agricultural Reviews, V34, P157; Rajcan I, 2004, WEED SCI, V52, P774, DOI 10.1614/WS-03-158R; Rezaie F, 2009, J FOOD AGRIC ENVIRON, V7, P516; Rogers JB, 1996, WEED TECHNOL, V10, P107, DOI 10.1017/S0890037X00045796; Rowland MW, 1999, WEED SCI, V47, P305, DOI 10.1017/S0043174500091815; RUSHING DW, 1985, WEED SCI, V33, P815, DOI 10.1017/S0043174500083417; RUSHING DW, 1985, WEED SCI, V33, P810, DOI 10.1017/S0043174500083405; SALISBURY CD, 1993, WEED SCI, V41, P69, DOI 10.1017/S004317450005760X; Scott GH, 2000, WEED SCI, V48, P613, DOI 10.1614/0043-1745(2000)048[0613:DSIASR]2.0.CO;2; Sheibany K, 2009, WEED BIOL MANAG, V9, P152, DOI 10.1111/j.1445-6664.2009.00333.x; Smith DT, 2000, WEED TECHNOL, V14, P122, DOI 10.1614/0890-037X(2000)014[0122:PAAPIO]2.0.CO;2; SNIPES CE, 1982, WEED SCI, V30, P553, DOI 10.1017/S0043174500041151; Teasdale JR, 1998, WEED SCI, V46, P447, DOI 10.1017/S0043174500090883; Telewski FW, 2002, AM J BOT, V89, P1285, DOI 10.3732/ajb.89.8.1285; Tingle CH, 2003, WEED SCI, V51, P586, DOI 10.1614/0043-1745(2003)051[0586:CACOSC]2.0.CO;2; Wood ML, 2002, WEED TECHNOL, V16, P495, DOI 10.1614/0890-037X(2002)016[0495:JSHDEO]2.0.CO;2	59	7	10	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0130475	10.1371/journal.pone.0130475	http://dx.doi.org/10.1371/journal.pone.0130475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057386	gold, Green Submitted, Green Published			2022-12-26	WOS:000356349000083
J	Swapna, G; Kumari, V; Nagaraja, V				Swapna, Ganduri; Kumari, Vandana; Nagaraja, Valakunja			Different Modes of Transactivation of Bacteriophage Mu Late Promoters by Transcription Factor C	PLOS ONE			English	Article							SUBTILIS RNA-POLYMERASE; PHAGE-LAMBDA REPRESSOR; MOM GENE; ESCHERICHIA-COLI; PROTEIN P4; ALPHA-SUBUNIT; ACTIVATION; DNA; INITIATION; EXPRESSION	Transactivator protein C is required for the expression of bacteriophage Mu late genes from lys, I, P and mom promoters during lytic life cycle of the phage. The mechanism of transcription activation of mom gene by C protein is well understood. C activates transcription at Pmom by initial unwinding of the promoter DNA, thereby facilitating RNA polymerase (RNAP) recruitment. Subsequently, C interacts with the (sic) subunit of RNAP to enhance promoter clearance. The mechanism by which C activates other late genes of the phage is not known. We carried out promoter-polymerase interaction studies with all the late gene promoters to determine the individual step of C mediated activation. Unlike at P-mom, at the other three promoters, RNAP recruitment and closed complex formation are not C dependent. Instead, the action of C at P-lys, P-I, and P-P is during the isomerization from closed complex to open complex with no apparent effect at other steps of initiation pathway. The mechanism of transcription activation of mom and other late promoters by their common activator is different. This distinction in the mode of activation (promoter recruitment and escape versus isomerization) by the same activator at different promoters appears to be important for optimized expression of each of the late genes.	[Swapna, Ganduri; Kumari, Vandana; Nagaraja, Valakunja] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Nagaraja, Valakunja] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Nagaraja, V (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	vraj@mcbl.iisc.ernet.in			Council of Scientific and Industrial Research, India; Department of Science and Technology, Government of India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, Government of India(Department of Science & Technology (India))	GS was a recipient of a senior research fellowship from Council of Scientific and Industrial Research, India. VN is a recipient of J.C. Bose fellowship and a grant from the Department of Science and Technology, Government of India.	Anthony LC, 2002, J BIOL CHEM, V277, P46433, DOI 10.1074/jbc.M208205200; BALKE V, 1992, NUCLEIC ACIDS RES, V20, P2777, DOI 10.1093/nar/20.11.2777; Basak S, 1998, J MOL BIOL, V284, P893, DOI 10.1006/jmbi.1998.2213; Basak S, 2001, J BIOL CHEM, V276, P19836, DOI 10.1074/jbc.M011790200; BOLKER M, 1989, EMBO J, V8, P2403, DOI 10.1002/j.1460-2075.1989.tb08370.x; BUSBY S, 1994, CELL, V79, P743, DOI 10.1016/0092-8674(94)90063-9; Chakraborty A, 2006, J BIOL CHEM, V281, P8511, DOI 10.1074/jbc.M512906200; Choy HE, 1997, J MOL BIOL, V272, P293, DOI 10.1006/jmbi.1997.1221; FAELEN M, 1973, VIROLOGY, V54, P117, DOI 10.1016/0042-6822(73)90121-9; GIPHARTGASSLER M, 1981, J MOL BIOL, V145, P139, DOI 10.1016/0022-2836(81)90338-7; GRUNDY FJ, 1985, VIROLOGY, V143, P485, DOI 10.1016/0042-6822(85)90388-5; HATTMAN S, 1985, GENE, V39, P71, DOI 10.1016/0378-1119(85)90109-X; HATTMAN S, 1979, J VIROL, V32, P468, DOI 10.1128/JVI.32.2.468-475.1979; HATTMAN S, 1982, P NATL ACAD SCI-BIOL, V79, P5518, DOI 10.1073/pnas.79.18.5518; Hattman S, 1999, PHARMACOL THERAPEUT, V84, P367, DOI 10.1016/S0163-7258(99)00042-X; HATTMAN S, 1987, GENE, V55, P345, DOI 10.1016/0378-1119(87)90295-2; HAWLEY DK, 1982, J MOL BIOL, V157, P493, DOI 10.1016/0022-2836(82)90473-9; ISHIHAMA A, 1993, J BACTERIOL, V175, P2483, DOI 10.1128/JB.175.9.2483-2489.1993; KAHMANN R, 1985, GENE, V39, P61, DOI 10.1016/0378-1119(85)90108-8; Kashlev M, 1996, METHOD ENZYMOL, V274, P326; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; KULDELL N, 1994, J BACTERIOL, V176, P2991, DOI 10.1128/JB.176.10.2991-2998.1994; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Li M, 1997, P NATL ACAD SCI USA, V94, P3691, DOI 10.1073/pnas.94.8.3691; MARGOLIN W, 1986, NUCLEIC ACIDS RES, V14, P4881, DOI 10.1093/nar/14.12.4881; Mencia M, 1996, P NATL ACAD SCI USA, V93, P6616, DOI 10.1073/pnas.93.13.6616; Monsalve M, 1996, EMBO J, V15, P383, DOI 10.1002/j.1460-2075.1996.tb00368.x; Monsalve M, 1996, P NATL ACAD SCI USA, V93, P8913, DOI 10.1073/pnas.93.17.8913; Niu W, 1996, CELL, V87, P1123, DOI 10.1016/S0092-8674(00)81806-1; NUEZ B, 1992, P NATL ACAD SCI USA, V89, P11401, DOI 10.1073/pnas.89.23.11401; RAMESH V, 1994, PROTEIN ENG, V7, P1053, DOI 10.1093/protein/7.8.1053; Ramesh V, 1996, J MOL BIOL, V260, P22, DOI 10.1006/jmbi.1996.0379; Roy S, 1998, J BIOL CHEM, V273, P14059, DOI 10.1074/jbc.273.23.14059; Sen R, 2000, J BIOL CHEM, V275, P10899, DOI 10.1074/jbc.275.15.10899; STODDARD SF, 1989, J BACTERIOL, V171, P3440, DOI 10.1128/jb.171.6.3440-3448.1989; Swapna G, 2011, MOL MICROBIOL, V80, P1169, DOI 10.1111/j.1365-2958.2011.07636.x; SWINTON D, 1983, P NATL ACAD SCI-BIOL, V80, P7400, DOI 10.1073/pnas.80.24.7400; TOUSSAINT A, 1976, VIROLOGY, V70, P17, DOI 10.1016/0042-6822(76)90232-4; WULCZYN FG, 1987, GENE, V51, P139, DOI 10.1016/0378-1119(87)90302-7; Yamamoto K, 2001, MOL MICROBIOL, V41, P1187, DOI 10.1046/j.1365-2958.2001.02585.x	40	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129504	10.1371/journal.pone.0129504	http://dx.doi.org/10.1371/journal.pone.0129504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058069	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000059
J	Yang, HC; Liu, MS; Li, XG; Cui, B; Fang, J; Cui, LY				Yang, Hecheng; Liu, Mingsheng; Li, Xiaoguang; Cui, Bo; Fang, Jia; Cui, Liying			Neurophysiological Differences between Flail Arm Syndrome and Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CLINICAL-FEATURES; MOTOR CORTEX; SPLIT-HAND; ALS VARIANTS; EXCITABILITY; DIAGNOSIS	There are many clinical features of flail arm syndrome (FAS) that are different from amyotrophic lateral sclerosis (ALS), suggesting they are probably different entities. Studies on electrophysiological differences between them are limited at present, and still inconclusive. Therefore, we aimed to find clinical and neurophysiological differences between FAS and ALS. Eighteen healthy control subjects, six FAS patients and forty-one ALS patients were recruited. The upper motor neuron signs (UMNS), split-hand index (SI), resting motor threshold (RMT), central motor conduction time (CMCT) were evaluated and compared. There was no obvious upper motor neuron signs in FAS. The SI and RMT level in FAS was similar to control subjects, but significantly lower than that of in ALS. Compared with control group, the RMT and SI in ALS group were both significantly increased to higher level. However, no significant difference of CMCT was found between any two of these three groups. The differences in clinical and neurophysiological findings between FAS and ALS, argue against they are the same disease entity. Since there was no obvious UMNS, no split-hand phenomenon, and no obvious changes of RMT and CMCT in FAS patients, the development of FAS might be probably not originated from motor cortex.	[Cui, Liying] Chinese Acad Med Sci, Dept Neurol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cui, LY (corresponding author), Chinese Acad Med Sci, Dept Neurol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	pumccuily@yahoo.com			Peking Union Medical College [2013-1002-02]	Peking Union Medical College	This work was supported by innovation fund of Peking Union Medical College (No. 2013-1002-02). The URL of the PUMC website is http://www.cams.ac.cn/. HY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Couratier P, 2000, MUSCLE NERVE, V23, P646, DOI 10.1002/(SICI)1097-4598(200004)23:4<646::AID-MUS26>3.0.CO;2-E; EISEN A, 1993, CAN J NEUROL SCI, V20, P11, DOI 10.1017/S031716710004734X; Eisen A, 2001, MUSCLE NERVE, V24, P564, DOI 10.1002/mus.1042; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Hu MTM, 1998, J NEUROL NEUROSUR PS, V65, P950, DOI 10.1136/jnnp.65.6.950; Katz JS, 1999, NEUROLOGY, V53, P1071, DOI 10.1212/WNL.53.5.1071; Kim JE, 2015, MUSCLE NERVE, V51, P333, DOI 10.1002/mus.24323; Menon P, 2014, JOVE-J VIS EXP, DOI 10.3791/51056; Menon P, 2014, CLIN NEUROPHYSIOL, V125, P186, DOI 10.1016/j.clinph.2013.07.022; Menon P, 2013, CLIN NEUROPHYSIOL, V124, P410, DOI 10.1016/j.clinph.2012.07.025; Mills KR, 1997, MUSCLE NERVE, V20, P1137, DOI 10.1002/(SICI)1097-4598(199709)20:9<1137::AID-MUS7>3.0.CO;2-9; Prudlo J, 2012, J NEUROL, V259, P1848, DOI 10.1007/s00415-012-6420-y; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sasaki S, 1999, J NEUROL NEUROSUR PS, V66, P581, DOI 10.1136/jnnp.66.5.581; Schulte-Mattler WJ, 1999, J NEUROL SCI, V170, P51, DOI 10.1016/S0022-510X(99)00201-4; Schuster C, 2013, J NEUROL, V260, P2856, DOI 10.1007/s00415-013-7083-z; Stuchevskaya TR, 2006, ZH NEVROL PSIKHIATR, V106, P14; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Vucic S, 2007, J NEUROL NEUROSUR PS, V78, P849, DOI 10.1136/jnnp.2006.105056; Weber M, 2000, J NEUROL SCI, V180, P66, DOI 10.1016/S0022-510X(00)00430-5; Wijesekera LC, 2009, NEUROLOGY, V72, P1087, DOI 10.1212/01.wnl.0000345041.83406.a2; Xu Ying-sheng, 2013, Zhonghua Yi Xue Za Zhi, V93, P23; Yoon Byung-Nam, 2014, Exp Neurobiol, V23, P253, DOI 10.5607/en.2014.23.3.253; Zanette G, 2002, J NEUROL, V249, P1723, DOI 10.1007/s00415-002-0926-7	27	10	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0127601	10.1371/journal.pone.0127601	http://dx.doi.org/10.1371/journal.pone.0127601			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26056822	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000010
J	Neumann, K; Erben, U; Kruse, N; Wechsung, K; Schumann, M; Klugewitz, K; Scheffold, A; Kuhl, AA				Neumann, Katrin; Erben, Ulrike; Kruse, Nils; Wechsung, Katja; Schumann, Michael; Klugewitz, Katja; Scheffold, Alexander; Kuehl, Anja A.			Chemokine Transfer by Liver Sinusoidal Endothelial Cells Contributes to the Recruitment of CD4(+) T Cells into the Murine Liver	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SURFACE PRESENTATION; ALLOGRAFT-REJECTION; LEUKOCYTE ADHESION; INFECTED LIVER; RECEPTOR CXCR3; IN-VIVO; EXPRESSION; TRANSCYTOSIS; INFLAMMATION	Leukocyte adhesion and transmigration are central features governing immune surveillance and inflammatory reactions in body tissues. Within the liver sinusoids, chemokines initiate the first crucial step of T-cell migration into the hepatic tissue. We studied molecular mechanisms involved in endothelial chemokine supply during hepatic immune surveillance and liver inflammation and their impact on the recruitment of CD4(+) T cells into the liver. In the murine model of Concanavalin A-induced T cell-mediated hepatitis, we showed that hepatic expression of the inflammatory CXC chemokine ligands (CXCL) 9 and CXCL10 strongly increased whereas homeostatic CXCL12 significantly decreased. Consistently, CD4(+) T cells expressing the CXC chemokine receptor (CXCR) 3 accumulated within the inflamed liver tissue. In histology, CXCL9 was associated with liver sinusoidal endothelial cells (LSEC) which represent the first contact site for T-cell immigration into the liver. LSEC actively transferred basolaterally internalized CXCL12, CXCL9 and CXCL10 via clathrin-coated vesicles to CD4(+) T cells leading to enhanced transmigration of CXCR4(+) total CD4(+) T cells and CXCR3(+) effector/memory CD4(+) T cells, respectively in vitro. LSEC-expressed CXCR4 mediated CXCL12 transport and blockage of endothelial CXCR4 inhibited CXCL12-dependent CD4(+) T-cell transmigration. In contrast, CXCR3 was not involved in the endothelial transport of its ligands CXCL9 and CXCL10. The clathrin-specific inhibitor chlorpromazine blocked endothelial chemokine internalization and CD4(+) T-cell transmigration in vitro as well as migration of CD4(+) T cells into the inflamed liver in vivo. Moreover, hepatic accumulation of CXCR3(+) CD4(+) T cells during T cell-mediated hepatitis was strongly reduced after administration of chlorpromazine. These data demonstrate that LSEC actively provide perivascularly expressed homeostatic and inflammatory chemokines by CXCR4-and clathrin-dependent intracellular transport mechanisms thereby contributing to the hepatic recruitment of CD4(+) T-cell populations during immune surveillance and liver inflammation.	[Neumann, Katrin; Erben, Ulrike; Kruse, Nils; Wechsung, Katja; Schumann, Michael; Klugewitz, Katja; Kuehl, Anja A.] Charite, Dept Med Gastroenterol Infect Dis & Rheumatol, D-13353 Berlin, Germany; [Neumann, Katrin; Erben, Ulrike; Kuehl, Anja A.] Charite, Res Ctr Immunosci, D-13353 Berlin, Germany; [Neumann, Katrin; Scheffold, Alexander] Charite, Dept Cellular Immunol, Clin Rheumatol & Clin Immunol, D-13353 Berlin, Germany; [Scheffold, Alexander] German Rheumatism Res Ctr Berlin, Inst Leibniz Assoc, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ)	Neumann, K (corresponding author), Charite, Dept Med Gastroenterol Infect Dis & Rheumatol, Campus Benjamin Franklin, D-13353 Berlin, Germany.	kat.neumann@uke.de	Scheffold, Alexander/S-2090-2016; Schumann, Michael/K-6426-2013	Scheffold, Alexander/0000-0002-0626-343X; Schumann, Michael/0000-0001-6391-9979; Neumann, Katrin/0000-0002-3858-3171; Kuhl, Anja/0000-0003-2293-5387	Deutsche Forschungsgemeinschaft [SFB633, KL 1183/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work received financial support from the Deutsche Forschungsgemeinschaft by SFB633 granted to KK, AS and AAK and project KL 1183/2-1 granted to KK and AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai K, 2002, CELL IMMUNOL, V219, P48, DOI 10.1016/S0008-8749(02)00584-1; Baekkevold ES, 2001, J EXP MED, V193, P1105, DOI 10.1084/jem.193.9.1105; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Curbishley SM, 2005, AM J PATHOL, V167, P887, DOI 10.1016/S0002-9440(10)62060-3; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Erhardt A, 2011, J IMMUNOL, V186, P5284, DOI 10.4049/jimmunol.1003750; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Ge SJ, 2008, J NEUROCHEM, V104, P1219, DOI 10.1111/j.1471-4159.2007.05056.x; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Goddard S, 2001, TRANSPLANTATION, V72, P1957, DOI 10.1097/00007890-200112270-00016; GOLDSTEIN JL, 1977, METABOLISM, V26, P1257, DOI 10.1016/0026-0495(77)90119-6; Hamann A, 2000, EUR J IMMUNOL, V30, P3207, DOI 10.1002/1521-4141(200011)30:11<3207::AID-IMMU3207>3.0.CO;2-L; Hancock WW, 2000, J EXP MED, V192, P1515, DOI 10.1084/jem.192.10.1515; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Hayer A, 2010, TRAFFIC, V11, P361, DOI 10.1111/j.1600-0854.2009.01023.x; Heydtmann M, 2005, J IMMUNOL, V174, P1055, DOI 10.4049/jimmunol.174.2.1055; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Ikeda K, 1997, IMMUNOL LETT, V55, P127, DOI 10.1016/S0165-2478(97)02700-4; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Kobayashi Hotaka, 2013, Commun Integr Biol, V6, pe25036, DOI 10.4161/cib.25036; Lalor PF, 2002, IMMUNOL CELL BIOL, V80, P52, DOI 10.1046/j.1440-1711.2002.01062.x; Lee WY, 2008, J HEPATOL, V48, P504, DOI 10.1016/j.jhep.2007.12.005; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MACPHEE PJ, 1995, AM J PHYSIOL-GASTR L, V269, pG692, DOI 10.1152/ajpgi.1995.269.5.G692; Maher JJ, 1998, AM J PHYSIOL-GASTR L, V275, pG847, DOI 10.1152/ajpgi.1998.275.4.G847; Marra F, 2002, FRONT BIOSCI, V7, pD1899, DOI 10.2741/marra; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Meyer M, 2001, EUR J IMMUNOL, V31, P2521, DOI 10.1002/1521-4141(200108)31:8<2521::AID-IMMU2521>3.0.CO;2-Q; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; Mordelet E, 2007, ENDOTHELIUM-J ENDOTH, V14, P7, DOI 10.1080/10623320601177312; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Murdoch C, 1999, CYTOKINE, V11, P704, DOI 10.1006/cyto.1998.0465; Neumann K, 2012, HEPATOLOGY, V55, P1976, DOI 10.1002/hep.24816; Okamoto CT, 1998, ADV DRUG DELIVER REV, V29, P215, DOI 10.1016/S0169-409X(97)00080-X; Oo YH, 2010, J AUTOIMMUN, V34, P45, DOI 10.1016/j.jaut.2009.07.011; Oo YH, 2012, J HEPATOL, V57, P1044, DOI 10.1016/j.jhep.2012.07.008; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Rot A, 2003, J IMMUNOL METHODS, V273, P63, DOI 10.1016/S0022-1759(02)00502-1; ROTHBERG KG, 1990, J CELL BIOL, V111, P2931, DOI 10.1083/jcb.111.6.2931; Schrage A, 2008, HEPATOLOGY, V48, P1262, DOI 10.1002/hep.22443; Schrage A, 2008, HISTOCHEM CELL BIOL, V129, P441, DOI 10.1007/s00418-008-0379-x; Schwabe RF, 2003, AM J PHYSIOL-GASTR L, V285, pG949, DOI 10.1152/ajpgi.00215.2003; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shetty S, 2011, J IMMUNOL, V186, P4147, DOI 10.4049/jimmunol.1002961; Shields PL, 1999, J IMMUNOL, V163, P6236; Signoret N, 2005, MOL BIOL CELL, V16, P902, DOI 10.1091/mbc.e04-08-0687; Stroh T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009488; Tanaka Y, 1998, ARTHRITIS RHEUM-US, V41, P1365, DOI 10.1002/1529-0131(199808)41:8<1365::AID-ART5>3.0.CO;2-W; Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003; Wald O, 2004, EUR J IMMUNOL, V34, P1164, DOI 10.1002/eji.200324441; Wang LC, 2005, NAT IMMUNOL, V6, P902, DOI 10.1038/ni1233; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Yang W, 1999, J BIOL CHEM, V274, P11328, DOI 10.1074/jbc.274.16.11328; Yoong KF, 1999, HEPATOLOGY, V30, P100, DOI 10.1002/hep.510300147; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500	61	42	43	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0123867	10.1371/journal.pone.0123867	http://dx.doi.org/10.1371/journal.pone.0123867			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052942	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300005
J	Purwaningrum, L; Funatsu, K; Xiong, JH; Rosyidi, CN; Muraki, S				Purwaningrum, Lu'lu'; Funatsu, Kyotaro; Xiong, Jinghong; Rosyidi, Cucuk Nur; Muraki, Satoshi			Effect of Furniture Weight on Carrying, Lifting, and Turning of Chairs and Desks among Elementary School Children	PLOS ONE			English	Article							SEATING ARRANGEMENTS; LOAD CARRIAGE; WALKING; DESIGN; ANTHROPOMETRY; PARAMETERS; PATTERNS	Rearranging furniture in elementary school classrooms encourages classroom activities. In elementary schools in Indonesia and some other developing countries, usually only one style of furniture is used for all children, and the furniture is heavy and oversized for younger children. This affects their ability to carry it. The objective of this study is to investigate the effects of elementary school furniture weight and children's age on performance of three carrying tasks (carrying a chair, lifting and turning a chair on a desk, and carrying both a chair and a desk together), from the ergonomics point of view. A total of 42 schoolchildren (ages 6-9; 17 Indonesian, 25 Japanese) participated in this study. Two types of Japanese chairs (Chair A and B, weight: 3.2 kg and 3.9 kg), one type of Indonesian chair (Chair C, weight: 5.0 kg), and two types of desks (height: 58 cm and 68 cm) were used. Indonesian chairs took significantly longer time to carry than the two Japanese chairs, and there was a significant negative relationship between age and task time for Chairs B and C, but not Chair A. Success rates for lifting and turning the chair declined as age decreased and chair weight increased, but were not significantly influenced by desk height. Success rates for carrying a chair and desk together significantly decreased with heavier furniture. Children aged six showed an extremely low success rate in almost all conditions. In conclusion, children's ability to carry furniture is affected by their age and furniture characteristics, especially weight. In order to encourage classroom activities in elementary school, school furniture should be of appropriate weight. Supervision for younger children is required during classroom furniture arrangement.	[Purwaningrum, Lu'lu'; Xiong, Jinghong] Kyushu Univ, Grad Sch Design, Human Sci Int Course, Fukuoka 812, Japan; [Purwaningrum, Lu'lu'] Sebelas Maret Univ, Fac Arts & Design, Dept Interior Design, Surakarta, Indonesia; [Funatsu, Kyotaro] Kyushu Kyoritsu Univ, Fac Sports Sci, Fukuoka, Japan; [Rosyidi, Cucuk Nur] Sebelas Maret Univ, Dept Ind Engn, Fac Engn, Surakarta, Indonesia; [Muraki, Satoshi] Kyushu Univ, Fac Design, Dept Human Sci, Fukuoka 812, Japan	Kyushu University; Sebelas Maret University; Sebelas Maret University; Kyushu University	Purwaningrum, L (corresponding author), Kyushu Univ, Grad Sch Design, Human Sci Int Course, Fukuoka 812, Japan.	lulupurwaningrum@gmail.com	Rosyidi, Cucuk Nur/ABD-3290-2021; purwaningrum, lulu/W-1089-2019	purwaningrum, lulu/0000-0002-5436-2088; Rosyidi, Cucuk Nur/0000-0001-9574-2848	International research collaboration and scientific research publication grant [499/UN27.11/PN/2014]; Direktorat Jendral Perguruan Tinggi (DIKTI); Ministry of Education and Culture, Republic of Indonesia	International research collaboration and scientific research publication grant; Direktorat Jendral Perguruan Tinggi (DIKTI); Ministry of Education and Culture, Republic of Indonesia	Collection of data regarding Indonesian chair weight and size was supported by International research collaboration and scientific research publication grant (499/UN27.11/PN/2014), Direktorat Jendral Perguruan Tinggi (DIKTI), and the Ministry of Education and Culture, Republic of Indonesia.	Adewole NA, 2012, INT J SCI ENG RES, V3, P388; Anderson M., 2010, PREPRINT; [Anonymous], 2011, 755519 SNI; [Anonymous], 1979, ISO5970, DOI [10.1684/abc.2008.0205, DOI 10.1684/ABC.2008.0205]; Beenakker EAC, 2001, NEUROMUSCULAR DISORD, V11, P441, DOI 10.1016/S0960-8966(01)00193-6; Breithecker D, 2007, WORKPLACE SCH DEMAND; Bridger R., 2008, INTRO ERGONOMICS; Castellucci HI, 2010, APPL ERGON, V41, P563, DOI 10.1016/j.apergo.2009.12.001; Chuan TK, 2010, INT J IND ERGONOM, V40, P757, DOI 10.1016/j.ergon.2010.05.001; Cotton Lance M, 2002, Work, V18, P269; Dhara Prakash Chandra, 2009, Environmental Health and Preventive Medicine, V14, P36, DOI 10.1007/s12199-008-0055-8; Domljan D, 2008, COLLEGIUM ANTROPOL, V32, P257; Feathers D, 2013, WORK J PREVENTION AS, V44, P73, DOI [10.3233/WOR-2012-01563, DOI 10.3233/WOR-2012-01563]; Field A., 2013, DISCOVERING STAT USI; Geldhof E, 2007, ERGONOMICS, V50, P1571, DOI 10.1080/00140130701587251; GRAITCER PL, 1981, LANCET, V2, P297; HABICHT JP, 1974, LANCET, V1, P611; Hager-Ross C, 2002, ACTA PAEDIATR, V91, P617, DOI 10.1080/080352502760068990; Haghighi MM, 2012, PROCD SOC BEHV, V36, P287, DOI 10.1016/j.sbspro.2012.03.032; Hong YL, 2000, GAIT POSTURE, V11, P254, DOI 10.1016/S0966-6362(00)00055-2; JEONG BY, 1990, ERGONOMICS, V33, P1511, DOI 10.1080/00140139008925350; KINOSHITA H, 1985, ERGONOMICS, V28, P1347, DOI 10.1080/00140138508963251; LaFiandra M, 2003, J BIOMECH, V36, P87, DOI 10.1016/S0021-9290(02)00243-9; Li JX, 2003, EUR J APPL PHYSIOL, V90, P35, DOI 10.1007/s00421-003-0848-9; Marx A., 2000, LEARNING ENVIRONMENT, V2, P249, DOI DOI 10.1023/A:1009901922191; Ministry of Education Culture Sports Science and Technology [MEXT) of Japan, 2014, PHYS FITN MOT AB INV; Ministry of Education Culture Sports Science and Technology of Japan, 2005, GUID START SCH; Ministry of Internal Affairs and Communications Statistics Bureau of Japan, 2014, PHYS FITN MOT AB INV; NIOSH, 1981, 81122 NIOSH US DEP H; NOTTRODT JW, 1989, ERGONOMICS, V32, P945, DOI 10.1080/00140138908966856; O'Loughlin J, 2000, AM J EPIDEMIOL, V152, P739, DOI 10.1093/aje/152.8.739; Purwaningrum L, 2011, P 4 INT PROD DES DEV; Purwaningrum L, 2014, P 1 AS C ERG DES 201; Rebok G, 2001, QUAL LIFE RES, V10, P59, DOI 10.1023/A:1016693417166; Rosyidi Cucuk Nur, 2014, Applied Mechanics and Materials, V660, P1057, DOI 10.4028/www.scientific.net/AMM.660.1057; Saarni L, 2007, ERGONOMICS, V50, P1561, DOI 10.1080/00140130701587368; Sander M, 1979, WEIGHT SCHOOLBAGS FR, P251; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; SNOOK SH, 1991, ERGONOMICS, V34, P1197, DOI 10.1080/00140139108964855; TANNER JM, 1966, ARCH DIS CHILD, V41, P454; Wannarka R, 2008, SUPPORT LEARN, V23, P89, DOI 10.1111/j.1467-9604.2008.00375.x; WATERLOW JC, 1977, B WORLD HEALTH ORGAN, V55, P489; WATERS TR, 1993, ERGONOMICS, V36, P749, DOI 10.1080/00140139308967940; Yosita L, 2006, DIMENSI TEKNIK ARSIT, V34, P122	44	6	6	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128843	10.1371/journal.pone.0128843	http://dx.doi.org/10.1371/journal.pone.0128843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053154	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300061
J	Spaulding, AC; MacGowan, RJ; Copeland, B; Shrestha, RK; Bowden, CJ; Kim, MJ; Margolis, A; Mustaafaa, G; Reid, LC; Heilpern, KL; Shah, BB				Spaulding, Anne C.; MacGowan, Robin J.; Copeland, Brittney; Shrestha, Ram K.; Bowden, Chava J.; Kim, Min J.; Margolis, Andrew; Mustaafaa, Genetha; Reid, Laurie C.; Heilpern, Katherine L.; Shah, Bijal B.			Costs of Rapid HIV Screening in an Urban Emergency Department and a Nearby County Jail in the Southeastern United States	PLOS ONE			English	Article							ADULTS; CARE	Emergency departments and jails provide medical services to persons at risk for HIV infection and are recommended venues for HIV screening. Our main objective in this study was to analyze the cost per new HIV diagnosis associated with the HIV screening program in these two venues. The emergency department's parallel testing program was conducted at Grady Memorial Hospital in Atlanta, Georgia starting in 2008; the jail's integrated testing program began at the Fulton County (GA) Jail in 2011. The two sites, four miles apart from one another, employed the same rapid HIV test. Ascertainment that cases were new differed by site; only the jail systematically checked identities against health department HIV registries. The program in the emergency department used dedicated HIV test counselors and made 242 diagnoses over a 40-month period at a cost of $2,981 per diagnosis. The jail program used staff nurses, and found 41 new HIV cases over 10.5 months at a cost of $6,688 per new diagnosis. Differences in methods for ascertainment of new diagnoses, previously undiagnosed HIV sero-positivity, and methodologies used for assessing program costs prevent concluding that one program was more economical than the other. Nonetheless, our findings show that testing in both venues yielded many new diagnoses, with the costs within the range reported in the literature.	[Spaulding, Anne C.; Bowden, Chava J.; Kim, Min J.; Mustaafaa, Genetha] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA; [MacGowan, Robin J.; Shrestha, Ram K.; Margolis, Andrew; Reid, Laurie C.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Copeland, Brittney; Heilpern, Katherine L.; Shah, Bijal B.] Emory Sch Med, Dept Emergency Med, Atlanta, GA USA	Emory University; Rollins School Public Health; Centers for Disease Control & Prevention - USA; Emory University	Spaulding, AC (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA.	ASpauld@emory.edu		MacGowan, Robin/0000-0002-8712-2849; Kim, Min Jung/0000-0003-3561-9308	ACS BBS;  [P30 AI050409];  [1H62PS003187-01]; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION [H62PS003187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	ACS BBS; ; ; NATIONAL CENTER FOR HIV, VIRAL HEPATITIS, STDS AND TB PREVENTION(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by www.cdc.gov; P30 AI050409 and 1H62PS003187-01; and ACS BBS. Under this collaborative project, CDC project officers contributed to the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 18 CDCP; [Anonymous], 2009, HIV TEST IMPL GUID C; Beckwith CG, 2007, AIDS PATIENT CARE ST, V21, P41, DOI 10.1089/apc.2006.006; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Centers for Disease Control and Prevention, 2012, 17 CDCP; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P429; Copeland B, 2012, AIDS PATIENT CARE ST, V26, P202, DOI 10.1089/apc.2011.0303; Fortuna RJ, 2010, J GEN INTERN MED, V25, P663, DOI 10.1007/s11606-010-1313-1; Hammett TH, 2007, 2001IJCXK018; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haukoos JS, 2010, JAMA-J AM MED ASSOC, V304, P284, DOI 10.1001/jama.2010.953; Heffelfinger JD, 2011, FUTURE VIROL, V6, P1299, DOI 10.2217/FVL.11.114; La Vigne NG, 2004, PRISONER REENTRY GEO; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Rothman RE, 2011, ANN EMERG MED, V58, pS3, DOI 10.1016/j.annemergmed.2011.03.016; Shrestha RK, 2012, J PUBLIC HEALTH MAN, V18, P259, DOI 10.1097/PHH.0b013e31822b2077; Shrestha RK, 2009, SEXUALLY TRANSMITTED, V36; Spaulding AC, 2013, MMWR-MORBID MORTAL W, V62, P495; U.S. Census Bureau, AM FACTFINDER TABL D; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Western Bruce, 2006, PUNISHMENT AND INEQU; Wheatley MA, 2011, J URBAN HEALTH, V88, P1015, DOI 10.1007/s11524-011-9588-z	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128408	10.1371/journal.pone.0128408	http://dx.doi.org/10.1371/journal.pone.0128408			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053140	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300035
J	Chen, JL; Zhou, X; Zeng, M; Wu, XC				Chen, Jieling; Zhou, Xiao; Zeng, Min; Wu, Xinchun			Post-Traumatic Stress Symptoms and Post-Traumatic Growth: Evidence from a Longitudinal Study following an Earthquake Disaster	PLOS ONE			English	Article							ADOLESCENTS; CHILDREN; CANCER	Objective The current longitudinal study aims to examine the bidirectional relationship between post-traumatic stress symptoms (PTSS) and post-traumatic growth (PTG). Method One hundred twenty-two adults in the most severely affected area were investigated by self-report questionnaires at 12 months and 18 months after the Wenchuan Earthquake occurred in China. Results The autoregressive cross-lagged structure equation analysis revealed that PTG at 12 months post-earthquake could negatively predict PTSS at 18 months post-earthquake above and beyond PTSS stability, whereas PTSS at 12 months post-earthquake could not significantly predict subsequent PTG. Moreover, PTG at 12 months post-earthquake could predict fewer subsequent intrusions, numbing and hyper-arousal symptoms but not avoidance symptoms. Conclusion Growth can play a role in reducing long-term post-traumatic stress symptoms, and the implication of a positive perspective in post-trauma circumstance is discussed.	[Chen, Jieling; Zhou, Xiao; Zeng, Min; Wu, Xinchun] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China	Beijing Normal University	Wu, XC (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	xcwu@bnu.edu.cn			"Key Projects of Humanities and Social Sciences Key Research Base, Ministry of Education, China" [11JD190006]	"Key Projects of Humanities and Social Sciences Key Research Base, Ministry of Education, China"	The study was supported by "Key Projects of Humanities and Social Sciences Key Research Base, Ministry of Education, China". The grant number is No. 11JD190006 (http://www.sinoss.net/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Anderson T.W., 1960, MATH METHODS SOCIAL, P205; Asmundson GJG, 2004, J TRAUMA STRESS, V17, P467, DOI 10.1007/s10960-004-5795-7; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bluvstein I, 2013, J CLIN PSYCHOL MED S, V20, P164, DOI 10.1007/s10880-012-9318-z; Bonanno GA, 2004, AM PSYCHOL, V59, P20, DOI 10.1037/0003-066X.59.1.20; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Browne M. W., 1993, TESTING STRUCTURAL E, P136, DOI DOI 10.1177/0049124192021002005; Calhoun L., 1999, FACILITATING POSTTRA; Calhoun L.G., 2006, HDB POSTTRAUMATIC GR; Calhoun PS, 2012, DEPRESS ANXIETY, V29, P1032, DOI 10.1002/da.22012; Copeland WE, 2007, ARCH GEN PSYCHIAT, V64, P577, DOI 10.1001/archpsyc.64.5.577; Cordova MJ, 2001, HEALTH PSYCHOL, V20, P176, DOI 10.1037//0278-6133.20.3.176; Davis CG, 1998, J PERS SOC PSYCHOL, V75, P561, DOI 10.1037/0022-3514.75.2.561; Dekel S, 2012, PSYCHOL TRAUMA-US, V4, P94, DOI 10.1037/a0021865; Erbes C., 2005, TRAUMATOLOGY, V11, P285, DOI DOI 10.1177/153476560501100407; Frazier P, 2001, J CONSULT CLIN PSYCH, V69, P1048, DOI 10.1037//0022-006X.69.6.1048; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; [黄国平 HUANG GuoPing], 2006, [中国心理卫生杂志, Chinese Mental Health Journal], V20, P28; Joseph S., 2008, TRAUMA RECOVERY GROW, P3, DOI [https://doi.org/10.1002/9781118269718.ch1, DOI 10.1002/9781118269718.CH1, DOI 10.1002/9781118269718]; King DW, 1998, PSYCHOL ASSESSMENT, V10, P90, DOI 10.1037/1040-3590.10.2.90; McElheran M, 2012, COUNS PSYCHOL Q, V25, P73, DOI 10.1080/09515070.2012.665225; McMillen JC, 1997, J CONSULT CLIN PSYCH, V65, P733, DOI 10.1037/0022-006X.65.5.733; McWilliams LA, 2005, J ANXIETY DISORD, V19, P626, DOI 10.1016/j.janxdis.2004.06.003; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Muthen BO, 2012, MPLUS VERSION 7 0; Norris FH, 2002, PSYCHIATRY, V65, P207, DOI 10.1521/psyc.65.3.207.20173; Phelps LF, 2008, REHABIL PSYCHOL, V53, P28, DOI 10.1037/0090-5550.53.1.28; Sahin NH, 2007, J TRAUMA STRESS, V20, P335, DOI 10.1002/jts.20217; Salsman JM, 2009, PSYCHO-ONCOLOGY, V18, P30, DOI 10.1002/pon.1367; Shigemoto Y, 2013, PSYCHOL TRAUMA-US, V5, P128, DOI 10.1037/a0026647; Taylor SE, 1996, J PERS, V64, P873, DOI 10.1111/j.1467-6494.1996.tb00947.x; Tedeschi R.G., 1995, TRAUMA TRANSFORMATIO, DOI [10.4135/9781483326931, DOI 10.4135/9781483326931]; Tedeschi RG, 2004, PSYCHOL INQ, V15, P1, DOI 10.1207/s15327965pli1501_01; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Weiss Daniel S., 1997, P399; Zhou X.-Y., 2014, ADV SCI TECHNOLOGY L, V46, P1; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008	38	32	34	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127241	10.1371/journal.pone.0127241	http://dx.doi.org/10.1371/journal.pone.0127241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046912	gold, Green Published			2022-12-26	WOS:000355652200017
J	Jiang, N; Leithold, LHE; Post, J; Ziehm, T; Mauler, J; Gremer, L; Cremer, M; Schartmann, E; Shah, NJ; Kutzsche, J; Langen, KJ; Breitkreutz, J; Willbold, D; Willuweit, A				Jiang, Nan; Leithold, Leonie H. E.; Post, Julia; Ziehm, Tamar; Mauler, Joerg; Gremer, Lothar; Cremer, Markus; Schartmann, Elena; Shah, N. Jon; Kutzsche, Janine; Langen, Karl-Josef; Breitkreutz, Joerg; Willbold, Dieter; Willuweit, Antje			Preclinical Pharmacokinetic Studies of the Tritium Labelled D-Enantiomeric Peptide D3 Developed for the Treatment of Alzheimer's Disease	PLOS ONE			English	Article							IMAGE PHAGE DISPLAY; DOUBLE TRANSGENIC MICE; PROTEIN; MIRROR; INFLAMMATION; DELIVERY; MODELS; BRAIN; BLOOD; BODY	Targeting toxic amyloid beta (A beta) oligomers is currently a very attractive drug development strategy for treatment of Alzheimer's disease. Using mirror-image phage display against A beta 1-42, we have previously identified the fully D-enantiomeric peptide D3, which is able to eliminate A beta oligomers and has proven therapeutic potential in transgenic Alzheimer's disease animal models. However, there is little information on the pharmacokinetic behaviour of D-enantiomeric peptides in general. Therefore, we conducted experiments with the tritium labelled D-peptide D3 (H-3-D3) in mice with different administration routes to study its distribution in liver, kidney, brain, plasma and gastrointestinal tract, as well as its bioavailability by i.p. and p.o. administration. In addition, we investigated the metabolic stability in liver microsomes, mouse plasma, brain, liver and kidney homogenates, and estimated the plasma protein binding. Based on its high stability and long biological half-life, our pharmacokinetic results support the therapeutic potential of D-peptides in general, with D3 being a new promising drug candidate for Alzheimer's disease treatment.	[Jiang, Nan; Leithold, Leonie H. E.; Post, Julia; Ziehm, Tamar; Gremer, Lothar; Schartmann, Elena; Kutzsche, Janine; Willbold, Dieter] Forschungszentrum Julich, Inst Complex Syst ICS 6, Struct Biochem, D-52425 Julich, Germany; [Mauler, Joerg; Shah, N. Jon; Langen, Karl-Josef; Willuweit, Antje] Forschungszentrum Julich, Inst Neurosci & Med INM 4, Med Imaging Phys, D-52425 Julich, Germany; [Gremer, Lothar] Forschungszentrum Julich, Inst Neurosci & Med INM 1, Struct & Funct Org Brain, D-52425 Julich, Germany; [Langen, Karl-Josef] Rhein Westfal TH Aachen, Univ Klinikum, Dept Nucl Med, D-52062 Aachen, Germany; [Breitkreutz, Joerg] Univ Dusseldorf, Inst Pharmaceut & Biopharmaceut, Dusseldorf, Germany; [Willbold, Dieter] Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; RWTH Aachen University; RWTH Aachen University Hospital; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Willbold, D (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS 6, Struct Biochem, D-52425 Julich, Germany.	D.Willbold@fz-juelich.de; A.Willuweit@fz-juelich.de	Kutzsche, Janine/G-6287-2013; Langen, Karl-Josef/H-4396-2013; Gremer, Lothar/H-9128-2013; Shah, N. Jon/H-5849-2013; Breitkreutz, Joerg/B-9581-2017; Willbold, Dieter/A-6280-2013	Kutzsche, Janine/0000-0003-0271-7390; Langen, Karl-Josef/0000-0003-1101-5075; Gremer, Lothar/0000-0001-7065-5027; Shah, N. Jon/0000-0002-8151-6169; Breitkreutz, Joerg/0000-0002-3982-9823; Willbold, Dieter/0000-0002-0065-7366; Schartmann, Anna Elena/0000-0001-6791-4761; Willuweit, Antje/0000-0002-6725-0755; Ziehm, Tamar/0000-0003-0957-2518	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; "Portfolio Drug Design" of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft	Portfolio Technology and Medicine; Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; "Portfolio Drug Design" of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft	DW was supported by grants from the "Portfolio Technology and Medicine" and the Helmholtz-Validierungsfonds of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft; KJL and DW were supported by the "Portfolio Drug Design" of the Impuls und Vernetzungs-Fonds der Helmholtzgemeinschaft (http://www.helmholtz.de/ueber_uns/impuls_und_vernetzungsfonds; no grant numbers available). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berchtold NC, 1998, NEUROBIOL AGING, V19, P173, DOI 10.1016/S0197-4580(98)00052-9; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Chapman ME, 2010, AM J PHYSIOL-RENAL, V299, pF280, DOI 10.1152/ajprenal.00113.2010; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Fletcher L.C.B., 2013, GMS HLTH TECHNOL ASS, V9, DOI [10.3205/HTA000107, DOI 10.3205/HTA000107]; Funke SA, 2010, ACS CHEM NEUROSCI, V1, P639, DOI 10.1021/cn100057j; Kayed R, 2013, J ALZHEIMERS DIS, V33, pS67, DOI 10.3233/JAD-2012-129001; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Lalatsa A, 2012, MOL PHARMACEUT, V9, P1764, DOI 10.1021/mp300068j; Liu M, 2010, P NATL ACAD SCI USA, V107, P14321, DOI 10.1073/pnas.1008930107; Mason JM, 2010, FUTURE MED CHEM, V2, P1813, DOI [10.4155/fmc.10.259, 10.4155/FMC.10.259]; Mikulca JA, 2014, J CLIN PHARM THER, V39, P25, DOI 10.1111/jcpt.12112; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; Nygaard HB, 2013, CLIN THER, V35, P1480, DOI 10.1016/j.clinthera.2013.09.009; Pollaro L, 2010, MEDCHEMCOMM, V1, P319, DOI 10.1039/c0md00111b; Reichel A, 2006, CURR DRUG METAB, V7, P183, DOI 10.2174/138920006775541525; Schenk D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006387; Schumacher TNM, 1996, SCIENCE, V271, P1854, DOI 10.1126/science.271.5257.1854; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Stockley JH, 2008, CELL MOL LIFE SCI, V65, P3265, DOI 10.1007/s00018-008-8271-3; Sun N, 2012, MINI-REV MED CHEM, V12, P388, DOI 10.2174/138955712800493942; Takagi H, 2010, PEPTIDES, V31, P1421, DOI 10.1016/j.peptides.2010.04.032; Tamaoka Akira, 2013, Rinsho Byori, V61, P1060; TD B, 1993, GENEREVIEWS R; van Groen T, 2013, J ALZHEIMERS DIS, V34, P609, DOI 10.3233/JAD-121792; van Groen T, 2012, ADV PROTEIN CHEM STR, V88, P133, DOI 10.1016/B978-0-12-398314-5.00005-2; van Groen T, 2008, CHEMMEDCHEM, V3, P1848, DOI 10.1002/cmdc.200800273; van Groen T, 2009, CHEMMEDCHEM, V4, P276, DOI 10.1002/cmdc.200800289; Wiesehan K, 2003, CHEMBIOCHEM, V4, P811, DOI 10.1002/cbic.200300570; Wong TW, 2010, J DRUG TARGET, V18, P79, DOI 10.3109/10611860903302815; ZAWADZKE LE, 1992, J AM CHEM SOC, V114, P4002, DOI 10.1021/ja00036a073	31	26	26	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128553	10.1371/journal.pone.0128553	http://dx.doi.org/10.1371/journal.pone.0128553			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046986	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200078
J	Ligeti, B; Penzvalto, Z; Vera, R; Gyorffy, B; Pongor, S				Ligeti, Balazs; Penzvalto, Zsofia; Vera, Roberto; Gyorffy, Balazs; Pongor, Sandor			A Network-Based Target Overlap Score for Characterizing Drug Combinations: High Correlation with Cancer Clinical Trial Results	PLOS ONE			English	Article							BREAST-CANCER; ADJUVANT CHEMOTHERAPY; ROC ANALYSIS; FOLLOW-UP; PRIORITIZATION; THERAPEUTICS; TRASTUZUMAB; EVALUATE; SEARCH; PLUS	Drug combinations are highly efficient in systemic treatment of complex multigene diseases such as cancer, diabetes, arthritis and hypertension. Most currently used combinations were found in empirical ways, which limits the speed of discovery for new and more effective combinations. Therefore, there is a substantial need for efficient and fast computational methods. Here, we present a principle that is based on the assumption that perturbations generated by multiple pharmaceutical agents propagate through an interaction network and can cause unexpected amplification at targets not immediately affected by the original drugs. In order to capture this phenomenon, we introduce a novel Target Overlap Score (TOS) that is defined for two pharmaceutical agents as the number of jointly perturbed targets divided by the number of all targets potentially affected by the two agents. We show that this measure is correlated with the known effects of beneficial and deleterious drug combinations taken from the DCDB, TTD and Drugs. com databases. We demonstrate the utility of TOS by correlating the score to the outcome of recent clinical trials evaluating trastuzumab, an effective anticancer agent utilized in combination with anthracycline-and taxane- based systemic chemotherapy in HER2-receptor (erb-b2 receptor tyrosine kinase 2) positive breast cancer.	[Ligeti, Balazs; Vera, Roberto; Pongor, Sandor] Pazmany Peter Catholic Univ, Fac Informat Technol, Budapest, Hungary; [Penzvalto, Zsofia; Gyorffy, Balazs] MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Vera, Roberto; Pongor, Sandor] Int Ctr Genet Engn & Biotechnol, Prot Struct & Bioinformat Grp, I-34012 Trieste, Italy; [Gyorffy, Balazs] Semmelweis Univ, Dept Pediat 2, H-1085 Budapest, Hungary; [Gyorffy, Balazs] MTA SE Pediat & Nephrol Res Grp, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; International Center for Genetic Engineering & Biotechnology (ICGEB); Semmelweis University; Semmelweis University	Gyorffy, B (corresponding author), MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary.	zsalab2@yahoo.com; pongor@icgeb.org	Gyorffy, Balazs/AAA-9135-2021	Gyorffy, Balazs/0000-0002-5772-3766; Vera Alvarez, Roberto/0000-0002-4108-5982	Hungarian Scientific Research Fund OTKA [K108655]	Hungarian Scientific Research Fund OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	LB and RV are graduate students at the Multidisciplinary Doctoral School of Sciences and Technology of Faculty of Information Technology, and Bionics, Pazmany Peter Catholic University, Budapest, Hungary. BG was supported by grant K108655 from the Hungarian Scientific Research Fund OTKA.	Agoston V, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.051909; [Anonymous], 2008, WALKING INTERACTOME; [Anonymous], 2005, P 11 ACM SIGKDD INT; [Anonymous], 2011, NUCL ACIDS RES DATAB; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Busa-Fekete R, 2008, J BIOCHEM BIOPH METH, V70, P1210, DOI 10.1016/j.jbbm.2007.06.003; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Cokol M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.71; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Dawood S, 2010, J CLIN ONCOL, V28, P92, DOI 10.1200/JCO.2008.19.9844; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gottlieb A, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.26; GRECO WR, 1995, PHARMACOL REV, V47, P331; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hosmer DW, 2013, WILEY SERIES PROBABI; Imming P, 2006, NAT REV DRUG DISCOV, V5, P821, DOI 10.1038/nrd2132; Jin GX, 2011, BIOINFORMATICS, V27, pI310, DOI 10.1093/bioinformatics/btr202; Katzung BGMSBTAJ, 2012, BASIC CLINICAL PHARM; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kuhn M, 2012, NUCLEIC ACIDS RES, V40, pD876, DOI 10.1093/nar/gkr1011; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Li S, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S1-S10; Ligeti B, 2013, BIOM CIRC SYST C BIO; Liu YB, 2010, BIOINFORMATICS, V26, P587, DOI 10.1093/bioinformatics/btp697; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Nitsch D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-460; O'Boyle NM, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-24; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Smith I, 2007, LANCET, V369, P29, DOI 10.1016/S0140-6736(07)60028-2; Sonego P, 2008, BRIEF BIOINFORM, V9, P198, DOI 10.1093/bib/bbm064; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Vera R, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat051; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105; Wu ZK, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S7; Xiong JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013937; Xu KJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S1-S5; Yang K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.60; Young SS, 1993, RESAMPLING BASED MUL; Zhao XM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002323; Zhu F, 2012, NUCLEIC ACIDS RES, V40, pD1128, DOI 10.1093/nar/gkr797; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	50	6	9	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129267	10.1371/journal.pone.0129267	http://dx.doi.org/10.1371/journal.pone.0129267			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047322	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000355652200140
J	Najjar, A; Amro, Y; Kitaneh, I; Abu-Sharar, S; Sawalha, M; Jamous, A; Qiq, M; Makharzeh, E; Laban, BS; Amro, W; Amro, A				Najjar, Anas; Amro, Yazan; Kitaneh, Islam; Abu-Sharar, Salam; Sawalha, Maryam; Jamous, Abrar; Qiq, Muhannad; Makharzeh, Enas; Laban, Bayan Subb; Amro, Wafa; Amro, Ahmad			Knowledge and Adherence to Medications among Palestinian Geriatrics Living with Chronic Diseases in the West Bank and East Jerusalem	PLOS ONE			English	Article							PITTSBURGH EPIDEMIOLOGY; SOCIOECONOMIC-STATUS; PATIENT ADHERENCE; ELDERLY-PATIENTS; OLDER; NONADHERENCE; ASSOCIATION; THERAPY; ADULTS; RECOMMENDATIONS	Background Adequate patient knowledge about medications is essential for appropriate drug taking behavior and patient adherence. This study aims to assess and quantify the level of knowledge and adherence to medications among Palestinian geriatrics living with chronic diseases and to investigate possible associated socio-demographic characteristics. Methods and Findings We conducted a cross-sectional study during June 2013 and January 2014 among Palestinian geriatrics >= 60 years old living with chronic disease in the West Bank and East Jerusalem. A stratified random sample was selected and a questionnaire-assisted interview was applied for data collection. T-test was applied for bivariate analyzing and one-way ANOVA test was applied for multivariate analyses. Results A total of 1192 Palestinian geriatrics were studied. The average age was 70.3 (SD=8.58) years and ranged from 60-110 years. The sample comprised 659 (55.3%) females and 533 (44.7%) males. The global knowledge and global adherence scores were (67.57%) and (89.29%), respectively. Adequate levels of knowledge were 71.4%, and of adherence 75%, which were recorded for 705 (59.1%) and 1088 (91.3%) participants, respectively. Significant higher levels of global knowledge and global adherence were recorded for males, and for participants who hold a Bachelor's degree, those who live on their own, and did physical activity for more than 40 hours/week (p-value <0.05). Furthermore, workers, participants with a higher monthly income, and non-smokers have a higher knowledge level with (p-value <0.05). We found positive correlation between participants' global adherence and global knowledge (r=0.487 and p-value <0.001). Negative correlation was found between participants' global knowledge and adherence with age (r=-0.236, p-value < 0.001 and r=-0.211 and p-value <0.001, respectively. Negative correlation between global knowledge and the number of drugs taken (r=-0.130, p-value <0.001) was predicted. Conclusion We concluded that patients with a higher level of knowledge are more adherent to their medications and that better understanding of socio-demographic factors has a clear influence on the level of knowledge and adherence to medications and thus contributes to the development of guidelines for treatment and may consequently lead to favourable clinical outcomes and savings of health care costs.	[Najjar, Anas; Kitaneh, Islam; Abu-Sharar, Salam; Sawalha, Maryam; Jamous, Abrar; Qiq, Muhannad; Makharzeh, Enas; Laban, Bayan Subb; Amro, Wafa; Amro, Ahmad] Al Quds Univ, Fac Pharm, Jerusalem, Israel; [Amro, Yazan] Al Quds Univ, Fac Med, Jerusalem, Israel		Amro, A (corresponding author), Al Quds Univ, Fac Pharm, Jerusalem, Israel.	aamro@pharm.alquds.edu	Amro, Ahmad/AAB-1778-2019	Amro, Ahmad/0000-0003-4123-2679				Alkatheri AM, 2013, ANN THORAC MED, V8, P105, DOI 10.4103/1817-1737.109823; ASCIONE FJ, 1986, MED CARE, V24, P1018, DOI 10.1097/00005650-198611000-00006; Barat I, 2001, BRIT J CLIN PHARMACO, V51, P615, DOI 10.1046/j.0306-5251.2001.01401.x; Burge S, 2005, FAM MED, V37, P712; CHUTKA DS, 1995, MAYO CLIN PROC, V70, P685, DOI 10.4065/70.7.685; Cline CMJ, 1999, EUR J HEART FAIL, V1, P145, DOI 10.1016/S1388-9842(99)00014-8; Colom F, 2005, BIPOLAR DISORD, V7, P24, DOI 10.1111/j.1399-5618.2005.00248.x; Cramer JA, 2008, INT J CLIN PRACT, V62, P76, DOI 10.1111/j.1742-1241.2007.01630.x; DiMatteo MR, 2002, MED CARE, V40, P794, DOI 10.1097/01.MLR.0000024612.61915.2D; DiMatteo MR, 2004, MED CARE, V42, P200, DOI 10.1097/01.mlr.0000114908.90348.f9; Dunbar-Jacob J, 2001, J CLIN EPIDEMIOL, V54, pS57, DOI 10.1016/S0895-4356(01)00457-7; Gadkari AS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-98; GERMAN PS, 1982, J AM GERIATR SOC, V30, P568, DOI 10.1111/j.1532-5415.1982.tb05663.x; Gurwitz JH, 2003, JAMA-J AM MED ASSOC, V289, P1107, DOI 10.1001/jama.289.9.1107; Hajjar Emily R, 2003, Am J Geriatr Pharmacother, V1, P82; Halpern MT, 2006, HYPERTENSION, V47, P1039, DOI 10.1161/01.HYP.0000222373.59104.3d; Hayes BD, 2009, J AM GERIATR SOC, V57, P653, DOI 10.1111/j.1532-5415.2008.02166.x; Hope CJ, 2004, AM J HEALTH-SYST PH, V61, P2043, DOI 10.1093/ajhp/61.19.2043; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Huther J, 2013, PATIENT PREFER ADHER, V7, P237, DOI 10.2147/PPA.S38373; Kalichman SC, 1999, J NATL MED ASSOC, V91, P439; Langkamp DL, 2001, AM J PERINAT, V18, P345, DOI 10.1055/s-2001-17860; Olivares JM, 2013, PATIENT PREFER ADHER, V7, P121, DOI [10.2147/PPA.S37534, 10.2147/PPA.537534]; Marks JR, 2010, PATIENT EDUC COUNS, V78, P372, DOI 10.1016/j.pec.2009.06.017; McDonald HP, 2002, JAMA-J AM MED ASSOC, V288, P2868, DOI 10.1001/jama.288.22.2868; Modig S, 2009, EUR J CLIN PHARMACOL, V65, P151, DOI 10.1007/s00228-008-0581-8; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Okuyan B, 2013, PHARMACOEPIDEM DR S, V22, P209, DOI 10.1002/pds.3275; Ownby RL, 2006, GERIATRICS, V61, P30; Piette JD, 2005, ARCH INTERN MED, V165, P1749, DOI 10.1001/archinte.165.15.1749; Ponnusankar S, 2004, PATIENT EDUC COUNS, V54, P55, DOI 10.1016/s0738-3991(03)00193-9; Secrest AM, 2011, ANN EPIDEMIOL, V21, P374, DOI 10.1016/j.annepidem.2011.02.007; Secrest AM, 2011, ANN EPIDEMIOL, V21, P367, DOI 10.1016/j.annepidem.2011.02.011; Sokol MC, 2005, MED CARE, V43, P521, DOI 10.1097/01.mlr.0000163641.86870.af; Val Jimenez A, 1992, Aten Primaria, V10, P767; van Eijken M, 2003, DRUG AGING, V20, P229, DOI 10.2165/00002512-200320030-00006; Wasti SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035547; Wroth TH, 2006, J AM BOARD FAM MED, V19, P478, DOI 10.3122/jabfm.19.5.478; Yaya I, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1308	39	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129240	10.1371/journal.pone.0129240	http://dx.doi.org/10.1371/journal.pone.0129240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046771	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200136
J	Wang, WY; Shen, T; Guerois, R; Zhang, FM; Kuerban, H; Lv, YC; Gigant, B; Knossow, M; Wang, CG				Wang, Weiyi; Shen, Ting; Guerois, Raphael; Zhang, Fuming; Kuerban, Hureshitanmu; Lv, Yuncong; Gigant, Benoit; Knossow, Marcel; Wang, Chunguang			New Insights into the Coupling between Microtubule Depolymerization and ATP Hydrolysis by Kinesin-13 Protein Kif2C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTROMERE-ASSOCIATED KINESIN; TUBULIN; COMPLEX; MODEL; MCAK; MECHANISM; SOFTWARE; MOTILITY; BINDING; DOMAIN	Kinesin-13 proteins depolymerize microtubules in an ATP hydrolysis-dependent manner. The coupling between these two activities remains unclear. Here, we first studied the role of the kinesin-13 subfamily-specific loop 2 and of the KVD motif at the tip of this loop. Shortening the loop, the lysine/glutamate interchange and the additional Val to Ser substitution all led to Kif2C mutants with decreased microtubule-stimulated ATPase and impaired depolymerization capability. We rationalized these results based on a structural model of the Kif2C-ATP-tubulin complex derived from the recently determined structures of kinesin-1 bound to tubulin. In this model, upon microtubule binding Kif2C undergoes a conformational change governed in part by the interaction of the KVD motif with the tubulin inter-dimer interface. Second, we mutated to an alanine the conserved glutamate residue of the switch 2 nucleotide binding motif. This mutation blocks motile kinesins in a post-conformational change state and inhibits ATP hydrolysis. This Kif2C mutant still depolymerized microtubules and yielded complexes of one Kif2C with two tubulin heterodimers. These results demonstrate that the structural change of Kif2C-ATP upon binding to microtubule ends is sufficient for tubulin release, whereas ATP hydrolysis is not required. Overall, our data suggest that the conformation reached by kinesin-13s upon tubulin binding is similar to that of tubulin-bound, ATP-bound, motile kinesins but that this conformation is adapted to microtubule depolymerization.	[Wang, Weiyi; Shen, Ting; Zhang, Fuming; Kuerban, Hureshitanmu; Lv, Yuncong; Wang, Chunguang] Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China; [Wang, Weiyi; Guerois, Raphael; Gigant, Benoit; Knossow, Marcel] Univ Paris Sud, CNRS, CEA, Inst Integrat Biol Cell, F-91198 Gif Sur Yvette, France; [Guerois, Raphael] Inst Biol & Technol Saclay iBiTecS, CEA, F-91191 Gif Sur Yvette, France	Tongji University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Wang, CG (corresponding author), Tongji Univ, Inst Prot Res, Shanghai 200092, Peoples R China.	chunguangwang@tongji.edu.cn	, raph/AAF-4380-2019; Wang, Weiyi/GZN-0408-2022	Gigant, Benoit/0000-0002-5946-6759	National Science Foundation of China [30700125, 31370771]; Ministry of Education of China [20130072110031]; Agence Nationale de la Recherche [ANR-12-BSV8-0002-01]; Fondation ARC pour la Recherche sur le Cancer	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported by National Science Foundation of China Grants 30700125 and 31370771 and Specialized Research Fund for the Doctoral Program of Ministry of Education of China Grant 20130072110031 (to C. W.) and by Agence Nationale de la Recherche Grant ANR-12-BSV8-0002-01 (to B. G.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Fondation ARC pour la Recherche sur le Cancer postdoctoral fellowship.	AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; Asenjo AB, 2013, CELL REP, V3, P759, DOI 10.1016/j.celrep.2013.01.030; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bricogne G., 2011, BUSTER; Cao LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6364; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Cross RA, 2004, TRENDS BIOCHEM SCI, V29, P301, DOI 10.1016/j.tibs.2004.04.010; Dagenbach EM, 2004, J CELL SCI, V117, P3, DOI 10.1242/jcs.00875; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friel CT, 2011, EMBO J, V30, P3928, DOI 10.1038/emboj.2011.290; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Gigant B, 2013, NAT STRUCT MOL BIOL, V20, P1001, DOI 10.1038/nsmb.2624; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kobayashi T, 2011, CELL, V145, P914, DOI 10.1016/j.cell.2011.04.028; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Maney T, 2001, J BIOL CHEM, V276, P34753, DOI 10.1074/jbc.M106626200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Moores CA, 2006, CELL CYCLE, V5, P1812, DOI 10.4161/cc.5.16.3134; Mulder AM, 2009, J CELL BIOL, V185, P51, DOI 10.1083/jcb.200812052; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sanhaji M, 2011, ONCOTARGET, V2, P935; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; Tan DY, 2008, STRUCTURE, V16, P1732, DOI 10.1016/j.str.2008.08.017; Tan DY, 2006, J CELL BIOL, V175, P25, DOI 10.1083/jcb.200605194; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wagenbach M, 2008, J CELL BIOL, V183, P617, DOI 10.1083/jcb.200805145; Walczak CE, 2013, ANNU REV CELL DEV BI, V29, P417, DOI 10.1146/annurev-cellbio-101512-122345; Wang WY, 2012, J BIOL CHEM, V287, P15143, DOI 10.1074/jbc.M111.317859; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	39	12	13	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18721	18731		10.1074/jbc.M115.646919	http://dx.doi.org/10.1074/jbc.M115.646919			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055718	hybrid, Green Published			2022-12-26	WOS:000358512100040
J	Hampe, L; Radjainia, M; Xu, C; Harris, PWR; Bashiri, G; Goldstone, DC; Brimble, MA; Wang, Y; Mitra, AK				Hampe, Lutz; Radjainia, Mazdak; Xu, Cheng; Harris, Paul W. R.; Bashiri, Ghader; Goldstone, David C.; Brimble, Margaret A.; Wang, Yu; Mitra, Alok K.			Regulation and Quality Control of Adiponectin Assembly by Endoplasmic Reticulum Chaperone ERp44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-WEIGHT ADIPONECTIN; PHASE PEPTIDE-SYNTHESIS; TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; CRYSTAL-STRUCTURE; VARIABLE DOMAIN; DISULFIDE-BOND; DSBA-L; PROTEIN; SECRETION	Adiponectin, a collagenous hormone secreted abundantly from adipocytes, possesses potent antidiabetic and anti-inflammatory properties. Mediated by the conserved Cys(39) located in the variable region of the N terminus, the trimeric (low molecular weight (LMW)) adiponectin subunit assembles into different higher order complexes, e.g. hexamers (middle molecular weight (MMW)) and 12-18-mers (high molecular weight (HMW)), the latter being mostly responsible for the insulin-sensitizing activity of adiponectin. The endoplasmic reticulum (ER) chaperone ERp44 retains adiponectin in the early secretory compartment and tightly controls the oxidative state of Cys39 and the oligomerization of adiponectin. Using cellular and in vitro assays, we show that ERp44 specifically recognizes the LMW and MMW forms but not the HMW form. Our binding assays with short peptide mimetics of adiponectin suggest that ERp44 intercepts and converts the pool of fully oxidized LMW and MMW adiponectin, but not the HMW form, into reduced trimeric precursors. These ERp44-bound precursors in the cis-Golgi may be transported back to the ER and released to enhance the population of adiponectin intermediates with appropriate oxidative state for HMW assembly, thereby underpinning the process of ERp44 quality control.	[Hampe, Lutz; Radjainia, Mazdak; Bashiri, Ghader; Goldstone, David C.; Mitra, Alok K.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand; [Xu, Cheng; Wang, Yu] Univ Hong Kong, State Key Lab Pharmaceut Biotechnol, Hong Kong 999007, Hong Kong, Peoples R China; [Xu, Cheng; Wang, Yu] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong 999007, Hong Kong, Peoples R China; [Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Sch Chem Sci, Auckland 1010, New Zealand; [Harris, Paul W. R.; Brimble, Margaret A.] Univ Auckland, Inst Innovat Biotechnol, Auckland 1010, New Zealand	University of Auckland; University of Auckland; University of Hong Kong; University of Hong Kong; University of Auckland; University of Auckland	Mitra, AK (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland 1010, New Zealand.	a.mitra@auckland.ac.nz	; Mitra, Alok/P-7800-2016; Bashiri, Ghader/R-4957-2017	Brimble, Margaret/0000-0002-7086-4096; wang, yu/0000-0001-8697-2940; Mitra, Alok/0000-0003-0891-5697; Goldstone, David/0000-0003-0069-9408; Bashiri, Ghader/0000-0002-5092-3749	University of Auckland; German Academic Exchange Service (DAAD) (Germany); Maurice Wilkins Centre for Molecular Biodiscovery; New Zealand Health Research Council; Rutherford Discovery Fellowship (New Zealand)	University of Auckland; German Academic Exchange Service (DAAD) (Germany)(Deutscher Akademischer Austausch Dienst (DAAD)); Maurice Wilkins Centre for Molecular Biodiscovery; New Zealand Health Research Council(Health Research Council of New Zealand); Rutherford Discovery Fellowship (New Zealand)(Royal Society of New Zealand)	This work was supported in part by a University of Auckland doctoral scholarship and the German Academic Exchange Service (DAAD) (Germany) (to L. H.), research funding from the Maurice Wilkins Centre for Molecular Biodiscovery (to A. K. M. and P. W. R. H.), and a New Zealand Health Research Council grant (to A. K. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Rutherford Discovery Fellowship (New Zealand).	ALBERICIO F, 1985, INT J PEPT PROT RES, V26, P92; Amblard M, 2006, MOL BIOTECHNOL, V33, P239, DOI 10.1385/MB:33:3:239; Anelli T, 2002, EMBO J, V21, P835, DOI 10.1093/emboj/21.4.835; Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844; Anelli Tiziana, 2013, Int J Cell Biol, V2013, P606703, DOI 10.1155/2013/606703; Anelli T, 2015, FREE RADICAL BIO MED, V83, P323, DOI 10.1016/j.freeradbiomed.2015.02.020; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Berner HS, 2004, BONE, V35, P842, DOI 10.1016/j.bone.2004.06.008; Briggs DB, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-24; Briggs DB, 2009, BIOCHEMISTRY-US, V48, P12345, DOI 10.1021/bi9015555; Garaulet M, 2007, PUBLIC HEALTH NUTR, V10, P1145, DOI 10.1017/S1368980007000638; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Goldstein BJ, 2004, J CLIN ENDOCR METAB, V89, P2563, DOI 10.1210/jc.2004-0518; Hara K, 2006, DIABETES CARE, V29, P1357, DOI 10.2337/dc05-1801; Harris PWR, 2014, BIOPOLYMERS, V102, P313, DOI 10.1002/bip.22501; Harris PWR, 2011, TETRAHEDRON LETT, V52, P6024, DOI 10.1016/j.tetlet.2011.09.010; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Kim JA, 2012, BIOSCIENCE REP, V32, P641, DOI 10.1042/BSR20120067; Kishore U, 2004, TRENDS IMMUNOL, V25, P551, DOI 10.1016/j.it.2004.08.006; Korner A, 2007, J CLIN ENDOCR METAB, V92, P1041, DOI 10.1210/jc.2006-1858; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P277, DOI [10.1007/978-0-387-46312-4, DOI 10.1007/978-0-387-46312-4_8]; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Otsu M, 2006, ANTIOXID REDOX SIGN, V8, P274, DOI 10.1089/ars.2006.8.274; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Pan CY, 2011, PROTEIN CELL, V2, P990, DOI 10.1007/s13238-011-1116-0; Peake PW, 2008, BIOCHEM BIOPH RES CO, V367, P560, DOI 10.1016/j.bbrc.2007.12.161; Qiang L, 2007, MOL CELL BIOL, V27, P4698, DOI 10.1128/MCB.02279-06; Radjainia M, 2008, J MOL BIOL, V381, P419, DOI 10.1016/j.jmb.2008.06.015; Radjainia M, 2012, FEBS J, V279, P2495, DOI 10.1111/j.1742-4658.2012.08630.x; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schraw T, 2008, ENDOCRINOLOGY, V149, P2270, DOI 10.1210/en.2007-1561; Shapiro L, 1998, CURR BIOL, V8, P335, DOI 10.1016/S0960-9822(98)70133-2; Shinoda Y, 2006, J CELL BIOCHEM, V99, P196, DOI 10.1002/jcb.20890; Simpson F, 2010, INT J BIOCHEM CELL B, V42, P785, DOI 10.1016/j.biocel.2009.12.021; Suzuki S, 2007, FEBS LETT, V581, P809, DOI 10.1016/j.febslet.2007.01.046; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; Tsao TS, 2003, J BIOL CHEM, V278, P50810, DOI 10.1074/jbc.M309469200; Vavassori S, 2013, MOL CELL, V50, P783, DOI 10.1016/j.molcel.2013.04.016; Wang LK, 2008, EMBO REP, V9, P642, DOI 10.1038/embor.2008.88; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2008, BIOCHEM J, V409, P623, DOI 10.1042/BJ20071492; Wang Y, 2007, CELL RES, V17, P280, DOI 10.1038/cr.2007.14; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Wang ZV, 2008, P NATL ACAD SCI USA, V105, P18077, DOI 10.1073/pnas.0810027105; Xu AM, 2005, J BIOL CHEM, V280, P18073, DOI 10.1074/jbc.M414231200; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233	48	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18111	18123		10.1074/jbc.M115.663088	http://dx.doi.org/10.1074/jbc.M115.663088			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26060250	hybrid, Green Published			2022-12-26	WOS:000358511700042
J	Pan, X; Chen, GQ; Kazachkov, M; Greer, MS; Caldo, KMP; Zou, JT; Weselake, RJ				Pan, Xue; Chen, Guanqun; Kazachkov, Michael; Greer, Michael S.; Caldo, Kristian Mark P.; Zou, Jitao; Weselake, Randall J.			In Vivo and in Vitro Evidence for Biochemical Coupling of Reactions Catalyzed by Lysophosphatidylcholine Acyltransferase and Diacylglycerol Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID ACCUMULATION; SACCHAROMYCES-CEREVISIAE; TRANSGENIC ARABIDOPSIS; LANDS CYCLE; YEAST; COA; METABOLISM; PLANTS; GLYCEROLIPIDS; EXPRESSION	Seed oils of flax (Linum usitatissimum L.) and many other plant species contain substantial amounts of polyunsaturated fatty acids (PUFAs). Phosphatidylcholine (PC) is the major site for PUFA synthesis. The exact mechanisms of how these PUFAs are channeled from PC into triacylglycerol (TAG) needs to be further explored. By using in vivo and in vitro approaches, we demonstrated that the PC deacylation reaction catalyzed by the reverse action of acyl-CoA:lysophosphatidylcholine acyltransferase (LPCAT) can transfer PUFAs on PC directly into the acylCoA pool, making these PUFAs available for the diacylglycerol acyltransferase (DGAT)-catalyzed reaction for TAG production. Two types of yeast mutants were generated for in vivo and in vitro experiments, respectively. Both mutants provide a null background with no endogenous TAG forming capacity and an extremely low LPCAT activity. In vivo experiments showed that co-expressing flax DGAT1-1 and LPCAT1 in the yeast quintuple mutant significantly increased 18-carbon PUFAs in TAG with a concomitant decrease of 18-carbon PUFAs in phospholipid. We further showed that after incubation of sn-2-[C-14]acyl-PC, formation of [C-14] TAG was only possible with yeast microsomes containing both LPCAT1 and DGAT1-1. Moreover, the specific activity of overall LPCAT1 and DGAT1-1 coupling process exhibited a preference for transferring C-14-labeled linoleoyl or linolenoyl than oleoyl moieties from the sn-2 position of PC to TAG. Together, our data support the hypothesis of biochemical coupling of the LPCAT1-catalyzed reverse reaction with the DGAT1-1-catalyzed reaction for incorporating PUFAs into TAG. This process represents a potential route for enriching TAG in PUFA content during seed development in flax.	[Pan, Xue; Chen, Guanqun; Greer, Michael S.; Caldo, Kristian Mark P.; Weselake, Randall J.] Univ Alberta, Dept Agr Food & Nutr Sci, Alberta Innovates Phytola Ctr, Edmonton, AB T6G 2P5, Canada; [Kazachkov, Michael; Zou, Jitao] Natl Res Council Canada, Saskatoon, SK S7N 0W9, Canada	Alberta Innovates; University of Alberta; National Research Council Canada	Weselake, RJ (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Alberta Innovates Phytola Ctr, Edmonton, AB T6G 2P5, Canada.	randall.weselake@ualberta.ca	Caldo, Kristian/AAM-8663-2020; pan, xue/AAE-3374-2019; Chen, Guanqun/K-7009-2012	pan, xue/0000-0001-9415-8316; Chen, Guanqun/0000-0001-5790-3903	Genome Alberta/Genome Canada; Canada Research Chairs Program; Canada Foundation for Innovation; Research Capacity Program of Alberta Enterprise and Advanced Education; AVAC Ltd.; Alberta Innovates Bio Solutions; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Doctoral Award	Genome Alberta/Genome Canada(Genome Canada); Canada Research Chairs Program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Research Capacity Program of Alberta Enterprise and Advanced Education; AVAC Ltd.; Alberta Innovates Bio Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Doctoral Award	Supported by Genome Alberta/Genome Canada, the Canada Research Chairs Program, the Canada Foundation for Innovation, the Research Capacity Program of Alberta Enterprise and Advanced Education, AVAC Ltd., Alberta Innovates Bio Solutions, and the Natural Sciences and Engineering Research Council of Canada. To whom correspondence should be addressed. Tel.: 780-492-4401; E-mail: randall.weselake@ualberta.ca.; Recipient of an Alberta Innovates Doctoral Award.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burgal J, 2008, PLANT BIOTECHNOL J, V6, P819, DOI 10.1111/j.1467-7652.2008.00361.x; Byers SD, 1999, LIPIDS, V34, P1143, DOI 10.1007/s11745-999-0465-6; Carlsson AS, 2011, EUR J LIPID SCI TECH, V113, P812, DOI 10.1002/ejlt.201100032; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Covello PS, 1996, PLANT PHYSIOL, V111, P223, DOI 10.1104/pp.111.1.223; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; Dyer JM, 2001, BIOCHEM BIOPH RES CO, V282, P1019, DOI 10.1006/bbrc.2001.4667; Gibson DG, 2011, METHOD ENZYMOL, V498, P349, DOI 10.1016/B978-0-12-385120-8.00015-2; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hegemann JH, 2011, METHODS MOL BIOL, V765, P189, DOI 10.1007/978-1-61779-197-0_12; Hu ZH, 2012, PLANT PHYSIOL, V158, P1944, DOI 10.1104/pp.111.192153; Kim HU, 2011, PLANT CELL PHYSIOL, V52, P983, DOI 10.1093/pcp/pcr051; Lager I, 2013, J BIOL CHEM, V288, P36902, DOI 10.1074/jbc.M113.521815; LANDS WEM, 1958, J BIOL CHEM, V231, P883; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Nei M., 2000, MOL EVOLUTION PHYLOG; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; Pan X, 2013, J BIOL CHEM, V288, P24173, DOI 10.1074/jbc.M113.475699; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Siloto RMP, 2009, LIPIDS, V44, P963, DOI 10.1007/s11745-009-3336-0; Sorensen BM, 2005, LIPIDS, V40, P1043, DOI 10.1007/s11745-005-1467-0; SPERLING P, 1993, J BIOL CHEM, V268, P26935; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; TAYLOR DC, 1990, ANAL BIOCHEM, V184, P311, DOI 10.1016/0003-2697(90)90686-4; van Erp H, 2011, PLANT PHYSIOL, V155, P683, DOI 10.1104/pp.110.167239; Venglat P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-74; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; Wang ZW, 2012, PLANT J, V72, P461, DOI 10.1111/j.1365-313X.2012.05093.x; WEISS SB, 1960, J BIOL CHEM, V235, P40; Wickramarathna A. D., 2015, BMC BIOTECH IN PRESS	38	24	26	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18068	18078		10.1074/jbc.M115.654798	http://dx.doi.org/10.1074/jbc.M115.654798			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26055703	Green Published, hybrid			2022-12-26	WOS:000358511700038
J	Dennison, S; McAlpin, S; Chapple, DG; Stow, AJ				Dennison, Siobhan; McAlpin, Steve; Chapple, David G.; Stow, Adam J.			Genetic Divergence among Regions Containing the Vulnerable Great Desert Skink (Liopholis kintorei) in the Australian Arid Zone	PLOS ONE			English	Article							EGERNIA-WHITII LACERTILIA; POPULATION-STRUCTURE; MOLECULAR PHYLOGEOGRAPHY; HABITAT SPECIFICITY; MICROSATELLITE LOCI; DIFFERENTIATION; SYSTEMATICS; SCINCIDAE; MAINTENANCE; SPECIATION	Knowledge of genetic structure and patterns of connectivity is valuable for implementation of effective conservation management. The arid zone of Australia contains a rich biodiversity, however this has come under threat due to activities such as altered fire regimes, grazing and the introduction of feral herbivores and predators. Suitable habitats for many species can be separated by vast distances, and despite an apparent lack of current geographical barriers to dispersal, habitat specialisation, which is exhibited by many desert species, may limit connectivity throughout this expansive region. We characterised the genetic structure and differentiation of the great desert skink (Liopholis kintorei), which has a patchy, but widespread distribution in the western region of the Australian arid zone. As a species of cultural importance to local Aboriginal groups and nationally listed as Vulnerable, it is a conservation priority for numerous land managers in central Australia. Analysis of mitochondrial ND4 sequence data and ten nuclear microsatellite loci across six sampling localities through the distribution of L. kintorei revealed considerable differentiation among sites, with mitochondrial F-ST and microsatellite F'(ST) ranging from 0.047-0.938 and 0.257-0.440, respectively. The extent of differentiation suggests three main regions that should be managed separately, in particular the southeastern locality of Uluru. Current genetic delineation of these regions should be maintained if future intervention such as translocation or captive breeding is to be undertaken.	[Dennison, Siobhan; McAlpin, Steve; Stow, Adam J.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia; [Dennison, Siobhan] Australian Wildlife Conservancy, Subiaco East, WA, Australia; [McAlpin, Steve] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia; [Chapple, David G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Macquarie University; University of New England; Monash University	Dennison, S (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW, Australia.	siobhan.dennison@mq.edu.au	Chapple, David/B-9073-2008	Chapple, David/0000-0002-7720-6280; Stow, Adam/0000-0002-6796-4854; Dennison, Siobhan/0000-0002-3308-2810	Macquarie University; Joyce W. Vickery Fund (Linnean Society of NSW); Rice Memorial Fund (Macquarie University); Monash University Faculty of Science Linkage Project Application Support (LPAS) Scheme	Macquarie University; Joyce W. Vickery Fund (Linnean Society of NSW); Rice Memorial Fund (Macquarie University); Monash University Faculty of Science Linkage Project Application Support (LPAS) Scheme	Most of the data collection and analysis of genetic material used in this study was funded by Macquarie University. Additional funding was provided by the Joyce W. Vickery Fund (Linnean Society of NSW, to SD) and the Rice Memorial Fund (Macquarie University, to SD). In kind support for sample collection was provided by the Australian Wildlife Conservancy and Parks Australia. DGC received funding from the Monash University Faculty of Science Linkage Project Application Support (LPAS) Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, COMPLETE GUIDE REPTI; [Anonymous], 1993, ACTION PLAN AUSTR RE; [Anonymous], 2006, MOL ECOL NOTES, DOI [DOI 10.1111/J.1471-8286.2005.01155.X, DOI doi:10.1111/j.1471-8286.2005.01155.x]; [Anonymous], LIOPH KINT SPEC NAT; [Anonymous], RECOVERY PLAN GREAT; [Anonymous], THESIS MACQUARIE U; AREVALO E, 1994, SYST BIOL, V43, P387, DOI 10.2307/2413675; Barr KR, 2008, MOL ECOL, V17, P3628, DOI 10.1111/j.1365-294X.2008.03868.x; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Chapple DG, 2004, MOL PHYLOGENET EVOL, V33, P549, DOI 10.1016/j.ympev.2004.08.010; Chapple DG, 2004, BIOL J LINN SOC, V83, P157, DOI 10.1111/j.1095-8312.2004.00378.x; Chessel D., 2004, R NEWS, V4, P5; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Dennison S, 2012, AUSTRAL ECOL, V37, P258, DOI 10.1111/j.1442-9993.2011.02270.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forsman A, 1995, FUNCT ECOL, V9, P818, DOI 10.2307/2389979; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Gardner MG, 1999, J HERED, V90, P301, DOI 10.1093/jhered/90.2.301; Gardner MG, 2008, ZOOL J LINN SOC-LOND, V154, P781, DOI 10.1111/j.1096-3642.2008.00422.x; Gauffre B, 2008, MOL ECOL, V17, P4619, DOI 10.1111/j.1365-294X.2008.03950.x; Greaves SNJ, 2007, MOL PHYLOGENET EVOL, V45, P729, DOI 10.1016/j.ympev.2007.06.008; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; HOLM S, 1979, SCAND J STAT, V6, P65; Horne JB, 2011, MOL ECOL, V20, P2291, DOI 10.1111/j.1365-294X.2011.05097.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Madsen T, 1996, BIOL CONSERV, V75, P113, DOI 10.1016/0006-3207(95)00067-4; McAlpin S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019041; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Morton S.R., 1990, Proceedings of the Ecological Society of Australia, V16, P201; Pearson David, 2001, Herpetofauna (Sydney), V31, P64; Pianka E.R., 2003, LIZARDS WINDOWS EVOL; PIANKA ER, 1972, COPEIA, P127; PIANKA ER, 1969, ECOLOGY, V50, P498, DOI 10.2307/1933908; Pritchard JK, 2000, GENETICS, V155, P945; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Read J, 2001, WILDLIFE RES, V28, P195, DOI 10.1071/WR99065; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Stow AJ, 2004, MOL ECOL, V13, P443, DOI 10.1046/j.1365-294X.2003.02060.x; Stow AJ, 2002, MOL ECOL NOTES, V2, P256, DOI 10.1046/j.1471-8286.2002.00209.x; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Sunnucks P, 2000, TRENDS ECOL EVOL, V15, P199, DOI 10.1016/S0169-5347(00)01825-5; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x	59	7	8	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128874	10.1371/journal.pone.0128874	http://dx.doi.org/10.1371/journal.pone.0128874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061141	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500105
J	Rivas, LF; Novaro, AJ; Funes, MC; Walker, RS				Rivas, Lorena F.; Novaro, Andres J.; Funes, Martin C.; Walker, R. Susan			Rapid Assessment of Distribution of Wildlife and Human Activities for Prioritizing Conservation Actions in a Patagonian Landscape	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; RHEA-PENNATA-PENNATA; LAND-USE; HABITAT; SELECTION; LIVESTOCK; GUANACOS; SUCCESS	Large landscapes encompassing reserves and areas with other human uses are necessary for conservation of many species. Generating information for conservation planning over such landscapes may be expensive and time-consuming, though resources for conservation are generally limited and conservation is often urgent. We developed a sign-based occupancy survey to help prioritize conservation interventions by simultaneously assessing the distribution of 3 species, the lesser rhea, guanaco, and mara, and their association with human activities in a 20,000-km(2) landscape in the northern Patagonian steppe. We used a single-season occupancy model with spatial rather than temporal replication of surveys in order to reduce costs of multiple visits to sites. We used covariates related to detectability, environmental factors, and different human activities to identify the most plausible models of occupancy, and calculated importance weights of covariates from these models to evaluate relative impacts of human activities on each species. Abundance of goats had the strongest negative association with lesser rheas and guanacos, and road density with maras. With six months of fieldwork, our results provided initial hypotheses for adaptive conservation interventions for each species. Addressing high livestock densities for rheas and guanacos, poaching by urban hunters for all three species, and hunting by rural people for rheas are priorities for conservation in this landscape. Our methodology provided new insights into the responses of these species, although low detection probabilities for maras indicate that the sampling scheme should be altered for future monitoring of this species. This method may be adapted for any large landscape where a rapid, objective means for prioritizing conservation actions on multiple species is needed and data are scarce.	[Rivas, Lorena F.; Novaro, Andres J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Medioambiente, Junin De Los Andes, Neuquen, Argentina; [Rivas, Lorena F.; Novaro, Andres J.; Funes, Martin C.; Walker, R. Susan] Wildlife Conservat Soc, Patagonian Steppe Program, Junin De Los Andes, Neuquen, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Rivas, LF (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Medioambiente, Junin De Los Andes, Neuquen, Argentina.	lrivas@wcs.org			Disney Worldwide Conservation Fund (Conservation of Wildlife of the Andean Patagonia Steppe); Wildlife Conservation Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina	Disney Worldwide Conservation Fund (Conservation of Wildlife of the Andean Patagonia Steppe); Wildlife Conservation Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This study was partially funded by a grant to the WCS Patagonian Steppe Program by the Disney Worldwide Conservation Fund (Conservation of Wildlife of the Andean Patagonia Steppe). Remaining funds were provided by the authors' institutions, the Wildlife Conservation Society and the Consejo Nacional de Investigaciones Cientificas y Tecnicas of Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso Roldan V, 2012, THESIS U NACL SUR; Bailey LL, 2004, ECOL APPL, V14, P692, DOI 10.1890/03-5012; Baldi R, 2007, J ARID ENVIRON, V68, P9, DOI 10.1016/j.jaridenv.2006.03.025; Baldi R, 2004, J WILDLIFE MANAGE, V68, P924, DOI 10.2193/0022-541X(2004)068[0924:HPFCBG]2.0.CO;2; Baldi R, 2001, OECOLOGIA, V129, P561, DOI 10.1007/s004420100770; Baldi Ricardo, 2010, P266, DOI 10.1002/9781444317091.ch10; Baldi Ricardo, 1997, Mastozoologia Neotropical, V4, P5; Barri FR, 2008, ORYX, V42, P607, DOI 10.1017/S0030605307000798; Beldomenico PM, 2003, VET PARASITOL, V118, P71, DOI 10.1016/j.vetpar.2003.09.008; Bellis LM, 2006, BIODIVERS CONSERV, V15, P3065, DOI 10.1007/s10531-005-5398-5; Bellis LM, 2004, BIODIVERS CONSERV, V13, P2589, DOI 10.1007/s10531-004-1086-0; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Chehebar C, 2013, IDENTIFICACION AREAS; Clark Labs, 2009, IDRISI 16 TAIGA ED; Cooch E, 2007, PROGRAM MARK GENTE I; De Wan AA, 2009, BIOL CONSERV, V142, P982, DOI 10.1016/j.biocon.2008.12.032; Funes M. C., 1999, Revista Argentina de Produccion Animal, V19, P265; Funes MC, 2000, PROYECTO MANEJO CONS, DOI [10.1186/s13059-015-0623-3.The, DOI 10.1186/S13059-015-0623-3]; Gibson LA, 2004, J APPL ECOL, V41, P213, DOI 10.1111/j.0021-8901.2004.00896.x; Gonzalez Alejandro, 2012, Human-Wildlife Interactions, V6, P327; Karanth KU, 2011, J APPL ECOL, V48, P1048, DOI 10.1111/j.1365-2664.2011.02002.x; Karesh WB, 1998, J ZOO WILDLIFE MED, V29, P134; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2003, ECOLOGY, V84, P2200, DOI 10.1890/02-3090; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Novaro A. J., 2005, LARGE CARNIVORES CON, P267; Ojeda R, 2008, DOLICHOTIS PATAGONUM; Pedrana J, 2011, EMU, V111, P350, DOI 10.1071/MU11007; Pedrana J, 2010, BIODIVERS CONSERV, V19, P3499, DOI 10.1007/s10531-010-9910-1; Polasky S, 2005, ECOL APPL, V15, P1387, DOI 10.1890/03-5423; Puig S, 2013, REV FAC CIENC AGRAR, V45, P211; Radovani NI, 2014, ORYX, P1; Rivas LF, 2004, THESIS U BUENOS AIRE; Rodriguez D, 2009, J ARID ENVIRON, V73, P444, DOI 10.1016/j.jaridenv.2008.12.010; Schroeder NM, 2013, J ZOOL, V291, P213, DOI 10.1111/jzo.12065; Schuette P, 2013, BIOL CONSERV, V158, P301, DOI 10.1016/j.biocon.2012.08.008; Schuette P, 2013, BIOL CONSERV, V157, P148, DOI 10.1016/j.biocon.2012.09.011; Shannon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094630; Stokes EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010294; Taber AB, 2009, J ZOOL, V227, P417; Burgi MV, 2012, ORYX, V46, P99, DOI 10.1017/S0030605311000214; Weller TJ, 2008, BIOL CONSERV, V141, P2279, DOI 10.1016/j.biocon.2008.06.018	44	6	6	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127265	10.1371/journal.pone.0127265	http://dx.doi.org/10.1371/journal.pone.0127265			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061066	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500031
J	Woods, DL; Wyma, JM; Herron, TJ; Yund, EW				Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William			The Effects of Aging, Malingering, and Traumatic Brain Injury on Computerized Trail-Making Test Performance	PLOS ONE			English	Article							REGRESSION-BASED NORMS; D-KEFS TRAIL; NORMATIVE DATA; COGNITIVE IMPAIRMENT; OLDER-ADULTS; TEST-A; TEST-B; AGE; SAMPLE; EDUCATION	The trail making test (TMT) is widely used to assess speed of processing and executive function. However, normative data sets gathered at different sites show significant inconsistencies. Here, we describe a computerized version of the TMT (C-TMT) that increases the precision and replicability of the TMT by permitting a segment-by-segment analysis of performance and separate analyses of dwell-time, move-time, and error time. Experiment 1 examined 165 subjects of various ages and found that completion times on both the C-TMT-A (where subjects connect successively numbered circles) and the C-TMT-B (where subjects connect circles containing alternating letters and numbers) were strongly influenced by age. Experiment 2 examined 50 subjects who underwent three test sessions. The results of the first test session were well fit by the normative data gathered in Experiment 1. Sessions 2 and 3 demonstrated significant learning effects, particularly on the C-TMT-B, and showed good test-retest reliability. Experiment 3 examined performance in subjects instructed to feign symptoms of traumatic brain injury: 44% of subjects produced abnormal completion times on the C-TMT-A, and 18% on the C-TMT-B. Malingering subjects could be distinguished from abnormally slow controls based on (1) disproportionate increases in dwell-time on the C-TMT-A, and (2) greater deficits on the C-TMT-A than on the C-TMT-B. Experiment 4 examined the performance of 28 patients with traumatic brain injury: C-TMT-B completion times were slowed, and TBI patients showed reduced movement velocities on both tests. The C-TMT improves the reliability and sensitivity of the trail making test of processing speed and executive function.	[Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William] Vet Affairs Northern Calif Heath Care Syst, Human Cognit Neurophysiol Lab, Martinez, CA 95553 USA; [Woods, David L.] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), Vet Affairs Northern Calif Heath Care Syst, Human Cognit Neurophysiol Lab, 150 Muir Rd, Martinez, CA 95553 USA.	dlwoods@ucdavis.edu		Herron, Timothy/0000-0002-4297-014X; Woods, David/0000-0002-8804-3587; Yund, E./0000-0002-6833-0052	VA Research Service Grants [CX000583, CX001000]; Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER	VA Research Service Grants; Veterans Affairs(US Department of Veterans Affairs)	This research was supported by a VA Research Service Grants CX000583 and CX001000 to DLW. The content is solely the responsibility of the authors and does not necessarily represent the official views of Department of Veterans Affairs or the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amodio P, 2002, AGING CLIN EXP RES, V14, P117, DOI 10.1007/BF03324425; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bashore TR, 2002, PSYCHOL BULL, V128, P151, DOI 10.1037/0033-2909.128.1.151; Bezdicek O, 2012, ARCH CLIN NEUROPSYCH, V27, P906, DOI 10.1093/arclin/acs084; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Buck KK, 2008, J CLIN EXP NEUROPSYC, V30, P312, DOI 10.1080/13803390701390483; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Cangoz B, 2009, J NEUROL SCI, V283, P73, DOI 10.1016/j.jns.2009.02.313; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P189, DOI 10.1093/arclin/acs115; de Frias CM, 2007, NEUROPSYCHOLOGIA, V45, P2499, DOI 10.1016/j.neuropsychologia.2007.03.022; Delis DC, 2001, DELIS KAPLAN EXECUTI; Demery JA, 2010, CLIN NEUROPSYCHOL, V24, P1292, DOI 10.1080/13854046.2010.528452; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Egeland J, 2007, APPL NEUROPSYCHOL, V14, P113, DOI 10.1080/09084280701319953; Era P, 2011, AGING CLIN EXP RES, V23, P135, DOI 10.1007/BF03351077; Fastenau PS, 1998, J CLIN EXP NEUROPSYC, V20, P906, DOI 10.1076/jcen.20.6.906.1104; Fernandez AL, 2008, SCAND J PSYCHOL, V49, P239, DOI 10.1111/j.1467-9450.2008.00637.x; Fine EM, 2011, CLIN NEUROPSYCHOL, V25, P1331, DOI 10.1080/13854046.2011.609838; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Giovagnoli AR, 1996, ITAL J NEUROL SCI, V17, P305, DOI 10.1007/BF01997792; Haines ME, 2001, CLIN NEUROPSYCHOL, V15, P171, DOI 10.1076/clin.15.2.171.1891; Hart T, 2003, ARCH PHYS MED REHAB, V84, P221, DOI 10.1053/apmr.2003.50023; Heaton RK, 1999, J CLIN EXP NEUROPSYC, V21, P571, DOI 10.1076/jcen.21.4.572.882; Heled E, 2012, J CLIN EXP NEUROPSYC, V34, P151, DOI 10.1080/13803395.2011.625351; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Ising M, 2014, GENES BRAIN BEHAV, V13, P501, DOI 10.1111/gbb.12132; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Kashluba S, 2008, ARCH PHYS MED REHAB, V89, P904, DOI 10.1016/j.apmr.2007.12.029; KENNEDY KJ, 1981, PERCEPT MOTOR SKILL, V52, P671, DOI 10.2466/pms.1981.52.2.671; KLUSMAN LE, 1989, PERCEPT MOTOR SKILL, V68, P1199, DOI 10.2466/pms.1989.68.3c.1199; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Levin, 2012, ARCH ASSESSMENT PSYC, V2, P57; Levine AJ, 2007, J CLIN EXP NEUROPSYC, V29, P669, DOI 10.1080/13803390600920471; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Li G, 2014, JAMA NEUROL, V71, P742, DOI 10.1001/jamaneurol.2014.445; Lovell MR, 2011, APPL NEUROPSYCHOL, V18, P197, DOI 10.1080/09084282.2011.595446; Lovell MR, 1999, CLIN J SPORT MED, V9, P193, DOI 10.1097/00042752-199910000-00002; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Onoda K, 2013, CLIN INTERV AGING, V8, P353, DOI 10.2147/CIA.S42342; Ozen LJ, 2010, J INT NEUROPSYCH SOC, V16, P556, DOI 10.1017/S1355617710000202; Pe~na-Casanova J, 2009, ARCH CLIN NEUROPSYCH; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Plotek W, 2014, MED SCI MONITOR, V20, P173, DOI 10.12659/MSM.889776; Powell MR, 2011, CLIN NEUROPSYCHOL, V25, P108, DOI 10.1080/13854046.2010.532912; Rabin LA, 2007, CLIN NEUROPSYCHOL, V21, P727, DOI 10.1080/13854040600888776; Reitan RM, 1985, HALSTEAD REITAN NEUR; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Schneider ALC, 2015, ALZ DIS ASSOC DIS, V29, P32, DOI 10.1097/WAD.0000000000000042; Soukup V M, 1998, Appl Neuropsychol, V5, P65, DOI 10.1207/s15324826an0502_2; Steinberg BA, 2005, CLIN NEUROPSYCHOL, V19, P329, DOI 10.1080/13854040590945210; Then FS, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-23; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024; Wecker NS, 2000, NEUROPSYCHOLOGY, V14, P409, DOI 10.1037//0894-4105.14.3.409; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Woods DL, 2015, J COGNITIVE EXPT NEU; Woods DL, 2015, ARCH CLIN NEUROPSYCH; Yochim B, 2007, J INT NEUROPSYCH SOC, V13, P704, DOI 10.1017/S1355617707070907; Zalonis I, 2008, CLIN NEUROPSYCHOL, V22, P842, DOI 10.1080/13854040701629301	66	32	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0124345	10.1371/journal.pone.0124345	http://dx.doi.org/10.1371/journal.pone.0124345			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1PO	26060999	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500006
J	Bandeira, LG; Bortolot, BS; Cecatto, MJ; Monte-Alto-Costa, A; Romana-Souza, B				Bandeira, Luana Graziella; Bortolot, Beatriz Salari; Cecatto, Matheus Jorand; Monte-Alto-Costa, Andrea; Romana-Souza, Bruna			Exogenous Tryptophan Promotes Cutaneous Wound Healing of Chronically Stressed Mice through Inhibition of TNF-alpha and IDO Activation	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; PSYCHOLOGICAL STRESS; T-CELLS; EXPRESSION; RESTRAINT; TOLERANCE; RATS; INDUCTION; NUTRITION; MELATONIN	Stress prolongs the inflammatory response compromising the dermal reconstruction and wound closure. Acute stress-induced inflammation increases indoleamine 2, 3-dioxygenase-stimulated tryptophan catabolism. To investigate the role of indoleamine 2, 3-dioxygenase expression and tryptophan administration in adverse effects of stress on cutaneous wound healing, mice were submitted to chronic restraint stress and treated with tryptophan daily until euthanasia. Excisional lesions were created on each mouse and 5 or 7 days later, the lesions were analyzed. In addition, murine skin fibroblasts were exposed to elevated epinephrine levels plus tryptophan, and fibroblast activity was evaluated. Tryptophan administration reversed the reduction of the plasma tryptophan levels and the increase in the plasma normetanephrine levels induced by stress 5 and 7 days after wounding. Five days after wounding, stress-induced increase in the protein levels of tumor necrosis factor-alpha and indoleamine 2, 3-dioxygenase, and this was inhibited by tryptophan. Stress-induced increase in the lipid peroxidation and the amount of the neutrophils, macrophages and T cells number was reversed by tryptophan 5 days after wounding. Tryptophan administration inhibited the reduction of myofibroblast density, collagen deposition, re-epithelialization and wound contraction induced by stress 5 days after wounding. In dermal fibroblast culture, the tryptophan administration increased the cell migration and AKT phosphorylation in cells treated with high epinephrine levels. In conclusion, tryptophan-induced reduction of inflammatory response and indoleamine 2, 3-dioxygenase expression may have accelerated cutaneous wound healing of chronically stressed mice.	[Bandeira, Luana Graziella; Bortolot, Beatriz Salari; Cecatto, Matheus Jorand; Monte-Alto-Costa, Andrea; Romana-Souza, Bruna] Univ Estado Rio De Janeiro, Dept Histol & Embryol, Lab Tissue Repair, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Monte-Alto-Costa, A (corresponding author), Univ Estado Rio De Janeiro, Dept Histol & Embryol, Lab Tissue Repair, Rio De Janeiro, Brazil.	amacosta@uerj.br	Romana-Souza, Bruna/ABI-7446-2020; Monte-Alto-Costa, Andréa/C-5224-2013; Romana-Souza, Bruna/O-9104-2017	Monte-Alto-Costa, Andréa/0000-0001-6572-7882; Romana-Souza, Bruna/0000-0001-5665-8694	Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ) [E-26/110.134/2014, E-26/112.1210/2012]; National Council for Scientific and Technological Development (CNPq) [302918/2012-4]	Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Funding for this study was received from Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ No E-26/110.134/2014; FAPERJ No E-26/112.1210/2012) and the National Council for Scientific and Technological Development (CNPq), #302918/2012-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de Brito TLA, 2014, LIFE SCI, V100, P138, DOI [10.1016/j.lfs.2014.02.007, 10.1016/j.lfs2014.02.007]; BADDELEY AJ, 1986, J MICROSC-OXFORD, V142, P259, DOI 10.1111/j.1365-2818.1986.tb04282.x; Cardoso JE, 2007, TOXICOL PATHOL, V35, P890, DOI 10.1080/01926230701459986; Chandran A, 2013, PROG NEURO-PSYCHOPH, V40, P240, DOI 10.1016/j.pnpbp.2012.08.001; Cohen S, 1999, PSYCHOSOM MED, V61, P175, DOI 10.1097/00006842-199903000-00009; Costa RA, 2011, WOUND REPAIR REGEN, V19, P487, DOI 10.1111/j.1524-475X.2011.00700.x; Cruz FC, 2012, INT J DEV NEUROSCI, V30, P19, DOI 10.1016/j.ijdevneu.2011.10.005; de Almeida TF, 2013, EXP DERMATOL, V22, P524, DOI 10.1111/exd.12186; Dunn Jeffrey H, 2013, Dermatol Online J, V19, P18561; Forouzandeh F, 2008, MOL CELL BIOCHEM, V309, P1, DOI 10.1007/s11010-007-9635-y; Freshney R.J, 2010, CULTURE ANIMAL CELLS, Vsixth, P163, DOI DOI 10.1002/9780470649367.CH11; Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hoyer D, 2002, PHARMACOL BIOCHEM BE, V71, P533, DOI 10.1016/S0091-3057(01)00746-8; Hsu HR, 2007, EUR J PHARMACOL, V566, P124, DOI 10.1016/j.ejphar.2007.03.040; Hughes MM, 2012, BRAIN BEHAV IMMUN, V26, P979, DOI 10.1016/j.bbi.2012.05.010; Jaworek J, 2004, J PINEAL RES, V37, P161, DOI 10.1111/j.1600-079X.2004.00153.x; Kiank C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011825; KIECOLTGLASER JK, 1995, LANCET, V346, P1194, DOI 10.1016/S0140-6736(95)92899-5; Konturek PC, 2008, J PHYSIOL PHARMACOL, V59, P53; Koopmans SJ, 2005, PHYSIOL BEHAV, V85, P469, DOI 10.1016/j.physbeh.2005.05.010; LAUER JW, 1958, ARCH NEURO PSYCHIATR, V80, P122, DOI 10.1001/archneurpsyc.1958.02340070140021; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Lieberman HR, 2003, APPETITE, V40, P245, DOI 10.1016/S0195-6663(03)00010-2; Majewska M, 2007, J PHYSIOL PHARMACOL, V58, P125; Markus CR, 2010, CLIN NUTR, V29, P610, DOI 10.1016/j.clnu.2010.01.003; Markus R, 2000, PHYSIOL BEHAV, V70, P333, DOI 10.1016/S0031-9384(00)00265-1; Marucha PT, 1998, PSYCHOSOM MED, V60, P362, DOI 10.1097/00006842-199805000-00025; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mercado AM, 2002, J NEUROIMMUNOL, V129, P74, DOI 10.1016/S0165-5728(02)00174-1; Metz R, 2012, ONCOIMMUNOLOGY, V1, P1460, DOI 10.4161/onci.21716; Muller Norbert, 2006, Expert Rev Neurother, V6, P1017, DOI 10.1586/14737175.6.7.1017; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Nascimento AP, 2006, BRIT J NUTR, V96, P1069, DOI 10.1017/BJN20061955; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Padgett DA, 1998, BRAIN BEHAV IMMUN, V12, P64, DOI 10.1006/brbi.1997.0512; PISANO JJ, 1960, CLIN CHIM ACTA, V5, P406; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Romana-Souza B, 2014, BRAIN BEHAV IMMUN, V36, P101, DOI 10.1016/j.bbi.2013.10.015; Romana-Souza B, 2011, EXP DERMATOL, V20, P413, DOI 10.1111/j.1600-0625.2010.01239.x; Romana-Souza B, 2010, EXP DERMATOL, V19, P821, DOI 10.1111/j.1600-0625.2010.01113.x; Romana-Souza B, 2010, BRAIN BEHAV IMMUN, V24, P427, DOI 10.1016/j.bbi.2009.11.012; Rosa AD, 2014, WOUND REPAIR REGEN, V22, P537, DOI 10.1111/wrr.12191; Saito Y, 2008, J INVEST DERMATOL, V128, P1838, DOI 10.1038/sj.jid.5701258; Sivamani RK, 2009, PLOS MED, V6, P105, DOI 10.1371/journal.pmed.1000012; SPIES JR, 1949, ANAL CHEM, V21, P1249, DOI 10.1021/ac60034a033; Squarize CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010643; Tanke MAC, 2008, NEUROCHEM INT, V52, P272, DOI 10.1016/j.neuint.2007.05.022; THOMSON J, 1982, PSYCHOL MED, V12, P741, DOI 10.1017/S0033291700049047; VARGA J, 1995, J CLIN INVEST, V96, P475, DOI 10.1172/JCI118058; Vedhara K, 1999, LANCET, V353, P627, DOI 10.1016/S0140-6736(98)06098-X; Wu HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089663	54	21	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128439	10.1371/journal.pone.0128439	http://dx.doi.org/10.1371/journal.pone.0128439			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057238	gold, Green Submitted, Green Published			2022-12-26	WOS:000356349000022
J	Seo, H; Kim, D; Jun, SC				Seo, Hyeon; Kim, Donghyeon; Jun, Sung Chan			Computational Study of Subdural Cortical Stimulation: Effects of Simulating Anisotropic Conductivity on Activation of Cortical Neurons	PLOS ONE			English	Article							MOTOR CORTEX STIMULATION; TRANSCRANIAL MAGNETIC STIMULATION; SURFACE-BASED ANALYSIS; DIFFUSION TENSOR MRI; WHITE-MATTER; ELECTRIC-FIELD; HEAD MODEL; BIFOCAL STIMULATION; PARKINSONS-DISEASE; PRECENTRAL GYRUS	Subdural cortical stimulation (SuCS) is an appealing method in the treatment of neurological disorders, and computational modeling studies of SuCS have been applied to determine the optimal design for electrotherapy. To achieve a better understanding of computational modeling on the stimulation effects of SuCS, the influence of anisotropic white matter conductivity on the activation of cortical neurons was investigated in a realistic head model. In this paper, we constructed pyramidal neuronal models (layers 3 and 5) that showed primary excitation of the corticospinal tract, and an anatomically realistic head model reflecting complex brain geometry. The anisotropic information was acquired from diffusion tensor magnetic resonance imaging (DT-MRI) and then applied to the white matter at various ratios of anisotropic conductivity. First, we compared the isotropic and anisotropic models; compared to the isotropic model, the anisotropic model showed that neurons were activated in the deeper bank during cathodal stimulation and in the wider crown during anodal stimulation. Second, several popular anisotropic principles were adapted to investigate the effects of variations in anisotropic information. We observed that excitation thresholds varied with anisotropic principles, especially with anodal stimulation. Overall, incorporating anisotropic conductivity into the anatomically realistic head model is critical for accurate estimation of neuronal responses; however, caution should be used in the selection of anisotropic information.	[Seo, Hyeon; Kim, Donghyeon; Jun, Sung Chan] Gwangju Inst Sci & Technol, Sch Informat & Commun, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST)	Jun, SC (corresponding author), Gwangju Inst Sci & Technol, Sch Informat & Commun, Gwangju, South Korea.	scjun@gist.ac.kr	JUN, SUNG/AAJ-2677-2020	JUN, SUNG/0000-0001-5357-4436	Integrative Aging Research Center of Gwangju Institute of Science and Technology (GIST)	Integrative Aging Research Center of Gwangju Institute of Science and Technology (GIST)	This work was supported by a grant from the Integrative Aging Research Center of Gwangju Institute of Science and Technology (GIST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai SW, 2014, NEUROIMAGE, V87, P332, DOI 10.1016/j.neuroimage.2013.11.015; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Brown JA, 2003, NEUROL RES, V25, P815, DOI 10.1179/016164103771953907; Brown JA, 2006, NEUROSURGERY, V58, P464, DOI 10.1227/01.NEU.0000197100.63931.04; Canavero S, 2006, NEUROMODULATION, V9, P28, DOI 10.1111/j.1525-1403.2006.00039.x; Canavero S, 2009, TEXTBOOK OF THERAPEUTIC CORTICAL STIMULATION, P1; Canavero S, 2002, J NEUROSURG, V97, P1208, DOI 10.3171/jns.2002.97.5.1208; Canavero S, 2000, MOVEMENT DISORD, V15, P169, DOI 10.1002/1531-8257(200001)15:1<169::AID-MDS1030>3.0.CO;2-W; Canavero S., 2014, TXB CORTICAL BRAIN S; CHAN CY, 1986, J PHYSIOL-LONDON, V371, P89, DOI 10.1113/jphysiol.1986.sp015963; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Datta A, 2008, J NEURAL ENG, V5, P163, DOI 10.1088/1741-2560/5/2/007; Datta A, 2011, BRAIN STIMUL, V4, P169, DOI 10.1016/j.brs.2010.11.001; Datta A, 2009, BRAIN STIMUL, V2, P201, DOI 10.1016/j.brs.2009.03.005; De Lucia M, 2007, NEUROIMAGE, V36, P1159, DOI 10.1016/j.neuroimage.2007.03.062; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P834, DOI 10.1016/j.clinph.2003.11.026; Edwards D, 2013, NEUROIMAGE, V74, P266, DOI 10.1016/j.neuroimage.2013.01.042; Fang QQ, 2009, I S BIOMED IMAGING, P1142, DOI 10.1109/ISBI.2009.5193259; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; GORMAN ALF, 1966, J NEUROPHYSIOL, V29, P547, DOI 10.1152/jn.1966.29.4.547; Gullmar D, 2010, NEUROIMAGE, V51, P145, DOI 10.1016/j.neuroimage.2010.02.014; Hallez H, 2008, PHYS MED BIOL, V53, P1877, DOI 10.1088/0031-9155/53/7/005; Hanajima R, 2002, CLIN NEUROPHYSIOL, V113, P635, DOI 10.1016/S1388-2457(02)00042-1; HERN JEC, 1962, J PHYSIOL-LONDON, V161, P73, DOI 10.1113/jphysiol.1962.sp006874; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holsheimer J, 2007, ACTA NEUROCHIR SUPPL, V97, P57; Holsheimer J, 2007, CLIN NEUROPHYSIOL, V118, P2287, DOI 10.1016/j.clinph.2007.07.015; Kim D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108028; Kim D, 2012, IEEE ENG MED BIO, P867, DOI 10.1109/EMBC.2012.6346069; Lefaucheur JP, 2010, EXP NEUROL, V223, P609, DOI 10.1016/j.expneurol.2010.02.008; Levy R, 2008, J NEUROSURG, V108, P707, DOI 10.3171/JNS/2008/108/4/0707; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Manola L, 2005, MED BIOL ENG COMPUT, V43, P335, DOI 10.1007/BF02345810; Manola L, 2007, CLIN NEUROPHYSIOL, V118, P464, DOI 10.1016/j.clinph.2006.09.012; NICHOLSON PW, 1965, EXP NEUROL, V13, P386, DOI 10.1016/0014-4886(65)90126-3; Nummenmaa A, 2014, BRAIN STIMUL, V7, P80, DOI 10.1016/j.brs.2013.10.001; Nummenmaa A, 2013, CLIN NEUROPHYSIOL, V124, P1995, DOI 10.1016/j.clinph.2013.04.019; Opitz A, 2011, NEUROIMAGE, V58, P849, DOI 10.1016/j.neuroimage.2011.06.069; Pagni CA, 2008, ACTA NEUROCHIR SUPPL, V101, P13; Parazzini M, 2014, CLIN NEUROPHYSIOL, V125, P577, DOI 10.1016/j.clinph.2013.09.039; Park JS, 2006, CLIN ANAT, V19, P216, DOI 10.1002/ca.20275; PATTON HD, 1954, J NEUROPHYSIOL, V17, P345, DOI 10.1152/jn.1954.17.4.345; PHILLIPS CG, 1962, J PHYSIOL-LONDON, V162, P532, DOI 10.1113/jphysiol.1962.sp006948; Rahman A, 2013, J PHYSIOL-LONDON, V591, P2563, DOI 10.1113/jphysiol.2012.247171; Ruffini G, 2014, NEUROIMAGE, V89, P216, DOI 10.1016/j.neuroimage.2013.12.002; Scientific Computing and Imaging Institute, SEG3D VOL IM SEGM VI; Seo H, 2013, IEEE ENG MED BIO, P241, DOI 10.1109/EMBC.2013.6609482; Seo H, 2012, IEEE ENG MED BIO, P1892, DOI 10.1109/EMBC.2012.6346322; Shahid S, 2014, BIOELECTROMAGNETICS, V35, P41, DOI 10.1002/bem.21814; Shahid SS, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036002; Si H, 2005, PROCEEDINGS OF THE 14TH INTERNATIONAL MESHING ROUNDTABLE, P147, DOI 10.1007/3-540-29090-7_9; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; STRUIJK JJ, 1992, IEEE T BIO-MED ENG, V39, P903, DOI 10.1109/10.256423; Suh HS, 2012, PHYS MED BIOL, V57, P6961, DOI 10.1088/0031-9155/57/21/6961; Truong DQ, 2013, NEUROIMAGE-CLIN, V2, P759, DOI 10.1016/j.nicl.2013.05.011; Tuch DS, 2001, P NATL ACAD SCI USA, V98, P11697, DOI 10.1073/pnas.171473898; Wagner S, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/1/016002; Windhoff M, 2013, HUM BRAIN MAPP, V34, P923, DOI 10.1002/hbm.21479; Wolters CH, 2006, NEUROIMAGE, V30, P813, DOI 10.1016/j.neuroimage.2005.10.014; Wongsarnpigoon A, 2012, CLIN NEUROPHYSIOL, V123, P160, DOI 10.1016/j.clinph.2011.06.005; Wongsarnpigoon A, 2008, J NEURAL ENG, V5, P443, DOI 10.1088/1741-2560/5/4/009; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zwartjes DGM, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/5/056005	63	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128590	10.1371/journal.pone.0128590	http://dx.doi.org/10.1371/journal.pone.0128590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057524	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000024
J	Chen, JH; Hsu, SN; Huang, TC; Wu, YY; Lin, C; Chang, PY; Chen, YC; Ho, CL				Chen, Jia-Hong; Hsu, Shun-Neng; Huang, Tzu-Chuan; Wu, Yi-Ying; Lin, Chin; Chang, Ping-Ying; Chen, Yeu-Chin; Ho, Ching-Liang			Prognostic Significance of Initial Serum Albumin and 24 Hour Daily Protein Excretion before Treatment in Multiple Myeloma	PLOS ONE			English	Article							STAGING SYSTEM; BETA-2 MICROGLOBULIN; RENAL IMPAIRMENT; BETA-2-MICROGLOBULIN; CREATININE; MANAGEMENT; SURVIVAL; FEATURES	Renal failure is a common morbidity in multiple myeloma (MM). Although proteinuria has been increasingly reported in malignancies, it is not routinely used to refine risk estimates of survival outcomes in patients with MM. Here we aimed to investigate initial serum albumin and 24-hour daily protein excretion (24-h DPE) before treatment as prognostic factors in patients with MM. We conducted a retrospective analysis of 102 patients with myeloma who were ineligible for haematopoietic stem cell transplantation between October 2000 and December 2012. Initial proteinuria was assessed before treatment by quantitative analysis of 24-hour urine samples. The demographic and laboratory characteristics, survival outcome, and significance of pre-treatment 24-h DPE and albumin in the new staging system of MM were analyzed. Pre-treatment proteinuria (>300 mg/day) was present in 66 patients (64.7%). The optimal cut-off value of 24-h DPE before treatment was 500 mg/day. Analysis of the time-dependent area under the curve showed that the serum albumin and 24-h DPE before treatment were better than 24-h creatinine clearance rate and beta 2-microglobulin. A subgroup analysis showed that an initial excess proteinuria (24-h DPE >= 500 mg) was associated with poor survival status (17.51 vs. 34.24 months, p = 0.002). Furthermore, initial serum albumin was an independent risk factor on multivariate analysis (<2.8 vs. >= 2.8, hazard ratio = 0.486, p = 0.029). Using the A-DPE staging system, there was a significant survival difference among patients with stage I, II, and III MM (p < 0.001). Initial serum albumin and 24-h DPE before treatment showed significant prognostic factors in patients with MM, and the new A-DPE staging system may be utilized instead of the International Staging System. Its efficacy should be evaluated by further large prospective studies.	[Chen, Jia-Hong; Huang, Tzu-Chuan; Wu, Yi-Ying; Chang, Ping-Ying; Chen, Yeu-Chin; Ho, Ching-Liang] Triserv Gen Hosp, Div Hematol Oncol, Dept Med, Natl Def Med Ctr, Taipei, Taiwan; [Chen, Jia-Hong] Taipei Med Univ, Grad Inst Clin Med, Coll Med, Taipei, Taiwan; [Hsu, Shun-Neng] Triserv Gen Hosp, Div Nephrol, Dept Med, Natl Def Med Ctr, Taipei, Taiwan; [Lin, Chin] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Lin, Chin] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center	Ho, CL (corresponding author), Triserv Gen Hosp, Div Hematol Oncol, Dept Med, Natl Def Med Ctr, Taipei, Taiwan.	hochingliang@yahoo.com.tw	Lin, Chin/M-2832-2015; Hsu, Shun-Neng/A-3602-2014	Lin, Chin/0000-0003-2337-2096; Wu, Yi-Ying/0000-0003-0411-6265; Hsu, Shun-Neng/0000-0002-8014-6311				ALEXANIAN R, 1994, NEW ENGL J MED, V330, P484; ALEXANIAN R, 1985, AM J HEMATOL, V20, P345, DOI 10.1002/ajh.2830200405; Bakris GL, 2008, CLIN J AM SOC NEPHRO, V3, pS3, DOI 10.2215/CJN.03250807; BATAILLE R, 1984, BLOOD, V63, P468; Chanan-Khan AA, 2012, CLIN CANCER RES, V18, P2145, DOI 10.1158/1078-0432.CCR-11-0498; Chowdhury T, 2013, AM J KIDNEY DIS, V61, P646, DOI 10.1053/j.ajkd.2012.11.030; Cravedi P, 2012, NAT REV NEPHROL, V8, P301, DOI 10.1038/nrneph.2012.42; CUZICK J, 1985, BRIT J CANCER, V52, P1, DOI 10.1038/bjc.1985.140; CUZICK J, 1990, BRIT J HAEMATOL, V75, P506, DOI 10.1111/j.1365-2141.1990.tb07790.x; Dimopoulos MA, 2009, CLIN LYMPHOMA MYELOM, V9, P302, DOI 10.3816/CLM.2009.n.059; Durie BGM, 2006, LEUKEMIA, V20, P1467, DOI 10.1038/sj.leu.2404284; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Eleftherakis-Papapiakovou E, 2011, LEUKEMIA LYMPHOMA, V52, P2299, DOI 10.3109/10428194.2011.597906; Faiman BM, 2011, CLIN J ONCOL NURS, V15, P66, DOI 10.1188/11.CJON.S1.66-76; Gaballa MR, 2012, EXPERT REV HEMATOL, V5, P51, DOI [10.1586/EHM.11.72, 10.1586/ehm.11.72]; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Grzasko N, 2014, CLIN LYMPHOMA MYELOM; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hutchison CA, 2012, NAT REV NEPHROL, V8, P43, DOI 10.1038/nrneph.2011.168; Jacobson JL, 2003, BRIT J HAEMATOL, V122, P441, DOI 10.1046/j.1365-2141.2003.04456.x; Kastritis E, 2013, EXPERT OPIN PHARMACO, V14, P1477, DOI 10.1517/14656566.2013.803068; Konta Tsuneo, 2013, Rinsho Byori, V61, P629; Kyle RA, 2003, MAYO CLIN PROC, V78, P21, DOI 10.4065/78.1.21; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Merchionne F, 2008, CLIN EXP MED, V8, P133, DOI 10.1007/s10238-008-0169-8; NORRIS SH, 1993, SEMIN NEPHROL, V13, P258; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Prakash J, 2009, J Assoc Physicians India, V57, P23; PUOLIJOKI H, 1989, NEPHROL DIAL TRANSPL, V4, P947, DOI 10.1093/ndt/4.11.947; SAWYER N, 1988, BMJ-BRIT MED J, V296, P1295, DOI 10.1136/bmj.296.6632.1295; SCARFFE JH, 1983, EUR J CANCER CLIN ON, V19, P1361; Yun JP, 2006, J KOREAN MED SCI, V21, P639, DOI 10.3346/jkms.2006.21.4.639	33	7	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128905	10.1371/journal.pone.0128905	http://dx.doi.org/10.1371/journal.pone.0128905			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053837	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300067
J	Gong, Y; Cao, KW; Xu, JS; Li, JX; Hong, K; Cheng, XS; Su, H				Gong, Yi; Cao, Kai-wu; Xu, Jin-song; Li, Ju-xiang; Hong, Kui; Cheng, Xiao-shu; Su, Hai			Valuation of Normal Range of Ankle Systolic Blood Pressure in Subjects with Normal Arm Systolic Blood Pressure	PLOS ONE			English	Article							BRACHIAL INDEX; ASSOCIATION; MORTALITY; EXERCISE	Subject This study aimed to establish a normal range for ankle systolic blood pressure (SBP). Methods A total of 948 subjects who had normal brachial SBP (90-139 mmHg) at investigation were enrolled. Supine BP of four limbs was simultaneously measured using four automatic BP measurement devices. The ankle-arm difference (An-a) on SBP of both sides was calculated. Two methods were used for establishing normal range of ankle SBP: the 99% method was decided on the 99% reference range of actual ankle BP, and the An-a method was the sum of An-a and the low or up limits of normal arm SBP (90-139 mmHg). Results Whether in the right or left side, the ankle SBP was significantly higher than the arm SBP (right: 137.1 +/- 16.9 vs 119.7 +/- 11.4 mmHg, P<0.05). Based on the 99% method, the normal range of ankle SBP was 94 +/- 181 mmHg for the total population, 84 +/- 166 mmHg for the young (18-44 y), 107 +/- 176 mmHg for the middle-aged(45-59 y) and 113 +/- 179 mmHg for the elderly (>= 60y) group. As the An-a on SBP was 13mmHg in the young group and 20mmHg in both middle-aged and elderly groups, the normal range of ankle SBP on the An-a method was 103-153 mmHg for young and 110-160 mmHg for middle-elderly subjects. Conclusion A primary reference for normal ankle SBP was suggested as 100-165 mmHg in the young and 110-170 mmHg in the middle-elderly subjects.	[Gong, Yi; Cao, Kai-wu; Xu, Jin-song; Li, Ju-xiang; Hong, Kui; Cheng, Xiao-shu; Su, Hai] Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China	Nanchang University	Su, H (corresponding author), Nanchang Univ, Affiliated Hosp 2, Dept Cardiol, Nanchang, Jiangxi, Peoples R China.	suyihappy@sohu.com			National High Technology Research and Development Program of China (863 Program) [2012AA02A516]; Ministry of Chinese Education Innovation Team Development Plan [IRT1141]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Ministry of Chinese Education Innovation Team Development Plan	This work was supported by a grant from the National High Technology Research and Development Program of China (863 Program, No. 2012AA02A516) and the Ministry of Chinese Education Innovation Team Development Plan (IRT1141). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2010, ATHEROSCLEROSIS, V211, P266, DOI 10.1016/j.atherosclerosis.2010.01.013; Bland JM, 1986, LANCET; Chen SC, 2012, CLIN J AM SOC NEPHRO, V7, P1646, DOI 10.2215/CJN.04570512; Drake MJP, 2013, ANAESTHESIA, V68, P461, DOI 10.1111/anae.12194; ENGVALL J, 1989, CLIN PHYSIOL, V9, P517, DOI 10.1111/j.1475-097X.1989.tb01005.x; Gemignani T, 2012, AM J HYPERTENS, V25, P1083, DOI 10.1038/ajh.2012.101; Hafner F, 2012, ANN THORAC SURG, V93, P1299, DOI 10.1016/j.athoracsur.2011.09.017; Hietanen H, 2010, J HUM HYPERTENS, V24, P577, DOI 10.1038/jhh.2009.102; Hietanen HJ, 2010, STROKE RES TREAT, V2010, DOI 10.4061/2010/729391; Jahangiri B, 2009, CAN J CARDIOL, V25, P111, DOI 10.1016/S0828-282X(09)70487-8; Jimenez M, 2014, ATHEROSCLEROSIS, V233, P72, DOI 10.1016/j.atherosclerosis.2013.12.021; Jones WS, 2014, AM HEART J, V167, P499, DOI 10.1016/j.ahj.2013.12.016; Moore C, 2008, ANAESTHESIA, V63, P1327, DOI 10.1111/j.1365-2044.2008.05633.x; O'Brien E, 2010, BLOOD PRESS MONIT, V15, P23, DOI 10.1097/MBP.0b013e3283360e98; Tarumi T, 2011, J HUM HYPERTENS, V25, P539, DOI 10.1038/jhh.2010.100	15	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0122248	10.1371/journal.pone.0122248	http://dx.doi.org/10.1371/journal.pone.0122248			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052703	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300004
J	Linneweber, GA; Winking, M; Fischbach, KF				Linneweber, Gerit Arne; Winking, Mathis; Fischbach, Karl-Friedrich			The Cell Adhesion Molecules Roughest, Hibris, Kin of Irre and Sticks and Stones Are Required for Long Range Spacing of the Drosophila Wing Disc Sensory Sensilla	PLOS ONE			English	Article							IMMUNOGLOBULIN-LIKE PROTEIN; PERIPHERAL NERVOUS-SYSTEM; MYOBLAST FUSION; AXONAL PROJECTIONS; SIGNALING PATHWAY; GENE-EXPRESSION; IRM-PROTEINS; RST PROTEIN; NOTCH; PATTERN	Most animal tissues and organ systems are comprised of highly ordered arrays of varying cell types. The development of external sensory organs requires complex cell-cell communication in order to give each cell a specific identity and to ensure a regular distributed pattern of the sensory bristles. This involves both long and short range signaling mediated by either diffusible or cell anchored factors. In a variety of processes the heterophilic Irre Cell Recognition Module, consisting of the Neph-like proteins: Roughest, Kin of irre and of the Nephrin-like proteins: Sticks and Stones, Hibris, plays key roles in the recognition events of different cell types throughout development. In the present study these proteins are apically expressed in the adhesive belt of epithelial cells participating in sense organ development in a partially exclusive and asymmetric manner. Using mutant analysis the GAL4/UAS system, RNAi and gain of function we found an involvement of all four Irre Cell Recognition Module-proteins in the development of a highly structured array of sensory organs in the wing disc. The proteins secure the regular spacing of sensory organs showing partial redundancy and may function in early lateral inhibition events as well as in cell sorting processes. Comparisons with other systems suggest that the Irre Cell Recognition module is a key organizer of highly repetitive structures.	[Linneweber, Gerit Arne; Winking, Mathis; Fischbach, Karl-Friedrich] Univ Freiburg, Dept Neurobiol, D-79104 Freiburg, Germany	University of Freiburg	Linneweber, GA (corresponding author), VIB Ctr Biol Dis, Herestr 49 Bus 602, Leuven, Belgium.	gerit.linneweber@cme.vib-kuleuven.be	Linneweber, Gerit A/B-1797-2014	Linneweber, Gerit A/0000-0001-8393-6426				Adler PN, 2012, CURR TOP DEV BIOL, V101, P1, DOI 10.1016/B978-0-12-394592-1.00001-6; Artero RD, 2001, DEVELOPMENT, V128, P4251; Artero RD, 2006, HEREDITAS, V143, P117; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; Bao SJ, 2005, DEV CELL, V8, P925, DOI 10.1016/j.devcel.2005.03.011; Baylies MK, 1998, CELL, V93, P921, DOI 10.1016/S0092-8674(00)81198-8; BOSCHERT U, 1990, J NEUROGENET, V6, P153, DOI 10.3109/01677069009107107; Bour BA, 2000, GENE DEV, V14, P1498; BRAND AH, 1993, DEVELOPMENT, V118, P401; COUSO JP, 1994, DEVELOPMENT, V120, P621; DECELIS JF, 1991, P NATL ACAD SCI USA, V88, P632, DOI 10.1073/pnas.88.2.632; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dworak HA, 2001, DEVELOPMENT, V128, P4265; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Fischbach KF, 2009, J NEUROGENET, V23, P48, DOI 10.1080/01677060802471668; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; Grzeschik NA, 2005, DEVELOPMENT, V132, P2035, DOI 10.1242/dev.01800; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hoekstra D, 2003, J LIPID RES, V44, P869, DOI 10.1194/jlr.R300003-JLR200; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; Jhaveri D, 2000, MECH DEVELOP, V99, P101, DOI 10.1016/S0925-4773(00)00487-1; Kesper DA, 2007, DEV DYNAM, V236, P404, DOI 10.1002/dvdy.21035; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kong LW, 2011, LIFE SCI, V88, P590, DOI 10.1016/j.lfs.2011.01.014; Kreiskother N, 2006, J MUSCLE RES CELL M, V27, P93, DOI 10.1007/s10974-006-9060-y; Land MF, 1997, ANNU REV ENTOMOL, V42, P147, DOI 10.1146/annurev.ento.42.1.147; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Li MF, 2011, NEPHROLOGY, V16, P118, DOI 10.1111/j.1440-1797.2010.01374.x; Linneweber GA, 2009, J NEUROGENET, V23, pS18; Liu T, 2012, J NEUROSCI, V32, P11879, DOI 10.1523/JNEUROSCI.1376-12.2012; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; Nishida K, 2010, J BIOL CHEM, V285, P373, DOI 10.1074/jbc.M109.060657; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; PALKA J, 1979, DEV BIOL, V69, P549, DOI 10.1016/0012-1606(79)90311-7; PHILLIPS RG, 1993, DEVELOPMENT, V118, P427; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; RABINOW L, 1990, GENETICS, V125, P41; RAMOS RGP, 1993, GENE DEV, V7, P2533, DOI 10.1101/gad.7.12b.2533; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Reddy GV, 1999, DEV GENES EVOL, V209, P581, DOI 10.1007/s004270050292; Reiter C, 1996, DEVELOPMENT, V122, P1931; Renaud O, 2002, MECH DEVELOP, V119, P201, DOI 10.1016/S0925-4773(02)00381-7; Renaud O, 2001, DEV BIOL, V240, P361, DOI 10.1006/dbio.2001.0482; Rokia-Mille SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002395; Machado MCR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022536; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; SCHNEIDER T, 1995, NEURON, V15, P259, DOI 10.1016/0896-6273(95)90032-2; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Shelton C, 2009, DEVELOPMENT, V136, P1159, DOI 10.1242/dev.026302; SIMPSON P, 1990, DEVELOPMENT, V109, P509; Singh J, 2012, DEV CELL, V23, P82, DOI 10.1016/j.devcel.2012.04.021; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Takemura M, 2011, DEV BIOL, V357, P336, DOI 10.1016/j.ydbio.2011.07.007; Tamura S, 2005, NEUROSCIENCE, V133, P615, DOI 10.1016/j.neuroscience.2005.03.030; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6	60	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128490	10.1371/journal.pone.0128490	http://dx.doi.org/10.1371/journal.pone.0128490			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053791	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300041
J	Zheng, L; Leung, E; Lee, N; Lui, G; To, KF; Chan, RCY; Ip, M				Zheng, Lin; Leung, Eric; Lee, Nelson; Lui, Grace; To, Ka-Fai; Chan, Raphael C. Y.; Ip, Margaret			Differential MicroRNA Expression in Human Macrophages with Mycobacterium tuberculosis Infection of Beijing/W and Non-Beijing/W Strain Types	PLOS ONE			English	Article							CELL-DEVELOPMENT; GENE-EXPRESSION; CANCER CELLS; INDUCTION; MIR-150; TRANSCRIPTION; INHIBITOR; RESPONSES; INVASION; TARGETS	Objectives The role of microRNAs in association with Mycobacterium tuberculosis(MTB) infection and the immunology regulated by microRNAs upon MTB infection have not been fully unravelled. We examined the microRNA profiles of THP-1 macrophages upon the MTB infection of Beijing/W and non-Beijing/W clinical strains. We also studied the microRNA profiles of the host macrophages by microarray in a small cohort with active MTB disease, latent infection (LTBI), and from healthy controls. Results The results revealed that 14 microRNAs differentiated infections of Beijing/W from non-Beijing/W strains (P < 0.05). A unique signature of 11 microRNAs in human macrophages was identified to differentiate active MTB disease from LTBI and healthy controls. Pathway analyses of these differentially expressed miRNAs suggest that the immune-regulatory interactions involving TGF-beta signalling pathway take part in the dysregulation of critical TB processes in the macrophages, resulting in active expression of both cell communication and signalling transduction systems. Conclusion We showed for the first time that the Beijing/W TB strains repressed a number of miRNAs expressions which may reflect their virulence characteristics in altering the host response. The unique signatures of 11 microRNAs may deserve further	[Zheng, Lin; Leung, Eric; Chan, Raphael C. Y.; Ip, Margaret] Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Lee, Nelson; Lui, Grace] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [To, Ka-Fai] Chinese Univ Hong Kong, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Ip, M (corresponding author), Chinese Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	margaretip@cuhk.edu.hk	Chan, Raphael Chiu Yeung/J-9649-2013; Ip, Margaret/K-1096-2013; Lui, Chung Yan Grace/N-5178-2016; Lee, Nelson/B-6418-2008; Lui, Grace/N-4498-2019	Ip, Margaret/0000-0003-1291-6537; Lui, Chung Yan Grace/0000-0001-5242-2967; Lee, Nelson/0000-0002-0783-6607; 	Health and Medical Research Fund, Food and Health Bureau, HKSAR government (RFCID) [09080392]	Health and Medical Research Fund, Food and Health Bureau, HKSAR government (RFCID)	The study was supported by the Health and Medical Research Fund (previously Research Fund for the Control of Infectious Diseases), Food and Health Bureau, HKSAR government (RFCID No. 09080392). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Bao LL, 2013, CANCER LETT, V337, P226, DOI 10.1016/j.canlet.2013.05.007; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Buu TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042323; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Chen CF, 2011, MOL PHARMACOL, V79, P735, DOI 10.1124/mol.110.069633; Chen J, 2007, TUBERCULOSIS, V87, P446, DOI 10.1016/j.tube.2007.05.014; Das K, 2013, TUBERCULOSIS, V93, pS47, DOI 10.1016/S1472-9792(13)70010-6; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Dong J, 2014, MOL MED REP, V10, P1426, DOI 10.3892/mmr.2014.2335; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Furci L, 2013, INT J MYCOBACT, V2, P128, DOI 10.1016/j.ijmyco.2013.04.006; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Ghisi M, 2011, BLOOD, V117, P7053, DOI 10.1182/blood-2010-12-326629; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; He QT, 2013, BBA-GEN SUBJECTS, V1830, P5258, DOI 10.1016/j.bbagen.2013.07.028; Hong L, 2010, ANN SURG, V251, P1056, DOI 10.1097/SLA.0b013e3181dd4ea9; Jackson AL, 2012, NUCLEIC ACID THER, V22, P213, DOI 10.1089/nat.2012.0356; Jacobsen M, 2007, J MOL MED, V85, P613, DOI 10.1007/s00109-007-0157-6; Jude JA, 2012, AM J PHYSIOL-LUNG C, V303, pL460, DOI 10.1152/ajplung.00041.2012; Kumar M, 2015, CELL HOST MICROBE, V17, P345, DOI 10.1016/j.chom.2015.01.007; Kwon JE, 2013, APOPTOSIS, V18, P896, DOI 10.1007/s10495-013-0841-7; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin YC, 2008, MOL BIOL EVOL, V25, P2189, DOI 10.1093/molbev/msn165; Liu CZ, 2010, J HEPATOL, V53, P98, DOI 10.1016/j.jhep.2010.02.021; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; Lucotti S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-52; Maertzdorf J, 2011, GENES IMMUN, V12, P15, DOI 10.1038/gene.2010.51; Miotto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080149; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Qi YH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-384; Rajaram MVS, 2011, P NATL ACAD SCI USA, V108, P17408, DOI 10.1073/pnas.1112660108; Schaefer JS, 2011, J IMMUNOL, V187, P5834, DOI 10.4049/jimmunol.1100922; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Shin KH, 2011, BIOCHEM BIOPH RES CO, V404, P896, DOI 10.1016/j.bbrc.2010.12.055; Singh Y, 2013, J BIOL CHEM, V288, P5056, DOI 10.1074/jbc.C112.439778; Stavrum R, 2012, GENES IMMUN, V13, P496, DOI 10.1038/gene.2012.24; Subbian S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-60; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; TSUCHIYA S, 1982, CANCER RES, V42, P1530; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Wong KC, 2007, CLIN VACCINE IMMUNOL, V14, P1279, DOI 10.1128/CVI.00190-07; Wu J, 2012, HUM IMMUNOL, V73, P31, DOI 10.1016/j.humimm.2011.10.003; Wu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038367; Wu ZW, 2012, FEBS LETT, V586, P2459, DOI 10.1016/j.febslet.2012.06.004; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yang HP, 2013, J CLIN INVEST, V123, P285, DOI 10.1172/JCI63861; Yi ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043184; Yu T, 2015, ONCOGENE, V34, P413, DOI 10.1038/onc.2013.574; Zhang HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088909; Zhang RW, 2015, NEUROMOL MED, V17, P24, DOI 10.1007/s12017-014-8335-5; Zhang X, 2014, MOL CANCER RES, V12, P1535, DOI 10.1158/1541-7786.MCR-13-0641; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076; Zhou BY, 2007, P NATL ACAD SCI USA, V104, P7080, DOI 10.1073/pnas.0702409104; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	61	36	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0126018	10.1371/journal.pone.0126018	http://dx.doi.org/10.1371/journal.pone.0126018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053546	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300012
J	Brown, PA; Akbari, A; Molnar, AO; Taran, S; Bissonnette, J; Sood, M; Hiremath, S				Brown, Pierre Antoine; Akbari, Ayub; Molnar, Amber O.; Taran, Shaurya; Bissonnette, Janice; Sood, Manish; Hiremath, Swapnil			Factors Associated with Unplanned Dialysis Starts in Patients followed by Nephrologists: A Retropective Cohort Study	PLOS ONE			English	Article							STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; SUBOPTIMAL INITIATION; REPLACEMENT THERAPY; CARE; SURVIVAL; MORTALITY; MODALITY; ACCESS	The number of patients starting dialysis is increasing world wide. Unplanned dialysis starts (patients urgently starting dialysis in hospital) is associated with increased costs and high morbidity and mortality. Risk factors for starting dialysis urgently in hospital have not been well studied. The primary objective of this study was to identify risk factors for unplanned dialysis starts in patients followed in a multidisciplinary chronic kidney disease (CKD) clinic. We performed a retrospective cohort study of 649 advanced CKD patients followed in a multidisciplinary CKD clinic at a tertiary care hospital from January 01, 2010 to April 30, 2013. Patients were classified as unplanned start (in hospital) or elective start. Multivariable logistic regression was used to identify variables associated with unplanned dialysis initiation. 184 patients (28.4%) initiated dialysis, of which 76 patients (41.3%) initiated dialysis in an unplanned fashion and 108 (58.7%) starting electively. Unplanned start patients were more likely to have diabetes (68.4% versus 51.9%; p = 0.04), CAD (42.1% versus 24.1%; p = 0.02), congestive heart failure (36.8% versus 17.6%; p = 0.01), and were less likely to receive modality education (64.5% vs 89.8%; p < 0.01) or be assessed by a surgeon for access creation (40.8% vesrus78.7% p < 0.01). On multivariable analysis, higher body mass index (OR 1.07, 95% CI 1.02, 1.13), and a history of congestive heart failure (OR 2.41, 95% CI 1.09, 5.41) were independently associated with an unplanned start. Unplanned dialysis initiation is common among advanced CKD patients, even if they are followed in a multidisciplinary chronic kidney disease clinic. Timely education and access creation in patients at risk may lead to lower costs and less morbidity and mortality.	[Brown, Pierre Antoine; Akbari, Ayub; Molnar, Amber O.; Bissonnette, Janice; Sood, Manish; Hiremath, Swapnil] Univ Ottawa, Div Nephrol, Dept Med, Ottawa, ON, Canada; [Brown, Pierre Antoine; Akbari, Ayub; Molnar, Amber O.; Bissonnette, Janice; Sood, Manish; Hiremath, Swapnil] Ottawa Hosp, Res Inst, Kidney Res Ctr, Ottawa, ON, Canada; [Akbari, Ayub; Molnar, Amber O.; Bissonnette, Janice; Sood, Manish; Hiremath, Swapnil] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Taran, Shaurya] Univ Ottawa, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Akbari, A (corresponding author), Univ Ottawa, Div Nephrol, Dept Med, Ottawa, ON, Canada.	aakbari@ottawahospital.on.ca	Sood, Manish M/H-3134-2019; Molnar, Amber/K-6093-2019; Hiremath, Swapnil/H-3492-2019; Taran, Shaurya/ABF-1571-2020; Brown, Pierre Antoine/L-2175-2019	Sood, Manish M/0000-0002-9146-2344; Hiremath, Swapnil/0000-0003-0010-3416; Brown, Pierre Antoine/0000-0002-0283-4530	Ottawa Hospital	Ottawa Hospital	An internal grant from The Ottawa Hospital was utilized for funding.	Avron J, 2002, ARCH INTERN MED, V162, P2002; Buck J, 2007, NEPHROL DIAL TRANSPL, V22, P3240, DOI 10.1093/ndt/gfm387; Cornelis T, 2013, HEMODIAL INT, V17, P639, DOI 10.1111/hdi.12042; Goransson LG, 2001, J INTERN MED, V250, P154, DOI 10.1046/j.1365-2796.2001.00869.x; Graham J, 2008, NEPHROL DIAL TRANSPL, V23, P3585, DOI 10.1093/ndt/gfn317; Hemmelgarn BR, 2007, J AM SOC NEPHROL, V18, P993, DOI 10.1681/ASN.2006080860; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Hiremath S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028453; Hughes SA, 2013, NEPHROL DIAL TRANSPL, V28, P392, DOI 10.1093/ndt/gfs431; Lee H, 2002, AM J KIDNEY DIS, V40, P611, DOI 10.1053/ajkd.2002.34924; Lorenzo V, 2004, AM J KIDNEY DIS, V43, P999, DOI 10.1053/j.ajkd.2004.02.012; Mendelssohn DC, 2011, NEPHROL DIAL TRANSPL, V26, P2959, DOI 10.1093/ndt/gfq843; Mendelssohn DC, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-22; O'Hare AM, 2012, AM J KIDNEY DIS, V59, P513, DOI 10.1053/j.ajkd.2011.11.044; Perl J, 2011, J AM SOC NEPHROL, V22, P1113, DOI 10.1681/ASN.2010111155; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Singhal R, 2014, KIDNEY INT, V86, P399, DOI 10.1038/ki.2014.16; Sud M, 2015, J AM SOC NEPHROL, V26, P715, DOI 10.1681/ASN.2014030253; Tennankore KK, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-72; Udayaraj UP, 2011, NEPHROL DIAL TRANSPL, V26, P3646, DOI 10.1093/ndt/gfr164; Winkelmayer WC, 2001, AM J KIDNEY DIS, V38, P1178, DOI 10.1053/ajkd.2001.29207; Zelmer JL, 2007, KIDNEY INT, V72, P1122, DOI 10.1038/sj.ki.5002459	23	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0130080	10.1371/journal.pone.0130080	http://dx.doi.org/10.1371/journal.pone.0130080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047510	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200172
J	Carbonelli, M; La Morgia, C; Savini, G; Cascavilla, ML; Borrelli, E; Chicani, F; Ramos, CD; Salomao, SR; Parisi, V; Sebag, J; Bandello, F; Sadun, AA; Carelli, V; Barboni, P				Carbonelli, Michele; La Morgia, Chiara; Savini, Giacomo; Cascavilla, Maria Lucia; Borrelli, Enrico; Chicani, Filipe; Ramos, Carolina do V. F.; Salomao, Solange R.; Parisi, Vincenzo; Sebag, Jerry; Bandello, Francesco; Sadun, Alfredo A.; Carelli, Valerio; Barboni, Piero			Macular Microcysts in Mitochondrial Optic Neuropathies: Prevalence and Retinal Layer Thickness Measurements	PLOS ONE			English	Article							NERVE-FIBER LAYER; INNER NUCLEAR LAYER; COHERENCE-TOMOGRAPHY; MULTIPLE-SCLEROSIS; ATROPHY; EDEMA; AGE; DEGENERATION; OPA1	Purpose To investigate the thickness of the retinal layers and to assess the prevalence of macular microcysts (MM) in the inner nuclear layer (INL) of patients with mitochondrial optic neuropathies (MON). Methods All patients with molecularly confirmed MON, i.e. Leber's Hereditary Optic Neuropathy (LHON) and Dominant Optic Atrophy (DOA), referred between 2010 and 2012 were enrolled. Eight patients with MM were compared with two control groups: MON patients without MM matched by age, peripapillary retinal nerve fiber layer (RNFL) thickness, and visual acuity, as well as age-matched controls. Retinal segmentation was performed using specific Optical coherence tomography (OCT) software (Carl Zeiss Meditec). Macular segmentation thickness values of the three groups were compared by one-way analysis of variance with Bonferroni post hoc corrections. Results MM were identified in 5/90 (5.6%) patients with LHON and 3/58 (5.2%) with DOA. The INL was thicker in patients with MON compared to controls regardless of the presence of MM [133.1 +/- 7 mu m vs 122.3 +/- 9 mu m in MM patients (p<0.01) and 128.5 +/- 8 mu m vs. 122.3 +/- 9 mu m in no-MM patients (p<0.05)], however the outer nuclear layer (ONL) was thicker in patients with MM (101.4 +/- 1m mu) compared to patients without MM [77.5v8m mu (p<0.001)] and controls 78.4 +/- 7m mu (p<0.001)]. ONL thickness did not significantly differ between patients without MM and controls. Conclusion The prevalence of MM in MON is low (5-6%), but associated with ONL thickening. We speculate that in MON patients with MM, vitreo-retinal traction contributes to the thickening of ONL as well as to the production of cystic spaces.	[Carbonelli, Michele; La Morgia, Chiara; Carelli, Valerio] Bellaria Hosp, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy; [La Morgia, Chiara; Carelli, Valerio] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Neurol Unit, Bologna, Italy; [Savini, Giacomo; Parisi, Vincenzo] IRCCS, GB Bietti Fdn, Rome, Italy; [Cascavilla, Maria Lucia; Borrelli, Enrico; Bandello, Francesco; Barboni, Piero] Ist Sci San Raffaele, I-20132 Milan, Italy; [Chicani, Filipe; Ramos, Carolina do V. F.; Salomao, Solange R.] Univ Fed Sao Paulo, UNIFESP, Dept Ophthalmol, Sao Paulo, Brazil; [Sebag, Jerry; Sadun, Alfredo A.] Univ Calif Los Angeles, Doheny Eye Inst, Los Angeles, CA USA; [Sebag, Jerry] VMR Inst Vitreous Macula Retina, Huntington Beach, CA USA; [Barboni, Piero] Studio Oculist Azeglio, Bologna, Italy	AUSL di Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); University of Bologna; IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universidade Federal de Sao Paulo (UNIFESP); Doheny Eye Institute; University of California System; University of California Los Angeles	Carbonelli, M (corresponding author), Bellaria Hosp, IRCCS, Ist Sci Neurol Bologna, Bologna, Italy.	m.carbonelli@studiodazeglio.it; p.barboni@studiodazeglio.it	Savini, Giacomo/J-9196-2018; bandello, francesco/AAH-2405-2019; Barboni, Piero/AAA-9936-2020; La Morgia, Chiara/H-6765-2012; Salomao, Solange R/G-9500-2012; Borrelli, Enrico/AAR-3693-2020; Parisi, Vincenzo/J-6137-2018; Sebag, J./AAF-3602-2020; Salomao, Solange/AAB-3234-2021	Savini, Giacomo/0000-0003-0075-3582; bandello, francesco/0000-0003-3238-9682; Barboni, Piero/0000-0002-0118-4177; Salomao, Solange R/0000-0002-3436-5599; Borrelli, Enrico/0000-0003-2815-5031; Salomao, Solange/0000-0002-3436-5599; CARELLI, VALERIO/0000-0003-4923-6404; Sebag, J/0000-0001-8648-5747; LA MORGIA, Chiara/0000-0002-4639-8929; Cascavilla, Maria Lucia/0000-0002-6344-5512	Italian Ministry of Health; Fondazione Roma; Telethon Italy [GGP06233]	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission); Telethon Italy(Fondazione Telethon)	This work was supported by the Italian Ministry of Health (to VC, GS and VP) and Fondazione Roma (to GS and VP) and Telethon Italy, grant #GGP06233 (to VC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg M, 2014, OPHTHALMOLOGY, V121, P142, DOI 10.1016/j.ophtha.2013.08.045; Abegg M, 2012, BRAIN, V135, DOI 10.1093/brain/aws215; Achilli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042242; Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; APPIAH AP, 1988, AM J OPHTHALMOL, V106, P533, DOI 10.1016/0002-9394(88)90581-8; Balk LJ, 2012, BRAIN, V135, DOI 10.1093/brain/aws216; Barboni P, 2005, OPHTHALMOLOGY, V112, P120, DOI 10.1016/j.ophtha.2004.06.034; Barboni P, 2013, BRAIN, V136, DOI 10.1093/brain/awt014; Barboni P, 2011, OPHTHALMOLOGY, V118, P2076, DOI 10.1016/j.ophtha.2011.02.027; Caporali L, 2013, BBA-MOL BASIS DIS, V1832, P445, DOI 10.1016/j.bbadis.2012.12.002; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Chen KN, 2014, J BIOMED MATER RES A, V102, P2001, DOI 10.1002/jbm.a.34858; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Gelfand JM, 2013, JAMA NEUROL, V70, P629, DOI 10.1001/jamaneurol.2013.1832; Gelfand JM, 2012, BRAIN, V135, P1786, DOI 10.1093/brain/aws098; Gocho K, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/676803; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Gupta P, 2011, BRIT J OPHTHALMOL, V95, P376, DOI 10.1136/bjo.2009.175109; Johnson MW, 2010, AM J OPHTHALMOL, V149, P371, DOI 10.1016/j.ajo.2009.11.022; Kaufhold F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071145; Kaushik M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078341; Knight OJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P312, DOI 10.1001/archopthalmol.2011.1576; Maresca A, 2014, CURR MOL MED; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Pau D, 2011, EYE, V25, P832, DOI 10.1038/eye.2011.81; Petzold A, 2010, LANCET NEUROL, V9, P921, DOI 10.1016/S1474-4422(10)70168-X; Ronnback C, 2014, OPHTHALMOLOGY, V121, pE30, DOI 10.1016/j.ophtha.2013.12.040; Saidha S, 2012, LANCET NEUROL, V11, P1021, DOI 10.1016/S1474-4422(12)70275-2; Saidha S, 2012, LANCET NEUROL, V11, P963, DOI 10.1016/S1474-4422(12)70213-2; Savini G, 2005, OPHTHALMOLOGY, V112, P127, DOI 10.1016/j.ophtha.2004.09.033; Schneider E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066151; Sebag J, 2009, Trans Am Ophthalmol Soc, V107, P35; SEBAG J, 1991, ARCH OPHTHALMOL-CHIC, V109, P966, DOI 10.1001/archopht.1991.01080070078039; Sebag J, 2012, VITREOUS VITREORETIN; Sebag J., 2002, CLIN OPHTHALMOLOGY, V5; Sebag J, 1989, VITREOUS STRUCTURE F; Strouthidis NG, 2009, INVEST OPHTH VIS SCI, V50, P4709, DOI 10.1167/iovs.09-3586; Sung KR, 2009, OPHTHALMOLOGY, V116, P1119, DOI 10.1016/j.ophtha.2009.01.004; Wang MY, 2009, RETINA-J RET VIT DIS, V29, P644, DOI 10.1097/IAE.0b013e31819e0d92; Wolff B, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/395189; Wolff B, 2013, RETINA-J RET VIT DIS, V33, P2133, DOI 10.1097/IAE.0b013e31828e68d0; Yu-Wai-Man P, 2011, PROG RETIN EYE RES, V30, P81, DOI 10.1016/j.preteyeres.2010.11.002	42	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127906	10.1371/journal.pone.0127906	http://dx.doi.org/10.1371/journal.pone.0127906			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047507	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200032
J	Durrans, A; Gao, D; Gupta, R; Fischer, KR; Choi, H; El Rayes, T; Ryu, S; Nasar, A; Spinelli, CF; Andrews, W; Elemento, O; Nolan, D; Stiles, B; Rafii, S; Narula, N; Davuluri, R; Altorki, NK; Mittal, V				Durrans, Anna; Gao, Dingcheng; Gupta, Ravi; Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Nasar, Abu; Spinelli, Cathy F.; Andrews, Weston; Elemento, Olivier; Nolan, Daniel; Stiles, Brendon; Rafii, Shahin; Narula, Navneet; Davuluri, Ramana; Altorki, Nasser K.; Mittal, Vivek			Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; LUNG-CANCER; TUMOR MICROENVIRONMENT; ISOFORM EXPRESSION; PROGENITOR CELLS; ANGIOGENESIS; RESISTANCE; THROMBOSPONDIN-1; OSTEOPONTIN; FIBROBLASTS	Lung cancer is the leading cause of cancer related mortality worldwide, with non-small cell lung cancer (NSCLC) as the most prevalent form. Despite advances in treatment options including minimally invasive surgery, CT-guided radiation, novel chemotherapeutic regimens, and targeted therapeutics, prognosis remains dismal. Therefore, further molecular analysis of NSCLC is necessary to identify novel molecular targets that impact prognosis and the design of new-targeted therapies. In recent years, tumor "activated/reprogrammed" stromal cells that promote carcinogenesis have emerged as potential therapeutic targets. However, the contribution of stromal cells to NSCLC is poorly understood. Here, we show increased numbers of bone marrow (BM)-derived hematopoietic cells in the tumor parenchyma of NSCLC patients compared with matched adjacent non-neoplastic lung tissue. By sorting specific cellular fractions from lung cancer patients, we compared the transcriptomes of intratumoral myeloid compartments within the tumor bed with their counterparts within adjacent non-neoplastic tissue from NSCLC patients. The RNA sequencing of specific myeloid compartments (immature monocytic myeloid cells and polymorphonuclear neutrophils) identified differentially regulated genes and mRNA isoforms, which were inconspicuous in whole tumor analysis. Genes encoding secreted factors, including osteopontin (OPN), chemokine (C-C motif) ligand 7 (CCL7) and thrombospondin 1 (TSP1) were identified, which enhanced tumorigenic properties of lung cancer cells indicative of their potential as targets for therapy. This study demonstrates that analysis of homogeneous stromal populations isolated directly from fresh clinical specimens can detect important stromal genes of therapeutic value.	[Durrans, Anna; Gao, Dingcheng; Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Nasar, Abu; Spinelli, Cathy F.; Andrews, Weston; Stiles, Brendon; Altorki, Nasser K.; Mittal, Vivek] Cornell Univ, Weill Cornell Med Coll, Dept Cardiothorac Surg, New York, NY 10065 USA; [Durrans, Anna; Gao, Dingcheng; Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Mittal, Vivek] Cornell Univ, Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Durrans, Anna; Gao, Dingcheng; Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina; Ryu, Seongho; Stiles, Brendon; Altorki, Nasser K.; Mittal, Vivek] Cornell Univ, Weill Cornell Med Coll, Neuberger Berman Lung Canc Ctr, New York, NY 10065 USA; [Gupta, Ravi; Davuluri, Ramana] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis Program, Philadelphia, PA 19104 USA; [Fischer, Kari R.; Choi, Hyejin; El Rayes, Tina] Cornell Univ, Weill Cornell Med Coll, Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Nolan, Daniel; Rafii, Shahin] Cornell Univ, Weill Cornell Med Coll, HHMI, Dept Med Genet, New York, NY 10065 USA; [Elemento, Olivier] Cornell Univ, Weill Cornell Med Coll, Inst Computat Biomed, Dept Physiol & Biophys, New York, NY 10065 USA; [Narula, Navneet] Cornell Univ, Weill Cornell Med Coll, Dept Pathol, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University; The Wistar Institute; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University	Altorki, NK (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Cardiothorac Surg, 1300 York Ave, New York, NY 10065 USA.	nkaltork@med.cornell.edu; vim2010@med.cornell.edu	Gao, Dingcheng/P-5889-2019; El Rayes, Tina/R-8202-2017; Choi, Hyejin/ABC-5099-2020; Choi, Hyejin/ABC-4915-2020; Gupta, Ravi/K-5977-2019	El Rayes, Tina/0000-0002-9935-388X; Choi, Hyejin/0000-0002-4884-2747; Choi, Hyejin/0000-0002-4884-2747; Gupta, Ravi/0000-0001-5242-9528; Andrews, Weston/0000-0003-3709-6838	Neuberger Berman Foundation Lung Cancer Center; Weill Cornell Cancer Center Pilot grant; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	Neuberger Berman Foundation Lung Cancer Center; Weill Cornell Cancer Center Pilot grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funds from The Neuberger Berman Foundation Lung Cancer Center and Weill Cornell Cancer Center Pilot grant.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; Choi YL, 2010, NEW ENGL J MED, V363, P1734, DOI 10.1056/NEJMoa1007478; Coffelt SB, 2010, AM J PATHOL, V176, P1564, DOI 10.2353/ajpath.2010.090786; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dai JX, 2010, CANCER IMMUNOL IMMUN, V59, P355, DOI 10.1007/s00262-009-0754-z; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Devy L, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/191670; Devy L, 2009, CANCER RES, V69, P1517, DOI 10.1158/0008-5472.CAN-08-3255; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Firlej V, 2011, CANCER RES, V71, P7649, DOI 10.1158/0008-5472.CAN-11-0833; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gao DC, 2008, SCIENCE, V319, P195, DOI 10.1126/science.1150224; Gao DC, 2012, CANCER RES, V72, P1384, DOI 10.1158/0008-5472.CAN-11-2905; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Goparaju CMV, 2010, J THORAC ONCOL, V5, P1516, DOI 10.1097/JTO.0b013e3181eba6bd; Haber DA, 2005, COLD SH Q B, V70, P419, DOI 10.1101/sqb.2005.70.043; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ito M, 2012, CHEST; JAFFE EA, 1985, BLOOD, V65, P79; JAFFE EA, 1983, P NATL ACAD SCI-BIOL, V80, P998, DOI 10.1073/pnas.80.4.998; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Kim H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-305; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lawler J, 2002, J CELL MOL MED, V6, P1, DOI 10.1111/j.1582-4934.2002.tb00307.x; Lo Iacono M, 2011, J THORAC ONCOL, V6, P473, DOI 10.1097/JTO.0b013e31820b86b0; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; MCPHERSON J, 1981, J BIOL CHEM, V256, P1330; Michalec L, 2002, J IMMUNOL, V168, P846, DOI 10.4049/jimmunol.168.2.846; Nakasone ES, 2012, CANCER CELL, V21, P488, DOI 10.1016/j.ccr.2012.02.017; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Oliver TG, 2010, GENE DEV, V24, P837, DOI 10.1101/gad.1897010; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Pal S, 2011, GENOME RES, V21, P1260, DOI 10.1101/gr.120535.111; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; RAUGI GJ, 1982, J CELL BIOL, V95, P351, DOI 10.1083/jcb.95.1.351; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Ruffell B, 2012, P NATL ACAD SCI USA, V109, P2796, DOI 10.1073/pnas.1104303108; Schmid MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/201026; Shojaei F, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-26; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Straussman R, 2012, NATURE, V487, P500, DOI 10.1038/nature11183; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; Tomita M, 2011, ANTICANCER RES, V31, P2995; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang W, 2009, CLIN CANCER RES, V15, P6630, DOI 10.1158/1078-0432.CCR-09-1001; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Yuan A, 2001, J CLIN ONCOL, V19, P432, DOI 10.1200/JCO.2001.19.2.432; Zeng QH, 2005, CANCER CELL, V8, P13, DOI 10.1016/j.ccr.2005.06.004; Zhang J, 2010, PROG MOL BIOL TRANSL, V95, P31, DOI 10.1016/B978-0-12-385071-3.00003-4; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	66	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129123	10.1371/journal.pone.0129123	http://dx.doi.org/10.1371/journal.pone.0129123			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046767	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200126
J	Bedard, N; Jammoul, S; Moore, T; Wykes, L; Hallauer, PL; Hastings, KEM; Stretch, C; Baracos, V; Chevalier, S; Plourde, M; Coyne, E; Wing, SS				Bedard, Nathalie; Jammoul, Samer; Moore, Tamara; Wykes, Linda; Hallauer, Patricia L.; Hastings, Kenneth E. M.; Stretch, Cynthia; Baracos, Vickie; Chevalier, Stephanie; Plourde, Marie; Coyne, Erin; Wing, Simon S.			Inactivation of the ubiquitin-specific protease 19 deubiquitinating enzyme protects against muscle wasting	FASEB JOURNAL			English	Article						cachexia; sarcopenia; deubiquitylation	RAT SKELETAL-MUSCLE; BODY-MASS INDEX; NF-KAPPA-B; GENE-EXPRESSION; CANCER CACHEXIA; ATROPHY; MICE; USP19; DENERVATION; PROTEOLYSIS	The ubiquitin system plays a critical role in muscle wasting. Previous work has focused on the roles of ubiquitination. However, a role for deubiquitination in this process has not been established. Because ubiquitin-specific protease (USP) 19 deubiquitinating enzyme is induced in skeletal muscle in many catabolic conditions, we generated USP19 knockout (KO) mice. These mice lost less muscle mass than wild-type (WT) animals in response to glucocorticoids, a common systemic cause of muscle atrophy as well as in response to denervation, a model of disuse atrophy. KO mice retained more strength and had less myofiber atrophy with both type I and type IIb fibers being protected. Rates of muscle protein synthesis were similar in WT and KO mice, suggesting that the sparing of atrophy was attributed to suppressed protein degradation. Consistent with this, expression of the ubiquitin ligases MuRF1 and MAFbx/atrogin-1 as well as several autophagy genes was decreased in the muscles of catabolic KO mice. Expression of USP19 correlates with that of MuRF1 and MAFbx/atrogin-1 in skeletal muscles from patients with lung cancer or gastrointestinal cancer, suggesting that USP19 is involved in human muscle wasting. Inhibition of USP19 may be a useful approach to the treatment of many muscle-wasting conditions.	[Bedard, Nathalie; Jammoul, Samer; Moore, Tamara; Plourde, Marie; Coyne, Erin; Wing, Simon S.] McGill Univ, Ctr Hlth, Dept Med, Polypeptide Lab, Montreal, PQ H4A 3J1, Canada; [Chevalier, Stephanie] McGill Univ, Ctr Hlth, Dept Med, Crabtree Nutr Labs, Montreal, PQ H4A 3J1, Canada; [Hallauer, Patricia L.; Hastings, Kenneth E. M.] McGill Univ, Montreal Neurol Inst, Mol Genet Lab, Montreal, PQ H4A 3J1, Canada; [Wykes, Linda] McGill Univ, Sch Dietet & Human Nutr, Ste Anne De Bellevue, PQ, Canada; [Stretch, Cynthia; Baracos, Vickie] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	McGill University; McGill University; McGill University; McGill University; University of Alberta	Wing, SS (corresponding author), McGill Univ, Ctr Hlth, Res Inst, 1001 Decarie Blvd,Room E02-7232, Montreal, PQ H4A 3J1, Canada.	simon.wing@mcgill.ca	Chevalier, Stephanie/AAA-5386-2021; Plourde, Marie-Claude/GQA-4616-2022	Stretch, Cynthia/0000-0002-5152-2728	Canadian Institutes of Health Research [SSW-MOP82734, SC-PET69773, KEMH-57864]; Terry Fox Research Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Research Institute	This work was supported by grants from the Canadian Institutes of Health Research (SSW-MOP82734, SC-PET69773, and KEMH-57864) and the Terry Fox Research Institute (to S.S.W.).	Anker SD, 1999, CHEST, V115, P836, DOI 10.1378/chest.115.3.836; Ausubel F. M., 2001, CURRENT PROTOCOLS MO; Baehr LM, 2011, J PHYSIOL-LONDON, V589, P4759, DOI 10.1113/jphysiol.2011.212845; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Braun TP, 2013, FASEB J, V27, P3572, DOI 10.1096/fj.13-230375; Combaret L, 2005, AM J PHYSIOL-ENDOC M, V288, pE693, DOI 10.1152/ajpendo.00281.2004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Harding SV, 2010, PEDIATR RES, V67, P268, DOI 10.1203/PDR.0b013e3181cb8e49; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; KOTLER DP, 1989, AM J CLIN NUTR, V50, P444, DOI 10.1093/ajcn/50.3.444; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Liu Q, 2011, J CELL BIOCHEM, V112, P2307, DOI 10.1002/jcb.23151; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marquis K, 2002, AM J RESP CRIT CARE, V166, P809, DOI 10.1164/rccm.2107031; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Mei YD, 2011, J BIOL CHEM, V286, P35380, DOI 10.1074/jbc.M111.282020; Ogawa M, 2013, BRIT J NUTR, V109, P1349, DOI 10.1017/S0007114512003297; Prado CMM, 2009, CLIN CANCER RES, V15, P2920, DOI 10.1158/1078-0432.CCR-08-2242; Robert F, 2012, CANCER RES, V72, P747, DOI 10.1158/0008-5472.CAN-11-2739; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Shen W, 2004, J APPL PHYSIOL, V97, P2333, DOI 10.1152/japplphysiol.00744.2004; Stretch C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065380; Sundaram P, 2009, AM J PHYSIOL-ENDOC M, V297, pE1283, DOI 10.1152/ajpendo.00409.2009; Varfolomeev E, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2001878; Welle S, 2006, AM J PHYSIOL-ENDOC M, V290, pE409, DOI 10.1152/ajpendo.00433.2005; Welle S, 2009, AM J PHYSIOL-ENDOC M, V296, pE567, DOI 10.1152/ajpendo.90862.2008; Wiles B, 2015, MOL BIOL CELL, V26, P913, DOI 10.1091/mbc.E14-06-1129; Wing SS, 2011, CRIT REV CL LAB SCI, V48, P49, DOI 10.3109/10408363.2011.586171; Wing SS, 2005, INT J BIOCHEM CELL B, V37, P2075, DOI 10.1016/j.biocel.2004.11.011; WING SS, 1995, BIOCHEM J, V307, P639, DOI 10.1042/bj3070639; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	33	31	36	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3889	3898		10.1096/fj.15-270579	http://dx.doi.org/10.1096/fj.15-270579			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26048142				2022-12-26	WOS:000359915600024
J	Li, N; Mruk, DD; Wong, CKC; Lee, WM; Han, DS; Cheng, CY				Li, Nan; Mruk, Dolores D.; Wong, Chris K. C.; Lee, Will M.; Han, Daishu; Cheng, C. Yan			Actin-bundling protein plastin 3 is a regulator of ectoplasmic specialization dynamics during spermatogenesis in the rat testis	FASEB JOURNAL			English	Article						actin microfilaments; blood-testis barrier; spermatid adhesion	GERM CELL-INTERACTIONS; FOCAL ADHESION KINASE; SERTOLI-CELL; BARRIER DYNAMICS; SEMINIFEROUS EPITHELIUM; ADHERENS JUNCTIONS; SPERMATID TRANSPORT; COMPLEX; ORGANIZATION; EXPRESSION	Ectoplasmic specialization (ES) is an actin-junction in the seminiferous epithelium of adult mammalian testes. ES is restricted to the Sertoli-spermatid (apical ES) interface, as well as the Sertoli cellp-cell (basal ES) interface at the blood-testis barrier (BTB). ES is typified by the presence of an array of bundles of actin microfilaments near the Sertoli cell plasma membrane. These actin microfilament bundles require rapid debundling to convert them from a bundled to branched/unbundled configuration and vice versa to confer plasticity to support the transport of 1) spermatids in the adluminal compartment and 2) preleptotene spermatocytes at the BTB while maintaining cell adhesion. Plastin 3 is one of the plastin family members abundantly found in yeast, plant and animal cells that confers actin microfilaments their bundled configuration. Herein, plastin 3 was shown to be a component of the apical and basal ES in the rat testis, displaying spatiotemporal expression during the epithelial cycle. A knockdown (KD) of plastin 3 in Sertoli cells by RNA interference using an in vitro model to study BTB function showed that a transient loss of plastin 3 perturbed the Sertoli cell tight junction-permeability barrier, mediated by changes in the localization of basal ES proteins N-cadherin and beta-catenin. More importantly, these changes were the result of an alteration of the actin microfilaments, converting from their bundled to branched configuration when examined microscopically, and validated by biochemical assays that quantified actin-bundling and polymerization activity. Moreover, these changes were confirmed by studies in vivo by plastin 3 KD in the testis in which mis-localization of N-cadherin and beta-catenin was also detected at the BTB, concomitant with defects in the transport of spermatids and phagosomes and a disruption of cell adhesion most notably in elongated spermatids due to a loss of actin-bundling capability at the apical ES, which in turn affected localization of adhesion protein complexes at the site. In summary, plastin 3 is a regulator of actin microfilament bundles at the ES in which it dictates the configuration of the filamentous actin network by assuming either a bundled or unbundled/branched configuration via changes in its spatiotemporal expression during the epithelial cycle.	[Li, Nan; Mruk, Dolores D.; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, New York, NY 10065 USA; [Wong, Chris K. C.] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Lee, Will M.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Han, Daishu] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Sch Basic Med, Beijing 100730, Peoples R China	Population Council; Hong Kong Baptist University; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Lee, Will M/D-2357-2009; wong, chris/GSN-0962-2022	Cheng, C Yan/0000-0003-3117-3791	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (Project 5) [R01 HD056034, U54 HD029990]; Hong Kong Baptist University [LSK/14-15/P06]; National Natural Science Foundation of China Research Grants Council of Hong Kong Joint Research Scheme [N_HKU 717/12, RGC 771513]; University of Hong Kong Committee on Research and Conference Grants Seed Funding; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD029990, R01HD056034] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (Project 5); Hong Kong Baptist University; National Natural Science Foundation of China Research Grants Council of Hong Kong Joint Research Scheme(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); University of Hong Kong Committee on Research and Conference Grants Seed Funding; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01 HD056034 and U54 HD029990 Project 5) both to C.Y.C.; Hong Kong Baptist University (LSK/14-15/P06) to C.K.C.W.; National Natural Science Foundation of China Research Grants Council of Hong Kong Joint Research Scheme (Grant N_HKU 717/12, RGC 771513); and University of Hong Kong Committee on Research and Conference Grants Seed Funding, both to W.M.L.	Babich A, 2013, IMMUNOL REV, V256, P80, DOI 10.1111/imr.12123; Beardsley A, 2006, J ENDOCRINOL, V190, P759, DOI 10.1677/joe.1.06867; Cao YY, 2014, J HUM GENET, V59, P24, DOI 10.1038/jhg.2013.111; Chen H, 2003, IMMUNITY, V19, P95, DOI 10.1016/S1074-7613(03)00172-9; Cheng C Yan, 2011, Spermatogenesis, V1, P99; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2011, BIOCHEM J, V435, P553, DOI 10.1042/BJ20102121; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; CLERMONT Y, 1987, ANN NY ACAD SCI, V513, P1, DOI 10.1111/j.1749-6632.1987.tb24994.x; Delanote V, 2005, ACTA PHARMACOL SIN, V26, P769, DOI 10.1111/j.1745-7254.2005.00145.x; GALDIERI M, 1981, J ANDROL, V2, P249; Giganti A, 2005, J CELL SCI, V118, P1255, DOI 10.1242/jcs.01698; GROVE BD, 1989, J CELL SCI, V93, P309; HESS RA, 1990, BIOL REPROD, V43, P517, DOI 10.1095/biolreprod43.3.517; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; JANECKI A, 1992, TOXICOL APPL PHARM, V112, P51, DOI 10.1016/0041-008X(92)90278-Z; Janji B, 2006, J CELL SCI, V119, P1947, DOI 10.1242/jcs.02874; Jones SL, 1998, P NATL ACAD SCI USA, V95, P9331, DOI 10.1073/pnas.95.16.9331; Kaitu'u-Lino TJ, 2007, REPRODUCTION, V133, P1169, DOI 10.1530/REP-06-0385; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; Lee NPY, 2004, J ANDROL, V25, P200; Lee NPY, 2003, ENDOCRINOLOGY, V144, P3114, DOI 10.1210/en.2002-0167; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Lie PPY, 2012, P NATL ACAD SCI USA, V109, P12562, DOI 10.1073/pnas.1202316109; Lie PPY, 2011, FASEB J, V25, P1244, DOI 10.1096/fj.10-169995; Lie PPY, 2010, INT J BIOCHEM CELL B, V42, P975, DOI 10.1016/j.biocel.2010.02.010; Lui WY, 2003, ENDOCRINOLOGY, V144, P1139, DOI 10.1210/en.2002-0211; Lui WY, 2003, BIOL REPROD, V68, P1597, DOI 10.1095/biolreprod.102.011387; Lyon AN, 2014, HUM MOL GENET, V23, P1990, DOI 10.1093/hmg/ddt595; Michel L, 2013, BLOOD, V121, P1477, DOI 10.1182/blood-2012-10-460535; Miyakawa T, 2012, BIOCHEM BIOPH RES CO, V429, P137, DOI 10.1016/j.bbrc.2012.10.126; Mok KW, 2013, FASEB J, V27, P1137, DOI 10.1096/fj.12-212977; Morley SC, 2013, IMMUNOL REV, V256, P48, DOI 10.1111/imr.12102; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Mulvihill BM, 2010, CLIN BIOMECH, V25, P491, DOI 10.1016/j.clinbiomech.2010.01.006; NAMBA Y, 1992, J BIOCHEM-TOKYO, V112, P503, DOI 10.1093/oxfordjournals.jbchem.a123929; Nicholls PK, 2009, ENDOCRINOLOGY, V150, P2481, DOI 10.1210/en.2008-1048; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; PALOMBI F, 1992, BIOL REPROD, V47, P1173, DOI 10.1095/biolreprod47.6.1173; Qian XJ, 2014, SEMIN CELL DEV BIOL, V30, P75, DOI 10.1016/j.semcdb.2014.04.018; Qian XJ, 2013, ENDOCRINOLOGY, V154, P1907, DOI 10.1210/en.2012-2269; Qiu LL, 2013, TOXICOL SCI, V135, P229, DOI 10.1093/toxsci/kft129; RUSSELL L, 1977, TISSUE CELL, V9, P475, DOI 10.1016/0040-8166(77)90007-6; RUSSELL LD, 1985, INT REV CYTOL, V94, P177, DOI 10.1016/S0074-7696(08)60397-6; Russell LD, 1993, SERTOLI CELL, P365; Salanova M, 1998, BIOL REPROD, V58, P371, DOI 10.1095/biolreprod58.2.371; Samstag Y, 2003, J LEUKOCYTE BIOL, V73, P30, DOI 10.1189/jlb.0602272; Shinomiya Hiroto, 2012, Int J Cell Biol, V2012, P213492, DOI 10.1155/2012/213492; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Siu MKY, 2003, ENDOCRINOLOGY, V144, P2141, DOI 10.1210/en.2002-221035; Su LL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2171; Su LL, 2011, P NATL ACAD SCI USA, V108, P19623, DOI 10.1073/pnas.1111414108; Suetsugu S, 2013, SEMIN CELL DEV BIOL, V24, P267, DOI 10.1016/j.semcdb.2013.01.006; van Dijk FS, 2013, NEW ENGL J MED, V369, P1529, DOI 10.1056/NEJMoa1308223; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Vogl AW, 2000, ARCH HISTOL CYTOL, V63, P1, DOI 10.1679/aohc.63.1; Wan HT, 2014, SEMIN CELL DEV BIOL, V30, P65, DOI 10.1016/j.semcdb.2014.04.013; Wan HT, 2014, ENDOCRINOLOGY, V155, P249, DOI 10.1210/en.2013-1657; Wan HT, 2013, AM J PHYSIOL-ENDOC M, V305, pE687, DOI 10.1152/ajpendo.00254.2013; Weinbaum S, 2011, CELL MOL BIOENG, V4, P510, DOI 10.1007/s12195-011-0179-6; Wolski KM, 2005, J ANDROL, V26, P354, DOI 10.2164/jandrol.04142; Xiao X, 2014, PHYSIOLOGY, V29, P286, DOI 10.1152/physiol.00001.2014; Xiao X, 2013, AM J PHYSIOL-ENDOC M, V304, pE145, DOI 10.1152/ajpendo.00422.2012; Xiao XA, 2011, INT J BIOCHEM CELL B, V43, P651, DOI 10.1016/j.biocel.2011.01.008; Yan Cheng C., 2015, SERTOLI CELL BIOL, Ved., P333, DOI [10.1016/B978-0-12-417047-6.00012-0, DOI 10.1016/B978-0-12-417047-6.00012.0, DOI 10.1016/B978-0-12-417047-6.00012-0]; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; Yan HHN, 2005, P NATL ACAD SCI USA, V102, P11722, DOI 10.1073/pnas.0503855102; Yokobori T, 2013, CANCER RES, V73, P2059, DOI 10.1158/0008-5472.CAN-12-0326	75	30	33	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3788	3805		10.1096/fj.14-267997	http://dx.doi.org/10.1096/fj.14-267997			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26048141	Green Published			2022-12-26	WOS:000359915600016
J	Shilo, V; Ben-Dov, IZ; Nechama, M; Silver, J; Naveh-Many, T				Shilo, Vitali; Ben-Dov, Iddo Z.; Nechama, Morris; Silver, Justin; Naveh-Many, Tally			Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia	FASEB JOURNAL			English	Article						secondary hyperparathyroidism; calcium-sensing receptor; renal failure	HORMONE GENE-EXPRESSION; SECONDARY HYPERPARATHYROIDISM; CDNA LIBRARIES; CALCIUM; RECEPTOR; MODEL; FGF23; RATS; CALCIMIMETICS; MORPHOGENESIS	MicroRNAs (miRNAs) down-regulate gene expression and have vital roles in biology but their functions in the parathyroid are unexplored. To study this, we generated parathyroid-specific Dicer1 knockout (PT-Dicer(-/-) 2) mice where parathyroid miRNA maturation is blocked. Remarkably, the PT-Dicer(-/-) mice did not increase serum parathyroid hormone (PTH) in response to acute hypocalcemia compared with the >5-fold increase in controls. PT-Dicer(-/-) glands cultured in low-calcium medium secreted 5-fold less PTH at 1.5 h than controls. Chronic hypocalcemia increased serum PTH >4-fold less in PT-Dicer(-/-) mice compared with control mice with no increase in PTH mRNA levels and parathyroid cell proliferation compared with the 2-to 3-fold increase in hypocalcemic controls. Moreover, uremic PT-Dicer(-/-) mice increased serum PTH and FGF23 significantly less than uremic controls. Therefore, stimulation of the parathyroid by both hypocalcemia and uremia is dependent upon intact dicer function and miRNAs. In contrast, the PT-Dicer(-/-) mice responded normally to activation of the parathyroid calcium-sensing receptor (Casr) by both hypercalcemia and a calcimimetic that decreases PTH secretion, demonstrating that they are dicer-independent. Therefore, miRNAs are essential for the response of the parathyroid to both acute and chronic hypocalcemia and uremia, the major stimuli for PTH secretion.	[Shilo, Vitali; Ben-Dov, Iddo Z.; Silver, Justin; Naveh-Many, Tally] Hadassah Hebrew Univ Med Ctr, Serv Nephrol, Minerva Ctr Calcium & Bone Metab, Jerusalem, Israel; [Nechama, Morris] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Hebrew University of Jerusalem; Harvard University; Beth Israel Deaconess Medical Center	Naveh-Many, T (corresponding author), Hadassah Hebrew Univ Hosp, Nephrol, IL-91120 Ein Kerem, Israel.	tally@cc.huji.ac.il	Ben-Dov, Iddo/F-3282-2010	Ben-Dov, Iddo/0000-0002-9180-3604	Israel Academy of Science [358/12]; Amgen; Harold and Ethel Pupkewitz Research Fund; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]	Israel Academy of Science; Amgen(Amgen); Harold and Ethel Pupkewitz Research Fund; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	The authors thank Eran Horenstein (Weizmann Institute, Rehovot, Israel) for the Dicer<SUP>lox/lox</SUP> mice and for helpful discussions. Valuable technical assistance was provided by Chofit Chai and Sivan Reytan (Hadassah, Jerusalem, Israel). This work was supported by the Israel Academy of Science (Grant 358/12 to T.N.-M.), Amgen, and the Harold and Ethel Pupkewitz Research Fund. I.Z.B.-D. was supported by the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (Grant No. 41/11).	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; BROWN EM, 1983, J CLIN ENDOCR METAB, V56, P572, DOI 10.1210/jcem-56-3-572; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Corbetta S, 2010, ENDOCR-RELAT CANCER, V17, P135, DOI 10.1677/ERC-09-0134; Dueck A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-123; Farazi TA, 2012, METHODS, V58, P171, DOI 10.1016/j.ymeth.2012.07.020; Fox J, 1999, J PHARMACOL EXP THER, V290, P473; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gurtan AM, 2013, J MOL BIOL, V425, P3582, DOI 10.1016/j.jmb.2013.03.007; Hafner M, 2012, METHODS, V58, P164, DOI 10.1016/j.ymeth.2012.07.030; Hansen D, 2012, NEPHROL DIAL TRANSPL, V27, P2263, DOI 10.1093/ndt/gfr668; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hasegawa H, 2010, KIDNEY INT, V78, P975, DOI 10.1038/ki.2010.313; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Imanishi Y, 2002, J BONE MINER RES, V17, P1656, DOI 10.1359/jbmr.2002.17.9.1656; Imanishi Y, 2001, J CLIN INVEST, V107, P1093, DOI 10.1172/JCI10523; Jia T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-116; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; KILAV R, 1995, J CLIN INVEST, V96, P327, DOI 10.1172/JCI118038; Kilav R, 2001, J BIOL CHEM, V276, P8727, DOI 10.1074/jbc.M005471200; Kolbert CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052517; Komaba H, 2010, CLIN J AM SOC NEPHRO, V5, P2305, DOI 10.2215/CJN.02110310; Kotorashvili A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034683; Lavi-Moshayoff V, 2010, AM J PHYSIOL-RENAL, V299, pF882, DOI 10.1152/ajprenal.00360.2010; Lavi-Moshayoff V, 2009, AM J PHYSIOL-RENAL, V297, pF713, DOI 10.1152/ajprenal.00161.2009; Levi R, 2006, J AM SOC NEPHROL, V17, P107, DOI 10.1681/ASN.2005070679; Libutti SK, 2003, CANCER RES, V63, P8022; MACISAAC RJ, 1991, ENDOCRINOLOGY, V129, P757, DOI 10.1210/endo-129-2-757; Meir T, 2014, KIDNEY INT, V86, P1106, DOI 10.1038/ki.2014.215; Meir T, 2009, AM J PHYSIOL-RENAL, V297, pF1192, DOI 10.1152/ajprenal.00360.2009; Meng W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064393; Moallem E, 1998, J BIOL CHEM, V273, P5253, DOI 10.1074/jbc.273.9.5253; NAVEHMANY T, 1995, J CLIN INVEST, V96, P1786, DOI 10.1172/JCI118224; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Nemeth EF, 2001, J PHARMACOL EXP THER, V299, P323; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; Olauson H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003975; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Rahbari R, 2011, ANN SURG ONCOL, V18, P1158, DOI 10.1245/s10434-010-1359-7; Ritter CS, 2011, J MOL ENDOCRINOL, V46, P63, DOI 10.1677/JME-10-0128; Silver J, 2002, AM J PHYSIOL-RENAL, V283, pF367, DOI 10.1152/ajprenal.00061.2002; Slatopolsky E, 2001, AM J KIDNEY DIS, V37, pS54, DOI 10.1053/ajkd.2001.20740; Vaira V, 2012, J MOL ENDOCRINOL, V49, P115, DOI 10.1530/JME-11-0189; Wettschureck N, 2007, MOL ENDOCRINOL, V21, P274, DOI 10.1210/me.2006-0110; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wu QX, 2012, J BIOL CHEM, V287, P25173, DOI 10.1074/jbc.M112.362053	49	21	24	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3964	3976		10.1096/fj.15-274191	http://dx.doi.org/10.1096/fj.15-274191			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26054367				2022-12-26	WOS:000359915600031
J	Volante, A; Alonso, JC				Volante, Andrea; Alonso, Juan C.			Molecular Anatomy of ParA-ParA and ParA-ParB Interactions during Plasmid Partitioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA; PROTEIN; PSM19035; ATP; TRANSPORT; GENES; RECOGNITION; BINDING; REGION	Firmicutes multidrug resistance inc18 plasmids encode parS sites and two small homodimeric ParA-like (delta(2)) and ParB-like (omega(2)) proteins to ensure faithful segregation. Protein omega(2) binds to parS DNA, forming a short left-handed helix wrapped around the full parS, and interacts with delta(2). Protein delta(2) interacts with delta(2) and, in the ATP-bound form, binds to nonspecific DNA (nsDNA), forming small clusters. Here, we have mapped the omega(2).delta(2) and delta(2).delta(2) interacting domains in the delta(2) that are adjacent to but distinct from each other. The delta(2) nsDNA binding domain is essential for stimulation of omega(2).parS-mediated ATP hydrolysis. From the data presented here, we propose that delta(2) interacts with ATP, nsDNA, and with omega(2) bound to parS at near equimolar concentrations, facilitating a delta(2) structural transition. This delta(2) "activated" state overcomes its impediment in ATP hydrolysis, with the subsequent release of both of the proteins from nsDNA (plasmid unpairing).	[Volante, Andrea; Alonso, Juan C.] CNB CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Alonso, JC (corresponding author), CNB CSIC, Ctr Nacl Biotecnol, Dept Microbial Biotechnol, Darwin Str 3, Madrid 28049, Spain.	jcalonso@cnb.csic.es	Alonso, Juan Carlos/D-2595-2009	Alonso, Juan Carlos/0000-0002-5178-7179; Volante, Andrea/0000-0002-3290-0148	Ministerio de Economia y Competitividad, Direccion General de Investigacion [BFU2012-39879-C02-01]; Comunidad de Madrid [S2009MAT-1507]; Consejeria de Educacion de la Comunidad de Madrid-European Social Fund Fellowship [CPI/0266/2008]	Ministerio de Economia y Competitividad, Direccion General de Investigacion; Comunidad de Madrid(Comunidad de Madrid); Consejeria de Educacion de la Comunidad de Madrid-European Social Fund Fellowship	This work was supported in part by Ministerio de Economia y Competitividad, Direccion General de Investigacion, Grant BFU2012-39879-C02-01 and by Comunidad de Madrid Grant S2009MAT-1507 (to J. C. A.). The authors declare that they have no conflict of interest.; Recipient of Consejeria de Educacion de la Comunidad de Madrid-European Social Fund Fellowship CPI/0266/2008.	Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Bartosik AA, 2014, MICROBIOL-SGM, V160, P2406, DOI 10.1099/mic.0.081216-0; Baxter JC, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0023-2014; Bloom K, 2010, NATURE, V463, P446, DOI 10.1038/nature08912; BRENNER SL, 1988, J MOL BIOL, V204, P959, DOI 10.1016/0022-2836(88)90055-1; Canas C, 2008, NUCLEIC ACIDS RES, V36, P5242, DOI 10.1093/nar/gkn500; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; CEGLOWSKI P, 1993, MOL GEN GENET, V241, P579, DOI 10.1007/BF00279900; DAVEY MJ, 1994, J BIOL CHEM, V269, P29908; de la Hoz AB, 2000, P NATL ACAD SCI USA, V97, P728, DOI 10.1073/pnas.97.2.728; de la Hoz AB, 2004, NUCLEIC ACIDS RES, V32, P3136, DOI 10.1093/nar/gkh633; Dmowski M, 2006, J BACTERIOL, V188, P4362, DOI 10.1128/JB.01922-05; Dmowski M, 2011, MICROBIOL-SGM, V157, P1009, DOI 10.1099/mic.0.045369-0; Graham TGW, 2014, GENE DEV, V28, P1228, DOI 10.1101/gad.242206.114; Hatano T, 2010, MOL MICROBIOL, V78, P1182, DOI 10.1111/j.1365-2958.2010.07398.x; Hester CM, 2007, P NATL ACAD SCI USA, V104, P20326, DOI 10.1073/pnas.0705196105; Hwang LC, 2013, EMBO J, V32, P1238, DOI 10.1038/emboj.2013.34; Lim HC, 2014, ELIFE, V3, DOI 10.7554/eLife.02758; Lioy VS, 2010, PLASMID, V64, P1, DOI 10.1016/j.plasmid.2010.04.002; LYNCH AS, 1995, P NATL ACAD SCI USA, V92, P1896, DOI 10.1073/pnas.92.6.1896; McIntosh JR, 2012, Q REV BIOPHYS, V45, P147, DOI 10.1017/S0033583512000017; Murayama K, 2001, J MOL BIOL, V314, P789, DOI 10.1006/jmbi.2001.5157; Murray H, 2006, MOL MICROBIOL, V61, P1352, DOI 10.1111/j.1365-2958.2006.05316.x; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Pratto F, 2009, J BIOL CHEM, V284, P30298, DOI 10.1074/jbc.M109.035410; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Ravin NV, 2003, J MOL BIOL, V329, P875, DOI 10.1016/S0022-2836(03)00525-4; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; Rodionov O, 1999, SCIENCE, V283, P546, DOI 10.1126/science.283.5401.546; Schumacher MA, 2012, J BIOL CHEM, V287, P26146, DOI 10.1074/jbc.M112.373696; Sengupta M, 2010, J BACTERIOL, V192, P1175, DOI 10.1128/JB.01245-09; Sherratt D, 2013, EMBO J, V32, P1208, DOI 10.1038/emboj.2013.84; Soberon NE, 2011, NUCLEIC ACIDS RES, V39, P2624, DOI 10.1093/nar/gkq1245; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szardenings F, 2011, CURR OPIN MICROBIOL, V14, P712, DOI 10.1016/j.mib.2011.09.008; Taylor JA, 2015, NUCLEIC ACIDS RES, V43, P719, DOI 10.1093/nar/gku1295; Vecchiarelli AG, 2014, P NATL ACAD SCI USA, V111, P4880, DOI 10.1073/pnas.1401025111; Vecchiarelli AG, 2013, P NATL ACAD SCI USA, V110, pE1390, DOI 10.1073/pnas.1302745110; Vecchiarelli AG, 2012, MOL MICROBIOL, V86, P513, DOI 10.1111/mmi.12017; Vecchiarelli AG, 2010, MOL MICROBIOL, V78, P78, DOI 10.1111/j.1365-2958.2010.07314.x; Volante A, 2014, THESIS U AUTONOMA MA; Weihofen WA, 2006, NUCLEIC ACIDS RES, V34, P1450, DOI 10.1093/nar/gkl015; Welfle K, 2005, BIOL CHEM, V386, P881, DOI 10.1515/BC.2005.103	43	18	18	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18782	18795		10.1074/jbc.M115.649632	http://dx.doi.org/10.1074/jbc.M115.649632			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055701	Green Published, hybrid			2022-12-26	WOS:000358512100045
J	Guan, W; Shao, J; Elbeaino, T; Davis, RE; Zhao, TC; Huang, Q				Guan, Wei; Shao, Jonathan; Elbeaino, Toufic; Davis, Robert E.; Zhao, Tingchang; Huang, Qi			Specific Detection and Identification of American Mulberry-Infecting and Italian Olive-Associated Strains of Xylella fastidiosa by Polymerase Chain Reaction	PLOS ONE			English	Article							BACTERIAL LEAF SCORCH; PIERCES-DISEASE; HOST; OLEANDER; CITRUS; QUANTIFICATION; GRAPEVINE; ALMOND; TREES	Xylella fastidiosa causes bacterial leaf scorch in many landscape trees including elm, oak, sycamore and mulberry, but methods for specific identification of a particular tree host species- limited strain or differentiation of tree-specific strains are lacking. It is also unknown whether a particular landscape tree-infecting X. fastidiosa strain is capable of infecting multiple landscape tree species in an urban environment. We developed two PCR primers specific for mulberry-infecting strains of X. fastidiosa based on the nucleotide sequence of a unique open reading frame identified only in mulberry-infecting strains among all the North and South American strains of X. fastidiosa sequenced to date. PCR using the primers allowed for detection and identification of mulberry-infecting X. fastidiosa strains in cultures and in samples collected from naturally infected mulberry trees. In addition, no mixed infections with or non-specific detections of the mulberry-infecting strains of X. fastidiosa were found in naturally X. fastidiosa-infected oak, elm and sycamore trees growing in the same region where naturally infected mulberry trees were grown. This genotype-specific PCR assay will be valuable for disease diagnosis, studies of strain-specific infections in insects and plant hosts, and management of diseases caused by X. fastidiosa. Unexpectedly but interestingly, the unique open reading frame conserved in the mulberry-infecting strains in the U.S. was also identified in the recently sequenced olive-associated strain CoDiRO isolated in Italy. When the primer set was tested against naturally infected olive plant samples collected in Italy, it allowed for detection of olive-associated strains of X. fastidiosa in Italy. This PCR assay, therefore, will also be useful for detection and identification of the Italian group of X. fastidiosa strains to aid understanding of the occurrence, evolution and biology of this new group of X. fastidiosa strains.	[Guan, Wei; Zhao, Tingchang] Chinese Acad Agr Sci, Inst Plant Protect, Beijing 100193, Peoples R China; [Guan, Wei; Huang, Qi] USDA ARS, Floral & Nursery Plants Res Unit, Beltsville, MD 20705 USA; [Shao, Jonathan; Davis, Robert E.] USDA ARS, Mol Plant Pathol Lab, Beltsville, MD USA; [Elbeaino, Toufic] Ist Agron Mediterraneo, Valenzano, BA, Italy	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); CIHEAM; CIHEAM BARI	Huang, Q (corresponding author), USDA ARS, Floral & Nursery Plants Res Unit, Beltsville, MD 20705 USA.	qi.huang@ars.usda.gov	Elbeaino, Toufic/W-7722-2019; Elbeaino, Toufic/AAB-8342-2022	Elbeaino, Toufic/0000-0003-2211-7907; Guan, Wei/0000-0002-5533-6682	United States Department of Agriculture, Agricultural Research Service; ARS [ARS-0423161] Funding Source: Federal RePORTER	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the United States Department of Agriculture, Agricultural Research Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RPP, 2008, APPL ENVIRON MICROB, V74, P3690, DOI 10.1128/AEM.02388-07; Cariddi C, 2014, J PLANT PATHOL, V96, P425; Chen J, 2005, PHYTOPATHOLOGY, V95, P708, DOI 10.1094/PHYTO-95-0708; Chen JC, 2002, CURR MICROBIOL, V45, P423, DOI 10.1007/s00284-002-3785-7; Costa HS, 2006, J ECON ENTOMOL, V99, P1058, DOI 10.1603/0022-0493-99.4.1058; Costa HS, 2004, PLANT DIS, V88, P1255, DOI 10.1094/PDIS.2004.88.11.1255; DeLong DM, 1949, HILGARDIA, V19, P71; DELONG DWIGHT M., 1950, HILGARDIA, V19, P339; Elbeaino T., 2014, PHYTOPATHOL MEDITERR, V53, P126; Elbeaino T, 2014, PHYTOPATHOL MEDITERR, V53, P533; Francis M, 2006, EUR J PLANT PATHOL, V115, P203, DOI 10.1007/s10658-006-9009-4; Giampetruzzi A, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01538-14; Guan W, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00773-14; Guan W, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00916-13; Guan W, 2013, J MICROBIOL METH, V92, P108, DOI 10.1016/j.mimet.2012.11.008; Harris JL, 2014, PLANT DIS, V98, P1611, DOI 10.1094/PDIS-02-14-0158-SR; Hendson M, 2001, APPL ENVIRON MICROB, V67, P895, DOI 10.1128/AEM.67.2.895-903.2001; Hernandez-Martinez R, 2006, PLANT DIS, V90, P1382, DOI 10.1094/PD-90-1382; Hernandez-Martinez R, 2006, PLANT DIS, V90, P1143, DOI 10.1094/PD-90-1143; Hernandez-Martinez R, 2009, PLANT DIS, V93, P1131, DOI 10.1094/PDIS-93-11-1131; Hernandez-Martinez R, 2007, PHYTOPATHOLOGY, V97, P857, DOI 10.1094/PHYTO-97-7-0857; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Huang Q, 2004, PLANT DIS, V88, P1049, DOI 10.1094/PDIS.2004.88.9.1049A; Huang Q, 2003, CAN J PLANT PATHOL, V25, P401; Huang Q, 2004, CURR MICROBIOL, V48, P73, DOI 10.1007/s00284-003-4109-2; Huang Q, 2007, CAN J PLANT PATHOL, V29, P299; Huang Q, 2009, CURR MICROBIOL, V58, P393, DOI 10.1007/s00284-008-9324-4; KOSTKA SJ, 1986, PLANT DIS, V70, P690, DOI 10.1094/PD-70-690; Krugner R, 2014, PLANT DIS, V98, P1186, DOI 10.1094/PDIS-01-14-0014-RE; MINSAVAGE GV, 1994, PHYTOPATHOLOGY, V84, P456, DOI 10.1094/Phyto-84-456; Nunney L, 2014, APPL ENVIRON MICROB, V80, P3025, DOI 10.1128/AEM.04112-13; POOLER MR, 1995, CURR MICROBIOL, V31, P377, DOI 10.1007/BF00294703; Purcell AH, 1999, PHYTOPATHOLOGY, V89, P53, DOI 10.1094/PHYTO.1999.89.1.53; Saponari M, 2013, J PLANT PATHOL, V95, P668; Saponari M, 2014, J ECON ENTOMOL, V53, P328; Sherald James L., 2007, Arboriculture & Urban Forestry, V33, P376; USDA NRCS, 2015, PLANTS DAT; WELLS JM, 1987, INT J SYST BACTERIOL, V37, P136, DOI 10.1099/00207713-37-2-136	38	14	14	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129330	10.1371/journal.pone.0129330	http://dx.doi.org/10.1371/journal.pone.0129330			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061051	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500139
J	Atkinson, M; Kirby, S; Smith, K				Atkinson, Mark; Kirby, Simon; Smith, Kenny			Speaker Input Variability Does Not Explain Why Larger Populations Have Simpler Languages	PLOS ONE			English	Article							TRAINING JAPANESE LISTENERS; R-VERTICAL-BAR; TARGET-REALIZATION DIFFERENCES; LONG-TERM RETENTION; TALKER VARIABILITY; WORD SEGMENTATION; SONORITY; DIVERSITY; EVOLUTION; CLIMATE	A learner's linguistic input is more variable if it comes from a greater number of speakers. Higher speaker input variability has been shown to facilitate the acquisition of phonemic boundaries, since data drawn from multiple speakers provides more information about the distribution of phonemes in a speech community. It has also been proposed that speaker input variability may have a systematic influence on individual-level learning of morphology, which can in turn influence the group-level characteristics of a language. Languages spoken by larger groups of people have less complex morphology than those spoken in smaller communities. While a mechanism by which the number of speakers could have such an effect is yet to be convincingly identified, differences in speaker input variability, which is thought to be larger in larger groups, may provide an explanation. By hindering the acquisition, and hence faithful cross-generational transfer, of complex morphology, higher speaker input variability may result in structural simplification. We assess this claim in two experiments which investigate the effect of such variability on language learning, considering its influence on a learner's ability to segment a continuous speech stream and acquire a morphologically complex miniature language. We ultimately find no evidence to support the proposal that speaker input variability influences language learning and so cannot support the hypothesis that it explains how population size determines the structural properties of language.	[Atkinson, Mark; Kirby, Simon; Smith, Kenny] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Language Evolut & Computat Res Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh	Atkinson, M (corresponding author), Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Language Evolut & Computat Res Unit, Edinburgh, Midlothian, Scotland.	m.d.atkinson@sms.ed.ac.uk	; Smith, Kenny/B-7046-2009	Atkinson, Mark/0000-0002-4242-5459; Smith, Kenny/0000-0002-4530-6914	Arts & Humanities Research Council PhD Studentship [AH/K503010/1]; Arts and Humanities Research Council [1222889] Funding Source: researchfish	Arts & Humanities Research Council PhD Studentship; Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	MA is supported by an Arts & Humanities Research Council (http://www.ahrc.ac.uk) PhD Studentship (grant number AH/K503010/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciuli J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00747; Atkinson QD, 2011, SCIENCE, V332, P346, DOI 10.1126/science.1199295; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barton M. E., 1994, INPUT INTERACTION LA, P109, DOI [DOI 10.1017/CBO9780511620690.007, 10.1017/CBO9780511620690.007]; Bates D., 2013, LME4 LINEAR MIXED EF; Be us S, 2004, P 3 SPEECH PROS C, P486; Bentz C, 2013, LANG DYN CHANG, V3, P1, DOI 10.1163/22105832-13030105; Boyd R., 1985, CULTURE EVOLUTIONARY; Bradlow AR, 1997, J ACOUST SOC AM, V101, P2299, DOI 10.1121/1.418276; Bradlow AR, 1999, PERCEPT PSYCHOPHYS, V61, P977, DOI 10.3758/BF03206911; Christiansen MH, 2008, BEHAV BRAIN SCI, V31, P489, DOI 10.1017/S0140525X08004998; Connolly JH, 1997, CLIN LINGUIST PHONET, V11, P267, DOI 10.3109/02699209708985195; Connolly JH, 1997, CLIN LINGUIST PHONET, V11, P289, DOI 10.3109/02699209708985196; Core Team R, 2013, R LANG ENV STAT COMP; Dahl Osten, 2004, GROWTH MAINTENANCE L; Dale R, 2012, ADV COMPLEX SYST, V15, DOI 10.1142/S0219525911500172; Dutoit T, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1393, DOI 10.1109/ICSLP.1996.607874; Ember CR, 2007, AM ANTHROPOL, V109, P180, DOI 10.1525/AA.2007.109.1.180; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Feher O., 2014, P 36 ANN C COGN SCI, P2187; Finn AS, 2015, J EXP PSYCHOL LEARN, V41, P1560, DOI 10.1037/xlm0000114; Finn AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101806; Fiser J, 2001, PSYCHOL SCI, V12, P499, DOI 10.1111/1467-9280.00392; Fought JG, 2004, CROSS-CULT RES, V38, P27, DOI 10.1177/1069397103259439; Frank MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052500; Frank MC, 2010, COGNITION, V117, P107, DOI 10.1016/j.cognition.2010.07.005; Haspelmath M, WORLD ATLAS LANGUAGE; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Hay J, 2007, LANGUAGE, V83, P388, DOI 10.1353/lan.2007.0071; Hirata Y, 2007, J ACOUST SOC AM, V121, P3837, DOI 10.1121/1.2734401; Iverson P, 2005, J ACOUST SOC AM, V118, P3267, DOI 10.1121/1.2062307; Jackendoff R, 1999, TRENDS COGN SCI, V3, P272, DOI 10.1016/S1364-6613(99)01333-9; Johnson EK, 2001, J MEM LANG, V44, P548, DOI 10.1006/jmla.2000.2755; Kachergis G, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00588; Kam CLH, 2009, COGNITIVE PSYCHOL, V59, P30, DOI 10.1016/j.cogpsych.2009.01.001; Kirby S., 1999, FUNCTION SELECTION I; Kirkham NZ, 2002, COGNITION, V83, pB35, DOI 10.1016/S0010-0277(02)00004-5; LIVELY SE, 1994, J ACOUST SOC AM, V96, P2076, DOI 10.1121/1.410149; LIVELY SE, 1993, J ACOUST SOC AM, V94, P1242, DOI 10.1121/1.408177; LOGAN JS, 1991, J ACOUST SOC AM, V89, P874, DOI 10.1121/1.1894649; Londe Zsuzsa Cziraky, 2006, PHONOLOGY, V23, P59, DOI [DOI 10.1017/S0952675706000765, 10.1017/S0952675706000765]; Lupyan G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008559; Maas U., 2009, LANGUAGE COMPLEXITY, P164; Martowicz Anna., 2011, THESIS U EDINBURGH; McWhorter J., 2005, DEFINING CREOLE; MULLENNIX JW, 1989, J ACOUST SOC AM, V85, P365, DOI 10.1121/1.397688; Munroe RL, 2009, CROSS-CULT RES, V43, P123, DOI 10.1177/1069397109331485; Nettle D, 1999, LINGUA, V108, P119, DOI 10.1016/S0024-3841(98)00047-3; Nettle D, 2012, PHILOS T R SOC B, V367, P1829, DOI 10.1098/rstb.2011.0216; Nichols J., 2009, LANGUAGE COMPLEXITY, P110; Perkins Revere Dale, 1992, DEIXIS GRAMMAR CULTU; Petersen AM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00943; Reali F., 2014, P 10 INT C EV LANG E, P270; Saffran JR, 1996, J MEM LANG, V35, P606, DOI 10.1006/jmla.1996.0032; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Sinnemaki Kaius, 2009, LANGUAGE COMPLEXITY, P126; Siptar P., 2007, PHONOLOGY HUNGARIAN; Smith K, 2012, STAT LEARNING LANGUA, P409; Smith K, 2008, PHILOS T R SOC B, V363, P3591, DOI 10.1098/rstb.2008.0145; Smith K, 2010, COGNITION, V116, P444, DOI 10.1016/j.cognition.2010.06.004; Snedeker J, 2004, COGNITIVE PSYCHOL, V49, P238, DOI 10.1016/j.cogpsych.2004.03.001; Sullivan J, 2010, DIACHRONICA, V27, P325, DOI 10.1075/dia.27.2.08sul; Thiessen ED, 2003, DEV PSYCHOL, V39, P706, DOI 10.1037/0012-1649.39.4.706; Trudgill P, 2011, SOCIOLINGUISTIC TYPO; Trudgill Peter, 2004, LINGUIST TYPOL, V8, P305, DOI DOI 10.1515/LITY.2004.8.3.305; Trueswell JC, 1999, COGNITION, V73, P89, DOI 10.1016/S0010-0277(99)00032-3; Vago, 1998, PHONOLOGY, V15, P393, DOI [10.1017/S0952675799003632, DOI 10.1017/S0952675799003632]; Wang Y, 1999, J ACOUST SOC AM, V106, P3649, DOI 10.1121/1.428217; Weighall AR, 2008, J EXP CHILD PSYCHOL, V99, P75, DOI 10.1016/j.jecp.2007.10.004; Weiss DJ, 2009, LANG LEARN DEV, V5, P30, DOI 10.1080/15475440802340101; Wichmann Soren, 2011, LINGUIST TYPOL, V2011, P177, DOI DOI 10.1515/LITY.2011.013; Witt A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053296; Wray A, 2007, LINGUA, V117, P543, DOI 10.1016/j.lingua.2005.05.005; Yang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042993	76	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129463	10.1371/journal.pone.0129463	http://dx.doi.org/10.1371/journal.pone.0129463			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6PC	26057624	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000055
J	Hu, W; Yan, Y; Hou, XW; He, YZ; Wei, YX; Yang, GX; He, GY; Peng, M				Hu, Wei; Yan, Yan; Hou, Xiaowan; He, Yanzhen; Wei, Yunxie; Yang, Guangxiao; He, Guangyuan; Peng, Ming			TaPP2C1, a Group F2 Protein Phosphatase 2C Gene, Confers Resistance to Salt Stress in Transgenic Tobacco	PLOS ONE			English	Article							ABSCISIC-ACID; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; OXIDATIVE DAMAGE; ARABIDOPSIS; TOLERANCE; EXPRESSION; OVEREXPRESSION; DEHYDRATION; RESPONSES	Group A protein phosphatases 2Cs (PP2Cs) are essential components of abscisic acid (ABA) signaling in Arabidopsis; however, the function of group F2 subfamily PP2Cs is currently less known. In this study, TaPP2C1 which belongs to group F2 was isolated and characterized from wheat. Expression of the TaPP2C1-GFP fusion protein suggested its ubiquitous localization within a cell. TaPP2C1 expression was downregulated by abscisic acid (ABA) and NaCl treatments, but upregulated by H2O2 treatment. Overexpression of TaPP2C1 in tobacco resulted in reduced ABA sensitivity and increased salt resistance of transgenic seedlings. Additionally, physiological analyses showed that improved resistance to salt stress conferred by TaPP2C1 is due to the reduced reactive oxygen species (ROS) accumulation, the improved antioxidant system, and the increased transcription of genes in the ABA-independent pathway. Finally, transgenic tobacco showed increased resistance to oxidative stress by maintaining a more effective antioxidant system. Taken together, these results demonstrated that TaPP2C1 negatively regulates ABA signaling, but positively regulates salt resistance. TaPP2C1 confers salt resistance through activating the antioxidant system and ABA-independent gene transcription process.	[Hu, Wei; Yan, Yan; Hou, Xiaowan; Wei, Yunxie; Peng, Ming] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Biol & Genet Resources Trop Crops, Haikou 571101, Hainan, Peoples R China; [He, Yanzhen; Yang, Guangxiao; He, Guangyuan] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys Chinese,Minist Educ, Wuhan 430074, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Huazhong University of Science & Technology	Yang, GX (corresponding author), Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Genet Engn Int Cooperat Base Chinese Minist Sci &, Key Lab Mol Biophys Chinese,Minist Educ, Wuhan 430074, Peoples R China.	ygx@mail.hust.edu.cn; hegy@mail.hust.edu.cn; mmpeng_2000@yahoo.com			Key Project of S & T Research of MoE of China [109105]; Research Fund for the Doctoral Program of Higher Education of China [2012014211075]; Open Research Fund of State Key Laboratory of Hybrid Rice in Wuhan University [KF201302]; National Nonprofit Institute Research Grant of CATAS [ITBB140204]; Major Technology Project of Hainan [ZDZX2013023-1]	Key Project of S & T Research of MoE of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Open Research Fund of State Key Laboratory of Hybrid Rice in Wuhan University; National Nonprofit Institute Research Grant of CATAS; Major Technology Project of Hainan	This work was supported by Key Project of S & T Research of MoE of China (grant no. 109105), Research Fund for the Doctoral Program of Higher Education of China (grant no. 2012014211075), Open Research Fund of State Key Laboratory of Hybrid Rice in Wuhan University (grant no. KF201302), National Nonprofit Institute Research Grant of CATAS (ITBB140204) and the Major Technology Project of Hainan (ZDZX2013023-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Allen GJ, 1999, PLANT CELL, V11, P1785, DOI 10.1105/tpc.11.9.1785; Bhaskara GB, 2012, PLANT PHYSIOL, V160, P379, DOI 10.1104/pp.112.202408; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Cherel I, 2002, PLANT CELL, V14, P1133, DOI 10.1105/tpc.000943; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gonzalez-Garcia MP, 2003, PLANT PHYSIOL, V133, P135, DOI 10.1104/pp.103.025569; Grant MR, 2009, SCIENCE, V324, P750, DOI 10.1126/science.1173771; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P1019, DOI 10.1016/0003-9861(68)90541-9; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Hu W, 2013, PLANT CELL ENVIRON, V36, P1449, DOI 10.1111/pce.12074; Hu W, 2012, PLANT CELL PHYSIOL, V53, P2127, DOI 10.1093/pcp/pcs154; Hu XL, 2010, J PLANT PHYSIOL, V167, P1307, DOI 10.1016/j.jplph.2010.04.014; Huang XS, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-230; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Komatsu K, 2009, PLANT MOL BIOL, V70, P327, DOI 10.1007/s11103-009-9476-z; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; Liu X, 2009, PLANT SCI, V176, P90, DOI 10.1016/j.plantsci.2008.09.012; Liu X, 2012, BIOCHEM BIOPH RES CO, V422, P710, DOI 10.1016/j.bbrc.2012.05.064; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Moore K, 1998, FREE RADICAL RES, V28, P659, DOI 10.3109/10715769809065821; Nishimura N, 2007, PLANT J, V50, P935, DOI 10.1111/j.1365-313X.2007.03107.x; Ohta M, 2003, P NATL ACAD SCI USA, V100, P11771, DOI 10.1073/pnas.2034853100; Pan JW, 2012, PLANTA, V235, P661, DOI 10.1007/s00425-011-1510-0; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; POLLE A, 1994, PLANT PHYSIOL, V106, P53, DOI 10.1104/pp.106.1.53; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Sakuma Y, 2006, PLANT CELL, V18, P1292, DOI 10.1105/tpc.105.035881; Schweighofer A, 2004, TRENDS PLANT SCI, V9, P236, DOI 10.1016/j.tplants.2004.03.007; Schweighofer A, 2007, PLANT CELL, V19, P2213, DOI 10.1105/tpc.106.049585; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sun HL, 2011, J EXP BOT, V62, P5713, DOI 10.1093/jxb/err274; Tahtiharju S, 2001, PLANT J, V26, P461, DOI 10.1046/j.1365-313X.2001.01048.x; Tougane K, 2010, PLANT PHYSIOL, V152, P1529, DOI 10.1104/pp.110.153387; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Whitmarsh AJ, 2000, CELL MOL LIFE SCI, V57, P1172, DOI 10.1007/PL00000757; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	43	19	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129589	10.1371/journal.pone.0129589	http://dx.doi.org/10.1371/journal.pone.0129589			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057628	gold, Green Submitted, Green Published			2022-12-26	WOS:000356349000065
J	Liu, GQ; Wu, Q; Li, JW; Zhang, GF; Wan, FH				Liu, Guiqing; Wu, Qiang; Li, Jianwei; Zhang, Guifen; Wan, Fanghao			RNAi-Mediated Knock-Down of transformer and transformer 2 to Generate Male-Only Progeny in the Oriental Fruit Fly, Bactrocera dorsalis (Hendel)	PLOS ONE			English	Article							SEX DETERMINATION; ANASTREPHA-SUSPENSA; FLIES DIPTERA; TEPHRITIDAE; EVOLUTION; MECHANISMS; SYSTEM; AUTOREGULATION; LETHALITY; PROVIDES	The transformer (tra) gene appears to act as the genetic switch that promotes female development by interaction with the transformer2 (tra-2) gene in several dipteran species including the Medfly, housefly and Drosophila melanogaster. In this study, we describe the isolation, expression and function of tra and tra-2 in the economically important agricultural pest, the oriental fruit fly, Bactrocera dorsalis (Hendel). Bdtra and Bdtra-2 are similar to their homologs from other tephritid species. Bdtra demonstrated sex-specific transcripts: one transcript in females and two transcripts in males. In contrast, Bdtra-2 only had one transcript that was common to males and females, which was transcribed continuously in different adult tissues and developmental stages. Bdtra-2 and the female form of Bdtra were maternally inherited in eggs, whereas the male form of Bdtra was not detectable until embryos of 1 and 2 h after egg laying. Function analyses of Bdtra and Bdtra-2 indicated that both were indispensable for female development, as nearly 100% males were obtained with embryonic RNAi against either Bdtra or Bdtra-2. The fertility of these RNAi-generated males was subsequently tested. More than 80% of RNAi-generated males could mate and the mated females could lay eggs, but only 40-48.6% males gave rise to progeny. In XX-reversed males and intersex individuals, no clear female gonadal morphology was observed after dissection. These results shed light on the development of a genetic sexing system with male-only release for this agricultural pest.	[Liu, Guiqing; Wu, Qiang; Li, Jianwei; Zhang, Guifen; Wan, Fanghao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Dept Biol Invas, Beijing 100193, Peoples R China; [Liu, Guiqing] Guangdong Entomol Inst, Guangdong Publ Lab Wild Anim Conservat & Utilizat, Guangdong Key Lab Integrated Pest Management Agr, Guangzhou, Guangdong, Peoples R China; [Wan, Fanghao] Chinese Acad Agr Sci, Agr Genome Inst Shenzhen, Shenzhen, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS	Wan, FH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Dept Biol Invas, Beijing 100193, Peoples R China.	wanfanghao@caas.cn		Li, Jianwei/0000-0002-0262-3901	Special Fund for Scientific Research in the Public Interest from Ministry of Environmental Protection [201409061]; FHW; Ministry of Human Resources and Social Security; Youth Elite Project of Chinese Academy of Agricultural Sciences (Type D)	Special Fund for Scientific Research in the Public Interest from Ministry of Environmental Protection; FHW; Ministry of Human Resources and Social Security; Youth Elite Project of Chinese Academy of Agricultural Sciences (Type D)	This study was supported by the Special Fund for Scientific Research in the Public Interest from Ministry of Environmental Protection (201409061), FHW, preparation of the manuscript; Selected Projects in 2014 on Scientific and Technological Activities of Oversea Chinese Scholars from Ministry of Human Resources and Social Security; Youth Elite Project of Chinese Academy of Agricultural Sciences (Type D), JWL, preparation of the manuscript; Project Based Personnel Exchange Program in 2013 with China Scholarship Council and German Academic Exchange Service. FHW, preparation of the manuscript.	AMREIN H, 1990, EMBO J, V9, P3619, DOI 10.1002/j.1460-2075.1990.tb07573.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOGGS RT, 1987, CELL, V50, P739, DOI 10.1016/0092-8674(87)90332-1; Burghardt G, 2005, DEV GENES EVOL, V215, P165, DOI 10.1007/s00427-004-0464-7; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152; Chen SL, 2008, INSECT BIOCHEM MOLEC, V38, P155, DOI 10.1016/j.ibmb.2007.10.003; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; Concha C, 2009, GENETICS, V182, P785, DOI 10.1534/genetics.109.100982; Erickson JW, 2007, PLOS BIOL, V5, P2821, DOI 10.1371/journal.pbio.0050332; Ruiz MF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001239; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Gabrieli P, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-12; Gempe T, 2011, BIOESSAYS, V33, P52, DOI 10.1002/bies.201000043; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; Handler AM, 2000, INSECT TRANSGENESIS, P3; Hediger M, 2010, GENETICS, V184, P155, DOI 10.1534/genetics.109.109249; HEDLEY ML, 1991, CELL, V65, P579, DOI 10.1016/0092-8674(91)90090-L; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Lagos D, 2007, INSECT MOL BIOL, V16, P221, DOI 10.1111/j.1365-2583.2006.00717.x; Li F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056303; Marin I, 1998, SCIENCE, V281, P1990, DOI 10.1126/science.281.5385.1990; MATTOX W, 1990, GENE DEV, V4, P789, DOI 10.1101/gad.4.5.789; McGuffin ME, 1998, GENETICS, V149, P1477; Nissen I, 2012, GENETICS, V192, P1015, DOI 10.1534/genetics.112.143925; Ogaugwu CE, 2013, INSECT BIOCHEM MOLEC, V43, P1, DOI 10.1016/j.ibmb.2012.10.010; Pane A, 2002, DEVELOPMENT, V129, P3715; Qi JL, 2007, MOL CELL BIOL, V27, P699, DOI 10.1128/MCB.01572-06; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Saccone G, 2002, GENETICA, V116, P15, DOI 10.1023/A:1020903523907; Saccone G, 2007, AREA WIDE CONTROL IN; Salvemini M, 2009, INT J DEV BIOL, V53, P109, DOI 10.1387/ijdb.082681ms; Sanchez L, 2008, INT J DEV BIOL, V52, P837, DOI 10.1387/ijdb.072396ls; Sarno F, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-140; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P790, DOI 10.1016/j.ibmb.2012.07.007; Schetelig MF, 2012, INSECT BIOCHEM MOLEC, V42, P51, DOI 10.1016/j.ibmb.2011.10.007; Schetelig MF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-4; Schliekelman P, 2005, J ECON ENTOMOL, V98, P18, DOI 10.1603/0022-0493-98.1.18; Schutze MK, 2015, SYST ENTOMOL, V40, P456, DOI 10.1111/syen.12113; Scolari F, 2008, NEW BIOTECHNOL, V25, P76, DOI 10.1016/j.nbt.2008.02.001; Shearman DCA, 2002, GENETICA, V116, P25, DOI 10.1023/A:1020955507978; Shukla JN, 2013, INSECT BIOCHEM MOLEC, V43, P1125, DOI 10.1016/j.ibmb.2013.08.010; Stephens AEA, 2007, B ENTOMOL RES, V97, P369, DOI 10.1017/S0007485307005044	44	30	33	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128892	10.1371/journal.pone.0128892	http://dx.doi.org/10.1371/journal.pone.0128892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057559	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000034
J	Shen, YF; Xu, SH; He, DH				Shen, Yifeng; Xu, Shaohan; He, Donghua			A Novel Europium Chelate Coated Nanosphere for Time-Resolved Fluorescence Immunoassay	PLOS ONE			English	Article							SILICA NANOPARTICLES; REAGENT	A novel europium ligand 2, 2', 2 '', 2 '''-(4, 7-diphenyl-1, 10-phenanthroline-2, 9-diyl) bis (methylene) bis (azanetriyl) tetra acetic acid (BC-EDTA) was synthesized and characterized. It shows an emission spectrum peak at 610 nm when it is excited at 360 nm, with a large Stock shift (250 nm). It is covalently coated on the surface of a bare silica nanosphere containi free amino groups, using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride and N-Hydroxysuccinimide. We also observed an interesting phenomenon that when BC-EDTA is labeled with a silica nanosphere, the chelate shows different excitation spectrum peaks of about 295 nm. We speculate that the carboxyl has a significant influence on its excitation spectrum. The BC-EDTA/Eu3+ coated nanosphere could be used as a fluorescent probe for time-resolved fluorescence immunoassay. We labeled the antibody with the fluorescent nanosphere to develop a nanosphere based hepatitis B surface antigen as a time-resolved fluorescence immunoassay reagent, which is very easy to operate and eliminates potential contamination of Eu3+ contained in the environment. The analytical and functional sensitivities are 0.0037 mu g/L and 0.08 mu g/L (S/N >= 2.0) respectively. The detection range is 0.08-166.67 mu g/L, which is much wider than that of ELISA (0.2-5 mu g/L). It is comparable to the commercial dissociation-enhanced lanthanide fluoro-immunoassay system (DELFIA) reagents (0.2-145 mu g/L). We propose that it can fulfill clinical applications.	[Shen, Yifeng] Fujian Med Univ, Sch Basic Med Sci, Key Lab Minist Educ Gastrointestinal Canc, Fuzhou, Fujian, Peoples R China; [Xu, Shaohan] Fujian Med Univ, Affiliated Hosp 1, Fuzhou, Fujian, Peoples R China; [Shen, Yifeng; He, Donghua] Triplex Int Biosci China CO Ltd, Xiamen, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	He, DH (corresponding author), Triplex Int Biosci China CO Ltd, Xiamen, Fujian, Peoples R China.	hdh@tibchina.com	XU, SHAOHAN/GRI-9302-2022; Shen, Yi/GRS-3602-2022		Triplex International Bioscience (China) CO., Ltd	Triplex International Bioscience (China) CO., Ltd	The authors received no specific funding for this work. Authors YS and DH are employed by Triplex International Bioscience (China) CO., Ltd. Triplex International Bioscience (China) CO., Ltd provided support in the form of salary for these authors but it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of these authors is articulated in the 'author contributions' section.	Bagwe RP, 2004, LANGMUIR, V2004, P19; DIAMANDIS EP, 1988, CLIN BIOCHEM, V21, P139, DOI 10.1016/S0009-9120(88)80104-8; DIAMANDIS EP, 1991, CLIN CHEM, V37, P1486; Diamandis EP, 2001, CLIN CHEM, V47, P380; EVANGELISTA RA, 1988, CLIN BIOCHEM, V21, P173, DOI 10.1016/0009-9120(88)90006-9; Harma H, 2001, CLIN CHEM, V47, P561; HEMMILA I, 1988, SCAND J CLIN LAB INV, V48, P389, DOI 10.3109/00365518809085747; HEMMILA I, 1985, CLIN CHEM, V31, P359; Huhtinen P, 2005, ANAL CHEM, V77, P2643, DOI 10.1021/ac048360i; Huhtinen P, 2004, J IMMUNOL METHODS, V294, P111, DOI 10.1016/j.jim.2004.09.002; Huhtinen P, 2004, CLIN CHEM, V50, P1935, DOI 10.1373/clinchem.2004.036962; Lin P, 2002, MICROCHIM ACTA, V140, P125, DOI 10.1007/s006040200074; MATHIS G, 1993, CLIN CHEM, V39, P1953; MORTON RC, 1990, ANAL CHEM, V62, P1841, DOI 10.1021/ac00216a021; Santra S, 2001, J BIOMED OPT, V6, P160, DOI 10.1117/1.1353590; Scorilas A, 2000, CLIN BIOCHEM, V33, P345, DOI 10.1016/S0009-9120(00)00082-5; Scorilas A, 2000, CLIN CHEM, V46, P1450; SOINI E, 1979, CLIN CHEM, V25, P353; SOINI E, 1987, CRC CR REV ANAL CHEM, V18, P105, DOI 10.1080/10408348708085565; Tan MQ, 2004, J MATER CHEM, V14, P2896, DOI 10.1039/b407535h; Tan MQ, 2004, CHEM MATER, V16, P2494, DOI 10.1021/cm030305n; WADDELL TG, 1981, J AM CHEM SOC, V103, P5303, DOI 10.1021/ja00408a005; Xu Y, 2007, CLIN CHEM, V53, P1503, DOI 10.1373/clinchem.2006.078485; Yuan JL, 1998, ANAL CHEM, V70, P596, DOI 10.1021/ac970936z	24	6	7	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129689	10.1371/journal.pone.0129689	http://dx.doi.org/10.1371/journal.pone.0129689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26056826	Green Submitted, Green Published, gold			2022-12-26	WOS:000356349000070
J	Hervella, M; Rotea, M; Izagirre, N; Constantinescu, M; Alonso, S; Ioana, M; Lazar, C; Ridiche, F; Soficaru, AD; Netea, MG; de-la-Rua, C				Hervella, Montserrat; Rotea, Mihai; Izagirre, Neskuts; Constantinescu, Mihai; Alonso, Santos; Ioana, Mihai; Lazar, Catalin; Ridiche, Florin; Soficaru, Andrei Dorian; Netea, Mihai G.; de-la-Rua, Concepcion			Ancient DNA from South-East Europe Reveals Different Events during Early and Middle Neolithic Influencing the European Genetic Heritage	PLOS ONE			English	Article							GENOMIC DIVERSITY; MITOCHONDRIAL-DNA; HUNTER-GATHERERS; EXPANSION; SEQUENCES; SUPPORTS; FARMERS; MODEL	The importance of the process of Neolithization for the genetic make-up of European populations has been hotly debated, with shifting hypotheses from a demic diffusion (DD) to a cultural diffusion (CD) model. In this regard, ancient DNA data from the Balkan Peninsula, which is an important source of information to assess the process of Neolithization in Europe, is however missing. In the present study we show genetic information on ancient populations of the South-East of Europe. We assessed mtDNA from ten sites from the current territory of Romania, spanning a time-period from the Early Neolithic to the Late Bronze Age. mtDNA data from Early Neolithic farmers of the Starcevo Cris culture in Romania (Carcea, Gura Baciului and Negrilesti sites), confirm their genetic relationship with those of the LBK culture (Linienbandkeramik Kultur) in Central Europe, and they show little genetic continuity with modern European populations. On the other hand, populations of the Middle-Late Neolithic (Boian, Zau and Gumelnita cultures), supposedly a second wave of Neolithic migration from Anatolia, had a much stronger effect on the genetic heritage of the European populations. In contrast, we find a smaller contribution of Late Bronze Age migrations to the genetic composition of Europeans. Based on these findings, we propose that permeation of mtDNA lineages from a second wave of Middle-Late Neolithic migration from North-West Anatolia into the Balkan Peninsula and Central Europe represent an important contribution to the genetic shift between Early and Late Neolithic populations in Europe, and consequently to the genetic make-up of modern European populations.	[Hervella, Montserrat; Izagirre, Neskuts; Alonso, Santos; de-la-Rua, Concepcion] Univ Basque Country UPV EHU, Dept Genet Phys Anthropol & Anim Physiol, Bizkaia, Spain; [Rotea, Mihai] Natl Hist Museum Transylvania, Cluj Napoca, Romania; [Constantinescu, Mihai; Soficaru, Andrei Dorian] Romanian Acad, Francisc I Rainer Inst Anthropol, Bucharest, Romania; [Ioana, Mihai; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands; [Lazar, Catalin] Natl Hist Museum Romania, Bucharest, Romania; [Ridiche, Florin] Oltenia Museum Craiova, Craiova, Romania; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 ED Nijmegen, Netherlands	University of Basque Country; Romanian Academy of Sciences; Radboud University Nijmegen; Radboud University Nijmegen	Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 ED Nijmegen, Netherlands.	Mihai.Netea@radboudumc.nl; conchi.delarua@ehu.es	Constantinescu, Mihai/AAR-6506-2021; Alonso, Santos/L-8316-2014; Soficaru, Andrei Dorian/S-5101-2019; Lazar, Catalin/N-4612-2015; Netea, Mihai/N-5155-2014; Soficaru, Andrei Dorian/A-5943-2011; Ioana, Mihai/N-4923-2016; Afonso, Montse Hervella/X-4520-2019	Constantinescu, Mihai/0000-0002-7875-9119; Alonso, Santos/0000-0003-0221-4048; Soficaru, Andrei Dorian/0000-0001-8658-6695; Lazar, Catalin/0000-0001-7559-1843; Soficaru, Andrei Dorian/0000-0001-8658-6695; Ioana, Mihai/0000-0002-2186-1606; IZAGIRRE ARRIBALZAGA, NESKUTS/0000-0002-3345-9825; HERVELLA AFONSO, MONTSERRAT/0000-0003-4594-2950; DE LA RUA VACA, CONCEPCION/0000-0003-4599-0020	Spanish Ministry of Science and Innovation [GCL2011-29057/BOS]; Basque Government to Research Groups of the Basque University System [IT542-10]; University of the Basque Country, UPV/EHU [UFI 11/09]; Vici Grant of Netherlands Organization for Scientific Research; Romanian National Authority for Scientific Research, CNCS-UEFISCDI [PNII-ID-PCCE-2011-2-0013, PNII-ID-PCE-2011-3-1015]; ERC Consolidator Grant [310372]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Basque Government to Research Groups of the Basque University System; University of the Basque Country, UPV/EHU; Vici Grant of Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Romanian National Authority for Scientific Research, CNCS-UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); ERC Consolidator Grant(European Research Council (ERC))	This work was supported by the Spanish Ministry of Science and Innovation, GCL2011-29057/BOS and grant IT542-10 from the Basque Government to Research Groups of the Basque University System, and (UFI 11/09) from the University of the Basque Country, UPV/EHU. MGN was supported by a Vici Grant of the Netherlands Organization for Scientific Research and an ERC Consolidator Grant (310372). The archeological work was supported by two grants of the Romanian National Authority for Scientific Research, CNCS-UEFISCDI, project numbers PNII-ID-PCCE-2011-2-0013 and PNII-ID-PCE-2011-3-1015. The funders had no role in study design, data collection and analysis, decision to publish, or manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bailey D.W., 2000, BALKAN PREHISTORY EX; Bollongino R, 2013, SCIENCE, V342, P479, DOI 10.1126/science.1245049; Boric D, 2013, P NATL ACAD SCI USA, V110, P3298, DOI 10.1073/pnas.1211474110; Bramanti B, 2009, SCIENCE, V326, P137, DOI 10.1126/science.1176869; Bramanti B, 2008, ANTHROPOL-INT J HUM, V46, P153; Brandt G, 2013, SCIENCE, V342, P257, DOI 10.1126/science.1241844; Brotherton P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2656; CAVALLISFORZA LL, 1993, EUR J HUM GENET, V1, P3; Cooper A, 2000, SCIENCE, V289, P1139; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; Deguilloux MF, 2011, AM J PHYS ANTHROPOL, V144, P108, DOI 10.1002/ajpa.21376; Dodd-Opritescu A, 1978, DACIA, V22, P87; Dumitrescu V, 1983, ESQUISSE PREHISTOIRE; Fernandez E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004401; Gamba C, 2012, MOL ECOL, V21, P45, DOI 10.1111/j.1365-294X.2011.05361.x; Gilbert M Thomas P, 2006, Med Secoli, V18, P701; Gimbutas M, 1997, KURGAN CULTURE INDOE; GINTHER C, 1992, NAT GENET, V2, P135, DOI 10.1038/ng1092-135; Govedarica B, 2004, ZEPTERTRAGER HERRSCH; Gronenborn D., 2003, DOCUMENTA PRAEHISTOR, V30, P79, DOI DOI 10.4312/dp.30.3; Guba Z, 2011, J HUM GENET, V56, P784, DOI 10.1038/jhg.2011.103; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Haak W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000536; HAGELBERG E, 1991, P ROY SOC B-BIOL SCI, V244, P45, DOI 10.1098/rspb.1991.0049; Handt O, 1996, AM J HUM GENET, V59, P368; Hervella M, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-56; Hervella M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034417; Heyd V, 2011, ANCESTRAL LANDSCAPES, P535; Hofreiter M, 2001, NUCLEIC ACIDS RES, V29, P4793, DOI 10.1093/nar/29.23.4793; Ilie C, 2004, NEGRILESTI SAT NEGRI, V185; Ion A, 2009, STUDII PREISTORIE, V6, P47; Izagirre N, 1999, AM J HUM GENET, V65, P199, DOI 10.1086/302442; Lacan M, 2011, P NATL ACAD SCI USA, V108, P9788, DOI 10.1073/pnas.1100723108; Lazar C, 2012, CATALOGUE NEOLITHIC; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lazarovici G, 1996, ACTA MUSEI NAPOCENSI, V33, P267; Lazarovici G, 1995, MONOGRAFIE ARHEOLOGI; Luca SA, 1999, SFARSITUL ENEOLITICU; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Malmstrom H, 2009, CURR BIOL, V19, P1758, DOI 10.1016/j.cub.2009.09.017; Maxim Z, 1999, NEOENEOLITICUL TRANS; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Meyer S, 1999, GENETICS, V152, P1103; Nei M., 1987, MOL EVOLUTIONARY GEN; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pavuk J, 1993, ANATOLICA, V19, P63; Perles C., 2001, EARLY NEOLITHIC GREE, DOI 10.1017/CBO9780511612855; Pinhasi R, 2012, TRENDS GENET, V28, P496, DOI 10.1016/j.tig.2012.06.006; Plantinga TS, 2012, EUR J HUM GENET, V20, P778, DOI 10.1038/ejhg.2011.254; Richards M, 2000, AM J HUM GENET, V67, P1251, DOI 10.1016/S0002-9297(07)62954-1; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rotea M, 2014, CULTURE METAL INTERA; Rotea M, 2015, CULTURE METAL INTERA; Rotea M, 2009, PAGINI DIN PREISTORI; Sampietro ML, 2007, P ROY SOC B-BIOL SCI, V274, P2161, DOI 10.1098/rspb.2007.0465; Sanchez-Ouinto F, 2012, CURR BIOL, V22, P1494, DOI 10.1016/j.cub.2012.06.005; Santos C, 2005, MOL BIOL EVOL, V22, P1490, DOI 10.1093/molbev/msi141; Schneider S, 1999, GENETICS, V152, P1079; Skoglund P, 2014, SCIENCE, V344, P747, DOI 10.1126/science.1253448; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Telegin D, 1994, ANTHROPOMORPHIC STEL; Ursulescu N, 2001, NEOENEOLITICUL ISTOR; Vlassa V, 1976, CEA MAI VECHE FAZA C, P198; Vulpe M, 2001, PETRESCU DAMBOVITA E, VI, P211; Wilde S, 2014, P NATL ACAD SCI USA, V111, P4832, DOI 10.1073/pnas.1316513111	68	25	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128810	10.1371/journal.pone.0128810	http://dx.doi.org/10.1371/journal.pone.0128810			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CK1GM	26053041	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000355955300059
J	Kumar, A; Kumar, A				Kumar, Ajay; Kumar, Ashok			Role of Staphylococcus aureus Virulence Factors in Inducing Inflammation and Vascular Permeability in a Mouse Model of Bacterial Endophthalmitis	PLOS ONE			English	Article							TOXIC-SHOCK-SYNDROME; MULLER GLIA; FAS LIGAND; PROTEIN; ACTIVATION; BARRIER; LIPOPOLYSACCHARIDE; RESPONSES; IMIPENEM; RELEASE	Staphylococcus (S.) aureus is a common causative agent of bacterial endophthalmitis, a vision threatening complication of eye surgeries. The relative contribution of S. aureusvirulence factors in the pathogenesis of endophthalmitis remains unclear. Here, we comprehensively analyzed the development of intraocular inflammation, vascular permeability, and the loss of retinal function in C57BL/6 mouse eyes, challenged with live S. aureus, heat-killed S. aureus(HKSA), peptidoglycan (PGN), lipoteichoic acid (LTA), staphylococcal protein A (SPA), alpha-toxin, and Toxic-shock syndrome toxin 1 (TSST1). Our data showed a dose-dependent (range 0.01 mu g/eye to 1.0 mu g/eye) increase in the levels of inflammatory mediators by all virulence factors. The cell wall components, particularly PGN and LTA, seem to induce higher levels of TNF-alpha, IL-6, KC, and MIP2, whereas the toxins induced IL-1 beta. Similarly, among the virulence factors, PGN induced higher PMN infiltration. The vascular permeability assay revealed significant leakage in eyes challenged with live SA (12-fold) and HKSA (7.3-fold), in comparison to other virulence factors (similar to 2-fold) and controls. These changes coincided with retinal tissue damage, as evidenced by histological analysis. The electroretinogram (ERG) analysis revealed a significant decline in retinal function in eyes inoculated with live SA, followed by HKSA, SPA, and alpha-toxin. Together, these findings demonstrate the differential innate responses of the retina to S. aureus virulence factors, which contribute to intraocular inflammation and retinal function loss in endophthalmitis.	[Kumar, Ajay; Kumar, Ashok] Wayne State Univ, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48202 USA; [Kumar, Ashok] Wayne State Univ, Dept Anat & Cell Biol, Detroit, MI USA; [Kumar, Ashok] Wayne State Univ, Dept Immunol & Microbiol, Detroit, MI USA	Wayne State University; Wayne State University; Wayne State University	Kumar, A (corresponding author), Wayne State Univ, Kresge Eye Inst, Dept Ophthalmol, Detroit, MI 48202 USA.	akuma@med.wayne.edu			National Institute of Health [R01 EY19888]; Research to Prevent Blindness (RPB) Williams and Mary Greve Special Scholar award; NATIONAL EYE INSTITUTE [R01EY019888] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB) Williams and Mary Greve Special Scholar award(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants from the National Institute of Health (Grant R01 EY19888) and Research to Prevent Blindness (RPB) Williams and Mary Greve Special Scholar award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; BHAKDI S, 1991, MICROBIOL REV, V55, P733, DOI 10.1128/MMBR.55.4.733-751.1991; BOOTH MC, 1995, INVEST OPHTH VIS SCI, V36, P1828; Booth MC, 1998, INFECT IMMUN, V66, P356, DOI 10.1128/IAI.66.1.356-360.1998; Booth MC, 1997, INFECT IMMUN, V65, P1550, DOI 10.1128/IAI.65.4.1550-1556.1997; Callegan MC, 1999, INFECT IMMUN, V67, P3348, DOI 10.1128/IAI.67.7.3348-3356.1999; Callegan MC, 2003, ADV THER, V20, P246, DOI 10.1007/BF02849853; Callegan MC, 2007, PROG RETIN EYE RES, V26, P189, DOI 10.1016/j.preteyeres.2006.12.001; Callegan MC, 2011, RETINA-J RET VIT DIS, V31, P1518, DOI 10.1097/IAE.0b013e318206d176; Classen A, 2011, EXP DERMATOL, V20, P48, DOI 10.1111/j.1600-0625.2010.01174.x; CLAUDIO L, 1994, LAB INVEST, V70, P850; Durand ML, 2013, CLIN MICROBIOL INFEC, V19, P227, DOI 10.1111/1469-0691.12118; Engelbert M, 2005, INVEST OPHTH VIS SCI, V46, P2479, DOI 10.1167/iovs.04-1139; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; FOX A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1063, DOI 10.1001/archopht.1984.01040030857033; Gao N, 2015, J INFECT DIS, V212, P116, DOI 10.1093/infdis/jiv016; Giebel SJ, 2005, LAB INVEST, V85, P597, DOI 10.1038/labinvest.3700251; Giese MJ, 2003, INVEST OPHTH VIS SCI, V44, P3077, DOI 10.1167/iovs.02-1250; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Gregory Meredith, 2007, Chem Immunol Allergy, V92, P266, DOI 10.1159/000099277; Hu P, 2000, AM J PATHOL, V156, P1139, DOI 10.1016/S0002-9440(10)64982-6; JACKSON JJ, 1992, J INFECT DIS, V165, P1033, DOI 10.1093/infdis/165.6.1033; Kebaier C, 2012, J INFECT DIS, V205, P807, DOI 10.1093/infdis/jir846; Kobayashi SD, 2013, MBIO, V4, DOI 10.1128/mBio.00764-13; Kochan T, 2012, INFECT IMMUN, V80, P2076, DOI 10.1128/IAI.00149-12; Kumar A, 2007, BIOCHEM BIOPH RES CO, V354, P955, DOI 10.1016/j.bbrc.2007.01.072; Kumar A, 2013, CRIT REV IMMUNOL, V33, P119, DOI 10.1615/CritRevImmunol.2013006618; Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029830; Major JC, 2010, AM J OPHTHALMOL, V149, P278, DOI 10.1016/j.ajo.2009.08.023; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; McGilligan VE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074010; Moyer AL, 2009, INVEST OPHTH VIS SCI, V50, P3783, DOI 10.1167/iovs.08-3051; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Pandey RK, 2013, INDIAN J MED RES, V138, P609; PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988; Peterson ML, 2005, INFECT IMMUN, V73, P2164, DOI 10.1128/IAI.73.4.2164-2174.2005; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Ramadan RT, 2006, CURR EYE RES, V31, P955, DOI 10.1080/02713680600976925; Rammes A, 1997, J BIOL CHEM, V272, P9496; Rarey KA, 2012, J OCUL PHARMACOL TH, V28, P12, DOI 10.1089/jop.2011.0107; Sadaka A, 2012, PROG RETIN EYE RES, V31, P316, DOI 10.1016/j.preteyeres.2012.03.004; Schaefers MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032813; Shamsuddin N, 2011, J IMMUNOL, V186, P7089, DOI 10.4049/jimmunol.1100565; Singh PK, 2014, ANTIMICROB AGENTS CH, V58, P4621, DOI 10.1128/AAC.00126-14; Singh PK, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-33; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; Sugi N, 2013, INFECT IMMUN, V81, P2217, DOI 10.1128/IAI.00405-12; Talreja D, 2015, INVEST OPHT IN PRESS; Talreja D, 2014, INVEST OPHTH VIS SCI, V55, P2392, DOI 10.1167/iovs.13-13401; UMEDA A, 1987, J BACTERIOL, V169, P2482, DOI 10.1128/jb.169.6.2482-2487.1987; van Langevelde P, 1998, ANTIMICROB AGENTS CH, V42, P739, DOI 10.1128/AAC.42.4.739; Votintseva AA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-63; Whiston EA, 2008, INFECT IMMUN, V76, P1781, DOI 10.1128/IAI.01285-07; Wiskur BJ, 2008, INVEST OPHTH VIS SCI, V49, P1480, DOI 10.1167/iovs.07-1303; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648	57	32	33	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128423	10.1371/journal.pone.0128423	http://dx.doi.org/10.1371/journal.pone.0128423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053426	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300038
J	Moledina, DG; Parikh, CR; Garg, AX; Thiessen-Philbrook, H; Koyner, JL; Patel, UD; Devarajan, P; Shlipak, MG; Coca, SG				Moledina, Dennis G.; Parikh, Chirag R.; Garg, Amit X.; Thiessen-Philbrook, Heather; Koyner, Jay L.; Patel, Uptal D.; Devarajan, Prasad; Shlipak, Michael G.; Coca, Steven G.		TRIBE-AKI Consortium	Association of Perioperative Plasma Neutrophil Gelatinase-Associated Lipocalin Levels with 3-Year Mortality after Cardiac Surgery: A Prospective Observational Cohort Study	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; GLOMERULAR-FILTRATION-RATE; POOR OUTCOMES; BIOMARKERS; DISEASE; NGAL; AKI	Background Higher levels of plasma neutrophil gelatinase-associated lipocalin (pNGAL) are an early marker of acute kidney injury and are associated with increased risk of short-term adverse outcomes. The independent association between pNGAL and long-term mortality is unknown. Methods In this prospective observational cohort study, we studied 1191 adults who underwent cardiac surgery between 2007 and 2009 at 6 centers in the TRIBE-AKI cohort. We measured the pNGAL on the pre-operative and first 3 post-operative days and assessed the relationship of peri-operative pNGAL concentrations with all-cause mortality. Results During a median follow-up of 3.0 years, 139 participants died (50/1000 person-years). Pre-operative levels of pNGAL were associated with 3-year mortality (unadjusted HR 1.96, 95% CI 1.34,2.85) and the association persisted after adjustment for pre-operative variables including estimated glomerular filtration rate (adjusted HR 1.48, 95% CI 1.04-2.12). After adjustment for pre- and intra-operative variables, including pre-operative NGAL levels, the highest tertiles of first post-operative and peak post-operative pNGAL were also independently associated with 3-year mortality risk (adjusted HR 1.31, 95% CI 1.0-1.7 and adjusted HR 1.78, 95% CI 1.2-2.7, respectively). However, after adjustment for peri-operative changes in serum creatinine, there was no longer an independent association between the first post-operative and peak post-operative pNGAL and long-term mortality (adjusted HR 0.98,95% CI 0.79-1.2 for first pNGAL and adjusted HR 1.19, 95% CI 0.87-1.61 for peak pNGAL). Conclusions Pre-operative pNGAL levels were independently associated with 3-year mortality after cardiac surgery. While post-operative pNGAL levels were also associated with 3-year mortality, this relationship was not independent of changes in serum creatinine. These findings suggest that while pre-operative pNGAL adds prognostic value for mortality beyond routinely available serum creatinine, post-operative pNGAL measurements may not be as useful for this purpose.	[Moledina, Dennis G.; Parikh, Chirag R.; Coca, Steven G.] Yale Univ, Sch Med, Dept Med, Nephrol Sect, New Haven, CT 06510 USA; [Moledina, Dennis G.; Parikh, Chirag R.; Coca, Steven G.] VA CT Healthcare Syst, West Haven, CT USA; [Moledina, Dennis G.; Parikh, Chirag R.; Coca, Steven G.] Yale Univ, Sch Med, Program Appl Translat Res, New Haven, CT 06510 USA; [Garg, Amit X.; Thiessen-Philbrook, Heather] Univ Western Ontario, Dept Med, Div Nephrol, London, ON, Canada; [Garg, Amit X.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Koyner, Jay L.] Univ Chicago, Dept Med, Nephrol Sect, Chicago, IL 60637 USA; [Patel, Uptal D.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Devarajan, Prasad] Cincinnati Childrens Hosp Med Ctr, Div Nephrol & Hypertens, Cincinnati, OH 45229 USA; [Shlipak, Michael G.] Univ Calif San Francisco, Div Gen Internal Med, San Francisco VA Med Ctr, San Francisco, CA 94143 USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Western University (University of Western Ontario); University of Toronto; University of Chicago; Duke University; Cincinnati Children's Hospital Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Parikh, CR (corresponding author), Yale Univ, Sch Med, Dept Med, Nephrol Sect, New Haven, CT 06510 USA.	chirag.parikh@yale.edu	Moledina, Dennis G/I-9268-2014; Coca, Steven/L-7801-2019; Garg, Amit X/G-3295-2011	Coca, Steven/0000-0002-0928-9168; Swaminathan, Madhav/0000-0001-9136-8609; Devarajan, Prasad/0000-0002-7847-8552; Parikh, Chirag/0000-0001-9051-7385; Thiessen Philbrook, Heather/0000-0003-2067-0514; Chu, Michael/0000-0002-9872-399X; Moledina, Dennis/0000-0002-9537-9038	NIH [RO1HL085757, K24DK090203, U01DK082185]; Career Development Award from NIH [K23DK080132]; O'Brien Kidney Center Grant [P30 DK079310-07]; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC);  [R01DK096549]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK090203, P30DK079310, K23DK080132, P50DK096418, R01DK096549, U01DK082185] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award from NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); O'Brien Kidney Center Grant; Institute for Clinical Evaluative Sciences (ICES) - Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by the NIH grant RO1HL085757 (CRP) to fund the TRIBE-AKI Consortium to study novel biomarkers of acute kidney injury in cardiac surgery. SGC has been supported by Career Development Award from the NIH (K23DK080132) and R01DK096549. CRP is also supported by NIH grant K24DK090203. CRP was supported by the P30 DK079310-07 O'Brien Kidney Center Grant. SGC, AXG, PD, and CRP are also members of the NIH-sponsored ASsess, Serial Evaluation, and Subsequent Sequelae in Acute Kidney Injury (ASSESS-AKI) Consortium (U01DK082185). The plasma NGAL assays were donated by Biosite. Biosite, Inc., did not participate in the protocol development, analysis, or interpretation of the results. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Coca SG, 2014, J AM SOC NEPHROL, V25, P1063, DOI 10.1681/ASN.2013070742; Daniels LB, 2012, J AM COLL CARDIOL, V59, P1101, DOI 10.1016/j.jacc.2011.11.046; Devarajan P, 2003, MOL GENET METAB, V80, P365, DOI 10.1016/j.ymgme.2003.09.012; Domanski MJ, 2011, JAMA-J AM MED ASSOC, V305, P585, DOI 10.1001/jama.2011.99; Donadio C, 2014, CRIT CARE, V18, DOI 10.1186/cc13752; Gustafsson F, 2014, BIOMARK MED, V8, P239, DOI 10.2217/bmm.13.95; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Hvidberg V, 2005, FEBS LETT, V579, P773, DOI 10.1016/j.febslet.2004.12.031; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lindberg S, 2014, ARTERIOSCL THROM VAS, V34, P2135, DOI 10.1161/ATVBAHA.114.303950; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Parikh CR, 2011, J AM SOC NEPHROL, V22, P1737, DOI 10.1681/ASN.2010111163; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Schmidt-Ott KM, 2006, CURR OPIN NEPHROL HY, V15, P442, DOI 10.1097/01.mnh.0000232886.81142.58; Soto K, 2013, CLIN J AM SOC NEPHRO, V8, P2053, DOI 10.2215/CJN.12181212	20	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129619	10.1371/journal.pone.0129619	http://dx.doi.org/10.1371/journal.pone.0129619			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053382	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300153
J	Oliver, D; Yuan, SQ; McSwiggin, H; Yan, W				Oliver, Daniel; Yuan, Shuiqiao; McSwiggin, Hayden; Yan, Wei			Pervasive Genotypic Mosaicism in Founder Mice Derived from Genome Editing through Pronuclear Injection	PLOS ONE			English	Article							CRISPR-CAS9 SYSTEM; CRISPR/CAS SYSTEMS; ENDONUCLEASES; ZEBRAFISH	Genome editing technologies, especially the Cas9/CRISPR system, have revolutionized biomedical research over the past several years. Generation of novel alleles has been simplified to unprecedented levels, allowing for rapid expansion of available genetic tool kits for researchers. However, the issue of genotypic mosaicism has become evident, making stringent analyses of the penetrance of genome-edited alleles essential. Here, we report that founder mice, derived from pronuclear injection of ZFNs or a mix of guidance RNAs and Cas9 mRNAs, display consistent genotypic mosaicism for both deletion and insertion alleles. To identify founders with greater possibility of transmitting the mutant allele through the germline, we developed an effective germline genotyping method. The awareness of the inherent genotypic mosaicism issue with genome editing will allow for a more efficient implementation of the technologies, and the germline genotyping method will save valuable time and resources.	[Oliver, Daniel; Yuan, Shuiqiao; McSwiggin, Hayden; Yan, Wei] Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Yan, W (corresponding author), Univ Nevada, Sch Med, Dept Physiol & Cell Biol, Reno, NV 89557 USA.	wyan@medicine.nevada.edu	Yan, Wei/AAH-7943-2019; Yuan, Shuiqiao/AAX-1467-2021	Yuan, Shuiqiao/0000-0003-1460-7682	National Institute of Health [HD060858, HD071736, HD074573]; National Institute of Health Centers of Biomedical Research Excellence [1P30GM110767]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060858, R03HD074573, R21HD071736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110767] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Health Centers of Biomedical Research Excellence; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Health: HD060858, HD071736 and HD074573 and the National Institute of Health Centers of Biomedical Research Excellence: 1P30GM110767. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett A, 2014, METHODS, V69, P128, DOI 10.1016/j.ymeth.2014.02.019; Carte J, 2014, MOL MICROBIOL, V93, P98, DOI 10.1111/mmi.12644; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Friedland AE, 2013, NAT METHODS, V10, P741, DOI 10.1038/nmeth.2532; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Li K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105779; Ma YW, 2014, CELL RES, V24, P122, DOI 10.1038/cr.2013.157; Manjunath N, 2013, VIRUSES-BASEL, V5, P2748, DOI 10.3390/v5112748; Mussolino C, 2013, NAT BIOTECHNOL, V31, P208, DOI 10.1038/nbt.2527; Nagy A., 2003, MANIPULATING MOUSE E; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Ramirez CL, 2012, NUCLEIC ACIDS RES, V40, P5560, DOI 10.1093/nar/gks179; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sampson TR, 2014, BIOESSAYS, V36, P34, DOI 10.1002/bies.201300135; Strauss A, 2013, MOL PLANT, V6, P1384, DOI 10.1093/mp/sst075; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Tan WF, 2013, P NATL ACAD SCI USA, V110, P16526, DOI 10.1073/pnas.1310478110; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yen ST, 2014, DEV BIOL, V393, P3, DOI 10.1016/j.ydbio.2014.06.017; Yuan SQ, 2015, P NATL ACAD SCI USA, V112, pE430, DOI 10.1073/pnas.1424648112; Yuan SQ, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119370	23	39	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129457	10.1371/journal.pone.0129457	http://dx.doi.org/10.1371/journal.pone.0129457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053263	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300127
J	Singh, K; Shandilya, M; Kundu, S; Kayastha, AM				Singh, Kritika; Shandilya, Manish; Kundu, Suman; Kayastha, Arvind M.			Heat, Acid and Chemically Induced Unfolding Pathways, Conformational Stability and Structure-Function Relationship in Wheat alpha-Amylase	PLOS ONE			English	Article							MOLTEN GLOBULE; GUANIDINE-HYDROCHLORIDE; PROTEIN DENATURATION; TRITICUM-AESTIVUM; CRYSTAL-STRUCTURE; FLUORESCENCE; INTERMEDIATE; AGGREGATION; EQUILIBRIUM; ENZYMES	Wheat alpha-amylase, a multi-domain protein with immense industrial applications, belongs to alpha + beta class of proteins with native molecular mass of 32 kDa. In the present study, the pathways leading to denaturation and the relevant unfolded states of this multi-domain, robust enzyme from wheat were discerned under the influence of temperature, pH and chemical denaturants. The structural and functional aspects along with thermodynamic parameters for a-amylase unfolding were probed and analyzed using fluorescence, circular dichroism and enzyme assay methods. The enzyme exhibited remarkable stability up to 70 degrees C with tendency to aggregate at higher temperature. Acid induced unfolding was also incomplete with respect to the structural content of the enzyme. Strong ANS binding at pH 2.0 suggested the existence of a partially unfolded intermediate state. The enzyme was structurally and functionally stable in the pH range 4.0-9.0 with 88% recovery of hydrolytic activity. Careful examination of biophysical properties of intermediate states populated in urea and GdHCl induced denaturation suggests that a-amylase unfolding undergoes irreversible and non-coincidental cooperative transitions, as opposed to previous reports of two-state unfolding. Our investigation highlights several structural features of the enzyme in relation to its catalytic activity. Since, alpha-amylase has been comprehensively exploited for use in a range of starch-based industries, in addition to its physiological significance in plants and animals, knowledge regarding its stability and folding aspects will promote its biotechnological applications.	[Singh, Kritika; Kayastha, Arvind M.] Banaras Hindu Univ, Fac Sci, Sch Biotechnol, Varanasi 221005, Uttar Pradesh, India; [Shandilya, Manish; Kundu, Suman] Univ Delhi, Dept Biochem, New Delhi, India	Banaras Hindu University (BHU); University of Delhi	Kundu, S (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi, India.	suman.kundu@south.du.ac.in; kayasthabhu@gmail.com	Shandilya, Manish/AAU-7961-2020	Shandilya, Manish/0000-0003-2983-7958; Kayastha, Arvind M./0000-0002-5090-7159	CSIR; UGC, Government of India; University of Delhi (RD grant); UGC	CSIR(Council of Scientific & Industrial Research (CSIR) - India); UGC, Government of India(University Grants Commission, India); University of Delhi (RD grant); UGC(University Grants Commission, India)	KS and MS would like to thank CSIR and UGC, Government of India, respectively, for fellowship in the form of Junior and Senior Fellowships. The authors acknowledge Central Instrumentation Facility at University of Delhi South Campus and Banaras Hindu University for permitting access to several equipments required for data collection. SK acknowledges University of Delhi (R&D grant) and UGC for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrio JL, 2014, BIOMOLECULES, V4, P117, DOI 10.3390/biom4010117; Ahluwalia U, 2012, J PROTEINS PROTEOMIC, V3, P85; Andersen CB, 2010, PROTEIN SCI, V19, P279, DOI 10.1002/pro.309; Asghari SM, 2004, ENZYME MICROB TECH, V35, P51, DOI 10.1016/j.enzmictec.2004.03.006; Auton M, 2007, P NATL ACAD SCI USA, V104, P15317, DOI 10.1073/pnas.0706251104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canchi DR, 2010, J AM CHEM SOC, V132, P2338, DOI 10.1021/ja909348c; CHRISPEE.MJ, 1967, PLANT PHYSIOL, V42, P398, DOI 10.1104/pp.42.3.398; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dubey VK, 2003, BIOCHEMISTRY-US, V42, P12287, DOI 10.1021/bi035047m; Duy C, 2006, BIOPHYS J, V90, P3704, DOI 10.1529/biophysj.105.078980; Duy C, 2005, J BIOL CHEM, V280, P37360, DOI 10.1074/jbc.M507530200; Dwivedi VD, 2012, INT J APPL BIOTECHNO, V1, P87; England JL, 2011, ANNU REV PHYS CHEM, V62, P257, DOI 10.1146/annurev-physchem-032210-103531; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Fitter J, 2004, BIOCHEMISTRY-US, V43, P9589, DOI 10.1021/bi0493362; Galdino Alexsandro Sobreira, 2011, Enzyme Res, V2011, P157294, DOI 10.4061/2011/157294; Giri R, 2013, J PROTEINS PROTEOMIC, V4, P165; GOTO Y, 1991, J MOL BIOL, V222, P679, DOI 10.1016/0022-2836(91)90504-Y; Greenfield NJ, 2006, NAT PROTOC, V1, P2733, DOI 10.1038/nprot.2006.229; Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jensen MT, 2003, J CEREAL SCI, V38, P289, DOI 10.1016/S0733-5210(03)00032-8; KADZIOLA A, 1994, J MOL BIOL, V239, P104, DOI 10.1006/jmbi.1994.1354; Kandra L, 2002, FEBS LETT, V518, P79, DOI 10.1016/S0014-5793(02)02649-2; KHURANA R, 1994, BIOCHEMISTRY-US, V33, P106, DOI 10.1021/bi00167a014; KIM PS, 1990, ANNU REV BIOCHEM, V59, P631, DOI 10.1146/annurev.biochem.59.1.631; Kishore D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050380; Kumar RSS, 2009, BIOCHIMIE, V91, P548, DOI 10.1016/j.biochi.2009.01.012; Kumari A, 2011, PROTEIN PEPTIDE LETT, V18, P253, DOI 10.2174/092986611794578305; Kumari A, 2010, BIOPHYS CHEM, V151, P54, DOI 10.1016/j.bpc.2010.05.005; MACHIUS M, 1995, J MOL BIOL, V246, P545, DOI 10.1006/jmbi.1994.0106; MANAVALAN P, 1983, NATURE, V305, P831, DOI 10.1038/305831a0; Pereira PJB, 1999, STRUCTURE, V7, P1079, DOI 10.1016/S0969-2126(99)80175-0; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SHIMAMURA J, 1976, CANCER, V38, P2121, DOI 10.1002/1097-0142(197611)38:5<2121::AID-CNCR2820380540>3.0.CO;2-E; Singh AR, 2010, EUR BIOPHYS J BIOPHY, V39, P289, DOI 10.1007/s00249-009-0539-5; Singh K, 2014, J MOL CATAL B-ENZYM, V104, P75, DOI 10.1016/j.molcatb.2014.03.014; Singh K, 2014, FOOD CHEM, V162, P1, DOI 10.1016/j.foodchem.2014.04.043; Singh S, 2014, PROTEIN PEPTIDE LETT, V21, P948, DOI 10.2174/092986652109140715124139; Strobl S, 1998, J MOL BIOL, V278, P617, DOI 10.1006/jmbi.1998.1667; Strucksberg KH, 2007, BBA-PROTEINS PROTEOM, V1774, P1591, DOI 10.1016/j.bbapap.2007.09.005; SUDO K, 1976, CLIN CHIM ACTA, V73, P1, DOI 10.1016/0009-8981(76)90296-5; Sundd M, 2002, J BIOCHEM MOL BIOL, V35, P143; SWIFT HJ, 1991, ACTA CRYSTALLOGR B, V47, P535, DOI 10.1107/S0108768191001970; Tripathi P, 2008, BIOPHYS CHEM, V137, P95, DOI 10.1016/j.bpc.2008.07.007; Tripathi T., 2013, J PROTEINS PROTEOMIC, V4, P85; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; WONG KP, 1973, J BIOL CHEM, V248, P8518; Yu SM, 1999, PLANT PHYSIOL, V121, P687, DOI 10.1104/pp.121.3.687	57	15	15	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129203	10.1371/journal.pone.0129203	http://dx.doi.org/10.1371/journal.pone.0129203			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053142	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300099
J	Caruso, V; Le Greves, M; Fard, SS; Haitina, T; Olszewski, PK; Alsio, J; Schioth, HB; Fredriksson, R				Caruso, Vanni; Le Greves, Madeleine; Fard, Shahrzad Shirazi; Haitina, Tatjana; Olszewski, Pawel K.; Alsio, Johan; Schioth, Helgi B.; Fredriksson, Robert			The Orphan G Protein-Coupled Receptor Gene GPR178 Is Evolutionary Conserved and Altered in Response to Acute Changes in Food Intake	PLOS ONE			English	Article							HIPPOCAMPUS; FAMILIES; MAJORITY; NUCLEUS; HISTORY; SATIETY	G protein-coupled receptors (GPCRs) are a class of integral membrane proteins mediating physiological functions fundamental for survival, including energy homeostasis. A few years ago, an amino acid sequence of a novel GPCR gene was identified and named GPR178. In this study, we provide new insights regarding the biological significance of Gpr178 protein, investigating its evolutionary history and tissue distribution as well as examining the relationship between its expression level and feeding status. Our phylogenetic analysis indicated that GPR178 is highly conserved among all animal species investigated, and that GPR178 is not a member of a protein family. Real-time PCR and in situ hybridization revealed wide expression of Gpr178 mRNA in both the brain and periphery, with high expression density in the hypothalamus and brainstem, areas involved in the regulation of food intake. Hence, changes in receptor expression were assessed following several feeding paradigms including starvation and overfeeding. Short-term starvation (12-48h) or food restriction resulted in upregulation of Gpr178 mRNA expression in the brainstem, hypothalamus and prefrontal cortex. Conversely, short-term (48h) exposure to sucrose or Intralipid solutions downregulated Gpr178 mRNA in the brainstem; long-term exposure (10 days) to a palatable high-fat and high-sugar diet resulted in a downregulation of Gpr178 in the amygdala but not in the hypothalamus. Our results indicate that hypothalamic Gpr178 gene expression is altered during acute exposure to starvation or acute exposure to palatable food. Changes in gene expression following palatable diet consumption suggest a possible involvement of Gpr178 in the complex mechanisms of feeding reward.	[Caruso, Vanni; Le Greves, Madeleine; Fard, Shahrzad Shirazi; Haitina, Tatjana; Olszewski, Pawel K.; Alsio, Johan; Schioth, Helgi B.; Fredriksson, Robert] Uppsala Univ, Unit Funct Pharmacol, Dept Neurosci, Uppsala, Sweden; [Olszewski, Pawel K.] Univ Waikato, Dept Biol Sci, Hamilton, New Zealand	Uppsala University; University of Waikato	Fredriksson, R (corresponding author), Uppsala Univ, Unit Funct Pharmacol, Dept Neurosci, Uppsala, Sweden.	robert.fredriksson@neuro.uu.se	Schioth, Helgi/AAQ-7239-2020; Fredriksson, Robert/AAH-3921-2019; Alsio, Johan/ABB-3210-2021	Fredriksson, Robert/0000-0002-2810-3226; Haitina, Tatjana/0000-0002-8754-5534; Caruso, Vanni/0000-0002-0523-6149; Olszewski, Pawel/0000-0002-2846-0485	Swedish Research Council; Ahlens Foundation; Swedish Brain Research Foundation; Novo Nordisk Foundation; Engkvist Foundation; Magnus Bergvall Foundation; Novo Nordisk Fonden [NNF15OC0016184, NNF13OC0005723, NNF12OC1016287] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ahlens Foundation; Swedish Brain Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Engkvist Foundation; Magnus Bergvall Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This study was supported by the Swedish Research Council (http://www.vr.se), Ahlens Foundation (http://www.ahlen-stiftelsen.se/), the Swedish Brain Research Foundation (http://www.hjarnfonden.se/), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/), Engkvist Foundation (http://www.engkviststiftelserna.se/) and Magnus Bergvall Foundation (http://www.magnbergvallsstiftelse.nu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 2002, J NEUROSCI, V22, P10958; Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Brauner-Osborne H, 2007, CURR DRUG TARGETS, V8, P169, DOI 10.2174/138945007779315614; Cadigan KM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002881; Carlini VP, 2004, BIOCHEM BIOPH RES CO, V313, P635, DOI 10.1016/j.bbrc.2003.11.150; Civelli O, 2013, ANNU REV PHARMACOL, V53, P127, DOI 10.1146/annurev-pharmtox-010611-134548; Davidson TL, 2009, HIPPOCAMPUS, V19, P235, DOI 10.1002/hipo.20499; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gloriam DE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-338; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lagerstrom MC, 2007, J NEUROCHEM, V100, P1129, DOI 10.1111/j.1471-4159.2006.04281.x; Lagerstrom MC, 2006, PLOS COMPUT BIOL, V2, P493, DOI 10.1371/journal.pcbi.0020054; Land BB, 2014, NAT NEUROSCI, V17, P248, DOI 10.1038/nn.3625; Mietlicki-Baase EG, 2013, AM J PHYSIOL-ENDOC M, V305, pE1367, DOI 10.1152/ajpendo.00413.2013; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Paxinos G, 2007, PAXINOS AND FRANKLIN; Pecina S, 2003, J NEUROSCI, V23, P9395; Qian ZHANG, 2011, [Frontiers in Biology, 生物学前沿], V6, P82; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Satoh N, 1997, ENDOCRINOLOGY, V138, P947, DOI 10.1210/en.138.3.947; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; STELLAR E, 1994, PSYCHOL REV, V101, P301, DOI 10.1037//0033-295X.101.2.301; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211	30	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0122061	10.1371/journal.pone.0122061	http://dx.doi.org/10.1371/journal.pone.0122061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047506	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200002
J	Cornet, E; Debliquis, A; Rimelen, V; Civic, N; Docquier, M; Troussard, X; Drenou, B; Matthes, T				Cornet, Edouard; Debliquis, Agathe; Rimelen, Valerie; Civic, Natacha; Docquier, Mylene; Troussard, Xavier; Drenou, Bernard; Matthes, Thomas			Developing Molecular Signatures for Chronic Lymphocytic Leukemia	PLOS ONE			English	Article							INDUCED CYTIDINE DEAMINASE; GENE-EXPRESSION; ZAP-70 EXPRESSION; MUTATION STATUS; GENOMIC ABERRATIONS; LIPOPROTEIN-LIPASE; B-CELLS; IMMUNOGLOBULIN; SURVIVAL; DIAGNOSIS	Chronic lymphocytic leukemia (CLL) is a clonal malignancy of mature B cells that displays a great clinical heterogeneity, with many patients having an indolent disease that will not require intervention for many years, while others present an aggressive and symptomatic leukemia requiring immediate treatment. Although there is no cure for CLL, the disease is treatable and current standard chemotherapy regimens have been shown to prolong survival. Recent advances in our understanding of the biology of CLL have led to the identification of numerous cellular and molecular markers with potential diagnostic, prognostic and therapeutic significance. We have used the recently developed digital multiplexed gene-expression technique (DMGE) to analyze a cohort of 30 CLL patients for the presence of specific genes with known diagnostic and prognostic potential. Starting from a set of 290 genes we were able to develop a molecular signature, based on the analysis of 13 genes, which allows distinguishing CLL from normal peripheral blood and from normal B cells, and a second signature based on 24 genes, which distinguishes mutated from unmutated cases (LymphCLL Mut). A third classifier (LymphCLL Diag), based on a 44-gene signature, distinguished CLL cases from a series of other B-cell chronic lymphoproliferative disorders (n = 51). While the methodology presented here has the potential to provide a "ready to use" classification tool in routine diagnostics and clinical trials, application to larger sample numbers are still needed and should provide further insights about its robustness and utility in clinical practice.	[Cornet, Edouard; Troussard, Xavier] CHU Caen, Hematol Lab, F-14000 Caen, France; [Cornet, Edouard; Troussard, Xavier] Univ Caen, Sch Med, F-14000 Caen, France; [Debliquis, Agathe; Rimelen, Valerie; Drenou, Bernard] Hop Mulhouse, Dept Hematol, F-68051 Mulhouse, France; [Civic, Natacha; Docquier, Mylene] Univ Med Ctr, Genom Platform iGE3, CH-1211 Geneva, Switzerland; [Matthes, Thomas] Univ Hosp Geneva, Hematol Serv, CH-1211 Geneva, Switzerland; [Matthes, Thomas] Univ Hosp Geneva, Clin Pathol Serv, CH-1211 Geneva, Switzerland	CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Universite de Franche-Comte; University of Geneva; University of Geneva; University of Geneva	Matthes, T (corresponding author), Univ Hosp Geneva, Hematol Serv, CH-1211 Geneva, Switzerland.	thomas.matthes@hcuge.ch	Cornet, Edouard/M-5625-2019; Cornet, Edouard/A-9757-2010	Cornet, Edouard/0000-0003-1667-3421; Cornet, Edouard/0000-0003-1667-3421	Swiss National Science foundation [320030_132926]; Fondation Dr Dubois-Ferriere/DinuLipatti; Roche	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Dr Dubois-Ferriere/DinuLipatti; Roche(Roche Holding)	This work was supported by the Swiss National Science foundation (http://www.snf.ch; No 320030_132926) (to Thomas Matthes), by the "Fondation Dr Dubois-Ferriere/DinuLipatti" (to Thomas Matthes), as well as by a grant from Roche (http://www.roche.com) (to Thomas Matthes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albesiano E, 2003, BLOOD, V102, P3333, DOI 10.1182/blood-2003-05-1585; Beaume M, 2011, J MICROBIOL METH, V84, P327, DOI 10.1016/j.mimet.2010.12.025; Chiorazzi N, 2012, HEMATOL-AM SOC HEMAT, P76, DOI 10.1182/asheducation-2012.1.76; Cinzia Bologna RB, 2012, J IMMUNOLOGY; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Cro L, 2009, HEMATOL ONCOL, V27, P140, DOI 10.1002/hon.888; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Duzkale H, 2011, BLOOD, V117, P4076, DOI 10.1182/blood-2010-09-304881; Eisele L, 2009, EUR J HAEMATOL, V83, P320, DOI 10.1111/j.1600-0609.2009.01287.x; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Fernandez P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049010; Ferreira PG, 2014, GENOME RES, V24, P212, DOI 10.1101/gr.152132.112; Frezzato F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039902; Gattei V, 2008, BLOOD, V111, P865, DOI 10.1182/blood-2007-05-092486; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Ghia P, 2007, LEUKEMIA, V21, P1, DOI 10.1038/sj.leu.2404457; Hallek M, 2008, BLOOD, V111, P5446, DOI 10.1182/blood-2007-06-093906; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Hanoun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034347; Haslinger C, 2004, J CLIN ONCOL, V22, P3937, DOI 10.1200/JCO.2004.12.133; Heintel D, 2005, LEUKEMIA, V19, P1216, DOI 10.1038/sj.leu.2403748; Jelinek DF, 2003, MOL CANCER RES, V1, P346; Kienle D, 2010, HAEMATOL-HEMATOL J, V95, P102, DOI 10.3324/haematol.2009.010298; Letestu R, 2006, CYTOM PART B-CLIN CY, V70B, P309, DOI 10.1002/cyto.b.20132; Li FJ, 2008, BLOOD, V112, P179, DOI 10.1182/blood-2008-01-131359; Maloum K, 2009, ANN HEMATOL, V88, P1215, DOI 10.1007/s00277-009-0742-6; Masque-Soler N, 2013, BLOOD, V122, P1985, DOI 10.1182/blood-2013-06-508937; MATUTES E, 1994, LEUKEMIA, V8, P1640; McCarthy H, 2003, BLOOD, V101, P4903, DOI 10.1182/blood-2002-09-2906; Oppezzo P, 2005, BLOOD, V106, P650, DOI 10.1182/blood-2004-08-3344; Patricia Weiss EAP, 2012, CANNABINOID RECEPTOR; Porpaczy E, 2013, LEUKEMIA RES, V37, P631, DOI 10.1016/j.leukres.2013.02.008; Rassenti LZ, 2008, BLOOD, V112, P1923, DOI 10.1182/blood-2007-05-092882; Schweighofer CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028277; Scott DW, 2014, BLOOD, V123, P1214, DOI 10.1182/blood-2013-11-536433; Stilgenbauer S, 2014, BLOOD, V123, P3247, DOI 10.1182/blood-2014-01-546150; Sulda ML, 2010, CANCER BIOL THER, V10, P180, DOI 10.4161/cbt.10.2.12168; Sutton LA, 2015, HAEMATOLOGICA, V100, P370, DOI 10.3324/haematol.2014.109777; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van't Veer MB, 2006, HAEMATOLOGICA, V91, P56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306; Wiggers TGH, 2014, CYTOM PART B-CLIN CY, V86, P280, DOI 10.1002/cyto.b.21132	44	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128990	10.1371/journal.pone.0128990	http://dx.doi.org/10.1371/journal.pone.0128990			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046539	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200114
J	Frouz, J; Kindlmann, P				Frouz, Jan; Kindlmann, Pavel			Source-Sink Colonization as a Possible Strategy of Insects Living in Temporary Habitats	PLOS ONE			English	Article							BUTTERFLY METAPOPULATION; EVOLUTIONARY STABILITY; OVIPOSITION BEHAVIOR; POPULATION; DYNAMICS; DIPTERA; MODEL; CHIRONOMIDAE; PREFERENCE; DISPERSAL	Continuous colonization and re-colonization is critical for survival of insect species living in temporary habitats. When insect populations in temporary habitats are depleted, some species may escape extinction by surviving in permanent, but less suitable habitats, in which long-term population survival can be maintained only by immigration from other populations. Such situation has been repeatedly described in nature, but conditions when and how this occurs and how important this phenomenon is for insect metapopulation survival are still poorly known, mainly because it is difficult to study experimentally. Therefore, we used a simulation model to investigate, how environmental stochasticity, growth rate and the incidence of dispersal affect the positive effect of permanent but poor ("sink") habitats on the likelihood of metapopulation persistence in a network of high quality but temporary ("source") habitats. This model revealed that permanent habitats substantially increase the probability of metapopulation persistence of insect species with poor dispersal ability if the availability of temporary habitats is spatio-temporally synchronized. Addition of permanent habitats to a system sometimes enabled metapopulation persistence even in cases in which the metapopulation would otherwise go extinct, especially for species with high growth rates. For insect species with low growth rates the probability of a metapopulation persistence strongly depended on the proportions of "source" to "source" and "sink" to "source" dispersal rates.	[Frouz, Jan; Kindlmann, Pavel] Charles Univ Prague, Inst Environm Studies, Prague, Czech Republic; [Frouz, Jan] Acad Sci Czech Republic, Inst Soil Biol, CR-37005 Ceske Budejovice, Czech Republic; [Kindlmann, Pavel] Acad Sci Czech Republic, Global Change Res Ctr, Dept Biodivers Res, Brno, Czech Republic	Charles University Prague; Czech Academy of Sciences; Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences	Kindlmann, P (corresponding author), Charles Univ Prague, Inst Environm Studies, Prague, Czech Republic.	pavel.kindlmann@centrum.cz	Kindlmann, Pavel/H-7718-2014; Frouz, Jan/G-2220-2014; Frouz, Jan/P-4388-2016	Frouz, Jan/0000-0002-0908-8606; Kindlmann, Pavel/0000-0003-4772-1182	Grant Agency of the Czech Republic [14-36098G, 526/98/P156]; Ministry of Education [CZ.1.05/1.1.00/02.0073]; Deutscher Akademischer Austauschdienst	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education; Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	PK was funded by the Grant Agency of the Czech Republic (www.gacr.cz) grant No. 14-36098G. JF was funded by the Grant Agency of the Czech Republic (www.gacr.cz) grant No. 526/98/P156, by Ministry of Education (www.msmt.cz) grant No. CZ.1.05/1.1.00/02.0073 and by Deutscher Akademischer Austauschdienst (www.daad.de) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigoni F, 2003, ADV APPL PROBAB, V35, P691, DOI 10.1239/aap/1059486824; Bansaye V, 2013, THEOR POPUL BIOL, V88, P31, DOI 10.1016/j.tpb.2013.06.003; Boughton DA, 1999, ECOLOGY, V80, P2727; DELETTRE YR, 1986, REV ECOL BIOL SOL, V23, P29; Donker SA, 2012, WILDLIFE RES, V39, P163, DOI 10.1071/WR11167; Frank K, 1998, LANDSCAPE ECOL, V13, P363, DOI 10.1023/A:1008054906030; Frouz J, 1997, RES POPUL ECOL, V39, P207, DOI 10.1007/BF02765267; Frouz J, 2001, OIKOS, V93, P50, DOI 10.1034/j.1600-0706.2001.930105.x; Griebeler EM, 2000, J INSECT CONSERV, V4, P225, DOI 10.1023/A:1011343609779; HANSKI I, 1989, TRENDS ECOL EVOL, V4, P113, DOI 10.1016/0169-5347(89)90061-X; HANSKI I, 1997, METAPOPULATION BIOL; Hanski I, 1989, METAPOPULATION DYNAM, P17; Harrison Susan, 1997, P27, DOI 10.1016/B978-012323445-2/50004-3; Holt RD, 1997, EVOL ECOL, V11, P723, DOI 10.1023/A:1018438403047; Joshi A, 1997, J BIOSCIENCES, V22, P325, DOI 10.1007/BF02703235; Krkosek M, 2010, THEOR ECOL-NETH, V3, P25, DOI 10.1007/s12080-009-0051-7; MAPPES J, 1993, OECOLOGIA, V93, P38, DOI 10.1007/BF00321188; MCLACHLAN AJ, 1988, ECOL ENTOMOL, V13, P185, DOI 10.1111/j.1365-2311.1988.tb00346.x; McVinish R, 2013, ECOL MODEL, V249, P84, DOI 10.1016/j.ecolmodel.2012.07.001; MINKENBERG OPJM, 1992, OIKOS, V65, P134, DOI 10.2307/3544896; MORRIS DW, 1991, AM NAT, V137, P907, DOI 10.1086/285200; Mustapha F, 1998, AUST J ZOOL, V46, P291; Nylin S, 2000, J INSECT BEHAV, V13, P469, DOI 10.1023/A:1007839200323; Petersen MJ, 2013, ECOL ENTOMOL, V38, P585, DOI 10.1111/een.12058; Pulliam RH, 1991, AM NAT             S, V137, P50; Pulliam RH, 1988, AM NAT, V132, P652, DOI DOI 10.1086/284880; Reigada C, 2012, OIKOS, V121, P1665, DOI 10.1111/j.1600-0706.2011.20259.x; Strasser CA, 2010, THEOR ECOL, V5, P167; Thomas CD, 1996, AM NAT, V148, P957, DOI 10.1086/285966; VALLADARES G, 1991, J ANIM ECOL, V60, P227, DOI 10.2307/5456; Vandermeer J, 2010, LANDSCAPE ECOL, V25, P509, DOI 10.1007/s10980-010-9449-2; Veenstra KH, 1998, PHYSIOL ENTOMOL, V23, P62, DOI 10.1046/j.1365-3032.1998.2310062.x; Zimmerman M, 1998, J INSECT BEHAV, V11, P371, DOI 10.1023/A:1020902714225	33	11	11	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127743	10.1371/journal.pone.0127743	http://dx.doi.org/10.1371/journal.pone.0127743			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047010	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200028
J	Han, HS; Iakovenko, L; Wilson, AC				Han, Hesong; Iakovenko, Liudmyla; Wilson, Adam C.			Loss of Homogentisate 1,2-Dioxygenase Activity in Bacillus anthracis Results in Accumulation of Protective Pigment	PLOS ONE			English	Article							VIRULENCE GENE-EXPRESSION; MELANIN PIGMENT; SUBTILIS; DEGRADATION; SPORULATION; STATE; MUTAGENESIS; RESISTANCE; TYROSINE; STRAINS	Melanin production is important to the pathogenicity and survival of some bacterial pathogens. In Bacillus anthracis, loss of hmgA, encoding homogentisate 1,2-dioxygenase, results in accumulation of a melanin-like pigment called pyomelanin. Pyomelanin is produced in the mutant as a byproduct of disrupted catabolism of L-tyrosine and L-phenylalanine. Accumulation of pyomelanin protects B. anthracis cells from UV damage but not from oxidative damage. Neither loss of hmgA nor accumulation of pyomelanin alter virulence gene expression, sporulation or germination. This is the first investigation of homogentisate 1,2-dioxygenase activity in the Gram-positive bacteria, and these results provide insight into a conserved aspect of bacterial physiology.	[Han, Hesong; Iakovenko, Liudmyla; Wilson, Adam C.] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Wilson, AC (corresponding author), Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA.	acwilson@gsu.edu						Arias-Barrau E, 2004, J BACTERIOL, V186, P5062, DOI 10.1128/jb.186.15.5062-5077.2004; Bongiorni C, 2007, J BACTERIOL, V189, P2637, DOI 10.1128/JB.01798-06; Chiang C, 2011, J BACTERIOL, V193, P52, DOI 10.1128/JB.01656-09; COON SL, 1994, APPL ENVIRON MICROB, V60, P3006, DOI 10.1128/AEM.60.8.3006-3010.1994; CRAWFORD RL, 1976, CAN J MICROBIOL, V22, P276, DOI 10.1139/m76-037; Cybulski RJ, 2009, INFECT IMMUN, V77, P274, DOI 10.1128/IAI.00515-08; Geng JF, 2013, P NATL ACAD SCI USA, V110, P9639, DOI 10.1073/pnas.1301544110; Hammerstrom TG, 2011, MOL MICROBIOL, V82, P634, DOI 10.1111/j.1365-2958.2011.07843.x; Han HS, 2013, J BACTERIOL, V195, P5242, DOI 10.1128/JB.00917-13; Hullo MF, 2001, J BACTERIOL, V183, P5426, DOI 10.1128/JB.183.18.5426-5430.2001; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Koehler TM, 2009, MOL ASPECTS MED, V30, P386, DOI 10.1016/j.mam.2009.07.004; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Lai EM, 2003, J BACTERIOL, V185, P1443, DOI 10.1128/JB.185.4.1443-1454.2003; Miller JH., 1972, EXPT MOL GENETICS; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Riesenman PJ, 2000, APPL ENVIRON MICROB, V66, P620, DOI 10.1128/AEM.66.2.620-626.2000; RISTROPH JD, 1983, INFECT IMMUN, V39, P483, DOI 10.1128/IAI.39.1.483-486.1983; Rodriguez-Rojas A, 2009, MICROBIOL-SGM, V155, P1050, DOI 10.1099/mic.0.024745-0; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Sambrook J., 2001, MOL CLONING LAB MANU; Sanchez-Amat A, 1998, COMP BIOCHEM PHYS B, V119, P557, DOI 10.1016/S0305-0491(98)00028-5; SCHAEFFER P, 1965, P NATL ACAD SCI USA, V54, P704, DOI 10.1073/pnas.54.3.704; Schmaler-Ripcke J, 2009, APPL ENVIRON MICROB, V75, P493, DOI 10.1128/AEM.02077-08; Tsvetanova B, 2007, MOL MICROBIOL, V63, P644, DOI 10.1111/j.1365-2958.2006.05543.x; Valeru SP, 2009, INFECT IMMUN, V77, P935, DOI 10.1128/IAI.00929-08; van Schaik W, 2009, INFECT IMMUN, V77, P4437, DOI 10.1128/IAI.00716-09; Wang Z, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00379; Wilson AC, 2008, J BACTERIOL, V190, P5522, DOI 10.1128/JB.00312-08; Wilson AC, 2007, J MICROBIOL METH, V71, P332, DOI 10.1016/j.mimet.2007.09.006; Wilson AC, 2011, METHODS MOL BIOL, V765, P359, DOI 10.1007/978-1-61779-197-0_21; Wilson AC, 2009, MOL MICROBIOL, V72, P109, DOI 10.1111/j.1365-2958.2009.06627.x; Zughaier SM, 1999, INFECT IMMUN, V67, P908, DOI 10.1128/IAI.67.2.908-913.1999	34	13	13	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128967	10.1371/journal.pone.0128967	http://dx.doi.org/10.1371/journal.pone.0128967			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047497	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200111
J	Hsin, YC; Zhuang, LZ; Yeh, KW; Chang, CW; Horng, JT; Huang, JL				Hsin, Yi-Chen; Zhuang, Lai-Zhen; Yeh, Kuo-Wei; Chang, Cheng-Wei; Horng, Jorng-Tzong; Huang, Jing-Long			Risk of Tuberculosis in Children with Juvenile Idiopathic Arthritis: A Nationwide Population-Based Study in Taiwan	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; THERAPY; SAFETY; ETANERCEPT; REGISTER; EFFICACY	Objective We aimed to determine the risk of tuberculosis in children with juvenile idiopathic arthritis (JIA) in Taiwan. Methods We used the Taiwan National Health Insurance Research Database (NHIRD) to conduct a nested case-control study. We identified a JIA cohort and matched each JIA child with non-JIA children for comparison. Methotrexate (MTX), tumor necrosis factor (TNF) inhibitor administration, and new tuberculosis cases were determined during our study period. To compare tuberculosis (TB) risk among our study groups, Cox proportional regression models were used to determine adjusted hazard ratios (aHRs). Results We identified 1495 children with JIA and 11592 non-JIA children. Majority (68.7%) children with JIA had not received MTX or TNF inhibitors; 23.9% used MTX without TNF inhibitors, and 7.4% received TNF inhibitors, irrespective of MTX administration. In total, 43 children developed tuberculosis. The overall tuberculosis infection rate for children with JIA was two times higher than that for non-JIA children. Compared with non-JIA children, children with JIA who used MTX without TNF inhibitors revealed a significantly increased of tuberculosis infection rate (aHR = 4.67; 95% CI: 1.65-13.17; P = 0.004). Children with JIA who either received TNF inhibitors or never used MTX and TNF inhibitors revealed a tuberculosis infection rate comparable to that of non-JIA children. Conclusions Analysis of nationwide data of Taiwan suggested that children with JIA were at higher risk of tuberculosis compared with those without JIA.	[Hsin, Yi-Chen; Yeh, Kuo-Wei; Huang, Jing-Long] Chang Gung Mem Hosp, Div Pediat, Dept Pediat Allergy Immunol & Rheumatol, Taoyuan, Taiwan; [Zhuang, Lai-Zhen; Horng, Jorng-Tzong] Natl Cent Univ, Dept Comp Sci & Informat Engn, Chungli 32054, Taiwan; [Chang, Cheng-Wei] Hsing Wu Univ, Dept Informat Management, New Taipei City, Taiwan; [Horng, Jorng-Tzong] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	Chang Gung Memorial Hospital; National Central University; Asia University Taiwan	Horng, JT (corresponding author), Natl Cent Univ, Dept Comp Sci & Informat Engn, Chungli 32054, Taiwan.	long@adm.cgmh.org.tw; horng@db.csie.ncu.edu.tw	Yeh, Kuo-Wei/V-3725-2019	Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753				Amine B, 2009, RHEUMATOL INT, V29, P275, DOI 10.1007/s00296-008-0672-y; Arkema EV, 2015, ANN RHEUM DIS, V74, P1212, DOI 10.1136/annrheumdis-2013-204960; Askling J, 2005, ARTHRITIS RHEUM-US, V52, P1986, DOI 10.1002/art.21137; Baronnet L, 2011, JOINT BONE SPINE, V78, P279, DOI 10.1016/j.jbspin.2010.12.004; Beukelman T, 2013, ARTHRITIS RHEUM-US, V65, P1384, DOI 10.1002/art.37866; Brassard P, 2009, ARTHRIT RHEUM-ARTHR, V61, P300, DOI 10.1002/art.24476; Centers for Disease Control R.O.C. (Taiwan), 2012, TAIW TUB CONTR REP 2; Chan PC, 2007, EMERG INFECT DIS, V13, P1361, DOI 10.3201/eid1309.061020; Coulson EJ, 2013, RHEUMATOLOGY, V52, P1163, DOI 10.1093/rheumatology/ket106; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Foster HE, 2003, ARTHRITIS RHEUM-US, V48, P767, DOI 10.1002/art.10863; Giannini EH, 2009, ARTHRITIS RHEUM, V60, P2794, DOI 10.1002/art.24777; Huang JL, 2004, CLIN EXP RHEUMATOL, V22, P776; Kuo HC, 2011, J MICROBIOL IMMUNOL, V44, P52, DOI 10.1016/j.jmii.2011.01.010; Lovell DJ, 2008, ARTHRITIS RHEUM-US, V58, P1496, DOI 10.1002/art.23427; Malviya A, 2012, ARTHRITIS RHEUM-US, V64, P3016, DOI 10.1002/art.34499; Prince FHM, 2009, ANN RHEUM DIS, V68, P635, DOI 10.1136/ard.2007.087411; Ruperto N, 2010, ANN RHEUM DIS, V69, P718, DOI 10.1136/ard.2009.100354; Shen CC, 2013, SEMIN ARTHRITIS RHEU, V42, P590, DOI 10.1016/j.semarthrit.2012.10.002; Tubach F, 2009, ARTHRITIS RHEUM-US, V60, P1884, DOI 10.1002/art.24632; Tynjala P, 2006, ANN RHEUM DIS, V65, P1044, DOI 10.1136/ard.2005.047225; Winthrop KL, 2013, ANN RHEUM DIS, V72, P37, DOI 10.1136/annrheumdis-2011-200690; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82; World Health Organization, GLOB TUB REP 2013; Xie X, 2014, J MICROBIOL IMMUNOL, V47, P268, DOI 10.1016/j.jmii.2013.03.005	25	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128768	10.1371/journal.pone.0128768	http://dx.doi.org/10.1371/journal.pone.0128768			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047099	gold, Green Submitted, Green Published			2022-12-26	WOS:000355652200099
J	Nickzad, A; Lepine, F; Deziel, E				Nickzad, Arvin; Lepine, Francois; Deziel, Eric			Quorum Sensing Controls Swarming Motility of Burkholderia glumae through Regulation of Rhamnolipids	PLOS ONE			English	Article							LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY; PSEUDOMONAS-AERUGINOSA; SYSTEM; BIOSYNTHESIS; PSEUDOMALLEI; EXPRESSION; VIRULENCE; BACTERIA	Burkholderia glumae is a plant pathogenic bacterium that uses an acyl-homoserine lactone-mediated quorum sensing system to regulate protein secretion, oxalate production and major virulence determinants such as toxoflavin and flagella. B. glumae also releases surface-active rhamnolipids. In Pseudomonas aeruginosa and Burkholderia thailandensis, rhamnolipids, along with flagella, are required for the social behavior called swarming motility. In the present study, we demonstrate that quorum sensing positively regulates the production of rhamnolipids in B. glumae and that rhamnolipids are necessary for swarming motility also in this species. We show that a rhlA-mutant, which is unable to produce rhamnolipids, loses its ability to swarm, and that this can be complemented by providing exogenous rhamnolipids. Impaired rhamnolipid production in a quorum sensing-deficient B. glumae mutant is the main factor responsible for its defective swarming motility behaviour.	[Nickzad, Arvin; Lepine, Francois; Deziel, Eric] INRS Inst Armand Frappier, Laval, PQ, Canada	University of Quebec; Institut national de la recherche scientifique (INRS)	Deziel, E (corresponding author), INRS Inst Armand Frappier, Laval, PQ, Canada.	eric.deziel@iaf.inrs.ca	Déziel, Eric/A-7678-2008	Déziel, Eric/0000-0002-4609-0115; Nickzad, Arvin/0000-0002-0705-9377	Natural Sciences and Engineering Research Council of Canada (NSERC) [312478]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	Investigations on rhamnolipids in the ED laboratory are funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant No. 312478. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2014, METHODS MOL BIOL, V1149, P359, DOI 10.1007/978-1-4939-0473-0_30; Abdel-Mawgoud AM, 2011, MICROBIOL MONOGR, V20, P13, DOI 10.1007/978-3-642-14490-5_2; Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Choi KH, 2008, APPL ENVIRON MICROB, V74, P1064, DOI 10.1128/AEM.02430-07; Chun H, 2009, J BACTERIOL, V191, P4152, DOI 10.1128/JB.00227-09; Costa SGVAO, 2011, LETT APPL MICROBIOL, V53, P620, DOI 10.1111/j.1472-765X.2011.03154.x; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Deziel E, 1999, BBA-MOL CELL BIOL L, V1440, P244, DOI 10.1016/S1388-1981(99)00129-8; Dubeau D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-263; Dusane DH, 2010, BIOTECHNOL GENET ENG, V27, P159, DOI 10.1080/02648725.2010.10648149; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Goo E, 2010, J PROTEOME RES, V9, P3184, DOI 10.1021/pr100045n; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; Haussler S, 2003, INFECT IMMUN, V71, P2970, DOI 10.1128/IAI.71.5.2970-2975.2003; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517; Jang MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084831; Jeong Y, 2003, PLANT DIS, V87, P890, DOI 10.1094/PDIS.2003.87.8.890; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Tans-Kersten J, 2001, J BACTERIOL, V183, P3597, DOI 10.1128/JB.183.12.3597-3605.2001; Tremblay J, 2007, ENVIRON MICROBIOL, V9, P2622, DOI 10.1111/j.1462-2920.2007.01396.x; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Tremblay J, 2008, J BASIC MICROB, V48, P509, DOI 10.1002/jobm.200800030; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; Zulianello L, 2006, INFECT IMMUN, V74, P3134, DOI 10.1128/IAI.01772-05	31	40	45	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128509	10.1371/journal.pone.0128509	http://dx.doi.org/10.1371/journal.pone.0128509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047513	Green Published, gold			2022-12-26	WOS:000355652200072
J	Oxlade, O; Huang, CC; Murray, M				Oxlade, Olivia; Huang, Chuan-Chin; Murray, Megan			Estimating the Impact of Reducing Under-Nutrition on the Tuberculosis Epidemic in the Central Eastern States of India: A Dynamic Modeling Study	PLOS ONE			English	Article							RISK; PRACTITIONERS; MALNUTRITION; PROGRESS; ENGLAND; WEIGHT; HEALTH; WALES	Background Tuberculosis (TB) and under-nutrition are widespread in many low and middle-income countries. Momentum to prioritize under-nutrition has been growing at an international level, as demonstrated by the "Scaling Up Nutrition" movement. Low body mass index is an important risk factor for developing TB disease. The objective of this study was to project future trends in TB related outcomes under different scenarios for reducing under-nutrition in the adult population in the Central Eastern states of India. Methods A compartmental TB transmission model stratified by body mass index was parameterized using national and regional data from India. We compared TB related mortality and incidence under several scenarios that represented a range of policies and programs designed to reduce the prevalence of under-nutrition, based on the experience and observed trends in similar countries. Results The modeled nutrition intervention scenarios brought about reductions in TB incidence and TB related mortality in the Central Eastern Indian states ranging from 43% to 71% and 40% to 68% respectively, relative to the scenario of no nutritional intervention. Modest reductions in under-nutrition averted 4.8 (95% UR 0.5, 17.1) million TB cases and 1.6 (95% UR 0.5, 5.2) million TB related deaths over a period of 20 years of intervention, relative to the scenario of no nutritional intervention. Complete elimination of under-nutrition in the Central Eastern states averted 9.4 (95% UR 1.5, 30.6) million TB cases and 3.2 (95% UR 0.7-, 10.1) million TB related deaths, relative to the scenario of no nutritional intervention. Conclusion Our study suggests that intervening on under-nutrition could have a substantial impact on TB incidence and mortality in areas with high prevalence of under-nutrition, even if only small gains in under-nutrition can be achieved. Focusing on under-nutrition may be an effective way to reduce both rates of TB and other diseases associated with under-nutrition.	[Oxlade, Olivia; Huang, Chuan-Chin; Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Murray, Megan] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Murray, Megan] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Murray, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	mmurray@hsph.harvard.edu			Canadian Institute of Health Research [FRN 106987]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	OO received a post doctoral fellowship from the Canadian Institute of Health Research (FRN 106987). MM and CCH had no specific funding for this project.	[Anonymous], 2013, MILL DEV GOALS REP 2; Arora VK, 2003, INT J TUBERC LUNG D, V7, P1131; Bowden S, 2014, EUR REV ECON HIST, V18, P57, DOI 10.1093/ereh/het018; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; Department of International Development/UKAID, 2011, SCAL NUTR UKS POS PA; Dewey KG, 2011, MATERN CHILD NUTR, V7, P5, DOI 10.1111/j.1740-8709.2011.00349.x; Dye C, 1998, LANCET, V352, P1886, DOI 10.1016/S0140-6736(98)03199-7; Dye C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021161; Food and Agriculture Organization of the United Nations, 2013, STAT FOOD INS WORLD, DOI [10.3945/an.112.003343, DOI 10.3945/AN.112.003343]; Gillespie S, 2013, LANCET, V382, P552, DOI 10.1016/S0140-6736(13)60842-9; Goverment of India, 2011, IND CENS; Indian Nutrition Profile Survey, 1995, IND NUTR PROF SURV; International Food Policy Research Institute, 2013, GLOB HUNG IND 2013; Lin HH, 2008, LANCET, V372, P1473, DOI 10.1016/S0140-6736(08)61345-8; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; LONNROTH K, 2010, TUBERCULOSIS ROLE RI, P219; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; Mehler PS, 2010, J NUTR METABOLISM 20, V2010; Menzies NA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001347; National AIDS Control Organization, IND HIV DAT; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Raviglione M, 2012, LANCET, V379, P1902, DOI 10.1016/S0140-6736(12)60727-2; Sachan D, 2013, LANCET, V382, P194, DOI 10.1016/S0140-6736(13)61586-X; SALISBURY JJ, 1995, INT J EAT DISORDER, V17, P337, DOI 10.1002/1098-108X(199505)17:4&lt;337::AID-EAT2260170405&gt;3.0.CO;2-Q; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Scaling Up Nutrition, 2013, STAT SUN MOVEMENT PR; Singh A, 2014, ECON DEV CULT CHANGE, V62, P275, DOI 10.1086/674097; SPRINGETT V H, 1971, Tubercle, V52, P73, DOI 10.1016/0041-3879(71)90015-8; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Styblo K, 1984, SELECTED PAPERS, V24; Subramanyam MA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000424; SUTHERLAND I, 1976, Bulletin of the International Union Against Tuberculosis, V51, P171; Svedberg P, 2008, WHY MALNUTRITION SHI; THOMPSON AM, 1991, IEEE T PATTERN ANAL, V13, P326, DOI 10.1109/34.88568; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; United Nations Department of Economic and Social Affairs Population Division, 2013, WORLD POP PROSP 2012; Uplekar M, 2001, LANCET, V358, P912, DOI 10.1016/S0140-6736(01)06076-7; Uplekar M, 1998, INT J TUBERC LUNG D, V2, P324; Vollmer S, 2014, LANCET GLOB HEALTH, V2, pE225, DOI 10.1016/S2214-109X(14)70025-7; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1	47	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128187	10.1371/journal.pone.0128187	http://dx.doi.org/10.1371/journal.pone.0128187			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046649	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200045
J	Schubert, M; Ruedin, P; Civardi, C; Richter, M; Hach, A; Christen, H				Schubert, Mark; Ruedin, Pascal; Civardi, Chiara; Richter, Michael; Hach, Andre; Christen, Herbert			Laccase-Catalyzed Surface Modification of Thermo-Mechanical Pulp (TMP) for the Production of Wood Fiber Insulation Boards Using Industrial Process Water	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; OXIDATION; LIGNIN; MEDIATORS; IMPROVES	Low-density wood fiber insulation boards are traditionally manufactured in a wet process using a closed water circuit (process water). The water of these industrial processes contains natural phenolic extractives, aside from small amounts of admixtures (e.g., binders and paraffin). The suitability of two fungal laccases and one bacterial laccase was determined by biochemical characterization considering stability and substrate spectra. In a series of laboratory scale experiments, the selected commercial laccase from Myceliophtora thermophila was used to catalyze the surface modification of thermo-mechanical pulp (TMP) using process water. The laccase catalyzed the covalent binding of the phenolic compounds of the process water onto the wood fiber surface and led to change of the surface chemistry directly via crosslinking of lignin moieties. Although a complete substitution of the binder was not accomplished by laccase, the combined use of laccase and latex significantly improved the mechanical strength properties of wood fiber boards. The enzymatically-treated TMP showed better interactions with the synthetic binder, as shown by FTIR-analysis. Moreover, the enzyme is extensively stable in the process water and the approach requires no fresh water as well as no cost-intensive mediator. By applying a second-order polynomial model in combination with the genetic algorithm (GA), the required amount of laccase and synthetic latex could be optimized enabling the reduction of the binder by 40%.	[Schubert, Mark; Civardi, Chiara; Hach, Andre] Empa, Swiss Fed Labs Mat Sci & Technol, Lab Appl Wood Mat, St Gallen, Switzerland; [Richter, Michael] Empa, Swiss Fed Labs Mat Sci & Technol, Lab Biointerfaces, St Gallen, Switzerland; [Civardi, Chiara] ETH, Inst Bldg Mat, Zurich, Switzerland; [Ruedin, Pascal; Christen, Herbert] Pavatex SA, Cham, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Schubert, M (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, Lab Appl Wood Mat, St Gallen, Switzerland.	mark.schubert@empa.ch		Schubert, Mark/0000-0002-6900-0370	Swiss CTI (innovation promotion agency) Research project Integration of the enzyme laccase in the production of wood fiber insulation boards [11476.2 PFIW-IW]; Pavatex SA	Swiss CTI (innovation promotion agency) Research project Integration of the enzyme laccase in the production of wood fiber insulation boards; Pavatex SA	The present study emerged from the Swiss CTI (innovation promotion agency): https://www.kti.admin.ch/kti/en/home.html, Research project 11476.2 PFIW-IW Integration of the enzyme laccase in the production of wood fiber insulation boards, Recipient: Mark Schubert. Pavatex SA provided support in the form of salaries for authors PR and HC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	[Anonymous], 2012, 13171 EN; BOURBONNAIS R, 1990, FEBS LETT, V267, P99, DOI 10.1016/0014-5793(90)80298-W; Calcaterra A, 2008, J MOL CATAL B-ENZYM, V51, P118, DOI 10.1016/j.molcatb.2007.11.023; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Canas AI, 2010, BIOTECHNOL ADV, V28, P694, DOI 10.1016/j.biotechadv.2010.05.002; Chen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025647; d'Acunzo F, 2003, EUR J BIOCHEM, V270, P3634, DOI 10.1046/j.1432-1033.2003.03752.x; Euring M, 2011, BIOTECHNOL J, V6, P1253, DOI 10.1002/biot.201100119; Fackler K, 2008, HOLZFORSCHUNG, V62, P223, DOI 10.1515/HF.2008.045; Felby C, 2004, IND CROP PROD, V20, P181, DOI 10.1016/j.indcrop.2004.04.020; Felby C, 2002, ENZYME MICROB TECH, V31, P736, DOI 10.1016/S0141-0229(02)00111-4; FELBY C, 1998, ACS SYM SER, V687, P88; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Hassingboe J, 1998, 7 INT C BIOT PULP PA; Hollmann F, 2012, POLYMERS-BASEL, V4, P759, DOI 10.3390/polym4010759; Jeyamkondan S, 2001, INT J FOOD MICROBIOL, V64, P343, DOI 10.1016/S0168-1605(00)00483-9; Kharazipour A, 1997, J ADHES SCI TECHNOL, V11, P419, DOI 10.1163/156856197X00796; Kudanga T, 2011, ENZYME MICROB TECH, V48, P195, DOI 10.1016/j.enzmictec.2010.11.007; Kues U., 2007, WOOD PRODUCTION WOOD, P433; Kulys J, 2005, BIOTECHNOL BIOENG, V92, P124, DOI 10.1002/bit.20610; Orsa F, 1997, WOOD SCI TECHNOL, V31, P279, DOI 10.1007/s002260050035; Oscar TR, 2005, J FOOD SCI, V70, pM129, DOI 10.1111/j.1365-2621.2005.tb07103.x; Pardo I., 2015, CELL MOL LIFE SCI, P1, DOI [10.1007/s00018-014-1710-4, DOI 10.1007/S00018-014-1710-4]; Patel SKS, 2014, J MICROBIOL BIOTECHN, V24, P639, DOI 10.4014/jmb.1401.01025; Reiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065633; Reiss R, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-9; Schroeder Marc, 2007, Biotechnology Journal, V2, P334, DOI 10.1002/biot.200600209; Schubert M, 2012, J BIOTECHNOL, V161, P429, DOI 10.1016/j.jbiotec.2012.08.003; Schubert M, 2010, APPL MICROBIOL BIOT, V85, P703, DOI 10.1007/s00253-009-2185-3; SJOSTROM J, 1990, J ANAL APPL PYROL, V17, P305, DOI 10.1016/0165-2370(90)85019-J; Unbehaun H, 2000, ACTA BIOTECHNOL, V20, P305, DOI 10.1002/abio.370200311; Widsten P, 2008, ENZYME MICROB TECH, V42, P293, DOI 10.1016/j.enzmictec.2007.12.003; Xu F, 1996, BIOCHEMISTRY-US, V35, P7608, DOI 10.1021/bi952971a; Zhou GW, 2009, BIORESOURCE TECHNOL, V100, P505, DOI 10.1016/j.biortech.2008.06.010	34	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128623	10.1371/journal.pone.0128623	http://dx.doi.org/10.1371/journal.pone.0128623			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046652	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200085
J	Stetzner, ZW; Li, DF; Feng, WC; Liu, MY; Liu, GH; Wiley, J; Lei, BF				Stetzner, Zachary W.; Li, Dengfeng; Feng, Wenchao; Liu, Mengyao; Liu, Guanghui; Wiley, James; Lei, Benfang			Serotype M3 and M28 Group A Streptococci Have Distinct Capacities to Evade Neutrophil and TNF-alpha Responses and to Invade Soft Tissues	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; HYALURONIC-ACID CAPSULE; GENOME SEQUENCE; MOLECULAR CHARACTERIZATION; ENHANCED VIRULENCE; GENE-EXPRESSION; M-PROTEIN; IN-VIVO; STRAIN; DISEASE	The M3 Serotype of Group A Streptococcus (GAS) is one of the three most frequent serotypes associated with severe invasive GAS infections, such as necrotizing fasciitis, in the United States and other industrialized countries. The basis for this association and hypervirulence of invasive serotype M3 GAS is not fully understood. In this study, the sequenced serotype M3 strain, MGAS315, and serotype M28 strain, MGAS6180, were characterized in parallel to determine whether contemporary M3 GAS has a higher capacity to invade soft tissues than M28 GAS. In subcutaneous infection, MGAS315 invaded almost the whole skin, inhibited neutrophil recruitment and TNF-alpha production, and was lethal in subcutaneous infection of mice, whereas MGAS6180 did not invade skin, induced robust neutrophil infiltration and TNF-alpha production, and failed to kill mice. In contrast to MGAS6180, MGAS315 had covS G1370T mutation. Either replacement of the covS(1370T) gene with wild-type covS in MGAS315 chromosome or in trans expression of wild-type covS in MGAS315 reduced expression of CovRS-controlled virulence genes hasA, spyCEP, and sse by >10 fold. MGAS315 covS(wt) lost the capacity to extensively invade skin and to inhibit neutrophil recruitment and had attenuated virulence, indicating that the covS G1370T mutation critically contribute to the hypervirulence of MGAS315. Under the background of functional CovRS, MGAS315 covS(wt) still caused greater lesions than MGAS6180, and, consistently under the background of covS deletion, MGAS6180 Delta covS caused smaller lesions than MGAS315 Delta covS. Thus, contemporary invasive M3 GAS has a higher capacity to evade neutrophil and TNF-alpha responses and to invade soft tissue than M28 GAS and that this skin-invading capacity of M3 GAS is maximized by natural CovRS mutations. These findings enhance our understanding of the basis for the frequent association of M3 GAS with necrotizing fasciitis.	[Stetzner, Zachary W.; Li, Dengfeng; Feng, Wenchao; Liu, Mengyao; Liu, Guanghui; Wiley, James; Lei, Benfang] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA	Montana State University System; Montana State University Bozeman	Lei, BF (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA.	blei@montana.edu		Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health [AI095704, AI097703, GM110732]; USDA Animal Formula Fund; Montana State Agricultural Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095704, R21AI097703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA Animal Formula Fund; Montana State Agricultural Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants AI095704, AI097703, and GM110732 from the National Institutes of Health, USDA Animal Formula Fund, and the Montana State Agricultural Experimental Station.	Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Beres SB, 2010, P NATL ACAD SCI USA, V107, P4371, DOI 10.1073/pnas.0911295107; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carroll RK, 2011, J CLIN INVEST, V121, P1956, DOI 10.1172/JCI45169; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Davies HD, 1996, NEW ENGL J MED, V335, P547, DOI 10.1056/NEJM199608223350803; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Flores AR, 2014, J INFECT DIS, V209, P1520, DOI 10.1093/infdis/jit674; Green NM, 2005, J INFECT DIS, V192, P760, DOI 10.1086/430618; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; Horstmann N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002311; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; KAPUR V, 1994, MICROB PATHOGENESIS, V16, P443, DOI 10.1006/mpat.1994.1044; KATZ AR, 1992, CLIN INFECT DIS, V14, P298, DOI 10.1093/clinids/14.1.298; Kaul R, 1997, AM J MED, V103, P18, DOI 10.1016/S0002-9343(97)00160-5; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li JQ, 2014, INFECT IMMUN, V82, P1579, DOI 10.1128/IAI.01458-13; Li JQ, 2013, INFECT IMMUN, V81, P974, DOI 10.1128/IAI.01218-12; Li ZY, 2003, J INFECT DIS, V188, P1587, DOI 10.1086/379050; Liu GH, 2013, INFECT IMMUN, V81, P3128, DOI 10.1128/IAI.00398-13; Liu MY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002624; Liu MY, 2006, MICROBIOL-SGM, V152, P967, DOI 10.1099/mic.0.28706-0; Ma YS, 2006, J BACTERIOL, V188, P7626, DOI 10.1128/JB.01059-06; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; MARTIN DR, 1993, J INFECT DIS, V167, P1112, DOI 10.1093/infdis/167.5.1112; Mishalian I, 2011, J IMMUNOL, V187, P6022, DOI 10.4049/jimmunol.1101385; Miyoshi-Akiyama T, 2006, J INFECT DIS, V193, P1677, DOI 10.1086/504263; MUSSER JM, 1993, J INFECT DIS, V167, P337, DOI 10.1093/infdis/167.2.337; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; Nakagawa I, 2003, GENOME RES, V13, P1042, DOI 10.1101/gr.1096703; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Olsen RJ, 2012, J INFECT DIS, V205, P1719, DOI 10.1093/infdis/jir825; SEPPALA H, 1994, J INFECT DIS, V169, P519, DOI 10.1093/infdis/169.3.519; Sharkawy A, 2002, CLIN INFECT DIS, V34, P454, DOI 10.1086/338466; Shea PR, 2011, P NATL ACAD SCI USA, V108, P5039, DOI 10.1073/pnas.1016282108; Sitkiewicz I, 2006, P NATL ACAD SCI USA, V103, P16009, DOI 10.1073/pnas.0607669103; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Trevino J, 2009, INFECT IMMUN, V77, P3141, DOI 10.1128/IAI.01560-08; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Zhou Y, 2013, VIRULENCE, V4, P698, DOI 10.4161/viru.26413; Zhu H, 2009, INFECT IMMUN, V77, P5225, DOI 10.1128/IAI.00636-09	55	15	15	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129417	10.1371/journal.pone.0129417	http://dx.doi.org/10.1371/journal.pone.0129417			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047469	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200161
J	Darda, DM; Wake, DB				Darda, David M.; Wake, David B.			Osteological Variation among Extreme Morphological Forms in the Mexican Salamander Genus Chiropterotriton (Amphibia: Plethodontidae): Morphological Evolution And Homoplasy	PLOS ONE			English	Article							NEOTROPICAL SALAMANDER; THORIUS AMPHIBIA; PHYLOGENETIC IMPLICATIONS; FAMILY PLETHODONTIDAE; LUNGLESS SALAMANDERS; CRANIAL MORPHOLOGY; TONGUE EVOLUTION; FOOT MORPHOLOGY; BOLITOGLOSSA; CAUDATA	Osteological variation is recorded among and within four of the most distinctive species of the Mexican salamander genus Chiropterotriton. Analysis of the data is consistent with the monophyletic status of the genus and documents previously unrecorded intraspecific and interspecific variation. Most of the recorded variation involves qualitative and quantitative proportional differences, but four fixed differences constitute autapomorphic states that affirm and diagnose some species (C. dimidiatus, C. magnipes). Osteological variation in 15 characters is analyzed with respect to predictions generated from four hypotheses: 1) phylogeny, 2) adaptation to specific habitats (the four species include cave-dwelling, terrestrial, and arboreal forms), 3) size-free shape, and 4) size. High levels of intraspecific variation suggest that the characters studied are not subject to rigid functional constraints in salamanders, regardless of size. The pattern predicted by the hypothesis based on size differences seen among these four Chiropterotriton species matches most closely the observed pattern of relative skull robustness. Since size change and heterochrony are often associated in plethodontid evolution, it is likely that changes in developmental timing play a role in the morphological transitions among these morphologically diverse taxa. Webbed feet, miniaturization, body shape, and an unusual tarsal arrangement are morphologies exhibited in species of Chiropterotrition that are shown to be homoplastic with other clades of tropical plethodontids. Although extensive homoplasy in salamanders might be seen as a roadblock to unraveling phylogenetic hypotheses, the homologous developmental systems that appear to underlie such homoplasy may reveal common and consistent evolutionary processes at work.	[Darda, David M.] Cent Washington Univ, Dept Biol Sci, Ellensburg, WA 98926 USA; [Wake, David B.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wake, David B.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA	Central Washington University; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Darda, DM (corresponding author), Cent Washington Univ, Dept Biol Sci, Ellensburg, WA 98926 USA.	dardad@cwu.edu	Wake, David/AAA-6766-2021	Wake, David/0000-0003-4835-2497				Alberch P, 1996, INT J DEV BIOL, V40, P845; ALBERCH P, 1981, EVOLUTION, V35, P84, DOI 10.1111/j.1558-5646.1981.tb04861.x; ALBERCH P, 1983, EVOLUTION, V37, P906, DOI 10.1111/j.1558-5646.1983.tb05620.x; ALBERCH P, 1981, J MORPHOL, V167, P249, DOI 10.1002/jmor.1051670208; Alberch P, 1980, THESIS U CALIFORNIA; AmphibiaWeb, 2014, AMPHIBIAWEB INFORM A; DARDA DM, 1994, HERPETOLOGICA, V50, P164; Darda DM, 1988, THESIS U CALIFORNIA; Elias P., 1983, P1; Garcia-Paris M, 2000, COPEIA, P42; GREEN DM, 1981, J MORPHOL, V170, P273, DOI 10.1002/jmor.1051700302; HANKEN J, 1983, J MORPHOL, V177, P255, DOI 10.1002/jmor.1051770304; HANKEN J, 1984, BIOL J LINN SOC, V23, P55, DOI 10.1111/j.1095-8312.1984.tb00806.x; HANKEN J, 1983, COPEIA, P1051; HANKEN J, 1982, J MORPHOL, V174, P57, DOI 10.1002/jmor.1051740106; Hanken J., 1981, Functional Photography, V16, P22; HANKEN J, 1980, THESIS U CALIFORNIA; Hanken J, 2015, BOST STUD PHILOS HIS, V307, P97, DOI 10.1007/978-94-017-9412-1_4; Jaekel M, 2007, P NATL ACAD SCI USA, V104, P20437, DOI 10.1073/pnas.0710216105; LARSON A, 1981, EVOLUTION, V35, P405, DOI 10.1111/j.1558-5646.1981.tb04902.x; LOMBARD RE, 1976, J MORPHOL, V148, P265, DOI 10.1002/jmor.1051480302; LOMBARD RE, 1977, J MORPHOL, V153, P39; Marlow R.W., 1979, NATURAL HIST MUSEUM, V308, P1; MAXSON LR, 1981, HERPETOLOGICA, V37, P109; Parra-Olea G, 2004, BIOL J LINN SOC, V81, P325, DOI 10.1111/j.1095-8312.2003.00303.x; Parra-Olea G, 2003, CAN J ZOOL, V81, P2048, DOI 10.1139/Z03-155; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rabb GB, 1956, CHICAGO NATURAL HIST, V39, P11, DOI 10.5962/bhl.title.2874; RABB GEORGE B., 1965, BREVIORA MUS COMP ZOOL HARVARD UNIV, V235, P1; Schmalhausen I, 1917, KESSL REV ZOOLOGIQUE, V2, P129; SHUBIN N, 1995, EVOLUTION, V49, P874, DOI 10.1111/j.1558-5646.1995.tb02323.x; Shubin Neil H., 2003, Amphibian Biology, V5, P1782; Taylor Edward H., 1944, UNIV KANSAS SCI BULL, V30, P189; TRUEB L, 1977, SYST ZOOL, V26, P165, DOI 10.2307/2412839; Wake D. B., 1963, Copeia, V1963, P382, DOI 10.2307/1441357; Wake D. B., 1969, Contributions in Science, VNo. 175, P1; Wake D.B., 1976, NAT HIST MUS LOS ANG, V25, P1; Wake D.B., 1966, MEMOIRS SO CALIFORNI, V4, P1; Wake D.B., 1983, CONTRIBUTIONS SCI NA, V345, P1, DOI [10.5962/p.208170, DOI 10.5962/P.208170]; Wake DB, 2015, BOST STUD PHILOS HIS, V307, P111, DOI 10.1007/978-94-017-9412-1_5; Wake DB, 2012, ZOOTAXA, P67; Wake DB, 2011, SCIENCE, V331, P1032, DOI 10.1126/science.1188545; Wake DB, 2009, ANNU REV ECOL EVOL S, V40, P333, DOI 10.1146/annurev.ecolsys.39.110707.173552; WAKE DB, 1987, SCIENCE, V238, P42, DOI 10.1126/science.238.4823.42; WAKE DB, 1991, AM NAT, V138, P543, DOI 10.1086/285234; WAKE DB, 1983, J THEOR BIOL, V101, P211, DOI 10.1016/0022-5193(83)90335-1; WAKE DB, 1963, J MORPHOL, V113, P77, DOI 10.1002/jmor.1051130106; WAKE DB, 1980, AM ZOOL, V20, P756; WAKE DB, 1987, ANN MO BOT GARD, V74, P242, DOI 10.2307/2399397; WAKE TA, 1983, J HERPETOL, V17, P10, DOI 10.2307/1563775; Wiens JJ, 2007, P ROY SOC B-BIOL SCI, V274, P919, DOI 10.1098/rspb.2006.0301	51	14	15	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127248	10.1371/journal.pone.0127248	http://dx.doi.org/10.1371/journal.pone.0127248			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26060996	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500030
J	Zhang, XZ; Lv, LJ; Lv, C; Guo, BJ; Xu, RG				Zhang, Xinzhong; Lv, Liangjie; Lv, Chao; Guo, Baojian; Xu, Rugen			Combining Ability of Different Agronomic Traits and Yield Components in Hybrid Barley	PLOS ONE			English	Article							HETEROSIS; PREDICTION; TOLERANCE; DIALLEL; CROSS	Selection of parents based on their combining ability is an effective approach in hybrid breeding. In this study, eight maintainer lines and nine restorer lines were used to obtain 72 crosses for analyzing the general combining ability (GCA) and special combining ability (SCA) for seven agronomic and yield characters including plant height (PH), spike length excluding awns (SL), inter-node length (IL), spikes per plant (SP), thousand kernel weight (TKW), kernel weight per plant (KWP) and dry matter weight per plant (DWP). The results showed that GCA was significantly different among parents and SCA was also significantly different among crosses. The performance of hybrid was significantly correlated with the sum of female and male GCA (TGCA), SCA and heterosis. Hu1154 A, Mian684 A, 86F098 A, 8036 R and 8041 R were excellent parents with greater general combining ability. Five crosses, Hu1154 Ax8032 R, Humai10 Ax8040 R, Mian684 Ax8037 R, Mian684 Ax8041 R and 86F098 Ax8037 R, showed superior heterosis for most characters.	[Zhang, Xinzhong; Lv, Liangjie; Lv, Chao; Guo, Baojian; Xu, Rugen] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Xinzhong; Lv, Liangjie; Lv, Chao; Guo, Baojian; Xu, Rugen] Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Xinzhong; Lv, Liangjie; Lv, Chao; Guo, Baojian; Xu, Rugen] Yangzhou Univ, Minist Educ, Key Lab Plant Funct Genom, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Xinzhong; Lv, Liangjie; Lv, Chao; Guo, Baojian; Xu, Rugen] Yangzhou Univ, Inst Barley Res, Yangzhou 225009, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University; Yangzhou University	Xu, RG (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Yangzhou 225009, Jiangsu, Peoples R China.	rgxu@yzu.edu.cn			National Natural Science Foundation of China [30971779, 31071407, 31128014]; National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China [CARS-05]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Scientific Research Initial Fund for New Researchers in Yangzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Scientific Research Initial Fund for New Researchers in Yangzhou University	This work was funded by the National Natural Science Foundation of China (30971779, 31071407, 31128014), the National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China (CARS-05), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and the Scientific Research Initial Fund for New Researchers in Yangzhou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Moneam M A, 2009, Pak J Biol Sci, V12, P433, DOI 10.3923/pjbs.2009.433.438; AHOKAS H, 1979, ACTA AGR SCAND, V29, P219, DOI 10.1080/00015127909435232; Bagheri N., 2010, International Journal of Biology, V2, P222; Chen ZG, 2008, CROP SCI, V48, P1382, DOI 10.2135/cropsci2007.10.0557; GARDNER CO, 1966, BIOMETRICS, V22, P439, DOI 10.2307/2528181; Gissa D. W., 2007, South African Journal of Plant and Soil, V24, P133; Gowda R. K., 2013, Molecular Plant Breeding, V2013, P116; Hochholdinger F, 2007, TRENDS PLANT SCI, V12, P427, DOI 10.1016/j.tplants.2007.08.005; Krystkowiak K, 2009, EUPHYTICA, V165, P419, DOI 10.1007/s10681-008-9761-y; Li YC, 1997, EUPHYTICA, V95, P337, DOI 10.1023/A:1003092432309; Longin CFH, 2012, THEOR APPL GENET, V125, P1087, DOI 10.1007/s00122-012-1967-7; Madic M. R., 2014, Journal of Central European Agriculture, V15, P108; MELCHINGER AE, 1987, THEOR APPL GENET, V74, P339, DOI 10.1007/BF00274716; Mo HD, 1982, ACAD J JIANGSU AGR C, V3, P51; Muhleisen J, 2013, CROP SCI, V53, P819, DOI 10.2135/cropsci2012.07.0411; Qu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028463; Tiwari D. K., 2011, International Journal of Botany, V7, P126, DOI 10.3923/ijb.2011.126.144; Walejkl RN, 1977, CROP SCI, V17, P747; Wricke G., 1986, QUANTITATIVE GENETIC; Xu RuGen, 2004, Acta Agronomica Sinica, V30, P668; Zhang Xu, 2013, Journal of Southeast University (English Edition), V29, P33, DOI 10.3969/j.issn.1003-7985.2013.01.007; Zhou MX, 2007, CROP SCI, V47, P278, DOI 10.2135/cropsci2006.02.0065; Zhou MX, 2008, J CEREAL SCI, V48, P789, DOI 10.1016/j.jcs.2008.05.006	23	26	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0126828	10.1371/journal.pone.0126828	http://dx.doi.org/10.1371/journal.pone.0126828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061000	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500018
J	Smith, BL; Lu, CP; Garcia-Cortes, B; Vinas, J; Yeh, SY; Bremer, JRA				Smith, Brad L.; Lu, Ching-Ping; Garcia-Cortes, Blanca; Vinas, Jordi; Yeh, Shean-Ya; Bremer, Jaime R. Alvarado			Multilocus Bayesian Estimates of Intra-Oceanic Genetic Differentiation, Connectivity, and Admixture in Atlantic Swordfish (Xiphias gladius L.)	PLOS ONE			English	Article							GLOBAL POPULATION-STRUCTURE; MELTING ANALYSIS HRMA; GADUS-MORHUA L.; MITOCHONDRIAL-DNA; MICROSATELLITE VARIATION; MOLECULAR VARIANCE; ADAPTIVE VARIATION; STOCK STRUCTURE; MARINE FISHES; INDIAN-OCEAN	Previous genetic studies of Atlantic swordfish (Xiphias gladius L.) revealed significant differentiation among Mediterranean, North Atlantic and South Atlantic populations using both mitochondrial and nuclear DNA data. However, limitations in geographic sampling coverage, and the use of single loci, precluded an accurate placement of boundaries and of estimates of admixture. In this study, we present multilocus analyses of 26 single nucleotide polymorphisms (SNPs) within 10 nuclear genes to estimate population differentiation and admixture based on the characterization of 774 individuals representing North Atlantic, South Atlantic, and Mediterranean swordfish populations. Pairwise F-ST values, AMOVA, PCoA, and Bayesian individual assignments support the differentiation of swordfish inhabiting these three basins, but not the current placement of the boundaries that separate them. Specifically, the range of the South Atlantic population extends beyond 5 degrees N management boundary to 20 degrees N-25 degrees N from 45 degrees W. Likewise the Mediterranean population extends beyond the current management boundary at the Strait of Gibraltar to approximately 10 degrees W. Further, admixture zones, characterized by asymmetric contributions of adjacent populations within samples, are confined to the Northeast Atlantic. While South Atlantic and Mediterranean migrants were identified within these Northeast Atlantic admixture zones no North Atlantic migrants were identified respectively in these two neighboring basins. Owing to both, the characterization of larger number of loci and a more ample spatial sampling coverage, it was possible to provide a finer resolution of the boundaries separating Atlantic swordfish populations than previous studies. Finally, the patterns of population structure and admixture are discussed in the light of the reproductive biology, the known patterns of dispersal, and oceanographic features that may act as barriers to gene flow to Atlantic swordfish.	[Smith, Brad L.; Bremer, Jaime R. Alvarado] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Smith, Brad L.; Lu, Ching-Ping; Bremer, Jaime R. Alvarado] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 75044 USA; [Garcia-Cortes, Blanca] Inst Espanol Oceanog, Ctr Oceanog A Coruna, La Coruna 15080, Spain; [Vinas, Jordi] Univ Girona, Dept Biol, E-17071 Girona, Spain; [Yeh, Shean-Ya] Natl Taiwan Univ, Inst Oceanog, Taipei 106, Taiwan	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; Spanish Institute of Oceanography; Universitat de Girona; National Taiwan University	Smith, BL (corresponding author), Texas A&M Univ, Dept Marine Biol, OCSB 3029, Galveston, TX 77553 USA.	brad.smith@byuh.edu	Viñas, Jordi/A-5397-2010	Viñas, Jordi/0000-0003-0193-1141	Texas Institute of Oceanography; McDaniel Charitable Foundation Small Grant Program; TAMUG-Graduate Research Office and Marine Biology Department; Erma Lee and Luke Mooney Graduate Student Travel Grant; Erma Lee and Luke Mooney Graduate Student Research Excellence Award; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	Texas Institute of Oceanography; McDaniel Charitable Foundation Small Grant Program; TAMUG-Graduate Research Office and Marine Biology Department; Erma Lee and Luke Mooney Graduate Student Travel Grant; Erma Lee and Luke Mooney Graduate Student Research Excellence Award; Texas A&M University Online Access to Knowledge (OAK) Fund; University Libraries; Office of the Vice President for Research	Funding and support was provided by Texas Institute of Oceanography (http://www.tamug.edu/research/TIO/TIO.html), The McDaniel Charitable Foundation Small Grant Program (http://mcdanielcharitablefoundation.org/research-grant-program/small-grant-program/) to JRAB, TAMUG-Graduate Research Office and Marine Biology Department, the Erma Lee and Luke Mooney Graduate Student Travel Grant, and the Erma Lee and Luke Mooney Graduate Student Research Excellence Award. The open access publishing fees for this manuscript have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal AJ, COLL VOL SC IN PRESS; Allendorf FW, 2010, NAT REV GENET, V11, P697, DOI 10.1038/nrg2844; Alvarado Bremer J.R., 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V61, P107; Alvarado Bremer J.R., 1999, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V49, P127; Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; [Anonymous], 2010, COLL VOL SCI PAP ICC, V65, P1; [Anonymous], 1978, MULTIVARIATE ANAL VE; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Avise J, 2004, MOL MARKERS NATURAL; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Avise JC, 1998, J HERED, V89, P377, DOI 10.1093/jhered/89.5.377; Banks MA, 2003, BIOINFORMATICS, V19, P1436, DOI 10.1093/bioinformatics/btg172; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Blair C, 2012, MOL ECOL RESOUR, V12, P822, DOI 10.1111/j.1755-0998.2012.03151.x; Bremer JRA, 2005, J EXP MAR BIOL ECOL, V327, P167, DOI 10.1016/j.jembe.2005.06.022; Bremer JRA, 1998, MAR BIOL, V132, P547, DOI 10.1007/s002270050420; Bremer JRA, 1996, J EXP MAR BIOL ECOL, V197, P295, DOI 10.1016/0022-0981(95)00164-6; BREMER JRA, 1999, ICCAT COLL VOL SCI P, V49, P457; Buonaccorsi VP, 1999, EVOLUTION, V53, P568, DOI 10.1111/j.1558-5646.1999.tb03792.x; Buonaccorsi VP, 2001, MOL ECOL, V10, P1179, DOI 10.1046/j.1365-294X.2001.01270.x; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Chow S, 2007, MAR BIOL, V152, P87, DOI 10.1007/s00227-007-0662-8; Chow S, 1997, MAR BIOL, V127, P359, DOI 10.1007/s002270050022; Chow S, 2000, J FISH BIOL, V56, P1087, DOI 10.1006/jfbi.2000.1229; De La Serna JM, 1990, COLLECTIVE VOLUME SC, V32, P353; Dewar H, 2011, FISH OCEANOGR, V20, P219, DOI 10.1111/j.1365-2419.2011.00581.x; DeWoody JA, 2000, J FISH BIOL, V56, P461, DOI 10.1111/j.1095-8649.2000.tb00748.x; Diaz RJ, 2001, J ENVIRON QUAL, V30, P275, DOI 10.2134/jeq2001.302275x; Diaz-Jaimes P, 2006, FISH RES, V80, P333, DOI 10.1016/j.fishres.2006.04.015; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ely B, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-19; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Finnerty John R., 1992, Molecular Marine Biology and Biotechnology, V1, P206; Fisher RA, 1935, J R STAT SOC, V98, P39, DOI 10.2307/2342435; Freamo H, 2011, MOL ECOL RESOUR, V11, P254, DOI 10.1111/j.1755-0998.2010.02952.x; Garcia-Cortes B., 2003, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V55, P1476; Gazave E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r21; Gonzalez EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-252; Govoni JJ, 2000, FISH B-NOAA, V98, P64; Graves JE, 2003, MAR FRESHWATER RES, V54, P287, DOI 10.1071/MF01290; GRAVES JE, 1995, MAR BIOL, V122, P193; Graves JE, 1998, J HERED, V89, P427, DOI 10.1093/jhered/89.5.427; Greig T.W., 2000, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V51, P1637; Grieg TW., 2000, THESIS U S CAROLINA; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Helyar SJ, 2011, MOL ECOL RESOUR, V11, P123, DOI 10.1111/j.1755-0998.2010.02943.x; Hess JE, 2013, MOL ECOL, V22, P2898, DOI 10.1111/mec.12150; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kasapidis P., 2008, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V62, P1142; Kasapidis P., 2007, COLLECTIVE VOLUME SC, V61, P89; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kotoulas G., 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V61, P79; Limborg MT, 2012, MOL ECOL, V21, P3686, DOI 10.1111/j.1365-294X.2012.05639.x; Lu C-P., 2014, THESIS TEXAS A M U; Lu CP, 2006, ZOOL STUD, V45, P269; McDowell JR, 2002, THESIS VIRGINIA I MA; Mejuto J., 1998, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V48, P205; Montes I, 2012, MAR ECOL PROG SER, V471, P183, DOI 10.3354/meps09991; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; Muths D, 2009, FISH RES, V97, P263, DOI 10.1016/j.fishres.2009.03.004; Muths D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063558; Nakamura Y, 1985, FAO FISH SYNOP, V125, P48; Neilson J, 2013, REV FISH SCI, V21, P59, DOI 10.1080/10641262.2012.754842; Neilson John D., 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V61, P25; Neilson JD, 2009, REV-METHODS TECHNOL, V9, P145, DOI 10.1007/978-1-4020-9640-2_9; Nielsen EE, 2006, MOL ECOL, V15, P3219, DOI 10.1111/j.1365-294X.2006.03025.x; Nielsen EE, 2009, MOL ECOL, V18, P3128, DOI 10.1111/j.1365-294X.2009.04272.x; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; O'Reilly PT, 2004, MOL ECOL, V13, P1799, DOI 10.1111/j.1365-294X.2004.02214.x; Palko B.J., 1981, FAO FISH SYNOPSIS, V75, P21; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Portnoy DS, 2010, MOL ECOL, V19, P1994, DOI 10.1111/j.1365-294X.2010.04626.x; Prince ED, 2010, FISH OCEANOGR, V19, P448, DOI 10.1111/j.1365-2419.2010.00556.x; Pritchard JK, 2000, GENETICS, V155, P945; Qiu F, 2013, MOL PHYLOGENET EVOL, V66, P463, DOI 10.1016/j.ympev.2012.05.002; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reeb CA, 2010, P NATL ACAD SCI USA, V107, P2377, DOI 10.1073/pnas.0914639107; Rey JCA E., 1988, COL VOL SCI PAP ICCA, V27, P178; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2006, MOL ECOL, V15, P2031, DOI 10.1111/j.1365-294X.2006.02839.x; Schrey AW, 2003, CAN J FISH AQUAT SCI, V60, P670, DOI 10.1139/F03-064; Sedberry GR, 2001, MAR BIOL, V139, P355; Seki MP, 2002, J OCEANOGR, V58, P739, DOI 10.1023/A:1022854609312; Skarstein TH, 2007, J FISH BIOL, V70, P271, DOI 10.1111/j.1095-8649.2007.01456.x; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smith BL, 2010, MOL ECOL RESOUR, V10, P193, DOI 10.1111/j.1755-0998.2009.02726.x; Smith BL, 2013, MAR GENOM, V9, P39, DOI 10.1016/j.margen.2012.10.001; Vinas J, 2004, MAR BIOL, V145, P225, DOI 10.1007/s00227-004-1319-5; Vinas J, 2010, ICES J MAR SCI, V67, P1222, DOI 10.1093/icesjms/fsq031; Vinas Jordi, 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V61, P99; Waples RS, 1998, J HERED, V89, P438, DOI 10.1093/jhered/89.5.438; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	104	13	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0127979	10.1371/journal.pone.0127979	http://dx.doi.org/10.1371/journal.pone.0127979			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057382	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000013
J	Accrombessi, M; Ouedraogo, S; Agbota, GC; Gonzalez, R; Massougbodji, A; Menendez, C; Cot, M				Accrombessi, Manfred; Ouedraogo, Smaila; Agbota, Gino Cedric; Gonzalez, Raquel; Massougbodji, Achille; Menendez, Clara; Cot, Michel			Malaria in Pregnancy Is a Predictor of Infant Haemoglobin Concentrations during the First Year of Life in Benin, West Africa	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; PLACENTAL MALARIA; YOUNG-CHILDREN; RISK-FACTORS; ANEMIA; SUSCEPTIBILITY; WOMEN	Background Anaemia is an increasingly recognized health problem in Africa, particularly in infants and pregnant women. Although malaria is known to be the main risk factor of anaemia in both groups, the consequences of maternal factors, particularly malaria in pregnancy (MiP), on infant haemoglobin (Hb) concentrations during the first months of life are still unclear. Methods We followed-up a cohort of 1005 Beninese pregnant women from the beginning of pregnancy until delivery. A subsample composed of the first 400 offspring of these women were selected at birth and followed until the first year of life. Placental histology and blood smear at 1st clinical antenatal visit (ANC), 2nd ANC and delivery were used to assess malaria during pregnancy. Infant Hb concentrations were measured at birth, 6, 9 and 12 months of age. A mixed multi-level model was used to assess the association between MiP and infant Hb variations during the first 12 months of life. Results Placental malaria (difference mean [dm] = -2.8 g/L, 95% CI [-5.3, -0.3], P = 0.03) and maternal peripheral parasitaemia at delivery (dm = -4.6 g/L, 95% CI [-7.9, -1.3], P = 0.007) were the main maternal factors significantly associated with infant Hb concentrations during the first year of life. Poor maternal nutritional status and malaria infection during infancy were also significantly associated with a decrease in infant Hb. Conclusion Antimalarial control and nutritional interventions before and during pregnancy should be reinforced to reduce specifically the incidence of infant anaemia, particularly in SubSaharan countries.	[Accrombessi, Manfred; Agbota, Gino Cedric; Cot, Michel] IRD, Mere & Enfant Face Infect Trop UMR216, Paris, France; [Accrombessi, Manfred; Agbota, Gino Cedric; Cot, Michel] Univ Paris 05, PRES Paris Sorbonne Cite, Paris, France; [Accrombessi, Manfred; Agbota, Gino Cedric; Massougbodji, Achille] Univ Abomey Calavi, Fac Med Cotonou, Cotonou, Benin; [Ouedraogo, Smaila] Univ Ouagadougou, Unite Format & Rech Sci Sante, Ouagadougou, Burkina Faso; [Gonzalez, Raquel; Menendez, Clara] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Gonzalez, Raquel; Menendez, Clara] Manhica Hlth Res Ctr CISM, Manhica, Mozambique	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Abomey Calavi; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Centro de Investigacao em Saude de Manhica	Accrombessi, M (corresponding author), IRD, Mere & Enfant Face Infect Trop UMR216, Paris, France.	accrombessimanfred@yahoo.fr	Menéndez, Clara/Q-3446-2016; Accrombessi, Manfred/W-1546-2017; Cot, Michel/E-7633-2011; Gonzalez, Raquel/J-3604-2017	Menéndez, Clara/0000-0002-2641-6907; Accrombessi, Manfred/0000-0001-9550-9413; Cot, Michel/0000-0003-3014-4294; Gonzalez, Raquel/0000-0001-5487-801X	Malaria in Pregnancy consortium; Bill and Melinda Gates Foundation; EDCTP [EDCTP-IP.07.31080.002]; Institut de Recherche pour le Developpement grant	Malaria in Pregnancy consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); EDCTP; Institut de Recherche pour le Developpement grant	This study was supported by the Malaria in Pregnancy consortium, which is funded through a grant from the Bill and Melinda Gates Foundation to the Liverpool School of Tropical Medicine. The MiPPAD study was supported by the EDCTP (EDCTP-IP.07.31080.002). Manfred Accrombessi was supported by an Institut de Recherche pour le Developpement grant while writing this paper.	[Anonymous], 2001, IRON DEFICIENCY ANAE; Huynh BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035342; Briand V, 2008, J INFECT DIS, V198, P594, DOI 10.1086/590114; Broen K, 2007, MOL BIOCHEM PARASIT, V151, P1, DOI 10.1016/j.molbiopara.2006.10.001; BULMER JN, 1993, HISTOPATHOLOGY, V22, P211, DOI 10.1111/j.1365-2559.1993.tb00110.x; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; Cot M, 2003, AM J EPIDEMIOL, V157, P203, DOI 10.1093/aje/kwf192; Cottrell G, 2005, AM J TROP MED HYG, V73, P1112, DOI 10.4269/ajtmh.2005.73.1112; DALLMAN PR, 1980, AM J CLIN NUTR, V33, P86, DOI 10.1093/ajcn/33.1.86; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai MR, 2005, AM J TROP MED HYG, V72, P47, DOI 10.4269/ajtmh.2005.72.47; Diouf I, 2007, J REPROD IMMUNOL, V74, P152, DOI 10.1016/j.jri.2006.10.001; Gambling L, 2011, AM J CLIN NUTR, V94, p1903S, DOI 10.3945/ajcn.110.000885; Gonzalez R, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001733; Ismaili J, 2003, CLIN EXP IMMUNOL, V133, P414, DOI 10.1046/j.1365-2249.2003.02243.x; Jonker FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042670; Kabyemela ER, 2008, J INFECT DIS, V198, P163, DOI 10.1086/589512; Kruger H S, 2005, Curationis, V28, P40; le Cessie S, 2002, ARCH DIS CHILD-FETAL, V86, P182, DOI 10.1136/fn.86.3.F182; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Lokeshwar M. R., 2003, Indian Journal of Pediatrics, V70, P893, DOI 10.1007/BF02730596; Magalhaes RJS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000438; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Morse K, 2009, BEST PRACT RES CL OB, V23, P809, DOI 10.1016/j.bpobgyn.2009.09.004; National Institute of Statistic and Economic Analysis (INSAE), 2006, NUTR STAT PREV AN BE, P204; Ouedraogo S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-348; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; REDD SC, 1994, AM J TROP MED HYG, V51, P170, DOI 10.4269/ajtmh.1994.51.170; Righetti AA, 2012, AM J TROP MED HYG, V87, P425, DOI 10.4269/ajtmh.2012.11-0788; Rogerson SJ, 2003, J CLIN MICROBIOL, V41, P1370, DOI 10.1128/JCM.41.4.1370-1374.2003; Sangare L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087743; Steketee RW, 2003, J NUTR, V133, p1661S, DOI 10.1093/jn/133.5.1661S; Swysen C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-223; Tine Roger C K, 2012, BMC Res Notes, V5, P565, DOI 10.1186/1756-0500-5-565; Uneke Chigozie J, 2007, Yale J Biol Med, V80, P95; United Nations Administrative Committee on Coordination, 2000, WHO TECHN REP SER; *WHO, 1972, WHO TECHN REP SER, V503; World Health Organization, 1995, PHYS STAT US INT ANT; YAMADA M, 1989, AM J TROP MED HYG, V41, P161, DOI 10.4269/ajtmh.1989.41.161	41	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129510	10.1371/journal.pone.0129510	http://dx.doi.org/10.1371/journal.pone.0129510			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052704	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300134
J	Bialk, P; Rivera-Torres, N; Strouse, B; Kmiec, EB				Bialk, Pawel; Rivera-Torres, Natalia; Strouse, Bryan; Kmiec, Eric B.			Regulation of Gene Editing Activity Directed by Single-Stranded Oligonucleotides and CRISPR/Cas9 Systems	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; DNA OLIGONUCLEOTIDES; MAMMALIAN-CELLS; SEQUENCE CORRECTION; CORRECTED CELLS; TARGETED REPAIR; GENOME; REPLICATION; CAS9; OLIGODEOXYNUCLEOTIDES	Single-stranded DNA oligonucleotides (ssODNs) can direct the repair of a single base mutation in human genes. While the regulation of this gene editing reaction has been partially elucidated, the low frequency with which repair occurs has hampered development toward clinical application. In this work a CRISPR/Cas9 complex is employed to induce double strand DNA breakage at specific sites surrounding the nucleotide designated for exchange. The result is a significant elevation in ssODN-directed gene repair, validated by a phenotypic readout. By analysing reaction parameters, we have uncovered restrictions on gene editing activity involving CRISPR/Cas9 complexes. First, ssODNs that hybridize to the nontranscribed strand direct a higher level of gene repair than those that hybridize to the transcribed strand. Second, cleavage must be proximal to the targeted mutant base to enable higher levels of gene editing. Third, DNA cleavage enables a higher level of gene editing activity as compared to single-stranded DNA nicks, created by modified Cas9 (Nickases). Fourth, we calculated the hybridization potential and free energy levels of ssODNs that are complementary to the guide RNA sequences of CRISPRs used in this study. We find a correlation between free energy potential and the capacity of single-stranded oligonucleotides to inhibit specific DNA cleavage activity, thereby indirectly reducing gene editing activity. Our data provide novel information that might be taken into consideration in the design and usage of CRISPR/Cas9 systems with ssODNs for gene editing.	[Bialk, Pawel] Helen F Graham Canc Ctr, Gene Editing Inst, Newark, DC USA	Helen F. Graham Cancer Center & Research Institute		eric@geneeditinginstitute.com			National Institute of Health [5R01CA89325-12]; NATIONAL CANCER INSTITUTE [R01CA089325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103446] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health [5R01CA89325-12]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts M, 2011, GENE THER, V18, P213, DOI 10.1038/gt.2010.161; Bedell VM, 2012, NATURE, V491, P114, DOI 10.1038/nature11537; Bertoni C, 2005, HUM MOL GENET, V14, P221, DOI 10.1093/hmg/ddi020; Bertoni C, 2009, NUCLEIC ACIDS RES, V37, P7468, DOI 10.1093/nar/gkp757; Bibikova M, 2002, GENETICS, V161, P1169; Bonner M, 2009, MUTAT RES-FUND MOL M, V669, P85, DOI 10.1016/j.mrfmmm.2009.05.004; Brachman EE, 2005, DNA REPAIR, V4, P445, DOI 10.1016/j.dnarep.2004.11.007; Brachman EE, 2002, CURR OPIN MOL THER, V4, P171; Briggs AW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks624; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davis L, 2014, P NATL ACAD SCI USA, V111, pE924, DOI 10.1073/pnas.1400236111; Ding QR, 2013, CELL STEM CELL, V12, P238, DOI 10.1016/j.stem.2012.11.011; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Engstrom JU, 2008, CELL CYCLE, V7, P1402, DOI 10.4161/cc.7.10.5826; Engstrom JU, 2009, BIOESSAYS, V31, P159, DOI 10.1002/bies.200800119; Ferrara L, 2006, DNA REPAIR, V5, P422, DOI 10.1016/j.dnarep.2005.11.009; Ferrara L, 2004, NUCLEIC ACIDS RES, V32, P5239, DOI 10.1093/nar/gkh822; Ferrara L, 2007, DNA REPAIR, V6, P1529, DOI 10.1016/j.dnarep.2007.04.007; Hu YL, 2005, MOL BIOTECHNOL, V29, P197, DOI 10.1385/MB:29:3:197; Huen MSY, 2006, NUCLEIC ACIDS RES, V34, P6183, DOI 10.1093/nar/gkl852; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Liu J, 2010, J BIOL CHEM, V285, P23196, DOI 10.1074/jbc.M110.123844; Liu L, 2002, MOL CELL BIOL, V22, P3852, DOI 10.1128/MCB.22.11.3852-3863.2002; Majumdar A, 2003, J BIOL CHEM, V278, P11072, DOI 10.1074/jbc.M211837200; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Olsen PA, 2005, J GENE MED, V7, P1534, DOI 10.1002/jgm.804; Olsen PA, 2005, GENE THER, V12, P546, DOI 10.1038/sj.gt.3302454; Papaioannou I, 2009, J GENE MED, V11, P267, DOI 10.1002/jgm.1296; Parekh-Olmedo H, 2007, GENE THER, V14, P1675, DOI 10.1038/sj.gt.3303053; Pierce EA, 2003, GENE THER, V10, P24, DOI 10.1038/sj.gt.3301857; Qiu P, 2004, BIOTECHNIQUES, V36, P702, DOI 10.2144/04364PF01; Radecke F, 2004, J GENE MED, V6, P1257, DOI 10.1002/jgm.613; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rivera-Torres N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096483; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; Strouse B, 2014, SCI REP-UK, V4, DOI 10.1038/srep03791; Wu XS, 2005, P NATL ACAD SCI USA, V102, P2508, DOI 10.1073/pnas.0406991102; YAMAMOTO T, 1992, GENETICS, V131, P811; Yang LH, 2013, NUCLEIC ACIDS RES, V41, P9049, DOI 10.1093/nar/gkt555	48	48	51	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129308	10.1371/journal.pone.0129308	http://dx.doi.org/10.1371/journal.pone.0129308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053390	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300115
J	Francois, C; Rahhali, N; Chalem, Y; Sorensen, P; Luquiens, A; Aubin, HJ				Francois, Clement; Rahhali, Nora; Chalem, Ylana; Sorensen, Per; Luquiens, Amandine; Aubin, Henri-Jean			The Effects of as-Needed Nalmefene on Patient-Reported Outcomes and Quality of Life in Relation to a Reduction in Alcohol Consumption in Alcohol-Dependent Patients	PLOS ONE			English	Article							USE DISORDERS; FOLLOW-UP; DRINKING; INTERVENTIONS; INSTRUMENTS; IMPROVEMENT; MORTALITY; EFFICACY; DISEASE; BURDEN	Background The objective of this article was to investigate the effect of as-needed nalmefene on health-related quality of life (HRQoL) in patients with alcohol dependence, and to relate changes in drinking behavior and status to HRQoL outcomes. Methods This post hoc analysis was conducted on a pooled subgroup of patients with at least a high drinking risk level (men: >60 g/day; women: >40 g/day) who participated in one of two randomized controlled 6-month studies, ESENSE 1 and ESENSE 2. Patients received nalmefene 18 mg or placebo on an as-needed basis, in addition to a motivational and adherence-enhancing intervention (BRENDA). At baseline and after 12 and 24 weeks questionnaires for the Medical Outcomes Study (MOS) 36-item Short-Form Health Survey (SF-36), European Quality of life-5 Dimensions (EQ-5D) and the Drinker Inventory of Consequences (DrInC-2R) were completed. Results The pooled population consisted of 667 patients (nalmefene: 335; placebo: 332), with no notable between-group differences in baseline patient demographics/characteristics. At week 24, nalmefene had a superior effect compared to placebo in improving SF-36 mental component summary scores (mean difference [95% CI], p-value: 3.09 [1.29, 4.89]; p=0.0008), SF-36 physical component summary scores (1.23 [0.15, 2.31]; p=0.026), EQ-5D utility index scores (0.03 [0.00, 0.06]; p=0.045), EQ-5D health state scores (3.46 [0.75, 6.17]; p=0.012), and DrInC-2R scores (-3.22 [-6.12, 0.33]; p=0.029). The improvements in SF-36 mental component summary scores at week 24, and the DrInC-2R total score change from baseline to week 24, were significantly correlated to reductions in heavy drinking days and total alcohol consumption at week 24. Conclusions As-needed nalmefene significantly improved almost all patient-reported HRQoL measures included in SF-36 and EQ-5D compared with placebo. These HRQoL gains were significantly correlated to reduced drinking behavior, as determined by reductions in heavy drinking days and total alcohol consumption.	[Francois, Clement; Rahhali, Nora; Chalem, Ylana] H Lundbeck & Co AS, Issy Les Moulineaux, France; [Sorensen, Per] H Lundbeck & Co AS, DK-2500 Valby, Denmark; [Luquiens, Amandine; Aubin, Henri-Jean] Hop Paul Brousse, AP HP, INSERM U669, Villejuif, France	Lundbeck Corporation; Lundbeck Corporation - France; Lundbeck Corporation; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Francois, C (corresponding author), H Lundbeck & Co AS, Issy Les Moulineaux, France.	CFR@lundbeck.com	Aubin, Henri-Jean/AAP-8605-2021; , Aubin/AAT-9739-2021; François, Clément/AAR-3163-2021	Luquiens, Amandine/0000-0002-9402-442X; Aubin, Henri-Jean/0000-0002-6604-6672	Lundbeck; Lundbeck SAS, France	Lundbeck(Lundbeck Corporation); Lundbeck SAS, France	The authors thank Steve Clissold and David Figgitt, Content Ed Net, for providing valuable editorial support in the preparation of the article. The study was funded by Lundbeck and funding for editorial support was provided by Lundbeck SAS, France. Lundbeck provided support in the form of salaries for authors CF, NR, YC and PS. The funding source was involved in the design of the study, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of the authors are listed in the authors contributions section.	Adamson SJ, 2010, ALCOHOL ALCOHOLISM, V45, P136, DOI 10.1093/alcalc/agq005; Anton RF, 2006, JAMA-J AM MED ASSOC, V295, P2003, DOI 10.1001/jama.295.17.2003; APA, 2000, DIAGN STAT MAN MENT; Bart G, 2005, NEUROPSYCHOPHARMACOL, V30, P2254, DOI 10.1038/sj.npp.1300811; Coons SJ, 2000, PHARMACOECONOMICS, V17, P13, DOI 10.2165/00019053-200017010-00002; Cuijpers P, 2004, ADDICTION, V99, P839, DOI 10.1111/j.1360-0443.2004.00778.x; Daeppen JB, 1998, AM J DRUG ALCOHOL AB, V24, P685, DOI 10.3109/00952999809019617; Dawson DA, 2009, ALCOHOL ALCOHOLISM, V44, P84, DOI 10.1093/alcalc/agn094; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Dolan P, 1995, SOCIAL TARIFF EUROQO; Donovan D, 2005, J STUD ALCOHOL, P119, DOI 10.15288/jsas.2005.s15.119; Foster JH, 2002, ADDICT BIOL, V7, P55, DOI 10.1080/135562101200100616; Frischknecht U, 2013, ALCOHOL ALCOHOLISM, V48, P579, DOI 10.1093/alcalc/agt038; Gual A, 2013, EUR NEUROPSYCHOPHARM, V23, P1432, DOI 10.1016/j.euroneuro.2013.02.006; Gunther O, 2007, DRUG ALCOHOL DEPEN, V86, P253, DOI 10.1016/j.drugalcdep.2006.07.001; Guther OH, 2008, DRUG ALCOHOL DEPEN, V92, P291, DOI 10.1016/j.drugalcdep.2007.07.016; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Laaksonen E, 2013, ALCOHOL ALCOHOLISM, V48, P687, DOI 10.1093/alcalc/agt053; Lahmek P, 2009, INT J MED SCI, V6, P160; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; Luquiens A, 2012, DRUG ALCOHOL DEPEN, V125, P192, DOI 10.1016/j.drugalcdep.2012.08.012; Luquiens A, 2011, ALCOHOL ALCOHOLISM, V46, P586, DOI 10.1093/alcalc/agr083; Mann K, 2013, BIOL PSYCHIAT, V73, P706, DOI 10.1016/j.biopsych.2012.10.020; Maruish ME., 2011, USERS MANUAL SF 36V2, V3rd ed.; Miller, 1995, DRINKER INVENTORY CO, V4; Morgan MY, 2004, ALCOHOL CLIN EXP RES, V28, P64, DOI 10.1097/01.ALC.0000108652.73143.4B; Pettinati HM, 2009, ALCOHOL CLIN EXP RES, V33, P350, DOI 10.1111/j.1530-0277.2008.00843.x; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rehm J, 2013, ALCOHOL ALCOHOLISM, V48, P509, DOI 10.1093/alcalc/agt021; Rehm J, 2011, ADDICTION, V106, P11, DOI 10.1111/j.1360-0443.2010.03326.x; Rehm J, 2009, LANCET, V373, P2223, DOI 10.1016/S0140-6736(09)60746-7; Starosta Aron N, 2006, J Psychiatr Pract, V12, P80, DOI 10.1097/00131746-200603000-00003; Stein MD, 1998, J SUBST ABUSE, V10, P75, DOI 10.1016/S0899-3289(99)80142-4; Substance Abuse and Mental Health Services Administration, 2009, NSDUH REP ALC TREATM; van den Brink W, 2013, ALCOHOL ALCOHOLISM, V48, P570, DOI 10.1093/alcalc/agt061; Ware JE, 1994, SF 36 PHYS MENTAL HL, DOI [10.1007/s11136-010-9658-9, DOI 10.1007/S11136-010-9658-9]; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; World Health Organization, 2000, INT GUID MON ALC CON	39	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129289	10.1371/journal.pone.0129289	http://dx.doi.org/10.1371/journal.pone.0129289			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1GM	26053024	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300110
J	Koblitz, L; Fiechtner, B; Baus, K; Lussnig, R; Pelster, B				Koeblitz, Louise; Fiechtner, Birgit; Baus, Katharina; Lussnig, Rebecca; Pelster, Bernd			Developmental Expression and Hypoxic Induction of Hypoxia Inducible Transcription Factors in the Zebrafish	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; OXYGEN; HIF-1-ALPHA; HOMEOSTASIS; HIF-1; HIF-2-ALPHA; MECHANISMS; RESPONSES; CLONING	The hypoxia inducible transcription factor (HIF) has been shown to coordinate the hypoxic response of vertebrates and is expressed in three different isoforms, HIF-1 alpha, HIF-2 alpha and HIF-3 alpha. Knock down of either Hif-1 alpha or Hif-2 alpha in mice results in lethality in embryonic or perinatal stages, suggesting that this transcription factor is not only controlling the hypoxic response, but is also involved in developmental phenomena. In the translucent zebrafish embryo the performance of the cardiovascular system is not essential for early development, therefore this study was designed to analyze the expression of the three Hif-isoforms during zebrafish development and to test the hypoxic inducibility of these transcription factors. To complement the existing zfHif-1 alpha antibody we expressed the whole zfHif-2 alpha protein and used it for immunization and antibody generation. Similarly, fragments of the zfHif-3 alpha protein were used for immunization and generation of a zfHif-3 alpha specific antibody. To demonstrate presence of the Hif-isoforms during development [between 1 day post fertilization (1 dpf) and 9 dpf] affinity-purified antibodies were used. Hif-1 alpha protein was present under normoxic conditions in all developmental stages, but no significant differences between the different developmental stages could be detected. Hif-2 alpha was also present from 1 dpf onwards, but in post hatching stages (between 5 and 9 dpf) the expression level was significantly higher than prior to hatching. Similarly, Hif-3 alpha was expressed from 1 dpf onwards, and the expression level significantly increased until 5 dpf, suggesting that Hif-2 alpha and Hif3 alpha play a particular role in early development. Hypoxic exposure (oxygen partial pressure = 5 kPa) in turn caused a significant increase in the level of Hif-1 alpha protein even at 1 dpf and in later stages, while neither Hif-2 alpha nor Hif-3 alpha protein level were affected. In these early developmental stages Hif-1a therefore appears to be more important for the coordination of hypoxic responsiveness.	[Koeblitz, Louise; Fiechtner, Birgit; Pelster, Bernd] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Koeblitz, Louise; Fiechtner, Birgit; Pelster, Bernd] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria	University of Innsbruck; University of Innsbruck	Pelster, B (corresponding author), Univ Innsbruck, Inst Zool, Technikerstr 25, A-6020 Innsbruck, Austria.	bernd.pelster@uibk.ac.at			University of Innsbruck, Nachwuchsforderung Tyrolean Science Foundation [134756, TWF 84232]	University of Innsbruck, Nachwuchsforderung Tyrolean Science Foundation	This work was supported by the University of Innsbruck, Nachwuchsforderung 134756 Tyrolean Science Foundation TWF 84232. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; Compernolle V, 2002, NAT MED, V8, P702, DOI 10.1038/nm721; Daniels CB, 2004, PHYSIOL BIOCHEM ZOOL, V77, P732, DOI 10.1086/422058; Egg M, 2013, CHRONOBIOL INT, V30, P510, DOI 10.3109/07420528.2012.754447; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Hara S, 2001, BIOCHEM BIOPH RES CO, V287, P808, DOI 10.1006/bbrc.2001.5659; Heikkila M, 2011, CELL MOL LIFE SCI, V68, P3885, DOI 10.1007/s00018-011-0679-5; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jacob E, 2002, AM J PHYSIOL-REG I, V283, pR911, DOI 10.1152/ajpregu.00673.2001; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Kopp R, 2011, PHYSIOL GENOMICS, V43, P506, DOI 10.1152/physiolgenomics.00250.2010; Kotch LE, 1999, DEV BIOL, V209, P254, DOI 10.1006/dbio.1999.9253; Law SHW, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-15; Mann KD, 2010, AM J PHYSIOL-REG I, V298, pR1288, DOI 10.1152/ajpregu.00302.2009; Maynard MA, 2005, FASEB J, V19, P1396, DOI 10.1096/fj.05-3788com; Maynard MA, 2003, J BIOL CHEM, V278, P11032, DOI 10.1074/jbc.M208681200; Pasanen A, 2010, INT J BIOCHEM CELL B, V42, P1189, DOI 10.1016/j.biocel.2010.04.008; Pascal LE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-246; Peng J, 2000, P NATL ACAD SCI USA, V97, P8386, DOI 10.1073/pnas.140087397; Prabhakar NR, 2012, PHYSIOL REV, V92, P967, DOI 10.1152/physrev.00030.2011; Prem C, 2000, AM J PHYSIOL-REG I, V279, pR2336, DOI 10.1152/ajpregu.2000.279.6.R2336; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Richards JG, 2009, FISH PHYSIOL, V27, P443, DOI 10.1016/S1546-5098(08)00010-1; Rojas DA, 2007, GENE EXPR PATTERNS, V7, P339, DOI 10.1016/j.modgep.2006.08.002; Rytkonen KT, 2014, GENE, V541, P60, DOI 10.1016/j.gene.2014.03.007; Rytkonen KT, 2013, EVOLUTION, V67, P873, DOI 10.1111/j.1558-5646.2012.01820.x; Santhakumar K, 2012, CANCER RES, V72, P4017, DOI 10.1158/0008-5472.CAN-11-3148; Schipani E, 2001, GENE DEV, V15, P2865; Schwerte T, 2006, J EXP BIOL, V209, P1093, DOI 10.1242/jeb.02117; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Semenza GL, 2001, CURR OPIN CELL BIOL, V13, P167, DOI 10.1016/S0955-0674(00)00194-0; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Sipe CW, 2004, DEV DYNAM, V230, P229, DOI 10.1002/dvdy.20049; Takarada T, 2012, J BIOL CHEM, V287, P36081, DOI 10.1074/jbc.M112.408963; Tian H, 1998, GENE DEV, V12, P3320, DOI 10.1101/gad.12.21.3320; Ton C, 2003, PHYSIOL GENOMICS, V13, P97, DOI 10.1152/physiolgenomics.00128.2002; Wei W, 2007, CANCER LETT, V257, P145, DOI 10.1016/j.canlet.2007.08.009; Winata CL, 2009, DEV BIOL, V331, P222, DOI 10.1016/j.ydbio.2009.04.035; Yin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018431; Zhang P, 2014, CELL REP, V6, P1110, DOI 10.1016/j.celrep.2014.02.011; Zhang P, 2012, AM J PHYSIOL-REG I, V303, pR1165, DOI 10.1152/ajpregu.00340.2012	47	24	25	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128938	10.1371/journal.pone.0128938	http://dx.doi.org/10.1371/journal.pone.0128938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052946	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300070
J	Solti, I; Kvell, K; Talaber, G; Veto, S; Acs, P; Gallyas, F; Illes, Z; Fekete, K; Zalan, P; Szanto, A; Bognar, Z				Solti, Izabella; Kvell, Krisztian; Talaber, Gergely; Veto, Sara; Acs, Peter; Gallyas, Ferenc, Jr.; Illes, Zsolt; Fekete, Katalin; Zalan, Petra; Szanto, Arpad; Bognar, Zita			Thymic Atrophy and Apoptosis of CD4(+)CD8(+) Thymocytes in the Cuprizone Model of Multiple Sclerosis	PLOS ONE			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; POLYMERASE CHAIN-REACTION; IN-VITRO; T-CELLS; NEURODEGENERATIVE DISEASES; EPITHELIAL-CELLS; DEMYELINATION; MITOCHONDRIA; ACTIVATION; DEATH	Previous studies on the degenerative animal model of multiple sclerosis suggested that the copper-chelator cuprizone might directly suppress T-cell functions. Peripheral T-cell function in the cuprizone model has already been explored; therefore, in the present study, we investigated, for the first time, how cuprizone feeding affects the thymus, the organ of T-cell maturation and selection. We found that even one week of cuprizone treatment induced significant thymic atrophy, affecting the cortex over the medulla. Fluorescent microscopy and flow-cytometric analyses of thymi from cuprizone- and vehicle-treated mice indicated that eradication of the cluster of the differentiation-4 (CD4)-CD8 double-positive T-cell subset was behind the substantial cell loss. This result was confirmed with CD3-CD4-CD8 triplestaining experiments. Ultrastructurally, we observed degraded as well as enlarged mitochondria, myelin-bodies, large lipid droplets, and large lysosomes in the thymi of cuprizonetreated mice. Some of these features were similar to those in physiological and steroid-induced accelerated aging. According to our results, apoptosis was mainly of mitochondrial origin mediated by both caspase-3- and apoptosis inducing factor-mediated mechanisms. Additionally, mitogen activated protein kinase activation and increased pro-apoptotic B cell lymphoma-2 family protein expression were the major underlying processes. Our results do not indicate a functional relationship between cuprizone-induced thymus involution and the absence of inflammatory responses or the selective demyelination observed in the cuprizone model. On the other hand, due to the reversible nature of cuprizone's deleterious effects, the cuprizone model could be valuable in studying thymus regeneration as well as remyelination processes.	[Solti, Izabella; Veto, Sara; Gallyas, Ferenc, Jr.; Fekete, Katalin; Zalan, Petra; Bognar, Zita] Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary; [Kvell, Krisztian] Univ Pecs, Dept Pharmaceut Biotechnol, Pecs, Hungary; [Talaber, Gergely] Karolinska Inst, Novum, Dept Biosci & Nutr, Huddinge, Sweden; [Acs, Peter] Univ Pecs, Dept Neurol, Pecs, Hungary; [Gallyas, Ferenc, Jr.] MTA PTE Nucl Mitochondrial Res Grp, Pecs, Hungary; [Gallyas, Ferenc, Jr.] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Illes, Zsolt] Univ Southern Denmark, Odense Univ Hosp, Inst Clin Res, Dept Neurol, Odense, Denmark; [Szanto, Arpad] Univ Pecs, Dept Urol, Pecs, Hungary	University of Pecs; University of Pecs; Karolinska Institutet; University of Pecs; University of Pecs; University of Southern Denmark; Odense University Hospital; University of Pecs	Bognar, Z (corresponding author), Univ Pecs, Dept Biochem & Med Chem, Pecs, Hungary.	zita.bognar@aok.pte.hu	Gallyas, Ferenc/AAY-5343-2020; Gallyas, Ferenc/C-2272-2012	Gallyas, Ferenc/0000-0002-1906-4333; Illes, Zsolt/0000-0001-9655-0450; Kvell MD PhD dr. habil., Krisztian/0000-0001-8609-6274	Hungarian grants [OTKA NN109841, PTE AOK KA 2013/4]	Hungarian grants	This work was supported by Hungarian grants OTKA NN109841 (FG) and PTE AOK KA 2013/4 (ZB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs P, 2013, J NEUROIMMUNOL, V262, P128, DOI 10.1016/j.jneuroim.2013.06.012; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Benveniste EN, 1997, J MOL MED-JMM, V75, P165, DOI 10.1007/s001090050101; Costantino CM, 2008, J CLIN IMMUNOL, V28, P697, DOI 10.1007/s10875-008-9236-x; Emerson MR, 2001, J NEUROIMMUNOL, V119, P205, DOI 10.1016/S0165-5728(01)00394-0; Ghadially F N, 1997, Ultrastruct Pathol, V21, P475; Green DR, 2014, SCIENCE, V345, P1466, DOI 10.1126/science.1250256; GRILLOT DAM, 1995, J EXP MED, V182, P1973, DOI 10.1084/jem.182.6.1973; Herder V, 2012, J NEUROIMMUNOL, V244, P84, DOI 10.1016/j.jneuroim.2012.01.010; Hiremath MM, 2008, J NEUROIMMUNOL, V203, P23, DOI 10.1016/j.jneuroim.2008.06.034; Komoly Samuel, 2005, Ideggyogy Sz, V58, P40; Kutlesa S, 2002, J CELL SCI, V115, P4505, DOI 10.1242/jcs.00142; Kvell K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010701; Lassmann H, 2007, REV NEUROL-FRANCE, V163, P651, DOI 10.1016/S0035-3787(07)90474-9; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mana P, 2009, J NEUROIMMUNOL, V210, P13, DOI 10.1016/j.jneuroim.2009.02.013; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; Miloso M, 2008, CURR MED CHEM, V15, P538, DOI 10.2174/092986708783769731; Park HJ, 2013, TOXICOL IN VITRO, V27, P2233, DOI 10.1016/j.tiv.2013.09.014; Pasquini LA, 2007, NEUROCHEM RES, V32, P279, DOI 10.1007/s11064-006-9165-0; Pearse G, 2006, TOXICOL PATHOL, V34, P504, DOI 10.1080/01926230600865549; Peter A, 2012, IDEGGYOGY SZEMLE, V65, P266; Peterson P, 2008, NAT REV IMMUNOL, V8, P948, DOI 10.1038/nri2450; Procaccio V, 2014, REV NEUROL-FRANCE, V170, P390, DOI 10.1016/j.neurol.2014.03.005; Racz B, 2010, FREE RADICAL BIO MED, V49, P1978, DOI 10.1016/j.freeradbiomed.2010.09.026; Remington LT, 2007, AM J PATHOL, V170, P1713, DOI 10.2353/ajpath.2007.060783; Ruppert SM, 2012, BBA-MOL CELL RES, V1823, P1877, DOI 10.1016/j.bbamcr.2012.06.017; RUSSANOV EM, 1980, GEN PHARMACOL, V11, P535, DOI 10.1016/0306-3623(80)90086-5; Ryan JA, 2010, P NATL ACAD SCI USA, V107, P12895, DOI 10.1073/pnas.0914878107; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; Schmittgen TD, 2000, ANAL BIOCHEM, V285, P194, DOI 10.1006/abio.2000.4753; Smith ME, 2001, MICROSC RES TECHNIQ, V54, P81, DOI 10.1002/jemt.1123; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; SUZUKI K, 1969, SCIENCE, V163, P81, DOI 10.1126/science.163.3862.81; SUZUKI K, 1969, AM J PATHOL, V54, P307; Talaber G, 2011, REJUV RES, V14, P241, DOI 10.1089/rej.2010.1110; TANDLER B, 1973, J CELL BIOL, V56, P266, DOI 10.1083/jcb.56.1.266; Torkildsen O, 2008, ACTA NEUROL SCAND, V117, P72, DOI 10.1111/j.1600-0404.2008.01036.x; UTZ U, 1994, J NEUROPATH EXP NEUR, V53, P351, DOI 10.1097/00005072-199407000-00005; van der Star BJ, 2012, CNS NEUROL DISORD-DR, V11, P570, DOI 10.2174/187152712801661284; Venken K, 2010, TRENDS MOL MED, V16, P58, DOI 10.1016/j.molmed.2009.12.003; VENTURINI G, 1973, J NEUROCHEM, V21, P1147, DOI 10.1111/j.1471-4159.1973.tb07569.x; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Veto S, 2010, BRAIN, V133, P822, DOI 10.1093/brain/awp337; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Zhang LS, 2009, ACTA BIOCH BIOPH SIN, V41, P437, DOI 10.1093/abbs/gmp031	47	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129217	10.1371/journal.pone.0129217	http://dx.doi.org/10.1371/journal.pone.0129217			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053248	gold, Green Submitted, Green Published			2022-12-26	WOS:000355955300100
J	Yuan, ML; Zhang, QL; Wang, ZF; Guo, ZL; Bao, GS				Yuan, Ming-Long; Zhang, Qi-Lin; Wang, Zhao-Feng; Guo, Zhong-Long; Bao, Gen-Sheng			Molecular Phylogeny of Grassland Caterpillars (Lepidoptera: Lymantriinae: Gynaephora) Endemic to the Qinghai-Tibetan Plateau	PLOS ONE			English	Article							UPLIFT; CLOCK; DIVERSIFICATION; QUATERNARY; EVOLUTION; RADIATION; PLANTS; DIVERGENCE; GLACIATION; LIKELIHOOD	Gynaephora (Lepidoptera Erebidae: Lymantriinae) is a small genus, consisting of 15 nominated species, of which eight species are endemic to the Qinghai-Tibetan Plateau (QTP). In this study, we employed both mitochondrial and nuclear loci to infer a molecular phylogeny for the eight QTP Gynaephora spp. We used the phylogeny to estimate divergence dates in a molecular dating analysis and to delimit species. This information allowed us to investigate associations between the diversification history of the eight QTP species and geological and climatic events. Phylogenetic analyses indicated that the eight QTP species formed a monophyletic group with strong supports in both Bayesian and maximum likelihood analyses. The low K2P genetic distances between the eight QTP species suggested that diversification occurred relatively quickly and recently. Out of the eight species, five species were highly supported as monophyletic, which were also recovered by species delimitation analyses. Samples of the remaining three species (G. aureata, G. rouergensis, and G. minora) mixed together, suggesting that further studies using extensive population sampling and comprehensive morphological approaches are necessary to clarify their species status. Divergence time estimation results demonstrated that the diversification and speciation of Gynaephora on the QTP began during the late Miocene/early Pliocene and was potentially affected by the QTP uplift and associated climate changes during this time.	[Yuan, Ming-Long; Zhang, Qi-Lin; Wang, Zhao-Feng; Guo, Zhong-Long; Bao, Gen-Sheng] Lanzhou Univ, State Key Lab Grassland Agroecosyst, Coll Pastoral Agr Sci & Technol, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University	Yuan, ML (corresponding author), Lanzhou Univ, State Key Lab Grassland Agroecosyst, Coll Pastoral Agr Sci & Technol, Lanzhou 730000, Gansu, Peoples R China.	yuanml@lzu.edu.cn	Yuan, Ming-Long/Q-6798-2019	Yuan, Ming-Long/0000-0002-4078-8723; Zhang, Qi-Lin/0000-0002-7055-897X	National Natural Science Foundation of China [31201520]; Program for Changjiang Scholars and Innovative Research Team in University [IRT13019]; Fundamental Research Funds for the Central Universities [lzujbky-2012-91]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The study was funded in part by the National Natural Science Foundation of China (31201520), the Program for Changjiang Scholars and Innovative Research Team in University (IRT13019), and the Fundamental Research Funds for the Central Universities (lzujbky-2012-91). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; Chao C., 2003, FAUNA SINICA INSECTA, V30; Che J, 2010, P NATL ACAD SCI USA, V107, P13765, DOI 10.1073/pnas.1008415107; Chou I., 1979, Entomotaxonomia, V1, P23; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gao YD, 2013, MOL PHYLOGENET EVOL, V68, P443, DOI 10.1016/j.ympev.2013.04.026; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Grebennikov VV, 2014, ZOOTAXA, V3838, P151, DOI 10.11646/zootaxa.3838.2.1; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; He DK, 2004, CHINESE SCI BULL, V49, P39, DOI 10.1360/03wc0212; Ho SYW, 2014, MOL ECOL, V23, P5947, DOI 10.1111/mec.12953; Ho SYW, 2013, AUST J ENTOMOL, V52, P101, DOI 10.1111/aen.12018; Jia GD, 2003, GEOLOGY, V31, P1093, DOI 10.1130/G19992.1; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lartillot N, 2006, SYST BIOL, V55, P195, DOI 10.1080/10635150500433722; Lei FM, 2014, CURR ZOOL, V60, P149, DOI 10.1093/czoolo/60.2.149; Li J., 1995, UPLIFT QINGHAI XIZAN; Li JT, 2013, P NATL ACAD SCI USA, V110, P3441, DOI 10.1073/pnas.1300881110; LI JJ, 1991, QUATERNARY SCI REV, V10, P479, DOI 10.1016/0277-3791(91)90041-R; Li SG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070282, 10.1371/journal.pone.0070461]; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu JQ, 2014, J SYST EVOL, V52, P241, DOI 10.1111/jse.12094; Liu JQ, 2012, J SYST EVOL, V50, P267, DOI 10.1111/j.1759-6831.2012.00214.x; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031453; Liu ZK, 1994, J QINGHAI ANIMAL HUS, V11, P26; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Marques JF, 2014, EVOL ECOL, V28, P829, DOI 10.1007/s10682-014-9701-3; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; Miller M.A., 2010, P GAT COMP ENV WORKS; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Peng ZG, 2006, MOL PHYLOGENET EVOL, V39, P568, DOI 10.1016/j.ympev.2005.10.016; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Qi DL, 2006, BIOCHEM GENET, V44, P270, DOI 10.1007/s10528-006-9022-5; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; Sauquet H, 2013, CR PALEVOL, V12, P355, DOI 10.1016/j.crpv.2013.07.003; Shi Y.F., 1999, ACTA GEOGRAPH SIN, V54, P10, DOI DOI 10.1007/S11295-016-0968-0; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Toussaint EFA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041377; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Wahlberg N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080875; Wan T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-232; Wang BH, 1992, XIZANG INSECT FAUNA; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061827; Wang YJ, 2009, BIOL J LINN SOC, V97, P893, DOI 10.1111/j.1095-8312.2009.01225.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Wen J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00004; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yan F, 2013, MOL ECOL, V22, P1120, DOI 10.1111/mec.12153; Yan L, 2006, ANN ENTOMOL SOC AM, V99, P1012, DOI 10.1603/0013-8746(2006)99[1012:NOIASD]2.0.CO;2; Yan L., 2006, THESIS LANZHOU U LAN; Zahiri R, 2012, SYST ENTOMOL, V37, P102, DOI 10.1111/j.1365-3113.2011.00607.x; Zahiri R, 2013, ZOOL SCR, V42, P488, DOI 10.1111/zsc.12022; Zahiri R, 2013, CLADISTICS, V29, P337, DOI 10.1111/cla.12001; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zhang JQ, 2014, MOL PHYLOGENET EVOL, V77, P147, DOI 10.1016/j.ympev.2014.04.013; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; [张棋麟 Zhang Qilin], 2013, [草业科学, Pratacultural Science], V30, P638; Zhou SZ, 2006, QUATERN INT, V154, P44, DOI 10.1016/j.quaint.2006.02.002; Zhou WW, 2012, MOL ECOL, V21, P960, DOI 10.1111/j.1365-294X.2011.05411.x	74	13	14	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0127257	10.1371/journal.pone.0127257	http://dx.doi.org/10.1371/journal.pone.0127257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053874	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300015
J	Zhuang, QY; Wang, KC; Liu, S; Hou, GY; Jiang, WM; Wang, SC; Li, JP; Yu, JM; Chen, JM				Zhuang, Qing-Ye; Wang, Kai-Cheng; Liu, Shuo; Hou, Guang-Yu; Jiang, Wen-Ming; Wang, Su-Chun; Li, Jin-Ping; Yu, Jian-Min; Chen, Ji-Ming			Genomic Analysis and Surveillance of the Coronavirus Dominant in Ducks in China	PLOS ONE			English	Article							IDENTIFICATION; RECOMBINATION; SEQUENCES	The genetic diversity, evolution, distribution, and taxonomy of some coronaviruses dominant in birds other than chickens remain enigmatic. In this study we sequenced the genome of a newly identified coronavirus dominant in ducks (DdCoV), and performed a large-scale surveillance of coronaviruses in chickens and ducks using a conserved RT-PCR assay. The viral genome harbors a tandem repeat which is rare in vertebrate RNA viruses. The repeat is homologous to some proteins of various cellular organisms, but its origin remains unknown. Many substitutions, insertions, deletions, and some frameshifts and recombination events have occurred in the genome of the DdCoV, as compared with the coronavirus dominant in chickens (CdCoV). The distances between DdCoV and CdCoV are large enough to separate them into different species within the genus Gammacoronavirus. Our surveillance demonstrated that DdCoVs and CdCoVs belong to different lineages and occupy different ecological niches, further supporting that they should be classified into different species. Our surveillance also demonstrated that DdCoVs and CdCoVs are prevalent in live poultry markets in some regions of China. In conclusion, this study shed novel insight into the genetic diversity, evolution, distribution, and taxonomy of the coronaviruses circulating in chickens and ducks.	[Zhuang, Qing-Ye; Wang, Kai-Cheng; Liu, Shuo; Hou, Guang-Yu; Jiang, Wen-Ming; Wang, Su-Chun; Li, Jin-Ping; Yu, Jian-Min; Chen, Ji-Ming] China Anim Hlth & Epidemiol Ctr, Qingdao 266032, Peoples R China	China Animal Health & Epidemiology Center	Chen, JM (corresponding author), China Anim Hlth & Epidemiol Ctr, Qingdao 266032, Peoples R China.	jmchen678@qq.com	Chen, Jiming/AAA-3575-2020; Chen, Ji-Ming/AHD-7398-2022	Chen, Jiming/0000-0003-3155-3145; Chen, Jiming/0000-0002-0404-0830	Avian Influenza Surveillance Program of Ministry of Agriculture; Sci-tech Basic Work Project of Ministry of Science and Technology in China [SQ2012FY3260033]	Avian Influenza Surveillance Program of Ministry of Agriculture; Sci-tech Basic Work Project of Ministry of Science and Technology in China	This work was supported by the Avian Influenza Surveillance Program of the Ministry of Agriculture, and the Sci-tech Basic Work Project of the Ministry of Science and Technology (SQ2012FY3260033) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Annan A, 2013, EMERG INFECT DIS, V19, P456, DOI 10.3201/eid1903.121503; Chen GQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072918; Cook JKA, 2012, AVIAN PATHOL, V41, P239, DOI 10.1080/03079457.2012.680432; Day JM, 2014, AVIAN DIS, V58, P313, DOI 10.1637/10674-092313-ResNote.1; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hofer U, 2013, NAT REV MICROBIOL, V11, P662, DOI 10.1038/nrmicro3125; Jiang WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052671; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Kim HR, 2014, J WILDLIFE DIS, V50, P964, DOI 10.7589/2013-11-298; King AMQ., 2012, VIRUS TAXONOMY, P806, DOI 10.1016/ B978-0-12-384684-6.00068-9; Li W.H., 1997, MOL EVOLUTION, P149, DOI [10.1371/journal.pone.0052671, DOI 10.1371/JOURNAL.PONE.0052671]; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Liu SW, 2005, J GEN VIROL, V86, P719, DOI 10.1099/vir.0.80546-0; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Mihindukulasuriya KA, 2008, J VIROL, V82, P5084, DOI 10.1128/JVI.02722-07; Muradrasoli S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013640; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SMITH JM, 1992, J MOL EVOL, V34, P126; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Woo PCY, 2006, J VIROL, V80, P7136, DOI 10.1128/JVI.00509-06; Woo PCY, 2014, J VIROL, V88, P1318, DOI 10.1128/JVI.02351-13; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	30	14	15	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129256	10.1371/journal.pone.0129256	http://dx.doi.org/10.1371/journal.pone.0129256			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053682	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300104
J	Adlowitz, DG; Barnard, J; Biear, JN; Cistrone, C; Owen, T; Wang, WS; Palanichamy, A; Ezealah, E; Campbell, D; Wei, CW; Looney, RJ; Sanz, I; Anolik, JH				Adlowitz, Diana G.; Barnard, Jennifer; Biear, Jamie N.; Cistrone, Christopher; Owen, Teresa; Wang, Wensheng; Palanichamy, Arumugam; Ezealah, Ezinma; Campbell, Debbie; Wei, Chungwen; Looney, R. John; Sanz, Inaki; Anolik, Jennifer H.			Expansion of Activated Peripheral Blood Memory B Cells in Rheumatoid Arthritis, Impact of B Cell Depletion Therapy, and Biomarkers of Response	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RITUXIMAB THERAPY; BONE-MARROW; SUBSETS; IDENTIFICATION; EXPRESSION; DISEASE; PREDICT; TISSUE	Although B cell depletion therapy (BCDT) is effective in a subset of rheumatoid arthritis (RA) patients, both mechanisms and biomarkers of response are poorly defined. Here we characterized abnormalities in B cell populations in RA and the impact of BCDT in order to elucidate B cell roles in the disease and response biomarkers. In active RA patients both CD27 + IgD-switched memory (SM) and CD27-IgD-double negative memory (DN) peripheral blood B cells contained significantly higher fractions of CD95+ and CD21-activated cells compared to healthy controls. After BCD the predominant B cell populations were memory, and residual memory B cells displayed a high fraction of CD21- and CD95+ compared to pre-depletion indicating some resistance of these activated populations to anti-CD20. The residual memory populations also expressed more Ki-67 compared to pre-treatment, suggesting homeostatic proliferation in the B cell depleted state. Biomarkers of clinical response included lower CD95+ activated memory B cells at depletion time points and a higher ratio of transitional B cells to memory at reconstitution. B cell function in terms of cytokine secretion was dependent on B cell subset and changed with BCD. Thus, SM B cells produced pro-inflammatory (TNF) over regulatory (IL10) cytokines as compared to naive/transitional. Notably, B cell TNF production decreased after BCDT and reconstitution compared to untreated RA. Our results support the hypothesis that the clinical and immunological outcome of BCDT depends on the relative balance of protective and pathogenic B cell subsets established after B cell depletion and repopulation.	[Adlowitz, Diana G.; Barnard, Jennifer; Biear, Jamie N.; Cistrone, Christopher; Owen, Teresa; Wang, Wensheng; Palanichamy, Arumugam; Ezealah, Ezinma; Campbell, Debbie; Looney, R. John; Anolik, Jennifer H.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Wei, Chungwen; Sanz, Inaki] Emory Univ, Dept Med, Atlanta, GA 30332 USA	University of Rochester; Emory University	Anolik, JH (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA.	Jennifer_anolik@urmc.rochester.edu	Cistrone, Christopher/AAG-9968-2020	Anolik, Jennifer/0000-0002-1450-1549	Autoimmunity Center of Excellence [R01 AI077674, P01 AI078907, U19 AI56390]; University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI056390, U19AI110483, P01AI078907, R01AI077674, R37AI049660] Funding Source: NIH RePORTER	Autoimmunity Center of Excellence; University of Rochester; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants R01 AI077674 (JA), P01 AI078907 (IS, JA, RJL), and U19 AI56390 Autoimmunity Center of Excellence (IS, RJL, JA) and internal funds from the University of Rochester (JA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloisi F, 2006, NAT REV IMMUNOL, V6, P205, DOI 10.1038/nri1786; Anolik JH, 2007, ARTHRITIS RHEUM, V56, P3044, DOI 10.1002/art.22810; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Bohnhorst JO, 2001, J IMMUNOL, V167, P3610, DOI 10.4049/jimmunol.167.7.3610; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Chatzidionysiou K, 2011, ANN RHEUM DIS, V70, P1575, DOI 10.1136/ard.2010.148759; Cuss AK, 2006, J IMMUNOL, V176, P1506, DOI 10.4049/jimmunol.176.3.1506; Daridon C, 2007, AUTOIMMUN REV, V6, P427, DOI 10.1016/j.autrev.2007.01.010; Dass S, 2008, ARTHRITIS RHEUM-US, V58, P2993, DOI 10.1002/art.23902; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; Edwards JCW, 2001, RHEUMATOLOGY, V40, P205, DOI 10.1093/rheumatology/40.2.205; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; Evans JG, 2007, J IMMUNOL, V178, P7868, DOI 10.4049/jimmunol.178.12.7868; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Fu YX, 1998, J EXP MED, V187, P1009, DOI 10.1084/jem.187.7.1009; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Illges H, 2000, CLIN EXP IMMUNOL, V122, P270, DOI 10.1046/j.1365-2249.2000.01379.x; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Kavanaugh A, 2008, ANN RHEUM DIS, V67, P402, DOI 10.1136/ard.2007.074229; Lal P, 2011, ARTHRITIS RHEUM-US, V63, P3681, DOI 10.1002/art.30596; Langkjaer A, 2012, CLIN IMMUNOL, V145, P1, DOI 10.1016/j.clim.2012.07.004; Leandro MJ, 2006, ARTHRITIS RHEUM-US, V54, P613, DOI 10.1002/art.21617; Linton PJ, 2000, J IMMUNOL, V165, P5558, DOI 10.4049/jimmunol.165.10.5558; Machold KP, 2007, RHEUMATOLOGY, V46, P342, DOI 10.1093/rheumatology/kel237; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moulin V, 2000, J EXP MED, V192, P475, DOI 10.1084/jem.192.4.475; Nakou M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2798; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Owczarczyk K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002432; Palanichamy A, 2009, J IMMUNOL, V182, P5982, DOI 10.4049/jimmunol.0801859; PASCUAL V, 1994, J EXP MED, V180, P329, DOI 10.1084/jem.180.1.329; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Rehnberg M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2789; Roll P, 2008, ARTHRITIS RHEUM-US, V58, P1566, DOI 10.1002/art.23473; Sellam J, 2011, ARTHRITIS RHEUM-US, V63, P3692, DOI 10.1002/art.30599; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Skok J, 1999, J IMMUNOL, V163, P4284; SMELAND EB, 1989, J EXP MED, V170, P1463, DOI 10.1084/jem.170.4.1463; Souto-Carneiro MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2718; SUNG SSJ, 1988, J EXP MED, V168, P1539, DOI 10.1084/jem.168.5.1539; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Thurlings RM, 2008, ANN RHEUM DIS, V67, P917, DOI 10.1136/ard.2007.080960; Turesson C, 1999, RHEUMATOLOGY, V38, P668, DOI 10.1093/rheumatology/38.7.668; Vital EM, 2015, ANN RHEUM DIS, V74, P1195, DOI 10.1136/annrheumdis-2013-204544; Vital EM, 2011, ARTHRITIS RHEUM-US, V63, P3038, DOI 10.1002/art.30466; Wei CW, 2011, CYTOM PART A, V79A, P894, DOI 10.1002/cyto.a.21112; Weyand CM, 2003, ANN NY ACAD SCI, V987, P140, DOI 10.1111/j.1749-6632.2003.tb06042.x; Wirths S, 2005, EUR J IMMUNOL, V35, P3433, DOI 10.1002/eji.200535364; Yanaba K, 2008, IMMUNITY, V28, P639, DOI 10.1016/j.immuni.2008.03.017	54	87	89	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128269	10.1371/journal.pone.0128269	http://dx.doi.org/10.1371/journal.pone.0128269			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047509	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200052
J	Higuchi, Y; Kojima, M; Ishii, G; Aoyagi, K; Sasaki, H; Ochiai, A				Higuchi, Youichi; Kojima, Motohiro; Ishii, Genichiro; Aoyagi, Kazuhiko; Sasaki, Hiroki; Ochiai, Atsushi			Gastrointestinal Fibroblasts Have Specialized, Diverse Transcriptional Phenotypes: A Comprehensive Gene Expression Analysis of Human Fibroblasts	PLOS ONE			English	Article							HUMAN PERITONEAL FIBROBLASTS; SMOOTH-MUSCLE-CELLS; LIVER FIBROSIS; STROMAL CELLS; STEM-CELLS; CANCER; CYTOKINES; TISSUE; BETA; MYOFIBROBLASTS	Background Fibroblasts are the principal stromal cells that exist in whole organs and play vital roles in many biological processes. Although the functional diversity of fibroblasts has been estimated, a comprehensive analysis of fibroblasts from the whole body has not been performed and their transcriptional diversity has not been sufficiently explored. The aim of this study was to elucidate the transcriptional diversity of human fibroblasts within the whole body. Methods Global gene expression analysis was performed on 63 human primary fibroblasts from 13 organs. Of these, 32 fibroblasts from gastrointestinal organs (gastrointestinal fibroblasts: GIFs) were obtained from a pair of 2 anatomical sites: the submucosal layer (submucosal fibroblasts: SMFs) and the subperitoneal layer (subperitoneal fibroblasts: SPFs). Using hierarchical clustering analysis, we elucidated identifiable subgroups of fibroblasts and analyzed the transcriptional character of each subgroup. Results In unsupervised clustering, 2 major clusters that separate GIFs and non-GIFs were observed. Organ-and anatomical site-dependent clusters within GIFs were also observed. The signature genes that discriminated GIFs from non-GIFs, SMFs from SPFs, and the fibroblasts of one organ from another organ consisted of genes associated with transcriptional regulation, signaling ligands, and extracellular matrix remodeling. Conclusions GIFs are characteristic fibroblasts with specific gene expressions from transcriptional regulation, signaling ligands, and extracellular matrix remodeling related genes. In addition, the anatomical site- and organ-dependent diversity of GIFs was also discovered. These features of GIFs contribute to their specific physiological function and homeostatic maintenance, and create a functional diversity of the gastrointestinal tract.	[Higuchi, Youichi; Ochiai, Atsushi] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Canc Biol Lab, Kashiwa, Chiba, Japan; [Kojima, Motohiro; Ishii, Genichiro; Ochiai, Atsushi] Natl Canc Ctr Hosp East, Res Ctr Innovat Oncol, Div Pathol, Kashiwa, Chiba, Japan; [Aoyagi, Kazuhiko; Sasaki, Hiroki] Natl Canc Ctr, Res Inst, Div Genet, Chuo Ku, Tokyo 104, Japan	University of Tokyo; National Cancer Center - Japan; National Cancer Center - Japan	Ochiai, A (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Canc Biol Lab, Kashiwa, Chiba, Japan.	aochiai@east.ncc.go.jp			Health and Labour Sciences Research Grants (Ministry of Health, Labour and Welfare) [26270601]; 3rd-term Comprehensive 10-year Strategy for Cancer Control (Ministry of Health, Labour and Welfare) [23-A-3]	Health and Labour Sciences Research Grants (Ministry of Health, Labour and Welfare); 3rd-term Comprehensive 10-year Strategy for Cancer Control (Ministry of Health, Labour and Welfare)	This work was supported by: Health and Labour Sciences Research Grants grant number 26270601 (Ministry of Health, Labour and Welfare, [http://www.mhlw.go.jp/: MK]) and a grant of a 3rd-term Comprehensive 10-year Strategy for Cancer Control grant number 23-A-3 (Ministry of Health, Labour and Welfare, [http://www.mhlw.go.jp/: AO]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa M, 2012, PANCREAS, V41, P512, DOI 10.1097/MPA.0b013e31823ca3e0; Balabanova S, 2014, CARCINOGENESIS, V35, P1798, DOI 10.1093/carcin/bgu086; BALLARDINI G, 1988, VIRCHOWS ARCH B, V56, P45, DOI 10.1007/BF02890000; Bauer M, 2010, ONCOGENE, V29, P1732, DOI 10.1038/onc.2009.463; Beswick EJ, 2014, J IMMUNOL, V193, P2218, DOI 10.4049/jimmunol.1203441; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; Darryl C, 2006, HISTOLOGY PATHOLOGIS, V3rd, P547; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Garcia-Arraras JE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-61; Gimenez-Bastida JA, 2009, J AGR FOOD CHEM, V57, P9305, DOI 10.1021/jf901983g; Gottschling S, 2013, LUNG CANCER, V80, P19, DOI 10.1016/j.lungcan.2012.12.015; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hoshino A, 2008, BIOCHEM BIOPH RES CO, V368, P305, DOI 10.1016/j.bbrc.2008.01.090; Janson DG, 2012, J INVEST DERMATOL, V132, P2565, DOI 10.1038/jid.2012.192; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kawazoe Y, 2002, DEV GROWTH DIFFER, V44, P77; KAYE GI, 1968, GASTROENTEROLOGY, V54, P852; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kojima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088018; Kurashima Y, 2014, IMMUNITY, V40, P530, DOI 10.1016/j.immuni.2014.01.014; Mclin VA, 2009, GASTROENTEROLOGY, V136, P2074, DOI 10.1053/j.gastro.2009.03.001; Miyoshi H, 2012, SCIENCE, V338, P108, DOI 10.1126/science.1223821; Nair DG, 2014, J CELL MOL MED, V18, P444, DOI 10.1111/jcmm.12193; Pabst O, 1999, DEVELOPMENT, V126, P2215; Peng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059348; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rinn JL, 2008, GENE DEV, V22, P303, DOI 10.1101/gad.1610508; Rinn JL, 2006, PLOS GENET, V2, P1084, DOI 10.1371/journal.pgen.0020119; Takashima S, 2013, DEV GENES EVOL, V223, P85, DOI 10.1007/s00427-012-0422-8; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Wilm B, 2005, DEVELOPMENT, V132, P5317, DOI 10.1242/dev.02141; Witowski J, 2001, AM J PATHOL, V158, P1441, DOI 10.1016/S0002-9440(10)64095-3; Witowski J, 2006, PERITON DIALYSIS INT, V26, P292; Witowski J, 2009, LAB INVEST, V89, P414, DOI 10.1038/labinvest.2009.1; Yamaguchi Y, 1999, J INVEST DERMATOL, V112, P483, DOI 10.1046/j.1523-1747.1999.00544.x	43	28	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129241	10.1371/journal.pone.0129241	http://dx.doi.org/10.1371/journal.pone.0129241			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046848	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200137
J	Mancini, E; Spinaci, MI; Gordicho, V; Caputo, B; Pombi, M; Vicente, JL; Dinis, J; Rodrigues, A; Petrarca, V; Weetman, D; Pinto, J; della Torre, A				Mancini, Emiliano; Spinaci, Maria Ida; Gordicho, Vasco; Caputo, Beniamino; Pombi, Marco; Vicente, Jose Luis; Dinis, Joao; Rodrigues, Amabelia; Petrarca, Vincenzo; Weetman, David; Pinto, Joao; della Torre, Alessandra			Adaptive Potential of Hybridization among Malaria Vectors: Introgression at the Immune Locus TEP1 between Anopheles coluzzii and A. gambiae in 'Far-West' Africa	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; MOLECULAR-FORMS; S FORMS; INCIPIENT SPECIATION; GENOMIC DIVERGENCE; RESISTANCE; S.S.; DIFFERENTIATION; SOFTWARE; ISLANDS	"Far-West" Africa is known to be a secondary contact zone between the two majormalaria vectors Anopheles coluzzii and A. gambiae. We investigated gene-flow and potentially adaptive introgression between these species along a west-to-east transect in Guinea Bissau, the putative core of this hybrid zone. To evaluate the extent and direction of gene flow, we geno-typed site 702 in Intron-1 of the para Voltage-Gated Sodium Channel gene, a species-diagnostic nucleotide position throughout most of A. coluzzii and A. gambiae sympatric range. We also analyzed polymorphismin the thioester-binding domain (TED) of the innate immunity-linked thioester-containing protein 1 (TEP1) to investigate whether elevated hybridization might facilitate the exchange of variants linked to adaptive immunity and Plasmodium refractoriness. Our results confirm asymmetric introgression of genetic material from A. coluzzii to A. gambiae and disruption of linkage between the centromeric "genomic islands" of inter-specific divergence. We report that A. gambiae from the Guinean hybrid zone possesses an introgressed TEP1 resistant allelic class, found exclusively in A. coluzzii elsewhere and apparently swept to fixation in West Africa (i.e. Mali and Burkina Faso). However, no detectable fixation of this allele was found in Guinea Bissau, which may suggest that ecological pressures driving segregation between the two species in larval habitats in this region may be different from those experienced in northern and more arid parts of the species' range. Finally, our results also suggest a genetic subdivision between coastal and inland A. gambiae Guinean populations and provide clues on the importance of ecological factors in intra-specific differentiation processes.	[Mancini, Emiliano; Spinaci, Maria Ida; Caputo, Beniamino; Pombi, Marco; della Torre, Alessandra] Univ Roma La Sapienza, Dipartimento Sanita Pubbl & Malattie Infett, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Gordicho, Vasco; Vicente, Jose Luis; Pinto, Joao] Univ Nova Lisboa, Inst Higiene & Med Trop, UEI Parasitol Med, P-1200 Lisbon, Portugal; [Gordicho, Vasco; Vicente, Jose Luis; Pinto, Joao] Univ Nova Lisboa, Inst Higiene & Med Trop, Ctr Malaria & Outras Doencas Trop, P-1200 Lisbon, Portugal; [Dinis, Joao; Rodrigues, Amabelia] Inst Nacl Saude Publ, Bissau, Guinea Bissau; [Petrarca, Vincenzo] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol C Darwin, I-00185 Rome, Italy; [Weetman, David] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England	Fondazione Cenci Bolognetti; Sapienza University Rome; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Sapienza University Rome; Liverpool School of Tropical Medicine; University of Liverpool	Mancini, E (corresponding author), Univ Rome Tre, Dipartimento Sci, I-00146 Rome, Italy.	emiliano.mancini@uniroma3.it	Caputo, Beniamino/I-2880-2015; Pombi, Marco/AAD-6525-2022; J., Pinto/H-6177-2019; Pinto, Joao/C-2208-2012; Weetman, David/M-1261-2014	Caputo, Beniamino/0000-0002-5650-8773; Pombi, Marco/0000-0002-4382-9922; J., Pinto/0000-0001-8572-7708; Pinto, Joao/0000-0001-8572-7708; Weetman, David/0000-0002-5820-1388; MANCINI, Emiliano/0000-0002-7988-4544	European Union's INFRAVEC project (under FP7 program) [228421]; FCT Portugal/FEDER (through program COMPETE) [PTDC/BIA-EVF/120407/2010]; Sapienza' Universita di Roma; MIUR-FIRB "Futuro in Ricerca" grant [RBFR106NTE]	European Union's INFRAVEC project (under FP7 program); FCT Portugal/FEDER (through program COMPETE); Sapienza' Universita di Roma; MIUR-FIRB "Futuro in Ricerca" grant(Ministry of Education, Universities and Research (MIUR))	This work was supported by the European Union's INFRAVEC project (Grant agreement no. 228421, under FP7 program) to AdT and JP; FCT Portugal/FEDER (through program COMPETE) cofunds (PTDC/BIA-EVF/120407/2010); AWARD 2013 grant by 'Sapienza' Universita di Roma to AdT, MIUR-FIRB "Futuro in Ricerca 2010" grant to BC (Grant No RBFR106NTE).	Abbott R, 2005, J EVOLUTION BIOL, V26, P229; [Anonymous], 1987, PUBLICATIONS S AFRIC; [Anonymous], 1968, PUBLICATIONS S AFRIC; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Blandin SA, 2009, SCIENCE, V326, P147, DOI 10.1126/science.1175241; Caputo B, 2014, MOL ECOL, V23, P4574, DOI 10.1111/mec.12866; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Cassone BJ, 2014, MOL ECOL, V23, P2242, DOI 10.1111/mec.12733; Clarkson CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5248; Coetzee M, 2013, ZOOTAXA, V3619, P246, DOI 10.11646/zootaxa.3619.3.2; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Diabate A, 2009, P ROY SOC B-BIOL SCI, V276, P4215, DOI 10.1098/rspb.2009.1167; Etang J, 2009, MOL ECOL, V18, P3076, DOI 10.1111/j.1365-294X.2009.04256.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gentile G, 2004, INSECT MOL BIOL, V13, P371, DOI 10.1111/j.0962-1075.2004.00494.x; Gimonneau G, 2012, MED VET ENTOMOL, V26, P9, DOI 10.1111/j.1365-2915.2011.00957.x; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Hervy JP, 1998, DIDACTIQUES; Kamdem C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031843; Kangah PAD, 2010, RAINFALL AGR CENTRAL; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Le BV, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002958; Lee Y, 2014, MOL ECOL RESOUR, V14, P297, DOI 10.1111/1755-0998.12181; Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebmann B, 2012, J CLIMATE, V25, P4304, DOI 10.1175/JCLI-D-11-00157.1; Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Nwakanma DC, 2013, GENETICS, V193, P1221, DOI 10.1534/genetics.112.148718; Obbard DJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-274; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pennetier C, 2010, CURR BIOL, V20, P131, DOI 10.1016/j.cub.2009.11.040; PETRARCA V, 1983, Parassitologia (Rome), V25, P29; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Reidenbach KR, 2012, GENOME BIOL EVOL, V4, P1202, DOI 10.1093/gbe/evs095; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santolamazza F, 2015, MALARIA J, V14, DOI 10.1186/s12936-014-0522-1; Santolamazza F, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-215; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Staden R, 2000, Methods Mol Biol, V132, P115; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Weetman D, 2012, MOL BIOL EVOL, V29, P279, DOI 10.1093/molbev/msr199; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White BJ, 2011, P NATL ACAD SCI USA, V108, P244, DOI 10.1073/pnas.1013648108; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Wilkins EE, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-125	50	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127804	10.1371/journal.pone.0127804	http://dx.doi.org/10.1371/journal.pone.0127804			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047479	gold, Green Published, Green Accepted			2022-12-26	WOS:000355652200031
J	Moccia, M; Liu, QS; Guida, T; Federico, G; Brescia, A; Zhao, Z; Choi, HG; Deng, XM; Tan, L; Wang, JH; Billaud, M; Gray, NS; Carlomagno, F; Santoro, M				Moccia, Marialuisa; Liu, Qingsong; Guida, Teresa; Federico, Giorgia; Brescia, Annalisa; Zhao, Zheng; Choi, Hwan Geun; Deng, Xianming; Tan, Li; Wang, Jinhua; Billaud, Marc; Gray, Nathanael S.; Carlomagno, Francesca; Santoro, Massimo			Identification of Novel Small Molecule Inhibitors of Oncogenic RET Kinase	PLOS ONE			English	Article							MEDULLARY-THYROID CANCER; CARCINOMA CELL-LINE; LUNG-CANCER; PONATINIB AP24534; POTENT INHIBITOR; GENE FUSION; BCR-ABL; MUTATIONS; RESISTANCE; ADENOCARCINOMA	Oncogenic mutation of the RET receptor tyrosine kinase is observed in several human malignancies. Here, we describe three novel type II RET tyrosine kinase inhibitors (TKI), ALW-II- 41-27, XMD15-44 and HG-6-63-01, that inhibit the cellular activity of oncogenic RET mutants at two digit nanomolar concentration. These three compounds shared a 3-trifluoro-methyl-4-methylpiperazinephenyl pharmacophore that stabilizes the 'DFG-out' inactive conformation of RET activation loop. They blocked RET-mediated signaling and proliferation with an IC50 in the nM range in fibroblasts transformed by the RET/C634R and RET/M918T oncogenes. They also inhibited autophosphorylation of several additional oncogenic RET-derived point mutants and chimeric oncogenes. At a concentration of 10 nM, ALW-II- 41-27, XMD15-44 and HG-6-63-01 inhibited RET kinase and signaling in human thyroid cancer cell lines carrying oncogenic RET alleles; they also inhibited proliferation of cancer, but not non-tumoral Nthy-ori-3-1, thyroid cells, with an IC50 in the nM range. The three compounds were capable of inhibiting the 'gatekeeper' V804M mutant which confers substantial resistance to established RET inhibitors. In conclusion, we have identified a type II TKI scaffold, shared by ALW-II-41-27, XMD15-44 and HG-6-63-01, that may be used as novel lead for the development of novel agents for the treatment of cancers harboring oncogenic activation of RET.	[Moccia, Marialuisa; Guida, Teresa; Federico, Giorgia; Brescia, Annalisa; Carlomagno, Francesca; Santoro, Massimo] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Moccia, Marialuisa; Guida, Teresa; Federico, Giorgia; Brescia, Annalisa; Carlomagno, Francesca; Santoro, Massimo] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Liu, Qingsong; Choi, Hwan Geun; Deng, Xianming; Tan, Li; Wang, Jinhua; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Qingsong; Choi, Hwan Geun; Deng, Xianming; Tan, Li; Wang, Jinhua; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Zhao, Zheng] Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China; [Billaud, Marc] CRI INSERM UJF U823, Inst Albert Bonniot, La Tronche, France	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Santoro, M (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.	masantor@unina.it	刘, 青松/AEM-1932-2022; Liu, Qingsong/AFS-0714-2022	刘, 青松/0000-0002-7829-2547; Liu, Qingsong/0000-0002-7829-2547; Federico, Giorgia/0000-0001-9420-6699; Tan, Li/0000-0002-1199-9046; Deng, Xianming/0000-0002-9354-5864	Italian Association for Cancer Research (AIRC); FIRB Merit grant of MIUR; NIH grant [R01 CA172592]; NATIONAL CANCER INSTITUTE [R01CA172592] Funding Source: NIH RePORTER	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); FIRB Merit grant of MIUR(Ministry of Education, Universities and Research (MIUR)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support was provided by the Italian Association for Cancer Research (AIRC) and FIRB Merit grant of MIUR to MS, and NIH grant R01 CA172592 to NSG.	Arnato KR, 2014, J CLIN INVEST, V124, P2037, DOI 10.1172/JCI72522; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ballerini P, 2012, LEUKEMIA, V26, P2384, DOI 10.1038/leu.2012.109; Bossi D, 2014, MOL ONCOL, V8, P221, DOI 10.1016/j.molonc.2013.11.004; CARLOMAGNO F, 1995, BIOCHEM BIOPH RES CO, V207, P1022, DOI 10.1006/bbrc.1995.1287; Carlomagno F, 2002, CANCER RES, V62, P7284; Carlomagno F, 2004, ONCOGENE, V23, P6056, DOI 10.1038/sj.onc.1207810; Carlomagno F, 2009, ENDOCR-RELAT CANCER, V16, P233, DOI 10.1677/ERC-08-0213; Choi Y, 2009, BIOORG MED CHEM LETT, V19, P4467, DOI 10.1016/j.bmcl.2009.05.029; De Falco V, 2013, J CLIN ENDOCR METAB, V98, pE811, DOI 10.1210/jc.2012-2672; de Groot JWB, 2006, ENDOCR REV, V27, P535, DOI 10.1210/er.2006-0017; Deng XM, 2010, BIOORG MED CHEM LETT, V20, P4196, DOI 10.1016/j.bmcl.2010.05.043; Elisei R, 2013, J CLIN ONCOL, V31, P3639, DOI 10.1200/JCO.2012.48.4659; Gild ML, 2011, NAT REV ENDOCRINOL, V7, P617, DOI 10.1038/nrendo.2011.141; ISHIZAKA Y, 1990, BIOCHEM BIOPH RES CO, V168, P402, DOI 10.1016/0006-291X(90)92335-W; Ju YS, 2012, GENOME RES, V22, P436, DOI 10.1101/gr.133645.111; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Li F, 2012, CELL RES, V22, P928, DOI 10.1038/cr.2012.27; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; Mologni L, 2013, MOL CELL ENDOCRINOL, V377, P1, DOI 10.1016/j.mce.2013.06.025; Mulligan LM, 2014, NAT REV CANCER, V14, P173, DOI 10.1038/nrc3680; O'Hare T, 2006, CURR OPIN GENET DEV, V16, P92, DOI 10.1016/j.gde.2005.11.002; Okram B, 2006, CHEM BIOL, V13, P779, DOI 10.1016/j.chembiol.2006.05.015; Pasini A, 1997, ONCOGENE, V15, P393, DOI 10.1038/sj.onc.1201199; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Santoro M, 2006, NAT CLIN PRACT ENDOC, V2, P42, DOI 10.1038/ncpendmet0073; SANTORO M, 1995, SCIENCE, V267, P381, DOI 10.1126/science.7824936; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Vitagliano D, 2011, ENDOCR-RELAT CANCER, V18, P1, DOI 10.1677/ERC-09-0292; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Wells SA, 2009, CLIN CANCER RES, V15, P7119, DOI 10.1158/1078-0432.CCR-08-2742; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhou TJ, 2011, CHEM BIOL DRUG DES, V77, P1, DOI 10.1111/j.1747-0285.2010.01054.x	36	17	18	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128364	10.1371/journal.pone.0128364	http://dx.doi.org/10.1371/journal.pone.0128364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046350	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200063
J	Zannin, E; Pellegrino, R; Di Toro, A; Antonelli, A; Dellaca, RL; Bernardi, L				Zannin, Emanuela; Pellegrino, Riccardo; Di Toro, Alessandro; Antonelli, Andrea; Dellaca, Raffaele L.; Bernardi, Luciano			Parasympathetic Stimuli on Bronchial and Cardiovascular Systems in Humans	PLOS ONE			English	Article							AIRWAY SMOOTH-MUSCLE; ARTERIAL BAROREFLEX SENSITIVITY; EXPIRATORY FLOW LIMITATION; HEART-RATE-VARIABILITY; REFLEX REGULATION; BLOOD-PRESSURE; OXYGEN; COPD; PATHWAYS; EXERCISE	Background It is not known whether parasympathetic outflow simultaneously acts on bronchial tone and cardiovascular system waxing and waning both systems in parallel, or, alternatively, whether the regulation is more dependent on local factors and therefore independent on each system. The aim of this study was to evaluate the simultaneous effect of different kinds of stimulations, all associated with parasympathetic activation, on bronchomotor tone and cardiovascular autonomic regulation. Methods Respiratory system resistance (Rrs, forced oscillation technique) and cardio-vascular activity (heart rate, oxygen saturation, tissue oxygenation index, blood pressure) were assessed in 13 volunteers at baseline and during a series of parasympathetic stimuli: O-2 inhalation, stimulation of the carotid sinus baroreceptors by neck suction, slow breathing, and inhalation of methacholine. Results Pure cholinergic stimuli, like O-2 inhalation and baroreceptors stimulation, caused an increase in Rrs and a reduction in heart rate and blood pressure. Slow breathing led to bradycardia and hypotension, without significant changes in Rrs. However slow breathing was associated with deep inhalations, and Rrs evaluated at the baseline lung volumes was significantly increased, suggesting that the large tidal volumes reversed the airways narrowing effect of parasympathetic activation. Finally inhaled methacholine caused marked airway narrowing, while the cardiovascular variables were unaffected, presumably because of the sympathetic activity triggered in response to hypoxemia. Conclusions All parasympathetic stimuli affected bronchial tone and moderately affected also the cardiovascular system. However the response differed depending on the nature of the stimulus. Slow breathing was associated with large tidal volumes that reversed the airways narrowing effect of parasympathetic activation.	[Zannin, Emanuela; Dellaca, Raffaele L.] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy; [Pellegrino, Riccardo; Antonelli, Andrea] ASO S Croce & Carle, Allergol & Fisiopatol Resp, Cuneo, Italy; [Di Toro, Alessandro] Univ Pavia, Dipartimento Med Interna, I-27100 Pavia, Italy; [Di Toro, Alessandro] IRCCS, Policlin S Matteo, Pavia, Italy; [Bernardi, Luciano] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Biomed Helsinki, Helsinki, Finland	Polytechnic University of Milan; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia; Folkhalsan Research Center; University of Helsinki	Zannin, E (corresponding author), Politecn Milan, Dipartimento Elettron Informaz & Bioingn, I-20133 Milan, Italy.	emanuela.zannin@gmail.com	Pellegrino, Riccardo/AAA-1667-2022; Dellaca', Raffaele/AAF-7078-2019; Di Toro, Alessandro/AAC-3139-2021	Dellaca', Raffaele/0000-0002-3672-4591; Di Toro, Alessandro/0000-0001-7625-1103	Signe and Ane Gyllenberg Foundation (Helsinki, Finland)	Signe and Ane Gyllenberg Foundation (Helsinki, Finland)	LB is recipient of a grant from the Signe and Ane Gyllenberg Foundation (Helsinki, Finland).	Bartels MN, 2000, CHEST, V118, P691, DOI 10.1378/chest.118.3.691; Belmonte Kristen E, 2005, Proc Am Thorac Soc, V2, P297, DOI 10.1513/pats.200504-043SR; BENICHOU M, 1990, J APPL PHYSIOL, V68, P1634, DOI 10.1152/jappl.1990.68.4.1634; Bernardi L, 1998, LANCET, V351, P1308, DOI 10.1016/S0140-6736(97)10341-5; Bernardi L, 2011, DIABETOLOGIA, V54, P2164, DOI 10.1007/s00125-011-2195-4; Bernardi L, 2002, CIRCULATION, V105, P143, DOI 10.1161/hc0202.103311; BERNARDI L, 1995, CIRCULATION, V92, P2895, DOI 10.1161/01.CIR.92.10.2895; Bernardi L, 1998, CIRCULATION, V97, P1368, DOI 10.1161/01.CIR.97.14.1368; Bernardi L, 2001, J HYPERTENS, V19, P2221, DOI 10.1097/00004872-200112000-00016; Bernardi L, 2010, CLIN AUTON RES, V20, P353, DOI 10.1007/s10286-010-0079-1; BERTINIERI G, 1985, J HYPERTENS, V3, pS79; Brown CM, 2002, CLIN SCI, V102, P623, DOI 10.1042/CS20010242; Budzinska K, 2008, J PHYSIOL PHARMACOL, V59, P163; Canning BJ, 2001, RESP PHYSIOL, V125, P113, DOI 10.1016/S0034-5687(00)00208-5; Canning BJ, 2006, J APPL PHYSIOL, V101, P971, DOI 10.1152/japplphysiol.00313.2006; Coleridge H.M., 1986, HDB PHYSL, P395, DOI [10.1002/cphy.cp030212, DOI 10.1002/CPHY.CP030212]; COLERIDGE HM, 1989, PHARMACOL THERAPEUT, V42, P1, DOI 10.1016/0163-7258(89)90021-1; Dean JB, 2004, J APPL PHYSIOL, V96, P784, DOI 10.1152/japplphysiol.00892.2003; Dellaca RL, 2009, EUR RESPIR J, V33, P1329, DOI 10.1183/09031936.00139608; Dellaca RL, 2004, EUR RESPIR J, V23, P232, DOI 10.1183/09031936.04.00046804; Furlan R, 2003, CIRCULATION, V108, P717, DOI 10.1161/01.CIR.0000084540.91605.0C; Gobbi A, 2009, INTERNATIONAL CONFERENCE ON EHEALTH, TELEMEDICINE, AND SOCIAL MEDICINE: ETELEMED 2009, PROCEEDINGS, P117, DOI 10.1109/eTELEMED.2009.18; Hautala AJ, 2009, NEUROSCI BIOBEHAV R, V33, P107, DOI 10.1016/j.neubiorev.2008.04.009; HUGHES JMB, 1972, J APPL PHYSIOL, V32, P25, DOI 10.1152/jappl.1972.32.1.25; Iellamo F, 2000, CIRCULATION, V102, P2588; Joseph CN, 2005, HYPERTENSION, V46, P714, DOI 10.1161/01.HYP.0000179581.68566.7d; Kaczka DW, ANN BIOMED ENG, V23, P135; Kaczka DW, ANN BIOMED ENG, V27, P340; KARLSSON JA, 1988, J APPL PHYSIOL, V65, P1007, DOI 10.1152/jappl.1988.65.3.1007; Keyl C, 2002, ANESTH ANALG, V95, P1629, DOI 10.1097/00000539-200212000-00029; Krishna BH, 2014, J CLIN DIAGN RES, V8, P14, DOI [10.7860/JCDR/20147784.3983, 10.7860/JCDR/2014/7844.3983]; Lund VE, 1999, ACTA PHYSIOL SCAND, V167, P29; Marczak M, 2004, J PHYSIOL PHARMACOL, V55, P127; MOLFINO NA, 1993, AM REV RESPIR DIS, V148, P1238, DOI 10.1164/ajrccm/148.5.1238; Muralikrishnan Krishnan, 2012, J Ayurveda Integr Med, V3, P91, DOI 10.4103/0975-9476.96528; NAVAJAS D, 1999, EUR RESP MON, V12, P112; Pellegrino R, 1998, EUR RESPIR J, V12, P1219, DOI 10.1183/0903.1936.98.12051219; Peslin R., 1986, HDB PHYSL 3, VIII, P145, DOI [10.1002/cphy.cp030311, DOI 10.1002/CPHY.CP030311]; Piepoli M, 1997, CIRCULATION, V95, P1813; Proskocil Becky J, 2005, Proc Am Thorac Soc, V2, P305, DOI 10.1513/pats.200504-038SR; Raupach T, 2008, EUR RESPIR J, V32, P387, DOI 10.1183/09031936.00109607; Ruan T, 2003, J APPL PHYSIOL, V94, P1987, DOI 10.1152/japplphysiol.01047.2002; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; Smith HJ, 2005, EUROPEAN RESP MONOGR, V31, P72, DOI [DOI 10.1183/1025448X.00031005, 10.1183/1025448x.00031005]; STEIN JF, 1975, RESP PHYSIOL, V25, P363, DOI 10.1016/0034-5687(75)90010-9; Waring WS, 2003, J CARDIOVASC PHARM, V42, P245, DOI 10.1097/00005344-200308000-00014; Weaver LK, 2009, J APPL PHYSIOL, V107, P336, DOI 10.1152/japplphysiol.91012.2008; Xing T, 2014, PROG BRAIN RES, V209, P131, DOI 10.1016/B978-0-444-63274-6.00007-2	48	12	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127697	10.1371/journal.pone.0127697	http://dx.doi.org/10.1371/journal.pone.0127697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046774	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200026
J	Zhang, K; Zhao, H; Ji, Z; Zhang, C; Zhou, P; Wang, L; Chen, Q; Wang, J; Zhang, P; Chen, Z; Zhu, HH; Gao, WQ				Zhang, K.; Zhao, H.; Ji, Z.; Zhang, C.; Zhou, P.; Wang, L.; Chen, Q.; Wang, J.; Zhang, P.; Chen, Z.; Zhu, H. H.; Gao, W-Q			Shp2 promotes metastasis of prostate cancer by attenuating the PAR3/PAR6/aPKC polarity protein complex and enhancing epithelial-to-mesenchymal transition	ONCOGENE			English	Article							HEMATOPOIETIC STEM; TUMOR-SUPPRESSOR; NOONAN-SYNDROME; PHOSPHATASE; KINASE; GAB1; TUMORIGENESIS; PROGRESSION; ACTIVATION; MECHANISMS	Epithelial-to-mesenchymal transition (EMT), marked by the dissolution of cell-cell junctions, loss of cell polarity and increased cell motility, is one of the essential steps for prostate cancer metastasis. However, the underlying mechanism has not been fully explored. We report in this study that Shp2 is upregulated in prostate cancers and is associated with a poor disease outcome, namely tumor metastasis and shortened patient survival. Overexpression of wild-type Shp2 or an oncogenic Shp2 mutant leads to increased prostate cancer cell proliferation, colony and sphere formation, and in vivo tumor formation. Opposite effects are seen in Shp2-knockdown cells. Moreover, Shp2 promotes in vitro migration and in vivo metastasis of prostatic tumor cells. Mechanistically, Shp2 interacts with PAR3 (partitioning-defective 3) via its Src homology-2 domain. Ectopic expression of Shp2 attenuates the phosphorylation of PAR3 and the formation of the PAR3/PAR6/atypical protein kinase C polarity protein complex, resulting in disrupted cell polarity, dysregulated cell-cell junctions and increased EMT. These findings provide a novel mechanism by which oncogenic signal-transduction molecules regulate cell polarity and induction of EMT.	[Zhang, K.; Zhao, H.; Ji, Z.; Zhang, C.; Zhou, P.; Wang, L.; Chen, Q.; Wang, J.; Zhu, H. H.; Gao, W-Q] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji MedX Clin Stem Cell Res Ctr, Ren Ji Hosp,Sch Biomed Engn, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Zhang, P.] Chinese Acad Sci, Key Lab Syst Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Chen, Z.] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhu, HH; Gao, WQ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Renji MedX Clin Stem Cell Res Ctr, Ren Ji Hosp,Sch Biomed Engn, 160 Pujian Rd, Shanghai 200127, Peoples R China.	zhuhecrane@shsmu.edu.cn; gao.weiqiang@sjtu.edu.cn	Gao, Wei/GXH-0380-2022	Wang, Jia/0000-0002-2343-4755	Chinese Ministry of Science and Technology [2012CB966800, 2013CB945600]; National Natural Science Foundation of China (NSFC) [81130038, 81372189]; Shanghai Health Bureau Key Discipline and Specialty Foundation; Shanghai Education Committee Key Discipline and Specialty Foundation [J50208]; KC Wong foundation; NSFC [81270627]; Science and Technology Commission of Shanghai Municipality (Pujiang program) [12PJ1406100]; Shanghai Education Committee [12CG16, 13YZ030]; Shanghai Institutions of Higher Learning	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Health Bureau Key Discipline and Specialty Foundation; Shanghai Education Committee Key Discipline and Specialty Foundation; KC Wong foundation; NSFC(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality (Pujiang program); Shanghai Education Committee; Shanghai Institutions of Higher Learning	The study is supported by funds to W-Q Gao from the Chinese Ministry of Science and Technology (2012CB966800 and 2013CB945600), the National Natural Science Foundation of China (NSFC, 81130038 and 81372189), the Science and Technology Commission of Shanghai Municipality (Pujiang program), the Shanghai Health Bureau Key Discipline and Specialty Foundation, the Shanghai Education Committee Key Discipline and Specialty Foundation (J50208) and the KC Wong foundation, and by funds to HH Zhu from the NSFC (81270627), the Science and Technology Commission of Shanghai Municipality (Pujiang program 12PJ1406100) and the Shanghai Education Committee (Chenguang program12CG16, 13YZ030 and young investigator program) and Shanghai Institutions of Higher Learning (The Program for Professor of Special Appointment (Young Eastern Scholar)).	Aceto N, 2012, NAT MED, V18, P529, DOI 10.1038/nm.2645; Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Bard-Chapeau EA, 2006, MOL CELL BIOL, V26, P4664, DOI 10.1128/MCB.02253-05; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Goldstein B, 2007, DEV CELL, V13, P609, DOI 10.1016/j.devcel.2007.10.007; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hartman ZR, 2013, MOL CANCER RES, V11, P651, DOI 10.1158/1541-7786.MCR-12-0578; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Iden S, 2012, CANCER CELL, V22, P389, DOI 10.1016/j.ccr.2012.08.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Karantanos T, 2013, ONCOGENE, V32, P5501, DOI 10.1038/onc.2013.206; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Li P, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-55; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lu Y, 2011, P NATL ACAD SCI USA, V108, P2957, DOI 10.1073/pnas.1009395108; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Mali RS, 2012, BLOOD, V120, P2669, DOI 10.1182/blood-2011-08-375873; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; McCaffrey LM, 2012, CANCER CELL, V22, P601, DOI 10.1016/j.ccr.2012.10.003; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Sausgruber N, 2015, ONCOGENE, V34, P2272, DOI 10.1038/onc.2014.170; Schneeberger VE, 2014, CARCINOGENESIS, V35, P1717, DOI 10.1093/carcin/bgu025; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Takahashi A, 2011, MOL CELL, V43, P45, DOI 10.1016/j.molcel.2011.05.014; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Wang FM, 2005, BREAST CANCER RES TR, V89, P5, DOI 10.1007/s10549-004-1002-z; Wang JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4415; Wang YG, 2006, EMBO J, V25, P5058, DOI 10.1038/sj.emboj.7601384; Wohrle FU, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-22; Yang XQ, 2010, MOL CELL BIOL, V30, P5306, DOI 10.1128/MCB.00326-10; Yang ZQ, 2012, MOL CELL, V47, P469, DOI 10.1016/j.molcel.2012.06.037; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54; Zhou ZC, 2014, GASTROENTEROLOGY, V147, P1043, DOI 10.1053/j.gastro.2014.07.021; Zhu HH, 2011, CELL CYCLE, V10, P2241, DOI 10.4161/cc.10.14.15861; Zhu HH, 2011, BLOOD, V117, P5350, DOI 10.1182/blood-2011-01-333476	44	44	46	0	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1271	1282		10.1038/onc.2015.184	http://dx.doi.org/10.1038/onc.2015.184			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26050620				2022-12-26	WOS:000371763100007
J	Ishibashi, Y; Hirabayashi, Y				Ishibashi, Yohei; Hirabayashi, Yoshio			AMP-activated Protein Kinase Suppresses Biosynthesis of Glucosylceramide by Reducing Intracellular Sugar Nucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYME REPLACEMENT THERAPY; POLYCYSTIC KIDNEY-DISEASE; GLYCOSPHINGOLIPID SYNTHESIS; CERAMIDE GLYCOSYLATION; GAUCHER-DISEASE; INSULIN SENSITIVITY; DRUG-RESISTANCE; CELL-GROWTH; IN-VIVO; SYNTHASE	The membrane glycolipid glucosylceramide (GlcCer) plays a critical role in cellular homeostasis. Its intracellular levels are thought to be tightly regulated. How cells regulate GlcCer levels remains to be clarified. AMP-activated protein kinase (AMPK), which is a crucial cellular energy sensor, regulates glucose and lipid metabolism to maintain energy homeostasis. Here, we investigated whether AMPK affects GlcCer metabolism. AMPK activators (5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside and metformin) decreased intracellular GlcCer levels and synthase activity in mouse fibroblasts. AMPK inhibitors or AMPK siRNA reversed these effects, suggesting that GlcCer synthesis is negatively regulated by an AMPK-dependent mechanism. Although AMPK did not affect the phosphorylation or expression of GlcCer synthase, the amount of UDP-glucose, an activated form of glucose required for GlcCer synthesis, decreased under AMPK-activating conditions. Importantly, the UDP-glucose pyrophosphatase Nudt14, which degrades UDP-glucose, generating UMP and glucose 1-phosphate, was phosphorylated and activated by AMPK. On the other hand, suppression of Nudt14 by siRNA had little effect on UDP-glucose levels, indicating that mammalian cells have an alternative UDPglucose pyrophosphatase that mainly contributes to the reduction of UDP-glucose under AMPK-activating conditions. Because AMPK activators are capable of reducing GlcCer levels in cells from Gaucher disease patients, our findings suggest that reducing GlcCer through AMPK activation may lead to a new strategy for treating diseases caused by abnormal accumulation of GlcCer.	[Ishibashi, Yohei; Hirabayashi, Yoshio] RIKEN Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama 3510198, Japan	RIKEN	Hirabayashi, Y (corresponding author), RIKEN Brain Sci Inst, Lab Mol Membrane Neurosci, Wako, Saitama 3510198, Japan.	hirabaya@riken.jp		Hirabayashi, Yoshio/0000-0002-5774-7354	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science, and Technology of Japan	RIKEN Brain Science Institute; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the RIKEN Brain Science Institute (to Y. H.) and RIKEN Special Postdoctoral Researchers Program (to Y. I.), a Grant-in-Aid for Young Scientists (B) (to Y. I.), the Research Activity Start-up (to Y. I.), and "Deciphering sugar chain-based signals regulating integrative neuronal functions" (to Y. H.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Banko MR, 2011, MOL CELL, V44, P878, DOI 10.1016/j.molcel.2011.11.005; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Cox TM, 2015, LANCET, V385, P2355, DOI 10.1016/S0140-6736(14)61841-9; Desnick RJ, 2012, ANNU REV GENOM HUM G, V13, P307, DOI 10.1146/annurev-genom-090711-163739; Duggleby RG, 1996, EUR J BIOCHEM, V235, P173, DOI 10.1111/j.1432-1033.1996.00173.x; Eguchi S, 2009, GENES CELLS, V14, P179, DOI 10.1111/j.1365-2443.2008.01260.x; Fuller M, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-113; Grabowski GA, 2008, LANCET, V372, P1263, DOI 10.1016/S0140-6736(08)61522-6; Gupta V, 2012, J BIOL CHEM, V287, P37195, DOI 10.1074/jbc.M112.396390; Gupta V, 2010, J LIPID RES, V51, P866, DOI 10.1194/jlr.D002949; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hanada K, 2005, JPN J INFECT DIS, V58, P131; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Heyen CA, 2009, BIOCHEM BIOPH RES CO, V390, P1414, DOI 10.1016/j.bbrc.2009.11.007; Ichikawa S, 1996, P NATL ACAD SCI USA, V93, P4638, DOI 10.1073/pnas.93.10.4638; Ishibashi Y, 2013, BBA-MOL CELL BIOL L, V1831, P1475, DOI 10.1016/j.bbalip.2013.06.001; Ito M, 2014, BBA-MOL CELL BIOL L, V1841, P682, DOI 10.1016/j.bbalip.2013.09.008; Jennemann R, 2013, PROG LIPID RES, V52, P231, DOI 10.1016/j.plipres.2013.02.001; Korschen HG, 2013, J BIOL CHEM, V288, P3381, DOI 10.1074/jbc.M112.414714; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Kohyama-Koganeya A, 2011, J LIPID RES, V52, P1392, DOI 10.1194/jlr.M014266; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Liu YY, 2011, INT J ONCOL, V39, P425, DOI 10.3892/ijo.2011.1052; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; MANGOOKARIM R, 1989, P NATL ACAD SCI USA, V86, P6007, DOI 10.1073/pnas.86.15.6007; Marks DL, 1999, J BIOL CHEM, V274, P451, DOI 10.1074/jbc.274.1.451; MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769; Marza E, 2009, J CELL SCI, V122, P822, DOI 10.1242/jcs.042754; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nakajima K, 2013, MOL CELL PROTEOMICS, V12, P2468, DOI 10.1074/mcp.M112.027151; Nakajima K, 2010, GLYCOBIOLOGY, V20, P865, DOI 10.1093/glycob/cwq044; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Nguyen HB, 2013, ONCOGENE, V32, P4100, DOI 10.1038/onc.2012.431; Nomura KH, 2011, GLYCOBIOLOGY, V21, P834, DOI 10.1093/glycob/cwr019; Nordstrom V, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001506; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; Schulze H, 2009, BBA-MOL CELL RES, V1793, P674, DOI 10.1016/j.bbamcr.2008.09.020; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Takiar V, 2011, P NATL ACAD SCI USA, V108, P2462, DOI 10.1073/pnas.1011498108; Tsuang D, 2012, NEUROLOGY, V79, P1944, DOI 10.1212/WNL.0b013e3182735e9a; Watanabe S, 2010, GLIA, V58, P1197, DOI 10.1002/glia.20999; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Yamashita T, 2002, BBA-GEN SUBJECTS, V1573, P236, DOI 10.1016/S0304-4165(02)00389-6; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	53	12	13	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18245	18260		10.1074/jbc.M115.658948	http://dx.doi.org/10.1074/jbc.M115.658948			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048992	Green Published, hybrid			2022-12-26	WOS:000358511700053
J	Chun, SI; Mun, CW				Chun, Song-I; Mun, Chi-Woong			Cytotoxicity of TSP in 3D Agarose Gel Cultured Cell	PLOS ONE			English	Article							DIFFERENTIATION; SPECTROSCOPY	Purpose A reference reagent, 3-(trimethylsilyl) propionic-2, 2, 3, 3-d4 acid sodium (TSP), has been used frequently in nuclear magnetic resonance (NMR) and magnetic resonance spectroscopy (MRS) as an internal reference to identify cell and tissue metabolites, and determine chemical and protein structures. This reference material has been exploited for the quantitative and dynamic analyses of metabolite spectra acquired from cells. The aim of this study was to evaluate the cytotoxicity of TSP on three-dimensionally, agarose gel, cultured cells. Materials and Methods A human osteosarcoma cell line (MG-63) was selected, and cells were three dimensionally cultured for two weeks in an agarose gel. The culture system contained a mixture of conventional culture medium and various concentrations (0, 1, 3, 5, 7, 10, 20 30 mM) of TSP. A DNA quantification assay was conducted to assess cell proliferation using Quant-iT Pico-Green dsDNA reagent and kit, and cell viability was determined using a LIVE/DEAD Viability/Cytotoxicity kit. Both examinations were performed simultaneously at 1, 3, 7 and 14 days from cell seeding. Results In this study, the cytotoxicity of TSP in the 3D culture of MG-63 cells was evaluated by quantifying DNA (cell proliferation) and cell viability. High concentrations of TSP (from 10 to 30 mM) reduced both cell proliferation and viability (to 30% of the control after one week of exposure), but no such effects were found using low concentrations of TSP (0-10mM). Conclusions This study shows that low concentrations of TSP in 3D cell culture medium can be used for quantitative NMR or MRS examinations for up to two weeks post exposure.	[Chun, Song-I; Mun, Chi-Woong] Inje Univ, Dept Biomed Engn, U HARC, Gyeongman, South Korea	Inje University	Mun, CW (corresponding author), Inje Univ, Dept Biomed Engn, U HARC, Gyeongman, South Korea.	mcw@inje.ac.kr			Basic Science Research Program through National Research Foundation of Korea(NRF) - Ministry of Education [NRF-2012R1A1A4A01013961]	Basic Science Research Program through National Research Foundation of Korea(NRF) - Ministry of Education	All authors (C.W. Mun, S.I. Chun) of this research were supported by Basic Science Research Program through the National Research Foundation of Korea(NRF) funded by the Ministry of Education (NRF-2012R1A1A4A01013961, http://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 2006, SHIMMING LOCKING NMR; Cao Y, 2006, J CLIN ONCOL, V24, P1228, DOI 10.1200/JCO.2005.04.7233; Chun SI, 2012, TISSUE ENG REGEN MED, V9, P101, DOI 10.1007/s13770-012-0016-6; Hoffman R, HOME PAGE NMR LAB; Kruger NJ, 2008, NAT PROTOC, V3, P1001, DOI 10.1038/nprot.2008.64; Kwak SY, 2012, TISSUE ENG REGEN MED, V9, pS81, DOI 10.1007/s13770-012-0338-4; Le Belle JE, 2002, NMR BIOMED, V15, P37, DOI 10.1002/nbm.740; Lin CY, 2007, METABOLOMICS, V3, P55, DOI 10.1007/s11306-006-0043-1; Lindon JC, 2007, NMR SPECTROSCOPY TEC, P58; Martin ML, 1980, PRACTICAL NMR SPECTR, P460; Mauck RL, 2006, OSTEOARTHR CARTILAGE, V14, P179, DOI 10.1016/j.joca.2005.09.002; MEDINA DJ, 1994, ANTIMICROB AGENTS CH, V38, P1824, DOI 10.1128/AAC.38.8.1824; Mun CW, 2004, MAGN RESON IMAGING, V22, P861, DOI 10.1016/j.mri.2004.01.045; Mun CW, 2014, PCTKR2013006755 INJ; Sellick CA, 2010, METABOLOMICS, V6, P427, DOI 10.1007/s11306-010-0216-9; Wu MH, 2007, BIOTECHNOL PROGR, V23, P430, DOI 10.1021/bp060024v; Zulak KG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-5; Zwischenberger JB, 2001, ANN THORAC SURG, V72, P234, DOI 10.1016/S0003-4975(01)02673-X	18	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128739	10.1371/journal.pone.0128739	http://dx.doi.org/10.1371/journal.pone.0128739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058017	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000028
J	Zhang, WJ; Shi, XP; Peng, Y; Wu, MY; Zhang, P; Xie, RY; Wu, Y; Yan, QQ; Liu, SD; Wang, JD				Zhang, Wenjing; Shi, Xinpeng; Peng, Ying; Wu, Meiyan; Zhang, Pei; Xie, Ruyi; Wu, Yao; Yan, Qingqing; Liu, Side; Wang, Jide			HIF-1 alpha Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer	PLOS ONE			English	Article							E-CADHERIN; COLON-CANCER; DOWN-REGULATION; TRANSCRIPTIONAL REPRESSOR; MOUSE MODEL; HYPOXIA; CELLS; EXPRESSION; CARCINOMA; HIF-1	It is well recognized that hypoxia-inducible factor 1 alpha (HIF-1 alpha) is involved in cancer metastasis, chemotherapy and poor prognosis. We previously found that deferoxamine, a hypoxia-mimetic agent, induces epithelial-mesenchymal transition (EMT) in colorectal cancer. Therefore, here we explored a new molecular mechanism for HIF-1 alpha contributing to EMT and cancer metastasis through binding to ZEB1. In this study, we showed that overexpression of HIF-1 alpha with adenovirus infection promoted EMT, cell invasion and migration in vitro and in vivo. On a molecular level, HIF-1 alpha directly binding to the proximal promoter of ZEB1 via hypoxia response element (HRE) sites thus increasing the transactivity and expression of ZEB1. In addition, inhibition of ZEB1 was able to abrogate the HIF-1 alpha-induced EMT and cell invasion. HIF-1 alpha expression was highly correlated with the expression of ZEB1 in normal colorectal epithelium, primary and metastatic CRC tissues. Interestingly, both HIF-1a and ZEB1 were positively associated with Vimentin, an important mesenchymal marker of EMT, whereas negatively associated with E-cadherin expression. These findings suggest that HIF-1 alpha enhances EMT and cancer metastasis by binding to ZEB1 promoter in CRC. HIF-1 alpha and ZEB1 are both widely considered as tumor-initiating factors, but our results demonstrate that ZEB1 is a direct downstream of HIF-1 alpha, suggesting a novel molecular mechanism for HIF-1 alpha-inducing EMT and cancer metastasis.	[Zhang, Wenjing; Shi, Xinpeng; Peng, Ying; Wu, Meiyan; Zhang, Pei; Xie, Ruyi; Wu, Yao; Yan, Qingqing; Liu, Side; Wang, Jide] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China; [Zhang, Wenjing] Kunming Univ Sci & Technol, Peoples Hosp Yunnan Prov 1, Dept Med Oncol, Kunming, Peoples R China	Southern Medical University - China; Kunming University of Science & Technology	Liu, SD (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangdong Prov Key Lab Gastroenterol, Guangzhou, Guangdong, Peoples R China.	liuside@163.com; Jidewang55@163.com	yan, qing/GZN-2287-2022		National Natural Science Foundation of China [81172057, 81302159]; President Foundation of Nanfang Hospital, Southern Medical University [2012C003, 2012B009]; high-level topic matching funds of Nanfang Hospital [G201227]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); President Foundation of Nanfang Hospital, Southern Medical University; high-level topic matching funds of Nanfang Hospital	This work was supported by National Natural Science Foundation of China (81172057, 81302159), President Foundation of Nanfang Hospital, Southern Medical University (2012C003, 2012B009), and high-level topic matching funds of Nanfang Hospital (G201227).	Barriga EH, 2013, J CELL BIOL, V201, P759, DOI 10.1083/jcb.201212100; Chien W, 2013, BRIT J CANCER, V109, P1795, DOI 10.1038/bjc.2013.531; Choi JY, 2011, J BREAST CANCER, V14, P88, DOI 10.4048/jbc.2011.14.2.88; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Espada J, 2011, NUCLEIC ACIDS RES, V39, P9194, DOI 10.1093/nar/gkr658; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; GIAVAZZI R, 1986, J NATL CANCER I, V77, P1303; Guo Z, 2010, MOL CARCINOGEN, V49, P826, DOI 10.1002/mc.20659; Higgins DF, 2007, J CLIN INVEST, V117, P3810, DOI 10.1172/JCI30487; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Imamura T, 2009, INT J CANCER, V124, P763, DOI 10.1002/ijc.24032; Jeong JS, 2008, CLIN CANCER RES, V14, P281, DOI 10.1158/1078-0432.CCR-07-1524; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Krishnamachary B, 2006, CANCER RES, V66, P2725, DOI 10.1158/0008-5472.CAN-05-3719; Le Bras GF, 2012, CELL ADHES MIGR, V6, P365, DOI 10.4161/cam.21326; Luo DC, 2011, MOL CANCER RES, V9, P234, DOI 10.1158/1541-7786.MCR-10-0214; Marchio S, 2012, EMBO MOL MED, V4, P1156, DOI 10.1002/emmm.201101164; Romero-Perez L, 2013, MODERN PATHOL, V26, P1514, DOI 10.1038/modpathol.2013.93; Shah PP, 2011, CANCER LETT, V311, P66, DOI 10.1016/j.canlet.2011.06.033; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Xiong H, 2012, J BIOL CHEM, V287, P5819, DOI 10.1074/jbc.M111.295964; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang L, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-108; Zhang WJ, 2014, ONCOL REP, V31, P111, DOI 10.3892/or.2013.2828; Zhang WJ, 2011, EUR J CANCER, V47, P121, DOI 10.1016/j.ejca.2010.07.045; Zhang WJ, 2010, CARCINOGENESIS, V31, P1220, DOI 10.1093/carcin/bgq094; Zhang WJ, 2010, INT J ONCOL, V36, P1031, DOI 10.3892/ijo_00000584; Zhou QY, 2011, CELL CYCLE, V10, P2233, DOI 10.4161/cc.10.13.16307	32	43	52	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129603	10.1371/journal.pone.0129603	http://dx.doi.org/10.1371/journal.pone.0129603			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057751	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000066
J	Goes, ESR; Lara, JAF; Gasparino, E; Del Vesco, AP; Goes, MD; Alexandre, L; Ribeiro, RP				Goes, Elenice S. R.; Lara, Jorge A. F.; Gasparino, Eliane; Del Vesco, Ana P.; Goes, Marcio D.; Alexandre Filho, Luiz; Ribeiro, Ricardo P.			Pre-Slaughter Stress Affects Ryanodine Receptor Protein Gene Expression and the Water-Holding Capacity in Fillets of the Nile Tilapia	PLOS ONE			English	Article							CROWDING STRESS; STORAGE-TEMPERATURE; SKELETAL-MUSCLES; HANDLING STRESS; FLESH QUALITY; MEAT QUALITY; ATLANTIC; TRANSPORTATION; MUTATION; WELFARE	Current study evaluated the effect of pre-slaughter stress on serum cortisol levels, pH, colorimetry, water-holding capacity (WHC) and gene expression of ryanodine receptors (RyR1 and RyR3) in the Nile tilapia. A 3x4 factorial scheme experiment was conducted comprising three densities (100, 200, 400 kg/m(3)) with four transportation times (60, 120, 180, and 240 minutes). Transportation times alone reduced cortisol levels up to 180 minutes, followed by increased WHC and mRNA expression, RyR1 and RyR3 (200 kg/m(3) density). No effect of density x transportation time interacted on the evaluated parameters. Results provided the first evidence that pre-slaughter stress affected ryanodine gene expression receptors and, consequently, the water-holding capacity in tilapia fillets.	[Goes, Elenice S. R.] Univ Estadual Maringa, BR-87020900 Maringa, Parana, Brazil; [Lara, Jorge A. F.] EMBRAPA Pantanal, Empresa Brasileira Pesquisa Agr, Corumba, MS, Brazil; [Gasparino, Eliane; Del Vesco, Ana P.; Alexandre Filho, Luiz; Ribeiro, Ricardo P.] Univ Estadual Maringa, Dept Anim Sci, BR-87020900 Maringa, Parana, Brazil; [Goes, Marcio D.] Univ Fed Parana UFPR, Palotina, Parana, Brazil	Universidade Estadual de Maringa; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual de Maringa; Universidade Federal do Parana	Goes, ESR (corresponding author), Univ Estadual Maringa, BR-87020900 Maringa, Parana, Brazil.	elenicesreis@yahoo.com.br	Del+Vesco, Ana/AAT-5956-2021; Souza dos Reis Goes, Elenice/HHS-6947-2022; Del Vesco, Ana/AAW-5174-2021	Souza dos Reis Goes, Elenice/0000-0003-2437-4800; Del Vesco, Ana/0000-0002-0145-7817; Goes, Marcio/0000-0002-7372-3942	Brazilian National Council for Research-CNPq [472622 / 2013-7]	Brazilian National Council for Research-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by and funded by the Brazilian National Council for Research-CNPq (No 472622 / 2013-7). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIREY JA, 1993, DEV DYNAM, V197, P169, DOI 10.1002/aja.1001970303; Bagni M, 2007, AQUACULTURE, V263, P52, DOI 10.1016/j.aquaculture.2006.07.049; Darbandi S, 2009, COMP BIOCHEM PHYS B, V154, P443, DOI 10.1016/j.cbpb.2009.09.003; Dobsikova R, 2006, ACTA VET BRNO, V75, P437, DOI 10.2754/avb200675030437; Droval AA, 2012, GENET MOL RES, V11, P821, DOI 10.4238/2012.April.3.4; Einen O, 2002, AQUACULTURE, V212, P129, DOI 10.1016/S0044-8486(01)00874-2; Erikson U, 1997, AQUACULTURE, V149, P243, DOI 10.1016/S0044-8486(96)01453-6; Franck JPC, 1998, AM J PHYSIOL-CELL PH, V275, pC401, DOI 10.1152/ajpcell.1998.275.2.C401; FUJII J, 1991, SCIENCE, V253, P448, DOI 10.1126/science.1862346; Gatica MC, 2010, VET REC, V166, P45, DOI 10.1136/vr.c71; Huff-Lonergan E, 2005, MEAT SCI, V71, P194, DOI 10.1016/j.meatsci.2005.04.022; Hultmann L, 2012, FOOD CHEM, V134, P1399, DOI 10.1016/j.foodchem.2012.03.038; Oda SHI, 2009, BRAZ ARCH BIOL TECHN, V52, P1519, DOI 10.1590/S1516-89132009000600024; Jurkat-Rott K, 2005, J CLIN INVEST, V115, P2000, DOI 10.1172/JCI25525; LOWE TE, 1993, J FOOD SCI, V58, P770, DOI 10.1111/j.1365-2621.1993.tb09355.x; Lund MN, 2011, MOL NUTR FOOD RES, V55, P83, DOI 10.1002/mnfr.201000453; Marx H, 1997, Z LEBENSM UNTERS F A, V204, P282, DOI 10.1007/s002170050078; Matos E, 2010, AQUACULTURE, V305, P66, DOI 10.1016/j.aquaculture.2010.04.020; Morzel M, 2003, AQUAC RES, V34, P1, DOI 10.1046/j.1365-2109.2003.00754.x; OLIVARES EB, 1991, BIOPHYS J, V59, P1153, DOI 10.1016/S0006-3495(91)82331-1; Olsson GB, 2003, LEBENSM-WISS TECHNOL, V36, P125, DOI 10.1016/S0023-6438(02)00205-0; Poli BM, 2009, ITAL J ANIM SCI, V8, P139; Rahmanifarah K., 2011, J FISH AQUAT SCI, V11, P139, DOI [10.4194/trjfas.20110118, DOI 10.4194/TRJFAS.2011.0118]; Robb DHF, 2000, AQUACULTURE, V182, P261, DOI 10.1016/S0044-8486(99)00273-2; Sigholt T, 1997, J FOOD SCI, V62, P898, DOI 10.1111/j.1365-2621.1997.tb15482.x; Skjervold PO, 2001, AQUACULTURE, V192, P265, DOI 10.1016/S0044-8486(00)00447-6; Stien LH, 2005, AQUAC RES, V36, P1197, DOI 10.1111/j.1365-2109.2005.01339.x; Strasburg GM, 2009, POULTRY SCI, V88, P1497, DOI 10.3382/ps.2009-00181; Tejpal CS, 2009, AQUACULTURE, V293, P272, DOI 10.1016/j.aquaculture.2008.09.014; Wu D, 2013, TALANTA, V116, P266, DOI 10.1016/j.talanta.2013.05.030; Yang CG, 2013, GENE, V527, P183, DOI 10.1016/j.gene.2013.06.013	31	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129145	10.1371/journal.pone.0129145	http://dx.doi.org/10.1371/journal.pone.0129145			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053858	Green Published, gold			2022-12-26	WOS:000355955300093
J	Strauss, AL; Kawasaki, F; Ordway, RW				Strauss, Alexandra L.; Kawasaki, Fumiko; Ordway, Richard W.			A Distinct Perisynaptic Glial Cell Type Forms Tripartite Neuromuscular Synapses in the Drosophila Adult	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; TERM SYNAPTIC DEPRESSION; GLUTAMINE-SYNTHETASE; PERIPHERAL GLIA; NEURONS; PLASTICITY; DYNAMICS; SYSTEM; ROLES	Previous studies of Drosophila flight muscle neuromuscular synapses have revealed their tripartite architecture and established an attractive experimental model for genetic analysis of glial function in synaptic transmission. Here we extend these findings by defining a new Drosophila glial cell type, designated peripheral perisynaptic glia (PPG), which resides in the periphery and interacts specifically with fine motor axon branches forming neuromuscular synapses. Identification and specific labeling of PPG was achieved through cell typespecific RNAi-mediated knockdown (KD) of a glial marker, Glutamine Synthetase 2 (GS2). In addition, comparison among different Drosophila neuromuscular synapse models from adult and larval developmental stages indicated the presence of tripartite synapses on several different muscle types in the adult. In contrast, PPG appear to be absent from larval body wall neuromuscular synapses, which do not exhibit a tripartite architecture but rather are imbedded in the muscle plasma membrane. Evolutionary conservation of tripartite synapse architecture and peripheral perisynaptic glia in vertebrates and Drosophila suggests ancient and conserved roles for glia-synapse interactions in synaptic transmission.	[Ordway, Richard W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; Penn State Univ, Ctr Mol & Cellular Neurosci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ordway, RW (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	rwo4@psu.edu			National Institutes of Health [1R01NS065983-01A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065983] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health 1R01NS065983-01A1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Bao S, 2006, RNA, V12, P2020, DOI 10.1261/rna.258406; Besson MT, 2000, CURR BIOL, V10, P207, DOI 10.1016/S0960-9822(00)00339-0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brill MS, 2011, J CELL BIOL, V195, P293, DOI 10.1083/jcb.201108005; CAIZZI R, 1990, J MOL BIOL, V212, P17, DOI 10.1016/0022-2836(90)90301-2; Danjo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017131; Featherstone DE, 2002, NAT NEUROSCI, V5, P141, DOI 10.1038/nn789; Feng ZH, 2007, CURR OPIN PHARMACOL, V7, P316, DOI 10.1016/j.coph.2006.12.003; Freeman MR, 2013, NEURON, V80, P613, DOI 10.1016/j.neuron.2013.10.034; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Hallermann S, 2013, TRENDS NEUROSCI, V36, P185, DOI 10.1016/j.tins.2012.10.001; Hartenstein V, 2011, GLIA, V59, P1237, DOI 10.1002/glia.21162; Hummel T, 2002, NEURON, V33, P193, DOI 10.1016/S0896-6273(01)00581-5; IKEDA K, 1988, J COMP NEUROL, V273, P436, DOI 10.1002/cne.902730312; Jackson FR, 2008, NEURON GLIA BIOL, V4, P11, DOI 10.1017/S1740925X09000027; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Kawasaki F, 2002, J NEUROSCI, V22, P5856; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2011, P NATL ACAD SCI USA, V108, pE222, DOI 10.1073/pnas.1102231108; Kawasaki F, 2009, P NATL ACAD SCI USA, V106, P14658, DOI 10.1073/pnas.0907144106; Menon KP, 2013, WIRES DEV BIOL, V2, P647, DOI 10.1002/wdev.108; Nedergaard M, 2012, GLIA, V60, P1013, DOI 10.1002/glia.22288; Rival T, 2006, J NEUROBIOL, V66, P1061, DOI 10.1002/neu.20270; Rodrigues F, 2011, CELL MOL LIFE SCI, V68, P55, DOI 10.1007/s00018-010-0512-6; Rose CF, 2013, BIOCHEM SOC T, V41, P1518, DOI 10.1042/BST20130237; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Sinakevitch I, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-10; Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008; Sugiura Y, 2011, BIOSCIENCE REP, V31, P295, DOI 10.1042/BSR20100107; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Sun YA, 1997, J COMP NEUROL, V387, P157; Tani H, 2014, NEURON, V81, P888, DOI 10.1016/j.neuron.2013.12.026; Thomas GB, 2007, DEVELOPMENT, V134, P591, DOI 10.1242/dev.02754; Thomas U, 2012, ADV EXP MED BIOL, V970, P3, DOI 10.1007/978-3-7091-0932-8_1; Todd KJ, 2010, J NEUROSCI, V30, P11870, DOI 10.1523/JNEUROSCI.3165-10.2010; Wu Y, 2005, J NEUROPHYSIOL, V93, P2396, DOI 10.1152/jn.01108.2004	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129957	10.1371/journal.pone.0129957	http://dx.doi.org/10.1371/journal.pone.0129957			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053860	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300171
J	Yuan, S; Li, Y; Peng, SB				Yuan, Shen; Li, Yong; Peng, Shaobing			Leaf Lateral Asymmetry in Morphological and Physiological Traits of Rice Plant	PLOS ONE			English	Article							CHLOROPHYLL METERS ESTIMATE; FLUCTUATING ASYMMETRY; PHOTOSYNTHESIS; LEAVES; MASS; IRRADIANCE; EFFICIENCY; READINGS; AREA	Leaf lateral asymmetry in width and thickness has been reported previously in rice. However, the differences between the wide and narrow sides of leaf blade in other leaf morphological and physiological traits were not known. This study was conducted to quantify leaf lateral asymmetry in leaf width, leaf thickness, specific leaf weight (SLW), leaf nitrogen (N) concentration based on dry weight (Nw) and leaf area (Na), and chlorophyll meter reading (SPAD). Leaf morphological and physiological traits of the two lateral halves of the top three leaves at heading stage were measured on 23 rice varieties grown in three growing seasons in two locations. Leaf lateral asymmetry was observed in leaf width, leaf thickness, Nw, Na, and SPAD, but not in SLW. On average, the leaf width of the wide side was about 17% higher than that of the narrow side. The wide side had higher leaf thickness than the narrow side whereas the narrow side had higher Nw, Na, and SPAD than the wide side. We conclude that the narrow side of leaf blade maintained higher leaf N status than the wide side based on all N-related parameters, which implies a possibility of leaf lateral asymmetry in photosynthetic rate in rice plant.	[Yuan, Shen; Li, Yong; Peng, Shaobing] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Key Lab Crop Ecophysiol & Farming Syst Middle Rea, Minist Agr,Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Peng, SB (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Key Lab Crop Ecophysiol & Farming Syst Middle Rea, Minist Agr,Coll Plant Sci & Technol, Wuhan, Hubei, Peoples R China.	speng@mail.hzau.edu.cn	Yuan, Shen/T-2431-2019; Yuan, shen/R-7265-2017	Yuan, Shen/0000-0003-4786-145X; Yuan, shen/0000-0003-4786-145X	Program for Changjiang Scholars and Innovative Research Team in University of China [IRT1247]; Program of Introducing Talents of Discipline to Universities in China (the 111 Project) [B14032]; Special Fund for Agro-scientific Research in the Public Interest of China from the Ministry of Agriculture [201203096]; Bill and Melinda Gates Foundation [OPP51587]	Program for Changjiang Scholars and Innovative Research Team in University of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Program of Introducing Talents of Discipline to Universities in China (the 111 Project); Special Fund for Agro-scientific Research in the Public Interest of China from the Ministry of Agriculture; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Program for Changjiang Scholars and Innovative Research Team in University of China (IRT1247), the Program of Introducing Talents of Discipline to Universities in China (the 111 Project no. B14032), the Special Fund for Agro-scientific Research in the Public Interest of China from the Ministry of Agriculture (No. 201203096), and grants from the Bill and Melinda Gates Foundation (OPP51587).	[Anonymous], 1981, FUNDAMENTALS RICE CR; CHATTERTON NJ, 1981, PLANT PHYSIOL, V67, P257, DOI 10.1104/pp.67.2.257; Chen YouDing, 2007, Agricultural Sciences in China, V6, P802, DOI 10.1016/S1671-2927(07)60115-1; Cornelissen T, 2004, GLOBAL CHANGE BIOL, V10, P27, DOI 10.1111/j.1365-2486.2003.00712.x; Evans JR, 2009, J EXP BOT, V60, P2235, DOI 10.1093/jxb/erp117; Fageria NK, 2007, J PLANT NUTR, V30, P843, DOI 10.1080/15226510701374831; Field C., 1986, EC PLANT FORM FUNCTI, P22; Hassiotou F, 2010, J EXP BOT, V61, P3015, DOI 10.1093/jxb/erq128; Ishii R., 1995, SCI RICE PLANT PHYSL, P491; Kokornaczyk MO, 2013, NATURWISSENSCHAFTEN, V100, P111, DOI 10.1007/s00114-012-0999-9; Korn RW, 2006, ANN BOT-LONDON, V97, P1011, DOI 10.1093/aob/mcl047; Kumagai E, 2009, PLANT PROD SCI, V12, P50, DOI 10.1626/pps.12.50; Li JW, 2011, PLANT PROD SCI, V14, P177, DOI 10.1626/pps.14.177; Li JW, 2009, FIELD CROP RES, V114, P426, DOI 10.1016/j.fcr.2009.09.009; Mae T, 1997, PLANT SOIL, V196, P201, DOI 10.1023/A:1004293706242; MURATA YOSHIO, 1961, BULL NATL INST AGRIC SCI SER D PLANT PHYSIOL, V9, P1; Murchie EH, 2002, PLANT PHYSIOL, V130, P1999, DOI 10.1104/pp.011098; Nobel PS, 2009, PHYSICOCHEMICAL AND ENVIRONMENTAL PLANT PHYSIOLOGY, 4TH EDITION, P1; Obara M, 2004, BREEDING SCI, V54, P157, DOI 10.1270/jsbbs.54.157; Peng S, 1996, FIELD CROP RES, V47, P243, DOI 10.1016/0378-4290(96)00018-4; Peng S, 2000, STUD PLAN S, V7, P213; PENG SB, 1993, AGRON J, V85, P987, DOI 10.2134/agronj1993.00021962008500050005x; Peng SB, 2008, FIELD CROP RES, V108, P32, DOI 10.1016/j.fcr.2008.04.001; Poorter H, 2009, NEW PHYTOL, V182, P565, DOI 10.1111/j.1469-8137.2009.02830.x; Pritchard SG, 1997, PLANT CELL ENVIRON, V20, P461, DOI 10.1046/j.1365-3040.1997.d01-92.x; Schroeder C. A., 1980, California Avocado Society Yearbook, V64, P143; Takai T, 2010, RICE, V3, P172, DOI 10.1007/s12284-010-9047-6; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; TSUNODA S., 1962, Ikushugaku Zasshi = Japanese Journal of Breeding, V12, P49; Wilsey BJ, 1998, ECOLOGY, V79, P2092, DOI 10.1890/0012-9658(1998)079[2092:LFAIWH]2.0.CO;2; WITKOWSKI ETF, 1991, OECOLOGIA, V88, P486, DOI 10.1007/BF00317710; YOSHIDA S, 1976, Soil Science and Plant Nutrition, V22, P207, DOI 10.1080/00380768.1976.10432983	32	13	16	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129832	10.1371/journal.pone.0129832	http://dx.doi.org/10.1371/journal.pone.0129832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053267	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300165
J	Zhang, Z; Schindler, CEM; Lange, OF; Zacharias, M				Zhang, Zhe; Schindler, Christina E. M.; Lange, Oliver F.; Zacharias, Martin			Application of Enhanced Sampling Monte Carlo Methods for High-Resolution Protein-Protein Docking in Rosetta	PLOS ONE			English	Article							STRUCTURE PREDICTION; DESIGN; SIMULATION; OPTIMIZATION; DISPLACEMENT; FLEXIBILITY; FUNNELS; SYSTEMS; MODEL	The high-resolution refinement of docked protein-protein complexes can provide valuable structural and mechanistic insight into protein complex formation complementing experiment. Monte Carlo (MC) based approaches are frequently applied to sample putative interaction geometries of proteins including also possible conformational changes of the binding partners. In order to explore efficiency improvements of the MC sampling, several enhanced sampling techniques, including temperature or Hamiltonian replica exchange and well-tempered ensemble approaches, have been combined with the MC method and were evaluated on 20 protein complexes using unbound partner structures. The well-tempered ensemble method combined with a 2-dimensional temperature and Hamiltonian replica exchange scheme (WTE-H-REMC) was identified as the most efficient search strategy. Comparison with prolonged MC searches indicates that the WTE-H-REMC approach requires approximately 5 times fewer MC steps to identify near native docking geometries compared to conventional MC searches.	[Zhang, Zhe; Schindler, Christina E. M.; Zacharias, Martin] Tech Univ Munich, Phys Dept T38, D-84748 Garching, Germany; [Lange, Oliver F.] Tech Univ Munich, Dept Chem, Biomol NMR, D-85748 Garching, Germany; [Lange, Oliver F.] Tech Univ Munich, Dept Chem, Munich Ctr Integrated Prot Sci, D-85748 Garching, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich	Zacharias, M (corresponding author), Tech Univ Munich, Phys Dept T38, James Franck Str 1, D-84748 Garching, Germany.	martin.zacharias@ph.tum.de		zhang, zhe/0000-0003-3983-1226	Deutsche Forschungsgemeinschaft (DFG) [SFB1035, B02, B09]; DFG-Excellence Cluster: Center of Protein Science Munich (CIPSM)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG-Excellence Cluster: Center of Protein Science Munich (CIPSM)	This work was supported by: Deutsche Forschungsgemeinschaft (DFG), SFB1035/project B02 and B09; DFG-Excellence Cluster: Center of Protein Science Munich (CIPSM); Supercomputer grant at Leibnitz Rechenzentrum (LRZ)/pr86pu. The funders had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, PROTEIN-STRUCT FUNCT; Baker D, 2006, PHILOS T ROY SOC B, V361, P459, DOI 10.1098/rstb.2005.1803; Baker D, 2014, BIOCHEM SOC T, V42, P225, DOI 10.1042/BST20130055; Barducci A, 2011, WIRES COMPUT MOL SCI, V1, P826, DOI 10.1002/wcms.31; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bonomi M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.190601; Camacho CJ, 1999, BIOPHYS J, V76, P1166, DOI 10.1016/S0006-3495(99)77281-4; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Dantas G, 2007, J MOL BIOL, V366, P1209, DOI 10.1016/j.jmb.2006.11.080; Deighan M, 2012, J CHEM THEORY COMPUT, V8, P2189, DOI 10.1021/ct300297t; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Earl DJ, 2005, PHYS CHEM CHEM PHYS, V7, P3910, DOI 10.1039/b509983h; Falcioni M, 1999, J CHEM PHYS, V110, P1754, DOI 10.1063/1.477812; Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510; Garma L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038913; Gray JJ, 2006, CURR OPIN STRUC BIOL, V16, P183, DOI 10.1016/j.sbi.2006.03.003; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gray JJ, 2003, PROTEINS, V52, P118, DOI 10.1002/prot.10384; Hansmann UHE, 1997, CHEM PHYS LETT, V281, P140, DOI 10.1016/S0009-2614(97)01198-6; Hritz J, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2888998; Huang SY, 2014, DRUG DISCOV TODAY, V19, P1081, DOI 10.1016/j.drudis.2014.02.005; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Katzgraber HG, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/03/P03018; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; London N, 2008, STRUCTURE, V16, P269, DOI 10.1016/j.str.2007.11.013; London N, 2014, J STRUCT BIOL, V185, P136, DOI 10.1016/j.jsb.2013.03.012; Lorenzen S, 2007, PROTEIN SCI, V16, P2716, DOI 10.1110/ps.072847207; Luitz MP, 2014, J CHEM INF MODEL, V54, P1669, DOI 10.1021/ci500296f; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Ostermeir K, 2013, BBA-PROTEINS PROTEOM, V1834, P847, DOI 10.1016/j.bbapap.2012.12.016; Parmeggiani F, 2015, J MOL BIOL, V427, P563, DOI 10.1016/j.jmb.2014.11.005; Rathore N, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1831273; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; SWENDSEN RH, 1986, PHYS REV LETT, V57, P2607, DOI 10.1103/PhysRevLett.57.2607; Vajda S, 2009, CURR OPIN STRUC BIOL, V19, P164, DOI 10.1016/j.sbi.2009.02.008; Yan QL, 1999, J CHEM PHYS, V111, P9509, DOI 10.1063/1.480282; Yan QL, 2000, J CHEM PHYS, V113, P1276, DOI 10.1063/1.481905; Yanover C, 2008, J COMPUT BIOL, V15, P899, DOI 10.1089/cmb.2007.0158; Zacharias M, 2003, PROTEIN SCI, V12, P1271, DOI 10.1110/ps.0239303; Zhang Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072096	50	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0125941	10.1371/journal.pone.0125941	http://dx.doi.org/10.1371/journal.pone.0125941			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053419	Green Published, gold			2022-12-26	WOS:000355955300011
J	Hofberger, JA; Ramirez, AM; van den Bergh, E; Zhu, XG; Bouwmeester, HJ; Schuurink, RC; Schranz, ME				Hofberger, Johannes A.; Ramirez, Aldana M.; van den Bergh, Erik; Zhu, Xinguang; Bouwmeester, Harro J.; Schuurink, Robert C.; Schranz, M. Eric			Large-Scale Evolutionary Analysis of Genes and Supergene Clusters from Terpenoid Modular Pathways Provides Insights into Metabolic Diversification in Flowering Plants	PLOS ONE			English	Article							ISOPENTENYL DIPHOSPHATE ISOMERASES; ARABIDOPSIS-THALIANA; GENOME DUPLICATIONS; WHOLE-GENOME; PROTEIN FAMILIES; DRAFT GENOME; 5-PHOSPHATE SYNTHASE; SECONDARY METABOLISM; MOLECULAR-BIOLOGY; NATURAL VARIATION	An important component of plant evolution is the plethora of pathways producing more than 200,000 biochemically diverse specialized metabolites with pharmacological, nutritional and ecological significance. To unravel dynamics underlying metabolic diversification, it is critical to determine lineage-specific gene family expansion in a phylogenomics framework. However, robust functional annotation is often only available for core enzymes catalyzing committed reaction steps within few model systems. In a genome informatics approach, we extracted information from early-draft gene-space assemblies and non-redundant transcriptomes to identify protein families involved in isoprenoid biosynthesis. Isoprenoids comprise terpenoids with various roles in plant-environment interaction, such as pollinator attraction or pathogen defense. Combining lines of evidence provided by synteny, sequence homology and Hidden-Markov-Modelling, we screened 17 genomes including 12 major crops and found evidence for 1,904 proteins associated with terpenoid biosynthesis. Our terpenoid genes set contains evidence for 840 core terpene-synthases and 338 triterpene-specific synthases. We further identified 190 prenyltransferases, 39 isopentenyl-diphosphate isomerases as well as 278 and 219 proteins involved in mevalonate and methylerithrol pathways, respectively. Assessing the impact of gene and genome duplication to lineage-specific terpenoid pathway expansion, we illustrated key events underlying terpenoid metabolic diversification within 250 million years of flowering plant radiation. By quantifying Angiosperm-wide versatility and phylogenetic relationships of pleiotropic gene families in terpenoid modular pathways, our analysis offers significant insight into evolutionary dynamics underlying diversification of plant secondary metabolism. Furthermore, our data provide a blueprint for future efforts to identify and more rapidly clone terpenoid biosynthetic genes from any plant species.	[Hofberger, Johannes A.; van den Bergh, Erik; Bouwmeester, Harro J.; Schranz, M. Eric] Wageningen Univ & Res Ctr, NL-6708 PB Wageningen, Netherlands; [Hofberger, Johannes A.; Zhu, Xinguang] Chinese Acad Sci, Max Planck Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Ramirez, Aldana M.; Schuurink, Robert C.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 XH Amsterdam, Netherlands	Wageningen University & Research; Chinese Academy of Sciences; Max Planck Society; University of Amsterdam	Schranz, ME (corresponding author), Wageningen Univ & Res Ctr, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands.	eric.schranz@wur.nl	Schranz, Michael/D-7155-2017; Bouwmeester, Harro J/C-1414-2008; Schranz, M. Eric/AAB-7601-2022	Schranz, Michael/0000-0001-6777-6565; Schranz, M. Eric/0000-0001-6777-6565; Bouwmeester, Harro/0000-0003-0907-2732; van den Bergh, Erik/0000-0001-9865-574X	Netherlands Organization for Scientific Research (NWO) Ecogenomics grant	Netherlands Organization for Scientific Research (NWO) Ecogenomics grant(Netherlands Organization for Scientific Research (NWO))	This work was funded by a Netherlands Organization for Scientific Research (NWO) Ecogenomics grant (M.E.S.).	Abel S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-72; Adams KL, 2007, J HERED, V98, P136, DOI 10.1093/jhered/esl061; Akhtar TA, 2013, PLANT J, V73, P640, DOI 10.1111/tpj.12063; Albert VA, 2013, SCIENCE, V342, P1467, DOI 10.1126/science.1241089; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; Aubourg S, 2002, MOL GENET GENOMICS, V267, P730, DOI 10.1007/s00438-002-0709-y; Avraham S, 2008, NUCLEIC ACIDS RES, V36, pD449, DOI 10.1093/nar/gkm908; Barker MS, 2009, GENOME BIOL EVOL, V1, P391, DOI 10.1093/gbe/evp040; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bekaert M, 2011, PLANT CELL, V23, P1719, DOI 10.1105/tpc.110.081281; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Benveniste Pierre, 2002, Arabidopsis Book, V1, pe0004, DOI 10.1199/tab.0004; Berthelot K, 2012, BIOCHIMIE, V94, P1621, DOI 10.1016/j.biochi.2012.03.021; Bohlmann J, 2000, ARCH BIOCHEM BIOPHYS, V375, P261, DOI 10.1006/abbi.1999.1669; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bombarely A, 2012, MOL PLANT MICROBE IN, V25, P1523, DOI 10.1094/MPMI-06-12-0148-TA; Boutanaev AM, 2015, P NATL ACAD SCI USA, V112, pE81, DOI 10.1073/pnas.1419547112; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bruskiewich R, 2002, COMPAR FUNCT GENOM, V3, P137, DOI 10.1002/cfg.154; Campos N, 2001, BIOCHEM J, V353, P59, DOI 10.1042/bj3530059; Carretero-Paulet L, 2013, GENE, V524, P40, DOI 10.1016/j.gene.2012.10.071; Carretero-Paulet L, 2012, MOL BIOL EVOL, V29, P3541, DOI 10.1093/molbev/mss162; Chen F, 2004, PLANT PHYSIOL, V135, P1956, DOI 10.1104/pp.104.044388; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Chen R, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-78; Cheng AX, 2007, J INTEGR PLANT BIOL, V49, P179, DOI 10.1111/j.1744-7909.2007.00395.x; Cheng SF, 2013, PLANT CELL, V25, P2813, DOI 10.1105/tpc.113.113480; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dai XB, 2010, PLANT PHYSIOL, V152, P44, DOI 10.1104/pp.109.145813; Dalquen DA, 2013, GENOME BIOL EVOL, V5, P1800, DOI 10.1093/gbe/evt132; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Dornelas MC, 2007, GENET MOL BIOL, V30, P832, DOI 10.1590/S1415-47572007000500011; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dvorakova L, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-412; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Estevez JM, 2000, PLANT PHYSIOL, V124, P95, DOI 10.1104/pp.124.1.95; Falara V, 2011, PLANT PHYSIOL, V157, P770, DOI 10.1104/pp.111.179648; Faldt J, 2003, PLANTA, V216, P745, DOI 10.1007/s00425-002-0924-0; Fang L, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00261; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; FITCH WM, 1970, SYST ZOOL, V19, P99, DOI 10.2307/2412448; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Glenn WS, 2013, CURR OPIN BIOTECH, V24, P354, DOI 10.1016/j.copbio.2012.08.003; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Guimil S, 2007, J EXP BOT, V58, P3829, DOI 10.1093/jxb/erm253; Haas BJ, 2004, BIOINFORMATICS, V20, P3643, DOI 10.1093/bioinformatics/bth397; Han K-H, 2001, ISOPENTENYL DIPHOSPH; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Haudry A, 2013, NAT GENET, V45, P891, DOI 10.1038/ng.2684; Hauser MT, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00320, 10.3389/fpsyg.2014.00401]; Herde M, 2008, PLANT CELL, V20, P1152, DOI 10.1105/tpc.106.049478; Heyndrickx KS, 2012, PLANT PHYSIOL, V159, P884, DOI 10.1104/pp.112.196725; Hofberger JA, 2015, GENOME BIOL EVOL, V7, P720, DOI 10.1093/gbe/evv020; Hofberger JA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-966; Hofberger JA, 2013, GENOME BIOL EVOL, V5, P2155, DOI 10.1093/gbe/evt162; Hu TT, 2011, NAT GENET, V43, P476, DOI 10.1038/ng.807; Huang MS, 2010, PLANT PHYSIOL, V153, P1293, DOI 10.1104/pp.110.154864; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jalswal P, 2005, COMP FUNCT GENOM, V6, P388, DOI 10.1002/cfg.496; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Johnston JB, 2007, MECH INVESTIGATIONS; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Joron M, 2006, PLOS BIOL, V4, P1831, DOI 10.1371/journal.pbio.0040303; Kamolsukyunyong W, 2013, RICE, V6, DOI 10.1186/1939-8433-6-18; Kang JH, 2014, PLANT PHYSIOL, V164, P80, DOI 10.1104/pp.113.230466; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kolesnikova MD, 2007, ORG LETT, V9, P5223, DOI 10.1021/ol702399g; Koonin EV, 2005, ANNU REV GENET, V39, P309, DOI 10.1146/annurev.genet.39.073003.114725; Kulheim C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-452; Lange BM, 2013, PLANT BIOTECHNOL J, V11, P2, DOI 10.1111/j.1467-7652.2012.00737.x; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lawler IR, 1998, OECOLOGIA, V116, P160, DOI 10.1007/s004420050575; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; Lipka V, 2005, CURR OPIN PLANT BIOL, V8, P625, DOI 10.1016/j.pbi.2005.09.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodeiro S, 2007, J AM CHEM SOC, V129, P11213, DOI 10.1021/ja073133u; Lyons E, 2008, PLANT PHYSIOL, V148, P1772, DOI 10.1104/pp.108.124867; Lyons E, 2008, PLANT J, V53, P661, DOI 10.1111/j.1365-313X.2007.03326.x; Mandel MA, 1996, PLANT J, V9, P649, DOI 10.1046/j.1365-313X.1996.9050649.x; Marks MD, 2009, MOL PLANT, V2, P803, DOI 10.1093/mp/ssp037; Martin DM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-226; Matsuba Y, 2013, PLANT CELL, V25, P2022, DOI 10.1105/tpc.113.111013; Maynard Smith J., 1989, EVOLUTIONARY GENETIC; Mendes MD, 2014, J PLANT PHYSL; Miller M. A., 2010, CIPRES PORTALS; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Moses T, 2013, NEW PHYTOL, V200, P27, DOI 10.1111/nph.12325; Muhlhausen S, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-202; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Naur P, 2003, PLANT PHYSIOL, V133, P63, DOI 10.1104/pp.102.019240; Nieuwenhuizen NJ, 2013, PLANT PHYSIOL, V161, P787, DOI 10.1104/pp.112.208249; Ohno S., 1970, P1; Okada K, 2008, PLANT CELL PHYSIOL, V49, P604, DOI 10.1093/pcp/pcn032; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Paetzold H, 2010, MOL PLANT, V3, P904, DOI 10.1093/mp/ssq032; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pattanaik S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00259; Phillips MA, 2008, PLANT CELL, V20, P677, DOI 10.1105/tpc.107.053926; Phillips MA, 2008, TRENDS PLANT SCI, V13, P619, DOI 10.1016/j.tplants.2008.09.003; Qiu YC, 2014, GENOME BIOL EVOL, V6, P1830, DOI 10.1093/gbe/evu144; Rambaut A., 2009, FIGTREE VERSION 1 3; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rizzon C, 2006, PLOS COMPUT BIOL, V2, P989, DOI 10.1371/journal.pcbi.0020115; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Roulin A, 2013, PLANT J, V73, P143, DOI 10.1111/tpj.12026; Sallaud C, 2012, PLANT J, V72, P1, DOI 10.1111/j.1365-313X.2012.05068.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schranz ME, 2012, CURR OPIN PLANT BIOL, V15, P147, DOI 10.1016/j.pbi.2012.03.011; Schranz ME, 2006, PLANT CELL, V18, P1152, DOI 10.1105/tpc.106.041111; Shack S, 1999, ONCOGENE, V18, P6021, DOI 10.1038/sj.onc.1203002; Shibuya M, 2007, J AM CHEM SOC, V129, P1450, DOI 10.1021/ja066873w; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soltis PS, 2013, ANGIOSPERM PHYLOGENY; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tang HB, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00172; Tang HB, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-102; Tholl D, 2005, PLANT J, V42, P757, DOI 10.1111/j.1365-313X.2005.02417.x; Tholl Dorothea, 2011, Arabidopsis Book, V9, pe0143, DOI 10.1199/tab.0143; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tissier A, 2012, PLANT J, V70, P51, DOI 10.1111/j.1365-313X.2012.04913.x; Trontin C, 2011, CURR OPIN PLANT BIOL, V14, P225, DOI 10.1016/j.pbi.2011.03.024; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; van den Bergh E, 2014, CURR PLANT BIOL, V1, P2, DOI 10.1016/j.cpb.2014.08.001; Vekemans D, 2012, MOL BIOL EVOL, V29, P3793, DOI 10.1093/molbev/mss183; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Wagner GJ, 2004, ANN BOT-LONDON, V93, P3, DOI 10.1093/aob/mch011; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Wang X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003255; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Woodhouse MR, 2011, PLANT CELL, V23, P4241, DOI 10.1105/tpc.111.093567; Xiang T, 2006, ORG LETT, V8, P2835, DOI 10.1021/ol060973p; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Yamaguchi S, 1998, PLANT PHYSIOL, V116, P1271, DOI 10.1104/pp.116.4.1271; Yeats C, 2006, NUCLEIC ACIDS RES, V34, pD281, DOI 10.1093/nar/gkj057; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao YJ, 2014, APPL MICROBIOL BIOT, V98, P2371, DOI 10.1007/s00253-013-5496-3	149	12	12	7	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128808	10.1371/journal.pone.0128808	http://dx.doi.org/10.1371/journal.pone.0128808			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046541	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200104
J	Perga, S; Albo, AG; Lis, K; Minari, N; Falvo, S; Marnetto, F; Caldano, M; Reviglione, R; Berchialla, P; Capobianco, MA; Malentacchi, M; Corpillo, D; Bertolotto, A				Perga, Simona; Albo, Alessandra Giuliano; Lis, Katarzyna; Minari, Nicoletta; Falvo, Sara; Marnetto, Fabiana; Caldano, Marzia; Reviglione, Raffaella; Berchialla, Paola; Capobianco, Marco A.; Malentacchi, Maria; Corpillo, Davide; Bertolotto, Antonio			Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis	PLOS ONE			English	Article							IDENTIFICATION; ASSOCIATION; PHENOTYPE; PROTOCOL; SERUM	Background Multiple sclerosis (MS) is a multifactorial autoimmune disease of the central nervous system with a heterogeneous and unpredictable course. To date there are no prognostic biomarkers even if they would be extremely useful for early patient intervention with personalized therapies. In this context, the analysis of inter-individual differences in cerebrospinal fluid (CSF) proteome may lead to the discovery of biological markers that are able to distinguish the various clinical forms at diagnosis. Methods To this aim, a two dimensional electrophoresis (2-DE) study was carried out on individual CSF samples from 24 untreated women who underwent lumbar puncture (LP) for suspected MS. The patients were clinically monitored for 5 years and then classified according to the degree of disease aggressiveness and the disease-modifying therapies prescribed during follow up. Results The hierarchical cluster analysis of 2-DE dataset revealed three protein spots which were identified by means of mass spectrometry as Apolipoprotein E (ApoE) and two isoforms of vitamin D binding protein (DBP). These three protein spots enabled us to subdivide the patients into subgroups correlated with clinical classification (MS aggressive forms identification: 80%). In particular, we observed an opposite trend of values for the two protein spots corresponding to different DBP isoforms suggesting a role of a post-translational modification rather than the total protein content in patient categorization. Conclusions These findings proved to be very interesting and innovative and may be developed as new candidate prognostic biomarkers of MS aggressiveness, if confirmed.	[Perga, Simona; Marnetto, Fabiana; Caldano, Marzia; Capobianco, Marco A.; Malentacchi, Maria; Bertolotto, Antonio] San Luigi Univ Hosp, Neurol Unit 2, Orbassano, Italy; [Perga, Simona; Marnetto, Fabiana; Caldano, Marzia; Capobianco, Marco A.; Malentacchi, Maria; Bertolotto, Antonio] San Luigi Univ Hosp, Reg Referral Multiple Sclerosis Ctr CReSM, Orbassano, Italy; [Albo, Alessandra Giuliano; Falvo, Sara; Reviglione, Raffaella; Corpillo, Davide] Bioind Pk Silvano Fumero SpA, ABLE Biosci, Colleretto Giacosa, Italy; [Albo, Alessandra Giuliano; Lis, Katarzyna; Minari, Nicoletta; Falvo, Sara; Reviglione, Raffaella; Corpillo, Davide] Bioind Pk Silvano Fumero SpA, LIMA, Colleretto Giacosa, Italy; [Perga, Simona; Marnetto, Fabiana; Caldano, Marzia; Bertolotto, Antonio] San Luigi Univ Hosp, Neurosci Inst Cavalieri Ottolenghi, Orbassano, Italy; [Berchialla, Paola] Univ Turin, Dept Clin & Biol Sci, Turin, Italy	University of Turin	Perga, S (corresponding author), San Luigi Univ Hosp, Neurol Unit 2, Orbassano, Italy.	simona.perga@unito.it	Capobianco, Marco/AAC-2215-2022; Berchialla, Paola/A-3208-2009; Bertolotto, Antonio/K-8346-2015	Capobianco, Marco/0000-0003-2501-2932; Berchialla, Paola/0000-0001-5835-5638; Bertolotto, Antonio/0000-0002-7052-1907	Fondazione Italiana Sclerosi Multipla (FISM) [2007/R/1]; ABLE Biosciences; LIMA	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); ABLE Biosciences; LIMA	This work was supported by the Fondazione Italiana Sclerosi Multipla (FISM - Grant number 2007/R/1). The sponsor had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, or in the preparation of the manuscript. ABLE Biosciences and LIMA provided support in the form of salaries for authors AGA, KL, NM, SF, RR, and DC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agrawal GK, 2005, PROTEOMICS, V5, P4684, DOI 10.1002/pmic.200500021; Axelsson M, 2013, J NEUROIMMUNOL, V264, P100, DOI 10.1016/j.jneuroim.2013.09.003; Bertolotto A, 2015, CEPHALALGIA; Chiasserini D, 2014, J PROTEOMICS, V106, P191, DOI 10.1016/j.jprot.2014.04.028; Chun RF, 2014, J STEROID BIOCHEM, V144, P132, DOI 10.1016/j.jsbmb.2013.09.012; Chun RF, 2012, CELL BIOCHEM FUNCT, V30, P445, DOI 10.1002/cbf.2835; Comabella M, 2014, LANCET NEUROL, V13, P113, DOI 10.1016/S1474-4422(13)70233-3; Craft GE, 2013, METHODS, V61, P186, DOI 10.1016/j.ymeth.2013.04.008; Disanto G, 2011, J NEUROL, V258, P353, DOI 10.1007/s00415-010-5797-8; Eriksson B, 2008, Patent No. [US2008171394, 2008171394]; Gibson DS, 2012, J PROTEOMICS, V75, P5479, DOI 10.1016/j.jprot.2012.06.024; Giovannoni G, 2014, HAND CLINIC, V122, P681, DOI 10.1016/B978-0-444-52001-2.00029-7; Huhmer AF, 2006, DIS MARKERS, V22, P3; Kroksveen AC, 2012, ACTA NEUROL SCAND, V126, P90, DOI 10.1111/ane.12029; Kroksveen AC, 2011, J PROTEOMICS, V74, P371, DOI 10.1016/j.jprot.2010.11.010; Kulakowska A, 2009, EUROPEAN J NEUROLOGY, V15, P584; Kulakowska A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-107; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lanzillo R, 2012, ACTA NEUROL SCAND, V126, P306, DOI 10.1111/j.1600-0404.2011.01622.x; Lauridsen AL, 2005, CALCIFIED TISSUE INT, V77, P15, DOI 10.1007/s00223-004-0227-5; Lauridsen AL, 2001, CLIN CHEM, V47, P753; Lehmensiek V, 2007, MULT SCLER, V13, P840, DOI 10.1177/1352458507076406; Liguori M, 2014, PLOS ONE, V6, P9; Mila S, 2009, BIOMARK MED, V3, P117, DOI 10.2217/BMM.09.4; Moy KA, 2014, AM J CLIN NUTR, V99, P1424, DOI 10.3945/ajcn.113.080309; Ottervald J, 2010, J PROTEOMICS, V73, P1117, DOI 10.1016/j.jprot.2010.01.004; Pacini S, 2012, ANTICANCER RES, V32, P45; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Qin ZY, 2009, CELL MOL NEUROBIOL, V29, P203, DOI 10.1007/s10571-008-9312-z; Ravnsborg T, 2010, BBA-PROTEINS PROTEOM, V1804, P909, DOI 10.1016/j.bbapap.2009.12.022; Rehder DS, 2009, PROTEIN SCI, V18, P2036, DOI 10.1002/pro.214; Robotti A, 2010, ELECTROPHORESIS, V31, P2882, DOI 10.1002/elps.201000171; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Singer B, 2011, INT J CLIN PRACT, V65, P887, DOI 10.1111/j.1742-1241.2011.02721.x; Smolders J, 2014, MULT SCLER J, V20, P433, DOI 10.1177/1352458513500552; Stoop MP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012442; Tamam Y, 2011, EUR REV MED PHARMACO, V15, P1122; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Teunissen CE, 2009, NEUROLOGY, V73, P1914, DOI 10.1212/WNL.0b013e3181c47cc2; Teunissen C, 2013, MULT SCLER J, V19, P1802, DOI 10.1177/1352458513488232; Tumani H, 2009, NEUROSCI LETT, V452, P214, DOI 10.1016/j.neulet.2009.01.057; Yang MC, 2013, MOL NEUROBIOL, V47, P946, DOI 10.1007/s12035-012-8387-1	42	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129291	10.1371/journal.pone.0129291	http://dx.doi.org/10.1371/journal.pone.0129291			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046356	gold, Green Submitted, Green Published			2022-12-26	WOS:000355652200143
J	Wu, JH; Wang, W; Liu, Y; Sun, J; Ye, Y; Li, BY; Liu, XN; Liu, HX; Sun, ZQ; Li, M; Cui, J; Sun, DJ; Yang, YM; Gao, YH				Wu, Junhua; Wang, Wei; Liu, Yang; Sun, Jing; Ye, Yan; Li, Bingyun; Liu, Xiaona; Liu, Hongxu; Sun, Zhenqi; Li, Mang; Cui, Jing; Sun, Dianjun; Yang, Yanmei; Gao, Yanhui			Modifying Role of GSTP1 Polymorphism on the Association between Tea Fluoride Exposure and the Brick-Tea Type Fluorosis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; BONE-MINERAL DENSITY; DENTAL FLUOROSIS; GENE POLYMORPHISMS; ENDEMIC FLUOROSIS; CONSUMPTION; ALUMINUM; QUALITY	Background Brick tea type fluorosis is a public health concern in the north-west area of China. The association between SNPs of genes influencing bone mass and fluorosis has attracted attention, but the association of SNPs with the risk of brick-tea type of fluorosis has not been reported. Objective To investigate the modifying roles of GSTP1 rs1695 polymorphisms on this association. Methods A cross-sectional study was conducted. Brick-tea water was tested by the standard of GB1996-2005 (China). Urinary fluoride was tested by the standard of WS/T 89-2006 (China). Skeletal fluorosis was diagnosed by X-ray, the part we scheduled was forearm, shank, and pelvic, then diagnosed the skeletal fluorosis by the standard of WS/192-2008 (China). Gene polymorphism was tested by Sequenom MassARRAY system. Result The prevalence rate in different ethnical participants was different: Tibetan individuals had the highest prevalence rate of skeletal fluorosis. There were significant differences in genotype frequencies of GSTP1 Rs1695 among different ethnical participants (p < 0.001): Tibetan, Mongolian and Han subjects with homozygous wild type (GSTP1-AA) genotype were numerically higher than Kazakh and Russian subjects (p < 0.001). Compared to Tibetan participants who carried homozygous A allele of GSTP1 Rs1695, Tibetan participants who carried G allele had a significantly decreased risk of skeletal fluorosis (OR = 0.558 [95% CI, 0.326-0.955]). For Kazakh participants, a decreased risk of skeletal fluorosis among carriers of the G allele was limited to non high-loaded fluoride status (OR = 0. 166 [95% CI, 0.03-0.780] vs. OR = 1.478 [95% CI, 0.866-2.552] in participants with high-loaded fluoride status). Neither SNP-IF nor SNP-age for GSTP1 Rs1695 was observed. Conclusion The prevalence rate of the brick tea type fluorosis might have ethnic difference. For Tibetan individuals, who had the highest prevalence rate, G allele of GSTP1 Rs1695 might be a protective factor for brick tea type skeletal fluorosis	[Yang, Yanmei] Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Key Lab Etiol & Epidemiol Educ Bur Heilongjiang P, Ctr Endem Dis Control, Harbin 150081, Heilongjiang Pr, Peoples R China; Minist Hlth 23618504, Harbin 150081, Heilongjiang Pr, Peoples R China	Chinese Center for Disease Control & Prevention; Harbin Medical University	Yang, YM (corresponding author), Harbin Med Univ, Chinese Ctr Dis Control & Prevent, Key Lab Etiol & Epidemiol Educ Bur Heilongjiang P, Ctr Endem Dis Control, Harbin 150081, Heilongjiang Pr, Peoples R China.	yangym0916@163.com; gaoyh411@163.com			National Natural Science Foundation of China [81172605, 30800956]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81172605 and 30800956).	AliOsman F, 1997, J BIOL CHEM, V272, P10004; Ba Y, 2011, BIOL TRACE ELEM RES, V143, P87, DOI 10.1007/s12011-010-8848-1; Ba Y, 2009, ECOTOX ENVIRON SAFE, V72, P2158, DOI 10.1016/j.ecoenv.2009.08.014; Cao J, 1997, FOOD CHEM TOXICOL, V35, P827, DOI 10.1016/S0278-6915(97)00049-5; Cao J, 1996, ENVIRON HEALTH PERSP, V104, P1340, DOI 10.2307/3432972; Cao J, 2003, FOOD CHEM TOXICOL, V41, P535, DOI 10.1016/S0278-6915(02)00285-5; Chandrajith R, 2007, ENVIRON GEOCHEM HLTH, V29, P429, DOI 10.1007/s10653-007-9087-z; Chen YL, 2010, BMC MED GENET, V11, DOI [10.1186/1471-2350-11-46, 10.1186/1471-2350-11-17]; Choubisa S L, 2001, Indian J Environ Health, V43, P177; Choubisa S. L., 2007, Journal of Communicable Diseases, V39, P171; Emekli-Alturfan E, 2009, FOOD CHEM TOXICOL, V47, P1495, DOI 10.1016/j.fct.2009.03.036; Everett ET, 2011, EUR J ORAL SCI, V119, P8, DOI 10.1111/j.1600-0722.2011.00868.x; Everett ET, 2009, CELLS TISSUES ORGANS, V189, P212, DOI 10.1159/000151383; Everett ET, 2002, J DENT RES, V81, P794, DOI 10.1177/0810794; Gavriliuk LA, 2007, KLINICHESKAIA LAB DI, V22, P35; Gong YQ, 1996, AM J HUM GENET, V59, P146; GRAHAM HN, 1992, PREV MED, V21, P334, DOI 10.1016/0091-7435(92)90041-F; GRYNPAS M D, 1990, Journal of Bone and Mineral Research, V5, pS169; Gupta P, 2012, J INT SOC PREV COMMU, V2, P64, DOI 10.4103/2231-0762.109371; Huang H, 2008, COMMUNITY DENT ORAL, V36, P517, DOI 10.1111/j.1600-0528.2007.00424.x; Huang QY, 2006, HUM HERED, V61, P237, DOI 10.1159/000095216; Jha SK, 2011, REV ENVIRON CONTAM T, V211, P121, DOI 10.1007/978-1-4419-8011-3_4; Jin C, 2003, ECOTOX ENVIRON SAFE, V56, P222, DOI 10.1016/S0147-6513(03)00065-4; KRISHNAMACHARI KAVR, 1986, PROG FOOD NUTR SCI, V10, P279; Kumar JV, 1998, AM J PUBLIC HEALTH, V88, P1866, DOI 10.2105/AJPH.88.12.1866; Lung SCC, 2008, J EXPO SCI ENV EPID, V18, P158, DOI 10.1038/sj.jes.7500574; MABELYA L, 1994, COMMUNITY DENT ORAL, V22, P415, DOI 10.1111/j.1600-0528.1994.tb00789.x; Malde M K, 2003, Int J Paediatr Dent, V13, P27, DOI 10.1046/j.1365-263X.2003.00422.x; Mandinic Z, 2009, FOOD CHEM TOXICOL, V47, P1080, DOI 10.1016/j.fct.2009.01.038; Peacock M, 2005, J CLIN ENDOCR METAB, V90, P3060, DOI 10.1210/jc.2004-2143; Shu WS, 2003, CHEMOSPHERE, V52, P1475, DOI 10.1016/S0045-6535(03)00485-5; SOGAARD CH, 1994, BONE, V15, P393, DOI 10.1016/8756-3282(94)90815-X; Varol E, 2013, TOXICOL IND HEALTH, V29, P175, DOI 10.1177/0748233711428641; Vieira APGF, 2005, CALCIFIED TISSUE INT, V76, P17, DOI 10.1007/s00223-004-0075-3; Wang Q, 2014, ENVIRON GEOCHEM HLTH, V36, P107, DOI 10.1007/s10653-013-9522-2; Watson MA, 1998, CARCINOGENESIS, V19, P275, DOI 10.1093/carcin/19.2.275; Wen SB, 2012, BIOL TRACE ELEM RES, V147, P84, DOI 10.1007/s12011-011-9313-5; Wong MH, 2003, TOXICOL LETT, V137, P111, DOI 10.1016/S0378-4274(02)00385-5; Yang G, 2005, CANCER-AM CANCER SOC, V103, P52, DOI 10.1002/cncr.20729; Yang LS, 2003, ENVIRON GEOCHEM HLTH, V25, P281, DOI 10.1023/A:1024543819240; Yi J, 2008, J FLUORINE CHEM, V129, P76, DOI 10.1016/j.jfluchem.2007.11.001; Yoder KM, 1998, COMMUNITY DENT ORAL, V26, P382, DOI 10.1111/j.1600-0528.1998.tb01976.x; Zhang T, 2013, BIOL TRACE ELEM RES, V152, P379, DOI 10.1007/s12011-013-9632-9; ZIMNIAK P, 1994, EUR J BIOCHEM, V224, P893, DOI 10.1111/j.1432-1033.1994.00893.x	44	15	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128280	10.1371/journal.pone.0128280	http://dx.doi.org/10.1371/journal.pone.0128280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046522	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200054
J	Csoka, B; Nemeth, ZH; Toro, G; Idzko, M; Zech, A; Koscso, B; Spolarics, Z; Antonioli, L; Cseri, K; Erdelyi, K; Pacher, P; Hasko, G				Csoka, Balazs; Nemeth, Zoltan H.; Toero, Gabor; Idzko, Marco; Zech, Andreas; Koscso, Balazs; Spolarics, Zoltan; Antonioli, Luca; Cseri, Karolina; Erdelyi, Katalin; Pacher, Pal; Hasko, Gyoergy			Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing	FASEB JOURNAL			English	Article						connexin; inflammasome; inflammation; pannexin; phagocytosis	INNATE; ACTIVATION; ADENOSINE; CHANNELS; CD39; INFLAMMASOME; NEUTROPHILS; INHIBITION; PYROPTOSIS; MORTALITY	Extracellular ATP binds to and signals through P2X7 receptors (P2X7Rs) to modulate immune function in both inflammasome-dependent and -independent manners. In this study, P2X7(-/-) mice, the pharmacological agonists ATP-magnesiumsalt (Mg-ATP; 100 mg/kg, EC50 approximate to 1.32 mM) and benzoylbenzoyl-ATP (Bz-ATP; 10 mg/kg, EC50 approximate to 285 mu M), and antagonist oxidized ATP (oxi-ATP; 40 mg/kg, IC50 approximate to 100 mu M) were used to show that P2X7R activation is crucial for the control of mortality, bacterial dissemination, and inflammation in cecal ligation and puncture-induced polymicrobial sepsis in mice. Our results with P2X7(-/-) bone marrow chimeric mice, adoptive transfer of peritoneal macrophages, and myeloid-specific P2X7(-/-) mice indicate that P2X7R signaling on macrophages is essential for the protective effect of P2X7Rs. P2X7R signaling protects through enhancing bacterial killing by macrophages, which is independent of the inflammasome. By using the connexin (Cx) channel inhibitor Gap27 (0.1 mg/kg, IC50 approximate to 0.25 mu M) and pannexin channel inhibitor probenecid (10 mg/kg, IC50 approximate to 11.7 mu M), we showed that ATP release through Cx is important for inhibiting inflammation and bacterial burden. In summary, targeting P2X7Rs provides a new opportunity for harnessing an endogenous protective immune mechanism in the treatment of sepsis.	[Csoka, Balazs; Nemeth, Zoltan H.; Toero, Gabor; Koscso, Balazs; Spolarics, Zoltan; Hasko, Gyoergy] Rutgers New Jersey Med Sch, Dept Surg, Newark, NJ 07103 USA; [Csoka, Balazs; Toero, Gabor; Spolarics, Zoltan; Hasko, Gyoergy] Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ USA; [Idzko, Marco; Zech, Andreas] Univ Freiburg, Freiburg Univ Med Ctr, Dept Pneumol, D-79106 Freiburg, Germany; [Antonioli, Luca] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Cseri, Karolina] Univ Debrecen, Med & Hlth Sci Ctr, Dept Med Chem, Debrecen, Hungary; [Erdelyi, Katalin; Pacher, Pal] NIAAA, NIH, Bethesda, MD USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Atlantic Health System; University of Freiburg; University of Pisa; University of Debrecen; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hasko, G (corresponding author), Rutgers New Jersey Med Sch, Dept Surg, 185 S Orange Ave, Newark, NJ 07103 USA.	haskoge@njms.rutgers.edu	Zech, Andreas/ABB-3040-2021; Pacher, Pal/B-6378-2008	Pacher, Pal/0000-0001-7036-8108; Koscso, Balazs/0000-0001-9676-2066	U.S. National Institutes of Health (NIH) Grant from National Institute of General Medical Sciences [R01GM66189]; U.S. Army Medical Research and Materiel Command Grant [09065004/W81XWH-10-1-1015]; Hungarian Scientific Research Fund Grants (OTKA) [CK 78275, K109178]; Intramural Research Program of NIH, National Institute on Alcohol Abuse and Alcoholism; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000375] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Grant from National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Army Medical Research and Materiel Command Grant(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Hungarian Scientific Research Fund Grants (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Intramural Research Program of NIH, National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by U.S. National Institutes of Health (NIH) Grant R01GM66189 from the National Institute of General Medical Sciences, U.S. Army Medical Research and Materiel Command Grant 09065004/W81XWH-10-1-1015, and Hungarian Scientific Research Fund Grants (OTKA) CK 78275 and K109178 (all to G.H.) and by funding from the Intramural Research Program of the NIH, National Institute on Alcohol Abuse and Alcoholism (to P.P.). The authors declare no conflicts of interests.	Ali SR, 2011, IMMUNITY, V35, P34, DOI 10.1016/j.immuni.2011.04.015; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; [Anonymous], 2009, CHEST; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bao Y, 2013, J BIOL CHEM, V288, P22650, DOI 10.1074/jbc.M113.476283; Bartlett R, 2014, PHARMACOL REV, V66, P638, DOI 10.1124/pr.113.008003; Benjamin CF, 2004, J LEUKOCYTE BIOL, V75, P408, DOI 10.1189/jlb.0503214; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Chaves MM, 2014, J IMMUNOL, V192, P4765, DOI 10.4049/jimmunol.1301058; Chen QX, 2014, INNATE IMMUN-LONDON, V20, P290, DOI 10.1177/1753425913490575; Christenson K, 2008, J LEUKOCYTE BIOL, V83, P139, DOI 10.1189/jlb.0507276; Csoka B, 2007, BLOOD, V110, P2685, DOI 10.1182/blood-2007-01-065870; Csoka B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006409; Csoka B, 2015, FASEB J, V29, P25, DOI 10.1096/fj.14-253567; Csoka B, 2010, J IMMUNOL, V185, P542, DOI 10.4049/jimmunol.0901295; Dubyak GR, 2012, CELL MICROBIOL, V14, P1697, DOI 10.1111/cmi.12001; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Eugenin EA, 2014, FEBS LETT, V588, P1389, DOI 10.1016/j.febslet.2014.01.030; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Gu BJ, 2013, FASEB J, V27, P1479, DOI 10.1096/fj.12-215368; Gu BJ, 2000, AM J PHYSIOL-CELL PH, V279, pC1189, DOI 10.1152/ajpcell.2000.279.4.C1189; Hasko G, 2011, J IMMUNOL, V187, P4256, DOI 10.4049/jimmunol.1003379; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; King EG, 2014, LAB INVEST, V94, P4, DOI 10.1038/labinvest.2013.110; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Lammas DA, 1997, IMMUNITY, V7, P433, DOI 10.1016/S1074-7613(00)80364-7; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Lohman AW, 2014, FEBS LETT, V588, P1379, DOI 10.1016/j.febslet.2014.02.004; Martel-Gallegos G, 2010, PURINERG SIGNAL, V6, P297, DOI 10.1007/s11302-010-9178-7; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Morandini Ana Carolina, 2014, Biomed J, V37, P169, DOI 10.4103/2319-4170.127803; Nemeth ZH, 2006, J IMMUNOL, V176, P5616, DOI 10.4049/jimmunol.176.9.5616; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Santana PT, 2015, J INNATE IMMUN, V7, P417, DOI 10.1159/000371388; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Senthil M, 2007, ANN SURG, V246, P822, DOI 10.1097/SLA.0b013e3180caa3af; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Ulloa L, 2009, CURR PHARM DESIGN, V15, P1918, DOI 10.2174/138161209788453248; van der Poll T, 2008, LANCET INFECT DIS, V8, P32, DOI 10.1016/S1473-3099(07)70265-7; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354	47	86	87	2	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3626	3637		10.1096/fj.15-272450	http://dx.doi.org/10.1096/fj.15-272450			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26060214	Green Published, Green Submitted			2022-12-26	WOS:000359915600003
J	Ranninger, C; Rurik, M; Limonciel, A; Ruzek, S; Reischl, R; Wilmes, A; Jennings, P; Hewitt, P; Dekant, W; Kohlbacher, O; Huber, CG				Ranninger, Christina; Rurik, Marc; Limonciel, Alice; Ruzek, Silke; Reischl, Roland; Wilmes, Anja; Jennings, Paul; Hewitt, Philip; Dekant, Wolfgang; Kohlbacher, Oliver; Huber, Christian G.			Nephron Toxicity Profiling via Untargeted Metabolome Analysis Employing a High Performance Liquid Chromatography-Mass Spectrometry-based Experimental and Computational Pipeline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTRAL DATA; PROTEOMICS; DATABASE; CELLS; ACID; DELINEATION; STRATEGIES; WORKFLOW; STRESS; SYSTEM	Untargeted metabolomics has the potential to improve the predictivity of in vitro toxicity models and therefore may aid the replacement of expensive and laborious animal models. Here we describe a long term repeat dose nephrotoxicity study conducted on the human renal proximal tubular epithelial cell line, RPTEC/TERT1, treated with 10 and 35 mu mol.liter(-1) of chloroacetaldehyde, a metabolite of the anti-cancer drug ifosfamide. Our study outlines the establishment of an automated and easy to use untargeted metabolomics workflow for HPLC-high resolution mass spectrometry data. Automated data analysis work-flows based on open source software (OpenMS, KNIME) enabled a comprehensive and reproducible analysis of the complex and voluminous metabolomics data produced by the profiling approach. Time-and concentration-dependent responses were clearly evident in the metabolomic profiles. To obtain a more comprehensive picture of the mode of action, transcriptomics and proteomics data were also integrated. For toxicity profiling of chloroacetaldehyde, 428 and 317 metabolite features were detectable in positive and negative modes, respectively, after stringent removal of chemical noise and unstable signals. Changes upon treatment were explored using principal component analysis, and statistically significant differences were identified using linear models for microarray assays. The analysis revealed toxic effects only for the treatment with 35 mmol.liter(-1) for 3 and 14 days. The most regulated metabolites were glutathione and metabolites related to the oxidative stress response of the cells. These findings are corroborated by proteomics and transcriptomics data, which show, among other things, an activation of the Nrf2 and ATF4 pathways.	[Ranninger, Christina; Ruzek, Silke; Reischl, Roland; Huber, Christian G.] Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, A-5020 Salzburg, Austria; [Rurik, Marc; Kohlbacher, Oliver] Univ Tubingen, Appl Bioinformat Grp, Ctr Bioinformat, Quantitat Biol Ctr, D-72076 Tubingen, Germany; [Rurik, Marc; Kohlbacher, Oliver] Univ Tubingen, Dept Comp Sci, D-72076 Tubingen, Germany; [Limonciel, Alice; Wilmes, Anja; Jennings, Paul] Med Univ Innsbruck, Div Physiol, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Hewitt, Philip] Nonclin Safety, Merck KGaA, Merck Serono, D-64293 Darmstadt, Germany; [Dekant, Wolfgang] Univ Wurzburg, Dept Toxicol, D-97078 Wurzburg, Germany	Salzburg University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Medical University of Innsbruck; Merck KGaA; EMD Serono Inc.; University of Wurzburg	Huber, CG (corresponding author), Salzburg Univ, Dept Mol Biol, Div Chem & Bioanalyt, Hellbrunner Str 34, A-5020 Salzburg, Austria.	c.huber@sbg.ac.at	Reischl, Roland/AAP-7190-2020; Huber, Christian G./E-5445-2011; Reischl, Roland J/I-4046-2012; Kohlbacher, Oliver/AAF-3297-2021	Huber, Christian G./0000-0001-8358-1880; Reischl, Roland J/0000-0003-3331-6565; Kohlbacher, Oliver/0000-0003-1739-4598; Jennings, Paul/0000-0002-6860-2898; Wilmes, Anja/0000-0001-9485-4565; Limonciel, Alice/0000-0001-6588-5944	European Union [202222]; Austrian Society for Analytical Chemistry	European Union(European Commission); Austrian Society for Analytical Chemistry	This work was supported by the European Union's 7th Framework Programme FP7/2007-2013 under Grant Agreement 202222, Predict-IV. Part of this work was presented by C. R. at Metabolomics 2013 in Glasgow, for which she received a travel grant awarded by the Austrian Society for Analytical Chemistry. The authors declare no other competing financial interest.	Aschauer L., 2014, TOXICOL IN IN PRESS; Aschauer L, 2013, MOL CELL BIOL, V33, P2535, DOI 10.1128/MCB.01435-12; Berthold M. R., 2008, KNIME KONSTANZ INFOR; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Bloomfield V.A., 2014, USING R NUMERICAL AN; BRASSFIELD HA, 1975, J AM CHEM SOC, V97, P4143, DOI 10.1021/ja00847a053; Breitwieser FP, 2011, J PROTEOME RES, V10, P2758, DOI 10.1021/pr1012784; Brown M, 2005, METABOLOMICS, V1, P39, DOI 10.1007/s11306-005-1106-4; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; Dickinson DA, 2004, FREE RADICAL BIO MED, V37, P1152, DOI 10.1016/j.freeradbiomed.2004.06.011; Ellis JK, 2011, MOL BIOSYST, V7, P247, DOI 10.1039/c0mb00146e; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Huang N, 1999, J AM SOC MASS SPECTR, V10, P1166, DOI 10.1016/S1044-0305(99)00089-6; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Jenkins S, 2013, METABOLITES, V3, P1102, DOI 10.3390/metabo3041102; Junker J, 2012, J PROTEOME RES, V11, P3914, DOI 10.1021/pr300187f; Kenar E, 2014, MOL CELL PROTEOMICS, V13, P348, DOI 10.1074/mcp.M113.031278; Kleinstreuer NC, 2011, TOXICOL APPL PHARM, V257, P111, DOI 10.1016/j.taap.2011.08.025; Kohlbacher O, 2007, BIOINFORMATICS, V23, pE191, DOI 10.1093/bioinformatics/btl299; Kumar A, 2012, CURR SCI INDIA, V102, P288; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Patti GJ, 2011, J SEP SCI, V34, P3460, DOI 10.1002/jssc.201100532; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Ramautar R, 2013, CURR OPIN CHEM BIOL, V17, P841, DOI 10.1016/j.cbpa.2013.06.015; Roux A, 2011, CLIN BIOCHEM, V44, P119, DOI 10.1016/j.clinbiochem.2010.08.016; Ruiz-Aracama A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-251; Savitha S, 2005, CLIN CHIM ACTA, V355, P173, DOI 10.1016/j.cccn.2004.12.005; Scheltema RA, 2011, ANAL CHEM, V83, P2786, DOI 10.1021/ac2000994; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sturm M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-163; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; West PR, 2010, TOXICOL APPL PHARM, V247, P18, DOI 10.1016/j.taap.2010.05.007; Wieser M, 2008, AM J PHYSIOL-RENAL, V295, pF1365, DOI 10.1152/ajprenal.90405.2008; Wilmes A, 2015, TOXICOL IN VITRO, V30, P117, DOI 10.1016/j.tiv.2014.10.006; Wilmes A, 2013, J PROTEOMICS, V79, P180, DOI 10.1016/j.jprot.2012.11.022; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Wojtczak L, 2003, BIOFACTORS, V17, P61, DOI 10.1002/biof.5520170107; Yapar K, 2007, EXP TOXICOL PATHOL, V59, P121, DOI 10.1016/j.etp.2007.02.009	45	9	10	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19121	19132		10.1074/jbc.M115.644146	http://dx.doi.org/10.1074/jbc.M115.644146			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26055719	hybrid, Green Published			2022-12-26	WOS:000358781100028
J	van den Berg, S; de Vogel, CP; van Belkum, A; Bakker-Woudenberg, IAJM				van den Berg, Sanne; de Vogel, Corne P.; van Belkum, Alex; Bakker-Woudenberg, Irma A. J. M.			Mild Staphylococcus aureus Skin Infection Improves the Course of Subsequent Endogenous S. aureus Bacteremia in Mice	PLOS ONE			English	Article							NASAL CARRIAGE; ANTIBODY-RESPONSES; CARRIERS; STATE; RISK; REVEALS; BINDING; PROTEIN	Staphylococcus aureus carriers with S. aureus bacteremia may have a reduced mortality risk compared to non-carriers. A role for the immune system is suggested. Here, we study in mice the effect of mild S. aureus skin infection prior to endogenous or exogenous S. aureus bacteremia, and evaluate protection in relation to anti-staphylococcal antibody levels. Skin infections once or twice by a clinical S. aureus isolate (isolate P) or S. aureus strain 8325-4 were induced in mice free of S. aureus and anti-staphylococcal antibodies. Five weeks later, immunoglobulin G (IgG) levels in blood against 25 S. aureus antigens were determined, and LD50 or LD100 bacteremia caused by S. aureus isolate P was induced. S. aureus skin infections led to elevated levels of anti-staphylococcal IgG in blood. One skin infection improved the course of subsequent severe endogenous bacteremia only. A second skin infection further improved animal survival rate, which was associated with increased pre-bacteremia IgG levels against Efb, IsaA, LukD, LukE, Nuc, PrsA and WTA. In conclusion, S. aureus isolate P skin infection in mice reduces the severity of subsequent endogenous S. aureus bacteremia only. Although cellular immune effects cannot be rules out, anti-staphylococcal IgG against specified antigens may contribute to this effect.	[van den Berg, Sanne; de Vogel, Corne P.; van Belkum, Alex; Bakker-Woudenberg, Irma A. J. M.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [van Belkum, Alex] bioMerieux, Microbiol R&D, La Balme Les Grottes, France	Erasmus University Rotterdam; Erasmus MC; bioMerieux	van den Berg, S (corresponding author), Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	s.vandenberg@erasmusmc.nl		van den Berg, Sanne/0000-0001-9209-0178	bioMerieux	bioMerieux	bioMerieux provided support for this work in the form of salaries for author Alex van Belkum, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Brown AE, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00507; Brown EL, 2009, CLIN MICROBIOL INFEC, V15, P156, DOI 10.1111/j.1469-0691.2008.02648.x; CALIA FM, 1969, J HYG-CAMB, V67, P49, DOI 10.1017/S0022172400041413; Chung MC, 2007, MOL MICROBIOL, V66, P1342, DOI 10.1111/j.1365-2958.2007.05989.x; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; den Reijer PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053391; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Kolata J, 2011, PROTEOMICS, V11, P3914, DOI 10.1002/pmic.201000760; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Martins TB, 2006, J IMMUNOL METHODS, V316, P97, DOI 10.1016/j.jim.2006.08.007; Melles DC, 2009, EUR J CLIN MICROBIOL, V28, P39, DOI 10.1007/s10096-008-0585-4; Montgomery CP, 2014, INFECT IMMUN, V82, P2125, DOI 10.1128/IAI.01491-14; Munoz P, 2008, J HOSP INFECT, V68, P25, DOI 10.1016/j.jhin.2007.08.010; Murphy AG, 2014, J IMMUNOL, V192, P3697, DOI 10.4049/jimmunol.1303420; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; NOVICK R, 1967, VIROLOGY, V33, P155, DOI 10.1016/0042-6822(67)90105-5; Prat C, 2006, J IMMUNOL, V177, P8017, DOI 10.4049/jimmunol.177.11.8017; Shannon O, 2005, THROMB HAEMOSTASIS, V93, P927, DOI 10.1160/TH04-08-0501; van den Berg S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059107; van den Berg S, 2011, J IMMUNOL METHODS, V365, P142, DOI 10.1016/j.jim.2010.12.013; Verkaik N, 2008, J IMMUNOL METHODS, V335, P121, DOI 10.1016/j.jim.2008.02.022; Verkaik NJ, 2010, CLIN INFECT DIS, V50, P61, DOI 10.1086/648673; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; WEINSTEIN HJ, 1959, NEW ENGL J MED, V260, P1303, DOI 10.1056/NEJM195906252602601; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; WILLIAMS REO, 1959, BMJ-BRIT MED J, V2, P658, DOI 10.1136/bmj.2.5153.658; Ziebandt AK, 2010, PROTEOMICS, V10, P1634, DOI 10.1002/pmic.200900313	31	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129150	10.1371/journal.pone.0129150	http://dx.doi.org/10.1371/journal.pone.0129150			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26060995	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500126
J	Alvarez-Zarate, J; Matlung, HL; Matozaki, T; Kuijpers, TW; Maridonneau-Parini, I; van den Berg, TK				Alvarez-Zarate, Julian; Matlung, Hanke L.; Matozaki, Takashi; Kuijpers, Taco W.; Maridonneau-Parini, Isabelle; van den Berg, Timo K.			Regulation of Phagocyte Migration by Signal Regulatory Protein-Alpha Signaling	PLOS ONE			English	Article							SIRP-ALPHA; ADHESION; TRANSMIGRATION; SHPS-1; MACROPHAGES; RESISTANCE; LEUKOCYTES; PODOSOMES; CELLS; SPOTS	Signaling through the inhibitory receptor signal regulatory protein-alpha (SIRP alpha) controls effector functions in phagocytes. However, there are also indications that interactions between SIRP alpha and its ligand CD47 are involved in phagocyte transendothelial migration. We have investigated the involvement of SIRP alpha signaling in phagocyte migration in vitro and in vivo using mice that lack the SIRP alpha cytoplasmic tail. During thioglycolate-induced peritonitis in SIRP alpha mutant mice, both neutrophil and macrophage influx were found to occur, but to be significantly delayed. SIRP alpha signaling appeared to be essential for an optimal transendothelial migration and chemotaxis, and for the amoeboid type of phagocyte migration in 3-dimensional environments. These findings demonstrate, for the first time, that SIRP alpha signaling can directly control phagocyte migration, and this may contribute to the impaired inflammatory phenotype that has been observed in the absence of SIRP alpha signaling.	[Alvarez-Zarate, Julian; Matlung, Hanke L.; Kuijpers, Taco W.; Maridonneau-Parini, Isabelle; van den Berg, Timo K.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands; [Matozaki, Takashi] Kobe Univ, Div Mol & Cellular Signaling, Dept Biochem & Mol Biol, Grad Sch Med, Kobe, Hyogo 6500017, Japan; [Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, Sanquin Res & Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Maridonneau-Parini, Isabelle] CNRS, UMR5089, Inst Pharmacol & Biol Struct, Toulouse, France; [Maridonneau-Parini, Isabelle] Univ Toulouse, UPS, IPBS, Toulouse, France	University of Amsterdam; Academic Medical Center Amsterdam; Kobe University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	van den Berg, TK (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, NL-1066 CX Amsterdam, Netherlands.	t.k.vandenberg@sanquin.nl	Maridonneau-Parini, Isabelle/F-1985-2011; van den Berg, Timo K/AAC-2479-2022; Matlung, Hanke/ABH-5649-2020	Maridonneau-Parini, Isabelle/0000-0003-0189-0976	NWO; Grants-in-Aid for Scientific Research [26291022] Funding Source: KAKEN	NWO(Netherlands Organization for Scientific Research (NWO)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from NWO (http://www.nwo.nl/) awarded to TKvdB, and a visitors grant from NWO awarded to IMP and TKvdB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 1998, J IMMUNOL, V161, P1853; Alenghat F.J., 2012, J CELL SCI; Bian Z, 2013, J IMMUNOL, V190, P411, DOI 10.4049/jimmunol.1201963; Call DR, 2001, AM J PATHOL, V158, P715, DOI 10.1016/S0002-9440(10)64014-X; Cougoule C, 2005, TRAFFIC, V6, P682, DOI 10.1111/j.1600-0854.2005.00307.x; Cougoule C, 2012, EUR J CELL BIOL, V91, P938, DOI 10.1016/j.ejcb.2012.07.002; CRANSHAW ML, 1990, ARCH HISTOL CYTOL, V53, P165, DOI 10.1679/aohc.53.Suppl_165; de Vries HE, 2002, J IMMUNOL, V168, P5832, DOI 10.4049/jimmunol.168.11.5832; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Inagaki K, 2000, EMBO J, V19, P6721, DOI 10.1093/emboj/19.24.6721; Isenberg JS, 2008, CURR DRUG TARGETS, V9, P833, DOI 10.2174/138945008785909338; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Matozaki T, 2009, TRENDS CELL BIOL, V19, P72, DOI 10.1016/j.tcb.2008.12.001; Okuzawa C, 2008, BIOCHEM BIOPH RES CO, V371, P561, DOI 10.1016/j.bbrc.2008.04.124; Saito Y, 2010, BLOOD, V116, P3517, DOI 10.1182/blood-2010-03-277244; Shah S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038368; Timms JF, 1999, CURR BIOL, V9, P927, DOI 10.1016/S0960-9822(99)80401-1; Tomizawa T, 2007, J IMMUNOL, V179, P869, DOI 10.4049/jimmunol.179.2.869; van Beek EM, 2012, CELL REP, V2, P748, DOI 10.1016/j.celrep.2012.08.027; Van Goethem E, 2011, EUR J CELL BIOL, V90, P224, DOI 10.1016/j.ejcb.2010.07.011; Van Goethem E, 2010, J IMMUNOL, V184, P1049, DOI 10.4049/jimmunol.0902223; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Wu QL, 2004, CELL MOL IMMUNOL, V1, P57	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0127178	10.1371/journal.pone.0127178	http://dx.doi.org/10.1371/journal.pone.0127178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057870	gold, Green Submitted, Green Published			2022-12-26	WOS:000356349000007
J	Corneli, A; Field, S; Namey, E; Agot, K; Ahmed, K; Odhiambo, J; Skhosana, J; Guest, G				Corneli, Amy; Field, Samuel; Namey, Emily; Agot, Kawango; Ahmed, Khatija; Odhiambo, Jacob; Skhosana, Joseph; Guest, Greg			Preparing for the Rollout of Pre-Exposure Prophylaxis (PrEP): A Vignette Survey to Identify Intended Sexual Behaviors among Women in Kenya and South Africa if Using PrEP	PLOS ONE			English	Article							HIV PREVENTION; RISK BEHAVIOR; FACTORIAL SURVEYS; RANDOMIZED-TRIAL; HETEROSEXUAL MEN; TRANSMISSION; TENOFOVIR; IMPACT	Introduction Several clinical trials have demonstrated the efficacy of pre-exposure prophylaxis (PrEP) in reducing HIV risk. One concern with introducing PrEP is whether users will engage in riskier sexual behaviors. Methods We assessed the effect that PrEP may have on sexual risk behaviors by administering a survey to 799 women in Bondo, Kenya, and Pretoria, South Africa. Participants were asked about their sexual behavior intentions twice-once as if they were taking PrEP and once as if they were not taking PrEP-within four risk situations (vignettes). They responded using a 5-point ordinal scale. We used a series of linear mixed effects models with an unstructured residual covariance matrix to estimate the between-and within-subject differences in the mean likelihood of engaging in risky sexual behavior across the PrEP and non-PrEP contexts. We also calculated the total percentage of participants who reported a greater likelihood of engaging in risky sexual behavior if taking PrEP than if not taking PrEP, by vignette. Results We found statistically significant differences in the mean likelihood of engaging in risky sexual behavior with the between-subject comparison (-0.17, p < 0.01) and with the within-subject comparison (-0.31, p < 0.001). Depending on the vignette, 27% to 40% of participants reported a greater likelihood of engaging in risky sexual behavior if taking PrEP than if not taking PrEP. Conclusions Our findings indicate that modest increases in risky sexual behavior could occur with PrEP. Although responses from the majority of participants suggest they would not be more likely to engage in risky sexual behavior if they took PrEP, a substantial proportion might. Programs rolling out PrEP should be prepared to assist similar women in making informed choices about reducing their risk of HIV and about their sexual health beyond HIV prevention.	[Corneli, Amy; Namey, Emily; Guest, Greg] FHI 360, Social & Behav Hlth Sci, Durham, NC 27701 USA; [Field, Samuel] FHI 360, Biostat, Durham, NC USA; [Agot, Kawango; Odhiambo, Jacob] Impact Res & Dev Org, Kisumu, Kenya; [Ahmed, Khatija; Skhosana, Joseph] Setshaba Res Ctr, Pretoria, South Africa	FHI 360; FHI 360	Corneli, A (corresponding author), FHI 360, Social & Behav Hlth Sci, Durham, NC 27701 USA.	acorneli@fhi360.org	Guest, Greg/AAO-8335-2020; Namey, Emily/K-1975-2019	Namey, Emily/0000-0003-3200-1633; Corneli, Amy/0000-0002-4629-4329; ahmed, khatija/0000-0003-0309-1641	National Institute of Mental Health [R01MH095531]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095531] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The research was funded by the National Institute of Mental Health under award number R01MH095531. The contents of the paper are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas UL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000875; AVAC, ONG PLANN PREP TRAIL; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Celum C, 2014, ANN INTERN MED, V161, P11, DOI 10.7326/M13-2471; Centers for Disease Control and Prevention Health Resources and Services Administration National Institutes of Health American Academy of HIV Medicine Association of Nurses in AIDS Care International Association of Providers of AIDS Care the National Minority AIDS Council Urban Coalition for HIV/AIDS Prevention Services, 2014, REC HIV PREV AD AD H, V2014; Corneli A, 2014, HIV RES PREV C CAP T; Corneli A, AIDS PATIEN IN PRESS; Donnell D, 2014, JAIDS-J ACQ IMM DEF, V66, P340, DOI 10.1097/QAI.0000000000000172; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; FINCH J, 1987, SOCIOLOGY, V21, P105, DOI 10.1177/0038038587021001008; Fleming P, 2014, PUBLIC HLTH RES METH, P611; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Guest G, 2008, SEX TRANSM DIS, V35, P1002, DOI 10.1097/OLQ.0b013e3181812939; Hennessy M, 1996, CONTROL CLIN TRIALS, V17, P209, DOI 10.1016/0197-2456(95)00155-7; HOX JJ, 1991, SOCIOL METHOD RES, V19, P493, DOI 10.1177/0049124191019004003; Hughes R, 1998, SOCIOL HEALTH ILL, V20, P381, DOI 10.1111/1467-9566.00107; Kim SC, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-24; Liu AY, 2013, JAIDS-J ACQ IMM DEF, V64, P87, DOI 10.1097/QAI.0b013e31828f097a; Ludwick R, 2001, NURS RES, V50, P129, DOI 10.1097/00006199-200103000-00009; Marcus JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081997; Mugwanya KK, 2013, LANCET INFECT DIS, V13, P1021, DOI 10.1016/S1473-3099(13)70226-3; Rossi P. H., 1982, MEASURING SOCIAL JUD; Taylor BJ, 2006, BRIT J SOC WORK, V36, P1187, DOI 10.1093/bjsw/bch345; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; Vissers DCJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002077; World Health Organization, 2014, POL BRIEF CONS GUID	29	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129177	10.1371/journal.pone.0129177	http://dx.doi.org/10.1371/journal.pone.0129177			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6PC	26056842	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000040
J	Wang, WR; Qiao, Y; Pan, WS; Yao, M				Wang, Weiran; Qiao, Yu; Pan, Wenshi; Yao, Meng			Low Genetic Diversity and Strong Geographical Structure of the Critically Endangered White-Headed Langur (Trachypithecus leucocephalus) Inferred from Mitochondrial DNA Control Region Sequences	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; SEX-BIASED DISPERSAL; KARST HILLS; CONSERVATION; MONKEYS; DIFFERENTIATION; MICROSATELLITE; IDENTIFICATION; CONSEQUENCES; MANAGEMENT	Many Asian colobine monkey species are suffering from habitat destruction and population size decline. There is a great need to understand their genetic diversity, population structure and demographic history for effective species conservation. The white-headed langur (Trachypithecus leucocephalus) is a Critically Endangered colobine species endemic to the limestone karst forests in southwestern China. We analyzed the mitochondrial DNA (mtDNA) control region sequences of 390 fecal samples from 40 social groups across the main distribution areas, which represented one-third of the total extant population. Only nine haplotypes and 10 polymorphic sites were identified, indicating remarkably low genetic diversity in the species. Using a subset of 77 samples from different individuals, we evaluated genetic variation, population structure, and population demographic history. We found very low values of haplotype diversity (h = 0.570 +/- 0.056) and nucleotide diversity (pi = 0.00323 +/- 0.00044) in the hypervariable region I (HVRI) of the mtDNA control region. Distribution of haplotypes displayed marked geographical pattern, with one population (Chong-zuo, CZ) showing a complete lack of genetic diversity (having only one haplotype), whereas the other population (Fusui, FS) having all nine haplotypes. We detected strong population genetic structure among habit patches (phi(ST) = 0.375, P < 0.001). In addition, the Mantel test showed a significant correlation between the pairwise genetic distances and geographical distances among social groups in FS (correlation coefficient = 0.267, P = 0.003), indicting isolation-by-distance pattern of genetic divergence in the mtDNA sequences. Analyses of demographic history suggested an overall stable historical population size and modest population expansion in the last 2,000 years. Our results indicate different genetic diversity and possibly distinct population history for different local populations, and suggest that CZ and FS should be considered as one evolutionarily significant unit (ESU) and two management units (MUs) pending further investigation using nuclear markers.	[Wang, Weiran; Qiao, Yu; Pan, Wenshi; Yao, Meng] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Pan, Wenshi; Yao, Meng] Peking Univ, Chongzuo Biodivers Res Inst, Guangxi, Peoples R China	Peking University; Peking University	Yao, M (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	yaom@pku.edu.cn	Yao, Meng/G-7219-2011; Yao, Meng/AAH-4854-2019	Yao, Meng/0000-0002-8906-1461; Yao, Meng/0000-0002-8906-1461	National Natural Science Foundataion of China [31272329]	National Natural Science Foundataion of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundataion of China, Grant No. 31272329 to MY. (http://www.nsfc.gov.cn/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bleisch B., 2008, IUCN RED LIST THREAT; Chaves PB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020722; DEUTER R, 1995, NUCLEIC ACIDS RES, V23, P3800, DOI 10.1093/nar/23.18.3800; Di Fiore A, 2005, CONSERV GENET, V6, P1053, DOI 10.1007/s10592-005-9086-5; Douadi MI, 2007, MOL ECOL, V16, P2247, DOI 10.1111/j.1365-294X.2007.03286.x; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; Eriksson J, 2006, MOL ECOL, V15, P939, DOI 10.1111/j.1365-294X.2006.02845.x; Evans BJ, 2003, EVOLUTION, V57, P1931; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2010, BIOL CONSERV, V143, P1919, DOI 10.1016/j.biocon.2010.05.011; Fu YX, 1997, GENETICS, V147, P915; Gibbs HL, 2000, MOL ECOL, V9, P2137, DOI 10.1046/j.1365-294X.2000.01136.x; Guangxi Bureau of Forestry, 2010, POP CENS REP WILD WH; Hagell S, 2013, ECOL EVOL, V3, P1388, DOI 10.1002/ece3.547; Hu G, 1998, J GUANGXI NORMAL U, V16, P64; Huang Chengming, 2008, Primate Conservation, V23, P133, DOI 10.1896/052.023.0116; Huang CM, 2002, BIOL CONSERV, V104, P221, DOI 10.1016/S0006-3207(01)00168-9; Huang CM, 2003, INT J PRIMATOL, V24, P813, DOI 10.1023/A:1024628822271; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; Jin T, 2009, AM J PRIMATOL, V71, P558, DOI 10.1002/ajp.20688; Jin T, 2009, AM J PRIMATOL, V71, P206, DOI 10.1002/ajp.20637; Kanthaswamy S, 2006, PRIMATES, V47, P310, DOI 10.1007/s10329-006-0191-y; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kmiec B, 2006, CURR GENET, V50, P149, DOI 10.1007/s00294-006-0082-1; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li DY, 2011, CURR ZOOL, V57, P260, DOI 10.1093/czoolo/57.3.260; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061659; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; MANTEL N, 1967, CANCER RES, V27, P209; Matsumura S, 2008, P ROY SOC B-BIOL SCI, V275, P1501, DOI 10.1098/rspb.2007.1724; Milinkovitch MC, 2004, P ROY SOC B-BIOL SCI, V271, P341, DOI 10.1098/rspb.2003.2607; MORITZ C, 1994, MOL ECOL, V3, P401, DOI 10.1111/j.1365-294X.1994.tb00080.x; Morrill BH, 2008, AM J PRIMATOL, V70, P976, DOI 10.1002/ajp.20590; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M, 1986, MOL EVOLUTIONARY GEN; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Ran WZ, 2003, THESIS PEKING U BEIJ; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roos C, 2014, ASIAN PRIMATES J, V4, P2; Rousset F, 1997, GENETICS, V145, P1219; Rylands A. B., 2013, HDB MAMMALS WORLD, V3; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; TAJIMA F, 1989, GENETICS, V123, P585; Thalmann O, 2004, MOL ECOL, V13, P321, DOI 10.1046/j.1365-294X.2003.02070.x; Vallet D, 2008, CONSERV GENET, V9, P677, DOI 10.1007/s10592-007-9361-8; Villesen Palle, 2006, BMC Ecology, V6, P8, DOI 10.1186/1472-6785-6-8; Villesen P, 2006, CONSERV GENET, V7, P455, DOI 10.1007/s10592-005-9044-2; von der Heyden S, 2014, B MAR SCI, V90, P123, DOI 10.5343/bms.2012.1079; Wang DZ, 2005, PRIMATES, V46, P219, DOI 10.1007/s10329-004-0122-8; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yang MY, 2012, AM J PHYS ANTHROPOL, V147, P1, DOI 10.1002/ajpa.21618; Zhang BW, 2006, BIOCH GENET, V44, P11; Zhao Q, 2011, BEHAV ECOL SOCIOBIOL, V65, P1535, DOI 10.1007/s00265-011-1163-9	65	12	13	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129782	10.1371/journal.pone.0129782	http://dx.doi.org/10.1371/journal.pone.0129782			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057239	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000072
J	Xiang, H; Zhang, RZ; Butler, RR; Liu, T; Zhang, L; Pombert, JF; Zhou, ZY				Xiang, Heng; Zhang, Ruizhi; Butler, Robert R., III; Liu, Tie; Zhang, Li; Pombert, Jean-Francois; Zhou, Zeyang			Comparative Analysis of Codon Usage Bias Patterns in Microsporidian Genomes	PLOS ONE			English	Article							DIRECTIONAL MUTATION PRESSURE; SYNONYMOUS CODON; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; GENES; REVEAL; CHOICE	The sub-3 Mbp genomes from microsporidian species of the Encephalitozoon genus are the smallest known among eukaryotes and paragons of genomic reduction and compaction in parasites. However, their diminutive stature is not characteristic of all Microsporidia, whose genome sizes vary by an order of magnitude. This large variability suggests that different evolutionary forces are applied on the group as a whole. In this study, we have compared the codon usage bias (CUB) between eight taxonomically distinct microsporidian genomes: Encephalitozoon intestinalis, Encephalitozoon cuniculi, Spraguea lophii, Trachipleistophora hominis, Enterocytozoon bieneusi, Nematocida parisii, Nosema bombycis and Nosema ceranae. While the CUB was found to be weak in all eight Microsporidia, nearly all (98%) of the optimal codons in S. lophii, T. hominis, E. bieneusi, N. parisii, N. bombycis and N. ceranae are fond of A/U in third position whereas most (64.6%) optimal codons in the Encephalitozoon species E. intestinalis and E. cuniculi are biased towards G/C. Although nucleotide composition biases are likely the main factor driving the CUB in Microsporidia according to correlation analyses, directed mutational pressure also likely affects the CUB as suggested by ENc-plots, correspondence and neutrality analyses. Overall, the Encephalitozoon genomes were found to be markedly different from the other microsporidians and, despite being the first sequenced representatives of this lineage, are uncharacteristic of the group as a whole. The disparities observed cannot be attributed solely to differences in host specificity and we hypothesize that other forces are at play in the lineage leading to Encephalitozoon species.	[Xiang, Heng] Southwest Univ, Coll Anim Sci & Technol, Chongqing 400715, Peoples R China; [Liu, Tie; Zhou, Zeyang] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing 400715, Peoples R China; [Butler, Robert R., III; Pombert, Jean-Francois] IIT, Dept Biol & Chem Sci, Chicago, IL 60616 USA; [Zhang, Ruizhi] Southwest Univ, Biotechnol Res Ctr, Chongqing 400715, Peoples R China; [Zhang, Li] China West Normal Univ, Dept Math & Informat, Nanchong 637000, Sichuan, Peoples R China	Southwest University - China; Southwest University - China; Illinois Institute of Technology; Southwest University - China; China West Normal University	Xiang, H (corresponding author), Southwest Univ, Coll Anim Sci & Technol, Chongqing 400715, Peoples R China.	hxiang@swu.edu.cn; zyzhou@swu.edu.cn		Pombert, Jean-Francois/0000-0002-3449-8375; Butler, Robert/0000-0003-0200-8682	National Natural Science Foundation of China [31302036, 30930067]; Ph.D. Programs Foundation of Ministry of Education of China [20110182120008]; Fundamental Research Funds for the Central Universities [XDJK2011C027, XDJK2015B024]; Ph.D. Programs Foundation of Southwest University [SWU110047]; China Scholarship Council [201206995026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ph.D. Programs Foundation of Southwest University; China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (Nos. 31302036 and 30930067), the Ph.D. Programs Foundation of Ministry of Education of China (No. 20110182120008), the Fundamental Research Funds for the Central Universities (Nos. XDJK2011C027 and XDJK2015B024), the Ph.D. Programs Foundation of Southwest University (No. SWU110047), and the China Scholarship Council (No. 201206995026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000261; Campbell SE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003676; Chiapello H, 1998, GENE, V209, pGC1, DOI 10.1016/S0378-1119(97)00671-9; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Corradi N, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1082; Cuomo CA, 2012, GENOME RES, V22, P2478, DOI 10.1101/gr.142802.112; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Greenacre Michael, 1984, THEORY APPL CORRES A; Heinz E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002979; IKEMURA T, 1981, J MOL BIOL, V151, P389, DOI 10.1016/0022-2836(81)90003-6; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Liu QP, 2006, BIOSYSTEMS, V85, P99, DOI 10.1016/j.biosystems.2005.12.003; Moriyama EN, 1998, NUCLEIC ACIDS RES, V26, P3188, DOI 10.1093/nar/26.13.3188; Morton BR, 2003, J MOL EVOL, V56, P616, DOI 10.1007/s00239-002-2430-1; Oresic M, 1998, J MOL BIOL, V281, P31, DOI 10.1006/jmbi.1998.1921; OSAWA S, 1988, P NATL ACAD SCI USA, V85, P1124, DOI 10.1073/pnas.85.4.1124; Pan GQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-186; Peyretaillade E, 2015, HEREDITY, V114, P441, DOI 10.1038/hdy.2014.78; Pombert JF, 2015, MBIO, V6, DOI 10.1128/mBio.02400-14; Pombert JF, 2012, P NATL ACAD SCI USA, V109, P12638, DOI 10.1073/pnas.1205020109; Pombert JF, 2013, EUKARYOT CELL, V12, P503, DOI 10.1128/EC.00312-12; Romero H, 2000, NUCLEIC ACIDS RES, V28, P2084, DOI 10.1093/nar/28.10.2084; Sau Keya, 2009, In Silico Biology, V9, P1, DOI 10.3233/ISB-2009-0383; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P7737, DOI 10.1093/nar/14.19.7737; SHARP PM, 1991, YEAST, V7, P657, DOI 10.1002/yea.320070702; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Sueoka N, 2000, GENE, V261, P53, DOI 10.1016/S0378-1119(00)00480-7; Sueoka N, 1999, GENE, V238, P53, DOI 10.1016/S0378-1119(99)00320-0; SUEOKA N, 1988, P NATL ACAD SCI USA, V85, P2653, DOI 10.1073/pnas.85.8.2653; Vossbrinck CR, 2005, FOLIA PARASIT, V52, P131, DOI 10.14411/fp.2005.017; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9; Zhang R, 2011, NEWSL SERICULTURAL S, V1, P1	34	21	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129223	10.1371/journal.pone.0129223	http://dx.doi.org/10.1371/journal.pone.0129223			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057384	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000043
J	Islam, R; Jackson, C; Eidet, JR; Messelt, EB; Corraya, RM; Lyberg, T; Griffith, M; Dartt, DA; Utheim, TP				Islam, Rakibul; Jackson, Catherine; Eidet, Jon R.; Messelt, Edward B.; Corraya, Rima Maria; Lyberg, Torstein; Griffith, May; Dartt, Darlene A.; Utheim, Tor P.			Effect of Storage Temperature on Structure and Function of Cultured Human Oral Keratinocytes	PLOS ONE			English	Article							LIMBAL EPITHELIAL-CELLS; CORNEAL EPITHELIUM; STEM-CELLS; ORGAN-CULTURE; TRANSPLANTATION; EXPRESSION; APOPTOSIS; THERAPY; RECONSTRUCTION; PROLIFERATION	Purpose/Aims To assess the effect of storage temperature on the viability, phenotype, metabolism, and morphology of cultured human oral keratinocytes (HOK). Materials and Methods Cultured HOK cells were stored in HEPES- and sodium bicarbonate-buffered Minimum Essential Medium (MEM) at nine temperatures in approximately 4 degrees C increments from 4 degrees C to 37 degrees C for seven days. Cells were characterized for viability by calcein fluorescence, phenotype retention by immunocytochemistry, metabolic parameters (pH, glucose, lactate, and O-2) within the storage medium by blood gas analysis, and morphology by scanning electron microscopy and light microscopy. Results Relative to the cultured, but non-stored control cells, a high percentage of viable cells were retained only in the 12 degrees C and 16 degrees C storage groups (85%+/- 13% and 68%+/- 10%, respectively). Expression of ABCG2, Bmi1, C/EBP delta, PCNA, cytokeratin 18, and caspase-3 were preserved after storage in the 5 groups between 4 degrees C and 20 degrees C, compared to the non-stored control. Glucose, pH and pO(2) in the storage medium declined, whereas lactate increased with increasing storage temperature. Morphology was best preserved following storage of the three groups between 12 degrees C, 16 degrees C, and 20 degrees C. Conclusion We conclude that storage temperatures of 12 degrees C and 16 degrees C were optimal for maintenance of cell viability, phenotype, and morphology of cultured HOK. The storage method described in the present study may be applicable for other cell types and tissues; thus its significance may extend beyond HOK and the field of ophthalmology.	[Islam, Rakibul; Messelt, Edward B.; Utheim, Tor P.] Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway; [Islam, Rakibul; Jackson, Catherine; Eidet, Jon R.; Corraya, Rima Maria; Lyberg, Torstein; Utheim, Tor P.] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Griffith, May] Linkoping Univ, Dept Clin & Expt Med, Integrat Regenerat Med Ctr, Linkoping, Sweden; [Islam, Rakibul; Corraya, Rima Maria; Dartt, Darlene A.; Utheim, Tor P.] Harvard Univ, Sch Med, Dept Ophthalmol, Schepens Eye Res Inst,Massachusetts Eye & Ear, Boston, MA USA	University of Oslo; University of Oslo; Linkoping University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Schepens Eye Research Institute	Islam, R (corresponding author), Univ Oslo, Fac Dent, Dept Oral Biol, Oslo, Norway.	rakibul.lubikar@gmail.com		Jackson, Catherine/0000-0001-9683-2343; Islam, Rakibul/0000-0002-7174-9225; Griffith, May/0000-0003-1222-6720	Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway [5142001]; NATIONAL EYE INSTITUTE [R01EY019470] Funding Source: NIH RePORTER	Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by Grant number 5142001, Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway (RI).	Ahmad S, 2010, J CELL PHYSIOL, V225, P15, DOI 10.1002/jcp.22251; Armitage WJ, 2009, DEV OPHTHALMOL, V43, P63, DOI 10.1159/000223839; Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; BATES RC, 1994, J CELL BIOL, V125, P403, DOI 10.1083/jcb.125.2.403; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Daniels JT, 2006, REGEN MED, V1, P715, DOI 10.2217/17460751.1.5.715; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Di Girolamo N, 2009, TRANSPLANTATION, V87, P1571, DOI 10.1097/TP.0b013e3181a4bbf2; Dua HS, 2005, BRIT J OPHTHALMOL, V89, P529, DOI 10.1136/bjo.2004.049742; Eidet JR, 2012, EXP EYE RES, V94, P109, DOI 10.1016/j.exer.2011.11.015; Eidet JR, 2014, CURR EYE RES, DOI 10.3109/02713683.2014.909497; Garzon I, 2009, J PERIODONTAL RES, V44, P588, DOI 10.1111/j.1600-0765.2008.01159.x; HALL PA, 1990, J PATHOL, V162, P285, DOI 10.1002/path.1711620403; HJORTDAL JO, 1989, ACTA OPHTHALMOL, V67, P295; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105808; Laidler K J, 1979, Methods Enzymol, V63, P234; Lee EJ, 2005, CRYOBIOLOGY, V50, P103, DOI 10.1016/j.cryobiol.2004.12.001; LINDEN MD, 1992, AM J CLIN PATHOL, V97, pS4; MAZUR P, 1984, AM J PHYSIOL, V247, pC125, DOI 10.1152/ajpcell.1984.247.3.C125; Metcalfe A, 1997, BIOESSAYS, V19, P711, DOI 10.1002/bies.950190812; Nakamura T, 2004, BRIT J OPHTHALMOL, V88, P1280, DOI 10.1136/bjo.2003.038497; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Pasovic L, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/216359; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; POOLE CA, 1993, J CELL SCI, V106, P685; Raeder S, 2007, INVEST OPHTH VIS SCI, V48, P5484, DOI 10.1167/iovs.07-0494; Raeder S, 2007, ACTA OPHTHALMOL SCAN, V85, P377, DOI 10.1111/j.1600-0420.2006.00873.x; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; REIM M, 1988, GRAEF ARCH CLIN EXP, V226, P353, DOI 10.1007/BF02172966; Rieder CL, 2002, CELL CYCLE, V1, P169, DOI 10.4161/cc.1.3.119; Slikker W, 2001, FREE RADICAL BIO MED, V31, P405, DOI 10.1016/S0891-5849(01)00593-7; Utheim TP, 2009, BRIT J OPHTHALMOL, V93, P980, DOI 10.1136/bjo.2008.149591; Utheim TP, 2007, BRIT J OPHTHALMOL, V91, P797, DOI 10.1136/bjo.2006.103218; Utheim Tor Paaske, 2013, Methods Mol Biol, V1014, P3, DOI 10.1007/978-1-62703-432-6_1	35	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128306	10.1371/journal.pone.0128306	http://dx.doi.org/10.1371/journal.pone.0128306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052937	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300031
J	Marx, V; Nagy, E				Marx, Viola; Nagy, Emese			Fetal Behavioural Responses to Maternal Voice and Touch	PLOS ONE			English	Article							EXPERIENCE; FETUS	Background Although there is data on the spontaneous behavioural repertoire of the fetus, studies on their behavioural responses to external stimulation are scarce. Aim, Methods The aim of the current study was to measure fetal behavioural responses in reaction to maternal voice; to maternal touch of the abdomen compared to a control condition, utilizing 3D real-time (4D) sonography. Behavioural responses of 23 fetuses (21st to 33rd week of gestation; N = 10 in the 2nd and N = 13 in the 3rd trimester) were frame-by-frame coded and analyzed in the three conditions. Results Results showed that fetuses displayed more arm, head, and mouth movements when the mother touched her abdomen and decreased their arm and head movements to maternal voice. Fetuses in the 3rd trimester showed increased regulatory (yawning), resting (arms crossed) and self-touch (hands touching the body) responses to the stimuli when compared to fetuses in the 2nd trimester. Conclusion In summary, the results from this study suggest that fetuses selectively respond to external stimulation earlier than previously reported, fetuses actively regulated their behaviours as a response to the external stimulation, and that fetal maturation affected the emergence of these differential responses to the environment.	[Marx, Viola; Nagy, Emese] Univ Dundee, Sch Psychol, Dundee, Scotland	University of Dundee	Marx, V (corresponding author), Univ Dundee, Sch Psychol, Dundee, Scotland.	v.marx@dundee.ac.uk		Marx, Viola/0000-0001-9258-2068				Baxter N, 2011, 3 LITTLE PIGS LADYBR; Bichat MFX, 1827, PHYSL RES LIFE DEATH; Castiello U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013199; DECASPER AJ, 1986, INFANT BEHAV DEV, V9, P133, DOI 10.1016/0163-6383(86)90025-1; Field T, 2004, J PSYCHOSOM OBST GYN, V25, P115, DOI 10.1080/01674820412331282231; Fifer W., 1987, PERINATAL DEV PSYCHO, P111; Fifer W.P., 1995, FETAL DEV PSYCHOBIOL, P351; FIFER WP, 1994, ACTA PAEDIATR, V83, P86, DOI 10.1111/j.1651-2227.1994.tb13270.x; Fifer WP, 1988, BEHAV FETUS; Granier-Deferre C, 2011, DEVELOPMENTAL SCI, V14, P336, DOI 10.1111/j.1467-7687.2010.00978.x; Hepper P. G., 1993, J REPRODUCTIVE INFAN, V11, P147, DOI [DOI 10.1080/02646839308403210, 10.1080/02646839308403210]; Hofer M.A., 1981, P77; Kisilevsky BS, 2009, INFANT BEHAV DEV, V32, P59, DOI 10.1016/j.infbeh.2008.10.002; Kisilevsky BS, 2003, PSYCHOL SCI, V14, P220, DOI 10.1111/1467-9280.02435; KISILEVSKY BS, 1992, CHILD DEV, V63, P1497; Lecanuet J., 2002, 13 INT C INF STUD TO; Montagu Ashley, 1978, TOUCHING HUMAN SIGNI; Moon C, 2000, J PERINATOLOGY, V20, P36; Moore ER, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub2; Nijhuis JG, 2003, NEUROBIOL AGING, V24, pS41, DOI 10.1016/S0197-4580(03)00054-X; Preyer W.T., 1937, MONOGR SOC RES CHILD, V2, P1; Reissland N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050569; REYNOLDS SR, 1962, AM J OBSTET GYNECOL, V83, P800, DOI 10.1016/0002-9378(62)90704-4; Rivers R, 1999, 1 FAVOURITE TALES JA; Robinson SR, 2000, BEHAV NEUROSCI, V114, P328, DOI 10.1037//0735-7044.114.2.328; RONCA AE, 1993, J COMP PSYCHOL, V107, P61, DOI 10.1037/0735-7036.107.1.61; SHAHIDULLAH S, 1994, EARLY HUM DEV, V36, P13, DOI 10.1016/0378-3782(94)90029-9; Sparling JW, 1999, PHYS THER, V79, P24, DOI 10.1093/ptj/79.1.24; VALMAN HB, 1980, BRIT MED J, V280, P233, DOI 10.1136/bmj.280.6209.233; VANDERMEER ALH, 1995, SCIENCE, V267, P693, DOI 10.1126/science.7839147; VINCE MA, 1985, EARLY HUM DEV, V11, P179, DOI 10.1016/0378-3782(85)90105-7; Voegtline KM, 2013, INFANT BEHAV DEV, V36, P526, DOI 10.1016/j.infbeh.2013.05.002; Walusinski O, 2010, FRONT NEUROL NEUROSC, V28, P32, DOI 10.1159/000307075; Windle WF, 1940, PHYSL FETUS ORIGIN E; Zoia S, 2007, EXP BRAIN RES, V176, P217, DOI 10.1007/s00221-006-0607-3; Zoia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080876	36	62	63	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129118	10.1371/journal.pone.0129118	http://dx.doi.org/10.1371/journal.pone.0129118			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1GM	26053388	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300089
J	Yin, WL; Sun, ZR; Mendenhall, JM; Walker, DM; Riha, PD; Bezner, KS; Gore, AC				Yin, Weiling; Sun, Zengrong; Mendenhall, John M.; Walker, Deena M.; Riha, Penny D.; Bezner, Kelsey S.; Gore, Andrea C.			Expression of Vesicular Glutamate Transporter 2 (vGluT2) on Large Dense-Core Vesicles within GnRH Neuroterminals of Aging Female Rats	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; AGE-RELATED-CHANGES; RECEPTOR GENE-EXPRESSION; EXCITATORY AMINO-ACIDS; MEDIAN-EMINENCE; NERVE-TERMINALS; PREOPTIC AREA; ESTROUS-CYCLE; MEDIOBASAL HYPOTHALAMUS; REPRODUCTIVE SENESCENCE	The pulsatile release of GnRH is crucial for normal reproductive physiology across the life cycle, a process that is regulated by hypothalamic neurotransmitters. GnRH terminals co-express the vesicular glutamate transporter 2 (vGluT2) as a marker of a glutamatergic phenotype. The current study sought to elucidate the relationship between glutamate and GnRH nerve terminals in the median eminence-the site of GnRH release into the portal capillary vasculature. We also determined whether this co-expression may change during reproductive senescence, and if steroid hormones, which affect responsiveness of GnRH neurons to glutamate, may alter the co-expression pattern. Female Sprague-Dawley rats were ovariectomized at young adult, middle-aged and old ages (similar to 4, 11, and 22 months, respectively) and treated four weeks later with sequential vehicle + vehicle (VEH + VEH), estradiol + vehicle (E-2 + VEH), or estradiol + progesterone (E-2+P-4). Rats were perfused 24 hours after the second hormone treatment. Confocal microscopy was used to determine colocalization of GnRH and vGluT2 immunofluorescence in the median eminence. Post-embedding immunogold labeling of GnRH and vGluT2, and a serial electron microscopy (EM) technique were used to determine the cellular interaction between GnRH terminals and glutamate signaling. Confocal analysis showed that GnRH and vGluT2 immunofluorescent puncta were extensively colocalized in the median eminence and that their density declined with age but was unaffected by short-term hormone treatment. EM results showed that vGluT2 immunoreactivity was extensively associated with large dense-core vesicles, suggesting a unique glutamatergic signaling pathway in GnRH terminals. Our results provide novel subcellular information about the intimate relationship between GnRH terminals and glutamate in the median eminence.	[Yin, Weiling; Riha, Penny D.; Bezner, Kelsey S.; Gore, Andrea C.] Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA; [Mendenhall, John M.; Walker, Deena M.; Gore, Andrea C.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Gore, Andrea C.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Sun, Zengrong] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Tianjin Medical University	Gore, AC (corresponding author), Univ Texas Austin, Coll Pharm, Div Pharmacol & Toxicol, Austin, TX 78712 USA.	andrea.gore@austin.utexas.edu	Walker, Deena/GOE-5789-2022		National Institutes of Health [AG16765]; University Continuing Fellowship from University of Texas at Austin; NATIONAL INSTITUTE ON AGING [P01AG016765] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University Continuing Fellowship from University of Texas at Austin; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by the National Institutes of Health (AG16765 to ACG) and University Continuing Fellowship from the University of Texas at Austin (to WY). The funders had no role in study design, data collection and analysis to publish, or preparation of the manuscript.	Adams MM, 2002, J NEUROSCI, V22, P3608; Arias P, 1996, BRAIN RES, V740, P234, DOI 10.1016/S0006-8993(96)00862-1; Berger UV, 2001, J COMP NEUROL, V433, P101, DOI 10.1002/cne.1128; Bilger M, 2001, ENDOCRINOLOGY, V142, P2102, DOI 10.1210/en.142.5.2102; Bonavera JJ, 1998, J NEUROENDOCRINOL, V10, P93, DOI 10.1046/j.1365-2826.1998.00177.x; Choi J, 2008, ENDOCRINOLOGY, V149, P6146, DOI 10.1210/en.2008-0432; Claypool LE, 2000, ENDOCRINOLOGY, V141, P219, DOI 10.1210/en.141.1.219; de Seranno S, 2010, ENDOCRINOLOGY, V151, P1760, DOI 10.1210/en.2009-0870; DONOSO AO, 1992, ENDOCRINOLOGY, V131, P1559, DOI 10.1210/en.131.3.1559; Dumalska I, 2008, J NEUROSCI, V28, P8003, DOI 10.1523/JNEUROSCI.1225-08.2008; Eyigor O, 1996, ENDOCRINE, V4, P133, DOI 10.1007/BF02782758; Feleder C, 1996, NEUROENDOCRINOLOGY, V64, P298, DOI 10.1159/000127132; Fiala JC, 2005, J MICROSC-OXFORD, V218, P52, DOI 10.1111/j.1365-2818.2005.01466.x; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Funabashi T, 2000, NEUROENDOCRINOLOGY, V71, P138, DOI 10.1159/000054529; Gibbs RB, 2000, NEUROBIOL AGING, V21, P107, DOI 10.1016/S0197-4580(00)00103-2; Glanowska KM, 2015, ENDOCRINOLOGY, V156, P231, DOI 10.1210/en.2014-1458; GORE AC, 1995, ENDOCRINOLOGY, V136, P889, DOI 10.1210/en.136.3.889; Gore AC, 1996, J NEUROSCI, V16, P5281; Gore AC, 2002, PROG BRAIN RES, V141, P193; Gore AC, 2002, J NEUROENDOCRINOL, V14, P300, DOI 10.1046/j.1365-2826.2002.00777.x; Gore AC, 2000, ENDOCRINOLOGY, V141, P4757, DOI 10.1210/en.141.12.4757; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hayashi M, 2003, J BIOL CHEM, V278, P1966, DOI 10.1074/jbc.M206758200; Herde MK, 2013, J NEUROSCI, V33, P12689, DOI 10.1523/JNEUROSCI.0579-13.2013; Hisano S, 2000, MOL BRAIN RES, V83, P34, DOI 10.1016/S0169-328X(00)00194-7; Hrabovszky E, 2007, NEUROSCIENCE, V144, P1383, DOI 10.1016/j.neuroscience.2006.10.053; Hrabovszky E, 2005, EUR J NEUROSCI, V21, P2120, DOI 10.1111/j.1460-9568.2005.04076.x; Hrabovszky E, 2004, ENDOCRINOLOGY, V145, P4018, DOI 10.1210/en.2004-0589; Hrabovszky E, 2006, NEUROCHEM INT, V48, P753, DOI 10.1016/j.neuint.2005.12.013; Hrabovszky E, 2005, ENDOCRINOLOGY, V146, P341, DOI 10.1210/en.2004-0856; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Kawakami S, 1998, GEN COMP ENDOCR, V112, P372, DOI 10.1006/gcen.1998.7140; Kawakami SI, 1998, ENDOCRINOLOGY, V139, P1458, DOI 10.1210/en.139.3.1458; Kermath BA, 2013, J NEUROENDOCRINOL, V25, P887, DOI 10.1111/jne.12087; Kermath BA, 2014, ENDOCRINOLOGY, V155, P3597, DOI 10.1210/en.2014-1017; Khan M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010172; Kiss J, 2003, EUR J NEUROSCI, V18, P3267, DOI 10.1111/j.1460-9568.2003.03085.x; Lin W, 2003, ENDOCRINOLOGY, V144, P662, DOI 10.1210/en.2002-220908; Liu XH, 2011, J NEUROSCI, V31, P2421, DOI 10.1523/JNEUROSCI.5759-10.2011; Maffucci JA, 2009, J NEUROENDOCRINOL, V21, P506, DOI 10.1111/j.1365-2826.2009.01860.x; Maffucci JA, 2009, INT REV CEL MOL BIO, V274, P69, DOI 10.1016/S1937-6448(08)02002-9; Matsuyama S, 2011, NEUROENDOCRINOLOGY, V94, P323, DOI 10.1159/000331576; Miller BH, 2002, ENDOCRINOLOGY, V143, P3568, DOI 10.1210/en.2002-220346; Neal-Perry GS, 2008, BIOL REPROD, V79, P878, DOI 10.1095/biolreprod.108.069831; Neal-Perry GS, 2005, ENDOCRINOLOGY, V146, P4331, DOI 10.1210/en.2005-0575; Ojeda SR, 2008, J NEUROENDOCRINOL, V20, P732, DOI 10.1111/j.1365-2826.2008.01712.x; Ottem EN, 2004, J NEUROSCI, V24, P8097, DOI 10.1523/JNEUROSCI.2267-04.2004; Parkash J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7385; Persson S, 2006, J COMP NEUROL, V497, P683, DOI 10.1002/cne.20987; PETERSEN SL, 1991, ENDOCRINOLOGY, V129, P1679, DOI 10.1210/endo-129-3-1679; Pielecka-Fortuna J, 2010, ENDOCRINOLOGY, V151, P291, DOI 10.1210/en.2009-0692; Prevot V, 1998, NEUROSCIENCE, V84, P177, DOI 10.1016/S0306-4522(97)00537-X; Prevot V, 1999, NEUROSCIENCE, V94, P809, DOI 10.1016/S0306-4522(99)00383-8; Prevot V, 2010, J NEUROENDOCRINOL, V22, P639, DOI 10.1111/j.1365-2826.2010.02033.x; Purnelle G, 1997, NEUROENDOCRINOLOGY, V66, P305, DOI 10.1159/000127253; Roberts CB, 2008, ENDOCRINOLOGY, V149, P3355, DOI 10.1210/en.2008-0152; RUBIN BS, 1989, NEUROENDOCRINOLOGY, V49, P225, DOI 10.1159/000125121; Sano A, 2000, NEUROENDOCRINOLOGY, V72, P199, DOI 10.1159/000054588; SCARBROUGH K, 1990, ENDOCRINOLOGY, V126, P884, DOI 10.1210/endo-126-2-884; Spergel DJ, 1999, J NEUROSCI, V19, P2037; Uenoyama Y, 2011, J NEUROENDOCRINOL, V23, P863, DOI 10.1111/j.1365-2826.2011.02199.x; URBANSKI HF, 1990, J REPROD FERTIL, V90, P157, DOI 10.1530/jrf.0.0900157; URBANSKI HF, 1990, ENDOCRINOLOGY, V126, P1774, DOI 10.1210/endo-126-3-1774; URBANSKI HF, 1991, BIOL REPROD, V44, P681, DOI 10.1095/biolreprod44.4.681; Windsor-Engnell BM, 2007, AM J PHYSIOL-ENDOC M, V292, pE1000, DOI 10.1152/ajpendo.00493.2006; WISE PM, 1988, BIOL REPROD, V39, P1060, DOI 10.1095/biolreprod39.5.1060; Wu D, 2009, J COMP NEUROL, V512, P688, DOI 10.1002/cne.21925; Yin W, 2007, EXP BIOL MED, V232, P662; Yin WL, 2009, ENDOCRINOLOGY, V150, P5498, DOI 10.1210/en.2009-0679; Yin WL, 2009, J COMP NEUROL, V517, P284, DOI 10.1002/cne.22156; Yin WL, 2006, REPRODUCTION, V131, P403, DOI 10.1530/rep.1.00617; Zhang J, 2013, J NEUROENDOCRINOL, V25, P753, DOI 10.1111/jne.12050; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257; ZOLI M, 1995, NEUROBIOL AGING, V16, P77, DOI 10.1016/0197-4580(95)80010-O	75	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129633	10.1371/journal.pone.0129633	http://dx.doi.org/10.1371/journal.pone.0129633			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053743	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300156
J	Hiroshima, Y; Zhang, Y; Zhao, M; Zhang, N; Murakami, T; Maawy, A; Mii, S; Uehara, F; Yamamoto, M; Miwa, S; Yano, S; Momiyama, M; Mori, R; Matsuyama, R; Chishima, T; Tanaka, K; Ichikawa, Y; Bouvet, M; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Zhang, Yong; Zhao, Ming; Zhang, Nan; Murakami, Takashi; Maawy, Ali; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models	PLOS ONE			English	Article							HUMAN PANCREATIC-CANCER; NUDE-MICE; LUNG METASTASIS; UTERINE CERVIX; BREAST-CANCER; CARCINOMA; EFFICACY; CHEMOTHERAPY; THERAPY; SPECIMENS	We have previously developed mouse models of HER-2-positive cervical cancer. Tumors in nude mice had histological structures similar to the original tumor and were stained by anti-HER-2 antibody in the same pattern as the patient's cancer. We have also previously developed tumor-targeting Salmonella typhimurium A1-R and have demonstrated its efficacy against patient-derived tumor mouse models, both alone and in combination. In the current study, we determined the efficacy of S. typhimurium A1-R in combination with trastuzumab on a patient-cancer nude-mouse model of HER-2 positive cervical cancer. Mice were randomized to 5 groups and treated as follows: (1) no treatment; (2) carboplatinum (30 mg/kg, ip, weekly, 5 weeks); (3) trastuzumab (20 mg/kg, ip, weekly, 5 weeks); (4) S. typhimurium A1-R (5 x 10(7) CFU/body, ip, weekly, 5 weeks); (5) S. typhimurium A1-R (5 x 10(7) CFU/body, ip, weekly, 5 weeks) + trastuzumab (20 mg/kg, ip, weekly, 5 weeks). All regimens had significant efficacy compared to the untreated mice. The relative tumor volume of S. typhimurium A1-R + trastuzumab-treated mice was smaller compared to trastuzumab alone (p = 0.007) and S. typhimurium A1-R alone (p = 0.039). No significant body weight loss was found compared to the no treatment group except for carboplatinum-treated mice (p = 0.021). Upon histological examination, viable tumor cells were not detected, and replaced by stromal cells in the tumors treated with S. typhimurium A1-R + trastuzumab. The results of the present study suggest that S. typhimurium A1-R and trastuzumab in combination are highly effective against HER-2-expressing cervical cancer.	[Hiroshima, Yukihiko; Zhang, Yong; Zhao, Ming; Zhang, Nan; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Hoffman, Robert M.] AntiCanc Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Maawy, Ali; Mii, Sumiyuki; Uehara, Fuminari; Yamamoto, Mako; Miwa, Shinji; Yano, Shuya; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Dept Surg Gastroenterol, Grad Sch Med, Yokohama, Kanagawa 232, Japan	AntiCancer, Inc.; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCanc Inc, San Diego, CA 92111 USA.	all@anticancer.com	Miwa, Shinji/AAI-9309-2020; Yano, Shuya/AAL-8028-2020	Miwa, Shinji/0000-0002-5962-8287; UEHARA, FUMINARI/0000-0001-6567-2113; Murakami, Takashi/0000-0002-9429-5705	National Cancer Institute [CA CA132971, CA142669]; JSPS KAKENHI [26830081, 26462070, 24592009]; NATIONAL CANCER INSTITUTE [R01CA142669, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Cancer Institute grant numbers CA CA132971 and CA142669 and JSPS KAKENHI grant numbers 26830081 to YH, 26462070 to IE and 24592009 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Costa MJ, 1995, AM J CLIN PATHOL, V104, P634; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; Fu X, 1993, ANTICANCER RES, V25, P283; FU XY, 1993, ANTICANCER RES, V13, P901; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; FURUKAWA T, 1993, INT J CANCER, V53, P608, DOI 10.1002/ijc.2910530414; Gamez RG, 2009, DIAGN CYTOPATHOL, V37, P381, DOI 10.1002/dc.21027; Gros SJ, 2010, MOL CANCER THER, V9, P2037, DOI 10.1158/1535-7163.MCT-10-0209; Hashimoto K, 2011, EUR J OBSTET GYN R B, V159, P394, DOI 10.1016/j.ejogrb.2011.07.001; Hayashi K, 2009, J CELL BIOCHEM, V106, P992, DOI 10.1002/jcb.22078; Hayashi K, 2009, CELL CYCLE, V8, P870, DOI 10.4161/cc.8.6.7891; Hiroshima Y, PLOS ONE IN PRESS; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hiroshima Y, 2013, CELL CYCLE, V12, P2774, DOI 10.4161/cc.25872; KIHANA T, 1994, CANCER, V73, P148, DOI 10.1002/1097-0142(19940101)73:1<148::AID-CNCR2820730125>3.0.CO;2-C; Kimura H, 2010, CELL PROLIFERAT, V43, P41, DOI 10.1111/j.1365-2184.2009.00652.x; Matsumoto Y, 2014, J CELL BIOCHEM, V115, P1996, DOI 10.1002/jcb.24871; Miwa S, 2014, ONCOTARGET, V5, P12849, DOI 10.18632/oncotarget.2561; Momiyama M, 2012, CELL CYCLE, V11, P628, DOI 10.4161/cc.11.3.19116; Nagakura C, 2009, ANTICANCER RES, V29, P1873; Sabatier R, 2012, CASE REP ONCOL, V5, P464, DOI 10.1159/000342255; Wang CW, 2009, AM J CLIN PATHOL, V131, P715, DOI 10.1309/AJCPTPBC6V5KUITM; WANG XO, 1992, INT J CANCER, V51, P992; Yam C, 2010, J SURG RES, V164, P248, DOI 10.1016/j.jss.2009.02.023; Yan M, 2014, CANCER TREAT REV, V40, P770, DOI 10.1016/j.ctrv.2014.02.008; Yano S, 2014, CELL CYCLE, V13, P3958, DOI 10.4161/15384101.2014.964115; Zhang Y, 2012, ANTICANCER RES, V32, P2501; Zhao M, 2005, P NATL ACAD SCI USA, V102, P755, DOI 10.1073/pnas.0408422102; Zhao M, 2007, P NATL ACAD SCI USA, V104, P10170, DOI 10.1073/pnas.0703867104; Zhao M, 2006, CANCER RES, V66, P7647, DOI 10.1158/0008-5472.CAN-06-0716; Zhao M, 2012, CELL CYCLE, V11, P187, DOI 10.4161/cc.11.1.18667	32	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0120358	10.1371/journal.pone.0120358	http://dx.doi.org/10.1371/journal.pone.0120358			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047477	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200001
J	Perera, OP; Shelby, KS; Popham, HJR; Gould, F; Adang, MJ; Jurat-Fuentes, JL				Perera, Omaththage P.; Shelby, Kent S.; Popham, Holly J. R.; Gould, Fred; Adang, Michael J.; Jurat-Fuentes, Juan Luis			Generation of a Transcriptome in a Model Lepidopteran Pest, Heliothis virescens, Using Multiple Sequencing Strategies for Profiling Midgut Gene Expression	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS CRY1A; ALKALINE-PHOSPHATASE CDNA; AMINOPEPTIDASE-N; BINDING-PROTEINS; COTTON BOLLWORM; DESERT LOCUST; INNATE IMMUNE; RNA-SEQ; INSECT; RESISTANCE	Heliothine pests such as the tobacco budworm, Heliothis virescens (F.), pose a significant threat to production of a variety of crops and ornamental plants and are models for developmental and physiological studies. The efforts to develop new control measures for H. virescens, as well as its use as a relevant biological model, are hampered by a lack of molecular resources. The present work demonstrates the utility of next-generation sequencing technologies for rapid molecular resource generation from this species for which lacks a sequenced genome. In order to amass a de novo transcriptome for this moth, transcript sequences generated from Illumina, Roche 454, and Sanger sequencing platforms were merged into a single de novo transcriptome assembly. This pooling strategy allowed a thorough sampling of transcripts produced under diverse environmental conditions, developmental stages, tissues, and infections with entomopathogens used for biological control, to provide the most complete transcriptome to date for this species. Over 138 million reads from the three platforms were assembled into the final set of 63,648 contigs. Of these, 29,978 had significant BLAST scores indicating orthologous relationships to transcripts of other insect species, with the top-hit species being the monarch butterfly (Danaus plexippus) and silkworm (Bombyx mori). Among identified H. virescens orthologs were immune effectors, signal transduction pathways, olfactory receptors, hormone biosynthetic pathways, peptide hormones and their receptors, digestive enzymes, and insecticide resistancgenomics and for new biological experimentation needed to develop efficient control efforts for this and related Noctuid pest moths.e enzymes. As an example, we demonstrate the utility of this transcriptomic resource to study gene expression profiling of larval midguts and detect transcripts of putative Bacillus thuringiensis (Bt) Cry toxin receptors. The substantial molecular resources described in this study will facilitate development of H. virescens as a relevant biological model for functional	[Perera, Omaththage P.] ARS, Southern Insect Management Res Unit, USDA, Stoneville, MS 38776 USA; [Shelby, Kent S.; Popham, Holly J. R.] ARS, USDA, Biol Control Insects Res Lab, Columbia, MO 65203 USA; [Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27607 USA; [Adang, Michael J.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Jurat-Fuentes, Juan Luis] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37996 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia; University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Perera, OP (corresponding author), ARS, Southern Insect Management Res Unit, USDA, Stoneville, MS 38776 USA.	OP.Perera@ars.usda.gov	; Shelby, Kent/E-1605-2011	Jurat-Fuentes, Juan Luis/0000-0002-8945-1814; Shelby, Kent/0000-0001-9859-3497	U. S. Department of Agriculture under National Research Initiative Award [2004-35607-19935]; U. S. Department of Agriculture under Biotechnology Risk Assessment Grant [2008-03046]	U. S. Department of Agriculture under National Research Initiative Award; U. S. Department of Agriculture under Biotechnology Risk Assessment Grant	This work was partially supported by the U. S. Department of Agriculture under National Research Initiative Award No. 2004-35607-19935 to M.J.A. and J.L.J.-F., and Biotechnology Risk Assessment Grant Award No. 2008-03046 to J.L.J.-F. and O.P.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6; Albernaz KC, 2012, B ENTOMOL RES, V102, P333, DOI 10.1017/S0007485311000678; Aronstein K., 2011, RNA PROCESSING, P157, DOI [10.5772/19768, DOI 10.5772/19768]; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Bachman PM, 2013, TRANSGENIC RES, V22, P1207, DOI 10.1007/s11248-013-9716-5; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Banks DJ, 2003, INSECT BIOCHEM MOLEC, V33, P499, DOI 10.1016/S0965-1748(03)00022-5; Banks DJ, 2001, INSECT BIOCHEM MOLEC, V31, P909, DOI 10.1016/S0965-1748(01)00038-8; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Baxter SW, 2011, GENETICS, V189, P675, DOI 10.1534/genetics.111.130971; Bel Y, 2009, INSECT BIOCHEM MOLEC, V39, P218, DOI 10.1016/j.ibmb.2008.11.005; Blander JM, 2012, NAT REV IMMUNOL, V12, P215, DOI 10.1038/nri3167; Breitenbach JE, 2013, ARCH VIROL, V158, P1517, DOI 10.1007/s00705-013-1640-8; Breitenbach JE, 2011, VIRUSES-BASEL, V3, P2047, DOI 10.3390/v3112047; Brito LO, 2001, COMP BIOCHEM PHYS B, V128, P365, DOI 10.1016/S1096-4959(00)00325-0; Cabrera AR, 2011, J INSECT PHYSIOL, V57, P52, DOI 10.1016/j.jinsphys.2010.09.006; Celorio-Mancera MD, 2012, ENTOMOL EXP APPL, V144, P123, DOI 10.1111/j.1570-7458.2012.01249.x; Celorio-Mancera MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026676; Chan QWT, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-387; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Clem RJ, 2010, INSECT VIROLOGY, P389; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Crava CM, 2013, INSECT BIOCHEM MOLEC, V43, P924, DOI 10.1016/j.ibmb.2013.07.009; Denolf P, 1997, EUR J BIOCHEM, V248, P748, DOI 10.1111/j.1432-1033.1997.t01-1-00748.x; Ewen-Campen B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-61; Fabrick JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097900; Falabella P, 2012, INSECT BIOCHEM MOLEC, V42, P203, DOI 10.1016/j.ibmb.2011.11.011; FITT GP, 1989, ANNU REV ENTOMOL, V34, P17, DOI 10.1146/annurev.en.34.010189.000313; Gahan LJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001248; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; GILL SS, 1995, J BIOL CHEM, V270, P27277, DOI 10.1074/jbc.270.45.27277; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Govind G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008735; Groot AT, 2013, MOL ECOL, V22, P1065, DOI 10.1111/mec.12171; Groot AT, 2011, MOL ECOL, V20, P2676, DOI 10.1111/j.1365-294X.2011.05129.x; Groot AT, 2009, INSECT BIOCHEM MOLEC, V39, P568, DOI 10.1016/j.ibmb.2009.05.002; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Hahn DA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-234; Heckel DG, 1998, PHILOS T ROY SOC B, V353, P1713, DOI 10.1098/rstb.1998.0323; Honeybee Genome Sequencing Consortium, 2007, NATURE, V443, P931; Hoover K, 2000, J INSECT PHYSIOL, V46, P999, DOI 10.1016/S0022-1910(99)00211-5; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hunter W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001160; Itoh M, 1999, INSECT BIOCHEM MOLEC, V29, P121, DOI 10.1016/S0965-1748(98)00115-5; ITOH M, 1991, BIOCHIM BIOPHYS ACTA, V1129, P135, DOI 10.1016/0167-4781(91)90229-F; Jiang H, 2010, INVERTEBRATE IMMUNIT, P163; JOHNSTON KA, 1995, INSECT BIOCHEM MOLEC, V25, P375, DOI 10.1016/0965-1748(94)00077-U; Jurat-Fuentes JL, 2004, BIOCHEMISTRY-US, V43, P14299, DOI 10.1021/bi048500i; Jurat-Fuentes JL, 2004, EUR J BIOCHEM, V271, P3127, DOI 10.1111/j.1432-1033.2004.04238.x; Jurat-Fuentes JL, 2007, J INVERTEBR PATHOL, V95, P187, DOI 10.1016/j.jip.2007.01.008; Jurat-Fuentes JL, 2006, J INVERTEBR PATHOL, V92, P166, DOI 10.1016/j.jip.2006.01.010; Jurat-Fuentes JL, 2006, BIOCHEMISTRY-US, V45, P9688, DOI 10.1021/bi0606703; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Karatolos N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-56; Kirkpatrick BA, 1998, J INVERTEBR PATHOL, V72, P63, DOI 10.1006/jipa.1997.4752; KLOCKE JA, 1982, J INSECT PHYSIOL, V28, P911, DOI 10.1016/0022-1910(82)90106-8; Krishnamoorthy M, 2007, INSECT BIOCHEM MOLEC, V37, P189, DOI 10.1016/j.ibmb.2006.10.004; KRUEGER CM, 1993, FLA ENTOMOL, V76, P382, DOI 10.2307/3495738; Loeb MJ, 2001, ARCH INSECT BIOCHEM, V47, P181, DOI 10.1002/arch.1050; Luo K, 1997, INSECT BIOCHEM MOLEC, V27, P735, DOI 10.1016/S0965-1748(97)00052-0; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Mao YB, 2011, TRANSGENIC RES, V20, P665, DOI 10.1007/s11248-010-9450-1; Margam VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021388; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mittapalli O, 2010, PLOS ONE; Montella IR, 2012, MEM I OSWALDO CRUZ, V107, P437, DOI 10.1590/S0074-02762012000400001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mukherjee K, 2010, APPL ENVIRON MICROB, V76, P310, DOI 10.1128/AEM.01301-09; Ning CM, 2010, J INSECT PHYSIOL, V56, P666, DOI 10.1016/j.jinsphys.2010.02.003; O'Neil ST, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-310; Oltean DI, 1999, APPL ENVIRON MICROB, V65, P4760; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Parthasarathy R, 2007, MECH DEVELOP, V124, P23, DOI 10.1016/j.mod.2006.09.002; Perera OP, 2009, INSECT BIOCHEM MOLEC, V39, P294, DOI 10.1016/j.ibmb.2009.01.006; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Popham HJR, 2010, J INSECT PHYSIOL, V56, P1237, DOI 10.1016/j.jinsphys.2010.03.024; Rotenberg D, 2010, INSECT MOL BIOL, V19, P537, DOI 10.1111/j.1365-2583.2010.01012.x; Schwartz D, 2009, BMC GENOMICS, V10, P663; Shelby KS, 2008, ARCH INSECT BIOCHEM, V69, P127, DOI 10.1002/arch.20274; Shelby Kent S., 2012, Insects, V3, P743, DOI 10.3390/insects3030743; Shelby KS, 2009, J INVERTEBR PATHOL, V101, P86, DOI 10.1016/j.jip.2009.05.002; Shelby KS, 1999, J INSECT PHYSIOL, V45, P507, DOI 10.1016/S0022-1910(98)00144-9; Shelby KS, 2000, J INVERTEBR PATHOL, V75, P218, DOI 10.1006/jipa.2000.4925; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Ulvila J, 2010, SCAND J IMMUNOL, V71, P146, DOI 10.1111/j.1365-3083.2009.02362.x; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Vodovar N, 2012, ADV INSECT PHYSIOL, V42, P1, DOI 10.1016/B978-0-12-387680-5.00001-X; Vogel H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-308; Vogel H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-29; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang YB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018644; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Wynant N, 2014, INSECT MOL BIOL, V23, P320, DOI 10.1111/imb.12083; Wynant N, 2014, J INSECT PHYSIOL, V64, P7, DOI 10.1016/j.jinsphys.2014.02.010; Xia QY, 2009, SCIENCE, V326, P433, DOI 10.1126/science.1176620; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Xue XY, 2012, ADV INSECT PHYSIOL, V42, P73, DOI 10.1016/B978-0-12-387680-5.00003-3; Yang GS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-2; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhu HS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001345	105	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128563	10.1371/journal.pone.0128563	http://dx.doi.org/10.1371/journal.pone.0128563			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047101	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200079
J	Wen, XX; Wang, FQ; Xu, C; Wu, ZX; Zhang, Y; Feng, YF; Yan, YB; Lei, W				Wen, Xin-Xin; Wang, Fa-Qi; Xu, Chao; Wu, Zi-Xiang; Zhang, Yang; Feng, Ya-Fei; Yan, Ya-Bo; Lei, Wei			Time Related Changes of Mineral and Collagen and Their Roles in Cortical Bone Mechanics of Ovariectomized Rabbits	PLOS ONE			English	Article							FTIR MICROSPECTROSCOPIC ANALYSIS; ILIAC CREST BIOPSIES; SPECTROSCOPIC CHARACTERIZATION; NANOMECHANICAL PROPERTIES; CRYSTAL SIZE; CROSS-LINKS; OSTEOPOROSIS; QUALITY; WOMEN; MICROSTRUCTURE	As cortical bone has a hierarchical structure, the macroscopic bone strength may be affected by the alterations of mineral crystal and collagen, which are main components of cortical bone. Limited studies focused on the time related alterations of these two components in osteoporosis, and their contributions to bone mechanics at tissue level and whole-bone level. Therefore, the purpose of this study was to elucidate the time related changes of mineral and collagen in cortical bone of ovariectomized (OVX) rabbits, and to relate these changes to cortical bone nanomechanics and macromechanics. 40 Rabbits (7-month-old) were randomly allocated into two groups (OVX and sham). OVX group received bilateral ovariectomy operation. Sham group received sham-OVX operation. Cortical bone quality of five rabbits in each group were assessed by DXA, mu CT, nanoindentation, Fourier transform infrared (FTIR) spectroscopy and biomechanical tests (3-point bending of femoral midshaft) at pre-OVX, 4, 6, and 8 weeks after OVX. As time increased from pre-OVX to 8 weeks, the mineral to matrix ratio decreased with time, while both collagen crosslink ratio and crystallinity increased with time in OVX group. Elastic modulus and hardness measured by nanoindentation, whole-bone strength measured by biomechanical tests all decreased in OVX group with time. Bone material properties measured by FTIR correlated well with nano or whole-bone level mechanics. However, bone mineral density (BMD), structure, tissue-level and whole-bone mechanical properties did not change with age in sham group. Our study demonstrated that OVX could affect the tissue-level mechanics and bone strength of cortical bone. And this influence was attributed to the time related alterations of mineral and collagen properties, which may help us to design earlier interventions and more effective treatment strategies on osteoporosis.	[Wen, Xin-Xin; Wang, Fa-Qi; Xu, Chao; Wu, Zi-Xiang; Zhang, Yang; Feng, Ya-Fei; Yan, Ya-Bo; Lei, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China	Air Force Military Medical University	Yan, YB (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Peoples R China.	yanyabo@gmail.com; leiwei@fmmu.edu.cn		Xu, Chao/0000-0001-9693-0218; Lei, Wei/0000-0002-7346-6915	National Nature Science Foundation of China [81301292]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (No. 81301292) to YBY (http://www.nsfc.gov.cn/).	Augat P, 2006, AGE AGEING, V35, P27, DOI 10.1093/ageing/afl081; BAUD CA, 1976, CALC TISS RES, V21, P452; Bi XH, 2011, J BIOMECH, V44, P297, DOI 10.1016/j.jbiomech.2010.10.009; Boskey A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1922927; Boskey AL, 2005, OSTEOPOROSIS INT, V16, P2031, DOI 10.1007/s00198-005-1992-3; BOSKEY AL, 1990, ORTHOP CLIN N AM, V21, P19; Boskey AL, 2005, VIB SPECTROSC, V38, P107, DOI 10.1016/j.vibspec.2005.02.015; Bourne GH, 1972, BIOCH PHYSL BONE; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bozzini C, 2012, ENDOCRINE, V42, P411, DOI 10.1007/s12020-012-9616-0; Brennan O, 2012, CALCIFIED TISSUE INT, V91, P440, DOI 10.1007/s00223-012-9657-7; Castaneda S, 2008, J BONE MINER METAB, V26, P53, DOI 10.1007/s00774-007-0797-1; Chang YT, 2011, J MECH BEHAV BIOMED, V4, P1412, DOI 10.1016/j.jmbbm.2011.05.011; Chen HF, 2014, ADVANCED CERAMICS FOR DENTISTRY, P5, DOI 10.1016/B978-0-12-394619-5.00002-X; Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K; Cowin S, 2001, BONE MECH HDB, V2nd, DOI DOI 10.1201/B14263; Currey JD, 1996, J BIOMECH, V29, P257, DOI 10.1016/0021-9290(95)00048-8; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; Donnelly E, 2010, J BIOMED MATER RES A, V92A, P1048, DOI 10.1002/jbm.a.32442; Eckstein F, 2004, BONE, V35, P364, DOI 10.1016/j.bone.2004.04.008; Fratzl P, 2004, J MATER CHEM, V14, P2115, DOI 10.1039/b402005g; Gadaleta SJ, 1996, CALCIFIED TISSUE INT, V58, P9, DOI 10.1007/s002239900004; Genant HK, 1996, J BONE MINER RES, V11, P707; Gourion-Arsiquaud S, 2009, J BONE MINER RES, V24, P1565, DOI [10.1359/JBMR.090414, 10.1359/jbmr.090414]; Hamed E, 2010, ACTA MECH, V213, P131, DOI 10.1007/s00707-010-0326-5; Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X; Huang RY, 2003, BONE, V33, P514, DOI 10.1016/S8756-3282(03)00233-3; Isaksson H, 2010, BONE, V47, P1030, DOI 10.1016/j.bone.2010.08.015; KENT GN, 1983, J BONE JOINT SURG BR, V65, P189, DOI 10.1302/0301-620X.65B2.6826629; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Li GW, 2012, EUR RADIOL, V22, P923, DOI 10.1007/s00330-011-2325-x; Li ZY, 2007, BIOMATERIALS, V28, P1452, DOI 10.1016/j.biomaterials.2006.11.001; Liu XL, 2012, MED ENG PHYS, V34, P2, DOI 10.1016/j.medengphy.2011.06.010; Malluche Hartmut H, 2013, J Bone Joint Surg Am, V95, pe1391, DOI 10.2106/JBJS.L.01281; Misof BM, 2012, J BONE MINER RES, V27, P2551, DOI 10.1002/jbmr.1699; Nazarian A, 2009, OSTEOPOROSIS INT, V20, P123, DOI 10.1007/s00198-008-0632-0; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Paschalis EP, 2011, CLIN ORTHOP RELAT R, V469, P2170, DOI 10.1007/s11999-010-1751-4; Paschalis EP, 2003, J BONE MINER RES, V18, P769, DOI 10.1359/jbmr.2003.18.4.769; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Paschalis EP, 1997, CALCIFIED TISSUE INT, V61, P487, DOI 10.1007/s002239900372; Paschalis EP, 1996, CALCIFIED TISSUE INT, V59, P480, DOI 10.1007/BF00369214; Pienkowski D, 1997, J BONE MINER RES, V12, P1936, DOI 10.1359/jbmr.1997.12.11.1936; PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0; Rho JY, 1999, J MATER SCI-MATER M, V10, P485, DOI 10.1023/A:1008901109705; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Sparke AJ, 2002, BRIT POULTRY SCI, V43, P127, DOI 10.1080/00071660120109962; Taeyong Lee, 2011, The Journal of Korean Society of Osteoporosis, V9, P222; Tamaki H, 1998, BONE, V23, P147, DOI 10.1016/S8756-3282(98)00075-1; Tommasini SM, 2012, BONE, V50, P596, DOI 10.1016/j.bone.2011.12.012; Vaughan TJ, 2012, J MECH BEHAV BIOMED, V12, P50, DOI 10.1016/j.jmbbm.2012.03.003; Yerramshetty JS, 2008, BONE, V42, P476, DOI 10.1016/j.bone.2007.12.001	54	15	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127973	10.1371/journal.pone.0127973	http://dx.doi.org/10.1371/journal.pone.0127973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046792	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200036
J	Xu, SP; Jiayong, ZP; Li, B; Zhu, H; Chang, H; Shi, W; Gao, ZX; Ning, XJ; Wang, JH				Xu, Shaopeng; Jiayong, Zepei; Li, Bin; Zhu, Hong; Chang, Hong; Shi, Wei; Gao, Zhengxuan; Ning, Xianjia; Wang, Jinghua			Prevalence and Clustering of Cardiovascular Disease Risk Factors among Tibetan Adults in China: A Population-Based Study	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; METABOLIC SYNDROME; BLOOD-PRESSURE; HYPERTENSION; AWARENESS; MEN; ASSOCIATIONS; MORTALITY; HERDSMEN; OBESITY	Objectives The prevalence of cardiovascular disease risk factors has increased worldwide. However, the prevalence and clustering of cardiovascular disease risk factors among Tibetans is currently unknown. We aimed to explore the prevalence and clustering of cardiovascular disease risk factors among Tibetan adults in China. Methods In 2011, 1659 Tibetan adults (aged >= 18 years) from Changdu, China were recruited to this cross-section study. The questionnaire, physical examinations and laboratory testing were completed and the prevalence of cardiovascular disease risk factors, including hypertension, diabetes, overweight/obesity, dyslipidemia, and current smoking, were counted. The association between the clustering of cardiovascular disease risk factors and demographic characteristics, and geographic altitude were assessed. Results The age-standardized prevalence of hypertension, diabetes, overweight or obesity, dyslipidemia, and current smoking were 62.4%, 6.4%, 34.3%, 42.7%, and 6.1%, respectively, and these risk factors were associated with age, gender, education level, yearly family income, altitude, occupation, and butter tea consumption (P < 0.05). Overall, the age-adjusted prevalence of clustering of >= 1, >= 2, and >= 3 cardiovascular disease risk factors were 79.4%, 47.1%, and 20.9%, respectively. There appeared higher clustering of >= 2 and >= 3 cardiovascular disease risk factors among Tibetans with higher education level and family income yearly, and those living at an altitude < 3500 m and in a township. Conclusions The prevalence of cardiovascular disease risk factors, especially hypertension, was high in Tibetans. Moreover, there was an increased clustering of cardiovascular disease risk factors among those with higher socioeconomic status, lamas and those living at an altitude <3500 m. These findings suggest that without the immediate implementation of an efficient policy to control these risk factors, cardiovascular disease will eventually become a major disease burden among Tibetans.	[Xu, Shaopeng] Tianjin Med Univ, Gen Hosp, Dept Cardiol, Tianjin, Peoples R China; [Jiayong, Zepei; Li, Bin; Chang, Hong; Gao, Zhengxuan] Changdu Reg Peoples Hosp, Dept Internal Med, Tibet, Peoples R China; [Zhu, Hong] Tianjin Med Univ, Dept Epidemiol, Tianjin, Peoples R China; [Shi, Wei] Changdu Reg Peoples Hosp, Clin Lab, Chengdu, Tibet, Peoples R China; [Ning, Xianjia; Wang, Jinghua] Tianjin Med Univ, Gen Hosp, Lab Epidemiol, Tianjin Neurol Inst, Tianjin, Peoples R China; [Ning, Xianjia; Wang, Jinghua] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Ning, XJ (corresponding author), Tianjin Med Univ, Gen Hosp, Lab Epidemiol, Tianjin Neurol Inst, Tianjin, Peoples R China.	xjn0906@gmail.com; jhw8799@yahoo.com			government of Changdu, Tibet; Tianjin Medical University General Hospital	government of Changdu, Tibet; Tianjin Medical University General Hospital	This study was funded by the government of Changdu, Tibet and Tianjin Medical University General Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad OB, 2001, GPE DISCUSSION PAPER, V31, P1; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Chinese Diabetes Society, 2011, CHINA GUIDELINE FOR; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Disease control Ministry of Health of the People's Republic of China, 2006, THE GUIDELINES OF CH; Erem C, 2008, ENDOCRINE, V34, P36, DOI 10.1007/s12020-008-9100-z; Gu DF, 2005, CIRCULATION, V112, P658, DOI 10.1161/CIRCULATIONAHA.104.515072; He J, 2004, CIRCULATION, V110, P405, DOI 10.1161/01.CIR.0000136583.52681.0D; He L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-34; Huang JP, 2011, KIDNEY BLOOD PRESS R, V34, P69, DOI 10.1159/000323164; Insaf TZ, 2014, J EPIDEMIOL COMMUN H, V68, P318, DOI 10.1136/jech-2013-202585; Kavanagh A, 2010, SOC SCI MED, V71, P1150, DOI 10.1016/j.socscimed.2010.05.038; Li H, 2010, J HYPERTENS, V28, P432, DOI 10.1097/HJH.0b013e328334b39e; Liu Longjian, 2004, Clin Exp Pharmacol Physiol, V31 Suppl 2, pS8, DOI 10.1111/j.1440-1681.2004.04105.x; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Murray CJL, 1996, THE GLOBAL BURDEN OF; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; PERLOFF D, 1993, CIRCULATION, V88, P2460, DOI 10.1161/01.CIR.88.5.2460; Ploubidis GB, 2013, INT J PUBLIC HEALTH, V58, P133, DOI 10.1007/s00038-012-0389-2; Reynolds K, 2007, OBESITY, V15, P10, DOI 10.1038/oby.2007.527; Safraj S, 2012, ASIA-PAC J PUBLIC HE, V24, P480, DOI 10.1177/1010539510387822; Sherpa LY, 2013, HIGH ALT MED BIOL, V14, P37, DOI 10.1089/ham.2012.1051; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Strand A, 2007, J AM SOC HYPERTENS, V1, P400, DOI 10.1016/j.jash.2007.07.002; The Ministry of Health of the People's Republic of China, 2011, CHINA HEALTH STATIST; Thomas GN, 2007, CLIN ENDOCRINOL, V66, P666, DOI 10.1111/j.1365-2265.2007.02798.x; Tripathy V, 2007, ANN HUM BIOL, V34, P470, DOI 10.1080/03014460701412284; Wang J, 2014, J HUM HYPERTENS, V28, P25, DOI 10.1038/jhh.2013.44; Wang Y, 2007, INT J OBESITY, V31, P177, DOI 10.1038/sj.ijo.0803354; World Health Organization, 2003, WORLD HEALTH REPORT; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yu ZJ, 2000, B WORLD HEALTH ORGAN, V78, P1296; Yusuf HR, 1998, PREV MED, V27, P1, DOI 10.1006/pmed.1997.0268; Zhang L, 2011, INT J CARDIOL, V151, P46, DOI 10.1016/j.ijcard.2010.04.056; Zhao XS, 2012, AM J HYPERTENS, V25, P583, DOI 10.1038/ajh.2012.9; Zheng X, 2012, CLIN EXP HYPERTENS, V34, P328, DOI 10.3109/10641963.2011.649930	38	46	47	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129966	10.1371/journal.pone.0129966	http://dx.doi.org/10.1371/journal.pone.0129966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047133	gold, Green Submitted, Green Published			2022-12-26	WOS:000355652200169
J	Yan, XQ; Zeng, RC; Ma, ZS; Chen, CZ; Chen, ED; Zhang, XH; Cao, FL				Yan, Xingqiang; Zeng, Ruichao; Ma, Zhaosheng; Chen, Chengze; Chen, Endong; Zhang, Xiaohua; Cao, Feilin			The Utility of Sentinel Lymph Node Biopsy in Papillary Thyroid Carcinoma with Occult Lymph Nodes	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC THYROIDITIS; RISK-FACTORS; METASTASIS; MICROCARCINOMA; DISSECTION; RECURRENCE; CANCER; SURVIVAL; PATTERN	Background The sentinel lymph node (SLN) is defined as the first draining node from the primary lesion, and it has proven to be a good indicator of the metastatic status of regional lymph nodes in solid tumors. The aim of this study was to evaluate the clinical application of SLN biopsy (SLNB) in papillary thyroid carcinoma (PTC) with occult lymph nodes. Methods From April 2006 to October 2012, 212 consecutive PTC patients were treated with SLNB using carbon nanoparticle suspension (CNS). Then, the stained nodes defined as SLN were collected, and prophylactic central compartment neck dissection (CCND) followed by total thyroidectomy or subtotal thyroidectomy were performed. All the samples were sent for pathological examination. Results There were 78 (36.8%) SLN metastasis (SLNM)-positive cases and 134 (63.2%) SLNM-negative cases. The sensitivity, specificity, positive and negative predictive values, and false-positive and false-negative rates of SLNB were 78.8%, 100%, 100%, 84.3%, 0%, and 21.2%, respectively. The PTC patients with SLNM were more likely to be male (48.2% vs. 32.7%, p = 0.039) and exhibited multifocality (52.6% vs. 33.3%, p = 0.025) and extrathyroidal extension (56.7% vs. 33.5%, p = 0.015). A greater incidence of non-SLN metastases in the central compartment was found in patients with SLNM (41/78, 52.6%) than in those without SLNM (21/134, 15.7%; p < 0.05). However, the SLNM-negative PTC patients with non-SLN metastases were more likely to be male (37.9% vs. 9.5%, p < 0.05). Conclusions The application of SLNB using CNS is technically feasible, safe, and useful, especially for male patients with co-existing multifocality and extrathyroidal extension. However, the sensitivity of SLNB must be improved and its false-negative rate reduced before it can be a routine procedure and replace prophylactic CCND. More attention should be paid to PTC patients (especially males) without SLNM for signs of non-SLN metastases.	[Yan, Xingqiang; Ma, Zhaosheng; Cao, Feilin] Wenzhou Med Univ, Taizhou Hosp, Dept Surg Oncol, Linhai, Zhejiang, Peoples R China; [Yan, Xingqiang; Zeng, Ruichao; Chen, Chengze; Chen, Endong; Zhang, Xiaohua] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg Oncol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Cao, FL (corresponding author), Wenzhou Med Univ, Taizhou Hosp, Dept Surg Oncol, Linhai, Zhejiang, Peoples R China.	zhangxiaohua577@163.com; cao_feilin@yahoo.com		Ruichao, Zeng/0000-0002-6990-0520				Ahn D, 2011, ACTA ONCOL, V50, P1228, DOI 10.3109/0284186X.2011.602109; Antonaci A, 2006, Clin Ter, V157, P225; Balasubramanian SP, 2011, BRIT J SURG, V98, P334, DOI 10.1002/bjs.7425; Catarci M, 1998, ANN SURG ONCOL, V5, P580, DOI 10.1007/BF02303825; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cunningham DK, 2010, ANN SURG ONCOL, V17, P2970, DOI 10.1245/s10434-010-1141-x; Dzodic R, 2006, WORLD J SURG, V30, P841, DOI 10.1007/s00268-005-0298-0; Gulben K, 2008, LANGENBECK ARCH SURG, V393, P25, DOI 10.1007/s00423-007-0213-2; Hao RT, 2012, EJSO-EUR J SURG ONC, V38, P718, DOI 10.1016/j.ejso.2012.02.001; Hay ID, 1993, SURGERY, V114, P1057; Henry JF, 1998, LANGENBECK ARCH SURG, V383, P167, DOI 10.1007/s004230050111; Ito Y, 2007, WORLD J SURG, V31, P2085, DOI 10.1007/s00268-007-9224-y; Kebebew E, 2001, WORLD J SURG, V25, P632, DOI 10.1007/s002680020165; Kim EY, 2009, CLIN ENDOCRINOL, V71, P581, DOI 10.1111/j.1365-2265.2009.03537.x; Kim SS, 2011, HEAD NECK-J SCI SPEC, V33, P1272, DOI 10.1002/hed.21594; Koo BS, 2009, ANN SURG, V249, P840, DOI 10.1097/SLA.0b013e3181a40919; KRAG DN, 1993, SURG ONCOL, V2, P335, DOI 10.1016/0960-7404(93)90064-6; Liu Chien-Liang, 2003, J Chin Med Assoc, V66, P406; Loh KC, 1999, J CLIN ENDOCR METAB, V84, P458, DOI 10.1210/jc.84.2.458; Lundgren CI, 2006, CANCER, V106, P524, DOI 10.1002/cncr.21653; Mazzaferri E L, 2000, Endocr Pract, V6, P469; Mazzaferri EL, 2009, THYROID, V19, P683, DOI 10.1089/thy.2009.1578; Patron V, 2012, ANN OTO RHINOL LARYN, V121, P283, DOI 10.1177/000348941212100501; Pelizzo MR, 2006, BIOMED PHARMACOTHER, V60, P405, DOI 10.1016/j.biopha.2006.08.001; Podnos YD, 2005, AM SURGEON, V71, P731; Raijmakers PGHM, 2008, WORLD J SURG, V32, P1961, DOI 10.1007/s00268-008-9657-y; Roh JL, 2008, ANN SURG ONCOL, V15, P2482, DOI 10.1245/s10434-008-0044-6; Schwartz GF, 2002, CANCER, V94, P2542, DOI 10.1002/cncr.10539; Shaha A R, 2000, Cancer Control, V7, P240; So YK, 2010, SURGERY, V148, P526, DOI 10.1016/j.surg.2010.01.003; VANDERVEEN H, 1994, BRIT J SURG, V81, P1769, DOI 10.1002/bjs.1800811220; Wada N, 2003, ANN SURG, V237, P399, DOI 10.1097/00000658-200303000-00015; Yang Y, 2014, CLINICAL ENDOCRINOLO; Zaydfudim V, 2008, SURGERY, V144, P1070, DOI 10.1016/j.surg.2008.08.034; Zhang L, 2012, J CLIN ENDOCR METAB, V97, P1250, DOI 10.1210/jc.2011-1546	35	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129304	10.1371/journal.pone.0129304	http://dx.doi.org/10.1371/journal.pone.0129304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046782	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200146
J	Xu, Y; Wu, XL; Her, CT				Xu, Yang; Wu, Xiling; Her, Chengtao			hMSH5 Facilitates the Repair of Camptothecin-induced Double-strand Breaks through an Interaction with FANCJ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; MUTS HOMOLOG HMSH5; ANEMIA GROUP J; MMS22L-NFKBIL2 COMPLEX; MMS22L-TONSL COMPLEX; MISMATCH REPAIR; PROTEIN; REPLICATION; HELICASE; RECOMBINATION	Replication stress from stalled or collapsed replication forks is a major challenge to genomic integrity. The anticancer agent camptothecin (CPT) is a DNA topoisomerase I inhibitor that causes fork collapse and double-strand breaks amid DNA replication. Here we report that hMSH5 promotes cell survival in response to CPT-induced DNA damage. Cells deficient in hMSH5 show elevated CPT-induced gamma-H2AX and RPA2 foci with concomitant reduction of Rad51 foci, indicative of impaired homologous recombination. In addition, CPT-treated hMSH5-deficient cells exhibit aberrant activation of Chk1 and Chk2 kinases and therefore abnormal cell cycle progression. Furthermore, the hMSH5-FANCJ chromatin recruitment underlies the effects of hMSH5on homologous recombination and Chk1 activation. Intriguingly, FANCJ depletion desensitizes hMSH5-deficient cells to CPT-elicited cell killing. Collectively, our data point to the existence of a functional interplay between hMSH5 and FANCJ in double-strand break repair induced by replication stress.	[Xu, Yang; Wu, Xiling; Her, Chengtao] Washington State Univ, Sch Mol Biosci, Coll Vet Med, Pullman, WA 99164 USA	Washington State University	Her, CT (corresponding author), Washington State Univ, Sch Mol Biosci, Coll Vet Med, Mail Drop 64-7520, Pullman, WA 99164 USA.	cher@wsu.edu			National Institutes of Health from the Public Health Service [GM084353]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084353] Funding Source: NIH RePORTER	National Institutes of Health from the Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM084353 from the Public Health Service (to C. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Britton S, 2013, J CELL BIOL, V202, P579, DOI 10.1083/jcb.201303073; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clark N, 2013, CURR GENOMICS, V14, P81, DOI 10.2174/1389202911314020002; Cloud V, 2012, SCIENCE, V337, P1222, DOI 10.1126/science.1219379; Costantino L, 2014, SCIENCE, V343, P88, DOI 10.1126/science.1243211; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; de Vries SS, 1999, GENE DEV, V13, P523, DOI 10.1101/gad.13.5.523; Dohrn L, 2012, BIOCHEM J, V441, P919, DOI 10.1042/BJ20110314; Duro E, 2010, MOL CELL, V40, P632, DOI 10.1016/j.molcel.2010.10.023; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Guillemette S, 2014, CANCER RES, V74, P932, DOI 10.1158/0008-5472.CAN-13-2474; Gupta R, 2005, J BIOL CHEM, V280, P25450, DOI 10.1074/jbc.M501995200; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hiom K, 2010, DNA REPAIR, V9, P250, DOI 10.1016/j.dnarep.2010.01.005; Hirokawa T, 2014, CANCER RES, V74, P3880, DOI 10.1158/0008-5472.CAN-13-3604; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Kato T, 2007, CANCER RES, V67, P8544, DOI 10.1158/0008-5472.CAN-07-1307; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Majka J, 2012, J BIOL CHEM, V287, P2328, DOI 10.1074/jbc.M111.307041; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; O'Connell BC, 2010, MOL CELL, V40, P645, DOI 10.1016/j.molcel.2010.10.022; O'Donnell L, 2010, MOL CELL, V40, P619, DOI 10.1016/j.molcel.2010.10.024; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Peng M, 2014, EMBO J, V33, P1698, DOI 10.15252/embj.201387530; Piwko W, 2010, EMBO J, V29, P4210, DOI 10.1038/emboj.2010.304; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Schwab RA, 2013, J CELL BIOL, V201, P33, DOI 10.1083/jcb.201208009; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Suhasini AN, 2013, MOL CELL BIOL, V33, P2212, DOI 10.1128/MCB.01256-12; Suhasini AN, 2012, TRENDS GENET, V28, P7, DOI 10.1016/j.tig.2011.09.003; Suhasini AN, 2011, EMBO J, V30, P692, DOI 10.1038/emboj.2010.362; Tompkins JD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-10; Vo AT, 2005, EMBO REP, V6, P438, DOI 10.1038/sj.embor.7400392; Wu XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073284; Xie J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002786; Xu KQ, 2012, J BIOL CHEM, V287, P29543, DOI 10.1074/jbc.M112.352302; Yi W, 2006, CANCER RES, V66, P151, DOI 10.1158/0008-5472.CAN-05-3019; Yi W, 2005, BIOCHEM BIOPH RES CO, V332, P524, DOI 10.1016/j.bbrc.2005.04.154; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	58	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18545	18558		10.1074/jbc.M115.642884	http://dx.doi.org/10.1074/jbc.M115.642884			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055704	Green Published, hybrid			2022-12-26	WOS:000358512100026
J	Itoh, Y; Sanosaka, M; Fuchino, H; Yahara, Y; Kumagai, A; Takemoto, D; Kagawa, M; Doi, J; Ohta, M; Tsumaki, N; Kawahara, N; Takemori, H				Itoh, Yumi; Sanosaka, Masato; Fuchino, Hiroyuki; Yahara, Yasuhito; Kumagai, Ayako; Takemoto, Daisaku; Kagawa, Mai; Doi, Junko; Ohta, Miho; Tsumaki, Noriyuki; Kawahara, Nobuo; Takemori, Hiroshi			Salt-inducible Kinase 3 Signaling Is Important for the Gluconeogenic Programs in Mouse Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; GLYCOGEN-STORAGE DISEASE; CREB COACTIVATOR TORC2; PHOSPHORYLASE-KINASE; GENE-EXPRESSION; INSULIN HYPERSENSITIVITY; LIVER GLYCOGENOSIS; KEY REGULATOR; IN-VIVO; METFORMIN	Salt-inducible kinases (SIKs), members of the 5'-AMP-activated protein kinase (AMPK) family, are proposed to be important suppressors of gluconeogenic programs in the liver via the phosphorylation-dependent inactivation of the CREB-specific coactivator CRTC2. Although a dramatic phenotype for glucose metabolism has been found in SIK3-KO mice, additional complex phenotypes, dysregulation of bile acids, cholesterol, and fat homeostasis can render it difficult to discuss the hepatic functions of SIK3. The aim of this study was to examine the cell autonomous actions of SIK3 in hepatocytes. To eliminate systemic effects, we prepared primary hepatocytes and screened the small compounds suppressing SIK3 signaling cascades. SIK3-KO primary hepatocytes produced glucose more quickly after treatment with the cAMP agonist forskolin than the WT hepatocytes, which was accompanied by enhanced gluconeogenic gene expression and CRTC2 dephosphorylation. Reporter-based screening identified pterosin B as a SIK3 signalingspecific inhibitor. Pterosin B suppressed SIK3 downstream cascades by up-regulating the phosphorylation levels in the SIK3 C-terminal regulatory domain. When pterosin B promoted glucose production by up-regulating gluconeogenic gene expression in mouse hepatoma AML-12 cells, it decreased the glycogen content and stimulated an association between the glycogen phosphorylase kinase gamma subunit (PHKG2) and SIK3. PHKG2 phosphorylated the peptides with sequences of the C-terminal domain of SIK3. Here we found that the levels of active AMPK were higher both in the SIK3-KO hepatocytes and in pterosin B-treated AML-12 cells than in their controls. These results suggest that SIK3, rather than SIK1, SIK2, or AMPKs, acts as the predominant suppressor in gluconeogenic gene expression in the hepatocytes.	[Itoh, Yumi; Sanosaka, Masato; Kumagai, Ayako; Takemoto, Daisaku; Kagawa, Mai; Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, Osaka 5670085, Japan; [Fuchino, Hiroyuki; Kawahara, Nobuo] Tsukuba Div, Res Ctr Med Plant Resources, Ibaraki 3050843, Japan; [Yahara, Yasuhito; Tsumaki, Noriyuki] Kyoto Univ, Dept Cell Growth & Differentiat, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Takemoto, Daisaku] Kansai Univ, Dept Life Sci & Biotechnol, Osaka 5648680, Japan; [Doi, Junko] Senri Kinran Univ, Dept Food & Nutr, Osaka 5650873, Japan; [Ohta, Miho] Soai Univ, Fac Human Dev, Dept Nutr & Hlth, Osaka 5590033, Japan	National Institute of Health Sciences - Japan; Kyoto University; Kansai University	Takemori, H (corresponding author), Natl Inst Biomed Innovat, Lab Cell Signaling & Metab, 7-6-8 Asagi, Osaka 5670085, Japan.	takemori@nibiohn.go.jp	Takemoto, Daisaku/AAE-1365-2019; Fuchino, Hiroyuki/ABD-5560-2020; Yahara, Yasuhito/AAO-7487-2020	Takemoto, Daisaku/0000-0001-7110-6302; Fuchino, Hiroyuki/0000-0002-6302-4507; Tsumaki, Noriyuki/0000-0002-0520-3654	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven RD); Ministry of Health, Labor, and Welfare; MEXT; Uehara Memorial Foundation	A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven RD); Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation)	This study was supported by Grants-in-Aid for Scientific Research from the A-STEP (Adaptable & Seamless Technology Transfer Program through Target-driven R & D); a grant from the Ministry of Health, Labor, and Welfare (2013-2017 and 2014-2016); funds from Scientific Research on Innovative Areas, a MEXT Grant-in-Aid Project 2012-2013; and a grant from the Uehara Memorial Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; Bertorello AM, 2015, CIRC RES, V116, P642, DOI 10.1161/CIRCRESAHA.116.304529; Blattmann P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003338; Burwinkel B, 2003, PEDIATR RES, V54, P834, DOI 10.1203/01.PDR.0000088069.09275.10; CHAN KFJ, 1982, J BIOL CHEM, V257, P3655; CHRISMAN TD, 1980, J BIOL CHEM, V255, P3270; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; DUNGER DB, 1982, ARCH DIS CHILD, V57, P384, DOI 10.1136/adc.57.5.384; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gan RY, 2014, INT J MOL SCI, V15, P16698, DOI 10.3390/ijms150916698; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; HANKS SK, 1987, P NATL ACAD SCI USA, V84, P388, DOI 10.1073/pnas.84.2.388; Hardie DG, 2014, CELL METAB, V20, P939, DOI 10.1016/j.cmet.2014.09.013; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; HAWORTH JC, 1981, J INHERIT METAB DIS, V4, P57, DOI 10.1007/BF02263589; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; Hsu FL, 2013, DIABETES, V62, P628, DOI 10.2337/db12-0585; Hurov JB, 2007, P NATL ACAD SCI USA, V104, P5680, DOI 10.1073/pnas.0701179104; IMAI E, 1993, J BIOL CHEM, V268, P5353; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Kumagai A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026148; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Maichele AJ, 1996, NAT GENET, V14, P337, DOI 10.1038/ng1196-337; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Milan D, 2000, SCIENCE, V288, P1248, DOI 10.1126/science.288.5469.1248; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; OEI TL, 1962, CLIN CHIM ACTA, V7, P193, DOI 10.1016/0009-8981(62)90009-8; Ota S, 2009, BIOCHEM BIOPH RES CO, V388, P311, DOI 10.1016/j.bbrc.2009.07.164; Park J, 2014, DIABETES, V63, P3659, DOI 10.2337/db13-1423; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Ratnoglik SL, 2014, MICROBIOL IMMUNOL, V58, P188, DOI 10.1111/1348-0421.12133; Sakamaki JI, 2014, NAT CELL BIOL, V16, P234, DOI 10.1038/ncb2919; Sasagawa S, 2012, DEVELOPMENT, V139, P1153, DOI 10.1242/dev.072652; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Sun C, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.388934; Takemori H, 2002, J BIOL CHEM, V277, P42334, DOI 10.1074/jbc.M204602200; Takemori H, 2008, J STEROID BIOCHEM, V108, P287, DOI 10.1016/j.jsbmb.2007.09.006; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Uebi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037803; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; Viollet B, 2009, FRONT BIOSCI-LANDMRK, V14, P19, DOI 10.2741/3229; Walkinshaw DR, 2013, J BIOL CHEM, V288, P9345, DOI 10.1074/jbc.M113.456996; Wang ZN, 1999, FEBS LETT, V453, P135, DOI 10.1016/S0014-5793(99)00708-5; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	54	33	34	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17879	17893		10.1074/jbc.M115.640821	http://dx.doi.org/10.1074/jbc.M115.640821			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048985	hybrid, Green Published			2022-12-26	WOS:000358511700023
J	Baba, M; Shimbo, T; Horio, M; Ando, M; Yasuda, Y; Komatsu, Y; Masuda, K; Matsuo, S; Maruyama, S				Baba, Mika; Shimbo, Takuro; Horio, Masaru; Ando, Masahiko; Yasuda, Yoshinari; Komatsu, Yasuhiro; Masuda, Katsunori; Matsuo, Seiichi; Maruyama, Shoichi			Longitudinal Study of the Decline in Renal Function in Healthy Subjects	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; KIDNEY-FUNCTION DECLINE; SURROGATE END-POINT; ESTIMATED GFR; REFERENCE VALUES; POPULATION; MORTALITY; RISK	Background Chronic kidney disease is an important concern in preventive medicine, but the rate of decline in renal function in healthy population is not well defined. The purpose of this study was to determine reference values for the estimated glomerular filtration rate (eGFR) and rate of decline of eGFR in healthy subjects and to evaluate factors associated with this decline using a large cohort in Japan. Methods Retrospective cross-sectional and longitudinal studies were performed with healthy subjects aged >= 18 years old who received a medical checkup. Reference values for eGFR were obtained using a nonparametric method and those for decline of eGFR were calculated by mixed model analysis. Relationships of eGFR decline rate with baseline variables were examined using a linear least-squares method. Results In the cross-sectional study, reference values for eGFR were obtained by gender and age in 72,521 healthy subjects. The mean (+/- SD) eGFR was 83.7 +/- 14.7ml/min/1.73m(2). In the longitudinal study, reference values for eGFR decline rate were obtained by gender, age, and renal stage in 45,586 healthy subjects. In the same renal stage, there was little difference in the rate of decline regardless of age. The decline in eGFR depended on the renal stage and was strongly related to baseline eGFR, with a faster decline with a higher baseline eGFR and a slower decline with a lower baseline eGFR. The mean (+/- SD) eGFR decline rate was. 1.07 +/- 0.42ml/min/1.73m(2)/year (1.29 +/- 0.41%/year) in subjects with a mean eGFR of 81.5 +/- 11.6ml/min/1.73m(2). Conclusions The present study clarified for the first time the reference values for the rate of eGFR decline stratified by gender, age, and renal stage in healthy subjects. The rate of eGFR decline depended mainly on baseline eGFR, but not on age, with a slower decline with a lower baseline eGFR.	[Baba, Mika; Masuda, Katsunori] St Lukes Int Univ, St Lukes Affiliated Clin, Ctr Prevent Med, Tokyo, Japan; [Shimbo, Takuro] Ohta Nishinouchi Hosp, Koriyama, Fukushima, Japan; [Horio, Masaru] Osaka Univ, Grad Sch Med, Dept Funct Diagnost Sci, Suita, Osaka, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Yasuda, Yoshinari; Matsuo, Seiichi; Maruyama, Shoichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan; [Komatsu, Yasuhiro] St Lukes Int Univ, St Lukes Hosp, Dept Med, Div Nephrol, Tokyo, Japan	St. Luke's International Hospital; Osaka University; Nagoya University; Nagoya University; St. Luke's International Hospital	Maruyama, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4648601, Japan.	marus@med.nagoya-u.ac.jp	Komatsu, Yasuhiro/AAW-1969-2020; ANDO, Masahiko/F-7035-2015		St. Luke's Life Science Institute, St. Luke's International University	St. Luke's Life Science Institute, St. Luke's International University	This study was funded by a grant from St. Luke's Life Science Institute, St. Luke's International University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; CLSI, 2010, EP28 A3C DEFINING ES, VThird; Coresh J, 2014, JAMA-J AM MED ASSOC, V311, P2518, DOI 10.1001/jama.2014.6634; den Hollander JG, 2005, CLIN ENDOCRINOL, V62, P423, DOI 10.1111/j.1365-2265.2005.02236.x; Glassock Richard J, 2009, Trans Am Clin Climatol Assoc, V120, P419; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Heerspink HJL, 2014, AM J KIDNEY DIS, V63, P244, DOI 10.1053/j.ajkd.2013.09.016; Henry RMA, 2002, KIDNEY INT, V62, P1402, DOI 10.1046/j.1523-1755.2002.00571.x; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Kovesdy CP, 2010, J AM SOC NEPHROL, V21, P1814, DOI 10.1681/ASN.2010090954; Kreisman SH, 1999, ARCH INTERN MED, V159, P79, DOI 10.1001/archinte.159.1.79; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; LINDEMAN RD, 1985, J AM GERIATR SOC, V33, P278, DOI 10.1111/j.1532-5415.1985.tb07117.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2009, J AM SOC NEPHROL, V20, P2617, DOI 10.1681/ASN.2009010025; Murussi M, 2006, J DIABETES COMPLICAT, V20, P210, DOI 10.1016/j.jdiacomp.2005.07.002; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Rifkin DE, 2008, ARCH INTERN MED, V168, P2212, DOI 10.1001/archinte.168.20.2212; Rosansky SJ, 2014, KIDNEY INT, V85, P723, DOI 10.1038/ki.2013.506; Shlipak MG, 2009, J AM SOC NEPHROL, V20, P2625, DOI 10.1681/ASN.2009050546; Silveiro SP, 1996, DIABETES CARE, V19, P171, DOI 10.2337/diacare.19.2.171; Wetzels JFM, 2008, KIDNEY INT, V73, P657, DOI 10.1038/sj.ki.5002755; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Winearls CG, 2009, KIDNEY INT, V75, P1009, DOI 10.1038/ki.2009.49	25	60	60	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129036	10.1371/journal.pone.0129036	http://dx.doi.org/10.1371/journal.pone.0129036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061083	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500116
J	Lu, S; Yin, XY; Spollen, W; Zhang, N; Xu, D; Schoelz, J; Bilyeu, K; Zhang, ZYJ				Lu, Sha; Yin, Xiaoyan; Spollen, William; Zhang, Ning; Xu, Dong; Schoelz, James; Bilyeu, Kristin; Zhang, Zhanyuan J.			Analysis of the siRNA-Mediated Gene Silencing Process Targeting Three Homologous Genes Controlling Soybean Seed Oil Quality	PLOS ONE			English	Article							GUIDE STRAND; RNA; SUPPRESSION; SELECTION; MICRORNA; DUPLEXES; RISC	In the past decade, RNA silencing has gained significant attention because of its success in genomic scale research and also in the genetic improvement of crop plants. However, little is known about the molecular basis of siRNA processing in association with its target transcript. To reveal this process for improving hpRNA-mediated gene silencing in crop plants, the soybean GmFAD3 gene family was chosen as a test model. We analyzed RNAi mutant soybean lines in which three members of the GmFAD3 gene family were silenced. The silencing levels of FAD3A, FAD3B and FAD3C were correlated with the degrees of sequence homology between the inverted repeat of hpRNA and the GmFAD3 transcripts in the RNAi lines. Strikingly, transgenes in two of the three RNAi lines were heavily methylated, leading to a dramatic reduction of hpRNA-derived siRNAs. Small RNAs corresponding to the loop portion of the hairpin transcript were detected while much lower levels of siRNAs were found outside of the target region. siRNAs generated from the 318-bp inverted repeat were found to be diced much more frequently at stem sequences close to the loop and associated with the inferred cleavage sites on the target transcripts, manifesting "hot spots". The top candidate hpRNA-derived siRNA share certain sequence features with mature miRNA. This is the first comprehensive and detailed study revealing the siRNA-mediated gene silencing mechanism in crop plants using gene family GmFAD3 as a test model.	[Lu, Sha; Yin, Xiaoyan; Zhang, Zhanyuan J.] Univ Missouri, Plant Transformat Core Facil, Columbia, MO 65211 USA; [Lu, Sha; Yin, Xiaoyan; Schoelz, James; Bilyeu, Kristin; Zhang, Zhanyuan J.] Univ Missouri, Div Plant Sci, Columbia, MO USA; [Spollen, William] Univ Missouri, Bioinformat Core Facil, Columbia, MO USA; [Zhang, Ning; Xu, Dong] Univ Missouri, Dept Comp Sci, Columbia, MO USA; [Zhang, Ning; Xu, Dong] Univ Missouri, Inst Informat, Columbia, MO USA; [Bilyeu, Kristin] Univ Missouri, USDA ARS, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; United States Department of Agriculture (USDA); University of Missouri System; University of Missouri Columbia	Zhang, ZYJ (corresponding author), Univ Missouri, Plant Transformat Core Facil, Columbia, MO 65211 USA.	zhangzh@missouri.edu	Zhang, Ning/ABH-9679-2020; Xu, Dong/Y-8605-2018	Zhang, Ning/0000-0001-6643-6980; Zhang, Ning/0000-0002-1218-5044	China Scholarship Council [2008632140]; National Institutes of Health (NIH) [R01 GM100701]; University of Missouri; USDA-ARS Core fund; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100701] Funding Source: NIH RePORTER; ARS [ARS-0424526] Funding Source: Federal RePORTER	China Scholarship Council(China Scholarship Council); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Missouri; USDA-ARS Core fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by 2008632140, China Scholarship Council (http://en.csc.edu.cn/). SL received the funding. An additional source of funding has been from National Institutes of Health (NIH) (R01 GM100701) (http://www.nih.gov/) and supports NZ (DX's lab). The grant funding agencies (China Scholarship Council and NIH) have no contribution to the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Except for SL and NZ, all remaining authors (XY, WS, DX, JS, ZZ) have been supported by their salary lines of the University of Missouri. KB's salary has been supported by USDA-ARS Core fund. Since these are salary support, not grants, the corresponding author hasn't described them in the fund source section.	Aleman LM, 2007, RNA, V13, P385, DOI 10.1261/rna.352507; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Baykal U, 2011, GEN-RES ISSUES, P255; Bleys A, 2006, PLANT PHYSIOL, V142, P788, DOI 10.1104/pp.106.083956; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dunoyer P, 2007, NAT GENET, V39, P848, DOI 10.1038/ng2081; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Flores T, 2008, TRANSGENIC RES, V17, P839, DOI 10.1007/s11248-008-9167-6; Frizzi A, 2010, PLANT BIOTECHNOL J, V8, P655, DOI 10.1111/j.1467-7652.2010.00505.x; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Koscianska E, 2005, PLANT MOL BIOL, V59, P647, DOI 10.1007/s11103-005-0668-x; LIU HR, 1992, J AM OIL CHEM SOC, V69, P528, DOI 10.1007/BF02636103; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Miki D, 2005, PLANT PHYSIOL, V138, P1903, DOI 10.1104/pp.105.063933; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Petersen BO, 2005, PLANT MOL BIOL, V58, P575, DOI 10.1007/s11103-005-7307-4; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Sanders M, 2002, EMBO J, V21, P5824, DOI 10.1093/emboj/cdf586; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shoemaker RC, 1996, GENETICS, V144, P329; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Watson JM, 2005, FEBS LETT, V579, P5982, DOI 10.1016/j.febslet.2005.08.014; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104	35	7	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129010	10.1371/journal.pone.0129010	http://dx.doi.org/10.1371/journal.pone.0129010			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061033	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500115
J	Ali, SA; Chew, YW				Ali, Syed A.; Chew, Yik Wei			FabV/Triclosan Is an Antibiotic-Free and Cost-Effective Selection System for Efficient Maintenance of High and Medium -Copy Number Plasmids in Escherichia coli	PLOS ONE			English	Article							ESSENTIAL GENE MARKER; TRICLOSAN; PERSPECTIVES; AUXOTROPHY; REDUCTASE; ACID	Antibiotic resistance genes and antibiotics are frequently used to maintain plasmid vectors in bacterial hosts such as Escherichia coli. Due to the risk of spread of antibiotic resistance, the regulatory authorities discourage the use of antibiotic resistance genes/antibiotics for the maintenance of plasmid vectors in certain biotechnology applications. Overexpression of E. coli endogenous fabI gene and subsequent selection on Triclosan has been proposed as a practical alternative to traditional antibiotic selection systems. Unfortunately, overexpression of fabI cannot be used to select medium -copy number plasmids, typically used for the expression of heterologous proteins in E. coli. Here we report that Vibrio cholera FabV, a functional homologue of E. coli FabI, can be used as a suitable marker for the selection and maintenance of both high and medium -copy number plasmid vectors in E. coli.	[Ali, Syed A.; Chew, Yik Wei] Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, Kepala Batas 13200, Pulau Pinang, Malaysia	Universiti Sains Malaysia	Ali, SA (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Oncol & Radiol Sci, Kepala Batas 13200, Pulau Pinang, Malaysia.	ali2@amdi.usm.edu.my	Chew, Yik Wei/M-9669-2017	Chew, Yik Wei/0000-0003-4772-0702	Ministry of Higher Education (MOHE), Government of Malaysia [203/CIPPT/6711206]; MyBrain15 program of Ministry of Higher Education (MOHE), Government of Malaysia [860208015480]	Ministry of Higher Education (MOHE), Government of Malaysia; MyBrain15 program of Ministry of Higher Education (MOHE), Government of Malaysia	This work was supported by the FRGS grant (203/CIPPT/6711206) from the Ministry of Higher Education (MOHE), Government of Malaysia to SAA. YWC is a recipient of MyMaster scholarship (KPM (B) 860208015480) under MyBrain15 program of Ministry of Higher Education (MOHE), Government of Malaysia.	Carnes AE, 2009, BIOTECHNOL BIOENG, V104, P505, DOI 10.1002/bit.22415; Cranenburgh RM, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e26; Dann AB, 2011, J APPL TOXICOL, V31, P285, DOI 10.1002/jat.1660; Dong WR, 2010, APPL ENVIRON MICROB, V76, P2295, DOI 10.1128/AEM.02462-09; Dryselius R, 2003, BIOTECHNIQUES, V35, P1060; El-Attar LMR, 2012, VACCINE, V30, P1702, DOI 10.1016/j.vaccine.2011.12.078; Goh S, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-61; Hagg P, 2004, J BIOTECHNOL, V111, P17, DOI 10.1016/j.jbiotec.2004.03.010; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jang CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057075; Kroll J, 2010, MICROB BIOTECHNOL, V3, P634, DOI 10.1111/j.1751-7915.2010.00170.x; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; Oliveira PH, 2013, TRENDS BIOTECHNOL, V31, P539, DOI 10.1016/j.tibtech.2013.06.001; Peubez I, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-65; Rodricks JV, 2010, CRIT REV TOXICOL, V40, P422, DOI 10.3109/10408441003667514; Selvamani RSV, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-58; STUBER D, 1981, P NATL ACAD SCI-BIOL, V78, P167, DOI 10.1073/pnas.78.1.167; Teow SY, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-107; Vandermeulen G, 2011, MOL THER, V19, P1942, DOI 10.1038/mt.2011.182; Vidal L, 2008, J BIOTECHNOL, V134, P127, DOI 10.1016/j.jbiotec.2008.01.011	23	5	6	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129547	10.1371/journal.pone.0129547	http://dx.doi.org/10.1371/journal.pone.0129547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057251	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000062
J	Fregel, R; Cabrera, V; Larruga, JM; Abu-Amero, KK; Gonzalez, AM				Fregel, Rosa; Cabrera, Vicente; Larruga, Jose M.; Abu-Amero, Khaled K.; Gonzalez, Ana M.			Carriers of Mitochondrial DNA Macrohaplogroup N Lineages Reached Australia around 50,000 Years Ago following a Northern Asian Route	PLOS ONE			English	Article							MODERN HUMAN DISPERSALS; HUMAN MTDNA GENOMES; MODERN HUMANS; Y-CHROMOSOME; HUMAN-POPULATIONS; SOUTHERN ROUTE; GENETIC DIVERSITY; EAST ASIANS; WEST ASIA; AFRICA	Background The modern human colonization of Eurasia and Australia is mostly explained by a single-out-of-Africa exit following a southern coastal route throughout Arabia and India. However, dispersal across the Levant would better explain the introgression with Neanderthals, and more than one exit would fit better with the different ancient genomic components discovered in indigenous Australians and in ancient Europeans. The existence of an additional Northern route used by modern humans to reach Australia was previously deduced from the phylogeography of mtDNA macrohaplogroup N. Here, we present new mtDNA data and new multidisciplinary information that add more support to this northern route. Methods MtDNA hypervariable segments and haplogroup diagnostic coding positions were analyzed in 2,278 Saudi Arabs, from which 1,725 are new samples. Besides, we used 623 published mtDNA genomes belonging to macrohaplogroup N, but not R, to build updated phylogenetic trees to calculate their coalescence ages, and more than 70,000 partial mtDNA sequences were screened to establish their respective geographic ranges. Results The Saudi mtDNA profile confirms the absence of autochthonous mtDNA lineages in Arabia with coalescence ages deep enough to support population continuity in the region since the out-of-Africa episode. In contrast to Australia, where N(xR) haplogroups are found in high frequency and with deep coalescence ages, there are not autochthonous N(xR) lineages in India nor N(xR) branches with coalescence ages as deep as those found in Australia. These patterns are at odds with the supposition that Australian colonizers harboring N(xR) lineages used a route involving India as a stage. The most ancient N(xR) lineages in Eurasia are found in China, and inconsistently with the coastal route, N(xR) haplogroups with the southernmost geographical range have all more recent radiations than the Australians. Conclusions Apart from a single migration event via a southern route, phylogeny and phylogeography of N(xR) lineages support that people carrying mtDNA N lineages could have reach Australia following a northern route through Asia. Data from other disciplines also support this scenario.	[Fregel, Rosa; Cabrera, Vicente; Larruga, Jose M.; Gonzalez, Ana M.] Univ La Laguna, Fac Biol, Dept Genet, Tenerife, Spain; [Abu-Amero, Khaled K.] King Saud Univ, Coll Med, Dept Ophthalmol, Riyadh 11461, Saudi Arabia	Universidad de la Laguna; King Saud University	Fregel, R (corresponding author), Univ La Laguna, Fac Biol, Dept Genet, Tenerife, Spain.	rfregel@gmail.com	Fregel, Rosa/H-4942-2015	Fregel, Rosa/0000-0002-2951-6508	Spanish Ministerio de Ciencia e Innovacion [CGL2010-16195]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by the Spanish Ministerio de Ciencia e Innovacion [CGL2010-16195 to A.M.G.] (http://www.idi.mineco.gob.es).	Abu-Amero KK, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-45; Abu-Amero KK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-32; Al-Abri A, 2012, AM J PHYS ANTHROPOL, V149, P291, DOI 10.1002/ajpa.22131; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Armitage SJ, 2011, SCIENCE, V331, P453, DOI 10.1126/science.1199113; Ashrafian-Bonab M, 2007, HEREDITY, V98, P151, DOI 10.1038/sj.hdy.6800918; Atkinson QD, 2008, MOL BIOL EVOL, V25, P468, DOI 10.1093/molbev/msm277; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barton RNE, 2009, QUATERNARY SCI REV, V28, P1914, DOI 10.1016/j.quascirev.2009.03.010; Behar DM, 2012, AM J HUM GENET, V90, P675, DOI 10.1016/j.ajhg.2012.03.002; Bekada A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056775; Beyin Amanuel, 2011, Int J Evol Biol, V2011, P615094, DOI 10.4061/2011/615094; Biagi P, 2011, PAPERS IN HONOUR OF; BROTHWELL DR, 1960, SARAWAK MUS J, V9, P323; Cabrera VM, 2009, VERTEBR PALEOBIOL PA, P79, DOI 10.1007/978-90-481-2719-1_6; Cerny V, 2011, MOL BIOL EVOL, V28, P71, DOI 10.1093/molbev/msq178; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chaubey G, 2014, EUR J HUM GENET, V22, P1404, DOI 10.1038/ejhg.2014.36; Chaubey G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-227; Cruciani F, 2002, AM J HUM GENET, V70, P1197, DOI 10.1086/340257; Cruciani F, 2007, MOL BIOL EVOL, V24, P1300, DOI 10.1093/molbev/msm049; Cruciani F, 2010, EUR J HUM GENET, V18, P800, DOI 10.1038/ejhg.2009.231; Dalen L, 2012, MOL BIOL EVOL, V29, P1893, DOI 10.1093/molbev/mss074; Delfin F, 2014, EUR J HUM GENET, V22, P228, DOI 10.1038/ejhg.2013.122; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Derbeneva O. A., 2002, Genetika, V38, P1554; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080673; Derevianko AP, 2009, MIDDLE TO UPPER PALE; Duggan AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083570; Fadhlaoui-Zid K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080293; Fedorova SA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-127; Fernandes V, 2012, AM J HUM GENET, V90, P347, DOI 10.1016/j.ajhg.2011.12.010; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Forster P, 1996, AM J HUM GENET, V59, P935; Fregel R, 2011, MITOCHONDRION, V11, P366, DOI 10.1016/j.mito.2010.11.001; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Fu QM, 2013, P NATL ACAD SCI USA, V110, P2223, DOI 10.1073/pnas.1221359110; Gazave E, 2014, P NATL ACAD SCI USA, V111, P757, DOI 10.1073/pnas.1310398110; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Gonzalez AM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-223; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gunnarsdottir ED, 2011, GENOME RES, V21, P1, DOI 10.1101/gr.107615.110; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HASEGAWA M, 1993, J MOL EVOL, V37, P347, DOI 10.1007/BF00178865; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Hill C, 2007, AM J HUM GENET, V80, P29, DOI 10.1086/510412; Hodgson JA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004393; Hudjashov G, 2007, P NATL ACAD SCI USA, V104, P8726, DOI 10.1073/pnas.0702928104; Huerta-Sanchez E, 2008, GENETICS, V178, P325, DOI 10.1534/genetics.107.073361; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kang LL, 2013, MOL BIOL EVOL, V30, P2579, DOI 10.1093/molbev/mst147; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kendall M.G., 1990, RANK CORRELATION MET, V5th; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Ko AMS, 2014, AM J HUM GENET, V94, P426, DOI 10.1016/j.ajhg.2014.02.003; Kong QP, 2011, MOL BIOL EVOL, V28, P513, DOI 10.1093/molbev/msq219; Krause J, 2007, NATURE, V449, P902, DOI 10.1038/nature06193; Kumar S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-173; Kushniarevich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066499; Larrasoana JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076514; Lazaridis I, 2013, ANCIENT HUMAN GENOME; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Liu H, 2006, AM J HUM GENET, V79, P230, DOI 10.1086/505436; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Maji S, 2008, INT J HUM GENET, V8, P85, DOI 10.1080/09723757.2008.11886022; Maji S, 2009, J GENET, V88, P127, DOI 10.1007/s12041-009-0020-3; Marks AE, 2005, MITTEILUNGEN GESELLS, V14, P81; MCDERMOTT F, 1993, NATURE, V363, P252, DOI 10.1038/363252a0; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; McEvoy B, 2004, AM J HUM GENET, V75, P693, DOI 10.1086/424697; Mele M, 2012, MOL BIOL EVOL, V29, P25, DOI 10.1093/molbev/msr213; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mendez FL, 2011, HUM BIOL, V83, P39, DOI 10.3378/027.083.0103; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Musilova E, 2011, AM J PHYS ANTHROPOL, V145, P592, DOI 10.1002/ajpa.21522; O'Connell JF, 2004, J ARCHAEOL SCI, V31, P835, DOI 10.1016/j.jas.2003.11.005; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Olivieri A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070492; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Otter M, 2007, ANTIQUITY, V81, P82, DOI 10.1017/S0003598X00094850; Pagani L, 2012, AM J HUM GENET, V91, P83, DOI 10.1016/j.ajhg.2012.05.015; Palanichamy MG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-304; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Peng MS, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-46; Pennarun E, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-234; Pereira L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-390; Petraglia MD, 2003, ANTIQUITY, V77, P671, DOI 10.1017/S0003598X00061639; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Pimenoff VN, 2008, EUR J HUM GENET, V16, P1254, DOI 10.1038/ejhg.2008.101; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Pugach I, 2013, P NATL ACAD SCI USA, V110, P1803, DOI 10.1073/pnas.1211927110; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintans B, 2004, FORENSIC SCI INT, V140, P251, DOI 10.1016/j.forsciint.2003.12.005; R Development Core Team, 2008, R A LANGUAGE AND ENV; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Reyes-Centeno H, 2014, P NATL ACAD SCI USA, V111, P7248, DOI 10.1073/pnas.1323666111; ROBERTS RG, 1990, NATURE, V345, P153, DOI 10.1038/345153a0; Rose JI, 2009, VERTEBR PALEOBIOL PA, P1, DOI 10.1007/978-90-481-2719-1_1; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Scally A, 2012, NAT REV GENET, V13, P745, DOI 10.1038/nrg3295; Scerri EleanorM.L., 2012, P SEMINAR ARABIAN ST, V42, P357; Schillaci MA, 2008, J HUM EVOL, V54, P814, DOI 10.1016/j.jhevol.2007.10.010; Schonberg A, 2011, EUR J HUM GENET, V19, P988, DOI 10.1038/ejhg.2011.62; Secher B, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-109; Shea JJ, 2003, EVOL ANTHROPOL, V12, P173, DOI 10.1002/evan.10101; Shen GJ, 2002, J HUM EVOL, V43, P817, DOI 10.1006/jhev.2002.0601; Shen GJ, 2013, J HUM EVOL, V65, P162, DOI 10.1016/j.jhevol.2013.05.002; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Soares P, 2012, MOL BIOL EVOL, V29, P915, DOI 10.1093/molbev/msr245; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Thangaraj K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006545; Underhill PA, 2001, ANN HUM GENET, V65, P43, DOI 10.1046/j.1469-1809.2001.6510043.x; van der Made J, 2011, QUATERNARY SCI REV, V30, P1353, DOI 10.1016/j.quascirev.2010.02.028; Pellekaan SMV, 2006, AM J PHYS ANTHROPOL, V131, P282, DOI 10.1002/ajpa.20426; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Vyas DN, 2014, BAYESIAN ANALYSES OF; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Wong LP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004377; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	138	13	13	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129839	10.1371/journal.pone.0129839	http://dx.doi.org/10.1371/journal.pone.0129839			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CK1GM	26053380	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300166
J	Shin, SH; Lee, EJ; Chun, J; Hyun, S; Kang, SS				Shin, Sung Hwa; Lee, Eun Jeoung; Chun, Jaesun; Hyun, Sunghee; Kang, Sang Sun			ULK2 Ser 1027 Phosphorylation by PKA Regulates Its Nuclear Localization Occurring through Karyopherin Beta 2 Recognition of a PY-NLS Motif	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; AUTOPHAGY; DYNAMICS; DOMAINS	Uncoordinated 51-like kinase 2 (ULK2), a member of the serine/threonine kinase family, plays an essential role in the regulation of autophagy in mammalian cells. Given the role of autophagy in normal cellular homeostasis and in multiple diseases, improved mechanistic insight into this process may result in the development of novel therapeutic approaches. Here, we present evidence that ULK2 associates with karyopherin beta 2 (Kap beta 2) for its transportation into the nucleus. We identify a potential PY-NLS motif ((774)gpgfgssppGaeaapslRyvPY(795)) in the S/P space domain of ULK2, which is similar to the consensus PY-NLS motif (R/K/H)X2-5PY. Using a pull-down approach, we observe that ULK2 interacts physically with Kap beta 2 both in vitro and in vivo. Confocal microscopy confirmed the co-localization of ULK2 and Kap beta 2. Localization of ULK2 to the nuclear region was disrupted by mutations in the putative Kap beta 2-binding motif (P794A). Furthermore, in transient transfection assays, the presence of the Kap beta 2 binding site mutant (the cytoplasmic localization form) was associated with a substantial increase in autophagy activity (but a decrease in the in vitro serine-phosphorylation) compared with the wild type ULK2. Mutational analysis showed that the phosphorylation on the Ser1027 residue of ULK2 by Protein Kinase A (PKA) is the regulatory point for its functional dissociation from Atg13 and FIP 200, nuclear localization, and autophagy. Taken together, our observations indicate that Kap beta 2 interacts with ULK2 through ULK2's putative PY-NLS motif, and facilitates transport from the cytoplasm to the nucleus, depending on its Ser1027 residue phosphorylation by PKA, thereby reducing autophagic activity.	[Shin, Sung Hwa; Kang, Sang Sun] Chungbuk Natl Univ, Dept Biol Educ, Cheongju, Chungbuk, South Korea; [Lee, Eun Jeoung] Chungbuk Natl Univ, Dept Internal Med, Cheongju, Chungbuk, South Korea; [Chun, Jaesun] Korea Natl Univ Educ, Dept Biol Educ, Cheongju, Chungbuk, South Korea; [Hyun, Sunghee] Eulji Univ, Dept Biomed Lab Sci, Taejon, South Korea	Chungbuk National University; Chungbuk National University; Korea National University of Education; Eulji University	Kang, SS (corresponding author), Chungbuk Natl Univ, Dept Biol Educ, 1 Chungdae Ro, Cheongju, Chungbuk, South Korea.	jin95324@cbu.ac.kr			Korean Research Foundation [NRF-2013R1A1A4A01005522, BK21]; Korean Research fellowship [NRF-2014R1A1A2009622, NRF-2013R1A1A2063994]	Korean Research Foundation(National Research Foundation of Korea); Korean Research fellowship	This work was supported by a Korean Research Foundation grant (NRF-2013R1A1A4A01005522 and BK21 plus) to S. S. Kang. Both Shin and Lee are Korean Research fellowship recipients (NRF-2014R1A1A2009622, NRF-2013R1A1A2063994).	Alers S, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-7; Alers S, 2011, AUTOPHAGY, V7, P1424, DOI 10.4161/auto.7.12.18027; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Dell'Acqua ML, 2006, EUR J CELL BIOL, V85, P627, DOI 10.1016/j.ejcb.2006.01.010; Fu SC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr493; Green DR, 2014, CELL, V157, P65, DOI 10.1016/j.cell.2014.02.049; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee EJ, 2011, AUTOPHAGY, V7, P689, DOI 10.4161/auto.7.7.15450; Lieu KG, 2014, J CELL BIOL, V205, P301, DOI 10.1083/jcb.201304055; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Nishiyama K, 2007, J BIOL CHEM, V282, P17200, DOI 10.1074/jbc.M611609200; Pyo JO, 2012, EXP MOL MED, V44, P73, DOI 10.3858/emm.2012.44.2.029; Ro SH, 2013, AUTOPHAGY, V9, P2103, DOI 10.4161/auto.26563; Rona G, 2014, CELL CYCLE, V13, P3551, DOI 10.4161/15384101.2014.960740; Shin SH, 2012, MOL CELLS, V34, P375, DOI 10.1007/s10059-012-0167-2; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; Wood JS, 1996, J BIOL CHEM, V271, P174, DOI 10.1074/jbc.271.1.174; Xu DR, 2010, CURR OPIN STRUC BIOL, V20, P782, DOI 10.1016/j.sbi.2010.09.008; Yan J, 1999, ONCOGENE, V18, P5850, DOI 10.1038/sj.onc.1202988; Zhang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109523; Zhou X, 2007, P NATL ACAD SCI USA, V104, P5842, DOI 10.1073/pnas.0701402104; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	30	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0127784	10.1371/journal.pone.0127784	http://dx.doi.org/10.1371/journal.pone.0127784			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052940	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300018
J	Wang, H; Tatsuo, S; Wang, SD; Zhang, Q; Hou, JF; Wang, J; Jin, C; Qian, HY; Yang, YJ				Wang Hong; Tatsuo, Shimosawa; Wang Shou-Dong; Zhang Qian; Hou Jian-Feng; Wang Jue; Jin Chen; Qian Hai-Yan; Yang Yue-Jin			Resveratrol Upregulates Cardiac SDF-1 in Mice with Acute Myocardial Infarction through the Deacetylation of Cardiac p53	PLOS ONE			English	Article							STEM-CELL RECRUITMENT; HISTONE DEACETYLASE; FACTOR-I; HEART; EXPRESSION; MOBILIZATION; ACETYLATION; INHIBITOR; IMPROVE; MODEL	Aims We previously demonstrated that resveratrol (RSV) administration causes cardiac stromal cell-derived factor (SDF)-1 upregulation and can enhance the mobilization of stem cells in mice with acute myocardial infarction (AMI). However, the upstream signal transduction involved in SDF-1 regulation in the setting of AMI and RSV administration remains unclear. Because RSV is a sirtuin 1 (SIRT1) activator and SIRT proteins act as deacetylases, we investigated the role of SIRT1 in SDF-1 upregulation and its subsequent effects. Methods and Results In vitro experiments with H9C2 cardiomyocytes under hypoxia and serum-deprivation conditions showed that p53 acted upstream of SDF-1. RSV could not regulate SDF-1 effectively after SIRT1 silencing, indicating that it is dependent on SIRT1. Subsequently, male C57BL/6 mice were divided into four groups: 1) sham, 2) MI, 3) MI+RSV, and 4) MI+RSV plus nicotinamide, an inhibitor of the deacetylase activity of SIRT (MI+RSV+NAM). Compared with the sham mice, AMI caused a slight increase in the cardiac p53 level and resulted in significant SIRT1 downregulation and p53 acetylation or activation. Compared with the MI mice, MI+RSV administration improved the cardiac SDF-1 level and reversed the reduction of SIRT1 and the activation of p53. Furthermore, we observed less cardiac dysfunction in MI+RSV mice and determined that NAM abolished the effects of RSV. Conclusions RSV enhances cardiac SDF-1 excretion after AMI partially through a SIRT1 normalization/p53 inactivation pathway.	[Wang Hong] Capital Med Univ, Beijing Anzhen Hosp, Ctr Cardiac Intens Care, Beijing, Peoples R China; [Tatsuo, Shimosawa] Univ Tokyo, Fac Med, Dept Clin Lab, Tokyo 113, Japan; [Wang Shou-Dong] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Zhang Qian; Hou Jian-Feng; Wang Jue; Jin Chen; Qian Hai-Yan; Yang Yue-Jin] Chinese Acad Med Sci, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhang Qian; Hou Jian-Feng; Wang Jue; Jin Chen; Qian Hai-Yan; Yang Yue-Jin] Chinese Acad Med Sci, Cardiovasc Inst, Beijing 100730, Peoples R China; [Zhang Qian; Hou Jian-Feng; Wang Jue; Jin Chen; Qian Hai-Yan; Yang Yue-Jin] Peking Union Med Coll, Beijing 100021, Peoples R China	Capital Medical University; University of Tokyo; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, YJ (corresponding author), Chinese Acad Med Sci, Fuwai Hosp, State Key Lab Cardiovasc Dis, Beijing 100730, Peoples R China.	yangyjfw@163.com			National Natural Science Foundation of China [81170129]; Health and Medical Development Foundation of China [2011-H25]; Basic Clinical Research Collaboration Fund of Capital Medical University [14JL61]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health and Medical Development Foundation of China; Basic Clinical Research Collaboration Fund of Capital Medical University	This study was supported by grants from the National Natural Science Foundation of China (81170129 to Y.J. Yang), the Health and Medical Development Foundation of China (2011-H25 to Y.J. Yang), and the Basic Clinical Research Collaboration Fund of Capital Medical University (14JL61 to H. Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Addadi Y, 2010, CANCER RES, V70, P9650, DOI 10.1158/0008-5472.CAN-10-1146; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Anderson GD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00021; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Borradaile NM, 2009, CURR PHARM DESIGN, V15, P110, DOI 10.2174/138161209787185742; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Ghadge SK, 2011, PHARMACOL THERAPEUT, V129, P97, DOI 10.1016/j.pharmthera.2010.09.011; Hsu CP, 2010, CIRCULATION, V122, P2170, DOI 10.1161/CIRCULATIONAHA.110.958033; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Jian BX, 2012, MOL MED, V18, P209, DOI 10.2119/molmed.2011.00365; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Mohsin S, 2011, CIRC RES, V109, P1415, DOI 10.1161/CIRCRESAHA.111.243071; Moskovits N, 2006, CANCER RES, V66, P10671, DOI 10.1158/0008-5472.CAN-06-2323; Nadtochiy SM, 2011, CARDIOVASC RES, V89, P643, DOI 10.1093/cvr/cvq287; Nguyen PD, 2010, WOUND REPAIR REGEN, V18, P553, DOI 10.1111/j.1524-475X.2010.00638.x; Olive M, 2008, J CLIN INVEST, V118, P2050, DOI 10.1172/JCI31244; Penn MS, 2012, GENE THER, V19, P583, DOI 10.1038/gt.2012.32; Penn MS, 2013, CIRC RES, V112, P816, DOI 10.1161/CIRCRESAHA.111.300440; Samuel SM, 2008, J AGR FOOD CHEM, V56, P9692, DOI 10.1021/jf802050h; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Singh S, 2009, CLIN CARDIOL, V32, P176, DOI 10.1002/clc.20470; Tang JM, 2010, MOL BIOL REP, V37, P1957, DOI 10.1007/s11033-009-9642-z; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang H, 2012, PHYSIOL RES, V61, P543, DOI 10.33549/physiolres.932390; Wang H, 2012, HEART FAIL REV, V17, P437, DOI 10.1007/s10741-011-9260-4; Wang YG, 2006, J MOL CELL CARDIOL, V41, P478, DOI 10.1016/j.yjmcc.2006.06.074; Wei SG, 2012, HYPERTENSION, V59, P991, DOI 10.1161/HYPERTENSIONAHA.111.188086; Xu W, 2014, SHOCK, V42, P440, DOI 10.1097/SHK.0000000000000225; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006	30	17	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128978	10.1371/journal.pone.0128978	http://dx.doi.org/10.1371/journal.pone.0128978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053177	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300073
J	Yusof, FH; Ung, NM; Wong, JHD; Jong, WL; Ath, V; Phua, VCE; Heng, SP; Ng, KH				Yusof, Fasihah Hanum; Ung, Ngie Min; Wong, Jeannie Hsiu Ding; Jong, Wei Loong; Ath, Vannyat; Phua, Vincent Chee Ee; Heng, Siew Ping; Ng, Kwan Hoong			On the Use of Optically Stimulated Luminescent Dosimeter for Surface Dose Measurement during Radiotherapy	PLOS ONE			English	Article							BREAST-CANCER; CHEST-WALL; CONTRALATERAL BREAST; 2ND PRIMARY; SKIN; PHOTON; HEAD; FILM; OSL; ASSOCIATION	This study was carried out to investigate the suitability of using the optically stimulated luminescence dosimeter (OSLD) in measuring surface dose during radiotherapy. The water equivalent depth (WED) of the OSLD was first determined by comparing the surface dose measured using the OSLD with the percentage depth dose at the buildup region measured using a Markus ionization chamber. Surface doses were measured on a solid water phantom using the OSLD and compared against the Markus ionization chamber and Gafchromic EBT3 film measurements. The effect of incident beam angles on surface dose was also studied. The OSLD was subsequently used to measure surface dose during tangential breast radiotherapy treatments in a phantom study and in the clinical measurement of 10 patients. Surface dose to the treated breast or chest wall, and on the contralateral breast were measured. The WED of the OSLD was found to be at 0.4 mm. For surface dose measurement on a solid water phantom, the Markus ionization chamber measured 15.95% for 6 MV photon beam and 12.64% for 10 MV photon beam followed by EBT3 film (23.79% and 17.14%) and OSLD (37.77% and 25.38%). Surface dose increased with the increase of the incident beam angle. For phantom and patient breast surface dose measurement, the response of the OSLD was higher than EBT3 film. The in-vivo measurements were also compared with the treatment planning system predicted dose. The OSLD measured higher dose values compared to dose at the surface (Hp(0.0)) by a factor of 2.37 for 6 MV and 2.01 for 10 MV photon beams, respectively. The measurement of absorbed dose at the skin depth of 0.4 mm by the OSLD can still be a useful tool to assess radiation effects on the skin dermis layer. This knowledge can be used to prevent and manage potential acute skin reaction and late skin toxicity from radiotherapy treatments.	[Yusof, Fasihah Hanum; Wong, Jeannie Hsiu Ding; Jong, Wei Loong; Ath, Vannyat; Ng, Kwan Hoong] Univ Malaya, Fac Med, Dept Biomed Imaging, Kuala Lumpur, Malaysia; [Ung, Ngie Min; Phua, Vincent Chee Ee] Univ Malaya, Fac Med, Clin Oncol Unit, Kuala Lumpur, Malaysia; [Wong, Jeannie Hsiu Ding; Ng, Kwan Hoong] Univ Malaya, Fac Med, Res Imaging Ctr, Kuala Lumpur, Malaysia; [Heng, Siew Ping] Pantai Hosp Kuala Lumpur, Inst Canc, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Ung, NM (corresponding author), Univ Malaya, Fac Med, Clin Oncol Unit, Kuala Lumpur, Malaysia.	nm_ung@um.edu.my	Ng, Kwan Hoong/D-2231-2009; WONG, JEANNIE HSIU DING/B-8705-2010; Jong, Wei Loong/L-2300-2015; UNG, NGIE MIN/B-9986-2010	WONG, JEANNIE HSIU DING/0000-0001-8080-1294; Jong, Wei Loong/0000-0002-2735-0938; Ung, Ngie Min/0000-0001-5700-3809	University of Malaya Research Grant [RG507-13HTM]; University of Malaya (UM)/Ministy Of High Education (MOHE) High Impact Research Grant [UM.C/625/1/HIR/MOHE/MED/38]	University of Malaya Research Grant; University of Malaya (UM)/Ministy Of High Education (MOHE) High Impact Research Grant	NMU is funded by the University of Malaya Research Grant (RG507-13HTM). JHDW is funded by the University of Malaya (UM)/Ministy Of High Education (MOHE) High Impact Research Grant (UM.C/625/1/HIR/MOHE/MED/38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanyali SD, 2013, ORGANS RISK RAD TOLE, P117; Alzoubi AS, 2010, AUSTRALAS PHYS ENG S, V33, P137, DOI 10.1007/s13246-010-0011-y; ARCHAMBEAU JO, 1995, INT J RADIAT ONCOL, V31, P1171, DOI 10.1016/0360-3016(94)00423-I; Balter S, 2010, RADIOLOGY, V254, P326, DOI 10.1148/radiol.2542082312; Bilge H, 2009, PHYS MEDICA, V25, P101, DOI 10.1016/j.ejmp.2008.05.001; Brenner DJ, 2010, JNCI-J NATL CANCER I, V102, P444, DOI 10.1093/jnci/djq058; Chandra B., 1982, Radiation Protection Dosimetry, V3, P161; Chang-Claude J, 2005, CLIN CANCER RES, V11, P4802, DOI 10.1158/1078-0432.CCR-04-2657; Chen FQ, 2010, AUSTRALAS PHYS ENG S, V33, P23, DOI 10.1007/s13246-010-0004-x; Cheung T, 2005, PHYS MED BIOL, V50, pN281, DOI 10.1088/0031-9155/50/20/N04; Chougule A, 2007, J CANC RES THERAPEUT, V3; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; Corradini N, 2013, MED PHYS, V40, P221; Devic S, 2006, MED PHYS, V33, P1116, DOI 10.1118/1.2179169; DRISCOLL CMH, 1986, RADIAT PROT DOSIM, V17, P367; Dunn L, 2013, RADIAT MEAS, V51-52, P31, DOI 10.1016/j.radmeas.2013.01.012; Fraass B, 1998, MED PHYS, V25, P1773, DOI 10.1118/1.598373; Fry R, 1992, BIOL BASIS DOSE LIMI; GERBI BJ, 1990, MED PHYS, V17, P17, DOI 10.1118/1.596522; HAMERS HP, 1991, RADIOTHER ONCOL, V22, P280, DOI 10.1016/0167-8140(91)90163-B; Hsu SH, 2008, PHYS MED BIOL, V53, P2593, DOI 10.1088/0031-9155/53/10/010; Jones D., 1994, MED PHYS, V21, P833, DOI DOI 10.1118/1.597396; Jong WL, 2014, J APPL CLIN MED PHYS, V15, P120, DOI 10.1120/jacmp.v15i5.4869; Jursinic PA, 2007, MED PHYS, V34, P4594, DOI 10.1118/1.2804555; Jursinic PA, 2011, MED PHYS, V38, P5432, DOI 10.1118/1.3633939; Jursinic PA, 2010, MED PHYS, V37, P132, DOI 10.1118/1.3267489; Kerns JR, 2011, MED PHYS, V38, P3955, DOI 10.1118/1.3596533; Kry SF, 2012, J APPL CLIN MED PHYS, V13, DOI [10.1120/jacmp.v13i3.3942, DOI 10.1120/JACMP.V13I3.3942]; KUTCHER GJ, 1994, MED PHYS, V21, P581, DOI 10.1118/1.597316; Kwan IS, 2008, RADIAT MEAS, V43, P929, DOI 10.1016/j.radmeas.2007.12.052; Laurent A, 2007, VACCINE, V25, P6423, DOI 10.1016/j.vaccine.2007.05.046; Nakano M, 2012, J APPL CLIN MED PHYS, V13, P83, DOI 10.1120/jacmp.v13i3.3727; Perks CA, 2008, RPA 12 12 INT C INT; Qi ZY, 2009, MED PHYS, V36, P59, DOI 10.1118/1.3030951; Quach KY, 2000, MED PHYS, V27, P1676, DOI 10.1118/1.599035; RAWLINSON JA, 1992, MED PHYS, V19, P641, DOI 10.1118/1.596896; Scalchi P, 1998, INT J RADIAT ONCOL, V40, P987, DOI 10.1016/S0360-3016(97)00894-8; Schembri V, 2007, MED PHYS, V34, P2113, DOI 10.1118/1.2737160; Sim G, 2013, J APPL CLIN MED PHYS, V14; Stovall M, 2008, INT J RADIAT ONCOL, V72, P1021, DOI 10.1016/j.ijrobp.2008.02.040; VANVLOTEN WA, 1987, CANCER, V59, P411, DOI 10.1002/1097-0142(19870201)59:3<411::AID-CNCR2820590310>3.0.CO;2-Z; Wahba A. G., 2009, MED J CAIRO U, V77; Yadav BS, 2008, RADIOTHER ONCOL, V86, P171, DOI 10.1016/j.radonc.2007.10.002; Yukihara EG, 2008, MED PHYS, V35, P260, DOI 10.1118/1.2816106	44	27	29	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128544	10.1371/journal.pone.0128544	http://dx.doi.org/10.1371/journal.pone.0128544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052690	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300043
J	Belian, E; Noseda, M; Paiva, MSA; Leja, T; Sampson, R; Schneider, MD				Belian, Elisa; Noseda, Michela; Paiva, Marta S. Abreu; Leja, Thomas; Sampson, Robert; Schneider, Michael D.			Forward Programming of Cardiac Stem Cells by Homogeneous Transduction with MYOCD plus TBX5	PLOS ONE			English	Article							SIDE POPULATION CELLS; SERUM RESPONSE FACTOR; GENE-EXPRESSION; TRANSCRIPTION FACTORS; PROGENITOR CELLS; FIBROBLASTS; HEART; CARDIOMYOCYTES; ACTIVATION; MYOCARDIN	Adult cardiac stem cells (CSCs) express many endogenous cardiogenic transcription factors including members of the Gata, Hand, Mef2, and T-box family. Unlike its DNA-binding targets, Myocardin (Myocd)-a co-activator not only for serum response factor, but also for Gata4 and Tbx5-is not expressed in CSCs. We hypothesised that its absence was a limiting factor for reprogramming. Here, we sought to investigate the susceptibility of adult mouse Sca1(+) side population CSCs to reprogramming by supplementing the triad of GATA4, MEF2C, and TBX5 (GMT), and more specifically by testing the effect of the missing co-activator, Myocd. Exogenous factors were expressed via doxycycline-inducible lentiviral vectors in various combinations. High throughput quantitative RT-PCR was used to test expression of 29 cardiac lineage markers two weeks post-induction. GMT induced more than half the analysed cardiac transcripts. However, no protein was detected for the induced sarcomeric genes Actc1, Myh6, and Myl2. Adding MYOCD to GMT affected only slightly the breadth and level of gene induction, but, importantly, triggered expression of all three proteins examined (alpha-cardiac actin, atrial natriuretic peptide, sarcomeric myosin heavy chains). MYOCD + TBX was the most effective pairwise combination in this system. In clonal derivatives homogenously expressing MYOCD + TBX at high levels, 93% of cardiac transcripts were up-regulated and all five proteins tested were visualized. In summary: (1) GMT induced cardiac genes in CSCs, but not cardiac proteins under the conditions used. (2) Complementing GMT with MYOCD induced cardiac protein expression, indicating a more complete cardiac differentiation program. (3) Homogeneous transduction with MYOCD + TBX5 facilitated the identification of differentiating cells and the validation of this combinatorial reprogramming strategy. Together, these results highlight the pivotal importance of MYOCD in driving CSCs toward a cardiac muscle fate.	[Belian, Elisa; Noseda, Michela; Paiva, Marta S. Abreu; Leja, Thomas; Sampson, Robert; Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, British Heart Fdn Ctr Res Excellence, Natl Heart & Lung Inst, London W14 0NN, England	Imperial College London	Schneider, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, British Heart Fdn Ctr Res Excellence, Natl Heart & Lung Inst, London W14 0NN, England.	m.d.schneider@imperial.ac.uk	Paiva, Marta/V-7397-2017	Paiva, Marta/0000-0003-2933-9895; Sampson, Robert/0000-0003-1983-9589; Noseda, Michela/0000-0002-9553-5029	British Heart Foundation [CH/08/002, RE/08/002, RG/08/007, SI/11/2/28875]; European Commission [223372]; European Research Council [233158]; Medical Research Council-British Heart Foundation Cardiovascular Stem Cell Research Strategic Development Grant [G0901467]; National Heart and Lung Institute Foundation; MRC [G0901467] Funding Source: UKRI; British Heart Foundation [RG/08/007/25296, RG/15/1/31165] Funding Source: researchfish; Medical Research Council [G0901467] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); European Commission(European CommissionEuropean Commission Joint Research Centre); European Research Council(European Research Council (ERC)European Commission); Medical Research Council-British Heart Foundation Cardiovascular Stem Cell Research Strategic Development Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart and Lung Institute Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the British Heart Foundation (CH/08/002, RE/08/002, RG/08/007, SI/11/2/28875), https://www.bhf.org.uk; European Commission (CardioCell, 223372), http://ec.europa.eu/research/fp7/index_en.cfm; European Research Council (233158), http://erc.europa.eu; and a Medical Research Council-British Heart Foundation Cardiovascular Stem Cell Research Strategic Development Grant (G0901467), http://www.mrc.ac.uk to MDS; and by the National Heart and Lung Institute Foundation, http://www.nhlif.info, to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis RC, 2013, J MOL CELL CARDIOL, V60, P97, DOI 10.1016/j.yjmcc.2013.04.004; Akkina RK, 1996, J VIROL, V70, P2581, DOI 10.1128/JVI.70.4.2581-2585.1996; Bailey B, 2012, CIRC RES, V111, P750, DOI 10.1161/CIRCRESAHA.112.274662; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bernstein H.S., 2013, PLOS CURR, V15, P5; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Chang CP, 2012, ANNU REV PHYSIOL, V74, P41, DOI 10.1146/annurev-physiol-020911-153242; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Chong JJH, 2011, CELL STEM CELL, V9, P527, DOI 10.1016/j.stem.2011.10.002; Christoforou N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063577; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Debril MB, 2004, J BIOL CHEM, V279, P16677, DOI 10.1074/jbc.M312288200; Epting CL, 2008, EXP CELL RES, V314, P1125, DOI 10.1016/j.yexcr.2007.11.010; Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530; Georges R, 2008, MOL CELL BIOL, V28, P4052, DOI 10.1128/MCB.02100-07; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; GREPIN C, 1994, MOL CELL BIOL, V14, P3115, DOI 10.1128/MCB.14.5.3115; GURDON JB, 1993, CELL, V75, P831, DOI 10.1016/0092-8674(93)90526-V; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hsueh YC, 2014, EMBO MOL MED, V6, P496, DOI 10.1002/emmm.201303687; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Inagawa K, 2013, J CARDIOVASC TRANSL, V6, P37, DOI 10.1007/s12265-012-9412-5; Koyanagi M, 2005, CIRC RES, V96, P1039, DOI 10.1161/01.RES.0000168650.23479.0c; Ladewig J, 2013, NAT REV MOL CELL BIO, V14, P225, DOI 10.1038/nrm3543; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Limana F, 2007, CIRC RES, V101, P1255, DOI 10.1161/CIRCRESAHA.107.150755; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Ma Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056554; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; MOLKENTIN JD, 1994, MOL CELL BIOL, V14, P4947, DOI 10.1128/MCB.14.7.4947; Mori AD, 2006, DEV BIOL, V297, P566, DOI 10.1016/j.ydbio.2006.05.023; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nam YJ, 2013, P NATL ACAD SCI USA, V110, P5588, DOI 10.1073/pnas.1301019110; Noseda M, NAT COMMUN IN PRESS; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Oyama T, 2007, J CELL BIOL, V176, P329, DOI 10.1083/jcb.200603014; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Pluta K, 2005, J GENE MED, V7, P803, DOI 10.1002/jgm.712; Protze S, 2012, J MOL CELL CARDIOL, V53, P323, DOI 10.1016/j.yjmcc.2012.04.010; Qian L, 2012, NATURE, V485, P593, DOI 10.1038/nature11044; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Rosenblatt-Velin N, 2012, FASEB J, V26, P229, DOI 10.1096/fj.11-189605; Rosenthal N, 2010, HEART DEVELOPMENT AN; Salmon Patrick, 2007, Curr Protoc Hum Genet, VChapter 12, DOI 10.1002/0471142905.hg1210s54; Seidler NW, 2013, GAPDH BIOLOGICAL PRO; Sepulveda JL, 1998, MOL CELL BIOL, V18, P3405, DOI 10.1128/MCB.18.6.3405; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Song KH, 2012, NATURE, V485, P599, DOI 10.1038/nature11139; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Toko H, 2014, J BIOL CHEM, V289, P5348, DOI 10.1074/jbc.M113.526442; van Berlo JH, 2014, NATURE, V509, P337, DOI 10.1038/nature13309; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; Vong L, 2006, DEV DYNAM, V235, P1809, DOI 10.1002/dvdy.20828; Wada R, 2013, P NATL ACAD SCI USA, V110, P12667, DOI 10.1073/pnas.1304053110; Wang CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024242; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang L, 2015, CIRC RES, V116, P237, DOI 10.1161/CIRCRESAHA.116.305547; WEISS RA, 1977, VIROLOGY, V76, P808, DOI 10.1016/0042-6822(77)90261-6; ZAVADA J, 1972, NATURE-NEW BIOL, V240, P122, DOI 10.1038/newbio240122a0; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048028; Zhou YG, 2011, CIRC RES, V109, P1067, DOI 10.1161/CIRCRESAHA.111.243709; ZHU H, 1991, MOL CELL BIOL, V11, P2273, DOI 10.1128/MCB.11.4.2273	81	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0125384	10.1371/journal.pone.0125384	http://dx.doi.org/10.1371/journal.pone.0125384			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047103	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200009
J	Han, DP; Wang, SX; Hu, YX; Zhang, YY; Dong, XG; Yang, Z; Wang, JK; Li, JY; Deng, XM				Han, Deping; Wang, Shuxiang; Hu, Yanxin; Zhang, Yuanyuan; Dong, Xianggui; Yang, Zu; Wang, Jiankui; Li, Junying; Deng, Xuemei			Hyperpigmentation Results in Aberrant Immune Development in Silky Fowl (Gallus gallus domesticus Brisson)	PLOS ONE			English	Article							PROHORMONE CONVERTASE 2; WHITE LEGHORN; LUNG INJURY; MELANOCYTES; MELANOBLASTS; PIGMENTATION; INFECTION; MIGRATION; MELANIN; CELLS	The Silky Fowl (SF) is known for its special phenotypes and atypical distribution of melanocytes among internal organs. Although the genes associated with melanocyte migration have been investigated substantially, there is little information on the postnatal distribution of melanocytes in inner organs and the effect of hyperpigmentation on the development of SF. Here, we analyzed melanocyte distribution in 26 tissues or organs on postnatal day 1 and weeks 2, 3, 4, 6, 10, and 23. Except for the liver, pancreas, pituitary gland, and adrenal gland, melanocytes were distributed throughout the body, primarily around blood vessels. Interaction between melanocytes and the tissue cells was observed, and melanin was transported by filopodia delivery through engulfed and internalized membrane-encapsulated melanosomes. SFs less than 10 weeks old have lower indices of spleen, thymus, and bursa of Fabricius than White Leghorns (WLs). The expression levels of interferon-gamma and interlukin-4 genes in the spleen, and serum antibody levels against H5N1 and infectious bursal disease virus were lower in SF than in WL. We also found immune organ developmental difference between Black-boned and non-Black-boned chickens from SFs and WLs hybrid F2 population. However, degeneration of the thymus and bursa of Fabricius occurred later in SF than in WL after sexual maturity. Analysis of apoptotic cells and apoptosis-associated Bax and Bcl-2 proteins indicated that apoptosis is involved in degeneration of the thymus and bursa of Fabricius. Therefore, these results suggest that hyperpigmentation in SF may have a close relationship with immune development in SF, which can provide an important animal model to investigate the roles of melanocyte.	[Han, Deping; Wang, Shuxiang; Zhang, Yuanyuan; Dong, Xianggui; Yang, Zu; Wang, Jiankui; Li, Junying; Deng, Xuemei] China Agr Univ, Minist Agr, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China; [Han, Deping; Wang, Shuxiang; Zhang, Yuanyuan; Dong, Xianggui; Yang, Zu; Wang, Jiankui; Li, Junying; Deng, Xuemei] China Agr Univ, Minist Agr, Key Lab Anim Genet Breeding & Reprod, Beijing 100193, Peoples R China; [Hu, Yanxin] China Agr Univ, Coll Vet Med, Beijing 100193, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Deng, XM (corresponding author), China Agr Univ, Minist Agr, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.	deng@cau.edu.cn	zhang, yuanyuan/GYA-4428-2022		National Nature Science Foundation [31472082, U1136605]; National Scientific Supporting Projects of China [2013AA102501]; Program for New Century Excellent Talents of the Ministry of Education of China [NCET-09-0730]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); National Scientific Supporting Projects of China; Program for New Century Excellent Talents of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET))	This work was supported in part by grants from the National Nature Science Foundation (31472082 and U1136605), the National Scientific Supporting Projects of China (2013AA102501), and the Program for New Century Excellent Talents of the Ministry of Education of China (NCET-09-0730). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladowicz E, 2013, FUTURE ONCOL, V9, P713, DOI [10.2217/fon.13.9, 10.2217/FON.13.9]; Brozyna AA, 2013, HUM PATHOL, V44, P2071, DOI 10.1016/j.humpath.2013.02.022; De Freitas PF, 2003, ANAT REC PART A, V273A, P705, DOI 10.1002/ar.a.10078; Dellinger RW, 2014, J PHOTOCH PHOTOBIO B, V138, P317, DOI 10.1016/j.jphotobiol.2014.06.006; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Faraco CD, 2001, DEV DYNAM, V220, P212, DOI 10.1002/1097-0177(20010301)220:3<212::AID-DVDY1105>3.0.CO;2-9; Golbar HM, 2014, J COMP PATHOL, V151, P63, DOI 10.1016/j.jcpa.2014.03.002; Han DP, 2014, VET MICROBIOL, V169, P135, DOI 10.1016/j.vetmic.2013.12.022; Hiramoto K, 2013, CLIN EXP DERMATOL, V38, P71, DOI 10.1111/j.1365-2230.2012.04439.x; Hiramoto K, 2014, PHOTODERMATOL PHOTO, V30, P302, DOI 10.1111/phpp.12131; Hu YX, 2012, J VIROL, V86, P3347, DOI 10.1128/JVI.06053-11; Jin XT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113257; Kawakami Akinori, 2011, J Invest Dermatol, V131, pE2, DOI 10.1038/skinbio.2011.2; Kumar V, 2010, MOL IMMUNOL, V48, P14, DOI 10.1016/j.molimm.2010.07.009; Levesque M, 2013, DIS MODEL MECH, V6, P508, DOI 10.1242/dmm.010371; Li YL, 2014, FRONT AGRIC SCI ENG, V1, P299, DOI 10.15302/J-FASE-2014040; Li YL, 2011, MOL BIOL REP, V38, P1433, DOI 10.1007/s11033-010-0248-2; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu H, 2006, HEILONGJIANG ANIMAL, V9, P104; Liu WY, 2013, J SCI FOOD AGR, V93, P2782, DOI 10.1002/jsfa.6099; Ma HJ, 2014, J DERMATOL SCI, V76, P222, DOI 10.1016/j.jdermsci.2014.09.005; Murillo-Cuesta S, 2010, PIGM CELL MELANOMA R, V23, P72, DOI 10.1111/j.1755-148X.2009.00646.x; Muroya S, 2000, J VET MED SCI, V62, P391, DOI 10.1292/jvms.62.391; Nishimura S, 2006, BRIT POULTRY SCI, V47, P426, DOI 10.1080/00071660600825082; Ortolani-Machado CF, 2009, TISSUE CELL, V41, P239, DOI 10.1016/j.tice.2008.11.005; Ortolani-Machado C, 2008, ANAT REC, V291, P55, DOI 10.1002/ar.20623; Plonka PM, 2009, EXP DERMATOL, V18, P799, DOI 10.1111/j.1600-0625.2009.00912.x; Reedy MV, 1998, DEV DYNAM, V213, P476, DOI 10.1002/(SICI)1097-0177(199812)213:4<476::AID-AJA12>3.0.CO;2-R; Rui J, 1979, JOURNAL OF FUDAN UNI, V3, P100; RuizMaldonado R, 1997, SEMIN CUTAN MED SURG, V16, P36, DOI 10.1016/S1085-5629(97)80034-X; Shinomiya A, 2012, GENETICS, V190, P627, DOI 10.1534/genetics.111.136705; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Slominski A, 2009, INT J CANCER, V124, P1470, DOI 10.1002/ijc.24005; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; Sun Q, 2008, AVIAN PATHOL, V37, P579, DOI 10.1080/03079450802499092; Sun SF, 2008, POULTRY SCI, V87, P1725, DOI 10.3382/ps.2007-00202; Suzuki I, 1996, ENDOCRINOLOGY, V137, P1627, DOI 10.1210/en.137.5.1627; Toyosaki T, 2007, BRIT POULTRY SCI, V48, P449, DOI 10.1080/00071660701466109; Tu YG, 2009, PIGM CELL MELANOMA R, V22, P134, DOI 10.1111/j.1755-148X.2008.00529.x; Wang DC, 2008, VET IMMUNOL IMMUNOP, V124, P19, DOI 10.1016/j.vetimm.2008.01.005; Wong Christina Yin Bin, 2013, N Am J Med Sci, V5, P499, DOI 10.4103/1947-2714.118918; Xie H, 2011, BIOMATERIALS, V32, P495, DOI 10.1016/j.biomaterials.2010.09.024; Yajima I, 2008, PIGM CELL MELANOMA R, V21, P471, DOI 10.1111/j.1755-148X.2008.00483.x; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P10388, DOI 10.1073/pnas.1205210109	46	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0125686	10.1371/journal.pone.0125686	http://dx.doi.org/10.1371/journal.pone.0125686			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047316	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200010
J	Pinho, AV; Bensellam, M; Wauters, E; Rees, M; Giry-Laterriere, M; Mawson, A; Ly, LQ; Biankin, AV; Wu, JM; Laybutt, DR; Rooman, I				Pinho, Andreia V.; Bensellam, Mohammed; Wauters, Elke; Rees, Maxine; Giry-Laterriere, Marc; Mawson, Amanda; Ly, Le Quan; Biankin, Andrew V.; Wu, Jianmin; Laybutt, D. Ross; Rooman, Ilse			Pancreas-Specific Sirt1-Deficiency in Mice Compromises Beta-Cell Function without Development of Hyperglycemia	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; STIMULATED INSULIN-SECRETION; SIRT1; MOUSE; DIFFERENTIATION; HOMEOSTASIS; CANCER; DAMAGE	Aims/Hypothesis Sirtuin 1 (Sirt1) has been reported to be a critical positive regulator of glucose-stimulated insulin secretion in pancreatic beta-cells. The effects on islet cells and blood glucose levels when Sirt1 is deleted specifically in the pancreas are still unclear. Methods This study examined islet glucose responsiveness, blood glucose levels, pancreatic islet histology and gene expression in Pdx1(Cre); Sirt1(ex4F/F) mice that have loss of function and loss of expression of Sirt1 specifically in the pancreas. Results We found that in the Pdx1(Cre); Sirt1(ex4F/F) mice, the relative insulin positive area and the islet size distribution were unchanged. However, beta-cells were functionally impaired, presenting with lower glucose-stimulated insulin secretion. This defect was not due to a reduced expression of insulin but was associated with a decreased expression of the glucose transporter Slc2a2/Glut2 and of the Glucagon like peptide-1 receptor (Glp1r) as well as a marked down regulation of endoplasmic reticulum (ER) chaperones that participate in the Unfolded Protein Response (UPR) pathway. Counter intuitively, the Sirt1-deficient mice did not develop hyperglycemia. Pancreatic polypeptide (PP) cells were the only other islet cells affected, with reduced numbers in the Sirt1-deficient pancreas. Conclusions/Interpretation This study provides new mechanistic insights showing that beta-cell function in Sirt1-deficient pancreas is affected due to altered glucose sensing and deregulation of the UPR pathway. Interestingly, we uncovered a context in which impaired beta-cell function is not accompanied by increased glycemia. This points to a unique compensatory mechanism. Given the reduction in PP, investigation of its role in the control of blood glucose is warranted.	[Pinho, Andreia V.; Rees, Maxine; Giry-Laterriere, Marc; Mawson, Amanda; Ly, Le Quan; Biankin, Andrew V.; Wu, Jianmin; Rooman, Ilse] Kinghorn Canc Ctr, Garvan Inst Med Res, Canc Div, Darlinghurst, NSW, Australia; [Pinho, Andreia V.; Bensellam, Mohammed; Giry-Laterriere, Marc; Wu, Jianmin; Laybutt, D. Ross; Rooman, Ilse] UNSW Australia, Fac Med, St Vincents Clin Sch, Randwick, NSW, Australia; [Bensellam, Mohammed; Laybutt, D. Ross] St Vincents Hosp, Garvan Inst Med Res, Diabet & Metab Div, Darlinghurst, NSW 2010, Australia; [Wauters, Elke; Rooman, Ilse] Vrije Univ Brussel, Diabet Res Ctr, Brussels, Belgium; [Biankin, Andrew V.] Univ Glasgow, Wolfson Wohl Canc Res Ctr, Glasgow, Lanark, Scotland	Garvan Institute of Medical Research; University of New South Wales Sydney; Garvan Institute of Medical Research; St Vincents Hospital Sydney; Vrije Universiteit Brussel; University of Glasgow	Rooman, I (corresponding author), Kinghorn Canc Ctr, Garvan Inst Med Res, Canc Div, Darlinghurst, NSW, Australia.	i.rooman@garvan.org.au	Bensellam, Mohammed/AAI-4760-2020	Biankin, Andrew/0000-0002-0362-5597; Pinho, Andreia V./0000-0003-0647-4015; Bensellam, Mohammed/0000-0002-1641-1694; Rooman, Ilse/0000-0001-7264-2246; Ly, Le Quan/0000-0003-1189-6175	Australian Research Council; National Health and Medical Research Council of Australia; Cancer Research UK [17263] Funding Source: researchfish	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK)	AVP and IR are fellows from Cancer Institute NSW (13ECF104 and 10FRL203). DRL is a recipient of a Future Fellowship from the Australian Research Council and a grant from the National Health and Medical Research Council of Australia. EW is a research fellow of the Fund for Scientific Research Flanders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Boutant M, 2014, MOL METAB, V3, P5, DOI 10.1016/j.molmet.2013.10.006; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Herranz D, 2010, NAT REV CANCER, V10, P819, DOI 10.1038/nrc2962; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hubbard BP, 2014, TRENDS PHARM SCI; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Laybutt DR, 2007, DIABETOLOGIA, V50, P2117, DOI 10.1007/s00125-007-0749-2; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2011, P NATL ACAD SCI USA, V108, P8885, DOI 10.1073/pnas.1105564108; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Luu L, 2013, DIABETOLOGIA, V56, P2010, DOI 10.1007/s00125-013-2946-5; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Ramsey KM, 2008, AGING CELL, V7, P78, DOI 10.1111/j.1474-9726.2007.00355.x; Thorens B, 2015, DIABETOLOGIA, V58, P221, DOI 10.1007/s00125-014-3451-1; Vetere A, 2014, NAT REV DRUG DISCOV, V13, P278, DOI 10.1038/nrd4231; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wang RH, 2013, INT J BIOL SCI, V9, P934, DOI 10.7150/ijbs.7529; Wang RH, 2011, J CLIN INVEST, V121, P4477, DOI 10.1172/JCI46243; Wauters E, 2013, CANCER RES, V73, P2357, DOI 10.1158/0008-5472.CAN-12-3359; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yulyaningsih E, 2014, CELL METAB, V19, P58, DOI 10.1016/j.cmet.2013.11.019	25	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128012	10.1371/journal.pone.0128012	http://dx.doi.org/10.1371/journal.pone.0128012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046931	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200037
J	Yang, L; Tang, CH; Xu, B; Wang, WX; Li, JJ; Li, XY; Qin, HF; Gao, HJ; He, K; Song, ST; Liu, XQ				Yang, Lin; Tang, Chuanhao; Xu, Bin; Wang, Weixia; Li, Jianjie; Li, Xiaoyan; Qin, Haifeng; Gao, Hongjun; He, Kun; Song, Santai; Liu, Xiaoqing			Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer	PLOS ONE			English	Article							EGFR MUTATIONS; OPEN-LABEL; PHASE-III; MASS-SPECTROMETRY; BREAST-CANCER; PLASMA DNA; GEFITINIB; CHEMOTHERAPY; BIOMARKER; ERLOTINIB	Objectives Epidermal growth factor receptor (EGFR) gene mutations in tumors predict tumor response to EGFR tyrosine kinase inhibitors (EGFR-TKIs) in non-small-cell lung cancer (NSCLC). However, obtaining tumor tissue for mutation analysis is challenging. Here, we aimed to detect serum peptides/proteins associated with EGFR gene mutation status, and test whether a classification algorithm based on serum proteomic profiling could be developed to analyze EGFR gene mutation status to aid therapeutic decision-making. Patients and Methods Serum collected from 223 stage IIIB or IV NSCLC patients with known EGFR gene mutation status in their tumors prior to therapy was analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) and ClinProTools software. Differences in serum peptides/proteins between patients with EGFR gene TKI-sensitive mutations and wild-type EGFR genes were detected in a training group of 100 patients; based on this analysis, a serum proteomic classification algorithm was developed to classify EGFR gene mutation status and tested in an independent validation group of 123 patients. The correlation between EGFR gene mutation status, as identified with the serum proteomic classifier and response to EGFR-TKIs was analyzed. Results Nine peptide/protein peaks were significantly different between NSCLC patients with EGFR gene TKI-sensitive mutations and wild-type EGFR genes in the training group. A genetic algorithm model consisting of five peptides/proteins (m/z 4092.4, 4585.05, 1365.1, 4643.49 and 4438.43) was developed from the training group to separate patients with EGFR gene TKI-sensitive mutations and wild-type EGFR genes. The classifier exhibited a sensitivity of 84.6% and a specificity of 77.5% in the validation group. In the 81 patients from the validation group treated with EGFR-TKIs, 28 (59.6%) of 47 patients whose matched samples were labeled as "mutant" by the classifier and 3 (8.8%) of 34 patients whose matched samples were labeled as "wild" achieved an objective response (p<0.0001). Patients whose matched samples were labeled as "mutant" by the classifier had a significantly longer progression-free survival (PFS) than patients whose matched samples were labeled as "wild" (p=0.001). Conclusion Peptides/proteins related to EGFR gene mutation status were found in the serum. Classification of EGFR gene mutation status using the serum proteomic classifier established in the present study in patients with stage IIIB or IV NSCLC is feasible and may predict tumor response to EGFR-TKIs.	[Yang, Lin; Tang, Chuanhao; Wang, Weixia; Li, Jianjie; Li, Xiaoyan; Qin, Haifeng; Gao, Hongjun; Liu, Xiaoqing] PLA, Hosp 307, Dept Pulm Oncol, Beijing, Peoples R China; [Xu, Bin; He, Kun] Natl Ctr Biomed Anal, Beijing, Peoples R China; [Song, Santai] PLA, Hosp 307, Ctr Canc, Beijing, Peoples R China		Liu, XQ (corresponding author), PLA, Hosp 307, Dept Pulm Oncol, Beijing, Peoples R China.	liuxq@medmail.com.cn			Ministry of Science and Technology of the People's Republic of China (Chinese National Instrumentation Program) [2011YQI70067]	Ministry of Science and Technology of the People's Republic of China (Chinese National Instrumentation Program)	This work was supported by a grant from the Ministry of Science and Technology of the People's Republic of China (Chinese National Instrumentation Program, No. 2011YQI70067; URL of funder's website: www.most.gov.cn; XQL received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annecke K, 2008, ADV CLIN CHEM, V45, P31, DOI 10.1016/S0065-2423(07)00002-9; Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Brevet M, 2011, LUNG CANCER, V73, P96, DOI 10.1016/j.lungcan.2010.10.014; Ciuleanu T, 2012, LANCET ONCOL, V13, P300, DOI 10.1016/S1470-2045(11)70385-0; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Gregorc V, 2014, LANCET ONCOL, V15, P713, DOI 10.1016/S1470-2045(14)70162-7; Guo JA, 2010, J CANCER RES CLIN, V136, P1341, DOI 10.1007/s00432-010-0785-z; He AL, 2012, INT J HEMATOL, V95, P668, DOI 10.1007/s12185-012-1080-3; He C, 2009, INT J CANCER, V125, P2393, DOI 10.1002/ijc.24653; Hojilla CV, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1980; Hong WX, 2013, TOXICOL APPL PHARM, V273, P121, DOI 10.1016/j.taap.2013.08.014; Kawaguchi T, 2014, J CLIN ONCOL, V32, P1902, DOI 10.1200/JCO.2013.52.4694; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; Kimura H, 2007, BRIT J CANCER, V97, P778, DOI 10.1038/sj.bjc.6603949; Kimura H, 2006, J THORAC ONCOL, V1, P260, DOI 10.1016/S1556-0864(15)31577-X; Liu J, 2012, J NEUROIMMUNOL, V250, P71, DOI [10.1016/j.jneuroim.2012.04.021, DOI 10.1016/J.JNEUROIM.2012.04.021]; Liu X, 2009, NEUROSCI LETT, V463, P6, DOI 10.1016/j.neulet.2009.07.056; Liu XQ, 2013, J CLIN PATHOL, V66, P1065, DOI 10.1136/jclinpath-2013-201728; Lopez-Otin C, 2007, NAT REV CANCER, V7, P800, DOI 10.1038/nrc2228; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Milan E, 2012, J PROTEOMICS, V76, P91, DOI 10.1016/j.jprot.2012.06.022; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Perez V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087731; Rauser S, 2010, J PROTEOME RES, V9, P1854, DOI 10.1021/pr901008d; Shi YK, 2013, LANCET ONCOL, V14, P953, DOI 10.1016/S1470-2045(13)70355-3; Shin S, 2007, J AM COLL SURGEONS, V204, P1065, DOI 10.1016/j.jamcollsurg.2007.01.036; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Taguchi F, 2007, J NATL CANCER I, V99, P838, DOI 10.1093/jnci/djk195; Tang W, 2011, FRONT BIOSCI-LANDMRK, V16, P2671; Wang L, 2014, EUR J OBSTET GYN R B, V177, P23, DOI 10.1016/j.ejogrb.2014.03.011; Wu X, 2013, ONCOTARGETS THER, V6, P1481, DOI 10.2147/OTT.S51887; Wu YL, 2014, LANCET ONCOL, V15, P213, DOI 10.1016/S1470-2045(13)70604-1; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Yang J, 2012, J CLIN LAB ANAL, V26, P148, DOI 10.1002/jcla.21502; Yung TKF, 2009, CLIN CANCER RES, V15, P2076, DOI 10.1158/1078-0432.CCR-08-2622; Zhang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107161	38	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128970	10.1371/journal.pone.0128970	http://dx.doi.org/10.1371/journal.pone.0128970			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047516	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200112
J	Zheng, JC; Yang, ZY; Madgwick, PJ; Carmo-Silva, E; Parry, MAJ; Hu, YG				Zheng, Jiacheng; Yang, Zhiyuan; Madgwick, Pippa J.; Carmo-Silva, Elizabete; Parry, Martin A. J.; Hu, Yin-Gang			TaER Expression Is Associated with Transpiration Efficiency Traits and Yield in Bread Wheat	PLOS ONE			English	Article							WATER-USE EFFICIENCY; RECEPTOR-LIKE KINASE; DRAFT GENOME; ARABIDOPSIS; FAMILY; GROWTH; PROTEIN	ERECTA encodes a receptor-like kinase and is proposed as a candidate for determining transpiration efficiency of plants. Two genes homologous to ERECTA in Arabidopsis were identified on chromosomes 6 (TaER2) and 7 (TaER1) of bread wheat (Triticum aestivum L.), with copies of each gene on the A, B and D genomes of wheat. Similar expression patterns were observed for TaER1 and TaER2 with relatively higher expression of TaER1 in flag leaves of wheat at heading (Z55) and grain-filling (Z73) stages. Significant variations were found in the expression levels of both TaER1 and TaER2 in the flag leaves at both growth stages among 48 diverse bread wheat varieties. Based on the expression of TaER1 and TaER2, the 48 wheat varieties could be classified into three groups having high (5 varieties), medium (27 varieties) and low (16 varieties) levels of TaER expression. Significant differences were also observed between the three groups varying for TaER expression for several transpiration efficiency (TE)-related traits, including stomatal density (SD), transpiration rate, photosynthetic rate (A), instant water use efficiency (WUEi) and carbon isotope discrimination (CID), and yield traits of biomass production plant(-1) (BYPP) and grain yield plant(-1) (GYPP). Correlation analysis revealed that the expression of TaER1 and TaER2 at the two growth stages was significantly and negatively associated with SD (P<0.01), transpiration rate (P<0.05) and CID (P<0.01), while significantly and positively correlated with flag leaf area (FLA, P<0.01), A (P<0.05), WUEi (P<0.05), BYPP (P<0.01) and GYPP (P<0.01), with stronger correlations for TaER1 than TaER2 and at grain-filling stage than at heading stage. These combined results suggested that TaER involved in development of transpiration efficiency -related traits and yield in bread wheat, implying a function for TaER in regulating leaf development of bread wheat and contributing to expression of these traits. Moreover, the results indicate that TaER could be exploitable for manipulating important agronomical traits in wheat improvement.	[Zheng, Jiacheng; Yang, Zhiyuan; Hu, Yin-Gang] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Zheng, Jiacheng; Yang, Zhiyuan; Hu, Yin-Gang] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Madgwick, Pippa J.; Carmo-Silva, Elizabete; Parry, Martin A. J.] Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England; [Hu, Yin-Gang] Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Parry, MAJ (corresponding author), Rothamsted Res, Dept Plant Biol & Crop Sci, Harpenden, Herts, England.	martin.parry@rothamsted.ac.uk; huyingang@126.com	Carmo-Silva, Elizabete/G-7437-2012	Carmo-Silva, Elizabete/0000-0001-6059-9359; Parry, Martin/0000-0002-4477-672X	sub-project of the 863 Program of the Ministry of Science and Technology [2013AA102902]; China 111 Projectct, P. R. China [B12007]; Joint PhD scholarship of the Chinese Scholarship Council; BBSRC 20:20 Wheat Institute Strategic Programme (BBSRC) [BB/J/00426X/1]; Biotechnology and Biological Sciences Research Council [BB/I017372/1, BBS/E/C/00004952, BB/N004485/1, BBS/E/C/00005202] Funding Source: researchfish; BBSRC [BBS/E/C/00004952, BB/I017372/1, BBS/E/C/00005202, BB/N004485/1] Funding Source: UKRI	sub-project of the 863 Program of the Ministry of Science and Technology; China 111 Projectct, P. R. China; Joint PhD scholarship of the Chinese Scholarship Council; BBSRC 20:20 Wheat Institute Strategic Programme (BBSRC); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2013AA102902) of the Ministry of Science and Technology, and the China 111 Project (B12007), P. R. China. Jia-Cheng Zheng was supported by a Joint PhD scholarship of the Chinese Scholarship Council. Pippa Madgwick, Elizabete Carmo-Silva and Martin Parry acknowledge financial support from the BBSRC 20:20 Wheat Institute Strategic Programme (BBSRC BB/J/00426X/1).	Bemis SM, 2013, J EXP BOT, V64, P5323, DOI 10.1093/jxb/ert270; Chen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062285; Chen XJ, 2012, FIELD CROP RES, V137, P195, DOI 10.1016/j.fcr.2012.09.008; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Huang LZ, 2013, AUST J CROP SCI, V3, pS381; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Masle J, 2005, NATURE, V436, P866, DOI 10.1038/nature03835; Olsen MT, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-77; Pillitteri LJ, 2012, ANNU REV PLANT BIOL, V63, P591, DOI 10.1146/annurev-arplant-042811-105451; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rieu I, 2009, PLANT CELL, V21, P1031, DOI 10.1105/tpc.109.066001; Roussel M, 2009, J EXP BOT, V60, P2419, DOI 10.1093/jxb/erp100; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; Shpak ED, 2004, DEVELOPMENT, V131, P1491, DOI 10.1242/dev.01028; Shpak ED, 2003, PLANT CELL, V15, P1095, DOI 10.1105/tpc.010413; Torii KU, 1996, PLANT CELL, V8, P735, DOI 10.1105/tpc.8.4.735; van Zanten M, 2009, TRENDS PLANT SCI, V14, P214, DOI 10.1016/j.tplants.2009.01.010; Villagarcia H, 2012, J EXP BOT, V63, P6493, DOI 10.1093/jxb/ers305; Xing HT, 2011, PLANTA, V234, P229, DOI 10.1007/s00425-011-1389-9; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x	21	16	18	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128415	10.1371/journal.pone.0128415	http://dx.doi.org/10.1371/journal.pone.0128415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047019	Green Submitted, gold, Green Published			2022-12-26	WOS:000355652200068
J	Kadoya, H; Satoh, M; Sasaki, T; Taniguchi, S; Takahashi, M; Kashihara, N				Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Taniguchi, Shun'ichiro; Takahashi, Masafumi; Kashihara, Naoki			Excess aldosterone is a critical danger signal for inflammasome activation in the development of renal fibrosis in mice	FASEB JOURNAL			English	Article						chronic inflammation; kidney; mineralocorticoid receptor; mitochondria; reactive oxygen species	OXIDATIVE STRESS; ANGIOTENSIN-II; DIABETIC-NEPHROPATHY; KIDNEY-DISEASE; DEFICIENCY; PROMOTES; INJURY; NLRP3-INFLAMMASOME; SPIRONOLACTONE; HYPERGLYCEMIA	High levels of aldosterone impair renal function by activating proinflammatory and profibrotic pathways. However, the molecular mechanism underlying aldosterone-induced inflammation and fibrosis is unknown. Inflammasome activation contributes to chronic kidney disease. We hypothesized that aldosterone induces renal tubulointerstitial inflammation and fibrosis by activating the inflammasome. Infusing wild-type mice with aldosterone (0.25 mg/kg/d) caused tubulointerstitial damage, increased expression of inflammasome components, caspase 1 activation, and overproduction of IL-1 beta and IL-18. These changes were suppressed by eplerenone treatment (100 mg/kg/d) in wild-type mice or in mice deficient in apoptosis-associated speck-like protein with a caspase-recruitment domain (ASC). Caspase 1-positive and F4/80-positive cells colocalized in the interstitium. Bone marrow transplantation using ASC-deficient mice indicated that inflammasome activation in macrophages mediated aldosterone-induced renal fibrosis. IL-18 was detected in culture supernatants of macrophages treated with aldosterone, and mitochondria-derived reactive oxygen species activated the inflammasome in these macrophages. Our results indicate that exposure of macrophages to high levels of aldosterone resulted in the activation of inflammasomes via the mitochondria-derived reactive oxygen species. Thus, inflammasome activation in macrophages may serve as a new therapeutic target for chronic kidney disease.	[Kadoya, Hiroyuki; Satoh, Minoru; Sasaki, Tamaki; Kashihara, Naoki] Kawasaki Med Sch, Dept Hypertens & Nephrol, Kurashiki, Okayama 7010192, Japan; [Taniguchi, Shun'ichiro] Shinshu Univ, Grad Sch Med, Dept Mol Oncol, Matsumoto, Nagano 390, Japan; [Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi, Japan	Kawasaki Medical School; Shinshu University; Jichi Medical University	Satoh, M (corresponding author), Kawasaki Med Sch, Dept Hypertens & Nephrol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	msatoh@med.kawasaki-m.ac.jp			Japan Society for the Promotion of Science [24390218, 24591220]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank E. Yorimasa and M. Yokohata for animal care, S. Hanada and K. Satoh (Kawasaki Medical School) for their help with in vitro assays, and M. Takahashi (Jichi Medical University) for invaluable research advice. This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (24390218 to N.K. and 24591220 to M.S.).	Blasi ER, 2003, KIDNEY INT, V63, P1791, DOI 10.1046/j.1523-1755.2003.00929.x; Bomback AS, 2007, NAT CLIN PRACT NEPHR, V3, P486, DOI 10.1038/ncpneph0575; Dooley R, 2012, MOL CELL ENDOCRINOL, V350, P223, DOI 10.1016/j.mce.2011.07.019; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Guney I, 2009, RENAL FAILURE, V31, P779, DOI 10.3109/08860220903150312; Hagiwara H, 2006, FEBS LETT, V580, P4463, DOI 10.1016/j.febslet.2006.07.015; Han SY, 2006, J AM SOC NEPHROL, V17, P1362, DOI 10.1681/ASN.2005111196; Irita J, 2011, AM J PHYSIOL-RENAL, V301, pF833, DOI 10.1152/ajprenal.00557.2010; Jiang YG, 2012, BIOCHEM BIOPH RES CO, V425, P121, DOI 10.1016/j.bbrc.2012.07.011; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Keidar S, 2004, CIRCULATION, V109, P2213, DOI 10.1161/01.CIR.0000127949.05756.9D; Komada T, 2014, AM J PATHOL, V184, P1287, DOI 10.1016/j.ajpath.2014.01.014; Kuwabara A, 2010, DIABETOLOGIA, V53, P2056, DOI 10.1007/s00125-010-1810-0; Lee SH, 2009, AM J PHYSIOL-RENAL, V297, pF1381, DOI 10.1152/ajprenal.00101.2009; Luheshi NM, 2012, EUR J IMMUNOL, V42, P716, DOI 10.1002/eji.201142079; Luo P, 2013, DIABETOLOGIA, V56, P901, DOI 10.1007/s00125-012-2814-8; Luther JM, 2012, KIDNEY INT, V82, P643, DOI 10.1038/ki.2012.170; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCurley A, 2012, NAT MED, V18, P1429, DOI 10.1038/nm.2891; Nagasu H, 2012, AM J PHYSIOL-RENAL, V302, pF1402, DOI 10.1152/ajprenal.00459.2011; Nakamura T, 2009, HYPERTENSION, V54, P544, DOI 10.1161/HYPERTENSIONAHA.109.135392; Nishi Y, 2013, KIDNEY INT, V83, P662, DOI 10.1038/ki.2012.475; Nolly MB, 2014, J MOL CELL CARDIOL, V67, P60, DOI 10.1016/j.yjmcc.2013.12.004; Ogawa Y, 2012, J AM SOC NEPHROL, V23, P1198, DOI 10.1681/ASN.2011100985; Patwari P, 2006, J BIOL CHEM, V281, P21884, DOI 10.1074/jbc.M600427200; Ptinopoulou AG, 2013, HYPERTENS RES, V36, P91, DOI 10.1038/hr.2012.157; Quinn S, 2014, STEROIDS, V81, P43, DOI 10.1016/j.steroids.2013.11.005; Remuzzi G, 2008, J AM SOC NEPHROL, V19, P1459, DOI 10.1681/ASN.2007101079; Schjoedt KJ, 2004, DIABETOLOGIA, V47, P1936, DOI 10.1007/s00125-004-1542-0; Schulze PC, 2004, J BIOL CHEM, V279, P30369, DOI 10.1074/jbc.M400549200; Shahzad K, 2015, KIDNEY INT, V87, P74, DOI 10.1038/ki.2014.271; Shibata S, 2007, HYPERTENSION, V49, P355, DOI 10.1161/01.HYP.0000255636.11931.a2; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; Taniguchi S, 2007, SEMIN IMMUNOPATHOL, V29, P231, DOI 10.1007/s00281-007-0082-3; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Tokuyama H, 2012, INT J OBESITY, V36, P1062, DOI 10.1038/ijo.2011.232; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; Vilaysane A, 2010, J AM SOC NEPHROL, V21, P1732, DOI 10.1681/ASN.2010020143; Wuhl E, 2011, NAT REV NEPHROL, V7, P434, DOI 10.1038/nrneph.2011.73; Yoneda T, 2007, AM J HYPERTENS, V20, P1329, DOI 10.1016/j.amjhyper.2007.09.001; Zhang C, 2012, HYPERTENSION, V60, P154, DOI 10.1161/HYPERTENSIONAHA.111.189688; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	43	45	48	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2015	29	9					3899	3910		10.1096/fj.15-271734	http://dx.doi.org/10.1096/fj.15-271734			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CP5IU	26054366				2022-12-26	WOS:000359915600025
J	Hong, S; Harris, KA; Fanning, KD; Sarachan, KL; Frohlich, KM; Agris, PF				Hong, Seoyeon; Harris, Kimberly A.; Fanning, Kathryn D.; Sarachan, Kathryn L.; Frohlich, Kyla M.; Agris, Paul F.			Evidence That Antibiotics Bind to Human Mitochondrial Ribosomal RNA Has Implications for Aminoglycoside Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECYCLING FACTOR; PROTEIN-SYNTHESIS; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; BACTERIAL RIBOSOME; 70S RIBOSOME; BASE-PAIR; GENTAMICIN; 16S; SPECTINOMYCIN	Aminoglycosides are a well known antibiotic family used to treat bacterial infections in humans and animals, but which can be toxic. By binding to the decoding site of helix44 of the small subunit RNA of the bacterial ribosome, the aminoglycoside antibiotics inhibit protein synthesis, cause misreading, or obstruct peptidyl-tRNA translocation. Although aminoglycosides bind helix69 of the bacterial large subunit RNA as well, little is known about their interaction with the homologous human helix69. To probe the role this binding event plays in toxicity, changes to thermal stability, base stacking, and conformation upon aminoglycoside binding to the human cytoplasmic helix69 were compared with those of the human mitochondrial and Escherichia coli helix69. Surprisingly, binding of gentamicin and kanamycin A to the chemically synthesized terminal hairpins of the human cytoplasmic, human mitochondrial, and E. coli helix69 revealed similar dissociation constants (1.3-1.7 and 4.0-5.4 mu M, respectively). In addition, aminoglycoside binding enhanced conformational stability of the human mitochondrial helix69 by increasing base stacking. Proton one-dimensional and two-dimensional NMR suggested significant and specific conformational changes of human mitochondrial and E. coli helix69 upon aminoglycoside binding, as compared with human cytoplasmic helix69. The conformational changes and similar aminoglycoside binding affinities observed for human mitochondrial helix69 and E. coli helix69, as well as the increase in structural stability shown for the former, suggest that this binding event is important to understanding aminoglycoside toxicity.	[Agris, Paul F.] SUNY Albany, RNA Inst, Albany, NY 12222 USA; SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Agris, PF (corresponding author), SUNY Albany, RNA Inst, 1400 Washington Ave, Albany, NY 12222 USA.	pagris@albany.edu		Harris, Kimberly/0000-0003-3028-5863; Sarachan, Kathryn/0000-0003-2511-1404	National Science Foundation [MCB 1101859]; Enhancing STEM Research Experiences for State University of New York (SUNY) Undergraduates	National Science Foundation(National Science Foundation (NSF)); Enhancing STEM Research Experiences for State University of New York (SUNY) Undergraduates	This work was supported by the National Science Foundation (Grant MCB 1101859) (to P. F. A.) and the Enhancing STEM Research Experiences for State University of New York (SUNY) Undergraduates (to S. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal RK, 2004, P NATL ACAD SCI USA, V101, P8900, DOI 10.1073/pnas.0401904101; Barsanti J. A., 1990, INFECT DIS DOG CAT, P515; Becker B, 2013, ACS CHEM BIOL, V8, P105, DOI 10.1021/cb3005116; BIEHL LG, 1986, VET CLIN N AM-FOOD A, V2, P481, DOI 10.1016/S0749-0720(15)31258-5; Borovinskaya MA, 2007, NAT STRUCT MOL BIOL, V14, P727, DOI 10.1038/nsmb1271; Bottger EC, 2001, EMBO REP, V2, P318, DOI 10.1093/embo-reports/kve062; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Brown A, 2014, SCIENCE, V346, P718, DOI 10.1126/science.1258026; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chen AA, 2013, P NATL ACAD SCI USA, V110, P16820, DOI 10.1073/pnas.1309392110; DAVIES J, 1968, J BIOL CHEM, V243, P3312; DAYAL VS, 1979, ANN OTO RHINOL LARYN, V88, P36, DOI 10.1177/000348947908800107; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dibrov SM, 2010, NUCLEIC ACIDS RES, V38, P4458, DOI 10.1093/nar/gkq159; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; FINEGOLD SM, 1966, ANN NY ACAD SCI, V132, P942, DOI 10.1111/j.1749-6632.1966.tb43018.x; Fox TD, 2012, GENETICS, V192, P1203, DOI 10.1534/genetics.112.141267; Francis SP, 2013, J NEUROSCI, V33, P3079, DOI 10.1523/JNEUROSCI.3430-12.2013; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; Hall AM, 2013, KIDNEY INT, V83, P72, DOI 10.1038/ki.2012.328; HAMDY AH, 1975, LAB ANIM SCI, V25, P570; Hermann T, 2007, BLOOD CELL MOL DIS, V38, P193, DOI 10.1016/j.bcmd.2006.11.006; Hinojosa R, 2001, LARYNGOSCOPE, V111, P1797, DOI 10.1097/00005537-200110000-00025; Hobbie SN, 2005, ANTIMICROB AGENTS CH, V49, P5112, DOI 10.1128/AAC.49.12.5112-5118.2005; Hobbie SN, 2008, P NATL ACAD SCI USA, V105, P3244, DOI 10.1073/pnas.0707265105; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Isefuku S, 2003, J ORTHOP TRAUMA, V17, P212, DOI 10.1097/00005131-200303000-00010; Jackson GL, 2003, PEDIATR NEPHROL, V18, P653, DOI 10.1007/s00467-003-1161-x; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; JANOSI L, 1994, P NATL ACAD SCI USA, V91, P4249, DOI 10.1073/pnas.91.10.4249; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KANE FJ, 1975, SOUTHERN MED J, V68, P1283, DOI 10.1097/00007611-197510000-00025; Kaul M, 2002, BIOCHEMISTRY-US, V41, P7695, DOI 10.1021/bi020130f; KELLEY G. W., 1960, CORNELL VET, V50, P60; KES P, 1990, MAGNESIUM TRACE ELEM, V9, P54; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; KOTECHA B, 1994, HEARING RES, V73, P173, DOI 10.1016/0378-5955(94)90232-1; Kurata S, 2010, P NATL ACAD SCI USA, V107, P10854, DOI 10.1073/pnas.1006247107; Lancaster L, 2002, CELL, V111, P129, DOI 10.1016/S0092-8674(02)00938-8; Lynch SR, 2001, J MOL BIOL, V306, P1037, DOI 10.1006/jmbi.2000.4420; Magnet S, 2005, CHEM REV, V105, P477, DOI 10.1021/cr0301088; McDowell JA, 1996, BIOCHEMISTRY-US, V35, P14077, DOI 10.1021/bi9615710; Meroueh M, 2000, NUCLEIC ACIDS RES, V28, P2075, DOI 10.1093/nar/28.10.2075; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P1003, DOI 10.1128/AAC.43.5.1003; MOAZED D, 1987, NATURE, V327, P389, DOI 10.1038/327389a0; Mueller U, 1999, RNA, V5, P670, DOI 10.1017/S1355838299982304; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; PEL HJ, 1994, MOL BIOL REP, V19, P183, DOI 10.1007/BF00986960; Perez-Fernandez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4112; Pfister P, 2003, ANTIMICROB AGENTS CH, V47, P1496, DOI 10.1128/AAC.47.5.1496-1502.2003; Poirrier AL, 2010, TOXICOL LETT, V193, P41, DOI 10.1016/j.toxlet.2009.12.003; Rodger A., 1997, CIRCULAR DICHROISM L, P25; Rolland N, 1999, P NATL ACAD SCI USA, V96, P5464, DOI 10.1073/pnas.96.10.5464; Sanchez-Perez J, 2001, CONTACT DERMATITIS, V44, P54; Scheunemann AE, 2010, NUCLEIC ACIDS RES, V38, P3094, DOI 10.1093/nar/gkp1253; Schulze S, 2003, ALLERGY, V58, P88, DOI 10.1034/j.1398-9995.2003.23710_5.x; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Shah S, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004496.pub2, DOI 10.1002/14651858.CD004496.PUB2]; SMITH CR, 1980, NEW ENGL J MED, V302, P1106, DOI 10.1056/NEJM198005153022002; Sosnick T R, 2001, Curr Protoc Nucleic Acid Chem, VChapter 11, DOI 10.1002/0471142700.nc1105s04; Sumita M, 2005, RNA, V11, P1420, DOI 10.1261/rna.2320605; Teyssier E, 2003, NUCLEIC ACIDS RES, V31, P4218, DOI 10.1093/nar/gkg449; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; TISCH DE, 1958, ANN NY ACAD SCI, V76, P44, DOI 10.1111/j.1749-6632.1958.tb54692.x; Walter P., 2002, MOL BIOL CELL, P819; WALTON JR, 1978, J ANTIMICROB CHEMOTH, V4, P309, DOI 10.1093/jac/4.4.309; Wang LY, 2012, NAT STRUCT MOL BIOL, V19, P957, DOI 10.1038/nsmb.2360; Wang Y, 1997, BIOCHEMISTRY-US, V36, P768, DOI 10.1021/bi962095g; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; WOODCOCK J, 1991, EMBO J, V10, P3099, DOI 10.1002/j.1460-2075.1991.tb07863.x; Yarian CS, 1999, NUCLEIC ACIDS RES, V27, P3543, DOI 10.1093/nar/27.17.3543; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	72	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2015	290	31					19273	19286		10.1074/jbc.M115.655092	http://dx.doi.org/10.1074/jbc.M115.655092			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN9PK	26060252	Green Published, hybrid			2022-12-26	WOS:000358781100040
J	De Gois, S; Slama, P; Pietrancosta, N; Erdozain, AM; Louis, F; Bouvrais-Veret, C; Daviet, L; Giros, B				De Gois, Stephanie; Slama, Patrick; Pietrancosta, Nicolas; Erdozain, Amaia M.; Louis, Franck; Bouvrais-Veret, Caroline; Daviet, Laurent; Giros, Bruno			Ctr9, a Protein in the Transcription Complex Paf1, Regulates Dopamine Transporter Activity at the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FUNCTIONAL INTERACTION; VESICULAR GLUTAMATE; MUTATIONAL ANALYSIS; POTASSIUM CHANNELS; TRAFFICKING; RECEPTOR; DOMAIN; INTERNALIZATION; BINDING	Dopamine (DA) is a major regulator of sensorimotor and cognitive functions. The DA transporter (DAT) is the key protein that regulates the spatial and temporal activity of DA release into the synaptic cleft via the rapid reuptake of DA into presynaptic termini. Several lines of evidence have suggested that transporter-interacting proteins may play a role in DAT function and regulation. Here, we identified the tetratricopeptide repeat domain-containing protein Ctr9 as a novel DAT binding partner using a yeast two-hybrid system. We showed that Ctr9 is expressed in dopaminergic neurons and forms a stable complex with DAT in vivo via GST pulldown and co-immunoprecipitation assays. In mammalian cells co-expressing both proteins, Ctr9 partially colocalizes with DAT at the plasma membrane. This interaction between DAT and Ctr9 results in a dramatic enhancement of DAT-mediated DA uptake due to an increased number of DAT transporters at the plasma membrane. We determined that the binding of Ctr9 to DAT requires residues YKF in the first half of the DAT C terminus. In addition, we characterized Ctr9, providing new insight into this protein. Using three-dimensional modeling, we identified three novel tetratricopeptide repeat domains in the Ctr9 sequence, and based on deletion mutation experiments, we demonstrated the role of the SH2 domain of Ctr9 in nuclear localization. Our results demonstrate that Ctr9 localization is not restricted to the nucleus, as previously described for the transcription complex Paf1. Taken together, our data provide evidence that Ctr9 modulates DAT function by regulating its trafficking.	[De Gois, Stephanie; Slama, Patrick; Erdozain, Amaia M.; Louis, Franck; Bouvrais-Veret, Caroline; Giros, Bruno] INSERM U952, F-75005 Paris, France; [De Gois, Stephanie; Slama, Patrick; Erdozain, Amaia M.; Louis, Franck; Bouvrais-Veret, Caroline; Giros, Bruno] CNRS UMR 7224, F-75005 Paris, France; [De Gois, Stephanie; Slama, Patrick; Erdozain, Amaia M.; Louis, Franck; Bouvrais-Veret, Caroline; Giros, Bruno] Univ Paris 06, Neurosci Paris Seine, F-75005 Paris, France; [De Gois, Stephanie; Giros, Bruno] McGill Univ, Dept Psychiat, Douglas Hosp Res Ctr, Verdun, PQ H4H 1R3, Canada; [Pietrancosta, Nicolas] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France; [Pietrancosta, Nicolas] CNRS, UMR 8601, F-75006 Paris, France; [Daviet, Laurent] Hybrigenics, F-75014 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; McGill University; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite	Giros, B (corresponding author), McGill Univ, Dept Psychiat, Douglas Hosp Res Ctr, Verdun, PQ H4H 1R3, Canada.	bruno.giros@mcgill.ca	Erdozain, Amaia M/Q-9664-2018; GIROS, Bruno/ABD-5790-2021; Erdozain, Amaia/AAD-1883-2021; pietrancosta, nicolas/AAC-2777-2019; pietrancosta, nicolas/B-5235-2019; Nicolas, PIetrancosta/P-4645-2017	GIROS, Bruno/0000-0001-5876-9822; pietrancosta, nicolas/0000-0002-9934-7818; pietrancosta, nicolas/0000-0002-9934-7818; Nicolas, PIetrancosta/0000-0002-9934-7818; Erdozain, Amaia Maite/0000-0003-0207-9122	Canadian Institutes for Health Research Operating Grant [240843]; INSERM/CNRS/Universite Pierre et Marie Curie funding; Fondation pour la Recherche Medicale; Basque Government; "Schizo'Oui" association; Canadian Institutes for Health Research	Canadian Institutes for Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); INSERM/CNRS/Universite Pierre et Marie Curie funding; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Basque Government(Basque Government); "Schizo'Oui" association; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research Operating Grant 240843 and by INSERM/CNRS/Universite Pierre et Marie Curie funding (to B. G.). Post doctoral support was provided by grants from the Fondation pour la Recherche Medicale and the Basque Government (to A. M. E.), "Schizo'Oui" association, and the Canadian Institutes for Health Research. The authors declare that they have no conflicts of interest with the contents of this article.	An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Bessis AS, 2000, PROTEIN SCI, V9, P2200, DOI 10.1110/ps.9.11.2200; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Boudanova E, 2008, MOL CELL NEUROSCI, V39, P211, DOI 10.1016/j.mcn.2008.06.011; Caraveo G, 2006, SCIENCE, V314, P122, DOI 10.1126/science.1127815; Carneiro AM, 2002, J NEUROSCI, V22, P7045; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Eddy SR, 2004, NAT BIOTECHNOL, V22, P1035, DOI 10.1038/nbt0804-1035; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fon EA, 2001, MUSCLE NERVE, V24, P581, DOI 10.1002/mus.1044; Foreman PK, 1996, GENETICS, V144, P1387; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Garcia-Olivares J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059788; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; GIROS B, 1992, MOL PHARMACOL, V42, P383; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Herve F, 2008, AAPS J, V10, P455, DOI 10.1208/s12248-008-9055-2; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Jaehning JA, 2010, BBA-GENE REGUL MECH, V1799, P379, DOI 10.1016/j.bbagrm.2010.01.001; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee FJS, 2007, EMBO J, V26, P2127, DOI 10.1038/sj.emboj.7601656; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Li L, 2003, PROTEINS, V53, P693, DOI 10.1002/prot.10460; Li LB, 2004, J BIOL CHEM, V279, P21012, DOI 10.1074/jbc.M311972200; Lichtenberg H, 1999, FEBS LETT, V457, P363, DOI 10.1016/S0014-5793(99)01068-6; Lin ZC, 2011, PROG MOL BIOL TRANSL, V98, P1, DOI 10.1016/B978-0-12-385506-0.00001-6; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Malek SN, 1996, J BIOL CHEM, V271, P6952, DOI 10.1074/jbc.271.12.6952; Malherbe P, 2003, J BIOL CHEM, V278, P8340, DOI 10.1074/jbc.M211759200; Marton HA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-4; Masson J, 1999, EUR J NEUROSCI, V11, P1349, DOI 10.1046/j.1460-9568.1999.00540.x; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Mortensen OV, 2003, EUR J PHARMACOL, V479, P159, DOI 10.1016/j.ejphar.2003.08.066; Moszczynska A, 2007, J MOL NEUROSCI, V32, P217, DOI 10.1007/s12031-007-0037-0; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Navaroli DM, 2011, J NEUROSCI, V31, P13758, DOI 10.1523/JNEUROSCI.2649-11.2011; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Pristupa ZB, 1998, SYNAPSE, V30, P79, DOI 10.1002/(SICI)1098-2396(199809)30:1<79::AID-SYN10>3.3.CO;2-I; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rickhag M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2568; Shibata R, 2003, J BIOL CHEM, V278, P36445, DOI 10.1074/jbc.M306142200; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Youn MY, 2007, J BIOL CHEM, V282, P34727, DOI 10.1074/jbc.M705411200	59	9	9	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17848	17862		10.1074/jbc.M115.646315	http://dx.doi.org/10.1074/jbc.M115.646315			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048990	hybrid, Green Published			2022-12-26	WOS:000358511700021
J	Kulasekaran, G; Nossova, N; Marat, AL; Lund, I; Cremer, C; Ioannou, MS; McPherson, PS				Kulasekaran, Gopinath; Nossova, Nadya; Marat, Andrea L.; Lund, Ingrid; Cremer, Christopher; Ioannou, Maria S.; McPherson, Peter S.			Phosphorylation-dependent Regulation of Connecdenn/DENND1 Guanine Nucleotide Exchange Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENN DOMAIN; GLUT4 TRANSLOCATION; PROTEIN; RAB; KINASE; FAMILY; PATHWAYS; BINDING; GTPASES; CELLS	Connecdenn 1/2 are DENN (differentially expressed in normal and neoplastic cells) domain-bearing proteins that function as GEFs (guanine nucleotide exchange factors) for the small GTPase Rab35. Disruption of connecdenn/Rab35 function leads to defects in the recycling of multiple cargo proteins from endosomes with altered cell function, yet the regulation of connecdenn GEF activity is unexplored. We now demonstrate that connecdenn 1/2 are autoinhibited such that the purified, fulllength proteins have significantly less Rab35 binding and GEF activity than the isolated DENN domain. Both proteins are phosphorylated with prominent phosphorylation sites between residues 500 and 600 of connecdenn 1. A large scale proteomics screen revealed that connecdenn 1 is phosphorylated at residues Ser-536 and Ser-538 in an Akt-dependent manner in response to insulin stimulation of adipocytes. Interestingly, we find that an Akt inhibitor reduces connecdenn 1 interaction with Rab35 after insulin treatment of adipocytes. Remarkably, a peptide flanking Ser-536/Ser-538 binds the DENN domain of connecdenn 1, whereas a phosphomimetic peptide does not. Moreover, connecdenn 1 interacts with 14-3-3 proteins, and this interaction is also disrupted by Akt inhibition and by mutation of Ser-536/Ser-538. We propose that Akt phosphorylation of connecdenn 1 downstream of insulin activation regulates connecdenn 1 function through an intramolecular interaction.	[Kulasekaran, Gopinath; Nossova, Nadya; Marat, Andrea L.; Lund, Ingrid; Cremer, Christopher; Ioannou, Maria S.; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca		Marat, Andrea/0000-0001-8571-4253	Canadian Institutes of Health [MOP15396]; Fonds de Recherche du Quebec-Sante; Jeanne Timmins-Costello fellowship from the Montreal Neurological Institute; Masters Award; Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research; Max E. Binz Fellowship from McGill University; Jeanne Timmins-Costello Studentship from the Montreal Neurological Institute; Lloyd Carr-Harris Fellowship from McGill University	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Jeanne Timmins-Costello fellowship from the Montreal Neurological Institute; Masters Award; Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Max E. Binz Fellowship from McGill University; Jeanne Timmins-Costello Studentship from the Montreal Neurological Institute; Lloyd Carr-Harris Fellowship from McGill University	This work was supported by Canadian Institutes of Health Research Grant MOP15396 (to P. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a fellowship from le Fonds de Recherche du Quebec-Sante and a Jeanne Timmins-Costello fellowship from the Montreal Neurological Institute.; Supported by a Masters Award, Frederick Banting and Charles Best Canada Graduate Scholarship from the Canadian Institutes of Health Research, a Max E. Binz Fellowship from McGill University, and a Jeanne Timmins-Costello Studentship from the Montreal Neurological Institute.; Supported by the Lloyd Carr-Harris Fellowship from McGill University.	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2013, J CELL SCI, V126, P722, DOI 10.1242/jcs.112375; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Chahdi A, 2008, MOL CELL BIOL, V28, P1679, DOI 10.1128/MCB.00898-07; Chaineau M, 2013, TRAFFIC, V14, P1109, DOI 10.1111/tra.12096; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Collins BC, 2013, NAT METHODS, V10, P1246, DOI [10.1038/NMETH.2703, 10.1038/nmeth.2703]; Davey JR, 2012, TRAFFIC, V13, P1429, DOI 10.1111/j.1600-0854.2012.01397.x; Dhillon AS, 2009, CELL SIGNAL, V21, P1645, DOI 10.1016/j.cellsig.2009.07.001; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ioannou MS, 2015, J CELL BIOL, V208, P629, DOI 10.1083/jcb.201407068; Levine TP, 2013, BIOINFORMATICS, V29, P499, DOI 10.1093/bioinformatics/bts725; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Marat AL, 2011, J BIOL CHEM, V286, P13791, DOI 10.1074/jbc.R110.217067; Marat AL, 2010, J BIOL CHEM, V285, P10627, DOI 10.1074/jbc.M109.050930; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; O'Toole TE, 2011, J CELL PHYSIOL, V226, P2965, DOI 10.1002/jcp.22644; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Xu J, 2015, EMBO REP, V16, P709, DOI 10.15252/embr.201440006; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yohe ME, 2007, J BIOL CHEM, V282, P13813, DOI 10.1074/jbc.M700185200; Yoshimura S, 2010, J CELL BIOL, V191, P367, DOI 10.1083/jcb.201008051; Zhang Dapeng, 2012, Frontiers in Genetics, V3, P283, DOI 10.3389/fgene.2012.00283; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717	32	14	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17999	18008		10.1074/jbc.M115.636712	http://dx.doi.org/10.1074/jbc.M115.636712			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26055712	Green Published, hybrid			2022-12-26	WOS:000358511700032
J	Kunda, S; Yuan, Y; Balsara, RD; Zajicek, J; Castellino, FJ				Kunda, Shailaja; Yuan, Yue; Balsara, Rashna D.; Zajicek, Jaroslav; Castellino, Francis J.			Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities toward Ion Channels of N-Methyl-D-aspartate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-CARBOXYGLUTAMATE RESIDUES; NMDA RECEPTORS; MOLECULAR-STRUCTURE; NONCOMPETITIVE INHIBITION; REGIONAL EXPRESSION; BINDING PROPERTIES; CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; XPLOR-NIH; IN-VITRO	Conantokins are similar to 20-amino acid peptides present in predatory marine snail venoms that function as allosteric antagonists of ion channels of the N-methyl-D-aspartate receptor (NMDAR). These peptides possess a high percentage of post-/co-translationally modified amino acids, particularly gamma-carboxyglutamate (Gla). Appropriately spaced Gla residues allow binding of functional divalent cations, which induces end-to-end alpha-helices in many conantokins. A smaller number of these peptides additionally contain 4-hydroxyproline (Hyp). Hyp should prevent adoption of the metal ion-induced full alpha-helix, with unknown functional consequences. To address this disparity, as well as the role of Hyp in conantokins, we have solved the high resolution three-dimensional solution structure of a Gla/Hyp-containing 18-residue conantokin, conRl-B, by high field NMR spectroscopy. We show that Hyp(10) disrupts only a small region of the alpha-helix of the Mn(2+.)peptide complex, which displays cation-induced alpha-helices on each terminus of the peptide. The function of conRl-B was examined by measuring its inhibition of NMDA/Gly-mediated current through NMDAR ion channels in mouse cortical neurons. The conRl-B displays high inhibitory selectivity for subclasses of NMDARs that contain the functionally important GluN2B subunit. Replacement of Hyp10 with N(8)Q results in a Mg2+-complexed end-to-end alpha-helix, accompanied by attenuation of NMDAR inhibitory activity. However, replacement of Hyp(10) with Pro(10) allowed the resulting peptide to retain its inhibitory property but diminished its GluN2B specificity. Thus, these modified amino acids, in specific peptide backbones, play critical roles in their subunit-selective inhibition of NMDAR ion channels, a finding that can be employed to design NMDAR antagonists that function at ion channels of distinct NMDAR subclasses.	[Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu	Yuan, Yue/S-5884-2017; Regan, Clinton/E-6250-2012	Yuan, Yue/0000-0003-1003-379X; 	National Institutes of Health [HL019982]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL019982. The authors declare that they have no conflicts of interest with the contents of this article.	Acker TM, 2011, MOL PHARMACOL, V80, P782, DOI 10.1124/mol.111.073239; Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; Bettini E, 2010, J PHARMACOL EXP THER, V335, P636, DOI 10.1124/jpet.110.172544; Blandl T, 1999, J PEPT RES, V53, P453, DOI 10.1034/j.1399-3011.1999.00042.x; Blandl T, 1997, BIOCHEM J, V328, P777, DOI 10.1042/bj3280777; Blandl T, 1998, FEBS LETT, V435, P257, DOI 10.1016/S0014-5793(98)01077-1; Brothwell SLC, 2008, J PHYSIOL-LONDON, V586, P739, DOI 10.1113/jphysiol.2007.144618; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Case D. A., 2014, AMBER 14 VERSION 4 1; Cerutti DS, 2013, J PHYS CHEM B, V117, P2328, DOI 10.1021/jp311851r; Chandler LJ, 2001, J BIOL CHEM, V276, P2627, DOI 10.1074/jbc.M003390200; Chen ZG, 1998, J BIOL CHEM, V273, P16248, DOI 10.1074/jbc.273.26.16248; Cnudde SE, 2007, J AM CHEM SOC, V129, P1586, DOI 10.1021/ja065722q; COLPITTS TL, 1993, INT J PEPT PROT RES, V41, P567; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dai QY, 2004, BIOCHEMISTRY-US, V43, P13225, DOI 10.1021/bi048796s; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gill AC, 2000, EMBO J, V19, P5324, DOI 10.1093/emboj/19.20.5324; Gowd KH, 2010, J PEPT SCI, V16, P375, DOI 10.1002/psc.1249; Gowd KH, 2012, BIOCHEMISTRY-US, V51, P4685, DOI 10.1021/bi300055n; HAACK JA, 1990, J BIOL CHEM, V265, P6025; HAACK JA, 1993, NEUROSCI LETT, V163, P63, DOI 10.1016/0304-3940(93)90229-E; Hansen KB, 2014, NAT CHEM BIOL, V10, P698, DOI 10.1038/nchembio.1614; Hansen KB, 2011, J NEUROSCI, V31, P3650, DOI 10.1523/JNEUROSCI.5565-10.2011; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hetman M, 2006, CURR TOP MED CHEM, V6, P787, DOI 10.2174/156802606777057553; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573; Huang LX, 2010, MOL CELL NEUROSCI, V45, P163, DOI 10.1016/j.mcn.2010.06.007; Kar K, 2007, BIOPOLYMERS, V87, P339, DOI 10.1002/bip.20834; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Karakas E, 2011, NATURE, V475, P249, DOI 10.1038/nature10180; Kunda S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081405; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Logan SM, 2007, J NEUROPHYSIOL, V98, P2693, DOI 10.1152/jn.00462.2007; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Moddel G, 2005, BRAIN RES, V1046, P10, DOI 10.1016/j.brainres.2005.03.042; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Mullasseril P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1085; Noda Y, 2004, EUR J PHARMACOL, V500, P121, DOI 10.1016/j.ejphar.2004.07.017; Ogden KK, 2011, TRENDS PHARMACOL SCI, V32, P726, DOI 10.1016/j.tips.2011.08.003; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Platt RJ, 2012, J BIOL CHEM, V287, P20727, DOI 10.1074/jbc.M112.350462; Prorok M, 1996, BIOCHEMISTRY-US, V35, P16528, DOI 10.1021/bi9621122; Prorok M, 1998, J BIOL CHEM, V273, P19573, DOI 10.1074/jbc.273.31.19573; Prorok M, 2001, CURR DRUG TARGETS, V2, P313, DOI 10.2174/1389450013348542; Prorok M, 2007, CURR DRUG TARGETS, V8, P633, DOI 10.2174/138945007780618481; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Rauner C, 2011, J BIOL CHEM, V286, P7558, DOI 10.1074/jbc.M110.182600; REID KBM, 1972, BIOCHEM J, V130, P749, DOI 10.1042/bj1300749; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2010, J BIOMOL NMR, V46, P199, DOI 10.1007/s10858-009-9395-y; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Teichert RW, 2007, J BIOL CHEM, V282, P36905, DOI 10.1074/jbc.M706611200; Tichelaar W, 2004, J MOL BIOL, V344, P435, DOI 10.1016/j.jmb.2004.09.048; Tovar KR, 2013, J NEUROSCI, V33, P9150, DOI 10.1523/JNEUROSCI.0829-13.2013; Tovar KR, 2012, J NEUROSCI, V32, P8065, DOI 10.1523/JNEUROSCI.0538-12.2012; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Warder SE, 1998, J BIOL CHEM, V273, P7512, DOI 10.1074/jbc.273.13.7512; Warder SE, 1997, FEBS LETT, V411, P19, DOI 10.1016/S0014-5793(97)00573-5; Wei JJ, 2006, NEUROSCI LETT, V405, P137, DOI 10.1016/j.neulet.2006.06.040; Wenzel A, 1996, J NEUROCHEM, V66, P1240; White HS, 2000, J PHARMACOL EXP THER, V292, P425; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Xiao C, 2008, NEUROPEPTIDES, V42, P601, DOI 10.1016/j.npep.2008.09.003; Yoshii A, 2007, NAT NEUROSCI, V10, P702, DOI 10.1038/nn1903; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82; Zhu D, 2002, AMINO ACIDS, V23, P11, DOI 10.1007/s00726-001-0103-9	79	6	8	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					18156	18172		10.1074/jbc.M115.650341	http://dx.doi.org/10.1074/jbc.M115.650341			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26048991	Green Published, hybrid			2022-12-26	WOS:000358511700046
J	Citro, A; Scrivo, R; Martini, H; Martire, C; De Marzio, P; Vestri, AR; Sidney, J; Sette, A; Barnaba, V; Valesini, G				Citro, Alessandra; Scrivo, Rossana; Martini, Helene; Martire, Carmela; De Marzio, Paolo; Vestri, Anna Rita; Sidney, John; Sette, Alessandro; Barnaba, Vincenzo; Valesini, Guido			CD8(+) T Cells Specific to Apoptosis-Associated Antigens Predict the Response to Tumor Necrosis Factor Inhibitor Therapy in Rheumatoid Arthritis	PLOS ONE			English	Article							CROSS-PRESENTATION; DENDRITIC CELLS; SELF-ANTIGENS; HEPATITIS-C; IDENTIFICATION; INFLAMMATION; INFECTION; BLOCKADE; PROTEINS; EPITOPES	CD8(+) T cells specific to caspase-cleaved antigens derived from apoptotic T cells (apoptotic epitopes) represent a principal player in chronic immune activation, which is known to amplify immunopathology in various inflammatory diseases. The purpose of the present study was to investigate the relationship involving these autoreactive T cells, the rheumatoid arthritis immunopathology, and the response to tumor necrosis factor-alpha inhibitor therapy. The frequency of autoreactive CD8(+) T cells specific to various apoptotic epitopes, as detected by both enzyme-linked immunospot assay and dextramers of major histocompatibility complex class I molecules complexed with relevant apoptotic epitopes, was longitudinally analyzed in the peripheral blood of rheumatoid arthritis patients who were submitted to etanercept treatment (or other tumor necrosis factor inhibitors as a control). The percentage of apoptotic epitope-specific CD8(+) T cells was significantly higher in rheumatoid arthritis patients than in healthy donors, and correlated with the disease activity. More important, it was significantly more elevated in responders to tumor necrosis factor-alpha inhibitor therapy than in non-responders before the start of therapy; it significantly dropped only in the former following therapy. These data indicate that apoptotic epitope-specific CD8(+) T cells may be involved in rheumatoid arthritis immunopathology through the production of inflammatory cytokines and that they may potentially represent a predictive biomarker of response to tumor necrosis factor-alpha inhibitor therapy to validate in a larger cohort of patients.	[Citro, Alessandra; Scrivo, Rossana; Martini, Helene; Martire, Carmela; De Marzio, Paolo; Barnaba, Vincenzo; Valesini, Guido] Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, I-00161 Rome, Italy; [Vestri, Anna Rita] Univ Roma La Sapienza, Dipartimento Sanita Pubbl & Malattie Infett, I-00161 Rome, Italy; [Sidney, John; Sette, Alessandro] La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA; [Barnaba, Vincenzo] Fdn Cenci Bolognetti, Ist Pasteur, I-00185 Rome, Italy	Sapienza University Rome; Sapienza University Rome; La Jolla Institute for Immunology; Fondazione Cenci Bolognetti	Barnaba, V (corresponding author), Univ Roma La Sapienza, Dipartimento Med Interna & Specialita Med, Viale Policlin 155, I-00161 Rome, Italy.	vincenzo.barnaba@uniroma1.it	Barnaba, Vincenzo/AAB-1945-2019; Sette, Alessandro/AFO-8916-2022	Valesini, Guido/0000-0002-7757-8092	Fondazione Italiana Sclerosi Multipla (FISM) onlus grant [m. 2011/R/4]; European Union [201169 - FP7-Health-2007-A, 261365 - FP7-Health-2010]; Ministero della Salute (Ricerca finalizzata) [RFPS-2006-3-337923, RFPS-2007-1-636647, RF-2010-23104368, RF-2010-2318269]; Istituto Superiore di Sanita (Progetto AIDS) [40H10]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) Programmi di ricerca di interesse nazionale: [PRIN] [7245/1, 2010LC747T-004]; Ateneo Sapienza [2009-C26A09PELN, 2010-C26A1029ZS, 2011-C26A11BYWP, 2012-C26A12JL55]; Fondo per gli investimenti di ricerca di base [FIRB] [RBAP10TPXK]; Fondazione Cariplo [2009-2721, 2012-1885]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [10756, 15199]; Istituto Italiano di Tecnologia (IIT); Fondazione Italiana per la Ricerca sull'Artrite (FIRA)	Fondazione Italiana Sclerosi Multipla (FISM) onlus grant(Fondazione Italiana Sclerosi Multipla (FISM)); European Union(European Commission); Ministero della Salute (Ricerca finalizzata)(Ministry of Health, Italy); Istituto Superiore di Sanita (Progetto AIDS); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) Programmi di ricerca di interesse nazionale: [PRIN]; Ateneo Sapienza; Fondo per gli investimenti di ricerca di base [FIRB]; Fondazione Cariplo(Fondazione Cariplo); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Istituto Italiano di Tecnologia (IIT)(Istituto Italiano di Tecnologia - IIT); Fondazione Italiana per la Ricerca sull'Artrite (FIRA)	This work was supported by the following grants awarded to V.B.: Fondazione Italiana Sclerosi Multipla (FISM) onlus grant m. 2011/R/4; European Union grants (IMECS n. 201169 - FP7-Health-2007-A and SPHYNX n. 261365 - FP7-Health-2010); Ministero della Salute (Ricerca finalizzata [RFPS-2006-3-337923, RFPS-2007-1-636647, RF-2010-23104368, and RF-2010-2318269]); Istituto Superiore di Sanita (Progetto AIDS-2008 n. 40H10); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) Programmi di ricerca di interesse nazionale: [PRIN]2008/10 n. 7245/1; [PRIN]-2011/13 n. 2010LC747T-004; Ateneo Sapienza [2009-C26A09PELN, 2010-C26A1029ZS, 2011-C26A11BYWP, and 2012-C26A12JL55]; Fondo per gli investimenti di ricerca di base [FIRB]-2011/13 n. RBAP10TPXK); Fondazione Cariplo (projects n. 2009-2721 and 2012-1885); Associazione Italiana per la Ricerca sul Cancro (AIRC) (AIRC IG-2010/13 no. 10756 and IG-2015/17 no. 15199); Istituto Italiano di Tecnologia (IIT) (A2 project 2013); and Fondazione Italiana per la Ricerca sull'Artrite (FIRA 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato F, 2009, NAT REV RHEUMATOL, V5, P325, DOI 10.1038/nrrheum.2009.80; Barnaba V, 2013, ADV EXP MED BIOL, V785, P27, DOI 10.1007/978-1-4614-6217-0_3; Behrens TW, 1996, J BIOL CHEM, V271, P23528, DOI 10.1074/jbc.271.38.23528; Boissier MC, 2012, J AUTOIMMUN, V39, P222, DOI 10.1016/j.jaut.2012.05.021; Brusca SB, 2014, CURR OPIN RHEUMATOL, V26, P101, DOI 10.1097/BOR.0000000000000008; Coppieters KT, 2011, CLIN EXP IMMUNOL, V165, P155, DOI 10.1111/j.1365-2249.2011.04420.x; Croia C, 2013, ANN RHEUM DIS, V72, P1559, DOI 10.1136/annrheumdis-2012-202352; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Franceschini D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002759; Gurung P, 2009, J IMMUNOL, V183, P6114, DOI 10.4049/jimmunol.0901676; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Li G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003487; Lolli F, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-94; Meloni F, 2008, CLIN IMMUNOL, V129, P286, DOI 10.1016/j.clim.2008.07.017; Nakken B, 2011, AUTOIMMUN REV, V11, P28, DOI 10.1016/j.autrev.2011.06.010; Nuti S, 1998, EUR J IMMUNOL, V28, P3448, DOI 10.1002/(SICI)1521-4141(199811)28:11<3448::AID-IMMU3448>3.0.CO;2-5; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Propato A, 2001, NAT MED, V7, P807, DOI 10.1038/89930; Rawson PM, 2007, NAT MED, V13, P1431, DOI 10.1038/nm1679; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Stahl EA, 2012, NAT GENET, V44, P483, DOI 10.1038/ng.2232; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; van Hamburg JP, 2013, ANN RHEUM DIS, V72, P1700, DOI 10.1136/annrheumdis-2012-202373; von Delwig A, 2010, ARTHRITIS RHEUM-US, V62, P143, DOI 10.1002/art.25064; Wentworth PA, 1996, INT IMMUNOL, V8, P651, DOI 10.1093/intimm/8.5.651; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; ZVAIFLER NJ, 1985, J CLIN INVEST, V76, P789, DOI 10.1172/JCI112036	34	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128607	10.1371/journal.pone.0128607	http://dx.doi.org/10.1371/journal.pone.0128607			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061065	gold, Green Published, Green Submitted			2022-12-26	WOS:000355979500091
J	Yang, SN; Li, FJ; Liao, YH; Chen, YS; Shen, WC; Huang, TC				Yang, Shih-Neng; Li, Fang-Jing; Liao, Yen-Hsiu; Chen, Yueh-Sheng; Shen, Wu-Chung; Huang, Tzung-Chi			Identification of Breast Cancer Using Integrated Information from MRI and Mammography	PLOS ONE			English	Article							HIGH-RISK; REGISTRATION; LESIONS; TRANSFORMATION; OPTIMIZATION; ENHANCEMENT; ACCURACY; WOMEN	Objectives Integration of information from corresponding regions between the breast MRI and an X-ray mammogram could benefit the detection of breast cancer in clinical diagnosis. We aimed to provide a framework of registration from breast MRI to mammography and to evaluate the diagnosis using the combined information. Materials and Methods 43 patients with 46 lesions underwent both MRI and mammography scans, and the interval between the two examinations was around one month. The distribution of malignant to benign lesions was 31/46 based on histological results. Maximum intensity projection and thin-plate spline methods were applied for image registration for MRI to mammography. The diagnosis using integrated information was evaluated using results of histology as the reference. The assessment of annotations and statistical analysis were performed by the two radiologists. Results For the cranio-caudal view, the mean post-registration error between MRI and mammography was 2.2 +/- 1.9 mm. For the medio-lateral oblique view, the proposed approach performed even better with a mean error of 3.0 +/- 2.4 mm. In the diagnosis using MRI assessment with information of mammography, the sensitivity was 91.9 +/- 2.3% (29/31, 28/31), specificity 70.0 +/- 4.7% (11/15, 10/15), accuracy 84.8 +/- 3.1% (40/46, 38/46), positive predictive value 86.4 +/- 2.1% (29/33, 28/33) and negative predictive value 80.8 +/- 5.4% (11/13, 10/13). Conclusion MRI with the aid of mammography shows potential improvements of sensitivity, specificity, accuracy, PPV and NPV in clinical breast cancer diagnosis compared to the use of MRI alone.	[Yang, Shih-Neng; Li, Fang-Jing; Chen, Yueh-Sheng; Shen, Wu-Chung; Huang, Tzung-Chi] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Yang, Shih-Neng] China Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Liao, Yen-Hsiu; Shen, Wu-Chung] China Med Univ Hosp, Dept Radiol, Taichung, Taiwan; [Huang, Tzung-Chi] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Huang, TC (corresponding author), China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan.	tzungchi.huang@mail.cmu.edu.tw	huang, tzungchi/O-4434-2015		school project of China Medical University, Taiwan [DMR-104-040]	school project of China Medical University, Taiwan	This study was financially supported by the school project of China Medical University, Taiwan (DMR-104-040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhigbe A O, 2013, Niger Postgrad Med J, V20, P346; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Cai HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087387; DeMartini Wendy, 2008, Top Magn Reson Imaging, V19, P143, DOI 10.1097/RMR.0b013e31818a40a5; El Khouli RH, 2010, RADIOLOGY, V256, P64, DOI 10.1148/radiol.10091367; El Khouli RH, 2009, AM J ROENTGENOL, V193, pW295, DOI 10.2214/AJR.09.2483; Erguvan-Dogan Basak, 2006, AJR Am J Roentgenol, V187, pW152, DOI 10.2214/AJR.05.0572; Gweon HM, 2014, EUR RADIOL, V24, P1800, DOI 10.1007/s00330-014-3166-1; Hopp T, 2013, MED IMAGE ANAL, V17, P209, DOI 10.1016/j.media.2012.10.003; Hopp T, 2012, INT J COMPUT ASS RAD, V7, P339, DOI 10.1007/s11548-011-0623-z; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Jiang YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099669; King V, 2011, RADIOLOGY, V260, P50, DOI 10.1148/radiol.11102156; Kuhl C, 2007, RADIOLOGY, V244, P356, DOI 10.1148/radiol.2442051620; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Lord SJ, 2007, EUR J CANCER, V43, P1905, DOI 10.1016/j.ejca.2007.06.007; Mertzanidou T, 2014, MED IMAGE ANAL, V18, P674, DOI 10.1016/j.media.2014.03.003; Mertzanidou T, 2012, MED IMAGE ANAL, V16, P966, DOI 10.1016/j.media.2012.03.001; Nakahara H, 2001, Breast Cancer, V8, P116, DOI 10.1007/BF02967490; Pediconi F, 2007, RADIOLOGY, V243, P670, DOI 10.1148/radiol.2433060838; Schmitz AC, 2008, EUR RADIOL, V18, P355, DOI 10.1007/s00330-007-0766-z; Schulz-Wendtland R, 2009, EUR J RADIOL, V72, P258, DOI 10.1016/j.ejrad.2009.05.052; Thomassin-Naggara I, 2011, RADIOLOGY, V261, P69, DOI 10.1148/radiol.11110190; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007; Yabuuchi H, 2011, EUR RADIOL, V21, P11, DOI 10.1007/s00330-010-1890-8; Yin-Chiao Tsai, 2000, Chinese Journal of Medical and Biological Engineering, V20, P203	27	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128404	10.1371/journal.pone.0128404	http://dx.doi.org/10.1371/journal.pone.0128404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26056841	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000020
J	Chu, PY; Tyan, YC; Chen, YS; Chen, HL; Lu, PL; Chen, YH; Chen, BC; Huang, TS; Wang, CF; Su, HJ; Shi, YY; Sanno-Duanda, B; Lin, KH; Motomura, K				Chu, Pei-Yu; Tyan, Yu-Chang; Chen, Yao-Shen; Chen, Hsiu-Lin; Lu, Po-Liang; Chen, Yu-Hsien; Chen, Bao-Chen; Huang, Tsi-Shu; Wang, Chu-Feng; Su, Hui-Ju; Shi, Yong-Ying; Sanno-Duanda, Bintou; Lin, Kuei-Hsiang; Motomura, Kazushi			Transmission and Demographic Dynamics of Coxsackievirus B1	PLOS ONE			English	Article							HUMAN-ENTEROVIRUS-B; GENETIC-RECOMBINATION; INFECTION; IDENTIFICATION; EPIDEMIOLOGY; ASSOCIATION; EMERGENCE; EVOLUTION; BOOTSTRAP; LINEAGES	The infectious activity of coxsackievirus B1 (CV-B1) in Taiwan was high from 2008 to 2010, following an alarming increase in severe neonate disease in the United States (US). To examine the relationship between CV-B1 strains isolated in Taiwan and those from other parts of the world, we performed a phylodynamic study using VP1 and partial 3D(pol) (414 nt) sequences from 22 strains of CV-B1 isolated in Taiwan (1989-2010) and compared them to sequences from strains isolated worldwide. Phylogenetic trees were constructed by neighbor-joining, maximum likelihood, and Bayesian Monte Carlo Markov Chain methods. Four genotypes (GI-IV) in the VP1 region of CV-B1 and three genotypes (GA-C) in the 3D(pol) region of enterovirus B were identified and had high support values. The phylogenetic analysis indicates that the GI and GIII strains in VP1 were geographically distributed in Taiwan (1993-1994) and in India (2007-2009). On the other hand, the GII and GIV strains appear to have a wider spatiotemporal distribution and ladder-like topology A stair-like phylogeny was observed in the VP1 region indicating that the phylogeny of the virus may be affected by different selection pressures in the specified regions. Further, most of the GI and GII strains in the VP1 tree were clustered together in GA in the 3D tree, while the GIV strains diverged into GB and GC. Taken together, these data provide important insights into the population dynamics of CV-B1 and indicate that incongruencies in specific gene regions may contribute to spatiotemporal patterns of epidemicity for this virus.	[Chu, Pei-Yu; Chen, Yu-Hsien; Shi, Yong-Ying; Sanno-Duanda, Bintou] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Sci, Kaohsiung 804, Taiwan; [Chu, Pei-Yu; Lu, Po-Liang; Wang, Chu-Feng; Su, Hui-Ju] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung 807, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ Hosp, Dept Med Imaging & Radiol Sci, Kaohsiung 807, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ Hosp, Translat Res Ctr, Kaohsiung 807, Taiwan; [Tyan, Yu-Chang] Kaohsiung Med Univ, Joint Res Ctr, Natl Sun Yat Sen Univ, Kaohsiung 804, Taiwan; [Tyan, Yu-Chang] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 804, Taiwan; [Chen, Yao-Shen] Kaohsiung Vet Gen Hosp, Div Infect Dis, Kaohsiung, Taiwan; [Chen, Yao-Shen; Chen, Bao-Chen; Huang, Tsi-Shu] Kaohsiung Vet Gen Hosp, Div Microbiol, Dept Pathol & Lab Med, Kaohsiung, Taiwan; [Chen, Yao-Shen] Natl Yang Ming Med Univ, Dept Internal Med, Taipei, Taiwan; [Chen, Hsiu-Lin] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung 807, Taiwan; [Chen, Hsiu-Lin] Kaohsiung Med Univ, Coll Med, Dept Resp Therapy, Kaohsiung 804, Taiwan; [Lu, Po-Liang; Lin, Kuei-Hsiang] Kaohsiung Med Univ, Coll Med, Dept Lab Med, Sch Med, Kaohsiung 804, Taiwan; [Sanno-Duanda, Bintou] Edward Francis Small Teaching Hosp, Banjul, Gambia; [Motomura, Kazushi] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo, Japan; [Motomura, Kazushi] Osaka Univ, Thailand Japan Res Collaborat Ctr Emerging & Re E, Microbial Dis Res Inst, Nonthaburi, Thailand	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; National Institute of Infectious Diseases (NIID)	Chu, PY (corresponding author), Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Coll Hlth Sci, Kaohsiung 804, Taiwan.	peiyuchu@kmu.edu.tw; kmotomura@biken.osaka-u.ac.jp	Chen, Hsiu-Lin/GRY-7492-2022; Chen, Hsiu-Lin/S-8325-2019; Chen, Hsiu-Lin/B-9238-2012; Lu, Po-Liang/D-4499-2009	Chen, Hsiu-Lin/0000-0002-0565-4631; Chen, Hsiu-Lin/0000-0002-0565-4631; Lu, Po-Liang/0000-0002-7423-6783	Ministry of Science and Technology, Taiwan, Republic of China (MOST) [MOST103-2320-B-037-024]	Ministry of Science and Technology, Taiwan, Republic of China (MOST)	This study was funded by grants from the Ministry of Science and Technology, Taiwan, Republic of China (MOST, url: http://www.most.gov.tw/) to PYC under grant no. MOST103-2320-B-037-024. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have no competing interests in the publication of this study.	Adams MJ, 2013, ARCH VIROL, V158, P2023, DOI 10.1007/s00705-013-1688-5; Alfaro ME, 2003, MOL BIOL EVOL, V20, P255, DOI 10.1093/molbev/msg028; Baek K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-297; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Chu PY, 2011, INFECT GENET EVOL, V11, P1426, DOI 10.1016/j.meegid.2011.05.010; Chu PY, 2009, J CLIN VIROL, V45, P16, DOI 10.1016/j.jcv.2009.02.012; Coyne KP, 2012, J VIROL, V86, P11356, DOI 10.1128/JVI.00701-12; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; DRUYTSVOETS E, 1993, J INFECTION, V27, P311, DOI 10.1016/0163-4453(93)92329-U; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hampl V, 2001, INT J SYST EVOL MICR, V51, P731, DOI 10.1099/00207713-51-3-731; Hovi T, 1998, CLIN DIAGN VIROL, V9, P89, DOI 10.1016/S0928-0197(97)10018-6; Ke GM, 2011, VIRUS GENES, V42, P178, DOI 10.1007/s11262-010-0565-5; Keller O, 2011, BIOINFORMATICS, V27, P757, DOI 10.1093/bioinformatics/btr010; Khetsuriani N, 2006, MMWR-MORBID MORTAL W, V55, P1; Kim H, 2013, J MED VIROL, V85, P110, DOI 10.1002/jmv.23359; Laitinen OH, 2014, DIABETES, V63, P446, DOI 10.2337/db13-0619; Lee HC, 2005, TAIWAN EPIDEMIOLOGY, P96; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Lin TY, 2003, PEDIATR INFECT DIS J, V22, P889, DOI 10.1097/01.inf.0000091294.63706.f3; Lindberg AM, 2003, J GEN VIROL, V84, P1223, DOI 10.1099/vir.0.18971-0; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lukashev AN, 2003, J VIROL, V77, P10423, DOI 10.1128/JVI.77.19.10423-10431.2003; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mascola L., 2008, Morbidity and Mortality Weekly Report, V57, P553; Mirand A, 2007, J GEN VIROL, V88, P166, DOI 10.1099/vir.0.82146-0; Oberste MS, 2004, J VIROL, V78, P2948, DOI 10.1128/JVI.78.6.2948-2955.2004; Oberste MS, 2003, J CLIN VIROL, V26, P375, DOI 10.1016/S1386-6532(03)00004-0; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 2000, J CLIN MICROBIOL, V38, P1170, DOI 10.1128/JCM.38.3.1170-1174.2000; Oikarinen S, 2014, DIABETES, V63, P655, DOI 10.2337/db13-0620; Oprisan G, 2002, J GEN VIROL, V83, P2193, DOI 10.1099/0022-1317-83-9-2193; Quinn KK, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00574-14; RICOHESSE R, 1987, VIROLOGY, V160, P311, DOI 10.1016/0042-6822(87)90001-8; TAM PE, 1991, J VIROL, V65, P6654, DOI 10.1128/JVI.65.12.6654-6660.1991; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tee KK, 2010, J VIROL, V84, P3339, DOI 10.1128/JVI.01019-09; Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006; Volz EM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002947; Wang SM, 1998, J INFECTION, V37, P270, DOI 10.1016/S0163-4453(98)92076-X; Wikswo ME, 2009, CLIN INFECT DIS, V49, pE44, DOI 10.1086/605090; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067157	48	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129272	10.1371/journal.pone.0129272	http://dx.doi.org/10.1371/journal.pone.0129272			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053872	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300106
J	Dai, BB; Yan, SY; Lara-Guerra, H; Kawashima, H; Sakai, R; Jayachandran, G; Majidi, M; Mehran, R; Wang, J; Bekele, BN; Baladandayuthapani, V; Yoo, SY; Wang, Y; Ying, J; Meng, F; Ji, L; Roth, JA				Dai, Bingbing; Yan, Shaoyu; Lara-Guerra, Humberto; Kawashima, Hiroyuki; Sakai, Ryo; Jayachandran, Gitanjali; Majidi, Mourad; Mehran, Reza; Wang, Jing; Bekele, B. Nebiyou; Baladandayuthapani, Veerabhadran; Yoo, Suk-Young; Wang, Ying; Ying, Jun; Meng, Feng; Ji, Lin; Roth, Jack A.			Exogenous Restoration of TUSC2 Expression Induces Responsiveness to Erlotinib in Wildtype Epidermal Growth Factor Receptor (EGFR) Lung Cancer Cells through Context Specific Pathways Resulting in Enhanced Therapeutic Efficacy	PLOS ONE			English	Article							HOMOZYGOUS DELETION REGION; HUMAN-CHROMOSOME 3P21.3; IN-VIVO; ACQUIRED-RESISTANCE; ADENOVIRUS VECTOR; TUMOR SUPPRESSION; FUS1 PROTEIN; INHIBITION; GEFITINIB; LIPOSOME	Expression of the tumor suppressor gene TUSC2 is reduced or absent in most lung cancers and is associated with worse overall survival. In this study, we restored TUSC2 gene expression in several wild type EGFR non-small cell lung cancer (NSCLC) cell lines resistant to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor erlotinib and analyzed their sensitivity to erlotinib in vitro and in vivo. A significant inhibition of cell growth and colony formation was observed with TUSC2 transient and stable expression. TUSC2-erlotinib cooperativity in vitro could be reproduced in vivo in subcutaneous tumor growth and lung metastasis formation lung cancer xenograft mouse models. Combination treatment with intravenous TUSC2 nanovesicles and erlotinib synergistically inhibited tumor growth and metastasis, and increased apoptotic activity. High-throughput qRT-PCR array analysis enabling multi-parallel expression profile analysis of eighty six receptor and non-receptor tyrosine kinase genes revealed a significant decrease of FGFR2 expression level, suggesting a potential role of FGFR2 in TUSC2-enhanced sensitivity to erlotinib. Western blots showed inhibition of FGFR2 by TUSC2 transient transfection, and marked increase of PARP, an apoptotic marker, cleavage level after TUSC2-erlotinb combined treatment. Suppression of FGFR2 by AZD4547 or gene knockdown enhanced sensitivity to erlotinib in some but not all tested cell lines. TUSC2 inhibits mTOR activation and the latter cell lines were responsive to the mTOR inhibitor rapamycin combined with erlotinib. These results suggest that TUSC2 restoration in wild type EGFR NSCLC may overcome erlotinib resistance, and identify FGFR2 and mTOR as critical regulators of this activity in varying cellular contexts. The therapeutic activity of TUSC2 could extend the use of erlotinib to lung cancer patients with wildtype EGFR.	[Dai, Bingbing; Yan, Shaoyu; Lara-Guerra, Humberto; Kawashima, Hiroyuki; Sakai, Ryo; Jayachandran, Gitanjali; Majidi, Mourad; Mehran, Reza; Meng, Feng; Ji, Lin; Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Sect Thorac Mol Oncol, Houston, TX 77030 USA; [Bekele, B. Nebiyou; Baladandayuthapani, Veerabhadran; Ying, Jun] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Wang, Jing; Yoo, Suk-Young; Wang, Ying] Univ Texas MD Anderson Canc Ctr, Dept Bioinfomat & Computat Biol, Houston, TX 77030 USA; [Kawashima, Hiroyuki] Nigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan; [Sakai, Ryo] Okayama Citizens Hosp, Okayama, Japan; [Bekele, B. Nebiyou] Gilead Sci, Foster City, CA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Niigata University; Gilead Sciences	Roth, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Sect Thorac Mol Oncol, Houston, TX 77030 USA.	jroth@mdanderson.org			National Institutes of Health/National Cancer Institute through The University of Texas MD Anderson Cancer Center's Cancer Center Support Grant - Lung Program and Shared Core Facilities [CA-016672]; Specialized Program of Research Excellence (SPORE) Grant [CA-070907]; R01 Grant [CA-116322]; Tobacco Settlement Funds; Genprex, Inc.; Cancer Prevention Research Institute of Texas [RP101502, RP140106]; NATIONAL CANCER INSTITUTE [R01CA116322, R01CA176568, P30CA016672, P50CA070907] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute through The University of Texas MD Anderson Cancer Center's Cancer Center Support Grant - Lung Program and Shared Core Facilities; Specialized Program of Research Excellence (SPORE) Grant; R01 Grant; Tobacco Settlement Funds; Genprex, Inc.; Cancer Prevention Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the National Institutes of Health/National Cancer Institute through The University of Texas MD Anderson Cancer Center's Cancer Center Support Grant CA-016672 - Lung Program and Shared Core Facilities, Specialized Program of Research Excellence (SPORE) Grant CA-070907 (J. Minna and J. A. Roth), an R01 Grant CA-116322 (L. Ji) and by a grant from the Tobacco Settlement Funds as appropriated by the Texas Legislature and by a sponsored research agreement from Genprex, Inc. (R. Mehran). H. Lara-Guerra was supported by an institutional training grant from the Cancer Prevention Research Institute of Texas (RP101502 and RP140106).	Aksentijevich I, 1996, HUM GENE THER, V7, P1111, DOI 10.1089/hum.1996.7.9-1111; Balak MN, 2006, CLIN CANCER RES, V12, P6494, DOI 10.1158/1078-0432.CCR-06-1570; Buck E, 2006, MOL CANCER THER, V5, P2676, DOI 10.1158/1535-7163.MCT-06-0166; Buvoli M, 2002, GENE THER, V9, P227, DOI 10.1038/sj.gt.3301640; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Hirsch FR, 2013, J THORAC ONCOL, V8, P373, DOI 10.1097/JTO.0b013e31827ed0ff; Ito I, 2004, CANCER GENE THER, V11, P733, DOI 10.1038/sj.cgt.7700756; Ito I, 2003, MOL THER, V7, P409, DOI 10.1016/S1525-0016(03)00004-2; Ji L, 2002, CANCER RES, V62, P2715; Ji L, 2008, J THORAC ONCOL, V3, P327, DOI 10.1097/JTO.0b013e31816bce65; Ji Lin, 2005, Future Oncol, V1, P79, DOI 10.1517/14796694.1.1.79; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kondo M, 2001, ONCOGENE, V20, P6258, DOI 10.1038/sj.onc.1204832; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Lerman MI, 2000, CANCER RES, V60, P6116; Lin J, 2007, ONCOGENE, V26, P6989, DOI 10.1038/sj.onc.1210500; Lu C, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034833, 10.1371/journal.pone.0038332]; Meng JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077067; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Prudkin L, 2008, CLIN CANCER RES, V14, P41, DOI 10.1158/1078-0432.CCR-07-1252; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Simberg D, 2005, HUM GENE THER, V16, P1087, DOI 10.1089/hum.2005.16.1087; Simberg D, 2007, P NATL ACAD SCI USA, V104, P932, DOI 10.1073/pnas.0610298104; Sridhar SS, 2003, LANCET ONCOL, V4, P397, DOI 10.1016/S1470-2045(03)01137-9; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Uno F, 2004, CANCER RES, V64, P2969, DOI 10.1158/0008-5472.CAN-03-3702; Ware Kathryn E, 2010, PLoS One, V5, pe14117, DOI 10.1371/journal.pone.0014117; WILKINSON GWG, 1992, NUCLEIC ACIDS RES, V20, P2233, DOI 10.1093/nar/20.9.2233; Wistuba II, 2000, CANCER RES, V60, P1949; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485; Zochbauer-Muller S, 2002, ANNU REV PHYSIOL, V64, P681, DOI 10.1146/annurev.physiol.64.081501.155828	32	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0123967	10.1371/journal.pone.0123967	http://dx.doi.org/10.1371/journal.pone.0123967			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053020	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300006
J	Doran, C; Chetrit, J; Holley, MC; Grundy, D; Nassar, MA				Doran, Ciara; Chetrit, Jonathan; Holley, Matthew C.; Grundy, David; Nassar, Mohammed A.			Mouse DRG Cell Line with Properties of Nociceptors	PLOS ONE			English	Article							ROOT GANGLION NEURONS; CREST STEM-CELLS; SODIUM-CHANNELS; SENSORY NEURONS; NERVOUS-SYSTEM; PAIN; EXPRESSION; EMERGENCE; OUTGROWTH; SUBTYPES	In vitro cell lines from DRG neurons aid drug discovery because they can be used for early stage, high-throughput screens for drugs targeting pain pathways, with minimal dependence on animals. We have established a conditionally immortal DRG cell line from the Immortomouse. Using immunocytochemistry, RT-PCR and calcium microfluorimetry, we demonstrate that the cell line MED17.11 expresses markers of cells committed to the sensory neuron lineage. Within a few hours under differentiating conditions, MED17.11 cells extend processes and following seven days of differentiation, express markers of more mature DRG neurons, such as NaV1.7 and Piezo2. However, at least at this time-point, the nociceptive marker NaV1.8 is not expressed, but the cells respond to compounds known to excite nociceptors, including the TRPV1 agonist capsaicin, the purinergic receptor agonist ATP and the voltage gated sodium channel agonist, veratridine. Robust calcium transients are observed in the presence of the inflammatory mediators bradykinin, histamine and norepinephrine. MED17.11 cells have the potential to replace or reduce the use of primary DRG culture in sensory, pain and developmental research by providing a simple model to study acute nociception, neurite outgrowth and the developmental specification of DRG neurons.	[Doran, Ciara; Chetrit, Jonathan; Holley, Matthew C.; Grundy, David; Nassar, Mohammed A.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Nassar, MA (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.nassar@sheffield.ac.uk		Holley, Matthew/0000-0001-9547-1953	NC3Rs [G1000000]; National Centre for the Replacement [G1000000/1] Funding Source: researchfish	NC3Rs(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	The project was funded by a grant (G1000000) from NC3Rs, https://www.nc3rs.org.uk/.	Baker MD, 1997, J NEUROPHYSIOL, V77, P1503, DOI 10.1152/jn.1997.77.3.1503; BARNES S, 1988, J GEN PHYSIOL, V91, P421, DOI 10.1085/jgp.91.3.421; Benn SC, 2001, J NEUROSCI, V21, P6077, DOI 10.1523/JNEUROSCI.21-16-06077.2001; Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Chen WR, 2007, J PERIPHER NERV SYST, V12, P121, DOI 10.1111/j.1529-8027.2007.00131.x; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; DRAY A, 1995, BRIT J ANAESTH, V75, P125, DOI 10.1093/bja/75.2.125; Fang X, 2006, J NEUROSCI, V26, P7281, DOI 10.1523/JNEUROSCI.1072-06.2006; Fjell J, 1999, MOL BRAIN RES, V67, P267, DOI 10.1016/S0169-328X(99)00070-4; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; JAT PS, 1991, P NATL ACAD SCI USA, V88, P5096, DOI 10.1073/pnas.88.12.5096; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; KUSANO K, 1993, J NEUROSCI RES, V34, P158, DOI 10.1002/jnr.490340203; Marmigere F, 2007, NAT REV NEUROSCI, V8, P114, DOI 10.1038/nrn2057; MATSUDA S, 1984, CELL TISSUE RES, V235, P13; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Molliver DC, 1997, J COMP NEUROL, V381, P428, DOI 10.1002/(SICI)1096-9861(19970519)381:4<428::AID-CNE3>3.0.CO;2-4; Montelius A, 2007, DIFFERENTIATION, V75, P404, DOI 10.1111/j.1432-0436.2006.00154.x; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Neirinckx V, 2013, STEM CELL TRANSL MED, V2, P284, DOI 10.5966/sctm.2012-0147; PLATIKA D, 1985, P NATL ACAD SCI USA, V82, P3499, DOI 10.1073/pnas.82.10.3499; Ravenall SJ, 2002, EUR J NEUROSCI, V15, P281, DOI 10.1046/j.0953-816x.2001.01862.x; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Sun YF, 2008, NAT NEUROSCI, V11, P1283, DOI 10.1038/nn.2209; Teichert RW, 2012, P NATL ACAD SCI USA, V109, P12758, DOI 10.1073/pnas.1209759109; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319; Vetter I, 2010, BIOCHEM PHARMACOL, V79, P908, DOI 10.1016/j.bcp.2009.10.020; Virginie Neirinckx CcC Bernard Rogister Sabine Wislet-Gendebien, 2013, NEURAL FATE MESENCHY; Wainger BJ, 2015, NAT NEUROSCI, V18, P17, DOI 10.1038/nn.3886; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084; Young GT, 2014, MOL THER, V22, P1530, DOI 10.1038/mt.2014.86	35	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128670	10.1371/journal.pone.0128670	http://dx.doi.org/10.1371/journal.pone.0128670			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053673	Green Published, Green Accepted, gold			2022-12-26	WOS:000355955300052
J	Houzet, L; Deleage, C; Satie, AP; Merlande, L; Mahe, D; Dejucq-Rainsford, N				Houzet, Laurent; Deleage, Claire; Satie, Anne-Pascale; Merlande, Laetitia; Mahe, Dominique; Dejucq-Rainsford, Nathalie			A New Method for Rapid Screening of End-Point PCR Products: Application to Single Genome Amplified HIV and SIV Envelope Amplicons	PLOS ONE			English	Article							INFECTION	PCR is the most widely applied technique for large scale screening of bacterial clones, mouse genotypes, virus genomes etc. A drawback of large PCR screening is that amplicon analysis is usually performed using gel electrophoresis, a step that is very labor intensive, tedious and chemical waste generating. Single genome amplification (SGA) is used to characterize the diversity and evolutionary dynamics of virus populations within infected hosts. SGA is based on the isolation of single template molecule using limiting dilution followed by nested PCR amplification and requires the analysis of hundreds of reactions per sample, making large scale SGA studies very challenging. Here we present a novel approach entitled Long Amplicon Melt Profiling (LAMP) based on the analysis of the melting profile of the PCR reactions using SYBR Green and/or EvaGreen fluorescent dyes. The LAMP method represents an attractive alternative to gel electrophoresis and enables the quick discrimination of positive reactions. We validate LAMP for SIV and HIV env-SGA, in 96- and 384-well plate formats. Because the melt profiling allows the screening of several thousands of PCR reactions in a cost-effective, rapid and robust way, we believe it will greatly facilitate any large scale PCR screening.	[Houzet, Laurent; Deleage, Claire; Satie, Anne-Pascale; Merlande, Laetitia; Mahe, Dominique; Dejucq-Rainsford, Nathalie] Univ Rennes 1, INSERM, U1085, IRSET,Struct Federat Rech Biosit, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Dejucq-Rainsford, N (corresponding author), Univ Rennes 1, INSERM, U1085, IRSET,Struct Federat Rech Biosit, Campus Beaulieu, Rennes, France.	nathalie.dejucq-rainsford@univ-rennes1.fr	DEJUCQ-RAINSFORD, Nathalie/I-2571-2015; MAHE, Dominique MD/I-7316-2015	Dejucq-Rainsford, Nathalie/0000-0002-1788-2690	Fond dotation Pierre Berge-Sidaction; Inserm; Region Bretagne; Sidaction; ANRS	Fond dotation Pierre Berge-Sidaction; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Bretagne(Region Bretagne); Sidaction; ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by Fond dotation Pierre Berge-Sidaction, Inserm and Region Bretagne. C. Deleage was the recipient of Sidaction and ANRS fellowships.	Bester R, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-219; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Butler DM, 2009, J VIROL METHODS, V162, P280, DOI 10.1016/j.jviromet.2009.08.002; Del Prete GQ, 2013, J VIROL, V87, P4584, DOI 10.1128/JVI.03507-12; Evering TH, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0065-0; Evering TH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002506; Fieni F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076367; Houzet L, 2014, J INFECT DIS, V210, pS622, DOI 10.1093/infdis/jiu328; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831; Li WJ, 2003, BIOTECHNIQUES, V35, P702, DOI 10.2144/03354bm07; Matusali G, 2015, J VIROL IN PRESS, P89; Moreau M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037348; Novitsky V, 2013, INFECT GENET EVOL; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Permar SR, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-88; Rasmussen JP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-107; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07	18	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128188	10.1371/journal.pone.0128188	http://dx.doi.org/10.1371/journal.pone.0128188			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053379	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300024
J	Hui, RK; Leung, FC				Hui, Raymond K.; Leung, Frederick C.			Differential Expression Profile of Chicken Embryo Fibroblast DF-1 Cells Infected with Cell-Adapted Infectious Bursal Disease Virus	PLOS ONE			English	Article							RNA-SEQ; GENE-EXPRESSION; IMMUNE-RESPONSE; RECEPTOR PATHWAY; CYTOKINE GENES; SEROTYPE-II; WILD-TYPE; PROTEIN; ACTIVATION; MACROPHAGES	RNA-Seq was used to unveil the transcriptional profile of DF-1 cells at the early stage of caIBDV infection. Total RNAs were extracted from virus-infected cells at 0, 6 and 12 hpi. RNA-Seq datasets of respective samples mapped to 56.5-57.6% of isoforms in the reference genome Galgal4.73. At 6 hpi, 23 isoforms underwent an elevated expression, while 128 isoforms were up-regulated and 5 were down-regulated at 12 hpi in the virus-infected group. Besides, 10 isoforms were exclusively expressed in the virus-infected cells. Though no significant change was detected in cytokine and interferon expression levels at the first 12 hours of infection, modulations of the upstream regulators were observed. In addition to the reported regulatory factors including EIF2AK2, MX, OAS*A, GBP7 and IFIT, IBDV infection also triggered a IFIT5-IRF1/3-RSAD5 pathway in the DF-1 cells which potentially restricted the viral replication cycle in the early infection stage. Over-expression of LIPA and CH25H, together with the suppression of STARD4, LSS and AACS genes implied a modulation of membrane fluidity and lipid raft arrangement in the infected cells. Alternative splicing of the EFR3 homolog A gene was also through to be involved in the lipid membrane regulation, and these cumulative responses projected an inhibition of viral endocytosis. Recognition of viral RNA genomes and intermediates was presumably enhanced by the elevated levels of IFIH1, DHX58 and TRIM25 genes which possess properties on detecting viral dsRNA. On the other hand, the caIBDV arrested the host's apoptotic process by inducing the expression of apoptosis inhibitors including NFKBIA/Z, TNFAIP2/3 and ITA at the first 12 hours of infection. In conclusion, the differential expression landscape demonstrated with RNA-Seq provides a comprehensive picture on the molecular interactions between host cells and virus at the early stage of infection.	[Hui, Raymond K.; Leung, Frederick C.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China; [Leung, Frederick C.] Nanjing Agr Univ, Bioinformat Ctr, Nanjing, Jiangsu, Peoples R China	University of Hong Kong; Nanjing Agricultural University	Leung, FC (corresponding author), Univ Hong Kong, Sch Biol Sci, Hong Kong, Peoples R China.	fcleung@hku.hk			Hong Kong Government; RGC GRF [HKU 771310M]; HKU University internal Fund	Hong Kong Government; RGC GRF(Hong Kong Research Grants Council); HKU University internal Fund	This project is partly supported by Hong Kong Government, RGC GRF: HKU 771310M and HKU University internal Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudinot P, 2000, J GEN VIROL, V81, P2675, DOI 10.1099/0022-1317-81-11-2675; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Broquet AH, 2011, J IMMUNOL, V186, P1618, DOI 10.4049/jimmunol.1002862; Brown MD, 1996, VIRUS RES, V40, P1, DOI 10.1016/0168-1702(95)01253-2; Chen XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073218; CHETTLE N, 1989, VET REC, V125, P271, DOI 10.1136/vr.125.10.271; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; COSGROVE AS, 1962, AVIAN DIS, V6, P385, DOI 10.2307/1587909; De Valck D, 1999, ONCOGENE, V18, P4182, DOI 10.1038/sj.onc.1202787; DeLuca DS, 2012, BIOINFORMATICS, V28, P1530, DOI 10.1093/bioinformatics/bts196; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eldaghayes I, 2006, VIRAL IMMUNOL, V19, P83, DOI 10.1089/vim.2006.19.83; FARAGHER JT, 1972, NATURE-NEW BIOL, V237, P118, DOI 10.1038/newbio237118a0; Flicek P, 2013, NUCLEIC ACIDS RES, V41, pD48, DOI 10.1093/nar/gks1236; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Grewal TS, 2000, FASEB J, V14, P523, DOI 10.1096/fasebj.14.3.523; Guo XF, 2012, ARCH VIROL, V157, P2189, DOI 10.1007/s00705-012-1403-y; Havaleshko DM, 2009, NEOPLASIA, V11, P1185, DOI 10.1593/neo.09898; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Hierholzer J. C., 1996, P25, DOI 10.1016/B978-012465330-6/50003-8; HUDSON L, 1975, EUR J IMMUNOL, V5, P675, DOI 10.1002/eji.1830051005; Ilnytska O, 2013, CELL HOST MICROBE, V14, P281, DOI 10.1016/j.chom.2013.08.002; JACKWOOD DJ, 1985, AVIAN DIS, V29, P1184, DOI 10.2307/1590472; JACKWOOD DJ, 1984, AVIAN DIS, V28, P100, DOI 10.2307/1590132; Jungmann A, 2001, J GEN VIROL, V82, P1107, DOI 10.1099/0022-1317-82-5-1107; Khatri M, 2005, VIRUS RES, V113, P44, DOI 10.1016/j.virusres.2005.04.014; Khatri M, 2008, VACCINE, V26, P4740, DOI 10.1016/j.vaccine.2008.06.053; Khatri M, 2006, VIRUS RES, V118, P70, DOI 10.1016/j.virusres.2005.11.015; Khatri M, 2009, VET IMMUNOL IMMUNOP, V127, P316, DOI 10.1016/j.vetimm.2008.10.327; Kim IJ, 1998, VET IMMUNOL IMMUNOP, V61, P331, DOI 10.1016/S0165-2427(97)00135-9; Kong BW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-571; Kurella M, 2001, J AM SOC NEPHROL, V12, P1072, DOI 10.1681/ASN.V1251072; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YP, 2007, ARCH VIROL, V152, P463, DOI 10.1007/s00705-006-0878-9; Liniger M, 2012, J VIROL, V86, P705, DOI 10.1128/JVI.00742-11; Liu HW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-364; Liu MH, 2006, J VIROL, V80, P3369, DOI 10.1128/JVI.80.7.3369-3377.2006; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lukert PD, 2003, DIS POULTRY, P161; Carballeda JM, 2011, IMMUNOBIOLOGY, V216, P1028, DOI 10.1016/j.imbio.2011.03.003; MCFERRAN JB, 1980, AVIAN PATHOL, V9, P395, DOI 10.1080/03079458008418423; Munemoto Y, 2004, MOL BRAIN RES, V128, P131, DOI 10.1016/j.molbrainres.2004.06.022; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Nagase T, 1995, DNA Res, V2, P167, DOI 10.1093/dnares/2.4.167; Nagase T., 1995, DNA RES, V2, P199; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Oshiumi H, 2012, J BIOCHEM, V151, P5, DOI 10.1093/jb/mvr111; Ovstebo R, 2008, INFECT IMMUN, V76, P2685, DOI 10.1128/IAI.01625-07; Palmquist JM, 2006, VIRAL IMMUNOL, V19, P305, DOI 10.1089/vim.2006.19.305; Ragland WL, 2002, J INTERF CYTOK RES, V22, P437, DOI 10.1089/10799900252952226; Rauf A, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-85; RODENBERG J, 1994, AVIAN DIS, V38, P16, DOI 10.2307/1591831; Ruby T, 2006, J VIROL, V80, P9207, DOI 10.1128/JVI.00929-06; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Schulze A, 2000, J CELL SCI, V113, P4151; Sessions OM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002107; Severa M, 2006, J BIOL CHEM, V281, P26188, DOI 10.1074/jbc.M604516200; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Sun LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069441; Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11; Tenev T, 2005, NAT CELL BIOL, V7, P70, DOI 10.1038/ncb1204; Tippenhauer M, 2013, DEV COMP IMMUNOL, V40, P1, DOI 10.1016/j.dci.2012.10.013; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; VANDENBERG TP, 1991, AVIAN PATHOL, V20, P133, DOI 10.1080/03079459108418748; VASCONCELOS AC, 1995, J COMP PATHOL, V112, P327, DOI 10.1016/S0021-9975(05)80014-3; VASCONCELOS AC, 1994, J GEN VIROL, V75, P1803, DOI 10.1099/0022-1317-75-7-1803; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wei L, 2011, VIROLOGY, V420, P156, DOI 10.1016/j.virol.2011.08.027; Wong RTY, 2007, J GEN VIROL, V88, P1785, DOI 10.1099/vir.0.82619-0; Wu YP, 2012, PROTEOMICS, V12, P1844, DOI 10.1002/pmic.201100479; Yang SB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-258; Zeng DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057515; Zhang BH, 2013, ACTA BIOCH BIOPH SIN, V45, P867, DOI 10.1093/abbs/gmt088; Zheng XJ, 2008, MOL CELL PROTEOMICS, V7, P612, DOI 10.1074/mcp.M700396-MCP200; Zhou ZL, 2007, J VIROL, V81, P7749, DOI 10.1128/JVI.02438-06	82	23	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0111771	10.1371/journal.pone.0111771	http://dx.doi.org/10.1371/journal.pone.0111771			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053856	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300001
J	Jung, CH; Seo, GH; Suh, S; Bae, JC; Kim, MK; Hwang, YC; Kim, JH; Lee, BW				Jung, Chang Hee; Seo, Gi Hyeon; Suh, Sunghwan; Bae, Ji Cheol; Kim, Mee Kyoung; Hwang, You-Cheol; Kim, Jae Hyeon; Lee, Byung-Wan			The Population-Based Risk of Need for Coronary Revascularization According to the Presence of Type 2 Diabetes Mellitus and History of Coronary Heart Disease in the Korean Population	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; FACTOR INTERVENTION TRIAL; INSURANCE CLAIMS DATA; LONG-TERM SURVIVAL; CARDIOVASCULAR-DISEASE; FOLLOW-UP; MORTALITY; EQUIVALENT; IMPACT; PROGNOSIS	Background Whether diabetic patients without a history of coronary heart disease (CHD) have the same risk of CHD events as non-diabetic patients with a history of CHD remains controversial. This study aimed to determine whether type 2 diabetes mellitus (T2DM) is a coronary heart disease (CHD) equivalent in the need for coronary revascularization procedures (RVs) in the Korean population. Methodology/Principal Findings We followed 2,168,698 subjects who had oral anti-diabetic drugs (OADs)-taking T2DM in 2008 and/or CHD in 2007-2008 (i.e., recent CHD). We used systematic datasets from the nationwide claims database of the Health Insurance Review and Assessment service of Korea, which is representative of the whole population of Korea, from January 2007 to December 2012. The primary study endpoint was the development of need for RVs (i.e., incident CHD) after January 2009 among three groups based on their status of T2DM and recent CHD, i.e., T2DM only, recent CHD only, and both T2DM and recent CHD. After adjustment for age and sex, patients with recent CHD only had 2.14 times the risk of incident CHD (95% CI, 2.11-2.18, P<0.001) compared with patients with T2DM only. Patients with both T2DM and recent CHD demonstrated approximately 2-fold increased risk of incident CHD compared with subjects with recent CHD only (95% CI, 1.75-1.82), while 4-fold increased risk compared with subjects with T2DM only (95% CI, 3.71-3.87). The risk of incident CHD also differed according to sex and age. Conclusions/Significance This analysis of data from the nationwide claims database revealed that T2DM did not have a recent CHD equivalent risk in the Korean population. These results suggest that an appropriate strategy for the CHD risk stratification in diabetic patients should be adopted to manage this population.	[Jung, Chang Hee] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med, Seoul, South Korea; [Seo, Gi Hyeon] Hlth Insurance Review & Assessment Serv, Seoul, South Korea; [Suh, Sunghwan] Dong A Univ, Med Ctr, Dept Internal Med, Busan, South Korea; [Bae, Ji Cheol; Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Kim, Mee Kyoung] Catholic Univ Korea, Dept Internal Med, Seoul, South Korea; [Hwang, You-Cheol] Kyung Hee Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Lee, Byung-Wan] Yonsei Univ, Coll Med, Severance Hosp, Dept Internal Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; Dong A University; Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea; Kyung Hee University; Yonsei University; Yonsei University Health System	Kim, JH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	jaehyeon@skku.edu; bwanlee@yuhs.ac	Wan, Lee Byung/K-2649-2019; Seo, Gihyeon/AGG-1178-2022; Jung, Chang Hee/AAU-7897-2020; Hwang, You-Cheol/AAA-4616-2022	Seo, Gihyeon/0000-0001-7414-0258; Suh, Sunghwan/0000-0001-6865-966X; Jung, Chang Hee/0000-0003-4043-2396; Lee, Byung-Wan/0000-0002-9899-4992; Hwang, You-Cheol/0000-0003-4033-7874				BARRETTCONNOR E, 1983, AM J EPIDEMIOL, V118, P489, DOI 10.1093/oxfordjournals.aje.a113654; Becker A, 2003, EUR HEART J, V24, P1406, DOI 10.1016/S0195-668X(03)00197-0; BIERMAN EL, 1992, ARTERIOSCLER THROMB, V12, P647, DOI 10.1161/01.ATV.12.6.647; Bulugahapitiya U, 2009, DIABETIC MED, V26, P142, DOI 10.1111/j.1464-5491.2008.02640.x; Chaturvedi N, 2003, HEART, V89, P681, DOI 10.1136/heart.89.6.681; Eberly LE, 2003, DIABETES CARE, V26, P848, DOI 10.2337/diacare.26.3.848; Evans JMM, 2002, BRIT MED J, V324, P939, DOI 10.1136/bmj.324.7343.939; Fox CS, 2004, DIABETES CARE, V27, P704, DOI 10.2337/diacare.27.3.704; FULLER JH, 1980, LANCET, V1, P1373; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Hadaegh F, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-84; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hu FB, 2001, ARCH INTERN MED, V161, P1717, DOI 10.1001/archinte.161.14.1717; JACOBY RM, 1992, J AM COLL CARDIOL, V20, P736, DOI 10.1016/0735-1097(92)90033-J; Jouven X, 2005, EUR HEART J, V26, P2142, DOI 10.1093/eurheartj/ehi376; Juutilainen A, 2005, DIABETES CARE, V28, P2901, DOI 10.2337/diacare.28.12.2901; Kang HY, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-230; Kannel W B, 1979, Diabetes Care, V2, P120, DOI 10.2337/diacare.2.2.120; Kim HK, 2013, DIABETES CARE, V36, P328, DOI 10.2337/dc12-0587; Kim NH, 2014, DIABETES METAB J, V38, P44, DOI 10.4093/dmj.2014.38.1.44; Lee CD, 2004, CIRCULATION, V109, P855, DOI 10.1161/01.CIR.0000116389.61864.DE; Lee SH, 2014, J CLIN ENDOCR METAB, V99, P1615, DOI 10.1210/jc.2013-3608; Lee YK, 2013, OSTEOPOROSIS INT, V24, P707, DOI 10.1007/s00198-012-2016-8; Lotufo PA, 2001, ARCH INTERN MED, V161, P242, DOI 10.1001/archinte.161.2.242; Malmberg K, 2000, CIRCULATION, V102, P1014, DOI 10.1161/01.CIR.102.9.1014; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; Mukamal KJ, 2001, DIABETES CARE, V24, P1422, DOI 10.2337/diacare.24.8.1422; Natarajan S, 2003, ARCH INTERN MED, V163, P1735, DOI 10.1001/archinte.163.14.1735; Norhammar A, 2013, DIABETOLOGIA, V56, P1, DOI 10.1007/s00125-012-2694-y; Saely CH, 2013, INT J CARDIOL, V167, P776, DOI 10.1016/j.ijcard.2012.03.042; Saely CH, 2013, VASC PHARMACOL, V59, P11, DOI 10.1016/j.vph.2013.05.003; Simons LA, 1998, NEW ENGL J MED, V339, P1714; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; STONE PH, 1989, J AM COLL CARDIOL, V14, P49, DOI 10.1016/0735-1097(89)90053-3; Vaccaro O, 2004, ARCH INTERN MED, V164, P1438, DOI 10.1001/archinte.164.13.1438; Whiteley L, 2005, DIABETES CARE, V28, P1588, DOI 10.2337/diacare.28.7.1588; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047	38	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128627	10.1371/journal.pone.0128627	http://dx.doi.org/10.1371/journal.pone.0128627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053222	gold, Green Submitted, Green Published			2022-12-26	WOS:000355955300048
J	Miller, CM; Zakrzewski, AM; Robinson, DP; Fuller, SJ; Walker, RA; Ikin, RJ; Bao, SJ; Grigg, ME; Wiley, JS; Smith, NC				Miller, Catherine M.; Zakrzewski, Alana M.; Robinson, Dionne P.; Fuller, Stephen J.; Walker, Robert A.; Ikin, Rowan J.; Bao, Shisan J.; Grigg, Michael E.; Wiley, James S.; Smith, Nicholas C.			Lack of a Functioning P2X7 Receptor Leads to Increased Susceptibility to Toxoplasmic Ileitis	PLOS ONE			English	Article							NF-KAPPA-B; P38 MAP KINASE; ORAL INFECTION; SMALL-INTESTINE; INTRACELLULAR PARASITE; CYTOKINE PRODUCTION; IL-1-BETA RELEASE; NITRIC-OXIDE; IFN-GAMMA; TNF-ALPHA	Background Oral infection of C57BL/6J mice with the protozoan parasite Toxoplasma gondii leads to a lethal inflammatory ileitis. Principal Findings Mice lacking the purinergic receptor P2X7R are acutely susceptible to toxoplasmic ileitis, losing significantly more weight than C57BL/6J mice and exhibiting much greater intestinal inflammatory pathology in response to infection with only 10 cysts of Toxoplasma gondii. This susceptibility is not dependent on the ability of P2X7R-deficient mice to control the parasite, which they accomplish just as efficiently as C57BL/6J mice. Rather, susceptibility is associated with elevated ileal concentrations of pro-inflammatory cytokines, reactive nitrogen intermediates and altered regulation of elements of NF kappa B activation in P2X7R-deficient mice. Conclusions Our data support the thesis that P2X7R, a well-documented activator of pro-inflammatory cytokine production, also plays an important role in the regulation of intestinal inflammation.	[Miller, Catherine M.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Smithfield, Qld 4878, Australia; [Zakrzewski, Alana M.; Ikin, Rowan J.] Univ Technol Sydney, Inst Biotechnol Infect Dis, Broadway, NSW 2007, Australia; [Robinson, Dionne P.; Grigg, Michael E.] NIAID, Mol Parasitol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Fuller, Stephen J.] Univ Sydney, Nepean Hosp, Sydney Med Sch, Camperdown, NSW 2006, Australia; [Walker, Robert A.; Smith, Nicholas C.] James Cook Univ, Queensland Trop Hlth Alliance Res Lab, Australian Inst Trop Hlth & Med, Smithfield, Qld 4878, Australia; [Bao, Shisan J.] Univ Sydney, Sch Med Sci, Discipline Pathol, Camperdown, NSW 2006, Australia; [Bao, Shisan J.] Univ Sydney, Bosch Inst, Camperdown, NSW 2006, Australia; [Wiley, James S.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia	James Cook University; University of Technology Sydney; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Nepean Hospital; University of Sydney; James Cook University; University of Sydney; University of Sydney; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Miller, CM (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, McGregor Rd, Smithfield, Qld 4878, Australia.	kate.miller1@jcu.edu.au	Miller, Catherine/G-9368-2011; Walker, Robert/C-3202-2013; Fuller, Stephen/W-6646-2019; Bao, Shisan/AAF-6464-2020; Bao, Shisan/C-6072-2014	Miller, Catherine/0000-0001-6071-5102; Walker, Robert/0000-0003-0032-9925; Fuller, Stephen/0000-0003-4637-7391; Bao, Shisan/0000-0002-6687-3846; Smith, Nicholas/0000-0002-7467-1451; Wiley, James/0000-0001-9421-4154	Australian Research Council [DP0666515]; Intramural 24 Research Program of National Institutes of Health, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001017] Funding Source: NIH RePORTER	Australian Research Council(Australian Research Council); Intramural 24 Research Program of National Institutes of Health, NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Professors Smith and Wiley gratefully acknowledge the support of the Australian Research Council for funding through its Discovery Project Scheme (Project number DP0666515). This work was also supported, in part, by the Intramural 24 Research Program of the National Institutes of Health, NIAID (Dr. Michael Grigg). Dr. Grigg is a Scholar of the Canadian Institute for Advanced Research (CIFAR) Integrated Microbial Biodiversity program. These funding bodies played no part in the experimental design, collection of data, interpretation, preparation of the manuscript or the decision to publish this research.	Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Amrouche-Mekkioui I, 2012, EUR J PHARMACOL, V691, P2019; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bachstetter AD, 2010, AGING DIS, V1, P199; Boyle JP, 2007, EXP PARASITOL, V116, P302, DOI 10.1016/j.exppara.2007.01.010; Brautigam VM, 2005, J NEUROIMMUNOL, V166, P113, DOI 10.1016/j.jneuroim.2005.05.012; Brenier-Pinchart MP, 2000, MOL CELL BIOCHEM, V209, P79, DOI 10.1023/A:1007075701551; BUFFET PA, 1995, ANTIMICROB AGENTS CH, V39, P2167, DOI 10.1128/AAC.39.9.2167; Buzoni-Gatel D, 2001, GASTROENTEROLOGY, V120, P914, DOI 10.1053/gast.2001.22432a; Cesaro A, 2010, AM J PHYSIOL-GASTR L, V299, pG32, DOI 10.1152/ajpgi.00282.2009; CHARDES T, 1993, IMMUNOLOGY, V78, P421; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Combe CL, 2006, P NATL ACAD SCI USA, V103, P6635, DOI 10.1073/pnas.0506180103; Correa G, 2010, MICROBES INFECT, V12, P497, DOI 10.1016/j.micinf.2010.03.004; Craven M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041594; de Campos NE, 2012, J INNATE IMMUN, V4, P529, DOI 10.1159/000336628; Egan CE, 2009, CLIN EXP IMMUNOL, V156, P17, DOI 10.1111/j.1365-2249.2009.03876.x; Egan CE, 2012, IMMUNOL CELL BIOL, V90, P668, DOI 10.1038/icb.2011.93; Ewald SE, 2014, INFECT IMMUN, V82, P460, DOI 10.1128/IAI.01170-13; Ferrari D, 1997, J IMMUNOL, V159, P1451; Friedle SA, 2011, GLIA, V59, P1, DOI 10.1002/glia.21071; Gaddi PJ, 2007, IMMUNOL CELL BIOL, V85, P155, DOI 10.1038/sj.icb.7100038; Gavala ML, 2008, J LEUKOCYTE BIOL, V84, P1159, DOI 10.1189/jlb.0907612; GAZZINELLI RT, 1994, EXP PARASITOL, V78, P217, DOI 10.1006/expr.1994.1022; Gorfu G, 2014, MBIO, V5, DOI 10.1128/mBio.01117-13; Gorska MM, 2007, J EXP MED, V204, P1637, DOI 10.1084/jem.20062621; Gregg B, 2013, INFECT IMMUN, V81, P1635, DOI 10.1128/IAI.01126-12; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Haas SL, 2007, SCAND J IMMUNOL, V65, P166, DOI 10.1111/j.1365-3083.2006.01876.x; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Heiss K, 2008, J IMMUNOL, V181, P3861, DOI 10.4049/jimmunol.181.6.3861; Hofman P, 2015, CANCER RES, V75, P835, DOI 10.1158/0008-5472.CAN-14-1778; Jamieson SE, 2010, GENES IMMUN, V11, P374, DOI 10.1038/gene.2010.31; Johnson RM, 2012, J IMMUNOL, V188, P1896, DOI 10.4049/jimmunol.1102764; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Khan IA, 1997, P NATL ACAD SCI USA, V94, P13955, DOI 10.1073/pnas.94.25.13955; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lees MP, 2010, J IMMUNOL, V184, P7040, DOI 10.4049/jimmunol.1000012; Lenertz LY, 2009, PURINERG SIGNAL, V5, P175, DOI 10.1007/s11302-009-9133-7; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; Mennechet FJD, 2004, EUR J IMMUNOL, V34, P1059, DOI 10.1002/eji.200324416; Miller CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002212; Miller CM, 2011, INT J PARASITOL, V41, P301, DOI 10.1016/j.ijpara.2010.10.001; Miller CM, 2009, INT J PARASITOL, V39, P23, DOI 10.1016/j.ijpara.2008.08.002; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; PFEFFERKORN ER, 1976, EXP PARASITOL, V36, P365, DOI 10.1016/0014-4894(76)90040-0; SIBLEY LD, 1991, J IMMUNOL, V147, P2340; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Suzuki Y, 2000, J IMMUNOL, V164, P5375, DOI 10.4049/jimmunol.164.10.5375; Trabanelli S, 2012, J IMMUNOL, V189, P1303, DOI 10.4049/jimmunol.1103800; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Wiley JS, 2011, TISSUE ANTIGENS, V78, P321, DOI 10.1111/j.1399-0039.2011.01780.x; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	61	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129048	10.1371/journal.pone.0129048	http://dx.doi.org/10.1371/journal.pone.0129048			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053862	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000355955300080
J	Morokutti-Kurz, M; Konig-Schuster, M; Koller, C; Graf, C; Graf, P; Kirchoff, N; Reutterer, B; Seifert, JM; Unger, H; Grassauer, A; Prieschl-Grassauer, E; Nakowitsch, S				Morokutti-Kurz, Martina; Koenig-Schuster, Marielle; Koller, Christiane; Graf, Christine; Graf, Philipp; Kirchoff, Norman; Reutterer, Benjamin; Seifert, Jan-Marcus; Unger, Hermann; Grassauer, Andreas; Prieschl-Grassauer, Eva; Nakowitsch, Sabine			The Intranasal Application of Zanamivir and Carrageenan Is Synergistically Active against Influenza A Virus in the Murine Model	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; NEURAMINIDASE INHIBITOR ZANAMIVIR; SULFATED POLYSACCHARIDES; ANTIVIRAL ACTIVITY; DENGUE VIRUS; COMMON COLD; NASAL SPRAY; IN-VITRO; EFFICACY; INFECTION	Background Carrageenan is a clinically proven and marketed compound for the treatment of viral upper respiratory tract infections. As infections caused by influenza virus are often accompanied by infections with other respiratory viruses the combination of a specific anti-influenza compound with the broadly active antiviral polymer has huge potential for the treatment of respiratory infections. Thus, the combination of the specific anti-influenza drug Zanamivir together with carrageenan in a formulation suitable for intranasal application was evaluated in-vitro and in-vivo. Principal Findings We show in-vitro that carrageenan and Zanamivir act synergistically against several influenza A virus strains (H1N1(09)pdm, H3N2, H5N1, H7N7). Moreover, we demonstrate in a lethal influenza model with a low pathogenic H7N7 virus (HA closely related to the avian influenza A(H7N9) virus) and a H1N1(09)pdm influenza virus in C57BL/6 mice that the combined use of both compounds significantly increases survival of infected animals in comparison with both mono-therapies or placebo. Remarkably, this benefit is maintained even when the treatment starts up to 72 hours post infection. Conclusion A nasal spray containing carrageenan and Zanamivir should therefore be tested for prevention and treatment of uncomplicated influenza in clinical trials.	[Morokutti-Kurz, Martina; Koenig-Schuster, Marielle; Koller, Christiane; Graf, Christine; Graf, Philipp; Kirchoff, Norman; Reutterer, Benjamin; Seifert, Jan-Marcus; Grassauer, Andreas; Prieschl-Grassauer, Eva; Nakowitsch, Sabine] Marinomed Biotechnol GmbH, Vienna, Austria; [Unger, Hermann] Vet Univ Vienna, Lab Trop Vet Med, A-1030 Vienna, Austria	University of Veterinary Medicine Vienna	Nakowitsch, S (corresponding author), Marinomed Biotechnol GmbH, Vienna, Austria.	sabine.nakowitsch@marinomed.com			Austrian Science Promotion Agency (FFG) [824211]; Marinomed Biotechnologie GmbH	Austrian Science Promotion Agency (FFG); Marinomed Biotechnologie GmbH	This work was co-funded by the Austrian Science Promotion Agency (FFG) project number 824211. https://www.ffg.at. Marinomed Biotechnologie GmbH provided support in the form of salaries for authors Martina Morokutti-Kurz, Marielle Konig-Schuster, Christiane Koller, Christine Graf, Philipp Graf, Norman Kirchoff, Benjamin Reutterer, Jan-Marcus Seifert, Andreas Grassauer, Eva Prieschl-Grassauer and Sabine Nakowitsch. Authors Hermann Unger, Andreas Grassauer and Eva Prieschl-Grassauer are co-founders of Marinomed Biotechnologie GmbH. Marinomed Biotechnologie GmbH had a role in study design, data collection and analysis, decision to publish, preparation of the manuscript and is financing the processing charge of the manuscript.	BABA M, 1988, ANTIMICROB AGENTS CH, V32, P1742, DOI 10.1128/AAC.32.11.1742; Baccala GP, 2008, J CLIN VIROL, V43, P407, DOI 10.1016/j.jcv.2008.08.010; Bantia S, 2001, ANTIMICROB AGENTS CH, V45, P1162, DOI 10.1128/AAC.45.4.1162-1167.2001; Barnard DL, 2009, ANTIVIR RES, V82, pA110, DOI 10.1016/j.antiviral.2008.12.014; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bogs J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011826; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Buck CB, 2006, PLOS PATHOG, V2, P671, DOI 10.1371/journal.ppat.0020069; Calfee DP, 1999, ANTIVIR THER, V4, P143; Carlucci MJ, 2004, ANTIVIR RES, V64, P137, DOI 10.1016/j.antiviral.2004.07.001; Carlucci MJ, 1999, ANTIVIR RES, V43, P93, DOI 10.1016/S0166-3542(99)00038-8; Centers for Disease Control and Prevention, 2009, US INFL H1N1 2009 MO, P1; Chand P, 2005, BIOORGAN MED CHEM, V13, P4071, DOI 10.1016/j.bmc.2005.03.048; Cohen SM, 2002, CRIT REV TOXICOL, V32, P413, DOI 10.1080/20024091064282; Cyranoski D, 2005, NATURE, V435, P1009, DOI 10.1038/4351009a; Damonte EB, 2004, CURR MED CHEM, V11, P2399, DOI 10.2174/0929867043364504; Debiaggi M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-247; Dines GD, 1998, DRUG SAFETY, V19, P233, DOI 10.2165/00002018-199819030-00006; Eccles R, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-108; Fawkner-Corbett DW, 2012, PEDIATR INFECT DIS J, V31, P653, DOI 10.1097/INF.0b013e3182501ff4; Fazekas T, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-147; FDA, 1999, APPL NUMB 21036 CLI; FDA, 1999, APPL NUMB 21036 ME 1; Ghosh T, 2009, GLYCOBIOLOGY, V19, P2, DOI 10.1093/glycob/cwn092; GIROND S, 1991, RES VIROLOGY, V142, P261, DOI 10.1016/0923-2516(91)90011-Q; Glaxo Wellcome Research and Development, 1998, STUDY NAIB2007; GONZALEZ ME, 1987, ANTIMICROB AGENTS CH, V31, P1388, DOI 10.1128/AAC.31.9.1388; Govorkova EA, 2007, ANTIMICROB AGENTS CH, V51, P1414, DOI 10.1128/AAC.01312-06; Grassauer A, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-107; Gubareva LV, 1998, J INFECT DIS, V178, P1592, DOI 10.1086/314515; HAMASUNA R, 1994, J GEN VIROL, V75, P111, DOI 10.1099/0022-1317-75-1-111; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; HAYDEN FG, 1980, ANTIMICROB AGENTS CH, V17, P865, DOI 10.1128/AAC.17.5.865; Hayden FG, 1996, JAMA-J AM MED ASSOC, V275, P295, DOI 10.1001/jama.275.4.295; Hayden FG, 1997, NEW ENGL J MED, V337, P874, DOI 10.1056/NEJM199709253371302; Hayden FG, 1996, INT CONGR SER, V1123, P718; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Hebar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122911; Hurt AC, 2009, J VIROL, V83, P10366, DOI 10.1128/JVI.01200-09; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2000, CLIN INFECT DIS, V30, P587, DOI 10.1086/313696; Kilmarx PH, 2008, SEX TRANSM DIS, V35, P226, DOI 10.1097/OLQ.0b013e31815d6e0d; Koenighofer M, 2014, MULTIDISCIP RESP MED, V9, DOI 10.1186/2049-6958-9-57; Lazarus R, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-014-0456-3; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Leibbrandt A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014320; Leneva IA, 2001, ANTIMICROB AGENTS CH, V45, P1216, DOI 10.1128/AAC.45.4.1216-1224.2001; Ludwig M, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-124; Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63; Meunier I, 2010, CRIT CARE MED, V38, pE21, DOI 10.1097/CCM.0b013e3181c8b4d5; Michel G, 2006, APPL MICROBIOL BIOT, V71, P23, DOI 10.1007/s00253-006-0377-7; Miron Dan, 2010, Pediatr Infect Dis J, V29, pe7, DOI 10.1097/INF.0b013e3181c2a212; Monto AS, 1999, J INFECT DIS, V180, P254, DOI 10.1086/314904; Nakowitsch S, 2012, ANT C CAMBR MA US EX; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Penn C., 2009, POINTS CONSIDER ANTI, P1; Pujol CA, 2006, PLANTA MED, V72, P121, DOI 10.1055/s-2005-373168; Qi X, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4752; Regoes RR, 2006, SCIENCE, V312, P389, DOI 10.1126/science.1122947; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Seibert CW, 2010, J VIROL, V84, P11219, DOI 10.1128/JVI.01424-10; Sidwell RW, 1998, ANTIVIR RES, V37, P107, DOI 10.1016/S0166-3542(97)00065-X; Sidwell RW, 2000, ANTIVIR RES, V48, P1, DOI 10.1016/S0166-3542(00)00125-X; Stempel HE, 2009, ACTA PAEDIATR, V98, P123, DOI 10.1111/j.1651-2227.2008.01023.x; Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043; Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; van de Velde F, 2002, TRENDS FOOD SCI TECH, V13, P73, DOI 10.1016/S0924-2244(02)00066-3; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2009, PROT HLTH CLIM CHANG, P1; Witvrouw M, 1997, GEN PHARMACOL-VASC S, V29, P497, DOI 10.1016/S0306-3623(96)00563-0; World Health Organization, 2013, ORAL HLTH SURVEYS BA, V5th ed., P1; World Health Organization, 2009, INF YOUNG CHILD FEED, P1, DOI 10.1659/0276-4741(2004)024[0019:MDFR]2.0.CO;2	74	28	31	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128794	10.1371/journal.pone.0128794	http://dx.doi.org/10.1371/journal.pone.0128794			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053018	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300058
J	Mou, WS; Li, DD; Luo, ZS; Mao, LC; Ying, TJ				Mou, Wangshu; Li, Dongdong; Luo, Zisheng; Mao, Linchun; Ying, Tiejin			Transcriptomic Analysis Reveals Possible Influences of ABA on Secondary Metabolism of Pigments, Flavonoids and Antioxidants in Tomato Fruit during Ripening	PLOS ONE			English	Article							TRIGGERING ETHYLENE BIOSYNTHESIS; ABSCISIC-ACID LEVELS; GENE-EXPRESSION; STRESS TOLERANCE; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; THIOREDOXIN/PEROXIREDOXIN SYSTEM; CAROTENOID BIOSYNTHESIS; PHOTOSYNTHETIC CAPACITY; CHLOROPHYLL BREAKDOWN; ARABIDOPSIS-THALIANA	Abscisic acid (ABA) has been proven to be involved in the regulation of climacteric fruit ripening, but a comprehensive investigation of its influence on ripening related processes is still lacking. By applying the next generation sequencing technology, we conducted a comparative analysis of the effects of exogenous ABA and NDGA (Nordihydroguaiaretic acid, an inhibitor of ABA biosynthesis) on tomato fruit ripening. The high throughput sequencing results showed that out of the 25728 genes expressed across all three samples, 10388 were identified as significantly differently expressed genes. Exogenous ABA was found to enhance the transcription of genes involved in pigments metabolism, including carotenoids biosynthesis and chlorophyll degradation, whereas NDGA treatment inhibited these processes. The results also revealed the crucial role of ABA in flavonoids synthesis and regulation of antioxidant system. Intriguingly, we also found that an inhibition of endogenous ABA significantly enhanced the transcriptional abundance of genes involved in photosynthesis. Our results highlighted the significance of ABA in regulating tomato ripening, which provided insight into the regulatory mechanism of fruit maturation and senescence process.	[Mou, Wangshu; Li, Dongdong; Luo, Zisheng; Mao, Linchun; Ying, Tiejin] Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Ying, TJ (corresponding author), Zhejiang Univ, Zhejiang R&D Ctr Food Technol & Equipment, Zhejiang Key Lab Agrofood Proc, Coll Biosyst Engn & Food Sci,Fuli Inst Food Sci, Hangzhou 310003, Zhejiang, Peoples R China.	tjying@zju.edu.cn			National Basic Research Program of China [2013CB127101]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Basic Research Program of China (2013CB127101).	Adato A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000777; Ruiz-Sola MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090765; Alba R, 2004, PLANT J, V39, P697, DOI 10.1111/j.1365-313X.2004.02178.x; ALLEN RD, 1995, PLANT PHYSIOL, V108, P35; [Anonymous], [No title captured]; ASADA K, 1993, NIPPON NOGEIK KAISHI, V67, P1255; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ayub R, 1996, NAT BIOTECHNOL, V14, P862, DOI 10.1038/nbt0796-862; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; Barickman TC, 2014, J AM SOC HORTIC SCI, V139, P261, DOI 10.21273/JASHS.139.3.261; Bendix I, 2012, BRAIN RES, V1484, P68, DOI 10.1016/j.brainres.2012.09.024; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bovy A, 2002, PLANT CELL, V14, P2509, DOI 10.1105/tpc.004218; BOWLER C, 1992, ANNU REV PLANT PHYS, V43, P83, DOI 10.1146/annurev.pp.43.060192.000503; Bramley PM, 2002, J EXP BOT, V53, P2107, DOI 10.1093/jxb/erf059; BRAVDO BA, 1977, PLANT PHYSIOL, V60, P309, DOI 10.1104/pp.60.2.309; Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; Buchert AM, 2011, J PLANT PHYSIOL, V168, P337, DOI 10.1016/j.jplph.2010.07.011; Bueno P, 1998, PLANT SCI, V138, P27, DOI 10.1016/S0168-9452(98)00154-X; Buker M, 1998, J EXP BOT, V49, P681, DOI 10.1093/jexbot/49.321.681; Carrara S, 2001, PHOTOSYNTHETICA, V39, P75, DOI 10.1023/A:1012495903093; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Chen TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080816; Choudhary R, 2012, J FOOD SCI TECH MYS, V49, P649, DOI 10.1007/s13197-011-0464-3; Cookson PJ, 2003, PLANTA, V217, P896, DOI 10.1007/s00425-003-1065-9; Dai SJ, 2014, PLANT PHYSIOL BIOCH, V82, P299, DOI 10.1016/j.plaphy.2014.06.013; Dibari B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-221; Drechsel DA, 2010, J BIOL CHEM, V285, P27850, DOI 10.1074/jbc.M110.101196; DUBICK MA, 1982, FED PROC, V41, P943; Escobar JA, 1996, FREE RADICAL BIO MED, V20, P285, DOI 10.1016/0891-5849(95)02037-3; Feng JJ, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0451-3; FRASER PD, 1994, PLANT PHYSIOL, V105, P405, DOI 10.1104/pp.105.1.405; Fujisawa M, 2014, PLANT CELL, V26, P89, DOI 10.1105/tpc.113.119453; Galpaz N, 2008, PLANT J, V53, P717, DOI 10.1111/j.1365-313X.2007.03362.x; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Guan LQM, 2000, PLANT J, V22, P87, DOI 10.1046/j.1365-313x.2000.00723.x; Guis M, 1997, J AM SOC HORTIC SCI, V122, P748, DOI 10.21273/JASHS.122.6.748; Gupta S, 2013, J EXP BOT, V64, P695, DOI 10.1093/jxb/ers365; HAHLBROCK K, 1979, ANNU REV PLANT PHYS, V30, P105, DOI 10.1146/annurev.pp.30.060179.000541; Hao GP, 2010, BIOTECHNOL LETT, V32, P305, DOI 10.1007/s10529-009-0139-6; Hetherington SE, 1998, J EXP BOT, V49, P1173, DOI 10.1093/jexbot/49.324.1173; Hu XL, 2005, PLANTA, V223, P57, DOI 10.1007/s00425-005-0068-0; Huang B, 2008, RUSS J PLANT PHYSL+, V55, P390, DOI 10.1134/S1021443708030163; Huang GJ, 2013, BOT STUD, V54; Ibrahim MH, 2013, MOLECULES, V18, P7957, DOI 10.3390/molecules18077957; Ishikawa T, 2008, BIOSCI BIOTECH BIOCH, V72, P1143, DOI 10.1271/bbb.80062; Jia HF, 2011, PLANT PHYSIOL, V157, P188, DOI 10.1104/pp.111.177311; Jiang HW, 2007, PLANT J, V52, P197, DOI 10.1111/j.1365-313X.2007.03221.x; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Jiang YM, 2003, PLANT GROWTH REGUL, V39, P171, DOI 10.1023/A:1022539901044; Jimenez A, 2003, J AGR FOOD CHEM, V51, P6293, DOI 10.1021/jf030052i; Kahlau S, 2008, PLANT CELL, V20, P856, DOI 10.1105/tpc.107.055202; Karlova R, 2014, J EXP BOT, V65, P4527, DOI 10.1093/jxb/eru316; Karppinen K, 2013, PHYTOCHEMISTRY, V95, P127, DOI 10.1016/j.phytochem.2013.06.023; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; KONDO S, 1991, J JPN SOC HORTIC SCI, V60, P505, DOI 10.2503/jjshs.60.505; Kondo S, 1997, J HORTIC SCI BIOTECH, V72, P221, DOI 10.1080/14620316.1997.11515509; Koyama K, 2010, FUNCT INTEGR GENOMIC, V10, P367, DOI 10.1007/s10142-009-0145-8; Lara I, 2000, J AM SOC HORTIC SCI, V125, P183, DOI 10.21273/JASHS.125.2.183; Leng P, 2009, CHINESE SCI BULL, V54, P2830, DOI 10.1007/s11434-009-0486-7; Li X, 2013, J PLANT PHYSIOL, V170, P1630, DOI 10.1016/j.jplph.2013.06.010; Li Z, 2010, J AGR FOOD CHEM, V58, P6503, DOI 10.1021/jf1006962; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohani S, 2004, POSTHARVEST BIOL TEC, V31, P119, DOI 10.1016/j.postharvbio.2003.08.001; Mansouri H, 2012, BIOL PLANTARUM, V56, P153, DOI 10.1007/s10535-012-0033-2; MartinezMadrid MC, 1996, PHYTOCHEMISTRY, V43, P323, DOI 10.1016/0031-9422(96)00192-6; Medina-Puche L, 2014, J EXP BOT, V65, P401, DOI 10.1093/jxb/ert377; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Nagira Y, 2006, J PLANT RES, V119, P137, DOI 10.1007/s10265-005-0256-9; Nakajima S, 2012, PLANT PHYSIOL, V160, P261, DOI 10.1104/pp.112.196881; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nitsch L, 2012, J PLANT PHYSIOL, V169, P878, DOI 10.1016/j.jplph.2012.02.004; Noguera-Mazon V, 2006, J BIOL CHEM, V281, P31736, DOI 10.1074/jbc.M602188200; OHTA K, 1992, J JPN SOC HORTIC SCI, V61, P49, DOI 10.2503/jjshs.61.49; Passaia G, 2014, J EXP BOT, V65, P1403, DOI 10.1093/jxb/ert486; PIECHULLA B, 1987, PLANT PHYSIOL, V84, P911, DOI 10.1104/pp.84.3.911; Ranjan S, 2012, PLANT PHYSIOL BIOCH, V52, P66, DOI 10.1016/j.plaphy.2011.11.008; RAO MV, 1995, PLANT PHYSIOL, V109, P421, DOI 10.1104/pp.109.2.421; Razzaq K, 2013, SCI HORTIC-AMSTERDAM, V160, P108, DOI 10.1016/j.scienta.2013.05.018; Ren J, 2011, NEW ZEAL J CROP HORT, V39, P161, DOI 10.1080/01140671.2011.563424; Renato M, 2014, PLANT PHYSIOL, V166, P920, DOI 10.1104/pp.114.243931; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rodrigo MJ, 2007, POSTHARVEST BIOL TEC, V43, P14, DOI 10.1016/j.postharvbio.2006.07.008; Rodrigo MJ, 2003, J EXP BOT, V54, P727, DOI 10.1093/jxb/erg083; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Rouhier N, 2008, BBA-GEN SUBJECTS, V1780, P1249, DOI 10.1016/j.bbagen.2007.12.007; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaffer AA, 1997, PLANT PHYSIOL, V113, P739, DOI 10.1104/pp.113.3.739; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schenk N, 2007, FEBS LETT, V581, P5517, DOI 10.1016/j.febslet.2007.10.060; Sheoran IS, 2006, PHYSIOL PLANTARUM, V127, P681, DOI 10.1111/j.1399-3054.2006.00697.x; Singh SP, 2014, POSTHARVEST BIOL TEC, V96, P14, DOI 10.1016/j.postharvbio.2014.05.005; Smillie RM, 1999, J EXP BOT, V50, P707, DOI 10.1093/jexbot/50.334.707; Smita S, 2013, J GENET, V92, P363, DOI 10.1007/s12041-013-0275-6; Song WW, 2011, PLANT PHYSIOL BIOCH, V49, P693, DOI 10.1016/j.plaphy.2011.03.018; Steinhauser MC, 2010, PLANT PHYSIOL, V153, P80, DOI 10.1104/pp.110.154336; Sun L, 2012, J EXP BOT, V63, P3097, DOI 10.1093/jxb/ers026; Sun Y, 2013, J PLANT GROWTH REGUL, V32, P233, DOI 10.1007/s00344-012-9293-5; Tan CK, 2012, SCI HORTIC-AMSTERDAM, V142, P23, DOI 10.1016/j.scienta.2012.04.030; Tanaka A, 2006, CURR OPIN PLANT BIOL, V9, P248, DOI 10.1016/j.pbi.2006.03.011; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Terrier N, 2005, PLANTA, V222, P832, DOI 10.1007/s00425-005-0017-y; THEOLOGIS A, 1993, DEV GENET, V14, P282, DOI 10.1002/dvg.1020140406; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsai YC, 2004, PLANT GROWTH REGUL, V43, P207, DOI 10.1023/B:GROW.0000046001.24746.df; Tung SA, 2008, PLANT CELL ENVIRON, V31, P968, DOI 10.1111/j.1365-3040.2008.01812.x; Wang H, 2009, PLANT CELL, V21, P1428, DOI 10.1105/tpc.108.060830; Wang HC, 2007, PLANT GROWTH REGUL, V52, P189, DOI 10.1007/s10725-007-9189-8; Wang Y, 2013, BMC GENOMICS, V14; Wang YP, 2013, PLANT PHYSIOL BIOCH, V64, P70, DOI 10.1016/j.plaphy.2012.12.015; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Yu LJ, 2012, NEW PHYTOL, V195, P97, DOI 10.1111/j.1469-8137.2012.04154.x; Zaharah SS, 2013, POSTHARVEST BIOL TEC, V75, P37, DOI 10.1016/j.postharvbio.2012.07.009; Zhang M, 2009, J PLANT PHYSIOL, V166, P1241, DOI 10.1016/j.jplph.2009.01.013; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhang YM, 2008, J PLANT GROWTH REGUL, V27, P151, DOI 10.1007/s00344-008-9041-z; Zhu MK, 2014, PLANT CELL PHYSIOL, V55, P119, DOI 10.1093/pcp/pct162; Zouari I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-221	120	54	54	7	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129598	10.1371/journal.pone.0129598	http://dx.doi.org/10.1371/journal.pone.0129598			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053166	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300151
J	Reddy, RC; Amodei, R; Estill, CT; Stormshak, F; Meaker, M; Roselli, CE				Reddy, Radhika C.; Amodei, Rebecka; Estill, Charles T.; Stormshak, Fred; Meaker, Mary; Roselli, Charles E.			Effect of Testosterone on Neuronal Morphology and Neuritic Growth of Fetal Lamb Hypothalamus-Preoptic Area and Cerebral Cortex in Primary Culture	PLOS ONE			English	Article							SEXUALLY DIMORPHIC NUCLEUS; ANDROGEN RECEPTOR; STEROID-HORMONES; SEX-DIFFERENCES; CELL-DEATH; IN-VITRO; DIFFERENTIATION; BRAIN; AROMATASE; BEHAVIOR	Testosterone plays an essential role in sexual differentiation of the male sheep brain. The ovine sexually dimorphic nucleus (oSDN), is 2 to 3 times larger in males than in females, and this sex difference is under the control of testosterone. The effect of testosterone on oSDN volume may result from enhanced expansion of soma areas and/or dendritic fields. To test this hypothesis, cells derived from the hypothalamus-preoptic area (HPOA) and cerebral cortex (CTX) of lamb fetuses were grown in primary culture to examine the direct morphological effects of testosterone on these cellular components. We found that within two days of plating, neurons derived from both the HPOA and CTX extend neuritic processes and express androgen receptors and aromatase immunoreactivity. Both treated and control neurites continue to grow and branch with increasing time in culture. Treatment with testosterone (10 nM) for 3 days significantly (P < 0.05) increased both total neurite outgrowth (35%) and soma size (8%) in the HPOA and outgrowth (21%) and number of branch points (33%) in the CTX. These findings indicate that testosterone-induced somal enlargement and neurite outgrowth	[Reddy, Radhika C.; Amodei, Rebecka; Roselli, Charles E.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Estill, Charles T.; Stormshak, Fred; Meaker, Mary] Oregon State Univ, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Estill, Charles T.] Oregon State Univ, Coll Vet Med, Dept Clin Sci, Corvallis, OR 97331 USA	Oregon Health & Science University; Oregon State University; Oregon State University	Roselli, CE (corresponding author), Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA.	roselllic@ohsu.edu			National Institutes of Health [NIH R01OD011047]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011047, P51OD011092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health NIH R01OD011047 (CER). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander Brenda M., 2011, FRONT NEUROENDOCRIN, V2, P1, DOI 10.3389/fendo.2011.00042; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; Beyer C, 1997, DEV BRAIN RES, V98, P74, DOI 10.1016/S0165-3806(96)00170-8; Cooke B, 1998, FRONT NEUROENDOCRIN, V19, P323, DOI 10.1006/frne.1998.0171; Davis EC, 1996, BRAIN RES, V734, P10, DOI 10.1016/0006-8993(96)00298-3; DIAZ H, 1992, J NEUROSCI RES, V33, P266, DOI 10.1002/jnr.490330210; DODSON RE, 1993, J NEUROBIOL, V24, P80, DOI 10.1002/neu.480240107; Estrada M, 2006, J CELL SCI, V119, P733, DOI 10.1242/jcs.02775; Forger NG, 2006, NEUROSCIENCE, V138, P929, DOI 10.1016/j.neuroscience.2005.07.006; Georget V, 1997, MOL CELL ENDOCRINOL, V129, P17, DOI 10.1016/S0303-7207(97)04034-3; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; GORSKI RA, 1980, J COMP NEUROL, V193, P529, DOI 10.1002/cne.901930214; HAMMER RP, 1984, INT J DEV NEUROSCI, V2, P77, DOI 10.1016/0736-5748(84)90062-5; Herbison AE, 1996, NEUROENDOCRINOLOGY, V63, P120, DOI 10.1159/000126948; HOUTSMULLER EJ, 1994, PHYSIOL BEHAV, V56, P535, DOI 10.1016/0031-9384(94)90298-4; Iwakura T, 2010, TOXICOLOGY, V272, P52, DOI 10.1016/j.tox.2010.04.005; Kay GW, 2006, J NEUROSCI METH, V155, P98, DOI 10.1016/j.jneumeth.2006.01.008; Lenz KM, 2010, EUR J NEUROSCI, V32, P2096, DOI 10.1111/j.1460-9568.2010.07511.x; Lepore G, 2009, EUR J HISTOCHEM, V53, P233, DOI 10.4081/ejh.2009.e28; Lepore G, 2013, NEUROENDOCRINOL LETT, V34, P395; Lombardo MV, 2012, J NEUROSCI, V32, P674, DOI 10.1523/JNEUROSCI.4389-11.2012; LUSTIG RH, 1994, HORM BEHAV, V28, P383, DOI 10.1006/hbeh.1994.1035; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Marron TU, 2005, J NEUROCHEM, V92, P10, DOI 10.1111/j.1471-4159.2004.02836.x; MCINTOSH GH, 1979, NEUROPATH APPL NEURO, V5, P103, DOI 10.1111/j.1365-2990.1979.tb00664.x; Mura A, 2010, NEUROENDOCRINOL LETT, V31, P690; Ottem EN, 2013, NEUROSCIENCE, V239, P124, DOI 10.1016/j.neuroscience.2012.12.019; Rakotoarivelo C, 2004, NEUROENDOCRINOLOGY, V80, P284, DOI 10.1159/000083611; Reddy RC, 2014, J NEUROENDOCRINOL, V26, P321, DOI 10.1111/jne.12152; Reddy RC, 2014, BRAIN RES, V1554, P21, DOI 10.1016/j.brainres.2014.01.041; Rhees RW, 1999, BRAIN RES BULL, V50, P193, DOI 10.1016/S0361-9230(99)00191-4; Roselli CE, 2012, J NEUROENDOCRINOL, V24, P443, DOI 10.1111/j.1365-2826.2011.02260.x; Roselli CE, 2009, BRAIN RES, V1249, P113, DOI 10.1016/j.brainres.2008.10.047; Roselli CE, 2004, ENDOCRINOLOGY, V145, P478, DOI 10.1210/en.2003-1098; Roselli CE, 2007, ENDOCRINOLOGY, V148, P4450, DOI 10.1210/en.2007-0454; Roselli CE, 2014, ENDOCRINOLOGY, V155, P5000, DOI 10.1210/en.2013-2176; Roselli CE, 2011, ENDOCRINOLOGY, V152, P2409, DOI 10.1210/en.2010-1445; TAKAGI K, 1993, INT J DEV NEUROSCI, V11, P63, DOI 10.1016/0736-5748(93)90035-C; TORANALLERAND CD, 1980, BRAIN RES, V189, P413, DOI 10.1016/0006-8993(80)90101-8; TORANALLERAND CD, 1991, PSYCHONEUROENDOCRINO, V16, P7, DOI 10.1016/0306-4530(91)90068-5; UCHIBORI M, 1985, INT J DEV NEUROSCI, V3, P169, DOI 10.1016/0736-5748(85)90007-3; Wallen K, 2005, FRONT NEUROENDOCRIN, V26, P7, DOI 10.1016/j.yfrne.2005.02.001	42	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129521	10.1371/journal.pone.0129521	http://dx.doi.org/10.1371/journal.pone.0129521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053052	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300137
J	Bosamia, TC; Mishra, GP; Thankappan, R; Dobaria, JR				Bosamia, Tejas C.; Mishra, Gyan P.; Thankappan, Radhakrishnan; Dobaria, Jentilal R.			Novel and Stress Relevant EST Derived SSR Markers Developed and Validated in Peanut	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; DENSITY GENETIC-MAP; ARACHIS-HYPOGAEA L.; CULTIVATED PEANUT; MICROSATELLITE MARKERS; LINKAGE MAP; IN-SILICO; RUST RESISTANCE; IDENTIFICATION; DISCOVERY	With the aim to increase the number of functional markers in resource poor crop like cultivated peanut (Arachis hypogaea), large numbers of available expressed sequence tags (ESTs) in the public databases, were employed for the development of novel EST derived simple sequence repeat (SSR) markers. From 16424 unigenes, 2784 (16.95%) SSRs containing unigenes having 3373 SSR motifs were identified. Of these, 2027 (72.81%) sequences were annotated and 4124 gene ontology terms were assigned. Among different SSR motif-classes, tri-nucleotide repeats (33.86%) were the most abundant followed by dinucleotide repeats (27.51%) while AG/CT (20.7%) and AAG/CTT (13.25%) were the most abundant repeat-motifs. A total of 2456 EST-SSR novel primer pairs were designed, of which 366 unigenes having relevance to various stresses and other functions, were PCR validated using a set of 11 diverse peanut genotypes. Of these, 340 (92.62%) primer pairs yielded clear and scorable PCR products and 39 (10.66%) primer pairs exhibited polymorphisms. Overall, the number of alleles per marker ranged from 1-12 with an average of 3.77 and the PIC ranged from 0.028 to 0.375 with an average of 0.325. The identified EST-SSRs not only enriched the existing molecular markers kitty, but would also facilitate the targeted research in marker-trait association for various stresses, inter-specific studies and genetic diversity analysis in peanut.	[Bosamia, Tejas C.; Mishra, Gyan P.; Thankappan, Radhakrishnan; Dobaria, Jentilal R.] ICAR Res Complex, Directorate Groundnut Res, Crop Improvement Div, Junagadh 362001, Gujarat, India; [Bosamia, Tejas C.] Junagadh Agr Univ, Dept Biotechnol, Coll Agr, Junagadh 362001, Gujarat, India	Indian Council of Agricultural Research (ICAR); ICAR - Directorate of Groundnut Research	Thankappan, R (corresponding author), ICAR Res Complex, Directorate Groundnut Res, Crop Improvement Div, Junagadh 362001, Gujarat, India.	radhakrishnan.nrcg@gmail.com	Mishra, Gyan P./E-5980-2010; bosamia, tejas/P-2264-2019	Mishra, Gyan P./0000-0002-7023-2638; bosamia, tejas/0000-0002-2079-2397				Agarwal G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052443; Akash MW, 2012, PLANT BREEDING, V131, P522, DOI 10.1111/j.1439-0523.2012.01969.x; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Asp T, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-36; Bao JS, 2002, THEOR APPL GENET, V105, P898, DOI 10.1007/s00122-002-1049-3; Benbouza Halima, 2006, Biotechnologie Agronomie Societe et Environnement, V10, P77; Bhauso Tengale Dipak, 2014, ScientificWorldJournal, V2014, P125967, DOI 10.1155/2014/125967; Blair MW, 2012, MOL ECOL RESOUR, V12, P661, DOI 10.1111/j.1755-0998.2012.03136.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Brautigam A, 2011, J EXP BOT, V62, P3093, DOI 10.1093/jxb/err029; Chen XP, 2013, PLANT BIOTECHNOL J, V11, P115, DOI 10.1111/pbi.12018; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Childs KL, 2007, NUCLEIC ACIDS RES, V35, pD846, DOI 10.1093/nar/gkl785; Chopra R, 2015, MOL GENET GENOMICS, V290, P1169, DOI 10.1007/s00438-014-0976-4; Chopra R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115055; Cuc LM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-55; Dodia SM, 2014, J PURE APPL MICROBIO, V8, P4623; Doyle J. J., 1987, PHYTOCHEM B, P11; Dutta S, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-17; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FAO, 2019, FOOD AGR ORG UN; Ferguson ME, 2004, THEOR APPL GENET, V108, P1064, DOI 10.1007/s00122-003-1535-2; Gajjar K. N., 2014, Australian Journal of Crop Science, V8, P927; Garg R, 2011, DNA RES, V18, P53, DOI 10.1093/dnares/dsq028; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; Gautami B., 2009, International Journal of Integrative Biology, V7, P100; Gimenes MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-9; Guimaraes PM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-387; Guo Baozhu, 2009, Int J Plant Genomics, V2009, P715605, DOI 10.1155/2009/715605; HALWARD TM, 1991, GENOME, V34, P1013, DOI 10.1139/g91-156; He GH, 2005, EUPHYTICA, V142, P131, DOI 10.1007/s10681-005-1043-3; He Guohao, 2003, BMC Plant Biology, V3, P3, DOI 10.1186/1471-2229-3-3; Hopkins MS, 1999, CROP SCI, V39, P1243, DOI 10.2135/cropsci1999.0011183X003900040047x; Jayashree B., 2006, In Silico Biology, V6, P607; Kalia RK, 2011, EUPHYTICA, V177, P309, DOI 10.1007/s10681-010-0286-9; Kaur S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-104; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Koilkonda P, 2012, MOL BREEDING, V30, P125, DOI 10.1007/s11032-011-9604-8; Krapovickas A., 1994, Bonplandia, V8, P1; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Kumpatla SP, 2005, GENOME, V48, P985, DOI 10.1139/G05-060; Leal-Bertioli SCM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-112; Li XY, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-58; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Liang XQ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-35; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Macedo Selma E, 2012, BMC Res Notes, V5, P86, DOI 10.1186/1756-0500-5-86; Martinez Beltran J., 2005, International salinity forum - managing saline soils and water: science, technology and social issues. Oral Presentation Abstracts, Riverside Convention Center, Riverside, California, USA, 25-28 April 2005, P311; Metzgar D, 2000, GENOME RES, V10, P72; Moretzsohn MC, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-40; Moretzsohn MC, 2005, THEOR APPL GENET, V111, P1060, DOI 10.1007/s00122-005-0028-x; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Nagy ED, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-469; Nagy ED, 2010, MOL BREEDING, V26, P357, DOI 10.1007/s11032-010-9430-4; Nakasugi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059534; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Pandey MK, 2012, PLANT BREEDING, V131, P139, DOI 10.1111/j.1439-0523.2011.01911.x; Peng Z, 2015, PLANT ANIMAL GENOME, VXXIII, pP0740; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Proite K, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-7; Qiu LJ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-278; Rathnakumar A.L., 2013, PEANUT CROP PROFILE, V118; Rathnakumar AL, 2013, ANN M GROUNDN RES AL, P1; Ren XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088091; Saha MC, 2004, THEOR APPL GENET, V109, P783, DOI 10.1007/s00122-004-1681-1; Sarkar T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110507; Sarvamangala C, 2011, FIELD CROP RES, V122, P49, DOI 10.1016/j.fcr.2011.02.010; Sato S, 2008, DNA RES, V15, P227, DOI 10.1093/dnares/dsn008; Singh D, 2015, J ENVIRON BIOL, V36, P441; SONG G, 2010, ELECTRON J BIOTECHN, V13, P3, DOI DOI 10.2225/VOL13-ISSUE3-FULLTEXT-10; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Sukruth M, 2015, EUPHYTICA, V204, P343, DOI 10.1007/s10681-014-1339-2; Tang JF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-374; Temnykh S, 2001, GENOME RES, V11, P1441, DOI 10.1101/gr.184001; Temsch EM, 2000, GENOME, V43, P449, DOI 10.1139/gen-43-3-449; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thirumalaisamy P. P., 2014, Journal of Mycology and Plant Pathology, V44, P459; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney Rajeev K., 2007, P207, DOI 10.1007/978-1-4020-6297-1_10; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vijay N, 2013, MOL ECOL, V22, P620, DOI 10.1111/mec.12014; Wang CT, 2007, ELECTRON J BIOTECHN, V10, P473, DOI 10.2225/vol10-issue3-fulltext-10; Wang H, 2012, BMC PLANT BIOL, V12, DOI [10.1186/1471-2229-12-10, 10.1186/1471-2229-12-194]; Wang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092029; Wu N, 2013, THEOR APPL GENET, V126, P1145, DOI 10.1007/s00122-013-2042-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Young ND, 1996, GENOME MAPPING PLANT, P211; Yuan M, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue6-fulltext-6; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao Y., 2012, BMC RES NOTES, V5, P362, DOI DOI 10.1186/1756-0500-5-362	91	33	35	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129127	10.1371/journal.pone.0129127	http://dx.doi.org/10.1371/journal.pone.0129127			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046991	Green Submitted, gold, Green Published			2022-12-26	WOS:000355652200128
J	Chen, CW; Wu, MS; Huang, YJ; Lin, PW; Shih, CJ; Lin, FP; Chang, CY				Chen, Chien-Wen; Wu, Ming-Shan; Huang, Yi-Jen; Lin, Pei-Wen; Shih, Chueh-Ju; Lin, Fu-Pang; Chang, Chi-Yao			Iridovirus CARD Protein Inhibits Apoptosis through Intrinsic and Extrinsic Pathways	PLOS ONE			English	Article							RANAVIRUS FAMILY IRIDOVIRIDAE; EPINEPHELUS-AWOARA TEMMINCK; CELL-DEATH; GROUPER IRIDOVIRUS; SWISS-MODEL; INTERLEUKIN-1-BETA GENERATION; COMPLETE GENOME; INFECTED CELLS; SEQUENCE; DOMAIN	Grouper iridovirus (GIV) belongs to the genus Ranavirus of the family Iridoviridae; the genomes of such viruses contain an anti-apoptotic caspase recruitment domain (CARD) gene. The GIV-CARD gene encodes a protein of 91 amino acids with a molecular mass of 10,505 Daltons, and shows high similarity to other viral CARD genes and human ICEBERG. In this study, we used Northern blot to demonstrate that GIV-CARD transcription begins at 4 h post-infection; furthermore, we report that its transcription is completely inhibited by cycloheximide but not by aphidicolin, indicating that GIV-CARD is an early gene. GIV-CARD-EGFP and GIV-CARD-FLAG recombinant proteins were observed to translocate from the cytoplasm into the nucleus, but no obvious nuclear localization sequence was observed within GIV-CARD. RNA interference-mediated knockdown of GIV-CARD in GK cells infected with GIV inhibited expression of GIV-CARD and five other viral genes during the early stages of infection, and also reduced GIV infection ability. Immunostaining was performed to show that apoptosis was effectively inhibited in cells expressing GIV-CARD. HeLa cells irradiated with UV or treated with anti-Fas antibody will undergo apoptosis through the intrinsic and extrinsic pathways, respectively. However, over-expression of recombinant GIV-CARD protein in HeLa cells inhibited apoptosis induced by mitochondrial and death receptor signaling. Finally, we report that expression of GIV-CARD in HeLa cells significantly reduced the activities of caspase-8 and -9 following apoptosis triggered by anti-Fas antibody. Taken together, these results demonstrate that GIV-CARD inhibits apoptosis through both intrinsic and extrinsic pathways.	[Chen, Chien-Wen; Wu, Ming-Shan; Huang, Yi-Jen; Lin, Pei-Wen; Shih, Chueh-Ju; Chang, Chi-Yao] Acad Sinica, Mol Genet Lab, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chen, Chien-Wen; Shih, Chueh-Ju; Chang, Chi-Yao] Natl Taiwan Univ, Inst Fisheries Sci, Taipei 10764, Taiwan; [Lin, Pei-Wen; Lin, Fu-Pang; Chang, Chi-Yao] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan	Academia Sinica - Taiwan; National Taiwan University; National Taiwan Ocean University	Chang, CY (corresponding author), Acad Sinica, Mol Genet Lab, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	cychang@gate.sinica.edu.tw		Lin, Pei-Wen/0000-0002-9744-9546	National Science Council (Ministry of Science and Technology), Taiwan [NSC99-2311-B-001-005-MY3]	National Science Council (Ministry of Science and Technology), Taiwan	This study was supported by Grant no. NSC99-2311-B-001-005-MY3 from the National Science Council (Ministry of Science and Technology), Taiwan. (http://www.most.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Benchoua A, 2002, J BIOL CHEM, V277, P34217, DOI 10.1074/jbc.M203941200; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Bouchier-Hayes L, 2002, EMBO REP, V3, P616, DOI 10.1093/embo-reports/kvf139; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chang MX, 2010, DEV COMP IMMUNOL, V34, P1, DOI 10.1016/j.dci.2009.08.002; Chen LY, 2003, MOL CELL BIOL, V23, P7108, DOI 10.1128/MCB.23.20.7108-7121.2003; D'Costa SM, 2001, ARCH VIROL, V146, P2165, DOI 10.1007/s007050170027; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; Duan H, 1997, NATURE, V385, P86, DOI 10.1038/385086a0; Everett H, 1999, TRENDS MICROBIOL, V7, P160, DOI 10.1016/S0966-842X(99)01487-0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; He JG, 2002, VIROLOGY, V292, P185, DOI 10.1006/viro.2001.1245; Hengartner MO, 1996, CURR OPIN GENET DEV, V6, P34, DOI 10.1016/S0959-437X(96)90007-6; Henry H, 2002, ONCOGENE, V21, P748, DOI 10.1038/sj.onc.1205125; Hofmann K, 1997, TRENDS BIOCHEM SCI, V22, P155, DOI 10.1016/S0968-0004(97)01043-8; Huang YH, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-224; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Jancovich JK, 2010, J VIROL, V84, P2636, DOI 10.1128/JVI.01991-09; Jancovich JK, 2003, VIROLOGY, V316, P90, DOI 10.1016/j.virol.2003.08.001; Kantari C, 2011, BBA-MOL CELL RES, V1813, P558, DOI 10.1016/j.bbamcr.2011.01.026; Lai YS, 2000, J FISH DIS, V23, P379, DOI 10.1046/j.1365-2761.2000.00247.x; Lamkanfi M, 2004, J BIOL CHEM, V279, P51729, DOI 10.1074/jbc.M407891200; Lin PW, 2008, APOPTOSIS, V13, P165, DOI 10.1007/s10495-007-0152-y; Marshall WL, 1999, J VIROL, V73, P5181, DOI 10.1128/JVI.73.6.5181-5185.1999; Matthews GM, 2012, ADV CANCER RES, V116, P165, DOI 10.1016/B978-0-12-394387-3.00005-7; Murali S, 2002, J FISH DIS, V25, P91, DOI 10.1046/j.1365-2761.2002.00343.x; Postigo A, 2006, CELL DEATH DIFFER, V13, P1651, DOI 10.1038/sj.cdd.4401853; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Ross L, 1997, VIROLOGY, V232, P105, DOI 10.1006/viro.1997.8557; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Sachdev S, 1998, MOL CELL BIOL, V18, P2524, DOI 10.1128/MCB.18.5.2524; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shisler JL, 2001, VIROLOGY, V282, P14, DOI 10.1006/viro.2001.0834; Tan WGH, 2004, VIROLOGY, V323, P70, DOI 10.1016/j.virol.2004.02.019; Thome M, 1998, CURR BIOL, V8, P885, DOI 10.1016/S0960-9822(07)00352-1; Thome M, 2001, J CELL BIOL, V152, P1115, DOI 10.1083/jcb.152.5.1115; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tsai CT, 2005, J VIROL, V79, P2010, DOI 10.1128/JVI.79.4.2010-2023.2005; Wallach D, 1997, TRENDS BIOCHEM SCI, V22, P107, DOI 10.1016/S0968-0004(97)01015-3; Wang X, 2006, BIOCHIM BIOPHYS ACTA, P1762; Yamazaki T, 2014, CLIN EXP VACCINE RES, V3, P5, DOI 10.7774/cevr.2014.3.1.5; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200	46	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129071	10.1371/journal.pone.0129071	http://dx.doi.org/10.1371/journal.pone.0129071			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047333	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200120
J	Chen, L; Yang, J; Zheng, MY; Kong, XY; Huang, T; Cai, YD				Chen, Lei; Yang, Jing; Zheng, Mingyue; Kong, Xiangyin; Huang, Tao; Cai, Yu-Dong			The Use of Chemical-Chemical Interaction and Chemical Structure to Identify New Candidate Chemicals Related to Lung Cancer	PLOS ONE			English	Article							TRANS-RETINOIC ACID; INDUCED MALIGNANT-TRANSFORMATION; MITOXANTRONE PLUS PREDNISONE; RESISTANT PROSTATE-CANCER; INDUCED GROWTH-INHIBITION; DNA-DAMAGE; PHASE-III; SOMATIC MUTATIONS; OXIDATIVE STRESS; PIK3CA MUTATION	Lung cancer causes over one million deaths every year worldwide. However, prevention and treatment methods for this serious disease are limited. The identification of new chemicals related to lung cancer may aid in disease prevention and the design of more effective treatments. This study employed a weighted network, constructed using chemical-chemical interaction information, to identify new chemicals related to two types of lung cancer: non-small lung cancer and small-cell lung cancer. Then, a randomization test as well as chemical-chemical interaction and chemical structure information were utilized to make further selections. A final analysis of these new chemicals in the context of the current literature indicates that several chemicals are strongly linked to lung cancer.	[Chen, Lei; Cai, Yu-Dong] Shanghai Univ, Coll Life Sci, Shanghai 200444, Peoples R China; [Chen, Lei] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China; [Yang, Jing; Kong, Xiangyin; Huang, Tao] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Zheng, Mingyue] Shanghai Inst Mat Med, Drug Discovery & Design Ctr, Shanghai 201203, Peoples R China	Shanghai University; Shanghai Maritime University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Huang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China.	tohuangtao@126.com; cai_yud@126.com	Zheng, Mingyue/Z-3582-2019; Zheng, Mingyue/B-4860-2010; Zheng, Mingyue/AAJ-8027-2020; Zheng, Mingyue/HHZ-4062-2022; Chen, Lei/A-2275-2011	Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Zheng, Mingyue/0000-0002-3323-3092; Chen, Lei/0000-0003-3068-1583; cai, yudong/0000-0001-5664-7979	National Basic Research Program of China [2011CB510101, 2011CB510102]; National Natural Science Foundation of China [61202021, 31371335, 61373028, 61303099]; Innovation Program of Shanghai Municipal Education Commission [12YZ120, 12ZZ087]; "The First-class Discipline of Universities in Shanghai" of the Shanghai Educational Development Foundation [12CG55]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); "The First-class Discipline of Universities in Shanghai" of the Shanghai Educational Development Foundation	This work was supported by National Basic Research Program of China (2011CB510101, 2011CB510102), the National Natural Science Foundation of China (61202021, 31371335, 61373028, 61303099), the Innovation Program of Shanghai Municipal Education Commission (12YZ120, 12ZZ087), and a grant from "The First-class Discipline of Universities in Shanghai" of the Shanghai Educational Development Foundation (12CG55). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanzar WE, 2002, JNCI-J NATL CANCER I, V94, P1888, DOI 10.1093/jnci/94.24.1888; Aisner DL, 2012, AM J CLIN PATHOL, V138, P332, DOI 10.1309/AJCPFR12WJKCEEZZ; Arcangeli A, 2009, CURR MED CHEM, V16, P66, DOI 10.2174/092986709787002835; Arrieta O, 2006, CANCER-AM CANCER SOC, V107, P1852, DOI 10.1002/cncr.22198; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Bains OS, 2013, J PHARMACOL EXP THER, V347, P375, DOI 10.1124/jpet.113.206805; Basu HS, 2009, CANCER RES, V69, P7689, DOI 10.1158/0008-5472.CAN-08-2472; Ben-Chetrit E, 1998, SEMIN ARTHRITIS RHEU, V28, P48, DOI 10.1016/S0049-0172(98)80028-0; Berthold DR, 2008, J CLIN ONCOL, V26, P242, DOI 10.1200/JCO.2007.12.4008; Blanco JG, 2008, CANCER-AM CANCER SOC, V112, P2789, DOI 10.1002/cncr.23534; Bredfeldt TG, 2006, TOXICOL APPL PHARM, V216, P69, DOI 10.1016/j.taap.2006.04.011; Brouwers L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022187; Buttitta F, 2006, INT J CANCER, V119, P2586, DOI 10.1002/ijc.22143; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Chanvorachote P, 2013, AM J PHYSIOL-CELL PH, V304, pC263, DOI 10.1152/ajpcell.00225.2012; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107767; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2013, CURR BIOINFORM, V8, P200, DOI 10.2174/1574893611308020008; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Craven J. B. M., 2005, MARKOV NETWORKS DETE; Cui X, 2004, TOXICOL PATHOL, V32, P64, DOI 10.1080/01926230490261348; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; De Greve J, 2012, LUNG CANCER, V76, P123, DOI 10.1016/j.lungcan.2012.01.008; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dunkel M, 2008, NUCLEIC ACIDS RES, V36, pW55, DOI 10.1093/nar/gkn307; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Filaire E, 2013, LUNG CANCER, V82, P383, DOI 10.1016/j.lungcan.2013.09.009; From the American Cancer Society, 2007, CA-CANCER J CLIN, V57, P29; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gilbert-Diamond D, 2013, ENV HLTH PERSPECT, V121, P154; GOLDFINGER SE, 1972, NEW ENGL J MED, V287, P1302; Gomez SE, 2005, BIOL TRACE ELEM RES, V108, P115, DOI 10.1385/BTER:108:1-3:115; Gormen T. H., 1990, INTRO ALGORITHMS; Graus F, 2002, NEUROLOGY, V59, P764, DOI 10.1212/WNL.59.5.764; GUPTA RS, 1986, J CELL PHYSIOL, V127, P197, DOI 10.1002/jcp.1041270202; Hauptman PJ, 1999, CIRCULATION, V99, P1265, DOI 10.1161/01.CIR.99.9.1265; Heinmoller P, 2003, CLIN CANCER RES, V9, P5238; Henriques BJ, 2010, CURR MED CHEM, V17, P3842; Hodkinson PS, 2007, INT J RADIAT BIOL, V83, P733, DOI 10.1080/09553000701570204; HOLTTA E, 1977, BIOCHEMISTRY-US, V16, P91, DOI 10.1021/bi00620a015; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Jimenez C, 1998, EMBO J, V17, P743, DOI 10.1093/emboj/17.3.743; Kaira Kyoichi, 2014, J Med Case Rep, V8, P119, DOI 10.1186/1752-1947-8-119; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katiyar SK, 2009, MOL CARCINOGEN, V48, P24, DOI 10.1002/mc.20453; Kawano O, 2006, LUNG CANCER, V54, P209, DOI 10.1016/j.lungcan.2006.07.006; Kheir MM, 2010, FOOD CHEM TOXICOL, V48, P1105, DOI 10.1016/j.fct.2010.01.033; Kojima C, 2009, JNCI-J NATL CANCER I, V101, P1670, DOI 10.1093/jnci/djp414; Kryston TB, 2011, MUTAT RES-FUND MOL M, V711, P193, DOI 10.1016/j.mrfmmm.2010.12.016; Kuhn M, 2008, NUCLEIC ACIDS RES, V36, pD684, DOI 10.1093/nar/gkm795; Kuhn M, 2014, NUCLEIC ACIDS RES, V42, pD401, DOI 10.1093/nar/gkt1207; Lakhman SS, 2005, DRUG METAB DISPOS, V33, P254, DOI 10.1124/dmd.104.002006; Li BQ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/267375; Li GW, 2011, J CELL PHYSIOL, V226, P3225, DOI 10.1002/jcp.22683; Li JY, 2003, BIOINFORMATICS, V19, pII93, DOI 10.1093/bioinformatics/btg1066; Lin JG, 1999, AM J CHINESE MED, V27, P265, DOI 10.1142/S0192415X99000306; Lin ZY, 2013, LIFE SCI, V93, P323, DOI 10.1016/j.lfs.2013.07.002; Luo Y, 2008, ACTA PHARMACOL SIN, V29, P628, DOI 10.1111/j.1745-7254.2008.00786.x; Maeno T, 2002, AM J RESP CELL MOL, V26, P246, DOI 10.1165/ajrcmb.26.2.4509; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; MISAKI T, 1982, CHEM PHARM BULL, V30, P354; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mu D, 2003, CANCER CELL, V3, P297, DOI 10.1016/S1535-6108(03)00054-0; Nesnow S, 2002, CHEM RES TOXICOL, V15, P1627, DOI 10.1021/tx025598y; Ni Y, 2012, HUM MOL GENET, V21, P300, DOI 10.1093/hmg/ddr459; Ninsontia C, 2014, ANTICANCER RES, V34, P5495; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; OGATA A, 1994, BLOOD, V84, P3040; Okudela K, 2007, PATHOL INT, V57, P664, DOI 10.1111/j.1440-1827.2007.02155.x; OLHABERRY JV, 1983, S AFR MED J, V64, P894; Osoba D, 1999, J CLIN ONCOL, V17, P1654, DOI 10.1200/JCO.1999.17.6.1654; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Paone A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.482; Pi JB, 2008, FREE RADICAL BIO MED, V45, P651, DOI 10.1016/j.freeradbiomed.2008.05.020; Pirker R, 2012, LANCET ONCOL, V13, P33, DOI 10.1016/S1470-2045(11)70318-7; Pospisil P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105/7/354; Prasad AS, 2009, NUTR CANCER, V61, P879, DOI 10.1080/01635580903285122; Prasad AS, 1998, J AM COLL NUTR, V17, P409, DOI 10.1080/07315724.1998.10718787; Prasad AS, 2000, J INFECT DIS, V182, pS62, DOI 10.1086/315916; Qi HW, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-22; Refaat A, 2013, ONCOL LETT, V6, P840, DOI 10.3892/ol.2013.1434; Ruanghirun T, 2014, ANTICANCER RES, V34, P2231; Saeh JC, 2005, J CHEM INF MODEL, V45, P1122, DOI 10.1021/ci049732r; Saito A, 2007, ENDOCRINOLOGY, V148, P1412, DOI 10.1210/en.2006-0900; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sawyer DB, 2010, PROG CARDIOVASC DIS, V53, P105, DOI 10.1016/j.pcad.2010.06.007; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; SIDELL N, 1991, J IMMUNOL, V146, P3809; Simunek T, 2009, PHARMACOL REP, V61, P154; Singal R, 2015, CLIN GENITOURIN CANC, V13, P22, DOI 10.1016/j.clgc.2014.07.008; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stueckle TA, 2012, TOXICOL APPL PHARM, V261, P204, DOI 10.1016/j.taap.2012.04.003; Styblo M, 2000, ARCH TOXICOL, V74, P289, DOI 10.1007/s002040000134; Sun Y, 2012, TOXICOL SCI, V125, P20, DOI 10.1093/toxsci/kfr282; Svensson A, 2005, ANTICANCER RES, V25, P207; Tabata C, 2006, AM J PHYSIOL-LUNG C, V290, pL597, DOI 10.1152/ajplung.00282.2005; Tabata C, 2009, EUR RESPIR J, V34, P1159, DOI 10.1183/09031936.00195708; Tannock IF, 1996, J CLIN ONCOL, V14, P1756, DOI 10.1200/JCO.1996.14.6.1756; Tokar EJ, 2012, ARCH TOXICOL, V86, P975, DOI 10.1007/s00204-012-0820-8; Tokar EJ, 2010, CRIT REV TOXICOL, V40, P912, DOI 10.3109/10408444.2010.506641; Tokar EJ, 2010, ENVIRON HEALTH PERSP, V118, P108, DOI 10.1289/ehp.0901059; Toma S, 1999, ANN ONCOL, V10, P95; Treat J, 1996, CANCER INVEST, V14, P415, DOI 10.3109/07357909609018898; Verheye-Dua F. A., 1996, Strahlentherapie und Onkologie, V172, P156; Waalkes MP, 2007, TOXICOL APPL PHARM, V222, P271, DOI 10.1016/j.taap.2006.12.034; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Wang Y, 2012, INT J BIOCHEM CELL B, V44, P1813, DOI 10.1016/j.biocel.2012.06.028; Wang YL, 2005, CANCER CHEMOTH PHARM, V56, P83, DOI 10.1007/s00280-004-0936-5; Wei D, 2013, INT J MOL SCI, V14, P7273, DOI 10.3390/ijms14047273; WEININGER D, 1988, J CHEM INF COMP SCI, V28, P31, DOI 10.1021/ci00057a005; Willett P, 1998, J CHEM INF COMP SCI, V38, P983, DOI 10.1021/ci9800211; Williams YN, 2006, ONCOGENE, V25, P1446, DOI 10.1038/sj.onc.1209192; Wise Sandra S., 2008, Reviews on Environmental Health, V23, P39; Wnek SM, 2010, TOXICOL SCI, V116, P44, DOI 10.1093/toxsci/kfq106; Wu SN, 1998, LIFE SCI, V62, P2283, DOI 10.1016/S0024-3205(98)00209-4; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Zhang WM, 2008, LIFE SCI, V82, P764, DOI 10.1016/j.lfs.2008.01.008; Zhao CQ, 1997, P NATL ACAD SCI USA, V94, P10907, DOI 10.1073/pnas.94.20.10907	125	10	11	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128696	10.1371/journal.pone.0128696	http://dx.doi.org/10.1371/journal.pone.0128696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047514	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200092
J	Collemare, J; Beenen, HG; Crous, PW; de Wit, PJGM; van der Burgt, A				Collemare, Jerome; Beenen, Henriek G.; Crous, Pedro W.; de Wit, Pierre J. G. M.; van der Burgt, Ate			Novel Introner-Like Elements in fungi Are Involved in Parallel Gains of Spliceosomal Introns	PLOS ONE			English	Article							EVOLUTION; GENE; CONSERVATION; POSITIONS; SEQUENCE	Spliceosomal introns are key components of the eukaryotic gene structure. Although they contributed to the emergence of eukaryotes, their origin remains elusive. In fungi, they might originate from the multiplication of invasive introns named Introner-Like Elements (ILEs). However, so far ILEs have been observed in six fungal species only, including Fulvia fulva and Dothistroma septosporum (Dothideomycetes), arguing against ILE insertion as a general mechanism for intron gain. Here, we identified novel ILEs in eight additional fungal species that are phylogenetically related to F. fulva and D. septosporum using PCR amplification with primers derived from previously identified ILEs. The ILE content appeared unique to each species, suggesting independent multiplication events. Interestingly, we identified four genes each containing two gained ILEs. By analysing intron positions in orthologues of these four genes in Ascomycota, we found that three ILEs had inserted within a 15 bp window that contains regular spliceosomal introns in other fungal species. These three positions are not the result of intron sliding because ILEs are newly gained introns. Furthermore, the alternative hypothesis of an inferred ancestral gain followed by independent losses contradicts the observed degeneration of ILEs. These observations clearly indicate three parallel intron gains in four genes that were randomly identified. Our findings suggest that parallel intron gain is a phenomenon that has been highly underestimated in ILE-containing fungi, and likely in the whole fungal kingdom.	[Collemare, Jerome; Beenen, Henriek G.; de Wit, Pierre J. G. M.; van der Burgt, Ate] Wageningen Univ, Lab Phytopathol, NL-6700 AP Wageningen, Netherlands; [Beenen, Henriek G.; van der Burgt, Ate] CBS KNAW Fungal Biodivers Ctr, Evolutionary Phytopathol, Utrecht, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Westerdijk Fungal Biodiversity Institute (KNAW)	Collemare, J (corresponding author), IRHS INRA, UMR1345, Beaucouze, France.	j.collemare@gmail.com	Crous, Pedro W/H-1489-2012	Crous, Pedro W/0000-0001-9085-8825; Collemare, Jerome/0000-0001-8152-6642				Ahmadinejad N, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-57; Carmel L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-192; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheewangkoon R, 2008, PERSOONIA, V21, P77, DOI 10.3767/003158508X370857; Collemare Jerome, 2013, Commun Integr Biol, V6, pe23147, DOI 10.4161/cib.23147; Csuros M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002150; Da Lage JL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-40; Da Lage JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019673; de Wit PJGM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003088; Denoeud F, 2010, SCIENCE, V330, P1381, DOI 10.1126/science.1194167; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flakowski J, 2006, J MOL EVOL, V63, P30, DOI 10.1007/s00239-005-0061-z; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-22; Krauss V, 2005, MOL BIOL EVOL, V22, P74, DOI 10.1093/molbev/msh255; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Li WL, 2014, GENOME BIOL EVOL, V6, P2218, DOI 10.1093/gbe/evu174; Li WL, 2009, SCIENCE, V326, P1260, DOI 10.1126/science.1179302; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Nguyen HD, 2005, PLOS COMPUT BIOL, V1, P631, DOI 10.1371/journal.pcbi.0010079; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14; Nielsen CB, 2004, PLOS BIOL, V2, P2234, DOI 10.1371/journal.pbio.0020422; Oda T, 2011, MOL BIOL REP, V38, P2285, DOI 10.1007/s11033-010-0360-3; Qiu WG, 2004, MOL BIOL EVOL, V21, P1252, DOI 10.1093/molbev/msh120; Rogozin IB, 2000, TRENDS GENET, V16, P430, DOI 10.1016/S0168-9525(00)02096-5; Roy SW, 2007, MOL BIOL EVOL, V24, P1447, DOI 10.1093/molbev/msm048; Roy SW, 2009, TRENDS GENET, V25, P67, DOI 10.1016/j.tig.2008.11.004; Roy SW, 2005, P NATL ACAD SCI USA, V102, P5773, DOI 10.1073/pnas.0500383102; Sambrook J., 2001, MOL CLONING LAB MANU; Stoltzfus A, 1997, P NATL ACAD SCI USA, V94, P10739, DOI 10.1073/pnas.94.20.10739; Sun Y, 2015, GENOME RES, V25, P100, DOI 10.1101/gr.175653.114; Sverdlov AV, 2005, NUCLEIC ACIDS RES, V33, P1741, DOI 10.1093/nar/gki316; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tarrio R, 2003, P NATL ACAD SCI USA, V100, P6580, DOI 10.1073/pnas.0731952100; Torriani SFF, 2011, CURR BIOL, V21, P2017, DOI 10.1016/j.cub.2011.10.041; van der Burgt A, 2012, CURR BIOL, V22, P1260, DOI 10.1016/j.cub.2012.05.011; Verhelst B, 2013, GENOME BIOL EVOL, V5, P2393, DOI 10.1093/gbe/evt189; Wang H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004843; Warf MB, 2010, TRENDS BIOCHEM SCI, V35, P169, DOI 10.1016/j.tibs.2009.10.004; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Yoshihama M, 2006, PLOS GENET, V2, P237, DOI 10.1371/journal.pgen.0020025	41	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129302	10.1371/journal.pone.0129302	http://dx.doi.org/10.1371/journal.pone.0129302			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046656	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200145
J	Kong, XY; Kase, ET; Herskedal, A; Schjalm, C; Damme, M; Nesset, CK; Thoresen, GH; Rustan, AC; Eskild, W				Kong, Xiang Yi; Kase, Eili Tranheim; Herskedal, Anette; Schjalm, Camilla; Damme, Markus; Nesset, Cecilie Kasi; Thoresen, G. Hege; Rustan, Arild C.; Eskild, Winnie			Lack of the Lysosomal Membrane Protein, GLMP, in Mice Results in Metabolic Dysregulation in Liver	PLOS ONE			English	Article							HEPATIC STEATOSIS; GLUCOSE-UPTAKE; KUPFFER CELLS; FATTY LIVER; TRANSCRIPTION FACTOR; PPAR-GAMMA; RECEPTOR; ACCUMULATION; EXPRESSION; DISEASE	Ablation of glycosylated lysosomal membrane protein (GLMP, formerly known as NCU-G1) has been shown to cause chronic liver injury which progresses into liver fibrosis in mice. Both lysosomal dysfunction and chronic liver injury can cause metabolic dysregulation. Glmp(gt/gt) mice (formerly known as Ncu-g1(gt/gt)mice) were studied between 3 weeks and 9 months of age. Body weight gain and feed efficiency of Glmpgt/gt mice were comparable to wild type siblings, only at the age of 9 months the Glmp(gt/gt) siblings had significantly reduced body weight. Reduced size of epididymal fat pads was accompanied by hepatosplenomegaly in Glmp(gt/gt) mice. Blood analysis revealed reduced levels of blood glucose, circulating triacylglycerol and non-esterified fatty acids in Glmp(gt/gt) mice. Increased flux of glucose, increased de novo lipogenesis and lipid accumulation were detected in Glmp(gt/gt) primary hepatocytes, as well as elevated triacylglycerol levels in Glmp(gt/gt) liver homogenates, compared to hepatocytes and liver from wild type mice. Gene expression analysis showed an increased expression of genes involved in fatty acid uptake and lipogenesis in Glmp(gt/gt) liver compared to wild type. Our findings are in agreement with the metabolic alterations observed in other mouse models lacking lysosomal proteins, and with alterations characteristic for advanced chronic liver injury.	[Kong, Xiang Yi; Herskedal, Anette; Schjalm, Camilla; Nesset, Cecilie Kasi; Eskild, Winnie] Univ Oslo, Dept Biosci, Oslo, Norway; [Kase, Eili Tranheim; Thoresen, G. Hege; Rustan, Arild C.] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway; [Damme, Markus] Univ Kiel, Inst Biochem, Kiel, Germany; [Thoresen, G. Hege] Univ Oslo, Inst Clin Med, Fac Med, Dept Pharmacol, Oslo, Norway; [Thoresen, G. Hege] Oslo Univ Hosp, Oslo, Norway	University of Oslo; University of Oslo; University of Kiel; University of Oslo; University of Oslo	Eskild, W (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	winnie.eskild@ibv.uio.no		Kong, Xiang Yi/0000-0003-3244-344X				Alroy Joseph, 2014, J. inborn errors metab. screen., V2, pe130001, DOI 10.1177/2326409813517663; Ballabio A, 2009, BBA-MOL CELL RES, V1793, P684, DOI 10.1016/j.bbamcr.2008.12.001; Bechmann LP, 2012, J HEPATOL, V56, P952, DOI 10.1016/j.jhep.2011.08.025; BERG T, 1973, BIOCHIM BIOPHYS ACTA, V321, P585, DOI 10.1016/0005-2744(73)90201-5; Boustany RMN, 2013, NAT REV NEUROL, V9, P583, DOI 10.1038/nrneurol.2013.163; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buque X, 2010, J LIPID RES, V51, P500, DOI 10.1194/jlr.M001966; Caron S, 2011, ARTERIOSCL THROM VAS, V31, P513, DOI 10.1161/ATVBAHA.110.220723; Cox TM, 2012, J PATHOL, V226, P241, DOI 10.1002/path.3021; Dateki M, 2011, J RECEPT SIG TRANSD, V31, P85, DOI 10.3109/10799893.2010.538405; Degrace P, 2006, J LIPID RES, V47, P2647, DOI 10.1194/jlr.M600140-JLR200; Dongiovanni P, 2011, J HEPATOL, V55, P920, DOI 10.1016/j.jhep.2011.05.008; Endo M, 2007, EXP BIOL MED, V232, P614; Feldstein AE, 2010, SEMIN LIVER DIS, V30, P391, DOI 10.1055/s-0030-1267539; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fredenrich A, 1997, J LIPID RES, V38, P1421; Garcia-Monzon C, 2014, EUR J CLIN INVEST, V44, P65, DOI 10.1111/eci.12192; Hansen B, 2002, MOL CELL BIOCHEM, V240, P1, DOI 10.1023/A:1020660303855; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Huang W, 2010, DIABETES, V59, P347, DOI 10.2337/db09-0016; Imano E, 1999, J HEPATOL, V31, P469, DOI 10.1016/S0168-8278(99)80039-7; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; JOHANSSON U, 1994, J HEPATOL, V20, P760, DOI 10.1016/S0168-8278(05)80147-3; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Kong XY, 2014, DIS MODEL MECH, V7, P351, DOI 10.1242/dmm.014050; KRAHENBUHL S, 1992, SCAND J GASTROENTERO, V27, P90, DOI 10.3109/00365529209096012; KRUSZYNSKA YT, 1993, J CLIN INVEST, V91, P1057, DOI 10.1172/JCI116263; LEATHERDALE BA, 1980, CLIN SCI, V59, P191, DOI 10.1042/cs0590191; Ma KL, 2008, HEPATOLOGY, V48, P770, DOI 10.1002/hep.22423; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Musso G, 2009, PROG LIPID RES, V48, P1, DOI 10.1016/j.plipres.2008.08.001; Nelson JE, 2011, HEPATOLOGY, V53, P448, DOI 10.1002/hep.24038; Nishikawa T, 2014, J HEPATOL, V60, P1203, DOI 10.1016/j.jhep.2014.02.014; Parkinson-Lawrence EJ, 2010, PHYSIOLOGY, V25, P102, DOI 10.1152/physiol.00041.2009; Pavlic M, 2008, ARTERIOSCL THROM VAS, V28, P1660, DOI 10.1161/ATVBAHA.108.169383; Pinzani M, 2011, BEST PRACT RES CL GA, V25, P281, DOI 10.1016/j.bpg.2011.02.009; Platt FM, 2012, J CELL BIOL, V199, P723, DOI 10.1083/jcb.201208152; Popov Y, 2005, J HEPATOL, V43, P1045, DOI 10.1016/j.jhep.2005.06.025; Riganti C, 2012, FREE RADICAL BIO MED, V53, P421, DOI 10.1016/j.freeradbiomed.2012.05.006; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Sahini N, 2014, PROG LIPID RES, V54, P86, DOI 10.1016/j.plipres.2014.02.002; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schieweck O, 2009, BIOCHEM J, V422, P83, DOI 10.1042/BJ20090567; SCHONFELD G, 1979, METABOLISM, V28, P1001, DOI 10.1016/0026-0495(79)90004-0; Schroder BA, 2010, PROTEOMICS, V10, P4053, DOI 10.1002/pmic.201000196; Schultz ML, 2011, TRENDS NEUROSCI, V34, P401, DOI 10.1016/j.tins.2011.05.006; Settembre C, 2014, TRENDS CELL BIOL, V24, P743, DOI 10.1016/j.tcb.2014.06.006; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; SHMUELI E, 1993, HEPATOLOGY, V18, P86, DOI 10.1016/0270-9139(93)90511-K; Steffensen KR, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-106; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Tsochatzis EA, 2014, LANCET, V383, P1749, DOI 10.1016/S0140-6736(14)60121-5; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103071; Wang YX, 2010, CELL RES, V20, P124, DOI 10.1038/cr.2010.13; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200; Woloszynek JC, 2009, J BIOL CHEM, V284, P29684, DOI 10.1074/jbc.M109.020818; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037	64	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129402	10.1371/journal.pone.0129402	http://dx.doi.org/10.1371/journal.pone.0129402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047317	Green Published, gold			2022-12-26	WOS:000355652200160
J	Llanos, P; Contreras-Ferrat, A; Barrientos, G; Valencia, M; Mears, D; Hidalgo, C				Llanos, Paola; Contreras-Ferrat, Ariel; Barrientos, Genaro; Valencia, Marco; Mears, David; Hidalgo, Cecilia			Glucose-Dependent Insulin Secretion in Pancreatic beta-Cell Islets from Male Rats Requires Ca2+ Release via ROS-Stimulated Ryanodine Receptors	PLOS ONE			English	Article							CHRONIC OXIDATIVE STRESS; CYCLIC ADP-RIBOSE; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; CALCIUM-RELEASE; INOSITOL 1,4,5-TRISPHOSPHATE; GLUTATHIONE-PEROXIDASE; ACTIVATION; MOBILIZATION; LINE	Glucose-stimulated insulin secretion (GSIS) from pancreatic beta-cells requires an increase in intracellular free Ca2+ concentration ([Ca2+]). Glucose uptake into beta-cells promotes Ca2+ influx and reactive oxygen species (ROS) generation. In other cell types, Ca2+ and ROS jointly induce Ca2+ releasemediated by ryanodine receptor (RyR) channels. Therefore, we explored here if RyR-mediated Ca2+ release contributes to GSIS in beta-cell islets isolated from male rats. Stimulatory glucose increased islet insulin secretion, and promoted ROS generation in islets and dissociated beta-cells. Conventional PCR assays and immunostaining confirmed that a cells express RyR2, the cardiac RyR isoform. Extended incubation of beta-cell islets with inhibitory ryanodine suppressed GSIS; so did the antioxidant N-acetyl cysteine (NAC), which also decreased insulin secretion induced by glucose plus caffeine. Inhibitory ryanodine or NAC did not affect insulin secretion induced by glucose plus carbachol, which engages inositol 1,4,5-trisphosphate receptors. Incubation of islets with H2O2 in basal glucose increased insulin secretion 2-fold. Inhibitory ryanodine significantly decreased H2O2-stimulated insulin secretion and prevented the 4.5-fold increase of cytoplasmic [Ca2+] produced by incubation of dissociated beta-cells with H2O2. Addition of stimulatory glucose or H2O2 (in basal glucose) to beta-cells disaggregated from islets increased RyR2 S-glutathionylation to similar levels, measured by a proximity ligation assay; in contrast, NAC significantly reduced the RyR2 S-glutathionylation increase produced by stimulatory glucose. We propose that RyR2-mediated Ca2+ release, induced by the concomitant increases in [Ca2+] and ROS produced by stimulatory glucose, is an essential step in GSIS.	[Llanos, Paola; Contreras-Ferrat, Ariel] Univ Chile, Fac Odontol, Inst Res Dent Sci, Santiago, Chile; [Llanos, Paola; Contreras-Ferrat, Ariel; Valencia, Marco; Mears, David; Hidalgo, Cecilia] Univ Chile, Fac Med, Ctr Mol Studies Cell, Santiago, Chile; [Barrientos, Genaro; Hidalgo, Cecilia] Univ Chile, Fac Med, Physiol & Biophys Program, Santiago, Chile; [Mears, David] Univ Chile, Fac Med, Inst Biomed Sci, Human Genet Program, Santiago, Chile; [Hidalgo, Cecilia] Univ Chile, Fac Med, Biomed Neurosci Inst, Santiago, Chile	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile	Llanos, P (corresponding author), Univ Chile, Fac Odontol, Inst Res Dent Sci, Santiago, Chile.	pllanos@med.uchile.cl; chidalgo@med.uchile.cl	HIDALGO, Cecilia/H-7107-2013	Llanos, Paola/0000-0003-1383-7961	Fondo de Investigacion Avanzada en Areas Prioritarias FONDAP-CEMC [15010006]; CONICYT-Chile; FONDECYT [3110105, 1050571, 11130267]; USUHS intramural grant program	Fondo de Investigacion Avanzada en Areas Prioritarias FONDAP-CEMC(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); CONICYT-Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); USUHS intramural grant program	Specific funding for this work was provided by Fondo de Investigacion Avanzada en Areas Prioritarias FONDAP-CEMC Grant 15010006, CONICYT-Chile (http://spl.conicyt.cl/auth/) to CH; FONDECYT 3110105, CONICYT-Chile (http://spl.conicyt.cl/auth/) to PL; FONDECYT 1050571, CONICYT-Chile (http://spl.conicyt.cl/auth/) and USUHS intramural grant program (www.usuhs.mil) to DM; and FONDECYT 11130267, CONICYT-Chile (http://spl.conicyt.cl/auth/) to AC-F.	Adasme T, 2015, BIOCHEM BIOPH RES CO, V458, P57, DOI 10.1016/j.bbrc.2015.01.065; Adasme T, 2011, P NATL ACAD SCI USA, V108, P3029, DOI 10.1073/pnas.1013580108; Beauvois MC, 2004, J PHYSIOL-LONDON, V559, P141, DOI 10.1113/jphysiol.2004.067454; Bindokas VP, 2003, J BIOL CHEM, V278, P9796, DOI 10.1074/jbc.M206913200; BLONDEL O, 1994, P NATL ACAD SCI USA, V91, P7777, DOI 10.1073/pnas.91.16.7777; Bruton JD, 2002, FASEB J, V16, P301, DOI 10.1096/fj.02-0481fje; Bull R, 2007, AM J PHYSIOL-CELL PH, V293, pC162, DOI 10.1152/ajpcell.00518.2006; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Choi KJ, 2011, KOREAN J PHYSIOL PHA, V15, P53, DOI 10.4196/kjpp.2011.15.1.53; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gamberucci A, 1999, FEBS LETT, V446, P309, DOI 10.1016/S0014-5793(99)00220-3; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; GRANKVIST K, 1981, BIOCHEM J, V199, P393, DOI 10.1042/bj1990393; Graves TK, 2003, ENDOCRINOLOGY, V144, P3565, DOI 10.1210/en.2002-0104; Gustafsson AJ, 2004, FASEB J, V18, P301, DOI 10.1096/fj.04-2621fje; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Hidalgo C, 2008, ANTIOXID REDOX SIGN, V10, P1275, DOI 10.1089/ars.2007.1886; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; ISLAM MS, 1992, FEBS LETT, V296, P287, DOI 10.1016/0014-5793(92)80306-2; Islam MS, 2002, DIABETES, V51, P1299, DOI 10.2337/diabetes.51.5.1299; ISLAM MS, 1993, SCIENCE, V262, P584, DOI 10.1126/science.8211188; Islam MS, 1998, P NATL ACAD SCI USA, V95, P6145, DOI 10.1073/pnas.95.11.6145; Janjic D, 1999, BIOCHEM PHARMACOL, V57, P639, DOI 10.1016/S0006-2952(98)00346-3; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kemmerling U, 2007, CELL CALCIUM, V41, P491, DOI 10.1016/j.ceca.2006.10.001; Kohler M, 1998, FEBS LETT, V441, P97, DOI 10.1016/S0014-5793(98)01539-7; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; Leloup C, 2009, DIABETES, V58, P673, DOI 10.2337/db07-1056; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; MALAISSE WJ, 1967, J CLIN INVEST, V46, P1724, DOI 10.1172/JCI105663; Marengo JJ, 1998, BIOPHYS J, V74, P1263, DOI 10.1016/S0006-3495(98)77840-3; Mears D, 1999, CELL CALCIUM, V25, P59, DOI 10.1054/ceca.1998.0007; Mears D, 2004, J MEMBRANE BIOL, V200, P57, DOI 10.1007/s00232-004-0692-9; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Mitchell KJ, 2001, J CELL BIOL, V155, P41, DOI 10.1083/jcb.200103145; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Nakagaki I, 2000, PFLUG ARCH EUR J PHY, V440, P828, DOI 10.1007/s004240000372; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Paula-Lima AC, ANTIOXIDANTS REDOX S, V14, P1209; Pi JB, 2007, DIABETES, V56, P1783, DOI 10.2337/db06-1601; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Robertson RP, 2004, J BIOL CHEM, V279, P42351, DOI 10.1074/jbc.R400019200; ROJAS E, 1994, ENDOCRINOLOGY, V134, P1771, DOI 10.1210/en.134.4.1771; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Santulli G, 2015, J CLIN INVEST, V125, P1968, DOI 10.1172/JCI79273; Shigeto M, 2007, J PHARMACOL EXP THER, V322, P1, DOI 10.1124/jpet.107.120592; Takasawa S, 1998, J BIOL CHEM, V273, P2497, DOI 10.1074/jbc.273.5.2497; Takasawa S, 2010, BIOCHEM BIOPH RES CO, V397, P140, DOI 10.1016/j.bbrc.2010.05.051; Tanaka Y, 2002, P NATL ACAD SCI USA, V99, P12363, DOI 10.1073/pnas.192445199; Tang JP, 2000, LIFE SCI, V68, P475, DOI 10.1016/S0024-3205(00)00944-9; Tengholm A, 2001, J PHYSIOL-LONDON, V530, P533, DOI 10.1111/j.1469-7793.2001.0533k.x; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Tsubouchi H, 2005, BIOCHEM BIOPH RES CO, V326, P60, DOI 10.1016/j.bbrc.2004.10.201; WILLMOTT NJ, 1995, FEBS LETT, V371, P99, DOI 10.1016/0014-5793(95)00848-4; WOLFF SP, 1987, BIOCHEM J, V245, P243, DOI 10.1042/bj2450243; WOLLHEIM CB, 1986, J BIOL CHEM, V261, P8314; Woolcott OO, 2006, CELL CALCIUM, V39, P529, DOI 10.1016/j.ceca.2006.02.003; Zheng J, 2012, BIOCHEM BIOPH RES CO, V423, P207, DOI 10.1016/j.bbrc.2012.04.114	67	45	47	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129238	10.1371/journal.pone.0129238	http://dx.doi.org/10.1371/journal.pone.0129238			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046640	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200135
J	Prabudiansyah, I; Kusters, I; Driessen, AJM				Prabudiansyah, Irfan; Kusters, Ilja; Driessen, Arnold J. M.			In Vitro Interaction of the Housekeeping SecA1 with the Accessory SecA2 Protein of Mycobacterium tuberculosis	PLOS ONE			English	Article							ESCHERICHIA-COLI; DIMERIC SECA; ATPASE SECA; PREPROTEIN TRANSLOCATION; CRYSTAL-STRUCTURE; OLIGOMERIC STATE; CATALYTIC CYCLE; SIGNAL-PEPTIDE; BINDING; SECRETION	The majority of proteins that are secreted across the bacterial cytoplasmic membrane leave the cell via the Sec pathway, which in its minimal form consists of the dimeric ATP-driven motor protein SecA that associates with the protein-conducting membrane pore SecYEG. Some Gram-positive bacteria contain two homologues of SecA, termed SecA1 and SecA2. SecA1 is the essential housekeeping protein, whereas SecA2 is not essential but is involved in the translocation of a subset of proteins, including various virulence factors. Some SecA2 containing bacteria also harbor a homologous SecY2 protein that may form a separate translocase. Interestingly, mycobacteria contain only one SecY protein and thus both SecA1 and SecA2 are required to interact with SecYEG, either individually or together as a heterodimer. In order to address whether SecA1 and SecA2 cooperate during secretion of SecA2 dependent proteins, we examined the oligomeric state of SecA1 and SecA2 of Mycobacterium tuberculosis and their interactions with SecA2 and the cognate SecA1, respectively. We conclude that both SecA1 and SecA2 individually form homodimers in solution but when both proteins are present simultaneously, they form dissociable heterodimers.	[Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, NL-9727 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9727 AG Groningen, Netherlands	University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Mol Microbiol, Nijenborgh 7, NL-9727 AG Groningen, Netherlands.	a.j.m.driessen@rug.nl	Institute, Zernike/W-7033-2019; Driessen, Arnold J.M./D-1876-2012; Kusters, Ilja/J-3492-2019	Kusters, Ilja/0000-0003-3739-8764; Driessen, Arnold J.M./0000-0001-9258-9104; Prabudiansyah, Irfan/0000-0001-7133-6933	Earth and Life Sciences (ALW); Netherlands Organization for scientific Research (NWO); Bernoulli Grant of the University of Groningen	Earth and Life Sciences (ALW); Netherlands Organization for scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Bernoulli Grant of the University of Groningen	This work was supported by Earth and Life Sciences (ALW), which is supported by the Netherlands Organization for scientific Research (NWO). IP was funded through a Bernoulli Grant of the University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA M, 1991, BIOCHEM BIOPH RES CO, V174, P211, DOI 10.1016/0006-291X(91)90507-4; Bacia K, 2007, NAT PROTOC, V2, P2842, DOI 10.1038/nprot.2007.410; Bechtluft P, 2010, MOL BIOSYST, V6, P620, DOI 10.1039/b915435c; Benach J, 2003, J BIOL CHEM, V278, P3628, DOI 10.1074/jbc.M205992200; Bensing BA, 2002, MOL MICROBIOL, V44, P1081, DOI 10.1046/j.1365-2958.2002.02949.x; Bensing BA, 2014, BBA-MOL CELL RES, V1843, P1674, DOI 10.1016/j.bbamcr.2013.10.019; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Braunstein M, 2001, J BACTERIOL, V183, P6979, DOI 10.1128/JB.183.24.6979-6990.2001; BREUKINK E, 1995, J BIOL CHEM, V270, P7902, DOI 10.1074/jbc.270.14.7902; Bu ZM, 2003, J MOL BIOL, V332, P23, DOI 10.1016/S0022-2836(03)00840-4; Caspers M, 2008, ARCH MICROBIOL, V189, P605, DOI 10.1007/s00203-008-0351-0; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; D'Lima NG, 2014, J BIOL CHEM, V289, P2307, DOI 10.1074/jbc.M113.533323; Das S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.182931; de Keyzer J, 2005, J BIOL CHEM, V280, P35255, DOI 10.1074/jbc.M506157200; Ding HY, 2003, BIOCHEMISTRY-US, V42, P8729, DOI 10.1021/bi0342057; DRIESSEN AJM, 1993, BIOCHEMISTRY-US, V32, P13190, DOI 10.1021/bi00211a030; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Du Plessis DJF, 2011, BBA-BIOMEMBRANES, V1808, P851, DOI 10.1016/j.bbamem.2010.08.016; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Fekkes P, 1998, MOL MICROBIOL, V29, P1179, DOI 10.1046/j.1365-2958.1998.00997.x; Feltcher ME, 2012, NAT REV MICROBIOL, V10, P779, DOI 10.1038/nrmicro2874; Gouridis G, 2013, MOL CELL, V52, P655, DOI 10.1016/j.molcel.2013.10.036; Halbedel S, 2014, MOL CELL PROTEOMICS, V13, P3063, DOI 10.1074/mcp.M114.041327; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hou JM, 2008, J BACTERIOL, V190, P4880, DOI 10.1128/JB.00412-08; Hunt JF, 2002, SCIENCE, V297, P2018, DOI 10.1126/science.1074424; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jilaveanu LB, 2005, P NATL ACAD SCI USA, V102, P7511, DOI 10.1073/pnas.0502774102; Kusters I, 2011, CELL MOL LIFE SCI, V68, P2053, DOI 10.1007/s00018-011-0681-y; Kusters I, 2011, STRUCTURE, V19, P430, DOI 10.1016/j.str.2010.12.016; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; Ligon LS, 2013, J BACTERIOL, V195, P4456, DOI 10.1128/JB.00630-13; Musial-Siwek M, 2005, BIOCHEMISTRY-US, V44, P13987, DOI 10.1021/bi050882k; Nijeholt JALA, 2012, PHILOS T R SOC B, V367, P1016, DOI 10.1098/rstb.2011.0201; Or E, 2005, J BIOL CHEM, V280, P9097, DOI 10.1074/jbc.M413947200; Or E, 2002, EMBO J, V21, P4470, DOI 10.1093/emboj/cdf471; Papanikolau Y, 2007, J MOL BIOL, V366, P1545, DOI 10.1016/j.jmb.2006.12.049; Rigel NW, 2008, MOL MICROBIOL, V69, P291, DOI 10.1111/j.1365-2958.2008.06294.x; Rigel NW, 2009, J BIOL CHEM, V284, P9927, DOI 10.1074/jbc.M900325200; Sardis MF, 2010, MOL MICROBIOL, V76, P1070, DOI 10.1111/j.1365-2958.2010.07176.x; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Seidel SAI, 2013, METHODS, V59, P301, DOI 10.1016/j.ymeth.2012.12.005; Sharma V, 2003, P NATL ACAD SCI USA, V100, P2243, DOI 10.1073/pnas.0538077100; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Sullivan JT, 2012, INFECT IMMUN, V80, P996, DOI 10.1128/IAI.05987-11; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; van der Woude AD, 2014, CELL MICROBIOL, V16, P280, DOI 10.1111/cmi.12221; Vassylyev DG, 2006, J MOL BIOL, V364, P248, DOI 10.1016/j.jmb.2006.09.061; Veldhuis G, 2006, PROTEIN SCI, V15, P1977, DOI 10.1110/ps.062113906; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Woodbury RL, 2002, PROTEIN SCI, V11, P875, DOI 10.1110/ps.4090102; Wowor AJ, 2011, J MOL BIOL, V408, P87, DOI 10.1016/j.jmb.2011.02.006; Zhou MX, 2011, J BACTERIOL, V193, P6560, DOI 10.1128/JB.05668-11; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335; Zimmer J, 2006, J MOL BIOL, V364, P259, DOI 10.1016/j.jmb.2006.08.044	59	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128788	10.1371/journal.pone.0128788	http://dx.doi.org/10.1371/journal.pone.0128788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047312	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200100
J	Tunon, J; Higueras, J; Tarin, N; Cristobal, C; Lorenzo, O; Blanco-Colio, L; Martin-Ventura, JL; Huelmos, A; Alonso, J; Acena, A; Pello, A; Carda, R; Asensio, D; Mahillo-Fernandez, I; Bescos, LL; Egido, J; Farre, J				Tunon, Jose; Higueras, Javier; Tarin, Nieves; Cristobal, Carmen; Lorenzo, Oscar; Blanco-Colio, Luis; Luis Martin-Ventura, Jose; Huelmos, Ana; Alonso, Joaquin; Acena, Alvaro; Pello, Ana; Carda, Rocio; Asensio, Dolores; Mahillo-Fernandez, Ignacio; Lopez Bescos, Lorenzo; Egido, Jesus; Farre, Jeronimo			N-Terminal Pro-Brain Natriuretic Peptide Is Associated with a Future Diagnosis of Cancer in Patients with Coronary Artery Disease	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL GROWTH-FACTOR; LUNG-CANCER; CARDIAC HORMONES; INTERLEUKIN-6 LEVELS; PREDICT MORTALITY; HODGKIN LYMPHOMA; PROGNOSTIC VALUE; CELL LYMPHOMA; ATRIAL	Objective Several papers have reported elevated plasma levels of natriuretic peptides in patients with a previous diagnosis of cancer. We have explored whether N-terminal pro-brain natriuretic peptide (NT-proBNP) plasma levels predict a future diagnosis of cancer in patients with coronary artery disease (CAD). Methods We studied 699 patients with CAD free of cancer. At baseline, NT-proBNP, galectin-3, monocyte chemoattractant protein-1, soluble tumor necrosis factor-like weak inducer of apoptosis, high-sensitivity C-reactive protein, and high-sensitivity cardiac troponin I plasma levels were assessed. The primary outcome was new cancer diagnosis. The secondary outcome was cancer diagnosis, heart failure requiring hospitalization, or death. Results After 2.15 +/- 0.98 years of follow-up, 24 patients developed cancer. They were older (68.5 [61.5, 75.8] vs 60.0 [52.0, 72.0] years; p=0.011), had higher NT-proBNP (302.0 [134.8, 919.8] vs 165.5 [87.4, 407.5] pg/ml; p=0.040) and high-sensitivity C-reactive protein (3.27 [1.33, 5.94] vs 1.92 [0.83, 4.00] mg/L; p=0.030), and lower triglyceride (92.5 [70.5, 132.8] vs 112.0 [82.0, 157.0] mg/dl; p=0.044) plasma levels than those without cancer. NT-proBNP (Hazard Ratio [HR]=1.030; 95% Confidence Interval [CI]=1.008-1.053; p=0.007) and triglyceride levels (HR=0.987; 95% CI= 0.975-0.998; p=0.024) were independent predictors of a new cancer diagnosis (multivariate Cox regression analysis). When patients in whom the suspicion of cancer appeared in the first one-hundred days after blood extraction were excluded, NT-proBNP was the only predictor of cancer (HR=1.061; 95% CI= 1.034-1.088; p<0.001). NT-proBNP was an independent predictor of cancer, heart failure, or death (HR=1.038; 95% CI= 1.023-1.052; p<0.001) along with age, and use of insulin and acenocumarol. Conclusions NT-proBNP is an independent predictor of malignancies in patients with CAD. New studies in large populations are needed to confirm these findings.	[Tunon, Jose] IIS Fdn Jimenez Diaz, Dept Cardiol, Madrid, Spain; [Tunon, Jose; Lorenzo, Oscar; Luis Martin-Ventura, Jose; Egido, Jesus; Farre, Jeronimo] Univ Autonoma Madrid, Madrid, Spain; [Tunon, Jose; Lorenzo, Oscar; Blanco-Colio, Luis; Luis Martin-Ventura, Jose; Egido, Jesus] IIS Fdn Jimenez Diaz, Lab Vasc Pathol, Madrid, Spain; [Higueras, Javier] Hosp Clin Univ San Carlos, Dept Cardiol, Madrid, Spain; [Tarin, Nieves] Hosp Univ Mostoles, Dept Cardiol, Madrid, Spain; [Cristobal, Carmen; Alonso, Joaquin] Hosp Fuenlabrada, Dept Cardiol, Madrid, Spain; [Cristobal, Carmen; Alonso, Joaquin; Lopez Bescos, Lorenzo] Rey Juan Carlos Univ, Madrid, Spain; [Huelmos, Ana] Hosp Univ Fdn Alcorcon, Dept Cardiol, Madrid, Spain; [Asensio, Dolores] IIS Fdn Jimenez Diaz, Dept Biochem, Madrid, Spain; [Mahillo-Fernandez, Ignacio] IIS Fdn Jimenez Diaz, Dept Prevent Med, Madrid, Spain; [Egido, Jesus] CIBERDEM, Madrid, Spain	Fundacion Jimenez Diaz; Autonomous University of Madrid; Fundacion Jimenez Diaz; Hospital Universitario Fuenlabrada; Universidad Rey Juan Carlos; Alcorcon Foundation University Hospital; Fundacion Jimenez Diaz; Fundacion Jimenez Diaz; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Tunon, J (corresponding author), IIS Fdn Jimenez Diaz, Dept Cardiol, Madrid, Spain.	jtunon@secardiologia.es	Tunon, Jose/ABA-8847-2020; Acena, Alvaro/AAG-4539-2021; Tuñón, José L/R-3037-2016; Tarin-Vicente, Nieves/O-6345-2015; Blanco-Colio, Luis M./Z-2390-2019; MARTIN-VENTURA, JOSE LUIS/Z-2386-2019; Lorenzo, Oscar/L-2526-2013; Tarín-Vicente, Nieves/O-2300-2019; Mahillo-Fernandez, Ignacio/T-2042-2018	Tuñón, José L/0000-0003-2220-180X; Tarin-Vicente, Nieves/0000-0002-7335-418X; Lorenzo, Oscar/0000-0001-5515-6078; Tarín-Vicente, Nieves/0000-0002-7335-418X; Alonso, Joaquin J/0000-0003-4360-5897; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541; Blanco-Colio, Luis Miguel/0000-0002-1560-6609; MARTIN-VENTURA, JOSE LUIS/0000-0003-2090-8641; Tunon, Jose/0000-0002-1373-0999; Higueras, Javier/0000-0002-3842-5990	Fondo de Investigaciones Sanitarias [PI05/0451, PI05/1497, PI05/2475, PI05/1043, PS09/01405, PI10/00072, PI10/0234, PI14/1567]; Spanish Society of Cardiology and Spanish Heart Foundation; Spanish Society of Arteriosclerosis; RECAVA [RD06/0014/0035]; Fundacion Lilly; Instituto de Salud Carlos III FEDER (FJD biobank) [RD09/0076/00101]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Spanish Society of Cardiology and Spanish Heart Foundation; Spanish Society of Arteriosclerosis; RECAVA; Fundacion Lilly; Instituto de Salud Carlos III FEDER (FJD biobank)	This work was supported by grants from Fondo de Investigaciones Sanitarias (PI05/0451, PI05/1497, PI05/2475, PI05/1043, PS09/01405, PI10/00072, and PI10/0234, PI14/1567, Programa de Estabilizacion to LBC); Spanish Society of Cardiology and Spanish Heart Foundation; Spanish Society of Arteriosclerosis; RECAVA (RD06/0014/0035, www.recava.com); Fundacion Lilly; and Instituto de Salud Carlos III FEDER (FJD biobank: RD09/0076/00101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aujollet N, 2010, CLIN LUNG CANCER, V11, P341, DOI 10.3816/CLC.2010.n.043; Barents M, 2008, J AM MED DIR ASSOC, V9, P580, DOI 10.1016/j.jamda.2008.05.002; Biggar RJ, 2008, CLIN CANCER RES, V14, P6974, DOI 10.1158/1078-0432.CCR-08-1026; Blanco-Colio LM, 2007, ARTERIOSCL THROM VAS, V27, P916, DOI 10.1161/01.ATV.0000258972.10109.ff; Burjonroppa SC, 2007, AM J CLIN ONCOL-CANC, V30, P287, DOI 10.1097/01.coc.0000256101.04404.b0; Daniels LB, 2008, J AM COLL CARDIOL, V52, P450, DOI 10.1016/j.jacc.2008.04.033; Daniels LB, 2007, J AM COLL CARDIOL, V50, P2357, DOI 10.1016/j.jacc.2007.09.021; DePinho RA, 2000, NATURE, V408, P248, DOI 10.1038/35041694; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Eggers KM, 2013, AM J CARDIOL, V111, P131, DOI 10.1016/j.amjcard.2012.08.058; Gimeno E, 2011, LEUKEMIA RES, V35, P715, DOI 10.1016/j.leukres.2011.01.018; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Knudsen CW, 2005, J AM COLL CARDIOL, V46, P838, DOI 10.1016/j.jacc.2005.05.057; Kritz H, 1996, J CLIN ONCOL, V14, P3043, DOI 10.1200/JCO.1996.14.11.3043; Kuwahara K, 2010, ENDOCR J, V57, P555, DOI 10.1507/endocrj.K10E-150; Lok DJA, 2010, CLIN RES CARDIOL, V99, P323, DOI 10.1007/s00392-010-0125-y; Manimala NJ, 2013, EUR J CLIN INVEST, V43, P1156, DOI 10.1111/eci.12153; Nguyen JP, 2012, EUR J CLIN INVEST, V42, P1061, DOI 10.1111/j.1365-2362.2012.02695.x; Niitsu N, 2002, EUR J HAEMATOL, V68, P91, DOI 10.1034/j.1600-0609.2002.01609.x; Ohsaki Y, 1999, ONCOLOGY-BASEL, V56, P155, DOI 10.1159/000011957; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Papazisis KT, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-489; Pedersen LM, 2005, BRIT J HAEMATOL, V128, P813, DOI 10.1111/j.1365-2141.2005.05393.x; Popat Jesal, 2013, Congest Heart Fail, V19, P143, DOI 10.1111/chf.12018; Sandri MT, 2005, CLIN CHEM, V51, P1405, DOI 10.1373/clinchem.2005.050153; SEYMOUR JF, 1995, J CLIN ONCOL, V13, P575, DOI 10.1200/JCO.1995.13.3.575; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Soualmia H, 2009, CLIN LAB, V55, P120; Subramanian V, 2014, EUR J PHARMACOL, V740, P388, DOI 10.1016/j.ejphar.2014.07.024; TORNBERG SA, 1989, JNCI-J NATL CANCER I, V81, P1917, DOI 10.1093/jnci/81.24.1917; Totsune K, 1996, EUR J ENDOCRINOL, V135, P352, DOI 10.1530/eje.0.1350352; Tunon J, 2014, AM J CARDIOL, V113, P434, DOI 10.1016/j.amjcard.2013.10.012; Vaes B, 2009, J AM GERIATR SOC, V57, P823, DOI 10.1111/j.1532-5415.2009.02218.x; Vesely BA, 2005, EUR J CLIN INVEST, V35, P388, DOI 10.1111/j.1365-2362.2005.01501.x; Willett W C, 2000, Oncologist, V5, P393, DOI 10.1634/theoncologist.5-5-393; Wu FY, 2003, CANCER RES, V63, P8318; Zhang J, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-174; Zhang J, 2013, ONCOL LETT, V6, P407, DOI 10.3892/ol.2013.1425	39	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0126741	10.1371/journal.pone.0126741	http://dx.doi.org/10.1371/journal.pone.0126741			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046344	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200013
J	Watanabe, K; Yabe, M; Kasahara, K; Kokubo, T				Watanabe, Kiyoshi; Yabe, Makoto; Kasahara, Koji; Kokubo, Tetsuro			A Random Screen Using a Novel Reporter Assay System Reveals a Set of Sequences That Are Preferred as the TATA or TATA-Like Elements in the CYC1 Promoter of Saccharomyces cerevisiae	PLOS ONE			English	Article							RNA-POLYMERASE-II; CORE-PROMOTER; BINDING PROTEIN; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; REGULATORY ELEMENTS; INHIBITORY DOMAIN; SITE SELECTION; DNA-SEQUENCES; RPS5 PROMOTER	In Saccharomyces cerevisiae, the core promoters of class II genes contain either TATA or TATA-like elements to direct accurate transcriptional initiation. Genome-wide analyses show that the consensus sequence of the TATA element is TATAWAWR (8 bp), whereas TATA-like elements carry one or two mismatches to this consensus. The fact that several functionally distinct TATA sequences have been identified indicates that these elements may function, at least to some extent, in a gene-specific manner. The purpose of the present study was to identify functional TATA sequences enriched in one particular core promoter and compare them with the TATA or TATA-like elements that serve as the pre-initiation complex (PIC) assembly sites on the yeast genome. For this purpose, we conducted a randomized screen of the TATA element in the CYC1 promoter by using a novel reporter assay system and identified several hundreds of unique sequences that were tentatively classified into nine groups. The results indicated that the 7 bp TATA element (i.e., TATAWAD) and several sets of TATA-like sequences are preferred specifically by this promoter. Furthermore, we find that the most frequently isolated TATA-like sequence, i.e., TATTTAAA, is actually utilized as a functional core promoter element for the endogenous genes, e.g., ADE5,7 and ADE6. Collectively, these results indicate that the sequence requirements for the functional TATA or TATA-like elements in one particular core promoter are not as stringent. However, the variation of these sequences differs significantly from that of the PIC assembly sites on the genome, presumably depending on promoter structures and reflecting the gene-specific function of these sequences.	[Watanabe, Kiyoshi; Yabe, Makoto; Kasahara, Koji; Kokubo, Tetsuro] Yokohama City Univ, Grad Sch Med Life Sci, Mol & Cellular Biol Lab, Yokohama, Kanagawa 232, Japan	Yokohama City University	Kokubo, T (corresponding author), Yokohama City Univ, Grad Sch Med Life Sci, Mol & Cellular Biol Lab, Yokohama, Kanagawa 232, Japan.	kokubo@tsurumi.yokohama-cu.ac.jp			Japan Society for the Promotion of Science [23370077]; Ministry of Education, Culture, Sports, Science and Technology of Japan [25118520]; CREST program of the Japan Science and Technology Corporation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST program of the Japan Science and Technology Corporation	This study was supported by grants from the Japan Society for the Promotion of Science (grant number 23370077 to TK), the Ministry of Education, Culture, Sports, Science and Technology of Japan (grant number 25118520 to TK), and the CREST program of the Japan Science and Technology Corporation to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth WB, 2012, YEAST, V29, P505, DOI 10.1002/yea.2931; Arnold CD, 2013, SCIENCE, V339, P1074, DOI 10.1126/science.1232542; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bjornsdottir G, 2008, NUCLEIC ACIDS RES, V36, P2906, DOI 10.1093/nar/gkn130; Bovee TFH, 2004, GENE, V325, P187, DOI 10.1016/j.gene.2003.10.015; Butler JEF, 2002, GENE DEV, V16, P2583, DOI 10.1101/gad.1026202; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; CHEN JJ, 1994, P NATL ACAD SCI USA, V91, P11909, DOI 10.1073/pnas.91.25.11909; Cheng JX, 2002, CURR BIOL, V12, P1828, DOI 10.1016/S0960-9822(02)01257-5; de Almeida RA, 2008, YEAST, V25, P71, DOI 10.1002/yea.1570; Gertz J, 2009, NATURE, V457, P215, DOI 10.1038/nature07521; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; HAHN S, 1989, P NATL ACAD SCI USA, V86, P5718, DOI 10.1073/pnas.86.15.5718; HAHN S, 1985, P NATL ACAD SCI USA, V82, P8562, DOI 10.1073/pnas.82.24.8562; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; HARBURY PAB, 1989, MOL CELL BIOL, V9, P5298, DOI 10.1128/MCB.9.12.5298; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Kadonaga JT, 2002, EXP MOL MED, V34, P259, DOI 10.1038/emm.2002.36; Kainth P, 2009, METHODS, V48, P258, DOI 10.1016/j.ymeth.2009.02.015; Kasahara K, 2008, NUCLEIC ACIDS RES, V36, P1343, DOI 10.1093/nar/gkm1068; Kedmi A, 2014, GENE DEV, V28, P2163, DOI 10.1101/gad.245670.114; Ki S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl135; Ki S, 2007, BIOTECHNIQUES, V42, P209, DOI 10.2144/000112319; Kitazono AA, 2002, YEAST, V19, P141, DOI 10.1002/yea.806; Kobayashi A, 2007, NUCLEIC ACIDS RES, V35, P4882, DOI 10.1093/nar/gkm519; Koehler RN, 2007, EUKARYOT CELL, V6, P1474, DOI 10.1128/EC.00068-07; Kokubo T, 1998, MOL CELL BIOL, V18, P1003, DOI 10.1128/MCB.18.2.1003; Kuraev I.S. VVM, 2004, BIOCH INORGANIC POLY, P15; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Lee SK, 2010, GENETICS, V184, P659, DOI 10.1534/genetics.109.113464; Lenhard B, 2012, NAT REV GENET, V13, P233, DOI 10.1038/nrg3163; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; LI WZ, 1991, MOL CELL BIOL, V11, P666, DOI 10.1128/MCB.11.2.666; Li XY, 2002, CURR BIOL, V12, P1240, DOI 10.1016/S0960-9822(02)00932-6; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lorenz B. SHC., 1999, PROGR MOL SUBCELLULA, P217; LUE NF, 1987, P NATL ACAD SCI USA, V84, P8839, DOI 10.1073/pnas.84.24.8839; Lundblack V., 1998, CURRENT PROTOCOLS MO, V2; Martens C, 2001, MOL MICROBIOL, V40, P1009, DOI 10.1046/j.1365-2958.2001.02445.x; Melnikov A, 2012, NAT BIOTECHNOL, V30, P271, DOI 10.1038/nbt.2137; Mencia M, 2002, MOL CELL, V9, P823, DOI 10.1016/S1097-2765(02)00490-2; Mogno I, 2013, GENOME RES, V23, P1908, DOI 10.1101/gr.157891.113; Moqtaderi Z, 1996, NATURE, V383, P188, DOI 10.1038/383188a0; Muller F, 2014, BBA-GENE REGUL MECH, V1839, P118, DOI 10.1016/j.bbagrm.2013.11.003; Muller F, 2007, J BIOL CHEM; Ohler U, 2010, DEVELOPMENT, V137, P15, DOI 10.1242/dev.035493; Park D, 2014, NUCLEIC ACIDS RES, V42, P3736, DOI 10.1093/nar/gkt1366; Parry TJ, 2010, GENE DEV, V24, P2013, DOI 10.1101/gad.1951110; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Patwardhan RP, 2009, NAT BIOTECHNOL, V27, P1173, DOI 10.1038/nbt.1589; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Seizl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027595; Sharon E, 2012, NAT BIOTECHNOL, V30, P521, DOI 10.1038/nbt.2205; SIMON MC, 1988, CELL, V52, P723, DOI 10.1016/0092-8674(88)90410-2; SINGER VL, 1990, GENE DEV, V4, P636, DOI 10.1101/gad.4.4.636; Smale ST, 2003, ANN REV BIOCH; STRUHL K, 1989, ANNU REV BIOCHEM, V58, P1051, DOI 10.1146/annurev.bi.58.070189.005155; Sugihara F, 2011, NUCLEIC ACIDS RES, V39, P59, DOI 10.1093/nar/gkq741; Takahata S, 2004, MOL CELL BIOL, V24, P3089, DOI 10.1128/MCB.24.8.3089-3099.2004; Takahata S, 2003, J BIOL CHEM, V278, P45888, DOI 10.1074/jbc.M306886200; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tsukihashi Y, 2001, J BIOL CHEM, V276, P25715, DOI 10.1074/jbc.M102416200; Tsukihashi Y, 2000, MOL CELL BIOL, V20, P2385, DOI 10.1128/MCB.20.7.2385-2399.2000; Wang YL, 2014, GENE DEV, V28, P1550, DOI 10.1101/gad.245662.114; WEFALD FC, 1990, NATURE, V344, P260, DOI 10.1038/344260a0; WOBBE CR, 1990, MOL CELL BIOL, V10, P3859, DOI 10.1128/MCB.10.8.3859; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Zabidi MA, 2015, NATURE, V518, P556, DOI 10.1038/nature13994; Zeevi D, 2011, GENOME RES, V21, P2114, DOI 10.1101/gr.119669.110; Zehavi Y, 2014, J BIOL CHEM, V289, P11993, DOI 10.1074/jbc.M114.550251	75	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129357	10.1371/journal.pone.0129357	http://dx.doi.org/10.1371/journal.pone.0129357			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046838	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200157
J	Hwang, B; McCool, K; Wan, J; Wuerzberger-Davis, SM; Young, EWK; Choi, EY; Cingolani, G; Weaver, BA; Miyamoto, S				Hwang, Byounghoon; McCool, Kevin; Wan, Jun; Wuerzberger-Davis, Shelly M.; Young, Edmond W. K.; Choi, Eun Young; Cingolani, Gino; Weaver, Beth A.; Miyamoto, Shigeki			IPO3-mediated Nonclassical Nuclear Import of NF-kappa B Essential Modulator (NEMO) Drives DNA Damage-dependent NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RISK MYELODYSPLASTIC SYNDROME; LOCALIZATION SIGNAL; NUCLEOCYTOPLASMIC TRANSPORT; ALPHA; PROTEIN; ATM; UBIQUITINATION; INHIBITION; SENESCENCE; PATHWAY	Activation of I kappa B kinase (IKK) and NF-kappa B by genotoxic stresses modulates apoptotic responses and production of inflammatory mediators, thereby contributing to therapy resistance and premature aging. We previously reported that genotoxic agents induce nuclear localization of NF-kappa B essential modulator (NEMO) via an undefined mechanism to arbitrate subsequent DNA damage-dependent IKK/NF-kappa B signaling. Here we show that a nonclassical nuclear import pathway via IPO3 (importin 3, transportin 2) mediates stress-induced NEMO nuclear translocation. We found putative nuclear localization signals in NEMO whose mutations disrupted stress-inducible nuclear translocation of NEMO and IKK/NF-kappa B activation in stably reconstituted NEMO-deficient cells. RNAi screening of both importin alpha and beta family members, as well as co-immunoprecipitation analyses, revealed that a nonclassical importin beta family member, IPO3, was the only importin that was able to associate with NEMO and whose reduced expression prevented genotoxic stress-induced NEMO nuclear translocation, IKK/NF-kappa B activation, and inflammatory cytokine transcription. Recombinant IPO3 interacted with recombinant NEMO but not the nuclear localization signal mutant version and induced nuclear import of NEMO in digitonin-permeabilized cells. We also provide evidence that NEMO is disengaged from IKK complex following genotoxic stress induction. Thus, the IPO3 nuclear import pathway is an early and crucial determinant of the IKK/NF-kappa B signaling arm of the mammalian DNA damage response.	[Hwang, Byounghoon; McCool, Kevin; Wuerzberger-Davis, Shelly M.; Choi, Eun Young; Miyamoto, Shigeki] Univ Wisconsin, Dept Oncol, Madison, WI USA; [McCool, Kevin] Univ Wisconsin, Mol & Cellular Pharmacol Program, Madison, WI USA; [Wan, Jun; Weaver, Beth A.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI USA; [Wuerzberger-Davis, Shelly M.; Weaver, Beth A.; Miyamoto, Shigeki] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Young, Edmond W. K.] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON M5S 3G8, Canada; [Young, Edmond W. K.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G8, Canada; [Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Toronto; University of Toronto; Jefferson University	Miyamoto, S (corresponding author), 6159 Wisconsin Inst Med Res, 1111 Highland Ave, Madison, WI 53705 USA.	smiyamot@wisc.edu	Regan, Clinton/E-6250-2012	Young, Edmond/0000-0002-1274-5478	National Institutes of Health [R01 CA77474, GM083681, CA140458]; NATIONAL CANCER INSTITUTE [P30CA056036, R01CA077474, R01CA140458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083681, T32GM008692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA77474 and GM083681 (to S. M.) and CA140458 (to B. W.). The authors declare that they have no conflicts of interest with the contents of this article.	Anest V, 2003, NATURE, V423, P659, DOI 10.1038/nature01648; Blanc V, 2003, J BIOL CHEM, V278, P41198, DOI 10.1074/jbc.M302951200; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Campbell KJ, 2004, MOL CELL, V13, P853, DOI 10.1016/S1097-2765(04)00131-5; Carvalho G, 2007, ONCOGENE, V26, P2299, DOI 10.1038/sj.onc.1210043; Cassany Aurelia, 2008, V464, P181; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Chien YC, 2011, GENE DEV, V25, P2125, DOI 10.1101/gad.17276711; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fagerlund R, 2008, CELL SIGNAL, V20, P1442, DOI 10.1016/j.cellsig.2008.03.012; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gilmore TD, 2011, CURR TOP MICROBIOL, V349, P245, DOI 10.1007/82_2010_105; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Grosjean-Raillard J, 2009, ONCOGENE, V28, P1099, DOI 10.1038/onc.2008.457; Gudleski N, 2010, P NATL ACAD SCI USA, V107, P9358, DOI 10.1073/pnas.1000304107; Guttinger S, 2004, P NATL ACAD SCI USA, V101, P2918, DOI 10.1073/pnas.0400342101; Harte MT, 2014, ONCOGENE, V33, P713, DOI 10.1038/onc.2013.10; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; Hinz M, 2010, MOL CELL, V40, P63, DOI 10.1016/j.molcel.2010.09.008; Huang TT, 2000, J BIOL CHEM, V275, P9501, DOI 10.1074/jbc.275.13.9501; Huang TT, 2002, MOL CELL BIOL, V22, P5813, DOI 10.1128/MCB.22.16.5813-5825.2002; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hwang B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116374; Imasaki T, 2007, MOL CELL, V28, P57, DOI 10.1016/j.molcel.2007.08.006; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Janssens S, 2012, CELL DEATH DIFFER, V19, P13, DOI 10.1038/cdd.2011.162; Jin HS, 2009, CANCER RES, V69, P1782, DOI 10.1158/0008-5472.CAN-08-2256; Jing H, 2011, GENE DEV, V25, P2137, DOI 10.1101/gad.17620611; Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63; Kose S, 2012, CELL, V149, P578, DOI 10.1016/j.cell.2012.02.058; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Liang PZ, 2013, TRAFFIC, V14, P1132, DOI 10.1111/tra.12097; Lott K, 2011, J BIOL CHEM, V286, P28160, DOI 10.1074/jbc.M111.228007; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Neish AS, 2011, TRENDS MICROBIOL, V19, P596, DOI 10.1016/j.tim.2011.08.004; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Osorio FG, 2012, GENE DEV, V26, P2311, DOI 10.1101/gad.197954.112; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Plafker SM, 2000, EMBO J, V19, P5502, DOI 10.1093/emboj/19.20.5502; Plafker SM, 2004, J CELL BIOL, V167, P649, DOI 10.1083/jcb.200406001; Plafker SM, 2002, MOL CELL BIOL, V22, P1266, DOI 10.1128/MCB.22.4.1266-1275.2002; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Rebane A, 2004, RNA, V10, P590, DOI 10.1261/rna.5224304; Rosato RR, 2010, J BIOL CHEM, V285, P10064, DOI 10.1074/jbc.M109.095208; Sabatel H, 2011, BIOCHEM PHARMACOL, V82, P1371, DOI 10.1016/j.bcp.2011.07.105; SCHREIBER V, 1992, EMBO J, V11, P3263, DOI 10.1002/j.1460-2075.1992.tb05404.x; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Sorokin AV, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1439, DOI 10.1134/S0006297907130032; Stilmann M, 2009, MOL CELL, V36, P365, DOI 10.1016/j.molcel.2009.09.032; Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785; Tsuchiya Y, 2010, MOL CELL, V39, P570, DOI 10.1016/j.molcel.2010.07.030; Twyffels L, 2014, FEBS LETT, V588, P1857, DOI 10.1016/j.febslet.2014.04.023; Wan J, 2014, CURR BIOL, V24, P2687, DOI 10.1016/j.cub.2014.09.052; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wittig I, 2009, PROTEOMICS, V9, P5214, DOI 10.1002/pmic.200900151; Wu LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018447; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wu ZH, 2008, EMBO J, V27, P1963, DOI 10.1038/emboj.2008.127; Wu ZH, 2010, MOL CELL, V40, P75, DOI 10.1016/j.molcel.2010.09.010; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Wuerzberger-Davis SM, 2005, MOL CANCER RES, V3, P345, DOI 10.1158/1541-7786.MCR-05-0028; Yamamoto Y, 2003, NATURE, V423, P655, DOI 10.1038/nature01576; Yang YB, 2011, MOL CELL BIOL, V31, P2774, DOI 10.1128/MCB.01139-10; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Zienkiewicz J, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000386	76	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2015	290	29					17967	17984		10.1074/jbc.M115.645960	http://dx.doi.org/10.1074/jbc.M115.645960			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZB	26060253	hybrid, Green Published			2022-12-26	WOS:000358511700030
J	Chien, LN; Ostrom, QT; Gittleman, H; Lin, JW; Sloan, AE; Barnett, GH; Elder, JB; McPherson, C; Warnick, R; Chiang, YH; Lin, CM; Rogers, LR; Chiou, HY; Barnholtz-Sloan, JS				Chien, Li-Nien; Ostrom, Quinn T.; Gittleman, Haley; Lin, Jia-Wei; Sloan, Andrew E.; Barnett, Gene H.; Elder, J. Bradley; McPherson, Christopher; Warnick, Ronald; Chiang, Yung-Hsiao; Lin, Chieh-Min; Rogers, Lisa R.; Chiou, Hung-Yi; Barnholtz-Sloan, Jill S.			International Differences in Treatment and Clinical Outcomes for High Grade Glioma	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; MALIGNANT GLIOMA; PROGNOSTIC-FACTORS; RADIATION-THERAPY; BREAST-CANCER; TEMOZOLOMIDE; SURVIVAL; CHEMOTHERAPY; SURGERY; TAIWAN	Background High grade gliomas are the most common type of malignant brain tumor, and despite their rarity, cause significant morbidity and mortality. This study aimed to compare the treatment patterns of high grade glioma to examine survival patterns in patients who receive specific treatments between cohorts in Ohio and Taiwan. Method Patients aged 18 years and older at age of diagnosis with World Health Organization (WHO) grade III or IV astrocytoma from 2007-2012 were selected from the Ohio Brain Tumor Study and the Taiwan Cancer Registry. The treatment information was derived from medical chart reviews in Ohio and National Health Insurance Research Data in Taiwan. Treatment examined included surgical procedure (brain biopsy and/or resection), radiotherapy (radiation and/or radiosurgery), and alkylating chemotherapy. Kaplan-Meier and parametric survival models were used to examine the effect of treatment on survival, adjusted for age, sex, and comorbidities. Results 294 patients in Ohio and 1,097 patients in Taiwan met the inclusion criteria. 70.3% patients in Ohio and 51.4% in Taiwan received surgical resection, followed by concurrent chemoradiation. Patients who received this treatment had the highest survival rate, with a 1-year survival rate of 72.8% in Ohio and 73.4% in Taiwan. Patients who did not receive surgical resection, followed by concurrent chemoradiation had an increased risk of death (hazard ratio of 5.03 [95% confidence interval (CI): 3.61-7.02] in Ohio and 1.49 [95% CI: 1.31-1.71] in Taiwan) after adjustment for age, sex, and comorbidities. Conclusion Surgical resection followed by concurrent chemoradiation was associated with higher survival rate of patients with high grade glioma in both Ohio and Taiwan; however, one-third of patients in Ohio and half in Taiwan did not receive this treatment.	[Chien, Li-Nien] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Hlth Care Adm, Taipei, Taiwan; [Ostrom, Quinn T.; Gittleman, Haley; Barnholtz-Sloan, Jill S.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Sch Med, Cleveland, OH 44106 USA; [Lin, Jia-Wei; Lin, Chieh-Min] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei, Taiwan; [Lin, Jia-Wei; Lin, Chieh-Min] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei City, Taiwan; [Sloan, Andrew E.; Rogers, Lisa R.] Univ Hosp, Brain Tumor & Neuro Oncol Ctr, Dept Neurosurg, Case Med Ctr,Case Western Reserve Sch Med, Cleveland, OH USA; [Barnett, Gene H.] Cleveland Clin, Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Dept Neurosurg, Neurol Inst, Cleveland, OH 44106 USA; [Elder, J. Bradley] James Comprehens Canc Ctr, Dardinger Neurooncol Ctr, Dept Neurosurg, Columbus, OH USA; [Elder, J. Bradley] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA; [McPherson, Christopher; Warnick, Ronald; Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med Sci & Technol, Program Neural Regenerat Med, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Chiou, Hung-Yi] Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Publ Hlth, Taipei, Taiwan	Taipei Medical University; Case Western Reserve University; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Case Western Reserve University; University Hospitals of Cleveland; Cleveland Clinic Foundation; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University	Chien, LN (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Sch Hlth Care Adm, Taipei, Taiwan.	lnchien@tmu.edu.tw	Sloan, Andrew/AAE-9842-2020; Ostrom, Quinn/F-1820-2018; Barnholtz-Sloan, Jill/A-4817-2011	Ostrom, Quinn/0000-0003-3469-7558; Barnholtz-Sloan, Jill/0000-0001-6190-9304; Warnick, Ronald/0000-0001-8509-7988; Chiou, Hung Yi/0000-0002-4545-9697	Health and Welfare surcharge of tobacco products of Taiwan [MOHW103-TD-B-111-01]; National Cancer Institute Case Comprehensive Cancer Center Support Grant [P30CA043703]; Peter D Cristal Endowment; Kimble Foundation; NATIONAL CANCER INSTITUTE [P30CA043703] Funding Source: NIH RePORTER	Health and Welfare surcharge of tobacco products of Taiwan; National Cancer Institute Case Comprehensive Cancer Center Support Grant; Peter D Cristal Endowment; Kimble Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Health and Welfare surcharge of tobacco products of Taiwan (Grant No.: MOHW103-TD-B-111-01). QTO, HG, AES, and JSB-S were supported by the National Cancer Institute Case Comprehensive Cancer Center Support Grant (P30CA043703). AES was also supported by the Peter D Cristal Endowment and the Kimble Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsen PC, 2011, J CLIN ONCOL, V29, P1335, DOI 10.1200/JCO.2010.31.2330; Asthagiri AR, 2007, NEUROL CLIN, V25, P975, DOI 10.1016/j.ncl.2007.07.006; Bauchet L, 2014, NEURO-ONCOLOGY, V16, P1459, DOI 10.1093/neuonc/nou063; Bhoo-Pathy N, 2013, EUR J CANCER, V49, P703, DOI 10.1016/j.ejca.2012.09.014; Buckner JC, 2003, SEMIN ONCOL, V30, P10, DOI 10.1053/j.seminoncol.2003.11.031; Camacho CV, 2015, ONCOGENE, V34, P1064, DOI 10.1038/onc.2014.29; Chang SM, 2005, JAMA-J AM MED ASSOC, V293, P557, DOI 10.1001/jama.293.5.557; Chiang CJ, 2010, JPN J CLIN ONCOL, V40, P897, DOI 10.1093/jjco/hyq057; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; CURRAN WJ, 1993, J NATL CANCER I, V85, P704, DOI 10.1093/jnci/85.9.704; del Alcazar CRG, 2014, CLIN CANCER RES, V20, P1235, DOI 10.1158/1078-0432.CCR-13-1607; Earle CC, 2001, J CLIN ONCOL, V19, P1064, DOI 10.1200/JCO.2001.19.4.1064; Farina P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/734281; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Giordano SH, 2006, J CLIN ONCOL, V24, P2750, DOI 10.1200/JCO.2005.02.3028; Huang YC, 2011, J CLIN NEUROSCI, V18, P784, DOI 10.1016/j.jocn.2010.10.016; Institute Nc, 2013, SEER MED CALC COM WE; Koppie TM, 2008, CANCER-AM CANCER SOC, V112, P2384, DOI 10.1002/cncr.23462; Krex D, 2007, BRAIN, V130, P2596, DOI 10.1093/brain/awm204; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Lu TH, 2000, INT J EPIDEMIOL, V29, P336, DOI 10.1093/ije/29.2.336; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; Mrugala MM, 2013, DISCOV MED, V15, P221; Oike T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078943; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Ostrom QT, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00019; Ray S, 2014, AM HEALTH DRUG BENEF, V7, P140; Shonka NA, 2013, J NEURO-ONCOL, V113, P305, DOI 10.1007/s11060-013-1116-4; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Weller M, 2014, LANCET ONCOL, V15, pE395, DOI 10.1016/S1470-2045(14)70011-7; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	36	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129602	10.1371/journal.pone.0129602	http://dx.doi.org/10.1371/journal.pone.0129602			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061037	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500151
J	Ferreira, AM; Marques, AT; Bhide, M; Cubric-Curik, V; Hollung, K; Knight, CH; Raundrup, K; Lippolis, J; Palmer, M; Sales-Baptista, E; Araujo, SS; de Almeida, AM				Ferreira, Ana Monteiro; Marques, Andreia Tomas; Bhide, Mangesh; Cubric-Curik, Vlatka; Hollung, Kristin; Knight, Christopher Harold; Raundrup, Katrine; Lippolis, John; Palmer, Mitchell; Sales-Baptista, Elvira; Araujo, Susana Sousa; de Almeida, Andre Martinho			Sequence Analysis of Bitter Taste Receptor Gene Repertoires in Different Ruminant Species	PLOS ONE			English	Article							EVOLUTION; IDENTIFICATION; FAMILIES	Bitter taste has been extensively studied in mammalian species and is associated with sensitivity to toxins and with food choices that avoid dangerous substances in the diet. At the molecular level, bitter compounds are sensed by bitter taste receptor proteins (T2R) present at the surface of taste receptor cells in the gustatory papillae. Our work aims at exploring the phylogenetic relationships of T2R gene sequences within different ruminant species. To accomplish this goal, we gathered a collection of ruminant species with different feeding behaviors and for which no genome data is available: American bison, chamois, elk, European bison, fallow deer, goat, moose, mouflon, muskox, red deer, reindeer and white tailed deer. The herbivores chosen for this study belong to different taxonomic families and habitats, and hence, exhibit distinct foraging behaviors and diet preferences. We describe the first partial repertoires of T2R gene sequences for these species obtained by direct sequencing. We then consider the homology and evolutionary history of these receptors within this ruminant group, and whether it relates to feeding type classification, using MEGA software. Our results suggest that phylogenetic proximity of T2R genes corresponds more to the traditional taxonomic groups of the species rather than reflecting a categorization by feeding strategy.	[Ferreira, Ana Monteiro; Sales-Baptista, Elvira] Univ Evora, ICAAM, P-7006554 Evora, Portugal; [Ferreira, Ana Monteiro; Araujo, Susana Sousa; de Almeida, Andre Martinho] Univ Nova Lisboa, Inst Tecnol Quim & Biol Antonio Xavier ITQB, Plant Cell Biotechnol Lab, P-2780157 Oeiras, Portugal; [Marques, Andreia Tomas; Araujo, Susana Sousa; de Almeida, Andre Martinho] Inst Invest Cient Trop, P-1300344 Lisbon, Portugal; [Bhide, Mangesh] Univ Vet & Pharm, Lab Biomed Microbiol & Immunol, Kosice 04181, Slovakia; [Cubric-Curik, Vlatka] Univ Zagreb, Fac Agr, Dept Anim Sci, Zagreb 10000, Croatia; [Hollung, Kristin] Norwegian Food Res Inst, NOFIMA, N-1430 As, Norway; [Knight, Christopher Harold] Univ Copenhagen, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark; [Raundrup, Katrine] Greenland Inst Nat Resources, Nuuk 3900, Greenland; [Lippolis, John] USDA, Natl Anim Dis Ctr, Ruminant Dis & Immunol Res Unit, Ames, IA 50010 USA; [Palmer, Mitchell] USDA, Natl Anim Dis Ctr, Bacterial Dis Livestock Res Unit, Ames, IA 50010 USA; [Sales-Baptista, Elvira] Univ Evora, Dept Zootecnia, P-7002554 Evora, Portugal; [de Almeida, Andre Martinho] CIISA, P-1300477 Lisbon, Portugal; [de Almeida, Andre Martinho] IBET, P-2780157 Oeiras, Portugal	University of Evora; Universidade Nova de Lisboa; University of Zagreb; Nofima; University of Copenhagen; Greenland Institute of Natural Resources; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Evora; Universidade de Lisboa	de Almeida, AM (corresponding author), Ross Univ, Sch Vet Med, PO 334, Basseterre, St Kitts & Nevi.	adealmeida@rossvet.edu.kn	Almeida, Andre/I-4369-2013; Bhide, Mangesh/ABE-9994-2021; Palmer, Mitchell/R-7091-2018; Araújo, Susana S/A-5482-2009; Marques, Andreia/AAP-8590-2021	Almeida, Andre/0000-0002-7810-3988; Palmer, Mitchell/0000-0002-5902-3333; Araújo, Susana S/0000-0003-2823-088X; Marques, Andreia/0000-0001-7302-1193	Fundacao para a Ciencia e a Tecnologia (Lisboa, Portugal) [SFRH/BPD/69655/2010, SFRH/BPD/90916/2012]; Ciencia program	Fundacao para a Ciencia e a Tecnologia (Lisboa, Portugal)(Portuguese Foundation for Science and Technology); Ciencia program	The authors acknowledge financial support from Fundacao para a Ciencia e a Tecnologia (Lisboa, Portugal) in the form of the grants SFRH/BPD/69655/2010 (A. M. Ferreira) and SFRH/BPD/90916/2012 (A. M. de Almeida) and Research Contract by the Ciencia 2008 program (S. S. Araujo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmanov AA, 2007, ANNU REV NUTR, V27, P389, DOI 10.1146/annurev.nutr.26.061505.111329; Baldwin MW, 2014, SCIENCE, V345, P929, DOI 10.1126/science.1255097; Behrens M, 2014, MOL BIOL EVOL, V31, P3216, DOI 10.1093/molbev/msu254; Born S, 2013, J NEUROSCI, V33, P201, DOI 10.1523/JNEUROSCI.3248-12.2013; Brockhoff A, 2010, P NATL ACAD SCI USA, V107, P11110, DOI 10.1073/pnas.0913862107; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Clauss M, 2003, OIKOS, V102, P253, DOI 10.1034/j.1600-0706.2003.12406.x; Conte C, 2003, PHYSIOL GENOMICS, V14, P73, DOI 10.1152/physiolgenomics.00060.2003; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Dong D, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-12; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferreira AM, 2013, ANIMAL, V7, P547, DOI 10.1017/S1751731112002030; Foley WJ, 2005, CURR OPIN PLANT BIOL, V8, P430, DOI 10.1016/j.pbi.2005.05.009; FORCHHAMMER MC, 1995, OECOLOGIA, V104, P169, DOI 10.1007/BF00328582; Garcia-Bailo B, 2009, OMICS, V13, P69, DOI 10.1089/omi.2008.0031; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Go Y, 2006, MOL BIOL EVOL, V23, P964, DOI 10.1093/molbev/msj106; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; HOFMANN R R, 1972, Mammalia, V36, P226, DOI 10.1515/mamm.1972.36.2.226; Hu Ling-Ling, 2013, Zoological Research, V34, pE75; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Li DY, 2014, MOL BIOL EVOL, V31, P303, DOI 10.1093/molbev/mst219; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Parry CM, 2004, P NATL ACAD SCI USA, V101, P14830, DOI 10.1073/pnas.0404894101; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sato JJ, 2012, NATURWISSENSCHAFTEN, V99, P655, DOI 10.1007/s00114-012-0939-8; Schibler L, 1998, GENOME RES, V8, P901, DOI 10.1101/gr.8.9.901; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; Slate J, 2002, GENETICS, V160, P1587; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Vistnes II, 2008, ARCT ANTARCT ALP RES, V40, P215, DOI 10.1657/1523-0430(07-001)[VISTNES]2.0.CO;2; Wiener A, 2012, NUCLEIC ACIDS RES, V40, pD413, DOI 10.1093/nar/gkr755	34	4	4	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0124933	10.1371/journal.pone.0124933	http://dx.doi.org/10.1371/journal.pone.0124933			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061084	Green Published, gold, Green Submitted			2022-12-26	WOS:000355979500008
J	Goldspink, LK; Edson, DW; Vidgen, ME; Bingham, J; Field, HE; Smith, CS				Goldspink, Lauren K.; Edson, Daniel W.; Vidgen, Miranda E.; Bingham, John; Field, Hume E.; Smith, Craig S.			Natural Hendra Virus Infection in Flying-Foxes - Tissue Tropism and Risk Factors	PLOS ONE			English	Article							PTEROPID BATS; NIPAH VIRUS; RESERVOIR	Hendra virus (HeV) is a lethal zoonotic agent that emerged in 1994 in Australia. Pteropid bats (flying-foxes) are the natural reservoir. To date, HeV has spilled over from flying-foxes to horses on 51 known occasions, and from infected horses to close-contact humans on seven occasions. We undertook screening of archived bat tissues for HeV by reverse transcription quantitative polymerase chain reaction (RT-qPCR). Tissues were tested from 310 bats including 295 Pteropodiformes and 15 Vespertilioniformes. HeV was detected in 20 individual flying-foxes (6.4%) from various tissues including spleen, kidney, liver, lung, placenta and blood components. Detection was significantly higher in Pteropus Alecto and P. conspicillatus, identifying species as a risk factor for infection. Further, our findings indicate that HeV has a predilection for the spleen, suggesting this organ plays an important role in HeV infection. The lack of detections in the foetal tissues of HeV-positive females suggests that vertical transmission is not a regular mode of transmission in naturally infected flying-foxes, and that placental and foetal tissues are not a major source of infection for horses. A better understanding of HeV tissue tropism will strengthen management of the risk of spill-over from flying-foxes to horses and ultimately humans.	[Goldspink, Lauren K.; Edson, Daniel W.; Vidgen, Miranda E.; Field, Hume E.; Smith, Craig S.] Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Biosecur Queensland, Coopers Plains, Qld, Australia; [Bingham, John] Commonwealth Sci & Ind Res Org, Australian Anim Hlth Lab, East Geelong, Vic, Australia; [Field, Hume E.] EcoHlth Alliance, New York, NY USA	Queensland Department of Agriculture & Fisheries; Commonwealth Scientific & Industrial Research Organisation (CSIRO); EcoHealth Alliance	Goldspink, LK (corresponding author), Queensland Ctr Emerging Infect Dis, Dept Agr & Fisheries, Biosecur Queensland, Coopers Plains, Qld, Australia.	lauren.goldspink@daf.qld.gov.au	Bingham, John/H-8591-2013	Bingham, John/0000-0003-2360-3827; Vidgen, Miranda/0000-0003-4131-0390	Biosecurity Queensland, Department of Agriculture and Fisheries, through the Queensland Centre for Emerging Infectious Diseases; State of Queensland; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program	Biosecurity Queensland, Department of Agriculture and Fisheries, through the Queensland Centre for Emerging Infectious Diseases; State of Queensland; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program	Logistic support and base funding was provided by Biosecurity Queensland, Department of Agriculture and Fisheries, through the Queensland Centre for Emerging Infectious Diseases. This research was partly supported by the State of Queensland, the State of New South Wales, and the Commonwealth of Australia under the National Hendra Virus Research Program. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2014, MOL PHYLOGENET EVOL, V77, P83, DOI 10.1016/j.ympev.2014.03.009; Anon, 2014, WHAT IS HENDRA VIRUS; [Anonymous], 2004, ECOLOGY HENDRA VIRUS; Breed A, 2011, PLOS ONE, V6; Dups J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040308; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field H, 2011, PLOS ONE, V6; Field HE, 2011, CURRENT OPINION VIRO, V1, P1; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; GenStat, 2013, GENSTAT WIND REL 15; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; McCullagh P, 1989, GEN LINEAR MODELS; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2124; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; Smith CS, 2014, PLOS ONE, V9, P1; Smith IL, 2001, J VIROL METHODS, V98, P33, DOI 10.1016/S0166-0934(01)00354-8; Wang H, 2013, PLOS ONE, V8; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364; Young P., 1997, RECENT ADV MICROBIOL; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	27	34	35	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128835	10.1371/journal.pone.0128835	http://dx.doi.org/10.1371/journal.pone.0128835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26060997	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000355979500102
J	Scumaci, D; Tamme, L; Fiumara, CV; Pappaianni, G; Concolino, A; Leone, E; Faniello, MC; Quaresima, B; Ricevuto, E; Costanzo, FS; Cuda, G				Scumaci, Domenica; Tamme, Laura; Fiumara, Claudia Vincenza; Pappaianni, Giusi; Concolino, Antonio; Leone, Emanuela; Faniello, Maria Concetta; Quaresima, Barbara; Ricevuto, Enrico; Costanzo, Francesco Saverio; Cuda, Giovanni			Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications	PLOS ONE			English	Article							ASSISTED-LASER-DESORPTION/IONIZATION; DOWN-REGULATION; QUANTITATIVE-ANALYSIS; TUMOR-MARKERS; GELSOLIN; BRCA1; PROTEINS; GEL; PROGRESSION; EXPRESSION	Background Breast cancer (BC) is a leading cause of death among women. Among the major risk factors, an important role is played by familial history of BC. Germ-line mutations in BRCA1/2 genes account for most of the hereditary breast and/or ovarian cancers. Gene expression profiling studies have disclosed specific molecular signatures for BRCA1/2-related breast tumors as compared to sporadic cases, which might help diagnosis and clinical follow-up. Even though, a clear hallmark of BRCA1/2-positive BC is still lacking. Many diseases are correlated with quantitative changes of proteins in body fluids. Plasma potentially carries important information whose knowledge could help to improve early disease detection, prognosis, and response to therapeutic treatments. The aim of this study was to develop a comprehensive approach finalized to improve the recovery of specific biomarkers from plasma samples of subjects affected by hereditary BC. Methods To perform this analysis, we used samples from patients belonging to highly homogeneous population previously reported. Depletion of high abundant plasma proteins, 2D gel analysis, liquid chromatography-tandem mass spectrometry (LC-MS/MS) and bioinformatics analysis were used into an integrated approach to investigate tumor-specific changes in the plasma proteome of BC patients and healthy familymembers sharing the same BRCA1 gene founder mutation (5083del19), previously reported by our group, with the aim to identify specific signatures. Results The comparative analysis of the experimental results led to the identification of gelsolin as the most promising biomarker. Conclusions Further analyses, performed using a panel of breast cancer cell lines, allowed us to further elucidate the signaling network that might modulate the expression of gelsolin in breast cancer.	[Scumaci, Domenica; Tamme, Laura; Fiumara, Claudia Vincenza; Pappaianni, Giusi; Concolino, Antonio; Leone, Emanuela; Faniello, Maria Concetta; Quaresima, Barbara; Costanzo, Francesco Saverio; Cuda, Giovanni] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Ricevuto, Enrico] Univ Aquila, Med Oncol, S Salvatore Hosp, I-67100 Laquila, Italy	Magna Graecia University of Catanzaro; University of L'Aquila	Scumaci, D (corresponding author), Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Salvatore Venuta Univ Campus, Catanzaro, Italy.	scumaci@unicz.it	Cuda, Giovanni/F-5359-2012; Cuda, Giovanni/AAC-2821-2019; Costanzo, Francesco Saverio/K-3168-2018; Scumaci, Domenica/AAH-1493-2019	Cuda, Giovanni/0000-0001-6313-1866; Cuda, Giovanni/0000-0001-6313-1866; Costanzo, Francesco Saverio/0000-0002-3096-9416; QUARESIMA, Barbara/0000-0003-3462-624X; FANIELLO, Concetta Maria/0000-0001-6938-2754; Scumaci, Domenica/0000-0002-8117-834X; RICEVUTO, Enrico/0000-0001-5641-3187	STAYWELL [PON04a2_00003]; PROMETEO [PON01 02834]	STAYWELL; PROMETEO	For this work GC received funding from STAYWELL, grant number PON04a2_00003, and from PROMETEO, grant number PON01 02834. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz SR, 2006, MOL CELL BIOL, V26, P9377, DOI 10.1128/MCB.01229-06; Baudi F, 2001, Hum Mutat, V18, P163, DOI 10.1002/humu.1167; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen P, 1996, J CELL BIOL, V134, P689, DOI 10.1083/jcb.134.3.689; Choi S, 2014, PROTEOMICS, V14, P1933, DOI 10.1002/pmic.201400030; Chung LP, 2012, EXPERT REV PROTEOMIC, V9, P599, DOI [10.1586/epr.12.62, 10.1586/EPR.12.62]; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Darde Veronica M, 2007, Methods Mol Biol, V357, P351; De Corte V, 2002, EMBO J, V21, P6781, DOI 10.1093/emboj/cdf680; Di Domenico M, 2013, FRONT BIOSCI-LANDMRK, V18, P564, DOI 10.2741/4120; Dong Y, 2002, EXP CELL RES, V276, P328, DOI 10.1006/excr.2002.5534; Duffy MJ, 2006, CLIN CHEM, V52, P345, DOI 10.1373/clinchem.2005.059832; Echan LA, 2005, PROTEOMICS, V5, P3292, DOI 10.1002/pmic.200401228; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Faniello MC, 2008, INT J BIOCHEM CELL B, V40, P2110, DOI 10.1016/j.biocel.2008.02.010; Ferlay J, 2012, GLOBOCAN 2012 ESTIMA; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gruvberger-Saal SK, 2006, ENDOCR-RELAT CANCER, V13, P1017, DOI 10.1677/erc.1.01246; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Houvras Y, 2000, J BIOL CHEM, V275, P36230, DOI 10.1074/jbc.M002539200; Kennedy RD, 2004, JNCI-J NATL CANCER I, V96, P1659, DOI 10.1093/jnci/djh312; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kusano H, 2000, ONCOGENE, V19, P4807, DOI 10.1038/sj.onc.1203868; Liu Jingbo, 2007, Cancer Genomics & Proteomics, V4, P377; Marks JR, 1997, ONCOGENE, V14, P115, DOI 10.1038/sj.onc.1200808; Morelli M, 2014, INT J GYNECOL CANCER, V24, P649, DOI 10.1097/IGC.0000000000000102; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; Rajan JV, 1996, P NATL ACAD SCI USA, V93, P13078, DOI 10.1073/pnas.93.23.13078; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Seillier-Moiseiwitsch F., 2005, PROTEOMICS PROTOCOLS, P239, DOI [DOI 10.1385/1592598900, 10.1385/1592598900]; Sinha P, 2001, PROTEOMICS, V1, P835, DOI 10.1002/1615-9861(200107)1:7<835::AID-PROT835>3.3.CO;2-U; Tanaka H, 2006, INT J CANCER, V118, P1680, DOI 10.1002/ijc.21559; Thor AD, 2001, CLIN CANCER RES, V7, P2415; Tirkkonen M, 1997, CANCER RES, V57, P1222; Veenstra TD, 2005, MOL CELL PROTEOMICS, V4, P409, DOI 10.1074/mcp.M500006-MCP200; Vehlow C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S19-S2; Wang H, 2005, MOL CELL PROTEOMICS, V4, P618, DOI 10.1074/mcp.M400126-MCP200; Weiss Walter, 2009, Methods Mol Biol, V564, P13, DOI 10.1007/978-1-60761-157-8_2; Welcsh PL, 2000, TRENDS GENET, V16, P69, DOI 10.1016/S0168-9525(99)01930-7; Winston JS, 2001, BREAST CANCER RES TR, V65, P11, DOI 10.1023/A:1006446108411; Yu VPCC, 2000, GENE DEV, V14, P1400; Zivy Michel, 2007, V355, P175	45	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129762	10.1371/journal.pone.0129762	http://dx.doi.org/10.1371/journal.pone.0129762			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061043	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500163
J	Sotoodehnejadnematalahi, F; Staples, KJ; Chrysanthou, E; Pearson, H; Ziegler-Heitbrock, L; Burke, B				Sotoodehnejadnematalahi, Fattah; Staples, Karl J.; Chrysanthou, Elvina; Pearson, Helen; Ziegler-Heitbrock, Loems; Burke, Bernard			Mechanisms of Hypoxic Up-Regulation of Versican Gene Expression in Macrophages	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; MONOCYTE-DERIVED MACROPHAGES; TRANSCRIPTIONAL RESPONSE; DIFFERENTIAL EXPRESSION; HIF-1-ALPHA; GROWTH; ALPHA; PROTEOGLYCANS; ANGIOGENESIS; ACTIVATION	Hypoxia is a hallmark of many pathological tissues. Macrophages accumulate in hypoxic sites and up-regulate a range of hypoxia-inducible genes. The matrix proteoglycan versican has been identified as one such gene, but the mechanisms responsible for hypoxic induction are not fully characterised. Here we investigate the up-regulation of versican by hypoxia in primary human monocyte-derived macrophages (HMDM), and, intriguingly, show that versican mRNA is up-regulated much more highly (>600 fold) by long term hypoxia (5 days) than by 1 day of hypoxia (48 fold). We report that versican mRNA decay rates are not affected by hypoxia, demonstrating that hypoxic induction of versican mRNA is mediated by increased transcription. Deletion analysis of the promoter identified two regions required for high level promoter activity of luciferase reporter constructs in human macrophages. The hypoxia-inducible transcription factor HIF-1 has previously been implicated as a key potential regulator of versican expression in hypoxia, however our data suggest that HIF-1 up-regulation is unlikely to be principally responsible for the high levels of induction observed in HMDM. Treatment of HMDM with two distinct specific inhibitors of Phosphoinositide 3-kinase (PI3K), LY290042 and wortmannin, significantly reduced induction of versican mRNA by hypoxia and provides evidence of a role for PI3K in hypoxic up-regulation of versican expression.	[Sotoodehnejadnematalahi, Fattah] Islamic Azad Univ, Sch Basic Sci, Sci & Res Branch, Dept Biol, Tehran, Iran; [Staples, Karl J.] Univ Southampton, Southampton Gen Hosp, Clin & Expt Sci, Fac Med,Sir Henry Wellcome Labs, Southampton, Hants, England; [Chrysanthou, Elvina; Pearson, Helen] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Ziegler-Heitbrock, Loems] Asklepios Fachkliniken, EvA Study Ctr, Gauting, Germany; [Ziegler-Heitbrock, Loems] Helmholtz Zentrum Muenchen, Gauting, Germany; [Burke, Bernard] Univ Birmingham, Sch Dent, Coll Med & Dent Sci, Birmingham, W Midlands, England	Islamic Azad University; University of Southampton; University of Leicester; University of Birmingham	Burke, B (corresponding author), Univ Birmingham, Sch Dent, Coll Med & Dent Sci, Birmingham, W Midlands, England.	b.burke.1@bham.ac.uk	Burke, Bernard/C-5075-2019	Burke, Bernard/0000-0001-5483-800X; Staples, Karl/0000-0003-3844-6457; sotoodehnejadnematalahi, fattah/0000-0002-4287-9792				Alvarez-Tejado M, 2001, J BIOL CHEM, V276, P22368, DOI 10.1074/jbc.M011688200; Ameri K, 2002, BRIT J CANCER, V87, P1173, DOI 10.1038/sj.bjc.6600576; ARNOLD F, 1987, BRIT J EXP PATHOL, V68, P569; Asplund A, 2010, GLYCOBIOLOGY, V20, P33, DOI 10.1093/glycob/cwp139; BEEKHUIZEN H, 1993, J LEUKOCYTE BIOL, V54, P363, DOI 10.1002/jlb.54.4.363; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bosco MC, 2006, J IMMUNOL, V177, P1941, DOI 10.4049/jimmunol.177.3.1941; Burke B, 2003, AM J PATHOL, V163, P1233, DOI 10.1016/S0002-9440(10)63483-9; Burke B, 2002, J PATHOL, V196, P204, DOI 10.1002/path.1029; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Crowther M, 2001, J LEUKOCYTE BIOL, V70, P478; Dentan C, 1996, EUR J BIOCHEM, V236, P48, DOI 10.1111/j.1432-1033.1996.00048.x; Domenzain C, 2003, BBA-MOL CELL RES, V1642, P107, DOI 10.1016/S0167-4889(03)00104-6; Fang HY, 2009, BLOOD, V114, P844, DOI 10.1182/blood-2008-12-195941; Genetos DC, 2010, J CELL BIOCHEM, V110, P457, DOI 10.1002/jcb.22559; Hammes HP, 1998, DIABETES, V47, P401, DOI 10.2337/diabetes.47.3.401; Hansch A, 1996, Z RHEUMATOL, V55, P401; HANSSON GK, 1988, ATHEROSCLEROSIS, V72, P135, DOI 10.1016/0021-9150(88)90074-3; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Igwe EI, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-408; IOZZO RV, 1992, GENOMICS, V14, P845, DOI 10.1016/S0888-7543(05)80103-X; ISSEKUTZ TB, 1981, AM J PATHOL, V103, P47; Jersmann HPA, 2003, CYTOM PART A, V51A, P7, DOI 10.1002/cyto.a.10005; Jin G, 2014, SURGERY, V156, P221, DOI 10.1016/j.surg.2014.03.038; Kischel P, 2010, INT J CANCER, V126, P640, DOI 10.1002/ijc.24812; Kodama J, 2007, EUR J CANCER, V43, P1460, DOI 10.1016/j.ejca.2007.02.007; LANDOLT RM, 1995, DEVELOPMENT, V121, P2303; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Lin SK, 2008, ARCH OTOLARYNGOL, V134, P522, DOI 10.1001/archotol.134.5.522; Mace KA, 2007, WOUND REPAIR REGEN, V15, P636, DOI 10.1111/j.1524-475X.2007.00278.x; Makatsori E, 2003, ANTICANCER RES, V23, P3303; MAPP PI, 1995, BRIT MED BULL, V51, P419, DOI 10.1093/oxfordjournals.bmb.a072970; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mojsilovic-Petrovic J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-12; NASO MF, 1994, J BIOL CHEM, V269, P32999; Negus RPM, 1997, AM J PATHOL, V150, P1723; OGORMAN MRG, 1995, CLIN DIAGN LAB IMMUN, V2, P227, DOI 10.1128/CDLI.2.2.227-232.1995; Oh YT, 2008, NEUROSCI LETT, V431, P155, DOI 10.1016/j.neulet.2007.11.033; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; PERIDES G, 1992, J BIOL CHEM, V267, P23883; Qu ZH, 2008, BIOCHEM BIOPH RES CO, V370, P332, DOI 10.1016/j.bbrc.2008.03.092; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Rahmani M, 2004, CAN J CARDIOL, V20, p58B; Ramanathan M, 2007, MOL BIOL CELL, V18, P14, DOI 10.1091/mbc.E06-07-0596; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Seidelmann SB, 2008, ARTERIOSCL THROM VAS, V28, P2180, DOI 10.1161/ATVBAHA.108.176800; Simanonok JP, 1996, MED HYPOTHESES, V46, P155, DOI 10.1016/S0306-9877(96)90017-1; Smythies LE, 2005, J CLIN INVEST, V115, P66, DOI 10.1172/JCI200519229; Sprowl S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003745; Staples KJ, 2011, IMMUNOBIOLOGY, V216, P832, DOI 10.1016/j.imbio.2010.12.005; Staples KJ, 2000, BIOCHEM BIOPH RES CO, V273, P811, DOI 10.1006/bbrc.2000.3023; Theocharis AD, 2000, BBA-MOL BASIS DIS, V1502, P201, DOI 10.1016/S0925-4439(00)00051-X; Theocharis AD, 2002, BBA-MOL BASIS DIS, V1588, P165, DOI 10.1016/S0925-4439(02)00161-8; VAUPEL P, 1991, CANCER RES, V51, P3316; Vaupel P, 2001, MED ONCOL, V18, P243, DOI 10.1385/MO:18:4:243; VOGELBERG KH, 1993, CLIN INVESTIGATOR, V71, P466; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Westra J, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-61; White JR, 2004, GENOMICS, V83, P1, DOI 10.1016/S0888-7543(03)00215-5; Wight TN, 2004, CIRC RES, V94, P1158, DOI 10.1161/01.RES.0000126921.29919.51; Yang WN, 2014, BBA-MOL CELL RES, V1843, P1373, DOI 10.1016/j.bbamcr.2014.02.015; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; ZIMMERMANN DR, 1994, VERH DEUT G, V78, P481	68	8	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0125799	10.1371/journal.pone.0125799	http://dx.doi.org/10.1371/journal.pone.0125799			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057378	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000356349000003
J	Tan, MP; Murray, A; Hawkins, T; Chadwick, TJ; Kerr, SRJ; Parry, SW				Tan, Maw Pin; Murray, Alan; Hawkins, Terry; Chadwick, Thomas J.; Kerr, Simon R. J.; Parry, Steve W.			Cardiac Iodine-123-Meta-Iodo-Benzylguanidine Uptake in Carotid Sinus Hypersensitivity	PLOS ONE			English	Article							NERVOUS-SYSTEM; OLDER-ADULTS; SYNCOPE; METAIODOBENZYLGUANIDINE; HEART; DIAGNOSIS; DISEASE; SCINTIGRAPHY; INNERVATION; INSIGHTS	Background Carotid sinus syndrome is the association of carotid sinus hypersensitivity with syncope, unexplained falls and drop attacks in generally older people. We evaluated cardiac sympathetic innervation in this disorder in individuals with carotid sinus syndrome, asymptomatic carotid sinus hypersensitivity and controls without carotid sinus hypersensitivity. Methods Consecutive patients diagnosed with carotid sinus syndrome at a specialist falls and syncope unit were recruited. Asymptomatic carotid sinus hypersensitivity and non-carotid sinus hypersensitivity control participants recruited from a community-dwelling cohort. Cardiac sympathetic innervation was determined using Iodine-123-metaiodobenzylguanidine (123-I- MIBG) scanning. Heart to mediastinal uptake ratio (H:M) were determined for early and late uptake on planar scintigraphy at 20 minutes and 3 hours following intravenous injection of 123-I-MIBG. Results Forty-two subjects: carotid sinus syndrome (n = 21), asymptomatic carotid sinus hypersensitivity (n = 12) and no carotid sinus hypersensitivity (n = 9) were included. Compared to the non-carotid sinus hypersensitivity control group, the carotid sinus syndrome group had significantly higher early H:M (estimated mean difference, B = 0.40; 95% confidence interval, CI = 0.13 to 0.67, p = 0.005) and late H:M (B = 0.32; 95% CI = 0.03 to 0.62, p = 0.032). There was, however, no significant difference in early H:M (p = 0.326) or late H:M (p = 0.351) between the asymptomatic carotid sinus hypersensitivity group and non-carotid sinus hypersensitivity controls. Conclusions Cardiac sympathetic neuronal activity is increased relative to age-matched controls in individuals with carotid sinus syndrome but not those with asymptomatic carotid sinus hypersensitivity. Blood pressure and heart rate measurements alone may therefore represent an over simplification in the assessment for carotid sinus syndrome and the relative increase in cardiac sympathetic innervation provides additional clues to understanding the mechanisms behind the symptomatic presentation of carotid sinus hypersensitivity.	[Tan, Maw Pin] Univ Malaya, Fac Med, Ageing & Age Associated Disorders Res Grp, Kuala Lumpur, Malaysia; [Murray, Alan; Hawkins, Terry] Freeman Rd Hosp, Dept Reg Med Phys, Newcastle Upon Tyne, Tyne & Wear, England; [Chadwick, Thomas J.] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Chadwick, Thomas J.; Kerr, Simon R. J.; Parry, Steve W.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Kerr, Simon R. J.; Parry, Steve W.] Newcastle Univ, Royal Victoria Infirm, Falls & Syncope Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Universiti Malaya; Newcastle Freeman Hospital; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Parry, SW (corresponding author), Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	swparry@hotmail.com	Tan, Maw Pin/G-6917-2011	Tan, Maw Pin/0000-0002-3400-8540; Murray, Alan/0000-0003-2621-4632	UK NIHR Biomedical Research Centre for Aging and Age-related disease award; Royal College of Physicians/Dunhill Medical Trust Joint Research Fellowship	UK NIHR Biomedical Research Centre for Aging and Age-related disease award; Royal College of Physicians/Dunhill Medical Trust Joint Research Fellowship	This work was supported by the UK NIHR Biomedical Research Centre for Aging and Age-related disease award to the Newcastle upon Tyne Foundation Hospitals NHS Trust and the Newcastle upon Tyne Hospitals Charitable Trust. MPT was the recipient of the Royal College of Physicians/Dunhill Medical Trust Joint Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berardelli A, 2013, EUR J NEUROL, V20, P16, DOI 10.1111/ene.12022; DEHN TCB, 1984, CARDIOVASC RES, V18, P746, DOI 10.1093/cvr/18.12.746; ESLER MD, 1995, CIRCULATION, V91, P351, DOI 10.1161/01.CIR.91.2.351; Finucane C, 2010, EUROPACE, V12, P247, DOI 10.1093/europace/eup385; Goldstein David S, 2013, Handb Clin Neurol, V117, P365, DOI 10.1016/B978-0-444-53491-0.00029-8; Hattori N, 2000, EUR J NUCL MED, V27, P1, DOI 10.1007/s002590050505; HENDERSON EB, 1988, CIRCULATION, V78, P1192, DOI 10.1161/01.CIR.78.5.1192; Kenny RAM, 2001, J AM COLL CARDIOL, V38, P1491, DOI 10.1016/S0735-1097(01)01537-6; Kerr SRJ, 2006, ARCH INTERN MED, V166, P515, DOI 10.1001/archinte.166.5.515; KLINE RC, 1981, J NUCL MED, V22, P129; Kochiadakis G, 2012, EUROPACE, V14, P1352, DOI 10.1093/europace/eus063; Lenska-Mieciek M, 2011, NEUROL NEUROCHIR POL, V45, P335; Lorincz I, 2009, NUCL MED COMMUN, V30, P134, DOI 10.1097/MNM.0b013e328319bfcc; Mangoni AA, 2003, J AM GERIATR SOC, V51, P853, DOI 10.1046/j.1365-2389.2003.51269.x; Miller VM, 2008, NEUROPATH APPL NEURO, V34, P403, DOI 10.1111/j.1365-2990.2007.00903.x; MORLEY CA, 1984, CARDIOVASC RES, V18, P752, DOI 10.1093/cvr/18.12.752; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; Ogita H, 2001, HEART, V86, P656, DOI 10.1136/heart.86.6.656; Olgunturk R, 2003, PACE, V26, P1926, DOI 10.1046/j.1460-9592.2003.00297.x; Parry SW, 2006, HEART, V92, P792, DOI 10.1136/hrt.2004.053348; Parry SW, 2009, HEART, V95, P416, DOI 10.1136/hrt.2007.136457; Parry SW, 2005, J AM GERIATR SOC, V53, P74, DOI 10.1111/j.1532-5415.2005.53013.x; Polvikoski T, 2006, J NEUROL NEUROSUR PS, V77, P1064, DOI 10.1136/jnnp.2005.083550; Sakata K, 2009, CIRC J, V73, P310, DOI 10.1253/circj.CJ-08-0614; SISSON JC, 1987, J NUCL MED, V28, P1620; Solari D, 2014, EUROPACE, V16, P928, DOI 10.1093/europace/eut283; Tan MP, 2010, EUROPACE, V12, P1630, DOI 10.1093/europace/euq317; Tea SH, 1996, CIRCULATION, V93, P1411; Teresinska A, 2012, NUCL MED REV, V15, P61, DOI [10.5603/nmr-18732, 10.5603/NMR.2012.0011]; Verberne HJ, 2008, EUR HEART J, V29, P1147, DOI 10.1093/eurheartj/ehn113; WIELAND DM, 1981, J NUCL MED, V22, P22	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0126241	10.1371/journal.pone.0126241	http://dx.doi.org/10.1371/journal.pone.0126241			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057525	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000004
J	Alharbi, NK; Spencer, AJ; Hill, AVS; Gilbert, SC				Alharbi, Naif Khalaf; Spencer, Alexandra J.; Hill, Adrian V. S.; Gilbert, Sarah C.			Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity	PLOS ONE			English	Article							HOST-RANGE; PROTEIN; MVA; STRAIN; RECEPTOR; REPLICATION; VACCINATION; INHIBITOR; SMALLPOX; MALARIA	Modified vaccinia virus Ankara (MVA) is a highly attenuated strain of vaccinia virus, which has been used as a recombinant vaccine vector in many vaccine development programmes. The loss of many immunosuppressive and host-range genes resulted in a safe and immunogenic vaccine vector. However it still retains some immunomodulatory genes that may reduce MVA immunogenicity. Earlier reports demonstrated that the deletion of the A41L, B15R, C6L, or C12L open reading frames (ORFs) enhanced cellular immune responses in recombinant MVA (rMVA) by up to 2-fold. However, previously, we showed that deletion of the C12L, A44L, A46R, B7R, or B15R ORFs from rMVA, using MVA-BAC recombineering technology, did not enhance rMVA immunogenicity at either peak or memory cellular immune responses. Here, we extend our previous study to examine the effect of deleting clusters of genes on rMVA cellular immunogenicity. Two clusters of fifteen genes were deleted in one rMVA mutant that encodes either the 85A antigen of Mycobacterium tuberculosis or an immunodominant H2-K-d-restricted murine malaria epitope (pb9). The deletion mutants were tested in prime only or prime and boost vaccination regimens. The responses showed no improved peak or memory CD8(+) T cell frequencies. Our results suggest that the reported small increases in MVA deletion mutants could not be replicated with different antigens, or epitopes. Therefore, the gene deletion strategy may not be taken as a generic approach for improving the immunogenicity of MVA-based vaccines, and should be carefully assessed for every individual recombinant antigen.	[Alharbi, Naif Khalaf; Spencer, Alexandra J.; Hill, Adrian V. S.; Gilbert, Sarah C.] Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England; [Alharbi, Naif Khalaf] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia	University of Oxford; Jenner Institute; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC)	Alharbi, NK (corresponding author), Univ Oxford, Jenner Inst, Oxford OX3 7DQ, England.	naif.alharbi@ndm.ox.ac.uk	Spencer, Alexandra/AAE-6494-2019; Gilbert, Sarah C./H-2857-2019	Spencer, Alexandra/0000-0001-7958-6961; Gilbert, Sarah C./0000-0002-6823-9750; Alharbi, Naif/0000-0002-6049-3383	Grand Challenges in Global Health; King Abdullah International Research Centre, Riyadh, Saudi Arabia	Grand Challenges in Global Health; King Abdullah International Research Centre, Riyadh, Saudi Arabia	This work was funded in part by a Grand Challenges in Global Health grant to Prof. Adrian V. S. Hill, Jenner Institute, University of Oxford administered by the Foundation for the National Institutes of Health. AJS is a Oxford Martin Fellow and SCG and AVS are Jenner Institute Investigators (http://www.jenner.ac.uk). NKA receives a scholarship fund from King Abdullah International Research Centre, Riyadh, Saudi Arabia (http://www.kaimrc.med.sa). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHN BY, 1990, J VIROL, V64, P3019, DOI 10.1128/JVI.64.6.3019-3024.1990; Alcock R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000490; Alejo A, 2006, P NATL ACAD SCI USA, V103, P5995, DOI 10.1073/pnas.0510462103; Almazan F, 2001, J VIROL, V75, P7018, DOI 10.1128/JVI.75.15.7018-7029.2001; Antoine G, 1998, VIROLOGY, V244, P365, DOI 10.1006/viro.1998.9123; BANHAM AH, 1993, J GEN VIROL, V74, P2807, DOI 10.1099/0022-1317-74-12-2807; BULLER RML, 1988, VIROLOGY, V164, P182, DOI 10.1016/0042-6822(88)90635-6; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Clark RH, 2006, J GEN VIROL, V87, P29, DOI 10.1099/vir.0.81417-0; Cooray S, 2007, J GEN VIROL, V88, P1656, DOI 10.1099/vir.0.82772-0; Cottingham MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001638; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; DUNCAN SA, 1992, J GEN VIROL, V73, P1235, DOI 10.1099/0022-1317-73-5-1235; Gomez CE, 2013, EXPERT REV VACCINES, V12, P1395, DOI 10.1586/14760584.2013.845531; Falivene J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032220; Ferguson BJ, 2013, J GEN VIROL, V94, P2070, DOI 10.1099/vir.0.054114-0; Garber DA, 2012, J VIROL, V86, P12605, DOI 10.1128/JVI.00246-12; Garber DA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005445; Garcia-Arriaza J, 2014, J VIROL, V88, P3392, DOI 10.1128/JVI.02723-13; Garcia-Arriaza J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066894; Garcia-Arriaza J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024244; Garcia-Arriaza J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012395; Geiben-Lynn R, 2008, CLIN VACCINE IMMUNOL, V15, P691, DOI 10.1128/CVI.00418-07; Gilbert SC, 2006, VACCINE, V24, P4554, DOI 10.1016/j.vaccine.2005.08.048; Hornemann S, 2003, J VIROL, V77, P8394, DOI 10.1128/JVI.77.15.8394-8407.2003; Kluczyk A, 2002, PEPTIDES, V23, P823, DOI 10.1016/S0196-9781(02)00006-2; LAW KM, 1992, J GEN VIROL, V73, P549, DOI 10.1099/0022-1317-73-3-549; Lousberg EL, 2011, EXPERT REV VACCINES, V10, P1435, DOI [10.1586/erv.11.121, 10.1586/ERV.11.121]; MACHESKY LM, 1994, BIOCHEMISTRY-US, V33, P10815, DOI 10.1021/bi00201a032; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; Moorthy VS, 2003, VACCINE, V21, P1995, DOI 10.1016/S0264-410X(02)00771-5; Najera JL, 2006, J VIROL, V80, P6033, DOI 10.1128/JVI.02108-05; OGUIURA N, 1993, J GEN VIROL, V74, P1409, DOI 10.1099/0022-1317-74-7-1409; Perdiguero B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048524; Price N, 2002, J GEN VIROL, V83, P873, DOI 10.1099/0022-1317-83-4-873; Price PJR, 2013, VACCINE, V31, P4231, DOI 10.1016/j.vaccine.2013.03.017; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; Reading PC, 2003, J VIROL, V77, P9960, DOI 10.1128/JVI.77.18.9960-9968.2003; Reading PC, 2003, J EXP MED, V197, P1269, DOI 10.1084/jem.20022201; Rehm KE, 2011, VACCINE, V29, P3276, DOI 10.1016/j.vaccine.2011.02.023; Rice AD, 2011, J VIROL, V85, P550, DOI 10.1128/JVI.00254-10; ROMERO P, 1990, IMMUNOL LETT, V25, P27, DOI 10.1016/0165-2478(90)90086-6; Sood CL, 2010, VIROLOGY, V396, P160, DOI 10.1016/j.virol.2009.10.025; Sridhar S, 2008, J VIROL, V82, P3822, DOI 10.1128/JVI.02568-07; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Staib C, 2000, BIOTECHNIQUES, V28, P1137, DOI 10.2144/00286st04; Staib C, 2005, J GEN VIROL, V86, P1997, DOI 10.1099/vir.0.80646-0; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Sutter Gerd, 2003, Current Drug Targets - Infectious Disorders, V3, P263, DOI 10.2174/1568005033481123; Symons JA, 2002, J GEN VIROL, V83, P1953, DOI 10.1099/0022-1317-83-8-1953; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Unterholzner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002247; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	53	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128626	10.1371/journal.pone.0128626	http://dx.doi.org/10.1371/journal.pone.0128626			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053118	gold, Green Published			2022-12-26	WOS:000355955300047
J	Azar, KMJ; Chung, S; Wang, EJ; Zhao, BN; Linde, RB; Lederer, J; Palaniappan, LP				Azar, Kristen M. J.; Chung, Sukyung; Wang, Elsie J.; Zhao, Beinan; Linde, Randolph B.; Lederer, Janet; Palaniappan, Latha P.			Impact of Education on Weight in Newly Diagnosed Type 2 Diabetes: Every Little Bit Helps	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; SELF-MANAGEMENT; INDIVIDUALS; ASSOCIATION; SUPPORT	Aims Highly structured, intensive behavioral lifestyle interventions have been shown to be efficacious in research settings for type 2 diabetes management and weight loss. We sought to evaluate the benefit of participation in more limited counseling and/or education among individuals with newly diagnosed type 2 diabetes in more modest real-world clinical settings. Methods Electronic Health Records of newly diagnosed type 2 diabetes patients age 35-74 from a large ambulatory group practice were analyzed (n = 1,314). We examined participation in clinic-based lifestyle counseling/education and subsequent weight loss. Results Of the total cohort, 599 (45.6%) patients received counseling/education with (26.2%) and without (19.4%) medication, 298(22.7%) patients received a prescription for medication alone, and 417(31.7%) patients were only monitored. On average, those who participated in counseling/education attended 2.5 sessions (approximately 2-3 hours). The average weight loss of patients who received counseling/education alone during the follow-up period (up to three years post-exposure to participation) was 6.3 lbs. (3.3% of body weight), and, if received with medication prescription, 8.1lbs. (4.0% of body weight) (all at P<0.001). The weight loss associated with medication was only 3.5 lbs. (P<0.001). No significant weight change was observed in the monitoring only group. Conclusions While efforts to improve both the short-term and long-term effectiveness of behavioral lifestyle interventions in real-world settings are ongoing, it is important for clinicians to continue to utilize less intensive, existing resources. Even relatively small "doses" of health education may help in promoting weight loss and may potentially reduce cardiometabolic risk.	[Azar, Kristen M. J.; Chung, Sukyung; Zhao, Beinan] Palo Alto Med Fdn Res Inst, Palo Alto, CA 94301 USA; [Linde, Randolph B.; Lederer, Janet] Palo Alto Med Fdn, Palo Alto, CA USA; [Wang, Elsie J.; Palaniappan, Latha P.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Palo Alto Medical Foundation Research Institute; Palo Alto Medical Foundation Research Institute; Stanford University	Azar, KMJ (corresponding author), Palo Alto Med Fdn Res Inst, Palo Alto, CA 94301 USA.	azark@pamfri.org		Palaniappan, Latha/0000-0002-1245-665X	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK081371-01]; Agency for Healthcare Research Quality [K01 HS019815]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K01HS019815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081371] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Agency for Healthcare Research Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by funds from National Institute of Diabetes and Digestive and Kidney Diseases (R01DK081371-01) http://www.niddk.nih.gov/Pages/default.aspx and the Agency for Healthcare Research & Quality (K01 HS019815) http://www.ahrq.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, DIABETES CARE, V28, pS4; [Anonymous], 2010, Diabetes Care, V33 Suppl 1, pS4, DOI 10.2337/dc10-S004; [Anonymous], 2009, NCHS DATA BRIEF; Aucott L, 2005, HYPERTENSION, V45, P1035, DOI 10.1161/01.HYP.0000165680.59733.d4; BLACKBURN G, 1995, OBES RES, V3, pS211, DOI 10.1002/j.1550-8528.1995.tb00466.x; Bray GA, 1999, DIABETES CARE, V22, P623; Bureau U.S.C, 2000, PROF GEN DEM CHAR 20; Cauch-Dudek K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-85; Chung S., 2014, PRIMARY CAR IN PRESS; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; Delahanty LM, 2008, J AM DIET ASSOC, V108, pS66, DOI 10.1016/j.jada.2008.01.026; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Espeland M, 2007, DIABETES CARE, V30, P1374; Forjuoh SN, 2011, PATIENT EDUC COUNS, V85, P133, DOI 10.1016/j.pec.2010.08.004; Gorin A, 2005, J CONSULT CLIN PSYCH, V73, P341, DOI 10.1037/0022-006X.73.2.341; Graziani C, 1999, Fam Med, V31, P358; Gregg EW, 2012, JAMA-J AM MED ASSOC, V308, P2489, DOI 10.1001/jama.2012.67929; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Norris SL, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004096.pub2, 10.1002/14651858.CD004095.pub2, 10.1002/14651858.CD005270]; Palaniappan LP, 2011, J AM BOARD FAM MED, V24, P326, DOI 10.3122/jabfm.2011.03.100220; Paul-Ebhohimhen V, 2009, OBESITY FACTS, V2, P17, DOI 10.1159/000186144; Poobalan A, 2004, Obes Rev, V5, P43, DOI 10.1111/j.1467-789X.2004.00127.x; Rao G, 2013, JAMA INTERN MED, V173, P111, DOI 10.1001/jamainternmed.2013.1232; Steinsbekk A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-213; Thomas SL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-34; Unick JL, 2013, AM J MED, V126, P236, DOI 10.1016/j.amjmed.2012.10.010; Verheijden MW, 2005, EUR J CLIN NUTR, V59, pS179, DOI 10.1038/sj.ejcn.1602194; Wadden TA, 2006, OBESITY, V14, P737; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334	33	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129348	10.1371/journal.pone.0129348	http://dx.doi.org/10.1371/journal.pone.0129348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052698	gold, Green Submitted, Green Published			2022-12-26	WOS:000355955300121
J	Bella, R; Lanza, G; Cantone, M; Giuffrida, S; Puglisi, V; Vinciguerra, L; Pennisi, M; Ricceri, R; D'Agate, CC; Malaguarnera, G; Ferri, R; Pennisi, G				Bella, Rita; Lanza, Giuseppe; Cantone, Mariagiovanna; Giuffrida, Salvatore; Puglisi, Valentina; Vinciguerra, Luisa; Pennisi, Manuela; Ricceri, Riccardo; D'Agate, Carmela Cinzia; Malaguarnera, Giulia; Ferri, Raffaele; Pennisi, Giovanni			Effect of a Gluten-Free Diet on Cortical Excitability in Adults with Celiac Disease	PLOS ONE			English	Article							SUBCLINICAL NEUROLOGICAL ABNORMALITIES; ISCHEMIC VASCULAR DEMENTIA; MOTOR-EVOKED-POTENTIALS; AGE-RELATED-CHANGES; CORTICOMOTOR EXCITABILITY; INTRACORTICAL INHIBITION; ANTINEURONAL ANTIBODIES; MAGNETIC STIMULATION; CHILDREN; RELIABILITY	Introduction An imbalance between excitatory and inhibitory synaptic excitability was observed in de novo patients with celiac disease (CD) in a previous study with Transcranial Magnetic Stimulation (TMS), suggesting a subclinical involvement of GABAergic and glutamatergic neurotransmission in asymptomatic patients. The aim of this investigation was to monitor the eventual changes in the same cohort of patients, evaluated after a period of gluten-free diet. Methods Patients were re-evaluated after a median period of 16 months during which an adequate gluten-free diet was maintained. Clinical, cognitive and neuropsychiatric assessment was repeated, as well as cortical excitability by means of single-and paired-pulse TMS from the first dorsal interosseous muscle of the dominant hand. Results Compared to baseline, patients showed a significant decrease of the median resting motor threshold (from 35% to 33%, p<0.01). The other single-pulse (cortical silent period, motor evoked potentials latency and amplitude, central motor conduction time) and paired-pulse TMS measures (intracortical inhibition and intracortical facilitation) did not change significantly after the follow-up period. Antibodies were still present in 7 subjects. Discussion In patients under a gluten-free diet, a global increase of cortical excitability was observed, suggesting a glutamate-mediated functional reorganization compensating for disease progression. We hypothesize that glutamate receptor activation, probably triggered by CD-related immune system dysregulation, might result in a long-lasting motor cortex hyperexcitability with increased excitatory post-synaptic potentials, probably related to phenomena of long-term plasticity. The impact of the gluten-free diet on subclinical neurological abnormalities needs to be further explored.	[Bella, Rita; Giuffrida, Salvatore; Puglisi, Valentina; Vinciguerra, Luisa; Ricceri, Riccardo] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy; [Lanza, Giuseppe; Cantone, Mariagiovanna; Ferri, Raffaele] Oasi Inst Res Mental Retardat & Brain Aging, IRCCS, Dept Neurol IC, Troina, EN, Italy; [Pennisi, Manuela] Emergency Hosp Cannizzaro, Spinal Unit, Catania, Italy; [D'Agate, Carmela Cinzia] Univ Catania, Gastroenterol & Endoscopy Unit, Catania, Italy; [Malaguarnera, Giulia] Univ Catania, Dept Biomed Sci, Catania, Italy; [Pennisi, Giovanni] Univ Catania, Dept Specialita Medicochirurg, Catania, Italy	University of Catania; IRCCS Oasi Maria SS; University of Catania; University of Catania; University of Catania	Pennisi, G (corresponding author), Univ Catania, Dept Specialita Medicochirurg, Catania, Italy.	pennigi@unict.it	Lanza, Giuseppe/R-3065-2017; Pennisi, Manuela/AAC-2362-2019; Cantone, Mariagiovanna/C-9392-2017; Ferri, Raffaele/B-5439-2013; Malaguarnera, Giulia/ABD-4968-2020	Lanza, Giuseppe/0000-0002-5659-662X; Pennisi, Manuela/0000-0003-0776-1411; Cantone, Mariagiovanna/0000-0002-9072-4971; Ferri, Raffaele/0000-0001-6937-3065; Malaguarnera, Giulia/0000-0003-3655-4307				Abenavoli L, 2008, J AM DIET ASSOC, V108, P1995, DOI 10.1016/j.jada.2008.10.027; Addolorato G, 2004, ALIMENT PHARM THER, V20, P777, DOI 10.1111/j.1365-2036.2004.02193.x; Addolorato G, 2001, SCAND J GASTROENTERO, V36, P502, DOI 10.1080/00365520119754; Biagi F, 2012, BRIT J NUTR, V108, P1884, DOI 10.1017/S0007114511007367; Briani C, 2004, ALIMENT PHARM THER, V20, P231, DOI 10.1111/j.1365-2036.2004.02016.x; Burk K, 2009, MOVEMENT DISORD, V24, P2358, DOI 10.1002/mds.22821; Cacchio A, 2011, J NEUROL SCI, V303, P90, DOI 10.1016/j.jns.2011.01.004; Cacchio A, 2009, CLIN NEUROPHYSIOL, V120, P414, DOI 10.1016/j.clinph.2008.11.019; Cakir D, 2007, J PEDIATR GASTR NUTR, V45, P366, DOI 10.1097/MPG.0b013e31806907e8; Chin RL, 2003, NEUROLOGY, V60, P1581, DOI 10.1212/01.WNL.0000063307.84039.C7; Christie A, 2007, J NEUROSCI METH, V164, P320, DOI 10.1016/j.jneumeth.2007.05.011; Cohen J, 1992, CURRENT DIRECTIONS P, V1, P98, DOI DOI 10.1111/1467-8721.EP10768783; CONGDON P, 1981, AM J DIS CHILD, V135, P118, DOI 10.1001/archpedi.1981.02130260010004; Coppi E, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00209; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fujiyama H, 2012, J COGNITIVE NEUROSCI, V24, P1253, DOI 10.1162/jocn_a_00201; Ganor Y, 2005, EXP NEUROL, V195, P92, DOI 10.1016/j.expneurol.2005.04.002; Giordano D, 2012, COMPUT METH PROG BIO, V107, P4, DOI 10.1016/j.cmpb.2011.10.008; GREFTE JMM, 1988, J CLIN PATHOL, V41, P886, DOI 10.1136/jcp.41.8.886; Groppa S, 2012, CLIN NEUROPHYSIOL, V123, P858, DOI 10.1016/j.clinph.2012.01.010; Guerra A, 2015, CLIN NEUROPHYSIOL, V126, P906, DOI 10.1016/j.clinph.2014.07.036; Hadjivassiliou M, 2006, MUSCLE NERVE, V34, P762, DOI 10.1002/mus.20642; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; HALLERT C, 1983, PSYCHOL MED, V13, P267, DOI 10.1017/S003329170005087X; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hu WT, 2006, ARCH NEUROL-CHICAGO, V63, P1440, DOI 10.1001/archneur.63.10.1440; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Jackson JR, 2012, PSYCHIAT QUART, V83, P91, DOI 10.1007/s11126-011-9186-y; Koski L, 2007, NEUROSCI RES, V58, P19, DOI 10.1016/j.neures.2007.01.007; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Levite M, 2014, J NEURAL TRANSM, V121, P1029, DOI 10.1007/s00702-014-1193-3; Liu H, 2014, J NEUROL SCI, V341, P105, DOI 10.1016/j.jns.2014.04.012; Luostarinen L, 2003, J NEUROL NEUROSUR PS, V74, P490, DOI 10.1136/jnnp.74.4.490; Mavroudi A, 2005, PEDIATR NEUROL, V33, P292, DOI 10.1016/j.pediatrneurol.2005.05.010; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliviero A, 2006, NEUROSCI RES, V55, P74, DOI 10.1016/j.neures.2006.02.002; Parisi P, 2015, SEIZURE-EUR J EPILEP, V25, P181, DOI 10.1016/j.seizure.2014.09.016; Paulus W, 2008, BRAIN STIMUL, V1, P151, DOI 10.1016/j.brs.2008.06.002; Peinemann A, 2001, NEUROSCI LETT, V313, P33, DOI 10.1016/S0304-3940(01)02239-X; Pellecchia MT, 1999, NEUROLOGY, V53, P1606, DOI 10.1212/WNL.53.7.1606-a; Pennisi G, 2015, CLIN NEUROPHYSIOL, V126, P851, DOI 10.1016/j.clinph.2014.09.001; Pennisi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102790; Petitjean M, 2013, CLIN NEUROPHYSIOL, V124, P346, DOI 10.1016/j.clinph.2012.07.006; Pynnonen PA, 2004, PSYCHOSOMATICS, V45, P325, DOI 10.1176/appi.psy.45.4.325; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; ROSSINI PM, 1992, BRAIN RES, V593, P14, DOI 10.1016/0006-8993(92)91256-E; Rothwell J.C., 1999, INT FED CLIN NEUROPH, V52, P97; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Selby WS, 1999, SCAND J GASTROENTERO, V34, P909, DOI 10.1080/003655299750025390; Shmerling DH, 1986, J PEDIAT GASTROENTER, V5, P560; Tursi A, 2006, DIGEST DIS SCI, V51, P1869, DOI 10.1007/s10620-005-9054-4; Volta U, 2002, SCAND J GASTROENTERO, V37, P1276, DOI 10.1080/003655202761020542; Wahab PJ, 2002, AM J CLIN PATHOL, V118, P459; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734	54	41	41	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129218	10.1371/journal.pone.0129218	http://dx.doi.org/10.1371/journal.pone.0129218			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053324	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300101
J	Sola Carvajal, A; McKenna, T; Arzt, EW; Eriksson, M				Sola Carvajal, Agustin; McKenna, Tomas; Arzt, Emelie Wallen; Eriksson, Maria			Overexpression of Lamin B Receptor Results in Impaired Skin Differentiation	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; NUCLEAR LAMINS; EXPRESSION; SENESCENCE; CHROMATIN; DISEASE; CELLS; MICE; PROLIFERATION; KERATINOCYTES	Hutchinson-Gilford progeria syndrome (HGPS) is a rare segmental progeroid disorder commonly caused by a point mutation in the LMNA gene that results in the increased activation of an intra-exonic splice site and the production of a truncated lamin A protein, named progerin. In our previous work, induced murine epidermal expression of this specific HGPS LMNA mutation showed impaired keratinocyte differentiation and upregulated lamin B receptor (LBR) expression in suprabasal keratinocytes. Here, we have developed a novel transgenic animal model with induced overexpression of LBR in the interfollicular epidermis. LBR overexpression resulted in epidermal hypoplasia, along with the downregulation and mislocalization of keratin 10, suggesting impaired keratinocyte differentiation. Increased LBR expression in basal and suprabasal cells did not coincide with increased proliferation. Similar to our previous report of HGPS mice, analyses of gamma H2AX, a marker of DNA doublestrand breaks, revealed an increased number of keratinocytes with multiple foci in LBR-overexpressing mice compared with wild-type mice. In addition, suprabasal LBR-positive cells showed densely condensed and peripherally localized chromatin. Our results show a moderate skin differentiation phenotype, which indicates that upregulation of LBR is not the sole contributor to the HGPS phenotype.	[Sola Carvajal, Agustin; McKenna, Tomas; Arzt, Emelie Wallen; Eriksson, Maria] Karolinska Inst, Ctr Innovat Med, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden	Karolinska Institutet	Eriksson, M (corresponding author), Karolinska Inst, Ctr Innovat Med, Dept Biosci & Nutr, SE-14183 Huddinge, Sweden.	maria.eriksson.2@ki.se		Sola Carvajal, Agustin/0000-0001-6568-0682	Swedish Research Council [521-2012-2654]; Karolinska Institutet	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This study was supported by the Swedish Research Council #521-2012-2654 and the Karolinska Institutet (provided salaries).	Adler AS, 2007, GENE DEV, V21, P3244, DOI 10.1101/gad.1588507; BAKER PB, 1981, ARCH PATHOL LAB MED, V105, P384; Burgess RC, 2014, CELL REP, V9, P1703, DOI 10.1016/j.celrep.2014.10.060; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Clowney EJ, 2012, CELL, V151, P724, DOI 10.1016/j.cell.2012.09.043; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; Diamond I, 2000, J INVEST DERMATOL, V115, P788, DOI 10.1046/j.1523-1747.2000.00144.x; Dreesen O, 2013, J CELL BIOL, V200, P605, DOI 10.1083/jcb.201206121; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Freund A, 2010, TRENDS MOL MED, V16, P238, DOI 10.1016/j.molmed.2010.03.003; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Hosseini M, 2015, J INVEST DERMATOL, V135, P1108, DOI 10.1038/jid.2014.511; Isermann P, 2013, CURR BIOL, V23, pR1113, DOI 10.1016/j.cub.2013.11.009; Jung HJ, 2014, MOL CELL BIOL, V34, P4534, DOI 10.1128/MCB.00997-14; Kriete Andres, 2008, Immun Ageing, V5, P5, DOI 10.1186/1742-4933-5-5; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Liu X, 2001, P NATL ACAD SCI USA, V98, P9139, DOI 10.1073/pnas.161016098; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; McKenna T, 2014, AGING CELL, V13, P292, DOI 10.1111/acel.12173; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Olins AL, 2010, NUCLEUS-PHILA, V1, P53, DOI 10.4161/nucl.1.1.10515; Politz JCR, 2013, NUCLEUS-AUSTIN, V4, P153, DOI 10.4161/nucl.24999; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Reichelt J, 2001, MOL BIOL CELL, V12, P1557, DOI 10.1091/mbc.12.6.1557; Rodriguez S, 2009, EUR J HUM GENET, V17, P928, DOI 10.1038/ejhg.2008.270; Rosengardten Y, 2011, AGING CELL, V10, P1011, DOI 10.1111/j.1474-9726.2011.00743.x; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schreiber KH, 2013, CELL, V152, P1365, DOI 10.1016/j.cell.2013.02.015; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tilstra JS, 2012, J CLIN INVEST, V122, P2601, DOI 10.1172/JCI45785; Wallace L, 2012, J CELL SCI, V125, P1750, DOI 10.1242/jcs.097139; Wilson KL, 2010, COLD SPRING HARBOR P, V2; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang SH, 2011, HUM MOL GENET, V20, P3537, DOI 10.1093/hmg/ddr266; YE Q, 1994, J BIOL CHEM, V269, P11306; Zouboulis CC, 2008, EXP GERONTOL, V43, P986, DOI 10.1016/j.exger.2008.09.001; Zwerger M, 2008, EXP HEMATOL, V36, P977, DOI 10.1016/j.exphem.2008.03.003	44	3	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128917	10.1371/journal.pone.0128917	http://dx.doi.org/10.1371/journal.pone.0128917			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053873	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300068
J	Badawi, M; Greve, P; Cordaux, R				Badawi, Myriam; Greve, Pierre; Cordaux, Richard			Feminization of the Isopod Cylisticus convexus after Transinfection of the wVulC Wolbachia Strain of Armadillidium vulgare	PLOS ONE			English	Article							FEMINIZING WOLBACHIA; DROSOPHILA-SIMULANS; CYTOPLASMIC INCOMPATIBILITY; MOLECULAR-IDENTIFICATION; REPRODUCTIVE PARASITES; TERRESTRIAL CRUSTACEAN; SEX-DETERMINATION; HOST; INFECTION; ENDOSYMBIONTS	Reproductive parasites such as Wolbachia are able to manipulate the reproduction of their hosts by inducing parthenogenesis, male-killing, cytoplasmic incompatibility or feminization of genetic males. Despite extensive studies, no underlying molecular mechanism has been described to date. The goal of this study was to establish a system with a single Wolbachia strain that feminizes two different isopod species to enable comparative analyses aimed at elucidating the genetic basis of feminization. It was previously suggested that Wolbachia wVulC, which naturally induces feminization in Armadillidium vulgare, induces the development of female secondary sexual characters in transinfected Cylisticus convexus adult males. However, this does not demonstrate that wVulC induces feminization in Cylisticus convexus since feminization is the conversion of genetic males into functional females that occurs during development. Nevertheless, it suggests that Cylisticus convexus may represent a feminization model suitable for further development. Knowledge about Cylisticus convexus sexual differentiation is also essential for comparative analyses, as feminization is thought to take place just before or during sexual differentiation. Consequently, we first described gonad morphological differentiation of Cylisticus convexus and compared it with that of Armadillidium vulgare. Then, wVulC was injected into male and female Cylisticus convexus adult individuals. The feminizing effect was demonstrated by the combined appearance of female secondary sexual characters in transinfected adult males, as well as the presence of intersexes and female biases in progenies in which wVulC was vertically transmitted from transinfected mothers. The establishment of a new model of feminization of a Wolbachia strain in a heterologous host constitutes a useful tool towards the understanding of the molecular mechanism of feminization.	[Badawi, Myriam; Greve, Pierre; Cordaux, Richard] Univ Poitiers, UMR CNRS Ecol & Biol Interact 7267, Equipe Ecol Evolut Symbiose, F-86073 Poitiers 9, France	Universite de Poitiers	Cordaux, R (corresponding author), Univ Poitiers, UMR CNRS Ecol & Biol Interact 7267, Equipe Ecol Evolut Symbiose, Bat B8,5 Rue Albert Turpin,TSA 51106, F-86073 Poitiers 9, France.	richard.cordaux@univ-poitiers.fr	badawi, Myriam/ABH-4097-2020	badawi, Myriam/0000-0001-5918-106X	European Research Council Starting (FP7, EndoSexDet) [260729]; Centre National de la Recherche Scientifique (CNRS); French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	European Research Council Starting (FP7, EndoSexDet); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche	This research was funded by a European Research Council Starting Grant (FP7/2007-2013, grant 260729 EndoSexDet) to RC and intramural funds from the Centre National de la Recherche Scientifique (CNRS) and the French Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi M, 2014, GENOME BIOL EVOL, V6, P2654, DOI 10.1093/gbe/evu207; Baldo L, 2007, CURR MICROBIOL, V55, P367, DOI 10.1007/s00284-007-9009-4; Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Bouchon D, 1998, P ROY SOC B-BIOL SCI, V265, P1081, DOI 10.1098/rspb.1998.0402; Bouchon D, 2008, INSECT SYMBIOSIS, P273; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Breeuwer JAJ, 1996, EXP APPL ACAROL, V20, P421, DOI 10.1007/BF00053306; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Bull J, 1983, EVOLUTION SEX DETERM, P192; CHARNIAUXCOTTON H, 1992, REPROD BIOL INVERTEB, V5, P281; COMBES C, 1995, COLLECTION ECOLOGIE, V26; Cordaux R, 2004, HEREDITY, V93, P78, DOI 10.1038/sj.hdy.6800482; Cordaux R, 2012, ZOOKEYS, P123, DOI 10.3897/zookeys.176.2284; Cordaux R, 2011, TRENDS GENET, V27, P332, DOI 10.1016/j.tig.2011.05.002; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Duron O, 2008, MOL ECOL, V17, P1427, DOI 10.1111/j.1365-294X.2008.03689.x; Duron O, 2012, P ROY SOC B-BIOL SCI, V279, P4473, DOI 10.1098/rspb.2012.1368; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Giorgini M, 2009, HEREDITY, V102, P365, DOI 10.1038/hdy.2008.135; Hagimori T, 2006, CURR MICROBIOL, V52, P97, DOI 10.1007/s00284-005-0092-0; Huigens ME, 2004, P ROY SOC B-BIOL SCI, V271, P509, DOI 10.1098/rspb.2003.2640; Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698; JUCHAULT P, 1974, Annales d'Embryologie et de Morphogenese, V7, P265; Juchault P, 1966, CONTRIBUTION ETUDE D; Kageyama D, 2002, HEREDITY, V88, P444, DOI 10.1038/sj.hdy.6800077; Kageyama D, 2008, MICROB ECOL, V56, P733, DOI 10.1007/s00248-008-9392-9; Kang L, 2003, HEREDITY, V90, P71, DOI 10.1038/sj.hdy.6800180; Katakura Y., 1984, S ZOOL SOC LONDON, V53, P127; Le Clec'h W, 2014, J INVERTEBR PATHOL, V116, P18, DOI 10.1016/j.jip.2013.12.003; Le Clec'h W, 2013, ENVIRON MICROBIOL, V15, P2922, DOI 10.1111/1462-2920.12172; Le Clec'h W, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002844; LEGRAND J J, 1978, Archives de l'Institut Pasteur de Tunis, V55, P507; LEGRAND JJ, 1986, B ZOOL, V53, P161; LEGRAND JJ, 1963, CR HEBD ACAD SCI, V256, P1606; LePage D, 2013, TRENDS PARASITOL, V29, P385, DOI 10.1016/j.pt.2013.06.003; Marcade I, 1999, HEREDITY, V83, P71, DOI 10.1038/sj.hdy.6885380; MARTIN G, 1973, CR ACAD SCI D NAT, V276, P2313; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; Michel-Salzat A, 2001, HEREDITY, V87, P428, DOI 10.1046/j.1365-2540.2001.00920.x; Moret Y, 2001, HEREDITY, V86, P325, DOI 10.1046/j.1365-2540.2001.00831.x; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Riegler M, 2004, APPL ENVIRON MICROB, V70, P273, DOI 10.1128/AEM.70.1.273-279.2004; Rigaud T, 1997, INFLUENTIAL PASSENGERS, P81; Rigaud T, 1997, BIOESSAYS, V19, P409, DOI 10.1002/bies.950190508; RIGAUD T, 1991, ENDOCYTOBIOSIS CELL, V7, P259; Rigaud T, 1998, CAN J ZOOL, V76, P493, DOI 10.1139/cjz-76-3-493; Rigaud T, 2001, J INVERTEBR PATHOL, V77, P251, DOI 10.1006/jipa.2001.5026; Rigaud T, 1999, HEREDITY, V83, P469, DOI 10.1038/sj.hdy.6885990; ROUSSET F, 1992, P ROY SOC B-BIOL SCI, V247, P163, DOI 10.1098/rspb.1992.0023; Sicard M, 2014, ENVIRON MICROBIOL, V16, P3583, DOI 10.1111/1462-2920.12573; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Suzuki Sachiko, 1995, Crustacean Research, V24, P93; Tabata J, 2011, MICROB ECOL, V61, P254, DOI 10.1007/s00248-010-9799-y; Van Meer MMM, 1999, HEREDITY, V82, P163, DOI 10.1038/sj.hdy.6884610; WERREN JH, 1995, P ROY SOC B-BIOL SCI, V261, P55, DOI 10.1098/rspb.1995.0117; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	58	3	3	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128660	10.1371/journal.pone.0128660	http://dx.doi.org/10.1371/journal.pone.0128660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047139	Green Submitted, gold, Green Published			2022-12-26	WOS:000355652200089
J	Jindal, HM; Le, CF; Yusof, MYM; Velayuthan, RD; Lee, VS; Zain, SM; Isa, DM; Sekaran, SD				Jindal, Hassan Mahmood; Le, Cheng Foh; Yusof, Mohd Yasim Mohd; Velayuthan, Rukumani Devi; Lee, Vannajan Sanghiran; Zain, Sharifuddin Md; Isa, Diyana Mohd; Sekaran, Shamala Devi			Antimicrobial Activity of Novel Synthetic Peptides Derived from Indolicidin and Ranalexin against Streptococcus pneumoniae	PLOS ONE			English	Article							SWISS-MODEL REPOSITORY; ANTIBACTERIAL ACTIVITY; VIRULENCE FACTORS; HYBRID PEPTIDES; IN-VITRO; DESIGN; TRYPTOPHAN; MECHANISMS; BACTERIA; STAPHYLOCOCCUS	Antimicrobial peptides (AMPs) represent promising alternatives to conventional antibiotics in order to defeat multidrug-resistant bacteria such as Streptococcus pneumoniae. In this study, thirteen antimicrobial peptides were designed based on two natural peptides indolicidin and ranalexin. Our results revealed that four hybrid peptides RN7-IN10, RN7-IN9, RN7-IN8, and RN7-IN6 possess potent antibacterial activity against 30 pneumococcal clinical isolates (MIC 7.81-15.62 mu g/ml). These four hybrid peptides also showed broad spectrum antibacterial activity (7.81 mu g/ml) against S. aureus, methicillin resistant S. aureus (MRSA), and E. coli. Furthermore, the time killing assay results showed that the hybrid peptides were able to eliminate S. pneumoniae within less than one hour which is faster than the standard drugs erythromycin and ceftriaxone. The cytotoxic effects of peptides were tested against human erythrocytes, WRL-68 normal liver cell line, and NL-20 normal lung cell line. The results revealed that none of the thirteen peptides have cytotoxic or hemolytic effects at their MIC values. The in silico molecular docking study was carried out to investigate the binding properties of peptides with three pneumococcal virulent targets by Autodock Vina. RN7IN6 showed a strong affinity to target proteins; autolysin, pneumolysin, and pneumococcal surface protein A (PspA) based on rigid docking studies. Our results suggest that the hybrid peptides could be suitable candidates for antibacterial drug development.	[Jindal, Hassan Mahmood; Yusof, Mohd Yasim Mohd; Velayuthan, Rukumani Devi; Sekaran, Shamala Devi] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Le, Cheng Foh] Fac Sci, Sch Pharm, Semenyih 43500, Selangor, Malaysia; [Lee, Vannajan Sanghiran; Zain, Sharifuddin Md; Isa, Diyana Mohd] Univ Malaya, Fac Sci, Dept Chem, Kuala Lumpur 50603, Malaysia	Universiti Malaya; Universiti Malaya	Sekaran, SD (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	shamalamy@yahoo.com	Devi, Shamala Devi/B-9735-2010; Jindal, Hassan/AAD-3807-2022; Sekaran, Shamala Devi/B-8482-2008; Lee, Vannajan Sanghiran/AAX-5564-2020	Devi, Shamala Devi/0000-0002-0478-0425; Sekaran, Shamala Devi/0000-0002-0478-0425; Jindal, Hassan/0000-0002-0788-3753; Le, Cheng Foh/0000-0002-2295-6690	University of Malaya High Impact Research grant [UM.C/HIR/MOHE/MED/40, H-848 20001-E000079]; University of Malaya Research Grant (UMRG Project) [RP020C-14AFR, RP001C-13ICT]	University of Malaya High Impact Research grant; University of Malaya Research Grant (UMRG Project)	This study was supported by University of Malaya High Impact Research grant (reference number: UM.C/HIR/MOHE/MED/40, account number: H-848 20001-E000079) and University of Malaya Research Grant (UMRG Project no. RP020C-14AFR and RP001C-13ICT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljunid S, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-248; ALONSODEVELASCO E, 1995, MICROBIOL REV, V59, P591, DOI 10.1128/MMBR.59.4.591-603.1995; [Anonymous], 2009, DISC STUD VERS 2 5 5; Badosa E, 2007, PEPTIDES, V28, P2276, DOI 10.1016/j.peptides.2007.09.010; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; Bravo LC, 2009, VACCINE, V27, P7282, DOI 10.1016/j.vaccine.2009.04.046; Brogden NK, 2011, INT J ANTIMICROB AG, V38, P217, DOI 10.1016/j.ijantimicag.2011.05.004; Cao J, 2007, VACCINE, V25, P4996, DOI 10.1016/j.vaccine.2007.04.069; Chaibou Y, 2014, MED MALADIES INFECT, V44, P117, DOI 10.1016/j.medmal.2014.01.014; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chen YX, 2007, ANTIMICROB AGENTS CH, V51, P1398, DOI 10.1128/AAC.00925-06; CLARK DP, 1994, J BIOL CHEM, V269, P10849; Clinical and Laboratory Standards Institute, 2012, METHODS DILUTION ANT, V9th; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Duval E, 2009, PEPTIDES, V30, P1608, DOI 10.1016/j.peptides.2009.06.022; Falla TJ, 1997, ANTIMICROB AGENTS CH, V41, P771, DOI 10.1128/AAC.41.4.771; Fehri LF, 2007, ANTIMICROB AGENTS CH, V51, P468, DOI 10.1128/AAC.01030-06; Giacometti A, 1999, J ANTIMICROB CHEMOTH, V44, P641, DOI 10.1093/jac/44.5.641; Hara S, 2008, BIOCHEM BIOPH RES CO, V374, P709, DOI 10.1016/j.bbrc.2008.07.093; Hirst RA, 2004, CLIN EXP IMMUNOL, V138, P195, DOI 10.1111/j.1365-2249.2004.02611.x; Hirst RA, 2008, J INFECT DIS, V197, P744, DOI 10.1086/527322; Jabes D, 2011, ANTIMICROB AGENTS CH, V55, P1671, DOI 10.1128/AAC.01288-10; Jauneikaite E, 2012, VACCINE, V30, P3503, DOI 10.1016/j.vaccine.2012.03.066; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Kaur H, 2007, PROTEIN PEPTIDE LETT, V14, P626; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li LR, 2013, APPL MICROBIOL BIOT, V97, P1711, DOI 10.1007/s00253-012-4352-1; Lin MC, 2013, PEPTIDES, V44, P139, DOI 10.1016/j.peptides.2013.04.004; Lin TY, 2010, VACCINE, V28, P7589, DOI 10.1016/j.vaccine.2010.07.053; Liu ZG, 2007, ANTIMICROB AGENTS CH, V51, P597, DOI 10.1128/AAC.00828-06; Lohner K, 1997, BIOCHEMISTRY-US, V36, P1525, DOI 10.1021/bi961300p; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mitchell AM, 2010, CLIN MICROBIOL INFEC, V16, P411, DOI 10.1111/j.1469-0691.2010.03183.x; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Moschioni M, 2012, VACCINE, V30, P1349, DOI 10.1016/j.vaccine.2011.12.080; Nusslein K, 2006, MICROBIOL-SGM, V152, P1913, DOI 10.1099/mic.0.28812-0; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Rekdal O, 2012, J BIOL CHEM, V287, P233, DOI 10.1074/jbc.M111.279281; Ren B, 2012, CLIN VACCINE IMMUNOL, V19, P1574, DOI 10.1128/CVI.00393-12; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanchez-Vasquez L, 2013, BBA-GEN SUBJECTS, V1830, P3427, DOI 10.1016/j.bbagen.2013.01.028; Saugar JM, 2006, ANTIMICROB AGENTS CH, V50, P1251, DOI 10.1128/AAC.50.4.1251-1256.2006; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; SELSTED ME, 1992, J BIOL CHEM, V267, P4292; Serrano GN, 2009, ANTIMICROB AGENTS CH, V53, P2215, DOI 10.1128/AAC.01100-08; SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562; Staples M, 2014, DIAGN MICR INFEC DIS, V78, P307, DOI 10.1016/j.diagmicrobio.2013.11.017; Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200; Tachi T, 2002, BIOCHEMISTRY-US, V41, P10723, DOI 10.1021/bi0256983; Tian ZG, 2009, APPL MICROBIOL BIOT, V82, P1097, DOI 10.1007/s00253-008-1839-x; Torcato IM, 2013, BBA-BIOMEMBRANES, V1828, P944, DOI 10.1016/j.bbamem.2012.12.002; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Urban E, 2007, INT J ANTIMICROB AG, V29, P317, DOI 10.1016/j.ijantimicag.2006.09.007; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang KR, 2013, PEPTIDES, V39, P80, DOI 10.1016/j.peptides.2012.11.002; Wilkins MR, 1999, METH MOL B, V112, P531; Xi D, 2013, PROCESS BIOCHEM, V48, P453, DOI 10.1016/j.procbio.2013.01.008; Yang ST, 2006, INT J ANTIMICROB AG, V27, P325, DOI 10.1016/j.ijantimicag.2005.11.014; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhu WL, 2006, BIOCHEMISTRY-US, V45, P13007, DOI 10.1021/bi060487+	65	55	58	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128532	10.1371/journal.pone.0128532	http://dx.doi.org/10.1371/journal.pone.0128532			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046345	Green Submitted, gold, Green Published			2022-12-26	WOS:000355652200073
J	Krause, BJ; Carrasco-Wong, I; Dominguez, A; Arnaiz, P; Farias, M; Barja, S; Mardones, F; Casanello, P				Krause, Bernardo J.; Carrasco-Wong, Ivo; Dominguez, Angelica; Arnaiz, Pilar; Farias, Marcelo; Barja, Salesa; Mardones, Francisco; Casanello, Paola			Micro-RNAs Let7e and 126 in Plasma as Markers of Metabolic Dysfunction in 10 to 12 Years Old Children	PLOS ONE			English	Article							CIRCULATING MICRORNAS; PERIPHERAL-BLOOD; MESSENGER-RNAS; BIOMARKERS; EXPRESSION; MIRNA; HYPERTENSION; INFLAMMATION; PROGRESSION; SIGNATURES	Background Growing evidence shows that metabolic syndrome (MetS) is already starting in childhood however there is no consensus regarding how to diagnose this condition in pediatric population. Studies in adults show that altered levels of specific micro-RNAs are related with components of the MetS. Objective We determined the plasma levels of four MetS-associated micro-RNAs (miR-126, miR-132, mir-145 and Let-7e) in 10 to 12 years old children with or without MetS traits. Design Pediatric subjects were selected from a cohort of 3325 school-age children, and clustered by the absence (control, n = 30), or the presence of 1 (n = 50), 2 (n = 41) or 3 (n = 35) MetS traits according to Cook's criteria. Micro-RNAs were isolated from plasma, and levels of miR-126, miR-132, miR-145 and Let-7e were determined by Taqman qPCR. Results Regression analysis of the different MetS traits regarding the different miRNAs analyzed showed that Let-7e presented a negative association with HDL-C levels, but a positive correlation with the number of MetS traits. Levels of miR-126 presented a positive correlation with waist circumference, waist to hip ratio, BMI, and plasma triglycerides and VLDL-C. Levels of miR-132 showed a positive correlation with waist to hip ratio. Plasma levels of Let-7e were increased (similar to 3.4 fold) in subjects with 3 MetS traits, and showed significant AUC (0.681; 95%CI = [0.58, 0.78]; p < 0.001) in the ROC analysis which were improved when miR-126 was included in the analysis (AUC 0.729; p < 0.001). In silico analysis of the interaction of proteins derived from mRNAs targeted by Let-7e and miR-126 showed an important effect of both Let-7e and miR-126 regulating the insulin signaling pathway. Conclusions These results suggest that changes in the plasma levels of Let-7e and miR-126 could represent early markers of metabolic dysfunction in children with MetS traits.	[Krause, Bernardo J.; Carrasco-Wong, Ivo; Farias, Marcelo; Casanello, Paola] Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynecol, Santiago, Chile; [Dominguez, Angelica; Mardones, Francisco] Pontificia Univ Catolica Chile, Fac Med, Dept Publ Hlth, Santiago, Chile; [Arnaiz, Pilar; Barja, Salesa; Casanello, Paola] Pontificia Univ Catolica Chile, Fac Med, Div Pediat, Santiago, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Casanello, P (corresponding author), Pontificia Univ Catolica Chile, Sch Med, Div Obstet & Gynecol, Alameda 340, Santiago, Chile.	pcasane@uc.cl	Casanello, Paola/X-7443-2019; Barja, Salesa/AGU-0677-2022; Dominguez, Angelica/HCI-9469-2022; Carrasco-Wong, Ivo/S-5521-2019; Mardones, Francisco/I-1691-2016; Farias, Marcelo/R-6063-2019; Krause, Bernardo J/F-4977-2013	Casanello, Paola/0000-0002-2355-1476; Barja, Salesa/0000-0001-8583-188X; Dominguez, Angelica/0000-0001-7477-7574; Carrasco-Wong, Ivo/0000-0003-1020-734X; Mardones, Francisco/0000-0002-0905-9493; Farias, Marcelo/0000-0003-0473-2295; Krause, Bernardo J/0000-0002-3563-6143	Direccion Investigacion de la Escuela de Medicina, Pontificia Universidad Catolica de Chile [PI 07-12]; Vicerrectoria de Investigacion Pontificia Universidad Catolica de Chile [VRI 1898]; Fondo Nacional de Desarrollo Cientifico y Tegnologico, FONDECYT Chile [1090594, 1120928, 1130801]	Direccion Investigacion de la Escuela de Medicina, Pontificia Universidad Catolica de Chile; Vicerrectoria de Investigacion Pontificia Universidad Catolica de Chile; Fondo Nacional de Desarrollo Cientifico y Tegnologico, FONDECYT Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	Direccion de Investigacion de la Escuela de Medicina, Pontificia Universidad Catolica de Chile, PI 07-12 (http://medicina.uc.cl/concursos/inv-cfp). Vicerrectoria de Investigacion Pontificia Universidad Catolica de Chile, VRI 1898 (http://investigacion.uc.cl/Fondos-concursables/fondos-concursables.html). Fondo Nacional de Desarrollo Cientifico y Tegnologico, FONDECYT Chile 1090594, 1120928, 1130801 (http://www.conicyt.cl/fondecyt/).	Bruce KD, 2010, J NUTR, V140, P648, DOI 10.3945/jn.109.111179; Carolan E, 2014, J CLIN ENDOCR METAB, V99, pE474, DOI 10.1210/jc.2013-3529; Chen PY, 2012, CELL REP, V2, P1684, DOI 10.1016/j.celrep.2012.10.021; Chu CY, 2007, J CELL PHYSIOL, V213, P412, DOI 10.1002/jcp.21230; de Boer HC, 2013, EUR HEART J, V34, P3451, DOI 10.1093/eurheartj/eht007; DeBoer MD, 2013, NUTRITION, V29, P379, DOI 10.1016/j.nut.2012.07.003; Dickinson BA, 2013, EUR J HEART FAIL, V15, P650, DOI 10.1093/eurjhf/hft018; Fernandez JR, 2004, J PEDIATR-US, V145, P439, DOI 10.1016/j.jpeds.2004.06.044; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Guay C, 2013, NAT REV ENDOCRINOL, V9, P513, DOI 10.1038/nrendo.2013.86; Heneghan HM, 2011, J CLIN ENDOCR METAB, V96, pE846, DOI 10.1210/jc.2010-2701; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Karolina DS, 2012, J CLIN ENDOCR METAB, V97, pE2271, DOI 10.1210/jc.2012-1996; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Liao XY, 2013, J CELL SCI, V126, P3848, DOI 10.1242/jcs.123570; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marcovecchio ML, 2013, CURR DIABETES REP, V13, P56, DOI 10.1007/s11892-012-0331-2; Mardones F, 2013, CHILE NUTRICION HOSP; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Meder B, 2011, BASIC RES CARDIOL, V106, P13, DOI 10.1007/s00395-010-0123-2; Mozumdar A, 2011, DIABETES CARE, V34, P216, DOI 10.2337/dc10-0879; Muller G, 2012, DIABET METAB SYND OB, V5, P247, DOI 10.2147/DMSO.S32923; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Nazari-Jahantigh M, 2012, THROMB HAEMOSTASIS, V107, P611, DOI 10.1160/TH11-12-0826; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Olivieri Fabiola, 2013, Frontiers in Genetics, V4, P121, DOI 10.3389/fgene.2013.00121; Perez LM, 2013, DIABETES, V62, P2368, DOI 10.2337/db12-1220; Polikepahad S, 2010, J BIOL CHEM, V285, P30139, DOI 10.1074/jbc.M110.145698; Prats-Puig A, 2013, J CLIN ENDOCR METAB, V98, pE1655, DOI 10.1210/jc.2013-1496; Ramasamy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121401; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Takwi AAL, 2012, EMBO MOL MED, V4, P896, DOI 10.1002/emmm.201101045; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; Vanagas Giedrius, 2004, Interact Cardiovasc Thorac Surg, V3, P319, DOI 10.1016/j.icvts.2004.01.008; Wei YY, 2013, AM J PHYSIOL-HEART C, V304, pH1050, DOI 10.1152/ajpheart.00267.2012; Weiss R, 2013, ANN NY ACAD SCI, V1281, P123, DOI 10.1111/nyas.12030; Willeit P, 2013, CIRC RES, V112, P595, DOI 10.1161/CIRCRESAHA.111.300539; Zampetaki A, 2010, CIRC RES, V107, P810, DOI 10.1161/CIRCRESAHA.110.226357; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	48	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128140	10.1371/journal.pone.0128140	http://dx.doi.org/10.1371/journal.pone.0128140			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046362	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200043
J	Le Gallic, C; Phalente, Y; Manens, L; Dublineau, I; Benderitter, M; Gueguen, Y; Lehoux, S; Ebrahimian, TG				Le Gallic, Clelia; Phalente, Yohann; Manens, Line; Dublineau, Isabelle; Benderitter, Marc; Gueguen, Yann; Lehoux, Stephanie; Ebrahimian, Teni G.			Chronic Internal Exposure to Low Dose Cs-137 Induces Positive Impact on the Stability of Atherosclerotic Plaques by Reducing Inflammation in ApoE(-/-) Mice	PLOS ONE			English	Article							IONIZING-RADIATION; MATRIX METALLOPROTEINASES; ACTIVATED MACROPHAGES; CHRONIC INGESTION; GENE-EXPRESSION; X-IRRADIATION; MAYAK PA; LESIONS; CELLS; RADIOTHERAPY	After Chernobyl and Fukushima Dai Chi, two major nuclear accidents, large amounts of radionuclides were released in the environment, mostly caesium 137 (Cs-137). Populations living in contaminated territories are chronically exposed to radionuclides by ingestion of contaminated food. However, questions still remain regarding the effects of low dose ionizing radiation exposure on the development and progression of cardiovascular diseases. We therefore investigated the effects of a chronic internal exposure to Cs-137 on atherosclerosis in predisposed ApoE(-/-) mice. Mice were exposed daily to 0, 4, 20 or 100 kBq/l Cs-137 in drinking water, corresponding to range of concentrations found in contaminated territories, for 6 or 9 months. We evaluated plaque size and phenotype, inflammatory profile, and oxidative stress status in different experimental groups. Results did not show any differences in atherosclerosis progression between mice exposed to Cs-137 and unexposed controls. However, Cs-137 exposed mice developed more stable plaques with decreased macrophage content, associated with reduced aortic expression of pro-inflammatory factors (CRP, TNF alpha, MCP-1, IFN gamma) and adhesion molecules (ICAM-1, VCAM-1 and E-selectin). Lesions of mice exposed to Cs-137 were also characterized by enhanced collagen and smooth muscle cell content, concurrent with reduced matrix metalloproteinase MMP8 and MMP13 expression. These results suggest that low dose chronic exposure of 137Cs in ApoE(-/-) mice enhances atherosclerotic lesion stability by inhibiting pro-inflammatory cytokine and MMP production, resulting in collagen-rich plaques with greater smooth muscle cell and less macrophage content.	[Le Gallic, Clelia; Phalente, Yohann; Manens, Line; Dublineau, Isabelle; Benderitter, Marc; Gueguen, Yann; Ebrahimian, Teni G.] IRSN, Inst Radioprotect & Surete Nucl, Lab RadioToxicol Expt, F-92262 Fontenay Aux Roses, France; [Lehoux, Stephanie] McGill Univ, Lady Davis Inst, Montreal, PQ, Canada	Lady Davis Institute; McGill University	Ebrahimian, TG (corresponding author), IRSN, Inst Radioprotect & Surete Nucl, Lab RadioToxicol Expt, F-92262 Fontenay Aux Roses, France.	teni.ebrahimian@irsn.fr		GUEGUEN, Yann/0000-0002-6234-2888	Electricite de France (EDF)	Electricite de France (EDF)(Electricite de France (EDF))	This work was supported by grants from Electricite de France (EDF) but the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Masanori, 2004, Semin Vasc Med, V4, P357, DOI 10.1055/s-2004-869592; AMENTO EP, 1991, ARTERIOSCLER THROMB, V11, P1223, DOI 10.1161/01.ATV.11.5.1223; ANGELINI A, 1985, INT J CARDIOL, V9, P371, DOI 10.1016/0167-5273(85)90034-8; [Anonymous], 2006, CHERN FOR GROUP ENV; Arenas M, 2012, STRAHLENTHER ONKOL, V188, P975, DOI 10.1007/s00066-012-0170-8; Azizova TV, 2010, RADIAT RES, V174, P851, DOI 10.1667/RR1928.1; Azizova TV, 2010, RADIAT RES, V174, P155, DOI 10.1667/RR1789.1; Bandazhevskaya GS, 2004, SWISS MED WKLY, V134, P725; Bandazhevsky YI, 2003, SWISS MED WKLY, V133, P488; Bashar K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110389; Bertho JM, 2012, RADIOPROTECTION, V47, P219, DOI 10.1051/radiopro/2011161; Bertho JM, 2011, J RADIOL PROT, V31, P25, DOI 10.1088/0952-4746/31/1/001; Bertho JM, 2010, RADIAT ENVIRON BIOPH, V49, P239, DOI 10.1007/s00411-010-0267-3; Bilora F, 2006, TUMORI, V92, P295, DOI 10.1177/030089160609200406; BURLEIGH MC, 1992, ATHEROSCLEROSIS, V96, P71, DOI 10.1016/0021-9150(92)90039-J; Calabrese EJ, 2011, MUTAT RES-GEN TOX EN, V726, P91, DOI 10.1016/j.mrgentox.2011.04.006; Cervelli T, 2014, ATHEROSCLEROSIS, V235, P510, DOI 10.1016/j.atherosclerosis.2014.05.932; Cozlea D L, 2013, Curr Health Sci J, V39, P225; Cwikel J G, 1997, Public Health Rev, V25, P317; Dam K, 1998, DEV BRAIN RES, V108, P39, DOI 10.1016/S0165-3806(98)00028-5; Daugherty Alan, 2003, Methods Mol Biol, V209, P293; Dublineau I, 2007, J TOXICOL ENV HEAL A, V70, P810, DOI 10.1080/15287390701209113; DUNSMORE LD, 1986, J AM COLL CARDIOL, V8, P239, DOI 10.1016/S0735-1097(86)80120-6; Falk E, 2007, ARTERIOSCL THROM VAS, V27, P248, DOI 10.1161/01.ATV.0000249644.86759.81; Frey B, 2009, AUTOIMMUNITY, V42, P346, DOI 10.1080/08916930902831738; Gabriels K, 2014, RADIOTHER ONCOL, V110, P455, DOI 10.1016/j.radonc.2014.01.006; GALIS ZS, 1994, CIRC RES, V75, P181, DOI 10.1161/01.RES.75.1.181; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Gaugler MH, 2010, M S-MED SCI, V26, P740, DOI 10.1051/medsci/2010268-9740; Gorenne I, 2006, CARDIOVASC RES, V72, P9, DOI 10.1016/j.cardiores.2006.06.004; Gueguen Y, 2008, CARDIOVASC TOXICOL, V8, P33, DOI 10.1007/s12012-008-9013-3; Gujral DM, 2014, RADIOTHER ONCOL, V110, P31, DOI 10.1016/j.radonc.2013.08.009; Handl J, 2003, HEALTH PHYS, V84, P502, DOI 10.1097/00004032-200304000-00010; Hildebrandt G, 2003, INT J RADIAT BIOL, V79, P993, DOI 10.1080/09553000310001636639; Hildebrandt G, 1998, INT J RADIAT BIOL, V74, P367, DOI 10.1080/095530098141500; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; Hoving S, 2008, INT J RADIAT ONCOL, V71, P848, DOI 10.1016/j.ijrobp.2008.02.031; Joven J, 2007, ATHEROSCLEROSIS, V195, pE85, DOI 10.1016/j.atherosclerosis.2007.06.012; Kataoka T, 2013, J RADIAT RES, V54, P587, DOI 10.1093/jrr/rrs141; Kaul Alexander, 2008, Annals of the ICRP, V38, P1; Kern PM, 2000, RADIOTHER ONCOL, V54, P273, DOI 10.1016/S0167-8140(00)00141-9; Khartchenko V. P., 2001, Meditsina Truda i Promyshlennaya Ekologiya, P29; Klug F, 2013, CANCER CELL, V24, P589, DOI 10.1016/j.ccr.2013.09.014; Kovaleva L I, 1992, Gig Tr Prof Zabol, P15; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; Little MP, 2008, RADIAT RES, V169, P99, DOI 10.1667/RR1070.1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodermann B, 2012, INT J RADIAT BIOL, V88, P727, DOI 10.3109/09553002.2012.689464; MCREYNOLDS RA, 1976, AM J MED, V60, P39, DOI 10.1016/0002-9343(76)90531-3; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Mitchel REJ, 2011, RADIAT RES, V175, P665, DOI 10.1667/RR2176.1; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003; Okishio Y, 2000, EUR J PHARMACOL, V388, P97, DOI 10.1016/S0014-2999(99)00856-0; Pakala Rajbabu, 2003, Cardiovasc Radiat Med, V4, P146, DOI 10.1016/S1522-1865(03)00182-3; Park BS, 2013, RADIAT RES, V179, P570, DOI 10.1667/RR3082.1; Puhakainen M, 2003, RADIAT PROT DOSIM, V103, P255, DOI 10.1093/oxfordjournals.rpd.a006141; Randolph GJ, 2013, NAT MED, V19, P1094, DOI 10.1038/nm.3316; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Schaue D, 2002, INT J RADIAT BIOL, V78, P567, DOI 10.1080/09553000210126457; Schiller NK, 2004, J LIPID RES, V45, P1398, DOI 10.1194/jlr.M400036-JLR200; Shao ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092574; Stewart FA, 2006, AM J PATHOL, V168, P649, DOI 10.2353/ajpath.2006.050409; Thalhammer C, 2015, VASA, V44, P23, DOI 10.1024/0301-1526/a000403; Trott K.-R., 1995, Strahlentherapie und Onkologie, V171, P534; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; von Pannewitz G, 1970, Radiologe, V10, P51; Vykhovanets EV, 2000, RADIAT RES, V153, P760, DOI 10.1667/0033-7587(2000)153[0760:AOBLSI]2.0.CO;2; Weissberg PL, 1996, LANCET, V347, P305, DOI 10.1016/S0140-6736(96)90472-9; Wethal T, 2014, RADIOTHER ONCOL, V110, P448, DOI 10.1016/j.radonc.2013.10.029; Whitman SC, 2000, AM J PATHOL, V157, P1819, DOI 10.1016/S0002-9440(10)64820-1; Wong FL, 1999, RADIAT RES, V151, P736, DOI 10.2307/3580213; Wunderlich R, 2015, CLIN EXP IMMUNOL, V179, P50, DOI 10.1111/cei.12344; Yentrapalli R, 2013, PROTEOMICS, V13, P1096, DOI 10.1002/pmic.201200463; Yu T, 2011, RADIAT RES, V175, P766, DOI 10.1667/RR2482.1; Zhang C, 2011, RADIAT RES, V175, P307, DOI 10.1667/RR1950.1	78	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128539	10.1371/journal.pone.0128539	http://dx.doi.org/10.1371/journal.pone.0128539			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046630	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200075
J	Shastri, MD; Stewart, N; Horne, J; Zaidi, STR; Sohal, SS; Peterson, GM; Korner, H; Gueven, N; Patel, RP				Shastri, Madhur D.; Stewart, Niall; Horne, James; Zaidi, Syed Tabish R.; Sohal, Sukhwinder Singh; Peterson, Gregory M.; Korner, Heinrich; Gueven, Nuri; Patel, Rahul P.			Non-Anticoagulant Fractions of Enoxaparin Suppress Inflammatory Cytokine Release from Peripheral Blood Mononuclear Cells of Allergic Asthmatic Individuals	PLOS ONE			English	Article							LOW-MOLECULAR-WEIGHT; FIBROBLAST-GROWTH-FACTOR; AIRWAY SMOOTH-MUSCLE; STRUCTURAL DETERMINANTS; HEPARAN-SULFATE; T-CELLS; ACTIVATION; BRONCHOCONSTRICTION; GLYCOSAMINOGLYCANS; 6-O-SULFATION	Background Enoxaparin, a low-molecular-weight heparin, is known to possess anti-inflammatory properties. However, its clinical exploitation as an anti-inflammatory agent is hampered by its anticoagulant effect and the associated risk of bleeding. Objective The aim of the current study was to examine the ability of non-anticoagulant fractions of enoxaparin to inhibit the release of key inflammatory cytokines in primed peripheral blood mononuclear cells derived from allergic mild asthmatics. Methods Peripheral blood mononuclear cells from allergic asthmatics were activated with phytohaemag glutinin (PHA), concanavalin-A (ConA) or phorbol 12-myristate 13-acetate (PMA) in the presence or absence of enoxaparin fractions before cytokine levels were quantified using specific cytokine bead arrays. Together with nuclear magnetic resonance analysis, time-dependent and target-specific effects of enoxaparin fractions were used to elucidate structural determinants for their anti-inflammatory effect and gain mechanistic insights into their anti-inflammatory activity. Results Two non-anticoagulant fractions of enoxaparin were identified that significantly inhibited T-cell activation. A disaccharide fraction of enoxaparin inhibited the release of IL-4, IL-5, IL-13 and TNF-alpha by more than 57% while a tetrasaccharide fraction was found to inhibit the release of tested cytokines by more than 68%. Our data suggest that the observed response is likely to be due to an interaction of 6-O-sulfated tetrasaccharide with cellular receptor(s). Conclusion and Clinical Relevance The two identified anti-inflammatory fractions lacked anticoagulant activity and are therefore not associated with risk of bleeding. The findings highlight the potential therapeutic use of enoxaparin-derived fractions, in particular tetrasaccharide, in patients with chronic inflammatory disorders.	[Shastri, Madhur D.; Stewart, Niall; Zaidi, Syed Tabish R.; Peterson, Gregory M.; Gueven, Nuri; Patel, Rahul P.] Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia; [Horne, James] Univ Tasmania, Cent Sci Lab, Hobart, Tas, Australia; [Korner, Heinrich] Univ Tasmania, Fac Hlth, Menzies Inst Med Res, Hobart, Tas, Australia; [Sohal, Sukhwinder Singh; Peterson, Gregory M.] Univ Tasmania, Sch Med, Fac Hlth, Breathe Well Ctr Res Excellence Chron Resp Dis &, Hobart, Tas, Australia	University of Tasmania; University of Tasmania; University of Tasmania; Menzies Institute for Medical Research; University of Tasmania	Patel, RP (corresponding author), Univ Tasmania, Fac Hlth, Sch Med, Pharm, Hobart, Tas, Australia.	Rahul.Patel@utas.edu.au	Korner, Heinrich/D-9970-2014; Zaidi, Syed Tabish R./J-7336-2014	Korner, Heinrich/0000-0003-4610-2814; Patel, Rahul/0000-0001-9344-1013; Peterson, Gregory/0000-0002-6764-3882; Sohal, Sukhwinder Singh/0000-0001-9627-6498; Shastri, Madhur/0000-0002-1012-2779; Zaidi, Syed Tabish R./0000-0002-2031-1055; Horne, James/0000-0002-1935-2378; Guven, Nuri/0000-0003-3782-767X	Royal Hobart Hospital Research Foundation, Australia [H22074]; University of Tasmania, Australia [105557]	Royal Hobart Hospital Research Foundation, Australia; University of Tasmania, Australia	This work was supported by the Starter Grant from Royal Hobart Hospital Research Foundation, Australia (Grant Number- H22074) awarded to NS, RP and MS (http://www.rhhresearchfoundation. org/index.php/site/research/), Research Enhancement Grant Schemes from University of Tasmania, Australia (Grant Number- 105557) awarded to RP and NG (http://www.utas.edu.au/research-admin/funding/funding-options/internal-funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 1999, AM J RESP CRIT CARE, V160, P576, DOI 10.1164/ajrccm.160.2.9812076; AHMED T, 1993, NEW ENGL J MED, V329, P90, DOI 10.1056/NEJM199307083290204; Baram D, 1997, CLIN EXP IMMUNOL, V110, P485, DOI 10.1046/j.1365-2249.1997.4541471.x; Barblu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032874; Barnes PJ, 1998, J ALLERGY CLIN IMMUN, V102, P531, DOI 10.1016/S0091-6749(98)70268-4; Bloemen K, 2007, IMMUNOL LETT, V113, P6, DOI 10.1016/j.imlet.2007.07.010; Bluestone JA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007542; Bousquet J, 2008, EXPERT OPIN BIOL TH, V8, P1921, DOI [10.1517/14712590802496928, 10.1517/14712590802496928 ]; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; CASTELLOT JJ, 1984, J CELL PHYSIOL, V120, P315, DOI 10.1002/jcp.1041200309; Chwae YJ, 2002, J IMMUNOL, V169, P3726, DOI 10.4049/jimmunol.169.7.3726; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; den Dekker E, 2008, J IMMUNOL, V180, P3680, DOI 10.4049/jimmunol.180.6.3680; DIAMOND MS, 1995, J CELL BIOL, V130, P1473, DOI 10.1083/jcb.130.6.1473; Faustino L, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/721817; FRIBERG D, 1994, CLIN DIAGN LAB IMMUN, V1, P261, DOI 10.1128/CDLI.1.3.261-268.1994; Fryer A, 1997, J PHARMACOL EXP THER, V282, P208; HAAHTELA T, 1994, NEW ENGL J MED, V331, P700, DOI 10.1056/NEJM199409153311103; Hochart H, 2006, BRIT J HAEMATOL, V133, P62, DOI 10.1111/j.1365-2141.2006.05959.x; Iraji Fariba, 2013, Adv Biomed Res, V2, P76, DOI 10.4103/2277-9175.115798; Kanabar V, 2008, BRIT J PHARMACOL, V154, P833, DOI 10.1038/bjp.2008.109; Kanabar V, 2005, BRIT J PHARMACOL, V146, P370, DOI 10.1038/sj.bjp.0706333; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Kilpatrick D, 1995, LECTINS BIOMEDICAL P, P131; Koller M, 2001, INFLAMMATION, V25, P331, DOI 10.1023/A:1012883916991; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Ludwig Ralf J, 2009, Curr Drug Discov Technol, V6, P281; LUKACS NW, 1995, J IMMUNOL, V154, P5411; Luo YD, 2003, J PHARM SCI-US, V92, P2117, DOI 10.1002/jps.10472; Ma Q, 2007, CURR PHARM DESIGN, V13, P1607, DOI 10.2174/138161207780765918; MILNER SM, 1977, NATURE, V268, P441, DOI 10.1038/268441a0; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Patel RP, 2009, J PHARM SCI-US, V98, P1700, DOI 10.1002/jps.21556; Pelaia G, 2012, NAT REV DRUG DISCOV, V11, P958, DOI 10.1038/nrd3792; Perrin PJ, 1997, IMMUNOLOGY, V90, P534, DOI 10.1046/j.1365-2567.04.00215.x; Peters SP, 2006, RESP MED, V100, P1139, DOI 10.1016/j.rmed.2006.03.031; Roy S, 2011, GLYCOBIOLOGY, V21, P1194, DOI 10.1093/glycob/cwr053; Ruiz-Calero V, 2001, ANALYST, V126, P169, DOI 10.1039/b007300h; Salas A, 2000, GUT, V47, P88, DOI 10.1136/gut.47.1.88; Sharek PJ, 2000, PEDIATRICS, V106, DOI 10.1542/peds.106.1.e8; Shastri MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118798; Shastri MD, 2014, EXPERT OPIN INV DRUG, V23, P357, DOI 10.1517/13543784.2014.866092; Shastri MD, 2013, ANAL BIOANAL CHEM, V405, P6043, DOI 10.1007/s00216-013-6996-9; Sheng GJ, 2013, J AM CHEM SOC, V135, P10898, DOI 10.1021/ja4027727; Shifren A., 2012, J ALLERGY CAIRO, V2012; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Torkvist L, 1999, ALIMENT PHARM THERAP, V13, P1323; TURNBULL JE, 1992, J BIOL CHEM, V267, P10337; Tyrrell DJ, 1999, ADV PHARMACOL, V46, P151, DOI 10.1016/S1054-3589(08)60471-8; VALENTINE MA, 1985, EUR J IMMUNOL, V15, P851, DOI 10.1002/eji.1830150821; Viegas A, 2011, J CHEM EDUC, V88, P990, DOI 10.1021/ed101169t; Vrij AA, 2001, SCAND J GASTROENTERO, V36, P41, DOI 10.1080/003655201753265091; Wang LC, 2002, J CLIN INVEST, V110, P127, DOI 10.1172/JCI200214996; Whitelock JM, 1996, J BIOL CHEM, V271, P10079, DOI 10.1074/jbc.271.17.10079; WISKOCIL R, 1985, J IMMUNOL, V134, P1599; WRIGHT TC, 1989, J BIOL CHEM, V264, P1534; Yang B, 2011, ANAL BIOANAL CHEM, V399, P541, DOI 10.1007/s00216-010-4117-6; Young E, 2008, THROMB RES, V122, P743, DOI 10.1016/j.thromres.2006.10.026; Zhang SY, 2012, J BIOL CHEM, V287, P5542, DOI 10.1074/jbc.M111.314716	59	22	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128803	10.1371/journal.pone.0128803	http://dx.doi.org/10.1371/journal.pone.0128803			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046354	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200103
J	Singh, R; Hassan, MI; Islam, A; Ahmad, F				Singh, Ritu; Hassan, Md. Imtaiyaz; Islam, Asimul; Ahmad, Faizan			Cooperative Unfolding of Residual Structure in Heat Denatured Proteins by Urea and Guanidinium Chloride	PLOS ONE			English	Article							FREE-ENERGY CHANGES; LINEAR EXTRAPOLATION METHOD; ALPHA-LACTALBUMIN; RIBONUCLEASE-A; SECONDARY STRUCTURE; STABILITY; STATES; LYSOZYME; CONFORMATION; EQUILIBRIUM	The denatured states of proteins have always attracted our attention due to the fact that the denatured state is the only experimentally achievable state of a protein, which can be taken as initial reference state for considering the in vitro folding and defining the native protein stability. It is known that heat and guanidinium chloride (GdmCl) give structurally different states of RNase-A, lysozyme, alpha-chymotrypsinogen A and alpha-lactalbumin. On the contrary, differential scanning calorimetric (DSC) and isothermal titration calorimetric measurements, reported in the literature, led to the conclusion that heat denatured and GdmCl denatured states are thermodynamically and structurally identical. In order to resolve this controversy, we have measured changes in the far-UV CD (circular dichroism) of these heat-denatured proteins on the addition of different concentrations of GdmCl. The observed sigmoidal curve of each protein was analyzed for Gibbs free energy change in the absence of the denaturant (Delta G(X-->D)(0)) associated with the process heat denatured (X) state <-> GdmCl denatured (D) state. To confirm that this thermodynamic property represents the property of the protein alone and is not a manifestation of salvation effect, we measured urea-induced denaturation curves of these heat denatured proteins under the same experimental condition in which GdmCl-induced denaturation was carried out. In this paper we report that (a) heat denatured proteins contain secondary structure, and GdmCl (or urea) induces a cooperative transition between X and D states, (b) for each protein at a given pH and temperature, thermodynamic cycle connects quantities, Delta G(N-->X)(0) (native (N) state <-> X state), Delta G(X-->D)(0) and Delta G(N-->D)(0) (N state <-> D state), and (c) there is not a good enthalpy difference between X and D states, which is the reason for the absence of endothermic peak in DSC scan for the transition, X state <-> D state.	[Singh, Ritu; Hassan, Md. Imtaiyaz; Islam, Asimul; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Jamia Millia Islamia	Ahmad, F (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	fahmad@jmi.ac.in	Ahmad, Faizan/AGH-4493-2022; Hassan, Mohammad/GZA-7507-2022; Hassan, Imtaiyaz/ABF-6485-2020; Hassan, Md Imtaiyaz/G-7072-2017; Islam, Asimul/V-4526-2019	Ahmad, Faizan/0000-0001-7021-7502; Hassan, Mohammad/0000-0002-1712-0004; Hassan, Imtaiyaz/0000-0002-3663-4940; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Islam, Asimul/0000-0001-9060-7970	Council of Scientific and Industrial Research, India [37(1237)/05/EMR-II]; Department of Science and Technology, India [SR/SO/BB-80/2004]	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology, India(Department of Science & Technology (India))	This work was supported by the Council of Scientific and Industrial Research, India (Grant No. 37(1237)/05/EMR-II) and the Department of Science and Technology, India (Grant No. SR/SO/BB-80/2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1991, INDIAN J BIOCHEM BIO, V28, P168; AHMAD F, 1982, J BIOL CHEM, V257, P2935; AHMAD F, 1983, J BIOL CHEM, V258, P7960; AHMAD F, 1992, BIOCHEM J, V287, P481, DOI 10.1042/bj2870481; ANANTHANARAYANAN VS, 1977, BIOCHIM BIOPHYS ACTA, V492, P194, DOI 10.1016/0005-2795(77)90226-4; AUNE KC, 1967, J BIOL CHEM, V242, P4486; Basharov MA, 2012, INDIAN J BIOCHEM BIO, V49, P7; BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P305; Bigelow CC, 1964, J MOL BIOL, V8, P696, DOI 10.1016/S0022-2836(64)80118-2; BISMUTO E, 1983, BIOCHEMISTRY-US, V22, P4165, DOI 10.1021/bi00287a001; Chalikian TV, 1997, J MOL BIOL, V274, P237, DOI 10.1006/jmbi.1997.1394; Chiti F, 1998, BIOCHEMISTRY-US, V37, P1447, DOI 10.1021/bi971692f; CONTAXIS CC, 1981, BIOCHEMISTRY-US, V20, P1618, DOI 10.1021/bi00509a032; FABIAN H, 1995, BIOCHEMISTRY-US, V34, P13651, DOI 10.1021/bi00041a046; FABIAN H, 1993, J MOL BIOL, V232, P967, DOI 10.1006/jmbi.1993.1442; FRANKS F, 1995, ADV PROTEIN CHEM, V46, P105, DOI 10.1016/S0065-3233(08)60333-2; Gast K, 1997, FEBS LETT, V403, P245, DOI 10.1016/S0014-5793(97)00058-6; Gupta R, 1996, BIOCHEMISTRY-US, V35, P11925, DOI 10.1021/bi961079g; HALTIA T, 1994, BIOCHEMISTRY-US, V33, P9731, DOI 10.1021/bi00198a044; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; KUGIMIYA M, 1973, CAN J BIOCHEM CELL B, V51, P581, DOI 10.1139/o73-072; LABHARDT AM, 1982, J MOL BIOL, V157, P331, DOI 10.1016/0022-2836(82)90238-8; McCarney ER, 2005, CRIT REV BIOCHEM MOL, V40, P181, DOI 10.1080/10409230591008143; Nolting B, 1997, BIOCHEMISTRY-US, V36, P9899, DOI 10.1021/bi962879u; Pace C N, 1986, Methods Enzymol, V131, P266; PACE C N, 1975, Critical Reviews in Biochemistry, V3, P1, DOI 10.3109/10409237509102551; Pace CN, 2000, PROTEINS, P1; Pace CN, 1995, METHOD ENZYMOL, V259, P538; PFEIL W, 1976, BIOPHYS CHEM, V4, P33, DOI 10.1016/0301-4622(76)80004-X; Pfeil W., 1998, PROTEIN STABILITY FO; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; PRIVALOV PL, 1989, J MOL BIOL, V205, P737, DOI 10.1016/0022-2836(89)90318-5; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; ROBERTSON AD, 1991, BIOCHEMISTRY-US, V30, P9907, DOI 10.1021/bi00105a014; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SARFARE PS, 1967, CAN J BIOCHEM CELL B, V45, P651, DOI 10.1139/o67-076; SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515; Sedlak E, 2001, BIOCHEMISTRY-US, V40, P9579, DOI 10.1021/bi010274e; SHARMA RN, 1974, J MOL BIOL, V88, P247, DOI 10.1016/0022-2836(74)90308-8; Singh R, 2008, BIOPHYS CHEM, V133, P81, DOI 10.1016/j.bpc.2007.12.006; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; TAMURA Y, 1995, BIOCHEMISTRY-US, V34, P1878, DOI 10.1021/bi00006a008; Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5; Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7; Wilson G, 1996, BIOCHEMISTRY-US, V35, P12518, DOI 10.1021/bi961314v; Yadav S, 2000, ANAL BIOCHEM, V283, P207, DOI 10.1006/abio.2000.4641; YANG JT, 1986, METHOD ENZYMOL, V130, P208	47	23	22	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128740	10.1371/journal.pone.0128740	http://dx.doi.org/10.1371/journal.pone.0128740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046628	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200095
J	Talmi, D; Caplan, JB; Richards, B; Moscovitch, M				Talmi, Deborah; Caplan, Jeremy B.; Richards, Brian; Moscovitch, Morris			Long-Term Recency in Anterograde Amnesia	PLOS ONE			English	Article							BILATERAL HIPPOCAMPAL-LESIONS; FREE-RECALL; RECOGNITION MEMORY; RETROACTIVE INTERFERENCE; STORAGE MECHANISMS; TEMPORAL-LOBE; RETRIEVAL; RETENTION; REHEARSAL; EXPLICIT	Amnesia is usually described as an impairment of a long-term memory (LTM) despite an intact short-term memory (STM). The intact recency effect in amnesia had supported this view. Although dual-store models of memory have been challenged by single-store models based on interference theory, this had relatively little influence on our understanding and treatment of amnesia, perhaps because the debate has centred on experiments in the neurologically intact population. Here we tested a key prediction of single-store models for free recall in amnesia: that people with amnesia will exhibit a memory advantage for the most recent items even when all items are stored in and retrieved from LTM, an effect called long-term recency. People with amnesia and matched controls studied, and then free-recalled, word lists with a distractor task following each word, including the last (continual distractor task, CDFR). This condition was compared to an Immediate Free Recall (IFR, no distractors) and a Delayed Free Recall (DFR, end-of-list distractor only) condition. People with amnesia demonstrated the full long-term recency pattern: the recency effect was attenuated in DFR and returned in CDFR. The advantage of recency over midlist items in CDFR was comparable to that of controls, confirming a key prediction of single-store models. Memory deficits appeared only after the first word recalled in each list, suggesting the impairment in amnesia may emerge only as the participant's recall sequence develops, perhaps due to increased susceptibility to output interference. Our findings suggest that interference mechanisms are preserved in amnesia despite the overall impairment to LTM, and challenge strict dual-store models of memory and their dominance in explaining amnesia. We discuss the implication of our findings for rehabilitation.	[Talmi, Deborah; Moscovitch, Morris] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Talmi, Deborah] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Caplan, Jeremy B.; Moscovitch, Morris] Baycrest, Rotman Res Inst, Toronto, ON, Canada; [Caplan, Jeremy B.] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Caplan, Jeremy B.] Univ Alberta, Ctr Neurosci, Edmonton, AB, Canada; [Richards, Brian] Baycrest Ctr Geriatr Care, Dept Psychol, Toronto, ON, Canada	University of Toronto; University of Manchester; University of Toronto; University Toronto Affiliates; Baycrest; University of Alberta; University of Alberta; University of Toronto; University Toronto Affiliates; Baycrest	Talmi, D (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	deborah.talmi@manchester.ac.uk			Canadian Institute of Health Research grant [MOP 49566]	Canadian Institute of Health Research grant(Canadian Institutes of Health Research (CIHR))	This work was supported by a Canadian Institute of Health Research grant MOP 49566 to MM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson RC, 1968, ADV RES THEOR, DOI [10.1080/0361073X.2012.672131, DOI 10.1080/0361073X.2012.672131]; Baddeley A. D., 1977, ATTENTION PERFORM, V6, P647; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; Banich M.N., 2011, COGNITIVE NEUROSCIEN; BJORK RA, 1974, COGNITIVE PSYCHOL, V6, P173, DOI 10.1016/0010-0285(74)90009-7; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; BROWN GG, 1980, NEUROPSYCHOLOGIA, V18, P185, DOI 10.1016/0028-3932(80)90064-0; Brown GDA, 2007, PSYCHOL REV, V114, P539, DOI 10.1037/0033-295X.114.3.539; Brown GDA, 2007, PSYCHON B REV, V14, P256, DOI 10.3758/BF03194061; CAPITANI E, 1992, CORTEX, V28, P315, DOI 10.1016/S0010-9452(13)80143-8; Carlesimo GA, 1996, NEUROPSYCHOLOGIA, V34, P177, DOI 10.1016/0028-3932(95)00100-X; Cowan N, 2004, BRAIN, V127, P825, DOI 10.1093/brain/awh107; Crowder R.G., 1976, PRINCIPLES LEARNING; CROWDER RG, 1982, ACTA PSYCHOL, V50, P291, DOI 10.1016/0001-6918(82)90044-0; CROWDER RG, 1993, MEM COGNITION, V21, P142, DOI 10.3758/BF03202725; Davelaar EJ, 2005, PSYCHOL REV, V112, P3, DOI 10.1037/0033-295X.112.1.3; Della SS, 2005, MEMORY, V13, P435; Dewar M, 2012, BRAIN COGNITION, V78, P189, DOI 10.1016/j.bandc.2011.12.005; Dewar M, 2010, NEUROPSYCHOLOGY, V24, P357, DOI 10.1037/a0018207; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; GLANZER M, 1966, J VERB LEARN VERB BE, V5, P351, DOI 10.1016/S0022-5371(66)80044-0; GREENE RL, 1986, PSYCHOL BULL, V99, P221, DOI 10.1037/0033-2909.99.2.221; HOGAN RM, 1975, MEM COGNITION, V3, P197, DOI 10.3758/BF03212898; Howard MW, 1999, J EXP PSYCHOL LEARN, V25, P923, DOI 10.1037/0278-7393.25.4.923; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kahana MJ, 2008, PSYCHOL REV, V115, P1119, DOI 10.1037/a0013724; Kolb B, 2010, INTRO BRAIN BEHAV; Kucera H., 1967, COMPUTATIONAL ANAL P; Laming D, 1999, INT J PSYCHOL, V34, P419, DOI 10.1080/002075999399774; Mayes A, 2007, TRENDS COGN SCI, V11, P126, DOI 10.1016/j.tics.2006.12.003; MAYES AR, 1987, NEUROPSYCHOLOGIA, V25, P211, DOI 10.1016/0028-3932(87)90132-1; McCabe DP, 2011, MEM COGNITION, V39, P389, DOI 10.3758/s13421-010-0040-5; Moscovitch M, 1982, AGING COGNITIVE PROC, P355; MOSCOVITCH M, 1982, HUMAN MEMORY AMNESIA, P337; MURDOCK BB, 1962, J EXP PSYCHOL, V64, P482, DOI 10.1037/h0045106; Polyn SM, 2009, PSYCHOL REV, V116, P129, DOI 10.1037/a0014420; POSTMAN L, 1965, Q J EXP PSYCHOL, V17, P132, DOI 10.1080/17470216508416422; Ranganath C, 2005, TRENDS COGN SCI, V9, P374, DOI 10.1016/j.tics.2005.06.009; Rosenbaum RS, 2005, NEUROPSYCHOLOGIA, V43, P989, DOI 10.1016/j.neuropsychologia.2004.10.007; Ryan L, 2001, MEM COGNITION, V29, P678, DOI 10.3758/BF03200470; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sederberg PB, 2008, PSYCHOL REV, V115, P893, DOI 10.1037/a0013396; Skotko BG, 2004, NEUROPSYCHOLOGY, V18, P756, DOI 10.1037/0894-4105.18.4.756; STRAUSS E, 1991, COMPENDIUM NEUROPSYC; Talmi D, 2006, MEMORY, V14, P424, DOI 10.1080/09658210500426623; Usher M, 2008, PSYCHOL REV, V115, P1108, DOI 10.1037/a0013725; WARRINGTON EK, 1968, NATURE, V217, P972, DOI 10.1038/217972a0; WAUGH NC, 1965, PSYCHOL REV, V72, P89, DOI 10.1037/h0021797; WILSON M, 1988, BEHAV RES METH INSTR, V20, P6, DOI 10.3758/BF03202594; Winocur G, 1996, BRAIN COGNITION, V30, P44, DOI 10.1006/brcg.1996.0004; Yonelinas AP, 2002, PSYCHON B REV, V9, P575, DOI 10.3758/BF03196315	52	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0124084	10.1371/journal.pone.0124084	http://dx.doi.org/10.1371/journal.pone.0124084			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046770	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200006
J	Vuillaume, B; Valette, V; Lepais, O; Grandjean, F; Breuil, M				Vuillaume, Barbara; Valette, Victorien; Lepais, Olivier; Grandjean, Frederic; Breuil, Michel			Genetic Evidence of Hybridization between the Endangered Native Species Iguana delicatissima and the Invasive Iguana iguana (Reptilia, Iguanidae) in the Lesser Antilles: Management Implications	PLOS ONE			English	Article							POPULATION-STRUCTURE; HYBRIDS; PHYLOGEOGRAPHY; MITOCHONDRIAL; CONSERVATION; INFERENCE; SQUAMATA; INSIGHTS	The worldwide increase of hybridization in different groups is thought to have become more important with the loss of isolating barriers and the introduction of invasive species. This phenomenon could result in the extinction of endemic species. This study aims at investigating the hybridization dynamics between the endemic and threatened Lesser Antillean iguana (Iguana delicatissima) and the invasive common green iguana (Iguana iguana) in the Lesser Antilles, as well as assessing the impact of interspecific hybridization on the decline of I. delicatissima. 59 I. delicatissima (5 localities), 47 I. iguana (12 localities) and 27 hybrids (5 localities), who were all identified based on morphological characters, have been genotyped at 15 microsatellites markers. We also sequenced hybrids using ND4 mitochondrial loci to further investigate mitochondrial introgression. The genetic clustering of species and hybrid genetic assignment were performed using a comparative approach, through the implementation of a Discriminant Analysis of Principal Component (DAPC) based on statistics, as well as genetic clustering approaches based on the genetic models of several populations (Structure, NewHybrids and HIest), in order to get full characterization of hybridization patterns and introgression dynamics across the islands. The iguanas identified as hybrids in the wild, thanks to morphological analysis, were all genetically F1, F2, or back-crosses. A high proportion of individuals were also the result of a longer-term admixture. The absence of reproductive barriers between species leads to hybridization when species are in contact. Yet morphological and behavioral differences between species could explain why males I. iguana may dominate I. delicatissima, thus resulting in short-term species displacement and extinction by hybridization and recurrent introgression from I. iguana toward I. delicatissima. As a consequence, I. delicatissima gets eliminated through introgression, as observed in recent population history over several islands. These results have profound implications for species management of the endangered I. delicatissima and practical conservation recommendations are being discussed in the light of these findings.	[Vuillaume, Barbara; Breuil, Michel] Natl Museum Nat Hist, Lab Reptiles & Amphibiens, F-75231 Paris 05, France; [Vuillaume, Barbara] Lab Genindexe, F-17000 La Rochelle, France; [Valette, Victorien; Grandjean, Frederic] Univ Poitiers, UMR CNRS 7267, Lab Ecol & Biol Interact, Equipe Ecol,Evolut,Symbiose, F-86022 Poitiers, France; [Lepais, Olivier] INRA, UMR 1224, Ecol Comportementale & Biol Populat Poissons, St Pee Sur Nivelle, France; [Lepais, Olivier] Univ Pau & Pays Adour, UMR 1224, Ecol Comportementale & Biol Populat Poissons, Anglet, France	Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; INRAE; Universite de Pau et des Pays de l'Adour; Universite de Pau et des Pays de l'Adour	Grandjean, F (corresponding author), Univ Poitiers, UMR CNRS 7267, Lab Ecol & Biol Interact, Equipe Ecol,Evolut,Symbiose, 6 Rue Michel Brunet, F-86022 Poitiers, France.	frederic.grandjean@univ-poitiers.fr	Lepais, Olivier/D-1849-2009; VUILLAUME, Barbara/AAV-1277-2021	Lepais, Olivier/0000-0002-6102-9478; VUILLAUME, Barbara/0000-0002-5099-6542; grandjean, frederic/0000-0002-8494-0985	Directions regionales de l'Environnement et du Logement de Martinique et de Guadeloupe; Natural Reserve of Saint-Barthelemy; Laboratoire Genindexe	Directions regionales de l'Environnement et du Logement de Martinique et de Guadeloupe; Natural Reserve of Saint-Barthelemy; Laboratoire Genindexe	Financial support of the project was provided by the Directions regionales de l'Environnement et du Logement de Martinique et de Guadeloupe and by the Natural Reserve of Saint-Barthelemy. Laboratoire Genindexe provided support in the form of salaries for author BV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Anderson EC, 2002, GENETICS, V160, P1217; Arnold M.L., 2006, EVOLUTION GENETIC EX, P271; Belkhir K., 2004, 5171 CNRS UMR; Lorvelec Olivier, 2008, Bulletin de la Societe Herpetologique de France, V128, P49; Breuil M, 2011, TROPICAL SAINT BARTH, P37; Breuil M, 2003, CONTRIBUTIONS HERPET, V20, P255; Breuil M., 2000, W INDIAN IGUANA SPEC, V3, P13; Breuil M, 2011, IGUANA IGUANA VERTEB, P82; Breuil M., 2002, PATRIMOINES NATURELS, V54; Breuil M., 2010, COURRIER NATURE, V251, P36; Breuil M, 1994, COURRIER NATURE, V143, P16; Breuil M, 2010, IUCN 2010 IUCN RED L; Breuil M, 2001, IGUANA SPECIALIST GR, V4, P9; Breuil M., 2007, IGUANA SPECIAL GROUP, V10, P15; Breuil Michel, 2013, Bulletin de la Societe Herpetologique de France, V147, P309; Breuil M, 2011, CONSERVATION OF CARIBBEAN ISLAND HERPETOFAUNAS, VOL 2: REGIONAL ACCOUNTS OF THE WEST INDIES, P311; Breuil M, 2009, APPL HERPETOL, V6, P123, DOI 10.1163/157075408X386114; Breuil Michel, 2008, Bulletin de la Societe Herpetologique de France, P41; Day M.L., 2000, W INDIAN IGUANAS STA, P62; Day ML, 1996, CONTRIBUTIONS W INDI, V12, P136; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falcon W, 2013, PAC SCI, V67, P157, DOI 10.2984/67.2.2; Falush D, 2003, GENETICS, V164, P1567; Fitzpatrick BM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-131; Grouard S, 2010, IGUANAS WHAT DINNER; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gutsche Alexander, 2004, Salamandra, V40, P201; Gutsche Alexander, 2008, Zoosystematics and Evolution, V84, P245, DOI 10.1002/zoos.200800009; Henderson RW, 2005, IGUANA, V12, P108; Henderson RW, 2012, BULL FLA MUS NAT HIS, V51, P148; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Krauss U., 2013, ACT C BIOD INS FLOR, P196; KRYSKO K. L., 2007, IGUANA, V14, P143; LAZELL J D JR, 1973, Bulletin of the Museum of Comparative Zoology, V145, P1; Lopez-Torres AL, 2012, BIOL INVASIONS, V14, P35, DOI 10.1007/s10530-011-0057-0; Lorvelec O, 1999, IGUANA PETITES ANTIL; Lorvelec Olivier, 2007, Applied Herpetology, V4, P131, DOI 10.1163/157075407780681356; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Malone Catherine L., 2004, P45; Malone CL, 2000, MOL PHYLOGENET EVOL, V17, P269, DOI 10.1006/mpev.2000.0836; McCleery, 1999, ESARBICA J, V115, P4, DOI 10.1080/00369220108733271; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parham JF, 2013, MOL PHYLOGENET EVOL, V67, P176, DOI 10.1016/j.ympev.2013.01.004; Pasachnik SA, 2012, REPTILES AMPHIBIANS, V19, P132, DOI [10.17161/randa.v19i2.13895, DOI 10.17161/RANDA.V19I2.13895]; Pasachnik Stesha A., 2006, Catalogue of American Amphibians and Reptiles, V811, P1; Powell R, 2005, IGUANA, V12, P63; Powell Robert, 2006, Applied Herpetology, V3, P293, DOI 10.1163/157075406778905090; Pritchard JK, 2000, GENETICS, V155, P945; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rassmann K, 1997, J ZOOL, V242, P729, DOI 10.1111/j.1469-7998.1997.tb05822.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Sites JW, 1996, MOL BIOL EVOL, V13, P1087, DOI 10.1093/oxfordjournals.molbev.a025671; Smith PF, 2003, MOL ECOL, V12, P2497, DOI 10.1046/j.1365-294X.2003.01905.x; Stephen CL, 2013, J BIOGEOGR, V40, P50, DOI 10.1111/j.1365-2699.2012.02780.x; Valette V, 2013, CONSERV GENET RESOUR, V5, P173, DOI 10.1007/s12686-012-9761-z	59	37	40	3	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127575	10.1371/journal.pone.0127575	http://dx.doi.org/10.1371/journal.pone.0127575			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046351	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200023
J	Willecke, F; Yuan, CJ; Oka, K; Chan, L; Hu, YY; Barnhart, S; Bornfeldt, KE; Goldberg, IJ; Fisher, EA				Willecke, Florian; Yuan, Chujun; Oka, Kazuhiro; Chan, Lawrence; Hu, Yunying; Barnhart, Shelley; Bornfeldt, Karin E.; Goldberg, Ira J.; Fisher, Edward A.			Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice	PLOS ONE			English	Article							DEPENDENT ADENOVIRAL VECTORS; APOLIPOPROTEIN-A-I; INSULIN-RESISTANCE; CHOLESTEROL; EXPRESSION; PROMOTES; MACROPHAGES; LESIONS; MOUSE; PROGRESSION	We tested whether a high fat diet (HFD) containing the inflammatory dietary fatty acid palmitate or insulin deficient diabetes altered the remodeling of atherosclerotic plaques in LDL receptor knockout (Ldlr(-/-)) mice. Cholesterol reduction was achieved by using a helperdependent adenovirus (HDAd) carrying the gene for the low-density lipoprotein receptor (Ldlr; HDAd-LDLR). After injection of the HDAd-LDLR, mice consuming either HFD, which led to insulin resistance but not hyperglycemia, or low fat diet (LFD), showed regression compared to baseline. However there was no difference between the two groups in terms of atherosclerotic lesion size, or CD68+ cell and lipid content. Because of the lack of effects of these two diets, we then tested whether viral-mediated cholesterol reduction would lead to defective regression in mice with greater hyperglycemia. In both normoglycemic and streptozotocin (STZ)-treated hyperglycemic mice, HDAd-LDLR significantly reduced plasma cholesterol levels, decreased atherosclerotic lesion size, reduced macrophage area and lipid content, and increased collagen content of plaque in the aortic sinus. However, reductions in anti-inflammatory and ER stress-related genes were less pronounced in STZ-diabetic mice compared to non-diabetic mice. In conclusion, HDAd-mediated Ldlr gene therapy is an effective and simple method to induce atherosclerosis regression in Ldlr(-/-) mice in different metabolic states.	[Willecke, Florian; Hu, Yunying; Goldberg, Ira J.] NYU, Langone Med Ctr, Div Endocrinol Diabet & Metab, New York, NY 10016 USA; [Yuan, Chujun; Fisher, Edward A.] NYU, Langone Med Ctr, Div Cardiol, New York, NY 10016 USA; [Oka, Kazuhiro; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Barnhart, Shelley; Bornfeldt, Karin E.] Univ Washington, Dept Med, Div Metab Endocrinol & Nutr Diabet & Obes, Ctr Excellence, Seattle, WA 98109 USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; Baylor College of Medicine; University of Washington; University of Washington Seattle	Goldberg, IJ (corresponding author), NYU, Langone Med Ctr, Div Endocrinol Diabet & Metab, New York, NY 10016 USA.	Ira.Goldberg@nyumc.org; Edward.Fisher@nyumc.org	Fisher, Edward/ABE-7469-2020; Bornfeldt, Karin/AAI-2241-2019	Bornfeldt, Karin/0000-0001-9208-6523; Fisher, Edward/0000-0001-9802-143X	Deutsche Forschungsgemeinschaft [Wi 4064/1-1]; National Institutes of Health [R01HL51586/DK105527, P30DK079638, R01HL062887, P01HL092969, R01HL097365, R01HL045095, HL087945, DK095684, HL117226]; American Heart Association [14GRNT20410033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117226, P01HL092969, R01HL051586, U01HL087945, R01HL045095, R01HL097365, R01HL062887] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047, P30DK079638, R01DK095684] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by the following: FW: Wi 4064/1-1; Deutsche Forschungsgemeinschaft; www.dfg.de. LC: National Institutes of Health; www.nih.gov, R01HL51586/DK105527, P30DK079638. KEB: National Institutes of Health; www.nih.gov, R01HL062887, P01HL092969, R01HL097365. American Heart Association; http://www.heart.org/HEARTORG/#, #14GRNT20410033. IJG: National Institutes of Health; www.nih.gov, R01HL045095. EAF: National Institutes of Health; www.nih.gov, HL087945, DK095684, HL117226. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouhlel MA, 2007, CELL METAB, V6, P137, DOI 10.1016/j.cmet.2007.06.010; Brosius F., 2003, LOW DOSE STREPTOZOTO; Calkin AC, 2010, ARTERIOSCL THROM VAS, V30, P1513, DOI 10.1161/ATVBAHA.109.191197; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chereshnev I, 2003, J SURG RES, V111, P171, DOI 10.1016/S0022-4804(03)00039-8; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Feig JE, 2013, METHODS MOL BIOL, V1027, P123, DOI 10.1007/978-1-60327-369-5_5; Feig JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028534; Feig JE, 2011, P NATL ACAD SCI USA, V108, P7166, DOI 10.1073/pnas.1016086108; Feig JE, 2011, CIRCULATION, V123, P989, DOI 10.1161/CIRCULATIONAHA.110.984146; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Gaudreault N, 2013, AM J PATHOL, V183, P1981, DOI 10.1016/j.ajpath.2013.08.019; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Goldberg IJ, 2008, DIABETES, V57, P1674, DOI 10.2337/db08-0083; Grundy SM, 2004, J CLIN ENDOCR METAB, V89, P2595, DOI 10.1210/jc.2004-0372; Harris JD, 2002, GENE THER, V9, P21, DOI 10.1038/sj.gt.3301615; Hsueh W, 2007, CIRC RES, V100, P1415, DOI 10.1161/01.RES.0000266449.37396.1f; Johansson F, 2008, P NATL ACAD SCI USA, V105, P2082, DOI 10.1073/pnas.0709958105; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Kawashiri M, 2001, J LIPID RES, V42, P943; Kennedy A, 2009, J NUTR, V139, P1, DOI 10.3945/jn.108.098269; Khallou-Laschet J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008852; Kim IH, 2001, P NATL ACAD SCI USA, V98, P13282, DOI 10.1073/pnas.241506298; Li Rongying, 2011, J Genet Syndr Gene Ther, V2, P106; Lieu HD, 2003, CIRCULATION, V107, P1315, DOI 10.1161/01.CIR.0000054781.50889.0C; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Moore RE, 2003, ARTERIOSCL THROM VAS, V23, P1914, DOI 10.1161/01.ATV.0000092328.66882.F5; Morral N, 1999, P NATL ACAD SCI USA, V96, P12816, DOI 10.1073/pnas.96.22.12816; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Nicholls SJ, 2011, NEW ENGL J MED, V365, P2078, DOI 10.1056/NEJMoa1110874; Nomura S, 2004, GENE THER, V11, P1540, DOI 10.1038/sj.gt.3302310; Nozue T, 2012, CIRC J, V76, P2188, DOI 10.1253/circj.CJ-11-1303; Oka K, 2005, METH MOLEC MED, V108, P329; Oka Kazuhiro, 2004, Curr Atheroscler Rep, V6, P203, DOI 10.1007/s11883-004-0033-6; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Potteaux S, 2011, J CLIN INVEST, V121, P2025, DOI 10.1172/JCI43802; Reis ED, 2001, J VASC SURG, V34, P541, DOI 10.1067/mva.2001.115963; Renard CB, 2004, J CLIN INVEST, V114, P659, DOI 10.1172/JCI200417867; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Rong X, 2013, CELL METAB, V18, P685, DOI 10.1016/j.cmet.2013.10.002; SPADY DK, 1993, ANNU REV NUTR, V13, P355, DOI [10.1146/annurev.nutr.13.1.355, 10.1146/annurev.nu.13.070193.002035]; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Tholstrup T, 2011, AM J CLIN NUTR, V94, P1426, DOI 10.3945/ajcn.111.018846; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Van Craeyveld E, 2011, J MOL MED, V89, P555, DOI 10.1007/s00109-011-0722-x; Vikramadithyan RK, 2005, J CLIN INVEST, V115, P2434, DOI 10.1172/JCI24819; Winzell MS, 2004, DIABETES, V53, pS215, DOI 10.2337/diabetes.53.suppl_3.S215; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017	51	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128996	10.1371/journal.pone.0128996	http://dx.doi.org/10.1371/journal.pone.0128996			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046657	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200115
J	Zhang, J; Chong, CCN; Chen, GG; Lai, PBS				Zhang, Jian; Chong, Charing C. N.; Chen, George G.; Lai, Paul B. S.			A Seven-microRNA Expression Signature Predicts Survival in Hepatocellular Carcinoma	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; MICRORNA EXPRESSION; CANCER; PATHWAY; THERAPEUTICS; PROGRESSION; METASTASIS; PROGNOSIS; APOPTOSIS; PROFILES	Hepatocellular carcinoma (HCC) is the fifth common cancer. The differential expression of microRNAs (miRNAs) has been associated with the prognosis of various cancers. However, limited information is available regarding genome-wide miRNA expression profiles in HCC to generate a tumor-specific miRNA signature of prognostic values. In this study, the miRNA profiles in 327 HCC patients, including 327 tumor and 43 adjacent non-tumor tissues, from The Cancer Genome Atlas (TCGA) Liver hepatocellular carcinoma (LIHC) were analyzed. The associations of the differentially expressed miRNAs with patient survival and other clinical characteristics were examined with t-test and Cox proportional regression model. Finally, a tumor-specific miRNA signature was generated and examined with Kaplan-Meier survival, univariate\multivariate Cox regression analyses and KEGG pathway analysis. Results showed that a total of 207 miRNAs were found differentially expressed between tumor and adjacent non-tumor HCC tissues. 78 of them were also discriminatively expressed with gender, race, tumor grade and AJCC tumor stage. Seven miRNAs were significantly associated with survival (P value <0.001). Among the seven significant miRNAs, six (hsa-mir-326, hsa-mir-3677, hsa-mir-511-1, hsa-mir-511-2, hsa-mir-9-1, and hsa-mir-9-2) were negatively associated with overall survival (OS), while the remaining one (hsa-mir-30d) was positively correlated. A tumor-specific 7-miRNAs signature was generated and validated as an independent prognostic predictor. Collectively, we have identified and validated an independent prognostic model based on the expression of seven miRNAs, which can be used to assess patients' survival. Additional work is needed to translate our model into clinical practice.	[Zhang, Jian; Chong, Charing C. N.; Chen, George G.; Lai, Paul B. S.] Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital	Chen, GG (corresponding author), Chinese Univ Hong Kong, Dept Surg, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China.	gchen@cuhk.edu.hk; paullai@surgery.cuhk.edu.hk	zhang, jian/E-7203-2010; Lai, Paul BS/K-8556-2015; ZHANG, Jian/ABB-7267-2020; Chen, George Gong/I-2757-2016; Chong, Charing CN/M-3455-2018	zhang, jian/0000-0001-8870-515X; Lai, Paul BS/0000-0002-9469-6728; ZHANG, Jian/0000-0001-8870-515X; Chong, Charing CN/0000-0002-8425-8767	SRFDP and RGC ERG Joint Research [M-CUHK406/13]; CUHK direct grant [4054160]	SRFDP and RGC ERG Joint Research; CUHK direct grant(Chinese University of Hong Kong)	This study was supported by SRFDP and RGC ERG Joint Research (No: M-CUHK406/13) and CUHK direct grant (4054160). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed I, 2009, SURGERY, V27, P30, DOI DOI 10.1016/J.MPSUR.2008.12.005; Anwar SL, 2013, INT J CANCER, V133, P660, DOI 10.1002/ijc.28068; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Barbano R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108950; Barry CT, 2012, AM J TRANSPLANT, V12, P428, DOI 10.1111/j.1600-6143.2011.03788.x; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Cao G, 2015, TUMOR BIOL, V36, P4453, DOI 10.1007/s13277-015-3085-z; Fleming NH, 2015, CANCER-AM CANCER SOC, V121, P51, DOI 10.1002/cncr.28981; Ge YZ, 2015, J CANCER RES CLIN, V141, P1291, DOI 10.1007/s00432-015-1927-0; Gu YY, 2015, ONCOTARGET, V6, P2397, DOI 10.18632/oncotarget.2963; Hong CC, 2014, CANCER RES, V74, P6280, DOI 10.1158/0008-5472.CAN-14-0524; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; LaCroix B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-292; Lee H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-174; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Li J, 2010, BMC EVOL BIOL, V10, DOI [10.1186/1471-2148-10-68, 10.1186/1471-2407-10-354]; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Omura Noriyuki, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P7; Onnis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012960; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Peters I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091440; Stewart BW, WORLD CANC REPORT 20; Trankenschuh W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013688; Vaira V, 2015, LIVER INT, V35, P1077, DOI 10.1111/liv.12636; Villanueva A, 2010, CLIN CANCER RES, V16, P4688, DOI 10.1158/1078-0432.CCR-09-1811; Wang S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0373-y; Wang Y, 2014, GENE, V533, P389, DOI 10.1016/j.gene.2013.09.038; Wong QWL, 2010, CLIN CANCER RES, V16, P867, DOI 10.1158/1078-0432.CCR-09-1840; Wu CL, 2013, CELL SIGNAL, V25, P1212, DOI 10.1016/j.cellsig.2013.01.028; Yan W, 2014, ONCOTARGET, V5, P12908, DOI 10.18632/oncotarget.2679; Yang NN, 2015, ADV DRUG DELIVER REV, V81, P62, DOI 10.1016/j.addr.2014.10.029; Yang XJ, 2013, BIOCHEM BIOPH RES CO, V431, P617, DOI 10.1016/j.bbrc.2012.12.083; Yao J, 2010, HEPATOLOGY, V51, P846, DOI 10.1002/hep.23443; Yu HS, 2014, ONCOL LETT, V7, P799, DOI 10.3892/ol.2013.1754; Zhang G, 2010, CURR GENOMICS, V11, P311, DOI 10.2174/138920210791616671; Zhang JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054111; Zhang PY, 2014, J PATHOL, V232, P308, DOI 10.1002/path.4294; Zhao YD, 2008, CANCER INFORM, V6, P9; Zhuang LP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731781	39	60	60	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128628	10.1371/journal.pone.0128628	http://dx.doi.org/10.1371/journal.pone.0128628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046780	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200086
J	Jiang, B; Zhu, CC; Huang, YD				Jiang, B.; Zhu, C. C.; Huang, Y. D.			Research of the Dispersity of the Functional Sericite/Methylphenyl-Silicone Resin	PLOS ONE			English	Article							PARTICLES; COMPOSITE	In order to improve the homogeneity and dispersity of the sericite in methylphenyl-silicone resin, the agglomerate state of the sericites was controlled effectively. The dispersive model of the sericite in methylphenyl-silicone resin was designed also. First, the modified sericite was prepared using hexadecyl trimethyl ammonium bromide as the intercalating agent. Then, functional sericite was incorporated into methylphenyl-silicone by terminal hydroxyl. The structure and dispersive performance of the hybrid polymers was charactered by analytical instruments. Scanning electron microscopy and Transmission electron microscope, Laser scanning confocal microscope and X-ray diffraction analysis showed that functional sericite was dispersed homogeneously in methylphenyl-silicone resin matrix. Xray photoelectron spectroscopy analysis showed that the absorption peaks of the Si-OH band of methylphenyl-silicone resin were decreased and the Si-O-Si band was increased. This change evidently showed a significant role to enhance the reaction degree of the functional sericite in methylphenyl-silicone resin.	[Jiang, B.] Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150090, Peoples R China; [Jiang, B.; Zhu, C. C.; Huang, Y. D.] Harbin Inst Technol, Sch Chem Engn & Technol, Polymer Mat & Engn Dept, Harbin 150001, Peoples R China	Harbin Institute of Technology; Harbin Institute of Technology	Jiang, B (corresponding author), Harbin Inst Technol, State Key Lab Urban Water Resource & Environm, Harbin 150090, Peoples R China.	jiangbo5981@hit.edu.cn			National Natural Science Foundation of China [50903025]; Fundamental Research Funds for the Central Universities [HIT NSRIF 2013046, HIT. IBRSEM.201318]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financilly supported by Grant No. 50903025 from the National Natural Science Foundation of China and from the Fundamental Research Funds for the Central Universities (Grant No. HIT NSRIF 2013046, HIT.IBRSEM.201318).	Anderson SE, 2006, CHEM MATER, V18, P1490, DOI 10.1021/cm052589c; Baalousha M, 2013, NAT NANOTECHNOL, V8, P308, DOI 10.1038/nnano.2013.78; Bianchi E, 2013, ACS NANO, V7, P4657, DOI 10.1021/nn401487m; Choi S, 2013, THIN SOLID FILMS, V537, P180, DOI 10.1016/j.tsf.2013.04.047; Kantola R, 2011, INT J PROSTHODONT, V24, P582; Kong LR, 2010, LANGMUIR, V26, P5985, DOI 10.1021/la904509v; Li R, 2013, ASIAN J CHEM, V25, P2541, DOI 10.14233/ajchem.2013.13448; Liao WJ, 2012, COLLOID SURFACE A, V396, P74, DOI 10.1016/j.colsurfa.2011.12.044; Liu YR, 2007, COMPOS SCI TECHNOL, V67, P2864, DOI 10.1016/j.compscitech.2007.01.023; Narisawa M, 2010, J MATER SCI, V45, P5642, DOI 10.1007/s10853-010-4629-7; Nguyen NT, 2012, POLYM COMPOSITE, V33, P1785; Register RA, 2012, NATURE, V483, P167, DOI 10.1038/483167a; Shih YJ, 2009, APPL CLAY SCI, V43, P282, DOI 10.1016/j.clay.2008.09.006; Yang XF, 2013, J APPL POLYM SCI, V127, P1717, DOI 10.1002/app.37897; Yiannourakou M, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3131691	15	1	1	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127735	10.1371/journal.pone.0127735	http://dx.doi.org/10.1371/journal.pone.0127735			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061002	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500054
J	Joly, K; Wasser, SK; Booth, R				Joly, Kyle; Wasser, Samuel K.; Booth, Rebecca			Non-Invasive Assessment of the Interrelationships of Diet, Pregnancy Rate, Group Composition, and Physiological and Nutritional Stress of Barren-Ground Caribou in Late Winter	PLOS ONE			English	Article							RANGIFER-TARANDUS; FEMALE CARIBOU; OVERWINTERING CARIBOU; SEXUAL SEGREGATION; ARCTIC CARIBOU; BODY CONDITION; REINDEER; HABITAT; DYNAMICS; PATTERNS	The winter diet of barren-ground caribou may affect adult survival, timing of parturition, neonatal survival, and postpartum mass. We used microhistological analyses and hormone levels in feces to determine sex-specific late-winter diets, pregnancy rates, group composition, and endocrine-based measures of physiological and nutritional stress. Lichens, which are highly digestible but contain little protein, dominated the diet (> 68%) but were less prevalent in the diets of pregnant females as compared to non-pregnant females and males. The amount of lichens in the diets of pregnant females decreased at higher latitudes and as winter progressed. Pregnancy rates (82.1%, 95% CI = 76.0 - 88.1%) of adult cows were within the expected range for a declining herd, while pregnancy status was not associated with lichen abundance in the diet. Most groups (80%) were of mixed sex. Male: female ratios (62: 100) were not skewed enough to affect the decline. Levels of hormones indicating nutritional stress were detected in areas of low habitat quality and at higher latitudes. Levels of hormones indicated that physiological stress was greatest for pregnant cows, which faced the increasing demands of gestation in late winter. These fecal-based measures of diet and stress provided contextual information for the potential mechanisms of the ongoing decline. Non-invasive techniques, such as monitoring diets, pregnancy rates, sex ratios and stress levels from fecal samples, will become increasingly important as monitoring tools as the industrial footprint continues to expand in the Arctic.	[Joly, Kyle] Natl Pk Serv, Gates Arct Natl Pk & Preserve, Fairbanks, AK 99709 USA; [Joly, Kyle] Natl Pk Serv, Arct Inventory & Monitoring Network, Fairbanks, AK USA; [Wasser, Samuel K.; Booth, Rebecca] Univ Washington, Ctr Conservat Biol, Seattle, WA 98195 USA	United States Department of the Interior; United States Department of the Interior; University of Washington; University of Washington Seattle	Joly, K (corresponding author), Natl Pk Serv, Gates Arct Natl Pk & Preserve, Fairbanks, AK 99709 USA.	kyle_joly@nps.gov	Wasser, Samuel K/I-5542-2015		National Park Service	National Park Service	The National Park Service funded this study.	ADAMCZEWSKI JZ, 1987, CAN J ZOOL, V65, P1149, DOI 10.1139/z87-180; ADAMCZEWSKI JZ, 1993, CAN J ZOOL, V71, P1221, DOI 10.1139/z93-167; Ashley NT, 2011, GEN COMP ENDOCR, V172, P382, DOI 10.1016/j.ygcen.2011.03.029; Ball MC, 2007, CONSERV GENET, V8, P577, DOI 10.1007/s10592-006-9193-y; Barboza PS, 2008, PHYSIOL BIOCHEM ZOOL, V81, P835, DOI 10.1086/590414; Barboza PS, 2000, J MAMMAL, V81, P473, DOI 10.1644/1545-1542(2000)081&lt;0473:SSIDDA&gt;2.0.CO;2; Boertje R. D., 2012, ALASKA DEP FISH GAME; BOERTJE RD, 1990, J APPL ECOL, V27, P420, DOI 10.2307/2404291; BOERTJE RD, 1984, ARCTIC, V37, P161; Boulanger J, 2014, 143 INT EC RES; Bubenik GA, 1998, COMP BIOCHEM PHYS C, V120, P307, DOI 10.1016/S0742-8413(98)10010-5; Cameron RD, 2005, ARCTIC, V58, P1; CAMERON RD, 1993, CAN J ZOOL, V71, P480, DOI 10.1139/z93-069; CAMERON RD, 1994, J WILDLIFE MANAGE, V58, P674, DOI 10.2307/3809681; CAMERON RD, 1979, J WILDLIFE MANAGE, V43, P626, DOI 10.2307/3808740; Chan-McLeod AC, 1999, CAN J ZOOL, V77, P1901, DOI 10.1139/cjz-77-12-1901; COLLINS WB, 1991, ARCTIC, V44, P217; Comiso JC, 2014, WIRES CLIM CHANGE, V5, P389, DOI 10.1002/wcc.277; Dale BW, 2008, J MAMMAL, V89, P1130, DOI 10.1644/07-MAMM-A-137.1; Dauphine TC, 1976, BIOL KAMINURAK POP 4; Douyon L, 2002, ENDOCRIN METAB CLIN, V31, P173, DOI 10.1016/S0889-8529(01)00023-8; Espmark Y, 1980, P 2 REINDEERCARIBOU, P485; Exponent, 2007, DMTS FUGITIVE DUST R; FANCY SG, 1987, CAN J ZOOL, V65, P122, DOI 10.1139/z87-018; Festa-Bianchet M, 2011, CAN J ZOOL, V89, P419, DOI [10.1139/z11-025, 10.1139/Z11-025]; Gerhart KL, 1997, J ZOOL, V242, P17, DOI 10.1111/j.1469-7998.1997.tb02926.x; Gustine DD, 2014, RAPID COMMUN MASS SP, V28, P625, DOI 10.1002/rcm.6825; Gustine DD, 2012, J MAMMAL, V93, P778, DOI 10.1644/11-MAMM-A-164.1; Gustine DD, 2011, J WILDLIFE MANAGE, V75, P178, DOI 10.1002/jwmg.11; Harper P, 2011, CAR MAN REP SURV INV; Johnson CJ, 2005, WILDLIFE MONOGR, P1; Joly K, 2011, ALASKA PARK SCI, V10, P26; Joly K, 2007, ARCTIC, V60, P401; Joly Kyle, 2011, Rangifer, V31, P75; Joly K, 2011, ECOGRAPHY, V34, P345, DOI 10.1111/j.1600-0587.2010.06377.x; Joly K, 2010, ECOSCIENCE, V17, P321, DOI 10.2980/17-3-3337; Joly K, 2007, CAN FIELD NAT, V121, P379, DOI 10.22621/cfn.v121i4.509; Kitaysky AS, 2005, HORM BEHAV, V47, P606, DOI 10.1016/j.yhbeh.2005.01.005; KLEIN DR, 1982, J RANGE MANAGE, V35, P390, DOI 10.2307/3898326; Latham ADM, 2011, J WILDLIFE MANAGE, V75, P204, DOI 10.1002/jwmg.28; Middleton AD, 2013, ECOLOGY, V94, P1245, DOI 10.1890/11-2298.1; Morden CJC, 2011, J WILDLIFE MANAGE, V75, P1426, DOI 10.1002/jwmg.185; Nellemann C, 2003, BIOL CONSERV, V113, P307, DOI 10.1016/S0006-3207(03)00048-X; Pachkowski M, 2013, CAN J ZOOL, V91, P473, DOI 10.1139/cjz-2012-0334; Parker KL, 2005, J MAMMAL, V86, P610, DOI 10.1644/1545-1542(2005)86[610:PCIFCR]2.0.CO;2; Person BT, 2007, ARCTIC, V60, P238; PERSON SJ, 1980, J WILDLIFE MANAGE, V44, P613, DOI 10.2307/3808008; ROBBINS CT, 1979, AM NAT, V114, P101, DOI 10.1086/283456; ROINE K, 1982, ACTA VET SCAND, V23, P107; Russell Don E., 1993, Rangifer, V13, P1; Saperstein Lisa, 1996, Rangifer, V16, P237; Schaefer JA, 2013, CAN J ZOOL, V91, P767, DOI 10.1139/cjz-2013-0132; SKOGLAND T, 1984, Rangifer, V4, P39; SKOGLAND T, 1983, OECOLOGIA, V60, P156, DOI 10.1007/BF00379517; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Thomas D, 2005, ARCTIC, V58, P241; Thomas DC, 1990, RANGIFER, V3, P257, DOI DOI 10.7557/2.10.3.867; Thompson DP, 2014, CAN J ZOOL, V92, P339, DOI 10.1139/cjz-2013-0265; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; White Robert G., 1992, P407; WHITTEN KR, 1992, J WILDLIFE MANAGE, V56, P201, DOI 10.2307/3808814; Whitten KR, 1991, J WILDLIFE MANAGE, V59, P273; Wilson RR, 2014, ARCTIC, V67, P472, DOI 10.14430/arctic4421; Wilson RR, 2013, CONSERV LETT, V6, P350, DOI 10.1111/conl.12016; Wilson RR, 2013, POLAR BIOL, V36, P419, DOI 10.1007/s00300-012-1272-6; Zar JH, 1999, BIOSTATISTICAL ANAL	68	25	26	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127586	10.1371/journal.pone.0127586	http://dx.doi.org/10.1371/journal.pone.0127586			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061003	Green Submitted, gold, Green Published			2022-12-26	WOS:000355979500042
J	Liu, DL; An, ZG; Mao, ZJ; Ma, LB; Lu, ZQ				Liu, Dali; An, Zhigang; Mao, Zijun; Ma, Longbiao; Lu, Zhenqiang			Enhanced Heavy Metal Tolerance and Accumulation by Transgenic Sugar Beets Expressing Streptococcus thermophilus StGCS-GS in the Presence of Cd, Zn and Cu Alone or in Combination	PLOS ONE			English	Article							GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; GLUTATHIONE SYNTHETASE; CADMIUM ACCUMULATION; INDIAN MUSTARD; PLANTS; BIOSYNTHESIS; HOMEOSTASIS; ABILITY; GENES; ZINC	Phytoremediation is a promising means of ameliorating heavy metal pollution through the use of transgenic plants as artificial hyperaccumulators. A novel Streptococcus thermophilus.-glutamylcysteine synthetase-glutathione synthetase (StGCS-GS) that synthesizes glutathione (GSH) with limited feedback inhibition was overexpressed in sugar beet (Beta vulgaris L.), yielding three transgenic lines (s2, s4 and s5) with enhanced tolerance to different concentrations of cadmium, zinc and copper, as indicated by their increased biomass, root length and relative growth compared with wild-type plants. Transgenic sugar beets accumulated more Cd, Zn and Cu ions in shoots than wild-type, as well as higher GSH and phytochelatin (PC) levels under different heavy metal stresses. This enhanced heavy metal tolerance and increased accumulation were likely due to the increased expression of StGCS-GS and consequent overproduction of both GSH and PC. Furthermore, when multiple heavy metal ions were present at the same time, transgenic sugar beets overexpressing StGCS-GS resisted two or three of the metal combinations (50 mu M Cd-Zn, Cd-Cu, Zn-Cu and Cd-Zn-Cu), with greater absorption in shoots. Additionally, there was no obvious competition between metals. Overall, the results demonstrate the explicit role of StGCS-GS in enhancing Cd, Zn and Cu tolerance and accumulation in transgenic sugar beet, which may represent a highly promising new tool for phytoremediation.	[Liu, Dali; Ma, Longbiao] Heilongjiang Univ, Acad Crop Sci, Key Lab Sugar Beet Genet & Breeding, Harbin 150080, Peoples R China; [Liu, Dali; An, Zhigang; Mao, Zijun] Northeast Forestry Univ, Minist Educ China, Key Lab Forest Plant Ecol, Harbin 150040, Peoples R China; [Lu, Zhenqiang] Heilongjiang Univ, Coll Life Sci, Key Lab Biochem & Mol Biol, Harbin 150080, Peoples R China	Heilongjiang University; Ministry of Education, China; Northeast Forestry University - China; Heilongjiang University	Ma, LB (corresponding author), Heilongjiang Univ, Acad Crop Sci, Key Lab Sugar Beet Genet & Breeding, Harbin 150080, Peoples R China.	caasmlb@hotmail.com; zhenqianglu@163.com		Liu, Dali/0000-0002-6831-6592	Heilongjiang Province Education Department Program [12541641, 12541608]; Harbin Science and Technology Bureau Program [2013RFQYJ025]; National Nature Science Foundation of China [31270307]; Sugar beet Modern Industrial Technology system [CARS-210104-04]; Open Fund for Key Laboratory of Sugar beet Genetics and Breeding of Heilongjiang University; Common College Science and Technology Innovation Team of Heilongjiang Province "Crop Resistant to Stress Innovation Team of Molecular Biology in Cold Region'' [2014TD004]	Heilongjiang Province Education Department Program; Harbin Science and Technology Bureau Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sugar beet Modern Industrial Technology system; Open Fund for Key Laboratory of Sugar beet Genetics and Breeding of Heilongjiang University; Common College Science and Technology Innovation Team of Heilongjiang Province "Crop Resistant to Stress Innovation Team of Molecular Biology in Cold Region''	This work was supported by Heilongjiang Province Education Department Program (#12541641 and 12541608), Harbin Science and Technology Bureau Program (#2013RFQYJ025), National Nature Science Foundation of China (#31270307), Sugar beet Modern Industrial Technology system (#CARS-210104-04), Open Fund for Key Laboratory of Sugar beet Genetics and Breeding of Heilongjiang University and The Common College Science and Technology Innovation Team of Heilongjiang Province "Crop Resistant to Stress Innovation Team of Molecular Biology in Cold Region (#2014TD004)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittsanszky A, 2005, ENVIRON INT, V31, P251, DOI 10.1016/j.envint.2004.10.001; Borgo F, 2013, J IND MICROBIOL BIOT, V40, P489, DOI 10.1007/s10295-013-1239-9; Chaoui A, 1997, PLANT SCI, V126, P21, DOI 10.1016/S0168-9452(97)00090-3; Ebbs SD, 1997, J ENVIRON QUAL, V26, P776, DOI 10.2134/jeq1997.00472425002600030026x; Foyer CH, 2005, PLANT CELL, V17, P1866, DOI 10.1105/tpc.105.033589; Gill S.S., 2011, PLANT STRESS, V5, P1, DOI DOI 10.4161/PSB.6.2.14880; Guo JB, 2008, CHEMOSPHERE, V72, P1020, DOI 10.1016/j.chemosphere.2008.04.018; Helbig K, 2008, J BACTERIOL, V190, P5431, DOI 10.1128/JB.00271-08; Janowiak BE, 2005, J BIOL CHEM, V280, P11829, DOI 10.1074/jbc.M414326200; Li Y, 2004, APPL MICROBIOL BIOT, V66, P233, DOI 10.1007/s00253-004-1751-y; Liedschulte V, 2010, PLANT BIOTECHNOL J, V8, P807, DOI 10.1111/j.1467-7652.2010.00510.x; Liu DL, 2014, ANN MICROBIOL, V64, P961, DOI 10.1007/s13213-013-0730-x; Maung TA, 2011, BIOMASS BIOENERG, V35, P3737, DOI 10.1016/j.biombioe.2011.05.022; Mohanpuria P, 2007, ENVIRON TOXICOL, V22, P368, DOI 10.1002/tox.20273; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Noctor G, 2012, PLANT CELL ENVIRON, V35, P454, DOI 10.1111/j.1365-3040.2011.02400.x; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Rausch T, 2007, PLANT BIOLOGY, V9, P565, DOI 10.1055/s-2007-965580; Reeves R. D., 2000, USING PLANTS CLEAN E, P193; Vergauwen B, 2006, J BIOL CHEM, V281, P4380, DOI 10.1074/jbc.M509517200; Wawrzynski A, 2006, J EXP BOT, V57, P2173, DOI 10.1093/jxb/erj176; Xiang CB, 2001, PLANT PHYSIOL, V126, P564, DOI 10.1104/pp.126.2.564; Yadav SK, 2010, S AFR J BOT, V76, P167, DOI 10.1016/j.sajb.2009.10.007; Zhao CZ, 2010, PLANT CELL ENVIRON, V33, P877, DOI 10.1111/j.1365-3040.2009.02113.x; Zhu YL, 1999, PLANT PHYSIOL, V121, P1169, DOI 10.1104/pp.121.4.1169; Zhu YL, 1999, PLANT PHYSIOL, V119, P73, DOI 10.1104/pp.119.1.73	26	64	66	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128824	10.1371/journal.pone.0128824	http://dx.doi.org/10.1371/journal.pone.0128824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057126	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000031
J	Piwowar, M; Jurkowski, W				Piwowar, Monika; Jurkowski, Wiktor			ONION: Functional Approach for Integration of Lipidomics and Transcriptomics Data	PLOS ONE			English	Article							FATTY-ACID; GENE-EXPRESSION; PPAR-GAMMA; METABOLISM; REGRESSION; PACKAGE	To date, the massive quantity of data generated by high-throughput techniques has not yet met bioinformatics treatment required to make full use of it. This is partially due to a mismatch in experimental and analytical study design but primarily due to a lack of adequate analytical approaches. When integrating multiple data types e.g. transcriptomics and metabolomics, multidimensional statistical methods are currently the techniques of choice. Typical statistical approaches, such as canonical correlation analysis (CCA), that are applied to find associations between metabolites and genes are failing due to small numbers of observations (e.g. conditions, diet etc.) in comparison to data size (number of genes, metabolites). Modifications designed to cope with this issue are not ideal due to the need to add simulated data resulting in a lack of p-value computation or by pruning of variables hence losing potentially valid information. Instead, our approach makes use of verified or putative molecular interactions or functional association to guide analysis. The workflow includes dividing of data sets to reach the expected data structure, statistical analysis within groups and interpretation of results. By applying pathway and network analysis, data obtained by various platforms are grouped with moderate stringency to avoid functional bias. As a consequence CCA and other multivariate models can be applied to calculate robust statistics and provide easy to interpret associations between metabolites and genes to leverage understanding of metabolic response. Effective integration of lipidomics and transcriptomics is demonstrated on publically available murine nutrigenomics data sets. We are able to demonstrate that our approach improves detection of genes related to lipid metabolism, in comparison to applying statistics alone. This is measured by increased percentage of explained variance (95% vs. 75-80%) and by identifying new metabolite-gene associations related to lipid metabolism.	[Piwowar, Monika] Jagiellonian Univ, Dept Bioinformat & Telemed, PL-31062 Krakow, Poland; [Jurkowski, Wiktor] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England	Jagiellonian University; The Genome Analysis Centre (TGAC)	Jurkowski, W (corresponding author), Genome Anal Ctr, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	wiktor.jurkowski@tgac.ac.uk	Piwowar, Monika Weronika/L-5452-2013	Piwowar, Monika Weronika/0000-0003-4645-8730	PL-Grid Infrastructure; Klaster LifeScience Krakow; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: researchfish; BBSRC [BBS/E/T/000PR6193, BBS/E/T/000PR5885] Funding Source: UKRI	PL-Grid Infrastructure; Klaster LifeScience Krakow; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported in part by PL-Grid Infrastructure and Klaster LifeScience Krakow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breslin A, 2007, BIOCHEM BIOPH RES CO, V363, P462, DOI 10.1016/j.bbrc.2007.09.052; Butts CT, 2012, YACCA YET ANOTHER CA; Chain B., 2012, AGILP AGILENT EXPRES; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Chun H, 2010, J R STAT SOC B, V72, P3, DOI 10.1111/j.1467-9868.2009.00723.x; Chung D., 2013, SPLS SPARSE PARTIAL; Crespo I, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-132; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cruz-Cano R., 2012, FRCC FAST REGULARIZE; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cserhati T, 1998, J BIOCHEM BIOPH METH, V36, P131, DOI 10.1016/S0165-022X(98)00008-6; Dong K, 2014, EUR REV MED PHARMACO, V18, P2306; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gomez-Cabrero D, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S2-I1; Gosline S, 2012, INTEGR BIOL, V246, P221; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jiang XC, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-75; Kaever A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089297; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kok BPC, 2012, J LIPID RES, V53, P105, DOI 10.1194/jlr.M019430; Le Cao KA, 2009, BIOINFORMATICS, V25, P2855, DOI 10.1093/bioinformatics/btp515; Le Cao KA, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-34; Lee K, 2011, J BIOL CHEM, V286, P25655, DOI 10.1074/jbc.M111.228692; Li XH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-44; Li Y, 2013, J BIOL CHEM, V288, P10490, DOI 10.1074/jbc.M112.429852; Martin PGP, 2007, HEPATOLOGY, V45, P767, DOI 10.1002/hep.21510; Merelli I, 2014, MANAGING ANAL INTEGR; Oliva J, 2012, EXP MOL PATHOL, V93, P26, DOI 10.1016/j.yexmp.2012.03.006; Peterlin B, 2012, BALK J MED GENET, V15, P45, DOI 10.2478/v10034-012-0018-7; Wang X, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S16; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Zhang PX, 2012, J BIOL CHEM, V287, P3485, DOI 10.1074/jbc.M111.296681; Zhao C, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-S1-S12	36	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128854	10.1371/journal.pone.0128854	http://dx.doi.org/10.1371/journal.pone.0128854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053255	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300062
J	Qi, Z; Li, T; Kong, F; Li, YG; Wang, R; Wang, JH; Xiao, QQ; Zhang, WQ; Sun, SZ; He, DC; Xiao, XY				Qi, Zhi; Li, Ting; Kong, Fei; Li, Yunguang; Wang, Rui; Wang, Junhao; Xiao, Qianqian; Zhang, Weiqing; Sun, Suozhu; He, Dacheng; Xiao, Xueyuan			The Characteristics and Function of S100A7 Induction in Squamous Cell Carcinoma: Heterogeneity, Promotion of Cell Proliferation and Suppression of Differentiation	PLOS ONE			English	Article							PSORIASIN S100A7; EXPRESSION; IDENTIFICATION	S100A7 is highly expressed in squamous cell carcinomas (SCC) and is related to the terminal differentiation of keratinocytes. However, its characteristic and function in SCC is not very known. In this present study, we used immunohistochemistry to examine the expression of S100A7 in 452 SCC specimens, including the lung, esophagus, oral cavity, skin, cervix, bladder, and three SCC cell lines. We found that S100A7-positive staining showed significant heterogeneity in six types of SCC specimen and three SCC cell lines. Further examination found that S100A7-positive cells and its expression at mRNA and protein levels could be induced in HCC94, FaDu, and A-431 cells both in vitro and in vivo using immunohistochemistry, real-time PCR, and Western blotting. Notably, the upregulation of squamous differentiation markers, including keratin-4, keratin-13, TG-1, and involucrin, also accompanied S100A7 induction, and a similar staining pattern of S100A7 and keratin-13 was found in HCC94 cells both in vitro and in vivo. Further study revealed that the overexpression of S100A7 significantly increased proliferation and inhibited squamous differentiation in A-431 cells both in vitro and in vivo. Conversely, silencing S100A7 inhibited cell growth and survival and increased the expression of keratin-4, keratin-13, TG-1, and involucrin in HCC94 cells. Therefore, these results demonstrate that S100A7 displays heterogeneous and inducible characteristic in SCC and also provide novel evidence that S100A7 acts as a dual regulator in promoting proliferation and suppressing squamous differentiation of SCC.	[Qi, Zhi; Li, Ting; Kong, Fei; Li, Yunguang; Wang, Rui; Wang, Junhao; Xiao, Qianqian; Zhang, Weiqing; Sun, Suozhu; Xiao, Xueyuan] Beijing Normal Univ, Minist Educ, Key Lab Cell Proliferat & Regulat, Beijing 100875, Peoples R China; [He, Dacheng] Univ Confederated Inst Prote, Beijing, Peoples R China; [Sun, Suozhu] Gen Hosp Second Artillery, Dept Pathol, Beijing, Peoples R China	Beijing Normal University	He, DC (corresponding author), Univ Confederated Inst Prote, Beijing, Peoples R China.	dhe@bnu.edu.cn; xyxiao@bnu.edu.cn			Ministry of Science and Technology of China of the National Natural Science Foundation of China [2011CB915504, 81172216, 81272604]	Ministry of Science and Technology of China of the National Natural Science Foundation of China	This work was supported by the Ministry of Science and Technology of China (2011CB915504), of the National Natural Science Foundation of China (81172216, 81272604). The funder's website is www.nsfc.gov.cn. X.Y. Xiao and D.C. He are the authors who received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Haddad S, 1999, AM J PATHOL, V155, P2057, DOI 10.1016/S0002-9440(10)65524-1; Alowami Salem, 2003, BMC Dermatol, V3, P1, DOI 10.1186/1471-5945-3-1; Barbieri Manuela R, 2011, BMC Res Notes, V4, P494, DOI 10.1186/1756-0500-4-494; Bloor BK, 2001, ORAL ONCOL, V37, P251, DOI 10.1016/S1368-8375(00)00094-4; Celis JE, 1996, J UROLOGY, V155, P2105, DOI 10.1016/S0022-5347(01)66118-4; Chanvorachote P, 2009, J BIOL CHEM, V284, P28476, DOI 10.1074/jbc.M109.050864; Choi DK, 2014, ARCH DERMATOL RES, V306, P489, DOI 10.1007/s00403-014-1453-y; Emberley ED, 2004, BREAST CANCER RES, V6, pR308, DOI 10.1186/bcr791; Emberley ED, 2004, BREAST CANCER RES, V6, P153, DOI 10.1186/bcr816; Kaur J, 2014, INT J CANCER, V134, P1379, DOI 10.1002/ijc.28473; Kesting MR, 2009, ORAL ONCOL, V45, P731, DOI 10.1016/j.oraloncology.2008.11.012; Kulski JK, 2003, J MOL EVOL, V56, P397, DOI 10.1007/s00239-002-2410-5; Lee KC, 2007, J INVEST DERMATOL, V127, P945, DOI 10.1038/sj.jid.5700663; Leygue E, 1996, CANCER RES, V56, P4606; MADSEN P, 1991, J INVEST DERMATOL, V97, P701, DOI 10.1111/1523-1747.ep12484041; Martinsson H, 2005, EXP DERMATOL, V14, P161, DOI 10.1111/j.0906-6705.2005.00239.x; Moubayed N, 2007, J CANCER RES CLIN, V133, P253, DOI 10.1007/s00432-006-0164-y; Nasser MW, 2012, CANCER RES, V72, P604, DOI 10.1158/0008-5472.CAN-11-0669; Ostergaard M, 1997, CANCER RES, V57, P4111; Qian ZL, 2014, MOL CANCER RES, V12, P335, DOI 10.1158/1541-7786.MCR-13-0391; RHEINWALD JG, 1980, CELL, V22, P629, DOI 10.1016/0092-8674(80)90373-6; SCOTT RE, 1988, AM J PATHOL, V133, P374; Tripathi SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011939; Wikramanayake TC, 2014, ADV WOUND CARE, V3, P272, DOI 10.1089/wound.2013.0503; Xu AJ, 2010, LUNG CANCER, V67, P48, DOI 10.1016/j.lungcan.2009.03.005; Zhang H, 2008, THORAX, V63, P352, DOI 10.1136/thx.2007.087015; Zhang H, 2007, LUNG CANCER, V57, P37, DOI 10.1016/j.lungcan.2007.02.020	27	14	14	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128887	10.1371/journal.pone.0128887	http://dx.doi.org/10.1371/journal.pone.0128887			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053695	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300066
J	Selin, C; Stietz, MS; Blanchard, JE; Gehrke, SS; Bernard, S; Hall, DG; Brown, ED; Cardona, ST				Selin, Carrie; Stietz, Maria S.; Blanchard, Jan E.; Gehrke, Sebastian S.; Bernard, Sylvain; Hall, Dennis G.; Brown, Eric D.; Cardona, Silvia T.			A Pipeline for Screening Small Molecules with Growth Inhibitory Activity against Burkholderia cenocepacia	PLOS ONE			English	Article							ANTIBACTERIAL COMPOUNDS; CYSTIC-FIBROSIS; MODEL; SOLUBILITY; CHALLENGES; SURVIVAL; TARGETS; STRAIN; HOST	Infections with the bacteria Burkholderia cepacia complex (Bcc) are very difficult to eradicate in cystic fibrosis patients due the intrinsic resistance of Bcc to most available antibiotics and the emergence of multiple antibiotic resistant strains during antibiotic treatment. In this work, we used a whole-cell based assay to screen a diverse collection of small molecules for growth inhibitors of a relevant strain of Bcc, B. cenocepacia K56-2. The primary screen used bacterial growth in 96-well plate format and identified 206 primary actives among 30,259 compounds. From 100 compounds with no previous record of antibacterial activity secondary screening and data mining selected a total of Bce bioactives that were further analyzed. An experimental pipeline, evaluating in vitro antibacterial and antibiofilm activity, toxicity and in vivo antibacterial activity using C. elegans was used for prioritizing compounds with better chances to be further investigated as potential Bcc antibacterial drugs. This high throughput screen, along with the in vitro and in vivo analysis highlights the utility of this experimental method to quickly identify bioactives as a starting point of antibacterial drug discovery.	[Selin, Carrie; Stietz, Maria S.; Cardona, Silvia T.] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada; [Cardona, Silvia T.] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Bernard, Sylvain; Hall, Dennis G.] Univ Alberta, Dept Chem, Edmonton, AB, Canada; [Blanchard, Jan E.; Gehrke, Sebastian S.; Brown, Eric D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Blanchard, Jan E.; Gehrke, Sebastian S.; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Blanchard, Jan E.; Brown, Eric D.] McMaster Univ, Dept Biochem & Biomed Sci, McMaster High Throughput Screening Lab, Hamilton, ON L8N 3Z5, Canada	University of Manitoba; University of Manitoba; University of Alberta; McMaster University; McMaster University; McMaster University	Cardona, ST (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada.	Silvia.Cardona@umanitoba.ca	Hall, Dennis/E-6865-2016	Hall, Dennis/0000-0001-8555-6400; Cardona, Silvia/0000-0002-0629-8886	Manitoba Health and Research Council (MHRC) [313614]; Canadian Institutes of Health Research (CIHR)-Regional Partnership Program (RPP) [STC 313615]; Cystic Fibrosis Canada (CFC) [STC 315366]; CIHR [MOP 8-81330]; MHRC	Manitoba Health and Research Council (MHRC); Canadian Institutes of Health Research (CIHR)-Regional Partnership Program (RPP)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada (CFC); CIHR(Canadian Institutes of Health Research (CIHR)); MHRC	This work was supported by operating grants from the Manitoba Health and Research Council (MHRC) (313614) and the Canadian Institutes of Health Research (CIHR)-Regional Partnership Program (RPP) (STC 313615), a research grant from Cystic Fibrosis Canada (CFC) to STC (STC 315366) and by an operating grant from the CIHR to EDB (MOP 8-81330). CS holds a postdoctoral fellowship from MHRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananthan S, 2009, TUBERCULOSIS, V89, P334, DOI 10.1016/j.tube.2009.05.008; [Anonymous], 2008, BIOCH CELL BIOL; [Anonymous], 2013, DRUG DISCOVERY; [Anonymous], 2008, BIOCH CELL BIOL, DOI DOI 10.1139/008-903; Avgeri SG, 2009, INT J ANTIMICROB AG, V33, P394, DOI 10.1016/j.ijantimicag.2008.09.010; Balakin KV, 2004, J BIOMOL SCREEN, V9, P22, DOI 10.1177/1087057103260006; Bolton EE, 2010, ANN REP COMP CHEM, V4, P217, DOI 10.1016/S1574-1400(08)00012-1; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; BRENNER S, 1974, GENETICS, V77, P71; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; BURKHOLDER WALTER H., 1950, PHYTOPATH, V40, P115; Coenye T, 2003, J CLIN MICROBIOL, V41, P2797, DOI 10.1128/JCM.41.6.2797-2798.2003; Conery Annie L, 2014, Curr Protoc Chem Biol, V6, P25, DOI 10.1002/9780470559277.ch130160; Conway S P, 2003, Am J Respir Med, V2, P321; Di L, 2006, DRUG DISCOV TODAY, V11, P446, DOI 10.1016/j.drudis.2006.03.004; Ewbank JJ, 2011, DIS MODEL MECH, V4, P300, DOI 10.1242/dmm.006684; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Hafkin J, 2009, CURR OPIN ORGAN TRAN, V14, P483, DOI 10.1097/MOT.0b013e32833062f6; HOLLOWAY BW, 1994, MICROBIOL-UK, V140, P2907, DOI 10.1099/13500872-140-11-2907; Jones AM, 2004, THORAX, V59, P948, DOI 10.1136/thx.2003.017210; Joyce Andrew R., 2008, V416, P433, DOI 10.1007/978-1-59745-321-9_30; Kaplan JB, 2012, J ANTIBIOT, V65, P73, DOI 10.1038/ja.2011.113; Li XM, 2004, CHEM BIOL, V11, P1423, DOI 10.1016/j.chembiol.2004.08.014; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Mahenthiralingam E, 2008, J APPL MICROBIOL, V104, P1539, DOI 10.1111/j.1365-2672.2007.03706.x; Mahenthiralingam E, 2005, NAT REV MICROBIOL, V3, P144, DOI 10.1038/nrmicro1085; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Mc Manus TE, 2003, J INFECTION, V46, P56, DOI 10.1053/jinf.2001.1077; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Oldenburg K, 2005, COMB CHEM HIGH T SCR, V8, P499, DOI 10.2174/1386207054867364; Pathania R, 2008, BIOCHEM CELL BIOL, V86, P111, DOI 10.1139/O08-011; Pathania R, 2009, NAT CHEM BIOL, V5, P849, DOI 10.1038/nchembio.221; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Peeters E, 2009, J ANTIMICROB CHEMOTH, V64, P801, DOI 10.1093/jac/dkp253; Richards JJ, 2009, J MED CHEM, V52, P4582, DOI 10.1021/jm900378s; Sass A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-373; Sperandio D, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-124; Stowe SD, 2012, DRUG CHEM TOXICOL, V35, P310, DOI 10.3109/01480545.2011.614620; Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039; Ulaczyk-Lesanko A, 2007, J COMB CHEM, V9, P695, DOI 10.1021/cc0700344; Valko K, 2013, EXPERT OPIN DRUG DIS, V8, P1225, DOI 10.1517/17460441.2013.815613; Valvano MA, 2005, CURR OPIN MICROBIOL, V8, P99, DOI 10.1016/j.mib.2004.12.002; Vial L, 2011, ENVIRON MICROBIOL, V13, P1, DOI 10.1111/j.1462-2920.2010.02343.x; Wang YL, 2014, NUCLEIC ACIDS RES, V42, pD1075, DOI 10.1093/nar/gkt978; Wikler M, 2008, APPROVED STANDARD, V29, P1; Zhang Chun-Ting, 2008, V416, P391, DOI 10.1007/978-1-59745-321-9_27; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	48	20	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128587	10.1371/journal.pone.0128587	http://dx.doi.org/10.1371/journal.pone.0128587			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053039	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300046
J	Tani, A; Sahin, N; Fujitani, Y; Kato, A; Sato, K; Kimbara, K				Tani, Akio; Sahin, Nurettin; Fujitani, Yoshiko; Kato, Akiko; Sato, Kazuhiro; Kimbara, Kazuhide			Methylobacterium Species Promoting Rice and Barley Growth and Interaction Specificity Revealed with Whole-Cell Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF/MS) Analysis	PLOS ONE			English	Article							SP-NOV.; PHYLLOSPHERE; PINK; RNA; POPULATIONS; INSIGHTS; METHANOL; CANOLA; GENE	Methylobacterium species frequently inhabit plant surfaces and are able to utilize the methanol emitted from plants as carbon and energy sources. As some of the Methylobacterium species are known to promote plant growth, significant attention has been paid to the mechanism of growth promotion and the specificity of plant-microbe interactions. By screening our Methylobacterium isolate collection for the high growth promotion effect in vitro, we selected some candidates for field and pot growth tests for rice and barley, respectively. We found that inoculation resulted in better ripening of rice seeds, and increased the size of barley grains but not the total yield. In addition, using whole-cell matrix-assister laser desorption/ionization-time-of-flight mass spectrometry (MALDI-TOF/MS) analysis, we identified and classified Methylobacterium isolates from Methylobacterium-inoculated rice plants. The inoculated species could not be recovered from the rice plants, and in some cases, the Methylobacterium community structure was affected by the inoculation, but not with predomination of the inoculated species. The isolates from non-inoculated barley of various cultivars grown in the same field fell into just two species. These results suggest that there is a strong selection pressure at the species level of Methylobacterium residing on a given plant species, and that selection of	[Tani, Akio; Fujitani, Yoshiko; Kato, Akiko; Sato, Kazuhiro; Kimbara, Kazuhide] Okayama Univ, Inst Plant Sci & Resources, Okayama, Japan; [Sahin, Nurettin] Mugla Sitki Kocman Univ, Egitim Fak, Mugla, Turkey; [Kimbara, Kazuhide] Shizuoka Univ, Fac Engn, Hamamatsu, Shizuoka 4328561, Japan	Okayama University; Mugla Sitki Kocman University; Shizuoka University	Tani, A (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Okayama, Japan.	atani@okayama-u.ac.jp	SATO, Kazuhiro/B-2504-2011; yoshiko, FUJITANI/Q-8432-2019; SAHIN, Nurettin/A-5068-2009; TANI, Akio/B-2516-2011	SATO, Kazuhiro/0000-0001-8818-5203; yoshiko, FUJITANI/0000-0002-2705-0185; SAHIN, Nurettin/0000-0002-1049-6180; Tani, Akio/0000-0001-7685-9063	Japan Science and Technology Agency [12-024]; Ryobi Teien Memorial Foundation; Japan Society for the Promotion of Science [23688012]; Grants-in-Aid for Scientific Research [15H04476] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ryobi Teien Memorial Foundation(Ryobi Teien Memory Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Science and Technology Agency, Innovative Seeds Grant, grant number 12-024 (http://www.jst.go.jp/chiiki/seeds/); Research Award from the Ryobi Teien Memorial Foundation (http://www.ryobi.gr.jp/teienzaidan/) (no grant number is available); and Grants-in-Aid for Scientific Research, Japan Society for the Promotion of Science, grant number 23688012 (http://www.jsps.go.jp/j-grantsinaid/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Babalola OO, 2010, BIOTECHNOL LETT, V32, P1559, DOI 10.1007/s10529-010-0347-0; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; Fall R, 1996, TRENDS PLANT SCI, V1, P296, DOI 10.1016/S1360-1385(96)88175-0; Hornschuh M, 2006, NATURWISSENSCHAFTEN, V93, P480, DOI 10.1007/s00114-006-0137-7; Jayashree S, 2011, ARCH MICROBIOL, V193, P543, DOI 10.1007/s00203-011-0691-z; Jourand P, 2004, INT J SYST EVOL MICR, V54, P2269, DOI 10.1099/ijs.0.02902-0; Kaga H, 2009, MICROBES ENVIRON, V24, P154, DOI 10.1264/jsme2.ME09113; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Knief C, 2008, APPL ENVIRON MICROB, V74, P2218, DOI 10.1128/AEM.02532-07; Knief C, 2012, ISME J, V6, P1378, DOI 10.1038/ismej.2011.192; Knief C, 2010, ISME J, V4, P719, DOI 10.1038/ismej.2010.9; Koenig RL, 2002, J BACTERIOL, V184, P1832, DOI 10.1128/JB.184.7.1832-1842.2002; Lacava PT, 2008, PESQUI AGROPECU BRAS, V43, P521, DOI 10.1590/S0100-204X2008000400011; Lidstrom ME, 2002, J BACTERIOL, V184, P1818, DOI 10.1128/JB.184.7.1818.2002; Madhaiyan M, 2009, INT J SYST EVOL MICR, V59, P22, DOI 10.1099/ijs.0.001693-0; Madhaiyan M, 2007, J MICROBIOL BIOTECHN, V17, P1645; Madhaiyan M, 2007, PLANTA, V226, P867, DOI 10.1007/s00425-007-0532-0; Mano H, 2008, MICROBES ENVIRON, V23, P109, DOI 10.1264/jsme2.23.109; Murray PR, 2010, CLIN MICROBIOL INFEC, V16, P1626, DOI 10.1111/j.1469-0691.2010.03364.x; Rastogi G, 2013, FEMS MICROBIOL LETT, V348, P1, DOI 10.1111/1574-6968.12225; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Roeckel P, 1997, TRANSGENIC RES, V6, P133, DOI 10.1023/A:1018425720949; Ryu J, 2006, J MICROBIOL BIOTECHN, V16, P1622; Schwar P., 2011, BARLEY PRODUCTION IM, P478, DOI DOI 10.1002/9780470958636.CH15; Senthilkumar M, 2009, MICROBIOL RES, V164, P92, DOI 10.1016/j.micres.2006.10.007; Shinohara H, 2011, FOLIA MICROBIOL, V56, P505, DOI 10.1007/s12223-011-0084-3; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Stackebrandt E, 2006, MICROBIOLOGY TODAY, V06, P152, DOI DOI 10.1038/MSB.2013.22; Tani A, 2012, INT J SYST EVOL MICR, V62, P2602, DOI 10.1099/ijs.0.037713-0; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040784; Tani A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033800; Xu FF, 2014, MICROBES ENVIRON, V29, P388, DOI 10.1264/jsme2.ME14038	34	29	33	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129509	10.1371/journal.pone.0129509	http://dx.doi.org/10.1371/journal.pone.0129509			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053875	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300133
J	Laass, MW; Rober, N; Range, U; Noss, L; Roggenbuck, D; Conrad, K				Laass, Martin W.; Roeber, Nadja; Range, Ursula; Noss, Lydia; Roggenbuck, Dirk; Conrad, Karsten			Loss and Gain of Tolerance to Pancreatic Glycoprotein 2 in Celiac Disease	PLOS ONE			English	Article							GRANULE MEMBRANE GLYCOPROTEIN; INFLAMMATORY BOWEL DISEASES; GLUTEN-FREE DIET; CROHNS-DISEASE; ANTIBODIES; GP2; AUTOANTIBODIES; PROTEIN; DIAGNOSIS; CLASSIFICATION	Background Autoantibodies against pancreatic secretory-granule membrane glycoprotein 2 (GP2) have been demonstrated in patients with Crohn's disease but recently also with celiac disease (CD). Both entities are characterized by intestinal barrier impairment with increased gut permeability. Pathophysiological hallmark of CD is a permanent loss of tolerance to alimentary gliadin and a transient loss of tolerance to the autoantigen human tissue transglutaminase (tTG). Therefore, we explored the behavior of loss of tolerance to GP2 reported in CD. Methods We assessed prevalences and levels of autoantibodies against GP2, CD-specific antibodies to endomysial antigens and tTG as well as Crohn's disease-specific anti-Saccharomyces cerevisiae antibodies in sera of 174 patients with active CD, 84 patients under glutenfree diet (GFD) and 129 controls. Furthermore, we looked for an association between anti-GP2 antibody positivity and degree of mucosal damage in CD. Results We found significantly elevated anti-GP2 IgA positivity in active CD patients (19.5%) compared to CD patients under GFD (0.0%) and controls (5.4%, p < 0.001, respectively). Anti-GP2 IgA levels correlated significantly with CD-specific antibodies (p < 0.001). Anti-GP2 autoantibody positivity disappeared under GFD similarly to CD-specific autoantibodies against tTG and endomysial antigens. For the first time, IgA antibody levels to GP2 are demonstrated to be associated with degree of villous atrophy according to Marsh classification. Conclusions Anti-GP2 IgA seems to be associated with disease activity in a distinct subgroup of patients with CD. The observed loss of tolerance to GP2 in a subset of patients with CD is transient and disappears under GFD.	[Laass, Martin W.; Noss, Lydia] Tech Univ Dresden, Med Fac Carl Gustav Carus, Childrens Hosp, D-01307 Dresden, Germany; [Roeber, Nadja; Conrad, Karsten] Tech Univ Dresden, Inst Immunol, D-01307 Dresden, Germany; [Range, Ursula] Tech Univ Dresden, Inst Med Informat & Biometry, D-01307 Dresden, Germany; [Roggenbuck, Dirk] GA Gener Assays GmbH, D-15827 Dahlewitz Berlin, Germany; [Roggenbuck, Dirk] Brandenburg Univ Technol Cottbus Senftenberg, Fac Sci, D-01968 Senftenberg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Brandenburg University of Technology Cottbus	Laass, MW (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Childrens Hosp, D-01307 Dresden, Germany.	martin.laass@uniklinikum-dresden.de		Roggenbuck, Dirk/0000-0002-6861-6827; Laass, Martin/0000-0003-3670-3640	GA Generic Assays GmbH	GA Generic Assays GmbH	GA Generic Assays GmbH provided support in the form of salary for author DR but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashorn S, 2009, J CLIN IMMUNOL, V29, P190, DOI 10.1007/s10875-008-9255-7; Bogdanos DP, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-102; Bogdanos DP, 2011, AUTOIMMUN REV, V11, P143, DOI 10.1016/j.autrev.2011.09.004; Bonaci-Nikolic B, 2012, CLIN CHIM ACTA, V413, P822, DOI 10.1016/j.cca.2012.01.005; Bonneau J, 2015, AUTOIMMUN REV, V14, P231, DOI 10.1016/j.autrev.2014.11.004; Conrad K, 2002, EUR J GASTROEN HEPAT, V14, P129, DOI 10.1097/00042737-200202000-00006; Conrad K, 2014, AUTOIMMUN REV, V13, P463, DOI 10.1016/j.autrev.2014.01.028; Conrad K, 2012, CLIN CHEM LAB MED, V50, P337, DOI [10.1515/CCLM.2011.760, 10.1515/cclm.2011.760]; De Beeck KO, 2012, GUT, V61, P162, DOI 10.1136/gut.2010.233148; Evans KE, 2010, DIGEST DIS SCI, V55, P2999, DOI 10.1007/s10620-010-1261-y; Festen EAM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001283; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gross S, 2014, J GASTROINTEST LIVER, V23, P127; Hase K, 2009, NATURE, V462, P226, DOI 10.1038/nature08529; Holzl MA, 2011, CELL IMMUNOL, V267, P88, DOI 10.1016/j.cellimm.2010.12.001; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Juste C, 2014, GUT, V63, P1566, DOI 10.1136/gutjnl-2012-303786; Komorowski L, 2013, J CROHNS COLITIS, V7, P780, DOI 10.1016/j.crohns.2012.10.011; Laass MW, 2014, AUTOIMMUN REV, V13, P467, DOI 10.1016/j.autrev.2014.01.029; Mallant-Hent RC, 2006, EUR J GASTROEN HEPAT, V18, P75, DOI 10.1097/00042737-200601000-00013; Mitsuyama K, 2014, J GASTROENTEROL, V49, P683, DOI 10.1007/s00535-013-0916-9; Ohno H, 2010, GUT MICROBES, V1, P407, DOI 10.4161/gmic.1.6.14078; Oxford EC, 2013, AM J GASTROENTEROL, V108, P1123, DOI 10.1038/ajg.2013.20; Pavlidis P, 2011, CLIN CHIM ACTA, V412, P1163, DOI 10.1016/j.cca.2011.02.005; Rieder F, 2013, GASTROENTEROLOGY, V144, pS617; Roggenbuck D, 2009, GUT, V58, P1620, DOI 10.1136/gut.2008.162495; Roggenbuck D., 2009, PATHOGENESIS THERAPY, P449; Roggenbuck D, 2015, CLIN CHEM LAB MED, V53, P1349, DOI 10.1515/cclm-2014-0238; Roggenbuck D, 2015, CLIN CHIM ACTA, V442, P82, DOI 10.1016/j.cca.2015.01.018; Roggenbuck D, 2014, CLIN CHEM LAB MED, V52, P483, DOI 10.1515/cclm-2013-0801; Roggenbuck Dirk, 2013, J Crohns Colitis, V7, pe273, DOI 10.1016/j.crohns.2012.12.013; Roggenbuck D, 2013, ADV CLIN CHEM, V60, P187, DOI 10.1016/B978-0-12-407681-5.00006-4; Roggenbuck D, 2013, J PEDIATR GASTR NUTR, V56, pE5, DOI 10.1097/MPG.0b013e318275fa77; Roggenbuck D, 2012, GUT, V61, P164, DOI 10.1136/gut.2010.237214; Roggenbuck D, 2011, CLIN CHIM ACTA, V412, P718, DOI 10.1016/j.cca.2010.12.029; RONZIO RA, 1978, BIOCHIM BIOPHYS ACTA, V508, P65, DOI 10.1016/0005-2736(78)90189-X; Schierack P, 2015, GUT, V64, DOI 10.1136/gutjnl-2014-307854; Somma V, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/683824; Suzuki H, 2008, GASTROENTEROLOGY, V135, P917, DOI 10.1053/j.gastro.2008.05.037; Terahara K, 2008, J IMMUNOL, V180, P7840, DOI 10.4049/jimmunol.180.12.7840; Watanabe C, 2014, J GASTROENTEROL, V49, P825, DOI 10.1007/s00535-013-0838-6; Werner Lael, 2013, J Crohns Colitis, V7, pe604, DOI 10.1016/j.crohns.2013.06.017; Werner Lael, 2013, J Crohns Colitis, V7, pe522, DOI 10.1016/j.crohns.2013.03.009; Werner L, 2012, J IMMUNOL, V189, P2774, DOI 10.4049/jimmunol.1103190; Yu S, 2004, J BIOL CHEM, V279, P50274, DOI 10.1074/jbc.M410599200; Yu S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-58	46	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128104	10.1371/journal.pone.0128104	http://dx.doi.org/10.1371/journal.pone.0128104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047356	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200040
J	Pedersen, L; Wogensen, L; Marcussen, N; Cecchi, CR; Dalsgaard, T; Dagnaes-Hansen, F				Pedersen, Lea; Wogensen, Lise; Marcussen, Niels; Cecchi, Claudia R.; Dalsgaard, Trine; Dagnaes-Hansen, Frederik			Restoration of Haemoglobin Level Using Hydrodynamic Gene Therapy with Erythropoietin Does Not Alleviate the Disease Progression in an Anaemic Mouse Model for TGF beta 1-Induced Chronic Kidney Disease	PLOS ONE			English	Article							LONG-TERM; EXTRACELLULAR-MATRIX; EXPRESSION; NORMALIZATION; PROTECTS; HORMONE; INJURY; DARBEPOETIN; GROWTH; BLOOD	Erythropoietin, Epo, is a 30.4 kDa glycoprotein hormone produced primarily by the fetal liver and the adult kidney. Epo exerts its haematopoietic effects by stimulating the proliferation and differentiation of erythrocytes with subsequent improved tissue oxygenation. Epo receptors are furthermore expressed in non-haematopoietic tissue and today, Epo is recognised as a cytokine with many pleiotropic effects. We hypothesize that hydrodynamic gene therapy with Epo can restore haemoglobin levels in anaemic transgenic mice and that this will attenuate the extracellular matrix accumulation in the kidneys. The experiment is conducted by hydrodynamic gene transfer of a plasmid encoding murine Epo in a transgenic mouse model that overexpresses TGF-beta 1 locally in the kidneys. This model develops anaemia due to chronic kidney disease characterised by thickening of the glomerular basement membrane, deposition of mesangial matrix and mild interstitial fibrosis. A group of age matched wildtype littermates are treated accordingly. After a single hydrodynamic administration of plasmid DNA containing murine EPO gene, sustained high haemoglobin levels are observed in both transgenic and wildtype mice from 7.5 +/- 0.6 mmol/L to 9.4 +/- 1.2 mmol/L and 10.7 +/- 0.3 mmol/L to 15.5 +/- 0.5 mmol/L, respectively. We did not observe any effects in the thickness of glomerular or tubular basement membrane, on the expression of different collagen types in the kidneys or in kidney function after prolonged treatment with Epo. Thus, Epo treatment in this model of chronic kidney disease normalises haemoglobin levels but has no effect on kidney fibrosis or function.	[Pedersen, Lea; Wogensen, Lise] Aarhus Univ Hosp, Inst Clin Med, Res Lab Biochem Pathol, DK-8000 Aarhus, Denmark; [Marcussen, Niels] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Cecchi, Claudia R.; Dalsgaard, Trine; Dagnaes-Hansen, Frederik] Aarhus Univ, Dept Biomed, Aarhus, Denmark	Aarhus University; University of Southern Denmark; Odense University Hospital; Aarhus University	Pedersen, L (corresponding author), Aarhus Univ Hosp, Inst Clin Med, Res Lab Biochem Pathol, DK-8000 Aarhus, Denmark.	lea.pedersen@ki.au.dk	Cecchi, Claudia R./H-7280-2012	Cecchi, Claudia R./0000-0001-8612-9216; Dagnaes-Hansen, Frederik/0000-0002-6622-0853	Aase og Ejnar Danielsens Fond [10881]; Fonden til Laegevidenskabens Fremme [12091]	Aase og Ejnar Danielsens Fond; Fonden til Laegevidenskabens Fremme	This project is funded by "Aase og Ejnar Danielsens Fond" (URL: http://www.danielsensfond.dk/Fonden_st%C3%B8tter/L%C3%A6gevidenskabelig_forskning.aspx) (Grant nr. 10881) and "Fonden til Laegevidenskabens Fremme" (URL: http://www.apmollerfonde.dk/ansoegning/laegefonden.aspx) (Grant nr. 12091). Both of these funds have financially supported the project and made it possible to purchase material and reagents. The funding is based on a project description composed by the 1st author (LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellizzi V, 1998, NEPHROL DIAL TRANSPL, V13, P2210, DOI 10.1093/ndt/13.9.2210; Chai Q, 2003, HISTOCHEM CELL BIOL, V119, P267, DOI 10.1007/s00418-003-0513-8; Dagnaes-Hansen F, 2002, J MOL MED-JMM, V80, P665, DOI 10.1007/s00109-002-0371-1; DANIELSEN CC, 1988, J BIOMECH, V21, P207, DOI 10.1016/0021-9290(88)90171-6; Diehl KH, 2001, J APPL TOXICOL, V21, P15, DOI 10.1002/jat.727; ESCHBACH JW, 1995, NEPHROL DIAL TRANSPL, V10, P96, DOI 10.1093/ndt/10.supp2.96; Fisher JW, 1996, BRIT J HAEMATOL, V95, P27, DOI 10.1046/j.1365-2141.1996.d01-1864.x; Fliser D, 2007, SEMIN HEMATOL, V44, P212, DOI 10.1053/j.seminhematol.2007.04.008; Frenay ARS, 2012, J RENIN-ANGIO-ALDO S, V13, P232, DOI 10.1177/1470320311432186; FRIED W, 1995, ANNU REV NUTR, V15, P353, DOI 10.1146/annurev.nu.15.070195.002033; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Gong H, 2004, KIDNEY INT, V66, P683, DOI 10.1111/j.1523-1755.2004.00791.x; Gurtler A, 2013, ANAL BIOCHEM, V433, P105, DOI 10.1016/j.ab.2012.10.010; GUNDERSEN HJG, 1978, J MICROSC-OXFORD, V113, P27, DOI 10.1111/j.1365-2818.1978.tb00091.x; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Hojman P, 2007, GENE THER, V14, P950, DOI 10.1038/sj.gt.3302951; Imamura R, 2007, TRANSPLANTATION, V83, P1371, DOI 10.1097/01.tp.0000264200.38926.70; JACOBS C, 1995, NEPHROL DIAL TRANSPL, V10, P43, DOI 10.1093/ndt/10.supp2.43; Jakobsen JE, 2011, TRANSGENIC RES, V20, P533, DOI 10.1007/s11248-010-9438-x; Johnson DW, 2006, KIDNEY INT, V69, P1806, DOI 10.1038/sj.ki.5000356; Kameda S, 2003, BIOCHEM BIOPH RES CO, V309, P929, DOI 10.1016/j.bbrc.2003.08.087; Kellenberger T, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.181; Krag S, 2005, KIDNEY INT, V68, P2651, DOI 10.1111/j.1523-1755.2005.00737.x; Krag S, 2000, LAB INVEST, V80, P1855, DOI 10.1038/labinvest.3780196; Krag S, 2007, NEPHROL DIAL TRANSPL, V22, P2485, DOI 10.1093/ndt/gfm229; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Loeffler I, 2013, AM J PHYSIOL-RENAL, V305, pF911, DOI 10.1152/ajprenal.00643.2012; Lombardero M, 2011, PATHOBIOLOGY, V78, P41, DOI 10.1159/000322975; Maruyama H, 2002, HUM GENE THER, V13, P455, DOI 10.1089/10430340252792585; Maruyama H, 2002, J GENE MED, V4, P333, DOI 10.1002/jgm.281; Miao CH, 2001, MOL THER, V3, P947, DOI 10.1006/mthe.2001.0333; Miner JH, 1999, KIDNEY INT, V56, P2016, DOI 10.1046/j.1523-1755.1999.00785.x; Nangaku M, 2013, KIDNEY INT, V84, P427, DOI 10.1038/ki.2013.140; Nemoto T, 2001, KIDNEY INT, V59, P246, DOI 10.1046/j.1523-1755.2001.00485.x; Sharpies EJ, 2006, SEMIN NEPHROL, V26, P325, DOI 10.1016/j.semnephrol.2006.05.010; Solling C, 2011, ACTA ANAESTH SCAND, V55, P185, DOI 10.1111/j.1399-6576.2010.02369.x; Sondergaard M, 2003, AM J PHYSIOL-ENDOC M, V285, pE427, DOI 10.1152/ajpendo.00573.2002; Tanaka T, 2012, EXP CELL RES, V318, P1068, DOI 10.1016/j.yexcr.2012.02.035; Teixeira AM, 2010, RENAL FAILURE, V32, P1073, DOI 10.3109/0886022X.2010.509897; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; Westenfelder C, 2002, EXP NEPHROL, V10, P294, DOI 10.1159/000065304; Wogensen L, 1999, DIABETES, V48, P182, DOI 10.2337/diabetes.48.1.182; Zhang G, 2000, GENE THER, V7, P1344, DOI 10.1038/sj.gt.3301229; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734	44	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128367	10.1371/journal.pone.0128367	http://dx.doi.org/10.1371/journal.pone.0128367			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046536	Green Submitted, gold, Green Published			2022-12-26	WOS:000355652200064
J	Ribbons, KA; McElduff, P; Boz, C; Trojano, M; Izquierdo, G; Duquette, P; Girard, M; Grand'Maison, F; Hupperts, R; Grammond, P; Oreja-Guevara, C; Petersen, T; Bergamaschi, R; Giuliani, G; Barnett, M; van Pesch, V; Amato, MP; Iuliano, G; Fiol, M; Slee, M; Verheul, F; Cristiano, E; Fernandez-Bolanos, R; Saladino, ML; Rio, ME; Cabrera-Gomez, J; Butzkueven, H; van Munster, E; Den Braber-Moerland, L; La Spitaleri, D; Lugaresi, A; Shaygannejad, V; Gray, O; Deri, N; Alroughani, R; Lechner-Scott, J				Ribbons, Karen Ann; McElduff, Patrick; Boz, Cavit; Trojano, Maria; Izquierdo, Guillermo; Duquette, Pierre; Girard, Marc; Grand'Maison, Francois; Hupperts, Raymond; Grammond, Pierre; Oreja-Guevara, Celia; Petersen, Thor; Bergamaschi, Roberto; Giuliani, Giorgio; Barnett, Michael; van Pesch, Vincent; Amato, Maria-Pia; Iuliano, Gerardo; Fiol, Marcela; Slee, Mark; Verheul, Freek; Cristiano, Edgardo; Fernandez-Bolanos, Ricardo; Saladino, Maria-Laura; Rio, Maria Edite; Cabrera-Gomez, Jose; Butzkueven, Helmut; van Munster, Erik; Den Braber-Moerland, Leontien; La Spitaleri, Daniele; Lugaresi, Alessandra; Shaygannejad, Vahid; Gray, Orla; Deri, Norma; Alroughani, Raed; Lechner-Scott, Jeannette			Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; NATURAL-HISTORY; BRITISH-COLUMBIA; AGE; DETERMINANT; PHASE	Background Multiple Sclerosis is more common in women than men and females have more relapses than men. In a large international cohort we have evaluated the effect of gender on disability accumulation and disease progression to determine if male MS patients have a worse clinical outcome than females. Methods Using the MSBase Registry, data from 15,826 MS patients from 25 countries was analysed. Changes in the severity of MS (EDSS) were compared between sexes using a repeated measures analysis in generalised linear mixed models. Kaplan-Meier analysis was used to test for sex difference in the time to reach EDSS milestones 3 and 6 and the secondary progressive MS. Results In relapse onset MS patients (n = 14,453), males progressed significantly faster in their EDSS than females (0.133 vs 0.112 per year, P<0.001,). Females had a reduced risk of secondary progressive MS (HR (95% CI) = 0.77 (0.67 to 0.90) P = 0.001). In primary progressive MS (n = 1,373), there was a significant increase in EDSS over time in males and females (P<0.001) but there was no significant sex effect on the annualized rate of EDSS change. Conclusion Among registrants of MSBase, male relapse-onset patients accumulate disability faster than female patients. In contrast, the rate of disability accumulation between male and female patients with primary progressive MS is similar.	[Ribbons, Karen Ann; Lechner-Scott, Jeannette] John Hunter Hosp, Newcastle, NSW, Australia; [McElduff, Patrick] Univ Newcastle, Newcastle, NSW 2300, Australia; [Boz, Cavit] Karadeniz Tech Univ, Trabzon, Turkey; [Trojano, Maria] Univ Bari, Bari, Italy; [Izquierdo, Guillermo] Univ Hosp, Seville, Spain; [Duquette, Pierre; Girard, Marc] Hop Notre Dame De Bon Secours, Montreal, PQ, Canada; [Grand'Maison, Francois] Neuro Rive Sud, Quebec City, PQ, Canada; [Hupperts, Raymond] Maaslandziekenhuis, Sittard, Netherlands; [Grammond, Pierre] Hotel Dieu de Levis, Quebec City, PQ, Canada; [Oreja-Guevara, Celia] Univ Hosp La Paz, IdiPAZ, Madrid, Spain; [Petersen, Thor] Kommunehosp, Aarhus C, Denmark; [Bergamaschi, Roberto] Neurol Inst IRCCS Mondino, Pavia, Italy; [Giuliani, Giorgio] Osped Macerata, Macerata, Italy; [Barnett, Michael] Brain & Mind Res Inst, Sydney, NSW, Australia; [van Pesch, Vincent] Clin Univ St Luc, B-1200 Brussels, Belgium; [Amato, Maria-Pia] Univ Florence, Dept Neurol, Florence, Italy; [Iuliano, Gerardo] Osped Riuniti Salerno, Salerno, Italy; [Fiol, Marcela] FLENI, Buenos Aires, DF, Argentina; [Slee, Mark] Flinders Med Ctr, Adelaide, SA, Australia; [Verheul, Freek] Groen Hart Ziekenhuis, Gouda, Netherlands; [Cristiano, Edgardo] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Fernandez-Bolanos, Ricardo] Hosp Univ Virgen de Valme, Seville, Spain; [Saladino, Maria-Laura] Craigavon Area Hosp, Craigavon, North Ireland; [Rio, Maria Edite] Hosp Sao Joao, Porto, Portugal; [Cabrera-Gomez, Jose] Int Ctr Neurol Restorat, Multiple Sclerosis Clin, Havana, Cuba; [Butzkueven, Helmut] Royal Melbourne Hosp, Melbourne, Vic, Australia; [van Munster, Erik] Jeroen Bosch Ziekenhuis, Den Bosch, Netherlands; [Den Braber-Moerland, Leontien] Francicus Ziekenhuis, Roosendaal, Netherlands; [La Spitaleri, Daniele] AORN San Giuseppe Moscati, Avellino, Italy; [Lugaresi, Alessandra] Univ G DAnnunzio, Dept Neurosci & Imaging, Chieti, Italy; [Shaygannejad, Vahid] Isfahan Univ Med Sci, Al Zahara Hop, Esfahan, Iran; [Gray, Orla] Craigavon Area Hosp, Armagh, North Ireland; [Deri, Norma] Hosp Fernandez, Buenos Aires, Argentina; [Alroughani, Raed] Amiri Hosp, Qurtoba, Kuwait	John Hunter Hospital; University of Newcastle; Karadeniz Technical University; Universita degli Studi di Bari Aldo Moro; Universite de Montreal; Laval University; Hospital Universitario La Paz; Aarhus University; IRCCS Fondazione Casimiro Mondino; University of Sydney; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Florence; Flinders Medical Centre; Hospital Italiano de Buenos Aires; University of Buenos Aires; Hospital Valme; Sao Joao Hospital; Royal Melbourne Hospital; Jeroen Bosch Ziekenhuis; San Giuseppe Moscati Hospital; G d'Annunzio University of Chieti-Pescara; Isfahan University Medical Science; University of Buenos Aires	Ribbons, KA (corresponding author), John Hunter Hosp, Newcastle, NSW, Australia.	Karen.Ribbons@hnehealth.nsw.gov.au	Lugaresi, Alessandra/C-7743-2012; Oreja-Guevara, Celia/N-5151-2019; van Pesch, Vincent/AAK-9506-2020; BOZ, Cavit/V-5127-2017; Shaygannejad, Vahid/N-3495-2018; amato, Maria Pia/AAL-5998-2020; Slee, Mark/J-4731-2015; Amato, Maria Pia/AAC-5940-2022; Boz, Cavit/AAR-2268-2020	Lugaresi, Alessandra/0000-0003-2902-5589; Oreja-Guevara, Celia/0000-0002-9221-5716; Shaygannejad, Vahid/0000-0002-6226-0161; amato, Maria Pia/0000-0003-3325-3760; Slee, Mark/0000-0003-4323-2453; Boz, Cavit/0000-0003-0956-3304; Lechner-Scott, Jeannette/0000-0002-3850-447X; Butzkueven, Helmut/0000-0003-3940-8727; van Pesch, Vincent/0000-0003-2885-9004; Petersen, Thor/0000-0001-5633-2600; Shaygannejad, Vahid/0000-0002-9732-4153; Trojano, Maria/0000-0002-6329-8946	Merck Serono	Merck Serono(Merck & Company)	Merck Serono supports iMED which is the software program used by MSBASE for data acquisition at each collaborating centre and does not impact on the studies derived from data collected by this program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bove R, 2013, CLIN IMMUNOL, V149, P201, DOI 10.1016/j.clim.2013.03.005; Bove R, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-73; Bove RM, 2012, MULT SCLER J, V18, P1472, DOI 10.1177/1352458512438236; Butzkueven H, 2006, MULT SCLER, V12, P769, DOI 10.1177/1352458506070775; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Cossburn M, 2012, MULT SCLER J, V18, P45, DOI 10.1177/1352458511417479; Cottrell DA, 1999, BRAIN, V122, P641, DOI 10.1093/brain/122.4.641; Cottrell DA, 1999, BRAIN, V122, P625, DOI 10.1093/brain/122.4.625; Debouverie M, 2008, EUR J NEUROL, V15, P916, DOI 10.1111/j.1468-1331.2008.02241.x; Debouverie M, 2009, J NEUROL SCI, V286, P14, DOI 10.1016/j.jns.2009.07.012; Ebers GC, 2004, MULT SCLER J, V10, pS8, DOI 10.1191/1352458504ms1025oa; Gholipour T, 2011, NEUROLOGY, V76, P1996, DOI 10.1212/WNL.0b013e31821e559d; Harding K, 2014, JOURNAL OF NEUROL NE; Kalincik T, 2013, BRAIN, V136, P3609, DOI 10.1093/brain/awt281; Katz Sand Ilana B, 2013, Continuum (Minneap Minn), V19, P922, DOI 10.1212/01.CON.0000433290.15468.21; Khaleeli Z, 2008, ANN NEUROL, V63, P790, DOI 10.1002/ana.21375; Koch M, 2008, MULT SCLER J, V14, P799, DOI 10.1177/1352458508089361; Koch M, 2007, J NEUROL SCI, V255, P35, DOI 10.1016/j.jns.2007.01.067; Koch M, 2010, J NEUROL NEUROSUR PS, V81, P1039, DOI 10.1136/jnnp.2010.208173; Koch M, 2009, NEUROLOGY, V73, P1996, DOI 10.1212/WNL.0b013e3181c5b47f; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Ramagopalan SV, 2010, EUR J NEUROL, V17, P634, DOI 10.1111/j.1468-1331.2009.02850.x; Rice GPA, 2002, MULT SCLER J, V8, P81, DOI 10.1177/135245850200800116; Scalfari A, 2010, BRAIN, V133, P1914, DOI 10.1093/brain/awq118; Shirani A, 2012, MULT SCLER J, V18, P442, DOI 10.1177/1352458511422097; Spelman T, 2013, MULT SCLER J, V19, P38; Stankoff B, 2007, NEUROLOGY, V68, P779, DOI 10.1212/01.wnl.0000256732.36565.4a; Tremlett H, 2005, NEUROLOGY, V65, P1919, DOI 10.1212/01.wnl.0000188880.17038.1d; Tremlett H, 2006, NEUROLOGY, V66, P172, DOI 10.1212/01.wnl.0000194259.90286.fe; Tremlett H, 2009, NEUROLOGY, V73, P1616, DOI 10.1212/WNL.0b013e3181c1e44f; Tremlett H, 2008, MULT SCLER J, V14, P314, DOI 10.1177/1352458507084264; Tremlett H, 2009, J NEUROL, V256, P374, DOI 10.1007/s00415-009-0039-7; Vukusic S, 2003, J NEUROL SCI, V206, P135, DOI 10.1016/S0022-510X(02)00426-4	37	93	94	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0122686	10.1371/journal.pone.0122686	http://dx.doi.org/10.1371/journal.pone.0122686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046348	gold, Green Published			2022-12-26	WOS:000355652200003
J	Szmolka, A; Wiener, Z; Matulova, ME; Varmuzova, K; Rychlik, I				Szmolka, Ama; Wiener, Zoltan; Matulova, Marta Elsheimer; Varmuzova, Karolina; Rychlik, Ivan			Gene Expression Profiles of Chicken Embryo Fibroblasts in Response to Salmonella Enteritidis Infection	PLOS ONE			English	Article							IMMUNE-RESPONSE; ENTERICA; TYPHIMURIUM; RESISTANT; CELLS	The response of chicken to non-typhoidal Salmonella infection is becoming well characterised but the role of particular cell types in this response is still far from being understood. Therefore, in this study we characterised the response of chicken embryo fibroblasts (CEFs) to infection with two different S. Enteritidis strains by microarray analysis. The expression of chicken genes identified as significantly up-or down-regulated (>= 3-fold) by microarray analysis was verified by real-time PCR followed by functional classification of the genes and prediction of interactions between the proteins using Gene Ontology and STRING Database. Finally the expression of the newly identified genes was tested in HD11 macrophages and in vivo in chickens. Altogether 19 genes were induced in CEFs after S. Enteritidis infection. Twelve of them were also induced in HD11 macrophages and thirteen in the caecum of orally infected chickens. The majority of these genes were assigned different functions in the immune response, however five of them (LOC101750351, K123, BU460569, MOBKL2C and G0S2) have not been associated with the response of chicken to Salmonella infection so far. K123 and G0S2 were the only 'non-immune' genes inducible by S. Enteritidis in fibroblasts, HD11 macrophages and in the caecum after oral infection. The function of K123 is unknown but G0S2 is involved in lipid metabolism and in beta-oxidation of fatty acids in mitochondria.	[Szmolka, Ama] Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary; [Wiener, Zoltan] Semmelweis Univ, Dept Genet Cell & Immunobiol, H-1085 Budapest, Hungary; [Matulova, Marta Elsheimer; Varmuzova, Karolina; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic	Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Hungarian Veterinary Medical Research Institute; Semmelweis University; Czech Veterinary Research Institute	Szmolka, A (corresponding author), Hungarian Acad Sci, Agr Res Ctr, Vet Med Res Inst, Budapest, Hungary.	szmolka.annamaria@agrar.mta.hu	, Ivan/GPS-9674-2022; Szmolka, Ama/Z-4598-2019	, Ivan/0000-0001-7995-6483; 	European Network of Excellence MedVetNet (EU) [5061022]; EU [265877]; Czech Ministry of Education [CZ.1.05/2.1.00/01.0006-ED0006/01/01]; Hungarian Academy of Sciences	European Network of Excellence MedVetNet (EU); EU(European Commission); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This study was supported by the European Network of Excellence MedVetNet (EU FP6 NoE Contract no. 5061022) and by the EU FP7 Collaborative Project PROMISE (Grant agreement no. 265877). Czech partners were supported by the AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education. A. Szmolka is holder of a Bolyai Janos Stipend from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Burlak C, 2006, MOL CELL PROTEOMICS, V5, P620, DOI 10.1074/mcp.M500336-MCP200; Cano DA, 2001, INFECT IMMUN, V69, P6463, DOI 10.1128/IAI.69.10.6463-6474.2001; Chausse AM, 2014, VET IMMUNOL IMMUNOP, V159, P16, DOI 10.1016/j.vetimm.2014.03.001; Chow A, 2010, INT J CANCER, V126, P2079, DOI 10.1002/ijc.24878; Correnti C, 2011, STRUCTURE, V19, P1796, DOI 10.1016/j.str.2011.09.019; Coudevylle N, 2011, BIOCHEMISTRY-US, V50, P9192, DOI 10.1021/bi201115q; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; EFSA, 2006, EFSA J, V81, P1; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fritsche G, 2003, J IMMUNOL, V171, P1994, DOI 10.4049/jimmunol.171.4.1994; Gewirtz AT, 1999, INFECT IMMUN, V67, P608, DOI 10.1128/IAI.67.2.608-617.1999; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; Haunshi S, 2014, POULTRY SCI, V93, P550, DOI 10.3382/ps.2013-03597; Heckmann BL, 2013, BBA-MOL CELL BIOL L, V1831, P276, DOI 10.1016/j.bbalip.2012.09.016; Higgs R, 2006, INFECT IMMUN, V74, P1692, DOI 10.1128/IAI.74.3.1692-1698.2006; Imre A, 2011, FEMS MICROBIOL LETT, V317, P52, DOI 10.1111/j.1574-6968.2011.02210.x; Keates AC, 2001, J BIOL CHEM, V276, P43713, DOI 10.1074/jbc.M107838200; KUNSCH C, 1993, MOL CELL BIOL, V13, P6137, DOI 10.1128/MCB.13.10.6137; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048101; METHNER U, 1995, J VET MED B, V42, P459, DOI 10.1111/j.1439-0450.1995.tb00737.x; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Portillo FGD, 2008, CURR OPIN MICROBIOL, V11, P46, DOI 10.1016/j.mib.2008.01.001; Schokker D, 2010, DEV COMP IMMUNOL, V34, P1090, DOI 10.1016/j.dci.2010.05.013; SUN SC, 1993, SCIENCE, V259, P1912, DOI 10.1126/science.8096091; Swaggerty CL, 2004, IMMUNOLOGY, V113, P139, DOI 10.1111/j.1365-2567.2004.01939.x; Van Immerseel F, 2002, DEV COMP IMMUNOL, V26, P355, DOI 10.1016/S0145-305X(01)00084-2; Withanage GSK, 2004, INFECT IMMUN, V72, P2152, DOI 10.1128/IAI.72.4.2152-2159.2004; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4	31	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127708	10.1371/journal.pone.0127708	http://dx.doi.org/10.1371/journal.pone.0127708			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046914	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000355652200027
J	Tang, FT; Chan, EQ; Lu, ML; Zhang, XW; Dai, CM; Mei, M; Zhang, SP; Wang, HX; Song, Q				Tang, Futian; Chan, Erqing; Lu, Meili; Zhang, Xiaowen; Dai, Chunmei; Mei, Meng; Zhang, Suping; Wang, Hongxin; Song, Qing			Calpain-1 Mediated Disorder of Pyrophosphate Metabolism Contributes to Vascular Calcification Induced by oxLDL	PLOS ONE			English	Article							ENDOTHELIUM-DEPENDENT RELAXATION; LOW-DENSITY-LIPOPROTEIN; ATP-SYNTHASE; INORGANIC PYROPHOSPHATE; BETA-GLYCEROPHOSPHATE; ALKALINE-PHOSPHATASE; RAT MODEL; VITAMIN-D; IN-VITRO; INHIBITION	We previously reported that oxidized low density lipoprotein (oxLDL) accelerated the calcification in aorta of rats and rat vascular smooth muscle cells (RVSMCs). However, the molecular mechanism underlying the acceleration remains poorly understood. The present study aimed to investigate the role of calpain-1, Ca2+-sensitive intracellular cysteine proteases, in the vascular calcification of rats treated with both high dose of vitamin D-2 and high cholesterol diet. The results showed that calpain activity significantly increased in calcified aortic tissue of rats and RVSMCs treated with oxLDL. Specific calpain inhibitor I (CAI, 0.5mg/kg, intraperitoneal) inhibited the vascular calcification in rats with hypercholesterolemia accompanied by the increase in the level of extracellular inorganic pyrophosphate (PPi), the endogenous inhibitor of vascular calcification. In addition, CAI increased the content of adenosine triphosphate (ATP), decreased the activity, mRNA and protein expression of alkaline phosphatase (ALP) and reduced the production of superoxide anion in calcified aortic tissue. CAI also increased the activity of ATP synthase as well as protein expression of ATP5D, delta subunit of ATP synthase. In the in vitro study, suppression of calpain-1 using siRNA assay inhibited the calcium deposition, increased the levels of PPi and ATP, improved the activity of ATP synthase as well as protein expression of ATP5D in RVSMCs treated with oxLDL. Calpain-1 suppression also decreased the activity, mRNA and protein expression of ALP and reduced the mitochondrial ROS (Mito-ROS) production in RVSMCs. However, mito-TEMPO, the mitochondria-targeted ROS scavenger, reduced the calcium deposition, increased the PPi in culture medium, decreased the activity, mRNA and protein expression of ALP in RVSMCs treated with oxLDL. Taken together, the results suggested that calpain-1 activation plays critical role in vascular calcification caused by oxLDL, which might be mediated by PPi metabolism disorder. The results also implied that Mito-ROS might contribute to the PPi metabolism disorder through regulation of the activity and expression of ALP.	[Tang, Futian; Lu, Meili; Dai, Chunmei; Mei, Meng; Zhang, Suping; Wang, Hongxin] Liaoning Med Univ, Inst Drug Res, Key Lab Cardio & Cerebrovasc Drug Res Liaoning Pr, Jinzhou, Peoples R China; [Chan, Erqing] Gansu Prov Hosp, Cerebrovasc Dis Ctr, Lanzhou, Peoples R China; [Zhang, Xiaowen] Guangzhou Inst Sports Sci, Guangzhou, Guangdong, Peoples R China; [Song, Qing] Guangzhou Vocat & Tech Coll, Guangzhou, Guangdong, Peoples R China	Jinzhou Medical University	Wang, HX (corresponding author), Liaoning Med Univ, Inst Drug Res, Key Lab Cardio & Cerebrovasc Drug Res Liaoning Pr, Jinzhou, Peoples R China.	jyhxwang@163.com; songqing168@hotmail.com			National Natural Science Foundation of China [81374008]; Talent Foundation of Liaoning Medical University of China [2014-18]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talent Foundation of Liaoning Medical University of China	This work was supported by the National Natural Science Foundation (No. 81374008) of China and the Talent Foundation of Liaoning Medical University (No. 2014-18) of China.	Ali MAM, 2012, BIOCHEM BIOPH RES CO, V423, P1, DOI 10.1016/j.bbrc.2012.05.005; Bear M, 2008, J CELL BIOCHEM, V105, P185, DOI 10.1002/jcb.21812; Chen LS, 2009, BIOCHEM PHARMACOL, V78, P583, DOI 10.1016/j.bcp.2009.05.019; Clinkinbeard T, 2013, BRAIN RES, V1499, P129, DOI 10.1016/j.brainres.2012.12.039; Costello JC, 2011, CONNECT TISSUE RES, V52, P139, DOI 10.3109/03008207.2010.491928; Fish RS, 2013, EUR J CLIN INVEST, V43, P405, DOI 10.1111/eci.12055; He K, 2014, AM J PHYSL HEART CIR; Hua YN, 2015, BBA-MOL BASIS DIS, V1852, P195, DOI 10.1016/j.bbadis.2014.04.032; Jansen RS, 2014, ARTERIOSCL THROM VAS, V34, P1985, DOI 10.1161/ATVBAHA.114.304017; Jiang LQ, 2012, HYPERTENSION, V60, P1192, DOI 10.1161/HYPERTENSIONAHA.112.196840; KITAGAWA S, 1992, JPN J PHARMACOL, V59, P339, DOI 10.1254/jjp.59.339; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Leopold Jane A, 2014, Cells, V3, P963, DOI 10.3390/cells3040963; Liu HY, 2014, MOL CELL BIOCHEM, V391, P85, DOI 10.1007/s11010-014-1990-x; Liu L, 2011, ACTA PHARMACOL SIN, V32, P1491, DOI 10.1038/aps.2011.128; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Loor G, 2011, BBA-MOL CELL RES, V1813, P1382, DOI 10.1016/j.bbamcr.2010.12.008; Lorenz-Depiereux B, 2010, AM J HUM GENET, V86, P267, DOI 10.1016/j.ajhg.2010.01.006; Lu Q, 2014, AM J CHINESE MED, V42, P337, DOI 10.1142/S0192415X14500220; Miyazaki T, 2013, J ATHEROSCLER THROMB, V20, P228, DOI 10.5551/jat.14787; Narisawa S, 2007, J BONE MINER RES, V22, P1700, DOI 10.1359/JBMR.070714; Natera-Naranjo O, 2012, MOL CELL NEUROSCI, V49, P263, DOI 10.1016/j.mcn.2011.12.006; Paloian NJ, 2014, AM J PHYSIOL-RENAL, V307, pF891, DOI 10.1152/ajprenal.00163.2014; Pandurangan Muthuraman, 2014, Pathophysiology, V21, P161, DOI 10.1016/j.pathophys.2014.01.003; PK S, 2014, J CLIN DIAGN RES, V8, DOI [10.7860/JCDR/2014/10150.5285, DOI 10.7860/JCDR/2014/10150.5285]; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Proudfoot D, 2001, Z Kardiol, V90 Suppl 3, P43; Ramio-Lluch L, 2014, REPROD FERT DEVELOP, V26, P883, DOI 10.1071/RD13145; Ruetten H, 1997, BRIT J PHARMACOL, V121, P695, DOI 10.1038/sj.bjp.0701180; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Takeshita D, 2013, J PHYSIOL SCI, V63, P113, DOI 10.1007/s12576-012-0243-6; Tang FT, 2006, CALCIFIED TISSUE INT, V79, P326, DOI 10.1007/s00223-006-0004-8; Tang FT, 2006, BIOCHEM PHARMACOL, V72, P558, DOI 10.1016/j.bcp.2006.05.018; Tang FT, 2007, VASC PHARMACOL, V46, P427, DOI 10.1016/j.vph.2007.01.001; Tantisattamo E, 2015, ARTERIOSCL THROM VAS, V35, P237, DOI 10.1161/ATVBAHA.114.304392; Taylor J, 2011, J CELL BIOCHEM, V112, P581, DOI 10.1002/jcb.22948; Tu L, 2013, MICROCIRCULATION, V20, P736, DOI 10.1111/micc.12074; Villa-Bellosta R, 2013, CIRC J, V77, P2145, DOI 10.1253/circj.CJ-13-0016; Villa-Bellosta R, 2013, CIRCULATION, V127, P2442, DOI 10.1161/CIRCULATIONAHA.112.000571; Villa-Bellosta R, 2011, CIRC J, V75, P2705, DOI 10.1253/circj.CJ-11-0477; Villa-Bellosta R, 2011, AM J PHYSIOL-HEART C, V301, pH61, DOI 10.1152/ajpheart.01020.2010; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; Wallin R, 2001, MED RES REV, V21, P274, DOI 10.1002/med.1010.abs; Zhang P, 2010, BIOCHEMISTRY-US, V49, P5570, DOI 10.1021/bi100656j; Zhu D, 2014, J CELL MOL MED	47	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129128	10.1371/journal.pone.0129128	http://dx.doi.org/10.1371/journal.pone.0129128			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047104	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200129
J	Harris, KA; Bobay, BG; Sarachan, KL; Sims, AF; Bilbille, Y; Deutsch, C; Iwata-Reuyl, D; Agris, PF				Harris, Kimberly A.; Bobay, Benjamin G.; Sarachan, Kathryn L.; Sims, Alexis F.; Bilbille, Yann; Deutsch, Christopher; Iwata-Reuyl, Dirk; Agris, Paul F.			NMR-based Structural Analysis of Threonylcarbamoyl-AMP Synthase and Its Substrate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA MODIFICATION; ESCHERICHIA-COLI; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; MODIFIED NUCLEOSIDES; KEOPS COMPLEX; T(6)A; BIOSYNTHESIS; ANTICODON; REVEALS	The hypermodified nucleoside N-6-threonylcarbamoyladenosine (t(6)A(37)) is present in many distinct tRNA species and has been found in organisms in all domains of life. This post-transcriptional modification enhances translation fidelity by stabilizing the anticodon/codon interaction in the ribosomal decoding site. The biosynthetic pathway of t(6)A(37) is complex and not well understood. In bacteria, the following four proteins have been discovered to be both required and sufficient for t(6)A(37) modification: TsaC, TsaD, TsaB, and TsaE. Of these, TsaC and TsaD are members of universally conserved protein families. Although TsaC has been shown to catalyze the formation of L-threonylcarbamoyl-AMP, a key intermediate in the biosynthesis of t(6)A(37), the details of the enzymatic mechanism remain unsolved. Therefore, the solution structure of Escherichia coli TsaC was characterized by NMR to further study the interactions with ATP and L-threonine, both substrates of TsaC in the biosynthesis of L-threonylcarbamoyl-AMP. Several conserved amino acids were identified that create a hydrophobic binding pocket for the adenine of ATP. Additionally, two residues were found to interact with L-threonine. Both binding sites are located in a deep cavity at the center of the protein. Models derived from the NMR data and molecular modeling reveal several sites with considerable conformational flexibility in TsaC that may be important for L-threonine recognition, ATP activation, and/or protein/protein interactions. These observations further the understanding of the enzymatic reaction catalyzed by TsaC, a threonylcarbamoyl-AMP synthase, and provide structure-based insight into the mechanism of t(6)A(37) biosynthesis.	[Harris, Kimberly A.; Bobay, Benjamin G.; Bilbille, Yann] N Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC 27695 USA; [Harris, Kimberly A.; Sarachan, Kathryn L.; Sims, Alexis F.; Agris, Paul F.] SUNY Albany, RNA Inst, Dept Biol Sci, Albany, NY 12222 USA; [Harris, Kimberly A.; Sarachan, Kathryn L.; Sims, Alexis F.; Agris, Paul F.] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Deutsch, Christopher; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA	University of North Carolina; North Carolina State University; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Portland State University	Agris, PF (corresponding author), SUNY Albany, RNA Inst, 1400 Washington Ave, Albany, NY 12222 USA.	pagris@albany.edu	Regan, Clinton/E-6250-2012; Bobay, Benjamin G/ABF-8860-2021	Bobay, Benjamin/0000-0003-4775-3686; Sarachan, Kathryn/0000-0003-2511-1404; Harris, Kimberly/0000-0003-3028-5863	National Institutes of Health [5R01-GM23037-25]; NIH [R01 GM110588]; National Science Foundation [MCB-0548602, MCB-1101859]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110588, R01GM023037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01-GM23037-25 (to P. F. A.) and NIH Grant R01 GM110588 (to P. F. A.; Manal Swairjo, P. I.). This work was also supported by National Science Foundation Grants MCB-0548602 and MCB-1101859 (to P. F. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Agari Y, 2008, PROTEINS, V70, P1108, DOI 10.1002/prot.21794; Auffinger P, 1998, MODIFICATION EDITING, P569; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Clore GM, 1999, J AM CHEM SOC, V121, P9008, DOI 10.1021/ja991789k; Daugeron MC, 2011, NUCLEIC ACIDS RES, V39, P6148, DOI 10.1093/nar/gkr178; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deutsch C, 2012, J BIOL CHEM, V287, P13666, DOI 10.1074/jbc.M112.344028; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Downey M, 2006, CELL, V124, P1155, DOI 10.1016/j.cell.2005.12.044; El Yacoubi B, 2011, EMBO J, V30, P882, DOI 10.1038/emboj.2010.363; El Yacoubi B, 2009, NUCLEIC ACIDS RES, V37, P2894, DOI 10.1093/nar/gkp152; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Ferrage F, 2003, J AM CHEM SOC, V125, P2541, DOI 10.1021/ja0211407; Goddard D., 2008, SPARKY 3; GROSJEAN H, 1995, BIOCHIMIE, V77, P139, DOI 10.1016/0300-9084(96)88117-X; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harris KA, 2011, RNA, V17, P1678, DOI 10.1261/rna.2592411; Hubbard SJ., 1993, COMPUTER PROGRAM; Jia J, 2002, PROTEINS, V49, P139, DOI 10.1002/prot.10178; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuratani M, 2011, PROTEINS, V79, P2065, DOI 10.1002/prot.23026; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lauhon CT, 2012, BIOCHEMISTRY-US, V51, P8950, DOI 10.1021/bi301233d; Lin CA, 2010, MOL CELL BIOL, V30, P354, DOI 10.1128/MCB.00754-09; Mao DYL, 2008, MOL CELL, V32, P259, DOI 10.1016/j.molcel.2008.10.002; Martin A. C., 1996, PROFIT VERSION 3 1; MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806; MILLER JP, 1976, NUCLEIC ACIDS RES, V3, P1185, DOI 10.1093/nar/3.5.1185; Morin A, 1998, RNA, V4, P24; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Nishimura S, 1972, Prog Nucleic Acid Res Mol Biol, V12, P49; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P9484, DOI 10.1093/nar/gkt720; Perrochia L, 2013, NUCLEIC ACIDS RES, V41, P1953, DOI 10.1093/nar/gks1287; Petkun S, 2011, STRUCTURE, V19, P1773, DOI 10.1016/j.str.2011.09.023; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sivashanmugam A, 2009, PROTEIN SCI, V18, P936, DOI 10.1002/pro.102; Srinivasan M, 2011, EMBO J, V30, P873, DOI 10.1038/emboj.2010.343; Teplova M, 2000, PROTEIN SCI, V9, P2557, DOI 10.1110/ps.9.12.2557; Vendeix FAP, 2012, J MOL BIOL, V416, P467, DOI 10.1016/j.jmb.2011.12.048; Wan LCK, 2013, NUCLEIC ACIDS RES, V41, P6332, DOI 10.1093/nar/gkt322; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200	50	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20032	20043		10.1074/jbc.M114.631242	http://dx.doi.org/10.1074/jbc.M114.631242			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26060251	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000359608900003
J	Minami, H; Tashiro, K; Okada, A; Hirata, N; Yamaguchi, T; Takayama, K; Mizuguchi, H; Kawabata, K				Minami, Haruka; Tashiro, Katsuhisa; Okada, Atsumasa; Hirata, Nobue; Yamaguchi, Tomoko; Takayama, Kazuo; Mizuguchi, Hiroyuki; Kawabata, Kenji			Generation of Brain Microvascular Endothelial-Like Cells from Human Induced Pluripotent Stem Cells by Co-Culture with C6 Glioma Cells	PLOS ONE			English	Article							IN-VITRO; BARRIER MODELS; DIFFERENTIATION; PERMEABILITY; MAINTENANCE; INDUCTION; LINES; CNS	The blood brain barrier (BBB) is formed by brain microvascular endothelial cells (BMECs) and tightly regulates the transport of molecules from blood to neural tissues. In vitro BBB models from human pluripotent stem cell (PSCs)-derived BMECs would be useful not only for the research on the BBB development and function but also for drug-screening for neurological diseases. However, little is known about the differentiation of human PSCs to BMECs. In the present study, human induced PSCs (iPSCs) were differentiated into endothelial cells (ECs), and further maturated to BMECs. Interestingly, C6 rat glioma cell-conditioned medium (C6CM), in addition to C6 co-culture, induced the differentiation of human iPSC-derived ECs (iPS-ECs) to BMEC-like cells, increase in the trans-endothelial electrical resistance, decreased in the dextran transport and up-regulation of gene expression of tight junction molecules in human iPS-ECs. Moreover, Wnt inhibitors attenuated the effects of C6CM. In summary, we have established a simple protocol of the generation of BMEC-like cells from human iPSCs, and have demonstrated that differentiation of iPS-ECs to BMEC-like cells is induced by C6CM-derived signals, including canonical Wnt signals.	[Minami, Haruka; Tashiro, Katsuhisa; Okada, Atsumasa; Hirata, Nobue; Yamaguchi, Tomoko; Kawabata, Kenji] Natl Inst Biomed Innovat, Lab Stem Cell Regulat, Ibaraki, Osaka 5670085, Japan; [Minami, Haruka; Kawabata, Kenji] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biomed Innovat, Suita, Osaka 5650871, Japan; [Takayama, Kazuo; Mizuguchi, Hiroyuki] Natl Inst Biomed Innovat, Lab Hepatocyte Regulat, Ibaraki, Osaka 5670085, Japan; [Takayama, Kazuo; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Suita, Osaka 5650871, Japan; [Takayama, Kazuo; Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Hepat Tox & Metab, Suita, Osaka 5650871, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	National Institute of Health Sciences - Japan; Osaka University; National Institute of Health Sciences - Japan; Osaka University; Osaka University; Osaka University	Kawabata, K (corresponding author), Natl Inst Biomed Innovat, Lab Stem Cell Regulat, 7-6-8 Saito Asagi, Ibaraki, Osaka 5670085, Japan.	kawabata@nibiohn.go.jp	Takayama, Kazuo/U-2360-2019	Mizuguchi, Hiroyuki/0000-0003-0594-8178; Takayama, Kazuo/0000-0002-1132-2457	Ministry of Health, Labour, and Welfare of Japan	Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants from the Ministry of Health, Labour, and Welfare of Japan. K. Takayama is supported by a Grant-in-aid for the Japan Society for the Promotion of Science Fellows.	Cioni Chiara, 2012, Front Psychiatry, V3, P47, DOI 10.3389/fpsyt.2012.00047; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Forster C, 2008, J PHYSIOL-LONDON, V586, P1937, DOI 10.1113/jphysiol.2007.146852; Higuchi K, 2015, DRUG METAB PHARMACOK, V30, P182, DOI 10.1016/j.dmpk.2014.12.006; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Naik P, 2012, J PHARM SCI-US, V101, P1337, DOI 10.1002/jps.23022; Nolan DJ, 2013, DEV CELL, V26, P204, DOI 10.1016/j.devcel.2013.06.017; Park SW, 2010, BLOOD, V116, P5762, DOI 10.1182/blood-2010-04-280719; Quincozes-Santos A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064372; RAUB TJ, 1992, EXP CELL RES, V199, P330, DOI 10.1016/0014-4827(92)90442-B; Sajja RK, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-8; Sone M, 2007, ARTERIOSCL THROM VAS, V27, P2127, DOI 10.1161/ATVBAHA.107.143149; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Syvanen S, 2009, DRUG METAB DISPOS, V37, P635, DOI 10.1124/dmd.108.024745; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taura D, 2009, ARTERIOSCL THROM VAS, V29, P1100, DOI 10.1161/ATVBAHA.108.182162; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Untucht C, 2011, MICROBIOL-SGM, V157, P2933, DOI 10.1099/mic.0.049106-0; Warren MS, 2009, PHARMACOL RES, V59, P404, DOI 10.1016/j.phrs.2009.02.007; Watson PMD, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-59; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	27	28	31	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0128890	10.1371/journal.pone.0128890	http://dx.doi.org/10.1371/journal.pone.0128890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061227	Green Submitted, Green Published, gold			2022-12-26	WOS:000355979500106
J	Martinez-Ramos, E; Martin-Borras, C; Trujillo, JM; Gine-Garriga, M; Martin-Cantera, C; Sola-Gonfaus, M; Castillo-Ramos, E; Pujol-Ribera, E; Rodriguez, D; Puigdomenech, E; Beltran, AM; Serra-Paya, N; Gascon-Catalan, A; Puig-Ribera, A				Martinez-Ramos, Elena; Martin-Borras, Carme; Trujillo, Jose-Manuel; Gine-Garriga, Maria; Martin-Cantera, Carlos; Sola-Gonfaus, Merce; Castillo-Ramos, Eva; Pujol-Ribera, Enriqueta; Rodriguez, Dolors; Puigdomenech, Elisa; Beltran, Angela-Maria; Serra-Paya, Noemi; Gascon-Catalan, Ana; Puig-Ribera, Anna			Prolonged Sitting Time: Barriers, Facilitators and Views on Change among Primary Healthcare Patients Who Are Overweight or Moderately Obese	PLOS ONE			English	Article							PHYSICAL-ACTIVITY PROMOTION; CARDIOVASCULAR-DISEASE; SEDENTARY BEHAVIOR; LIFE-STYLE; ADULTS; RISK; INTERVENTION; ASSOCIATIONS; DEFINITION; MORTALITY	Background and Objectives Prolonged sitting time has negative consequences on health, although the population is not well aware of these harmful effects. We explored opinions expressed by primary care patients diagnosed as overweight or moderately obese concerning their time spent sitting, willingness to change, and barriers, facilitators, goals and expectations related to limiting this behaviour. Methods A descriptive-interpretive qualitative study was carried out at three healthcare centres in Barcelona, Spain, and included 23 patients with overweight or moderate obesity, aged 25 to 65 years, who reported sitting for at least 6 hours a day. Exclusion criteria were inability to sit down or stand up from a chair without help and language barriers that precluded interview participation. Ten in-depth, semi-structured interviews (5 group, 5 individual) were audio recorded from January to July 2012 and transcribed. The interview script included questions about time spent sitting, willingness to change, barriers and facilitators, and the prospect of assistance from primary healthcare professionals. An analysis of thematic content was made using ATLAS. Ti and triangulation of analysts. Results The most frequent sedentary activities were computer use, watching television, and motorized journeys. There was a lack of awareness of the amount of time spent sitting and its negative consequences on health. Barriers to reducing sedentary time included work and family routines, lack of time and willpower, age and sociocultural limitations. Facilitators identified were sociocultural change, free time and active work, and family surroundings. Participants recognized the abilities of health professionals to provide help and advice, and reported a preference for patient-centred or group interventions. Conclusions Findings from this study have implications for reducing sedentary behaviour. Patient insights were used to design an intervention to reduce sitting time within the frame of the SEDESTACTIV clinical trial.	[Martinez-Ramos, Elena] Inst Catala Salut, Primary Healthcare Ctr, Vilanova 1, Barcelona, Spain; [Martinez-Ramos, Elena; Martin-Borras, Carme; Martin-Cantera, Carlos; Pujol-Ribera, Enriqueta; Rodriguez, Dolors; Puigdomenech, Elisa; Beltran, Angela-Maria] Inst Univ Invest Atencio Primaria Jordi Gol IDIAP, Lifestyles Study Grp, RedIAPP, Barcelona, Spain; [Martin-Borras, Carme; Gine-Garriga, Maria] Univ Ramon Llull, Dept Phys Act & Sport Sci, FPCEE Blanquerna, Barcelona, Spain; [Trujillo, Jose-Manuel] Cuevas del Almanzora, Primary Healthcare Ctr, North Almeria Reg, Spain; [Gine-Garriga, Maria] Univ Ramon Llull, Dept Phys Therapy, FCS Blanquerna, Barcelona, Spain; [Martin-Cantera, Carlos; Pujol-Ribera, Enriqueta; Puigdomenech, Elisa] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain; [Sola-Gonfaus, Merce; Castillo-Ramos, Eva] ICS, Primary Healthcare Ctr, Barcelona, Spain; [Pujol-Ribera, Enriqueta] Inst Catala Salut, Generalitat Catalunya, Barcelona, Spain; [Serra-Paya, Noemi] Univ Lleida, Dept Nursing, Lleida, Spain; [Gascon-Catalan, Ana] Univ Zaragoza, Dept Hlth Sci, Zaragoza, Spain; [Puig-Ribera, Anna] Univ Cent Catalunya UVic UCC, Univ Vic, Grp Recerca Esport & Activitat Fis, Vic, Spain	Universitat Ramon Llull; Universitat Ramon Llull; Autonomous University of Barcelona; Universitat de Lleida; University of Zaragoza; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC)	Martinez-Ramos, E (corresponding author), Inst Catala Salut, Primary Healthcare Ctr, Vilanova 1, Barcelona, Spain.	sedestactiv@gmail.com; mariacarmenmb@blanquerna.url.edu	Gascon, Ana/AAH-1376-2020; Giné-Garriga, Maria/F-4089-2016; Martin Cantera, Carlos/D-2693-2011; Serra, Noemi/AAB-7629-2019; Giné-Garriga, Maria/AAF-9828-2019	Gascon, Ana/0000-0003-0335-0404; Giné-Garriga, Maria/0000-0003-4449-3524; Martin Cantera, Carlos/0000-0003-0656-8126; Serra, Noemi/0000-0002-1048-9546; Giné-Garriga, Maria/0000-0003-4449-3524; Martinez Ramos, Elena/0000-0002-0195-6376; Pujol Ribera, Enriqueta/0000-0002-9475-0755	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III [PI11/01082]; VI Catedra of European University of Madrid	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III(Instituto de Salud Carlos III); VI Catedra of European University of Madrid	The study was supported by research grants from Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (PI11/01082) and VI Catedra of the European University of Madrid.	Aadahl M, 2014, AM J PREV MED, V47, P576, DOI 10.1016/j.amepre.2014.06.020; Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; De Greef KP, 2011, PATIENT EDUC COUNS, V84, P275, DOI 10.1016/j.pec.2010.07.010; de Heer HD, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-896; Dunstan DW, 2012, DIABETES RES CLIN PR, V97, P368, DOI 10.1016/j.diabres.2012.05.020; Farinola M, 2011, CONDUCTA SEDENTARIA; Gardiner PA, 2011, AM J PREV MED, V41, P174, DOI 10.1016/j.amepre.2011.03.020; Gilson ND, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-43; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; John D, 2010, MED SCI SPORT EXER, V42, P38, DOI 10.1249/01.MSS.0000384859.60808.5c; Katzmarzyk PT, 2009, MED SCI SPORT EXER, V41, P998, DOI 10.1249/MSS.0b013e3181930355; King AC, 2010, AM J PREV MED, V38, P17, DOI 10.1016/j.amepre.2009.08.032; Marshall AL, 2010, MED SCI SPORT EXER, V42, P1094, DOI 10.1249/MSS.0b013e3181c5ec18; Martin-Borras C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-228; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Ortis L. C., 2006, REV PSICOL, V15, P53; Otten JJ, 2009, ARCH INTERN MED, V169, P2109, DOI 10.1001/archinternmed.2009.430; Owen N, 2009, BRIT J SPORT MED, V43, P81, DOI 10.1136/bjsm.2008.055269; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Ribera AP, 2006, HEALTH EDUC RES, V21, P538, DOI 10.1093/her/cyl008; Ribera AP, 2005, EUR J PUBLIC HEALTH, V15, P569, DOI 10.1093/eurpub/cki045; Scottish Intercollegiate Guidelines Network, 2010, MAN OB AN CLIN GUID; Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175; Suggs S, 2010, AM J HLTH STUD, V25, P69; Teychenne M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049583; Thorp AA, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-96; Thorp AA, 2010, DIABETES CARE, V33, P327, DOI 10.2337/dc09-0493; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Word Medical Association, 2013, WMA DECL HELS ETH PR; World Cancer Research Fund/American Institute for Cancer Research, 2007, POL ACT CANC PREV FO	36	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0125739	10.1371/journal.pone.0125739	http://dx.doi.org/10.1371/journal.pone.0125739			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6PC	26057237	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000002
J	Orita, M; Hayashida, N; Nakayama, Y; Shinkawa, T; Urata, H; Fukushima, Y; Endo, Y; Yamashita, S; Takamura, N				Orita, Makiko; Hayashida, Naomi; Nakayama, Yumi; Shinkawa, Tetsuko; Urata, Hideko; Fukushima, Yoshiko; Endo, Yuuko; Yamashita, Shunichi; Takamura, Noboru			Bipolarization of Risk Perception about the Health Effects of Radiation in Residents after the Accident at Fukushima Nuclear Power Plant	PLOS ONE			English	Article							EXPOSURE; VILLAGE; RETURN	The late health effects of low-dose rate radiation exposure are still a serious public concern in the Fukushima area even four years after the accident at Fukushima Daiichi Nuclear Power Plant (FNPP). To clarify the factors associated with residents' risk perception of radiation exposure and consequent health effects, we conducted a survey among residents of Kawauchi village in May and June 2014, which is located within 30 km of FNPP. 85 of 285 residents (29.8%) answered that acute radiation syndrome might develop in residents after the accident, 154 (54.0%) residents responded that they had anxieties about the health effects of radiation on children, and 140 (49.1%) residents indicated that they had anxieties about the health effects of radiation on offspring. Furthermore, 107 (37.5%) residents answered that they had concerns about health effects that would appear in the general population simply by living in an environment with a 0.23 mu Sv per hour ambient dose for one year, 149 (52.2%) residents reported that they were reluctant to eat locally produced foods, and 164 (57.5%) residents believed that adverse health effects would occur in the general population by eating 100 Bq per kg of mushrooms every day for one year. The present study shows that a marked bipolarization of the risk perception about the health effects of radiation among residents could have a major impact on social well-being after the accident at FNPP.	[Orita, Makiko; Nakayama, Yumi; Takamura, Noboru] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 8528523, Japan; [Orita, Makiko; Nakayama, Yumi; Shinkawa, Tetsuko; Urata, Hideko] Nagasaki Univ, Grad Sch Biomed Sci, Dept Nursing, Nagasaki 8528523, Japan; [Hayashida, Naomi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Div Strateg Collaborat Res,Ctr Promot Collaborat, Nagasaki 8528523, Japan; [Yamashita, Shunichi] Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Radiat Med Sci, Nagasaki 8528523, Japan; [Fukushima, Yoshiko] Hirosaki Univ, Sch Hlth Sci, Hirosaki, Aomori 0368560, Japan; [Endo, Yuuko] Kawauchi Municipal Govt, Fukushima 9791201, Japan	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; Hirosaki University	Takamura, N (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Atom Bomb Dis Inst, Dept Global Hlth Med & Welf, Nagasaki 8528523, Japan.	takamura@nagasaki-u.ac.jp	Yamashita, Shunichi/GVS-9508-2022	Yamashita, Shunichi/0000-0001-6399-6261; Takamura, Noboru/0000-0002-5552-3234	research projects on health effects of nuclear disasters of the Ministry of the Environment; Grants-in-Aid for Scientific Research [15K00540] Funding Source: KAKEN	research projects on health effects of nuclear disasters of the Ministry of the Environment; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported primarily by the research projects on health effects of nuclear disasters of the Ministry of the Environment (http://www.env.go.jp/en/index.html).	[Anonymous], 2014, AG 16 REV BOARD M FU; Bolus N E, 2001, J Nucl Med Technol, V29, P67; Fukushima International Association, INF RAD RAD MAT Q A; Harada KH, 2014, P NATL ACAD SCI USA, V111, pE914, DOI 10.1073/pnas.1315684111; Hayashida N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083220; Huang L, 2013, P NATL ACAD SCI USA, V110, P19742, DOI 10.1073/pnas.1313825110; International Commission on Radiological Protection, 2007, INT COMM RAD PROT PU, V103; Mettler FA, 2012, J RADIOL PROT, V32, pN9, DOI 10.1088/0952-4746/32/1/N9; Nagataki S, 2014, CURR OPIN ENDOCRINOL, V21, P384, DOI 10.1097/MED.0000000000000098; Nagataki S, 2013, RADIAT RES, V180, P439, DOI 10.1667/RR13351.1; Nuclear Emergency Response Headquarters of Japanese Government, ADD REP JAP GOV IAEA; Nuclear Emergency Response Headquarters of Japanese Government, REP JAP GOV IAEA MIN; Orita M, 2013, RADIAT PROT DOSIM, V156, P383, DOI 10.1093/rpd/nct082; Saenko V, 2011, CLIN ONCOL-UK, V23, P234, DOI 10.1016/j.clon.2011.01.502; Sakata R, 2012, MATURITAS, V72, P99, DOI 10.1016/j.maturitas.2012.02.009; Taira Y, 2014, ENVIRON SCI TECHNOL, V48, P4556, DOI 10.1021/es404534y; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; United Nations Scientific Committee on the Effects of Atomic Radiation, UNSCEAR 2013 REP; Yasumura S, 2012, J EPIDEMIOL, V22, P375, DOI 10.2188/jea.JE20120105	20	42	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129227	10.1371/journal.pone.0129227	http://dx.doi.org/10.1371/journal.pone.0129227			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057539	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000044
J	Kawabe, S; Matsuda, S; Tsunekawa, N; Endo, H				Kawabe, Soichiro; Matsuda, Seiji; Tsunekawa, Naoki; Endo, Hideki			Ontogenetic Shape Change in the Chicken Brain: Implications for Paleontology	PLOS ONE			English	Article							RAPID GROWTH; LOWER EOCENE; BIRDS; SIZE; EVOLUTION; SKULL; CHARACTERS; MORPHOLOGY; THEROPODA; ANATOMY	Paleontologists have investigated brain morphology of extinct birds with little information on post-hatching changes in avian brain morphology. Without the knowledge of ontogenesis, assessing brain morphology in fossil taxa could lead to misinterpretation of the phylogeny or neurosensory development of extinct species. Hence, it is imperative to determine how avian brain morphology changes during post-hatching growth. In this study, chicken brain shape was compared at various developmental stages using three-dimensional (3D) geometric morphometric analysis and the growth rate of brain regions was evaluated to explore post-hatching morphological changes. Microscopic MRI (mu MRI) was used to acquire in vivo data from living and post-mortem chicken brains. The telencephalon rotates caudoventrally during growth. This change in shape leads to a relative caudodorsal rotation of the cerebellum and myelencephalon. In addition, all brain regions elongate rostrocaudally and this leads to a more slender brain shape. The growth rates of each brain region were constant and the slopes from the growth formula were parallel. The dominant pattern of ontogenetic shape change corresponded with interspecific shape changes due to increasing brain size. That is, the interspecific and ontogenetic changes in brain shape due to increased size have similar patterns. Although the shape of the brain and each brain region changed considerably, the volume ratio of each brain region did not change. This suggests that the brain can change its shape after completing functional differentiation of the brain regions. Moreover, these results show that consideration of ontogenetic changes in brain shape is necessary for an accurate assessment of brain morphology in paleontological studies.	[Kawabe, Soichiro] Gifu Prefectural Museum, Gifu, Japan; [Kawabe, Soichiro; Endo, Hideki] Univ Tokyo, Univ Museum, Tokyo, Japan; [Matsuda, Seiji] Ehime Univ, Sch Med, Dept Anat & Embryol, Matsuyama, Ehime 790, Japan; [Tsunekawa, Naoki] Univ Tokyo, Dept Vet Anat, Tokyo, Japan	University of Tokyo; Ehime University; University of Tokyo	Kawabe, S (corresponding author), Gifu Prefectural Museum, Gifu, Japan.	kawabe_soichiro@yahoo.co.jp			Japan Society for the Promotion of Science [11J08692, 26916003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science 11J08692 & 26916003 (http://www.jsps.go.jp/english/e-grants/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann Rebecca Rogers, 2002, Anatomical Record, V269, P142, DOI 10.1002/ar.10119; Alonso PD, 2004, NATURE, V430, P666, DOI 10.1038/nature02706; Balanoff AM, 2013, NATURE, V501, P93, DOI 10.1038/nature12424; BANG BG, 1968, AUK, V85, P55; Bhullar BAS, 2012, NATURE, V487, P223, DOI 10.1038/nature11146; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Carlson WD, 2003, GEOL SOC SPEC PUBL, V215, P7, DOI 10.1144/GSL.SP.2003.215.01.02; Charvet CJ, 2009, P R SOC B, V276, P3421, DOI 10.1098/rspb.2009.0888; Corfield JR, 2008, NAT PROTOC, V3, P597, DOI 10.1038/nprot.2008.17; de Beer G., 1954, CRAFTSMANS HDB; Edinger T, 1941, AM J SCI, V239, P665, DOI 10.2475/ajs.239.9.665; Edinger T, 1969, AM ZOOL, V4, P5; EDINGER TILLY, 1926, ANN & MAG NAT HIST, V18, P151; Elzanowski A., 1991, Journal of Vertebrate Paleontology, V11, P90; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Frahm HD, 1998, BRAIN BEHAV EVOLUT, V52, P292, DOI 10.1159/000006574; Galatius A, 2011, J MORPHOL, V272, P136, DOI 10.1002/jmor.10900; Garamszegi LZ, 2002, P ROY SOC B-BIOL SCI, V269, P961, DOI 10.1098/rspb.2002.1967; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Gille U, 2000, J ZOOL, V252, P399, DOI 10.1111/j.1469-7998.2000.tb00635.x; Goodwin MB, 2006, J VERTEBR PALEONTOL, V26, P103, DOI 10.1671/0272-4634(2006)26[103:TSKTSN]2.0.CO;2; GRABER RICHARD R., 1965, CONDOR, V67, P300, DOI 10.2307/1365578; HANCOCK CE, 1995, BRIT POULTRY SCI, V36, P247, DOI 10.1080/00071669508417773; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Iwaniuk AN, 2003, CAN J ZOOL, V81, P1913, DOI 10.1139/Z03-190; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P40, DOI 10.1159/000081110; Iwaniuk AN, 2007, BRAIN BEHAV EVOLUT, V69, P196, DOI 10.1159/000096987; Iwaniuk AN, 2006, J COMP PHYSIOL A, V192, P1313, DOI 10.1007/s00359-006-0161-2; JERISON HJ, 1968, NATURE, V219, P1381, DOI 10.1038/2191381a0; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773; Kamon K, 1906, ANAT HEFTE, V30, P562; Kawabe S, 2013, J ANAT, V223, P495, DOI 10.1111/joa.12109; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Ksepka DT, 2012, ZOOL J LINN SOC-LOND, V166, P202, DOI 10.1111/j.1096-3642.2012.00835.x; Larsson Hans C.E., 2001, P19; Latimer HB, 1925, J COMP NEUROL, V38, P251, DOI 10.1002/cne.900380303; Macrini TE, 2007, J MORPHOL, V268, P844, DOI 10.1002/jmor.10556; Maisey John G., 2005, Bulletin of the American Museum of Natural History, V288, P1, DOI 10.1206/0003-0090(2005)288<0001:BOTUDS>2.0.CO;2; Marino Lori, 2003, Anatomical Record, V272B, P107, DOI 10.1002/ar.b.10018; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Monteiro LR, 1997, J MORPHOL, V231, P53, DOI 10.1002/(SICI)1097-4687(199701)231:1<53::AID-JMOR5>3.0.CO;2-P; Neff M, 1973, REV SUISSE ZOOL, V79, P1471; PEACOCK AJ, 1989, AM REV RESPIR DIS, V139, P1524, DOI 10.1164/ajrccm/139.6.1524; PEARSON R, 1972, AVIAN BRAIN; Portmann A, 1945, SCHWEIZER ARCH ORNIT, V2, P181; PORTMANN ADOLPHE, 1947, ALAUDA, V15, P1; PORTMANN ADOLPHE, 1947, ALAUDA, V15, P161; REHKAMPER G, 1991, BRAIN BEHAV EVOLUT, V37, P125, DOI 10.1159/000114353; ROGERS KT, 1960, J EXP ZOOL, V144, P77, DOI 10.1002/jez.1401440108; Rogers L. J., 1995, DEV BRAIN BEHAV CHIC; Rogers SW, 1998, NEURON, V21, P673, DOI 10.1016/S0896-6273(00)80585-1; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Sampson SD, 2007, J VERTEBR PALEONTOL, V27, P32, DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO;2; Schlabritzky E., 1954, Zeitschrift fuer Morphologie und Oekologie, V41, P278, DOI 10.1007/BF00496990; Skutch A.F., 1976, PARENT BIRDS THEIR Y; Smith NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049584; Starck J.M., 1989, Courier Forschungsinstitut Senckenberg, V114, P1; Starck J.M., 1993, Current Ornithology, V10, P275; Strauss RE, 1984, CAN J ZOOL, V63, P1582; Tsuihiji T, 2011, J VERTEBR PALEONTOL, V31, P497, DOI 10.1080/02724634.2011.557116; Walsh S, 2011, J SYST PALAEONTOL, V9, P173, DOI 10.1080/14772019.2010.513703; Walsh SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067176; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; Wiens JJ, 1998, SYST BIOL, V47, P427, DOI 10.1080/106351598260806; Wiens JJ, 1999, ANNU REV ECOL SYST, V30, P327, DOI 10.1146/annurev.ecolsys.30.1.327; Wiens JJ, 1995, SYST BIOL, V44, P482, DOI 10.2307/2413656; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Young R.M., 1990, MIND BRAIN; Zelenitsky DK, 2011, P ROY SOC B-BIOL SCI, V278, P3625, DOI 10.1098/rspb.2011.0238; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075	73	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129939	10.1371/journal.pone.0129939	http://dx.doi.org/10.1371/journal.pone.0129939			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053849	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300170
J	Pizza, F; Jaussent, I; Lopez, R; Pesenti, C; Plazzi, G; Drouot, X; Leu-Semenescu, S; Beziat, S; Arnulf, I; Dauvilliers, Y				Pizza, Fabio; Jaussent, Isabelle; Lopez, Regis; Pesenti, Carole; Plazzi, Giuseppe; Drouot, Xavier; Leu-Semenescu, Smaranda; Beziat, Severine; Arnulf, Isabelle; Dauvilliers, Yves			Car Crashes and Central Disorders of Hypersomnolence: A French Study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SIMULATED DRIVING PERFORMANCE; MOTOR-VEHICLE CRASHES; DAYTIME SLEEPINESS; WAKEFULNESS TEST; GENERAL-POPULATION; THORACIC SOCIETY; NARCOLEPSY; RISK; ACCIDENTS	Background Drowsiness compromises driving ability by reducing alertness and attentiveness, and delayed reaction times. Sleep-related car crashes account for a considerable proportion of accident at the wheel. Narcolepsy type 1 (NT1), narcolepsy type 2 (NT2) and idiopathic hypersomnia (IH) are rare central disorders of hypersomnolence, the most severe causes of sleepiness thus being potential dangerous conditions for both personal and public safety with increasing scientific, social, and political attention. Our main objective was to assess the frequency of recent car crashes in a large cohort of patients affected with well-defined central disorders of hypersomnolence versus subjects from the general population. Methods We performed a cross-sectional study in French reference centres for rare hypersomnia diseases and included 527 patients and 781 healthy subjects. All participants included needed to have a driving license, information available on potential accident events during the last 5 years, and on potential confounders; thus analyses were performed on 282 cases (71 IH, 82 NT2, 129 NT1) and 470 healthy subjects. Results Patients reported more frequently than healthy subjects the occurrence of recent car crashes (in the previous five years), a risk that was confirmed in both treated and untreated subjects at study inclusion (Untreated, OR = 2.21 95%CI = [1.30-3.76], Treated OR = 2.04 95%CI = [1.26-3.30]), as well as in all disease categories, and was modulated by subjective sleepiness level (Epworth scale and naps). Conversely, the risk of car accidents of patients treated for at least 5 years was not different to healthy subjects (OR = 1.23 95%CI = [0.56-2.69]). Main risk factors were analogous in patients and healthy subjects. Conclusion Patients affected with central disorders of hypersomnolence had increased risk of recent car crashes compared to subjects from the general population, a finding potentially reversed by long-term treatment.	[Pizza, Fabio; Lopez, Regis; Pesenti, Carole; Dauvilliers, Yves] CHU Montpellier, Gui de Chauliac Hosp, Sleep Disorders Ctr, Dept Neurol, Montpellier, France; [Pizza, Fabio; Plazzi, Giuseppe] Univ Bologna, Dept Biomed & Neuromotor Sci DIBINEM, Bologna, Italy; [Pizza, Fabio; Plazzi, Giuseppe] ASL Bologna, IRCCS Ist Sci Neurol, Bologna, Italy; [Jaussent, Isabelle; Lopez, Regis; Pesenti, Carole; Beziat, Severine; Dauvilliers, Yves] Inserm U1061, Montpellier, France; [Jaussent, Isabelle; Lopez, Regis; Pesenti, Carole; Beziat, Severine; Dauvilliers, Yves] Univ Montpellier I, Montpellier, France; [Lopez, Regis; Pesenti, Carole; Leu-Semenescu, Smaranda; Arnulf, Isabelle; Dauvilliers, Yves] Narcolepsy Idiopath Hypersomnia & Kleine Levin Sy, Natl Reference Ctr Orphan Dis, Paris, France; [Drouot, Xavier] CHU Poitiers, Dept Clin Neurophysiol, F-8600 Poitiers, France; [Leu-Semenescu, Smaranda; Arnulf, Isabelle] Univ Paris 06, Sorbonne Univ, Pitie Salpetriere Univ Hosp,CNRS UMR 7225, AP HP,Sleep Disorders Unit,Brain Res Inst,CRICM,I, F-75005 Paris, France	Universite de Montpellier; CHU de Montpellier; University of Bologna; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Dauvilliers, Y (corresponding author), CHU Montpellier, Gui de Chauliac Hosp, Sleep Disorders Ctr, Dept Neurol, Montpellier, France.	ydauvilliers@yahoo.fr	Plazzi, Giuseppe/AAB-9627-2020; Pizza, Fabio/AAC-1794-2020; Lopez, Regis/X-4694-2019	Drouot, Xavier/0000-0002-3940-4825; Arnulf, Isabelle/0000-0002-2240-2516; Jaussent, Isabelle/0000-0002-8205-7590; Plazzi, Giuseppe/0000-0002-1051-0472; Dauvilliers, yves/0000-0003-0683-6506; PIZZA, FABIO/0000-0003-2294-9551; Lopez, Regis/0000-0001-8591-0553	French Health Ministry (promotor: Assistance Publique Hopitaux de Paris, IA) [PHRC AOM07-138]; European narcolepsy Network (EU-NN) Senior Investigator Grant	French Health Ministry (promotor: Assistance Publique Hopitaux de Paris, IA); European narcolepsy Network (EU-NN) Senior Investigator Grant	The study was financed and supported by the PHRC AOM07-138 from the French Health Ministry (promotor: Assistance Publique Hopitaux de Paris, IA), and a European narcolepsy Network (EU-NN) Senior Investigator Grant 2014 to FP.	ALDRICH MS, 1989, SLEEP, V12, P487, DOI 10.1093/sleep/12.6.487; American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; Ayas N, 2014, CAN RESPIR J, V21, P114, DOI 10.1155/2014/357327; Bayon V, 2009, SLEEP MED REV, V13, P421, DOI 10.1016/j.smrv.2009.02.001; BROUGHTON RJ, 1984, EPILEPSIA, V25, P423, DOI 10.1111/j.1528-1157.1984.tb03438.x; Dauvilliers Y, 2009, J NEUROL NEUROSUR PS, V80, P636, DOI 10.1136/jnnp.2008.161588; Dauvilliers Y, 2006, CURR NEUROL NEUROSCI, V6, P156, DOI 10.1007/s11910-996-0039-2; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; Drake C, 2010, SLEEP, V33, P745, DOI 10.1093/sleep/33.6.745; Ellen RLB, 2006, J CLIN SLEEP MED, V2, P193; Findley LJ, 1999, SLEEP, V22, P804, DOI 10.1093/sleep/22.6.804; Garbarino S, 2011, G Ital Med Lav Ergon, V33, P199; Garbarino S, 2001, SLEEP, V24, P203; George CFP, 1996, SLEEP, V19, P711, DOI 10.1093/sleep/19.9.711; Goncalves M, 2015, J SLEEP RES, V24, P242, DOI 10.1111/jsr.12267; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Ingravallo F, 2012, SLEEP MED, V13, P1293, DOI 10.1016/j.sleep.2012.08.002; Jennum P, 2013, SLEEP, V36, P835, DOI 10.5665/sleep.2706; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Karimi M, 2014, SLEEP; Kim H, 2005, SLEEP, V28, P625, DOI 10.1093/sleep/28.5.625; Kotterba S, 2004, CLIN NEUROL NEUROSUR, V106, P275, DOI 10.1016/j.clineuro.2003.12.003; Kotterba S, 2002, SOMNOLOGIE, V6, P39; Littner MR, 2005, SLEEP, V28, P113, DOI 10.1093/sleep/28.1.113; Lyznicki JM, 1998, JAMA-J AM MED ASSOC, V279, P1908, DOI 10.1001/jama.279.23.1908; Ohayon MM, 2014, SLEEP, V37, P439, DOI 10.5665/sleep.3470; Ohayon MM, 2012, ARCH GEN PSYCHIAT, V69, P71, DOI 10.1001/archgenpsychiatry.2011.1240; Ozaki A, 2008, J CLIN SLEEP MED, V4, P572; Philip P, 2005, SLEEP, V28, P1511, DOI 10.1093/sleep/28.12.1511; Philip P, 2008, ANN NEUROL, V64, P410, DOI 10.1002/ana.21448; Philip P, 2014, SLEEP, V37, P483, DOI 10.5665/sleep.3480; Philip P, 2013, INT J PSYCHOPHYSIOL, V89, P195, DOI 10.1016/j.ijpsycho.2013.05.013; Philip P, 2010, SLEEP MED, V11, P973, DOI 10.1016/j.sleep.2010.07.010; Pizza F, 2011, THORAX, V66, P725, DOI 10.1136/thx.2010.140988; Pizza F, 2009, SLEEP, V32, P382, DOI 10.1093/sleep/32.3.382; Powell NB, 2007, SLEEP, V30, P331, DOI 10.1093/sleep/30.3.331; Rodenstein D, 2008, J SLEEP RES, V17, P281, DOI 10.1111/j.1365-2869.2008.00669.x; Strohl KP, 2013, AM J RESP CRIT CARE, V187, P1259, DOI 10.1164/rccm.201304-0726ST; Thorpy MJ, 2015, SLEEP MED, V16, P9, DOI 10.1016/j.sleep.2014.10.002; Thorpy MJ, 2014, SLEEP MED, V15, P502, DOI 10.1016/j.sleep.2014.01.015; Tran Jason, 2014, J Public Health Epidemiol, V8, P202; Tregear S, 2009, J CLIN SLEEP MED, V5, P573	42	43	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129386	10.1371/journal.pone.0129386	http://dx.doi.org/10.1371/journal.pone.0129386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052938	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300122
J	Sompong, W; Cheng, H; Adisakwattana, S				Sompong, Weerachat; Cheng, Henrique; Adisakwattana, Sirichai			Protective Effects of Ferulic Acid on High Glucose-Induced Protein Glycation, Lipid Peroxidation, and Membrane Ion Pump Activity in Human Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; ATPASE ACTIVITIES; OXIDATIVE STRESS; PHENOLIC-ACIDS; NA/K-ATPASE; K+-ATPASE; IN-VITRO; PHOSPHATIDYLSERINE; GLYCOSYLATION; INHIBITION	Ferulic acid (FA) is the ubiquitous phytochemical phenolic derivative of cinnamic acid. Experimental studies in diabetic models demonstrate that FA possesses multiple mechanisms of action associated with anti-hyperglycemic activity. The mechanism by which FA prevents diabetes-associated vascular damages remains unknown. The aim of study was to investigate the protective effects of FA on protein glycation, lipid peroxidation, membrane ion pump activity, and phosphatidylserine exposure in high glucose-exposed human erythrocytes. Our results demonstrated that FA (10-100 mu M) significantly reduced the levels of glycated hemoglobin (HbA1c) whereas 0.1-100 mu M concentrations inhibited lipid peroxidation in erythrocytes exposed to 45 mM glucose. This was associated with increased glucose consumption. High glucose treatment also caused a significant reduction in Na+/K+-ATPase activity in the erythrocyte plasma membrane which could be reversed by FA. Furthermore, we found that FA (0.1-100 mu M) prevented high glucose-induced phosphatidylserine exposure. These findings provide insights into a novel mechanism of FA for the prevention of vascular dysfunction associated with diabetes.	[Sompong, Weerachat] Chulalongkorn Univ, Fac Allied Hlth Sci, Program Clin Biochem & Mol Med, Dept Clin Chem, Bangkok, Thailand; [Sompong, Weerachat; Adisakwattana, Sirichai] Chulalongkorn Univ, Res Grp Herbal Med Prevent & Therapeut Metab Dis, Bangkok, Thailand; [Cheng, Henrique] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Adisakwattana, Sirichai] Chulalongkorn Univ, Dept Nutr & Dietet, Fac Allied Hlth Sci, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Chulalongkorn University	Adisakwattana, S (corresponding author), Chulalongkorn Univ, Res Grp Herbal Med Prevent & Therapeut Metab Dis, Bangkok, Thailand.	sirichai.a@chula.ac.th		adisakwattana, sirichai/0000-0002-7938-6561	Chula Dusadee Pipat project; Asahi Glass Foundation	Chula Dusadee Pipat project; Asahi Glass Foundation	This work was supported by the Chula Dusadee Pipat project and The Asahi Glass Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisakwattana S, 2008, J AGR FOOD CHEM, V56, P7838, DOI 10.1021/jf801208t; Adisakwattana S, 2009, J ENZYM INHIB MED CH, V24, P1194, DOI 10.1080/14756360902779326; Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440; Balasubashini MS, 2003, ACTA DIABETOL, V40, P118, DOI 10.1007/s00592-003-0099-6; Baumann E, 2000, ACTA HISTOCHEM, V102, P21, DOI 10.1078/0065-1281-00534; Chang HK, 2003, J PHARM PHARMACOL, V55, P833, DOI 10.1211/002235703765951456; Choi R, 2011, EXP MOL MED, V43, P676, DOI 10.3858/emm.2011.43.12.078; Closse C, 1999, BRIT J HAEMATOL, V107, P300, DOI 10.1046/j.1365-2141.1999.01718.x; Derham BK, 2003, EUR J BIOCHEM, V270, P2605, DOI 10.1046/j.1432-1033.2003.03631.x; Di Leo MAS, 2002, AMINO ACIDS, V23, P401, DOI 10.1007/s00726-002-0202-2; Djemli-Shipkolye A, 2001, CELL MOL BIOL, V47, P297; Fiske CH, 1925, J BIOL CHEM, V66, P375; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Horvat A, 2006, PHYSIOL RES, V55, P325, DOI 10.33549/physiolres.930696; HUNT JV, 1988, BIOCHEM J, V256, P205, DOI 10.1042/bj2560205; Ihm SH, 1999, METABOLISM, V48, P1141, DOI 10.1016/S0026-0495(99)90128-2; Iwalokun BA, 2007, BMC ENDOCR DISORD; Jain SK, 2000, FREE RADICAL BIO MED, V29, P1122, DOI 10.1016/S0891-5849(00)00410-X; Jain SK, 2006, FREE RADICAL BIO MED, V41, P92, DOI 10.1016/j.freeradbiomed.2006.03.008; Jain SK, 2001, FREE RADICAL BIO MED, V30, P232, DOI 10.1016/S0891-5849(00)00462-7; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; Kanski J, 2002, J NUTR BIOCHEM, V13, P273, DOI 10.1016/S0955-2863(01)00215-7; Kesavulu MM, 2000, DIABETES METAB, V26, P387; Koc B, 2003, ENDOCRINE, V21, P273, DOI 10.1385/ENDO:21:3:273; Kurlbaum M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063197; LAMBOURNE JE, 1988, DIABETOLOGIA, V31, P379, DOI 10.1007/BF02341507; LUPU F, 1988, THROMB RES, V50, P605, DOI 10.1016/0049-3848(88)90319-2; Malfatti CRM, 2012, SCI WORLD J, DOI 10.1100/2012/348246; Martinez V, 2012, J AGR FOOD CHEM, V60, P4090, DOI 10.1021/jf2051784; Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007; Mattila P, 2006, J AGR FOOD CHEM, V54, P7193, DOI 10.1021/jf0615247; Mishra N, 2012, CELL MOL BIOL, V58, P148, DOI 10.1170/T934; Naka K, 1995, DIABETES RES CLIN PR, V30, P153, DOI 10.1016/0168-8227(95)01184-6; Nandhini TA, 2003, CLIN CHIM ACTA, V336, P129, DOI 10.1016/S0009-8981(03)00337-1; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Quan GB, 2008, CRYOBIOLOGY, V56, P53, DOI 10.1016/j.cryobiol.2007.11.001; Quan GB, 2006, CRYOBIOLOGY, V53, P107, DOI 10.1016/j.cryobiol.2006.03.014; RAJESWARI P, 1991, J CELL PHYSIOL, V149, P100, DOI 10.1002/jcp.1041490113; Sakai S, 1999, MEDIAT INFLAMM, V8, P173, DOI 10.1080/09629359990513; Sompong W, 2013, MOLECULES, V18, P13886, DOI 10.3390/molecules181113886; Sprague RS, 1996, AM J PHYSIOL-HEART C, V271, pH2717, DOI 10.1152/ajpheart.1996.271.6.H2717; Sprague RS, 1995, AM J PHYSIOL-HEART C, V269, pH1941, DOI 10.1152/ajpheart.1995.269.6.H1941; Srinivasan M, 2006, TOXICOLOGY, V228, P249, DOI 10.1016/j.tox.2006.09.004; Vague P, 2004, EXP DIABESITY RES, V5, P37, DOI 10.1080/15438600490424514; van Wijk R, 2005, BLOOD, V106, P4034, DOI 10.1182/blood-2005-04-1622; Vlachos DG, 2010, SCAND J CLIN LAB INV, V70, P568, DOI 10.3109/00365513.2010.527365; WALTERS MI, 1968, CLIN CHEM, V14, P682; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	48	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129495	10.1371/journal.pone.0129495	http://dx.doi.org/10.1371/journal.pone.0129495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053739	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300131
J	Umeda, C; Paine, TD				Umeda, Colin; Paine, Timothy D.			Evidence of a Genetic Basis for Differences in Parasitization Success between Strains of Avetianella longoi (Siscaro)	PLOS ONE			English	Article							PHORACANTHA; INSECT; EGG; COLEOPTERA; CERAMBYCIDAE; SEMIPUNCTATA; PARASITOIDS; BIOLOGY	When the cerambycid, Phoracantha recurva, invaded California in the mid 1990' s a parasitoid wasp was imported from its native range in Australia as part of a biological control program. The wasp was later identified to be Avetianella longoi, which had already been released years earlier to control the congener longhorned beetle, Phoracantha semipunctata. Despite being recognized as the same species, the two wasps exhibited differential success on P. recurva eggs, indicating the presence of two separate strains. Here we determine if the differentiating factor between the two strains of A. longoi is a heritable genetic trait. All four pairings between the two strains were conducted, resulting in two homogenous and two heterogeneous crosses. All crosses except one produced viable F1 female offspring. F1 females were allowed to oviposit on P. recurva eggs and the survival of their offspring was compared to determine if survival can be affected by paternal contributions. The result was that the offspring of females with fathers from the second introduced strain showed significantly increased survival compared to F1 females with parents from the first introduced strain. This increased survival demonstrated that there is a heritable dominant trait that is associated with increased survival on P. recurva host eggs.	[Umeda, Colin; Paine, Timothy D.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Paine, TD (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	timothy.paine@ucr.edu			College of Natural and Agricultural Sciences Research Support Application Program	College of Natural and Agricultural Sciences Research Support Application Program	The research was supported by funds provided by the College of Natural and Agricultural Sciences Research Support Application Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, SAS VERS 9 2; AUSTIN AD, 1994, B ENTOMOL RES, V84, P145, DOI 10.1017/S000748530003964X; Beckage NE, 1998, PARASITOLOGY, V116, pS57, DOI 10.1017/S0031182000084948; Bigot Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006397; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Dani MP, 2009, ARCH INSECT BIOCHEM, V71, P191, DOI 10.1002/arch.20315; Dobzhansky T., 1937; Fang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026888; Federici BA, 2009, CURR TOP MICROBIOL, V328, P171; Federici BA, 2003, J INSECT PHYSIOL, V49, P419, DOI 10.1016/S0022-1910(03)00059-3; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hanks L. M., 1996, California Agriculture, V50, P14, DOI 10.3733/ca.v050n03p14; HANKS LM, 1993, OECOLOGIA, V95, P22, DOI 10.1007/BF00649502; HANKS LM, 1995, ANN ENTOMOL SOC AM, V88, P666, DOI 10.1093/aesa/88.5.666; Luhring KA, 2000, BIOL CONTROL, V19, P95, DOI 10.1006/bcon.2000.0853; Luhring KA, 2004, BIOL CONTROL, V30, P382, DOI 10.1016/j.biocontrol.2004.01.008; Maheshwari S, 2011, ANNU REV GENET, V45, P331, DOI 10.1146/annurev-genet-110410-132514; Muller HJ, 1942, BIOL S, V6, P71; ONEILL SL, 1992, P NATL ACAD SCI USA, V89, P2699, DOI 10.1073/pnas.89.7.2699; Reed DA, 2007, BIOL CONTROL, V41, P214, DOI 10.1016/j.biocontrol.2007.01.010; ROTHERAM S, 1973, PROC R SOC SER B-BIO, V183, P179, DOI 10.1098/rspb.1973.0012; SALT G, 1968, BIOL REV, V43, P200, DOI 10.1111/j.1469-185X.1968.tb00959.x; Stasiak K, 2005, J INSECT PHYSIOL, V51, P103, DOI 10.1016/j.jinsphys.2004.07.004; Teramoto T, 2004, J INSECT PHYSIOL, V50, P1103, DOI 10.1016/j.jinsphys.2004.08.005; Wang Q, 1999, ANN ENTOMOL SOC AM, V92, P631, DOI 10.1093/aesa/92.5.631; Wang Q, 2008, J ECON ENTOMOL, V101, P1771, DOI 10.1603/0022-0493-101.6.1771; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; Xue HJ, 2009, J EVOLUTION BIOL, V22, P2258, DOI 10.1111/j.1420-9101.2009.01841.x	29	0	0	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129558	10.1371/journal.pone.0129558	http://dx.doi.org/10.1371/journal.pone.0129558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053514	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300142
J	Arora, A; Shafiq, N; Jain, S; Khuller, GK; Sharma, S; Malhotra, S				Arora, Anjuman; Shafiq, Nusrat; Jain, Sanjay; Khuller, G. K.; Sharma, Sadhana; Malhotra, Samir			Development of Sustained Release "NanoFDC (Fixed Dose Combination)" for Hypertension - An Experimental Study	PLOS ONE			English	Article							DRUG-DELIVERY; ARTERIAL-HYPERTENSION; MANAGEMENT; NANOPARTICLES; OPTIMIZATION; THERAPY	Objectives The present study was planned to formulate, characterize and evaluate the pharmacokinetics of a novel "NanoFDC" comprising three commonly prescribed anti-hypertensive drugs, hydrochlorothiazide (a diuretic), candesartan (ARB) and amlodipine (a calcium channel blocker). Basic Methods The candidate drugs were loaded in Poly (DL-lactide-co-gycolide) (PLGA) by emulsion-diffusion-evaporation method. The formulations were evaluated for their size, morphology, drug loading and in vitro release individually. Single dose pharmacokinetic profiles of the nanoformulations alone and in combination, as a NanoFDC, were evaluated in Wistar rats. Results The candidate drugs encapsulated inside PLGA showed entrapment efficiencies ranging from 30%, 33.5% and 32% for hydrochlorothiazide, candesartan and amlodipine respectively. The nanoparticles ranged in size from 110 to 180 nm. In vitro release profile of the nanoformulation showed 100% release by day 6 in the physiological pH 7.4 set up with PBS (phosphate buffer saline) and by day 4-5 in the intestinal pH 1.2 and 8.0 set up SGF (simulated gastric fluid) and SIF (simulated intestinal fluid) respectively. In pharmacokinetic analysis a sustained-release for 6 days and significant increase in the mean residence time (MRT), as compared to the respective free drugs was noted [MRT of amlodipine, hydrochlorothiazide and candesartan changed from 8.9 to 80.59 hours, 11 to 69.20 hours and 9 to 101.49 hours respectively]. Conclusion We have shown for the first time that encapsulating amlodipine, hydrochlorothiazide and candesartan into a single nanoformulation, to get the "NanoFDC (Fixed Dose Combination)" is a feasible strategy which aims to decrease pill burden.	[Arora, Anjuman; Shafiq, Nusrat; Malhotra, Samir] Postgrad Inst Med Educ & Res, Dept Pharmacol, Chandigarh 160012, India; [Jain, Sanjay] Postgrad Inst Med Educ & Res, Dept Internal Med, Chandigarh 160012, India; [Khuller, G. K.; Sharma, Sadhana] Postgrad Inst Med Educ & Res, Dept Biochem, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Malhotra, S (corresponding author), Postgrad Inst Med Educ & Res, Dept Pharmacol, Chandigarh 160012, India.	Samirmalhotra345@yahoo.com		Jain, Sanjay K/0000-0002-9241-3114	Department of Science and Technology, new Delhi [SR/FT/LS-047/2008]	Department of Science and Technology, new Delhi(Department of Science & Technology (India))	Funding provided by Department of Science and Technology, new Delhi: SR/FT/LS-047/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, PHARM TOXICOLOGY JUL; Arora A, 2014, CURR NANOSCI, V10, P816, DOI 10.2174/1573413710666140512221814; Baggarly SA, 2014, RES SOC ADMIN PHARM, P1, DOI [10.1016/j.sapharm.2014.04.002, DOI 10.1016/J.SAPHARM.2014.04.002]; Barrios V, 2010, EXPERT REV CARDIOVAS, V8, P1609, DOI [10.1586/erc.10.115, 10.1586/ERC.10.115]; Cao Y, 2011, FUTURE ONCOL, V7, P1347, DOI [10.2217/FON.11.109, 10.2217/fon.11.109]; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dickson M, 2008, AM J CARDIOVASC DRUG, V8, P45, DOI 10.2165/00129784-200808010-00006; Hackam DG, 2010, CAN J CARDIOL, V26, P249, DOI 10.1016/S0828-282X(10)70379-2; He WL, 2007, INT J PHARMACEUT, V334, P173, DOI 10.1016/j.ijpharm.2006.10.025; Heng D, 2008, PHARM RES-DORDR, V25, P1696, DOI 10.1007/s11095-008-9560-0; Italia JL, 2007, J CONTROL RELEASE, V119, P197, DOI 10.1016/j.jconrel.2007.02.004; Jain R, 1998, DRUG DEV IND PHARM, V24, P703, DOI 10.3109/03639049809082719; Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0; JAMES PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Khan MU, 2014, J PHARM BIOALLIED SC, V6, P104, DOI 10.4103/0975-7406.129175; Kumar G, 2012, J PHARM SCI-US, V101, P2165, DOI 10.1002/jps.23087; Kumar G, 2011, DRUG DELIV, V18, P65, DOI 10.3109/10717544.2010.509367; Mancia G, 2007, J HYPERTENS, V25, P1751, DOI 10.1097/HJH.0b013e3282f0580f; Martin J., 2008, JLGH, V3, P91; Okuda T., 2012, J BIOMATER NANOBIOTE, V3, P50; Pandey Rajesh, 2006, Indian Journal of Experimental Biology, V44, P459; Rojas J, 1999, INT J PHARM, V183, P67, DOI 10.1016/S0378-5173(99)00046-0; Sanz G, 2009, NAT CLIN PRACT CARD, V6, P101, DOI 10.1038/ncpcardio1419; Stevanovic M, 2009, CURR NANOSCI, V5, P1, DOI 10.2174/157341309787314566; Thrall G, 2004, J HUM HYPERTENS, V18, P595, DOI 10.1038/sj.jhh.1001722; Tocci G, 2011, HIGH BLOOD PRESS CAR, V18, P3, DOI 10.2165/1159615-s0-000000000-00000; Ullavapally KR, 2011, J PHARM RES, V4, P894; van Galen KA, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/967073; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Wald NJ, 2004, UK patent GB, Patent No. 2361186; Xinhuan W, 2014, ASIAN J PHARM SCI, V9, P1, DOI 10.1016/j.ajps.2013.12.005	31	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128208	10.1371/journal.pone.0128208	http://dx.doi.org/10.1371/journal.pone.0128208			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047011	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200048
J	Berding, G; Wilke, F; Rode, T; Haense, C; Joseph, G; Meyer, GJ; Mamach, M; Lenarz, M; Geworski, L; Bengel, FM; Lenarz, T; Lim, HH				Berding, Georg; Wilke, Florian; Rode, Thilo; Haense, Cathleen; Joseph, Gert; Meyer, Geerd J.; Mamach, Martin; Lenarz, Minoo; Geworski, Lilli; Bengel, Frank M.; Lenarz, Thomas; Lim, Hubert H.			Positron Emission Tomography Imaging Reveals Auditory and Frontal Cortical Regions Involved with Speech Perception and Loudness Adaptation	PLOS ONE			English	Article							COCHLEAR IMPLANT; SINGLE-SUBJECT; DEAFNESS REHABILITATION; MIDBRAIN IMPLANT; BRAIN; TINNITUS; PET; STIMULATION; ACTIVATION; PLASTICITY	Considerable progress has been made in the treatment of hearing loss with auditory implants. However, there are still many implanted patients that experience hearing deficiencies, such as limited speech understanding or vanishing perception with continuous stimulation (i.e., abnormal loudness adaptation). The present study aims to identify specific patterns of cerebral cortex activity involved with such deficiencies. We performed O-15-water positron emission tomography (PET) in patients implanted with electrodes within the cochlea, brainstem, or midbrain to investigate the pattern of cortical activation in response to speech or continuous multi-tone stimuli directly inputted into the implant processor that then delivered electrical patterns through those electrodes. Statistical parametric mapping was performed on a single subject basis. Better speech understanding was correlated with a larger extent of bilateral auditory cortex activation. In contrast to speech, the continuous multi-tone stimulus elicited mainly unilateral auditory cortical activity in which greater loudness adaptation corresponded to weaker activation and even deactivation. Interestingly, greater loudness adaptation was correlated with stronger activity within the ventral prefrontal cortex, which could be up-regulated to suppress the irrelevant or aberrant signals into the auditory cortex. The ability to detect these specific cortical patterns and differences across patients and stimuli demonstrates the potential for using PET to diagnose auditory function or dysfunction in implant patients, which in turn could guide the development of appropriate stimulation strategies for improving hearing rehabilitation. Beyond hearing restoration, our study also reveals a potential role of the frontal cortex in suppressing irrelevant or aberrant activity within the auditory cortex, and thus may be relevant for understanding and treating tinnitus.	[Berding, Georg; Haense, Cathleen; Meyer, Geerd J.; Mamach, Martin; Bengel, Frank M.] Hannover Med Sch, Dept Nucl Med, Hannover, Germany; [Berding, Georg; Rode, Thilo; Mamach, Martin; Lenarz, Thomas] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany; [Wilke, Florian; Geworski, Lilli] Hannover Med Sch, Dept Med Phys & Radiat Protect, Hannover, Germany; [Rode, Thilo; Joseph, Gert; Lenarz, Thomas] Hannover Med Sch, Dept Otorhinolaryngol, Hannover, Germany; [Lenarz, Minoo] Charite, Dept Otolaryngol, D-13353 Berlin, Germany; [Lim, Hubert H.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN USA; [Lim, Hubert H.] Univ Minnesota, Dept Otolaryngol Head & Neck Surg, Minneapolis, MN USA	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Berding, G (corresponding author), Hannover Med Sch, Dept Nucl Med, Hannover, Germany.	berding.georg@mh-hannover.de	Bengel, Frank/AAR-7353-2020	Mamach, Martin/0000-0002-3461-2668; Bengel, Frank/0000-0003-4529-7963; Lim, Hubert/0000-0001-5653-9679	German Ministry of Research and Education [01GQ0816]; University of Minnesota (Institute for Translational Neuroscience); University of Minnesota (College of Science and Engineering)	German Ministry of Research and Education(Federal Ministry of Education & Research (BMBF)); University of Minnesota (Institute for Translational Neuroscience); University of Minnesota (College of Science and Engineering)	This work was funded by the German Ministry of Research and Education (Grant No. 01GQ0816). Start-up funds were received from the University of Minnesota (Institute for Translational Neuroscience and the College of Science and Engineering).	ALHO K, 1994, ELECTROEN CLIN NEURO, V91, P353, DOI 10.1016/0013-4694(94)00173-1; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Chmielowska J, 1999, J CEREBR BLOOD F MET, V19, P570, DOI 10.1097/00004647-199905000-00011; Chmielowska J, 1998, J CEREBR BLOOD F MET, V18, P433, DOI 10.1097/00004647-199804000-00012; Coez A, 2008, J NUCL MED, V49, P60, DOI 10.2967/jnumed.107.044545; Coez Arnaud, 2011, Cochlear Implants Int, V12 Suppl 1, pS124, DOI 10.1179/146701011X13001036693539; Coez A, 2009, NEUROIMAGE, V47, P1792, DOI 10.1016/j.neuroimage.2009.05.053; De Ridder D, 2013, BRAIN STIMUL, V6, P355, DOI 10.1016/j.brs.2012.07.002; De Ridder D, 2012, WORLD NEUROSURG, V77, P778, DOI 10.1016/j.wneu.2011.09.009; Di Nardo W, 2004, Acta Otorhinolaryngol Ital, V24, P321; Di Nardo W, 2001, EUR ARCH OTO-RHINO-L, V258, P496, DOI 10.1007/s004050100379; FRACKOWIAK RSJ, 1994, J ANAT, V184, P211; Fujiki N, 2000, ANN OTO RHINOL LARYN, V109, P12, DOI 10.1177/0003489400109S1204; Fujiki Nobuya, 1999, Auris Nasus Larynx, V26, P229, DOI 10.1016/S0385-8146(99)00009-7; Giraud AL, 2001, AUDIOL NEURO-OTOL, V6, P381, DOI 10.1159/000046847; Giraud AL, 2001, BRAIN, V124, P1307, DOI 10.1093/brain/124.7.1307; Gu JW, 2010, J NEUROPHYSIOL, V104, P3361, DOI 10.1152/jn.00226.2010; Henry JA, 2014, J AM ACAD AUDIOL, V25, P5, DOI 10.3766/jaaa.25.1.2; Hirano S, 2000, Auris Nasus Larynx, V27, P303, DOI 10.1016/S0385-8146(00)00072-9; Johnson MD, 2013, IEEE T BIO-MED ENG, V60, P610, DOI 10.1109/TBME.2013.2244890; Johnsrude IS, 2002, AUDIOL NEURO-OTOL, V7, P251, DOI 10.1159/000064446; Kaltenbach JA, 2011, HEARING RES, V276, P52, DOI 10.1016/j.heares.2010.12.003; Kinahan PE, 1999, NEUROIMAGE, V9, P430, DOI 10.1006/nimg.1998.0420; KNIGHT RT, 1989, BRAIN RES, V504, P338, DOI 10.1016/0006-8993(89)91381-4; Lanting CP, 2009, HEARING RES, V255, P1, DOI 10.1016/j.heares.2009.06.009; Lenarz T, 2006, OTOL NEUROTOL, V27, P838, DOI 10.1097/01.mao.0000232010.01116.e9; Lim HH, 2008, NEUROSCIENCE, V154, P370, DOI 10.1016/j.neuroscience.2008.02.041; Lim HH, 2015, BRAIN STIMUL, V8, P439, DOI 10.1016/j.brs.2014.10.016; Lim HH, 2015, HEARING RES, V322, P212, DOI 10.1016/j.heares.2015.01.006; Lim Hubert H, 2009, Trends Amplif, V13, P149, DOI 10.1177/1084713809348372; Matzke K.-H., 1993, Journal of Labelled Compounds and Radiopharmaceuticals, V32, P459; Miyamoto RT, 2001, J COMMUN DISORD, V34, P473, DOI 10.1016/S0021-9924(01)00062-4; Miyamoto RT, 1999, AM J OTOL, V20, P596; Moller AR, 2011, TEXTBOOK OF TINNITUS, P1; Morris JS, 1998, P ROY SOC B-BIOL SCI, V265, P649, DOI 10.1098/rspb.1998.0343; NAITO Y, 1995, COGNITIVE BRAIN RES, V2, P207, DOI 10.1016/0926-6410(95)90009-8; Nishimura H, 2000, NEUROREPORT, V11, P811, DOI 10.1097/00001756-200003200-00031; Okazawa H, 1996, BRAIN, V119, P1297, DOI 10.1093/brain/119.4.1297; Rauschecker JP, 2011, AUDITORY CORTEX, P99, DOI 10.1007/978-1-4419-0074-6_4; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Warburton E, 1999, J NEUROL NEUROSUR PS, V66, P155, DOI 10.1136/jnnp.66.2.155; Zatorre RJ, 2012, SPRINGER HANDB AUDIT, V43, P261, DOI 10.1007/978-1-4614-2314-0_10	42	20	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128743	10.1371/journal.pone.0128743	http://dx.doi.org/10.1371/journal.pone.0128743			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046763	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200096
J	Fu, XL; Wang, JL; Di, YB; Wang, HM				Fu, Xiaoli; Wang, Jianlei; Di, Yuebao; Wang, Huimin			Differences in Fine-Root Biomass of Trees and Understory Vegetation among Stand Types in Subtropical Forests	PLOS ONE			English	Article							BELOW-GROUND CARBON; NORWAY SPRUCE; SPECIES-DIVERSITY; INTERSPECIFIC COMPETITION; EUROPEAN BEECH; PINE; PRODUCTIVITY; PLANTATIONS; CHINA; AGE	Variation of total fine-root biomass among types of tree stands has previously been attributed to the characteristics of the stand layers. The effects of the understory vegetation on total fine-root biomass are less well studied. We examined the variation of total fine-root biomass in subtropical tree stands at two sites of Datian and Huitong in China. The two sites have similar humid monsoon climate but different soil organic carbon. One examination compared two categories of basal areas (high vs. low basal area) in stands of single species. A second examination compared single-species and mixed stands with comparable basal areas. Low basal area did not correlate with low total fine-root biomass in the single-species stands. The increase in seedling density but decrease in stem density for the low basal area stands at Datian and the quite similar stand structures for the basal-area contrast at Huitong helped in the lack of association between basal area and total fine-root biomass at the two sites, respectively. The mixed stands also did not yield higher total fine-root biomasses. In addition to the lack of niche complementarity between tree species, the differences in stem and seedling densities and the belowground competition between the tree and non-tree species also contributed to the similarity of the total fine-root biomasses in the mixed and single-species stands. Across stand types, the more fertile site Datian yielded higher tree, non-tree and total fine-root biomasses than Huitong. However, the contribution of non-tree fine-root biomass to the total fine-root biomass was higher at Huitong (29.4%) than that at Datian (16.7%). This study suggests that the variation of total fine-root biomass across stand types not only was associated with the characteristics of trees, but also may be highly dependent on the understory layer.	[Fu, Xiaoli; Wang, Jianlei; Di, Yuebao; Wang, Huimin] Chinese Acad Sci, Qianyanzhou Ecol Stn, Key Lab Ecosystem Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Wang, HM (corresponding author), Chinese Acad Sci, Qianyanzhou Ecol Stn, Key Lab Ecosystem Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China.	wanghm@igsnrr.ac.cn	wang, huimin/HDM-8421-2022		National Key Basic Research Special Foundation Project [2012CB416903]; NSFC Projects of International Cooperation and Exchanges [31210103920]; National Natural Science Foundations of China [41101203]; National Key Technology Support Program [2012BAC11B05]	National Key Basic Research Special Foundation Project(National Basic Research Program of China); NSFC Projects of International Cooperation and Exchanges; National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program)	This work was funded by the National Key Basic Research Special Foundation Project (2012CB416903), the NSFC Projects of International Cooperation and Exchanges (31210103920), the National Natural Science Foundations of China (41101203), and the National Key Technology Support Program (2012BAC11B05).	Bakker MR, 2006, PLANT SOIL, V286, P37, DOI 10.1007/s11104-006-9024-4; Barnes PW, 1999, J VEG SCI, V10, P525, DOI 10.2307/3237187; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Bolte A, 2006, EUR J FOREST RES, V125, P15, DOI 10.1007/s10342-005-0075-5; Brassard BW, 2013, J ECOL, V101, P210, DOI 10.1111/1365-2745.12023; Brassard BW, 2011, FUNCT ECOL, V25, P238, DOI 10.1111/j.1365-2435.2010.01769.x; Chen Guang-Shui, 2008, Zhiwu Shengtai Xuebao, V32, P1285, DOI 10.3773/j.issn.1005-264x.2008.06.009; Chen J, 2014, FOREST RES, V27, P99, DOI [10.1021/tx400350b, DOI 10.1021/TX400350B]; Claus A, 2005, CAN J FOREST RES, V35, P1617, DOI 10.1139/x05-079; Duan WJ, 2010, RESTOR ECOL, V18, P206, DOI 10.1111/j.1526-100X.2008.00444.x; [樊后保 FAN Houbao], 2011, [生态学报, Acta Ecologica Sinica], V31, P3277; Finer L, 2011, FOREST ECOL MANAG, V261, P265, DOI 10.1016/j.foreco.2010.10.016; Helmisaari HS, 2007, TREE PHYSIOL, V27, P1493, DOI 10.1093/treephys/27.10.1493; Hwang J, 2007, J PLANT NUTR, V30, P1821, DOI 10.1080/01904160701628940; Jacob A, 2013, OIKOS, V122, P463, DOI 10.1111/j.1600-0706.2012.20476.x; Kucbel S, 2011, PLANT ROOT, V5, P46, DOI 10.3117/plantroot.5.46; Laclau JP, 2013, OECOLOGIA, V172, P903, DOI 10.1007/s00442-012-2526-2; Lang'at JKS, 2013, OECOLOGIA, V172, P271, DOI 10.1007/s00442-012-2490-x; Lei PF, 2012, OECOLOGIA, V169, P1105, DOI 10.1007/s00442-012-2259-2; Leuschner C, 2004, PLANT SOIL, V258, P43, DOI 10.1023/B:PLSO.0000016508.20173.80; Lopez BC, 2003, TREE PHYSIOL, V23, P1217, DOI 10.1093/treephys/23.17.1217; Lu L, 2012, J SUBTROPICAL RESOUR, V7, P70; Margalef R., 1957, GEN SYST, V3, P36, DOI DOI 10.12691/AJSS-2-5-1; Maron JL, 2011, ECOL LETT, V14, P36, DOI 10.1111/j.1461-0248.2010.01547.x; McHugh TA, 2006, NEW PHYTOL, V171, P171, DOI 10.1111/j.1469-8137.2006.01735.x; Meinen C, 2009, TREES-STRUCT FUNCT, V23, P941, DOI 10.1007/s00468-009-0336-x; Rewald B, 2009, EUR J FOREST RES, V128, P387, DOI 10.1007/s10342-009-0276-4; Rolo V, 2012, TREES-STRUCT FUNCT, V26, P977; Schmid I, 2002, FOREST ECOL MANAG, V159, P37, DOI 10.1016/S0378-1127(01)00708-3; Schmid I, 2002, BASIC APPL ECOL, V3, P339, DOI 10.1078/1439-1791-00116; Tian DL, 2010, PEDOSPHERE, V20, P486, DOI 10.1016/S1002-0160(10)60038-0; Tong S, 1989, FOR SCI TECHNOL, V8, P9; Vargas R, 2009, BIOTROPICA, V41, P302, DOI 10.1111/j.1744-7429.2009.00494.x; Vogt KA, 1996, PLANT SOIL, V187, P159, DOI 10.1007/BF00017088; VOGT KA, 1987, J ECOL, V75, P857, DOI 10.2307/2260210; Wang QK, 2008, FOREST ECOL MANAG, V255, P1210, DOI 10.1016/j.foreco.2007.10.026; Yanai RD, 2006, CAN J FOREST RES, V36, P450, DOI 10.1139/X05-254; Yang Y.S., 2001, SCI SILVAE SINICAE, V37, P35; Zhang WJ, 2011, BIOGEOSCIENCES, V8, P1667, DOI 10.5194/bg-8-1667-2011; Zhao J, 2012, SOIL BIOL BIOCHEM, V49, P78, DOI 10.1016/j.soilbio.2012.02.020	40	15	20	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128894	10.1371/journal.pone.0128894	http://dx.doi.org/10.1371/journal.pone.0128894			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047358	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200110
J	Su, M; Alonso, S; Jones, JW; Yu, JS; Kane, MA; Jones, RJ; Ghiaur, G				Su, Meng; Alonso, Salvador; Jones, Jace W.; Yu, Jianshi; Kane, Maureen A.; Jones, Richard J.; Ghiaur, Gabriel			All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; DIFFERENTIATION THERAPY; SELF-RENEWAL; BLAST CELLS; IN-VIVO; ATRA; AML; CHEMOTHERAPY; TRANSCRIPTION; METABOLISM	Differentiation therapy with all-trans retinoic acid (atRA) has markedly improved outcome in acute promyelocytic leukemia (APL) but has had little clinical impact in other AML subtypes. Cell intrinsic mechanisms of resistance have been previously reported, yet the majority of AML blasts are sensitive to atRA in vitro. Even in APL, single agent atRA induces remission without cure. The microenvironment expression of cytochrome P450 (CYP) 26, a retinoid-metabolizing enzyme was shown to determine normal hematopoietic stem cell fate. Accordingly, we hypothesized that the bone marrow (BM) microenvironment is responsible for difference between in vitro sensitivity and in vivo resistance of AML to atRA-induced differentiation. We observed that the pro-differentiation effects of atRA on APL and non-APL AML cells as well as on leukemia stem cells from clinical specimens were blocked by BM stroma. In addition, BM stroma produced a precipitous drop in atRA levels. Inhibition of CYP26 rescued atRA levels and AML cell sensitivity in the presence of stroma. Our data suggest that stromal CYP26 activity creates retinoid low sanctuaries in the BM that protect AML cells from systemic atRA therapy. Inhibition of CYP26 provides new opportunities to expand the clinical activity of atRA in both APL and non-APL AML.	[Su, Meng; Alonso, Salvador; Jones, Richard J.; Ghiaur, Gabriel] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Jones, Jace W.; Yu, Jianshi; Kane, Maureen A.] Univ Maryland, Sch Pharm, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore	Ghiaur, G (corresponding author), Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	gghiaur1@jhmi.edu		Ghiaur, Gabriel/0000-0002-3955-7944; Jones, Jace/0000-0003-0460-0380; Alonso Martinez, Salvador/0000-0003-4604-7691	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [HHSN272202000046C]; University of Maryland School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; NIH [P01 CA15396, CA70790]; American Society of Hematology Research Fellow Award; Maryland Stem Cell Research Award; Passano Clinician Scientist Award; NATIONAL CANCER INSTITUTE [R21CA070790, P01CA015396] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL127269] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Maryland School of Pharmacy Mass Spectrometry Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Research Fellow Award; Maryland Stem Cell Research Award; Passano Clinician Scientist Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by: National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases #HHSN272202000046C and the University of Maryland School of Pharmacy Mass Spectrometry Center #SOP1841-IQB2014 (MAK); NIH Grants P01 CA15396 and CA70790 (RJJ) and American Society of Hematology Research Fellow Award, Maryland Stem Cell Research Award and Passano Clinician Scientist Award (GG).	Adamson PC, 1997, J CLIN ONCOL, V15, P3330, DOI 10.1200/JCO.1997.15.11.3330; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; ASOU H, 1991, BLOOD, V77, P2031; Balusu R, 2011, BLOOD, V118, P3096, DOI 10.1182/blood-2010-09-309674; BEDI A, 1995, BLOOD, V86, P1148, DOI 10.1182/blood.V86.3.1148.bloodjournal8631148; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Bullinger L, 2013, CLIN CANCER RES, V19, P2562, DOI 10.1158/1078-0432.CCR-11-2524; Burnett AK, 2007, CANCER, V109, P1114, DOI 10.1002/cncr.22496; Burnett AK, 2010, BLOOD, V115, P948, DOI 10.1182/blood-2009-08-236588; dos Santos GA, 2013, J EXP MED, V210, P2793, DOI 10.1084/jem.20131121; ECKHOFF C, 1991, J NUTR, V121, P1016, DOI 10.1093/jn/121.7.1016; Estey EH, 1999, BLOOD, V93, P2478, DOI 10.1182/blood.V93.8.2478.408k04_2478_2484; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Gerber JM, 2012, BLOOD, V119, P3571, DOI 10.1182/blood-2011-06-364182; Geria AN, 2008, CURR OPIN INVEST DR, V9, P1228; Ghiaur G, 2013, P NATL ACAD SCI USA, V110, P16121, DOI 10.1073/pnas.1305937110; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; LANOTTE M, 1991, BLOOD, V77, P1080; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lehmann S, 2002, LEUKEMIA LYMPHOMA, V43, P851, DOI 10.1080/10428190290016999; Lehmann S, 2000, LEUKEMIA RES, V24, P19, DOI 10.1016/S0145-2126(99)00153-8; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Manfredini R, 1999, CANCER RES, V59, P3803; Matsui WH, 2002, CELL GROWTH DIFFER, V13, P275; Milligan DW, 2006, BLOOD, V107, P4614, DOI 10.1182/blood-2005-10-4202; Nazha A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00218; Osanai M, 2005, MOL PHARMACOL, V67, P1808, DOI 10.1124/mol.104.005769; Ozpolat B, 2005, LEUKEMIA LYMPHOMA, V46, P1497, DOI 10.1080/10428190500174737; Petrie K, 2009, CURR OPIN HEMATOL, V16, P84, DOI 10.1097/MOH.0b013e3283257aee; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Rice AM, 2004, LEUKEMIA RES, V28, P1227, DOI 10.1016/j.leukres.2004.03.017; Ryningen A, 2008, EXPERT OPIN INV DRUG, V17, P1623, DOI [10.1517/13543784.17.11.1623, 10.1517/13543784.17.11.1623 ]; Sakamoto K, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.25; SAKASHITA A, 1993, BLOOD, V81, P1009; Schlenk RF, 2004, LEUKEMIA, V18, P1798, DOI 10.1038/sj.leu.2403528; Schlenk RF, 2009, HAEMATOL-HEMATOL J, V94, P54, DOI 10.3324/haematol.13378; Seiter K, 2000, BRIT J HAEMATOL, V108, P40, DOI 10.1046/j.1365-2141.2000.01804.x; Theodosiou M, 2010, CELL MOL LIFE SCI, V67, P1423, DOI 10.1007/s00018-010-0268-z; Tobita T, 1997, BLOOD, V90, P967, DOI 10.1182/blood.V90.3.967.967_967_973; TURHAN AG, 1995, BLOOD, V85, P2154, DOI 10.1182/blood.V85.8.2154.bloodjournal8582154; VENDITTI A, 1995, LEUKEMIA, V9, P1121; Wang YP, 2002, ARCH BIOCHEM BIOPHYS, V401, P235, DOI 10.1016/S0003-9861(02)00043-7; WANG Z Y, 1990, Nouvelle Revue Francaise d'Hematologie, V32, P34; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; WARRELL RP, 1991, NEW ENGL J MED, V324, P1385, DOI 10.1056/NEJM199105163242002; WILLIAMS JB, 1985, P NATL ACAD SCI USA, V82, P4658, DOI 10.1073/pnas.82.14.4658	48	42	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127790	10.1371/journal.pone.0127790	http://dx.doi.org/10.1371/journal.pone.0127790			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047326	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200030
J	Yang, Q; Fang, LF; Fu, Y; Du, XX; Shen, YQ; Yu, YS				Yang, Qing; Fang, Lanfang; Fu, Ying; Du, Xiaoxing; Shen, Yuqin; Yu, Yunsong			Dissemination of NDM-1-Producing Enterobacteriaceae Mediated by the IncX3-Type Plasmid	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; NDM-1; IDENTIFICATION; EMERGENCE; WORLDWIDE; ISOLATE; SPREAD; HEALTH	The emergence and spread of NDM-1-producing Enterobacteriaceae have resulted in a worldwide public health risk that has affected some provinces of China. China is an exceptionally large country, and there is a crucial need to investigate the epidemic of blaNDM-1positive Enterobacteriaceae in our province. A total of 186 carbapenem-resistant Enterobacteriaceae isolates (CRE) were collected in a grade-3 hospital in Zhejiang province. Carbapenem-resistant genes, including bla(KPC), bla(IMP), bla(VIM), bla(OXA-48) and bla(NDM-1) were screened and sequenced. Ninety isolates were identified as harboring the bla(KPC-2) genes, and five bla(NDM-1)-positive isolates were uncovered. XbaI-PFGE revealed that three bla(NDM-1)- positive K. pneumoniae isolates belonged to two different clones. S1-PFGE and southern blot suggested that the bla(NDM-1) genes were located on IncX3-type plasmids with two different sizes ranging from 33.3 to 54.7 kb (n=4) and 104.5 to 138.9 kb (n=1), respectively, all of which could easily transfer to Escherichia coli by conjugation and electrotransformation. The high-throughput sequencing of two plasmids was performed leading to the identification of a smaller 54-kb plasmid, which had high sequence similarity with a previously reported pCFNDM-CN, and a larger plasmid in which only a 7.8-kb sequence of a common gene environment around bla(NDM-1) (bla(NDM-1)-trpF-dsbC-cutA1-groEL-Delta InsE,) was detected. PCR mapping and sequencing demonstrated that four smaller bla(NDM-1) plasmids contained a common gene environment around blaNDM-1 (IS5-bla(NDM-1)-trpF-dsbC-cutA1-groEL). We monitored the CRE epidemic in our hospital and determined that KPC-2 carbapenemase was a major risk to patient health and the IncX3-type plasmid played a vital role in the spread of the bla(NDM-1) gene among the CRE.	[Yang, Qing; Shen, Yuqin; Yu, Yunsong] Zhejiang Univ, State Key Lab Diag & Treatment Infect Dis, Collaborat Innovat Ctr Diag & Treatment Infect Di, Coll Med,Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Fang, Lanfang] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Fu, Ying; Du, Xiaoxing; Yu, Yunsong] Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China	Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Zhejiang University; Zhejiang University	Yu, YS (corresponding author), Zhejiang Univ, Coll Med, Sir Run Run Shaw Hosp, Dept Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	yvys119@163.com			National Natural Science Foundation of China [NSFC31170130, NSFC81471986]; National High-Technology Research and Development Program ("863" Program) of China [2013AA020203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China (no. NSFC31170130 and no. NSFC81471986) and National High-Technology Research and Development Program ("863" Program) of China (no. 2013AA020203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Dolejska M, 2013, J ANTIMICROB CHEMOTH, V68, P34, DOI 10.1093/jac/dks357; Doyle D, 2012, J CLIN MICROBIOL, V50, P3877, DOI 10.1128/JCM.02117-12; Du XX, 2013, J MED MICROBIOL, V62, P1332, DOI 10.1099/jmm.0.057091-0; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Ho PL, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.37; Ho PL, 2012, J ANTIMICROB CHEMOTH, V67, P1553, DOI 10.1093/jac/dks095; Johnson TJ, 2012, PLASMID, V68, P43, DOI 10.1016/j.plasmid.2012.03.001; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Mulvey MR, 2011, EMERG INFECT DIS, V17, P103, DOI 10.3201/eid1701.101358; Nordmann P, 2014, MED MALADIES INFECT, V44, P51, DOI 10.1016/j.medmal.2013.11.007; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Pharmaceuticals, W TYPACIL PRODUCT IN; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Qin SS, 2014, ANTIMICROB AGENTS CH, V58, P4275, DOI 10.1128/AAC.02813-13; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Schwaber MJ, 2008, JAMA-J AM MED ASSOC, V300, P2911, DOI 10.1001/jama.2008.896; Shen P, 2009, ANTIMICROB AGENTS CH, V53, P4333, DOI 10.1128/AAC.00260-09; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Wei ZQ, 2007, ANTIMICROB AGENTS CH, V51, P763, DOI 10.1128/AAC.01053-06; Witonski D, 2006, J CLIN MICROBIOL, V44, P3849, DOI 10.1128/JCM.00469-06; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09	25	12	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129454	10.1371/journal.pone.0129454	http://dx.doi.org/10.1371/journal.pone.0129454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047502	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200162
J	Zhou, S; Zu, Y; Sun, ZL; Zhuang, FY; Yang, C				Zhou, Shuai; Zu, Yan; Sun, Zhenglong; Zhuang, Fengyuan; Yang, Chun			Effects of Hypergravity on Osteopontin Expression in Osteoblasts	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT FIBROBLASTS; THYROID-CANCER CELLS; EXTRACELLULAR-MATRIX; MECHANICAL-STRESS; GENE-EXPRESSION; MC3T3-E1 OSTEOBLASTS; BONE-RESORPTION; MESSENGER-RNA; FLUID-FLOW; MECHANOTRANSDUCTION	Mechanical stimuli play crucial roles in bone remodeling and resorption. Osteopontin (OPN), a marker for osteoblasts, is important in cell communication and matrix mineralization, and is known to function during mechanotransduction. Hypergravity is a convenient approach to forge mechanical stimuli on cells. It has positive effects on certain markers of osteoblast maturation, making it a possible strategy for bone tissue engineering. We investigated the effects of hypergravity on OPN expression and cell signaling in osteoblasts. Hypergravity treatment at 20 g for 24 hours upregulated OPN expression in MC3T3-E1 cells at the protein as well as mRNA level. Hypergravity promoted OPN expression by facilitating focal adhesion assembly, strengthening actin bundles, and increasing Runx2 expression. In the hypergravity-triggered OPN expression pathway, focal adhesion assembly-associated FAK phosphorylation was upstream of actin bundle assembly.	[Zhou, Shuai; Zhuang, Fengyuan] Beihang Univ, Sch Biol Sci & Med Engn, Beijing 100191, Peoples R China; [Zu, Yan; Sun, Zhenglong; Yang, Chun] Tsinghua Univ, Sch Aerosp Engn, Inst Biomechan & Med Engn, Beijing 100084, Peoples R China	Beihang University; Tsinghua University	Yang, C (corresponding author), Tsinghua Univ, Sch Aerosp Engn, Inst Biomechan & Med Engn, Beijing 100084, Peoples R China.	yangchun@mail.tsinghua.edu.cn	Yang, Chun/A-7467-2008	Yang, Chun/0000-0003-1191-7642	National Natural Science Foundation of China [31170885, 31370939]; Tsinghua University [2011Z02175]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	This work was financially supported by the National Natural Science Foundation of China (Nos. 31170885 and 31370939), and Tsinghua University (2011Z02175). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batra NN, 2005, J BIOMECH, V38, P1909, DOI 10.1016/j.jbiomech.2004.08.009; Ciofani G, 2012, J BIOSCI BIOENG, V113, P258, DOI 10.1016/j.jbiosc.2011.09.025; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; DENHARDT DT, 1993, FASEB J, V7, P1475, DOI 10.1096/fasebj.7.15.8262332; Denhardt DT, 2001, BIOCHEM BIOPH RES CO, V288, P448, DOI 10.1006/bbrc.2001.5780; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Fitzgerald J, 1996, EXP CELL RES, V228, P168, DOI 10.1006/excr.1996.0313; Fitzgerald J, 1999, FASEB J, V13, P553, DOI 10.1096/fasebj.13.3.553; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Giachelli CM, 2000, MATRIX BIOL, V19, P615, DOI 10.1016/S0945-053X(00)00108-6; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Hong SY, 2010, MOL CELL BIOCHEM, V335, P263, DOI 10.1007/s11010-009-0276-1; Ishijima M, 2002, J BONE MINER RES, V17, P661, DOI 10.1359/jbmr.2002.17.4.661; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Ishijima M, 2006, EXP CELL RES, V312, P3075, DOI 10.1016/j.yexcr.2006.06.003; Jackson RA, 2006, J CELL PHYSIOL, V209, P894, DOI 10.1002/jcp.20779; Jeon YM, 2009, MOL CELL BIOCHEM, V320, P45, DOI 10.1007/s11010-008-9897-z; Kacena MA, 2004, MICROGRAVITY SCI TEC, V15, P28, DOI 10.1007/BF02870949; Kim CH, 2003, J BONE MINER RES, V18, P2116, DOI 10.1359/jbmr.2003.18.12.2116; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Kreke MR, 2005, BONE, V36, P1047, DOI 10.1016/j.bone.2005.03.008; Li J, 2008, MOL CELL BIOCHEM, V309, P41, DOI 10.1007/s11010-007-9641-0; Long FX, 2012, NAT REV MOL CELL BIO, V13, P27, DOI 10.1038/nrm3254; Ma X, 2014, FASEB J, V28, P813, DOI 10.1096/fj.13-243287; Mishra S, 2012, INTEGR BIOL-UK, V4, P1498, DOI 10.1039/c2ib20200j; Mori N, 2007, MATRIX BIOL, V26, P42, DOI 10.1016/j.matbio.2006.09.002; Morita S, 2004, ANN NY ACAD SCI, V1030, P158, DOI 10.1196/annals.1329.020; Nabavi N, 2011, BONE, V49, P965, DOI 10.1016/j.bone.2011.07.036; Nishimori S, 2001, J BIOL CHEM, V276, P10700, DOI 10.1074/jbc.M007499200; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Prodanov L, 2013, TISSUE ENG PT A, V19, P114, DOI [10.1089/ten.TEA.2012.0267, 10.1089/ten.tea.2012.0267]; Qin YX, 2003, J BIOMECH, V36, P1427, DOI 10.1016/S0021-9290(03)00127-1; Rath B, 2008, J BIOMECH, V41, P1095, DOI 10.1016/j.jbiomech.2007.11.024; REINHOLT FP, 1990, P NATL ACAD SCI USA, V87, P4473, DOI 10.1073/pnas.87.12.4473; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Saito M, 2003, J BONE MINER RES, V18, P1695, DOI 10.1359/jbmr.2003.18.9.1695; Searby ND, 2005, AM J PHYSIOL-CELL PH, V289, pC148, DOI 10.1152/ajpcell.00524.2003; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Standal T, 2004, EXP ONCOL, V26, P179; Terai K, 1999, J BONE MINER RES, V14, P839, DOI 10.1359/jbmr.1999.14.6.839; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Tomakidi P, 2014, CELL TISSUE RES, V357, P515, DOI 10.1007/s00441-014-1945-2; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Wei FL, 2008, ARCH ORAL BIOL, V53, P35, DOI 10.1016/j.archoralbio.2007.07.008; Zhang ZL, 2012, BIOTECHNOL LETT, V34, P197, DOI 10.1007/s10529-011-0756-8; Ziros PG, 2002, J BIOL CHEM, V277, P23934, DOI 10.1074/jbc.M109881200	49	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128846	10.1371/journal.pone.0128846	http://dx.doi.org/10.1371/journal.pone.0128846			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046934	gold, Green Submitted, Green Published			2022-12-26	WOS:000355652200107
J	O'Leary, L; van der Sloot, AM; Reis, CR; Deegan, S; Ryan, AE; Dhami, SPS; Murillo, LS; Cool, RH; de Sampaio, PC; Thompson, K; Murphy, G; Quax, WJ; Serrano, L; Samali, A; Szegezdi, E				O'Leary, L.; van der Sloot, A. M.; Reis, C. R.; Deegan, S.; Ryan, A. E.; Dhami, S. P. S.; Murillo, L. S.; Cool, R. H.; de Sampaio, P. Correa; Thompson, K.; Murphy, G.; Quax, W. J.; Serrano, L.; Samali, A.; Szegezdi, E.			Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity	ONCOGENE			English	Article							INDUCED APOPTOSIS; DEATH; EXPRESSION; SIGNALS; FADD	Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) is a death ligand cytokine known for its cytotoxic activity against malignantly transformed cells. TRAIL induces cell death through binding to death receptors DR4 and DR5. The inhibitory decoy receptors (DcR1 and DcR2) co-expressed with death receptor 4 (DR4)/DR5 on the same cell can block the transmission of the apoptotic signal. Here, we show that DcRs also regulate TRAIL sensitivity at a supracellular level and thus represent a mechanism by which the microenvironment can diminish tumour TRAIL sensitivity. Mathematical modelling and layered or spheroid stroma-extracellular matrix-tumour cultures were used to model the tumour microenvironment. By engineering TRAIL to escape binding by DcRs, we found that DcRs do not only act in a cell-autonomous or cis-regulatory manner, but also exert trans-cellular regulation originating from stromal cells and affect tumour cells, highlighting the potent inhibitory effect of DcRs in the tumour tissue and the necessity of selective targeting of the two death-inducing TRAIL receptors to maximise efficacy.	[O'Leary, L.; Deegan, S.; Dhami, S. P. S.; Samali, A.; Szegezdi, E.] Natl Univ Ireland, Apoptosis Res Ctr, Galway, Ireland; [van der Sloot, A. M.; Serrano, L.] CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [van der Sloot, A. M.] Univ Montreal, Inst Res Immunol & Canc, 2950 Chemin Polytech Pavillon Marcelle Coutu, Montreal, PQ, Canada; [Reis, C. R.; Cool, R. H.; Quax, W. J.] Univ Groningen, Dept Pharmaceut Biol, Antonius Deusinglaan 1, NL-9713 AV Groningen, Netherlands; [Ryan, A. E.] Natl Univ Ireland, Sch Med, Discipline Pharmacol & Therapeut, Galway, Ireland; [Murillo, L. S.] Natl Univ Ireland, Natl Ctr Biomed Engn Sci, Galway, Ireland; [de Sampaio, P. Correa; Murphy, G.] Univ Cambridge, Canc Res UK Cambridge Res Inst, Dept Oncol, Li Ka Shing Ctr, Cambridge, England; [Thompson, K.] Natl Univ Ireland, Ctr Microscopy & Imaging, Galway, Ireland; [O'Leary, L.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England; [Reis, C. R.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [de Sampaio, P. Correa] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77030 USA	Ollscoil na Gaillimhe-University of Galway; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Universite de Montreal; University of Groningen; Ollscoil na Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of Galway; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Ollscoil na Gaillimhe-University of Galway; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Samali, A; Szegezdi, E (corresponding author), Natl Univ Ireland, Apoptosis Res Ctr, Discipline Biochem, Univ Rd, Galway, Ireland.	afshin.samali@nuigalway.ie; eva.szegezdi@nuigalway.ie	Quax, Wim/K-2802-2012; Dhami, Sukhraj Pal Singh/AFP-2634-2022; Quax, Wim/O-2875-2019; Samali, Afshin/A-9571-2008; Deegan, Shane/P-4793-2017; Serrano, Luis/B-3355-2013; Szegezdi, Eva/B-7142-2008; Ryan, Aideen/H-3909-2019; van der Sloot, Almer/M-7083-2015	Quax, Wim/0000-0002-5162-9947; Dhami, Sukhraj Pal Singh/0000-0003-1326-9845; Quax, Wim/0000-0002-5162-9947; Samali, Afshin/0000-0002-8610-8375; Deegan, Shane/0000-0001-8824-9617; Serrano, Luis/0000-0002-5276-1392; Szegezdi, Eva/0000-0002-5708-3535; Ryan, Aideen/0000-0002-5831-6783; Thompson, Kerry/0000-0003-2721-8977; Correa de Sampaio, Pedro/0000-0001-5597-2825; van der Sloot, Almer/0000-0003-0049-2044; Cool, Robbert/0000-0002-9845-2202	Enterprise Ireland; National Development Plan of Ireland; Commercialisation Fund [CFTD/06/112]; SFI SIRG award [09/SIRG/B1575]; NUIG	Enterprise Ireland; National Development Plan of Ireland; Commercialisation Fund; SFI SIRG award; NUIG	Financial Support: The project was funded by Enterprise Ireland, National Development Plan of Ireland, Commercialisation Fund to AS and ES (CFTD/06/112), SFI SIRG award to ES (09/SIRG/B1575) and Millennium Grant to ES from the NUIG.	Allen JE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004828; Ander M., 2004, Systems Biology, V1, P129, DOI 10.1049/sb:20045017; Anees M, 2011, CANCER-AM CANCER SOC, V117, P1172, DOI 10.1002/cncr.25504; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Boland K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.250; Chamuleau MED, 2011, LEUKEMIA RES, V35, P741, DOI 10.1016/j.leukres.2010.12.032; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Cullen SP, 2013, MOL CELL, V49, P1034, DOI 10.1016/j.molcel.2013.01.025; de Sampaio PC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030753; Dublanche Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100081; Dyer MJS, 2007, J CLIN ONCOL, V25, P4505, DOI 10.1200/JCO.2007.13.1011; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Finnberg N, 2008, J CLIN INVEST, V118, P111, DOI 10.1172/JCI29900; Furth PA, 1997, APOPTOSIS, V2, P19, DOI 10.1023/A:1026454207398; Ganten TM, 2009, J MOL MED, V87, P995, DOI 10.1007/s00109-009-0510-z; Ivanov VN, 2014, APOPTOSIS, V19, P399, DOI 10.1007/s10495-013-0925-4; Kim KL, 2005, AM J RESP CELL MOL, V33, P541, DOI 10.1165/rcmb.2004-0355OC; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; Koksal IT, 2008, UROL ONCOL-SEMIN ORI, V26, P158, DOI 10.1016/j.urolonc.2007.01.022; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Luce A, 2009, CARCINOGENESIS, V30, P432, DOI 10.1093/carcin/bgp008; Mahalingam D, 2010, BRIT J CANCER, V102, P754, DOI 10.1038/sj.bjc.6605545; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Perez-Garijo A, 2013, ELIFE, V2, DOI 10.7554/eLife.01004; Reis CR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.61; Riccioni R, 2005, HAEMATOLOGICA, V90, P612; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Sanlioglu AD, 2007, INT J RADIAT ONCOL, V69, P716, DOI 10.1016/j.ijrobp.2007.03.057; Schneider P, 2003, J BIOL CHEM, V278, P5444, DOI 10.1074/jbc.M210783200; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shareef MM, 2007, CANCER RES, V67, P11811, DOI 10.1158/0008-5472.CAN-07-0722; Shirley S, 2011, RECENT PAT ANTI-CANC, V6, P311, DOI 10.2174/157489211796957757; Szegezdi E, 2012, MOL CELL PROTEOMICS, P11; Szegezdi E, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013730; Szegezdi E, 2011, J CELL MOL MED, V15, P2216, DOI 10.1111/j.1582-4934.2010.01211.x; Tur V, 2008, J BIOL CHEM, V283, P20560, DOI 10.1074/jbc.M800457200; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; van Dijk M, 2013, CELL DEATH DIS, P4; Wang QD, 2002, J BIOL CHEM, V277, P36602, DOI 10.1074/jbc.M206306200; Wilson NS, 2012, CANCER CELL, V22, P80, DOI 10.1016/j.ccr.2012.05.014; Wu GS, 1999, CANCER RES, V59, P2770; Zhang XD, 1999, CANCER RES, V59, P2747	46	46	48	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1261	1270		10.1038/onc.2015.180	http://dx.doi.org/10.1038/onc.2015.180			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26050621	Green Published			2022-12-26	WOS:000371763100006
J	Lichnerova, K; Kaniakova, M; Park, SP; Skrenkova, K; Wang, YX; Petralia, RS; Suh, YH; Horak, M				Lichnerova, Katarina; Kaniakova, Martina; Park, Seung Pyo; Skrenkova, Kristyna; Wang, Ya-Xian; Petralia, Ronald S.; Suh, Young Ho; Horak, Martin			Two N-glycosylation Sites in the GluN1 Subunit Are Essential for Releasing N-methyl-D-aspartate (NMDA) Receptors from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL DOMAIN; CELL-SURFACE EXPRESSION; ER RETENTION SIGNAL; FUNCTIONAL EXPRESSION; SUBTYPE-DEPENDENCE; NR2 SUBUNITS; TRAFFICKING; BINDING; MODULATION; DELIVERY	NMDA receptors (NMDARs) comprise a subclass of neurotransmitter receptors whose surface expression is regulated at multiple levels, including processing in the endoplasmic reticulum (ER), intracellular trafficking via the Golgi apparatus, internalization, recycling, anddegradation. With respect to early processing, NMDARs are regulated by the availability of GluN subunits within the ER, the presence of ER retention and export signals, and post translational modifications, including phosphorylation and palmitoylation. However, the role of N-glycosylation, one of the most common posttranslational modifications, in regulating NMDAR processing has not been studied in detail. Using biochemistry, confocal and electron microscopy, and electrophysiology in conjunction with a lentivirus-based molecular replacement strategy, we found that NMDARs are released from the ER only when two asparagine residues in the GluN1 subunit (Asn-203 and Asn-368) are N-glycosylated. Although the GluN2A and GluN2B subunits are also N-glycosylated, their N-glycosylation sites do not appear to be essential for surface delivery of NMDARs. Furthermore, we found that removing N-glycans from native NMDAR saltered the receptor affinity for glutamate. Our results suggest a novel mechanism by which neurons ensure that postsynaptic membranes contain sufficient numbers of functional NMDARs.	[Lichnerova, Katarina; Kaniakova, Martina; Skrenkova, Kristyna; Horak, Martin] Acad Sci Czech Republ Vvi, Inst Physiol, Prague 14220 4, Czech Republic; [Lichnerova, Katarina] Charles Univ Prague, Dept Physiol, Fac Sci, Prague 12843 2, Czech Republic; [Park, Seung Pyo; Suh, Young Ho] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Neurosci Res Inst, Seoul 110799, South Korea; [Wang, Ya-Xian; Petralia, Ronald S.] NIDCD, Adv Imaging Core, NIH, Bethesda, MD 20892 USA	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD)	Suh, YH (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 103 Daehak Ro, Seoul 110799, South Korea.	suhyho@snu.ac.kr; mhorak@biomed.cas.cz	Horak, Martin/F-9819-2010; Suh, Young Ho/AAJ-6405-2021; Kaniakova, Martina/C-2593-2012; Skrenkova, Kristyna/Q-1046-2017; Rehakova, Kristyna/AAH-3522-2019	Horak, Martin/0000-0002-4359-051X; Suh, Young Ho/0000-0003-3979-1615; Kaniakova, Martina/0000-0002-7956-3265; Skrenkova, Kristyna/0000-0003-2110-6587; 	Grant Agency of the Czech Republic [14-02219S]; Marie Curie International Reintegration Grant [PIRG-GA-2010-276827]; Grant Agency of Charles University [1520-243-253483]; Research Project of the AS CR [RVO:67985823]; BIOCEV/Biotechnology and Biomedicine Center of Academy of Sciences; Charles University in Vestec; European Regional Development Fund; NIDCD/National Institutes of Health; National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning [2011-0011694]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZICDC000081] Funding Source: NIH RePORTER	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Marie Curie International Reintegration Grant(European Commission); Grant Agency of Charles University; Research Project of the AS CR; BIOCEV/Biotechnology and Biomedicine Center of Academy of Sciences; Charles University in Vestec; European Regional Development Fund(European Commission); NIDCD/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Research Foundation of Korea - Ministry of Science, ICT, and Future Planning; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by project 14-02219S from the Grant Agency of the Czech Republic (to M. H., K. L., M. K., and K. S.), Marie Curie International Reintegration Grant PIRG-GA-2010-276827 (to M. H.), Grant Agency of Charles University Grant 1520-243-253483 (to K. L.), and the Research Project of the AS CR RVO:67985823 and BIOCEV/Biotechnology and Biomedicine Center of Academy of Sciences and Charles University in Vestec (project supported by the European Regional Development Fund (to M. H., K. L., and K. S.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Intramural Research Program of the NIDCD/National Institutes of Health.; Supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT, and Future Planning (2011-0011694). To whom correspondence may be addressed: Dept. of Biomedical Sciences, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, South Korea. E-mail: suhyho@snu.ac.kr.	Alvarez VA, 2007, J NEUROSCI, V27, P7365, DOI 10.1523/JNEUROSCI.0956-07.2007; Borschel WF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1512; Chazot PL, 1997, J NEUROCHEM, V68, P507; Chazot PL, 1995, MOL MEMBR BIOL, V12, P331, DOI 10.3109/09687689509072435; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Clark RAC, 1998, J NEUROCHEM, V70, P2594; Copits BA, 2014, J PHYSIOL-LONDON, V592, P2079, DOI 10.1113/jphysiol.2013.269597; Everts I, 1997, MOL PHARMACOL, V52, P861, DOI 10.1124/mol.52.5.861; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Fukaya M, 2003, P NATL ACAD SCI USA, V100, P4855, DOI 10.1073/PNAS.0830996100; Gleichman AJ, 2012, J NEUROSCI, V32, P11082, DOI 10.1523/JNEUROSCI.0064-12.2012; Horak M, 2006, NEUROSCIENCE, V137, P93, DOI 10.1016/j.neuroscience.2005.08.058; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Horak M, 2009, J BIOL CHEM, V284, P9683, DOI 10.1074/jbc.M807050200; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Kaniakova M, 2012, J NEUROCHEM, V123, P385, DOI 10.1111/jnc.12002; Kaniakova M, 2012, J BIOL CHEM, V287, P26423, DOI 10.1074/jbc.M112.339085; Karakas E, 2014, SCIENCE, V344, P992, DOI 10.1126/science.1251915; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lichnerova K, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00375; Luo JH, 2002, NEUROPHARMACOLOGY, V42, P306, DOI 10.1016/S0028-3908(01)00188-5; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Okabe S, 1999, J NEUROSCI, V19, P7781; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Petralia RS, 2009, FRONT NEUROSCI, P149; Petralia RS, 1999, METH MOL B, V128, P73; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Prybylowski K, 2002, J NEUROSCI, V22, P8902; Qiu S, 2009, J BIOL CHEM, V284, P20285, DOI 10.1074/jbc.M109.004960; Sanz-Clemente A, 2013, NEUROSCIENTIST, V19, P62, DOI 10.1177/1073858411435129; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; She K, 2012, J BIOL CHEM, V287, P27432, DOI 10.1074/jbc.M112.345108; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Storey GP, 2011, J NEUROSCI, V31, P6311, DOI 10.1523/JNEUROSCI.5553-10.2011; Taylor EW, 2014, J NEUROSCI, V34, P10, DOI 10.1523/JNEUROSCI.4761-12.2014; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Tucholski J, 2013, SCHIZOPHR RES, V146, P177, DOI 10.1016/j.schres.2013.01.031; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zheng CY, 2015, BIOCHEM J, V465, P471, DOI 10.1042/BJ20140806; Zhu SJ, 2013, NAT STRUCT MOL BIOL, V20, P477, DOI 10.1038/nsmb.2522	45	37	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18379	18390		10.1074/jbc.M115.656546	http://dx.doi.org/10.1074/jbc.M115.656546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26045554	hybrid, Green Published			2022-12-26	WOS:000358512100011
J	Lin, S; Ikegami, M; Moon, C; Naren, AP; Shannon, JM				Lin, Sui; Ikegami, Machiko; Moon, Changsuk; Naren, Anjaparavanda P.; Shannon, John M.			Lysophosphatidylcholine Acyltransferase 1 (LPCAT1) Specifically Interacts with Phospholipid Transfer Protein StarD10 to Facilitate Surfactant Phospholipid Trafficking in Alveolar Type II Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLCHOLINE TRANSFER PROTEIN; LIPID-TRANSFER; CRYSTAL-STRUCTURE; ACYL-COA; MEMBRANE-PROTEIN; LUNG SURFACTANT; TRANSPORT; IDENTIFICATION; METABOLISM; EXPRESSION	Pulmonary surfactant, a mixture of proteins and phospholipids, plays an important role in facilitating gas exchange by maintaining alveolar stability. Saturated phosphatidylcholine (SatPC), the major component of surfactant, is synthesized both de novo and by the remodeling of unsaturated phosphatidylcholine (PC) by lyso-PC acyltransferase 1 (LPCAT1). After synthesis in the endoplasmic reticulum, SatPC is routed to lamellar bodies (LBs) for storage prior to secretion. The mechanism by which SatPC is transported to LB is not understood. The specificity of LPCAT1 for lyso-PC as an acyl acceptor suggests that formation of SatPC via LPCAT1 reacylation is a final step in SatPC synthesis prior to transport. We hypothesized that LPCAT1 forms a transient complex with SatPC and specific phospholipid transport protein(s) to initiate trafficking of SatPC from the endoplasmic reticulum to the LB. Herein we have assessed the ability of different StarD proteins to interact with LPCAT1. We found that LPCAT1 interacts with StarD10, that this interaction is direct, and that amino acids 79-271 of LPCAT1 and the steroidogenic acute regulatory protein-related lipid transfer (START) domain of START domain-containing protein 10 (StarD10) are sufficient for this interaction. The role of StarD10 in trafficking of phospholipid to LB was confirmed by the observation that knockdown of StarD10 significantly reduced transport of phospholipid to LB. LPCAT1 also interacted with one isoform of StarD7 but showed no interaction with StarD2/PC transfer protein.	[Lin, Sui; Ikegami, Machiko; Shannon, John M.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Moon, Changsuk; Naren, Anjaparavanda P.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Shannon, JM (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA.	john.shannon@cchmc.org	Regan, Clinton/E-6250-2012		National Institutes of Health [HL098319, DK080834, DK093045]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080834, R01DK093045, R01DK058545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL098319 (to J. M. S.), DK080834 (to A. P. N.), and DK093045 (to A. P. N.). The authors declare no conflicts of interest with the contents of this article.	Agassandian M, 2010, FASEB J, V24, P1271, DOI 10.1096/fj.09-136044; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Alpy F, 2014, BIOCHIMIE, V96, P85, DOI 10.1016/j.biochi.2013.09.015; Anantharaman V, 2002, GENOME BIOL, V3; AVERY ME, 1959, AMA J DIS CHILD, V97, P517, DOI 10.1001/archpedi.1959.02070010519001; BANKAITIS VA, 1990, NATURE, V347, P561, DOI 10.1038/347561a0; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Besnard V, 2010, AM J PHYSIOL-LUNG C, V298, pL646, DOI 10.1152/ajplung.00409.2009; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bridges JP, 2010, J CLIN INVEST, V120, P1736, DOI 10.1172/JCI38061; Butler PL, 2010, J BIOL CHEM, V285, P6246, DOI 10.1074/jbc.M109.017350; CESARONE CF, 1979, ANAL BIOCHEM, V100, P188, DOI 10.1016/0003-2697(79)90131-3; Chen XN, 2006, P NATL ACAD SCI USA, V103, P11724, DOI 10.1073/pnas.0604946103; CHEVALIER G, 1972, ANAT RECORD, V174, P289, DOI 10.1002/ar.1091740303; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Conkright JJ, 2010, AM J RESP CELL MOL, V42, P181, DOI 10.1165/rcmb.2009-0058OC; DENBREEJEN JN, 1989, BIOCHIM BIOPHYS ACTA, V1002, P277, DOI 10.1016/0005-2760(89)90341-X; Ellis Bryon, 2012, World J Biol Chem, V3, P159, DOI 10.4331/wjbc.v3.i7.159; Favale NO, 2010, BBA-MOL CELL BIOL L, V1801, P1184, DOI 10.1016/j.bbalip.2010.07.003; Feng L, 2000, BIOCHEMISTRY-US, V39, P15399, DOI 10.1021/bi001076a; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Goss V, 2013, BBA-MOL CELL BIOL L, V1831, P448, DOI 10.1016/j.bbalip.2012.11.009; Grupp K, 2013, MOL ONCOL, V7, P1001, DOI 10.1016/j.molonc.2013.07.009; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; HAWCO MW, 1981, J APPL PHYSIOL, V51, P509, DOI 10.1152/jappl.1981.51.2.509; Hishikawa D, 2013, FASEB J, V27, P5131, DOI 10.1096/fj.13-237941; Holthuis JCM, 2005, NAT REV MOL CELL BIO, V6, P209, DOI 10.1038/nrm1591; Horibata Y, 2010, J BIOL CHEM, V285, P7358, DOI 10.1074/jbc.M109.056960; Ito M, 2013, BBA-MOL CELL BIOL L, V1831, P459, DOI 10.1016/j.bbalip.2012.11.008; Kanno K, 2007, J BIOL CHEM, V282, P30728, DOI 10.1074/jbc.M703745200; KAPLAN MR, 1985, J CELL BIOL, V101, P441, DOI 10.1083/jcb.101.2.441; KENNEDY EP, 1961, FED PROC, V20, P934; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Lo B, 2008, J IMMUNOL, V180, P881, DOI 10.4049/jimmunol.180.2.881; Mansilla F, 2009, J MOL MED, V87, P85, DOI 10.1007/s00109-008-0409-0; MASON RJ, 1984, BIOCHIM BIOPHYS ACTA, V794, P392, DOI 10.1016/0005-2760(84)90005-5; MASON RJ, 1976, J LIPID RES, V17, P281; Moessinger C, 2011, J BIOL CHEM, V286, P21330, DOI 10.1074/jbc.M110.202424; Mulugeta S, 2002, J BIOL CHEM, V277, P22147, DOI 10.1074/jbc.M201812200; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Olayioye MA, 2005, J BIOL CHEM, V280, P27436, DOI 10.1074/jbc.M413330200; Olayioye MA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M701990200; Osanai K, 2006, RESPIROLOGY, V11, pS70, DOI 10.1111/j.1440-1843.2006.00813.x; Osanai K, 2001, BBA-MOL CELL BIOL L, V1531, P222, DOI 10.1016/S1388-1981(01)00104-4; Osanai K, 1998, AM J RESP CELL MOL, V19, P929, DOI 10.1165/ajrcmb.19.6.3292; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; PISON U, 1989, AM REV RESPIR DIS, V140, P1033, DOI 10.1164/ajrccm/140.4.1033; POSSMAYER F, 1984, CAN J BIOCHEM CELL B, V62, P1121, DOI 10.1139/o84-146; Possmayer F, 2004, FETAL NEONATAL PHYSL, V2, P1014, DOI DOI 10.1016/B978-0-7216-9654-6.50104-1; Prinz WA, 2010, CELL, V143, P870, DOI 10.1016/j.cell.2010.11.031; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Romanowski MJ, 2002, P NATL ACAD SCI USA, V99, P6949, DOI 10.1073/pnas.052140699; ROONEY SA, 1985, AM REV RESPIR DIS, V131, P439; Schmidt R, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-55; Sha BD, 1998, NATURE, V391, P506, DOI 10.1038/35179; SLEIGHT RG, 1984, J CELL BIOL, V99, P742, DOI 10.1083/jcb.99.2.742; Soccio RE, 2003, J BIOL CHEM, V278, P22183, DOI 10.1074/jbc.R300003200; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Soupene E, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-8; Stocker A, 2002, STRUCTURE, V10, P1533, DOI 10.1016/S0969-2126(02)00884-5; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; van Helvoort A, 1999, P NATL ACAD SCI USA, V96, P11501, DOI 10.1073/pnas.96.20.11501; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Veldhuizen R, 2004, SUB CELL BIOCHEM, V37, P359; Voelker DR, 2003, J LIPID RES, V44, P441, DOI 10.1194/jlr.R200020-JLR200; VOORHOUT WF, 1993, MICROSC RES TECHNIQ, V26, P366, DOI 10.1002/jemt.1070260504; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; WIRTZ KWA, 1991, ANNU REV BIOCHEM, V60, P73, DOI 10.1146/annurev.biochem.60.1.73; Wu MS, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-44; Yamano G, 2001, FEBS LETT, V508, P221, DOI 10.1016/S0014-5793(01)03056-3; Zhang M, 2002, J BIOL CHEM, V277, P33300, DOI 10.1074/jbc.M200003200; Zou CB, 2011, J BIOL CHEM, V286, P28019, DOI 10.1074/jbc.M111.253385	78	16	17	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18559	18574		10.1074/jbc.M115.666701	http://dx.doi.org/10.1074/jbc.M115.666701			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26048993	Green Published, hybrid			2022-12-26	WOS:000358512100027
J	Abreha, KB; Alexandersson, E; Vossen, JH; Anderson, P; Andreasson, E				Abreha, Kibrom B.; Alexandersson, Erik; Vossen, Jack H.; Anderson, Peter; Andreasson, Erik			Inoculation of Transgenic Resistant Potato by Phytophthora infestans Affects Host Plant Choice of a Generalist Moth	PLOS ONE			English	Article							BROAD-SPECTRUM RESISTANCE; LATE BLIGHT RESISTANCE; OVIPOSITION BEHAVIOR; R-GENE; LEPIDOPTERA; NOCTUIDAE; CULTIVARS; INFECTION; PATHOGENS; FUNGUS	Pathogen attack and the plant's response to this attack affect herbivore oviposition preference and larval performance. Introduction of major resistance genes against Phytophthora infestans (Rpi-genes), the cause of the devastating late blight disease, from wild Solanum species into potato changes the plant-pathogen interaction dynamics completely, but little is known about the effects on non-target organisms. Thus, we examined the effect of P. infestans itself and introduction of an Rpi-gene into the crop on host plant preference of the generalist insect herbivore, Spodoptera littoralis (Lepidoptera: Noctuidae). In two choice bio-assays, S. littoralis preferred to oviposit on P. infestans-inoculated plants of both the susceptible potato (cv. Desiree) and an isogenic resistant clone (A01-22: cv. Desiree transformed with Rpi-blb1), when compared to uninoculated plants of the same genotype. Both cv. Desiree and clone A01-22 were equally preferred for oviposition by S. littoralis when uninoculated plants were used, while cv. Desiree received more eggs compared to the resistant clone when both were inoculated with the pathogen. No significant difference in larval and pupal weight was found between S. littoralis larvae reared on leaves of the susceptible potato plants inoculated or uninoculated with P. infestans. Thus, the herbivore's host plant preference in this system was not directly associated with larval performance. The results indicate that the Rpi-blb1 based resistance in itself does not influence insect behavior, but that herbivore oviposition preference is affected by a change in the plant-microbe interaction.	[Abreha, Kibrom B.; Alexandersson, Erik; Anderson, Peter; Andreasson, Erik] Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden; [Vossen, Jack H.] Univ Wageningen & Res Ctr, Wageningen UR Plant Breeding, Wageningen, Netherlands	Swedish University of Agricultural Sciences; Wageningen University & Research	Andreasson, E (corresponding author), Swedish Univ Agr Sci, Dept Plant Protect Biol, Alnarp, Sweden.	erik.andreasson@slu.se	Abreha, Kibrom B./J-7551-2019	Abreha, Kibrom B./0000-0001-8084-8340; Andreasson, Erik/0000-0003-0666-7204	Swedish Mistra Biotech research program; Swedish Foundation for Strategic Research [RBb08-0006]	Swedish Mistra Biotech research program; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	EA: The Swedish Mistra Biotech research program, EA: the Swedish Foundation for Strategic Research (RBb08-0006).	Ali A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-497; Ali A, 2012, PLANT SIGNAL BEHAV, V7, P400, DOI 10.4161/psb.19149; Anderson P, 1999, ENTOMOL EXP APPL, V92, P45, DOI 10.1023/A:1003749730428; Anderson P, 2011, BEHAV ECOL, V22, P1272, DOI 10.1093/beheco/arr124; Andreu A, 2001, POTATO RES, V44, P1, DOI 10.1007/BF02360281; Bengtsson T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-315; Blanco-Ulate B, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00142; Bradeen JM, 2009, MOL PLANT MICROBE IN, V22, P437, DOI 10.1094/MPMI-22-4-0437; BROWN ES, 1975, B ENTOMOL RES, V65, P221, DOI 10.1017/S0007485300005939; Burra DD, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0254-y; Cardoza YJ, 2006, J CHEM ECOL, V32, P1755, DOI 10.1007/s10886-006-9107-y; Cardoza YJ, 2003, ENVIRON ENTOMOL, V32, P220, DOI 10.1603/0046-225X-32.1.220; CATEN CE, 1968, CAN J BOTANY, V46, P329, DOI 10.1139/b68-055; D'Alessandro M, 2014, PLANT CELL ENVIRON, V37, P813, DOI 10.1111/pce.12220; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Friedli J, 2001, OECOLOGIA, V129, P571, DOI 10.1007/s004420100763; Fry W, 2008, MOL PLANT PATHOL, V9, P385, DOI [10.1111/j.1364-3703.2007.00465.x, 10.1111/J.1364-3703.2007.00465.X]; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Hannukkala AO, 2007, PLANT PATHOL, V56, P167, DOI 10.1111/j.1365-3059.2006.01451.x; Hatcher PE, 2004, ECOLOGY, V85, P59, DOI 10.1890/02-0724; Haverkort AJ, 2009, POTATO RES, V52, P249, DOI 10.1007/s11540-009-9136-3; HINKS CF, 1976, CAN ENTOMOL, V108, P1345, DOI 10.4039/Ent1081345-12; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jallow MFA, 2008, ARTHROPOD-PLANT INTE, V2, P53, DOI 10.1007/s11829-008-9033-8; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kruess A, 2002, OECOLOGIA, V130, P563, DOI 10.1007/s00442-001-0829-9; Laothawornkitkul J, 2010, CROP PROT, V29, P872, DOI 10.1016/j.cropro.2010.03.003; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Moushib LI, 2013, EUR J PLANT PATHOL, V136, P261, DOI 10.1007/s10658-012-0160-9; Orlowska E, 2012, PLANT CELL REP, V31, P187, DOI 10.1007/s00299-011-1155-2; Pieterse CMJ, 2007, TRENDS PLANT SCI, V12, P564, DOI 10.1016/j.tplants.2007.09.004; R Core Team, 2021, R LANGUAGE ENV STAT; Rao M. Srinivasa, 2012, Journal of Insect Science (Tucson), V12, P1; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Rodewald J, 2013, MOL PLANT PATHOL, V14, P740, DOI 10.1111/mpp.12036; Ros B, 2005, PLANT BIOLOGY, V7, P686, DOI 10.1055/s-2005-872946; Rostas M, 2002, AGR FOREST ENTOMOL, V4, P223, DOI 10.1046/j.1461-9563.2002.00147.x; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Saveer AM, 2012, P ROY SOC B-BIOL SCI, V279, P2314, DOI 10.1098/rspb.2011.2710; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Simon M, 2003, AGR FOREST ENTOMOL, V5, P275, DOI 10.1046/j.1461-9563.2003.00189.x; Song JQ, 2003, P NATL ACAD SCI USA, V100, P9128, DOI 10.1073/pnas.1533501100; Stout MJ, 1999, PHYSIOL MOL PLANT P, V54, P115, DOI 10.1006/pmpp.1998.0193; Tack AJM, 2013, FUNCT ECOL, V27, P633, DOI 10.1111/1365-2435.12087; Thoming G, 2013, ECOLOGY, V94, P1744, DOI 10.1890/12-0907.1; van der Vossen E, 2003, PLANT J, V36, P867, DOI 10.1046/j.1365-313X.2003.01934.x; Vleeshouwers VGAA, 2011, ANNU REV PHYTOPATHOL, V49, P507, DOI 10.1146/annurev-phyto-072910-095326; Yang FZ, 2013, ENTOMOL EXP APPL, V148, P39, DOI 10.1111/eea.12069; Zakir A, 2013, J EXP BIOL, V216, P3257, DOI 10.1242/jeb.083188; Zakir A, 2013, J ECOL, V101, P410, DOI 10.1111/1365-2745.12041; Zhang Y, 2013, J GENET GENOMICS, V40, P23, DOI 10.1016/j.jgg.2012.11.003	51	15	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129815	10.1371/journal.pone.0129815	http://dx.doi.org/10.1371/journal.pone.0129815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053171	gold, Green Published, Green Submitted			2022-12-26	WOS:000355955300164
J	Majety, M; Pradel, LP; Gies, M; Ries, CH				Majety, Meher; Pradel, Leon P.; Gies, Manuela; Ries, Carola H.			Fibroblasts Influence Survival and Therapeutic Response in a 3D Co-Culture Model	PLOS ONE			English	Article							CELL-LUNG-CANCER; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; TUMOR-STROMA; PANCREATIC-CANCER; PROGRESSION; RESISTANCE; EXPRESSION; CULTURE	In recent years, evidence has indicated that the tumor microenvironment (TME) plays a significant role in tumor progression. Fibroblasts represent an abundant cell population in the TME and produce several growth factors and cytokines. Fibroblasts generate a suitable niche for tumor cell survival and metastasis under the influence of interactions between fibroblasts and tumor cells. Investigating these interactions requires suitable experimental systems to understand the cross-talk involved. Most in vitro experimental systems use 2D cell culture and trans-well assays to study these interactions even though these paradigms poorly represent the tumor, in which direct cell-cell contacts in 3D spaces naturally occur. Investigating these interactions in vivo is of limited value due to problems regarding the challenges caused by the species-specificity of many molecules. Thus, it is essential to use in vitro models in which human fibroblasts are co-cultured with tumor cells to understand their interactions. Here, we developed a 3D co-culture model that enables direct cell-cell contacts between pancreatic, breast and or lung tumor cells and human fibroblasts/or tumor-associated fibroblasts (TAFs). We found that co-culturing with fibroblasts/TAFs increases the proliferation in of several types of cancer cells. We also observed that co-culture induces differential expression of soluble factors in a cancer type-specific manner. Treatment with blocking antibodies against selected factors or their receptors resulted in the inhibition of cancer cell proliferation in the co-cultures. Using our co-culture model, we further revealed that TAFs can influence the response to therapeutic agents in vitro. We suggest that this model can be reliably used as a tool to investigate the interactions between a tumor and the TME.	[Majety, Meher; Pradel, Leon P.; Gies, Manuela; Ries, Carola H.] Roche Innovat Ctr Penzberg, Pharmaceut Res & Early Dev, Discovery Oncol, Penzberg, Germany		Majety, M (corresponding author), Roche Innovat Ctr Penzberg, Pharmaceut Res & Early Dev, Discovery Oncol, Penzberg, Germany.	meher.majety@roche.com			Roche Diagnostics GmbH	Roche Diagnostics GmbH	This study was funded internally by Roche Diagnostics GmbH. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Angeli F, 2009, TUMOR BIOL, V30, P109, DOI 10.1159/000218708; BERGMANN U, 1995, CANCER RES, V55, P2007; Bremnes RM, 2011, J THORAC ONCOL, V6, P209, DOI 10.1097/JTO.0b013e3181f8a1bd; Camp JT, 2011, MOL CANCER RES, V9, P3, DOI 10.1158/1541-7786.MCR-10-0372; Castoldi R, 2012, PROTEIN ENG DES SEL, V25, P551, DOI 10.1093/protein/gzs048; Chong CR, 2013, NAT MED, V19, P1389, DOI 10.1038/nm.3388; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; de Kruijf EM, 2011, BREAST CANCER RES TR, V125, P687, DOI 10.1007/s10549-010-0855-6; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Fujita H, 2009, CANCER SCI, V100, P2309, DOI 10.1111/j.1349-7006.2009.01317.x; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Li Q, 2011, AM J PATHOL, V179, P1483, DOI 10.1016/j.ajpath.2011.05.060; Micke P, 2004, LUNG CANCER, V45, pS163, DOI 10.1016/j.lungcan.2004.07.977; Mishra P, 2011, J LEUKOCYTE BIOL, V89, P31, DOI 10.1189/jlb.0310182; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; RonnovJessen L, 1996, PHYSIOL REV, V76, P69, DOI 10.1152/physrev.1996.76.1.69; Ryden L, 2010, BREAST CANCER RES TR, V120, P491, DOI 10.1007/s10549-010-0758-6; Samoszuk M, 2005, BREAST CANCER RES, V7, pR274, DOI 10.1186/bcr995; Shay JW, 2007, CANCER CELL, V12, P100, DOI 10.1016/j.ccr.2007.07.012; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P287; Yamada T, 2010, CLIN CANCER RES, V16, P174, DOI 10.1158/1078-0432.CCR-09-1204; Zucali PA, 2008, ANN ONCOL, V19, P1605, DOI 10.1093/annonc/mdn240	24	73	74	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0127948	10.1371/journal.pone.0127948	http://dx.doi.org/10.1371/journal.pone.0127948			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053043	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300020
J	Mekov, E; Slavova, Y; Tsakova, A; Genova, M; Kostadinov, D; Minchev, D; Marinova, D; Tafradjiiska, M				Mekov, Evgeni; Slavova, Yanina; Tsakova, Adelina; Genova, Marianka; Kostadinov, Dimitar; Minchev, Delcho; Marinova, Dora; Tafradjiiska, Maya			Vitamin D Deficiency and Insufficiency in Hospitalized COPD Patients	PLOS ONE			English	Article							BONE-MINERAL DENSITY; 3RD NATIONAL-HEALTH; 25-HYDROXYVITAMIN D; PULMONARY-FUNCTION; LUNG-FUNCTION; RISK; EXACERBATIONS; ASSOCIATION; DISEASE	Introduction 31-77% of patients with COPD have vitamin D deficiency and insufficiency, with results being highly variable between studies. Vitamin D may also correlate with disease characteristics. Aim To find out the prevalence of vitamin D deficiency and insufficiency in patients with COPD admitted for exacerbation and a risk factors for lower vitamin D levels among comorbidities and COPD characteristics. Methods 152 patients were studied for vitamin D serum levels (25(OH) D). All of them were also assessed for diabetes mellitus (DM) and metabolic syndrome (MS). Data were gathered also for smoking status and exacerbations in last year. All patients completed CAT and mMRC questionnaires and underwent spirometry. Results A total of 83,6% of patients have reduced levels of vitamin D. 42,8% (65/152) have vitamin D insufficiency (defined as 25-50 nmol/L) and 40,8% (62/152) have vitamin D deficiency (<25 nmol/L). The mean level of 25(OH) D for all patients is 31,97 nmol/L (95% CI 29,12-34,68). Vitamin D deficiency and insufficiency are more prevalent in females vs. males (97,7 vs 77,8%; p = 0.003). The prevalence and severity of vitamin D deficiency and insufficiency in this study is significantly higher when compared to an unselected Bulgarian population (prevalence 75,8%; mean level 38,75 nmol/L). Vitamin D levels correlate with quality of life (measured by the mMRC scale) and lung function (FVC, FEV1, FEV6, FEF2575, FEV3, but not with FEV1/FVC ratio and PEF), it does not correlate with the presence of arterial hypertension, DM, MS and number of moderate, severe and total exacerbations. Vitamin D deficiency is a risk factor for longer hospital stay. Conclusions The patients with COPD admitted for exacerbation are a risk group for vitamin D deficiency and insufficiency, which is associated with worse disease characteristics.	[Mekov, Evgeni; Slavova, Yanina; Kostadinov, Dimitar; Minchev, Delcho; Marinova, Dora; Tafradjiiska, Maya] SHATPD Sveta Sofia, Clin Ctr Pulm Dis, Sofia, Bulgaria; [Tsakova, Adelina; Genova, Marianka] UMHAT Alexandrovska, Cent Clin Lab, Sofia, Bulgaria	Medical University Sofia; Medical University Sofia	Mekov, E (corresponding author), SHATPD Sveta Sofia, Clin Ctr Pulm Dis, Sofia, Bulgaria.	dr_mekov@abv.bg	Tsakova, Adelina/AAD-2412-2022	Marinova, Dora/0000-0001-7633-6342; Tsakova, Adelina/0000-0002-8611-3908	Medical University-Sofia, Sofia, Bulgaria [15-D/2014, 22-D/2014]	Medical University-Sofia, Sofia, Bulgaria	This work was supported by Medical University-Sofia, Sofia, Bulgaria (grant number 15-D/2014, project number 22-D/2014) (http://mu-sofia.bg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Ampikaipakan SN, 2011, THORAX, V66, P541, DOI 10.1136/thx.2009.134338; Bahar-Shany K, 2010, J CELL PHYSIOL, V222, P729, DOI 10.1002/jcp.22004; Black PN, 2005, CHEST, V128, P3792, DOI 10.1378/chest.128.6.3792; Borissova A-M, 2012, ENDOCRINOLOGIA, V17, P135; Borissova A-M, 2012, ENDOCRINOLOGIA, V3, P122; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Forli L, 2004, J INTERN MED, V256, P56, DOI 10.1111/j.1365-2796.2004.01337.x; Forman JP, 2007, HYPERTENSION, V49, P1063, DOI 10.1161/HYPERTENSIONAHA.107.087288; Franco CB, 2009, OSTEOPOROSIS INT, V20, P1881, DOI 10.1007/s00198-009-0890-5; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; GOLD, 2011, GLOB STRAT DIAGN MAN; Graat-Verboom L, 2008, EUR RESPIR J, pP3374; Heulens N, 2013, AM J RESP CRIT CARE, V187, P214, DOI 10.1164/ajrccm.187.2.214a; Hewison M, 2011, NAT REV ENDOCRINOL, V7, P336, DOI 10.1038/nrendo.2010.226; Holmgaard DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053670; Institute of Medicine, 2011, DIETARY REFERENCE IN; Janssens W, 2010, THORAX, V65, P215, DOI 10.1136/thx.2009.120659; Kunisaki KM, 2011, EUR RESPIR J, V37, P238, DOI 10.1183/09031936.00146509; Kunisaki KM, 2012, AM J RESP CRIT CARE, V185, P286, DOI 10.1164/rccm.201109-1644OC; Lange NE, 2012, AM J RESP CRIT CARE, V186, P616, DOI 10.1164/rccm.201110-1868OC; Mahlin C, 2014, CLIN RESPIR J, V8, P24, DOI 10.1111/crj.12030; Mekov E, 2014, THORACIC MED, V6, P18; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Persson LJP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038934; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Puhan MA, 2014, CHEST, V145, P37, DOI 10.1378/chest.13-1296; Quint JK, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-28; Razzaque MS, 2006, FASEB J, V20, P720, DOI 10.1096/fj.05-5432fje; Romme EAPM, 2013, ANN MED, V45, P91, DOI 10.3109/07853890.2012.671536; Schlaich C, 1998, OSTEOPOROSIS INT, V8, P261, DOI 10.1007/s001980050063; Shaheen SO, 2011, THORAX, V66, P692, DOI 10.1136/thx.2010.155234; Sin DD, 2003, AM J MED, V114, P10, DOI 10.1016/S0002-9343(02)01297-4; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; US Centers for Disease Control and Prevention, 2010, VITAL HLTH STAT SERI, V10, P80; Vestbo J, 2014, CLIN CHEST MED, V35, P1, DOI 10.1016/j.ccm.2013.10.010; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; World Health Organization, 2008, WHO STEPWISE APPR SU; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Wright RJ, 2005, CHEST, V128, P3781, DOI 10.1378/chest.128.6.3781; Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388; Zittermann A, 2006, PROG BIOPHYS MOL BIO, V92, P39, DOI 10.1016/j.pbiomolbio.2006.02.001	43	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129080	10.1371/journal.pone.0129080	http://dx.doi.org/10.1371/journal.pone.0129080			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047485	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200121
J	Navarro-Lopez, J; Fargallo, JA				Navarro-Lopez, Juan; Antonio Fargallo, Juan			Trophic Niche in a Raptor Species: The Relationship between Diet Diversity, Habitat Diversity and Territory Quality	PLOS ONE			English	Article							BREEDING PERFORMANCE; EURASIAN KESTRELS; HETEROGENEITY; POPULATION; PATTERNS; GENERALISTS; PREFERENCES; PREDATION; SELECTION; BIRDS	Recent research reports that many populations of species showing a wide trophic niche (generalists) are made up of both generalist individuals and individuals with a narrow trophic niche (specialists), suggesting trophic specializations at an individual level. If true, foraging strategies should be associated with individual quality and fitness. Optimal foraging theory predicts that individuals will select the most favourable habitats for feeding. In addition, the "landscape heterogeneity hypothesis" predicts a higher number of species in more diverse landscapes. Thus, it can be predicted that individuals with a wider realized trophic niche should have foraging territories with greater habitat diversity, suggesting that foraging strategies, territory quality and habitat diversity are inter-correlated. This was tested for a population of common kestrels Falco tinnunculus. Diet diversity, territory occupancy (as a measure of territory quality) and habitat diversity of territories were measured over an 8-year period. Our results show that: 1) territory quality was quadratically correlated with habitat diversity, with the best territories being the least and most diverse; 2) diet diversity was not correlated with territory quality; and 3) diet diversity was negatively correlated with landscape heterogeneity. Our study suggests that niche generalist foraging strategies are based on an active search for different prey species within or between habitats rather than on the selection of territories with high habitat diversity.	[Navarro-Lopez, Juan; Antonio Fargallo, Juan] CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Madrid 28006, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Navarro-Lopez, J (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Ecol Evolut, Jose Gutierrez Abascal 2, Madrid 28006, Spain.	navarro-lopez.juan@mncn.csic.es	Fargallo, Juan A/I-5585-2015	Fargallo, Juan A/0000-0003-4090-9000	Project of Ministerio de economia y competitividad (MIMECO) [CGL2007-61395, CGL2010-15726]; Ministerio de economia y competitividad (MIMECO) [BES-2011-043956]	Project of Ministerio de economia y competitividad (MIMECO); Ministerio de economia y competitividad (MIMECO)	This work was supported by Project of Ministerio de economia y competitividad (MIMECO) CGL2007-61395 and Project of Ministerio de economia y competitividad (MIMECO) CGL2010-15726 (http://www.mineco.gob.es/). JNL was supported by a fellowship of Ministerio de economia y competitividad (MIMECO) BES-2011-043956 (http://www.mineco.gob.es/).	Allouche O, 2012, P NATL ACAD SCI USA, V109, P17495, DOI 10.1073/pnas.1208652109; Aparicio JM, 1998, J AVIAN BIOL, V29, P121, DOI 10.2307/3677189; Aparicio JM, 2000, ORNIS FENNICA, V77, P169; Araujo MS, 2011, ECOL LETT, V14, P948, DOI 10.1111/j.1461-0248.2011.01662.x; Barrientos R, 2014, BIRD CONSERV INT, V24, P138, DOI 10.1017/S0959270913000270; Barton K., MUMIN MULTIMODEL INF; Begon M., 2009, ECOLOGY INDIVIDUALS; Bernays EA, 1999, P ROY SOC B-BIOL SCI, V266, P151, DOI 10.1098/rspb.1999.0615; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.1890/0012-9658(2002)083[2936:MILRS]2.0.CO;2; Byholm P, 2007, J ANIM ECOL, V76, P392, DOI 10.1111/j.1365-2656.2007.01211.x; Cucherousset J, 2011, OECOLOGIA, V167, P75, DOI 10.1007/s00442-011-1974-4; Dayan T, 2005, ECOL LETT, V8, P875, DOI 10.1111/j.1461-0248.2005.00791.x; Dennis RLH, 2011, BIOL J LINN SOC, V104, P725, DOI 10.1111/j.1095-8312.2011.01789.x; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Fargallo JA, 2001, BIRD STUDY, V48, P236, DOI 10.1080/00063650109461223; Fargallo JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004311; Germain RR, 2014, ECOLOGY, V95, P436, DOI 10.1890/13-0467.1; Kadmon R, 2007, AM NAT, V170, P443, DOI 10.1086/519853; KORPIMAKI E, 1991, ECOLOGY, V72, P814, DOI 10.2307/1940584; KORPIMAKI E, 1986, Ornis Fennica, V63, P84; Kuznetsova A., 2013, CHRISTENSEN RHB LMER; LACK D, 1969, BIRD STUDY, V16, P193, DOI 10.1080/00063656909476244; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Margalida A, 2007, J ORNITHOL, V148, P309, DOI 10.1007/s10336-007-0133-5; Margalida A, 2012, IBIS, V154, P184, DOI 10.1111/j.1474-919X.2011.01189.x; Margalida A, 2009, IBIS, V151, P235; Martin T.E., 1992, Current Ornithology, V9, P163; Martinez-Padilla J, 2008, NATURWISSENSCHAFTEN, V95, P391, DOI 10.1007/s00114-007-0337-9; Mayntz D, 2001, OECOLOGIA, V127, P207, DOI 10.1007/s004420000591; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Navarro-Lopez J, 2014, OECOLOGIA, V174, P1215, DOI 10.1007/s00442-013-2855-9; Newton I., 1998, POPULATION LIMITATIO; Newton I., 1979, POPULATION ECOLOGY R; Oksanen J., 2013, PACKAGE VEGAN, DOI 10.1109/MSPEC.2006.1611759; Penteriani V, 2002, J ZOOL, V257, P365, DOI 10.1017/S0952836902000961; Ponce C, 2014, ECOL EVOL, V4, P2834, DOI 10.1002/ece3.1125; PYKE GH, 1977, Q REV BIOL, V52, P137, DOI 10.1086/409852; Quevedo M, 2009, ECOLOGY, V90, P2263, DOI 10.1890/07-1580.1; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Sergio F, 2003, J ANIM ECOL, V72, P857, DOI 10.1046/j.1365-2656.2003.00758.x; SHRUBB M, 1993, BIRD STUDY, V40, P63, DOI 10.1080/00063659309477130; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stephens D.W., 1986, pi; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Tanferna A, 2013, BIOL CONSERV, V160, P1, DOI 10.1016/j.biocon.2012.12.031; Tapia L, 2008, VIE MILIEU, V58, P257; Telleria JL, 2008, ECOGRAPHY, V31, P381, DOI 10.1111/j.0906-7590.2008.05283.x; Terraube J, 2011, BIODIVERS CONSERV, V20, P2111, DOI 10.1007/s10531-011-0077-1; Tews J, 2004, J BIOGEOGR, V31, P79, DOI 10.1046/j.0305-0270.2003.00994.x; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Torre I, 2007, BASIC APPL ECOL, V8, P565, DOI 10.1016/j.baae.2006.09.016; VILLAGE A, 1982, BIRD STUDY, V29, P129, DOI 10.1080/00063658209476747; Village A., 1990, THE KESTREL; Zabala J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090254	57	18	19	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128855	10.1371/journal.pone.0128855	http://dx.doi.org/10.1371/journal.pone.0128855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047025	gold, Green Submitted, Green Published			2022-12-26	WOS:000355652200108
J	Molina, R; Marcaida, MJ; Redondo, P; Marenchino, M; Duchateau, P; D'Abramo, M; Montoya, G; Prieto, J				Molina, Rafael; Jose Marcaida, Maria; Redondo, Pilar; Marenchino, Marco; Duchateau, Phillippe; D'Abramo, Marco; Montoya, Guillermo; Prieto, Jesus			Engineering a Nickase on the Homing Endonuclease I-DmoI Scaffold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; MOLECULAR-BASIS; RESTRICTION; RECOGNITION; EFFICIENT; VARIANTS; CREI; GENE	Homing endonucleases are useful tools for genome modification because of their capability to recognize and cleave specifically large DNA targets. These endonucleases generate a DNA double strand break that can be repaired by the DNA damage response machinery. The break can be repaired by homologous recombination, an error-free mechanism, or by non-homologous end joining, a process susceptible to introducing errors in the repaired sequence. The type of DNA cleavage might alter the balance between these two alternatives. The use of "nickases" producing a specific single strand break instead of a double strand break could be an approach to reduce the toxicity associated with non-homologous end joining by promoting the use of homologous recombination to repair the cleavage of a single DNA break. Taking advantage of the sequential DNA cleavage mechanism of I-DmoI LAGLIDADG homing endonuclease, we have developed a new variant that is able to cut preferentially the coding DNA strand, generating a nicked DNA target. Our structural and biochemical analysis shows that by decoupling the action of the catalytic residues acting on each strand we can inhibit one of them while keeping the other functional.	[Molina, Rafael; Jose Marcaida, Maria; Redondo, Pilar; Montoya, Guillermo; Prieto, Jesus] Spanish Natl Canc Res Ctr CNIO, Macromol Crystallog Grp, Madrid 28029, Spain; [Marenchino, Marco] Spanish Natl Canc Res Ctr CNIO, NMR Unit, Struct Biol & Biocomp Program, Madrid 28029, Spain; [Duchateau, Phillippe] CELLECTIS SA, F-75013 Paris, France; [D'Abramo, Marco] Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy; [Montoya, Guillermo] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Prot Struct & Funct Program, Fac Hlth & Med Sci, DK-2200 Copenhagen, Denmark	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Sapienza University Rome; University of Copenhagen	Montoya, G (corresponding author), Spanish Natl Canc Res Ctr CNIO, Macromol Crystallog Grp, C Melchor Fernandez Almagro 3, Madrid 28029, Spain.	guillermo.montoya@cpr.ku.dk; jprieto@cnio.es	Molina, Rafael/AAG-6552-2019; Molina, Rafael/L-6203-2016; D'Abramo, Marco/B-7035-2008; Marcaida, Maria Jose/I-1644-2017; Redondo, Pilar/L-7612-2014	Molina, Rafael/0000-0002-6443-4989; Molina, Rafael/0000-0002-6443-4989; D'Abramo, Marco/0000-0001-6020-8581; Marcaida, Maria Jose/0000-0003-0663-5309; Redondo, Pilar/0000-0002-6723-0818	European Community [283570]; Novo Nordisk Foundation [NNF14CC0001]; Novo Nordisk Foundation Center for Protein Research [PI Guillermo Montoya] Funding Source: researchfish	European Community(European Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Foundation Center for Protein Research	We thank the Swiss Light Source and XALOC beamline staff for support. This research received funding from the European Community's FP7 Grant Agreement 283570 (BioStruct-X; providing access to Swiss Light Source and ALBA synchrotrons). The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen is supported financially by the Novo Nordisk Foundation (Grant agreement NNF14CC0001).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armalyte E, 2005, J BIOL CHEM, V280, P41584, DOI 10.1074/jbc.M506775200; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; Daboussi F, 2012, NUCLEIC ACIDS RES, V40, P6367, DOI 10.1093/nar/gks268; Dapprich S, 1999, J MOL STRUC-THEOCHEM, V461, P1, DOI 10.1016/S0166-1280(98)00475-8; Davis L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023981; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Grizot S, 2009, NUCLEIC ACIDS RES, V37, P5405, DOI 10.1093/nar/gkp548; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Joshi R, 2011, J MOL BIOL, V405, P185, DOI 10.1016/j.jmb.2010.10.029; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lee GS, 2004, CELL, V117, P171, DOI 10.1016/S0092-8674(04)00301-0; LykkeAndersen J, 1997, EMBO J, V16, P3272, DOI 10.1093/emboj/16.11.3272; Marcaida MJ, 2010, CELL MOL LIFE SCI, V67, P727, DOI 10.1007/s00018-009-0188-y; Marciada MJ, 2008, P NATL ACAD SCI USA, V105, P16888, DOI 10.1073/pnas.0804795105; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metzger MJ, 2011, NUCLEIC ACIDS RES, V39, P926, DOI 10.1093/nar/gkq826; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Molina R, 2015, NAT STRUCT MOL BIOL, V22, P65, DOI 10.1038/nsmb.2932; Munoz IG, 2011, NUCLEIC ACIDS RES, V39, P729, DOI 10.1093/nar/gkq801; Niu Y, 2008, J MOL BIOL, V382, P188, DOI 10.1016/j.jmb.2008.07.010; Prieto J, 2008, J BIOL CHEM, V283, P4364, DOI 10.1074/jbc.M706323200; Prieto J, 2007, NUCLEIC ACIDS RES, V35, P3262, DOI 10.1093/nar/gkm183; Redondo P, 2008, NATURE, V456, P107, DOI 10.1038/nature07343; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Silva GH, 2004, NUCLEIC ACIDS RES, V32, P3156, DOI 10.1093/nar/gkh618; Smith AM, 2009, P NATL ACAD SCI USA, V106, P5099, DOI 10.1073/pnas.0810588106; van Nierop GP, 2009, NUCLEIC ACIDS RES, V37, P5725, DOI 10.1093/nar/gkp643; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	32	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18534	18544		10.1074/jbc.M115.658666	http://dx.doi.org/10.1074/jbc.M115.658666			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26045557	Green Published, hybrid			2022-12-26	WOS:000358512100025
J	Rostovtseva, TK; Gurnev, PA; Protchenko, O; Hoogerheide, DP; Yap, TL; Philpott, CC; Lee, JC; Bezrukov, SM				Rostovtseva, Tatiana K.; Gurnev, Philip A.; Protchenko, Olga; Hoogerheide, David P.; Yap, Thai Leong; Philpott, Caroline C.; Lee, Jennifer C.; Bezrukov, Sergey M.			alpha-Synuclein Shows High Affinity Interaction with Voltage-dependent Anion Channel, Suggesting Mechanisms of Mitochondrial Regulation and Toxicity in Parkinson Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX-I; ALZHEIMERS-DISEASE; FIBRIL FORMATION; INNER MEMBRANE; VDAC; PROTEIN; TRANSLOCATION; TUBULIN; MUTATION; BINDING	Participation of the small, intrinsically disordered protein alpha-synuclein (alpha-syn) in Parkinson disease (PD) pathogenesis has been well documented. Although recent research demonstrates the involvement of alpha-syn in mitochondrial dysfunction in neurodegeneration and suggests direct interaction of alpha-syn with mitochondria, the molecular mechanism(s) of alpha-syn toxicity and its effect on neuronal mitochondria remain vague. Here we report that at nanomolar concentrations, alpha-syn reversibly blocks the voltage-dependent anion channel (VDAC), the major channel of the mitochondrial outer membrane that controls most of the metabolite fluxes in and out of the mitochondria. Detailed analysis of the blockage kinetics of VDAC reconstituted into planar lipid membranes suggests that alpha-syn is able to translocate through the channel and thus target complexes of the mitochondrial respiratory chain in the inner mitochondrial membrane. Supporting our in vitro experiments, a yeast model of PD shows that alpha-syn toxicity in yeast depends on VDAC. The functional interactions between VDAC and alpha-syn, revealed by the present study, point toward the long sought after physiological and pathophysiological roles for monomeric alpha-syn in PD and in other alpha-synucleinopathies.	[Rostovtseva, Tatiana K.; Gurnev, Philip A.; Hoogerheide, David P.; Bezrukov, Sergey M.] Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, Bethesda, MD 20892 USA; [Gurnev, Philip A.] Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA; [Protchenko, Olga; Philpott, Caroline C.] NIDDK, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Hoogerheide, David P.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Yap, Thai Leong; Lee, Jennifer C.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Massachusetts System; University of Massachusetts Amherst; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institute of Standards & Technology (NIST) - USA; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rostovtseva, TK (corresponding author), Eunice Kennedy Shriver NICHD, Program Phys Biol, NIH, 9000 Rockville Pike,Bldg 9,Rm 1E-106, Bethesda, MD 20892 USA.	rostovtt@mail.nih.gov	Lee, Jennifer/E-9658-2015; Hoogerheide, David P./AAB-3753-2019; Protchenko, Olga/AAU-9237-2021; Regan, Clinton/E-6250-2012	Lee, Jennifer/0000-0003-0506-8349; Hoogerheide, David P./0000-0003-2918-1469; Protchenko, Olga/0000-0002-4688-4214	National Institutes of Health (NIH); Eunice Kennedy Shriver NICHD; NIDDK; NHLBI; National Science Foundation EAGER [1249199]; National Research Council at the National Institute of Standards and Technology; National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000072] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054513] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Science Foundation EAGER; National Research Council at the National Institute of Standards and Technology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health (NIH), Eunice Kennedy Shriver NICHD, NIDDK, and NHLBI. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by National Science Foundation EAGER Award 1249199.; Recipient of a National Research Council Research Associateship Award at the National Institute of Standards and Technology and the National Institutes of Health.	Alavian KN, 2015, MOL PHARMACOL, V87, P1, DOI 10.1124/mol.114.095661; Banerjee K, 2010, FEBS LETT, V584, P1571, DOI 10.1016/j.febslet.2010.03.012; Bezrukov SM, 2004, BIOPHYS J, V87, P3162, DOI 10.1529/biophysj.104.044453; BLAUSTEIN RO, 1990, J GEN PHYSIOL, V96, P921, DOI 10.1085/jgp.96.5.921; Buettner S, 2013, CELL DEATH DIFFER, V20, P465, DOI 10.1038/cdd.2012.142; Buttner S, 2008, J BIOL CHEM, V283, P7554, DOI 10.1074/jbc.M708477200; Buttner S, 2013, EMBO J, V32, P3041, DOI 10.1038/emboj.2013.228; Carneiro CMM, 2003, BBA-BIOMEMBRANES, V1612, P144, DOI 10.1016/S0005-2736(03)00113-5; Ciaccioli G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055848; Cole NB, 2008, EXP CELL RES, V314, P2076, DOI 10.1016/j.yexcr.2008.03.012; COLOMBINI M, 1989, J MEMBRANE BIOL, V111, P103, DOI 10.1007/BF01871775; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Crowther RA, 1998, FEBS LETT, V436, P309, DOI 10.1016/S0014-5793(98)01146-6; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; De Pinto V, 2010, BBA-BIOENERGETICS, V1797, P1268, DOI 10.1016/j.bbabio.2010.01.031; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Elkon H, 2002, J MOL NEUROSCI, V18, P229, DOI 10.1385/JMN:18:3:229; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Federico A, 2012, J NEUROL SCI, V322, P254, DOI 10.1016/j.jns.2012.05.030; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Goedert M, 2001, METH MOLEC MED, V62, P33, DOI 10.1385/1-59259-142-6:33; Gurnev PA, 2014, BIOPHYS J, V106, P556, DOI 10.1016/j.bpj.2013.12.028; Gurnev PA, 2011, FEBS LETT, V585, P2363, DOI 10.1016/j.febslet.2011.06.008; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Junn E, 2002, NEUROSCI LETT, V320, P146, DOI 10.1016/S0304-3940(02)00016-2; Kokoszka JE, 2004, NATURE, V427, P461, DOI 10.1038/nature02229; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Lemeshko VV, 2006, EUR BIOPHYS J BIOPHY, V36, P57, DOI 10.1007/s00249-006-0101-7; Lemeshko VV, 2014, BBA-BIOMEMBRANES, V1838, P1362, DOI 10.1016/j.bbamem.2014.01.001; Li WW, 2007, NEUROREPORT, V18, P1543, DOI 10.1097/WNR.0b013e3282f03db4; Liu GW, 2009, NEUROSCI LETT, V454, P187, DOI 10.1016/j.neulet.2009.02.056; Lu LL, 2013, ACTA BIOCH BIOPH SIN, V45, P170, DOI 10.1093/abbs/gms114; Luth ES, 2014, J BIOL CHEM, V289, P21490, DOI 10.1074/jbc.M113.545749; Maglia G, 2008, P NATL ACAD SCI USA, V105, P19720, DOI 10.1073/pnas.0808296105; Maldonado EN, 2012, J PHARMACOL EXP THER, V342, P637, DOI 10.1124/jpet.112.192153; Maldonado EN, 2010, CANCER RES, V70, P10192, DOI 10.1158/0008-5472.CAN-10-2429; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; McCommis KS, 2012, BBA-BIOMEMBRANES, V1818, P1444, DOI 10.1016/j.bbamem.2011.10.025; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Murray IVJ, 2003, BIOCHEMISTRY-US, V42, P8530, DOI 10.1021/bi027363r; Nakamura K, 2013, NEUROTHERAPEUTICS, V10, P391, DOI 10.1007/s13311-013-0182-9; Nakamura K, 2011, J BIOL CHEM, V286, P20710, DOI 10.1074/jbc.M110.213538; Nakamura K, 2008, J NEUROSCI, V28, P12305, DOI 10.1523/JNEUROSCI.3088-08.2008; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Robotta M, 2014, CHEMBIOCHEM, V15, P2499, DOI 10.1002/cbic.201402281; Rochet JC, 2012, PROG MOL BIOL TRANSL, V107, P125, DOI 10.1016/B978-0-12-385883-2.00011-4; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; Rostovtseva T, 1997, BIOPHYS J, V72, P1954, DOI 10.1016/S0006-3495(97)78841-6; Rostovtseva TK, 2006, J BIOL CHEM, V281, P37496, DOI 10.1074/jbc.M602548200; Rostovtseva TK, 2012, BBA-BIOMEMBRANES, V1818, P1526, DOI 10.1016/j.bbamem.2011.11.004; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Rostovtseva TK, 2005, J BIOENERG BIOMEMBR, V37, P129, DOI 10.1007/s10863-005-6566-8; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shen JM, 2014, BRAIN RES, V1591, P14, DOI 10.1016/j.brainres.2014.09.046; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Shoshan-Barmatz V, 2012, MITOCHONDRION, V12, P24, DOI 10.1016/j.mito.2011.04.001; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Su LHJ, 2010, DIS MODEL MECH, V3, P194, DOI 10.1242/dmm.004267; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wilhelm BG, 2014, SCIENCE, V344, P1023, DOI 10.1126/science.1252884; Wolfe AJ, 2007, J AM CHEM SOC, V129, P14034, DOI 10.1021/ja0749340; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Zakharov SD, 2007, BIOCHEMISTRY-US, V46, P14369, DOI 10.1021/bi701275p	77	129	131	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2015	290	30					18467	18477		10.1074/jbc.M115.641746	http://dx.doi.org/10.1074/jbc.M115.641746			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CN5ZE	26055708	hybrid, Green Published			2022-12-26	WOS:000358512100018
J	Collin, SM; Granell, R; Westgarth, C; Murray, J; Paul, ES; Sterne, JAC; Henderson, AJ				Collin, Simon M.; Granell, Raquel; Westgarth, Carri; Murray, Jane; Paul, Elizabeth S.; Sterne, Jonathan A. C.; Henderson, A. John			Associations of Pet Ownership with Wheezing and Lung Function in Childhood: Findings from a UK Birth Cohort	PLOS ONE			English	Article							ASTHMA; EXPOSURE; RISK; CHILDREN; ATOPY; GENE; LIFE; PREGNANCY; ENDOTOXIN; ALLERGEN	Background Asthma is a heterogeneous condition and differential effects of pet ownership on non-atopic versus atopic asthma have been reported. The aim of this study was to investigate whether pet ownership during pregnancy and early childhood was associated with wheezing from birth to age 7 years and with lung function at age 8 years in a UK population-based birth cohort. Methods Data from the Avon Longitudinal Study of Parents and Children (ALSPAC) were used to investigate associations of pet ownership at six time-points from pregnancy to age 7 years with concurrent episodes of wheezing, wheezing trajectories (phenotypes) and lung function at age 8 years using logistic regression models adjusted for child's sex, maternal history of asthma/atopy, maternal smoking during pregnancy, and family adversity. Results 4,706 children had complete data on pet ownership and wheezing. From birth to age 7 years, cat ownership was associated with an overall 6% lower odds of wheezing (OR=0.94 (0.89-0.99)). Rabbit and rodent ownership was associated with 21% (OR=1.21 (1.12-1.31)) and 11% (OR=1.11 (1.02-1.21)) higher odds of wheezing, respectively, with strongest effects evident during infancy. Rabbit and rodent ownership was positively associated with a 'persistent wheeze' phenotype. Pet ownership was not associated with lung function at age 8 years, with the exception of positive associations of rodent and bird ownership with better lung function. Conclusions Cat ownership was associated with reduced risk, and rabbit and rodent ownership with increased risk, of wheezing during childhood. The mechanisms behind these differential effects warrant further investigation.	[Collin, Simon M.] Univ Bristol, Ctr Child & Adolescent Hlth, Bristol, Avon, England; [Collin, Simon M.; Granell, Raquel; Sterne, Jonathan A. C.; Henderson, A. John] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Westgarth, Carri] Univ Liverpool, Dept Epidemiol & Populat Hlth, Liverpool L69 3BX, Merseyside, England; [Westgarth, Carri] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Murray, Jane; Paul, Elizabeth S.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England	University of Bristol; University of Bristol; University of Liverpool; University of Liverpool; University of Bristol	Henderson, AJ (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	a.j.henderson@bristol.ac.uk	Granell, Raquel/AAB-5256-2022; Granell, Raquel/AAY-4846-2020; Collin, S M/AAK-6789-2020; Sterne, Jonathan/Z-3106-2019	Granell, Raquel/0000-0002-4890-4012; Collin, S M/0000-0002-1239-1681; Sterne, Jonathan/0000-0001-8496-6053	Eunice Kennedy Shriver National Institute of Child Health & Human Development [1R03HD070663-01]; Mars-WALTHAM; UK Medical Research Council Population Health Scientist Fellowship; Cats Protection; UK Medical Research Council; Wellcome Trust; University of Bristol; MRC [G1002402] Funding Source: UKRI; Medical Research Council [MC_PC_15018, G1002402] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10168] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R03HD070663] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Mars-WALTHAM; UK Medical Research Council Population Health Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cats Protection; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Bristol; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The UK Medical Research Council, the Wellcome Trust and the University of Bristol provide core support for ALSPAC. The project described was supported by Grant Number 1R03HD070663-01 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development and Mars-WALTHAM. This publication is the work of the authors and AJH will serve as guarantor for the content of this paper. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development, the National Institutes of Health, or Mars-WALTHAM. Carri Westgarth is supported by a UK Medical Research Council Population Health Scientist Fellowship. Jane Murray is funded by Cats Protection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; Apelberg BJ, 2001, J ALLERGY CLIN IMMUN, V107, P455, DOI 10.1067/mai.2001.113240; Belgrave DCM, 2013, J ALLERGY CLIN IMMUN, V132, P575, DOI 10.1016/j.jaci.2013.05.041; Blekic M, 2013, ANN ALLERG ASTHMA IM, V110, P347, DOI 10.1016/j.anai.2013.01.021; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Brussee JE, 2005, J ALLERGY CLIN IMMUN, V115, P946, DOI 10.1016/j.jaci.2005.02.035; Callard RE, 2002, CLIN EXP ALLERGY, V32, P990, DOI 10.1046/j.1365-2222.2002.01414.x; Carlsen KCL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043214; Celedon JC, 2002, LANCET, V360, P781, DOI 10.1016/S0140-6736(02)09906-3; Chen CM, 2010, INT J HYG ENVIR HEAL, V213, P1, DOI 10.1016/j.ijheh.2009.12.003; CHINN S, 1992, THORAX, V47, P707, DOI 10.1136/thx.47.9.707; Collin SM, 2015, CLIN EXP ALLERGY, V45, P200, DOI 10.1111/cea.12380; Cookson H, 2009, J ALLERGY CLIN IMMUN, V123, P847, DOI 10.1016/j.jaci.2009.01.042; Dick S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006554; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Granell R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048359; Heinrich J, 2001, CLIN EXP ALLERGY, V31, P1839, DOI 10.1046/j.1365-2222.2001.01220.x; Henderson J, 2008, THORAX, V63, P974, DOI 10.1136/thx.2007.093187; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Kauffmann F, 2012, J ALLERGY CLIN IMMUN, V130, P1229, DOI 10.1016/j.jaci.2012.10.038; Litonjua AA, 2002, J ALLERGY CLIN IMMUN, V110, P736, DOI 10.1067/mai.2002.128948; Liu Andrew H, 2004, Paediatr Respir Rev, V5 Suppl A, pS65, DOI 10.1016/S1526-0542(04)90013-9; Lodge CJ, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/176484; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Perzanowski MS, 2008, J ALLERGY CLIN IMMUN, V121, P1047, DOI 10.1016/j.jaci.2008.02.005; Peters JL, 2013, CURR OPIN ALLERGY CL, V13, P187, DOI 10.1097/ACI.0b013e32835e82d3; Remes ST, 2001, J ALLERGY CLIN IMMUN, V108, P509, DOI 10.1067/mai.2001.117797; Sandin A, 2004, PEDIATR ALLERGY IMMU, V15, P316, DOI 10.1111/j.1399-3038.2004.00166.x; Savenije OE, 2011, J ALLERGY CLIN IMMUN, V127, P1505, DOI 10.1016/j.jaci.2011.02.002; Sennhauser Felix H, 2005, Paediatr Respir Rev, V6, P2, DOI 10.1016/j.prrv.2004.11.001; Shaheen SO, 2009, THORAX, V64, P411, DOI 10.1136/thx.2008.104703; Shaheen SO, 2005, CLIN EXP ALLERGY, V35, P18, DOI 10.1111/j.1365-2222.2005.02151.x; Shaheen SO, 2004, EUR RESPIR J, V24, P292, DOI 10.1183/09031936.04.00117803; Svanes C, 2006, J ALLERGY CLIN IMMUN, V118, P691, DOI 10.1016/j.jaci.2006.06.017; Takkouche B, 2008, ALLERGY, V63, P857, DOI 10.1111/j.1398-9995.2008.01732.x; Westgarth C, 2010, INT J ENV RES PUB HE, V7, P3704, DOI 10.3390/ijerph7103704; Wildhaber J, 2012, PEDIATR PULM, V47, P346, DOI 10.1002/ppul.21557	38	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0127756	10.1371/journal.pone.0127756	http://dx.doi.org/10.1371/journal.pone.0127756			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26061067	Green Published, Green Submitted, gold			2022-12-26	WOS:000355979500056
J	Stahl, RS; Ellis, CK; Nol, P; Waters, WR; Palmer, M; VerCauteren, KC				Stahl, Randal S.; Ellis, Christine K.; Nol, Pauline; Waters, W. Ray; Palmer, Mitchell; VerCauteren, Kurt C.			Fecal Volatile Organic Ccompound Profiles from White-Tailed Deer (Odocoileus virginianus) as Indicators of Mycobacterium bovis Exposure or Mycobacterium bovis Bacille Calmette-Guerin (BCG) Vaccination	PLOS ONE			English	Article							LONG-CHAIN ALCOHOLS; CATTLE; TUBERCULOSIS; MANURE; TRANSMISSION; PERSISTENCE; INFECTION; DANISH; MODEL; ASSAY	White-tailed deer (Odocoileus virginianus) serve as a reservoir for bovine tuberculosis, caused by Mycobacterium bovis, and can be a source of infection in cattle. Vaccination with M. bovis Bacille Calmette Guerin (BCG) is being considered for management of bovine tuberculosis in deer. Presently, no method exists to non-invasively monitor the presence of bovine tuberculosis in deer. In this study, volatile organic compound profiles of BCG-vaccinated and non-vaccinated deer, before and after experimental challenge with M. bovis strain 95-1315, were generated using solid phase microextraction fiber head-space sampling over suspended fecal pellets with analysis by gas chromatography/mass spectrometry. Chromatograms were processed using XCMS Online to characterize ion variation among treatment groups. The principal component scores resulting from significant (alpha = 0.05) ion responses were used to build linear discriminant analysis models. The sensitivity and specificity of these models were used to evaluate the feasibility of using this analytical approach to distinguish within group comparisons between pre- and post-M. bovis challenge: non-vaccinated male or female deer, BCG-vaccinated male deer, and the mixed gender non-vaccinated deer data. Seventeen compounds were identified in this analysis. The peak areas for these compounds were used to build a linear discriminant classification model based on principal component analysis scores to evaluate the feasibility of discriminating between fecal samples from M. bovis challenged deer, irrespective of vaccination status. The model best representing the data had a sensitivity of 78.6% and a specificity of 91.4%. The fecal head-space sampling approach presented in this pilot study provides a non-invasive method to discriminate between M. bovis challenged deer and BCG-vaccinated deer. Additionally, the technique may prove invaluable for BCG efficacy studies with free-ranging deer as well as for use as a non-invasive monitoring system for the detection of tuberculosis in captive deer and other livestock.	[Stahl, Randal S.; Ellis, Christine K.; VerCauteren, Kurt C.] USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA; [Nol, Pauline] USDA APHIS, Wildlife Livestock Dis Invest Team, Vet Serv Sci Technol & Anal Serv, Ft Collins, CO USA; [Waters, W. Ray; Palmer, Mitchell] USDA ARS, Infect Bacterial Dis Res Unit, Natl Anim Dis Ctr, Ames, IA USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Stahl, RS (corresponding author), USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80521 USA.	randal.s.stahl@aphis.usda.gov	Stahl, Randal/AAC-6492-2021; Palmer, Mitchell/R-7091-2018	Palmer, Mitchell/0000-0002-5902-3333				Abubakar U. B., 2011, Veterinary Research (Pakistan), V4, P24; Ameni G., 2003, International Journal of Applied Research in Veterinary Medicine, V1, P17; Archibeque SL, 2006, J ANIM SCI, V84, P1767, DOI 10.2527/jas.2005-448; Biet F, 2005, VET RES, V36, P411, DOI 10.1051/vetres:2005001; Cleaveland S, 2007, TUBERCULOSIS, V87, P30, DOI 10.1016/j.tube.2006.03.001; Cosivi O, 1998, EMERG INFECT DIS, V4, P59, DOI 10.3201/eid0401.980108; CROTEAU R, 1988, J BIOL CHEM, V263, P15449; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; deLisle GW, 2001, MYCOBACTERIUM BOVIS; Elgaali H, 2002, J BASIC MICROB, V42, P373, DOI 10.1002/1521-4028(200212)42:6<373::AID-JOBM373>3.0.CO;2-4; Ellis CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089280; Essey M. A., 1981, Proceedings of the United States Animal Health Association, V85, P538; Filzmoser P., 2009, INTRO MULTIVARIATE S; Francisco TI, 2014, JAVMA-J AM VET MED A, V244, P805, DOI 10.2460/javma.244.7.805; Gerstman T, 2003, EPIDEMIOLOGY KEPT SI; Hakim M, 2012, CHEM REV, V112, P5949, DOI 10.1021/cr300174a; Hamilton-Kemp T, 2005, CURR MICROBIOL, V51, P82, DOI 10.1007/s00284-005-4469-x; Huws SA, 2011, ENVIRON MICROBIOL, V13, P1500, DOI 10.1111/j.1462-2920.2011.02452.x; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; Lyashchenko KP, 2013, CLIN VACCINE IMMUNOL, V20, P907, DOI 10.1128/CVI.00120-13; Miller DN, 2006, J ENVIRON QUAL, V35, P2383, DOI 10.2134/jeq2006.0065; Miller DN, 2002, J ANIM SCI, V80, P2214, DOI 10.2527/animalsci2002.80E-Suppl_2E1x; Nol P, 2008, J WILDLIFE DIS, V44, P247, DOI 10.7589/0090-3558-44.2.247; Norden D., 1996, 0296 CADIA USDA AN P; OKUMURA J, 1985, J DAIRY SCI, V68, P11, DOI 10.3168/jds.S0022-0302(85)80790-6; Olmstead AL, 2004, J ECON HIST, V64, P734, DOI 10.1017/S0022050704002955; Palmer MV, 2014, TRANSBOUND EMERG DIS, V61, P266, DOI 10.1111/tbed.12032; Palmer MV, 2010, ZOONOSES PUBLIC HLTH, V57, pE206, DOI 10.1111/j.1863-2378.2010.01329.x; Palmer MV, 2009, ZOONOSES PUBLIC HLTH, V56, P243, DOI 10.1111/j.1863-2378.2008.01198.x; Palmer MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097031; Palmer MV, 1999, J WILDLIFE DIS, V35, P450, DOI 10.7589/0090-3558-35.3.450; Palmer MV, 2004, J WILDLIFE DIS, V40, P87, DOI 10.7589/0090-3558-40.1.87; Palmer MV, 2001, AM J VET RES, V62, P692, DOI 10.2460/ajvr.2001.62.692; Palmer MV, 2001, J VET DIAGN INVEST, V13, P530, DOI 10.1177/104063870101300614; PANNELL LK, 1991, J DAIRY SCI, V74, P2054, DOI 10.3168/jds.S0022-0302(91)78376-8; Peled N, 2012, SENSOR ACTUAT B-CHEM, V171, P588, DOI 10.1016/j.snb.2012.05.038; Phillips M, 2010, TUBERCULOSIS, V90, P145, DOI 10.1016/j.tube.2010.01.003; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Schmitt SM, 1997, J WILDLIFE DIS, V33, P749, DOI 10.7589/0090-3558-33.4.749; Schmitt SM, 2002, ANN NY ACAD SCI, V969, P262, DOI 10.1111/j.1749-6632.2002.tb04390.x; Scott-Thomas A, 2013, J BREATH RES, V7, DOI 10.1088/1752-7155/7/3/037108; Trabue S, 2011, ATMOS ENVIRON, V45, P4243, DOI 10.1016/j.atmosenv.2011.04.081; USDA, 1999, 9145011 USDA APHIS; USDA, 2014, USDA VS GUID 6701 2; Who, 2011, EX SUMM GLOB TUB CON; Winglee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097048	46	15	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2015	10	6							e0129740	10.1371/journal.pone.0129740	http://dx.doi.org/10.1371/journal.pone.0129740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1PO	26060998	Green Published, gold			2022-12-26	WOS:000355979500162
J	Feng, MB; Qu, RJ; Habteselassie, M; Wu, J; Yang, SG; Sun, P; Huang, QG; Wang, ZY				Feng, Mingbao; Qu, Ruijuan; Habteselassie, Mussie; Wu, Jun; Yang, Shaogui; Sun, Ping; Huang, Qingguo; Wang, Zunyao			Hepatic Transcriptome Responses in Mice (Mus musculus) Exposed to the Nafion Membrane and Its Combustion Products	PLOS ONE			English	Article							OXIDATIVE STRESS; UDP-GLUCURONOSYLTRANSFERASES; GENE-EXPRESSION; FUEL-CELL; DEGRADATION; INTOXICATION; PARAMETERS; FLUORIDE; ASSAY; LIVER	Nafion 117 membrane (N117), an important polymer electrolyte membrane (PEM), has been widely used for numerous chemical technologies. Despite its increasing production and use, the toxicity data for N117 and its combustion products remain lacking. Toxicity studies are necessary to avoid problems related to waste disposal in landfills and incineration that may arise. In this study, we investigated the histopathological alterations, oxidative stress biomarker responses, and transcriptome profiles in the liver of male mice exposed to N117 and its combustion products for 24 days. An ion-chromatography system and liquid chromatography system coupled to a hybrid quadrupole time-of-flight mass spectrometry were used to analyze the chemical compositions of these combustion products. The transcriptomics analysis identified several significantly altered molecular pathways, including the metabolism of xenobiotics, carbohydrates and lipids; signal transduction; cellular processes; immune system; and signaling molecules and interaction. These studies provide preliminary data for the potential toxicity of N117 and its combustion products on living organisms and may fill the information gaps in the toxicity databases for the currently used PEMs.	[Feng, Mingbao; Qu, Ruijuan; Yang, Shaogui; Sun, Ping; Wang, Zunyao] Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resources Reuse, Nanjing 210023, Jiangsu, Peoples R China; [Habteselassie, Mussie; Huang, Qingguo] Univ Georgia, Coll Agr & Environm Sci, Dept Crop & Soil Sci, Griffin, GA 30223 USA; [Wu, Jun] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing 210046, Jiangsu, Peoples R China	Nanjing University; University System of Georgia; University of Georgia; Nanjing Agricultural University	Sun, P (corresponding author), Nanjing Univ, Sch Environm, State Key Lab Pollut Control & Resources Reuse, Nanjing 210023, Jiangsu, Peoples R China.	sunping@nju.edu.cn; wangzy@nju.edu.cn	Wang, Zunyao/H-8526-2016; Feng, Mingbao/R-2627-2019; Qu, Ruijuan/AAG-6705-2021	Wang, Zunyao/0000-0002-7655-9244; Feng, Mingbao/0000-0003-4532-2209; Qu, ruijuan/0000-0001-8643-1546	National Natural Science Foundation of China [41071319, 21377051]; Major Science and Technology Program for Water Pollution Control and Treatment of China [2012ZX07506-001]; Scientific Research Foundation of Graduate School of Nanjing University [2013CL08]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Program for Water Pollution Control and Treatment of China; Scientific Research Foundation of Graduate School of Nanjing University(Nanjing University)	This research was financially supported by the National Natural Science Foundation of China (No. 41071319, 21377051), the Major Science and Technology Program for Water Pollution Control and Treatment of China (No. 2012ZX07506-001) and the Scientific Research Foundation of Graduate School of Nanjing University (2013CL08).	Ahlborn GJ, 2008, TOXICOL APPL PHARM, V227, P400, DOI 10.1016/j.taap.2007.10.029; Beliaeff B, 2002, ENVIRON TOXICOL CHEM, V21, P1316, DOI 10.1002/etc.5620210629; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Cele N, 2009, MACROMOL MATER ENG, V294, P719, DOI 10.1002/mame.200900143; Chattopadhyay A, 2011, ARCH TOXICOL, V85, P327, DOI 10.1007/s00204-010-0588-7; Chen C, 2007, J POWER SOURCES, V169, P288, DOI 10.1016/j.jpowsour.2007.03.037; Chouhan S, 2010, J APPL TOXICOL, V30, P63, DOI 10.1002/jat.1474; Chouhan S, 2008, TOXICOLOGY, V254, P61, DOI 10.1016/j.tox.2008.09.008; Devanathan R, 2008, ENERG ENVIRON SCI, V1, P101, DOI 10.1039/b808149m; DuPont Fuel Cells, 2009, SAF HANDL US PERFL A; Geng WH, 2007, FUEL, V86, P715, DOI 10.1016/j.fuel.2006.08.025; Gervin K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002454; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Iida C, 2007, ARCH TOXICOL, V81, P489, DOI 10.1007/s00204-007-0181-x; Iwai Y, 2008, J MEMBRANE SCI, V322, P249, DOI 10.1016/j.memsci.2008.05.045; Kanbur M, 2009, FOOD CHEM TOXICOL, V47, P1184, DOI 10.1016/j.fct.2009.02.008; Keshava C, 2009, ENVIRON MOL MUTAGEN, V50, P134, DOI 10.1002/em.20449; Kobayashi Y, 2009, J AM CHEM SOC, V131, P9849, DOI 10.1021/ja9040829; Krieglstein CF, 2001, AM J HYPERTENS, V14, p44S, DOI 10.1016/S0895-7061(01)02069-6; Kurniawan D, 2013, MICROCHEM J, V106, P384, DOI 10.1016/j.microc.2012.10.004; Lee HJ, 2012, POLYM DEGRAD STABIL, V97, P1010, DOI 10.1016/j.polymdegradstab.2012.03.016; Lettieri T, 2006, ENVIRON HEALTH PERSP, V114, P4, DOI 10.1289/ehp.8194; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Li ZH, 2011, J HAZARD MATER, V185, P870, DOI 10.1016/j.jhazmat.2010.09.102; Li ZH, 2010, CHEMOSPHERE, V80, P530, DOI 10.1016/j.chemosphere.2010.04.046; Lien HL, 2007, J HAZARD MATER, V144, P194, DOI 10.1016/j.jhazmat.2006.10.004; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Matkovic LB, 2011, TOXICOLOGY, V290, P22, DOI 10.1016/j.tox.2011.08.014; Mauritz KA, 2004, CHEM REV, V104, P4535, DOI 10.1021/cr0207123; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nasef MM, 2009, DESALINATION, V249, P677, DOI 10.1016/j.desal.2008.12.059; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Qiu YY, 2011, J HAZARD MATER, V190, P480, DOI 10.1016/j.jhazmat.2011.03.071; REDEGELD FAM, 1988, ANAL BIOCHEM, V174, P489, DOI 10.1016/0003-2697(88)90048-6; Rowland A, 2013, INT J BIOCHEM CELL B, V45, P1121, DOI 10.1016/j.biocel.2013.02.019; Santibanez JF, 2011, CLIN SCI, V121, P233, DOI 10.1042/CS20110086; Scott K, 2005, IMMUNOLOGY, V116, P245, DOI 10.1111/j.1365-2567.2005.02218.x; Shanthakumari D, 2004, TOXICOLOGY, V204, P219, DOI 10.1016/j.tox.2004.06.058; Song YJ, 2011, ARCH TOXICOL, V85, P663, DOI 10.1007/s00204-011-0667-4; Sugawara T, 2011, J POWER SOURCES, V196, P2615, DOI 10.1016/j.jpowsour.2010.10.043; Tam DNN, 2012, TOXICOL APPL PHARM, V259, P329, DOI 10.1016/j.taap.2012.01.010; TEPHLY TR, 1990, TRENDS PHARMACOL SCI, V11, P276, DOI 10.1016/0165-6147(90)90008-V; Wang C, 2011, ENVIRON SCI TECHNOL, V45, P3746, DOI 10.1021/es1037047; Wang FQ, 2010, ENVIRON SCI TECHNOL, V44, P1847, DOI 10.1021/es902799f; Wang Z, 2011, ARCH TOXICOL, V85, P1407, DOI 10.1007/s00204-011-0697-y; Wei YH, 2008, TOXICOL APPL PHARM, V226, P285, DOI 10.1016/j.taap.2007.09.023; Wu B, 2012, ENVIRON SCI TECHNOL, V46, P10758, DOI 10.1021/es301804t; Xie YX, 2007, TOXICOLOGY, V236, P7, DOI 10.1016/j.tox.2007.03.021; Yagi K, 1998, Methods Mol Biol, V108, P101; Yeh MH, 2012, CARBON, V50, P4192, DOI 10.1016/j.carbon.2012.05.001; Yu TH, 2011, J AM CHEM SOC, V133, P19857, DOI 10.1021/ja2074642; Zhang Y, 2013, ENVIRON SCI TECHNOL, V47, P2918, DOI 10.1021/es3048976	53	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128591	10.1371/journal.pone.0128591	http://dx.doi.org/10.1371/journal.pone.0128591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057616	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000025
J	Gohil, R; Crosby-Nwaobi, R; Forbes, A; Burton, B; Hykin, P; Sivaprasad, S				Gohil, Rishma; Crosby-Nwaobi, Roxanne; Forbes, Angus; Burton, Ben; Hykin, Phil; Sivaprasad, Sobha			Caregiver Burden in Patients Receiving Ranibizumab Therapy for Neovascular Age Related Macular Degeneration	PLOS ONE			English	Article							VISUAL IMPAIRMENT; OLDER-PEOPLE; CARE	Purpose To assess the caregiver burden and factors determining the burden in patients receiving ranibizumab therapy for neovascular AMD (nAMD). Methods This is a cross-sectional questionnaire survey of 250 matched patient caregiver dyads across three large ophthalmic treatment centres in United Kingdom. The primary outcome was the subjective caregiver burden measured using caregiver reaction assessment scale (CRA). Objective caregiver burden was determined by the caregiver tasks and level of care provided. The factors that may predict the caregiver burden such as the patient's visual acuity of the better eye and vision related quality of life, demographics, satisfaction and support provided by the healthcare and the health status of the dyads were also collected and assessed in a hierarchical regression model. Results The mean CRA score was 3.2 +/- 0.5, similar to the score reported by caregivers for atrial fibrillation who require regular hospital appointments for monitoring their thromboprophylaxis. Caregiver tasks including accompanying for hospital appointments for eye treatment and patient's visual acuity in the better eye were the biggest contributors to the caregiver burden hierarchical model explaining 18% and 11% of the variance respectively. Conclusion Ranibizumab therapy for nAMD is associated with significant caregiver burden. Both disease impact and treatment frequency contributed to the overall burden.	[Gohil, Rishma; Crosby-Nwaobi, Roxanne; Forbes, Angus; Hykin, Phil; Sivaprasad, Sobha] NIHR Moorfields Biomed Res Ctr, London, England; [Gohil, Rishma; Crosby-Nwaobi, Roxanne; Sivaprasad, Sobha] Kings Coll London, London, England; [Burton, Ben] James Paget Univ Hosp, Great Yarmouth, England; [Crosby-Nwaobi, Roxanne; Sivaprasad, Sobha] Kings Coll Hosp London, London, England	University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Sivaprasad, S (corresponding author), NIHR Moorfields Biomed Res Ctr, London, England.	sobha.sivaprasad@moorfields.nhs.uk	Sivaprasad, S./D-6876-2015	Sivaprasad, S./0000-0001-8952-0659; Burton, Ben/0000-0001-9579-9078; Forbes, Angus/0000-0003-3331-755X	Macular Society, Hampshire [MDS 2012]; Bayer Plc Berkshire [ISS 16709]	Macular Society, Hampshire; Bayer Plc Berkshire	SS: Macular Society, Hampshire, http://www.macularsociety.org/, Grant number: MDS 2012 Sivaprasad. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SS: Bayer Plc Berkshire, http://www.bayer.co.uk/scripts/pages/en/index.php, Grant number: ISS 16709. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attkisson C.G., 2004, USE PSYCHOL TESTING; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Brouwer WBF, 2004, ARTHRIT RHEUM-ARTHR, V51, P570, DOI 10.1002/art.20528; Buckle M, 2015, EYE, V29, P403, DOI 10.1038/eye.2014.296; Buys L, 2008, AUST J RURAL HEALTH, V16, P33, DOI 10.1111/j.1440-1584.2007.00948.x; Coleman CI, 2012, INT J CLIN PRACT, V66, P984, DOI 10.1111/j.1742-1241.2012.02996.x; Evans JR, 2008, ARCH OPHTHALMOL-CHIC, V126, P1428, DOI 10.1001/archopht.126.10.1428; Evans JR, 2004, OPHTHALMOLOGY, V111, P513, DOI 10.1016/j.ophtha.2003.07.012; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Forbes A, 2007, CLIN REHABIL, V21, P563, DOI 10.1177/0269215507075035; Freeman EE, 2005, INVEST OPHTH VIS SCI, V46, P4040, DOI 10.1167/iovs.05-0687; Gitlin LN, 2005, J AGING HEALTH, V17, P148, DOI 10.1177/0898264304274184; GIVEN CW, 1992, RES NURS HEALTH, V15, P271, DOI 10.1002/nur.4770150406; Godwin KM, 2013, AGING MENT HEALTH, V17, P423, DOI 10.1080/13607863.2012.756457; Hanly P, 2015, SUPPORT CARE CANCER, V23, P1941, DOI 10.1007/s00520-014-2551-2; Jacobi CE, 2003, RHEUMATOLOGY, V42, P1226, DOI 10.1093/rheumatology/keg366; Kay S, 2014, OPHTHAL EPIDEMIOL, V21, P66, DOI 10.3109/09286586.2014.888456; Ke KM, 2007, BRIT J OPHTHALMOL, V91, P1279, DOI 10.1136/bjo.2006.113142; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mitchell P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101072; Muniraju R, 2013, OPHTHALMOLOGICA, V230, P27, DOI 10.1159/000350238; Nijboer C, 1999, SOC SCI MED, V48, P1259, DOI 10.1016/S0277-9536(98)00426-2; Viitanen O, 2014, CLIN OPHTHALMOL, V8, P1913, DOI 10.2147/OPTH.S69246; Wang JJ, 1999, AUST NZ J PUBL HEAL, V23, P147, DOI 10.1111/j.1467-842X.1999.tb01225.x	26	44	44	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129361	10.1371/journal.pone.0129361	http://dx.doi.org/10.1371/journal.pone.0129361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK6PC	26056840	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000050
J	Klenk, J; Kerse, N; Rapp, K; Nikolaus, T; Becker, C; Rothenbacher, D; Peter, R; Denkinger, MD				Klenk, Jochen; Kerse, Ngaire; Rapp, Kilian; Nikolaus, Thorsten; Becker, Clemens; Rothenbacher, Dietrich; Peter, Richard; Denkinger, Michael Dieter		ActiFE Study Grp	Physical Activity and Different Concepts of Fall Risk Estimation in Older People-Results of the ActiFE-Ulm Study	PLOS ONE			English	Article							ELDERLY-PEOPLE; ACTIVITY MONITOR; CONTROLLED-TRIAL; WALKING; ASSOCIATION; ADULTS; CIRCUMSTANCES; PERFORMANCE; FRACTURES; CARE	Objectives To investigate the relationship between physical activity and two measures of fall incidence in an elderly population using person-years as well as hours walked as denominators and to compare these two approaches. Design Prospective cohort study with one-year follow-up of falls using fall calendars. Physical activity was defined as walking duration and recorded at baseline over one week using a thigh-worn uni-axial accelerometer (activPAL; PAL Technologies, Glasgow, Scotland). Average daily physical activity was extracted from these data and categorized in low (0-59 min), medium (60-119 min) and high (120 min and more) activity. Setting The ActiFE Ulm study located in Ulm and adjacent regions in Southern Germany. Participants 1,214 community-dwelling older people (>= 65 years, 56.4% men). Measurements Negative-binomial regression models were used to calculate fall rates and incidence rate ratios for each activity category each with using (1) person-years and (2) hours walked as denominators stratified by gender, age group, fall history, and walking speed. All analyses were adjusted either for gender, age, or both. Results No statistically significant association was seen between falls per person-year and average daily physical activity. However, when looking at falls per 100 hours walked, those who were low active sustained more falls per hours walked. The highest incidence rates of falls were seen in low-active persons with slow walking speed (0.57 (95% confidence interval (95% CI): 0.33 to 0.98) falls per 100 hours walked) or history of falls (0.60 (95% CI: 0.36 to 0.99) falls per 100 hours walked). Conclusion Falls per hours walked is a relevant and sensitive outcome measure. It complements the concept of incidence per person years, and gives an additional perspective on falls in community- dwelling older people.	[Klenk, Jochen; Rapp, Kilian; Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Klenk, Jochen; Rapp, Kilian; Becker, Clemens] Robert Bosch Krankenhaus, Dept Clin Gerontol & Rehabil, Stuttgart, Germany; [Kerse, Ngaire] Univ Auckland, Sch Populat Hlth, Dept Gen Practice & Primary Hlth Care, Auckland 1, New Zealand; [Nikolaus, Thorsten; Denkinger, Michael Dieter] Agaples Bethesda Clin, Ulm, Germany; [Peter, Richard] Univ Ulm, Inst Hist Philosophy & Eth Med, D-89069 Ulm, Germany	Ulm University; Bosch; Robert Bosch Krankenhaus; University of Auckland; Ulm University	Klenk, J (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.	jochen.klenk@uni-ulm.de	Kerse, Ngaire/AFF-8119-2022; Klenk, Jochen/R-3614-2019; Steinacker, Juergen M. M/E-6876-2015; Stingl, Julia C./ABA-7201-2020; Denkinger, Michael D/E-1814-2013; Nagel, Gabriele/C-3635-2012; Rapp, Kilian/AAJ-3370-2020; Klenk, Jochen/C-2164-2012; Becker, Clemens/ABI-5405-2020	Klenk, Jochen/0000-0002-5987-447X; Steinacker, Juergen M. M/0000-0001-8901-9450; Stingl, Julia C./0000-0002-1566-8156; Denkinger, Michael D/0000-0002-8097-060X; Nagel, Gabriele/0000-0001-6185-8535; Rapp, Kilian/0000-0003-1625-2571; Rothenbacher, Dietrich/0000-0002-3563-2791; Koenig, Wolfgang/0000-0002-2064-9603	Ministry of Science, Research and Arts, state of Baden-Wuerttemberg, Germany, Geriatric Competence Center, Ulm University; "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany	Ministry of Science, Research and Arts, state of Baden-Wuerttemberg, Germany, Geriatric Competence Center, Ulm University; "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany	The study was funded by a grant from the Ministry of Science, Research and Arts, state of Baden-Wuerttemberg, Germany, as part of the Geriatric Competence Center, Ulm University (http://mwk.baden-wuerttemberg.de). Kilian Rapp and Michael Denkinger were supported by a "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany (http://www.bosch-stiftung.de). None of the sources had any influence on the content.	Ainsworth BE, 2009, BRIT J SPORT MED, V43, P6, DOI 10.1136/bjsm.2008.052449; Berg WP, 1997, AGE AGEING, V26, P261, DOI 10.1093/ageing/26.4.261; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Campbell AJ, 1997, AGE AGEING, V26, P315, DOI 10.1093/ageing/26.4.315; CAMPBELL AJ, 1985, J EPIDEMIOL COMMUN H, V39, P337, DOI 10.1136/jech.39.4.337; CAMPBELL AJ, 1990, AGE AGEING, V19, P136, DOI 10.1093/ageing/19.2.136; Chan BKS, 2007, AM J EPIDEMIOL, V165, P696, DOI 10.1093/aje/kwk050; Clemes SA, 2008, BRIT J SPORT MED, V42, P68, DOI 10.1136/bjsm.2007.038521; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Denkinger MD, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-50; Ebrahim S, 1997, AGE AGEING, V26, P253, DOI 10.1093/ageing/26.4.253; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Graafmans WC, 2003, Z GERONTOL GERIATR, V36, P23, DOI 10.1007/s00391-003-0143-8; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Gregg EW, 2000, J AM GERIATR SOC, V48, P883, DOI 10.1111/j.1532-5415.2000.tb06884.x; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Heesch KC, 2008, J EPIDEMIOL COMMUN H, V62, P421, DOI 10.1136/jech.2007.064147; Janz KF, 2006, BRIT J SPORT MED, V40, P191, DOI 10.1136/bjsm.2005.023036; Jefferis BJ, 2015, MED SCI SPORT EXER, V47, P2119, DOI 10.1249/MSS.0000000000000635; Jorstad EC, 2005, J AM GERIATR SOC, V53, P501; Kempen GIJM, 2008, AGE AGEING, V37, P45, DOI 10.1093/ageing/afm157; Kerse N, 2005, J AM GERIATR SOC, V53, P1951, DOI 10.1111/j.1532-5415.2005.00466.x; Khan KM, 2001, BRIT J SPORT MED, V35, P144, DOI 10.1136/bjsm.35.3.144; Klenk J, 2012, J EPIDEMIOL COMMUN H, V66, P474, DOI 10.1136/jech.2010.128090; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Lawton BA, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2509; Li WJ, 2006, AM J PUBLIC HEALTH, V96, P1192, DOI 10.2105/AJPH.2005.083055; Mertz KJ, 2010, AM J PREV MED, V39, P15, DOI 10.1016/j.amepre.2010.03.013; Parkkari J, 1999, CALCIFIED TISSUE INT, V65, P183; Peeters GMEE, 2010, OSTEOPOROSIS INT, V21, P1189, DOI 10.1007/s00198-009-1053-4; Rapp K, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-105; Rapp K, 2012, AGING CLIN EXP RES, V24, P455, DOI 10.3275/8264; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Voukelatos A, 2015, AGE AGEING, V44, P377, DOI 10.1093/ageing/afu186; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Wijlhuizen GJ, 2010, PREV MED, V50, P143, DOI 10.1016/j.ypmed.2009.12.014; Zieschang T, 2012, INT PSYCHOGERIATR, V24, P587, DOI 10.1017/S1041610211002122	41	54	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129098	10.1371/journal.pone.0129098	http://dx.doi.org/10.1371/journal.pone.0129098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26058056	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000038
J	Bellamy, C; Altringham, J				Bellamy, Chloe; Altringham, John			Predicting Species Distributions Using Record Centre Data: Multi-Scale Modelling of Habitat Suitability for Bat Roosts	PLOS ONE			English	Article							LONG-EARED BAT; SPATIAL-ANALYSIS; PIPISTRELLE BAT; CONSERVATION; SELECTION; BIODIVERSITY; FEATURES; MAXENT; MUSEUM	Conservation increasingly operates at the landscape scale. For this to be effective, we need landscape scale information on species distributions and the environmental factors that underpin them. Species records are becoming increasingly available via data centres and online portals, but they are often patchy and biased. We demonstrate how such data can yield useful habitat suitability models, using bat roost records as an example. We analysed the effects of environmental variables at eight spatial scales (500 m - 6 km) on roost selection by eight bat species (Pipistrellus pipistrellus, P. pygmaeus, Nyctalus noctula, Myotis mystacinus, M. brandtii, M. nattereri, M. daubentonii, and Plecotus auritus) using the presence-only modelling software MaxEnt. Modelling was carried out on a selection of 418 data centre roost records from the Lake District National Park, UK. Target group pseudoabsences were selected to reduce the impact of sampling bias. Multi-scale models, combining variables measured at their best performing spatial scales, were used to predict roosting habitat suitability, yielding models with useful predictive abilities. Small areas of deciduous woodland consistently increased roosting habitat suitability, but other habitat associations varied between species and scales. Pipistrellus were positively related to built environments at small scales, and depended on large-scale woodland availability. The other, more specialist, species were highly sensitive to human-altered landscapes, avoiding even small rural towns. The strength of many relationships at large scales suggests that bats are sensitive to habitat modifications far from the roost itself. The fine resolution, large extent maps will aid targeted decision-making by conservationists and planners. We have made available an ArcGIS toolbox that automates the production of multi-scale variables, to facilitate the application of our methods to other taxa and locations. Habitat suitability modelling has the potential to become a standard tool for supporting landscape-scale decision-making as relevant data and open source, user-friendly, and peer-reviewed software become widely available.	[Bellamy, Chloe; Altringham, John] Univ Leeds, Fac Biol Sci, Sch Biol, Leeds, W Yorkshire, England	University of Leeds	Altringham, J (corresponding author), Univ Leeds, Fac Biol Sci, Sch Biol, Leeds, W Yorkshire, England.	j.d.altringham@leeds.ac.uk			University of Leeds Research Scholarship; People's Trust for Endangered Species; Forestry Commission; Cumbria Wildlife Trust	University of Leeds Research Scholarship; People's Trust for Endangered Species; Forestry Commission; Cumbria Wildlife Trust	CB was supported by a University of Leeds Research Scholarship (www.leeds.ac.uk), with additional funding from the People's Trust for Endangered Species (www.ptes.org), the Forestry Commission (www.forestry.gov.uk) and the Cumbria Wildlife Trust (www.cumbriawildlifetrust.org.uk). The funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Avila-Flores R, 2005, J MAMMAL, V86, P1193, DOI 10.1644/04-MAMM-A-085R1.1; Barratt EM, 1997, NATURE, V387, P138, DOI 10.1038/387138b0; Bellamy C, 2013, J APPL ECOL, V50, P892, DOI 10.1111/1365-2664.12117; Berthinussen A, 2012, J APPL ECOL, V49, P82, DOI 10.1111/j.1365-2664.2011.02068.x; Boughey KL, 2011, BIOL CONSERV, V144, P2300, DOI 10.1016/j.biocon.2011.06.008; Bradter U, 2013, METHODS ECOL EVOL, V4, P167, DOI 10.1111/j.2041-210x.2012.00253.x; Brambilla M, 2014, BIOL CONSERV, V174, P39, DOI 10.1016/j.biocon.2014.03.018; De Marco P, 2008, BIOL LETTERS, V4, P577, DOI 10.1098/rsbl.2008.0210; Duchamp JE, 2008, LANDSCAPE ECOL, V23, P849, DOI 10.1007/s10980-008-9241-8; Elith J, 2007, DIVERS DISTRIB, V13, P265, DOI 10.1111/j.1472-4642.2007.00340.x; Entwistle AC, 1997, J APPL ECOL, V34, P399, DOI 10.2307/2404885; Fabianek F, 2011, ECOSCIENCE, V18, P9, DOI 10.2980/18-1-3373; Graham CH, 2004, TRENDS ECOL EVOL, V19, P497, DOI 10.1016/j.tree.2004.07.006; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Jenkins EV, 1998, ANIM BEHAV, V56, P909, DOI 10.1006/anbe.1998.0858; Jones Gareth, 2009, Endangered Species Research, V8, P93, DOI 10.3354/esr00182; Lawton J.H., 2010, MAKING SPACE NATURE; Lesinski G, 2008, ANN ZOOL FENN, V45, P277, DOI 10.5735/086.045.0406; Liu CR, 2013, J BIOGEOGR, V40, P778, DOI 10.1111/jbi.12058; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Mackie LJ, 2007, BIOL CONSERV, V140, P70, DOI 10.1016/j.biocon.2007.07.031; Mateo RG, 2010, DIVERS DISTRIB, V16, P84, DOI 10.1111/j.1472-4642.2009.00617.x; Merckx B, 2011, ECOL MODEL, V222, P588, DOI 10.1016/j.ecolmodel.2010.11.016; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Oakeley SF, 1998, J ZOOL, V245, P222, DOI 10.1111/j.1469-7998.1998.tb00094.x; Parolo G, 2008, J APPL ECOL, V45, P1410, DOI 10.1111/j.1365-2664.2008.01516.x; Pawar S, 2007, BIOL CONSERV, V136, P346, DOI 10.1016/j.biocon.2006.12.012; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2011, BRIEF TUTORIAL MAXEN, P32; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Rainho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019227; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Razgour O, 2011, BIOL CONSERV, V144, P2922, DOI 10.1016/j.biocon.2011.08.010; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Russ JM, 2003, J ZOOL, V259, P289, DOI 10.1017/S0952836902003254; Senior P, 2005, P ROY SOC B-BIOL SCI, V272, P2467, DOI 10.1098/rspb.2005.3237; Shcheglovitova M, 2013, ECOL MODEL, V269, P9, DOI 10.1016/j.ecolmodel.2013.08.011; Siemers BM, 2011, P ROY SOC B-BIOL SCI, V278, P1646, DOI 10.1098/rspb.2010.2262; Stone E.L., 2009, CURR BIOL, V19, P1, DOI DOI 10.1016/J.CUB.2008.11.058; Threlfall C, 2011, ECOGRAPHY, V34, P814, DOI 10.1111/j.1600-0587.2010.06939.x; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Warton DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079168; Watrous KS, 2006, J WILDLIFE MANAGE, V70, P1228, DOI 10.2193/0022-541X(2006)70[1228:PMHCFT]2.0.CO;2; Watts K, 2010, LANDSCAPE ECOL, V25, P1305, DOI 10.1007/s10980-010-9507-9; Yackulic CB, 2013, METHODS ECOL EVOL, V4, P236, DOI 10.1111/2041-210x.12004	54	22	22	5	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128440	10.1371/journal.pone.0128440	http://dx.doi.org/10.1371/journal.pone.0128440			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053548	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300039
J	Jha, P; Lu, DS; Xu, SH				Jha, Pankaj; Lu, Dongsheng; Xu, Shuhua			Natural Selection and Functional Potentials of Human Noncoding Elements Revealed by Analysis of Next Generation Sequencing Data	PLOS ONE			English	Article							HUMAN-POPULATION HISTORY; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; PURIFYING SELECTION; ADAPTIVE EVOLUTION; GENE; DNA; INFERENCE; GENOTYPE; SCALE	Noncoding DNA sequences (NCS) have attracted much attention recently due to their functional potentials. Here we attempted to reveal the functional roles of noncoding sequences from the point of view of natural selection that typically indicates the functional potentials of certain genomic elements. We analyzed nearly 37 million single nucleotide polymorphisms (SNPs) of Phase I data of the 1000 Genomes Project. We estimated a series of key parameters of population genetics and molecular evolution to characterize sequence variations of the noncoding genome within and between populations, and identified the natural selection footprints in NCS in worldwide human populations. Our results showed that purifying selection is prevalent and there is substantial constraint of variations in NCS, while positive selectionis more likely to be specific to some particular genomic regions and regional populations. Intriguingly, we observed larger fraction of non-conserved NCS variants with lower derived allele frequency in the genome, indicating possible functional gain of non-conserved NCS. Notably, NCS elements are enriched for potentially functional markers such as eQTLs, TF motif, and DNase I footprints in the genome. More interestingly, some NCS variants associated with diseases such as Alzheimer's disease, Type 1 diabetes, and immune-related bowel disorder (IBD) showed signatures of positive selection, although the majority of NCS variants, reported as risk alleles by genome-wide association studies, showed signatures of negative selection. Our analyses provided compelling evidence of natural selection forces on noncoding sequences in the human genome and advanced our understanding of their functional potentials that play important roles in disease etiology and human evolution.	[Jha, Pankaj; Lu, Dongsheng; Xu, Shuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol PICB, Key Lab Computat Biol,Max Planck Independent Res, Shanghai, Peoples R China; [Xu, Shuhua] ShanghaiTec Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Xu, Shuhua] Collaborat Innovat Ctr Genet & Dev, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; ShanghaiTech University	Xu, SH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol PICB, Key Lab Computat Biol,Max Planck Independent Res, Shanghai, Peoples R China.	xushua@picb.ac.cn	Xu, Shuhua/AAH-7620-2020; XU, SHUHUA/D-5345-2009; Kumar, Pankaj/AAV-4797-2020	Xu, Shuhua/0000-0002-1975-1002; XU, SHUHUA/0000-0002-1975-1002; Kumar, Pankaj/0000-0003-2584-937X	National Natural Science Foundation of China (NSFC) [91331204, 31171218]; Strategic Priority Research Program of Chinese Academy of Sciences (CAS) [XDB13040100]; International Young Scientist fellowship of Chinese Academy of Sciences [2011Y2SB10]; National Program for Top-notch Young Innovative Talents of The "Wanren Jihua" Project	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of Chinese Academy of Sciences (CAS); International Young Scientist fellowship of Chinese Academy of Sciences; National Program for Top-notch Young Innovative Talents of The "Wanren Jihua" Project	These studies were supported by the National Natural Science Foundation of China (NSFC) grants (91331204 and 31171218), by the Strategic Priority Research Program of the Chinese Academy of Sciences (CAS) (XDB13040100). PJ is supported by International Young Scientist fellowship of Chinese Academy of Sciences (2011Y2SB10). SX is Max-Planck Independent Research Group Leader and member of CAS Youth Innovation Promotion Association. SX also gratefully acknowledges the support of National Program for Top-notch Young Innovative Talents of The "Wanren Jihua" Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arbiza L, 2013, NAT GENET, V45, P723, DOI 10.1038/ng.2658; Asthana S, 2007, P NATL ACAD SCI USA, V104, P12410, DOI 10.1073/pnas.0705140104; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bhartiya D, 2012, HUM MUTAT, V33, pE2367, DOI 10.1002/humu.22158; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brescianini S, 2007, GUT, V56, P149, DOI 10.1136/gut.2006.102723; Bush EC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-17; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Delgado-Vega AM, 2012, ANN RHEUM DIS, V71, P1219, DOI 10.1136/annrheumdis-2011-200987; Doolittle WF, 2013, P NATL ACAD SCI USA, V110, P5294, DOI 10.1073/pnas.1221376110; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fay JC, 2000, GENETICS, V155, P1405; Fox CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002695; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; FU YX, 1993, GENETICS, V133, P693; Gaffney DJ, 2005, GENOME RES, V15, P1086, DOI 10.1101/gr.3895005; Gautier M, 2012, BIOINFORMATICS, V28, P1176, DOI 10.1093/bioinformatics/bts115; Geslain R, 2011, P NATL ACAD SCI USA, V108, P16489, DOI 10.1073/pnas.1113715108; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Hahn MW, 2007, GENETICA, V129, P7, DOI 10.1007/s10709-006-0029-y; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hu HY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2146; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; Hutter S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-409; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040; Kim SY, 2007, PLOS GENET, V3, P1572, DOI 10.1371/journal.pgen.0030147; Kiss T, 2004, J CELL SCI, V117, P5949, DOI 10.1242/jcs.01487; Kutter C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002841; Larsson H, 2013, G3-GENES GENOM GENET, V3, P795, DOI 10.1534/g3.112.005462; Lavner Y, 2005, GENE, V345, P127, DOI 10.1016/j.gene.2004.11.035; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li JJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002578; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Lohmueller KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002326; Lu J, 2012, GENOME RES, V22, P1243, DOI 10.1101/gr.132514.111; Maeda T, 2007, DRUG METAB DISPOS, V35, P394, DOI 10.1124/dmd.106.012112; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mu XJ, 2011, NUCLEIC ACIDS RES, V39, P7058, DOI 10.1093/nar/gkr342; Murrell JR, 2006, ARCH NEUROL-CHICAGO, V63, P431, DOI 10.1001/archneur.63.3.431; Oceandy D, 2009, CIRCULATION, V120, P607, DOI 10.1161/CIRCULATIONAHA.109.868554; Oleksyk TK, 2010, PHILOS T R SOC B, V365, P185, DOI 10.1098/rstb.2009.0219; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pei BK, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r51; Ponting CP, 2011, GENOME RES, V21, P1769, DOI 10.1101/gr.116814.110; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Quach H, 2009, AM J HUM GENET, V84, P316, DOI 10.1016/j.ajhg.2009.01.022; Reddy MVPL, 2011, GENES IMMUN, V12, P208, DOI 10.1038/gene.2010.70; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; TAJIMA F, 1983, GENETICS, V105, P437; Torgerson DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000592; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Vernot B, 2012, GENOME RES, V22, P1689, DOI 10.1101/gr.134890.111; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Ward LD, 2012, NAT BIOTECHNOL, V30, P1095, DOI 10.1038/nbt.2422; Ward LD, 2012, SCIENCE, V337, P1675, DOI 10.1126/science.1225057; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wooding SP, 2002, AM J HUM GENET, V71, P528, DOI 10.1086/342260; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yang Q, 2014, ONCOGENE, V33, P193, DOI 10.1038/onc.2012.569; Yao ZG, 2012, CELL MOL NEUROBIOL, V32, P1337, DOI 10.1007/s10571-012-9859-6; Zhao ZM, 2000, P NATL ACAD SCI USA, V97, P11354, DOI 10.1073/pnas.200348197	81	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129023	10.1371/journal.pone.0129023	http://dx.doi.org/10.1371/journal.pone.0129023			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053627	Green Submitted, gold, Green Published			2022-12-26	WOS:000355955300077
J	Lin, HJ; Ding, YY; Liu, X; Wu, QH; Shen, WW; He, N				Lin, Haijiang; Ding, Yingying; Liu, Xing; Wu, Qionghai; Shen, Weiwei; He, Na			High Prevalence of HIV Infection and Bisexual Networks among a Sample of Men Who Have Sex with Men in Eastern China	PLOS ONE			English	Article							SYPHILIS INFECTIONS; TRANSMISSION; POPULATION; EPIDEMIC; BRIDGE; RISK; MUNICIPALITY; PREVENTION; BEHAVIORS; PROVINCE	Objective To examine homosexual and heterosexual behaviors, behavioral networks and HIV infection among men who have sex with men (MSM) in Eastern China. Methods A cross-sectional survey was conducted among MSM in 2013 in a rural prefecture of Zhejiang province. Participants were interviewed for their sexual behaviors and sexual networks and were tested for HIV infection. Results A total of 620 MSM from gay bath houses and bars participated in the survey. Of them, 58.2% aged 18 to 39 years and 49.5% were currently married with a female. The age of first homosexual contact was 26.7 years on average, ranging from 12 to 66 years. 91.0% had multiple male sex partners and 86.1% also had female sex partners in lifetime. 70 (11.3%) of the participants were tested HIV-positive. A total of 620 independent egocentric sexual networks involving 620 study participants and 1,971 reported sexual partners in the past 12 months were constructed, including 70 networks for the 70 HIV-positive participants with their 221 sexual partners and 550 networks for the 550 HIV-negative participants with their 1,750 sexual partners. The median network degree was 3 (IQR 2-4) overall and was not different between HIV-positive participants (Median: 3; IQR: 2-4) and HIV-negative participants (Median: 3; IQR: 2-4) (Mann-Whitney test, Z=-0.015, P=0.998). The proportion of networks with a multiple male sexual partnership was 63.7% overall, 62.8% for HIV-positive participants and 63.8% for HIV-negative participants (chi(2)=0.025, P=0.875). The proportion of networks with both male and female sexual partners was 44.8% overall, 47.1% for HIV-positive participants and 44.5% for HIV-negative participants (chi(2)=0.169, P=0.681). Consistent condom use and knowledge of HIV infection status were rare within the network partners. Conclusions The currently high HIV prevalence and complicated bisexual networks among MSM in the study area provides enhanced evidence for developing tailored prevention strategies for HIV transmission among and beyond the MSM population.	[Lin, Haijiang; Ding, Yingying; Liu, Xing; He, Na] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Lin, Haijiang; Ding, Yingying; Liu, Xing; He, Na] Minist Educ, Key Lab Publ Hlth Safety, Shanghai, Peoples R China; [Lin, Haijiang; Wu, Qionghai; Shen, Weiwei] Taizhou City Ctr Dis Control & Prevent, Taizhou City, Zhejiang, Peoples R China; [Lin, Haijiang; He, Na] Fudan Univ, Collaborat Innovat Ctr Social Risks Governance Hl, Shanghai 200433, Peoples R China	Fudan University; Fudan University	He, N (corresponding author), Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai 200433, Peoples R China.	nhe@shmu.edu.cn	ding, yy/HHS-9589-2022		Shanghai Municipal Health Bureau [XBR2011043]; National Major Science and Technology Project on Infectious Diseases including AIDS, Tuberculosis and Hepatitis [2012ZX10001007-006]	Shanghai Municipal Health Bureau; National Major Science and Technology Project on Infectious Diseases including AIDS, Tuberculosis and Hepatitis	This study was supported by Shanghai Municipal Health Bureau (grant no. XBR2011043) and the National Major Science and Technology Project on Infectious Diseases including AIDS, Tuberculosis and Hepatitis (2012ZX10001007-006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, INCR ACC HIV TEST CO; Choi KH, 2004, SEX TRANSM DIS, V31, P475, DOI 10.1097/01.olq.0000135988.19969.62; Choi KH, 2004, AIDS EDUC PREV, V16, P19, DOI 10.1521/aeap.16.1.19.27721; Chow EPF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607261; Chow EPF, 2013, SEX HEALTH, V10, P533, DOI 10.1071/SH13097; Chow EPF, 2012, INT J INFECT DIS, V16, pE312, DOI 10.1016/j.ijid.2012.01.012; Chow EPF, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-242; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; He Q, 2012, SEX TRANSM INFECT, V88, P229, DOI 10.1136/sextrans-2011-050230; He Q, 2006, AIDS BEHAV, V10, pS17, DOI 10.1007/s10461-006-9125-3; Heffelefinger JD, 2008, PUBLIC HEALTH REP, V123, P5, DOI 10.1177/00333549081230S302; Jeffries WL, 2009, AM J PUBLIC HEALTH, V99, P1042, DOI 10.2105/AJPH.2007.125674; Koopman JS, 1999, AM J PUBLIC HEALTH, V89, P1170, DOI 10.2105/AJPH.89.8.1170; Lau JTF, 2011, PUBLIC HEALTH, V125, P260, DOI 10.1016/j.puhe.2011.01.007; Lau JTF, 2008, SEX TRANSM DIS, V35, P406, DOI 10.1097/OLQ.0b013e318164467f; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Li HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023431; Lin HJ, 2013, AM J EPIDEMIOL, V177, P343, DOI 10.1093/aje/kws256; Lin HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-533; Ministry of Health People's Republic of China Joint United Nations Programme on HIV/AIDS World Health Organization, 2011, 2011 EST HIV AIDS EP; Qu S, 2002, CHIN J STD AIDS PREV, V8, P145; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Shang H, 2012, NATURE, V485, P576, DOI 10.1038/485576a; Sullivan SG, 2010, AIDS, V24, pS49, DOI 10.1097/01.aids.0000390089.60682.26; Wang Lan, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P20; Wang Ning, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P1205; Weinhardt LS, 2004, JAIDS-J ACQ IMM DEF, V36, P1057, DOI 10.1097/00126334-200408150-00009; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xiao Y, 2010, JAIDS-J ACQ IMM DEF, V53, pS66, DOI 10.1097/QAI.0b013e3181c7db43; Xiao Y, 2009, SEX TRANSM DIS, V36, P647, DOI 10.1097/OLQ.0b013e3181aac23d; Yang HT, 2014, CLIN INFECT DIS, V58, P1753, DOI 10.1093/cid/ciu175; Yun K, 2011, SEX TRANSM INFECT, V87, P563, DOI 10.1136/sextrans-2011-050079; ZHANG B, 2008, CHINESE J AIDS STD, V14, P541; Zhang L, 2013, LANCET INFECT DIS, V13, P955, DOI 10.1016/S1473-3099(13)70245-7; Zhang W., 2002, CHINESE EC REFORMS F	35	15	16	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129300	10.1371/journal.pone.0129300	http://dx.doi.org/10.1371/journal.pone.0129300			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CK1GM	26053179	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300113
J	Nilsson, D; Sutton, R; Tas, W; Burri, P; Melander, O; Fedorowski, A				Nilsson, David; Sutton, Richard; Tas, Widet; Burri, Philippe; Melander, Olle; Fedorowski, Artur			Orthostatic Changes in Hemodynamics and Cardiovascular Biomarkers in Dysautonomic Patients	PLOS ONE			English	Article							HEAD-UP TILT; IMMUNOLUMINOMETRIC ASSAY; NATRIURETIC-PEPTIDE; HYPOTENSION; MANAGEMENT; SYNCOPE; PLASMA; PERFORMANCE; INTOLERANCE; ENDOTHELIN	Background Impaired autonomic control of postural homeostasis results in orthostatic intolerance. However, the role of neurohormones in orthostatic intolerance has not been explained. Methods Six-hundred-and-seventy-one patients (299 males; 55 +/- 22 years) with unexplained syncope underwent head-up tilt (HUT) with serial blood sampling. Systolic blood pressure (SBP) and heart rate (HR) supine, after 3min, and lowest BP/highest HR during HUT were recorded. Plasma levels of epinephrine, norepinephrine, renin, C-terminal-pro-arginine-vasopressin (CT-proAVP), C-terminal-endothelin-1 (CT-proET-1), and mid-regional-fragment of pro-atrial-natriuretic-peptide (MR-proANP) were determined at supine and 3min of HUT. Multivariate-adjusted logistic regression model was applied to compare 1st (reference) with 4th quartile of 3 min and maximal Delta SBP/Delta HR (i.e. pronounced hypotension or tachycardia) vs. changes in neuroendocrine biomarkers, respectively. Results Higher resting CT-proET-1 predicted BP fall at 3min (Odds ratio (OR) per 1 SD: 1.62, 95% CI 1.18-2.22; p = 0.003), and max BP fall during HUT (1.82, 1.28-2.61; p = 0.001). Higher resting CT-proAVP predicted BP fall at 3min (1.33, 1.03-1.73; p = 0.03), which was also associated with increase in CT-proAVP (1.86, 1.38-2.51; p = 0.00005) and epinephrine (1.47, 1.12-1.92; p = 0.05) during HUT. Lower resting MR-proANP predicted tachycardia at 3min (0.37, 0.24-0.59; p = 0.00003), and max tachycardia during HUT (0.47, 0.29-0.77; p = 0.002). Further, tachycardia during HUT was associated with increase in epinephrine (1.60, 1.15-2.21; p = 0.005), and norepinephrine (1.87, 1.38-2.53; p = 0.005). Conclusions Resting CT-proET-1 and CT-proAVP are increased in orthostatic hypotension, while resting MR-proANP is decreased in postural tachycardia. Moreover, early BP fall during orthostasis evokes increase in CT-proAVP and epinephrine, while postural tachycardia is associated with increase in norepinephrine and epinephrine.	[Nilsson, David] Lund Univ, Dept Clin Sci, Clin Physiol & Nucl Med Unit, Skane Univ Hosp, Malmo, Sweden; [Sutton, Richard] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Tas, Widet; Burri, Philippe; Melander, Olle; Fedorowski, Artur] Lund Univ, Dept Clin Sci, Hypertens & Cardiovasc Dis Grp, Clin Res Ctr,Skane Univ Hosp, Malmo, Sweden; [Fedorowski, Artur] Skane Univ Hosp, Dept Cardiol, Malmo, Sweden	Lund University; Skane University Hospital; Imperial College London; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Nilsson, D (corresponding author), Lund Univ, Dept Clin Sci, Clin Physiol & Nucl Med Unit, Skane Univ Hosp, Malmo, Sweden.	david.nilsson@med.lu.se	Fedorowski, Artur/I-3937-2019	Fedorowski, Artur/0000-0002-5352-6327; Melander, Olle/0000-0002-2581-484X	European Research Council [StG 282225]; Swedish Medical Research Council; Swedish Heart and Lung Foundation; Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Wallenberg Foundation; Lennart Hanssons Memorial Foundation; Anna Lisa and Sven-Erik Lundgrens Foundation	European Research Council(European Research Council (ERC)European Commission); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Medical Faculty of Lund University; Malmo University Hospital; Albert Pahlsson Research Foundation; Crafoord Foundation; Ernhold Lundstroms Research Foundation; Region Skane; Hulda and Conrad Mossfelt Foundation; King Gustaf V and Queen Victoria Foundation; Wallenberg Foundation(European Commission); Lennart Hanssons Memorial Foundation; Anna Lisa and Sven-Erik Lundgrens Foundation	This study was supported by grants from the European Research Council (StG 282225), Swedish Medical Research Council, the Swedish Heart and Lung Foundation, the Medical Faculty of Lund University, Malmo University Hospital, the Albert Pahlsson Research Foundation, the Crafoord Foundation, the Ernhold Lundstroms Research Foundation, the Region Skane, the Hulda and Conrad Mossfelt Foundation, the King Gustaf V and Queen Victoria Foundation, the Wallenberg Foundation, the Lennart Hanssons Memorial Foundation, and the Anna Lisa and Sven-Erik Lundgrens Foundation.	Bartoletti A, 2000, EUROPACE, V2, P339, DOI 10.1053/eupc.2000.0125; Dietz JR, 2005, CARDIOVASC RES, V68, P8, DOI 10.1016/j.cardiores.2005.06.008; Fedorowski A, 2013, J INTERN MED, V273, P322, DOI 10.1111/joim.12021; Fedorowski A, 2013, J INTERN MED, V273, P359, DOI 10.1111/joim.12043; Fedorowski A, 2012, EUR HEART J, V33, P2331, DOI 10.1093/eurheartj/ehs058; Fitzpatrick A. TWT, 1992, EUROPEAN JOURNAL OF; Freeman R, 2011, CLIN AUTON RES, V21, P69, DOI 10.1007/s10286-011-0119-5; Freitas J, 2007, INT J CARDIOL, V116, P242, DOI 10.1016/j.ijcard.2006.03.052; Freitas Joao, 2005, Rev Port Cardiol, V24, P81; Geelen G, 2002, J APPL PHYSIOL, V92, P1401, DOI 10.1152/japplphysiol.00548.2001; Grubb BP, 2008, CIRCULATION, V117, P2814, DOI 10.1161/CIRCULATIONAHA.107.761643; Hinghofer-Szalkay H, 2011, EUR J CLIN INVEST, V41, P1180, DOI 10.1111/j.1365-2362.2011.02523.x; Holmegard HN, 2012, SCAND J CLIN LAB INV, V72, P265, DOI 10.3109/00365513.2012.659282; Jardine DL, 1997, AM J CARDIOL, V79, P1302, DOI 10.1016/S0002-9149(9X)00084-9; KAUFMANN H, 1991, LANCET, V338, P1542, DOI 10.1016/0140-6736(91)92370-H; KAUFMANN H, 1992, NEUROLOGY, V42, P590, DOI 10.1212/WNL.42.3.590; Lanier JB, 2011, AM FAM PHYSICIAN, V84, P527; Mack KJ, 2010, SEMIN PEDIATR NEUROL, V17, P109, DOI 10.1016/j.spen.2010.04.006; Magerkurth C, 2005, CLIN AUTON RES, V15, P299, DOI 10.1007/s10286-005-0291-6; Morgenthaler NG, 2006, CLIN CHEM, V52, P112, DOI 10.1373/clinchem.2005.060038; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Mosqueda-Garcia R, 2000, CIRCULATION, V102, P2898; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; OPARIL S, 1970, CIRCULATION, V41, P89, DOI 10.1161/01.CIR.41.1.89; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Petersen MEV, 2000, HEART, V84, P509, DOI 10.1136/heart.84.5.509; Romero-Ortuno R, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-73; Roul G, 1999, PACE, V22, P1020, DOI 10.1111/j.1540-8159.1999.tb00566.x; Schattenkerk DWE, 2009, AM J HYPERTENS, V22, P378, DOI 10.1038/ajh.2008.368; Ungar A, 2014, J HUM HYPERTENS, V28, P259, DOI 10.1038/jhh.2013.95; Vanderheyden M, 1998, AM HEART J, V135, P67, DOI 10.1016/S0002-8703(98)70344-8; VANDERHOORN FAJ, 1989, J CHROMATOGR-BIOMED, V487, P17, DOI 10.1016/S0378-4347(00)83003-0	32	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128962	10.1371/journal.pone.0128962	http://dx.doi.org/10.1371/journal.pone.0128962			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053073	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300072
J	Ovalle-Bracho, C; Franco-Munoz, C; Londono-Barbosa, D; Restrepo-Montoya, D; Clavijo-Ramirez, C				Ovalle-Bracho, Clemencia; Franco-Munoz, Carlos; Londono-Barbosa, Diana; Restrepo-Montoya, Daniel; Clavijo-Ramirez, Carlos			Changes in Macrophage Gene Expression Associated with Leishmania (Viannia) braziliensis Infection	PLOS ONE			English	Article							CERAMIDE GENERATION; DONOVANI INFECTION; SURVIVAL; CHOLESTEROL; ACTIVATION; PATHWAYS	Different Leishmania species cause distinct clinical manifestations of the infectious disease leishmaniasis. It is fundamentally important to understand the mechanisms governing the interaction between Leishmania and its host cell. Little is known about this interaction between Leishmania (Viannia) braziliensis and human macrophages. In this study, we aimed to identify differential gene expression between non-infected and L. (V) braziliensis-infected U937-derived macrophages. We deployed a whole human transcriptome microarray analysis using 72 hours post-infection samples and compared those samples with their noninfected counterparts. We found that 218 genes were differentially expressed between infected and non-infected macrophages. A total of 71.6% of these genes were down-regulated in the infected macrophages. Functional enrichment analyses identified the steroid and sterol/cholesterol biosynthetic processes between regulatory networks down-regulated in infected macrophages. RT-qPCR further confirmed this down-regulation in genes belonging to these pathways. These findings contrast with those from studies involving other Leishmania species at earlier infection stages, where gene up-regulation for this metabolic pathway has been reported. Sterol biosynthesis could be an important biological process associated with the expression profile of macrophages infected by L. (V.) braziliensis. Differential transcriptional results suggest a negative regulation of the genetic regulatory network involved in cholesterol biosynthesis.	[Ovalle-Bracho, Clemencia; Franco-Munoz, Carlos; Londono-Barbosa, Diana; Restrepo-Montoya, Daniel] Ctr Dermatol Federico Lleras Acosta, Bogota, Colombia; [Ovalle-Bracho, Clemencia] Univ Nacl Colombia, Fac Med, Bogota, Colombia; [Clavijo-Ramirez, Carlos] Univ Nacl Colombia, Dept Biol, Bogota, Colombia	Universidad Nacional de Colombia; Universidad Nacional de Colombia	Ovalle-Bracho, C (corresponding author), Ctr Dermatol Federico Lleras Acosta, Bogota, Colombia.	clemovalle@gmail.com	Ovalle-bracho, Clemencia/O-4004-2018	Londono Barbosa, Diana Alexandra/0000-0002-0158-5157; Restrepo-Montoya, Daniel/0000-0003-4910-7880; Clavijo-Ramirez, Carlos Arturo/0000-0001-8546-1831	Centro Dermatologico Federico Lleras Acosta; Departamento Administrativo de Ciencia y Tecnologia - COLCIENCIAS [212051928534, RC 314-2010];  [4000.16.1N]	Centro Dermatologico Federico Lleras Acosta; Departamento Administrativo de Ciencia y Tecnologia - COLCIENCIAS(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); 	Funding provided by Centro Dermatologico Federico Lleras Acosta (www.dermatologia.gov.co); project was approved in scientific committee 10 - 2010 with project code 4000.16.1N, COB; Departamento Administrativo de Ciencia y Tecnologia - COLCIENCIAS (www.colciencias.gov.co) with project code 212051928534 and contract number RC 314-2010, COB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barr SD, 2003, J BIOL CHEM, V278, P10816, DOI 10.1074/jbc.M212990200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buates S, 2001, J IMMUNOL, V166, P3416, DOI 10.4049/jimmunol.166.5.3416; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cho RJ, 2001, NAT GENET, V27, P48, DOI 10.1038/83751; Dogra N, 2007, INFECT IMMUN, V75, P3506, DOI 10.1128/IAI.00277-07; Edgar R, 2006, NAT BIOTECHNOL, V24, P1471, DOI 10.1038/nbt1206-1471; Ettinger NA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000252; Forget G, 2005, EUR J IMMUNOL, V35, P1906, DOI 10.1002/eji.200526037; Ghosh S, 2003, BIOCHEM J, V369, P447, DOI 10.1042/BJ20021684; Ghosh S, 2002, INFECT IMMUN, V70, P6828, DOI 10.1128/IAI.70.12.6828-6838.2002; Giudice A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-75; Goldston AM, 2012, TRENDS PARASITOL, V28, P417, DOI 10.1016/j.pt.2012.07.002; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Gregory DJ, 2008, INFECT IMMUN, V76, P1186, DOI 10.1128/IAI.01320-07; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jaramillo M, 2011, CELL HOST MICROBE, V9, P331, DOI 10.1016/j.chom.2011.03.008; Kaye P, 2011, NAT REV MICROBIOL, V9, P604, DOI 10.1038/nrmicro2608; KAYE PM, 1994, EUR J IMMUNOL, V24, P2850, DOI 10.1002/eji.1830241140; Lemaire J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002478; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Majumder S, 2012, J INFECT DIS, V205, P1607, DOI 10.1093/infdis/jis229; McConville MJ, 2011, ANNU REV MICROBIOL, V65, P543, DOI 10.1146/annurev-micro-090110-102913; MINTA JO, 1985, AM J PATHOL, V119, P111; Misra S, 2005, J BIOL CHEM, V280, P29364, DOI 10.1074/jbc.M504162200; Moreira D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004684; Mougneau E, 2011, IMMUNOL REV, V240, P286, DOI 10.1111/j.1600-065X.2010.00983.x; Novais FO, 2015, J INVEST DERMATOL, V135, P94, DOI 10.1038/jid.2014.305; Osorio y Fortea Jose, 2009, BMC Genomics, V10, P119, DOI 10.1186/1471-2164-10-119; PAHO, 2013, LEISHMANIASES EPIDEM; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Pucadyil TJ, 2004, MOL BIOCHEM PARASIT, V133, P145, DOI 10.1016/j.molbiopara.2003.10.002; Rabhi I, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-723; Rabhi I, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001763; Ramirez C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001866; REINER NE, 1987, J IMMUNOL, V138, P1926; Rodriguez NE, 2004, INFECT IMMUN, V72, P2111, DOI 10.1128/IAI.72.4.2111-2122.2004; Rodriguez NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019000; Rub A, 2009, NAT IMMUNOL, V10, P273, DOI 10.1038/ni.1705; Zhang SY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000648	42	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128934	10.1371/journal.pone.0128934	http://dx.doi.org/10.1371/journal.pone.0128934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26052705	Green Published, Green Submitted, gold			2022-12-26	WOS:000355955300069
J	Barnett, J; Dastjerdi, A; Davison, N; Deaville, R; Everest, D; Peake, J; Finnegan, C; Jepson, P; Steinbach, F				Barnett, James; Dastjerdi, Akbar; Davison, Nick; Deaville, Rob; Everest, David; Peake, Julie; Finnegan, Christopher; Jepson, Paul; Steinbach, Falko			Identification of Novel Cetacean Poxviruses in Cetaceans Stranded in South West England	PLOS ONE			English	Article							SEALS HALICHOERUS-GRYPUS; POX-LIKE LESIONS; INCIDENTAL LESIONS; BRITISH WATERS; PARAPOXVIRUS; INFECTION; MORTALITY; PARASITES; DOLPHINS; PHOCOENA	Poxvirus infections in marine mammals have been mainly reported through their clinical lesions and electron microscopy (EM). Poxvirus particles in association with such lesions have been demonstrated by EM and were previously classified as two new viruses, cetacean poxvirus 1 (CePV-1) and cetacean poxvirus 2 (CePV-2). In this study, epidermal pox lesions in cetaceans stranded in South West England (Cornwall) between 2008 and 2012 were investigated by electron microscopy and molecular analysis. PCR and sequencing of a highly conserved region within the viral DNA polymerase gene ruled out both parapox- and orthopoxviruses. Moreover, phylogenetic analysis of the PCR product clustered the sequences with those previously described as cetacean poxviruses. However, taking the close genetic distance of this gene fragment across the family of poxviridae into account, it is reasonable to postulate further, novel cetacean poxvirus species. The nucleotide similarity within each cluster (tentative species) detected ranged from 98.6% to 100%, whilst the similarity between the clusters was no more than 95%. The detection of several species of poxvirus in different cetacean species confirms the likelihood of a heterogeneous cetacean poxvirus genus, comparable to the heterogeneity observed in other poxvirus genera.	[Barnett, James; Davison, Nick] Anim & Plant Hlth Agcy, Truro, England; [Dastjerdi, Akbar; Peake, Julie; Finnegan, Christopher; Steinbach, Falko] APHA, Div Sci, Dept Virol, Addlestone, Surrey, England; [Deaville, Rob; Jepson, Paul] Zool Soc London, Inst Zool, UK Cetacean Strandings Invest Programme, London NW1 4RY, England; [Everest, David] APHA, Div Sci, Dept Pathol, Addlestone, Surrey, England; [Barnett, James] Univ Exeter Cornwall Campus, Environm & Sustainabil Inst, Penryn, England; [Davison, Nick] Scottish Marine Anim Stranding Scheme, SRUC Vet Serv, Inverness, Scotland; [Steinbach, Falko] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford GU2 5XH, Surrey, England	Animal & Plant Health Agency UK; Zoological Society of London; University of Exeter; University of Surrey	Barnett, J (corresponding author), Anim & Plant Hlth Agcy, Truro, England.	jamesbarnettvet@gmail.com	Steinbach, Falko/V-1682-2019; Dastjerdi, Akbar/E-1803-2011	Steinbach, Falko/0000-0003-1236-2837; Davison, Nicholas/0000-0001-7286-1836	Defra, UK; Devolved Administrations in Scotland and Wales; Defra [SE0537]	Defra, UK(Department for Environment, Food & Rural Affairs (DEFRA)); Devolved Administrations in Scotland and Wales; Defra(Department for Environment, Food & Rural Affairs (DEFRA))	Post-mortem investigations were carried out under the UK Cetacean Strandings Investigation Programme, which is funded by Defra, UK and the Devolved Administrations in Scotland and Wales. The molecular analysis was supported by Defra grant SE0537. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER JR, 1992, VET REC, V130, P569, DOI 10.1136/vr.130.26.569; BAKER JR, 1992, VET REC, V130, P554, DOI 10.1136/vr.130.25.554; Barnett J, 2013, MARINE MAMMAL MEDIC; Blacklaws BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071734; Bracht AJ, 2006, ARCH VIROL, V151, P423, DOI 10.1007/s00705-005-0679-6; Burek KA, 2005, J WILDLIFE DIS, V41, P745, DOI 10.7589/0090-3558-41.4.745; Davison NJ, 2011, VET REC, V169, DOI 10.1136/vr.d2714; Deaville R, UK CETACEAN STRANDIN; FLOM JO, 1979, J WILDLIFE DIS, V15, P593, DOI 10.7589/0090-3558-15.4.593; GERACI JR, 1979, CAN J COMP MED, V43, P399; Geraci JR., 2005, MARINE MAMMALS ASHOR, V2; HICKS BD, 1987, J WILDLIFE DIS, V23, P1, DOI 10.7589/0090-3558-23.1.1; Inoshima Y, 2000, J VIROL METHODS, V84, P201, DOI 10.1016/S0166-0934(99)00144-5; Muller G, 2003, VET PATHOL, V40, P445, DOI 10.1354/vp.40-4-445; OKADA K, 1984, JPN J VET SCI, V46, P401; OSTERHAUS ADME, 1994, VET REC, V135, P601; OSTERHAUS ADME, 1990, VET REC, V127, P91; SIMPSON VR, 1994, VET REC, V134, P292, DOI 10.1136/vr.134.12.292; Suttle CA, 2005, NATURE, V437, P356, DOI 10.1038/nature04160; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; SWEENEY JC, 1975, J AM VET MED ASSOC, V167, P533; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; van Elk N, 2000, IAAAM 31 ANN C P NEW; VanBressem MF, 1996, MAR MAMMAL SCI, V12, P371; VANBRESSEM MF, 1993, J WILDLIFE DIS, V29, P109, DOI 10.7589/0090-3558-29.1.109; Yang W-C, 2007, IAAAM 38 ANN C P ORL	26	16	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0124315	10.1371/journal.pone.0124315	http://dx.doi.org/10.1371/journal.pone.0124315			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046847	Green Submitted, Green Published, gold			2022-12-26	WOS:000355652200007
J	Pellegrina, DVD; Severino, P; Barbeiro, HV; Andreghetto, FM; Velasco, IT; de Souza, HP; Machado, MCC; Reis, EM; da Silva, FP				da Silva Pellegrina, Diogo Vieira; Severino, Patricia; Barbeiro, Hermes Vieira; Andreghetto, Flavia Maziero; Velasco, Irineu Tadeu; de Souza, Heraldo Possolo; Cesar Machado, Marcel Cerqueira; Reis, Eduardo Moraes; da Silva, Fabiano Pinheiro			Septic Shock in Advanced Age: Transcriptome Analysis Reveals Altered Molecular Signatures in Neutrophil Granulocytes	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; HEMATOPOIETIC STEM-CELLS; CYTOKINE PRODUCTION; OXIDATIVE STRESS; EXPRESSION PROFILES; MITOCHONDRIAL-DNA; MONONUCLEAR-CELLS; INNATE IMMUNITY; OLDER PATIENTS; HUMAN SEPSIS	Sepsis is one of the highest causes of mortality in hospitalized people and a common complication in both surgical and clinical patients admitted to hospital for non-infectious reasons. Sepsis is especially common in older people and its incidence is likely to increase substantially as a population ages. Despite its increased prevalence and mortality in older people, immune responses in the elderly during septic shock appear similar to that in younger patients. The purpose of this study was to conduct a genome-wide gene expression analysis of circulating neutrophils from old and young septic patients to better understand how aged individuals respond to severe infectious insult. We detected several genes whose expression could be used to differentiate immune responses of the elderly from those of young people, including genes related to oxidative phosphorylation, mitochondrial dysfunction and TGF-a signaling, among others. Our results identify major molecular pathways that are particularly affected in the elderly during sepsis, which might have a pivotal role in worsening clinical outcomes compared with young people with sepsis.	[da Silva Pellegrina, Diogo Vieira] Univ Sao Paulo, Programa Interunidades Posgrad Bioinformat, Sao Paulo, Brazil; [Severino, Patricia; Andreghetto, Flavia Maziero] Hosp Israelita Albert Einstein, Inst Israelita Ensino & Pesquisa, Sao Paulo, Brazil; [Barbeiro, Hermes Vieira; Velasco, Irineu Tadeu; de Souza, Heraldo Possolo; Cesar Machado, Marcel Cerqueira; da Silva, Fabiano Pinheiro] Univ Sao Paulo, Fac Med, Dept Emergencias Clin, Sao Paulo, Brazil; [Reis, Eduardo Moraes] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil	Universidade de Sao Paulo; Hospital Israelita Albert Einstein; Universidade de Sao Paulo; Universidade de Sao Paulo	da Silva, FP (corresponding author), Univ Sao Paulo, Fac Med, Dept Emergencias Clin, Sao Paulo, Brazil.	pinheirofabiano@hotmail.com	Souza, Heraldo P/C-2498-2012; Severino, Patricia/H-2013-2012; Barbeiro, Hermes V/E-2814-2010; Reis, Eduardo M/H-2008-2011; Reis, Eduardo Moraes Rego/AAF-3553-2020; Barbeiro, Hermes V/S-5926-2016; da Silva, Fabiano Pinheiro/F-3464-2011; Souza, Heraldo Possolo/AAX-7878-2021	Severino, Patricia/0000-0002-6682-9343; Barbeiro, Hermes V/0000-0002-8209-4463; Reis, Eduardo M/0000-0002-9556-3070; Barbeiro, Hermes V/0000-0002-8209-4463; da Silva, Fabiano Pinheiro/0000-0003-2673-2202; Souza, Heraldo Possolo/0000-0003-2499-5674; Pellegrina, Diogo/0000-0001-6423-5093	Sao Paulo Research Foundation [2012/03677-9]; CNPq; National Council for Scientific and Technological Development [470539/2013-15]; FAPESP [2014/03150-6]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	MCCM is supported by FAPESP, the Sao Paulo Research Foundation (grant # 2012/03677-9). FPS is supported by CNPq, the National Council for Scientific and Technological Development (grant # 470539/2013-15). DVSP receives a M.Sc. fellowship from FAPESP (2014/03150-6) and EMR received an established investigator fellowship from CNPq.	Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Boehmer ED, 2004, J LEUKOCYTE BIOL, V75, P342, DOI 10.1189/jlb.0803389; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Bone RC, 1996, JAMA-J AM MED ASSOC, V276, P565, DOI 10.1001/jama.276.7.565; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bone RC, 1996, CRIT CARE MED, V24, P1125, DOI 10.1097/00003246-199607000-00010; Bosmann M, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-4; Cannizzo ES, 2011, J PROTEOMICS, V74, P2313, DOI 10.1016/j.jprot.2011.06.005; Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Christie JD, 2005, CRIT CARE MED, V33, pS449, DOI 10.1097/01.CCM.0000186078.26361.96; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cordero D, 2014, CURRENT PHARM BIOTEC; Cvijanovich N, 2008, PHYSIOL GENOMICS, V34, P127, DOI 10.1152/physiolgenomics.00025.2008; da Silva FP, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-21; da Silva FP, 2013, PEPTIDES, V44, P135, DOI 10.1016/j.peptides.2013.03.029; De Gaudio AR, 2009, CURR DRUG TARGETS, V10, P60, DOI 10.2174/138945009787122879; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Deutschman CS, 2013, CRIT CARE, V17, DOI 10.1186/cc12723; FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950; Florian MC, 2013, NATURE, V503, P392, DOI 10.1038/nature12631; Floyd RA, 2011, FREE RADICAL BIO MED, V51, P931, DOI 10.1016/j.freeradbiomed.2011.04.014; Franceschi C, 2000, VACCINE, V18, P1717, DOI 10.1016/S0264-410X(99)00513-7; Galley HF, 2011, BRIT J ANAESTH, V107, P57, DOI 10.1093/bja/aer093; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girard TD, 2005, CLIN INFECT DIS, V40, P719, DOI 10.1086/427876; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Harries LW, 2014, GENES-BASEL, V5, P656, DOI 10.3390/genes5030656; Heppner HJ, 2013, CRIT CARE CLIN, V29, P757, DOI 10.1016/j.ccc.2013.03.016; Hiraki S, 2012, SURGERY, V151, P313, DOI 10.1016/j.surg.2011.07.019; Hong FX, 2006, BIOINFORMATICS, V22, P2825, DOI 10.1093/bioinformatics/btl476; Howcroft TK, 2013, AGING-US, V5, P84, DOI 10.18632/aging.100531; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Kale S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013852; Kale SS, 2011, AGING DIS, V2, P501; Kelly E, 2009, RESPIROLOGY, V14, P210, DOI 10.1111/j.1440-1843.2008.01423.x; Khoo MLM, 2014, AGING CELL, V13, P744, DOI 10.1111/acel.12229; Kim SD, 2012, J IMMUNOL, V189, P2000, DOI 10.4049/jimmunol.1200635; Kritas SK, 2014, INT J IMMUNOPATH PH, V27, P15, DOI 10.1177/039463201402700103; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manni L, 2013, GROWTH FACTORS, V31, P115, DOI 10.3109/08977194.2013.804073; MARI D, 1995, BLOOD, V85, P3144, DOI 10.1182/blood.V85.11.3144.bloodjournal85113144; Mascarucci P, 2001, AGING-CLIN EXP RES, V13, P85, DOI 10.1007/BF03351530; Maslove DM, 2014, TRENDS MOL MED, V20, P204, DOI 10.1016/j.molmed.2014.01.006; Maslove DM, 2012, CRIT CARE, V16, DOI 10.1186/cc11667; Muller L, 2014, BRAIN BEHAV IMMUN, V39, P8, DOI 10.1016/j.bbi.2013.11.015; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Nasa Prashant, 2012, World J Crit Care Med, V1, P23, DOI 10.5492/wjccm.v1.i1.23; Oh SA, 2013, J IMMUNOL, V191, P3973, DOI 10.4049/jimmunol.1301843; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Plackett TP, 2003, FASEB J, V17, P688, DOI 10.1096/fj.02-0452fje; Plackett TP, 2004, J LEUKOCYTE BIOL, V76, P291, DOI 10.1189/jlb.1103592; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Renshaw M, 2002, J IMMUNOL, V169, P4697, DOI 10.4049/jimmunol.169.9.4697; Risco A, 2012, P NATL ACAD SCI USA, V109, P11200, DOI 10.1073/pnas.1207290109; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Severino P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091886; Shanley TP, 2007, MOL MED, V13, P495, DOI 10.2119/2007-00065.Shanley; Sharma L, 2014, METHODS MOL BIOL, V1172, P137, DOI 10.1007/978-1-4939-0928-5_12; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shi Y, 2012, INFLAMM RES, V61, P1369, DOI 10.1007/s00011-012-0538-3; Shinkai S, 1998, CAN J PHYSIOL PHARM, V76, P562, DOI 10.1139/cjpp-76-5-562; Silva-Garcia O, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/310183; Starr ME, 2014, AGING DIS, V5, P126, DOI 10.14336/AD.2014.0500126; Su DM, 2013, CURR OPIN IMMUNOL, V25, P498, DOI 10.1016/j.coi.2013.05.018; Suliman HB, 2003, AM J RESP CRIT CARE, V167, P570, DOI 10.1164/rccm.200206-518OC; Tang BM, 2010, CRIT CARE, V14, DOI 10.1186/cc9392; Tang BMP, 2007, AM J RESP CRIT CARE, V176, P676, DOI 10.1164/rccm.200612-1819OC; Tang BMP, 2009, CRIT CARE MED, V37, P882, DOI 10.1097/CCM.0b013e31819b52fd; Tateda K, 1996, INFECT IMMUN, V64, P769, DOI 10.1128/IAI.64.3.769-774.1996; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tseng CW, 2014, CURR OPIN IMMUNOL, V29, P43, DOI 10.1016/j.coi.2014.03.009; Tu E, 2014, CYTOKINE GROWTH F R, V25, P423, DOI 10.1016/j.cytogfr.2014.07.014; Turnbull IR, 2003, SHOCK, V19, P310, DOI 10.1097/00024382-200304000-00003; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valencia J, 2011, J IMMUNOL, V187, P4129, DOI 10.4049/jimmunol.1101243; Van Camp J, 2014, STEM CELL REV REP, V10, P207, DOI 10.1007/s12015-013-9486-8; Weidner CI, 2014, BIOL CHEM, V395, P1307, DOI 10.1515/hsz-2014-0180; Weksler ME, 2002, SPRINGER SEMIN IMMUN, V24, P35, DOI 10.1007/s00281-001-0094-3; Wendel M, 2010, WIEN MED WOCHENSCHR, V160, P118, DOI 10.1007/s10354-010-0766-5; Wong HR, 2010, PEDIATR CRIT CARE ME, V11, P349, DOI 10.1097/PCC.0b013e3181c519b4; Wong HR, 2009, CRIT CARE MED, V37, P1558, DOI 10.1097/CCM.0b013e31819fcc08; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Zhang DY, 2013, MOL CELL BIOCHEM, V374, P13, DOI 10.1007/s11010-012-1498-1; Zhong B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003708	89	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128341	10.1371/journal.pone.0128341	http://dx.doi.org/10.1371/journal.pone.0128341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047321	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200060
J	Dietrich, SJ; Fass, MI; Jacobo, PV; Sobarzo, CMA; Lustig, L; Theas, MS				Jarazo Dietrich, Sabrina; Irina Fass, Monica; Veronica Jacobo, Patricia; Alejandro Sobarzo, Cristian Marcelo; Lustig, Livia; Susana Theas, Maria			Inhibition of NOS-NO System Prevents Autoimmune Orchitis Development in Rats: Relevance of NO Released by Testicular Macrophages in Germ Cell Apoptosis and Testosterone Secretion	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; LEYDIG-CELL; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; EXPRESSION; STEROIDOGENESIS; TESTES; ACETYLCYSTEINE; ANTIOXIDANT	Background Although the testis is considered an immunoprivileged organ it can orchestrate immune responses against pathological insults such as infection and trauma. Experimental autoimmune orchitis (EAO) is a model of chronic inflammation whose main histopathological features it shares with human orchitis. In EAO an increased number of macrophages infiltrate the interstitium concomitantly with progressive germ cell degeneration and impaired steroidogenesis. Up-regulation of nitric oxide (NO)-NO synthase (NOS) system occurs, macrophages being the main producers of NO. Objective The aim of our study was to evaluate the role of NO-NOS system in orchitis development and determine the involvement of NO released by testicular macrophages on germ cell apoptosis and testosterone secretion. Method and Results EAO was induced in rats by immunization with testicular homogenate and adjuvants (E group) and a group of untreated normal rats (N) was also studied. Blockage of NOS by i.p. injection of E rats with a competitive inhibitor of NOS, L-NAME (8mg/kg), significantly reduced the incidence and severity of orchitis and lowered testicular nitrite content. L-NAME reduced germ cell apoptosis and restored intratesticular testosterone levels, without variations in serum LH. Co-culture of N testicular fragments with testicular macrophages obtained from EAO rats significantly increased germ cell apoptosis and testosterone secretion, whereas addition of L-NAME lowered both effects and reduced nitrite content. Incubation of testicular fragments from N rats with a NO donor DETA-NOnoate (DETA-NO) induced germ cell apoptosis through external and internal apoptotic pathways, an effect prevented by N-acetyl-L-cysteine (NAC). DETA-NO inhibited testosterone released from Leydig cells, whereas NAC (from 2.5 to 15 mM) did not prevent this effect. Conclusions We demonstrated that NO-NOS system is involved in the impairment of testicular function in orchitis. NO secreted mainly by testicular macrophages could promote oxidative stress inducing ST damage and interfering in Leydig cell function.	[Jarazo Dietrich, Sabrina; Irina Fass, Monica; Veronica Jacobo, Patricia; Alejandro Sobarzo, Cristian Marcelo; Lustig, Livia; Susana Theas, Maria] Univ Buenos Aires, Fac Med, Inst Invest Biomed UBA CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires	Theas, MS (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed UBA CONICET, Buenos Aires, DF, Argentina.	msusanatheas@yahoo.com.ar	THEAS, MARIA SUSANA/AAU-3250-2020; Lustig, Livia/ABI-4914-2020	THEAS, MARIA SUSANA/0000-0002-8971-9833; 	Universidad Nacional de Buenos Aires (UBA) [UBA M 0194]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 01481]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) [PICT 00993]	Universidad Nacional de Buenos Aires (UBA)(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT)	This work was supported by Universidad Nacional de Buenos Aires (UBA) UBA M 0194, www.uba.ar, MST; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) PIP 01481, www.conicet.gov.ar, LL MST; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT) PICT 00993, www.agencia.mincyt.gob.ar, LL MST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidi P, 2008, J ENDOCRINOL, V198, P193, DOI 10.1677/JOE-07-0570; Afane M, 1998, ANDROLOGIA, V30, P71; Chae IH, 2004, CLIN CHIM ACTA, V341, P83, DOI 10.1016/j.cccn.2003.11.009; Costur P, 2012, ANDROLOGIA, V44, P654, DOI 10.1111/j.1439-0272.2011.01245.x; DelPunta K, 1996, ENDOCRINOLOGY, V137, P5337, DOI 10.1210/en.137.12.5337; DONCEL GF, 1989, AM J REPROD IMMUNOL, V20, P44, DOI 10.1111/j.1600-0897.1989.tb00638.x; Doronzo G, 2011, ATHEROSCLEROSIS, V216, P44, DOI 10.1016/j.atherosclerosis.2011.01.019; Ducsay CA, 2011, J ENDOCRINOL, V210, P259, DOI 10.1530/JOE-11-0034; Fijak M, 2015, AM J REPROD IMMUNOL, V74, P12, DOI 10.1111/aji.12363; Frungieri MB, 2002, FERTIL STERIL, V78, P298, DOI 10.1016/S0015-0282(02)03206-5; Fujisawa M, 2001, BJU INT, V87, P85, DOI 10.1046/j.1464-410x.2001.00986.x; Gharagozloo P, 2011, HUM REPROD, V26, P1628, DOI 10.1093/humrep/der132; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hogg N, 1999, BBA-BIOENERGETICS, V1411, P378, DOI 10.1016/S0005-2728(99)00027-4; Jacobo P, 2011, AUTOIMMUN REV, V10, P201, DOI 10.1016/j.autrev.2010.09.026; Jarazo-Dietrich S, 2012, IMMUNOBIOLOGY, V217, P778, DOI 10.1016/j.imbio.2012.04.007; Lasram MM, 2014, LIFE SCI, V107, P50, DOI 10.1016/j.lfs.2014.04.033; Le Bras M, 2005, HISTOL HISTOPATHOL, V20, P205, DOI 10.14670/HH-20.205; Lee YW, 2000, FEBS LETT, V485, P122, DOI 10.1016/S0014-5793(00)02208-0; LOMBARDVIGNON N, 1992, INT J ANDROL, V15, P144, DOI 10.1111/j.1365-2605.1992.tb01123.x; Lustig L, 2006, AUTOIMMUNE DISEASES, 4TH EDITION, P841, DOI 10.1016/B978-012595961-2/50063-9; Maheshwari A, 2011, MOL REPROD DEV, V78, P69, DOI 10.1002/mrd.21268; Vigueras-Villasenor RM, 2011, INT J EXP PATHOL, V92, P131, DOI 10.1111/j.1365-2613.2010.00757.x; Mauduit C, 1998, ENDOCRINOLOGY, V139, P2863, DOI 10.1210/en.139.6.2863; MCCARTNEYFRANCIS N, 1993, J EXP MED, V178, P749, DOI 10.1084/jem.178.2.749; Nishimura Y, 2008, HYPERTENS RES, V31, P535, DOI 10.1291/hypres.31.535; NOUROOZZADEH J, 1994, ANAL BIOCHEM, V220, P403, DOI 10.1006/abio.1994.1357; Park SY, 2004, EUR J BIOCHEM, V271, P4222, DOI 10.1111/j.1432-1033.2004.04362.x; Payabvash S, 2007, UROL INT, V79, P248, DOI 10.1159/000107958; Pomerantz DK, 1998, ENDOCRINOLOGY, V139, P922, DOI 10.1210/en.139.3.922; Qi FH, 2012, FOOD CHEM TOXICOL, V50, P295, DOI 10.1016/j.fct.2011.10.040; Ranade AV, 2011, SINGAP MED J, V52, P742; Rival C, 2008, J PATHOL, V215, P108, DOI 10.1002/path.2328; Rival C, 2006, J REPROD IMMUNOL, V70, P43, DOI 10.1016/j.jri.2005.10.006; Roulet V, 2006, HUM REPROD, V21, P1564, DOI 10.1093/humrep/del018; Schuppe HC, 2008, ANDROLOGIA, V40, P84, DOI 10.1111/j.1439-0272.2008.00837.x; SUESCUN MO, 1994, J ANDROL, V15, P442; Suescun MO, 2000, AM J REPROD IMMUNOL, V43, P116, DOI 10.1111/j.8755-8920.2000.430208.x; SUN XR, 1993, ENDOCRINOLOGY, V132, P186, DOI 10.1210/en.132.1.186; Theas MS, 2008, HUM REPROD, V23, P1865, DOI 10.1093/humrep/den240; Theas MS, 2006, HUM REPROD, V21, P1734, DOI 10.1093/humrep/del066; Theas M. S., 2013, SPERMATOGENESIS, V3; Theas S, 2003, AM J REPROD IMMUNOL, V50, P166, DOI 10.1034/j.1600-0897.2003.00074.x; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132; Valenti S, 1999, INT J ANDROL, V22, P336, DOI 10.1046/j.1365-2605.1999.00189.x; Perez CV, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101709; Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x; Wang YQ, 2010, PROTEIN CELL, V1, P133, DOI 10.1007/s13238-010-0018-x; WARREN DW, 1990, J ANDROL, V11, P353; WEINBERG JB, 1994, J EXP MED, V179, P651, DOI 10.1084/jem.179.2.651; Wurstle ML, 2012, EXP CELL RES, V318, P1213, DOI 10.1016/j.yexcr.2012.02.013; YEE JB, 1985, ENDOCRINOLOGY, V116, P2682, DOI 10.1210/endo-116-6-2682	53	22	24	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128709	10.1371/journal.pone.0128709	http://dx.doi.org/10.1371/journal.pone.0128709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046347	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200093
J	Massari, F; Bria, E; Ciccarese, C; Munari, E; Modena, A; Zambonin, V; Sperduti, I; Artibani, W; Cheng, L; Martignoni, G; Tortora, G; Brunelli, M				Massari, Francesco; Bria, Emilio; Ciccarese, Chiara; Munari, Enrico; Modena, Alessandra; Zambonin, Valentina; Sperduti, Isabella; Artibani, Walter; Cheng, Liang; Martignoni, Guido; Tortora, Giampaolo; Brunelli, Matteo			Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder	PLOS ONE			English	Article							III BETA-TUBULIN; LUNG-CANCER; EXPRESSION; INHIBITION	Background To date, putative prognostic biomarkers have shown limited utility from the clinical perspective for bladder urothelial carcinoma. Herein, the expression of beta-tubulin-3 and c-Myc was evaluated to determine their prognostic potential. Methods In formalin fixed-paraffin embedded blocks, immunohistochemical expression of c-Myc and beta-tubulin-3 was evaluated. H score ranging from 0 to 300 was obtained by multiplying the percentage of positive cells by intensity (0-3); c-Myc and beta-tubulin-3 expression was defined: 0: negative, 1: weakly positive, 2: strongly positive. Results beta-tubulin-3 and c-Myc immunoexpression was available for 46 cases. At the univariate analysis, node-involvement, beta-tubulin-3 and c-Myc overexpression discriminate shorter DFS (HR 2.19, p = 0.043; HR 3.10, p = 0.24 and HR 3.05, p = 0.011, respectively); 2-yrs DFS log-rank analysis according to low versus high level of immunoexpression were statistically significant; beta-tubulin-3, 53% low vs 12.7% high (p = value 0.02) and c-Myc 28 low vs 8 high (p-value 0.007). Patients displaying negative beta-tubulin-3/c-Myc had statistically significant better 2-yrs DFS than those with mixed expression or double positivity (54.5% versus 18.7% versus 0%, log-rank p = 0.006). Conclusions c-Myc and beta-tubulin-3 show improvement for prognostic risk stratification in patients with muscle invasive bladder urothelial carcinoma. These molecular pathways may also be candidate to improve predictiveness to targeted therapies.	[Massari, Francesco; Bria, Emilio; Ciccarese, Chiara; Modena, Alessandra; Zambonin, Valentina; Tortora, Giampaolo] AOUI, Med Oncol dU, Verona, Italy; [Massari, Francesco; Bria, Emilio; Ciccarese, Chiara; Munari, Enrico; Modena, Alessandra; Zambonin, Valentina; Artibani, Walter; Martignoni, Guido; Tortora, Giampaolo; Brunelli, Matteo] Univ Verona, I-37100 Verona, Italy; [Munari, Enrico; Martignoni, Guido; Brunelli, Matteo] AOUI, Dept Pathol & Diagnost, Verona, Italy; [Sperduti, Isabella] Regina Elena Inst Canc Res, Biostat, Rome, Italy; [Artibani, Walter] AOUI, Dept Oncol & Surg Sci, Urol Clin, Verona, Italy; [Cheng, Liang] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; Indiana University System; Indiana University Bloomington	Tortora, G (corresponding author), AOUI, Med Oncol dU, Verona, Italy.	giampaolo.tortora@univr.it	Sperduti, Isabella/K-8902-2016; Bria, Emilio/A-8574-2019; Brunelli, Matteo/AAA-7679-2019; Tortora, Giampaolo/AAA-1252-2019; Massari, Francesco/K-7239-2016; Ciccarese, Chiara/AAB-7602-2019; Tortora, Giampaolo/HGB-6261-2022; Munari, Enrico/J-7516-2016	Sperduti, Isabella/0000-0001-5115-3099; Bria, Emilio/0000-0002-2333-704X; Massari, Francesco/0000-0001-6476-6871; Ciccarese, Chiara/0000-0002-3283-4339; Munari, Enrico/0000-0002-3867-6685; BRUNELLI, Matteo/0000-0002-3832-2676; Tortora, Giampaolo/0000-0002-1378-4962	Italian Association for Cancer Research [AIRC-MFAG 14282, IG 11930]; MIUR-PRIN [2009X23L78_005]	Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); MIUR-PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was supported by a grant of the Italian Association for Cancer Research (AIRC-MFAG 14282 and IG 11930) and from MIUR-PRIN (2009X23L78_ 005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buti S, 2015, FUTURE ONCOL, V11, P107, DOI 10.2217/fon.14.172; Cheng L, 2014, CRIT REV ONCOL HEMAT, V89, P73, DOI 10.1016/j.critrevonc.2013.08.008; Cheng LA, 2011, HUM PATHOL, V42, P455, DOI 10.1016/j.humpath.2010.07.007; Choi JW, 2014, WORLD J UROL, V32, P347, DOI 10.1007/s00345-012-0993-z; COX DR, 1972, J R STAT SOC B, V34, P187; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Edelman MJ, 2013, J CLIN ONCOL, V31, P1990, DOI 10.1200/JCO.2012.45.3282; HESS KR, 1995, STAT MED, V14, P1707, DOI 10.1002/sim.4780141510; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Larsson LG, 2010, EXP CELL RES, V316, P1429, DOI 10.1016/j.yexcr.2010.03.025; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Mahdy E, 2001, ANTICANCER RES, V21, P3167; Ploussard G, 2010, CANCER RES, V70, P9253, DOI 10.1158/0008-5472.CAN-10-1447; Senetta R, 2013, J NEUROPATH EXP NEUR, V72, P432, DOI 10.1097/NEN.0b013e3182901f41; Seruga B, 2011, NAT REV CLIN ONCOL, V8, P12, DOI 10.1038/nrclinonc.2010.136; Seve P, 2005, MOL CANCER THER, V4, P2001, DOI 10.1158/1535-7163.MCT-05-0244; Seve P, 2005, CLIN CANCER RES, V11, P5481, DOI 10.1158/1078-0432.CCR-05-0285; SHUSTER JJ, 1991, J CLIN ONCOL, V9, P191, DOI 10.1200/JCO.1991.9.1.191; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Soucek L, 2013, GENE DEV, V27, P504, DOI 10.1101/gad.205542.112; Watters AD, 2002, BRIT J CANCER, V87, P654, DOI 10.1038/sj.bjc.6600531; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Zaharieva B, 2005, INT J CANCER, V117, P952, DOI 10.1002/ijc.21253	24	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127908	10.1371/journal.pone.0127908	http://dx.doi.org/10.1371/journal.pone.0127908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046361	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200033
J	Sunde, M; Simonsen, GS; Slettemeas, JS; Bockerman, I; Norstrom, M				Sunde, Marianne; Simonsen, Gunnar Skov; Slettemeas, Jannice Schau; Bockerman, Inger; Norstrom, Madelaine			Integron, Plasmid and Host Strain Characteristics of Escherichia coli from Humans and Food Included in the Norwegian Antimicrobial Resistance Monitoring Programs	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; GENE CASSETTES; MOLECULAR ANALYSIS; CLASS-1 INTEGRONS; MEAT-PRODUCTS; RETAIL MEATS; ENTEROBACTERIACEAE; PREVALENCE; VIRULENCE; SWINE	Antimicrobial resistant Escherichia coli (n=331) isolates from humans with bloodstream infections were investigated for the presence of class 1 and class 2 integrons. The integron cassettes arrays were characterized and the findings were compared with data from similar investigations on resistant Escherichia coli from meat and meat products (n=241) produced during the same time period. All isolates were obtained from the Norwegian monitoring programs for antimicrobial resistance in human pathogens and in the veterinary sector. Methods used included PCR, sequencing, conjugation experiments, plasmid replicon typing and subtyping, pulsed-field-gel-electrophoresis and serotyping. Integrons of class 1 and 2 occurred significantly more frequently among human isolates; 45.4% (95% CI: 39.9-50.9) than among isolates from meat; 18% (95% CI: 13.2 -23.3), (p<0.01, Chi-square test). Identical cassette arrays including dfrA1-aadA1, aadA1, dfrA12-orfF-aadA2, oxa-30-aadA1 (class 1 integrons) and dfrA1-sat1-aadA1(class 2 integrons) were detected from both humans and meat. However, the most prevalent cassette array in human isolates, dfrA17-aadA5, did not occur in isolates from meat, suggesting a possible linkage between this class 1 integron and a subpopulation of Escherichia coli adapted to a human host. The drfA1-aadA1and aadA1class 1 integrons were found frequently in both human and meat isolates. These isolates were subjected to further studies to investigate similarities with regard to transferability, plasmid and host strain characteristics. We detected incF plasmids with pMLST profile F24:A-:B1 carrying drfA1-aadA1integrons in isolates from pork and in a more distantly related Escherichia coli strain from a human with septicaemia. Furthermore, we showed that most of the class 1 integrons with aadA1 were located on incF plasmids with pMLST profile F51:A-:B10 in human isolates. The plasmid was present in unrelated as well as closely related host strains, demonstrating that dissemination of this integron also could be attributed to clonal spread. In conclusion, among the systematically collected isolates from two different sources, some significant differences concerning integron prevalence and integron variants were observed. However, closely related plasmids as vehicles for specific class 1 integrons in isolates from meat and from a human with bloodstream infection were found. The occurrence of similar multi-resistance plasmids in bacteria from a food source and from a human clinical sample highlights the possible role of meat as a source of resistance elements for pathogenic bacteria.	[Sunde, Marianne; Slettemeas, Jannice Schau; Bockerman, Inger] Norwegian Vet Inst, Dept Lab Serv, Oslo, Norway; [Simonsen, Gunnar Skov] Univ Hosp North Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Simonsen, Gunnar Skov] Norwegian Arctic Univ, Univ Tromso, Res Grp Host Microbe Interact, Inst Med Biol,Fac Hlth Sci, Tromso, Norway; [Norstrom, Madelaine] Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway	Norwegian Veterinary Institute; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; Norwegian Veterinary Institute	Norstrom, M (corresponding author), Norwegian Vet Inst, Dept Hlth Surveillance, Oslo, Norway.	madelaine.norstrom@vetinst.no		Slettemeas, Jannice Schau/0000-0003-2542-6991; Sunde, Marianne/0000-0002-2326-4338	Norwegian Research Council [167822/I10]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by a grant from the Norwegian Research Council; www.forskningsraadet.no - grant no 167822/I10. The following authors received the funding: MS, IB, JSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Sapper S, 2013, ANTIMICROB AGENTS CH, V57, P490, DOI 10.1128/AAC.01025-12; [Anonymous], 2001, NORM NORM VET 2001 C; [Anonymous], 2002, NORM NORM VET 2002 C; [Anonymous], 2003, NORM NORM VET 2003 U; [Anonymous], 2000, NORM NORM VET 2000 C; BARTON BM, 1995, ANAL BIOCHEM, V226, P235, DOI 10.1006/abio.1995.1220; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2001, VET RES, V32, P243, DOI 10.1051/vetres:2001122; de Been M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004776; Deng YT, 2011, ANTIMICROB AGENTS CH, V55, P4926, DOI 10.1128/AAC.00133-11; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; Fluit AC, 2004, CLIN MICROBIOL INFEC, V10, P272, DOI 10.1111/j.1198-743X.2004.00858.x; Hannah EL, 2009, FOODBORNE PATHOG DIS, V6, P285, DOI 10.1089/fpd.2008.0176; Johnson JR, 2008, J CLIN MICROBIOL, V46, P417, DOI 10.1128/JCM.00674-07; Johnson JR, 2009, CLIN INFECT DIS, V49, P195, DOI 10.1086/599830; Kadlec K, 2008, J ANTIMICROB CHEMOTH, V62, P469, DOI 10.1093/jac/dkn233; Kang HY, 2005, J ANTIMICROB CHEMOTH, V55, P639, DOI 10.1093/jac/dki076; Kluytmans JAJW, 2013, CLIN INFECT DIS, V56, P478, DOI 10.1093/cid/cis929; Lapierre L, 2008, MICROB DRUG RESIST, V14, P265, DOI 10.1089/mdr.2008.0810; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Li D, 2010, J MICROBIOL METH, V82, P71, DOI 10.1016/j.mimet.2010.04.008; Machado E, 2008, J ANTIMICROB CHEMOTH, V62, P296, DOI 10.1093/jac/dkn179; Machado E, 2007, ANTIMICROB AGENTS CH, V51, P2201, DOI 10.1128/AAC.01389-06; Machado E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00080; Marchant M, 2013, VET MICROBIOL, V163, P124, DOI 10.1016/j.vetmic.2012.12.011; Naseer U, 2011, MICROB DRUG RESIST, V17, P83, DOI 10.1089/mdr.2010.0132; Peigne C, 2009, INFECT IMMUN, V77, P2272, DOI 10.1128/IAI.01333-08; Recchia GD, 1995, MICROBIOL-UK, V141, P3015, DOI 10.1099/13500872-141-12-3015; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; del Castillo BR, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-84; STOKES HW, 1989, MOL MICROBIOL, V3, P1669, DOI 10.1111/j.1365-2958.1989.tb00153.x; Sunde M, 2005, J ANTIMICROB CHEMOTH, V56, P1019, DOI 10.1093/jac/dki377; Sunde M, 2008, VET MICROBIOL, V130, P422, DOI 10.1016/j.vetmic.2008.02.001; Sunde M, 2006, J ANTIMICROB CHEMOTH, V58, P741, DOI 10.1093/jac/dkl294; Team RC, 2012, R LANG ENV STAT COMP; van Essen-Zandbergen A, 2007, J ANTIMICROB CHEMOTH, V59, P746, DOI 10.1093/jac/dkl549; Vasilakopoulou A, 2009, FOODBORNE PATHOG DIS, V6, P1211, DOI 10.1089/fpd.2009.0281; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Vinue L, 2008, J ANTIMICROB CHEMOTH, V62, P934, DOI 10.1093/jac/dkn331; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Zhao WH, 2009, J MED MICROBIOL, V58, P1080, DOI 10.1099/jmm.0.010017-0	42	33	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0128797	10.1371/journal.pone.0128797	http://dx.doi.org/10.1371/journal.pone.0128797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047499	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200102
J	Thekkiniath, J; Zabet-Moghaddam, M; Kottapalli, KR; Pasham, MR; Francisco, SS; Francisco, MS				Thekkiniath, Jose; Zabet-Moghaddam, Masoud; Kottapalli, Kameswara Rao; Pasham, Mithun R.; Francisco, Susan San; Francisco, Michael San			Quantitative Proteomics of an Amphibian Pathogen, Batrachochytrium dendrobatidis, following Exposure to Thyroid Hormone	PLOS ONE			English	Article							FUNGUS BLASTOCLADIELLA-EMERSONII; EMERGING INFECTIOUS-DISEASE; HEAT-SHOCK-PROTEIN; CHYTRID FUNGUS; SACCHAROMYCES-CEREVISIAE; POPULATION DECLINES; CYTOSOLIC CALCIUM; L-6 MYOBLASTS; PLANT-CELLS; EXPRESSION	Batrachochytrium dendrobatidis(Bd), a chytrid fungus, has increasingly been implicated as a major factor in the worldwide decline of amphibian populations. The fungus causes chytridiomycosis in susceptible species leading to massive die-offs of adult amphibians. Although Bd infects the keratinized mouthparts of tadpoles and negatively affects foraging behavior, these infections are non-lethal. An important morphogen controlling amphibian metamorphosis is thyroid hormone (T-3). Tadpoles may be infected with Bd and the fungus may be exposed to T-3 during metamorphosis. We hypothesize that exposure of Bd to T-3 may induce the expression of factors associated with host colonization and pathogenicity. We utilized a proteomics approach to better understand the dynamics of the Bd-T-3 interaction. Using liquid chromatography-mass spectrometry (LC-MS), we generated a data set of a large number of cytoplasmic and membrane proteins following exposure of Bd to T-3. From these data, we identified a total of 263 proteins whose expression was significantly changed following T-3 exposure. We provide evidence for expression of an array of proteins that may play key roles in both genomic and non-genomic actions of T-3 in Bd. Additionally, our proteomics study shows an increase in several proteins including proteases and a class of uncommon crinkler and crinkler-like effector proteins suggesting their importance in Bd pathogenicity as well as those involved in metabolism and energy transfer, protein fate, transport and stress responses. This approach provides insights into the mechanistic basis of the Bd-amphibian interaction following T-3 exposure.	[Thekkiniath, Jose] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Zabet-Moghaddam, Masoud; Kottapalli, Kameswara Rao; Francisco, Susan San] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79402 USA; [Pasham, Mithun R.] Harvard Univ, Sch Med, Dept Cell Biol & Pediat, Boston, MA 02115 USA; [Pasham, Mithun R.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Francisco, Susan San; Francisco, Michael San] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA	Yale University; Texas Tech University System; Texas Tech University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Texas Tech University System; Texas Tech University	Francisco, MS (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	Michael.sanfrancisco@ttu.edu			Department of Biological Sciences	Department of Biological Sciences	We thank the Department of Biological Sciences for support during this work.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BANUETT F, 1994, GENE DEV, V8, P1367, DOI 10.1101/gad.8.12.1367; BARDWELL L, 1994, DEV BIOL, V166, P363, DOI 10.1006/dbio.1994.1323; Berger L, 2005, DIS AQUAT ORGAN, V68, P65, DOI 10.3354/dao068065; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bleackley R C, 1995, Curr Top Microbiol Immunol, V198, P145; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandhorst TT, 2004, J IMMUNOL, V173, P7444, DOI 10.4049/jimmunol.173.12.7444; Brutyn M, 2012, FUNGAL GENET BIOL, V49, P830, DOI 10.1016/j.fgb.2012.07.002; BUSH DS, 1993, PLANT PHYSIOL, V103, P7, DOI 10.1104/pp.103.1.7; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Coppolino MG, 1999, BIOCHEM J, V340, P41, DOI 10.1042/0264-6021:3400041; Corrao S, 2010, LIFE SCI, V86, P145, DOI 10.1016/j.lfs.2009.11.004; D'Arezzo S, 2004, ENDOCRINOLOGY, V145, P5694, DOI 10.1210/en.2004-0890; Daszak P, 1999, EMERG INFECT DIS, V5, P735, DOI 10.3201/eid0506.990601; DAVIS FB, 1983, J CLIN INVEST, V71, P579, DOI 10.1172/JCI110803; Ebanks RO, 2006, PROTEOMICS, V6, P2147, DOI 10.1002/pmic.200500100; Ellison AR, 2014, G3-GENES GENOM GENET, V4, P1275, DOI 10.1534/g3.114.010744; Fernandez-Arenas E, 2007, MOL CELL PROTEOMICS, V6, P460, DOI 10.1074/mcp.M600210-MCP200; Fisher MC, 2009, MOL ECOL, V18, P415, DOI 10.1111/j.1365-294X.2008.04041.x; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Friesema ECH, 2005, VITAM HORM, V70, P137, DOI 10.1016/S0083-6729(05)70005-4; GALO MG, 1981, J BIOL CHEM, V256, P7113; GEHRING CA, 1990, P NATL ACAD SCI USA, V87, P9645, DOI 10.1073/pnas.87.24.9645; Genevieve S, 2000, J TOXICOL ENV HEAL B, V3, P109; GOMES SL, 1979, FEBS LETT, V99, P39, DOI 10.1016/0014-5793(79)80243-4; Gonzalez-Fernandez R, 2012, J PROTEOME RES, V11, P3, DOI 10.1021/pr200873p; Hepler PK, 2005, PLANT CELL, V17, P2142, DOI 10.1105/tpc.105.032508; Hoffmann B, 2000, MOL GEN GENET, V262, P1001, DOI 10.1007/PL00008643; Hong SW, 2001, PLANT J, V27, P25, DOI 10.1046/j.1365-313x.2001.01066.x; Incerpi S, 1999, ENDOCRINOLOGY, V140, P683, DOI 10.1210/en.140.2.683; INGBAR SH, 1975, ANNU REV MED, V26, P443, DOI 10.1146/annurev.me.26.020175.002303; Fernandez-Acero FJ, 2007, ARCH MICROBIOL, V187, P207, DOI 10.1007/s00203-006-0188-3; Jia Haibo, 2011, Int J Biochem Mol Biol, V2, P47; Johnson BJ, 2005, J BIOL CHEM, V280, P4037, DOI 10.1074/jbc.M411569200; Kamoun S, 2006, ANNU REV PHYTOPATHOL, V44, P41, DOI 10.1146/annurev.phyto.44.070505.143436; Keeler SJ, 2000, PLANT PHYSIOL, V123, P1121, DOI 10.1104/pp.123.3.1121; Krain LP, 2004, J ENDOCRINOL, V181, P91, DOI 10.1677/joe.0.1810091; Krauke Y., 2008, BMC MICROBIOL, V8, P1, DOI DOI 10.1186/1471-2180-8-1; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; LAKSHMANAN M, 1990, ENDOCRINOLOGY, V126, P3245, DOI 10.1210/endo-126-6-3245; Lee SC, 1998, MOL CELLS, V8, P698; LEONHARDT SA, 1993, MOL CELL BIOL, V13, P6304, DOI 10.1128/MCB.13.10.6304; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; MACHLIS L, 1957, J BACTERIOL, V73, P627, DOI 10.1128/JB.73.5.627-631.1957; May P, 2008, GENETICS, V179, P157, DOI 10.1534/genetics.108.088336; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; McMahon TA, 2013, P NATL ACAD SCI USA, V110, P210, DOI 10.1073/pnas.1200592110; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; Montero-Barrientos M, 2007, CURR GENET, V52, P45, DOI 10.1007/s00294-007-0140-3; Moss AS, 2010, DIS AQUAT ORGAN, V92, P149, DOI 10.3354/dao02223; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Pugliese L, 2008, GENE, V411, P59, DOI 10.1016/j.gene.2008.01.005; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rosenblum EB, 2008, P NATL ACAD SCI USA, V105, P17034, DOI 10.1073/pnas.0804173105; Rosenblum EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049924; Rosenblum EB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006494; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Shapiro RS, 2009, CURR BIOL, V19, P621, DOI 10.1016/j.cub.2009.03.017; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shi Y.-B., 1999, AMPHIBIAN METAMORPHO; Sun GL, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-195; Sung DY, 2003, TRENDS PLANT SCI, V8, P179, DOI 10.1016/S1360-1385(03)00047-5; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tata JR, 1996, DEV GROWTH DIFFER, V38, P223; Thekkiniath JC, 2013, FUNGAL BIOL-UK, V117, P451, DOI 10.1016/j.funbio.2013.05.002; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Venesky MD, 2010, J PARASITOL, V96, P552, DOI 10.1645/GE-2353.1; Vieira ALG, 2010, EUKARYOT CELL, V9, P415, DOI 10.1128/EC.00312-09; VINCENZI FF, 1980, FED PROC, V39, P2427; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Warwar V, 1996, APPL ENVIRON MICROB, V62, P74, DOI 10.1128/AEM.62.1.74-79.1996; White B.A., 1981, P363; WILLIAMS RJP, 1992, CELL CALCIUM, V13, P355, DOI 10.1016/0143-4160(92)90049-X; Yajima W, 2006, PROTEOMICS, V6, P5995, DOI 10.1002/pmic.200600424; Yang JK, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002179; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	89	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0123637	10.1371/journal.pone.0123637	http://dx.doi.org/10.1371/journal.pone.0123637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046527	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200004
J	Wang, JP; Chiu, CC; Yang, TH; Liu, TH; Wu, CY; Chou, P				Wang, Jen-Pang; Chiu, Chih-Chiang; Yang, Tsu-Hui; Liu, Tzong-Hsien; Wu, Chia-Yi; Chou, Pesus			The Low Proportion and Associated Factors of Involuntary Admission in the Psychiatric Emergency Service in Taiwan	PLOS ONE			English	Article							INFLUENCING COMPULSORY ADMISSION; HEALTH ACT 1983; MENTALLY-ILL; CHANGING PATTERNS; BIPOLAR DISORDER; ACUTE MANIA; AMSTERDAM; RISK; ETHNICITY; CARE	Background The involuntary admission regulated under the Mental Health Act has become an increasingly important issue in the developed countries in recent years. Most studies about the distribution and associated factors of involuntary admission were carried out in the western countries; however, the results may vary in different areas with different legal and sociocultural backgrounds. Aims The aim of this study was to investigate the proportion and associated factors of involuntary admission in a psychiatric emergency service in Taiwan. Methods The study cohort included patients admitted from a psychiatric emergency service over a two-year period. Demographic, psychiatric emergency service utilization, and clinical variables were compared between those who were voluntarily and involuntarily admitted to explore the associated factors of involuntary admission. Results Among 2,777 admitted patients, 110 (4.0%) were involuntarily admitted. Police referrals and presenting problems as violence assessed by psychiatric nurses were found to be associated with involuntary admission. These patients were more likely to be involuntarily admitted during the night shift and stayed longer in the psychiatric emergency service. Conclusions The proportion of involuntary admissions in Taiwan was in the lower range when compared to Western countries. Dangerous conditions evaluated by the psychiatric nurses and police rather than diagnosis made by the psychiatrists were related factors of involuntary admission. As it spent more time to admit involuntary patients, it was suggested that multidisciplinary professionals should be included in and educated for during the process of involuntary admission.	[Wang, Jen-Pang; Chou, Pesus] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan; [Wang, Jen-Pang; Chou, Pesus] Natl Yang Ming Univ, Community Med Res Ctr, Taipei 112, Taiwan; [Wang, Jen-Pang; Chiu, Chih-Chiang; Yang, Tsu-Hui; Liu, Tzong-Hsien] Taipei City Hosp, Taipei City Psychiat Ctr, Dept Psychiat, Taipei, Taiwan; [Wang, Jen-Pang] Natl Taipei Univ Nursing & Hlth Sci, Dept Healthcare Management, Taipei, Taiwan; [Chiu, Chih-Chiang] Taipei Med Univ, Sch Med, Dept Psychiat, Taipei, Taiwan; [Yang, Tsu-Hui] Taipei City Govt, Dept Hlth, Med Affairs Div, Taipei, Taiwan; [Wu, Chia-Yi] Natl Taiwan Univ, Coll Med, Dept Nursing, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Taipei University of Nursing & Health Science (NTUNHS); Taipei Medical University; National Taiwan University	Chou, P (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei 112, Taiwan.	pschou@ym.edu.tw	WU, CHIA-YI/E-4992-2010	WU, CHIA-YI/0000-0003-1756-557X	Taipei City Hospital, Taiwan [10201-62-051]	Taipei City Hospital, Taiwan	This study was funded by Taipei City Hospital, Taiwan in 2013 (grant number: 10201-62-051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBBINGTON PE, 1994, BRIT J PSYCHIAT, V165, P743, DOI 10.1192/bjp.165.6.743; Beveridge R., 1999, CAN J EMERG MED, V1, pS1; Bola JR, 2011, COMMUNITY MENT HLT J, V47, P603, DOI 10.1007/s10597-011-9396-7; Chen YY, 2008, LANCET, V372, P1629, DOI 10.1016/S0140-6736(08)61679-7; Chen YY, 2012, EPIDEMIOL REV, V34, P129, DOI 10.1093/epirev/mxr025; Cougnard A, 2004, SOC PSYCH PSYCH EPID, V39, P804, DOI 10.1007/s00127-004-0826-5; Davies S, 1996, BRIT MED J, V312, P533, DOI 10.1136/bmj.312.7030.533; Douzenis A, 2012, INT J SOC PSYCHIATR, V58, P172, DOI 10.1177/0020764010387477; Dressing H, 2004, SOC PSYCH PSYCH EPID, V39, P797, DOI 10.1007/s00127-004-0814-9; Fennig S, 1999, PSYCHIAT SERV, V50, P1049, DOI 10.1176/ps.50.8.1049; Hansson L, 1999, SOC PSYCH PSYCH EPID, V34, P99, DOI 10.1007/s001270050118; Hotopf M, 2000, BRIT J PSYCHIAT, V176, P479, DOI 10.1192/bjp.176.5.479; Keown P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3736; Keown P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1837; Kessell ER, 2006, PSYCHIAT SERV, V57, P1435, DOI 10.1176/appi.ps.57.10.1435; Lelliott P, 2003, BRIT J PSYCHIAT, V182, P68, DOI 10.1192/bjp.182.1.68; Lindsey MA, 2010, GEN HOSP PSYCHIAT, V32, P300, DOI 10.1016/j.genhosppsych.2010.01.007; Morgan C, 2005, BRIT J PSYCHIAT, V186, P281, DOI 10.1192/bjp.186.4.281; Mulder CL, 2008, INT J LAW PSYCHIAT, V31, P331, DOI 10.1016/j.ijlp.2008.06.007; Mulder CL, 2006, BRIT J PSYCHIAT, V188, P386, DOI 10.1192/bjp.188.4.386; Myklebust LH, 2012, NORD J PSYCHIAT, V66, P178, DOI 10.3109/08039488.2011.611252; Oluwatayo O, 2004, SOC PSYCH PSYCH EPID, V39, P739, DOI 10.1007/s00127-004-0794-9; RIECHER A, 1991, PSYCHOL MED, V21, P197, DOI 10.1017/S0033291700014781; RIECHERROSSLER A, 1993, ACTA PSYCHIAT SCAND, V87, P231, DOI 10.1111/j.1600-0447.1993.tb03363.x; Salize HJ, 2004, BRIT J PSYCHIAT, V184, P163, DOI 10.1192/bjp.184.2.163; Schuepbach D, 2008, PHARMACOPSYCHIATRY, V41, P29, DOI 10.1055/s-2007-993213; Schuepbach D, 2006, J AFFECT DISORDERS, V90, P57, DOI 10.1016/j.jad.2005.09.012; Singh SP, 1998, SOC PSYCH PSYCH EPID, V33, P39; THOMAS CS, 1993, BRIT J PSYCHIAT, V163, P91, DOI 10.1192/bjp.163.1.91; van der Post L, 2012, INT J SOC PSYCHIATR, V58, P374, DOI 10.1177/0020764011399970; van der Post L, 2009, PSYCHIAT SERV, V60, P1543, DOI 10.1176/appi.ps.60.11.1543; van der Post LFM, 2014, INT J SOC PSYCHIATR, V60, P125, DOI 10.1177/0020764012470234; van der Post LFM, 2014, SOC PSYCH PSYCH EPID, V49, P283, DOI 10.1007/s00127-013-0742-7; van der Post LFM, 2012, PSYCHIAT SERV, V63, P577, DOI 10.1176/appi.ps.201100080; Wierdsma AI, 2007, J EPIDEMIOL COMMUN H, V61, P613, DOI 10.1136/jech.2005.044974; Wierdsma Andre I, 2009, Int J Integr Care, V9, pe90; Zinkler M, 2002, ACTA PSYCHIAT SCAND, V106, P3, DOI 10.1034/j.1600-0447.2002.02268.x	37	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129204	10.1371/journal.pone.0129204	http://dx.doi.org/10.1371/journal.pone.0129204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046529	gold, Green Published			2022-12-26	WOS:000355652200134
J	Kurppa, KJ; Denessiouk, K; Johnson, MS; Elenius, K				Kurppa, K. J.; Denessiouk, K.; Johnson, M. S.; Elenius, K.			Activating ERBB4 mutations in non-small cell lung cancer	ONCOGENE			English	Article							KINASE DOMAIN; GROWTH; MECHANISM; CLEAVAGE; INHIBITION; RECEPTORS; SURVIVAL; ISOFORMS; LIGAND	Recent efforts to comprehensively characterize the mutational landscape of non-small cell lung cancer have identified frequent mutations in the receptor tyrosine kinase ERBB4. However, the significance of mutated ERBB4 in non-small cell lung cancer remains elusive. Here, we have functionally characterized nine ERBB4 mutations previously identified in lung adenocarcinoma. Four out of the nine mutations, Y285C, D595V, D931Y and K935I, were found to be activating, increasing both basal and ligand-induced ErbB4 phosphorylation. According to structural analysis, the four activating mutations were located at critical positions at the dimerization interfaces of the ErbB4 extracellular (Y285C and D595V) and kinase (D931Y and K935I) domains. Consistently, the mutations enhanced ErbB4 dimerization and increased the trans activation in ErbB4 homodimers and ErbB4-ErbB2 heterodimers. The expression of the activating ERBB4 mutants promoted survival of NIH 3T3 cells in the absence of serum. Interestingly, serum starvation of NIH 3T3 cells expressing the ERBB4 mutants only moderately increased the phosphorylation of canonical ErbB signaling pathway effectors Erk1/2 and Akt as compared with wild-type ERBB4. In contrast, the mutations clearly enhanced the proteolytic release of signaling-competent ErbB4 intracellular domain. These results suggest the presence of activating driver mutations of ERBB4 in non-small cell lung cancer.	[Kurppa, K. J.; Elenius, K.] Univ Turku, Dept Med Biochem & Genet, MediC Res Labs, FIN-20520 Turku, Finland; [Kurppa, K. J.] Turku Doctoral Programme Mol Med, Turku, Finland; [Denessiouk, K.; Johnson, M. S.] Abo Akad Univ, Fac Sci & Engn, Biochem, Struct Bioinformat Lab, Turku, Finland; [Elenius, K.] Turku Univ Hosp, Dept Oncol, FIN-20520 Turku, Finland	University of Turku; Abo Akademi University; University of Turku	Elenius, K (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FIN-20520 Turku, Finland.	klaus.elenius@utu.fi	Elenius, Klaus/AAI-7594-2021	Elenius, Klaus/0000-0001-5700-0827	Academy of Finland, Finnish Cancer Organizations; Sigrid Juselius Foundation; Turku University Central Hospital; Abo Akademi Center fo Excellence in Cell Stress and Aging; Joe, Pentti and Tor Borg memorial fund; Cancer Foundation Finland sr [130077, 160067] Funding Source: researchfish	Academy of Finland, Finnish Cancer Organizations(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Turku University Central Hospital; Abo Akademi Center fo Excellence in Cell Stress and Aging; Joe, Pentti and Tor Borg memorial fund; Cancer Foundation Finland sr	We thank Maria Tuominen, Minna Santanen and Mika Savisalo for excellent technical assistance. This work was financially supported by the Academy of Finland, Finnish Cancer Organizations, the Sigrid Juselius Foundation, the Turku University Central Hospital, the Abo Akademi Center fo Excellence in Cell Stress and Aging and the Joe, Pentti and Tor Borg memorial fund. The use of computational infrastructures of Biocenter Finland (bioinformatics) and CSC IT Center for Science is gratefully acknowledged.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Greulich H, 2012, P NATL ACAD SCI USA, V109, P14476, DOI 10.1073/pnas.1203201109; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hegde GV, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004438; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Jaiswal BS, 2013, CANCER CELL, V23, P603, DOI 10.1016/j.ccr.2013.04.012; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150; Junttila TT, 2003, CLIN CANCER RES, V9, P5346; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kurppa K, 2009, PIGM CELL MELANOMA R, V22, P708, DOI 10.1111/j.1755-148X.2009.00635.x; Lee HJ, 2002, J BIOL CHEM, V277, P6318, DOI 10.1074/jbc.M110371200; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2010, NAT REV CANCER, V10, P760, DOI 10.1038/nrc2947; Prickett TD, 2009, NAT GENET, V41, P1127, DOI 10.1038/ng.438; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Reck M, 2013, LANCET, V382, P709, DOI 10.1016/S0140-6736(13)61502-0; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Settleman J, 2009, CANCER CELL, V16, P278, DOI 10.1016/j.ccr.2009.09.013; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Sundvall M, 2010, MOL BIOL CELL, V21, P4275, DOI 10.1091/mbc.E10-04-0332; Takahashi Y, 2013, AM J HUM GENET, V93, P900, DOI 10.1016/j.ajhg.2013.09.008; Toivanen PI, 2009, J BIOL CHEM, V284, P16037, DOI 10.1074/jbc.M109.001123; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	40	43	44	0	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 10	2016	35	10					1283	1291		10.1038/onc.2015.185	http://dx.doi.org/10.1038/onc.2015.185			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DG0NY	26050618				2022-12-26	WOS:000371763100008
J	Li, G; Xu, F; Zhu, J; Krawczyk, M; Zhang, Y; Yuan, J; Patel, S; Wang, YJ; Lin, Y; Zhang, M; Cai, HM; Chen, D; Zhang, MX; Cao, GQ; Yeh, E; Lin, DN; Su, Q; Li, WW; Sen, GL; Afshari, N; Chen, SC; Maas, RL; Fu, XD; Zhang, K; Liu, YZ; Ouyang, H				Li, Gen; Xu, Fan; Zhu, Jie; Krawczyk, Michal; Zhang, Ying; Yuan, Jin; Patel, Sherrinal; Wang, Yujuan; Lin, Ying; Zhang, Ming; Cai, Huimin; Chen, Daniel; Zhang, Meixia; Cao, Guiqun; Yeh, Emily; Lin, Danni; Su, Qiao; Li, Wen-wen; Sen, George L.; Afshari, Natalie; Chen, Shaochen; Maas, Richard L.; Fu, Xiang-Dong; Zhang, Kang; Liu, Yizhi; Ouyang, Hong			Transcription Factor PAX6 (Paired Box 6) Controls Limbal Stem Cell Lineage in Development and Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LARGE GENE LISTS; CORNEAL EPITHELIUM; P63; DIFFERENTIATION; MORPHOGENESIS; HOMEOSTASIS; SOFTWARE; KERATINS; CANCER; TOOLS	PAX6 is a master regulatory gene involved in neuronal cell fate specification. It also plays a critical role in early eye field and subsequent limbal stem cell (LSC) determination during eye development. Defects in Pax6 cause aniridia and LSC deficiency in humans and the Sey (Small eye) phenotype in mice (Masse, K., Bhamra, S., Eason, R., Dale, N., and Jones, E. A. (2007) Nature 449, 1058-1062). However, how PAX6 specifies LSC and corneal fates during eye development is not well understood. Here, we show that PAX6 is expressed in the primitive eye cup and later in corneal tissue progenitors in early embryonic development. In contrast, p63 expression commences after that of PAX6 in ocular adnexal and skin tissue progenitors and later in LSCs. Using an in vitro feeder-free culture system, we show that PAX6 knockdown in LSCs led to up-regulation of skin epidermis-specific keratins concomitant with differentiation to a skin fate. Using gene expression analysis, we identified the involvement of Notch, Wnt, and TGF-beta signaling pathways in LSC fate determination. Thus, loss of PAX6 converts LSCs to epidermal stem cells, as demonstrated by a switch in the keratin gene expression profile and by the appearance of congenital dermoid tissue.	[Li, Gen; Zhang, Ming; Cai, Huimin; Zhang, Meixia; Cao, Guiqun; Zhang, Kang] Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Xu, Fan; Yuan, Jin; Wang, Yujuan; Lin, Ying; Zhang, Kang; Liu, Yizhi; Ouyang, Hong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510060, Guangdong, Peoples R China; [Zhu, Jie; Krawczyk, Michal; Patel, Sherrinal; Chen, Daniel; Yeh, Emily; Lin, Danni; Afshari, Natalie; Zhang, Kang; Ouyang, Hong] Univ Calif San Diego, Dept Ophthalmol, Biomat & Tissue Engn Ctr, Inst Engn Med, La Jolla, CA 92093 USA; [Sen, George L.; Fu, Xiang-Dong; Zhang, Kang] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Chen, Shaochen; Zhang, Kang] Univ Calif San Diego, Dept Nanoengn, La Jolla, CA 92093 USA; [Zhang, Ying; Cao, Guiqun; Maas, Richard L.] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Zhang, Ying; Cao, Guiqun; Maas, Richard L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Cai, Huimin] Guangzhou KangRui Biol Pharmaceut Technol Co Ltd, Guangzhou 510005, Guangdong, Peoples R China; [Li, Wen-wen] Sun Yat Sen Univ, Affiliated Hosp 1, Lab Anim Ctr, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Kang] Vet Adm Healthcare Syst, San Diego, CA 92161 USA	Sichuan University; Sun Yat Sen University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Sun Yat Sen University	Zhang, K (corresponding author), Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA.	kang.zhang@gmail.com	liu, yi/GXE-9662-2022; wang, yujuan/C-8428-2016; Zhu, Jie/AAD-1330-2022; Zhang, Kang/Y-2740-2019	Zhu, Jie/0000-0001-6862-9022; Zhang, Kang/0000-0002-4549-1697; Ouyang, Hong/0000-0002-7622-7733	973 Program [2015CB94600, 2014CB964900]; State Key Laboratory of Ophthalmology [RO1EY025090-A1, RO1EY021374]; NATIONAL EYE INSTITUTE [R01EY021374, R01EY025090, R01EY010123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	973 Program(National Basic Research Program of China); State Key Laboratory of Ophthalmology; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by 973 Program Grants 2015CB94600 and 2014CB964900 and by State Key Laboratory of Ophthalmology Grants RO1EY025090-A1 and RO1EY021374. The authors declare that they have no conflicts of interest with the contents of this article.	Arwert EN, 2012, NAT REV CANCER, V12, P170, DOI 10.1038/nrc3217; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Collu GM, 2014, CELL MOL LIFE SCI, V71, P3553, DOI 10.1007/s00018-014-1644-x; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; EICHNER R, 1984, J CELL BIOL, V98, P1388, DOI 10.1083/jcb.98.4.1388; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; KOPAN R, 1989, GENE DEV, V3, P1, DOI 10.1101/gad.3.1.1; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Lien WH, 2014, GENE DEV, V28, P1517, DOI 10.1101/gad.244772.114; Masse K, 2007, NATURE, V449, P1058, DOI 10.1038/nature06189; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Ouyang H, 2014, NATURE, V511, P358, DOI 10.1038/nature13465; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Ramaesh T, 2003, INVEST OPHTH VIS SCI, V44, P1871, DOI 10.1167/iovs.02-0576; Rowan S, 2008, DEV BIOL, V321, P111, DOI 10.1016/j.ydbio.2008.06.002; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zhao B, 2008, INVEST OPHTH VIS SCI, V49, P3395, DOI 10.1167/iovs.07-1263	29	42	44	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20448	20454		10.1074/jbc.M115.662940	http://dx.doi.org/10.1074/jbc.M115.662940			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	26045558	hybrid, Green Published			2022-12-26	WOS:000359608900042
J	Barroso, SPC; Nico, D; Nascimento, D; Santos, ACV; Couceiro, JNSS; Bozza, FA; Ferreira, AMA; Ferreira, DF; Palatnik-de-Sousa, CB; Souza, TML; Gomes, AMO; Silva, JL; Oliveira, AC				Barroso, Shana P. C.; Nico, Dirlei; Nascimento, Danielle; Santos, Ana Clara V.; Couceiro, Jose Nelson S. S.; Bozza, Fernando A.; Ferreira, Ana M. A.; Ferreira, Davis F.; Palatnik-de-Sousa, Clarisa B.; Souza, Thiago Moreno L.; Gomes, Andre M. O.; Silva, Jerson L.; Oliveira, Andrea C.			Intranasal Immunization with Pressure Inactivated Avian Influenza Elicits Cellular and Humoral Responses in Mice	PLOS ONE			English	Article							FC-ALPHA-RI; HYDROSTATIC-PRESSURE; A-VIRUS; HIGH IMMUNOGENICITY; IMMUNE-RESPONSES; VACCINE; PROTECTION; CHALLENGE; INFECTION; H5N1	Influenza viruses pose a serious global health threat, particularly in light of newly emerging strains, such as the avian influenza H5N1 and H7N9 viruses. Vaccination remains the primary method for preventing acquiring influenza or for avoiding developing serious complications related to the disease. Vaccinations based on inactivated split virus vaccines or on chemically inactivated whole virus have some important drawbacks, including changes in the immunogenic properties of the virus. To induce a greater mucosal immune response, intranasally administered vaccines are highly desired as they not only prevent disease but can also block the infection at its primary site. To avoid these drawbacks, hydrostatic pressure has been used as a potential method for viral inactivation and vaccine production. In this study, we show that hydrostatic pressure inactivates the avian influenza A H3N8 virus, while still maintaining hemagglutinin and neuraminidase functionalities. Challenged vaccinated animals showed no disease signs (ruffled fur, lethargy, weight loss, and huddling). Similarly, these animals showed less Evans Blue dye leakage and lower cell counts in their bronchoalveolar lavage fluid compared with the challenged non-vaccinated group. We found that the whole inactivated particles were capable of generating a neutralizing antibody response in serum, and IgA was also found in nasal mucosa and feces. After the vaccination and challenge we observed Th1/Th2 cytokine secretion with a prevalence of IFN-gamma Our data indicate that the animals present a satisfactory immune response after vaccination and are protected against infection. Our results may pave the way for the development of a novel pressure-based vaccine against influenza virus.	[Barroso, Shana P. C.; Santos, Ana Clara V.; Gomes, Andre M. O.; Silva, Jerson L.; Oliveira, Andrea C.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil; [Barroso, Shana P. C.; Santos, Ana Clara V.; Bozza, Fernando A.; Gomes, Andre M. O.; Silva, Jerson L.; Oliveira, Andrea C.] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Nico, Dirlei; Couceiro, Jose Nelson S. S.; Ferreira, Ana M. A.; Ferreira, Davis F.; Palatnik-de-Sousa, Clarisa B.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, BR-21941590 Rio De Janeiro, RJ, Brazil; [Nascimento, Danielle; Bozza, Fernando A.] Fundacao Oswaldo Cruz FIOCRUZ, Fundacao Pesquisa Clin Evandro Chagas, Rio De Janeiro, RJ, Brazil; [Barroso, Shana P. C.; Souza, Thiago Moreno L.] Fiocruz MS, Inst Oswaldo Cruz, WHO NIC, Lab Virus Resp, BR-21045900 Rio De Janeiro, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Oliveira, AC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.	cheble@bioqmed.ufrj.br	NASCIMENTO, DANIELLE/ABE-1057-2020; SILVA, JERSON Lima/GRF-1442-2022; Ferreira, Davis/D-9356-2014; Souza, Thiago Moreno L./G-2900-2012; Gomes, Andre M.O./C-4009-2014; Nico, Dirlei/GZA-3726-2022; Bozza, Fernando A/A-2618-2013; Silva, Jerson/J-8984-2014; Oliveira, Andrea C/O-6695-2018; Couceiro, José Nelson SS/J-3933-2016; Barroso, Shana/ABH-9716-2020	NASCIMENTO, DANIELLE/0000-0001-8946-6998; SILVA, JERSON Lima/0000-0001-9523-9441; Souza, Thiago Moreno L./0000-0003-2212-3899; Gomes, Andre M.O./0000-0003-1052-8004; Bozza, Fernando A/0000-0003-4878-0256; Silva, Jerson/0000-0001-9523-9441; Couceiro, José Nelson SS/0000-0001-8712-4847; Palatnik-de-Sousa, Clarisa B./0000-0002-6231-0608; Barroso, Shana/0000-0001-7890-9255; de Amorim Ferreira, Ana Maria/0000-0003-2507-0171	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB), Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB), and Programa de Apoio a Nucleos de Excelencia (PRONEX) to J.L.S., A.M.O.G., and A.C.O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2010, MED PRIN PRACT, V19, P421, DOI 10.1159/000320299; Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6; [Anonymous], 2003, INFL OV; Asanuma H, 2007, VACCINE, V25, P6975, DOI 10.1016/j.vaccine.2007.06.060; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Belser JA, 2010, J VIROL, V84, P4194, DOI 10.1128/JVI.02742-09; Boonyaratanakornkit BB, 2002, BBA-PROTEIN STRUCT M, V1595, P235, DOI 10.1016/S0167-4838(01)00347-8; Calci KR, 2005, APPL ENVIRON MICROB, V71, P339, DOI 10.1128/AEM.71.1.339-343.2005; Capua I, 2004, AVIAN PATHOL, V33, P393, DOI 10.1080/03079450410001724085; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Castleman WL, 2010, VET PATHOL, V47, P507, DOI 10.1177/0300985810363718; Ceylan C, 2012, VET MICROBIOL, V154, P266, DOI 10.1016/j.vetmic.2011.07.026; Chawla R, 2011, J FOOD SCI TECH MYS, V48, P260, DOI 10.1007/s13197-010-0180-4; Committee for Proprietary Medicinal Products, 1997, NOT GUID HARM REQ IN; Cox RJ, 2009, INFLUENZA OTHER RESP, V3, P107, DOI 10.1111/j.1750-2659.2009.00082.x; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Dumard CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080785; Epstein SL, 2002, EMERG INFECT DIS, V8, P796; Freitas TRP, 2003, J VIROL METHODS, V108, P205, DOI 10.1016/S0166-0934(02)00289-6; Fukushi M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021207; Gaspar LP, 2008, J VIROL METHODS, V150, P57, DOI 10.1016/j.jviromet.2008.03.002; Geeraedts F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000138; Geeraedts F, 2008, INFLUENZA OTHER RESP, V2, P41, DOI 10.1111/j.1750-2659.2008.00038.x; Gehlen Marcelo Luiz, 2004, Arq. Bras. Oftalmol., V67, P219, DOI 10.1590/S0004-27492004000200007; Gomes AMO, 2003, BIOCHEMISTRY-US, V42, P5540, DOI 10.1021/bi027207k; Hannoun C, 2004, VIRUS RES, V103, P133, DOI 10.1016/j.virusres.2004.02.025; Hehme N, 2002, MED MICROBIOL IMMUN, V191, P203, DOI 10.1007/s00430-002-0147-9; Heremans K, 1998, BBA-PROTEIN STRUCT M, V1386, P353, DOI 10.1016/S0167-4838(98)00102-2; Hierholzer JC, 1995, VIROLOGY METHODS MAN, P25; Hoffman AM, 1997, VET CLIN N AM-EQUINE, V13, P463, DOI 10.1016/S0749-0739(17)30224-9; INGRAM DK, 1982, MECH AGEING DEV, V20, P253, DOI 10.1016/0047-6374(82)90092-6; JAKAB GJ, 1983, AM REV RESPIR DIS, V128, P730; JURKIEWICZ E, 1995, P NATL ACAD SCI USA, V92, P6935, DOI 10.1073/pnas.92.15.6935; KIDA H, 1987, VIROLOGY, V159, P109, DOI 10.1016/0042-6822(87)90353-9; Kingsley DH, 2007, APPL ENVIRON MICROB, V73, P581, DOI 10.1128/AEM.02117-06; Koyama S, 2007, J IMMUNOL, V179, P4711, DOI 10.4049/jimmunol.179.7.4711; Kreijtz JHCM, 2008, J VIROL, V82, P5161, DOI 10.1128/JVI.02694-07; LaMere MW, 2011, J VIROL, V85, P5027, DOI 10.1128/JVI.00150-11; Lamm ME, 2002, J EXP MED, V195, pF5, DOI 10.1084/jem.20011910; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li JE, 2013, SCI CHINA LIFE SCI, V56, P619, DOI 10.1007/s11427-013-4504-2; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069649; Longhi MP, 2008, PLOS PATHOG, V4, DOI [10.1371/ journal. ppat. 1000006, DOI 10.1371/J0URNAL.PPAT.1000006]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LU BL, 1982, INFECT IMMUN, V38, P530, DOI 10.1128/IAI.38.2.530-535.1982; Marchal S, 2005, BRAZ J MED BIOL RES, V38, P1175, DOI 10.1590/S0100-879X2005000800004; Masson Patrick, 2001, Journal of Biomedicine and Biotechnology, V1, P85, DOI 10.1155/S1110724301000158; Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07; Mei L, 2013, BIOSCI TRENDS, V7, P64, DOI 10.5582/bst.2013.v7.2.64; Mesquita M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101056; Moran TM, 1999, J INFECT DIS, V180, P579, DOI 10.1086/314952; Otten MA, 2004, IMMUNOL LETT, V92, P23, DOI 10.1016/j.imlet.2003.11.018; PALADINI AA, 1981, BIOCHEMISTRY-US, V20, P2587, DOI 10.1021/bi00512a034; Proietti E, 2002, J IMMUNOL, V169, P375, DOI 10.4049/jimmunol.169.1.375; REED L. J., 1938, AMER JOUR HYG, V27, P493; Riberdy JM, 1999, J VIROL, V73, P1453, DOI 10.1128/JVI.73.2.1453-1459.1999; Rovozzo GC, 1973, MANUAL VIROLOGICAL B; Schwarcz WD, 2004, CELL MOL BIOL, V50, P419; Silva JL, 2014, CHEM REV, V114, P7239, DOI 10.1021/cr400204z; SILVA JL, 1992, J VIROL, V66, P2111, DOI 10.1128/JVI.66.4.2111-2117.1992; Silva JL, 1996, CURR OPIN STRUC BIOL, V6, P166, DOI 10.1016/S0959-440X(96)80071-6; Silva JL, 2001, TRENDS BIOCHEM SCI, V26, P612, DOI 10.1016/S0968-0004(01)01949-1; Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sundararajan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034377; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Tian SM, 2000, EUR J BIOCHEM, V267, P4486, DOI 10.1046/j.1432-1327.2000.01496.x; Tian SM, 1999, ACTA BIOCH BIOPH SIN, V31, P334; van Egmond M, 2000, NAT MED, V6, P680, DOI 10.1038/76261; Van Reeth K, 2000, VET MICROBIOL, V74, P109, DOI 10.1016/S0378-1135(00)00171-1; van Schaik SM, 2000, J MED VIROL, V62, P257, DOI 10.1002/1096-9071(200010)62:2<257::AID-JMV19>3.0.CO;2-M; Vandegrift KJ, 2010, ANN NY ACAD SCI, V1195, P113, DOI 10.1111/j.1749-6632.2010.05451.x; WHO, MAN AN INFL DIAGN SU; Wilschut JC, 2006, INFLUENZA, P150; WOOD JM, 1998, TXB INFLUENZA, P333; Yondon M, 2014, EMERG INFECT DIS, V20, P2144, DOI 10.3201/eid2012.140435; Zosky GR, 2009, J APPL PHYSIOL, V107, P1472, DOI 10.1152/japplphysiol.00393.2009	79	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0128785	10.1371/journal.pone.0128785	http://dx.doi.org/10.1371/journal.pone.0128785			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26056825	Green Published, Green Submitted, gold			2022-12-26	WOS:000356349000030
J	Bin, BH; Bhin, J; Yang, SH; Shin, M; Nam, YJ; Choi, DH; Shin, DW; Lee, AY; Hwang, D; Cho, EG; Lee, TR				Bin, Bum-Ho; Bhin, Jinhyuk; Yang, Seung Ha; Shin, Misun; Nam, Yeon-Ju; Choi, Dong-Hwa; Shin, Dong Wook; Lee, Ai-Young; Hwang, Daehee; Cho, Eun-Gyung; Lee, Tae Ryong			Membrane-Associated Transporter Protein (MATP) Regulates Melanosomal pH and Influences Tyrosinase Activity	PLOS ONE			English	Article							OCULOCUTANEOUS ALBINISM; GENE; MUTATIONS; SKIN; PIGMENTATION; PHEOMELANIN; BIOGENESIS; EUMELANIN; BIOLOGY; FAMILY	The SLC45A2 gene encodes a Membrane-Associated Transporter Protein (MATP). Mutations of this gene cause oculocutaneous albinism type 4 (OCA4). However, the molecular mechanism of its action in melanogenesis has not been elucidated. Here, we discuss the role of MATP in melanin production. The SLC45A2 gene is highly enriched in human melanocytes and melanoma cell lines, and its protein, MATP, is located in melanosomes. The knockdown of MATP using siRNAs reduced melanin content and tyrosinase activity without any morphological change in melanosomes or the expression of melanogenesis-related proteins. Interestingly, the knockdown of MATP significantly lowered the melanosomal pH, as verified through DAMP analysis, suggesting that MATP regulates melanosomal pH and therefore affects tyrosinase activity. Finally, we found that the reduction of tyrosinase activity associated with the knockdown of MATP was readily recovered by copper treatment in the in vitro L-DOPA oxidase activity assay of tyrosinase. Considering that copper is an important element for tyrosinase activity and that its binding to tyrosinase depends on melanosomal pH, MATP may play an important role in regulating tyrosinase activity via controlling melanosomal pH.	[Bin, Bum-Ho; Yang, Seung Ha; Shin, Misun; Shin, Dong Wook; Cho, Eun-Gyung; Lee, Tae Ryong] Amorepacific Corp, R&D Ctr, Biosci Res Inst, Yongin, South Korea; [Bhin, Jinhyuk; Hwang, Daehee] POSTECH, Dept Chem Engn, Pohang, South Korea; [Nam, Yeon-Ju; Choi, Dong-Hwa] Gyeonggi Inst Sci & Technol Promot, Gyeonggi Bio Ctr, Suwon, South Korea; [Lee, Ai-Young] Dongguk Univ, Ilsan Hosp, Dept Dermatol, Goyang, South Korea	Samsung; Pohang University of Science & Technology (POSTECH); Dongguk University; NHIS Ilsan Hospital	Cho, EG (corresponding author), Amorepacific Corp, R&D Ctr, Biosci Res Inst, Yongin, South Korea.	egcho@amorepacific.com; TRLee@amorepacific.com	Bhin, jinhyuk/ABC-9131-2021		Amorepacific Corporation RD Center	Amorepacific Corporation RD Center	Amorepacific Corporation R&D Center provided support in the form of salaries for authors BHB, SHY, MS, DWS, EGC and TRL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartolke R, 2014, BIOCHEM J, V464, P193, DOI 10.1042/BJ20140572; Bin BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105965; Branza-Nichita N, 2000, CHEM REV, V100, P4697, DOI 10.1021/cr990291y; Carlson JA, 2005, J AM ACAD DERMATOL, V52, P743, DOI 10.1016/j.jaad.2004.08.034; Cheli Y, 2009, J BIOL CHEM, V284, P18699, DOI 10.1074/jbc.M109.005819; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Cichorek M, 2013, POSTEP DERM ALERGOL, V30, P30, DOI 10.5114/pdia.2013.33376; Costin GE, 2003, J CELL SCI, V116, P3203, DOI 10.1242/jcs.00598; Forrest LR, 2011, BBA-BIOENERGETICS, V1807, P167, DOI 10.1016/j.bbabio.2010.10.014; Fukamachi S, 2001, NAT GENET, V28, P381, DOI 10.1038/ng584; Ginger RS, 2008, J BIOL CHEM, V283, P5486, DOI 10.1074/jbc.M707521200; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Gronskov K, 2014, EUR J HUM GENET, V22, DOI 10.1038/ejhg.2013.307; Inagaki K, 2006, PIGM CELL RES, V19, P451, DOI 10.1111/j.1600-0749.2006.00332.x; Ito S, 2011, J EUR ACAD DERMATOL, V25, P1369, DOI 10.1111/j.1468-3083.2011.04278.x; Ito S, 2003, PIGM CELL RES, V16, P523, DOI 10.1034/j.1600-0749.2003.00072.x; Kamaraj B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/905472; Kaplan J, 2008, CURR OPIN HEMATOL, V15, P22, DOI 10.1097/MOH.0b013e3282f2bcce; Kushimoto T, 2001, P NATL ACAD SCI USA, V98, P10698, DOI 10.1073/pnas.191184798; Land EJ, 2004, METHOD ENZYMOL, V378, P88; Li Hong-Yi, 2006, Yichuan, V28, P1149; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Marles LK, 2003, EXP DERMATOL, V12, P61, DOI 10.1034/j.1600-0625.2003.120108.x; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Meyer H, 2011, J CELL SCI, V124, P1984, DOI 10.1242/jcs.082024; Moellmann G, 1988, PIGMENT CELL RES, V1, P79, DOI DOI 10.1111/J.1600-0749.1988.TB00798.X; Newton JM, 2001, AM J HUM GENET, V69, P981, DOI 10.1086/324340; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Schallreuter KU, 2008, EXP DERMATOL, V17, P395, DOI 10.1111/j.1600-0625.2007.00675.x; Schneier AJ, 2013, SEMIN OPHTHALMOL, V28, P387, DOI 10.3109/08820538.2013.825280; Setty SRG, 2008, NATURE, V454, P1142, DOI 10.1038/nature07163; Sharp PA, 2003, INT J BIOCHEM CELL B, V35, P288, DOI 10.1016/S1357-2725(02)00134-6; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Slominski A, 2005, J INVEST DERMATOL, V124, P13, DOI 10.1111/j.0022-202X.2004.23528.x; Slominski A, 2012, PIGM CELL MELANOMA R, V25, P14, DOI 10.1111/j.1755-148X.2011.00898.x; Smith DR, 2004, EXP CELL RES, V298, P521, DOI 10.1016/j.yexcr.2004.04.033; Suzuki T, 2005, BRIT J DERMATOL, V152, P174, DOI 10.1111/J.1365-2133.2005.06403.X; Vitavska O, 2013, MOL ASPECTS MED, V34, P655, DOI 10.1016/j.mam.2012.05.014; Ward Diane McVey, 2002, Current Molecular Medicine (Hilversum), V2, P469, DOI 10.2174/1566524023362339; Wolnicka-Glubisz A, 2015, ARCH DERMATOL RES, V307, P89, DOI 10.1007/s00403-014-1523-1; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yuasa I, 2006, ANN HUM GENET, V70, P802, DOI 10.1111/j.1469-1809.2006.00261.x	42	55	60	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129273	10.1371/journal.pone.0129273	http://dx.doi.org/10.1371/journal.pone.0129273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057890	gold, Green Published, Green Submitted			2022-12-26	WOS:000356349000047
J	Svensson-Farbom, P; Almgren, P; Hedblad, B; Engstrom, G; Persson, M; Christensson, A; Melander, O				Svensson-Farbom, Patrik; Almgren, Peter; Hedblad, Bo; Engstrom, Gunnar; Persson, Margaretha; Christensson, Anders; Melander, Olle			Cystatin C Is Not Causally Related to Coronary Artery Disease	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; HEART-DISEASE; METABOLIC SYNDROME; RENAL-FUNCTION; RISK; ASSOCIATION; CREATININE; MARKER; PREDICTION; MORTALITY	Background Strong and independent associations between plasma concentration of cystatin C and risk of cardiovascular disease (CVD) suggests causal involvement of cystatin C. Aim The aim of our study was to assess whether there is a causal relationship between plasma concentration of cystatin C and risk of coronary artery disease (CAD) using a Mendelian Randomization approach. Methods We estimated the strength of association of plasma cystatin C on CAD risk and the strength of association of the strongest GWAS derived cystatin C SNP (rs13038305) on plasma cystatin C in the population-based Malmo Diet and Cancer Study (MDC) and thereafter the association between rs13038305 and CAD in the MDC (3200 cases of CAD and 24418 controls) and CARDIOGRAM (22233 cases of CAD and 64762 controls). Results Each standard deviation (SD) increment of plasma cystatin C was associated with increased risk of CAD (OR = 1.20, 95% CI 1.07-1.34) after full adjustment. Each copy of the major allele of rs13038305 was associated with 0.34 SD higher plasma concentration of cystatin C (P<1 x 10(-35)), resulting in a power of >98% to detect a significant relationship between rs13038305 and CAD in MDC and CARDIOGRAM pooled. The odds ratio for CAD (per copy of the major rs13038305 allele) was 1.00 (0.94-1.07); P = 0.92 in MDC, 0.99 (0.96-1.03); P = 0.84 in CARDIOGRAM and 1.00 (0.97-1.03); P = 0.83 in MDC and CARDIOGRAM pooled. Conclusion Genetic elevation of plasma cystatin C is not related to altered risk of CAD, suggesting that there is no causal relationship between plasma cystatin C and CAD. Rather, the association between cystatin C and CAD appears to be due to the association of eGFR and CAD.	[Svensson-Farbom, Patrik] Trelleborg Hosp, Dept Internal Med, Trelleborg, Sweden; [Svensson-Farbom, Patrik; Almgren, Peter; Hedblad, Bo; Engstrom, Gunnar; Persson, Margaretha; Christensson, Anders; Melander, Olle] Lund Univ, Inst Clin Sci, Malmo, Sweden; [Persson, Margaretha; Melander, Olle] Skane Univ Hosp, Dept Internal Med, Malmo, Sweden; [Christensson, Anders] Skane Univ Hosp, Dept Nephrol, Malmo, Sweden	Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Svensson-Farbom, P (corresponding author), Trelleborg Hosp, Dept Internal Med, Trelleborg, Sweden.	patrik.svensson@med.lu.se		Christensson, Anders/0000-0002-7328-8418; Melander, Olle/0000-0002-2581-484X; Persson, Margaretha/0000-0001-8188-5792	European Research Council [StG-282255]; Swedish Heart and Lung Foundation; Swedish Research Council; Novo Nordisk Foundation; Skane University Hospital donation funds; Medical Faculty, Lund University; Governmental funding of clinical research within the national health services; Albert Pahlsson Research Foundation; Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	European Research Council(European Research Council (ERC)European Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Skane University Hospital donation funds; Medical Faculty, Lund University; Governmental funding of clinical research within the national health services; Albert Pahlsson Research Foundation; Region Skane; King Gustaf V and Queen Victoria Foundation; Marianne and Marcus Wallenberg Foundation	Funding was obtained from the European Research Council (StG-282255), the Swedish Heart and Lung Foundation, Swedish Research Council; the Novo Nordisk Foundation, the Skane University Hospital donation funds; the Medical Faculty, Lund University; the Governmental funding of clinical research within the national health services, the Albert Pahlsson Research Foundation, Region Skane, the King Gustaf V and Queen Victoria Foundation and the Marianne and Marcus Wallenberg Foundation.	[Anonymous], 2000, EV QUAL DIAGN AC MYO; Aoki T, 2008, STROKE, V39, P2603, DOI 10.1161/STROKEAHA.107.513648; BARRETT AJ, 1984, BIOCHEM BIOPH RES CO, V120, P631, DOI 10.1016/0006-291X(84)91302-0; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Enhorning S, 2010, CIRCULATION, V121, P2102, DOI 10.1161/CIRCULATIONAHA.109.909663; GRUBB A, 1985, ACTA MED SCAND, V218, P499; Grubb A, 2012, SCAND J CLIN LAB INV, V72, P73, DOI 10.3109/00365513.2011.634023; Grubb AO, 2001, ADV CLIN CHEM, V35, P63, DOI 10.1016/S0065-2423(01)35015-1; Hoke M, 2010, STROKE, V41, P674, DOI 10.1161/STROKEAHA.109.573162; Ix JH, 2007, CIRCULATION, V115, P173, DOI 10.1161/CIRCULATIONAHA.106.644286; JACOBSSON B, 1995, HISTOPATHOLOGY, V26, P559, DOI 10.1111/j.1365-2559.1995.tb00275.x; Jernberg T, 2004, CIRCULATION, V110, P2342, DOI 10.1161/01.CIR.0000145166.44942.E0; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Koenig W, 2005, CLIN CHEM, V51, P321, DOI 10.1373/clinchem.2004.041889; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Lagerqvist B, 2007, NEW ENGL J MED, V356, P1009, DOI 10.1056/NEJMoa067722; Loew M, 2005, ARTERIOSCL THROM VAS, V25, P1470, DOI 10.1161/01.ATV.0000168416.74206.62; Magnusson M, 2013, J INTERN MED, V274, P192, DOI 10.1111/joim.12051; McGuigan FEA, 2002, PSYCHIATR GENET, V12, P133, DOI 10.1097/00041444-200209000-00003; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Newton-Cheh C, 2009, NAT GENET, V41, P348, DOI 10.1038/ng.328; Peralta CA, 2011, J AM SOC NEPHROL, V22, P147, DOI 10.1681/ASN.2010050483; Persson M, 2007, ARTERIOSCL THROM VAS, V27, P1411, DOI 10.1161/ATVBAHA.107.142679; Salgado JV, 2013, J CARDIOLOGY; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Shlipak MG, 2006, ANN INTERN MED, V145, P237, DOI 10.7326/0003-4819-145-4-200608150-00003; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Shlipak MG, 2006, J AM SOC NEPHROL, V17, P254, DOI 10.1681/ASN.2005050545; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Taglieri N, 2010, ATHEROSCLEROSIS, V209, P300, DOI 10.1016/j.atherosclerosis.2009.09.022; Taglieri N, 2009, CLIN CHEM, V55, P1932, DOI 10.1373/clinchem.2009.128397; Tangri N, 2011, KIDNEY INT, V79, P471, DOI 10.1038/ki.2010.431; Tenstad O, 1996, SCAND J CLIN LAB INV, V56, P409, DOI 10.3109/00365519609088795; Thomassen SA, 2002, SPINAL CORD, V40, P524, DOI 10.1038/sj.sc.3101320; Westhuyzen J, 2006, ANN CLIN LAB SCI, V36, P387	37	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2015	10	6							e0129269	10.1371/journal.pone.0129269	http://dx.doi.org/10.1371/journal.pone.0129269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK6PC	26057752	Green Published, gold, Green Submitted			2022-12-26	WOS:000356349000046
J	Hernandez, K; Myers, LG; Bowser, M; Kidd, T				Hernandez, Karla; Myers, Logan G.; Bowser, Micah; Kidd, Thomas			Genetic Tools for the Analysis of Drosophila Stomatogastric Nervous System Development	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; EXPRESSION; DIFFERENTIATION; SPECIFICATION; MELANOGASTER; PRECURSORS; MIGRATION; ENDODERM; PATTERNS; RESOURCE	The Drosophila stomatogastric nervous system (SNS) is a compact collection of neurons that arises from the migration of neural precursors. Here we describe genetic tools allowing functional analysis of the SNS during the migratory phase of development. We constructed GAL4 lines driven by fragments of the Ret promoter, which yielded expression in a subset of migrating neural SNS precursors and also included a distinct set of midgut associated cells. Screening of additional GAL4 lines driven by fragments of the Gfrl/Munin, forkhead, twist and goosecoid (Gsc) promoters identified a Gsc fragment with expression from initial selection of SNS precursors until the end of embryogenesis. Inhibition of EGFR signaling using three identified lines disrupted the correct patterning of the frontal and recurrent nerves. To manipulate the environment traveled by SNS precursors, a FasII-GAL4 line with strong expression throughout the entire intestinal tract was identified. The transgenic lines described offer the ability to specifically manipulate the migration of SNS precursors and will allow the modeling and in-depth analysis of neuronal migration in ENS disorders such as Hirschsprung's disease.	[Hernandez, Karla; Myers, Logan G.; Bowser, Micah; Kidd, Thomas] Univ Nevada, Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Kidd, T (corresponding author), Univ Nevada, Biol, MS 314, Reno, NV 89557 USA.	tkidd@unr.edu	Kidd, Thomas/AAT-9993-2020	Kidd, Thomas/0000-0001-7190-4208; Myers, Logan/0000-0002-5590-7959	National Institutes of Health [R15NS075918]; NIH National Institute of General Medical Sciences [P20 GM103650, P20 GM103554, P20 GM103440]; Michael (Mick) J. M. Hitchcock, Ph. D. Graduate Student Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103554, P20GM103440, P20GM103650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS075918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Michael (Mick) J. M. Hitchcock, Ph. D. Graduate Student Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This project was supported by a grant from the National Institutes of Health (R15NS075918) to T. K. This study also received funding from the NIH National Institute of General Medical Sciences grants P20 GM103650, P20 GM103554, P20 GM103440. Additionally, Michael (Mick) J. M. Hitchcock, Ph. D. Graduate Student Research Fund to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buff E, 1998, DEVELOPMENT, V125, P2075; COPENHAVER PF, 1991, DEVELOPMENT, V113, P1115; COPENHAVER PF, 1990, DEVELOPMENT, V109, P17; Cossais F, 2010, DEV BIOL, V341, P267, DOI 10.1016/j.ydbio.2010.01.038; De Velasco B, 2004, DEV BIOL, V274, P280, DOI 10.1016/j.ydbio.2004.07.015; Dumstrei K, 1998, DEVELOPMENT, V125, P3417; Forjanic JP, 1997, DEV BIOL, V186, P139, DOI 10.1006/dbio.1997.8590; Gasque G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02120; Gonzalez-Gaitan M, 2000, EMBO REP, V1, P366, DOI 10.1093/embo-reports/kvd064; GONZALEZGAITAN M, 1995, DEVELOPMENT, V121, P2313; Gottlieb S, 1998, HUM MOL GENET, V7, P1497, DOI 10.1093/hmg/7.9.1497; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HACKER U, 1992, P NATL ACAD SCI USA, V89, P8754, DOI 10.1073/pnas.89.18.8754; Hahn M, 1996, EMBO J, V15, P3077, DOI 10.1002/j.1460-2075.1996.tb00670.x; Hahn M, 2001, P NATL ACAD SCI USA, V98, P1053, DOI 10.1073/pnas.021558598; Hammonds AS, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-12-r140; HARTENSTEIN V, 1994, J COMP NEUROL, V350, P367, DOI 10.1002/cne.903500304; Hartenstein V, 1997, TRENDS NEUROSCI, V20, P421, DOI 10.1016/S0166-2236(97)01066-7; Hartenstein V, 1996, DEV BIOL, V173, P213, DOI 10.1006/dbio.1996.0018; Ibanez CF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009134; Jannot AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062519; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kallijarvi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051997; Knipp S, 2009, DEV DYNAM, V238, P2837, DOI 10.1002/dvdy.22115; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Kuwajima T, 2013, DEVELOPMENT, V140, P1364, DOI 10.1242/dev.091844; Lake JI, 2013, AM J PHYSIOL-GASTR L, V305, pG1, DOI 10.1152/ajpgi.00452.2012; Lemaitre B, 2013, ANNU REV GENET, V47, P377, DOI 10.1146/annurev-genet-111212-133343; Liu YC, 2003, METHODS, V30, P86, DOI 10.1016/S1046-2023(03)00010-0; Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516; McKeown SJ, 2013, WIRES DEV BIOL, V2, P113, DOI 10.1002/wdev.57; Melcher C, 2005, PLOS BIOL, V3, P1618, DOI 10.1371/journal.pbio.0030305; Neckameyer WS, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-26; Ni JQ, 2009, GENETICS, V182, P1089, DOI 10.1534/genetics.109.103630; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Parry DA, 2013, AM J HUM GENET, V93, P1135, DOI 10.1016/j.ajhg.2013.10.027; PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Sharma Y, 2002, GENESIS, V34, P115, DOI 10.1002/gene.10127; Soba P, 2015, ELIFE, V4, DOI 10.7554/eLife.05491; Spiess R, 2008, J MORPHOL, V269, P272, DOI 10.1002/jmor.10581; Sprecher SG, 2007, GENE EXPR PATTERNS, V7, P584, DOI 10.1016/j.modgep.2007.01.004; TEPASS U, 1994, DEVELOPMENT, V120, P579; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Ward EJ, 2002, GENESIS, V34, P46, DOI 10.1002/gene.10138	48	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0128290	10.1371/journal.pone.0128290	http://dx.doi.org/10.1371/journal.pone.0128290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053861	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300029
J	Madar, I; Naor, E; Holt, D; Ravert, H; Dannals, R; Wahl, R				Madar, Igal; Naor, Elinor; Holt, Daniel; Ravert, Hayden; Dannals, Robert; Wahl, Richard			Brown Adipose Tissue Response Dynamics: In Vivo Insights with the Voltage Sensor F-18-Fluorobenzyl Triphenyl Phosphonium	PLOS ONE			English	Article							DIET-INDUCED THERMOGENESIS; ENERGY-BALANCE; MICE; FAT; PET; MEMBRANE; OBESITY; BINDING; COLD; MITOCHONDRIA	Brown adipose tissue (BAT) thermogenesis is an emerging target for prevention and treatment of obesity. Mitochondria are the heat generators of BAT. Yet, there is no noninvasive means to image the temporal dynamics of the mitochondrial activity in BAT in vivo. Here, we report a technology for quantitative monitoring of principal kinetic components of BAT adaptive thermogenesis in the living animal, using the PET imaging voltage sensor F-18-fluorobenzyltriphenylphosphonium (F-18-FBnTP). F-18-FBnTP targets the mitochondrial membrane potential (Delta Psi m)-the voltage analog of heat produced by mitochondria. Dynamic F-18-FBnTP PET imaging of rat's BAT was acquired just before and during localized skin cooling or systemic pharmacologic stimulation, with and without administration of propranolol. At ambient temperature, F-18-FBnTP demonstrated rapid uptake and prolonged steady-state retention in BAT. Conversely, cold-induced mitochondrial uncoupling resulted in an immediate washout of F-18-FBnTP from BAT, which was blocked by propranolol. Specific variables of BAT evoked activity were identified and quantified, including response latency, magnitude and kinetics. Cold stimulation resulted in partial washout of F-18-FBnTP (39.1%+/- 14.4% of basal activity). The bulk of F-18-FBnTP washout response occurred within the first minutes of the cold stimulation, while colonic temperature remained nearly intact. Drop of colonic temperature to shivering zone did not have an additive effect. The beta 3-adrenergic agonist CL-316,243 elicited F-18-FBnTP washout from BAT of kinetics similar to those caused by cold stimulation. Thus, monitoring Delta Psi m in vivo using F-18-FBnTP PET provides insights into the kinetic physiology of BAT. F-18-FBnTP PET depicts BAT as a highly sensitive and rapidly responsive organ, emitting heat in short burst during the first minutes of stimulation, and preceding change in core temperature. F-18-FBnTP PET provides a novel set of quantitative metrics highly important for identifying novel therapeutic targets at the mitochondrial level, for developing means to maximize BAT mass and activity, and assessing intervention efficacy.	[Madar, Igal; Naor, Elinor; Holt, Daniel; Ravert, Hayden; Dannals, Robert; Wahl, Richard] Johns Hopkins Med Inst, Div Nucl Med, Russell H Morgan Dept Radiol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Madar, I (corresponding author), Johns Hopkins Med Inst, Div Nucl Med, Russell H Morgan Dept Radiol, 615 N Wolfe St, Baltimore, MD 21205 USA.	imadar@jhmi.edu		WAHL, RICHARD L./0000-0002-7306-2590	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK201822]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK201822, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://www.niddk.nih.gov).	Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bartelt A., 2012, Journal of Molecular Medicine, V90, P887, DOI 10.1007/s00109-012-0858-3; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohade C, 2003, J NUCL MED, V44, P1267; Cohade C, 2010, SEMIN NUCL MED, V40, P283, DOI 10.1053/j.semnuclmed.2010.02.001; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Golozoubova V, 2004, MOL ENDOCRINOL, V18, P384, DOI 10.1210/me.2003-0267; GOODBODY AE, 1981, BIOCHEM J, V194, P1019, DOI 10.1042/bj1941019; HIMMSHAGEN J, 1978, BIOCHEM BIOPH RES CO, V83, P628, DOI 10.1016/0006-291X(78)91036-7; Kozak LP, 2000, ANNU REV NUTR, V20, P339, DOI 10.1146/annurev.nutr.20.1.339; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Madar I, 2012, J NUC MED, V5, P97; Madar I, 2007, EUR J NUCL MED MOL I, V34, P2057, DOI 10.1007/s00259-007-0500-8; Madar I, 2006, J NUCL MED, V47, P1359; Madar I, 2011, J NUCL MED, V52, P808, DOI 10.2967/jnumed.110.084657; Madar I, 2009, J NUCL MED, V50, P774, DOI 10.2967/jnumed.108.061283; MARCHINGTON D, 1983, J NUTR, V113, P1395; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Muzik O, 2013, J NUCL MED, V54, P523, DOI 10.2967/jnumed.112.111336; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nicholls DG, 2012, METHODS MOL BIOL, V810, P119, DOI 10.1007/978-1-61779-382-0_8; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; NICHOLLS DG, 1977, EUR J BIOCHEM, V77, P349, DOI 10.1111/j.1432-1033.1977.tb11674.x; POWER GG, 1989, J DEV PHYSIOL, V12, P295; Ravert HT, 2004, J LABELLED COMPD RAD, V47, P469, DOI 10.1002/jlcr.835; RICHARD D, 1988, CAN J PHYSIOL PHARM, V66, P1297, DOI 10.1139/y88-212; Richard D, 2007, Minerva Endocrinol, V32, P173; ROTHWELL NJ, 1982, PHARMACOL THERAPEUT, V17, P251, DOI 10.1016/0163-7258(82)90016-X; ROTHWELL NJ, 1982, BRIT J NUTR, V47, P461, DOI 10.1079/BJN19820058; ROTHWELL NJ, 1982, BIOSCIENCE REP, V2, P543, DOI 10.1007/BF01314214; Rothwell NJ, 1997, OBES RES, V5, P650, DOI 10.1002/j.1550-8528.1997.tb00591.x; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Shekelle PG, 2003, JAMA-J AM MED ASSOC, V289, P1537, DOI 10.1001/jama.289.12.1537; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; TRAYHURN P, 1982, P NUTR SOC, V41, P127, DOI 10.1079/PNS19820022; TRAYHURN P, 1982, NATURE, V295, P323, DOI 10.1038/295323a0; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555	42	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129627	10.1371/journal.pone.0129627	http://dx.doi.org/10.1371/journal.pone.0129627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053485	Green Submitted, Green Published, gold			2022-12-26	WOS:000355955300154
J	Roggeveen, S; van Os, J; Viechtbauer, W; Lousberg, R				Roggeveen, Suzanne; van Os, Jim; Viechtbauer, Wolfgang; Lousberg, Richel			EEG Changes Due to Experimentally Induced 3G Mobile Phone Radiation	PLOS ONE			English	Article							RADIOFREQUENCY ELECTROMAGNETIC-FIELDS; CEREBRAL-BLOOD-FLOW; COGNITIVE PERFORMANCE; BRAIN EXCITABILITY; RESTING EEG; HUMANS; EMISSIONS; EXPOSURE; ADULTS; SLEEP	The aim of this study was to investigate whether a 15-minute placement of a 3G dialing mobile phone causes direct changes in EEG activity compared to the placement of a sham phone. Furthermore, it was investigated whether placement of the mobile phone on the ear or the heart would result in different outcomes. Thirty-one healthy females participated. All subjects were measured twice: on one of the two days the mobile phone was attached to the ear, the other day to the chest. In this single-blind, cross-over design, assessments in the sham phone condition were conducted directly preceding and following the mobile phone exposure. During each assessment, EEG activity and radiofrequency radiation were recorded jointly. Delta, theta, alpha, slowbeta, fastbeta, and gamma activity was computed. The association between radiation exposure and the EEG was tested using multilevel random regression analyses with radiation as predictor of main interest. Significant radiation effects were found for the alpha, slowbeta, fastbeta, and gamma bands. When analyzed separately, ear location of the phone was associated with significant results, while chest placement was not. The results support the notion that EEG alterations are associated with mobile phone usage and that the effect is dependent on site of placement.	[Roggeveen, Suzanne; van Os, Jim; Viechtbauer, Wolfgang; Lousberg, Richel] Maastricht Univ, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England	Maastricht University; University of London; King's College London	Roggeveen, S (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, NL-6200 MD Maastricht, Netherlands.	s.roggeveen@maastrichtuniversity.nl	van Os, Jim/V-8884-2019; Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Viechtbauer, Wolfgang/M-1549-2013; van Os, Jim/C-2113-2014	van Os, Jim/0000-0002-7245-1586; Viechtbauer, Wolfgang/0000-0003-3463-4063; 				Aalto S, 2006, J CEREBR BLOOD F MET, V26, P885, DOI 10.1038/sj.jcbfm.9600279; Adair ER, 2003, BIOELECTROMAGNETICS, pS17, DOI 10.1002/bem.10133; Baan R, 2011, LANCET ONCOL, V12, P624, DOI 10.1016/S1470-2045(11)70147-4; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; CACOT P, 1995, ELECTROEN CLIN NEURO, V94, P305, DOI 10.1016/0013-4694(94)00298-Y; Carrubba S, 2007, NEUROSCIENCE, V144, P356, DOI 10.1016/j.neuroscience.2006.08.068; Coggon D, 2012, MOBILE TELECOMMUNICA; Croft RJ, 2008, BIOELECTROMAGNETICS, V29, P1, DOI 10.1002/bem.20352; Croft RJ, 2010, BIOELECTROMAGNETICS, V31, P434, DOI 10.1002/bem.20583; Croft RJ, 2002, CLIN NEUROPHYSIOL, V113, P1623, DOI 10.1016/S1388-2457(02)00215-8; Curcio G, 2005, NEUROSCI RES, V53, P265, DOI 10.1016/j.neures.2005.07.003; Ferreri F, 2006, ANN NEUROL, V60, P188, DOI 10.1002/ana.20906; Hall JE, 2020, GUYTON HALL TXB MED; Huber R, 2002, J SLEEP RES, V11, P289, DOI 10.1046/j.1365-2869.2002.00314.x; Huss A, 2006, ENVIRON HEALTH PERSP, V115, P1; ICNIRP, 2009, EXP HIGH FREQ EL FIE; International Communication Union, 2013, ICT FACTS FIG; JASPER HH, 1958, ELECTROENCEPHALOGRAP, V10, P370, DOI DOI 10.1016/0013-4694(58)90053-1; Kleinlogel H, 2008, BIOELECTROMAGNETICS, V29, P479, DOI 10.1002/bem.20419; Kwon MS, 2011, BIOELECTROMAGNETICS, V32, P253, DOI 10.1002/bem.20635; Lopes da Silva F., 1991, ELECTROENCEPHALOGRAP, V79, P81, DOI DOI 10.1016/0013-4694(91)90044-5; Loughran S, 2013, CLIN NEUROPHYSIOLOGY; Marino AA, 2009, ELECTROMAGN BIOL MED, V28, P250, DOI [10.1080/15368370902918912, 10.3109/15368370902918912]; Perentos N, 2007, AUSTRALAS PHYS ENG S, V30, P274, DOI 10.1007/BF03178437; Pinheiro J, 2001, MIXED EFFECTS MODELS; Regel SJ, 2007, J SLEEP RES, V16, P253, DOI 10.1111/j.1365-2869.2007.00603.x; Regel SJ, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-10; Reiser H, 1995, Eur J Med Res, V1, P27; Roschke J, 1997, BIOELECTROMAGNETICS, V18, P172, DOI 10.1002/(SICI)1521-186X(1997)18:2<172::AID-BEM10>3.0.CO;2-T; Salerno S, 2012, EUR J NEUROSCI, V36, P2716, DOI 10.1111/j.1460-9568.2012.08176.x; Tombini M, 2013, BRAIN STIMUL, V6, P448, DOI 10.1016/j.brs.2012.07.006; Trunk A, 2013, BIOELECTROMAGNETICS, V34, P31, DOI 10.1002/bem.21740; Valentini E, 2007, BIOELECTROMAGNETICS, V28, P415, DOI 10.1002/bem.20323; van Deventer E, 2011, BIOELECTROMAGNETICS, V32, P417, DOI 10.1002/bem.20660; Verbeke G, 2000, LINEAR MIXED MODELS	36	30	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2015	10	6							e0129496	10.1371/journal.pone.0129496	http://dx.doi.org/10.1371/journal.pone.0129496			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK1GM	26053854	Green Published, gold, Green Submitted			2022-12-26	WOS:000355955300132
J	Chen, Y; Yan, H; Song, ZQ; Chen, FR; Wang, H; Niu, J; Shi, XW; Zhang, DM; Zhang, N; Zhai, ZF; Zhong, BY; Cheng, LJ; Qian, T; Hao, F				Chen, Yan; Yan, Heng; Song, Zhiqiang; Chen, Fangru; Wang, Huan; Niu, Jun; Shi, Xiaowei; Zhang, Dongmei; Zhang, Na; Zhai, Zhifang; Zhong, Baiyu; Cheng, Liangjin; Qian, Tian; Hao, Fei			Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of Dermatitis	PLOS ONE			English	Article							NF-KAPPA-B; SUSCEPTIBILITY LOCI; A20-BINDING INHIBITOR; PLAQUE-FORMATION; GENE-EXPRESSION; SKIN; PROTEIN; ASSOCIATION; BINDING; CELLS	Psoriasis is a chronic, inflammatory skin disease involving both environmental and genetic factors. According to genome-wide association studies (GWAS), the TNIP1 gene, which encodes the TNF-alpha-induced protein 3-interacting protein 1 (TNIP1), is strongly linked to the susceptibility of psoriasis. TNIP1 is a widely expressed ubiquitin sensor that binds to the ubiquitin-editing protein A20 and restricts TNF- and TLR-induced signals. In our study, TNIP1 expression decreased in specimens of epidermis affected by psoriasis. Based on previous studies suggesting a role for TNIP1 in modulating cancer cell growth, we investigated its role in keratinocyte proliferation, which is clearly abnormal in psoriasis. To mimic the downregulation or upregulation of TNIP1 in HaCaT cells and primary human keratinocytes (PHKs), we used a TNIP1 specific small interfering hairpin RNA (TNIP1 shRNA) lentiviral vector or a recombinant TNIP1 (rTNIP1) lentiviral vector, respectively. Blocking TNIP1 expression increased keratinocyte proliferation, while overexpression of TNIP1 decreased keratinocyte proliferation. Furthermore, we showed that TNIP1 signaling might involve extracellular signal-regulated kinase1/2 (Erk1/2) and CCAAT/enhancer-binding protein beta (C/EBP beta) activity. Intradermal injection of TNIP1 shRNA in BALB/c mice led to exaggerated psoriatic conditions in imiquimod (IMQ)-induced psoriasis-like dermatitis. These findings indicate that TNIP1 has a protective role in psoriasis and therefore could be a promising therapeutic target.	[Chen, Yan; Yan, Heng; Song, Zhiqiang; Chen, Fangru; Wang, Huan; Niu, Jun; Shi, Xiaowei; Zhang, Dongmei; Zhang, Na; Zhai, Zhifang; Zhong, Baiyu; Cheng, Liangjin; Qian, Tian; Hao, Fei] Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China	Army Medical University	Hao, F (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Dermatol, Chongqing, Peoples R China.	haofei62@medmail.com.cn	zhai, zhifang/AAK-8284-2020	zhai, zhifang/0000-0003-2565-0272	National Science Foundation of China [NO 81101200]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Science Foundation of China (NO 81101200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; Albanesi C, 2007, CLIN DERMATOL, V25, P581, DOI 10.1016/j.clindermatol.2007.08.013; Allen M, 2003, AM J HUM GENET, V73, P430; Baek SC, 2001, HUM GENE THER, V12, P1551, DOI 10.1089/10430340152480276; Battle A, 2015, SCIENCE, V347, P664, DOI 10.1126/science.1260793; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Callahan JA, 2013, J IMMUNOL, V191, P535, DOI 10.4049/jimmunol.1203335; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; El Bakkouri K, 2005, J BIOL CHEM, V280, P17938, DOI 10.1074/jbc.M413588200; Flores AM, 2011, ARCH BIOCHEM BIOPHYS, V516, P58, DOI 10.1016/j.abb.2011.08.014; Gateva V, 2009, NAT GENET, V41, P1228, DOI 10.1038/ng.468; Gurevich I, 2011, J HISTOCHEM CYTOCHEM, V59, P1101, DOI 10.1369/0022155411427728; Gurevich I, 2009, BIOCHEM BIOPH RES CO, V389, P409, DOI 10.1016/j.bbrc.2009.08.159; Han JW, 2009, NAT GENET, V41, P1234, DOI 10.1038/ng.472; Heyninck K, 1999, J CELL BIOL, V145, P1471, DOI 10.1083/jcb.145.7.1471; Heyninck K, 2003, FEBS LETT, V536, P135, DOI 10.1016/S0014-5793(03)00041-3; HSU W, 1994, MOL CELL BIOL, V14, P268, DOI 10.1128/MCB.14.1.268; Huang L, 2008, ONCOGENE, V27, P6131, DOI 10.1038/onc.2008.208; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jakobsen M, 2009, MOL THER, V17, P1743, DOI 10.1038/mt.2009.141; Johansen C, 2005, BRIT J DERMATOL, V152, P37, DOI 10.1111/J.1365-2133.2004.06304.X; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Komine M, 2001, J INVEST DERMATOL, V116, P330, DOI 10.1046/j.1523-1747.2001.01249.x; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li CC, 2006, BIOCHEM BIOPH RES CO, V342, P300, DOI 10.1016/j.bbrc.2006.01.114; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; MCKAY IA, 1995, CLIN DERMATOL, V13, P105, DOI 10.1016/0738-081X(95)93817-8; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nanda SK, 2011, J EXP MED, V208, P1215, DOI 10.1084/jem.20102177; Olarerin-George AO, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-19; Oshima S, 2009, NATURE, V457, P906, DOI 10.1038/nature07575; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Schon MP, 2007, BRIT J DERMATOL, V157, P8, DOI 10.1111/j.1365-2133.2007.08265.x; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Shen F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000066; Song LB, 2013, CELL RES, V23, P274, DOI 10.1038/cr.2012.174; Sun LD, 2010, NAT GENET, V42, P1005, DOI 10.1038/ng.690; Sun W, 2010, ANNU REV BIOMED ENG, P121; Tejasvi T, 2012, J INVEST DERMATOL, V132, P593, DOI 10.1038/jid.2011.376; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Verstrepen L, 2009, BIOCHEM PHARMACOL, V78, P105, DOI 10.1016/j.bcp.2009.02.009; Wagner S, 2008, ONCOGENE, V27, P3739, DOI 10.1038/sj.onc.1211042; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Woodley DT, 2004, MOL THER, V10, P318, DOI 10.1016/j.ymthe.2004.05.016; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zellmer S, 2001, HISTOCHEM CELL BIOL, V115, P41, DOI 10.1007/s004180000225; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang DM, 2013, J RHEUMATOL, V40, P1535, DOI 10.3899/jrheum.121391; Zhang SL, 2002, BIOCHEM BIOPH RES CO, V297, P17, DOI 10.1016/S0006-291X(02)02086-7; Zhou JR, 2011, P NATL ACAD SCI USA, V108, pE998, DOI 10.1073/pnas.1106232108	57	27	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0127957	10.1371/journal.pone.0127957	http://dx.doi.org/10.1371/journal.pone.0127957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046540	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200034
J	Kirkpatrick, BW; Morris, CA				Kirkpatrick, Brian W.; Morris, Chris A.			A Major Gene for Bovine Ovulation Rate	PLOS ONE			English	Article							PREMATURE OVARIAN FAILURE; GROWTH-DIFFERENTIATION FACTOR-9; BONE MORPHOGENETIC PROTEIN-15; GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAIT LOCI; SHEEP OVIS-ARIES; BMP15 GENE; CANDIDATE GENES; BOOROOLA SHEEP; LACAUNE SHEEP	Half-sib daughters sired by a bull believed to be a carrier of a major gene for high ovulation rate were evaluated for ovulation rate and genotyped in an effort to both test the hypothesis of segregation of a major gene and to map the gene's location. A total of 131 daughters were produced over four consecutive years at a University of Wisconsin-Madison research farm. All were evaluated for ovulation rate over an average of four estrous cycles using transrectal ultrasonography. The sire and all daughters were genotyped using a 3K SNP chip and the genotype and phenotype data were used in a linkage analysis. Subsequently, daughters recombinant within the QTL region and the sire were genotyped successively with 50K and 777K SNP chips to refine the location of the causative polymorphism. Positional candidate genes within the fine-mapped region were examined for polymorphism by Sanger sequencing of PCR amplicons encompassing coding and 5' and 3' flanking regions of the genes. Sire DNA was used as template in the PCR reactions. Strong evidence of a major gene for ovulation rate was observed (p<1x10(-28)) with the gene localized to bovine chromosome 10. Fine-mapping subsequently reduced the location to a 1.2 Mb region between 13.6 and 14.8 Mb on chromosome 10. The location identified does not correspond to that for any previously identified major gene for ovulation rate. This region contains three candidate genes, SMAD3, SMAD6 and IQCH. While candidate gene screening failed to identify the causative polymorphism, three polymorphisms were identified that can be used as a haplotype to track inheritance of the high ovulation rate allele in descendants of the carrier sire.	[Kirkpatrick, Brian W.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA; [Morris, Chris A.] AgResearch, Ruakura Res Ctr, Hamilton, New Zealand	University of Wisconsin System; University of Wisconsin Madison; AgResearch - New Zealand	Kirkpatrick, BW (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA.	bwkirkpa@wisc.edu			Agricultural Experiment Station at the University of Wisconsin-Madison [WIS01648]	Agricultural Experiment Station at the University of Wisconsin-Madison	This work was supported by a Hatch grant (WIS01648) from the Agricultural Experiment Station at the University of Wisconsin-Madison. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barzegari A, 2010, REPROD DOMEST ANIM, V45, P666, DOI 10.1111/j.1439-0531.2008.01327.x; Bindon B M, 1986, Basic Life Sci, V37, P67; Bodin L, 2002, GENET SEL EVOL, V34, P447, DOI [10.1186/1297-9686-34-4-447, 10.1051/gse:2002017]; Bodin L, 2007, ENDOCRINOLOGY, V148, P393, DOI 10.1210/en.2006-0764; Chand AL, 2006, FERTIL STERIL, V86, P1009, DOI 10.1016/j.fertnstert.2006.02.107; Chu MX, 2007, ANIM BIOTECHNOL, V18, P263, DOI 10.1080/10495390701331114; Chu MX, 2007, J ANIM SCI, V85, P598, DOI 10.2527/jas.2006-324; Chu MX, 2004, ANIM BIOTECHNOL, V15, P111, DOI [10.1081/ABIO-200032582, 10.1081/labt-200032582]; Cobanoglu O, 2005, ANIM GENET, V36, P303, DOI 10.1111/j.1365-2052.2005.01299.x; Davis GH, 2002, BIOL REPROD, V66, P1869, DOI 10.1095/biolreprod66.6.1869; DAVIS GH, 1982, NEW ZEAL J AGR RES, V25, P525, DOI 10.1080/00288233.1982.10425216; Davis GH, 2001, BIOL REPROD, V64, P216, DOI 10.1095/biolreprod64.1.216; DAVIS GH, 1991, BIOL REPROD, V44, P620, DOI 10.1095/biolreprod44.4.620; Di Pasquale E, 2006, J CLIN ENDOCR METAB, V91, P1976, DOI 10.1210/jc.2005-2650; Di Pasquale E, 2004, AM J HUM GENET, V75, P106, DOI 10.1086/422103; Dixit H, 2006, HUM GENET, V119, P408, DOI 10.1007/s00439-006-0150-0; Dixit H, 2005, MENOPAUSE, V12, P749, DOI 10.1097/01.gme.0000184424.96437.7a; Drouilhet L, 2009, ANIM GENET, V40, P804, DOI 10.1111/j.1365-2052.2009.01919.x; Drouilhet L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003809; Echternkamp SE, 2007, J ANIM SCI, V85, P3228, DOI 10.2527/jas.2007-0209; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Ewens KG, 2010, J CLIN ENDOCR METAB, V95, P2306, DOI 10.1210/jc.2009-2703; Galloway SM, 2000, NAT GENET, V25, P279, DOI 10.1038/77033; Gonzalez A, 2008, FERTIL STERIL, V90, P447, DOI 10.1016/j.fertnstert.2007.06.083; Goodarzi MO, 2008, HUM REPROD, V23, P2842, DOI 10.1093/humrep/den324; Gregory KE, 1997, J ANIM SCI, V75, P1213; Hanrahan JP, 2004, BIOL REPROD, V70, P900, DOI 10.1095/biolreprod.103.023093; Inagaki K, 2010, MOL CELL ENDOCRINOL, V328, P1, DOI 10.1016/j.mce.2010.05.017; Juengel JL, 2011, BIOL REPROD, V85, P113, DOI 10.1095/biolreprod.110.090514; Khatib H, 2004, PLANT AN GEN 12 C SA, P290; Kirkpatrick BW, 1998, MAMM GENOME, V9, P97, DOI 10.1007/s003359900696; Kovanci E, 2007, FERTIL STERIL, V87, P143, DOI 10.1016/j.fertnstert.2006.05.079; Laissue P, 2006, EUR J ENDOCRINOL, V154, P739, DOI 10.1530/eje.1.02135; Monteagudo LV, 2009, ANIM REPROD SCI, V110, P139, DOI 10.1016/j.anireprosci.2008.01.005; Montgomery GW, 2004, TWIN RES, V7, P548, DOI 10.1375/1369052042663823; Morris CA, 2010, LIVEST SCI, V128, P193, DOI 10.1016/j.livsci.2009.11.009; Mulsant P, 2001, P NATL ACAD SCI USA, V98, P5104, DOI 10.1073/pnas.091577598; Nicol L, 2009, REPRODUCTION, V138, P921, DOI 10.1530/REP-09-0193; O'Shea T, 1996, P AUST SOC ANIM PROD, V21, P200; Palmer JS, 2006, J CLIN ENDOCR METAB, V91, P4713, DOI 10.1210/jc.2006-0970; Polley S, 2010, TROP ANIM HEALTH PRO, V42, P985, DOI 10.1007/s11250-009-9518-1; Scaramuzzi RJ, 2006, REPROD NUTR DEV, V46, P339, DOI 10.1051/rnd:2006016; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Schneider JF, 2014, J ANIM SCI, V92, P3792, DOI 10.2527/jas.2014-7788; Schneider JF, 2012, J ANIM SCI, V90, P3360, DOI 10.2527/jas.2011-4759; Silva BDM, 2011, ANIM GENET, V42, P89, DOI 10.1111/j.1365-2052.2010.02078.x; Souza CJH, 2001, J ENDOCRINOL, V169, pR1, DOI 10.1677/joe.0.169R001; Spelman RJ, 1996, GENETICS, V144, P1799; Sproul K, 2010, BJOG-INT J OBSTET GY, V117, P756, DOI 10.1111/j.1471-0528.2010.02527.x; Teixeira FL, 2002, J CLIN ENDOCR METAB, V87, P1337, DOI 10.1210/jc.87.3.1337; Tiotiu D, 2010, HUM REPROD, V25, P1581, DOI 10.1093/humrep/deq073; Vinet AT JL, 2010, 9 MAP WORLD C GEN AP; Wang BB, 2010, REPROD BIOMED ONLINE, V21, P344, DOI 10.1016/j.rbmo.2010.04.013; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225; Ye X, 2006, POULTRY SCI, V85, P1165, DOI 10.1093/ps/85.7.1165; Zhao ZZ, 2008, HUM REPROD, V23, P2372, DOI 10.1093/humrep/den268	57	20	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129025	10.1371/journal.pone.0129025	http://dx.doi.org/10.1371/journal.pone.0129025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046917	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200117
J	Li, B; Li, W; Ahmad, H; Zhang, LL; Wang, C; Wang, T				Li, Bo; Li, Wei; Ahmad, Hussain; Zhang, Lili; Wang, Chao; Wang, Tian			Effects of Choline on Meat Quality and Intramuscular Fat in Intrauterine Growth Retardation Pigs	PLOS ONE			English	Article							IMPAIRED OXIDATIVE-PHOSPHORYLATION; DIETARY CHOLINE; SKELETAL-MUSCLE; PROGRAMMED OBESITY; FETAL; STRESS; LIVER; RESTRICTION; MODEL; GENE	The aim of this study was to investigate the effects of choline supplementation on intramuscular fat (IMF) and lipid oxidation in IUGR pigs. Twelve normal body weight (NBW) and twelve intrauterine growth retardation (IUGR) newborn piglets were collected and distributed into 4 treatments (Normal: N, Normal+Choline: N+C, IUGR: I, and IUGR+Choline: I+C) with 6 piglets in each treatment. At 23 d of age, NBW and IUGR pigs were fed basal or choline supplemented diets. The results showed that the IUGR pigs had significantly lower (P<0.05) BW as compared with the NBW pigs at 23 d, 73 d, and 120 d of age, however, there was a slight decreased (P>0.05) in BW of IUGR pigs than the NBW pigs at 200 d. Compared with the NBW pigs, pH of meat longissimus dorsi muscle was significantly lower (P<0.05), and the meat color was improved in IUGR pigs. The malondialdehyde (MDA) levels were significantly decreased (P<0.05), while triglyceride (TG) and IMF contents were significantly higher (P<0.05) in the IUGR pigs than the NBW pigs. IUGR up-regulated the mRNA gene expression of fatty acid synthetase (FAS) and acetyl-CoA carboxylase (ACC). Dietary choline significantly increased (P<0.05) the BW at 120d of age, however, significantly decreased (P<0.05) the TG and IMF contents in both IUGR and NBW pigs. FAS and sterol regulatory element-binding proteins 1 (SREBP1) mRNA gene expressions were increased (P<0.05) while the muscle-carnitine palmityl transferase (M-CPT) and peroxisome proliferators-activated receptor. (PPAR.) mRNA (P<0.05) gene expressions were decreased in the muscles of the IUGR pigs by choline supplementation. Furthermore, choline supplementation significantly increased (P<0.05) the MDA content as well as the O2 center dot scavenging activity in meat of IUGR pigs. The results suggested that IUGR pigs showed a permanent stunting effect on the growth performance, increased fat deposition and oxidative stress in muscles. However, dietary supplementation of choline improved the fat deposition via enhancing the lipogenesis and reducing the lipolysis.	[Li, Bo; Li, Wei; Ahmad, Hussain; Zhang, Lili; Wang, Chao; Wang, Tian] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, T (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	tianwangnjau@163.com	Ahmad, hussain/AAP-9386-2020	Wang, Tian/0000-0002-9038-5009	National Natural Science Foundation of China [31272454]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This experiment was supported by the National Natural Science Foundation of China (Grant No. 31272454).	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Beijing animal husbandry and veterinary institute Chinese academy of agricultural sciences, DAT CHIN FEED; Best CH, 1935, J PHYSIOL-LONDON, V83, P255, DOI 10.1113/jphysiol.1935.sp003227; Cheng ZH, 2006, J AGR FOOD CHEM, V54, P7429, DOI 10.1021/jf0611668; DARRAGH AJ, 1995, J PEDIATR GASTR NUTR, V21, P387, DOI 10.1097/00005176-199511000-00004; Desai M, 2005, AM J PHYSIOL-REG I, V288, pR91, DOI 10.1152/ajpregu.00340.2004; Desai M, 2011, SEMIN REPROD MED, V29, P237, DOI 10.1055/s-0031-1275517; Dudonne S, 2009, J AGR FOOD CHEM, V57, P1768, DOI 10.1021/jf803011r; Fernandez-Figares I, 2012, ANIMAL, V6, P1058, DOI 10.1017/S1751731111002308; Fujita K, 2006, CIRC J, V70, P1437, DOI 10.1253/circj.70.1437; Fukami T, 2012, REPROD SCI, V19, P423, DOI 10.1177/1933719111424448; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Germani D, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-14; Hensley K, 2000, CARCINOGENESIS, V21, P983, DOI 10.1093/carcin/21.5.983; Hongu N, 2000, J NUTR, V130, P152, DOI 10.1093/jn/130.2.152; Jangjoo A, 2010, INDIAN J SURG, V72, P236, DOI 10.1007/s12262-010-0059-7; Karunaratne JF, 2005, J ANAT, V207, P763, DOI 10.1111/j.1469-7580.2005.00494.x; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; KENNEY JL, 1995, INT J SPORTS MED, V16, P114, DOI 10.1055/s-2007-972975; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Mehta AK, 2010, IMMUNOBIOLOGY, V215, P527, DOI 10.1016/j.imbio.2009.09.004; MERLETBENICHOU C, 1994, PEDIATR NEPHROL, V8, P175, DOI 10.1007/BF00865473; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; Michel CL, 2012, J EXP ZOOL PART A, V317A, P24, DOI 10.1002/jez.714; Michel V, 2011, FOOD FUNCT, V2, P53, DOI 10.1039/c0fo00069h; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; Neitzke U, 2011, MICROCIRCULATION, V18, P304, DOI 10.1111/j.1549-8719.2011.00089.x; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Ossani GP, 2013, FOOD FUNCT, V4, P448, DOI 10.1039/c2fo30229b; Pacelli C, 2010, J NUTR, V140, P1072, DOI 10.3945/jn.109.116673; PESTI GM, 1980, POULTRY SCI, V59, P1073, DOI 10.3382/ps.0591073; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Puglianiello A, 2007, PEDIATR RES, V61, P433, DOI 10.1203/pdr.0b013e3180332d4e; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Redmer DA, 2004, DOMEST ANIM ENDOCRIN, V27, P199, DOI 10.1016/j.domaniend.2004.06.006; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Sachan DS, 2005, J AM COLL NUTR, V24, P172, DOI 10.1080/07315724.2005.10719462; SAUNDERSON CL, 1990, BRIT J NUTR, V63, P339, DOI 10.1079/BJN19900120; Schugar RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074806; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Symonds ME, 2013, ANN NUTR METAB, V62, P137, DOI 10.1159/000345598; Tryndyak V, 2012, FASEB J, V26, P4592, DOI 10.1096/fj.12-209569; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156; Wu GS, 2013, J BIOL CHEM, V288, P837, DOI 10.1074/jbc.M112.415117; Wu G, 2010, ASIAN POLIT ECON SEC, P27; Wu GY, 2004, J NUTR, V134, P2169, DOI 10.1093/jn/134.9.2169; Wu P, 2013, FISH SHELLFISH IMMUN, V35, P697, DOI 10.1016/j.fsi.2013.05.030; XU RJ, 1994, J PEDIATR GASTR NUTR, V18, P231, DOI 10.1097/00005176-199402000-00018; ZEISEL SH, 1981, ANNU REV NUTR, V1, P95, DOI 10.1146/annurev.nu.01.070181.000523	51	17	18	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129109	10.1371/journal.pone.0129109	http://dx.doi.org/10.1371/journal.pone.0129109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046629	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200125
J	Pester, B; Ligges, C; Leistritz, L; Witte, H; Schiecke, K				Pester, Britta; Ligges, Carolin; Leistritz, Lutz; Witte, Herbert; Schiecke, Karin			Advanced Insights into Functional Brain Connectivity by Combining Tensor Decomposition and Partial Directed Coherence	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; EVENT-RELATED-POTENTIALS; EEG DATA; MEMORY; EFFICIENT; NUMBER; FORM	Quantification of functional connectivity in physiological networks is frequently performed by means of time-variant partial directed coherence (tvPDC), based on time-variant multi-variate autoregressive models. The principle advantage of tvPDC lies in the combination of directionality, time variance and frequency selectivity simultaneously, offering a more differentiated view into complex brain networks. Yet the advantages specific to tvPDC also cause a large number of results, leading to serious problems in interpretability. To counter this issue, we propose the decomposition of multi-dimensional tvPDC results into a sum of rank-1 outer products. This leads to a data condensation which enables an advanced interpretation of results. Furthermore it is thereby possible to uncover inherent interaction patterns of induced neuronal subsystems by limiting the decomposition to several relevant channels, while retaining the global influence determined by the preceding multivariate AR estimation and tvPDC calculation of the entire scalp. Finally a comparison between several subjects is considerably easier, as individual tvPDC results are summarized within a comprehensive model equipped with subject-specific loading coefficients. A proof-of-principle of the approach is provided by means of simulated data; EEG data of an experiment concerning visual evoked potentials are used to demonstrate the applicability to real data.	[Pester, Britta; Leistritz, Lutz; Witte, Herbert; Schiecke, Karin] Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Bernstein Grp Computat Neurosci Jena, Jena, Germany; [Ligges, Carolin] Univ Jena, Jena Univ Hosp, Dept Child & Adolescent Psychiat Psychosomat Med, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Pester, B (corresponding author), Univ Jena, Jena Univ Hosp, Inst Med Stat Comp Sci & Documentat, Bernstein Grp Computat Neurosci Jena, Bachstr 18, Jena, Germany.	Britta.Pester@med.uni-jena.de	Ligges, Carolin/ABA-7581-2021	Ligges, Carolin/0000-0002-3973-0532	German Research Foundation [Wi 1166/16-1, Le 2025/6-1]; Federal Ministry of Education and Research (Germany) [01GQ1202]; Interdisciplinary Center for Clinical Research Jena [T.P. 1.2/B 307-04004]; Innovationsfonds fur Zwecke der Gleichstellung Friedrich Schiller University Jena; habilitation grant from the Hochschul- und Wissenschaftsprogramm/Thuringia	German Research Foundation(German Research Foundation (DFG)); Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); Interdisciplinary Center for Clinical Research Jena; Innovationsfonds fur Zwecke der Gleichstellung Friedrich Schiller University Jena; habilitation grant from the Hochschul- und Wissenschaftsprogramm/Thuringia	This work was supported by the German Research Foundation under Wi 1166/16-1 and Le 2025/6-1 (www.dfg.de; HW LL), by the grant 01GQ1202 of the Federal Ministry of Education and Research (Germany, www.bmbf.de; LL), by the Interdisciplinary Center for Clinical Research Jena under T.P. 1.2/B 307-04004 (www.izkf.uniklinikumjena.de; CL), Innovationsfonds fur Zwecke der Gleichstellung Friedrich Schiller University Jena (www.uni-jena.de; CL), and by a habilitation grant from the Hochschul- und Wissenschaftsprogramm/Thuringia (personal grant for Carolin Ligges). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; Astolfi L, 2007, HUM BRAIN MAPP, V28, P143, DOI 10.1002/hbm.20263; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Baccala LA, 2007, DIG SIGN PROC 2007 1; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; Bro R, 1997, CHEMOMETR INTELL LAB, V38, P149, DOI 10.1016/S0169-7439(97)00032-4; Bro R., 1998, MULTIWAY ANAL FOOD I; Bugli C, 2007, BIOMETRICAL J, V49, P312, DOI 10.1002/bimj.200510285; BURDICK DS, 1995, CHEMOMETR INTELL LAB, V28, P229, DOI 10.1016/0169-7439(95)98599-2; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Chen ZP, 2001, ANAL CHIM ACTA, V444, P295, DOI 10.1016/S0003-2670(01)01179-5; Cichocki A, 2009, NONNEGATIVE MATRIX A; DURELL SR, 1990, ARCH BIOCHEM BIOPHYS, V278, P148, DOI 10.1016/0003-9861(90)90243-R; Estienne F, 2001, CHEMOMETR INTELL LAB, V58, P59, DOI 10.1016/S0169-7439(01)00140-X; Faes L, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/140513; FIELD A S, 1991, Brain Topography, V3, P407, DOI 10.1007/BF01129000; Godsil C.D., 2001, ALGEBRAIC GRAPH THEO; Gomez-Herrero G, 2008, NEUROIMAGE, V43, P497, DOI 10.1016/j.neuroimage.2008.07.032; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Harshman Richard A., 1970, FDN PARAFAC PROCEDUR; Haufe S, 2013, NEUROIMAGE, V64, P120, DOI 10.1016/j.neuroimage.2012.09.036; Hitchcock FL, 1927, EXPRESSION TENSOR PO; Katzner S, 2013, CURR OPIN NEUROBIOL, V23, P202, DOI 10.1016/j.conb.2013.01.019; Kayser J, 2003, COGNITIVE BRAIN RES, V16, P11, DOI 10.1016/S0926-6410(02)00205-7; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Krijnen WP, 2008, PSYCHOMETRIKA, V73, P431, DOI 10.1007/s11336-008-9056-1; Leistritz L, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0616; Liitkepohl H, 2007, NEW INTRO MULTIPLE T; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Mecklinger A, 1996, J COGNITIVE NEUROSCI, V8, P453, DOI 10.1162/jocn.1996.8.5.453; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; MOCKS J, 1988, BIOL PSYCHOL, V26, P199, DOI 10.1016/0301-0511(88)90020-8; Morup M, 2006, NEUROIMAGE, V29, P938, DOI 10.1016/j.neuroimage.2005.08.005; Onton J, 2006, NEUROSCI BIOBEHAV R, V30, P808, DOI 10.1016/j.neubiorev.2006.06.007; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Plomp G, 2014, NEUROIMAGE, V97, P206, DOI 10.1016/j.neuroimage.2014.04.016; Richards JE, 2004, INT J PSYCHOPHYSIOL, V54, P201, DOI 10.1016/j.ijpsycho.2004.03.009; Sakkalis V, 2011, COMPUT BIOL MED, V41, P1110, DOI 10.1016/j.compbiomed.2011.06.020; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Schulte-Korne G, 2004, NEUROREPORT, V15, P1075, DOI 10.1097/01.wnr.000012338787650.e2; Sidiropoulos ND, 2000, J CHEMOMETR, V14, P229, DOI 10.1002/1099-128X(200005/06)14:3<229::AID-CEM587>3.0.CO;2-N; Vialatte FB, 2010, PROG NEUROBIOL, V90, P418, DOI 10.1016/j.pneurobio.2009.11.005; Wacker M, 2011, IEEE T BIO-MED ENG, V58, P3069, DOI 10.1109/TBME.2011.2160640; Wang KM, 2000, BRAIN TOPOGR, V12, P263, DOI 10.1023/A:1023455404934; Weis M, 2009, INT CONF ACOUST SPEE, P349, DOI 10.1109/ICASSP.2009.4959592	49	12	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129293	10.1371/journal.pone.0129293	http://dx.doi.org/10.1371/journal.pone.0129293			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CJ7CR	26046537	Green Published, gold, Green Submitted			2022-12-26	WOS:000355652200144
J	Platel, M; Goldar, A; Wiggins, JM; Barbosa, P; Libeau, P; Priam, P; Narassimprakash, H; Grodzenski, X; Marheineke, K				Platel, Marie; Goldar, Arach; Wiggins, Jennifer M.; Barbosa, Pedro; Libeau, Pierre; Priam, Pierre; Narassimprakash, Hemalatha; Grodzenski, Xenia; Marheineke, Kathrin			Tight Chk1 Levels Control Replication Cluster Activation in Xenopus	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; S-PHASE CHECKPOINT; REPLICON CLUSTERS; FORK PROGRESSION; PROTEIN-KINASE; FIRING TIME; ATR; ORIGINS; INITIATION; TARGETS	DNA replication in higher eukaryotes initiates at thousands of origins according to a spatio-temporal program. The ATR/Chk1 dependent replication checkpoint inhibits the activation of later firing origins. In the Xenopus in vitro system initiations are not sequence dependent and 2-5 origins are grouped in clusters that fire at different times despite a very short S phase. We have shown that the temporal program is stochastic at the level of single origins and replication clusters. It is unclear how the replication checkpoint inhibits late origins but permits origin activation in early clusters. Here, we analyze the role of Chk1 in the replication program in sperm nuclei replicating in Xenopus egg extracts by a combination of experimental and modelling approaches. After Chk1 inhibition or immunodepletion, we observed an increase of the replication extent and fork density in the presence or absence of external stress. However, overexpression of Chk1 in the absence of external replication stress inhibited DNA replication by decreasing fork densities due to lower Cdk2 kinase activity. Thus, Chk1 levels need to be tightly controlled in order to properly regulate the replication program even during normal S phase. DNA combing experiments showed that Chk1 inhibits origins outside, but not inside, already active clusters. Numerical simulations of initiation frequencies in the absence and presence of Chk1 activity are consistent with a global inhibition of origins by Chk1 at the level of clusters but need to be combined with a local repression of Chk1 action close to activated origins to fit our data.	[Platel, Marie; Goldar, Arach; Wiggins, Jennifer M.; Barbosa, Pedro; Libeau, Pierre; Priam, Pierre; Narassimprakash, Hemalatha; Grodzenski, Xenia; Marheineke, Kathrin] Paris South Univ, CEA, CNRS, Dept Genome Biol,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Marheineke, K (corresponding author), Paris South Univ, CEA, CNRS, Dept Genome Biol,Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.	kathrin.marheineke@cgm.cnrs-gif.fr		WIGGINS, JENNIFER/0000-0002-5196-2299; Marheineke, Kathrin/0000-0002-1514-0167	"Fondation pour la recherche contre le Cancer" [SFI20111203831]; LIGUE contre le cancer [5FI10137LJMK]; Paris-South University; Ministery for Education, Research and Technology	"Fondation pour la recherche contre le Cancer"; LIGUE contre le cancer(Ligue nationale contre le cancer); Paris-South University; Ministery for Education, Research and Technology	This work was supported by the "Fondation pour la recherche contre le Cancer, SFI20111203831, (http://www.fondation-arc.org/)" and "LIGUE contre le cancer," 5FI10137LJMK, (http://www.ligue-cancer.net/) for KM lab. M.P. has a PhD-fellowship of the Paris-South University and the Ministery for Education, Research and Technology (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; Blow JJ, 2001, J CELL BIOL, V152, P15, DOI 10.1083/jcb.152.1.15; Busby EC, 2000, CANCER RES, V60, P2108; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Conn CW, 2004, DEV CELL, V7, P275, DOI 10.1016/j.devcel.2004.07.003; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Feijoo C, 2001, J CELL BIOL, V154, P913, DOI 10.1083/jcb.200104099; Gaggioli V, 2013, NUCLEIC ACIDS RES, V41, P7313, DOI 10.1093/nar/gkt494; Ge XQ, 2010, J CELL BIOL, V191, P1285, DOI 10.1083/jcb.201007074; Goldar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005899; Goldar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002919; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Guo C, 2015, MOL CELL, V57, P492, DOI 10.1016/j.molcel.2014.12.003; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Han XZ, 2014, J BIOL CHEM, V289, P24716, DOI 10.1074/jbc.M114.575035; Herrick J, 2002, J MOL BIOL, V320, P741, DOI 10.1016/S0022-2836(02)00522-3; Hoglund A, 2011, CLIN CANCER RES, V17, P7067, DOI 10.1158/1078-0432.CCR-11-1198; Hyrien O, 2003, BIOESSAYS, V25, P116, DOI 10.1002/bies.10208; HYRIEN O, 1993, EMBO J, V12, P4511, DOI 10.1002/j.1460-2075.1993.tb06140.x; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; Jin JP, 2003, GENE DEV, V17, P3062, DOI 10.1101/gad.1157503; Katsuno Y, 2009, P NATL ACAD SCI USA, V106, P3184, DOI 10.1073/pnas.0809350106; Knott SRV, 2012, CELL, V148, P99, DOI 10.1016/j.cell.2011.12.012; Krasinska L, 2008, EMBO J, V27, P758, DOI 10.1038/emboj.2008.16; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; Labit H, 2008, NUCLEIC ACIDS RES, V36, P5623, DOI 10.1093/nar/gkn533; Lam MH, 2004, CANCER CELL, V6, P45, DOI 10.1016/j.ccr.2004.06.015; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lopez-Contreras AJ, 2012, J EXP MED, V209, P455, DOI 10.1084/jem.20112147; Luciani MG, 2004, J CELL SCI, V117, P6019, DOI 10.1242/jcs.01400; MacDougall CA, 2007, GENE DEV, V21, P898, DOI 10.1101/gad.1522607; Marheineke K, 2004, J BIOL CHEM, V279, P28071, DOI 10.1074/jbc.M401574200; Marheineke K, 2001, J BIOL CHEM, V276, P17092, DOI 10.1074/jbc.M100271200; Marheineke Kathrin, 2009, V521, P575, DOI [10.1007/978-1-60327-817-5_33, 10.1007/978-1-60327-815-7_33]; Marsolier MC, 2000, GENETICS, V154, P1523; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Murphy CM, 2013, J BIOL CHEM, V288, P29382, DOI 10.1074/jbc.M113.499012; NEWPORT J, 1989, J CELL SCI, P149; Oza V, 2012, J MED CHEM, V55, P5130, DOI 10.1021/jm300025r; Peng A, 2007, MOL CELL BIOL, V27, P6852, DOI 10.1128/MCB.00195-07; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Shechter D, 2004, NAT CELL BIOL, V6, P648, DOI 10.1038/ncb1145; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Shirahige K, 1998, NATURE, V395, P618, DOI 10.1038/27007; Sive Hazel L, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4737; Smits VAJ, 2006, CURR BIOL, V16, P150, DOI 10.1016/j.cub.2005.11.066; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Taricani L, 2009, CELL CYCLE, V8, P482, DOI 10.4161/cc.8.3.7661; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Trenz K, 2008, EMBO J, V27, P876, DOI 10.1038/emboj.2008.29; Verlinden L, 2007, CANCER RES, V67, P6574, DOI 10.1158/0008-5472.CAN-06-3545; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yekezare M, 2013, J CELL SCI, V126, P1297, DOI 10.1242/jcs.096701; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	63	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129090	10.1371/journal.pone.0129090	http://dx.doi.org/10.1371/journal.pone.0129090			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26046346	gold, Green Published, Green Submitted			2022-12-26	WOS:000355652200123
J	Zhbanov, A; Yang, S				Zhbanov, Alexander; Yang, Sung			Effects of Aggregation on Blood Sedimentation and Conductivity	PLOS ONE			English	Article							ERYTHROCYTE SEDIMENTATION; HEMATOCRIT; FLOW; TEMPERATURE; RESISTIVITY; SUSPENSIONS; MECHANISM; VISCOSITY; IMPEDANCE; BEDS	The erythrocyte sedimentation rate (ESR) test has been used for over a century. The Westergren method is routinely used in a variety of clinics. However, the mechanism of erythrocyte sedimentation remains unclear, and the 60 min required for the test seems excessive. We investigated the effects of cell aggregation during blood sedimentation and electrical conductivity at different hematocrits. A sample of blood was drop cast into a small chamber with two planar electrodes placed on the bottom. The measured blood conductivity increased slightly during the first minute and decreased thereafter. We explored various methods of enhancing or retarding the erythrocyte aggregation. Using experimental measurements and theoretical calculations, we show that the initial increase in blood conductivity was indeed caused by aggregation, while the subsequent decrease in conductivity resulted from the deposition of erythrocytes. We present a method for calculating blood conductivity based on effective medium theory. Erythrocytes are modeled as conducting spheroids surrounded by a thin insulating membrane. A digital camera was used to investigate the erythrocyte sedimentation behavior and the distribution of the cell volume fraction in a capillary tube. Experimental observations and theoretical estimations of the settling velocity are provided. We experimentally demonstrate that the disaggregated cells settle much slower than the aggregated cells. We show that our method of measuring the electrical conductivity credibly reflected the ESR. The method was very sensitive to the initial stage of aggregation and sedimentation, while the sedimentation curve for the Westergren ESR test has a very mild slope in the initial time. We tested our method for rapid estimation of the Westergren ESR. We show a correlation between our method of measuring changes in blood conductivity and standard Westergren ESR method. In the future, our method could be examined as a potential means of accelerating ESR tests in clinical practice.	[Zhbanov, Alexander; Yang, Sung] Gwangju Inst Sci & Technol, Dept Med Syst Engn, Gwangju, South Korea; [Yang, Sung] Gwangju Inst Sci & Technol, Sch Mechatron, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST)	Yang, S (corresponding author), Gwangju Inst Sci & Technol, Dept Med Syst Engn, Gwangju, South Korea.	syang@gist.ac.kr	Zhbanov, Alexander/AAC-7537-2022	Zhbanov, Alexander/0000-0003-2336-5494	Ministry of Education, Science and Technology (MEST) [KRF-20110028861]; institute of Medical System Engineering (iMSE) at the Gwangju Institute of Science and Technology (GIST), Republic of Korea	Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); institute of Medical System Engineering (iMSE) at the Gwangju Institute of Science and Technology (GIST), Republic of Korea	This work was funded by grants from the Ministry of Education, Science and Technology (MEST, KRF-20110028861) and the institute of Medical System Engineering (iMSE) at the Gwangju Institute of Science and Technology (GIST), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexy T, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3212564; An R, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4867557; Antonova N, 2010, CLIN HEMORHEOL MICRO, V45, P253, DOI 10.3233/CH-2010-1310; Antonova N, 2010, IFMBE P SERIES, V29, P647; Asami K, 2002, PROG POLYM SCI, V27, P1617, DOI 10.1016/S0079-6700(02)00015-1; Asami K, 2007, J PHYS D APPL PHYS, V40, P2197, DOI 10.1088/0022-3727/40/7/051; Bruggeman DAG, 1935, ANN PHYS-BERLIN, V24, P636, DOI 10.1002/andp.19354160705; CHA K, 1994, PHYSIOL MEAS, V15, P499, DOI 10.1088/0967-3334/15/4/011; DIFELICE R, 1995, CHEM ENG SCI, V50, P1213, DOI 10.1016/0009-2509(95)98838-6; Elad D, 2003, STANDARD HDB BIOMEDI; Elsner R, 2004, MAR MAMMAL SCI, V20, P339, DOI 10.1111/j.1748-7692.2004.tb01163.x; FABRY TL, 1987, BLOOD, V70, P1572; Fahraeus R, 1918, BIOCHEM Z, V89, P355; GEDDES LA, 1976, MED BIOL ENG, V14, P180, DOI 10.1007/BF02478745; Giordano S, 2003, J ELECTROSTAT, V58, P59, DOI 10.1016/S0304-3886(02)00199-7; Giordano S, 2008, EUR PHYS J B, V66, P29, DOI 10.1140/epjb/e2008-00382-7; Grzybowski A, 2011, J RHEUMATOL, V38, P1521, DOI 10.3899/jrheum.101312; Hawkins BG, 2011, ANAL CHEM, V83, P3507, DOI 10.1021/ac2002017; HILL DW, 1975, MED BIOL ENG, V13, P182, DOI 10.1007/BF02477725; HIRSCH FG, 1950, BLOOD, V5, P1017, DOI 10.1182/blood.V5.11.1017.1017; IDONUMA A, 1994, JPN J APPL PHYS 1, V33, P2128, DOI 10.1143/JJAP.33.2128; Jou JM, 2011, INT J LAB HEMATOL, V33, P125, DOI 10.1111/j.1751-553X.2011.01302.x; Kaliviotis E, 2010, CLIN HEMORHEOL MICRO, V44, P43, DOI 10.3233/CH-2009-1251; KENNER T, 1989, BASIC RES CARDIOL, V84, P111, DOI 10.1007/BF01907921; KERNICK D, 1974, CAN J PHYSIOL PHARM, V52, P1167, DOI 10.1139/y74-152; Kesmarky G, 2008, CLIN HEMORHEOL MICRO, V39, P243, DOI 10.3233/CH-2008-1088; Kim M, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4871706; Kim M, 2012, BIOSENS BIOELECTRON, V35, P416, DOI 10.1016/j.bios.2012.02.010; Leonard KM, 2011, ELECTROPHORESIS, V32, P2512, DOI 10.1002/elps.201100077; Loth E, 2008, POWDER TECHNOL, V182, P342, DOI 10.1016/j.powtec.2007.06.001; MOHAPATRA SN, 1975, EUR J INTEN CARE MED, V1, P153, DOI 10.1007/BF00624433; Neu B, 2008, BIOPHYS J, V95, P3059, DOI 10.1529/biophysj.108.130328; Nguyen NQ, 2005, J FLUID MECH, V525, P73, DOI 10.1017/S0022112004002563; OKA S, 1985, BIORHEOLOGY, V22, P315; Pribush A, 2011, INT J LAB HEMATOL, V33, P251, DOI 10.1111/j.1751-553X.2010.01277.x; Pribush A, 2010, COLLOID SURFACE B, V75, P224, DOI 10.1016/j.colsurfb.2009.08.037; Pribush A, 2010, COLLOID SURFACE B, V75, P214, DOI 10.1016/j.colsurfb.2009.08.036; Pribush A, 2011, COLLOID SURFACE B, V82, P518, DOI 10.1016/j.colsurfb.2010.10.010; PUCCINI C, 1977, BIORHEOLOGY, V14, P43; Richardson J.F., 1954, T I CHEM ENG-LOND, V32, P35, DOI DOI 10.1016/S0263-8762(97)80006-8; SANDBERG K, 1981, PEDIATR RES, V15, P964, DOI 10.1203/00006450-198106000-00017; SCHMIDSCHONBEIN H, 1973, RES EXP MED, V161, P58, DOI 10.1007/BF01851023; Schwan H., 1948, COLLOID POLYM SCI, V111, P53; Sethu P, 2006, LAB CHIP, V6, P83, DOI 10.1039/b512049g; Shteinshnaider M, 2010, EUR J INTERN MED, V21, P226, DOI 10.1016/j.ejim.2010.02.002; Thelen TV, 1997, CHEM ENG SCI, V52, P3333, DOI 10.1016/S0009-2509(97)00149-8; VISSER KR, 1992, MED BIOL ENG COMPUT, V30, P636, DOI 10.1007/BF02446796; Vykoukal DM, 2009, INTEGR BIOL-UK, V1, P477, DOI 10.1039/b906137a; Westergren A., 1921, ACTA MED SCAND, V54, P247, DOI DOI 10.1111/J.0954-6820.1921.TB15179.X; YAGUPSKY P, 1987, PEDIATR INFECT DIS J, V6, P494; Yang JZ, 2003, CHEM ENG J, V92, P7, DOI 10.1016/S1385-8947(02)00084-0; ZHAO TX, 1993, BIOCHIM BIOPHYS ACTA, V1153, P243, DOI 10.1016/0005-2736(93)90411-R; Zhbanov A, 2012, 6 INT C QUANT NAN MI, P18	54	48	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 5	2015	10	6							e0129337	10.1371/journal.pone.0129337	http://dx.doi.org/10.1371/journal.pone.0129337			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CJ7CR	26047511	Green Published, Green Submitted, gold			2022-12-26	WOS:000355652200152
